data_2jzk_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2jzk _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' SER . . . . . 0.539 ' HG ' ' HA ' ' A' ' 91' ' ' ASN . 9.2 m . . . . . 0 N--CA 1.449 -0.485 0 N-CA-C 110.426 -0.213 . . . . 0.0 110.426 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 18.6 p90 -51.73 -34.18 37.98 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 123.448 0.468 . . . . 0.0 111.519 179.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -56.3 -18.8 11.77 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 -178.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -58.02 -32.91 68.4 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 121.261 0.553 . . . . 0.0 110.093 178.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 33.5 m -137.44 37.94 2.47 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.338 178.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.438 ' HA ' ' O ' ' A' ' 22' ' ' GLU . 20.3 t -147.23 147.97 30.99 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.271 -179.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 9.7 ptp180 -140.58 169.75 17.07 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.086 -179.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 65.7 m-80 57.39 52.32 8.8 Favored 'General case' 0 N--CA 1.465 0.296 0 O-C-N 123.93 0.769 . . . . 0.0 111.53 -179.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -82.47 118.12 23.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.465 179.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 27.0 m -121.55 170.8 11.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.67 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.594 HD22 ' HG ' ' A' ' 64' ' ' LEU . 3.3 mm? -105.14 114.57 28.85 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.118 -179.546 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.496 HG23 ' NE ' ' A' ' 20' ' ' ARG . 35.3 p -111.79 170.37 8.19 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.978 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 59.49 46.25 12.48 Favored 'General case' 0 CA--C 1.521 -0.137 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.289 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 86.01 -34.92 3.32 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 121.007 -0.616 . . . . 0.0 112.134 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.481 ' O ' HG22 ' A' ' 62' ' ' ILE . . . 136.2 38.02 0.17 Allowed Glycine 0 N--CA 1.447 -0.583 0 N-CA-C 111.437 -0.665 . . . . 0.0 111.437 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.646 ' HB2' ' HB2' ' A' ' 38' ' ' ASP . 3.3 ptp180 -125.23 -12.91 6.81 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.256 0.55 . . . . 0.0 110.98 -179.389 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.5 m -115.21 137.74 51.69 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.429 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.799 HD13 HD12 ' A' ' 90' ' ' LEU . 59.6 mt -96.13 118.66 33.16 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.734 179.565 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.496 ' NE ' HG23 ' A' ' 13' ' ' THR . 34.5 ttm180 -113.84 120.98 42.61 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 178.262 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.403 ' O ' ' HA ' ' A' ' 32' ' ' THR . . . -152.72 167.32 29.37 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.827 0.346 . . . . 0.0 111.532 -179.122 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.438 ' O ' ' HA ' ' A' ' 7' ' ' SER . 39.4 mt-10 -89.68 105.95 18.14 Favored 'General case' 0 CA--C 1.512 -0.516 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 178.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.53 ' SG ' HD11 ' A' ' 100' ' ' LEU . 56.0 m -96.23 119.22 34.33 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 -179.276 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.478 ' HB2' ' CZ3' ' A' ' 30' ' ' TRP . 45.9 ttp180 -72.85 111.28 7.83 Favored 'General case' 0 N--CA 1.437 -1.113 0 N-CA-C 110.197 -0.297 . . . . 0.0 110.197 179.386 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 31.9 p30 -81.18 168.9 18.03 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.669 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -51.54 -32.01 26.39 Favored 'General case' 0 N--CA 1.465 0.284 0 O-C-N 123.643 0.59 . . . . 0.0 112.096 -179.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -67.65 -14.12 62.67 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.404 0.621 . . . . 0.0 110.94 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 89.15 22.07 39.49 Favored Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.772 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.409 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 2.3 m-80 -111.77 150.38 30.37 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.838 0.351 . . . . 0.0 111.449 -179.101 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.478 ' CZ3' ' HB2' ' A' ' 24' ' ' ARG . 97.3 m95 -91.63 109.3 20.6 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.201 179.242 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.9 m -109.87 129.42 64.83 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 CA-C-O 120.965 0.412 . . . . 0.0 110.232 178.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.403 ' HA ' ' O ' ' A' ' 21' ' ' ALA . 27.7 m -78.98 113.16 16.87 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.854 -179.372 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 68.7 m -121.19 157.26 30.6 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.403 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.668 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 51.3 mt-10 -131.78 132.35 43.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.763 -179.583 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.455 ' HB2' HD21 ' A' ' 100' ' ' LEU . 1.9 tm? -124.91 132.63 53.27 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.571 -0.899 . . . . 0.0 108.571 178.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.444 ' N ' HD13 ' A' ' 35' ' ' LEU . 12.9 m-20 -91.45 109.95 21.25 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.76 0.314 . . . . 0.0 110.512 -179.113 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.437 HD21 ' CD1' ' A' ' 93' ' ' ILE . 0.9 OUTLIER -83.47 -15.99 47.43 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.296 -179.521 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.745 ' OD2' ' HA ' ' A' ' 54' ' ' ASN . 8.5 t70 -63.17 -8.48 8.11 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.071 0.462 . . . . 0.0 110.969 -179.297 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 73.0 p -87.14 -22.37 25.39 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.49 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 29.0 m -125.56 -5.04 7.1 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -178.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 56.7 mt -113.72 136.16 51.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.66 0.267 . . . . 0.0 110.407 179.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -146.65 157.35 27.37 Favored Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.86 -0.686 . . . . 0.0 111.855 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 21.8 p30 -159.53 46.28 0.21 Allowed Pre-proline 0 CA--C 1.539 0.534 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -70.84 -19.16 31.31 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 122.182 1.922 . . . . 0.0 112.012 -178.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -96.53 1.93 51.88 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.912 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.424 ' HA2' ' HB2' ' A' ' 75' ' ' PRO . . . 92.89 8.44 61.88 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.185 -1.007 . . . . 0.0 112.693 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.53 ' HA ' HE22 ' A' ' 86' ' ' GLN . 56.6 m-85 -125.88 134.49 51.59 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.952 0.376 . . . . 0.0 110.716 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.464 HD23 HG21 ' A' ' 88' ' ' ILE . 10.8 mp -88.6 147.26 24.66 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.904 -178.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 172.18 175.32 40.22 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.968 -0.634 . . . . 0.0 111.825 178.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.404 ' CD1' HD13 ' A' ' 88' ' ' ILE . 95.8 m95 -97.72 130.35 44.7 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.952 0.406 . . . . 0.0 110.346 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 147.31 -60.81 0.46 Allowed Glycine 0 N--CA 1.447 -0.593 0 N-CA-C 111.542 -0.623 . . . . 0.0 111.542 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.902 ' HE2' ' HA ' ' A' ' 52' ' ' MET . 1.7 tpt -77.85 171.61 14.71 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 179.09 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -132.19 171.23 13.93 Favored 'General case' 0 C--N 1.32 -0.715 0 O-C-N 121.845 -0.534 . . . . 0.0 110.907 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.745 ' HA ' ' OD2' ' A' ' 38' ' ' ASP . 13.6 m120 65.3 45.7 2.83 Favored 'General case' 0 C--N 1.328 -0.336 0 O-C-N 124.041 0.838 . . . . 0.0 111.77 178.657 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 25.5 p90 -65.65 -30.02 70.67 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.411 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 12.0 m -59.48 -26.81 65.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.297 0.57 . . . . 0.0 110.767 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 75.5 m80 -75.96 -13.59 60.24 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.635 -178.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 27.1 m -131.66 32.23 4.16 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 120.853 0.359 . . . . 0.0 110.978 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 29.2 p -145.58 154.1 41.79 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.611 -0.436 . . . . 0.0 111.328 179.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 68.3 mt-10 -131.47 148.75 52.67 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.368 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 60.29 59.65 2.25 Favored 'General case' 0 C--N 1.331 -0.229 0 O-C-N 123.848 0.718 . . . . 0.0 110.956 178.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.531 HG21 HD22 ' A' ' 71' ' ' LEU . 75.2 mt -83.45 113.83 23.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.116 -179.57 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 35.7 ttmt -149.74 154.73 38.98 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.994 179.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.594 ' HG ' HD22 ' A' ' 12' ' ' LEU . 72.6 mt -82.63 130.65 35.16 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.834 0.35 . . . . 0.0 110.509 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.408 ' C ' ' H ' ' A' ' 67' ' ' GLY . 20.9 tt0 -88.09 -58.52 2.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.634 -178.58 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.505 ' HB2' ' HB2' ' A' ' 69' ' ' ARG . 26.6 mt-10 -80.91 33.78 0.33 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.87 0.366 . . . . 0.0 111.318 -179.556 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.408 ' H ' ' C ' ' A' ' 65' ' ' GLU . . . 67.4 2.14 18.77 Favored Glycine 0 C--N 1.32 -0.342 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.879 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.522 ' HA2' HD13 ' A' ' 64' ' ' LEU . . . 145.37 -14.96 1.85 Allowed Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 120.095 -1.05 . . . . 0.0 112.669 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.505 ' HB2' ' HB2' ' A' ' 66' ' ' GLU . 19.1 mmt180 -79.67 -18.51 51.19 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 30.7 ttpt -149.22 140.24 22.94 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.123 -178.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.542 ' HB2' HD13 ' A' ' 90' ' ' LEU . 9.8 tt -109.49 124.26 50.76 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.306 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 6.6 p -111.41 137.01 49.74 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.232 0.539 . . . . 0.0 111.224 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 21.4 p -161.61 164.08 29.58 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.163 179.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.413 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 28.7 ttt180 -99.88 103.27 21.1 Favored Pre-proline 0 C--N 1.318 -0.78 0 CA-C-N 116.722 -0.217 . . . . 0.0 110.47 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.458 ' HD2' ' HA ' ' A' ' 85' ' ' ARG . 56.6 Cg_endo -70.02 116.03 4.4 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 122.403 2.069 . . . . 0.0 110.002 178.314 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.87 ' HE2' ' HA2' ' A' ' 81' ' ' GLY . 0.0 OUTLIER -119.34 141.61 48.87 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.301 -179.182 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.711 HG21 ' O ' ' A' ' 82' ' ' PHE . 12.2 t -67.57 132.6 47.87 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 179.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 14.0 p -68.58 -14.19 18.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 O-C-N 124.149 0.905 . . . . 0.0 111.128 -179.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -64.54 -28.03 69.37 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.72 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.481 ' HA3' ' CE1' ' A' ' 82' ' ' PHE . . . -155.12 -26.67 0.03 OUTLIER Glycine 0 CA--C 1.518 0.266 0 C-N-CA 120.138 -1.03 . . . . 0.0 113.858 -179.412 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.87 ' HA2' ' HE2' ' A' ' 76' ' ' LYS . . . 102.94 18.64 14.73 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.998 -0.62 . . . . 0.0 111.599 -179.31 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.711 ' O ' HG21 ' A' ' 77' ' ' THR . 18.9 p90 -112.36 145.52 39.93 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 119.274 -0.393 . . . . 0.0 110.053 -178.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.67 ' HB2' ' HA ' ' A' ' 76' ' ' LYS . 0.1 OUTLIER 173.9 -145.34 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.84 0.352 . . . . 0.0 111.62 -179.86 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -128.64 160.3 32.88 Favored 'General case' 0 C--O 1.222 -0.353 0 CA-C-N 115.586 -0.733 . . . . 0.0 109.52 -179.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.458 ' HA ' ' HD2' ' A' ' 75' ' ' PRO . 25.0 ttt180 -89.47 154.97 19.61 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.302 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . 0.53 HE22 ' HA ' ' A' ' 47' ' ' PHE . 1.6 mt-30 -155.31 -169.55 3.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.333 0.587 . . . . 0.0 111.981 -178.581 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -163.08 142.97 8.25 Favored Glycine 0 N--CA 1.445 -0.709 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.771 179.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.464 HG21 HD23 ' A' ' 48' ' ' LEU . 10.9 tt -127.21 132.61 69.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.042 0.449 . . . . 0.0 110.548 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -75.23 141.29 43.55 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 179.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.799 HD12 HD13 ' A' ' 19' ' ' LEU . 63.4 mt -107.3 61.71 0.62 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.691 0.757 . . . . 0.0 110.854 -178.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.539 ' HA ' ' HG ' ' A' ' 2' ' ' SER . 25.0 m-80 -90.89 -0.07 57.63 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.354 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 9.8 mtp180 -96.01 -15.51 22.23 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.995 179.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.437 ' CD1' HD21 ' A' ' 37' ' ' LEU . 28.1 mm -89.88 110.03 21.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 -179.277 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.418 ' NE2' ' HA ' ' A' ' 2' ' ' SER . 23.5 mm-40 -111.17 167.16 10.49 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.425 -178.018 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 21.4 p-10 -126.67 112.42 15.44 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.574 178.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.7 p -111.55 116.66 53.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 120.96 0.409 . . . . 0.0 110.407 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 13.6 m-80 56.32 35.09 25.25 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.762 -178.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 87.02 -10.26 69.13 Favored Glycine 0 N--CA 1.442 -0.906 0 CA-C-N 115.65 -0.705 . . . . 0.0 113.311 179.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -94.11 123.14 37.29 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 117.459 0.63 . . . . 0.0 110.119 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.53 HD11 ' SG ' ' A' ' 23' ' ' CYS . 5.7 tp -79.69 119.21 22.31 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 54.1 t -133.23 145.6 33.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.398 -178.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 26.2 t80 -78.24 129.7 35.39 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 . . . . . 0 C--O 1.25 1.111 0 CA-C-O 117.986 -1.007 . . . . 0.0 110.802 -179.191 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' SER . . . . . 0.449 ' O ' ' HB2' ' A' ' 5' ' ' ASP . 17.1 m . . . . . 0 N--CA 1.452 -0.365 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.421 ' HD1' ' O ' ' A' ' 93' ' ' ILE . 22.2 p90 -57.84 -36.77 72.75 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.083 0.468 . . . . 0.0 110.334 178.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -58.32 -18.71 29.29 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 115.446 -0.797 . . . . 0.0 112.523 -178.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.449 ' HB2' ' O ' ' A' ' 2' ' ' SER . 0.9 OUTLIER -62.41 -26.89 68.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.928 0.394 . . . . 0.0 110.298 179.161 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 27.1 m -134.63 30.08 3.49 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.819 179.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.406 ' HA ' ' HZ3' ' A' ' 30' ' ' TRP . 21.0 m -139.31 155.55 47.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.247 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.548 ' HG2' ' CZ3' ' A' ' 30' ' ' TRP . 2.3 ptp180 -142.1 169.84 16.84 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.869 -179.468 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 53.4 57.8 5.84 Favored 'General case' 0 C--O 1.232 0.179 0 O-C-N 123.769 0.668 . . . . 0.0 111.696 178.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -87.86 121.56 30.43 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.839 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 27.8 m -127.93 172.17 15.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.68 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.693 HD21 ' HG ' ' A' ' 64' ' ' LEU . 3.6 mm? -104.55 118.65 37.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.454 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 19.6 p -117.52 166.53 12.26 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.948 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 62.46 26.99 16.07 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.479 179.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 101.81 -22.68 37.49 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.485 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 124.51 21.49 2.21 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.703 -0.76 . . . . 0.0 111.981 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 11.5 ptm180 -106.41 -21.61 13.04 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.102 0.477 . . . . 0.0 110.031 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 3.6 m -111.89 136.11 51.64 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.953 -178.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.822 HD11 HD13 ' A' ' 90' ' ' LEU . 26.9 mt -96.95 117.06 30.31 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.18 179.08 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 24.5 ttm180 -109.9 121.01 44.25 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -152.58 166.62 31.5 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.645 -179.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -91.22 108.83 20.14 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 107.605 -1.258 . . . . 0.0 107.605 178.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.423 ' SG ' HD11 ' A' ' 100' ' ' LEU . 65.8 m -95.34 124.54 39.43 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 -179.065 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.484 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 38.4 ttt180 -76.11 112.34 12.46 Favored 'General case' 0 N--CA 1.439 -0.982 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 179.469 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 35.9 p30 -73.54 167.64 20.91 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.619 -179.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.06 -27.73 67.2 Favored 'General case' 0 C--N 1.33 -0.245 0 O-C-N 123.557 0.536 . . . . 0.0 111.507 -178.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -68.46 -18.21 64.36 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.22 0.533 . . . . 0.0 109.991 179.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 94.63 33.16 6.88 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.857 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.484 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 7.2 t-20 -123.92 164.38 19.41 Favored 'General case' 0 C--N 1.323 -0.571 0 O-C-N 122.773 -0.251 . . . . 0.0 110.734 -178.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.548 ' CZ3' ' HG2' ' A' ' 8' ' ' ARG . 98.4 m95 -100.51 120.41 39.97 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.385 -179.616 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 6.7 m -122.78 139.5 49.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.889 179.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 13.5 m -79.48 114.08 18.13 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.793 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 68.3 m -124.6 146.08 49.26 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.764 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.596 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 50.7 mt-10 -131.5 135.22 46.9 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.1 -179.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.519 ' HB2' HD21 ' A' ' 100' ' ' LEU . 1.6 tm? -130.08 131.67 45.85 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.166 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.447 ' N ' HD12 ' A' ' 35' ' ' LEU . 18.1 m-20 -87.11 110.23 19.97 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.842 0.353 . . . . 0.0 110.221 179.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.545 HD11 ' HG ' ' A' ' 19' ' ' LEU . 2.1 mt -86.54 -18.04 32.53 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.981 -179.479 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.417 ' HA ' ' HD1' ' A' ' 55' ' ' PHE . 0.5 OUTLIER -66.12 -13.91 60.91 Favored 'General case' 0 C--O 1.222 -0.357 0 C-N-CA 120.525 -0.47 . . . . 0.0 111.949 -177.72 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.406 HG23 ' HG ' ' A' ' 40' ' ' CYS . 14.6 t -87.0 -4.38 59.17 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.135 0.493 . . . . 0.0 110.233 179.42 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.406 ' HG ' HG23 ' A' ' 39' ' ' THR . 56.5 m -127.26 -22.73 3.67 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 120.872 0.367 . . . . 0.0 111.508 -179.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 65.3 mt -102.57 138.81 25.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 110.235 -0.283 . . . . 0.0 110.235 179.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -149.23 158.79 27.8 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.892 -0.67 . . . . 0.0 111.605 179.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.703 ' ND2' ' HB2' ' A' ' 55' ' ' PHE . 8.2 p30 -162.42 47.78 0.21 Allowed Pre-proline 0 CA--C 1.534 0.353 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -67.54 -21.73 45.72 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 121.501 1.467 . . . . 0.0 111.413 -179.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -84.53 -16.7 41.4 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.144 179.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.567 ' CA ' ' HG2' ' A' ' 83' ' ' ARG . . . 108.41 8.8 28.36 Favored Glycine 0 N--CA 1.442 -0.933 0 C-N-CA 120.341 -0.933 . . . . 0.0 113.374 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -125.73 134.88 51.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 117.1 0.45 . . . . 0.0 111.043 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 91.2 mt -83.33 131.8 35.05 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.889 -178.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -175.34 170.2 43.19 Favored Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.842 178.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 84.8 m95 -95.63 135.02 37.85 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 179.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 137.09 16.22 0.76 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.375 -0.917 . . . . 0.0 113.527 179.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 1.1 ttt -155.8 -165.79 2.05 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -147.3 167.88 23.15 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.307 -0.557 . . . . 0.0 111.718 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 67.14 41.67 2.53 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.061 -0.972 . . . . 0.0 112.254 178.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.703 ' HB2' ' ND2' ' A' ' 43' ' ' ASN . 3.2 p90 -70.15 -25.12 63.31 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.737 0.303 . . . . 0.0 111.07 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 44.9 t -60.76 -41.21 95.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.443 -178.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 8.5 m-70 -70.62 -14.85 62.64 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.459 -178.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.407 ' HA ' ' HD2' ' A' ' 76' ' ' LYS . 20.1 m -113.48 18.99 17.27 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 111.777 0.288 . . . . 0.0 111.777 -179.229 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 61.2 m -138.97 153.74 48.21 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 121.448 -0.783 . . . . 0.0 112.46 -179.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -118.83 142.76 47.43 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.343 179.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 56.25 77.12 0.26 Allowed 'General case' 0 N--CA 1.466 0.354 0 O-C-N 123.666 0.604 . . . . 0.0 112.127 178.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.497 HG21 HD23 ' A' ' 71' ' ' LEU . 88.2 mt -92.31 112.63 26.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 121.041 0.448 . . . . 0.0 110.278 179.515 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 34.3 ttmt -149.23 153.99 38.42 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.344 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.693 ' HG ' HD21 ' A' ' 12' ' ' LEU . 42.1 mt -81.91 126.44 31.92 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.462 0.649 . . . . 0.0 111.067 -179.046 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.478 ' HB2' ' CG2' ' A' ' 72' ' ' THR . 39.4 tt0 -74.52 -52.32 12.24 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 114.925 -1.034 . . . . 0.0 111.201 -179.151 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.486 ' HB2' ' HB2' ' A' ' 69' ' ' ARG . 21.0 mm-40 -89.37 0.91 56.48 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.003 179.671 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 77.09 32.36 49.15 Favored Glycine 0 N--CA 1.446 -0.692 0 CA-C-N 115.519 -0.764 . . . . 0.0 112.142 -179.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 142.79 -42.75 1.08 Allowed Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.391 -0.909 . . . . 0.0 112.422 179.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.486 ' HB2' ' HB2' ' A' ' 66' ' ' GLU . 13.3 mmt180 -70.02 -30.22 67.47 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.842 0.353 . . . . 0.0 111.117 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 46.2 tttt -144.36 145.97 32.27 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -177.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.528 ' HB2' HD11 ' A' ' 90' ' ' LEU . 10.5 tt -111.68 135.44 52.27 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.382 -0.826 . . . . 0.0 108.969 179.131 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.478 ' CG2' ' HB2' ' A' ' 65' ' ' GLU . 2.6 p -123.53 131.93 53.76 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.037 0.446 . . . . 0.0 111.501 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 26.0 p -158.99 164.46 35.54 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.338 -0.846 . . . . 0.0 108.717 179.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.416 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 31.6 ttt180 -99.76 103.55 22.54 Favored Pre-proline 0 C--N 1.317 -0.806 0 C-N-CA 120.424 -0.51 . . . . 0.0 110.394 179.548 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 85' ' ' ARG . 59.7 Cg_endo -71.31 127.91 13.97 Favored 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 122.543 2.162 . . . . 0.0 110.825 178.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.698 ' HA ' ' HB2' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -120.16 146.61 45.83 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.932 -179.81 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.698 HG23 ' O ' ' A' ' 82' ' ' PHE . 8.9 t -71.94 130.33 40.74 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 177.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 9.8 p -71.44 -8.16 10.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 O-C-N 123.619 0.574 . . . . 0.0 111.425 -178.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -70.71 -24.78 62.71 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.119 0.485 . . . . 0.0 110.612 179.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.543 ' HA3' ' CE2' ' A' ' 82' ' ' PHE . . . -151.58 -30.03 0.04 OUTLIER Glycine 0 CA--C 1.519 0.334 0 C-N-CA 120.623 -0.799 . . . . 0.0 113.015 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 104.54 17.16 15.78 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 121.051 -0.595 . . . . 0.0 112.112 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.698 ' O ' HG23 ' A' ' 77' ' ' THR . 17.2 p90 -112.72 153.71 27.29 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 118.904 -0.57 . . . . 0.0 109.766 -179.037 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.698 ' HB2' ' HA ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 169.3 -150.45 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.105 0.479 . . . . 0.0 112.138 179.481 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -129.29 154.9 46.39 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.355 -0.838 . . . . 0.0 110.428 -177.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.416 ' HA ' ' HA ' ' A' ' 74' ' ' ARG . 36.4 ttt180 -86.27 145.88 26.75 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 18.8 mt-30 -151.96 -171.3 3.89 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.565 -178.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -146.74 149.31 21.44 Favored Glycine 0 N--CA 1.448 -0.506 0 N-CA-C 111.261 -0.736 . . . . 0.0 111.261 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 12.0 tt -131.39 133.23 62.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 117.073 0.437 . . . . 0.0 110.877 -179.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -75.65 137.71 40.89 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.679 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.822 HD13 HD11 ' A' ' 19' ' ' LEU . 47.4 mt -101.52 40.23 1.33 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.48 0.657 . . . . 0.0 110.287 -179.513 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.478 ' N ' HD21 ' A' ' 91' ' ' ASN . 0.9 OUTLIER -74.12 0.04 15.11 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.657 -179.486 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 18.3 mtp180 -96.57 -12.63 23.74 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.926 179.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.421 ' O ' ' HD1' ' A' ' 3' ' ' TYR . 23.0 mm -99.02 114.65 37.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 -179.214 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 20.6 mt-30 -132.33 156.53 46.42 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.136 0.493 . . . . 0.0 111.712 -178.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.407 ' HA ' ' O ' ' A' ' 99' ' ' ARG . 20.4 p-10 -104.58 131.92 51.42 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.499 179.367 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 40.9 t -115.18 111.61 36.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 179.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 28.4 m-80 58.06 19.49 6.05 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.866 -179.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 117.46 -28.35 7.19 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.681 -0.771 . . . . 0.0 113.92 178.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.407 ' O ' ' HA ' ' A' ' 95' ' ' ASN . 0.2 OUTLIER -87.11 142.23 28.08 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 117.277 0.538 . . . . 0.0 110.991 -178.916 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.519 HD21 ' HB2' ' A' ' 35' ' ' LEU . 8.6 tp -87.74 125.78 34.62 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 24.6 t -131.36 140.35 48.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.014 -178.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.451 ' HB2' HD13 ' A' ' 35' ' ' LEU . 13.6 t80 -82.04 131.38 35.24 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 177.58 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 . . . . . 0 C--N 1.312 -1.024 0 CA-C-O 118.906 -0.568 . . . . 0.0 111.241 -179.259 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 38.0 m . . . . . 0 N--CA 1.449 -0.483 0 CA-C-O 120.364 0.126 . . . . 0.0 110.996 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.477 ' HH ' ' HA2' ' A' ' 68' ' ' GLY . 9.3 p90 -54.23 -34.59 61.01 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.833 0.349 . . . . 0.0 110.867 178.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.576 ' HB1' ' HD2' ' A' ' 69' ' ' ARG . . . -57.27 -19.23 20.42 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.437 -179.029 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -70.75 -18.41 62.78 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.071 0.462 . . . . 0.0 110.867 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 41.6 m -140.67 33.8 1.81 Allowed 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 178.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 10.3 t -146.24 157.86 43.84 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.231 -179.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.413 ' HG2' ' CZ3' ' A' ' 30' ' ' TRP . 2.1 ptp180 -137.44 158.42 44.45 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.663 -0.244 . . . . 0.0 110.981 -179.748 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 57.54 61.62 2.41 Favored 'General case' 0 C--O 1.233 0.229 0 O-C-N 123.967 0.792 . . . . 0.0 111.127 178.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.527 ' HA ' ' HB1' ' A' ' 21' ' ' ALA . . . -89.83 118.52 29.48 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.917 -179.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 30.0 m -123.07 170.56 13.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.612 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.544 HD22 ' HG ' ' A' ' 64' ' ' LEU . 3.8 mm? -105.36 122.4 45.88 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.145 -179.57 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.411 ' OG1' ' HB ' ' A' ' 18' ' ' THR . 33.5 p -116.0 162.14 17.81 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.69 0.281 . . . . 0.0 110.892 179.543 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 63.51 29.29 15.38 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.904 -0.589 . . . . 0.0 112.078 179.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 97.09 -15.79 61.93 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.502 179.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 122.09 20.85 2.97 Favored Glycine 0 CA--C 1.507 -0.417 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.36 179.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 4.1 ptm180 -103.98 -22.64 13.44 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.029 0.442 . . . . 0.0 110.54 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.411 ' HB ' ' OG1' ' A' ' 13' ' ' THR . 5.5 m -113.48 137.89 50.89 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.893 -178.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.646 ' O ' ' HA ' ' A' ' 34' ' ' GLU . 83.8 mt -100.41 120.32 39.79 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.438 179.129 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 56.2 ttp180 -118.27 120.25 37.1 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.586 -0.446 . . . . 0.0 109.876 178.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.527 ' HB1' ' HA ' ' A' ' 10' ' ' ALA . . . -154.48 167.58 29.56 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.383 -179.416 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -89.43 105.96 18.14 Favored 'General case' 0 CA--C 1.51 -0.569 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 177.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 69.3 m -96.46 136.29 37.16 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 120.727 0.299 . . . . 0.0 110.625 -178.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.546 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 16.2 ttp180 -76.94 119.31 20.51 Favored 'General case' 0 N--CA 1.44 -0.934 0 CA-C-N 116.196 -0.457 . . . . 0.0 109.835 179.336 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 37.4 p30 -80.32 174.55 11.49 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.153 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.27 -30.87 63.03 Favored 'General case' 0 C--O 1.235 0.303 0 O-C-N 123.649 0.593 . . . . 0.0 112.516 -178.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -77.4 -10.51 59.5 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.319 0.58 . . . . 0.0 110.135 -179.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 89.82 29.36 15.96 Favored Glycine 0 N--CA 1.447 -0.597 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.472 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.546 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 4.8 t-20 -110.64 164.02 13.16 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 121.086 -0.246 . . . . 0.0 111.129 -178.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.413 ' CZ3' ' HG2' ' A' ' 8' ' ' ARG . 82.4 m95 -97.62 119.44 36.2 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.011 0.434 . . . . 0.0 111.954 -179.388 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 5.8 m -124.39 135.03 65.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.938 178.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 62.0 m -81.3 111.02 17.3 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.926 0.393 . . . . 0.0 110.506 -179.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 70.5 m -120.5 155.84 32.75 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.481 -179.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.646 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 41.6 mt-10 -135.12 142.65 46.25 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.564 179.319 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.495 HD13 ' HB2' ' A' ' 102' ' ' PHE . 1.4 tm? -138.92 131.39 28.68 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.304 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.442 ' N ' HD12 ' A' ' 35' ' ' LEU . 22.1 m-20 -89.83 110.89 21.79 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.425 HD13 ' HG ' ' A' ' 19' ' ' LEU . 1.1 mt -86.62 -19.42 29.35 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.659 -178.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.422 ' HA ' ' HD1' ' A' ' 55' ' ' PHE . 3.2 p-10 -68.45 -8.68 42.97 Favored 'General case' 0 C--O 1.221 -0.398 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -178.006 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.427 HG21 ' O ' ' A' ' 36' ' ' ASP . 13.7 t -87.27 -1.72 58.11 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 179.107 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 75.2 m -135.33 -23.32 1.47 Allowed 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 116.176 -0.465 . . . . 0.0 112.02 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 55.1 mt -96.91 145.03 9.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 O-C-N 122.222 -0.299 . . . . 0.0 110.476 -179.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -153.1 158.39 27.9 Favored Glycine 0 N--CA 1.447 -0.569 0 N-CA-C 111.277 -0.729 . . . . 0.0 111.277 179.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -159.91 53.91 0.58 Allowed Pre-proline 0 CA--C 1.538 0.511 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -179.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -71.54 -16.93 30.45 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 121.942 1.762 . . . . 0.0 112.216 -179.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -102.61 13.65 33.95 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.092 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.485 ' CA ' ' HG2' ' A' ' 83' ' ' ARG . . . 79.47 12.56 83.64 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.463 -0.875 . . . . 0.0 112.961 179.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.759 ' HA ' HE22 ' A' ' 86' ' ' GLN . 37.9 m-85 -125.31 130.74 52.59 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.879 0.371 . . . . 0.0 110.303 179.718 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 87.6 mt -84.33 132.51 34.6 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.745 -178.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -171.95 170.49 43.45 Favored Glycine 0 N--CA 1.443 -0.837 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.139 179.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 87.4 m95 -96.22 131.51 42.62 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 141.56 17.72 0.34 Allowed Glycine 0 CA--C 1.519 0.333 0 C-N-CA 120.46 -0.876 . . . . 0.0 113.821 179.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 5.3 ttt -153.57 -156.05 0.65 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 117.366 0.583 . . . . 0.0 109.801 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.404 ' HA ' ' O ' ' A' ' 38' ' ' ASP . 27.6 pt20 -148.04 167.62 24.49 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.705 0.288 . . . . 0.0 111.137 -179.341 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 35.9 m-80 61.63 44.74 8.69 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.452 -0.794 . . . . 0.0 112.938 178.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.422 ' HD1' ' HA ' ' A' ' 38' ' ' ASP . 1.2 p90 -71.01 -26.81 63.29 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.523 -0.471 . . . . 0.0 110.73 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.508 ' HA ' HD12 ' A' ' 62' ' ' ILE . 79.6 p -72.94 -29.35 63.04 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.035 0.445 . . . . 0.0 110.504 -179.413 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 41.8 m80 -82.81 -9.25 59.42 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.398 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.3 p -114.89 6.94 15.56 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.961 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 72.0 m -130.21 153.29 48.73 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.128 0.49 . . . . 0.0 110.745 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 86.7 mt-10 -119.09 134.67 55.06 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.403 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.5 t70 58.53 82.89 0.13 Allowed 'General case' 0 N--CA 1.465 0.317 0 O-C-N 123.938 0.774 . . . . 0.0 111.507 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.508 HD12 ' HA ' ' A' ' 56' ' ' SER . 72.0 mt -95.31 124.54 47.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.108 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.9 tptm -149.84 149.54 30.63 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.544 ' HG ' HD22 ' A' ' 12' ' ' LEU . 52.2 mt -83.39 135.94 34.52 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.823 0.344 . . . . 0.0 110.98 -179.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.407 ' C ' ' H ' ' A' ' 67' ' ' GLY . 34.4 tt0 -91.82 -59.03 2.22 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.958 -179.643 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.421 ' CB ' ' HB2' ' A' ' 69' ' ' ARG . 20.2 mm-40 -82.03 27.03 0.49 Allowed 'General case' 0 CA--C 1.516 -0.348 0 CA-C-O 121.106 0.479 . . . . 0.0 111.507 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.407 ' H ' ' C ' ' A' ' 65' ' ' GLU . . . 62.84 16.65 56.98 Favored Glycine 0 N--CA 1.448 -0.507 0 CA-C-N 115.278 -0.874 . . . . 0.0 112.722 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.477 ' HA2' ' HH ' ' A' ' 3' ' ' TYR . . . 144.08 -30.4 1.9 Allowed Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 120.104 -1.046 . . . . 0.0 113.189 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.576 ' HD2' ' HB1' ' A' ' 4' ' ' ALA . 7.2 mpt_? -74.37 -24.12 59.11 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 117.553 0.677 . . . . 0.0 111.12 -179.397 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 33.4 tttp -141.37 139.91 33.61 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.842 -178.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.526 ' HB2' HD11 ' A' ' 90' ' ' LEU . 10.1 tt -112.89 133.82 54.69 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.618 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.9 p -119.46 135.09 54.91 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.902 0.382 . . . . 0.0 111.083 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 25.3 p -162.49 172.23 15.83 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.37 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.557 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 32.2 ttt180 -106.98 99.38 25.9 Favored Pre-proline 0 C--N 1.319 -0.758 0 C-N-CA 120.356 -0.538 . . . . 0.0 110.741 178.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -67.4 123.86 11.35 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 122.784 2.323 . . . . 0.0 110.103 178.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.712 ' HA ' ' HB2' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -120.29 142.97 48.6 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.066 0.46 . . . . 0.0 111.956 -178.914 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.706 HG23 ' O ' ' A' ' 82' ' ' PHE . 14.8 t -75.38 138.69 41.89 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.027 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 11.1 p -76.18 -12.95 14.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.217 -179.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -66.05 -21.9 66.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.11 0.481 . . . . 0.0 111.002 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.699 ' HA3' ' CE2' ' A' ' 82' ' ' PHE . . . -155.63 -21.41 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.29 -0.957 . . . . 0.0 113.105 179.623 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.498 ' HA2' ' CE ' ' A' ' 76' ' ' LYS . . . 95.53 12.57 53.57 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.05 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.706 ' O ' HG23 ' A' ' 77' ' ' THR . 16.7 p90 -112.47 158.61 19.68 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 118.926 -0.559 . . . . 0.0 110.015 -178.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.775 ' HA ' ' HE ' ' A' ' 83' ' ' ARG . 0.0 OUTLIER 168.65 -152.42 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 O-C-N 123.805 0.691 . . . . 0.0 111.656 178.707 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -125.73 155.88 40.27 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.358 -177.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.557 ' HA ' ' HA ' ' A' ' 74' ' ' ARG . 32.2 ttt180 -80.3 155.52 27.23 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 179.476 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . 0.759 HE22 ' HA ' ' A' ' 47' ' ' PHE . 8.8 tt0 -162.45 177.12 9.79 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 120.976 0.417 . . . . 0.0 111.407 -178.054 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.477 ' H ' ' HG2' ' A' ' 86' ' ' GLN . . . -140.2 143.82 14.13 Favored Glycine 0 N--CA 1.445 -0.711 0 N-CA-C 111.456 -0.657 . . . . 0.0 111.456 179.388 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 10.1 tt -124.38 140.69 46.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 109.751 -0.462 . . . . 0.0 109.751 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -82.46 136.47 34.9 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.861 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.596 HD13 HD12 ' A' ' 19' ' ' LEU . 83.2 mt -106.82 44.6 1.04 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.352 0.596 . . . . 0.0 110.861 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 18.5 m-80 -76.97 2.66 14.18 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.751 179.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 18.5 mtp180 -98.82 -15.05 19.4 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.087 -0.96 . . . . 0.0 110.316 179.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.556 HG21 HD13 ' A' ' 19' ' ' LEU . 29.3 mm -98.91 105.13 16.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 121.017 0.436 . . . . 0.0 109.993 -179.315 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -130.85 156.47 44.97 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.007 -179.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 13.1 p-10 -95.71 110.72 22.81 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.127 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 58.8 t -90.87 104.44 15.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 59.89 35.24 21.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.989 -179.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 98.45 -27.27 20.3 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.75 -0.738 . . . . 0.0 113.431 179.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.92 128.82 35.06 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.944 0.372 . . . . 0.0 110.136 -178.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.42 ' HA ' HD11 ' A' ' 100' ' ' LEU . 9.2 tp -75.72 120.33 20.96 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 -179.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 32.2 t -129.61 142.09 44.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.168 -178.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.495 ' HB2' HD13 ' A' ' 35' ' ' LEU . 18.1 t80 -82.28 124.61 30.11 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 177.384 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.421 -0.799 . . . . 0.0 110.877 -179.504 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' SER . . . . . 0.45 ' OG ' ' HA ' ' A' ' 91' ' ' ASN . 9.5 m . . . . . 0 N--CA 1.451 -0.383 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.522 ' HA ' ' OD1' ' A' ' 95' ' ' ASN . 13.2 p90 -58.7 -38.14 77.62 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.524 0.202 . . . . 0.0 111.322 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -57.84 -23.93 55.07 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.357 -0.383 . . . . 0.0 112.023 -179.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -69.97 -16.24 63.16 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.654 0.242 . . . . 0.0 111.654 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 20.8 m -141.22 30.09 1.79 Allowed 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 22.4 t -144.92 158.46 43.8 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 115.509 -0.768 . . . . 0.0 110.103 -179.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 18.3 ptt180 -140.3 165.49 27.27 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.441 -179.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 55.18 54.76 8.37 Favored 'General case' 0 N--CA 1.467 0.378 0 O-C-N 123.829 0.705 . . . . 0.0 111.404 179.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.413 ' HA ' ' HB3' ' A' ' 21' ' ' ALA . . . -81.08 117.32 21.56 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.59 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 33.8 m -122.56 168.86 14.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.686 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.632 HD22 ' HG ' ' A' ' 64' ' ' LEU . 3.9 mm? -105.15 117.08 33.1 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.005 -179.546 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.463 HG21 ' NE ' ' A' ' 20' ' ' ARG . 20.9 p -115.48 165.89 12.49 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.062 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.433 ' O ' ' HG2' ' A' ' 17' ' ' ARG . 93.9 m-20 60.35 31.14 20.31 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.8 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 96.3 -17.96 58.33 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.827 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 122.86 10.15 5.93 Favored Glycine 0 C--O 1.229 -0.197 0 C-N-CA 121.025 -0.607 . . . . 0.0 111.608 -179.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.433 ' HG2' ' O ' ' A' ' 14' ' ' ASN . 5.2 ptm180 -91.26 -24.17 19.94 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.257 0.551 . . . . 0.0 110.337 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 23.2 m -115.49 138.43 51.03 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.869 -178.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.705 HD13 HD12 ' A' ' 90' ' ' LEU . 92.1 mt -97.49 120.92 38.74 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.326 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.463 ' NE ' HG21 ' A' ' 13' ' ' THR . 34.5 ttm180 -114.12 120.46 40.62 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 178.252 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.413 ' HB3' ' HA ' ' A' ' 10' ' ' ALA . . . -153.11 167.71 28.35 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 120.938 0.399 . . . . 0.0 111.168 -178.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -88.9 105.95 18.09 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 178.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.419 ' SG ' ' HB2' ' A' ' 33' ' ' SER . 67.7 m -91.26 129.7 37.22 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.65 -178.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.504 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 24.7 ttp180 -75.69 116.38 16.35 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.521 179.124 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 36.2 p30 -82.16 173.3 12.25 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.177 179.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.18 -30.45 62.26 Favored 'General case' 0 N--CA 1.464 0.268 0 O-C-N 123.361 0.413 . . . . 0.0 112.084 -178.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -72.83 -13.5 61.31 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.662 0.744 . . . . 0.0 109.96 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 88.61 25.55 29.91 Favored Glycine 0 CA--C 1.503 -0.694 0 N-CA-C 110.8 -0.92 . . . . 0.0 110.8 -179.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.504 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 8.7 t-20 -106.6 161.97 14.16 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.575 -0.313 . . . . 0.0 110.323 -178.55 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 87.4 m95 -100.04 122.55 43.1 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.955 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 5.6 m -124.33 136.11 61.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.27 178.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 13.2 m -75.42 109.73 9.2 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.953 0.406 . . . . 0.0 110.958 -179.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.419 ' HB2' ' SG ' ' A' ' 23' ' ' CYS . 69.8 m -124.05 148.0 47.41 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.697 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.634 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 47.9 mt-10 -124.94 150.9 46.13 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.237 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.557 HD11 ' HB2' ' A' ' 102' ' ' PHE . 1.6 tm? -141.84 130.86 23.18 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 178.582 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.447 ' N ' HD13 ' A' ' 35' ' ' LEU . 2.1 p-10 -88.35 109.7 20.19 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.303 0.573 . . . . 0.0 110.605 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.494 HD12 ' HG ' ' A' ' 19' ' ' LEU . 1.0 OUTLIER -86.65 -21.05 26.95 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.965 179.532 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.411 ' HA ' ' HD1' ' A' ' 55' ' ' PHE . 5.1 p-10 -64.03 -13.73 49.02 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -178.445 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 64.1 p -83.63 -11.32 57.44 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 120.89 0.376 . . . . 0.0 110.801 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 35.5 m -130.41 -9.94 4.13 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.231 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.424 HD12 HD11 ' A' ' 88' ' ' ILE . 63.4 mt -113.26 137.05 47.67 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-O 120.682 0.277 . . . . 0.0 110.704 179.479 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -149.45 159.03 27.9 Favored Glycine 0 N--CA 1.446 -0.7 0 C-N-CA 120.967 -0.635 . . . . 0.0 111.581 179.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.433 ' OD1' ' HB2' ' A' ' 58' ' ' SER . 24.8 p30 -157.57 48.31 0.31 Allowed Pre-proline 0 CA--C 1.535 0.367 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -68.74 -22.21 37.53 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 121.829 1.686 . . . . 0.0 112.166 -178.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 70.6 m-20 -91.79 0.44 57.49 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.43 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.519 ' CA ' ' HG2' ' A' ' 83' ' ' ARG . . . 92.48 6.74 64.02 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.669 -0.776 . . . . 0.0 112.236 -179.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -120.78 132.25 54.93 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.938 0.399 . . . . 0.0 110.798 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 14.8 mt -84.31 146.79 27.55 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.399 -178.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 169.35 171.0 34.57 Favored Glycine 0 N--CA 1.442 -0.904 0 C-N-CA 120.254 -0.974 . . . . 0.0 112.64 178.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.413 ' HH2' HD11 ' A' ' 93' ' ' ILE . 90.8 m95 -96.1 126.17 41.14 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 149.82 -43.94 0.73 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.995 -0.621 . . . . 0.0 111.853 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.935 ' HE1' ' HA ' ' A' ' 52' ' ' MET . 0.7 OUTLIER -94.24 -177.04 4.15 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 179.104 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -143.14 170.19 16.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 119.076 0.853 . . . . 0.0 112.215 -178.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 30.0 m-80 66.11 36.68 5.54 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.091 -0.959 . . . . 0.0 112.307 179.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.411 ' HD1' ' HA ' ' A' ' 38' ' ' ASP . 9.1 p90 -62.86 -28.33 69.96 Favored 'General case' 0 C--O 1.221 -0.444 0 CA-C-O 120.651 0.262 . . . . 0.0 110.455 179.442 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 9.5 p -58.68 -34.34 71.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.351 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 26.5 m80 -80.06 -10.05 59.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.553 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.433 ' HB2' ' OD1' ' A' ' 43' ' ' ASN . 16.4 m -123.5 28.98 6.79 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.45 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 45.0 m -137.49 150.31 47.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.062 0.458 . . . . 0.0 111.079 179.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 71.5 mt-10 -129.86 134.01 47.26 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.677 179.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 38.5 t70 61.62 79.73 0.24 Allowed 'General case' 0 N--CA 1.468 0.455 0 O-C-N 123.705 0.628 . . . . 0.0 110.689 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.502 HG22 HD21 ' A' ' 71' ' ' LEU . 64.3 mt -98.67 125.06 52.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.037 -179.25 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.1 tptm -149.21 156.07 41.59 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.016 0.436 . . . . 0.0 111.285 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.632 ' HG ' HD22 ' A' ' 12' ' ' LEU . 83.0 mt -98.99 128.84 45.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.144 179.086 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -93.52 -65.7 0.97 Allowed 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -178.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.494 ' HB2' ' HB2' ' A' ' 69' ' ' ARG . 4.8 mm-40 -76.29 50.28 0.63 Allowed 'General case' 0 CA--C 1.516 -0.33 0 CA-C-O 121.117 0.484 . . . . 0.0 112.192 -178.013 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 59.94 16.35 39.32 Favored Glycine 0 C--N 1.318 -0.44 0 CA-C-N 115.117 -0.947 . . . . 0.0 112.795 179.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.507 ' HA2' HD11 ' A' ' 64' ' ' LEU . . . 121.11 -12.29 9.8 Favored Glycine 0 N--CA 1.442 -0.909 0 C-N-CA 120.394 -0.907 . . . . 0.0 113.241 179.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.494 ' HB2' ' HB2' ' A' ' 66' ' ' GLU . 2.8 mtt85 -77.69 -22.16 50.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 117.525 0.663 . . . . 0.0 110.721 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 33.0 tptt -131.63 127.56 37.27 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.294 -178.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.514 ' HB2' HD13 ' A' ' 90' ' ' LEU . 10.6 tt -110.04 121.2 44.7 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.442 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.4 p -109.66 136.61 48.74 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.176 0.513 . . . . 0.0 110.837 179.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.408 ' HG ' ' CD2' ' A' ' 71' ' ' LEU . 17.7 p -162.87 169.43 19.8 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.102 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.532 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 30.2 ttt180 -103.8 102.45 31.09 Favored Pre-proline 0 C--N 1.313 -0.979 0 C-N-CA 120.095 -0.642 . . . . 0.0 110.609 179.116 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.541 ' HD2' ' HA ' ' A' ' 85' ' ' ARG . 48.0 Cg_endo -67.77 116.15 4.13 Favored 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 122.539 2.159 . . . . 0.0 110.023 178.385 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.676 ' HA ' ' HB2' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -117.86 144.97 44.94 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.088 0.47 . . . . 0.0 111.455 -178.927 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.717 HG22 ' O ' ' A' ' 82' ' ' PHE . 15.3 t -77.86 140.73 39.37 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 179.402 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 32.2 m -74.52 -1.64 3.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 O-C-N 123.989 0.806 . . . . 0.0 111.145 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 -68.4 -32.01 71.76 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.174 0.511 . . . . 0.0 110.144 179.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -160.67 -9.51 0.04 OUTLIER Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.476 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.554 ' HA2' ' CE ' ' A' ' 76' ' ' LYS . . . 90.63 19.71 43.42 Favored Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 120.577 -0.821 . . . . 0.0 111.776 179.627 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.717 ' O ' HG22 ' A' ' 77' ' ' THR . 26.3 p90 -110.93 146.64 36.21 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 119.226 -0.416 . . . . 0.0 110.047 -179.028 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.676 ' HB2' ' HA ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 170.53 -154.92 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.224 0 O-C-N 123.925 0.766 . . . . 0.0 110.433 179.27 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -118.37 173.02 7.06 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.41 -178.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.541 ' HA ' ' HD2' ' A' ' 75' ' ' PRO . 31.3 ttt85 -104.3 153.43 21.03 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 178.244 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . 0.688 ' HG2' ' H ' ' A' ' 87' ' ' GLY . 9.0 tt0 -165.61 -174.65 3.19 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 120.655 0.264 . . . . 0.0 110.698 -178.503 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.688 ' H ' ' HG2' ' A' ' 86' ' ' GLN . . . -141.11 151.9 22.86 Favored Glycine 0 N--CA 1.45 -0.369 0 N-CA-C 111.736 -0.545 . . . . 0.0 111.736 179.181 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.424 HD11 HD12 ' A' ' 41' ' ' ILE . 12.1 tt -125.49 145.6 32.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 120.965 0.412 . . . . 0.0 110.208 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -82.47 121.98 27.45 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.845 -179.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.705 HD12 HD13 ' A' ' 19' ' ' LEU . 59.8 mt -98.59 37.08 1.53 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.558 0.695 . . . . 0.0 110.632 179.476 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.45 ' HA ' ' OG ' ' A' ' 2' ' ' SER . 0.9 OUTLIER -75.27 -0.65 20.32 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 114.949 -1.023 . . . . 0.0 110.381 -179.958 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 20.1 mtp180 -92.09 -14.81 28.66 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.226 -179.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.413 HD11 ' HH2' ' A' ' 50' ' ' TRP . 21.0 mm -92.22 111.7 24.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 -179.445 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 21.9 tp60 -124.71 134.85 52.69 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.283 0.563 . . . . 0.0 111.315 -178.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.522 ' OD1' ' HA ' ' A' ' 3' ' ' TYR . 19.6 p-10 -95.45 119.82 34.62 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.843 178.105 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.3 p -114.95 119.2 61.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.177 0.513 . . . . 0.0 110.602 -179.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 58.54 30.22 19.49 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.002 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 94.87 -15.79 62.65 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.774 -0.727 . . . . 0.0 113.289 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -93.03 123.18 36.1 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 117.555 0.677 . . . . 0.0 110.089 -179.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 16.1 tp -82.57 117.22 22.39 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.8 t -128.6 149.98 33.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.769 0.319 . . . . 0.0 111.088 -179.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.557 ' HB2' HD11 ' A' ' 35' ' ' LEU . 8.5 t80 -89.61 126.0 35.45 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 178.113 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.316 -0.89 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.321 179.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.8 p . . . . . 0 N--CA 1.45 -0.436 0 CA-C-O 120.429 0.157 . . . . 0.0 111.319 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.435 ' HA ' ' OD1' ' A' ' 95' ' ' ASN . 12.8 p90 -58.59 -38.61 78.31 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -179.615 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.578 ' HA ' ' OG ' ' A' ' 7' ' ' SER . . . -55.29 -19.09 7.52 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 -177.371 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -61.71 -37.07 82.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.963 0.411 . . . . 0.0 111.037 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 8.1 t -130.63 45.02 2.88 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 121.295 0.569 . . . . 0.0 109.754 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.578 ' OG ' ' HA ' ' A' ' 4' ' ' ALA . 86.4 p -147.06 165.54 29.6 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.225 179.017 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 11.9 ptm180 -149.24 166.6 28.42 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.661 -179.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 59.44 54.43 4.66 Favored 'General case' 0 C--O 1.234 0.254 0 O-C-N 123.93 0.769 . . . . 0.0 111.136 179.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -86.69 117.36 25.4 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.014 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 34.2 m -124.57 168.49 17.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.786 -179.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.725 HD23 ' HG ' ' A' ' 64' ' ' LEU . 3.5 mm? -105.21 114.9 29.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.121 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 19.2 p -110.06 167.2 10.35 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.166 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 60.64 49.94 6.04 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.778 -0.647 . . . . 0.0 111.449 179.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 83.76 -30.15 3.57 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.348 179.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 130.64 48.09 0.13 Allowed Glycine 0 N--CA 1.446 -0.689 0 N-CA-C 111.133 -0.787 . . . . 0.0 111.133 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 41.7 ptt85 -132.16 -27.07 1.85 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.017 0.436 . . . . 0.0 111.202 -179.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 4.2 m -100.94 133.88 44.76 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.828 -179.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.778 HD12 HD11 ' A' ' 90' ' ' LEU . 70.3 mt -94.17 115.95 28.3 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.275 179.084 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 53.3 ttp180 -114.36 121.28 43.12 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.504 -0.479 . . . . 0.0 109.983 178.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -153.43 166.05 33.89 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.845 0.355 . . . . 0.0 110.662 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -89.95 106.03 18.2 Favored 'General case' 0 CA--C 1.508 -0.643 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 178.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.45 ' SG ' HD12 ' A' ' 100' ' ' LEU . 45.3 m -98.81 132.17 44.37 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 120.876 -0.33 . . . . 0.0 110.191 -178.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.489 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 17.6 ttp85 -74.62 117.19 16.17 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.283 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 36.7 p30 -80.96 168.7 18.41 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.153 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.76 -33.21 55.06 Favored 'General case' 0 C--O 1.235 0.31 0 O-C-N 123.589 0.556 . . . . 0.0 112.118 -178.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -68.64 -17.88 64.18 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.289 0.566 . . . . 0.0 110.549 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 94.61 27.01 12.08 Favored Glycine 0 N--CA 1.446 -0.655 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.382 -179.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.489 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 62.0 t30 -111.09 164.06 13.23 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.547 0.213 . . . . 0.0 111.047 -178.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.406 ' HZ3' ' HA ' ' A' ' 7' ' ' SER . 89.8 m95 -100.36 113.84 26.88 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.534 179.318 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.9 m -116.55 131.03 70.36 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.877 179.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.3 m -74.93 109.22 8.22 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.445 179.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 66.9 m -119.26 146.62 45.09 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.408 -179.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.628 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 49.7 mt-10 -130.78 139.71 50.24 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.899 -179.301 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.486 HD13 HD23 ' A' ' 37' ' ' LEU . 1.4 tm? -132.81 129.12 38.12 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 178.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.451 ' N ' HD11 ' A' ' 35' ' ' LEU . 15.8 m-20 -88.88 108.93 19.81 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.486 HD23 HD13 ' A' ' 35' ' ' LEU . 0.5 OUTLIER -86.72 -9.11 56.66 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.363 -0.381 . . . . 0.0 112.017 -179.56 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -66.16 -14.93 62.64 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -178.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 8.9 t -87.47 0.48 55.48 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.974 0.416 . . . . 0.0 110.609 179.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.534 ' SG ' ' HZ3' ' A' ' 50' ' ' TRP . 1.7 p -140.63 -14.8 0.95 Allowed 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 54.5 mt -111.65 135.98 49.21 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-O 120.733 0.302 . . . . 0.0 110.502 179.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -152.93 158.33 27.84 Favored Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 111.468 -0.653 . . . . 0.0 111.468 179.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.678 ' ND2' ' HB2' ' A' ' 55' ' ' PHE . 3.7 p30 -161.72 52.03 0.37 Allowed Pre-proline 0 C--N 1.327 -0.412 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 179.556 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -78.03 -9.27 16.7 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.298 1.999 . . . . 0.0 111.647 -179.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 35.7 m-80 -99.35 2.04 44.96 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.618 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.458 ' CA ' ' HG2' ' A' ' 83' ' ' ARG . . . 93.33 0.74 67.27 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.402 -0.904 . . . . 0.0 112.093 -179.446 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.459 ' HA ' HE22 ' A' ' 86' ' ' GLN . 65.7 m-85 -125.47 131.37 52.86 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.986 0.422 . . . . 0.0 111.006 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.513 HD21 HG21 ' A' ' 88' ' ' ILE . 9.9 mp -84.58 153.99 22.89 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.479 -179.422 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 168.04 170.6 32.98 Favored Glycine 0 N--CA 1.443 -0.842 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.651 179.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.534 ' HZ3' ' SG ' ' A' ' 40' ' ' CYS . 90.5 m95 -95.86 125.24 40.29 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 149.24 -34.83 1.08 Allowed Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.804 -0.713 . . . . 0.0 112.405 -179.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 12.9 tpt -98.48 174.22 6.56 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 -179.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -128.71 168.97 15.05 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 117.93 0.332 . . . . 0.0 110.97 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 61.31 49.43 5.39 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.438 -0.801 . . . . 0.0 112.455 178.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.678 ' HB2' ' ND2' ' A' ' 43' ' ' ASN . 15.9 p90 -70.08 -25.72 63.66 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.104 179.157 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.476 ' HA ' HD11 ' A' ' 62' ' ' ILE . 10.6 p -60.93 -44.9 96.56 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.262 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 30.5 m80 -79.98 -11.36 59.79 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.999 0.428 . . . . 0.0 110.762 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 20.6 m -101.41 2.33 39.32 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.997 -178.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 62.3 p -144.57 160.82 40.52 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.548 -0.461 . . . . 0.0 111.421 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 59.1 mm-40 -117.23 152.23 35.27 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.966 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 50.22 76.36 0.15 Allowed 'General case' 0 N--CA 1.472 0.644 0 O-C-N 123.994 0.809 . . . . 0.0 111.777 179.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.522 HG22 HD23 ' A' ' 71' ' ' LEU . 83.8 mt -92.61 117.09 35.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.416 -179.334 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 32.1 ttmt -148.94 154.91 40.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.108 -0.497 . . . . 0.0 109.851 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.725 ' HG ' HD23 ' A' ' 12' ' ' LEU . 60.2 mt -83.73 135.95 34.36 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.193 0.52 . . . . 0.0 111.224 -179.616 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -92.17 -66.26 0.94 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.406 -0.815 . . . . 0.0 111.82 -178.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -78.6 40.98 0.39 Allowed 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 120.95 0.405 . . . . 0.0 111.671 -178.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 60.91 17.81 52.06 Favored Glycine 0 C--N 1.32 -0.324 0 CA-C-N 115.653 -0.703 . . . . 0.0 113.113 179.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.458 ' HA2' HD13 ' A' ' 64' ' ' LEU . . . 129.58 -16.06 5.67 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.222 -0.989 . . . . 0.0 112.668 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.466 ' HD2' ' HB2' ' A' ' 4' ' ' ALA . 0.1 OUTLIER -77.5 -19.17 56.26 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.134 0.492 . . . . 0.0 109.783 -179.796 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 65.3 tttt -150.35 144.33 25.43 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.936 -178.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.559 ' HB2' HD12 ' A' ' 90' ' ' LEU . 9.7 tt -112.29 126.66 55.48 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.56 179.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.5 p -114.04 137.71 51.36 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.099 0.476 . . . . 0.0 111.358 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 25.0 p -161.76 175.85 11.53 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.607 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.479 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 44.7 ttt180 -107.91 99.54 30.98 Favored Pre-proline 0 C--N 1.317 -0.833 0 N-CA-C 110.154 -0.313 . . . . 0.0 110.154 179.377 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.556 ' HD2' ' HA ' ' A' ' 85' ' ' ARG . 56.1 Cg_endo -67.06 122.91 10.29 Favored 'Trans proline' 0 CA--C 1.513 -0.564 0 C-N-CA 123.129 2.553 . . . . 0.0 111.332 -179.667 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.676 ' HA ' ' HB2' ' A' ' 83' ' ' ARG . 0.2 OUTLIER -120.13 147.03 45.39 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 120.947 0.403 . . . . 0.0 111.191 -179.85 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.721 HG22 ' O ' ' A' ' 82' ' ' PHE . 10.3 t -74.21 130.22 39.33 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 178.55 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.1 m -72.18 -3.39 3.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 O-C-N 123.629 0.581 . . . . 0.0 111.204 -179.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -70.52 -34.54 72.42 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.789 178.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.409 ' HA3' ' CE1' ' A' ' 82' ' ' PHE . . . -144.51 -24.72 0.13 Allowed Glycine 0 CA--C 1.521 0.441 0 C-N-CA 120.73 -0.747 . . . . 0.0 113.285 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 102.65 14.79 26.48 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 121.022 -0.609 . . . . 0.0 112.277 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.721 ' O ' HG22 ' A' ' 77' ' ' THR . 29.4 p90 -112.85 157.9 20.82 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 118.372 -0.823 . . . . 0.0 110.105 -179.206 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.817 ' HA ' ' HE ' ' A' ' 83' ' ' ARG . 0.0 OUTLIER 163.44 -154.03 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.75 0 O-C-N 123.932 0.77 . . . . 0.0 112.381 178.528 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 47.8 mm-40 -109.14 -173.96 2.39 Favored 'General case' 0 C--O 1.226 -0.161 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.468 -178.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.556 ' HA ' ' HD2' ' A' ' 75' ' ' PRO . 61.5 ttt180 -113.75 156.03 24.56 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 177.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . 0.777 ' HG2' ' H ' ' A' ' 87' ' ' GLY . 6.8 tt0 -169.07 -165.78 0.57 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 120.526 -0.47 . . . . 0.0 111.462 -178.284 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.777 ' H ' ' HG2' ' A' ' 86' ' ' GLN . . . -162.15 154.42 25.38 Favored Glycine 0 N--CA 1.449 -0.434 0 N-CA-C 111.217 -0.753 . . . . 0.0 111.217 179.424 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.513 HG21 HD21 ' A' ' 48' ' ' LEU . 12.8 tt -130.78 137.54 55.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.952 0.376 . . . . 0.0 110.323 -179.558 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.409 ' HB2' ' ND2' ' A' ' 91' ' ' ASN . 1.8 p-10 -76.65 140.58 41.0 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.961 0.41 . . . . 0.0 109.92 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.778 HD11 HD12 ' A' ' 19' ' ' LEU . 55.8 mt -109.44 40.02 1.95 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.347 0.594 . . . . 0.0 110.834 -179.473 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.409 ' ND2' ' HB2' ' A' ' 89' ' ' ASP . 55.4 m-80 -75.45 2.36 11.69 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.806 -179.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 19.6 mtp180 -95.77 -11.25 27.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.015 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.403 ' CD1' HD22 ' A' ' 37' ' ' LEU . 23.1 mm -98.18 100.01 9.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 29.3 tp60 -107.21 145.6 32.42 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.953 -178.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.435 ' OD1' ' HA ' ' A' ' 3' ' ' TYR . 19.4 p-10 -94.78 118.82 32.38 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.54 178.144 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 47.5 t -106.28 107.78 23.52 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 27.8 m-80 59.46 32.51 21.78 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.022 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 97.99 -25.69 26.51 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.571 -0.823 . . . . 0.0 113.239 179.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -87.07 143.28 27.39 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 117.252 0.526 . . . . 0.0 110.603 -178.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.45 HD12 ' SG ' ' A' ' 23' ' ' CYS . 2.7 tp -87.42 124.23 33.2 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.78 0.324 . . . . 0.0 110.845 -179.25 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 21.7 t -131.19 138.15 53.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.419 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -83.14 130.95 35.15 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 177.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 22.0 tt0 . . . . . 0 C--O 1.25 1.119 0 CA-C-O 118.329 -0.844 . . . . 0.0 111.046 -179.076 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' SER . . . . . 0.401 ' HG ' ' HA ' ' A' ' 91' ' ' ASN . 13.4 m . . . . . 0 N--CA 1.453 -0.302 0 N-CA-C 110.46 -0.2 . . . . 0.0 110.46 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.472 ' CZ ' HD11 ' A' ' 19' ' ' LEU . 26.4 p90 -57.95 -38.5 76.12 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.672 0.273 . . . . 0.0 111.296 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.506 ' HA ' ' OG ' ' A' ' 7' ' ' SER . . . -58.97 -19.78 46.33 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -178.088 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -72.56 -17.78 61.68 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.297 0.57 . . . . 0.0 110.347 -179.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 48.8 m -136.74 36.42 2.64 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.333 179.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.506 ' OG ' ' HA ' ' A' ' 4' ' ' ALA . 68.6 p -149.61 171.43 16.67 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.485 179.373 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.483 ' HG2' ' CZ3' ' A' ' 30' ' ' TRP . 1.9 ptp180 -149.98 167.11 27.64 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.948 -179.532 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 53.73 56.05 7.71 Favored 'General case' 0 C--O 1.233 0.192 0 O-C-N 123.867 0.729 . . . . 0.0 111.322 178.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.474 ' HA ' ' HB1' ' A' ' 21' ' ' ALA . . . -88.24 117.32 27.06 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.181 179.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 35.9 m -124.13 170.22 14.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.596 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.828 HD21 ' HG ' ' A' ' 64' ' ' LEU . 3.3 mm? -104.68 114.17 28.21 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.832 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 18.7 p -108.88 166.63 10.67 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.622 -0.263 . . . . 0.0 110.95 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 59.37 48.5 9.94 Favored 'General case' 0 CA--C 1.522 -0.112 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.912 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 86.76 -39.35 3.08 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.953 -0.641 . . . . 0.0 112.35 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 140.01 38.32 0.1 OUTLIER Glycine 0 N--CA 1.445 -0.709 0 N-CA-C 111.305 -0.718 . . . . 0.0 111.305 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 39.2 ptt85 -122.14 -23.37 5.37 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.094 0.473 . . . . 0.0 110.779 -179.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 3.9 m -105.84 134.73 48.5 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.923 -179.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.666 HD12 HD11 ' A' ' 90' ' ' LEU . 81.9 mt -93.67 110.99 22.59 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.404 179.237 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 20.4 ttt180 -108.11 119.35 39.22 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 178.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.474 ' HB1' ' HA ' ' A' ' 10' ' ' ALA . . . -153.66 167.04 30.89 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.982 0.42 . . . . 0.0 111.483 -178.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -90.3 105.0 17.51 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 107.1 -1.445 . . . . 0.0 107.1 178.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.429 ' SG ' HD12 ' A' ' 100' ' ' LEU . 58.6 m -92.34 125.27 36.92 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.557 -178.218 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.418 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 33.8 ttp180 -73.3 117.82 15.51 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.582 179.055 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 35.1 p30 -82.35 167.62 18.35 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.62 -24.26 63.68 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 -178.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -75.08 -16.15 60.58 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.315 0.579 . . . . 0.0 109.727 179.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 93.32 36.32 5.97 Favored Glycine 0 N--CA 1.447 -0.624 0 CA-C-N 115.186 -0.915 . . . . 0.0 111.733 -179.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.418 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 9.2 t-20 -123.48 163.91 19.97 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.606 0.241 . . . . 0.0 110.417 -179.125 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.483 ' CZ3' ' HG2' ' A' ' 8' ' ' ARG . 89.2 m95 -101.16 118.47 37.05 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.381 -179.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.5 m -122.08 130.78 74.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.429 178.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 15.8 m -76.0 110.95 10.88 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.583 -179.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 67.8 m -123.25 154.65 38.52 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.745 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.642 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 50.4 mt-10 -135.02 143.08 46.58 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.055 -179.54 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.525 HD12 ' HB2' ' A' ' 102' ' ' PHE . 2.0 tm? -136.36 129.66 31.64 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 178.457 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.429 ' N ' HD11 ' A' ' 35' ' ' LEU . 15.1 m-20 -88.42 109.18 19.8 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 -179.576 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.478 HD23 HD13 ' A' ' 35' ' ' LEU . 3.8 mt -81.27 -20.01 41.82 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.764 -179.334 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -66.26 -5.33 10.06 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.874 0.369 . . . . 0.0 111.341 -178.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 77.6 p -82.9 -11.57 58.08 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.686 179.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 29.0 t -141.48 -3.86 1.15 Allowed 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 57.7 mt -109.59 135.06 49.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 178.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -146.0 155.63 26.6 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.93 -0.653 . . . . 0.0 111.519 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 23.6 p30 -159.69 45.19 0.19 Allowed Pre-proline 0 CA--C 1.538 0.486 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -179.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -66.66 -23.31 49.3 Favored 'Trans proline' 0 C--N 1.355 0.901 0 C-N-CA 121.793 1.662 . . . . 0.0 111.68 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 73.9 m-20 -83.95 -15.42 47.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.507 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 105.86 6.68 37.19 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.494 -0.86 . . . . 0.0 112.114 -179.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.726 ' HA ' HE22 ' A' ' 86' ' ' GLN . 55.7 m-85 -124.9 132.75 53.26 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.867 0.365 . . . . 0.0 110.171 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.471 HD23 ' SG ' ' A' ' 73' ' ' CYS . 11.0 mp -87.27 138.43 31.49 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.642 -0.708 . . . . 0.0 112.339 -178.173 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -177.37 171.14 43.87 Favored Glycine 0 N--CA 1.439 -1.14 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.611 178.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 91.6 m95 -94.99 125.39 39.63 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 156.11 -58.82 0.37 Allowed Glycine 0 N--CA 1.447 -0.58 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 -179.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 7.3 tpt -84.71 178.47 7.65 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 179.008 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.0 pt20 -137.2 177.7 7.66 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 118.596 0.635 . . . . 0.0 111.726 -179.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 44.9 m-80 62.73 39.68 10.78 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.408 -0.815 . . . . 0.0 112.083 179.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 10.1 p90 -66.26 -32.2 73.47 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 120.478 0.18 . . . . 0.0 111.296 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 42.3 p -61.81 -31.84 72.09 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.057 0.456 . . . . 0.0 111.118 -179.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 38.4 m80 -78.39 -12.0 59.98 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.08 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 43.9 m -119.6 23.63 11.07 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.956 0.408 . . . . 0.0 110.704 179.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 66.2 m -138.4 152.27 48.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.085 0.469 . . . . 0.0 111.09 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 78.6 mt-10 -130.18 136.41 49.23 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.119 179.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 29.7 t70 65.58 82.62 0.18 Allowed 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.329 0.585 . . . . 0.0 110.268 -178.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.489 HG21 HD23 ' A' ' 71' ' ' LEU . 64.2 mt -104.68 121.98 57.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.197 -179.248 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 27.8 tptt -147.33 153.7 40.01 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.828 ' HG ' HD21 ' A' ' 12' ' ' LEU . 73.4 mt -85.89 125.95 33.71 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.962 0.411 . . . . 0.0 110.764 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -78.56 -58.32 3.31 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.593 -178.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -89.02 39.13 0.92 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.94 0.4 . . . . 0.0 111.175 -179.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 61.92 10.9 28.42 Favored Glycine 0 N--CA 1.453 -0.225 0 CA-C-N 115.516 -0.765 . . . . 0.0 113.28 179.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.518 ' HA2' HD11 ' A' ' 64' ' ' LEU . . . 136.66 -14.6 3.89 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.415 -0.898 . . . . 0.0 112.705 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -79.07 -22.15 45.71 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.415 0.626 . . . . 0.0 109.349 -179.669 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.9 ttmp? -144.91 137.43 26.22 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.014 -179.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.55 ' HB2' HD12 ' A' ' 90' ' ' LEU . 10.6 tt -104.69 127.58 52.5 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.571 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.4 p -117.73 131.93 56.54 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.048 0.451 . . . . 0.0 111.405 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.471 ' SG ' HD23 ' A' ' 48' ' ' LEU . 28.4 p -158.2 165.57 34.56 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.569 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 12.0 ttt-85 -106.33 101.65 36.24 Favored Pre-proline 0 C--N 1.316 -0.885 0 C-N-CA 120.173 -0.611 . . . . 0.0 109.941 179.067 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.45 141.37 42.25 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 122.567 2.178 . . . . 0.0 110.417 178.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.628 ' HA ' ' HB2' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -121.66 143.62 49.23 Favored 'General case' 0 C--N 1.318 -0.8 0 O-C-N 123.567 0.542 . . . . 0.0 111.098 179.913 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.656 HG21 ' O ' ' A' ' 82' ' ' PHE . 11.4 t -79.83 143.14 34.64 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 178.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 8.8 p -70.4 -12.36 16.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 O-C-N 124.184 0.927 . . . . 0.0 111.577 -179.04 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 -63.43 -23.14 67.28 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.283 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -173.08 -14.62 0.02 OUTLIER Glycine 0 C--O 1.228 -0.255 0 C-N-CA 120.312 -0.947 . . . . 0.0 113.163 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 98.76 20.97 17.47 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.549 -0.834 . . . . 0.0 111.849 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.656 ' O ' HG21 ' A' ' 77' ' ' THR . 24.9 p90 -110.91 149.5 30.54 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -179.133 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.648 ' CD ' ' HB ' ' A' ' 77' ' ' THR . 0.0 OUTLIER 177.35 -143.15 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.763 -0.375 . . . . 0.0 111.896 -179.768 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -143.91 152.46 41.15 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.051 -178.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.569 ' HA ' ' HA ' ' A' ' 74' ' ' ARG . 31.6 ttt-85 -77.55 154.1 32.7 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 110.206 -0.294 . . . . 0.0 110.206 -179.68 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . 0.726 HE22 ' HA ' ' A' ' 47' ' ' PHE . 8.1 tt0 -161.72 179.68 7.94 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 120.586 0.231 . . . . 0.0 110.587 -179.028 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.595 ' H ' ' HG2' ' A' ' 86' ' ' GLN . . . -145.51 148.56 20.37 Favored Glycine 0 N--CA 1.448 -0.545 0 N-CA-C 111.683 -0.567 . . . . 0.0 111.683 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.413 HG21 HD22 ' A' ' 48' ' ' LEU . 14.8 tt -126.18 137.84 56.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.199 0.523 . . . . 0.0 110.538 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -77.4 128.3 34.02 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.872 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.666 HD11 HD12 ' A' ' 19' ' ' LEU . 44.7 mt -96.7 42.06 1.1 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.613 0.721 . . . . 0.0 110.746 -179.163 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.401 ' HA ' ' HG ' ' A' ' 2' ' ' SER . 11.2 m-80 -78.86 3.2 17.56 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 115.053 -0.976 . . . . 0.0 111.041 -179.696 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 24.7 mtp180 -100.18 -3.98 30.52 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.677 178.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 22.1 mm -104.16 108.99 25.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 -179.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 26.6 tp60 -122.18 141.96 50.91 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.985 -178.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 17.0 p-10 -94.73 119.72 33.8 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.066 178.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 44.2 t -104.82 104.81 17.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.641 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 34.9 m-80 61.0 37.19 18.26 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 121.273 0.559 . . . . 0.0 110.651 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 91.05 -16.64 58.14 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.924 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 7.1 mpt_? -87.1 123.09 31.78 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.429 HD12 ' SG ' ' A' ' 23' ' ' CYS . 9.0 tp -81.6 114.9 20.61 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.684 -0.488 . . . . 0.0 109.684 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 39.5 t -128.7 143.11 42.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 120.933 0.397 . . . . 0.0 111.001 -178.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.525 ' HB2' HD12 ' A' ' 35' ' ' LEU . 6.7 t80 -81.47 136.05 35.64 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 178.36 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 . . . . . 0 C--O 1.245 0.85 0 CA-C-O 118.805 -0.617 . . . . 0.0 110.686 -179.976 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' SER . . . . . 0.58 ' OG ' ' HA ' ' A' ' 91' ' ' ASN . 5.5 m . . . . . 0 N--CA 1.454 -0.23 0 CA-C-O 120.946 0.403 . . . . 0.0 111.45 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.493 ' HA ' ' OD1' ' A' ' 95' ' ' ASN . 21.0 p90 -59.06 -33.92 71.34 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.857 178.388 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.482 ' HB2' ' HG2' ' A' ' 69' ' ' ARG . . . -56.34 -19.22 13.52 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 -178.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -69.43 -14.53 62.94 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 121.107 0.48 . . . . 0.0 110.808 179.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 14.9 p -149.5 33.7 0.71 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.655 0.741 . . . . 0.0 109.354 178.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 17.4 t -148.47 155.78 41.62 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.256 -0.884 . . . . 0.0 109.394 -179.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 1.5 ptp180 -148.74 170.24 18.63 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.76 -0.2 . . . . 0.0 110.858 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 62.56 44.6 6.79 Favored 'General case' 0 C--O 1.232 0.151 0 O-C-N 124.003 0.814 . . . . 0.0 111.18 178.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.418 ' HA ' ' HB3' ' A' ' 21' ' ' ALA . . . -80.33 126.34 31.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.88 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 35.5 m -126.77 172.62 13.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.552 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -105.94 114.88 29.3 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.68 -179.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 22.6 p -111.15 166.87 10.71 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.951 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.424 ' O ' ' HG2' ' A' ' 17' ' ' ARG . 83.9 m-20 56.83 42.28 26.78 Favored 'General case' 0 N--CA 1.461 0.108 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.604 -179.206 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 87.69 -41.03 3.07 Favored Glycine 0 CA--C 1.517 0.212 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.542 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 146.33 44.29 0.04 OUTLIER Glycine 0 N--CA 1.447 -0.617 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.424 ' HG2' ' O ' ' A' ' 14' ' ' ASN . 6.4 ptm180 -126.24 -26.18 3.4 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.894 0.378 . . . . 0.0 110.93 -179.191 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 3.7 m -107.08 135.97 47.73 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.971 -179.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.776 HD13 HD11 ' A' ' 90' ' ' LEU . 39.7 mt -94.62 115.87 28.08 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.209 178.708 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 78.0 ttt180 -112.98 119.04 36.53 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 178.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.43 ' O ' ' HA ' ' A' ' 32' ' ' THR . . . -154.08 166.78 31.98 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.728 0.299 . . . . 0.0 111.461 -179.139 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -90.99 106.64 18.66 Favored 'General case' 0 CA--C 1.513 -0.458 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 178.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.46 ' SG ' HD12 ' A' ' 100' ' ' LEU . 70.2 m -99.01 135.76 39.94 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 120.76 0.314 . . . . 0.0 110.765 -178.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 15.9 ttp180 -77.66 120.02 22.01 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.791 179.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 36.4 p30 -86.13 168.63 13.85 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.971 -0.291 . . . . 0.0 110.385 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -52.59 -36.28 55.78 Favored 'General case' 0 C--N 1.328 -0.369 0 O-C-N 123.837 0.71 . . . . 0.0 112.02 -179.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -67.45 -17.21 64.61 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.329 0.585 . . . . 0.0 111.041 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 92.6 34.98 6.68 Favored Glycine 0 N--CA 1.448 -0.528 0 N-CA-C 111.304 -0.718 . . . . 0.0 111.304 -179.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -119.77 158.08 27.27 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 110.237 -0.283 . . . . 0.0 110.237 -178.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 77.0 m95 -95.1 116.53 28.83 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.241 179.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.5 m -122.78 129.53 75.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.361 179.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.43 ' HA ' ' O ' ' A' ' 21' ' ' ALA . 21.0 m -74.77 114.5 13.29 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.202 0.525 . . . . 0.0 110.26 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 58.5 m -114.95 149.41 37.34 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.909 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.625 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 26.3 mt-10 -132.65 130.85 40.69 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.881 -178.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.571 HD13 ' HB2' ' A' ' 102' ' ' PHE . 2.1 tm? -132.64 132.83 42.87 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.449 ' N ' HD12 ' A' ' 35' ' ' LEU . 14.6 m-20 -88.96 110.19 20.9 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 -179.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.529 HD13 ' HG ' ' A' ' 19' ' ' LEU . 2.6 mt -81.11 -18.29 47.01 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.095 -179.123 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.45 ' HA ' ' HD1' ' A' ' 55' ' ' PHE . 5.7 p-10 -65.05 -7.22 11.08 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.28 -179.358 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 58.1 p -80.73 -13.04 59.34 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.271 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.405 ' SG ' ' HE3' ' A' ' 50' ' ' TRP . 18.8 t -139.96 -12.9 1.09 Allowed 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 112.138 0.422 . . . . 0.0 112.138 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 54.3 mt -97.55 135.46 31.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 O-C-N 121.814 -0.554 . . . . 0.0 110.057 179.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -142.15 144.64 14.44 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.731 -0.747 . . . . 0.0 111.743 179.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.482 ' OD1' ' HB2' ' A' ' 58' ' ' SER . 27.8 p30 -152.95 48.37 0.43 Allowed Pre-proline 0 CA--C 1.539 0.542 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 -179.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -76.78 -16.46 16.4 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 121.697 1.598 . . . . 0.0 112.339 -178.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -96.19 2.71 53.26 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.921 -179.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.578 ' CA ' ' HG2' ' A' ' 83' ' ' ARG . . . 92.48 5.58 65.02 Favored Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.295 -0.955 . . . . 0.0 112.26 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.455 ' HD1' ' NE2' ' A' ' 86' ' ' GLN . 31.9 m-85 -125.85 134.49 51.62 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.899 0.38 . . . . 0.0 110.497 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.461 HD22 HG21 ' A' ' 88' ' ' ILE . 9.5 mp -85.04 158.51 20.44 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.58 -0.737 . . . . 0.0 111.653 -178.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 159.55 167.26 19.94 Favored Glycine 0 N--CA 1.443 -0.864 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.95 178.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.442 ' CD1' HD12 ' A' ' 88' ' ' ILE . 85.2 m95 -95.33 125.12 39.73 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 166.29 -43.01 0.27 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.87 -179.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 8.4 ttp -107.86 -156.94 0.6 Allowed 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.4 pt20 -146.83 173.92 11.95 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 121.091 -0.244 . . . . 0.0 110.899 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 63.03 45.43 5.28 Favored 'General case' 0 N--CA 1.465 0.285 0 O-C-N 123.663 0.602 . . . . 0.0 112.351 178.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.45 ' HD1' ' HA ' ' A' ' 38' ' ' ASP . 10.1 p90 -71.63 -28.79 64.02 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.978 -0.289 . . . . 0.0 110.76 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.43 ' HA ' HD12 ' A' ' 62' ' ' ILE . 35.0 p -61.39 -37.61 84.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.079 0.466 . . . . 0.0 110.917 -179.333 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 27.2 m80 -81.06 -3.46 51.97 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.106 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.482 ' HB2' ' OD1' ' A' ' 43' ' ' ASN . 12.2 m -119.13 12.68 12.74 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.396 -179.436 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 22.0 p -145.88 155.3 42.79 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 120.995 0.426 . . . . 0.0 111.459 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -116.35 148.05 40.99 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.872 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 28.1 t70 54.0 78.44 0.16 Allowed 'General case' 0 N--CA 1.467 0.401 0 O-C-N 123.921 0.763 . . . . 0.0 111.168 -179.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.517 HG21 HD22 ' A' ' 71' ' ' LEU . 67.0 mt -97.04 117.64 42.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.784 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -148.03 153.78 39.41 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.825 0.345 . . . . 0.0 110.626 -179.159 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.421 HD22 ' HA2' ' A' ' 68' ' ' GLY . 43.0 mt -83.07 133.14 35.08 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.24 0.543 . . . . 0.0 111.041 -179.173 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -86.8 -61.44 1.73 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.68 -178.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.542 ' HB2' ' HB2' ' A' ' 69' ' ' ARG . 19.1 mt-10 -84.71 34.9 0.54 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.806 0.336 . . . . 0.0 111.42 -178.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 65.04 13.15 57.03 Favored Glycine 0 N--CA 1.452 -0.252 0 CA-C-N 115.972 -0.558 . . . . 0.0 113.504 179.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.421 ' HA2' HD22 ' A' ' 64' ' ' LEU . . . 140.26 -24.76 2.66 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.147 -1.025 . . . . 0.0 113.072 179.717 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.542 ' HB2' ' HB2' ' A' ' 66' ' ' GLU . 3.8 mmt85 -74.08 -21.34 59.95 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.967 0.413 . . . . 0.0 110.943 -179.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -146.17 143.05 29.03 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.743 -178.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.574 ' HB2' HD12 ' A' ' 90' ' ' LEU . 10.2 tt -113.19 135.32 53.94 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.013 -0.539 . . . . 0.0 109.617 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 8.9 p -127.16 139.13 53.17 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.018 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 26.4 p -162.54 172.0 16.14 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.269 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.617 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 75.1 ttt180 -108.86 98.87 31.88 Favored Pre-proline 0 C--N 1.321 -0.664 0 C-N-CA 120.562 -0.455 . . . . 0.0 110.349 178.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.502 ' HB2' ' HA2' ' A' ' 46' ' ' GLY . 41.4 Cg_endo -66.74 128.4 18.88 Favored 'Trans proline' 0 N--CA 1.459 -0.5 0 C-N-CA 122.847 2.365 . . . . 0.0 110.828 179.302 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.698 ' HA ' ' HB2' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -120.78 141.57 50.38 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.349 -179.268 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.708 HG21 ' O ' ' A' ' 82' ' ' PHE . 9.5 t -70.86 131.47 43.82 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 178.402 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.7 m -70.55 -6.84 7.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 123.818 0.699 . . . . 0.0 112.069 -178.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -69.29 -33.91 73.9 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.956 0.408 . . . . 0.0 110.313 179.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.428 ' HA3' ' CE1' ' A' ' 82' ' ' PHE . . . -143.98 -25.45 0.14 Allowed Glycine 0 N--CA 1.453 -0.187 0 C-N-CA 120.557 -0.83 . . . . 0.0 112.7 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 100.66 17.62 23.15 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 121.02 -0.609 . . . . 0.0 112.133 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.708 ' O ' HG21 ' A' ' 77' ' ' THR . 24.7 p90 -111.8 153.11 27.05 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 118.763 -0.637 . . . . 0.0 109.878 -178.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.698 ' HB2' ' HA ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 167.04 -154.88 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.582 0 O-C-N 123.697 0.623 . . . . 0.0 111.364 179.4 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -123.44 170.84 9.96 Favored 'General case' 0 C--O 1.223 -0.304 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.265 -178.023 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.617 ' HA ' ' HA ' ' A' ' 74' ' ' ARG . 30.1 ttt85 -96.81 157.97 15.65 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.246 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . 0.455 ' NE2' ' HD1' ' A' ' 47' ' ' PHE . 6.4 tt0 -158.91 179.57 8.96 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.072 0.463 . . . . 0.0 111.58 -179.243 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.451 ' H ' ' HG2' ' A' ' 86' ' ' GLN . . . -144.54 143.82 12.53 Favored Glycine 0 N--CA 1.45 -0.426 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.612 179.22 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.461 HG21 HD22 ' A' ' 48' ' ' LEU . 13.9 tt -130.29 140.85 47.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.825 0.345 . . . . 0.0 110.556 -179.374 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -80.15 137.4 36.7 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.776 HD11 HD13 ' A' ' 19' ' ' LEU . 64.2 mt -104.71 41.28 1.35 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.292 0.568 . . . . 0.0 111.382 -179.285 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.58 ' HA ' ' OG ' ' A' ' 2' ' ' SER . 21.3 m-80 -76.0 3.31 10.55 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.976 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 8.4 mtp180 -96.7 -11.19 25.44 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.562 178.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.42 ' CD1' HD23 ' A' ' 37' ' ' LEU . 21.7 mm -98.38 95.91 4.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 21.6 tp60 -106.15 139.54 40.5 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.201 -177.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.493 ' OD1' ' HA ' ' A' ' 3' ' ' TYR . 16.8 p-10 -94.67 116.35 28.65 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.596 178.314 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.7 p -114.13 123.57 69.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 116.185 -0.461 . . . . 0.0 109.938 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 62.57 20.11 11.75 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.956 -179.156 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 95.84 -9.59 68.36 Favored Glycine 0 N--CA 1.446 -0.657 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.759 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.433 ' O ' ' HA ' ' A' ' 95' ' ' ASN . 0.0 OUTLIER -96.1 144.41 26.38 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-N 117.257 0.529 . . . . 0.0 110.826 -178.944 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.46 HD12 ' SG ' ' A' ' 23' ' ' CYS . 5.3 tp -89.55 116.38 27.66 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.145 -0.48 . . . . 0.0 109.796 -179.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 46.8 t -131.12 141.85 45.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.422 -179.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.571 ' HB2' HD13 ' A' ' 35' ' ' LEU . 22.8 t80 -80.27 128.68 33.82 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 179.153 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.163 -0.922 . . . . 0.0 110.864 -179.347 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.448 -0.533 0 N-CA-C 110.464 -0.198 . . . . 0.0 110.464 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.604 ' HA ' ' OD1' ' A' ' 95' ' ' ASN . 8.3 p90 -58.22 -41.41 84.02 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.772 -0.195 . . . . 0.0 111.399 -179.429 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -60.18 -19.37 53.78 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.849 -178.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -68.29 -21.81 64.76 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.146 0.498 . . . . 0.0 110.429 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 51.1 m -138.85 34.88 2.17 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.671 179.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.432 ' HG ' ' C ' ' A' ' 3' ' ' TYR . 92.8 p -149.96 167.67 26.02 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.182 179.258 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 16.0 ptm180 -149.9 169.11 21.9 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.648 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 60.4 52.87 4.52 Favored 'General case' 0 N--CA 1.465 0.296 0 O-C-N 123.646 0.591 . . . . 0.0 110.692 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -90.12 119.96 30.89 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.209 -179.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 35.3 m -122.49 170.71 12.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.165 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.686 HD21 ' HG ' ' A' ' 64' ' ' LEU . 3.4 mm? -104.81 116.29 31.76 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 -179.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.442 ' OG1' ' HB ' ' A' ' 18' ' ' THR . 29.4 p -110.7 167.62 10.09 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.072 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 56.95 55.62 5.99 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.93 179.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 82.24 -37.97 2.58 Favored Glycine 0 N--CA 1.453 -0.206 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.337 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 137.29 36.57 0.17 Allowed Glycine 0 N--CA 1.445 -0.757 0 N-CA-C 111.381 -0.688 . . . . 0.0 111.381 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.457 ' HD2' ' CG ' ' A' ' 38' ' ' ASP . 34.5 ptt85 -120.46 -23.11 6.22 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.93 0.395 . . . . 0.0 110.71 -179.222 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.442 ' HB ' ' OG1' ' A' ' 13' ' ' THR . 4.6 m -103.33 134.7 46.27 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.841 -179.258 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.64 ' O ' ' HA ' ' A' ' 34' ' ' GLU . 68.8 mt -95.26 116.18 28.41 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.395 179.19 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 39.0 ttt-85 -111.01 120.18 41.52 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 178.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -153.58 166.63 32.16 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.845 0.355 . . . . 0.0 111.488 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -89.9 105.68 17.97 Favored 'General case' 0 CA--C 1.512 -0.49 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 178.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.553 ' SG ' HD13 ' A' ' 100' ' ' LEU . 58.7 m -92.72 128.74 38.69 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.134 -177.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.424 ' HB2' ' CZ3' ' A' ' 30' ' ' TRP . 11.0 ttp180 -77.79 116.46 18.33 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.34 179.034 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 35.2 p30 -84.96 170.92 12.56 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -51.29 -31.41 21.28 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -179.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -73.88 -11.58 60.41 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.621 0.724 . . . . 0.0 110.601 -179.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 85.79 25.02 39.64 Favored Glycine 0 N--CA 1.447 -0.633 0 N-CA-C 110.629 -0.988 . . . . 0.0 110.629 -179.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.409 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 8.8 t-20 -104.73 156.12 18.27 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.459 -0.371 . . . . 0.0 110.243 -178.581 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.424 ' CZ3' ' HB2' ' A' ' 24' ' ' ARG . 90.7 m95 -97.6 116.02 29.01 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.775 -179.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.3 m -118.64 128.32 75.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.349 178.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 19.7 m -74.48 109.35 7.89 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.362 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 69.3 m -122.12 147.66 45.86 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.445 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.64 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 50.7 mt-10 -128.79 142.84 50.85 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.012 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.675 HD13 ' HB2' ' A' ' 102' ' ' PHE . 2.1 tm? -135.49 132.45 37.36 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.729 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.46 ' N ' HD12 ' A' ' 35' ' ' LEU . 16.2 m-20 -89.59 110.36 21.23 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.461 HD12 HD22 ' A' ' 90' ' ' LEU . 2.9 mt -82.25 -20.76 36.96 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.68 -178.644 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.457 ' CG ' ' HD2' ' A' ' 17' ' ' ARG . 5.1 p-10 -66.9 -5.2 11.58 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 121.008 -0.277 . . . . 0.0 111.272 -178.501 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 37.5 p -73.52 -28.12 61.72 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.055 0.455 . . . . 0.0 110.261 178.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 17.0 t -126.48 -4.39 6.62 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.909 -179.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 57.8 mt -104.7 134.65 45.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 O-C-N 121.718 -0.613 . . . . 0.0 110.655 179.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -149.98 158.85 27.85 Favored Glycine 0 N--CA 1.449 -0.456 0 N-CA-C 111.463 -0.655 . . . . 0.0 111.463 179.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.658 ' OD1' ' HB2' ' A' ' 55' ' ' PHE . 1.7 p-10 -163.64 56.37 0.54 Allowed Pre-proline 0 CA--C 1.538 0.484 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -66.64 -25.52 46.95 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.134 1.889 . . . . 0.0 112.068 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -96.54 3.94 52.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.03 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.631 ' HA2' ' HB2' ' A' ' 75' ' ' PRO . . . 89.9 11.99 62.76 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.305 -0.95 . . . . 0.0 113.288 179.453 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.485 ' HA ' HE22 ' A' ' 86' ' ' GLN . 27.1 m-85 -118.38 123.48 45.37 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 120.929 0.395 . . . . 0.0 109.987 179.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.525 HD21 ' SG ' ' A' ' 73' ' ' CYS . 8.0 mp -83.56 137.51 33.81 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.734 -178.427 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -179.97 172.62 44.18 Favored Glycine 0 N--CA 1.437 -1.254 0 C-N-CA 120.748 -0.739 . . . . 0.0 111.422 178.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 91.2 m95 -95.05 125.03 39.43 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 165.05 -55.25 0.27 Allowed Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.991 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 5.6 ttt -91.69 -158.07 0.55 Allowed 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.825 0.312 . . . . 0.0 110.226 -179.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -148.57 167.64 24.89 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 120.788 0.328 . . . . 0.0 111.466 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 23.8 m-80 63.6 48.61 3.31 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.303 -0.862 . . . . 0.0 112.82 178.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.658 ' HB2' ' OD1' ' A' ' 43' ' ' ASN . 8.8 p90 -69.73 -27.94 65.38 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.856 0.36 . . . . 0.0 110.423 179.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 21.7 t -61.26 -33.1 72.98 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.156 -179.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 24.3 m80 -78.37 -3.51 43.51 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.918 -179.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 40.0 m -133.94 24.56 3.94 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.956 0.408 . . . . 0.0 110.942 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 22.1 m -139.55 147.75 41.63 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.136 0.493 . . . . 0.0 111.465 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -123.06 151.5 41.91 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.59 179.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.438 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 28.2 t70 54.01 73.81 0.36 Allowed 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.356 0.598 . . . . 0.0 111.245 179.313 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.452 HG23 HD22 ' A' ' 71' ' ' LEU . 56.3 mt -98.48 116.13 40.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.887 -179.595 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.2 tptt -144.45 149.84 36.66 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.258 -179.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.686 ' HG ' HD21 ' A' ' 12' ' ' LEU . 65.0 mt -83.67 130.83 34.97 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 179.417 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 16.2 tp10 -83.13 -58.01 3.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.259 -178.134 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -85.59 23.14 1.43 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.158 0.504 . . . . 0.0 111.21 -179.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 76.49 3.38 77.8 Favored Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 115.487 -0.778 . . . . 0.0 112.963 179.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.447 ' HA2' HD21 ' A' ' 64' ' ' LEU . . . 147.62 -22.5 1.5 Allowed Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.671 -0.776 . . . . 0.0 111.997 -179.684 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 2.8 tpp180 -74.01 -12.53 60.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.267 0.556 . . . . 0.0 110.048 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 48.5 tttp -160.14 142.41 13.13 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.269 -178.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.583 ' HB2' HD13 ' A' ' 90' ' ' LEU . 10.3 tt -112.39 139.02 48.3 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.5 p -127.77 134.83 49.51 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.748 179.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.525 ' SG ' HD21 ' A' ' 48' ' ' LEU . 25.7 p -158.39 175.83 13.22 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.021 0.439 . . . . 0.0 110.259 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.541 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 2.8 tmt_? -110.92 98.79 39.99 Favored Pre-proline 0 C--N 1.316 -0.881 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 178.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.631 ' HB2' ' HA2' ' A' ' 46' ' ' GLY . 61.2 Cg_endo -71.18 124.98 10.96 Favored 'Trans proline' 0 CA--C 1.512 -0.604 0 C-N-CA 123.301 2.667 . . . . 0.0 111.468 179.612 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.641 ' HA ' ' HB2' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -120.63 138.47 53.9 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.942 179.56 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.708 HG22 ' O ' ' A' ' 82' ' ' PHE . 14.8 t -72.62 132.66 44.04 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.364 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.7 p -74.87 -10.0 13.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.84 -179.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -67.44 -29.51 69.0 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.233 179.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.592 ' HA3' ' CE2' ' A' ' 82' ' ' PHE . . . -146.49 -23.33 0.1 Allowed Glycine 0 C--O 1.228 -0.232 0 C-N-CA 120.342 -0.932 . . . . 0.0 113.676 -179.202 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.411 ' HA2' ' CE ' ' A' ' 76' ' ' LYS . . . 97.76 12.11 48.18 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.302 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.708 ' O ' HG22 ' A' ' 77' ' ' THR . 29.6 p90 -111.91 158.64 19.23 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 118.419 -0.8 . . . . 0.0 109.793 -178.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.641 ' HB2' ' HA ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 162.62 -158.94 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.588 0 O-C-N 123.956 0.785 . . . . 0.0 111.731 179.514 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -120.02 -171.09 2.08 Favored 'General case' 0 C--O 1.225 -0.189 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.625 -178.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.594 ' HA ' ' HD2' ' A' ' 75' ' ' PRO . 30.6 ttt180 -109.58 155.6 21.22 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 177.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . 0.485 HE22 ' HA ' ' A' ' 47' ' ' PHE . 9.2 tt0 -169.1 162.06 10.69 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 120.407 -0.517 . . . . 0.0 112.265 -179.085 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -123.74 157.19 18.12 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 121.221 -0.514 . . . . 0.0 112.062 179.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 15.1 tt -131.43 143.82 39.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.027 0.441 . . . . 0.0 110.246 179.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.539 ' OD1' ' HB2' ' A' ' 91' ' ' ASN . 17.3 t70 -82.74 131.89 35.19 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.265 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.64 HD12 HD11 ' A' ' 19' ' ' LEU . 56.1 mt -105.34 34.15 3.37 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 112.943 0.719 . . . . 0.0 112.943 -177.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.539 ' HB2' ' OD1' ' A' ' 89' ' ' ASP . 10.8 m-80 -74.72 3.69 7.53 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 121.096 0.474 . . . . 0.0 111.464 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 32.3 mtp180 -92.86 -11.14 34.3 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.493 178.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 19.9 mm -99.59 106.46 19.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 19.9 tp60 -117.4 140.24 49.83 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.085 0.469 . . . . 0.0 111.269 -178.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.604 ' OD1' ' HA ' ' A' ' 3' ' ' TYR . 16.5 p-10 -95.14 101.28 13.02 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.399 0.619 . . . . 0.0 109.808 177.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.2 p -91.42 114.39 28.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 121.439 0.638 . . . . 0.0 110.424 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 61.24 29.75 18.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.57 -179.61 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 91.08 -10.82 73.96 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.038 -179.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.409 ' HD2' ' N ' ' A' ' 99' ' ' ARG . 9.6 mpt_? -92.11 123.54 35.54 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.684 0.278 . . . . 0.0 110.327 -179.33 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.553 HD13 ' SG ' ' A' ' 23' ' ' CYS . 5.5 tp -78.71 114.56 17.74 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 -179.537 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 53.4 t -132.14 140.98 46.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.189 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.675 ' HB2' HD13 ' A' ' 35' ' ' LEU . 8.3 t80 -83.06 133.75 35.06 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.137 179.327 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 . . . . . 0 C--O 1.248 1.008 0 CA-C-O 118.764 -0.636 . . . . 0.0 109.956 179.994 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' SER . . . . . 0.67 ' OG ' ' HA ' ' A' ' 91' ' ' ASN . 12.3 m . . . . . 0 N--CA 1.451 -0.408 0 CA-C-O 120.533 0.206 . . . . 0.0 110.903 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.413 ' CZ ' HD13 ' A' ' 19' ' ' LEU . 22.8 p90 -58.21 -36.92 73.84 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.257 179.652 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -56.68 -21.04 24.76 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -178.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -73.55 -9.74 58.99 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 120.991 0.424 . . . . 0.0 111.006 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 51.0 m -148.07 29.23 0.9 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.317 0.58 . . . . 0.0 109.529 178.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 36.7 m -143.29 164.48 30.1 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.576 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 2.3 ptm180 -148.57 165.97 29.66 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.327 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 57.83 57.29 4.26 Favored 'General case' 0 N--CA 1.462 0.174 0 O-C-N 123.647 0.592 . . . . 0.0 111.46 178.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -88.93 125.91 35.17 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.934 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 23.0 m -129.05 174.19 12.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.4 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.611 HD22 ' HG ' ' A' ' 64' ' ' LEU . 3.5 mm? -106.0 114.42 28.55 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.945 -179.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 28.3 p -111.54 171.24 7.6 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.126 -179.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 56.67 40.27 29.33 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.608 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 90.02 -20.43 36.39 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.677 179.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 121.73 34.92 0.82 Allowed Glycine 0 N--CA 1.443 -0.84 0 C-N-CA 120.926 -0.654 . . . . 0.0 111.727 -179.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 11.9 ptt180 -124.34 -15.41 6.7 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.218 0.533 . . . . 0.0 110.477 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 11.4 m -114.18 138.67 50.15 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.231 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.734 HD11 HD13 ' A' ' 90' ' ' LEU . 56.8 mt -95.17 113.71 25.43 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.93 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.413 ' C ' ' HD2' ' A' ' 20' ' ' ARG . 4.5 tmm_? -107.94 119.46 39.53 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 178.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -153.71 167.23 30.31 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.95 0.405 . . . . 0.0 111.401 -179.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -89.52 105.96 18.14 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 178.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.519 ' SG ' HD12 ' A' ' 100' ' ' LEU . 22.5 m -96.82 133.27 41.63 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.565 -0.288 . . . . 0.0 110.584 -177.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 16.7 ttp180 -76.4 116.63 17.27 Favored 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 179.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 36.1 p30 -81.75 165.01 21.31 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.14 -15.68 15.76 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -177.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -87.49 -6.22 58.47 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.745 0.783 . . . . 0.0 109.974 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 83.41 37.76 11.82 Favored Glycine 0 N--CA 1.448 -0.561 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.677 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -124.5 161.25 26.51 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 110.353 -0.24 . . . . 0.0 110.353 -179.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 72.8 m95 -98.56 120.87 39.72 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.72 179.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.6 m -124.67 134.87 65.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.979 179.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 46.1 m -75.76 109.38 9.31 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.756 179.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 55.4 m -122.83 153.51 39.48 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.755 -179.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.632 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 44.0 mt-10 -135.52 139.17 43.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.117 -179.483 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.678 HD13 ' HB2' ' A' ' 102' ' ' PHE . 2.5 tm? -131.71 131.95 43.5 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 179.049 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.494 ' O ' HG23 ' A' ' 39' ' ' THR . 38.8 m-20 -84.8 110.52 18.87 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.973 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.532 HD12 ' HG ' ' A' ' 19' ' ' LEU . 5.2 mt -81.2 -27.44 35.32 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.663 0.268 . . . . 0.0 111.385 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -65.65 -5.79 9.42 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.292 0.479 . . . . 0.0 112.292 -177.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.494 HG23 ' O ' ' A' ' 36' ' ' ASP . 14.0 t -78.75 -10.15 59.67 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 110.274 -0.269 . . . . 0.0 110.274 178.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 40.2 t -141.53 3.84 1.72 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.463 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 56.9 mt -113.88 132.58 62.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 O-C-N 121.95 -0.468 . . . . 0.0 110.621 179.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -146.47 155.48 26.55 Favored Glycine 0 N--CA 1.447 -0.568 0 N-CA-C 111.408 -0.677 . . . . 0.0 111.408 179.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.431 ' OD1' ' HB2' ' A' ' 55' ' ' PHE . 4.3 p-10 -153.3 45.16 0.27 Allowed Pre-proline 0 CA--C 1.541 0.626 0 N-CA-C 113.515 0.932 . . . . 0.0 113.515 -179.046 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -68.96 -20.38 38.77 Favored 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 121.522 1.481 . . . . 0.0 111.315 -179.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -81.07 -16.46 53.11 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.814 179.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 103.44 6.11 44.87 Favored Glycine 0 N--CA 1.443 -0.835 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.7 -178.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -122.26 135.04 54.68 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.826 0.346 . . . . 0.0 110.389 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 94.2 mt -83.53 130.96 35.02 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.8 -178.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -174.64 172.47 45.44 Favored Glycine 0 N--CA 1.441 -0.98 0 C-N-CA 120.699 -0.762 . . . . 0.0 111.807 179.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.414 ' HH2' HD11 ' A' ' 93' ' ' ILE . 81.5 m95 -94.36 125.93 39.3 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 179.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 170.66 -58.33 0.18 Allowed Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.516 -179.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 11.0 ttp -95.0 -153.12 0.38 Allowed 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -146.54 170.5 16.77 Favored 'General case' 0 C--N 1.33 -0.25 0 O-C-N 122.184 -0.322 . . . . 0.0 111.336 -179.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 62.29 41.84 9.91 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 113.153 0.797 . . . . 0.0 113.153 178.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.431 ' HB2' ' OD1' ' A' ' 43' ' ' ASN . 8.8 p90 -63.23 -26.77 68.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.13 0.49 . . . . 0.0 110.464 179.113 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 32.3 t -62.69 -32.6 73.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.499 -179.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 30.0 m80 -82.61 -4.07 57.13 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.846 0.355 . . . . 0.0 111.084 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 24.1 m -125.36 16.13 8.31 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.484 179.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 65.1 m -137.58 149.17 46.48 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.133 0.492 . . . . 0.0 111.041 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -128.95 158.12 39.7 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.469 179.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.501 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 36.5 t70 57.22 67.69 0.95 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.477 0.656 . . . . 0.0 110.405 179.226 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.511 HG21 HD23 ' A' ' 71' ' ' LEU . 71.6 mt -95.21 114.06 30.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.147 -178.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.8 tptm -145.33 143.91 30.42 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.317 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.611 ' HG ' HD22 ' A' ' 12' ' ' LEU . 79.2 mt -82.3 120.82 25.89 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.803 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -72.71 -56.35 5.41 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.778 -179.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.435 ' HB2' ' HB2' ' A' ' 69' ' ' ARG . 29.4 mt-10 -82.72 4.22 25.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.954 0.407 . . . . 0.0 110.64 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 81.19 13.78 80.19 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.293 -179.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.423 ' HA2' HD11 ' A' ' 64' ' ' LEU . . . 155.34 -31.51 0.64 Allowed Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 119.916 -1.135 . . . . 0.0 113.299 179.377 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.435 ' HB2' ' HB2' ' A' ' 66' ' ' GLU . 7.2 mmt85 -78.11 -33.15 50.72 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.022 0.439 . . . . 0.0 111.647 -179.47 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 28.6 tptt -131.65 135.23 46.75 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.437 -178.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.549 ' HB2' HD11 ' A' ' 90' ' ' LEU . 10.0 tt -110.68 124.5 52.05 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -112.2 128.14 56.15 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 120.972 0.415 . . . . 0.0 111.143 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.501 ' HA ' ' O ' ' A' ' 61' ' ' ASP . 24.5 p -155.0 166.21 34.29 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 179.53 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.518 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 29.3 ttt180 -101.29 100.61 14.0 Favored Pre-proline 0 C--N 1.314 -0.946 0 CA-C-O 120.797 0.332 . . . . 0.0 110.556 179.56 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.482 ' HD2' ' HA ' ' A' ' 85' ' ' ARG . 46.0 Cg_endo -69.7 120.88 7.6 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 122.48 2.12 . . . . 0.0 109.897 178.159 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.607 ' HA ' ' HB2' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -115.7 143.69 45.01 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.008 0.433 . . . . 0.0 110.884 -179.348 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.651 HG23 ' O ' ' A' ' 82' ' ' PHE . 13.1 t -78.49 142.0 37.79 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 179.505 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 28.9 m -70.59 -8.56 11.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 O-C-N 124.046 0.841 . . . . 0.0 112.002 -179.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -59.67 -35.11 73.8 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.046 0.45 . . . . 0.0 110.173 179.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -164.52 -13.08 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.56 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.611 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.504 ' HA2' ' CE ' ' A' ' 76' ' ' LYS . . . 99.73 23.0 11.29 Favored Glycine 0 N--CA 1.442 -0.961 0 C-N-CA 120.484 -0.865 . . . . 0.0 112.064 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.651 ' O ' HG23 ' A' ' 77' ' ' THR . 30.5 p90 -110.47 144.85 38.66 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 -178.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.607 ' HB2' ' HA ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 172.34 -151.82 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 O-C-N 123.645 0.591 . . . . 0.0 110.724 -179.676 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 23.9 mm-40 -122.41 176.56 5.82 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.09 -177.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.518 ' HA ' ' HA ' ' A' ' 74' ' ' ARG . 39.2 ttt-85 -112.74 151.01 30.77 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 177.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -166.52 -172.37 2.16 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.86 0.362 . . . . 0.0 111.472 -179.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -135.22 152.48 20.84 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.462 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 13.4 tt -122.81 149.94 26.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -86.61 124.79 33.29 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.77 0.319 . . . . 0.0 111.104 -179.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.734 HD13 HD11 ' A' ' 19' ' ' LEU . 44.3 mt -97.88 34.43 1.9 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.644 0.735 . . . . 0.0 110.134 179.254 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.67 ' HA ' ' OG ' ' A' ' 2' ' ' SER . 0.9 OUTLIER -75.17 2.03 11.87 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 114.806 -1.088 . . . . 0.0 110.704 -179.726 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 18.8 mtp180 -98.52 1.21 46.37 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.256 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.433 HD11 HD22 ' A' ' 37' ' ' LEU . 22.1 mm -105.65 112.96 41.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.144 0.497 . . . . 0.0 109.885 -179.228 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 5.1 mm-40 -117.69 145.56 44.33 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.996 -178.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -97.41 102.32 14.06 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.548 178.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 46.7 t -92.13 106.56 17.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.835 -178.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 61.08 25.29 15.32 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.161 179.469 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 106.0 -23.4 29.28 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.533 -0.842 . . . . 0.0 112.751 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.12 132.49 34.3 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.902 0.351 . . . . 0.0 110.062 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.519 HD12 ' SG ' ' A' ' 23' ' ' CYS . 7.9 tp -82.54 114.69 21.12 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 -179.474 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 5.5 t -125.93 146.41 31.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 120.937 0.399 . . . . 0.0 111.155 -178.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.678 ' HB2' HD13 ' A' ' 35' ' ' LEU . 18.6 t80 -79.8 138.22 37.18 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 178.314 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 . . . . . 0 C--N 1.316 -0.852 0 CA-C-O 118.81 -0.614 . . . . 0.0 110.427 -179.198 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.449 -0.479 0 N-CA-C 111.548 0.203 . . . . 0.0 111.548 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.502 ' HA ' ' OD1' ' A' ' 95' ' ' ASN . 11.8 p90 -48.73 -36.65 16.81 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -179.348 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -54.9 -19.32 6.37 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 -178.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -57.9 -39.19 77.3 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.237 0.541 . . . . 0.0 110.262 178.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 24.4 m -129.55 39.51 3.72 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.536 -0.757 . . . . 0.0 109.479 179.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 8.6 t -141.27 149.71 41.66 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.864 -179.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 10.6 ptm85 -138.16 158.55 44.08 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.633 -179.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 62.47 52.81 2.86 Favored 'General case' 0 N--CA 1.463 0.207 0 O-C-N 123.914 0.759 . . . . 0.0 111.374 179.035 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.47 ' HA ' ' HB2' ' A' ' 21' ' ' ALA . . . -82.25 117.58 22.46 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.239 179.69 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 36.0 m -124.18 169.17 15.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.05 -179.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.513 HD23 ' HG ' ' A' ' 64' ' ' LEU . 3.1 mm? -104.85 120.5 41.56 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.99 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 23.3 p -114.48 167.12 11.01 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 120.862 0.363 . . . . 0.0 111.277 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 64.03 31.4 13.59 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.402 179.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 92.36 -21.78 36.13 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.855 -0.688 . . . . 0.0 113.106 179.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 129.27 56.22 0.1 Allowed Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.775 -0.726 . . . . 0.0 111.407 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 2.4 ptm180 -143.13 -32.25 0.47 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.983 0.42 . . . . 0.0 111.077 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.8 m -103.11 135.25 45.14 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.952 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.643 HD12 HD11 ' A' ' 90' ' ' LEU . 62.5 mt -94.29 113.13 24.98 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.118 178.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 40.5 ttm180 -109.68 120.43 42.45 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 178.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.47 ' HB2' ' HA ' ' A' ' 10' ' ' ALA . . . -153.38 166.57 32.22 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.852 0.358 . . . . 0.0 111.048 -179.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -90.98 112.14 23.9 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 178.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.477 ' SG ' HD13 ' A' ' 100' ' ' LEU . 65.2 m -101.32 130.49 47.49 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.747 0.308 . . . . 0.0 110.816 -178.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.5 ttt180 -83.77 109.88 17.88 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 35.1 p30 -77.82 167.71 21.09 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.329 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -50.91 -33.07 22.68 Favored 'General case' 0 C--N 1.329 -0.292 0 O-C-N 123.674 0.609 . . . . 0.0 112.356 -179.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -67.24 -16.22 64.16 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.204 0.526 . . . . 0.0 110.825 -179.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 91.24 25.51 23.82 Favored Glycine 0 N--CA 1.446 -0.638 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.671 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -115.1 151.78 33.7 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.617 0.246 . . . . 0.0 111.074 -179.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -92.05 115.01 27.7 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.102 0.477 . . . . 0.0 110.911 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 5.0 m -113.38 132.79 61.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.561 179.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 53.2 m -79.58 110.19 14.68 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.037 0.446 . . . . 0.0 110.542 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 73.6 m -120.95 148.85 43.52 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.815 -179.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.557 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 46.3 mt-10 -130.92 138.55 49.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.832 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.551 HD11 ' HB2' ' A' ' 102' ' ' PHE . 1.9 tm? -132.38 130.2 40.37 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 179.026 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -88.86 109.58 20.33 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.969 0.414 . . . . 0.0 110.332 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.491 HD21 HD12 ' A' ' 35' ' ' LEU . 1.6 mt -84.67 -11.49 55.8 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.742 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -66.76 -6.0 14.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.156 -179.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 72.1 p -88.96 -13.09 39.75 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.018 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.534 ' SG ' ' HZ3' ' A' ' 50' ' ' TRP . 0.8 OUTLIER -136.05 -9.61 2.03 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -178.432 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 51.3 mt -107.16 132.17 55.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 O-C-N 122.241 -0.287 . . . . 0.0 110.455 178.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -151.97 162.01 29.56 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.199 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.643 ' ND2' ' HB2' ' A' ' 55' ' ' PHE . 5.3 p30 -159.4 57.98 1.13 Allowed Pre-proline 0 CA--C 1.535 0.382 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -72.39 -15.36 28.03 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.059 1.839 . . . . 0.0 112.374 -179.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 53.5 m-80 -100.26 -5.12 28.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.953 0.406 . . . . 0.0 110.466 179.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.51 ' CA ' ' HG2' ' A' ' 83' ' ' ARG . . . 98.99 9.48 51.95 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.41 -179.658 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -123.46 133.1 54.09 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.928 0.394 . . . . 0.0 110.852 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 79.0 mt -83.49 139.82 32.68 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.406 -178.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 178.33 172.58 42.88 Favored Glycine 0 N--CA 1.44 -1.095 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.437 179.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.534 ' HZ3' ' SG ' ' A' ' 40' ' ' CYS . 93.0 m95 -94.82 125.03 39.21 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 158.76 -63.94 0.3 Allowed Glycine 0 N--CA 1.45 -0.416 0 N-CA-C 111.588 -0.605 . . . . 0.0 111.588 -179.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 13.1 tpt -78.31 173.82 11.89 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -129.55 172.39 11.62 Favored 'General case' 0 C--N 1.322 -0.599 0 O-C-N 122.159 -0.338 . . . . 0.0 111.399 -179.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 20.9 m-80 61.07 48.81 6.11 Favored 'General case' 0 C--O 1.233 0.187 0 O-C-N 123.982 0.801 . . . . 0.0 111.967 179.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.643 ' HB2' ' ND2' ' A' ' 43' ' ' ASN . 18.8 p90 -67.91 -28.51 67.56 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.628 -179.502 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.1 m -63.47 -28.38 69.93 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.873 0.368 . . . . 0.0 111.125 -179.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 26.4 m80 -79.99 -9.04 59.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.001 0.429 . . . . 0.0 111.013 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 47.5 p -125.58 15.31 8.18 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.064 0.459 . . . . 0.0 110.659 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 68.2 m -133.61 150.5 51.6 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.302 0.572 . . . . 0.0 111.052 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 57.2 mt-10 -125.68 142.3 51.58 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.412 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.414 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 21.4 t70 60.01 78.41 0.27 Allowed 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 121.402 0.62 . . . . 0.0 110.367 -179.708 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.52 HG23 HD21 ' A' ' 71' ' ' LEU . 73.2 mt -101.73 115.47 43.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.36 -178.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 36.6 ttmt -148.96 156.99 43.08 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 179.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.513 ' HG ' HD23 ' A' ' 12' ' ' LEU . 42.5 mt -83.2 135.93 34.6 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.161 0.505 . . . . 0.0 110.947 -179.448 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 18.7 tp10 -90.23 -57.29 2.9 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.934 -178.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.476 ' HB2' ' HB2' ' A' ' 69' ' ' ARG . 20.5 mm-40 -84.15 24.11 0.98 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.158 0.504 . . . . 0.0 111.1 -179.336 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 68.24 16.72 69.36 Favored Glycine 0 N--CA 1.45 -0.39 0 CA-C-N 115.429 -0.805 . . . . 0.0 112.435 179.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.4 ' HA2' HD12 ' A' ' 64' ' ' LEU . . . 141.24 -28.12 2.37 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.013 -1.089 . . . . 0.0 112.806 179.556 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.476 ' HB2' ' HB2' ' A' ' 66' ' ' GLU . 12.6 mmt180 -73.07 -25.34 60.87 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.057 0.456 . . . . 0.0 110.582 -179.407 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -146.48 142.72 28.37 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.888 -178.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.588 ' HB2' HD12 ' A' ' 90' ' ' LEU . 8.9 tt -111.63 131.75 55.05 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.738 -0.468 . . . . 0.0 109.738 179.574 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.3 p -115.26 130.57 56.95 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.233 0.54 . . . . 0.0 111.066 179.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.414 ' HA ' ' O ' ' A' ' 61' ' ' ASP . 26.7 p -153.28 165.15 36.62 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.333 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.444 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 3.3 tmt_? -102.12 99.35 12.25 Favored Pre-proline 0 C--N 1.314 -0.958 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.418 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.55 ' HD2' ' HA ' ' A' ' 85' ' ' ARG . 61.7 Cg_endo -70.09 123.14 9.71 Favored 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 122.801 2.334 . . . . 0.0 111.443 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.669 ' HA ' ' HB2' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -119.67 144.21 47.31 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.76 -179.793 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.683 HG22 ' O ' ' A' ' 82' ' ' PHE . 14.6 t -76.92 140.78 40.63 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.547 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 8.9 p -73.8 -9.44 12.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.452 -0.794 . . . . 0.0 111.288 -179.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -64.2 -23.12 67.2 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.054 0.454 . . . . 0.0 110.872 179.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -166.26 -21.84 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.51 -0.852 . . . . 0.0 112.908 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.51 ' HA2' ' CE ' ' A' ' 76' ' ' LYS . . . 101.75 20.87 11.99 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.773 -0.727 . . . . 0.0 111.893 -179.544 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.683 ' O ' HG22 ' A' ' 77' ' ' THR . 22.2 p90 -111.15 147.7 34.35 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 119.031 -0.509 . . . . 0.0 109.766 -178.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.669 ' HB2' ' HA ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 169.26 -154.94 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.361 0 O-C-N 123.592 0.558 . . . . 0.0 111.315 179.716 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -117.62 -175.76 2.89 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.368 -178.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.55 ' HA ' ' HD2' ' A' ' 75' ' ' PRO . 31.6 ttt180 -110.59 155.68 22.01 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 177.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . 0.518 ' HG2' ' H ' ' A' ' 87' ' ' GLY . 9.2 tt0 -165.17 176.69 8.25 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 120.512 -0.475 . . . . 0.0 111.712 -178.178 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.518 ' H ' ' HG2' ' A' ' 86' ' ' GLN . . . -137.91 140.83 11.54 Favored Glycine 0 N--CA 1.449 -0.466 0 N-CA-C 111.42 -0.672 . . . . 0.0 111.42 178.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 11.4 tt -118.44 133.84 63.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.371 0.605 . . . . 0.0 110.707 -179.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.468 ' OD1' ' HB2' ' A' ' 91' ' ' ASN . 14.5 t70 -74.79 136.48 41.66 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.809 -179.614 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.643 HD11 HD12 ' A' ' 19' ' ' LEU . 64.2 mt -110.77 37.34 2.81 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 -178.28 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.468 ' HB2' ' OD1' ' A' ' 89' ' ' ASP . 6.4 m-80 -73.92 -1.87 21.49 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-O 121.194 0.521 . . . . 0.0 111.037 179.373 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 21.0 mtp180 -88.11 -10.88 48.65 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.174 179.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.437 ' CD1' HD23 ' A' ' 37' ' ' LEU . 22.7 mm -99.15 98.59 7.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -179.383 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 1.2 mm-40 -107.68 152.21 24.62 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.743 -178.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.502 ' OD1' ' HA ' ' A' ' 3' ' ' TYR . 19.4 p-10 -106.82 105.54 15.63 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.106 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.2 p -98.42 113.85 34.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-O 121.286 0.565 . . . . 0.0 110.177 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 59.44 30.22 19.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.814 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 92.97 -13.54 67.41 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 121.005 -0.617 . . . . 0.0 113.276 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? -92.25 131.03 37.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 117.405 0.603 . . . . 0.0 110.257 -179.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.477 HD13 ' SG ' ' A' ' 23' ' ' CYS . 3.2 tp -84.16 115.54 22.46 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.08 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 46.5 t -129.98 142.66 43.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.333 -179.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.551 ' HB2' HD11 ' A' ' 35' ' ' LEU . 5.5 t80 -84.2 122.81 29.37 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.236 0.541 . . . . 0.0 110.089 178.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 . . . . . 0 C--N 1.312 -1.034 0 CA-C-O 118.193 -0.908 . . . . 0.0 110.408 179.737 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' SER . . . . . 0.488 ' OG ' ' HA ' ' A' ' 91' ' ' ASN . 19.5 m . . . . . 0 N--CA 1.453 -0.28 0 CA-C-O 120.535 0.207 . . . . 0.0 111.128 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.525 ' HA ' ' OD1' ' A' ' 95' ' ' ASN . 28.6 p90 -55.51 -34.09 64.33 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.724 179.742 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -54.46 -18.74 4.59 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -178.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -57.34 -41.71 80.53 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.151 0.501 . . . . 0.0 110.426 179.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 50.0 m -130.48 35.66 4.02 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.093 179.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 15.0 m -143.18 156.33 44.74 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.12 179.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.425 HH11 ' HD2' ' A' ' 8' ' ' ARG . 10.8 ptm85 -144.35 167.95 21.25 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.751 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 57.24 59.76 3.23 Favored 'General case' 0 C--O 1.235 0.337 0 O-C-N 123.736 0.648 . . . . 0.0 111.715 179.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.431 ' HA ' ' HB2' ' A' ' 21' ' ' ALA . . . -89.88 117.53 28.78 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.192 179.606 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 31.9 m -120.53 173.11 6.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.748 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.517 HD22 ' HG ' ' A' ' 64' ' ' LEU . 3.6 mm? -104.64 114.99 29.57 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.765 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.401 ' OG1' ' HB ' ' A' ' 18' ' ' THR . 21.0 p -108.53 164.65 12.16 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.479 179.786 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 62.16 43.67 8.45 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.412 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 87.73 -46.19 3.43 Favored Glycine 0 N--CA 1.449 -0.448 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.745 179.06 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 150.55 57.77 0.01 OUTLIER Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 110.404 -1.078 . . . . 0.0 110.404 -179.135 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 7.9 ptm180 -142.91 -30.37 0.53 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.947 0.403 . . . . 0.0 111.086 -179.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.401 ' HB ' ' OG1' ' A' ' 13' ' ' THR . 3.0 m -103.92 137.95 41.18 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.189 -178.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.714 HD11 HD11 ' A' ' 90' ' ' LEU . 58.3 mt -98.17 115.86 29.19 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.171 178.585 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 45.3 ttp180 -112.67 123.0 49.31 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 178.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.431 ' HB2' ' HA ' ' A' ' 10' ' ' ALA . . . -151.77 167.2 28.98 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.928 0.394 . . . . 0.0 111.408 -179.307 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -90.08 105.98 18.18 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 178.058 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 80.2 m -99.3 127.18 45.28 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.636 -178.557 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 9.4 ttp180 -77.42 115.09 16.9 Favored 'General case' 0 N--CA 1.436 -1.144 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.887 179.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 36.7 p30 -76.54 165.72 24.4 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.22 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.07 -27.75 54.83 Favored 'General case' 0 N--CA 1.464 0.235 0 O-C-N 123.61 0.569 . . . . 0.0 111.993 -179.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -69.26 -19.39 63.93 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.296 0.57 . . . . 0.0 110.327 179.433 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 96.11 30.25 7.98 Favored Glycine 0 N--CA 1.449 -0.488 0 CA-C-N 115.536 -0.756 . . . . 0.0 112.244 179.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -124.91 150.43 46.54 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.514 0.157 . . . . 0.0 110.773 -179.095 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 94.1 m95 -84.88 123.1 30.09 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.755 0.312 . . . . 0.0 111.391 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.0 m -124.77 134.72 66.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 121.089 0.471 . . . . 0.0 110.593 178.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 16.2 m -79.5 116.33 19.65 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.816 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 72.4 m -126.73 159.53 33.45 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.372 179.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.612 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 46.3 mt-10 -139.1 145.9 40.06 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-O 120.867 0.365 . . . . 0.0 111.444 -178.778 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.577 HD13 ' HB2' ' A' ' 102' ' ' PHE . 1.5 tm? -138.81 132.29 30.36 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.054 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.476 ' N ' HD12 ' A' ' 35' ' ' LEU . 27.3 m-20 -90.98 110.59 21.85 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.025 0.441 . . . . 0.0 110.391 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.444 HD11 HD11 ' A' ' 19' ' ' LEU . 1.5 mt -86.1 -16.66 37.31 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.572 -179.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.443 ' HA ' ' HD1' ' A' ' 55' ' ' PHE . 4.4 p-10 -63.65 -20.39 65.65 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -178.021 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 12.3 t -83.23 0.62 44.65 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.121 0.486 . . . . 0.0 110.87 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 57.6 m -136.32 -26.44 1.13 Allowed 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -179.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 61.7 mt -94.49 137.21 23.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 110.204 -0.295 . . . . 0.0 110.204 179.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.432 ' HA3' ' CB ' ' A' ' 52' ' ' MET . . . -153.72 156.2 26.64 Favored Glycine 0 N--CA 1.443 -0.885 0 C-N-CA 120.685 -0.769 . . . . 0.0 111.617 179.401 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.59 ' ND2' ' HB2' ' A' ' 55' ' ' PHE . 6.3 p30 -154.24 50.68 0.57 Allowed Pre-proline 0 C--N 1.326 -0.446 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.26 -18.93 39.12 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 121.712 1.608 . . . . 0.0 111.868 -179.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.437 ' N ' HD21 ' A' ' 45' ' ' ASN . 0.9 OUTLIER -90.77 -5.74 55.28 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.316 179.614 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.534 ' HA3' ' HG2' ' A' ' 83' ' ' ARG . . . 95.95 8.57 57.92 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.407 -179.485 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.403 ' HD1' HE22 ' A' ' 86' ' ' GLN . 51.7 m-85 -125.28 135.89 52.97 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.764 0.316 . . . . 0.0 110.314 179.795 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 72.7 mt -83.29 137.24 34.07 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.325 -178.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 179.11 171.74 42.61 Favored Glycine 0 N--CA 1.445 -0.717 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.832 179.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 83.4 m95 -95.35 125.46 39.99 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 161.24 -47.81 0.37 Allowed Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.309 -179.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.432 ' CB ' ' HA3' ' A' ' 42' ' ' GLY . 0.0 OUTLIER -90.41 -161.28 0.78 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.643 0.259 . . . . 0.0 110.836 -179.188 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -146.82 168.98 20.07 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.685 -0.234 . . . . 0.0 110.444 -179.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 18.7 m-80 56.77 45.74 21.2 Favored 'General case' 0 N--CA 1.465 0.32 0 O-C-N 123.796 0.685 . . . . 0.0 112.253 178.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.59 ' HB2' ' ND2' ' A' ' 43' ' ' ASN . 7.5 p90 -65.65 -28.64 69.25 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.902 -0.319 . . . . 0.0 110.793 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.534 ' HA ' HD12 ' A' ' 62' ' ' ILE . 13.8 m -58.13 -37.12 74.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.534 -179.62 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 17.8 m80 -73.18 -17.83 61.32 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.042 0.448 . . . . 0.0 111.446 179.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 47.9 m -112.89 14.9 19.86 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.497 -178.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 54.5 m -136.1 148.44 48.26 Favored 'General case' 0 C--N 1.32 -0.684 0 O-C-N 121.749 -0.595 . . . . 0.0 111.641 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 60.9 mm-40 -117.58 145.62 44.16 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.825 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 55.87 58.83 4.14 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 123.925 0.765 . . . . 0.0 111.687 178.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.534 HD12 ' HA ' ' A' ' 56' ' ' SER . 81.5 mt -75.95 113.6 15.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.512 179.767 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.41 ' HD2' HD21 ' A' ' 12' ' ' LEU . 15.2 tptm -147.74 154.84 41.05 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 -179.692 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.524 HD13 ' HA2' ' A' ' 68' ' ' GLY . 67.2 mt -82.41 138.9 34.3 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.314 0.578 . . . . 0.0 111.233 -179.161 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -89.17 -75.27 0.44 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 114.697 -1.138 . . . . 0.0 111.129 -178.492 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.584 ' HB2' ' HB2' ' A' ' 69' ' ' ARG . 19.7 mt-10 -77.87 45.53 0.52 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.754 -178.317 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 65.39 2.46 10.17 Favored Glycine 0 CA--C 1.518 0.255 0 CA-C-N 115.837 -0.619 . . . . 0.0 113.671 179.254 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.524 ' HA2' HD13 ' A' ' 64' ' ' LEU . . . 141.63 -13.81 2.69 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.081 -1.056 . . . . 0.0 112.985 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.584 ' HB2' ' HB2' ' A' ' 66' ' ' GLU . 14.3 mmt180 -78.27 -19.48 53.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.261 0.553 . . . . 0.0 109.825 179.746 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 40.7 tttt -144.46 143.54 30.93 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.596 -178.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.542 ' HB2' HD12 ' A' ' 90' ' ' LEU . 10.1 tt -110.5 132.81 53.86 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.753 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.9 p -121.0 132.42 54.89 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.03 0.443 . . . . 0.0 111.586 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 24.7 p -161.19 167.36 26.25 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.208 179.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 25.0 ttt180 -100.4 102.83 20.05 Favored Pre-proline 0 C--N 1.316 -0.85 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.343 179.012 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.425 ' HD2' ' HA ' ' A' ' 85' ' ' ARG . 39.0 Cg_endo -67.06 121.01 8.13 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 122.539 2.159 . . . . 0.0 110.58 178.649 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.603 ' HA ' ' HB2' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -119.25 146.58 45.1 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.764 -179.354 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.664 ' HB ' ' HD2' ' A' ' 83' ' ' ARG . 5.6 t -79.67 144.94 33.27 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 179.527 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.2 p -72.03 -9.47 12.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.436 -177.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -58.63 -29.37 66.45 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.224 0.535 . . . . 0.0 110.231 179.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -169.81 -24.62 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.304 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.869 -179.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 111.98 26.05 4.54 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.848 -0.692 . . . . 0.0 111.718 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.552 ' O ' HG22 ' A' ' 77' ' ' THR . 20.3 p90 -110.3 141.09 43.78 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 -178.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.664 ' HD2' ' HB ' ' A' ' 77' ' ' THR . 0.0 OUTLIER 174.13 -149.48 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 O-C-N 123.654 0.596 . . . . 0.0 110.027 -179.791 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -121.55 176.15 5.84 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 122.271 0.228 . . . . 0.0 110.982 -178.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.425 ' HA ' ' HD2' ' A' ' 75' ' ' PRO . 42.0 ttt-85 -98.35 156.81 16.55 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 178.075 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . 0.403 HE22 ' HD1' ' A' ' 47' ' ' PHE . 9.2 tt0 -166.55 173.09 10.11 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 120.927 0.394 . . . . 0.0 111.524 -178.713 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.403 ' N ' ' HG2' ' A' ' 86' ' ' GLN . . . -135.8 144.42 16.23 Favored Glycine 0 N--CA 1.45 -0.388 0 N-CA-C 111.626 -0.589 . . . . 0.0 111.626 178.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 12.2 tt -121.57 134.67 64.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.093 0.473 . . . . 0.0 110.793 -179.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -77.73 136.76 38.2 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.113 -179.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.714 HD11 HD11 ' A' ' 19' ' ' LEU . 68.6 mt -108.38 56.48 0.63 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.735 0.778 . . . . 0.0 111.219 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.488 ' HA ' ' OG ' ' A' ' 2' ' ' SER . 19.7 m-80 -91.09 3.19 55.42 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.686 179.478 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 36.9 mtp180 -96.77 -6.69 35.63 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.846 179.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 16.4 mm -105.47 101.64 12.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -179.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 27.8 tp60 -113.95 145.09 42.01 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.022 -178.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.525 ' OD1' ' HA ' ' A' ' 3' ' ' TYR . 19.2 p-10 -95.44 115.7 27.79 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.157 178.817 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 57.8 t -106.24 110.78 32.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.04 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 30.7 m-80 58.48 28.8 17.45 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.995 -179.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 100.2 -23.55 35.48 Favored Glycine 0 N--CA 1.445 -0.748 0 C-N-CA 120.522 -0.847 . . . . 0.0 113.157 179.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.41 ' N ' ' HD2' ' A' ' 99' ' ' ARG . 3.3 mpt_? -86.95 138.18 31.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 117.242 0.521 . . . . 0.0 110.195 -179.367 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.449 HD21 ' HB2' ' A' ' 35' ' ' LEU . 4.9 tp -86.21 123.57 31.63 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 14.6 t -128.21 143.78 39.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.93 -179.027 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.577 ' HB2' HD13 ' A' ' 35' ' ' LEU . 9.9 t80 -92.66 128.3 38.47 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.161 0.505 . . . . 0.0 109.788 178.161 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 . . . . . 0 C--O 1.25 1.091 0 CA-C-O 118.181 -0.914 . . . . 0.0 110.651 179.742 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' SER . . . . . 0.463 ' HG ' ' HA ' ' A' ' 91' ' ' ASN . 19.9 m . . . . . 0 N--CA 1.448 -0.533 0 N-CA-C 110.781 -0.081 . . . . 0.0 110.781 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.431 ' CZ ' HD11 ' A' ' 19' ' ' LEU . 13.4 p90 -48.43 -37.53 17.38 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.42 ' HB1' ' HD2' ' A' ' 69' ' ' ARG . . . -53.18 -19.1 2.71 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -178.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -56.63 -42.62 79.16 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 121.335 0.588 . . . . 0.0 110.149 178.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 18.5 m -129.78 40.47 3.57 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.481 179.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 18.5 t -146.67 150.44 35.43 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.186 -179.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 9.3 ptp180 -136.87 175.29 9.74 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.279 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.581 HD22 ' HB2' ' A' ' 22' ' ' GLU . 8.9 p30 47.06 46.86 16.17 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 124.254 0.971 . . . . 0.0 112.107 -179.38 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.537 ' HA ' ' HB3' ' A' ' 21' ' ' ALA . . . -74.01 118.44 16.96 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.619 179.59 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 27.4 m -122.14 168.28 14.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.842 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.751 HD23 ' HG ' ' A' ' 64' ' ' LEU . 3.3 mm? -104.75 123.02 46.92 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.634 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.481 HG23 ' CZ ' ' A' ' 20' ' ' ARG . 20.6 p -123.19 168.71 12.07 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.811 0.338 . . . . 0.0 111.81 -178.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 59.94 42.75 15.7 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.003 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 92.17 -23.02 29.05 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.812 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.486 ' O ' HG22 ' A' ' 62' ' ' ILE . . . 122.32 41.23 0.48 Allowed Glycine 0 N--CA 1.445 -0.736 0 N-CA-C 111.39 -0.684 . . . . 0.0 111.39 179.837 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.632 ' HB2' ' HB2' ' A' ' 38' ' ' ASP . 15.9 ptt180 -126.14 -26.27 3.42 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.109 0.481 . . . . 0.0 110.582 -179.338 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.409 ' HB ' ' OG1' ' A' ' 13' ' ' THR . 2.8 m -101.11 130.32 47.14 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.48 -179.245 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.632 HD12 HD13 ' A' ' 90' ' ' LEU . 92.9 mt -91.23 112.22 24.04 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.01 179.529 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.481 ' CZ ' HG23 ' A' ' 13' ' ' THR . 43.9 ttm180 -109.07 119.39 39.42 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 179.375 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.537 ' HB3' ' HA ' ' A' ' 10' ' ' ALA . . . -154.79 167.38 30.41 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.818 0.342 . . . . 0.0 111.293 -179.434 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.581 ' HB2' HD22 ' A' ' 9' ' ' ASN . 0.4 OUTLIER -88.54 111.74 22.2 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 177.427 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 69.4 m -99.65 126.97 45.75 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 -179.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.446 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 34.3 ttt180 -76.1 114.07 14.35 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 116.3 -0.409 . . . . 0.0 109.936 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 35.1 p30 -77.95 170.23 16.95 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.372 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.75 -29.18 62.29 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 -178.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -73.98 -13.09 60.82 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.468 0.651 . . . . 0.0 110.253 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 91.21 27.89 16.84 Favored Glycine 0 N--CA 1.448 -0.54 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.629 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.446 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 10.7 t-20 -111.53 158.54 19.06 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 110.14 -0.319 . . . . 0.0 110.14 -178.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 98.9 m95 -99.57 119.43 38.04 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.953 0.406 . . . . 0.0 110.765 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 11.1 m -122.25 137.53 55.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.252 -179.461 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 16.8 m -75.92 109.57 9.65 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.105 179.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 69.3 m -122.43 137.13 54.97 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.41 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.599 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 3.0 mp0 -122.55 146.73 47.15 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.514 -179.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.452 ' HB2' HD23 ' A' ' 100' ' ' LEU . 1.2 tm? -138.53 126.83 22.97 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 178.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.413 ' N ' HD13 ' A' ' 35' ' ' LEU . 4.4 m-20 -85.95 110.07 19.2 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.868 0.366 . . . . 0.0 110.475 179.547 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.407 HD13 HD21 ' A' ' 90' ' ' LEU . 2.1 mt -83.91 -12.57 55.24 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.034 178.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.683 ' OD2' ' HA ' ' A' ' 54' ' ' ASN . 9.6 t70 -60.94 -29.23 69.51 Favored 'General case' 0 C--O 1.221 -0.426 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.89 -178.607 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.6 t -83.48 1.02 43.79 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.827 0.346 . . . . 0.0 111.459 -178.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 37.3 m -128.97 -24.68 2.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.829 0.347 . . . . 0.0 111.775 -179.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 71.9 mt -102.8 137.05 32.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.549 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -143.84 146.92 17.96 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.68 -0.771 . . . . 0.0 111.835 179.177 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.535 HD21 ' CB ' ' A' ' 75' ' ' PRO . 30.5 p-10 -152.44 48.86 0.48 Allowed Pre-proline 0 CA--C 1.539 0.557 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -178.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -71.79 -22.12 24.11 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 121.661 1.574 . . . . 0.0 111.747 -179.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -83.97 -14.54 50.53 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.885 179.173 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.535 ' CA ' ' HG2' ' A' ' 83' ' ' ARG . . . 106.26 8.62 33.14 Favored Glycine 0 N--CA 1.443 -0.874 0 C-N-CA 120.315 -0.945 . . . . 0.0 112.596 -179.149 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.531 ' HA ' HE22 ' A' ' 86' ' ' GLN . 66.5 m-85 -124.08 133.29 53.66 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.676 0.274 . . . . 0.0 110.282 179.476 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 95.3 mt -83.54 130.24 35.0 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.513 -178.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -173.5 172.65 45.36 Favored Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.097 179.029 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 88.3 m95 -95.03 125.1 39.47 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 168.64 -59.18 0.2 Allowed Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.493 -0.861 . . . . 0.0 112.602 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 6.1 ttp -96.75 -154.66 0.45 Allowed 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -146.79 173.75 12.1 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.43 0.157 . . . . 0.0 111.013 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.683 ' HA ' ' OD2' ' A' ' 38' ' ' ASP . 42.7 m-80 64.92 55.37 1.18 Allowed 'General case' 0 C--O 1.237 0.416 0 O-C-N 123.858 0.724 . . . . 0.0 111.52 179.523 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.476 ' CD1' ' HA ' ' A' ' 38' ' ' ASP . 11.8 p90 -87.46 -26.17 23.38 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.16 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 32.4 p -61.0 -35.89 78.04 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.998 0.428 . . . . 0.0 111.105 -178.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 26.7 m80 -77.49 -11.94 59.91 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.192 179.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.47 ' HB2' ' OD1' ' A' ' 43' ' ' ASN . 2.7 m -113.41 20.25 16.25 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.053 0.454 . . . . 0.0 110.353 -179.624 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 24.8 m -136.1 156.0 49.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.09 0.471 . . . . 0.0 111.46 -179.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -129.2 138.31 51.64 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.282 178.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.414 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 32.2 t70 58.22 79.31 0.21 Allowed 'General case' 0 N--CA 1.469 0.49 0 O-C-N 123.735 0.647 . . . . 0.0 110.721 -179.291 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.513 HG21 HD22 ' A' ' 71' ' ' LEU . 68.0 mt -98.74 112.74 31.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.548 -179.566 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.28 164.94 26.59 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.307 -179.057 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.751 ' HG ' HD23 ' A' ' 12' ' ' LEU . 55.9 mt -96.05 114.84 26.58 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 178.481 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -65.95 -54.34 27.58 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.12 -177.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 43.1 mm-40 -88.36 7.84 30.5 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.112 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 73.23 21.09 80.01 Favored Glycine 0 N--CA 1.447 -0.623 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.678 -179.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 156.53 -49.84 0.45 Allowed Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 120.131 -1.033 . . . . 0.0 112.946 179.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.42 ' HD2' ' HB1' ' A' ' 4' ' ' ALA . 5.1 mpt_? -66.31 -26.66 67.41 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -179.365 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 32.0 ttpt -141.91 144.62 33.88 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.651 -0.419 . . . . 0.0 111.677 -178.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.548 ' HB2' HD11 ' A' ' 90' ' ' LEU . 8.7 tt -115.45 124.08 50.24 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.305 -0.861 . . . . 0.0 108.983 179.286 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.415 HG23 ' HA3' ' A' ' 87' ' ' GLY . 1.1 p -115.8 133.4 56.07 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.375 0.607 . . . . 0.0 111.114 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.414 ' HA ' ' O ' ' A' ' 61' ' ' ASP . 26.3 p -156.2 172.32 18.66 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.336 -0.847 . . . . 0.0 108.868 -179.773 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.472 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 4.4 tmt_? -104.23 98.57 14.37 Favored Pre-proline 0 C--N 1.316 -0.861 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 179.283 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.535 ' CB ' HD21 ' A' ' 43' ' ' ASN . 54.9 Cg_endo -69.35 123.82 10.62 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 122.902 2.401 . . . . 0.0 110.653 179.026 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.651 ' HA ' ' HB2' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -120.91 149.41 42.67 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.619 -179.077 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.701 HG21 ' O ' ' A' ' 82' ' ' PHE . 13.2 t -79.59 134.5 36.47 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 177.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 31.3 m -72.44 -7.85 10.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 O-C-N 123.706 0.629 . . . . 0.0 111.402 -179.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -66.98 -33.63 75.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.533 179.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -150.0 -20.34 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.364 -0.922 . . . . 0.0 113.162 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.461 ' HA2' ' CE ' ' A' ' 76' ' ' LYS . . . 98.01 18.04 28.21 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.579 -0.82 . . . . 0.0 111.685 -179.712 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.701 ' O ' HG21 ' A' ' 77' ' ' THR . 32.0 p90 -111.55 153.18 26.62 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 118.872 -0.585 . . . . 0.0 109.891 -178.785 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.651 ' HB2' ' HA ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 167.84 -150.4 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.405 0 O-C-N 123.679 0.612 . . . . 0.0 111.442 179.502 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -127.58 154.92 44.62 Favored 'General case' 0 C--O 1.226 -0.142 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.7 -178.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.472 ' HA ' ' HA ' ' A' ' 74' ' ' ARG . 35.8 ttt180 -84.32 146.83 27.52 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 178.335 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . 0.531 HE22 ' HA ' ' A' ' 47' ' ' PHE . 36.8 mt-30 -151.49 -170.17 3.58 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.619 0.723 . . . . 0.0 112.091 -177.702 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.415 ' HA3' HG23 ' A' ' 72' ' ' THR . . . -155.05 142.99 9.43 Favored Glycine 0 N--CA 1.442 -0.904 0 N-CA-C 110.23 -1.148 . . . . 0.0 110.23 178.645 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 13.0 tt -122.75 134.83 64.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.257 0.551 . . . . 0.0 110.734 -178.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -74.37 130.9 40.53 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.625 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.632 HD13 HD12 ' A' ' 19' ' ' LEU . 61.4 mt -102.04 46.55 0.93 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.676 0.751 . . . . 0.0 110.848 -179.746 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.463 ' HA ' ' HG ' ' A' ' 2' ' ' SER . 13.6 m-80 -81.3 4.63 19.91 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.317 179.665 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 19.1 mtp180 -100.54 -6.64 25.1 Favored 'General case' 0 C--O 1.226 -0.179 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.7 178.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 23.5 mm -106.15 108.03 24.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 -178.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 20.9 tp60 -125.98 145.93 50.08 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.783 -178.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 13.9 p-10 -95.08 115.31 27.27 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.331 0.586 . . . . 0.0 110.023 178.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 52.0 t -101.78 112.82 36.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.128 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 13.6 m-80 57.84 33.5 23.28 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.091 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 94.55 -23.87 30.33 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.837 179.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.24 124.89 33.81 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.945 0.372 . . . . 0.0 110.031 -179.486 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.452 HD23 ' HB2' ' A' ' 35' ' ' LEU . 11.8 tp -76.31 119.38 20.12 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 38.8 t -129.9 141.73 45.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.002 0.43 . . . . 0.0 111.154 -178.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.409 ' HB2' HD11 ' A' ' 35' ' ' LEU . 6.5 t80 -83.79 132.34 34.83 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 177.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 3.7 tp-100 . . . . . 0 C--N 1.314 -0.953 0 CA-C-O 118.745 -0.645 . . . . 0.0 110.231 179.946 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' SER . . . . . 0.59 ' OG ' ' HA ' ' A' ' 91' ' ' ASN . 8.7 m . . . . . 0 N--CA 1.452 -0.364 0 CA-C-O 120.687 0.279 . . . . 0.0 111.287 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.428 ' CZ ' HD13 ' A' ' 19' ' ' LEU . 14.9 p90 -63.28 -34.46 77.73 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.667 0.27 . . . . 0.0 110.69 178.705 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -56.32 -24.26 42.42 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.806 -0.633 . . . . 0.0 112.597 -178.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -65.78 -16.51 63.86 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 121.205 0.526 . . . . 0.0 110.835 179.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 62.0 m -140.19 29.63 2.02 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.585 178.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 19.3 m -146.06 156.51 43.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.496 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 11.7 ptp180 -143.09 166.24 25.19 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.657 179.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 67.4 m-80 58.9 54.42 5.11 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.117 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.467 ' HA ' ' O ' ' A' ' 20' ' ' ARG . . . -88.65 118.47 28.34 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.311 179.555 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 27.3 m -118.93 171.58 6.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.193 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.536 HD22 ' HG ' ' A' ' 64' ' ' LEU . 3.3 mm? -104.99 115.0 29.54 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.147 -179.496 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.485 ' OG1' ' HB ' ' A' ' 18' ' ' THR . 21.9 p -110.06 167.73 9.96 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.931 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 57.97 53.27 6.97 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.948 -179.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 81.68 -35.36 2.48 Favored Glycine 0 CA--C 1.519 0.322 0 CA-C-N 116.035 -0.529 . . . . 0.0 112.686 179.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 136.75 49.22 0.07 OUTLIER Glycine 0 N--CA 1.447 -0.598 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 -179.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.47 ' HD2' ' CG ' ' A' ' 38' ' ' ASP . 15.7 ptt180 -133.91 -27.65 1.44 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.885 0.374 . . . . 0.0 111.317 -179.415 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.485 ' HB ' ' OG1' ' A' ' 13' ' ' THR . 3.9 m -99.04 135.73 40.03 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.794 -178.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.752 HD11 HD12 ' A' ' 90' ' ' LEU . 61.6 mt -94.3 114.65 26.76 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.628 179.337 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.467 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 1.6 tmt_? -110.47 120.51 42.66 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 178.589 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -153.2 167.23 30.01 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.835 0.35 . . . . 0.0 111.63 -179.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -90.73 105.63 17.95 Favored 'General case' 0 CA--C 1.512 -0.49 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 177.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.449 ' SG ' HD11 ' A' ' 100' ' ' LEU . 83.7 m -92.61 122.8 35.39 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 120.88 0.372 . . . . 0.0 110.963 -178.474 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.494 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 37.3 ttp180 -71.12 110.95 6.1 Favored 'General case' 0 N--CA 1.435 -1.208 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.64 178.609 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 37.4 p30 -76.84 167.19 22.26 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.12 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.42 -31.45 45.21 Favored 'General case' 0 C--N 1.329 -0.324 0 O-C-N 123.672 0.607 . . . . 0.0 112.289 -178.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -70.9 -17.64 62.7 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.306 0.574 . . . . 0.0 110.773 -179.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 95.08 28.39 9.98 Favored Glycine 0 CA--C 1.51 -0.243 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.551 -179.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.494 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 13.9 t-20 -113.08 164.03 13.99 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 -178.738 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.448 ' CZ3' ' HB2' ' A' ' 24' ' ' ARG . 96.6 m95 -105.21 116.82 32.59 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.77 0.319 . . . . 0.0 110.8 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.5 m -118.56 138.03 50.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.737 179.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 13.3 m -80.33 114.79 19.49 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.154 -179.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 75.5 m -126.13 147.6 49.58 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.244 179.268 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.655 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 50.9 mt-10 -131.7 141.39 49.55 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.887 -179.497 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.514 ' HB2' HD22 ' A' ' 100' ' ' LEU . 1.3 tm? -137.53 127.41 25.62 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.288 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.401 ' N ' HD12 ' A' ' 35' ' ' LEU . 18.6 m-20 -81.54 109.72 16.25 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.284 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.516 HD12 ' HG ' ' A' ' 19' ' ' LEU . 4.1 mt -82.01 -23.07 36.16 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 121.086 -0.246 . . . . 0.0 111.59 -178.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.47 ' CG ' ' HD2' ' A' ' 17' ' ' ARG . 6.5 p-10 -66.44 -6.16 13.61 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.796 0.332 . . . . 0.0 111.475 -178.421 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 55.7 p -76.55 -21.77 55.23 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.249 0.547 . . . . 0.0 109.727 178.361 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.456 ' SG ' ' HE3' ' A' ' 50' ' ' TRP . 29.0 t -128.79 -14.61 4.51 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.656 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 54.0 mt -99.42 133.98 40.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 O-C-N 122.149 -0.344 . . . . 0.0 110.136 178.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -152.28 165.33 30.81 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 121.011 -0.614 . . . . 0.0 111.857 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.712 ' ND2' ' HB2' ' A' ' 55' ' ' PHE . 5.3 p30 -163.86 54.35 0.4 Allowed Pre-proline 0 CA--C 1.537 0.442 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -179.503 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -73.13 -22.74 18.92 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 121.753 1.635 . . . . 0.0 111.241 179.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -85.07 -17.11 38.41 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.311 179.02 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.592 ' CA ' ' HG2' ' A' ' 83' ' ' ARG . . . 105.66 13.65 23.52 Favored Glycine 0 N--CA 1.441 -0.977 0 CA-C-N 115.459 -0.791 . . . . 0.0 113.152 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -125.3 134.2 52.35 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.831 0.348 . . . . 0.0 110.431 179.095 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 88.7 mt -82.79 129.85 35.05 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.107 -178.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -176.85 175.87 47.79 Favored Glycine 0 N--CA 1.442 -0.958 0 C-N-CA 120.663 -0.78 . . . . 0.0 111.873 179.241 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.456 ' HE3' ' SG ' ' A' ' 40' ' ' CYS . 88.1 m95 -96.22 125.45 40.75 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 159.88 -62.16 0.3 Allowed Glycine 0 N--CA 1.45 -0.373 0 N-CA-C 111.443 -0.663 . . . . 0.0 111.443 -179.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 42.4 tpp -80.67 173.82 12.22 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 179.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -129.44 166.85 18.78 Favored 'General case' 0 C--N 1.323 -0.558 0 O-C-N 122.147 -0.346 . . . . 0.0 111.629 -179.199 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 67.53 47.36 1.23 Allowed 'General case' 0 N--CA 1.463 0.212 0 O-C-N 124.175 0.922 . . . . 0.0 112.276 179.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.712 ' HB2' ' ND2' ' A' ' 43' ' ' ASN . 3.9 p90 -70.44 -26.19 63.54 Favored 'General case' 0 C--O 1.222 -0.343 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.589 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 32.9 t -60.34 -38.3 83.37 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.93 0.395 . . . . 0.0 110.834 -179.116 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 26.2 m80 -80.86 -2.81 48.92 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.57 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 49.8 m -124.91 16.28 8.59 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.648 0.261 . . . . 0.0 111.572 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 69.7 m -131.67 149.42 52.49 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.459 0.647 . . . . 0.0 111.981 -179.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -120.3 139.68 52.38 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.913 -1.04 . . . . 0.0 109.295 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.482 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 28.4 t70 61.34 72.07 0.53 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.482 0.658 . . . . 0.0 110.546 179.343 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.514 HG21 HD21 ' A' ' 71' ' ' LEU . 65.6 mt -96.3 113.48 30.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.242 -179.694 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 17.3 ttmt -150.33 149.99 30.86 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.859 0.361 . . . . 0.0 110.834 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.561 HD13 ' HA2' ' A' ' 68' ' ' GLY . 33.7 mt -88.67 136.83 32.8 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.849 -179.411 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.433 ' C ' ' H ' ' A' ' 67' ' ' GLY . 30.1 mt-10 -91.23 -67.08 0.87 Allowed 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.09 0.471 . . . . 0.0 110.988 179.436 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -74.88 42.29 0.17 Allowed 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 115.395 -0.82 . . . . 0.0 112.07 -178.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.433 ' H ' ' C ' ' A' ' 65' ' ' GLU . . . 60.9 13.92 35.56 Favored Glycine 0 C--N 1.314 -0.662 0 CA-C-N 115.249 -0.887 . . . . 0.0 113.426 179.091 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.561 ' HA2' HD13 ' A' ' 64' ' ' LEU . . . 130.92 -13.82 5.51 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.103 -1.046 . . . . 0.0 113.197 179.587 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 2.3 ttp85 -78.17 -20.04 52.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.343 0.592 . . . . 0.0 109.869 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -140.26 140.88 35.85 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.432 -179.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.549 ' HB2' HD13 ' A' ' 90' ' ' LEU . 10.3 tt -118.54 132.1 56.22 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.989 -0.551 . . . . 0.0 109.927 -179.414 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -118.19 129.91 55.78 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.634 178.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.482 ' HA ' ' O ' ' A' ' 61' ' ' ASP . 28.8 p -157.84 163.55 37.87 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.475 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.565 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 33.4 ttt180 -99.76 104.16 26.36 Favored Pre-proline 0 C--N 1.316 -0.886 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.32 179.488 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.566 ' HD2' ' HA ' ' A' ' 85' ' ' ARG . 43.5 Cg_endo -67.82 115.66 3.88 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 122.449 2.1 . . . . 0.0 109.802 178.202 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.645 ' HA ' ' HB2' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -119.3 140.33 50.47 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.65 -179.661 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.67 HG21 ' O ' ' A' ' 82' ' ' PHE . 15.3 t -75.85 130.14 38.09 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 17.3 m -72.59 -6.24 7.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.309 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -67.45 -34.01 76.31 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.845 179.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.581 ' HA3' ' CE2' ' A' ' 82' ' ' PHE . . . -143.26 -20.58 0.21 Allowed Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.902 179.769 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.498 ' HA2' ' CE ' ' A' ' 76' ' ' LYS . . . 95.23 12.54 54.51 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.363 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.67 ' O ' HG21 ' A' ' 77' ' ' THR . 21.3 p90 -111.96 157.68 20.4 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 118.83 -0.605 . . . . 0.0 110.64 -178.49 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.645 ' HB2' ' HA ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 165.54 -152.49 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.633 0 O-C-N 124.107 0.879 . . . . 0.0 111.862 178.238 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -132.6 151.3 51.98 Favored 'General case' 0 C--O 1.225 -0.192 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.189 -178.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.566 ' HA ' ' HD2' ' A' ' 75' ' ' PRO . 45.3 ttt-85 -85.95 151.48 23.71 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.547 0.213 . . . . 0.0 110.62 -179.39 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -154.05 -172.9 4.37 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.296 -178.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -141.54 144.47 14.46 Favored Glycine 0 N--CA 1.451 -0.34 0 N-CA-C 111.091 -0.804 . . . . 0.0 111.091 179.127 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 9.2 tt -131.77 137.53 54.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 120.935 0.398 . . . . 0.0 110.896 -179.144 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -82.03 136.88 35.18 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.269 179.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.752 HD12 HD11 ' A' ' 19' ' ' LEU . 50.8 mt -101.05 45.03 0.98 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.598 0.713 . . . . 0.0 110.587 -179.311 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.59 ' HA ' ' OG ' ' A' ' 2' ' ' SER . 0.9 OUTLIER -74.87 -0.94 20.16 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.931 -179.354 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 11.0 mtp180 -94.98 -11.98 27.53 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.809 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 23.5 mm -101.64 112.57 35.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 -179.268 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -129.1 162.21 28.24 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.589 0.709 . . . . 0.0 112.093 -178.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.481 ' HA ' ' O ' ' A' ' 99' ' ' ARG . 19.8 p-10 -106.94 124.55 49.78 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.728 -1.123 . . . . 0.0 110.308 179.144 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 46.1 t -106.69 104.02 16.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 33.9 m-80 59.78 19.39 8.21 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.71 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 119.44 -25.95 7.52 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.607 -0.806 . . . . 0.0 113.52 178.294 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.481 ' O ' ' HA ' ' A' ' 95' ' ' ASN . 1.9 ptm180 -86.76 144.7 26.95 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 117.092 0.446 . . . . 0.0 110.393 -179.267 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.514 HD22 ' HB2' ' A' ' 35' ' ' LEU . 6.9 tp -93.43 119.71 32.84 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 23.9 t -129.34 139.31 52.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.736 -178.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.414 ' HB2' HD13 ' A' ' 35' ' ' LEU . 13.7 t80 -82.98 130.68 35.17 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.873 -0.418 . . . . 0.0 109.873 178.508 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 . . . . . 0 C--N 1.316 -0.887 0 CA-C-O 118.37 -0.824 . . . . 0.0 110.117 179.63 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' SER . . . . . 0.514 ' HG ' ' HA ' ' A' ' 91' ' ' ASN . 13.2 m . . . . . 0 N--CA 1.449 -0.486 0 CA-C-O 120.746 0.307 . . . . 0.0 111.13 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.443 ' CG ' HD13 ' A' ' 100' ' ' LEU . 18.9 p90 -57.6 -38.13 74.4 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.104 -0.498 . . . . 0.0 112.095 179.782 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.548 ' HB3' ' CG ' ' A' ' 69' ' ' ARG . . . -53.85 -18.72 3.55 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 -177.699 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -63.98 -30.41 71.49 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.381 0.61 . . . . 0.0 109.764 179.076 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 18.8 m -131.84 28.97 4.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.924 179.255 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.402 ' HA ' ' HZ3' ' A' ' 30' ' ' TRP . 13.6 m -143.33 155.98 44.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.921 -179.81 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.405 HH11 ' HD2' ' A' ' 8' ' ' ARG . 12.7 ptm180 -145.84 169.9 17.64 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 110.436 -0.209 . . . . 0.0 110.436 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 63.02 53.42 2.34 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 123.715 0.634 . . . . 0.0 110.803 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.474 ' HA ' ' HB1' ' A' ' 21' ' ' ALA . . . -92.06 119.86 32.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.201 -179.614 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 34.4 m -123.13 170.42 13.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.209 179.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.613 HD23 ' HG ' ' A' ' 64' ' ' LEU . 3.3 mm? -105.51 115.33 30.07 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.1 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.433 ' OG1' ' HB ' ' A' ' 18' ' ' THR . 21.8 p -112.26 171.23 7.64 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.35 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 58.9 45.88 14.57 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.486 179.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 88.56 -30.77 5.15 Favored Glycine 0 N--CA 1.451 -0.358 0 CA-C-N 115.892 -0.595 . . . . 0.0 112.366 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 131.31 53.72 0.09 OUTLIER Glycine 0 N--CA 1.445 -0.731 0 N-CA-C 111.059 -0.817 . . . . 0.0 111.059 -179.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.439 ' HD2' ' OD1' ' A' ' 38' ' ' ASP . 14.6 ptt180 -141.46 -29.28 0.64 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.864 0.364 . . . . 0.0 111.579 -179.712 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.433 ' HB ' ' OG1' ' A' ' 13' ' ' THR . 3.7 m -95.92 132.62 41.02 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.417 -179.631 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.704 HD11 HD12 ' A' ' 90' ' ' LEU . 87.5 mt -93.76 114.33 26.59 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.08 179.533 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 56.0 ttp180 -112.1 119.78 39.58 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 178.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.474 ' HB1' ' HA ' ' A' ' 10' ' ' ALA . . . -154.15 167.47 29.76 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.209 -179.317 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -89.89 108.94 20.01 Favored 'General case' 0 CA--C 1.513 -0.466 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 177.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.546 ' SG ' HD12 ' A' ' 100' ' ' LEU . 18.7 m -96.23 128.36 43.08 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.252 -178.641 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.492 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 25.0 ttp180 -72.87 116.73 13.72 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 179.411 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 36.3 p30 -84.16 171.58 12.7 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.052 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.44 -28.88 47.19 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 112.654 0.612 . . . . 0.0 112.654 -178.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -75.56 -10.59 59.58 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.394 0.616 . . . . 0.0 110.368 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 86.03 28.15 29.27 Favored Glycine 0 N--CA 1.447 -0.629 0 N-CA-C 110.916 -0.874 . . . . 0.0 110.916 -179.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.492 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 3.3 t-20 -110.31 160.35 16.63 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.572 0.225 . . . . 0.0 110.92 -178.479 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.402 ' HZ3' ' HA ' ' A' ' 7' ' ' SER . 84.1 m95 -99.98 112.9 25.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.074 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.1 m -115.79 131.88 66.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.365 178.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 21.6 m -77.46 109.02 11.04 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.943 0.401 . . . . 0.0 110.747 -179.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 70.3 m -118.29 151.69 37.21 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.726 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.604 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 45.1 mt-10 -128.89 144.5 51.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.817 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.61 HD11 ' HB2' ' A' ' 102' ' ' PHE . 1.4 tm? -138.86 128.84 25.19 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 178.472 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.402 ' N ' HD13 ' A' ' 35' ' ' LEU . 10.9 m-20 -90.31 109.85 20.94 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.479 -179.161 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.483 HD22 HD12 ' A' ' 35' ' ' LEU . 0.8 OUTLIER -87.21 -14.34 41.38 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -179.652 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.439 ' OD1' ' HD2' ' A' ' 17' ' ' ARG . 0.9 OUTLIER -64.64 -17.18 63.8 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -177.698 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.417 HG23 ' SG ' ' A' ' 40' ' ' CYS . 9.3 t -85.02 -2.63 58.19 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.894 0.378 . . . . 0.0 110.486 179.622 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.417 ' SG ' HG23 ' A' ' 39' ' ' THR . 35.8 m -132.28 -14.12 3.01 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.698 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 57.2 mt -116.41 134.89 58.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 CA-C-O 120.745 0.307 . . . . 0.0 110.402 179.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -153.16 164.64 30.99 Favored Glycine 0 N--CA 1.446 -0.635 0 N-CA-C 111.026 -0.83 . . . . 0.0 111.026 179.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.451 ' OD1' ' HB2' ' A' ' 55' ' ' PHE . 2.3 p-10 -157.14 52.44 0.6 Allowed Pre-proline 0 CA--C 1.537 0.468 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -179.586 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -69.4 -19.77 37.42 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 121.708 1.605 . . . . 0.0 111.899 -179.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -89.78 -2.84 58.33 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.463 179.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.531 ' CA ' ' HG2' ' A' ' 83' ' ' ARG . . . 95.32 4.86 60.82 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.477 -0.868 . . . . 0.0 112.699 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 52.6 m-85 -126.19 137.44 53.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.69 0.245 . . . . 0.0 110.648 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.449 HD23 HG21 ' A' ' 88' ' ' ILE . 5.5 mp -82.67 149.47 27.34 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.403 -179.313 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 171.4 171.98 37.07 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.396 178.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.47 ' CD1' HD13 ' A' ' 88' ' ' ILE . 91.8 m95 -95.62 133.8 39.26 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 138.65 -39.77 1.53 Allowed Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.879 -0.677 . . . . 0.0 111.636 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 4.4 tpt -94.03 -172.01 2.72 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -146.13 169.96 17.67 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.178 -0.609 . . . . 0.0 111.955 -179.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 45.5 m-80 62.41 42.71 8.7 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.062 -0.972 . . . . 0.0 112.39 179.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.451 ' HB2' ' OD1' ' A' ' 43' ' ' ASN . 20.9 p90 -63.34 -32.65 74.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.06 0.457 . . . . 0.0 110.302 179.337 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.475 ' HA ' HD11 ' A' ' 62' ' ' ILE . 8.8 m -64.05 -35.52 81.01 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.464 -179.399 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 27.3 m80 -79.15 -5.03 53.22 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.84 0.353 . . . . 0.0 111.173 -179.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 6.2 p -128.0 20.49 6.42 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.544 -179.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 66.9 m -135.8 152.41 51.06 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 121.26 0.552 . . . . 0.0 112.239 -179.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 -114.05 149.4 35.51 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.052 179.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 15.7 t70 47.25 72.51 0.24 Allowed 'General case' 0 N--CA 1.469 0.513 0 O-C-N 124.15 0.906 . . . . 0.0 111.526 179.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.514 HG23 HD21 ' A' ' 71' ' ' LEU . 73.1 mt -90.56 117.68 34.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.19 -179.595 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -149.12 164.62 34.17 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.074 179.452 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.613 ' HG ' HD23 ' A' ' 12' ' ' LEU . 62.7 mt -91.07 136.42 33.09 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.085 0.469 . . . . 0.0 110.954 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -92.76 -66.1 0.95 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.841 -178.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -81.65 46.1 0.94 Allowed 'General case' 0 CA--C 1.514 -0.424 0 CA-C-O 120.985 0.421 . . . . 0.0 111.709 -178.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 57.77 22.46 47.3 Favored Glycine 0 C--N 1.317 -0.525 0 CA-C-N 115.174 -0.921 . . . . 0.0 113.189 179.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.541 ' HA2' HD11 ' A' ' 64' ' ' LEU . . . 121.53 -12.59 9.5 Favored Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 120.225 -0.988 . . . . 0.0 113.575 179.616 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.548 ' CG ' ' HB3' ' A' ' 4' ' ' ALA . 17.9 mtm105 -92.68 1.9 57.02 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 117.806 0.803 . . . . 0.0 110.899 -179.498 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 17.8 tttp -157.65 133.22 9.09 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 -179.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.534 ' HB2' HD13 ' A' ' 90' ' ' LEU . 10.5 tt -109.35 129.14 55.54 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -179.803 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.519 HG21 ' HA3' ' A' ' 87' ' ' GLY . 2.4 p -121.07 131.22 54.14 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.355 0.597 . . . . 0.0 111.575 -179.476 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.408 ' SG ' HD21 ' A' ' 48' ' ' LEU . 25.0 p -158.03 174.26 15.5 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.786 -179.494 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.538 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 57.1 ttt180 -106.72 100.11 29.2 Favored Pre-proline 0 C--N 1.319 -0.735 0 C-N-CA 121.084 -0.246 . . . . 0.0 110.449 178.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.435 ' HD2' ' HA ' ' A' ' 85' ' ' ARG . 19.6 Cg_endo -65.39 126.12 15.68 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.493 2.129 . . . . 0.0 110.471 178.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.628 ' HA ' ' HB2' ' A' ' 83' ' ' ARG . 0.1 OUTLIER -120.26 145.01 47.47 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.987 0.423 . . . . 0.0 111.561 -179.806 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.634 HG22 ' O ' ' A' ' 82' ' ' PHE . 15.1 t -74.31 142.25 45.2 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.095 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.6 p -72.74 -12.05 15.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.525 -178.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -64.24 -28.52 69.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.558 179.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -161.24 -16.5 0.03 OUTLIER Glycine 0 CA--C 1.518 0.246 0 C-N-CA 120.065 -1.064 . . . . 0.0 113.496 -179.338 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.43 20.7 21.8 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.761 -0.733 . . . . 0.0 111.787 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.634 ' O ' HG22 ' A' ' 77' ' ' THR . 26.7 p90 -112.17 150.68 30.47 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 119.373 -0.346 . . . . 0.0 110.186 -179.202 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.628 ' HB2' ' HA ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 167.13 -152.86 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.302 0 O-C-N 123.953 0.783 . . . . 0.0 109.482 179.247 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 48.8 mm-40 -117.05 175.78 5.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.453 0.168 . . . . 0.0 111.427 -177.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.538 ' HA ' ' HA ' ' A' ' 74' ' ' ARG . 23.6 ttt180 -111.89 149.73 31.43 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 178.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -168.35 -161.9 0.38 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.642 -178.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.519 ' HA3' HG21 ' A' ' 72' ' ' THR . . . -153.25 161.74 29.84 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.785 179.742 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.47 HD13 ' CD1' ' A' ' 50' ' ' TRP . 13.9 tt -130.82 139.92 49.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 179.645 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -82.21 138.24 34.71 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.047 0.451 . . . . 0.0 110.812 -179.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.704 HD12 HD11 ' A' ' 19' ' ' LEU . 56.5 mt -104.94 50.32 0.79 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.618 0.723 . . . . 0.0 111.26 -178.655 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.514 ' HA ' ' HG ' ' A' ' 2' ' ' SER . 34.5 m-80 -82.96 3.34 30.41 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.324 179.027 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 40.3 mtp180 -98.85 -2.71 37.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.58 179.034 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 21.7 mm -110.4 96.26 4.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 24.9 tp60 -112.04 148.33 34.09 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.489 -178.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.441 ' OD1' ' HA ' ' A' ' 3' ' ' TYR . 17.7 p-10 -94.36 119.72 33.52 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.862 179.015 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.9 p -114.59 119.37 61.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.689 179.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 59.18 27.22 16.16 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.802 -179.486 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 92.43 -8.48 77.16 Favored Glycine 0 N--CA 1.447 -0.628 0 CA-C-N 115.971 -0.559 . . . . 0.0 113.155 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.21 135.08 43.27 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 117.409 0.604 . . . . 0.0 110.932 -179.154 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.546 HD12 ' SG ' ' A' ' 23' ' ' CYS . 3.9 tp -80.74 118.77 22.57 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.689 179.495 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 47.0 t -132.57 138.07 52.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 120.926 0.393 . . . . 0.0 110.79 -179.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.61 ' HB2' HD11 ' A' ' 35' ' ' LEU . 12.1 t80 -80.93 129.3 34.46 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 178.348 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 . . . . . 0 C--N 1.313 -0.993 0 CA-C-O 118.309 -0.853 . . . . 0.0 110.185 -179.604 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' SER . . . . . 0.552 ' OG ' ' HA ' ' A' ' 91' ' ' ASN . 3.8 m . . . . . 0 N--CA 1.449 -0.475 0 N-CA-C 110.17 -0.307 . . . . 0.0 110.17 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.42 ' HA ' ' OD1' ' A' ' 95' ' ' ASN . 21.4 p90 -59.54 -39.55 84.32 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.786 0.327 . . . . 0.0 110.915 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -56.24 -19.77 15.41 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 -178.328 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -69.69 -22.88 63.38 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.087 0.47 . . . . 0.0 110.35 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 24.0 m -138.36 35.6 2.28 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.456 0.646 . . . . 0.0 109.259 178.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.431 ' HA ' ' HZ3' ' A' ' 30' ' ' TRP . 9.0 t -138.18 161.03 37.87 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.477 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 25.0 ptt180 -149.49 165.58 31.73 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.496 -179.266 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 54.66 52.97 11.28 Favored 'General case' 0 C--N 1.331 -0.208 0 O-C-N 123.855 0.722 . . . . 0.0 111.704 178.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.407 ' HA ' ' HB2' ' A' ' 21' ' ' ALA . . . -86.51 117.83 25.54 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.095 179.61 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 34.5 m -118.22 169.08 9.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.328 -179.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.718 HD23 ' HG ' ' A' ' 64' ' ' LEU . 3.2 mm? -105.95 114.61 28.85 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.649 -179.115 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.423 ' OG1' ' HB ' ' A' ' 18' ' ' THR . 24.0 p -110.55 163.39 13.77 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.003 -179.733 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 62.7 27.76 16.26 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.043 179.342 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 98.8 -17.74 57.85 Favored Glycine 0 N--CA 1.454 -0.12 0 C-N-CA 120.457 -0.878 . . . . 0.0 112.583 179.459 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 121.86 35.13 0.8 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.802 -0.714 . . . . 0.0 112.09 179.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.5 ptm180 -118.76 -25.64 6.3 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.149 0.499 . . . . 0.0 110.551 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.423 ' HB ' ' OG1' ' A' ' 13' ' ' THR . 4.8 m -108.31 135.26 49.91 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.827 -179.686 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.643 HD13 HD13 ' A' ' 90' ' ' LEU . 63.0 mt -97.65 113.76 25.57 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.787 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.461 ' HA ' ' HG2' ' A' ' 34' ' ' GLU . 16.7 ttm180 -107.02 118.68 37.33 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 178.527 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.407 ' HB2' ' HA ' ' A' ' 10' ' ' ALA . . . -154.5 168.05 28.01 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.016 0.436 . . . . 0.0 111.853 -178.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -89.54 111.6 22.57 Favored 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 177.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.423 ' SG ' HD13 ' A' ' 100' ' ' LEU . 61.1 m -97.89 122.89 41.54 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 -179.36 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 19.0 ttt180 -77.23 111.07 12.46 Favored 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 179.073 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 34.9 p30 -74.96 168.0 20.81 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.168 179.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.68 -27.44 27.8 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -178.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -77.92 -4.56 47.44 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.342 0.591 . . . . 0.0 110.964 -179.099 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 81.28 29.5 40.55 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.962 -0.637 . . . . 0.0 111.568 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -112.95 153.03 28.65 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.431 ' HZ3' ' HA ' ' A' ' 7' ' ' SER . 99.1 m95 -99.14 114.5 27.29 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.149 0.499 . . . . 0.0 111.205 -179.156 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 6.9 m -114.17 131.89 64.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.385 179.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 17.3 m -79.41 109.57 13.9 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.894 0.378 . . . . 0.0 110.45 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 74.3 m -123.1 154.44 38.59 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.753 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.636 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 46.1 mt-10 -132.84 132.98 42.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.786 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.574 HD11 ' HB2' ' A' ' 102' ' ' PHE . 2.5 tm? -124.37 131.61 53.51 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.259 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.429 ' N ' HD13 ' A' ' 35' ' ' LEU . 8.4 m-20 -89.86 108.52 19.75 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.082 -179.666 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.496 HD23 HD12 ' A' ' 35' ' ' LEU . 1.6 mt -81.69 -16.93 49.7 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.894 -179.571 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -61.79 -11.88 14.49 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.442 -179.264 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 54.0 p -76.66 -24.68 53.24 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.431 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 34.8 t -128.64 -8.33 5.09 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.206 0.446 . . . . 0.0 112.206 -179.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 47.3 mt -103.44 132.67 49.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 O-C-N 121.851 -0.531 . . . . 0.0 110.046 178.324 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -149.71 159.51 28.11 Favored Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.799 -0.715 . . . . 0.0 111.538 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.413 HD21 ' CD1' ' A' ' 48' ' ' LEU . 19.1 p30 -163.35 50.17 0.25 Allowed Pre-proline 0 CA--C 1.537 0.47 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -179.689 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -68.46 -23.52 37.48 Favored 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 121.924 1.749 . . . . 0.0 112.227 -179.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -87.31 -15.96 36.5 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.537 179.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.483 ' HA2' ' HB2' ' A' ' 75' ' ' PRO . . . 108.6 11.68 22.7 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.461 -0.876 . . . . 0.0 112.741 -179.161 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -125.82 132.07 52.31 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.62 0.248 . . . . 0.0 110.392 179.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.439 HD21 ' SG ' ' A' ' 73' ' ' CYS . 9.2 mp -83.7 144.8 29.13 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.878 -178.807 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 171.76 170.38 35.68 Favored Glycine 0 N--CA 1.439 -1.134 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.11 178.245 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 90.3 m95 -94.88 125.8 39.78 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 153.43 -52.87 0.46 Allowed Glycine 0 N--CA 1.448 -0.56 0 N-CA-C 111.191 -0.764 . . . . 0.0 111.191 -179.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.867 ' HA ' ' HE3' ' A' ' 52' ' ' MET . 2.9 tpt -86.59 174.36 8.95 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.595 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -133.67 169.8 16.49 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 118.69 0.677 . . . . 0.0 111.85 -179.174 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 65.81 38.57 5.09 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.389 -0.823 . . . . 0.0 112.855 178.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 14.0 p90 -61.78 -29.85 70.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.721 0.296 . . . . 0.0 110.929 179.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 23.3 t -56.61 -36.12 69.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.158 -0.474 . . . . 0.0 112.042 -178.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 28.2 m80 -80.92 -18.43 47.17 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.899 -0.32 . . . . 0.0 111.543 -179.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 19.8 m -106.75 19.37 20.58 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.527 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 49.3 m -136.82 152.77 50.66 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.331 0.586 . . . . 0.0 111.628 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -129.06 136.27 50.04 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.197 178.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.407 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 33.6 m-20 63.63 83.65 0.16 Allowed 'General case' 0 N--CA 1.469 0.511 0 O-C-N 123.608 0.567 . . . . 0.0 111.304 -179.317 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.491 HG23 HD23 ' A' ' 71' ' ' LEU . 70.2 mt -101.51 124.19 55.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.285 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.8 tptt -145.03 154.61 42.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.766 0.317 . . . . 0.0 111.247 -179.396 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.718 ' HG ' HD23 ' A' ' 12' ' ' LEU . 86.1 mt -99.5 124.83 45.03 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.018 178.412 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.418 ' C ' ' H ' ' A' ' 67' ' ' GLY . 30.0 mt-10 -86.62 -60.26 2.04 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-O 121.194 0.521 . . . . 0.0 111.42 -179.61 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.407 ' OE1' ' HB2' ' A' ' 70' ' ' LYS . 20.3 mt-10 -78.19 38.44 0.29 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.665 -178.42 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.418 ' H ' ' C ' ' A' ' 65' ' ' GLU . . . 67.73 -4.76 3.87 Favored Glycine 0 N--CA 1.454 -0.117 0 CA-C-N 115.77 -0.65 . . . . 0.0 113.633 179.075 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.537 ' HA2' HD12 ' A' ' 64' ' ' LEU . . . 145.98 -6.96 1.4 Allowed Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.129 -179.429 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 5.5 tpp180 -81.7 -18.23 45.13 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.087 0.47 . . . . 0.0 109.807 179.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.407 ' HB2' ' OE1' ' A' ' 66' ' ' GLU . 35.6 ttmt -143.42 136.21 27.54 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.916 -179.234 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.565 ' HB2' HD11 ' A' ' 90' ' ' LEU . 10.5 tt -115.07 118.45 33.41 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.47 -0.787 . . . . 0.0 109.923 -179.709 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.482 HG23 ' HA3' ' A' ' 87' ' ' GLY . 3.6 p -108.82 134.13 51.93 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.241 0.543 . . . . 0.0 110.874 179.388 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.439 ' SG ' HD21 ' A' ' 48' ' ' LEU . 18.0 p -156.55 164.25 38.43 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.001 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.546 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 33.4 ttt-85 -100.87 101.87 17.51 Favored Pre-proline 0 C--N 1.316 -0.872 0 C-N-CA 120.424 -0.511 . . . . 0.0 110.254 178.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.581 ' HD2' ' HA ' ' A' ' 85' ' ' ARG . 57.9 Cg_endo -70.55 129.2 16.38 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.636 2.224 . . . . 0.0 110.167 178.631 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.64 ' HA ' ' HB2' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -121.2 140.99 51.28 Favored 'General case' 0 C--N 1.313 -1.009 0 O-C-N 123.28 0.362 . . . . 0.0 110.949 179.85 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.729 HG23 ' O ' ' A' ' 82' ' ' PHE . 14.0 t -76.86 130.73 38.01 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 178.478 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 35.3 m -72.66 -6.01 7.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 123.557 0.536 . . . . 0.0 111.492 -179.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -67.78 -35.97 79.62 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.229 178.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.432 ' HA3' ' CE2' ' A' ' 82' ' ' PHE . . . -145.3 -14.18 0.21 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.413 -0.898 . . . . 0.0 113.152 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 88.23 16.78 58.6 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.011 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.729 ' O ' HG23 ' A' ' 77' ' ' THR . 37.8 p90 -111.29 148.46 32.87 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 118.789 -0.624 . . . . 0.0 109.33 -179.195 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.665 ' HA ' ' HE ' ' A' ' 83' ' ' ARG . 0.0 OUTLIER 172.05 -160.14 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.987 0.423 . . . . 0.0 111.938 179.753 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 -125.74 173.22 9.19 Favored 'General case' 0 C--O 1.223 -0.317 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.006 -177.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.581 ' HA ' ' HD2' ' A' ' 75' ' ' PRO . 72.5 ttt180 -109.41 153.71 23.61 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 110.07 -0.344 . . . . 0.0 110.07 178.711 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -166.23 -170.24 1.64 Allowed 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.581 -179.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.482 ' HA3' HG23 ' A' ' 72' ' ' THR . . . -143.12 151.61 23.35 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.335 -0.936 . . . . 0.0 113.358 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.428 HG22 HD23 ' A' ' 48' ' ' LEU . 13.0 tt -123.31 137.49 56.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.025 0.441 . . . . 0.0 109.883 179.408 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -79.8 138.02 37.13 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.787 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.643 HD13 HD13 ' A' ' 19' ' ' LEU . 37.2 mt -106.08 40.88 1.5 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.499 0.666 . . . . 0.0 110.936 -179.014 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.552 ' HA ' ' OG ' ' A' ' 2' ' ' SER . 39.5 m-80 -76.03 3.55 10.15 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.079 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 20.9 mtp180 -96.95 -6.6 35.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.641 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 18.7 mm -98.78 116.75 42.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 -179.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 24.5 tp60 -126.81 143.36 51.28 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.275 0.559 . . . . 0.0 111.301 -178.229 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.42 ' OD1' ' HA ' ' A' ' 3' ' ' TYR . 12.9 p-10 -95.19 110.82 22.74 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.304 178.529 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 40.8 t -96.97 106.45 18.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.693 179.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 20.3 m-80 56.98 36.76 28.21 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.272 0.558 . . . . 0.0 111.304 -179.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 96.14 -22.05 41.82 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.828 -0.701 . . . . 0.0 113.388 179.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.413 ' HD2' ' N ' ' A' ' 99' ' ' ARG . 3.6 mpt_? -86.21 122.61 30.45 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 117.295 0.547 . . . . 0.0 110.211 -179.474 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.423 HD13 ' SG ' ' A' ' 23' ' ' CYS . 11.6 tp -79.63 114.59 18.67 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 32.7 t -128.15 140.71 48.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 120.984 0.421 . . . . 0.0 110.878 -178.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.574 ' HB2' HD11 ' A' ' 35' ' ' LEU . 8.3 t80 -83.93 129.3 34.93 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.121 -0.491 . . . . 0.0 109.81 178.665 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 2.7 tp-100 . . . . . 0 C--O 1.249 1.073 0 CA-C-O 119.031 -0.509 . . . . 0.0 110.451 179.396 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.8 m . . . . . 0 N--CA 1.454 -0.274 0 CA-C-O 120.276 0.084 . . . . 0.0 110.98 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 9.8 p90 -59.62 -34.09 72.33 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.724 0.297 . . . . 0.0 111.543 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -55.35 -18.32 6.39 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 112.84 0.681 . . . . 0.0 112.84 -178.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -56.24 -38.29 70.91 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.326 0.584 . . . . 0.0 110.064 178.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 44.3 m -129.02 40.58 3.61 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.218 179.214 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.402 ' HA ' ' O ' ' A' ' 22' ' ' GLU . 29.3 t -148.1 148.44 30.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.264 -179.529 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -143.45 163.74 32.27 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.669 -179.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 64.22 49.04 2.71 Favored 'General case' 0 N--CA 1.465 0.318 0 O-C-N 123.718 0.636 . . . . 0.0 111.441 179.349 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.525 ' HA ' ' HB3' ' A' ' 21' ' ' ALA . . . -77.92 117.29 19.12 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.361 179.563 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 33.8 m -119.14 167.99 11.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.207 -179.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.578 HD22 ' HG ' ' A' ' 64' ' ' LEU . 3.3 mm? -104.38 114.53 28.82 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.661 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.468 HG23 ' NE ' ' A' ' 20' ' ' ARG . 28.4 p -112.4 166.69 11.07 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.548 -179.458 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 60.89 42.55 12.88 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.962 179.563 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 97.53 -48.03 1.54 Allowed Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 120.661 -0.781 . . . . 0.0 111.546 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 145.98 46.79 0.03 OUTLIER Glycine 0 N--CA 1.444 -0.824 0 N-CA-C 110.306 -1.117 . . . . 0.0 110.306 -179.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.549 ' HB2' ' HB2' ' A' ' 38' ' ' ASP . 7.1 ptp180 -132.95 -25.59 1.81 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.355 -0.423 . . . . 0.0 111.313 -178.595 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.456 ' HB ' ' OG1' ' A' ' 13' ' ' THR . 2.9 m -100.36 133.3 44.99 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.76 -179.688 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.779 HD13 HD12 ' A' ' 90' ' ' LEU . 68.8 mt -92.52 111.54 23.16 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.325 179.1 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.468 ' NE ' HG23 ' A' ' 13' ' ' THR . 37.4 ttm180 -110.42 120.22 41.73 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.721 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.525 ' HB3' ' HA ' ' A' ' 10' ' ' ALA . . . -152.96 167.24 29.83 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.76 0.314 . . . . 0.0 111.369 -179.125 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.402 ' O ' ' HA ' ' A' ' 7' ' ' SER . 37.1 mt-10 -91.01 107.76 19.41 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 178.262 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 65.9 m -100.32 133.11 45.23 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 120.914 0.387 . . . . 0.0 110.212 -179.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.422 HH11 ' HD2' ' A' ' 24' ' ' ARG . 6.7 ttp85 -80.78 117.63 21.61 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-O 120.918 0.39 . . . . 0.0 110.483 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 38.7 p30 -80.31 165.75 22.01 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.103 179.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.13 -18.69 38.04 Favored 'General case' 0 N--CA 1.464 0.266 0 O-C-N 123.807 0.692 . . . . 0.0 112.137 -179.012 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -75.85 -13.48 60.27 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.457 0.646 . . . . 0.0 109.716 179.192 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 91.0 23.83 28.9 Favored Glycine 0 N--CA 1.447 -0.58 0 CA-C-N 115.327 -0.851 . . . . 0.0 112.609 179.463 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -122.76 158.61 29.8 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.755 0.312 . . . . 0.0 111.67 -179.105 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 96.7 m95 -90.32 130.73 36.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.14 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.2 m -129.17 137.47 57.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.533 178.454 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 37.6 m -78.58 109.95 13.25 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.467 179.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 61.6 m -118.06 152.5 35.43 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.609 -179.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.596 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 44.9 mt-10 -132.5 154.41 49.96 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.156 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.531 ' HB2' HD21 ' A' ' 100' ' ' LEU . 1.1 tm? -150.5 126.31 10.38 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 178.78 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -88.77 109.21 19.98 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.482 HD22 HD11 ' A' ' 35' ' ' LEU . 2.2 mt -81.73 -12.73 58.48 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.329 -179.395 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.707 ' OD2' ' HA ' ' A' ' 54' ' ' ASN . 3.0 t70 -65.96 -5.85 10.71 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.115 0.484 . . . . 0.0 110.845 -179.271 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 49.6 p -85.45 -26.38 26.38 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.857 -0.61 . . . . 0.0 112.03 -179.383 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 16.1 t -127.19 -2.59 6.35 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.573 -0.451 . . . . 0.0 112.089 -178.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.438 ' HB ' ' CD1' ' A' ' 55' ' ' PHE . 54.8 mt -111.21 134.34 53.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 O-C-N 122.124 -0.36 . . . . 0.0 110.388 179.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -148.72 158.41 27.65 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 121.12 -0.562 . . . . 0.0 111.787 179.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.625 ' ND2' ' HB2' ' A' ' 55' ' ' PHE . 9.2 p30 -157.04 46.62 0.26 Allowed Pre-proline 0 CA--C 1.537 0.475 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 179.635 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.566 ' HG2' ' SD ' ' A' ' 52' ' ' MET . 14.0 Cg_exo -66.99 -19.67 51.64 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 121.75 1.634 . . . . 0.0 111.671 -179.678 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 73.9 m-20 -88.77 -8.89 53.63 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.559 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.589 ' CA ' ' HG2' ' A' ' 83' ' ' ARG . . . 98.52 7.71 55.47 Favored Glycine 0 N--CA 1.443 -0.885 0 C-N-CA 120.488 -0.863 . . . . 0.0 112.557 -179.309 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -125.57 135.61 52.41 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.753 0.311 . . . . 0.0 110.286 179.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 86.4 mt -83.66 141.84 31.21 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.532 -178.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 176.51 168.28 36.36 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.447 179.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 89.1 m95 -95.71 134.81 38.2 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 147.35 -52.25 0.56 Allowed Glycine 0 CA--C 1.508 -0.404 0 N-CA-C 111.676 -0.569 . . . . 0.0 111.676 179.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.566 ' SD ' ' HG2' ' A' ' 44' ' ' PRO . 36.7 ttm -95.74 172.12 8.23 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 178.783 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -123.7 173.23 8.25 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 118.824 0.738 . . . . 0.0 111.507 -178.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.707 ' HA ' ' OD2' ' A' ' 38' ' ' ASP . 13.9 m120 66.82 63.37 0.49 Allowed 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 114.926 -1.034 . . . . 0.0 111.68 178.59 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.625 ' HB2' ' ND2' ' A' ' 43' ' ' ASN . 20.7 p90 -87.11 -35.95 18.39 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.336 179.452 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 17.7 t -64.47 -27.56 69.06 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.353 -178.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 69.5 m80 -76.37 -12.81 60.12 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.881 -179.259 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 24.3 p -128.19 26.29 5.76 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.878 0.37 . . . . 0.0 111.303 -179.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 68.2 m -132.99 151.08 52.11 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 120.576 -0.45 . . . . 0.0 111.173 179.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -119.39 134.31 55.28 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.303 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.418 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 38.2 t70 61.1 84.65 0.13 Allowed 'General case' 0 N--CA 1.465 0.286 0 O-C-N 124.037 0.836 . . . . 0.0 110.934 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.472 HG21 HD21 ' A' ' 71' ' ' LEU . 72.2 mt -101.51 118.07 47.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.03 -179.127 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -145.44 150.21 36.11 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 -179.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.578 ' HG ' HD22 ' A' ' 12' ' ' LEU . 56.1 mt -83.01 123.19 29.22 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.315 0.579 . . . . 0.0 111.456 -179.517 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.446 ' C ' ' H ' ' A' ' 67' ' ' GLY . 33.0 tt0 -78.37 -61.79 1.89 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.13 -0.941 . . . . 0.0 111.973 -178.372 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 33.6 mm-40 -79.54 34.8 0.27 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.15 0.5 . . . . 0.0 111.433 -179.504 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.446 ' H ' ' C ' ' A' ' 65' ' ' GLU . . . 66.01 10.44 51.44 Favored Glycine 0 C--N 1.316 -0.575 0 CA-C-N 115.295 -0.866 . . . . 0.0 112.569 179.69 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.568 ' HA2' HD12 ' A' ' 64' ' ' LEU . . . 137.7 -16.95 3.5 Favored Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 120.348 -0.929 . . . . 0.0 112.963 179.807 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 27.2 mtt180 -83.23 -9.85 58.9 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 117.349 0.574 . . . . 0.0 110.779 -179.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 66.3 tttt -150.13 138.07 20.17 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.983 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.546 ' HB2' HD13 ' A' ' 90' ' ' LEU . 10.4 tt -107.2 126.44 52.41 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.958 -179.262 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.0 p -116.53 132.0 56.8 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.991 179.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.418 ' HA ' ' O ' ' A' ' 61' ' ' ASP . 26.8 p -159.97 175.4 13.06 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.065 -179.602 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.566 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 29.4 ttt180 -107.34 99.12 26.09 Favored Pre-proline 0 C--N 1.315 -0.892 0 C-N-CA 120.228 -0.589 . . . . 0.0 110.405 178.627 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.405 ' HD2' ' HA ' ' A' ' 74' ' ' ARG . 55.3 Cg_endo -69.38 125.44 12.35 Favored 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 122.713 2.275 . . . . 0.0 110.492 178.686 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.697 ' HA ' ' HB2' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -120.52 139.99 52.11 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.904 0.383 . . . . 0.0 111.422 -179.693 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.712 HG23 ' O ' ' A' ' 82' ' ' PHE . 15.2 t -73.39 135.63 44.26 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 179.649 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 26.9 m -76.22 -8.99 12.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.63 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.522 -179.35 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -68.57 -30.18 68.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.776 179.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.553 ' HA3' ' CE2' ' A' ' 82' ' ' PHE . . . -146.01 -19.26 0.14 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.502 -0.856 . . . . 0.0 113.281 179.431 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.97 14.05 55.47 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.931 -0.652 . . . . 0.0 111.86 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.712 ' O ' HG23 ' A' ' 77' ' ' THR . 37.6 p90 -111.8 157.37 20.63 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 118.901 -0.571 . . . . 0.0 110.173 -178.349 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.697 ' HB2' ' HA ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 166.6 -157.57 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.357 0 O-C-N 123.661 0.601 . . . . 0.0 112.258 178.456 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 41.5 mm-40 -123.42 176.57 6.08 Favored 'General case' 0 CA--C 1.521 -0.173 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.384 -177.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.566 ' HA ' ' HA ' ' A' ' 74' ' ' ARG . 30.9 ttt85 -98.85 154.75 17.79 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 178.009 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . 0.406 ' HG2' ' N ' ' A' ' 87' ' ' GLY . 9.1 tt0 -161.92 171.48 17.61 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.533 -178.086 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.406 ' N ' ' HG2' ' A' ' 86' ' ' GLN . . . -134.12 138.25 9.93 Favored Glycine 0 N--CA 1.447 -0.622 0 N-CA-C 111.695 -0.562 . . . . 0.0 111.695 178.696 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 11.1 tt -118.4 134.82 60.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 121.052 0.453 . . . . 0.0 110.09 -179.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -76.1 136.98 39.86 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.232 -178.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.779 HD12 HD13 ' A' ' 19' ' ' LEU . 52.4 mt -105.74 40.46 1.56 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.382 0.611 . . . . 0.0 111.451 -179.128 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 29.5 m-80 -74.29 -2.91 27.12 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.27 179.413 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 8.4 mtp180 -91.79 -7.45 49.52 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.741 179.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 23.4 mm -105.47 112.1 37.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 -179.332 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -132.56 159.38 39.62 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.143 0.497 . . . . 0.0 111.477 -179.433 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.409 ' HA ' ' O ' ' A' ' 99' ' ' ARG . 13.2 p-10 -104.48 134.0 48.4 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.876 179.523 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 49.3 t -114.93 105.08 17.94 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.395 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -179.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 17.7 m-80 61.81 26.91 16.38 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.858 -179.021 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 113.88 -35.84 4.3 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.688 -0.767 . . . . 0.0 114.602 178.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.409 ' O ' ' HA ' ' A' ' 95' ' ' ASN . 0.0 OUTLIER -86.8 139.33 30.8 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 118.029 0.914 . . . . 0.0 112.817 -177.891 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.531 HD21 ' HB2' ' A' ' 35' ' ' LEU . 7.1 tp -81.29 120.05 24.42 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.968 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 26.2 t -128.29 141.52 46.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.308 -179.102 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.408 ' HB2' HD13 ' A' ' 35' ' ' LEU . 16.9 t80 -80.53 132.24 35.64 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 178.705 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 2.7 tp-100 . . . . . 0 C--O 1.253 1.25 0 CA-C-O 118.595 -0.717 . . . . 0.0 110.045 179.703 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' SER . . . . . 0.606 ' HB2' ' HG2' ' A' ' 69' ' ' ARG . 20.1 m . . . . . 0 N--CA 1.451 -0.379 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.479 ' HA ' ' OD1' ' A' ' 95' ' ' ASN . 12.6 p90 -54.89 -40.89 70.25 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -179.58 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.406 ' HB3' ' CG ' ' A' ' 69' ' ' ARG . . . -62.2 -18.45 61.08 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 -178.445 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.473 ' HB2' ' O ' ' A' ' 2' ' ' SER . 0.9 OUTLIER -64.43 -22.43 66.96 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 121.329 0.585 . . . . 0.0 110.572 179.626 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 49.6 m -140.92 39.21 1.8 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.274 179.075 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.406 ' HA ' ' HZ3' ' A' ' 30' ' ' TRP . 13.2 t -145.63 154.66 42.37 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.926 -1.034 . . . . 0.0 108.698 179.831 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 21.0 ptt180 -140.47 164.09 31.08 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.734 0.302 . . . . 0.0 111.26 -179.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 57.96 51.42 8.98 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.686 178.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.507 ' HA ' ' HB2' ' A' ' 21' ' ' ALA . . . -81.98 117.39 22.16 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.206 179.444 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 26.7 m -119.24 169.88 9.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.349 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.587 HD21 ' HG ' ' A' ' 64' ' ' LEU . 3.2 mm? -105.15 115.27 29.98 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.803 -179.478 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 23.5 p -111.74 169.6 8.72 Favored 'General case' 0 C--O 1.243 0.72 0 CA-C-O 121.115 0.483 . . . . 0.0 111.692 -179.43 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 62.67 26.87 15.88 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 115.285 -0.87 . . . . 0.0 112.56 179.218 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 101.8 -14.3 57.53 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.437 179.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 116.8 43.17 0.63 Allowed Glycine 0 N--CA 1.443 -0.869 0 N-CA-C 111.209 -0.756 . . . . 0.0 111.209 -179.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.654 ' HB2' ' HB2' ' A' ' 38' ' ' ASP . 14.0 ptm180 -130.6 -29.69 1.93 Allowed 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.301 -0.45 . . . . 0.0 111.26 -179.384 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.418 ' HA ' ' HA ' ' A' ' 36' ' ' ASP . 10.3 m -104.37 136.32 44.17 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.435 -179.628 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.651 ' O ' ' HA ' ' A' ' 34' ' ' GLU . 84.5 mt -93.3 117.61 30.28 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.369 179.698 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 44.3 ttt85 -113.81 119.85 38.76 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 178.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.507 ' HB2' ' HA ' ' A' ' 10' ' ' ALA . . . -153.76 167.14 30.63 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.924 0.393 . . . . 0.0 111.443 -178.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -90.98 109.13 20.37 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 177.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.494 ' SG ' HD12 ' A' ' 100' ' ' LEU . 68.5 m -100.09 135.64 41.2 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 120.897 0.38 . . . . 0.0 111.313 -178.122 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 17.3 ttp180 -80.02 115.55 19.66 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.99 179.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 34.3 p30 -80.29 167.62 20.05 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.789 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -52.04 -32.24 33.49 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 -178.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -71.35 -13.45 61.87 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.288 0.566 . . . . 0.0 111.004 -179.335 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 90.43 28.91 15.42 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.971 -0.633 . . . . 0.0 111.644 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -120.01 157.82 28.06 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.618 0.247 . . . . 0.0 110.834 -179.507 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.406 ' HZ3' ' HA ' ' A' ' 7' ' ' SER . 91.9 m95 -90.34 131.43 36.14 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.755 0.312 . . . . 0.0 111.362 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.9 m -133.32 130.6 57.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.116 178.164 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.4 m -77.11 112.87 14.23 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.573 -179.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 66.4 m -124.11 160.19 28.32 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.978 -179.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.651 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 47.4 mt-10 -139.32 143.77 37.98 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.104 -179.817 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.409 HD13 HD21 ' A' ' 37' ' ' LEU . 1.8 tm? -138.47 127.77 24.44 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 178.61 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.418 ' HA ' ' HA ' ' A' ' 18' ' ' THR . 27.1 t70 -91.01 109.79 21.04 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.94 0.4 . . . . 0.0 110.599 -179.177 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.482 HD12 HD11 ' A' ' 19' ' ' LEU . 1.5 mt -81.23 -14.24 57.69 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.747 -179.645 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.757 ' OD2' ' HA ' ' A' ' 54' ' ' ASN . 6.6 t70 -63.23 -15.71 57.92 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.291 0.567 . . . . 0.0 110.55 -179.301 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 68.1 p -80.21 -22.41 41.87 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.554 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 21.0 m -122.94 -8.68 8.33 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -177.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 65.4 mt -111.73 134.16 55.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 110.335 -0.246 . . . . 0.0 110.335 179.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -140.94 151.98 22.85 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.827 -0.702 . . . . 0.0 111.871 179.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 38.7 p-10 -160.57 48.53 0.25 Allowed Pre-proline 0 CA--C 1.54 0.561 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -179.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_exo -68.28 -18.21 44.68 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 121.883 1.722 . . . . 0.0 111.798 -179.164 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -93.28 -6.63 47.07 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.294 -0.866 . . . . 0.0 111.146 -179.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.479 ' HA3' ' HG2' ' A' ' 83' ' ' ARG . . . 100.22 9.33 48.29 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.11 -1.043 . . . . 0.0 112.926 -179.506 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.659 ' HA ' HE22 ' A' ' 86' ' ' GLN . 49.5 m-85 -125.08 128.98 49.32 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.119 0.485 . . . . 0.0 110.891 179.776 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.654 HD12 ' HG ' ' A' ' 73' ' ' CYS . 84.7 mt -83.41 137.87 33.74 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.782 -178.116 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -178.94 170.69 42.61 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 120.874 -0.679 . . . . 0.0 111.659 178.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 90.4 m95 -95.78 135.44 37.48 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.991 0.424 . . . . 0.0 110.153 -179.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 147.89 -67.12 0.39 Allowed Glycine 0 N--CA 1.445 -0.706 0 N-CA-C 111.498 -0.641 . . . . 0.0 111.498 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 14.7 ttt -80.35 -179.46 7.13 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -131.36 168.07 18.19 Favored 'General case' 0 C--N 1.321 -0.668 0 O-C-N 122.082 -0.386 . . . . 0.0 111.111 -179.327 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.757 ' HA ' ' OD2' ' A' ' 38' ' ' ASP . 0.9 OUTLIER 69.4 61.21 0.3 Allowed 'General case' 0 N--CA 1.461 0.087 0 O-C-N 124.079 0.862 . . . . 0.0 111.762 179.002 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.41 ' HD1' ' HA ' ' A' ' 38' ' ' ASP . 16.6 p90 -87.21 -37.35 17.35 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.319 179.484 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 72.2 p -64.74 -22.42 66.98 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.409 0.623 . . . . 0.0 110.501 -179.11 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 76.6 m80 -75.94 -11.53 59.98 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.096 -179.43 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.0 p -133.65 33.65 3.49 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.556 179.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 38.6 m -136.45 154.19 50.85 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.311 0.577 . . . . 0.0 111.678 -179.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -131.22 146.52 52.35 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.142 -0.935 . . . . 0.0 109.652 179.399 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.476 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 33.4 t70 58.72 66.86 1.0 Allowed 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 121.335 0.588 . . . . 0.0 110.917 178.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.507 HG21 HD21 ' A' ' 71' ' ' LEU . 74.5 mt -93.9 114.15 29.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.633 -179.583 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 29.0 tptt -144.54 147.65 33.47 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.992 0.425 . . . . 0.0 110.305 -179.574 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.587 ' HG ' HD21 ' A' ' 12' ' ' LEU . 65.6 mt -83.35 140.89 32.16 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.401 179.69 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -102.41 -55.27 2.5 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.023 -0.535 . . . . 0.0 112.232 -178.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -83.81 36.26 0.55 Allowed 'General case' 0 CA--C 1.515 -0.4 0 CA-C-O 121.061 0.457 . . . . 0.0 111.199 -179.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 70.49 -2.08 17.46 Favored Glycine 0 C--N 1.315 -0.589 0 CA-C-N 115.263 -0.881 . . . . 0.0 112.799 179.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.538 ' HA2' HD12 ' A' ' 64' ' ' LEU . . . 146.77 -12.84 1.51 Allowed Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.406 -0.902 . . . . 0.0 113.323 -179.712 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.606 ' HG2' ' HB2' ' A' ' 2' ' ' SER . 53.3 mtm180 -94.2 4.21 54.2 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 117.557 0.678 . . . . 0.0 111.174 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 39.9 tptt -151.45 119.74 6.37 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 -179.401 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.525 ' HB2' HD13 ' A' ' 90' ' ' LEU . 9.7 tt -104.29 120.07 40.36 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 -179.763 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.8 p -113.65 133.72 55.14 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.007 0.432 . . . . 0.0 110.798 179.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.654 ' HG ' HD12 ' A' ' 48' ' ' LEU . 26.2 p -159.98 175.61 12.82 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.887 -179.416 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.54 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 3.7 tmt_? -110.28 98.18 34.47 Favored Pre-proline 0 C--N 1.311 -1.084 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 178.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.409 ' HD2' ' HA ' ' A' ' 74' ' ' ARG . 59.1 Cg_endo -71.64 134.53 24.3 Favored 'Trans proline' 0 CA--C 1.515 -0.448 0 C-N-CA 123.221 2.614 . . . . 0.0 111.599 179.72 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.664 ' HA ' ' HB2' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -121.42 144.03 48.9 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 123.294 0.371 . . . . 0.0 111.347 179.44 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.755 HG23 ' O ' ' A' ' 82' ' ' PHE . 14.4 t -81.15 138.1 35.89 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.103 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 35.6 m -76.97 -4.68 6.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 O-C-N 124.057 0.848 . . . . 0.0 111.481 -179.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -69.95 -33.81 72.6 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.006 0.431 . . . . 0.0 110.352 178.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.449 ' HA3' ' CE2' ' A' ' 82' ' ' PHE . . . -148.25 -17.23 0.11 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.363 -0.922 . . . . 0.0 113.202 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.68 16.41 45.7 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.577 -0.82 . . . . 0.0 111.473 -179.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.755 ' O ' HG23 ' A' ' 77' ' ' THR . 33.2 p90 -112.2 154.16 25.98 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 118.754 -0.641 . . . . 0.0 109.478 -178.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.664 ' HB2' ' HA ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 170.8 -160.13 0.01 OUTLIER 'General case' 0 C--O 1.234 0.263 0 O-C-N 123.311 0.382 . . . . 0.0 111.772 179.477 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -124.77 -174.33 3.0 Favored 'General case' 0 C--O 1.226 -0.132 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.527 -177.489 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.54 ' HA ' ' HA ' ' A' ' 74' ' ' ARG . 35.1 ttt-85 -99.61 155.95 17.32 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 177.768 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . 0.659 HE22 ' HA ' ' A' ' 47' ' ' PHE . 8.9 tt0 -163.73 165.78 22.8 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 121.088 0.47 . . . . 0.0 111.854 -178.766 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -134.95 144.3 16.22 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 121.066 -0.588 . . . . 0.0 111.636 179.413 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 12.1 tt -123.64 138.92 51.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 120.975 0.417 . . . . 0.0 110.312 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -78.63 129.69 35.04 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.561 -179.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.626 HD12 HD11 ' A' ' 19' ' ' LEU . 60.4 mt -99.44 45.69 0.99 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.711 0.767 . . . . 0.0 110.291 179.807 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.456 ' N ' HD21 ' A' ' 91' ' ' ASN . 0.8 OUTLIER -79.15 3.13 18.55 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 114.821 -1.081 . . . . 0.0 110.039 -179.609 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 11.7 mtp180 -101.89 0.18 35.05 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.267 -179.122 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.422 HD11 HD23 ' A' ' 37' ' ' LEU . 21.9 mm -107.19 114.96 47.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 -179.321 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 27.0 tp60 -125.78 144.59 50.57 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.908 -178.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.479 ' OD1' ' HA ' ' A' ' 3' ' ' TYR . 12.9 p-10 -95.36 102.02 13.8 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.276 178.758 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 54.1 t -86.37 109.3 18.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 179.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 26.3 m-80 57.64 31.6 20.62 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.02 0.438 . . . . 0.0 110.789 -178.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 95.1 -18.95 56.36 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.566 -0.826 . . . . 0.0 112.831 179.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 5.6 mpt_? -86.18 124.36 32.49 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 -179.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.494 HD12 ' SG ' ' A' ' 23' ' ' CYS . 6.7 tp -76.21 116.48 16.94 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 -179.648 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 44.9 t -130.99 143.19 41.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.622 -179.074 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.404 ' HB2' HD12 ' A' ' 35' ' ' LEU . 16.0 t80 -79.04 135.52 36.9 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.757 -0.461 . . . . 0.0 109.757 178.509 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.558 ' HA ' HE21 ' A' ' 103' ' ' GLN . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.653 -0.689 . . . . 0.0 110.163 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' SER . . . . . 0.558 ' OG ' ' HA ' ' A' ' 91' ' ' ASN . 3.6 m . . . . . 0 N--CA 1.449 -0.522 0 CA-C-O 120.621 0.248 . . . . 0.0 110.46 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.436 ' CB ' HD11 ' A' ' 100' ' ' LEU . 13.6 p90 -57.25 -34.43 68.6 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.037 0.446 . . . . 0.0 110.411 178.335 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -57.29 -23.06 46.02 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 115.481 -0.781 . . . . 0.0 112.531 -179.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -64.98 -16.78 63.78 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 121.063 0.459 . . . . 0.0 110.815 179.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 49.7 m -146.66 35.48 0.95 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.712 178.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 44.5 m -145.48 163.55 34.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.879 179.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 6.1 ptp180 -148.05 165.12 31.75 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.596 -179.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 61.1 m-80 59.51 51.83 6.22 Favored 'General case' 0 N--CA 1.464 0.248 0 O-C-N 123.689 0.618 . . . . 0.0 111.376 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.45 ' HA ' ' HB3' ' A' ' 21' ' ' ALA . . . -83.89 117.38 23.29 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.391 179.418 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 31.2 m -123.0 168.9 14.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.481 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.796 HD23 ' HG ' ' A' ' 64' ' ' LEU . 3.4 mm? -104.45 114.32 28.48 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.68 -179.457 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 18.4 p -107.56 168.57 9.16 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.516 -179.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 60.4 39.8 18.13 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.039 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 89.62 -31.21 5.32 Favored Glycine 0 CA--C 1.519 0.335 0 CA-C-N 115.941 -0.572 . . . . 0.0 112.657 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 136.29 56.49 0.06 OUTLIER Glycine 0 N--CA 1.449 -0.472 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 -179.314 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.5 ptm180 -142.52 -31.89 0.51 Allowed 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.856 0.36 . . . . 0.0 111.078 -179.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.5 m -101.3 136.77 40.6 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.764 -179.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.735 HD12 HD12 ' A' ' 90' ' ' LEU . 67.8 mt -94.63 118.07 31.12 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.65 179.052 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 21.8 ttt180 -114.6 119.97 38.57 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 178.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.45 ' HB3' ' HA ' ' A' ' 10' ' ' ALA . . . -154.05 168.94 24.75 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.693 0.282 . . . . 0.0 111.317 -178.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -87.65 106.2 17.87 Favored 'General case' 0 CA--C 1.513 -0.461 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 178.048 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.544 ' SG ' HD13 ' A' ' 100' ' ' LEU . 30.4 m -93.25 121.26 34.43 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.451 -177.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.509 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 9.5 ttp180 -70.03 112.94 6.77 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.147 179.264 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 36.2 p30 -78.69 170.65 16.32 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.359 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.96 -27.4 52.36 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -178.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -80.31 -1.44 41.0 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.498 0.666 . . . . 0.0 110.409 -179.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.97 28.95 48.5 Favored Glycine 0 N--CA 1.448 -0.55 0 CA-C-N 115.534 -0.757 . . . . 0.0 112.107 179.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.509 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 57.7 t30 -110.98 163.02 14.25 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 121.212 -0.195 . . . . 0.0 110.818 -179.03 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 92.5 m95 -101.55 115.71 31.13 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.528 179.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.8 m -116.49 148.87 18.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 120.993 0.425 . . . . 0.0 110.835 179.224 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 28.3 m -86.11 110.52 19.6 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.269 179.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.473 ' HB2' ' SG ' ' A' ' 23' ' ' CYS . 70.1 m -128.99 147.22 50.84 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.682 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.64 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 51.9 mt-10 -129.84 148.72 51.74 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.548 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.56 HD13 ' HB2' ' A' ' 102' ' ' PHE . 1.8 tm? -140.51 129.34 23.15 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 178.753 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.423 ' N ' HD12 ' A' ' 35' ' ' LEU . 14.5 m-20 -87.13 109.21 19.29 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 -179.565 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.511 HD21 HD11 ' A' ' 35' ' ' LEU . 1.9 mt -85.12 -21.43 29.28 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -179.19 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -65.18 -6.96 10.65 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.744 0.307 . . . . 0.0 111.568 -178.386 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 69.0 p -81.09 -16.14 53.99 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.641 179.034 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 29.2 t -133.28 -10.02 2.91 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.718 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 51.1 mt -104.81 134.26 46.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 178.264 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -148.33 155.73 26.55 Favored Glycine 0 N--CA 1.442 -0.919 0 C-N-CA 120.577 -0.821 . . . . 0.0 112.112 -179.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 27.0 p30 -158.2 43.92 0.18 Allowed Pre-proline 0 CA--C 1.542 0.648 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -67.46 -23.06 44.24 Favored 'Trans proline' 0 C--N 1.356 0.952 0 C-N-CA 121.967 1.778 . . . . 0.0 111.683 -179.219 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 52.5 m-80 -89.3 -1.92 58.25 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.11 179.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.489 ' HA3' ' HG2' ' A' ' 83' ' ' ARG . . . 92.6 11.17 59.64 Favored Glycine 0 N--CA 1.443 -0.843 0 C-N-CA 120.385 -0.912 . . . . 0.0 112.657 -179.692 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 43.5 m-85 -125.19 132.44 53.02 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.767 0.318 . . . . 0.0 110.588 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.407 HD21 HG21 ' A' ' 88' ' ' ILE . 10.3 mp -86.0 146.03 26.84 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.892 -178.863 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 169.22 171.31 34.79 Favored Glycine 0 N--CA 1.442 -0.944 0 CA-C-N 115.476 -0.784 . . . . 0.0 112.066 178.156 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.432 ' CD1' HD13 ' A' ' 88' ' ' ILE . 90.3 m95 -95.48 125.18 39.91 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.496 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 153.29 -44.85 0.59 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.936 -0.649 . . . . 0.0 111.637 -179.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 12.7 tpt -94.2 174.61 7.06 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 -130.72 171.56 12.96 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.993 -179.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 64.23 37.41 8.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.991 177.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 11.7 p90 -62.33 -38.42 89.4 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.528 -0.469 . . . . 0.0 109.865 179.191 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 15.6 t -60.09 -29.98 68.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.12 -179.215 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 27.9 m80 -77.03 -12.62 59.96 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.815 0.341 . . . . 0.0 111.301 -179.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 19.7 m -126.54 27.77 6.06 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.078 0.466 . . . . 0.0 111.166 -179.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 38.6 m -132.41 147.56 52.38 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.195 0.522 . . . . 0.0 111.258 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -121.23 142.44 49.91 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.51 178.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.402 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 37.6 t70 58.43 80.39 0.18 Allowed 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.55 0.691 . . . . 0.0 110.477 -178.691 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.486 HG22 HD23 ' A' ' 71' ' ' LEU . 70.5 mt -102.77 119.66 51.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.997 -179.267 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.4 tpmt? -148.97 156.82 42.82 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 -179.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.796 ' HG ' HD23 ' A' ' 12' ' ' LEU . 71.9 mt -88.39 121.3 30.63 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.984 0.421 . . . . 0.0 110.099 178.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -71.88 -55.45 7.5 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.899 -178.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.518 ' CB ' ' HB2' ' A' ' 69' ' ' ARG . 8.8 mm-40 -87.08 13.57 9.09 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.884 -179.396 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 69.9 23.17 77.11 Favored Glycine 0 N--CA 1.448 -0.528 0 CA-C-N 115.7 -0.682 . . . . 0.0 112.578 179.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 145.27 -36.76 1.36 Allowed Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.029 -1.082 . . . . 0.0 112.956 179.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.518 ' HB2' ' CB ' ' A' ' 66' ' ' GLU . 8.3 mmt85 -72.39 -29.12 63.46 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.928 0.394 . . . . 0.0 111.396 -179.784 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 41.7 tttp -140.45 140.09 35.33 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.976 -177.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.556 ' HB2' HD13 ' A' ' 90' ' ' LEU . 9.9 tt -111.35 122.93 49.15 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 179.142 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.2 p -110.87 131.89 54.66 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.361 0.6 . . . . 0.0 110.873 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.402 ' HA ' ' O ' ' A' ' 61' ' ' ASP . 24.6 p -156.61 167.51 30.22 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.708 -179.659 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.507 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 67.5 ttt180 -103.81 101.3 23.99 Favored Pre-proline 0 C--N 1.314 -0.958 0 N-CA-C 109.865 -0.421 . . . . 0.0 109.865 178.807 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.633 ' HD2' ' HA ' ' A' ' 85' ' ' ARG . 61.5 Cg_endo -71.04 119.01 6.0 Favored 'Trans proline' 0 CA--C 1.513 -0.54 0 C-N-CA 122.871 2.381 . . . . 0.0 111.029 179.483 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.647 ' HA ' ' HB2' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -119.63 135.76 54.67 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 120.76 0.314 . . . . 0.0 110.486 179.795 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.728 HG23 ' O ' ' A' ' 82' ' ' PHE . 14.7 t -70.18 128.67 37.08 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 12.4 p -71.41 -12.57 16.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.474 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -60.24 -30.42 69.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.08 179.277 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.593 ' HA3' ' CE2' ' A' ' 82' ' ' PHE . . . -146.5 -35.68 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.433 0 CA-C-N 115.578 -0.737 . . . . 0.0 112.458 179.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 111.91 12.41 14.35 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 121.237 -0.506 . . . . 0.0 112.058 -179.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.728 ' O ' HG23 ' A' ' 77' ' ' THR . 16.1 p90 -112.66 152.82 28.54 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 118.782 -0.628 . . . . 0.0 110.37 -178.55 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.647 ' HB2' ' HA ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 167.52 -158.25 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.603 0 O-C-N 123.682 0.614 . . . . 0.0 111.994 178.675 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 57.4 mm-40 -117.62 -173.26 2.39 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.978 -178.088 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.633 ' HA ' ' HD2' ' A' ' 75' ' ' PRO . 73.2 ttt180 -115.93 151.38 35.5 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 178.524 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -157.95 -170.1 3.05 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.379 0.609 . . . . 0.0 112.335 -178.387 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -155.33 145.98 13.46 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.09 179.304 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.432 HD13 ' CD1' ' A' ' 50' ' ' TRP . 12.4 tt -128.46 142.17 44.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.953 0.377 . . . . 0.0 110.474 -179.628 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -82.5 133.82 35.2 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.184 0.516 . . . . 0.0 110.693 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.735 HD12 HD12 ' A' ' 19' ' ' LEU . 26.5 mt -101.02 39.64 1.37 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.616 -179.247 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.558 ' HA ' ' OG ' ' A' ' 2' ' ' SER . 9.4 m-80 -73.88 2.95 7.4 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.068 -0.969 . . . . 0.0 111.048 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 9.8 mtp180 -97.23 -11.07 24.63 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.459 179.316 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.432 ' CD1' HD23 ' A' ' 37' ' ' LEU . 23.3 mm -96.56 102.73 13.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 121.392 0.615 . . . . 0.0 109.449 -179.354 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 8.4 mm-40 -107.83 153.82 22.45 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.563 -178.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 22.8 p-10 -112.57 112.09 23.37 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.723 178.363 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 9.0 p -111.51 120.51 62.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.105 0.479 . . . . 0.0 110.176 -179.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 38.1 m-80 59.15 28.93 18.37 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.98 -178.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 88.09 -9.73 73.63 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.517 -179.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 10.5 mpt_? -91.4 124.8 35.86 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 -179.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.544 HD13 ' SG ' ' A' ' 23' ' ' CYS . 5.9 tp -82.16 117.11 22.06 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 16.6 t -129.24 138.07 55.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 120.651 0.262 . . . . 0.0 110.77 -179.136 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.56 ' HB2' HD13 ' A' ' 35' ' ' LEU . 6.8 t80 -80.91 125.72 30.48 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 177.829 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 . . . . . 0 C--N 1.311 -1.076 0 CA-C-O 118.077 -0.964 . . . . 0.0 110.856 179.848 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' SER . . . . . 0.491 ' OG ' ' HA ' ' A' ' 91' ' ' ASN . 11.8 m . . . . . 0 N--CA 1.452 -0.344 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 34.6 p90 -59.86 -35.14 74.16 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 121.094 -0.242 . . . . 0.0 110.99 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -55.84 -22.09 23.21 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 112.114 0.412 . . . . 0.0 112.114 -179.356 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -68.27 -22.68 64.73 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 120.878 0.371 . . . . 0.0 110.716 179.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 9.6 p -139.73 29.97 2.1 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.31 0.576 . . . . 0.0 110.181 179.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 9.3 t -150.71 156.82 42.09 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -179.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 9.4 ptp180 -149.07 166.93 27.24 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.655 0.264 . . . . 0.0 111.127 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 57.3 m-80 57.85 60.71 2.65 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.967 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -90.48 125.47 35.6 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.853 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 34.0 m -122.62 170.65 12.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.8 179.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.606 HD21 ' HG ' ' A' ' 64' ' ' LEU . 3.2 mm? -104.8 114.21 28.29 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.355 -179.235 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 21.6 p -110.3 167.47 10.17 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.812 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 57.52 50.34 11.3 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.889 179.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 85.29 -37.95 3.01 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 121.01 -0.614 . . . . 0.0 112.516 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 138.59 38.83 0.11 Allowed Glycine 0 N--CA 1.447 -0.595 0 N-CA-C 111.284 -0.727 . . . . 0.0 111.284 -179.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 48.7 ptt85 -123.49 -23.23 4.84 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.939 0.4 . . . . 0.0 110.744 -179.267 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.3 m -105.28 137.5 42.96 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.027 -179.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.726 HD13 HD12 ' A' ' 90' ' ' LEU . 58.5 mt -97.05 116.17 28.78 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.576 179.294 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.82 119.68 40.12 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 178.242 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -152.33 168.07 26.6 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.979 0.419 . . . . 0.0 111.776 -178.348 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -89.99 106.09 18.25 Favored 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 178.513 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 58.1 m -97.95 130.68 44.8 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 120.761 0.315 . . . . 0.0 110.633 -178.218 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.508 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 10.5 ttp180 -78.37 122.2 25.47 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.497 179.831 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 35.6 p30 -86.83 168.36 13.53 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.827 179.415 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.84 -31.32 49.03 Favored 'General case' 0 N--CA 1.464 0.255 0 O-C-N 123.555 0.535 . . . . 0.0 112.356 -179.11 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -69.51 -17.84 63.63 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.446 0.641 . . . . 0.0 110.662 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 93.72 28.7 10.82 Favored Glycine 0 N--CA 1.446 -0.684 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.313 -179.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.508 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 43.9 t30 -112.91 160.97 17.52 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.644 0.259 . . . . 0.0 110.901 -179.106 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 94.6 m95 -100.37 114.33 27.77 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.93 0.395 . . . . 0.0 111.049 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.6 m -117.75 129.19 74.55 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.381 178.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 13.7 m -75.01 111.66 10.45 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.877 -0.602 . . . . 0.0 111.015 -179.415 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 73.5 m -121.58 153.3 38.22 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.609 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.593 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 42.8 mt-10 -129.4 141.46 51.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.206 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.589 HD13 ' HB2' ' A' ' 102' ' ' PHE . 1.9 tm? -136.54 131.96 34.58 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.387 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.406 ' N ' HD12 ' A' ' 35' ' ' LEU . 31.8 m-20 -88.58 109.8 20.38 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 -179.646 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.447 HD11 ' HG ' ' A' ' 19' ' ' LEU . 4.4 mt -79.64 -20.56 46.45 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.286 -179.636 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -65.99 -5.87 10.92 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.629 -0.259 . . . . 0.0 111.461 -178.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 72.9 p -81.08 -20.84 40.65 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.625 179.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.447 ' SG ' ' HE3' ' A' ' 50' ' ' TRP . 40.9 t -129.05 -11.51 4.72 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.616 -179.871 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 51.3 mt -100.14 128.8 51.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.083 178.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -139.34 154.34 23.44 Favored Glycine 0 N--CA 1.443 -0.876 0 C-N-CA 120.852 -0.69 . . . . 0.0 111.518 179.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.528 HD21 ' CB ' ' A' ' 75' ' ' PRO . 33.0 p-10 -160.95 44.24 0.15 Allowed Pre-proline 0 CA--C 1.539 0.533 0 N-CA-C 113.142 0.794 . . . . 0.0 113.142 -179.263 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -70.95 -16.76 32.5 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 121.404 1.403 . . . . 0.0 111.895 -179.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -89.07 -9.55 50.75 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.493 179.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.544 ' CA ' ' HG2' ' A' ' 83' ' ' ARG . . . 102.21 6.47 48.16 Favored Glycine 0 N--CA 1.443 -0.899 0 C-N-CA 120.482 -0.866 . . . . 0.0 112.503 -179.38 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.476 ' HD1' HE22 ' A' ' 86' ' ' GLN . 64.5 m-85 -125.14 134.42 52.44 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 122.732 -0.275 . . . . 0.0 110.85 179.808 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 88.0 mt -83.99 146.42 27.99 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.218 -179.166 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 170.82 169.99 34.52 Favored Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 120.539 -0.839 . . . . 0.0 112.361 178.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.447 ' HE3' ' SG ' ' A' ' 40' ' ' CYS . 90.8 m95 -95.3 124.98 39.62 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 110.048 -0.352 . . . . 0.0 110.048 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 160.73 -60.05 0.3 Allowed Glycine 0 N--CA 1.448 -0.558 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.791 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -86.69 -162.15 0.74 Allowed 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -147.25 175.19 10.95 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.768 -0.373 . . . . 0.0 111.708 -179.468 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 43.7 m-80 62.72 54.15 2.39 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 123.936 0.773 . . . . 0.0 112.236 179.278 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -87.5 -17.25 32.54 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.179 178.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.1 p -55.21 -55.65 28.87 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 -177.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 47.4 m80 -80.96 -10.23 59.74 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.926 0.393 . . . . 0.0 111.264 -179.179 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 15.0 m -96.01 14.41 23.78 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.942 0.401 . . . . 0.0 110.79 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 19.5 m -136.56 152.93 51.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.0 0.428 . . . . 0.0 111.551 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -119.1 145.69 45.73 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.477 178.19 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 35.9 t70 49.93 74.59 0.2 Allowed 'General case' 0 N--CA 1.47 0.561 0 O-C-N 123.787 0.679 . . . . 0.0 111.662 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.504 HG22 HD22 ' A' ' 71' ' ' LEU . 75.0 mt -91.51 115.46 30.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.489 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 15.0 tptm -149.07 150.97 33.64 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 121.031 0.443 . . . . 0.0 111.532 -179.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.606 ' HG ' HD21 ' A' ' 12' ' ' LEU . 64.1 mt -88.95 129.93 35.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.383 179.35 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -86.43 -57.22 3.09 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-O 121.126 0.488 . . . . 0.0 111.186 -179.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -71.9 -5.74 36.79 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.189 -179.183 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 95.51 -0.07 63.14 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 121.014 -0.612 . . . . 0.0 111.759 -179.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 164.34 -39.55 0.31 Allowed Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.434 -0.889 . . . . 0.0 112.555 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 7.9 mmt180 -62.31 -33.48 74.76 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 32.2 ttpt -135.44 139.09 43.84 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.915 0.388 . . . . 0.0 111.962 -178.292 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.522 ' HB2' HD13 ' A' ' 90' ' ' LEU . 10.5 tt -117.55 132.81 56.47 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.485 -0.779 . . . . 0.0 109.355 179.42 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.428 HG22 ' HA3' ' A' ' 87' ' ' GLY . 18.7 p -125.64 144.78 50.44 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.937 0.398 . . . . 0.0 111.04 179.437 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 24.0 p -162.6 175.45 11.4 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.544 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 52.9 ttt180 -109.3 98.25 30.5 Favored Pre-proline 0 C--N 1.311 -1.101 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 178.616 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.528 ' CB ' HD21 ' A' ' 43' ' ' ASN . 32.1 Cg_endo -64.3 127.21 18.6 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 122.866 2.377 . . . . 0.0 110.279 179.338 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.658 ' HA ' ' HB2' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -120.28 147.56 44.83 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.068 0.461 . . . . 0.0 111.619 -179.663 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.705 HG23 ' O ' ' A' ' 82' ' ' PHE . 14.5 t -81.61 141.47 33.67 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 179.007 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.1 m -73.87 -8.3 11.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 O-C-N 123.923 0.764 . . . . 0.0 111.321 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 53.0 m-20 -63.89 -34.04 77.06 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-O 120.955 0.407 . . . . 0.0 110.312 179.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -157.0 -10.92 0.05 OUTLIER Glycine 0 CA--C 1.519 0.298 0 C-N-CA 120.468 -0.872 . . . . 0.0 113.183 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.35 18.49 42.07 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.768 -0.729 . . . . 0.0 111.881 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.705 ' O ' HG23 ' A' ' 77' ' ' THR . 39.2 p90 -111.4 157.85 19.77 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 118.677 -0.678 . . . . 0.0 109.418 -179.144 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.658 ' HB2' ' HA ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 167.36 -149.08 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.428 0 O-C-N 123.543 0.527 . . . . 0.0 111.516 179.659 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -130.31 157.04 43.62 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.088 -178.184 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.544 ' HA ' ' HA ' ' A' ' 74' ' ' ARG . 38.8 ttt85 -82.85 154.03 24.86 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 179.181 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . 0.476 HE22 ' HD1' ' A' ' 47' ' ' PHE . 8.8 tt0 -162.57 164.57 26.74 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.795 -0.362 . . . . 0.0 111.309 -177.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.428 ' HA3' HG22 ' A' ' 72' ' ' THR . . . -128.22 146.0 16.45 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.094 179.6 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 12.3 tt -128.74 136.01 60.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 120.977 0.417 . . . . 0.0 110.305 179.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -80.34 138.85 36.76 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.057 0.456 . . . . 0.0 110.348 179.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.726 HD12 HD13 ' A' ' 19' ' ' LEU . 50.0 mt -101.98 43.38 1.07 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.804 0.811 . . . . 0.0 109.857 -179.755 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.491 ' HA ' ' OG ' ' A' ' 2' ' ' SER . 0.9 OUTLIER -76.67 0.28 20.89 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 114.689 -1.142 . . . . 0.0 111.097 -179.347 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 14.6 mtp180 -98.12 -6.11 32.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.517 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 22.8 mm -101.48 118.89 48.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 -179.131 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -132.1 143.89 50.33 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.004 -178.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -96.92 102.92 14.8 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.654 0.74 . . . . 0.0 110.487 178.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.2 p -87.81 117.84 32.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.232 0.539 . . . . 0.0 110.047 179.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 60.43 27.18 16.78 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.228 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 95.83 -9.42 68.37 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.813 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.473 ' HD2' ' N ' ' A' ' 99' ' ' ARG . 4.0 mpt_? -99.77 124.82 45.43 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 122.394 -0.474 . . . . 0.0 110.17 -179.642 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 12.2 tp -75.76 114.99 14.99 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.977 -179.247 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 45.7 t -130.4 145.73 35.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.25 -179.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.589 ' HB2' HD13 ' A' ' 35' ' ' LEU . 11.8 t80 -78.67 135.65 37.25 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 178.538 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.947 0 CA-C-O 118.774 -0.631 . . . . 0.0 109.996 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.448 -0.54 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.425 ' CB ' HD11 ' A' ' 100' ' ' LEU . 6.7 p90 -54.71 -39.89 68.66 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 -177.799 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.596 ' HA ' ' OG ' ' A' ' 7' ' ' SER . . . -60.62 -20.42 60.65 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -178.266 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -68.42 -35.48 77.69 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.418 0.628 . . . . 0.0 109.808 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 8.1 m -120.38 34.8 5.08 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.855 -179.12 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.596 ' OG ' ' HA ' ' A' ' 4' ' ' ALA . 92.6 p -142.73 167.14 22.79 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 121.053 0.454 . . . . 0.0 110.161 178.826 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 13.5 ptp180 -152.19 166.46 31.66 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.018 -179.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 51.0 m-80 59.31 47.57 11.25 Favored 'General case' 0 N--CA 1.466 0.367 0 O-C-N 123.646 0.591 . . . . 0.0 110.959 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -80.53 118.45 22.14 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.823 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 29.6 m -126.52 170.52 16.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.12 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.768 HD22 ' HG ' ' A' ' 64' ' ' LEU . 3.1 mm? -104.53 114.77 29.21 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.237 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.425 ' OG1' ' HB ' ' A' ' 18' ' ' THR . 14.8 p -109.89 166.37 10.98 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.736 179.742 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.521 ' O ' ' HG2' ' A' ' 17' ' ' ARG . 90.4 m-20 57.15 50.28 12.1 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.13 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 83.42 -34.2 2.91 Favored Glycine 0 N--CA 1.452 -0.27 0 CA-C-N 115.962 -0.563 . . . . 0.0 112.841 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 135.59 42.44 0.12 Allowed Glycine 0 N--CA 1.447 -0.567 0 N-CA-C 111.194 -0.762 . . . . 0.0 111.194 -179.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.521 ' HG2' ' O ' ' A' ' 14' ' ' ASN . 5.4 ptm180 -124.55 -27.53 3.7 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.95 0.405 . . . . 0.0 110.712 -179.419 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.425 ' HB ' ' OG1' ' A' ' 13' ' ' THR . 2.3 m -102.63 134.52 45.87 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.192 -179.177 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.691 HD13 HD12 ' A' ' 90' ' ' LEU . 45.9 mt -94.43 111.08 22.82 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.05 178.75 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.432 ' HA ' ' HG2' ' A' ' 34' ' ' GLU . 25.7 ttt85 -106.98 120.03 40.96 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 179.421 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -155.06 167.03 31.73 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.873 0.368 . . . . 0.0 111.247 -179.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -89.09 108.03 19.37 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 177.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.584 ' SG ' HD13 ' A' ' 100' ' ' LEU . 46.8 m -95.93 129.73 43.11 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 120.778 0.323 . . . . 0.0 110.734 -178.376 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.559 ' HB2' ' CZ3' ' A' ' 30' ' ' TRP . 11.3 ttt85 -82.82 117.63 22.84 Favored 'General case' 0 N--CA 1.438 -1.06 0 N-CA-C 110.171 -0.307 . . . . 0.0 110.171 179.167 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 32.4 p30 -80.38 166.61 21.12 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.928 179.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.84 -26.03 44.82 Favored 'General case' 0 N--CA 1.465 0.285 0 O-C-N 123.702 0.626 . . . . 0.0 112.262 -178.59 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -71.12 -16.09 62.54 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.168 0.509 . . . . 0.0 110.091 179.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 93.21 24.67 21.48 Favored Glycine 0 N--CA 1.447 -0.567 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.22 179.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.414 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 32.7 m-20 -116.55 160.01 21.27 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.851 0.357 . . . . 0.0 111.449 -179.247 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.559 ' CZ3' ' HB2' ' A' ' 24' ' ' ARG . 93.5 m95 -95.73 122.62 38.7 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.067 0.46 . . . . 0.0 111.876 -179.305 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.4 m -122.8 134.08 67.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.59 178.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 23.1 m -75.23 113.09 12.19 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.05 179.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.4 ' HB2' ' SG ' ' A' ' 23' ' ' CYS . 74.4 m -128.43 153.57 46.96 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.08 -179.601 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.58 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 49.3 mt-10 -137.93 144.54 41.29 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.768 -179.582 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.439 HD13 ' N ' ' A' ' 36' ' ' ASP . 1.8 tm? -137.86 129.28 27.91 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 178.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.439 ' N ' HD13 ' A' ' 35' ' ' LEU . 13.6 m-20 -86.88 109.74 19.51 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.417 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.469 HD12 HD22 ' A' ' 90' ' ' LEU . 3.0 mt -82.02 -18.27 43.89 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 112.57 0.581 . . . . 0.0 112.57 -178.655 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.442 ' HA ' ' HD1' ' A' ' 55' ' ' PHE . 6.7 p-10 -65.7 -6.18 10.76 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.708 0.29 . . . . 0.0 111.522 -178.56 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 46.9 p -78.76 -23.25 45.46 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.836 179.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 17.2 t -130.31 -10.77 4.14 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -179.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 49.0 mt -99.77 128.76 51.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 178.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -142.47 150.9 22.57 Favored Glycine 0 N--CA 1.442 -0.952 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.119 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.482 ' OD1' ' HB2' ' A' ' 58' ' ' SER . 31.1 p-10 -157.11 47.94 0.31 Allowed Pre-proline 0 C--N 1.323 -0.579 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -179.713 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -73.01 -17.25 25.18 Favored 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 121.638 1.558 . . . . 0.0 111.87 -179.303 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -93.09 -5.84 49.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.467 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.547 ' HA3' ' HG2' ' A' ' 83' ' ' ARG . . . 101.56 7.15 49.13 Favored Glycine 0 N--CA 1.443 -0.871 0 C-N-CA 120.334 -0.936 . . . . 0.0 112.834 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -125.45 131.55 52.86 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.015 0.436 . . . . 0.0 111.309 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 81.7 mt -83.77 137.68 33.62 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.378 -178.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 177.62 171.66 41.32 Favored Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 120.861 -0.685 . . . . 0.0 111.854 179.08 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -96.29 125.04 40.52 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.997 0.427 . . . . 0.0 110.191 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 154.85 -58.3 0.39 Allowed Glycine 0 CA--C 1.507 -0.449 0 N-CA-C 110.916 -0.874 . . . . 0.0 110.916 -179.297 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 44.7 tpp -82.93 174.3 11.04 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 178.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -132.11 176.66 8.19 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 118.654 0.661 . . . . 0.0 111.798 -179.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 15.1 m-80 64.65 43.04 4.43 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.467 -0.788 . . . . 0.0 112.342 179.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.442 ' HD1' ' HA ' ' A' ' 38' ' ' ASP . 6.3 p90 -69.12 -25.5 64.43 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.997 -0.372 . . . . 0.0 109.997 179.217 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 9.4 p -58.24 -42.7 86.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.355 -179.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 41.4 m80 -80.26 -9.99 59.74 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.011 0.434 . . . . 0.0 111.215 -179.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.656 ' HA ' ' HD2' ' A' ' 76' ' ' LYS . 10.2 m -113.28 18.26 17.97 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.604 -178.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 23.5 m -131.85 143.64 50.32 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-O 121.158 0.504 . . . . 0.0 111.336 179.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 67.2 mm-40 -113.58 134.51 54.67 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.675 178.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 23.9 t70 57.34 79.6 0.19 Allowed 'General case' 0 C--N 1.322 -0.601 0 O-C-N 123.994 0.809 . . . . 0.0 111.33 -179.236 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.506 HG23 HD22 ' A' ' 71' ' ' LEU . 75.6 mt -91.6 123.57 43.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.882 179.691 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 27.8 tptt -149.05 149.88 31.85 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 110.156 -0.312 . . . . 0.0 110.156 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.768 ' HG ' HD22 ' A' ' 12' ' ' LEU . 70.3 mt -85.89 141.27 29.7 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.188 0.518 . . . . 0.0 110.608 179.233 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -100.68 -70.84 0.72 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.432 -0.804 . . . . 0.0 112.515 -178.283 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -74.67 49.0 0.38 Allowed 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -178.185 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 64.95 7.97 32.68 Favored Glycine 0 C--N 1.32 -0.326 0 CA-C-N 115.938 -0.574 . . . . 0.0 112.848 179.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.556 ' HA2' HD12 ' A' ' 64' ' ' LEU . . . 127.26 -3.3 7.24 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.645 -0.788 . . . . 0.0 113.122 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 29.9 ttp85 -95.43 0.38 53.31 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.793 0.806 . . . . 0.0 110.317 -179.448 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -147.69 129.49 15.21 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.403 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.536 ' HB2' HD13 ' A' ' 90' ' ' LEU . 10.0 tt -105.82 118.98 37.99 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 179.599 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.5 p -108.79 128.1 54.59 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.018 179.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 26.5 p -157.74 172.11 19.09 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.054 -179.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.496 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 78.9 ttt180 -108.16 100.44 36.82 Favored Pre-proline 0 C--N 1.31 -1.112 0 C-N-CA 120.225 -0.59 . . . . 0.0 109.971 178.614 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.477 ' CB ' HD21 ' A' ' 43' ' ' ASN . 19.2 Cg_endo -60.29 130.46 34.13 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 122.655 2.237 . . . . 0.0 110.246 178.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.656 ' HD2' ' HA ' ' A' ' 58' ' ' SER . 0.0 OUTLIER -119.97 154.14 34.93 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.256 0.551 . . . . 0.0 111.665 -179.133 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.691 ' HB ' ' CD ' ' A' ' 83' ' ' ARG . 6.3 t -94.08 147.64 22.94 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.69 -0.687 . . . . 0.0 109.551 179.131 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.4 p -72.34 -6.67 8.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 O-C-N 123.834 0.709 . . . . 0.0 111.941 -178.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -65.39 -23.15 66.89 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.108 0.48 . . . . 0.0 110.367 179.212 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -177.8 -8.99 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.987 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 94.42 22.1 25.27 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.707 -0.759 . . . . 0.0 111.72 179.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.606 ' O ' HG23 ' A' ' 77' ' ' THR . 26.7 p90 -111.33 153.1 26.45 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 -179.367 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.691 ' CD ' ' HB ' ' A' ' 77' ' ' THR . 0.0 OUTLIER 171.63 -148.39 0.0 OUTLIER 'General case' 0 C--O 1.233 0.224 0 O-C-N 123.683 0.614 . . . . 0.0 110.956 179.958 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -123.4 160.14 27.45 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.173 -177.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.496 ' HA ' ' HA ' ' A' ' 74' ' ' ARG . 41.8 ttt180 -86.66 155.09 20.54 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 179.562 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -163.99 169.32 18.16 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 121.091 0.472 . . . . 0.0 110.992 -178.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -136.85 133.06 6.29 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.841 -0.695 . . . . 0.0 111.686 179.169 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 10.1 tt -115.28 134.51 58.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-O 121.047 0.451 . . . . 0.0 110.18 -179.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -80.26 141.14 35.83 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.142 -179.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.691 HD12 HD13 ' A' ' 19' ' ' LEU . 16.6 mt -106.73 43.5 1.15 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.455 0.645 . . . . 0.0 110.887 -178.343 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 45.4 m-80 -79.63 3.28 19.52 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.463 -179.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 32.6 mtp180 -93.69 -9.89 36.28 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.576 178.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 17.2 mm -96.02 112.1 27.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 -179.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -119.1 147.01 44.63 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.149 -178.044 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 16.8 p-10 -95.6 102.89 14.73 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.51 0.671 . . . . 0.0 109.602 178.12 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 46.7 t -92.05 105.94 17.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.971 -179.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 60.7 33.88 20.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.842 -179.488 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 94.98 -23.03 35.03 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 121.037 -0.601 . . . . 0.0 113.007 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 3.7 mpt_? -87.13 129.39 34.95 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.945 0.373 . . . . 0.0 110.107 -179.181 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.584 HD13 ' SG ' ' A' ' 23' ' ' CYS . 6.7 tp -78.38 117.64 19.8 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -179.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 25.4 t -128.93 141.03 47.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.262 -179.155 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -86.55 135.0 33.61 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 178.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.596 ' HA ' HE21 ' A' ' 103' ' ' GLN . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.178 0 CA-C-O 118.506 -0.759 . . . . 0.0 110.234 179.43 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.1 m . . . . . 0 N--CA 1.448 -0.527 0 CA-C-O 120.439 0.161 . . . . 0.0 110.645 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.501 ' HA ' ' OD1' ' A' ' 95' ' ' ASN . 11.0 p90 -57.49 -35.19 69.88 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.666 -0.243 . . . . 0.0 111.298 179.245 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -57.29 -22.24 40.37 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -178.978 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -66.27 -13.6 60.68 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.05 0.453 . . . . 0.0 110.977 179.565 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 11.0 p -149.25 33.98 0.73 Allowed 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 178.814 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 15.9 t -146.95 150.7 35.7 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.021 -179.268 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 34.6 ptt180 -129.55 164.5 23.67 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.666 -179.232 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 51.25 65.32 1.52 Allowed 'General case' 0 C--N 1.329 -0.299 0 O-C-N 123.826 0.704 . . . . 0.0 112.151 178.503 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.414 ' HA ' ' HB1' ' A' ' 21' ' ' ALA . . . -91.3 117.85 30.0 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.155 179.449 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 33.8 m -119.39 166.95 13.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.881 -179.372 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.617 HD23 ' HG ' ' A' ' 64' ' ' LEU . 3.1 mm? -105.22 117.14 33.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.014 -179.734 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.474 ' OG1' ' HB ' ' A' ' 18' ' ' THR . 23.5 p -111.29 164.21 13.14 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.639 -179.65 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 62.26 39.08 12.86 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.71 179.265 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 84.62 -8.47 68.77 Favored Glycine 0 CA--C 1.517 0.179 0 C-N-CA 120.742 -0.742 . . . . 0.0 113.325 179.144 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 114.09 53.88 0.43 Allowed Glycine 0 N--CA 1.443 -0.873 0 C-N-CA 120.527 -0.844 . . . . 0.0 111.383 179.421 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.4 ptm180 -137.78 -34.01 0.69 Allowed 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.088 0.471 . . . . 0.0 110.573 -179.91 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.474 ' HB ' ' OG1' ' A' ' 13' ' ' THR . 4.2 m -102.36 135.06 44.65 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.54 -179.798 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.725 HD13 HD12 ' A' ' 90' ' ' LEU . 62.6 mt -94.95 116.4 28.65 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.218 179.136 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 33.5 ttm180 -111.4 120.39 42.0 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 178.732 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.414 ' HB1' ' HA ' ' A' ' 10' ' ' ALA . . . -153.7 165.34 36.29 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.862 0.363 . . . . 0.0 111.418 -179.526 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -91.44 106.0 18.17 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 177.801 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 64.0 m -96.01 134.89 38.49 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 120.911 0.386 . . . . 0.0 110.984 -178.495 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.484 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 15.1 ttp180 -77.54 111.41 13.24 Favored 'General case' 0 N--CA 1.439 -0.999 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.052 179.558 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 38.2 p30 -75.71 169.38 18.22 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.48 -179.786 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.86 -33.29 64.42 Favored 'General case' 0 C--O 1.235 0.296 0 O-C-N 123.416 0.447 . . . . 0.0 111.718 -179.151 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -68.22 -14.69 63.17 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.327 0.584 . . . . 0.0 110.677 179.969 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 88.66 37.56 7.38 Favored Glycine 0 N--CA 1.447 -0.589 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 -179.504 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.484 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 53.7 t30 -124.81 164.16 20.6 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.496 0.189 . . . . 0.0 110.891 -179.082 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 91.1 m95 -98.05 124.89 42.77 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.885 179.587 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.4 m -128.42 137.88 56.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.028 178.544 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 37.4 m -84.1 109.32 17.61 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.002 0.43 . . . . 0.0 111.055 -179.048 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 69.6 m -119.09 148.8 42.64 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.138 179.409 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.638 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 45.4 mt-10 -127.86 145.33 50.97 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.867 -179.955 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.765 HD12 ' HB2' ' A' ' 102' ' ' PHE . 1.8 tm? -139.71 130.58 26.12 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 179.507 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.484 ' N ' HD11 ' A' ' 35' ' ' LEU . 39.7 m-20 -87.26 110.53 20.26 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.002 179.825 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.469 HD11 ' HG ' ' A' ' 19' ' ' LEU . 1.8 mt -84.86 -20.79 30.27 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.845 0.355 . . . . 0.0 110.871 -179.923 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.413 ' HA ' ' HD1' ' A' ' 55' ' ' PHE . 5.6 p-10 -67.35 -5.88 16.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.983 -178.195 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.43 HG22 ' O ' ' A' ' 36' ' ' ASP . 10.6 t -84.65 -8.51 58.85 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.867 0.365 . . . . 0.0 110.358 179.415 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 21.8 t -140.49 -5.41 1.22 Allowed 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 179.511 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 59.5 mt -106.95 136.7 41.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 O-C-N 122.036 -0.415 . . . . 0.0 109.882 178.957 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -146.72 154.38 25.94 Favored Glycine 0 N--CA 1.443 -0.846 0 C-N-CA 120.89 -0.671 . . . . 0.0 111.777 179.553 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 27.6 p30 -155.28 48.15 0.36 Allowed Pre-proline 0 CA--C 1.537 0.454 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 179.986 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -68.69 -23.75 35.83 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 121.722 1.614 . . . . 0.0 112.238 -179.084 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 72.0 m-20 -91.94 0.59 57.47 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.923 -179.582 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.526 ' CA ' ' HG2' ' A' ' 83' ' ' ARG . . . 93.05 7.28 62.59 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.287 -0.959 . . . . 0.0 112.049 -179.301 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.567 ' HA ' HE22 ' A' ' 86' ' ' GLN . 47.7 m-85 -122.55 133.95 54.55 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.851 0.357 . . . . 0.0 110.807 179.831 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 34.0 mt -84.5 147.89 26.81 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.536 -0.757 . . . . 0.0 111.664 -179.172 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 170.37 168.95 32.91 Favored Glycine 0 N--CA 1.441 -1.023 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.974 179.121 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 89.1 m95 -95.64 125.33 40.15 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 179.975 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 161.77 -53.72 0.32 Allowed Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 121.026 -0.607 . . . . 0.0 112.249 -179.696 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 4.1 tpt -90.92 -164.82 1.23 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 -179.952 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -146.3 170.58 16.5 Favored 'General case' 0 C--O 1.234 0.275 0 O-C-N 122.025 -0.422 . . . . 0.0 111.939 -178.815 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 42.2 m-80 64.0 36.13 10.17 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.454 -0.794 . . . . 0.0 112.599 178.991 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.413 ' HD1' ' HA ' ' A' ' 38' ' ' ASP . 8.0 p90 -65.23 -29.75 70.58 Favored 'General case' 0 C--O 1.224 -0.288 0 CA-C-O 120.684 0.278 . . . . 0.0 111.193 -179.896 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 13.4 t -57.07 -36.69 70.85 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -178.315 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 13.3 m-70 -80.82 -6.56 58.72 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.151 0.5 . . . . 0.0 110.984 -179.528 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 12.9 m -119.03 25.78 9.96 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.118 -179.987 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.513 ' HB2' HD11 ' A' ' 62' ' ' ILE . 11.6 m -137.3 140.23 41.4 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-O 121.059 0.457 . . . . 0.0 111.321 179.788 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -108.71 141.2 41.04 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.179 179.063 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 39.1 t70 52.35 75.94 0.21 Allowed 'General case' 0 C--N 1.32 -0.7 0 O-C-N 123.998 0.811 . . . . 0.0 111.402 179.95 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.514 HG22 HD23 ' A' ' 71' ' ' LEU . 81.6 mt -90.22 122.25 41.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.235 179.591 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.7 tptm -146.97 160.32 42.5 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.124 -178.892 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.617 ' HG ' HD23 ' A' ' 12' ' ' LEU . 55.8 mt -93.66 130.01 39.75 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.267 0.556 . . . . 0.0 110.012 178.602 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 45.2 tp10 -77.71 -66.33 0.85 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.39 -178.108 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -88.68 31.43 0.84 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.189 -178.889 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 68.04 17.91 70.3 Favored Glycine 0 N--CA 1.446 -0.638 0 CA-C-N 115.8 -0.636 . . . . 0.0 113.091 179.83 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.512 ' HA2' HD22 ' A' ' 64' ' ' LEU . . . 137.14 -21.96 3.28 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 119.828 -1.177 . . . . 0.0 113.3 179.184 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.444 HH11 ' HD2' ' A' ' 69' ' ' ARG . 0.8 OUTLIER -76.74 -21.05 55.81 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.579 0.704 . . . . 0.0 109.987 -179.642 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 2.6 ttmp? -148.43 138.46 22.42 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.094 -178.708 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.563 ' HB2' HD13 ' A' ' 90' ' ' LEU . 10.2 tt -108.89 124.96 51.46 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.309 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.1 p -116.16 127.77 55.08 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.544 0.687 . . . . 0.0 111.014 179.561 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 26.6 p -153.51 175.86 12.7 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.314 -179.721 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.571 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 12.0 ttt180 -108.33 98.74 28.77 Favored Pre-proline 0 C--N 1.31 -1.114 0 C-N-CA 120.623 -0.431 . . . . 0.0 110.007 178.654 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.436 ' HD2' ' HA ' ' A' ' 74' ' ' ARG . 49.4 Cg_endo -67.12 122.54 9.86 Favored 'Trans proline' 0 CA--C 1.516 -0.4 0 C-N-CA 122.835 2.357 . . . . 0.0 110.82 179.478 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.708 ' HA ' ' HB2' ' A' ' 83' ' ' ARG . 0.3 OUTLIER -120.29 147.04 45.5 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-O 120.914 0.388 . . . . 0.0 111.564 -179.333 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.736 HG22 ' O ' ' A' ' 82' ' ' PHE . 7.9 t -74.84 137.82 42.11 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 178.988 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 29.6 m -73.2 -12.33 15.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 123.82 0.7 . . . . 0.0 111.355 -179.635 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -63.55 -33.38 75.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.652 179.379 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.552 ' HA3' ' CE2' ' A' ' 82' ' ' PHE . . . -145.81 -23.07 0.12 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.42 -0.895 . . . . 0.0 113.088 179.73 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 98.68 14.7 36.6 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 121.049 -0.596 . . . . 0.0 111.877 -179.706 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.736 ' O ' HG22 ' A' ' 77' ' ' THR . 28.2 p90 -112.48 154.26 26.15 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 119.029 -0.51 . . . . 0.0 110.608 -178.492 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.708 ' HB2' ' HA ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 167.38 -153.13 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.461 0 O-C-N 123.745 0.653 . . . . 0.0 111.202 178.308 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -116.48 -177.34 3.16 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.143 -177.24 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.571 ' HA ' ' HA ' ' A' ' 74' ' ' ARG . 68.0 ttt180 -107.21 155.31 20.05 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 178.783 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . 0.567 HE22 ' HA ' ' A' ' 47' ' ' PHE . 8.9 tt0 -166.37 167.74 15.57 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 120.87 0.366 . . . . 0.0 111.491 -178.976 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.45 ' N ' ' HG2' ' A' ' 86' ' ' GLN . . . -130.39 144.08 15.4 Favored Glycine 0 N--CA 1.45 -0.428 0 N-CA-C 111.564 -0.614 . . . . 0.0 111.564 178.601 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 9.4 tt -126.57 138.92 53.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 120.93 0.395 . . . . 0.0 110.517 -179.846 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -77.42 135.91 38.35 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.369 179.811 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.725 HD12 HD13 ' A' ' 19' ' ' LEU . 53.9 mt -105.38 39.43 1.74 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.688 -179.884 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 18.8 m-80 -75.35 2.53 11.03 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.104 -179.541 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 49.0 mtp180 -95.88 -10.48 28.72 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.657 -0.702 . . . . 0.0 109.967 178.33 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 20.9 mm -100.66 99.51 8.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -179.764 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 24.4 tp60 -115.98 143.14 45.85 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.089 -178.485 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.501 ' OD1' ' HA ' ' A' ' 3' ' ' TYR . 15.0 p-10 -95.18 122.81 38.25 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.008 178.728 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.3 p -115.04 115.75 50.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-O 121.16 0.505 . . . . 0.0 109.944 179.313 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 32.1 m-80 60.37 28.3 17.92 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.709 -179.166 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 94.77 -14.94 64.4 Favored Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 120.804 -0.712 . . . . 0.0 113.048 179.915 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.468 ' HD2' ' N ' ' A' ' 99' ' ' ARG . 3.3 mpt_? -91.7 131.93 36.74 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 117.158 0.479 . . . . 0.0 110.559 -179.12 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 8.5 tp -84.29 116.54 23.05 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.251 -179.28 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 24.4 t -125.54 140.3 48.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 120.798 0.332 . . . . 0.0 110.914 -179.287 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.765 ' HB2' HD12 ' A' ' 35' ' ' LEU . 3.9 t80 -91.67 124.37 35.76 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 178.396 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 . . . . . 0 C--N 1.314 -0.969 0 CA-C-O 118.002 -0.999 . . . . 0.0 110.955 179.82 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 2' ' ' SER . . . . . 0.578 ' OG ' ' HA ' ' A' ' 91' ' ' ASN . 3.3 m . . . . . 0 N--CA 1.452 -0.355 0 N-CA-C 109.97 -0.382 . . . . 0.0 109.97 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.551 ' HA ' ' OD1' ' A' ' 95' ' ' ASN . 23.4 p90 -58.31 -37.65 75.5 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.53 0.205 . . . . 0.0 111.446 -179.892 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -55.09 -19.2 6.77 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.792 -0.64 . . . . 0.0 112.623 -178.794 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -59.15 -38.15 79.03 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.389 0.614 . . . . 0.0 109.956 179.168 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 49.2 m -133.08 46.5 2.6 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.15 179.086 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.424 ' HA ' ' HZ3' ' A' ' 30' ' ' TRP . 16.5 t -148.79 152.18 36.09 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.22 -179.329 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 3.9 ptp180 -149.39 171.69 16.14 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.314 -179.846 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 49.1 m-80 62.96 45.84 5.16 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 122.959 0.504 . . . . 0.0 110.437 -179.286 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -83.16 118.07 23.34 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.996 -179.718 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 27.1 m -126.24 170.69 15.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.193 179.519 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.51 HD22 ' HG ' ' A' ' 64' ' ' LEU . 3.0 mm? -105.37 117.64 34.53 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 -179.332 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 28.0 p -113.87 162.17 16.69 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.974 0.416 . . . . 0.0 111.508 -179.745 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 64.32 30.33 13.39 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.526 179.652 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 95.92 -18.87 56.64 Favored Glycine 0 C--O 1.228 -0.255 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.755 179.46 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 123.47 42.6 0.38 Allowed Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.508 -0.853 . . . . 0.0 111.768 179.78 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -126.77 -29.02 2.9 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.096 0.474 . . . . 0.0 110.541 -179.91 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 4.9 m -104.53 134.25 48.02 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.555 -179.877 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.776 HD13 HD13 ' A' ' 90' ' ' LEU . 33.6 mt -94.23 113.32 25.22 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.118 179.02 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 45.1 ttt180 -106.96 119.51 39.57 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 178.843 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -154.12 166.36 33.32 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.878 0.37 . . . . 0.0 111.151 -179.762 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 56.2 mm-40 -90.71 113.45 25.54 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 178.276 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.44 ' SG ' HD13 ' A' ' 100' ' ' LEU . 60.4 m -100.31 123.53 44.66 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 110.34 -0.245 . . . . 0.0 110.34 -178.957 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.495 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 11.7 ttp180 -72.6 114.47 10.77 Favored 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 179.015 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 35.4 p30 -77.66 171.04 15.54 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.85 -179.23 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.36 -33.87 63.77 Favored 'General case' 0 N--CA 1.464 0.252 0 O-C-N 123.675 0.609 . . . . 0.0 111.917 -178.776 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -67.92 -18.69 64.85 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.361 0.601 . . . . 0.0 110.613 -179.851 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 93.69 33.66 6.97 Favored Glycine 0 N--CA 1.443 -0.849 0 N-CA-C 111.085 -0.806 . . . . 0.0 111.085 -179.475 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.495 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 10.8 t-20 -118.49 159.89 22.71 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 110.013 -0.365 . . . . 0.0 110.013 -179.221 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.424 ' HZ3' ' HA ' ' A' ' 7' ' ' SER . 95.5 m95 -98.37 117.67 33.31 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.855 0.36 . . . . 0.0 110.6 179.918 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 12.5 m -119.23 132.27 69.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.38 178.773 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 27.9 m -74.86 110.36 9.09 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.021 0.439 . . . . 0.0 110.231 -179.624 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 60.7 m -121.29 145.62 47.68 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.599 -179.606 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.589 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 50.4 mt-10 -129.03 130.59 46.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.931 -179.505 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.417 HD12 ' N ' ' A' ' 36' ' ' ASP . 2.4 tm? -124.86 131.62 53.42 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.437 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.417 ' N ' HD12 ' A' ' 35' ' ' LEU . 9.0 m-20 -89.78 109.16 20.17 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.841 0.353 . . . . 0.0 110.189 -179.114 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.472 HD13 ' CD1' ' A' ' 19' ' ' LEU . 2.4 mt -81.87 -17.84 45.9 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.164 -179.494 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -62.18 -10.18 9.78 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.817 0.342 . . . . 0.0 111.149 -179.317 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 59.5 p -78.99 -20.4 49.18 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.191 179.585 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.425 ' SG ' ' HE3' ' A' ' 50' ' ' TRP . 20.5 t -132.36 -8.66 3.32 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -179.191 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 53.9 mt -104.69 133.45 48.79 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 O-C-N 122.132 -0.355 . . . . 0.0 110.225 178.777 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -147.84 160.28 28.27 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.921 -0.657 . . . . 0.0 111.823 179.91 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.419 HD21 ' CD1' ' A' ' 48' ' ' LEU . 21.6 p30 -162.3 54.15 0.46 Allowed Pre-proline 0 CA--C 1.537 0.45 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -179.799 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -72.16 -18.17 27.32 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 121.923 1.749 . . . . 0.0 112.311 -179.242 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -93.25 -16.51 24.69 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.437 179.822 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.496 ' HA3' ' HG2' ' A' ' 83' ' ' ARG . . . 109.82 9.64 24.3 Favored Glycine 0 N--CA 1.442 -0.964 0 C-N-CA 120.467 -0.873 . . . . 0.0 112.542 -179.333 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.488 ' HD1' HE22 ' A' ' 86' ' ' GLN . 54.6 m-85 -125.55 134.67 51.9 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.872 0.368 . . . . 0.0 110.623 179.716 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.575 HD22 HG22 ' A' ' 88' ' ' ILE . 10.5 mp -84.23 142.91 29.94 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.345 0.593 . . . . 0.0 111.848 -178.603 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 176.96 171.33 40.44 Favored Glycine 0 N--CA 1.439 -1.148 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.611 178.956 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.425 ' HE3' ' SG ' ' A' ' 40' ' ' CYS . 91.4 m95 -96.11 124.74 40.23 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 179.835 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 160.2 -58.81 0.31 Allowed Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 121.21 -0.519 . . . . 0.0 111.873 -179.708 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 12.8 tpt -85.89 175.2 8.77 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 -179.893 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -128.8 167.0 17.95 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.722 -0.391 . . . . 0.0 111.075 -179.712 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 11.3 m-80 64.56 49.79 2.3 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.449 179.026 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 21.1 p90 -68.48 -31.2 70.31 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.07 0.462 . . . . 0.0 110.187 179.021 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.412 ' HA ' HD13 ' A' ' 62' ' ' ILE . 3.5 p -56.53 -38.16 71.48 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.591 -178.699 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 22.4 m80 -72.49 -30.94 64.96 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.632 0.253 . . . . 0.0 111.331 -179.52 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 14.1 m -96.88 18.36 14.74 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.011 -179.488 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 45.4 m -130.79 165.31 23.25 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.199 0.523 . . . . 0.0 111.491 -179.756 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -137.64 136.14 37.19 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.245 -0.889 . . . . 0.0 108.95 178.589 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 37.0 t70 58.88 80.22 0.19 Allowed 'General case' 0 N--CA 1.467 0.425 0 O-C-N 123.649 0.593 . . . . 0.0 110.86 -179.705 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.473 HG23 HD21 ' A' ' 71' ' ' LEU . 59.9 mt -100.95 122.16 52.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.261 -179.13 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 72.9 tttt -149.22 165.1 32.89 Favored 'General case' 0 C--O 1.221 -0.407 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 179.466 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.51 ' HG ' HD22 ' A' ' 12' ' ' LEU . 71.2 mt -90.84 127.39 36.34 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.068 0.461 . . . . 0.0 111.072 -179.603 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -76.29 -57.97 3.55 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.443 -0.798 . . . . 0.0 110.676 -179.179 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -85.03 11.84 8.81 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.789 -179.521 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 71.61 28.07 69.98 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.383 179.973 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 136.86 -34.48 2.21 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.207 -0.996 . . . . 0.0 112.627 179.448 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 2.1 tpp180 -75.62 -18.47 59.69 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.116 0.484 . . . . 0.0 110.589 -179.551 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -151.42 141.88 22.53 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.067 -178.804 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.534 ' HB2' HD11 ' A' ' 90' ' ' LEU . 10.5 tt -110.52 128.62 55.72 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.104 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.2 p -123.16 128.11 49.6 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.317 0.58 . . . . 0.0 111.293 -179.905 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 20.5 p -151.94 169.91 21.15 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.516 179.875 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.596 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 29.4 ttt180 -106.35 99.73 25.64 Favored Pre-proline 0 C--N 1.321 -0.645 0 C-N-CA 120.263 -0.575 . . . . 0.0 110.492 179.126 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.429 ' HB2' ' HA2' ' A' ' 46' ' ' GLY . 60.5 Cg_endo -71.75 137.85 30.68 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 122.622 2.215 . . . . 0.0 110.273 178.718 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.658 ' HA ' ' HB2' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -121.39 140.68 51.82 Favored 'General case' 0 C--N 1.317 -0.807 0 O-C-N 123.483 0.49 . . . . 0.0 111.113 -179.883 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.725 HG23 ' O ' ' A' ' 82' ' ' PHE . 12.5 t -75.61 138.86 41.71 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 179.291 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 34.7 m -73.18 -9.78 13.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 O-C-N 124.122 0.889 . . . . 0.0 111.199 -179.826 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -66.92 -31.39 71.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.054 179.673 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.407 ' HA3' ' CE2' ' A' ' 82' ' ' PHE . . . -154.48 -12.49 0.06 OUTLIER Glycine 0 CA--C 1.521 0.428 0 C-N-CA 120.519 -0.848 . . . . 0.0 113.359 179.751 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.25 16.25 53.88 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.959 -0.639 . . . . 0.0 112.082 -179.792 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.725 ' O ' HG23 ' A' ' 77' ' ' THR . 35.4 p90 -111.76 158.35 19.45 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 118.694 -0.669 . . . . 0.0 109.612 -178.866 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.658 ' HB2' ' HA ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 171.37 -148.25 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 179.431 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -142.99 152.49 42.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.373 -0.831 . . . . 0.0 109.496 -178.195 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.596 ' HA ' ' HA ' ' A' ' 74' ' ' ARG . 27.8 ttt85 -77.84 150.43 34.22 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 123.229 0.331 . . . . 0.0 110.123 -179.794 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . 0.488 HE22 ' HD1' ' A' ' 47' ' ' PHE . 8.9 tt0 -155.58 158.85 39.07 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.317 -178.806 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -123.32 144.34 15.58 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.088 179.412 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.575 HG22 HD22 ' A' ' 48' ' ' LEU . 12.8 tt -123.96 135.04 64.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 179.563 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -77.1 140.92 40.4 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.068 0.461 . . . . 0.0 110.017 -179.882 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.776 HD13 HD13 ' A' ' 19' ' ' LEU . 26.4 mt -106.35 41.17 1.47 Allowed 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.334 0.588 . . . . 0.0 110.765 -179.424 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.578 ' HA ' ' OG ' ' A' ' 2' ' ' SER . 28.8 m-80 -75.06 2.85 9.62 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.763 -179.96 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 9.7 mtp180 -96.72 -16.54 20.84 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.165 179.797 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 22.4 mm -92.73 114.36 29.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 109.684 -0.488 . . . . 0.0 109.684 -178.904 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 23.1 tp60 -124.6 141.46 52.08 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.356 0.598 . . . . 0.0 111.545 -178.157 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.551 ' OD1' ' HA ' ' A' ' 3' ' ' TYR . 13.1 p-10 -94.62 102.22 14.13 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.673 178.176 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.7 p -90.56 110.41 22.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.504 -179.348 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 60.42 27.32 16.92 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.14 -179.919 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 100.29 -17.04 57.48 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.735 -0.745 . . . . 0.0 113.225 179.739 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.412 ' HD2' ' N ' ' A' ' 99' ' ' ARG . 1.7 mpt_? -91.53 126.09 36.49 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 117.23 0.515 . . . . 0.0 109.871 -179.541 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.44 HD13 ' SG ' ' A' ' 23' ' ' CYS . 11.2 tp -82.84 114.03 20.87 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.233 -179.203 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 38.4 t -131.47 146.48 33.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 120.694 0.283 . . . . 0.0 110.321 -179.338 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.417 ' HB2' HD13 ' A' ' 35' ' ' LEU . 11.7 t80 -78.67 133.94 37.17 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 178.771 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 . . . . . 0 C--O 1.247 0.951 0 CA-C-O 118.632 -0.699 . . . . 0.0 110.067 179.824 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 2' ' ' SER . . . . . 0.839 ' HB2' ' HG2' ' A' ' 69' ' ' ARG . 4.7 m . . . . . 0 N--CA 1.452 -0.328 0 CA-C-O 120.639 0.257 . . . . 0.0 110.848 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.421 ' CD2' HD13 ' A' ' 100' ' ' LEU . 4.2 p90 -59.85 -33.27 71.56 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.228 -0.442 . . . . 0.0 112.032 -179.713 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.581 ' HA ' ' OG ' ' A' ' 7' ' ' SER . . . -55.16 -18.41 5.72 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -178.167 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -58.32 -42.85 87.65 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.976 0.417 . . . . 0.0 111.166 179.727 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 25.6 m -123.02 38.44 4.19 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 121.044 0.45 . . . . 0.0 110.903 -179.486 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.581 ' OG ' ' HA ' ' A' ' 4' ' ' ALA . 52.5 p -141.28 168.19 20.37 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.21 179.143 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 37.1 ptt180 -149.76 168.23 24.27 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.005 -178.564 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 55.25 43.24 29.52 Favored 'General case' 0 C--N 1.33 -0.244 0 O-C-N 124.089 0.868 . . . . 0.0 112.203 178.078 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -72.28 117.0 13.38 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 179.251 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.447 HG21 HH21 ' A' ' 20' ' ' ARG . 27.8 m -124.0 172.74 11.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.713 -179.423 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.558 HD22 ' HG ' ' A' ' 64' ' ' LEU . 3.7 mm? -104.74 115.81 30.95 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.775 -179.311 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 27.9 p -112.45 161.08 17.11 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.666 179.387 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 59.25 44.58 15.35 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.17 179.553 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 87.35 -23.61 11.62 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.218 -179.715 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 124.85 17.01 2.88 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 121.109 -0.567 . . . . 0.0 111.894 -179.867 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.684 ' HB2' ' HB2' ' A' ' 38' ' ' ASP . 3.6 ptm180 -95.78 -22.05 17.75 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.227 0.537 . . . . 0.0 110.375 -179.609 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.7 m -111.29 135.99 51.03 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.788 -178.978 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.679 HD12 HD13 ' A' ' 90' ' ' LEU . 41.8 mt -97.46 112.55 24.35 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.768 179.361 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.447 HH21 HG21 ' A' ' 11' ' ' VAL . 30.5 ttp180 -105.1 120.65 42.03 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 178.439 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -152.97 162.41 41.35 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.906 0.384 . . . . 0.0 111.062 -179.878 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -90.84 105.75 18.04 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 178.439 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.55 ' SG ' HD12 ' A' ' 100' ' ' LEU . 40.2 m -94.21 132.09 39.12 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 -179.449 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 8.0 ttp180 -84.28 116.46 23.0 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-O 120.776 0.322 . . . . 0.0 110.747 -179.886 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 31.4 p30 -82.07 162.23 22.63 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.086 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.49 -21.72 17.78 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -178.68 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -74.69 -13.77 60.66 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.317 0.58 . . . . 0.0 110.195 179.764 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 89.74 32.13 10.47 Favored Glycine 0 N--CA 1.449 -0.456 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.93 179.987 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 -124.47 151.62 44.34 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.826 0.346 . . . . 0.0 111.364 -179.519 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 93.9 m95 -90.96 120.59 32.09 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.568 179.384 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -118.56 127.3 75.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 116.247 -0.433 . . . . 0.0 109.918 178.079 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 25.5 m -76.48 111.52 12.04 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.194 179.935 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 66.7 m -123.06 145.66 48.35 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.906 -179.376 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.592 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 44.8 mt-10 -124.91 133.07 53.19 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.882 179.708 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.699 HD13 ' HB2' ' A' ' 102' ' ' PHE . 1.5 tm? -125.42 131.59 52.89 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.167 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.45 ' O ' HG21 ' A' ' 39' ' ' THR . 14.5 m-20 -90.05 110.27 21.27 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.012 0.434 . . . . 0.0 110.241 -179.779 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.486 HD12 ' HG ' ' A' ' 19' ' ' LEU . 1.5 mt -83.8 -23.89 31.25 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.031 -179.749 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.719 ' OD2' ' HA ' ' A' ' 54' ' ' ASN . 20.9 t70 -60.49 -15.14 24.06 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.19 -0.459 . . . . 0.0 112.151 -178.647 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.45 HG21 ' O ' ' A' ' 36' ' ' ASP . 11.6 t -77.44 -14.48 59.69 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.721 -0.218 . . . . 0.0 111.387 -179.656 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.413 ' SG ' ' HE3' ' A' ' 50' ' ' TRP . 42.5 t -134.33 -0.79 2.94 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -179.609 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.443 ' HB ' ' CD1' ' A' ' 55' ' ' PHE . 60.4 mt -108.84 135.24 48.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 178.589 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -138.61 156.53 24.2 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.095 -179.826 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 39.9 p-10 -164.81 43.79 0.09 OUTLIER Pre-proline 0 CA--C 1.542 0.664 0 N-CA-C 113.102 0.778 . . . . 0.0 113.102 -179.377 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -73.17 -22.65 18.92 Favored 'Trans proline' 0 C--N 1.354 0.858 0 C-N-CA 121.661 1.574 . . . . 0.0 112.346 -178.913 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -84.4 -14.11 50.31 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.819 179.923 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.487 ' CA ' ' HG2' ' A' ' 83' ' ' ARG . . . 107.29 8.17 31.49 Favored Glycine 0 N--CA 1.444 -0.81 0 C-N-CA 120.301 -0.952 . . . . 0.0 111.994 -178.866 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.56 ' HA ' HE22 ' A' ' 86' ' ' GLN . 71.3 m-85 -125.91 139.1 53.73 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 110.391 -0.226 . . . . 0.0 110.391 179.82 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 7.8 mp -89.89 151.04 21.94 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.225 0.536 . . . . 0.0 111.975 -178.931 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 167.24 170.99 32.79 Favored Glycine 0 N--CA 1.444 -0.782 0 CA-C-N 115.601 -0.727 . . . . 0.0 112.122 178.469 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.417 ' CD1' HD13 ' A' ' 88' ' ' ILE . 90.8 m95 -95.73 132.24 41.15 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 179.98 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 156.42 -63.08 0.33 Allowed Glycine 0 N--CA 1.451 -0.355 0 N-CA-C 111.573 -0.611 . . . . 0.0 111.573 179.915 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 39.7 ttm -88.63 176.63 7.04 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 179.34 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -130.65 172.41 11.98 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 118.288 0.495 . . . . 0.0 111.654 -179.294 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.719 ' HA ' ' OD2' ' A' ' 38' ' ' ASP . 36.0 m-80 68.54 46.85 0.95 Allowed 'General case' 0 C--O 1.234 0.263 0 O-C-N 123.945 0.778 . . . . 0.0 111.697 179.129 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.443 ' CD1' ' HB ' ' A' ' 41' ' ' ILE . 13.7 p90 -76.6 -26.88 55.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.517 179.78 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 7.1 m -62.69 -30.45 71.41 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.199 0.523 . . . . 0.0 110.97 -178.694 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 17.7 m-70 -82.11 -3.54 55.0 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.754 -179.519 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 42.4 m -128.29 28.69 5.45 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.112 0.482 . . . . 0.0 110.358 179.333 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.43 ' HA ' ' O ' ' A' ' 74' ' ' ARG . 15.4 p -143.61 157.85 44.11 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.105 179.829 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -127.0 136.86 52.82 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.991 179.663 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.414 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 36.5 t70 60.29 84.48 0.12 Allowed 'General case' 0 N--CA 1.467 0.381 0 O-C-N 123.608 0.568 . . . . 0.0 111.68 179.511 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 75.4 mt -97.92 120.38 47.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.103 179.547 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.6 tptm -147.33 148.19 31.13 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.123 -179.79 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.564 HD11 HD22 ' A' ' 19' ' ' LEU . 36.3 mt -88.56 145.23 25.84 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.868 -179.474 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -105.34 -62.14 1.39 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.044 -0.525 . . . . 0.0 112.107 -179.046 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.542 ' HB2' ' HB2' ' A' ' 69' ' ' ARG . 44.6 mm-40 -79.21 42.93 0.51 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.831 -178.527 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 62.49 20.41 61.27 Favored Glycine 0 C--N 1.317 -0.525 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.594 179.33 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.538 ' HA2' HD13 ' A' ' 64' ' ' LEU . . . 121.4 -14.88 9.31 Favored Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.388 -179.996 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.839 ' HG2' ' HB2' ' A' ' 2' ' ' SER . 48.3 mtm105 -84.02 2.27 39.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.13 0.491 . . . . 0.0 110.804 -179.718 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -155.26 134.36 12.27 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.975 179.917 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.601 ' HB2' HD11 ' A' ' 90' ' ' LEU . 9.8 tt -116.77 125.71 52.03 Favored 'General case' 0 C--N 1.318 -0.794 0 O-C-N 123.576 0.548 . . . . 0.0 109.94 -179.723 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.7 p -113.97 136.29 53.06 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.769 179.208 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.414 ' HA ' ' O ' ' A' ' 61' ' ' ASP . 25.8 p -162.26 165.57 26.55 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.252 179.84 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.502 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 31.9 ttt180 -99.48 103.44 21.05 Favored Pre-proline 0 C--N 1.319 -0.745 0 C-N-CA 120.676 -0.409 . . . . 0.0 110.733 179.496 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.554 ' HD2' ' HA ' ' A' ' 85' ' ' ARG . 43.8 Cg_endo -67.64 119.63 6.64 Favored 'Trans proline' 0 CA--C 1.512 -0.58 0 C-N-CA 122.569 2.18 . . . . 0.0 110.149 178.564 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.636 ' HA ' ' HB2' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -119.91 140.61 50.61 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 120.764 0.316 . . . . 0.0 111.682 -178.808 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.713 HG22 ' O ' ' A' ' 82' ' ' PHE . 12.9 t -72.52 135.22 45.59 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.695 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 26.7 m -73.33 -4.33 5.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 123.943 0.777 . . . . 0.0 112.056 -178.938 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -68.95 -32.9 72.83 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.13 0.49 . . . . 0.0 109.902 179.342 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -151.65 -20.23 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.678 179.819 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.22 20.73 22.25 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.751 -0.738 . . . . 0.0 111.949 -179.887 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.713 ' O ' HG22 ' A' ' 77' ' ' THR . 27.6 p90 -111.88 143.22 43.21 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 -178.876 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.636 ' HB2' ' HA ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 175.06 -154.21 0.01 OUTLIER 'General case' 0 C--O 1.234 0.241 0 CA-C-O 120.796 0.332 . . . . 0.0 111.702 179.881 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -113.84 177.16 4.73 Favored 'General case' 0 C--O 1.225 -0.207 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.486 -178.708 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.554 ' HA ' ' HD2' ' A' ' 75' ' ' PRO . 59.1 ttt180 -110.39 150.86 28.2 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 178.77 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . 0.56 HE22 ' HA ' ' A' ' 47' ' ' PHE . 22.1 mt-30 -156.84 -175.25 5.32 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -178.152 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -150.3 142.89 10.06 Favored Glycine 0 N--CA 1.45 -0.423 0 CA-C-N 114.803 -1.09 . . . . 0.0 111.108 179.09 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.417 HD13 ' CD1' ' A' ' 50' ' ' TRP . 13.2 tt -123.97 142.73 39.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 121.052 0.453 . . . . 0.0 110.649 -178.683 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -79.14 133.61 36.73 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.623 179.807 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.679 HD13 HD12 ' A' ' 19' ' ' LEU . 74.9 mt -106.27 41.25 1.45 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.324 0.583 . . . . 0.0 111.286 -179.44 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.551 ' HA ' ' OG ' ' A' ' 2' ' ' SER . 22.8 m-80 -76.12 2.05 14.01 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.192 179.575 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 13.3 mtp180 -94.03 -6.98 44.02 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.783 179.392 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 17.7 mm -101.92 106.36 19.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -179.782 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 21.7 tp60 -118.93 149.35 41.74 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.994 -178.008 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.409 ' OD1' ' HA ' ' A' ' 3' ' ' TYR . 14.7 p-10 -99.3 117.94 34.86 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.29 0.567 . . . . 0.0 110.435 178.858 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 48.1 t -103.71 100.4 10.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.5 179.191 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 7.3 m-80 58.69 43.5 18.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.858 -179.197 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 89.99 -23.42 20.76 Favored Glycine 0 N--CA 1.444 -0.792 0 CA-C-N 115.512 -0.767 . . . . 0.0 113.496 179.48 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.421 ' HD2' ' N ' ' A' ' 99' ' ' ARG . 4.4 mpt_? -86.78 123.39 31.87 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 117.116 0.458 . . . . 0.0 110.574 -179.271 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.55 HD12 ' SG ' ' A' ' 23' ' ' CYS . 5.6 tp -76.01 122.15 23.79 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.166 -179.403 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 24.1 t -129.35 138.95 53.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.933 -179.183 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.699 ' HB2' HD13 ' A' ' 35' ' ' LEU . 12.5 t80 -85.51 131.92 34.29 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.052 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 17.3 tt0 . . . . . 0 C--N 1.315 -0.892 0 CA-C-O 117.968 -1.015 . . . . 0.0 110.44 -179.954 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 2' ' ' SER . . . . . 0.497 ' HG ' ' HA ' ' A' ' 91' ' ' ASN . 17.7 m . . . . . 0 N--CA 1.448 -0.539 0 CA-C-O 120.564 0.221 . . . . 0.0 110.663 . . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.436 ' CG ' HD13 ' A' ' 100' ' ' LEU . 25.2 p90 -57.17 -30.64 64.67 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.201 179.362 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.425 ' HB1' ' HD2' ' A' ' 69' ' ' ARG . . . -53.7 -18.86 3.42 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.33 -179.363 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -61.06 -36.27 79.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.296 0.57 . . . . 0.0 109.977 179.043 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 24.5 m -133.95 36.46 3.27 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.805 179.691 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.413 ' HA ' ' HZ3' ' A' ' 30' ' ' TRP . 23.2 t -148.75 145.77 27.76 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.399 -179.987 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 4.5 ptp180 -136.61 167.9 20.52 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.585 -0.279 . . . . 0.0 111.646 -178.874 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 67.1 m-80 55.78 65.21 1.51 Allowed 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.435 179.893 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -92.55 120.03 32.61 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.661 179.622 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 26.6 m -120.41 169.11 12.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.317 -179.731 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.727 HD22 ' HG ' ' A' ' 64' ' ' LEU . 3.1 mm? -104.67 116.91 32.86 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.24 -179.634 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.478 ' OG1' ' HB ' ' A' ' 18' ' ' THR . 18.9 p -109.81 161.94 14.96 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.452 179.48 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 62.15 40.87 11.34 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.945 -179.803 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 91.02 -45.38 2.85 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 121.034 -0.603 . . . . 0.0 112.459 179.62 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 149.77 52.42 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.506 0 N-CA-C 111.481 -0.648 . . . . 0.0 111.481 -179.469 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.44 ' HB2' ' HB2' ' A' ' 38' ' ' ASP . 3.7 ptm180 -135.57 -33.46 0.87 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.146 0.498 . . . . 0.0 110.808 -179.811 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.478 ' HB ' ' OG1' ' A' ' 13' ' ' THR . 3.0 m -97.53 133.5 42.01 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.524 -179.968 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.635 HD13 HD12 ' A' ' 90' ' ' LEU . 44.1 mt -95.89 113.65 25.29 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.231 179.349 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 17.9 ttm180 -107.86 120.68 42.94 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 178.76 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -152.77 167.85 27.64 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.929 0.395 . . . . 0.0 111.365 -178.896 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -89.63 106.09 18.23 Favored 'General case' 0 CA--C 1.512 -0.491 0 N-CA-C 107.969 -1.122 . . . . 0.0 107.969 178.405 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.574 ' SG ' HD12 ' A' ' 100' ' ' LEU . 58.5 m -96.39 125.91 41.22 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 120.713 0.292 . . . . 0.0 110.225 -178.959 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.596 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 22.4 ttt180 -77.94 111.83 14.2 Favored 'General case' 0 N--CA 1.44 -0.933 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.087 179.639 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 36.0 p30 -74.18 170.65 15.1 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.318 -179.62 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.26 -11.73 23.68 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -177.806 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -88.15 -10.23 50.62 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 178.676 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 88.45 27.94 23.59 Favored Glycine 0 N--CA 1.448 -0.511 0 CA-C-N 114.956 -1.02 . . . . 0.0 111.535 -179.522 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.596 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 51.9 t30 -112.75 161.45 16.88 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.526 0.203 . . . . 0.0 111.162 -178.661 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.439 ' CZ3' ' HB2' ' A' ' 24' ' ' ARG . 95.4 m95 -102.5 116.85 33.46 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.715 179.596 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 6.2 m -118.82 141.1 40.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.608 179.309 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 61.6 m -81.1 108.62 14.92 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 179.209 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 50.3 m -120.34 150.43 40.76 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.351 -179.536 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.592 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 48.3 mt-10 -131.2 145.6 52.0 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.915 -179.893 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.628 HD11 ' HB2' ' A' ' 102' ' ' PHE . 2.2 tm? -139.45 132.0 28.75 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 178.777 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.476 ' N ' HD13 ' A' ' 35' ' ' LEU . 5.7 m-20 -90.33 110.25 21.32 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.919 0.39 . . . . 0.0 110.992 179.967 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.473 HD13 HD22 ' A' ' 90' ' ' LEU . 2.4 mt -80.67 -19.73 44.57 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.705 179.268 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.528 ' OD1' ' HA ' ' A' ' 54' ' ' ASN . 22.4 t70 -58.74 -18.7 33.85 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.389 -0.823 . . . . 0.0 112.339 -178.812 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.436 HG21 ' O ' ' A' ' 36' ' ' ASP . 14.6 t -82.61 -6.74 59.52 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 121.103 -0.239 . . . . 0.0 111.449 -179.639 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.522 ' SG ' ' HE3' ' A' ' 50' ' ' TRP . 25.8 t -135.0 -18.63 1.81 Allowed 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.816 -0.354 . . . . 0.0 111.467 179.556 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 56.0 mt -98.28 129.13 48.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 178.359 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -141.11 164.69 26.45 Favored Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 120.64 -0.791 . . . . 0.0 111.67 179.784 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.517 ' OD1' ' HB2' ' A' ' 58' ' ' SER . 32.1 p-10 -161.92 47.26 0.21 Allowed Pre-proline 0 CA--C 1.538 0.487 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 -179.144 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -71.9 -23.21 22.39 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 121.562 1.508 . . . . 0.0 111.625 -179.536 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -84.26 -14.95 48.51 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.588 -179.893 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 103.98 8.22 39.66 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.051 -178.831 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -125.21 140.07 53.18 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 179.43 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 92.3 mt -86.68 145.64 26.61 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.012 -179.712 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 171.39 172.33 37.4 Favored Glycine 0 N--CA 1.444 -0.784 0 C-N-CA 120.785 -0.722 . . . . 0.0 111.745 179.207 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.522 ' HE3' ' SG ' ' A' ' 40' ' ' CYS . 87.2 m95 -95.53 125.2 39.96 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.826 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 159.99 -52.16 0.36 Allowed Glycine 0 CA--C 1.518 0.25 0 C-N-CA 121.129 -0.557 . . . . 0.0 112.453 -179.997 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.625 ' HA ' ' HE3' ' A' ' 52' ' ' MET . 0.1 OUTLIER -97.15 178.03 5.39 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.29 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -129.99 171.78 12.42 Favored 'General case' 0 C--N 1.318 -0.798 0 O-C-N 122.04 -0.412 . . . . 0.0 111.295 -179.18 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.528 ' HA ' ' OD1' ' A' ' 38' ' ' ASP . 21.7 m-80 64.31 59.98 0.98 Allowed 'General case' 0 C--O 1.235 0.311 0 O-C-N 123.963 0.789 . . . . 0.0 111.285 179.458 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.441 ' HA ' ' OD1' ' A' ' 43' ' ' ASN . 18.6 p90 -86.56 -32.24 20.79 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.645 -179.991 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 13.3 m -62.05 -36.9 83.01 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.269 -179.024 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 38.2 m80 -81.28 -3.59 52.95 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.728 179.218 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.517 ' HB2' ' OD1' ' A' ' 43' ' ' ASN . 4.7 m -121.33 18.67 11.44 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.551 -179.676 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 58.1 p -145.55 171.69 14.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.097 0.475 . . . . 0.0 111.096 179.882 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -140.85 154.03 46.02 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.065 179.433 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 62.3 63.04 1.09 Allowed 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.022 0.439 . . . . 0.0 110.929 -179.703 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.467 HG21 HD22 ' A' ' 71' ' ' LEU . 63.6 mt -90.7 117.27 33.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.973 -179.681 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 42.5 tptt -148.85 149.45 31.32 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.772 -179.895 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.727 ' HG ' HD22 ' A' ' 12' ' ' LEU . 76.5 mt -82.46 132.57 35.2 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.931 0.396 . . . . 0.0 110.106 179.317 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -80.25 -62.61 1.63 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.488 -178.862 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -85.49 28.05 0.78 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.584 -179.86 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 64.97 15.95 61.12 Favored Glycine 0 N--CA 1.448 -0.545 0 CA-C-N 115.624 -0.717 . . . . 0.0 113.066 179.812 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.509 ' HA2' HD12 ' A' ' 64' ' ' LEU . . . 142.66 -21.98 2.35 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 119.904 -1.141 . . . . 0.0 113.091 179.459 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.425 ' HD2' ' HB1' ' A' ' 4' ' ' ALA . 0.2 OUTLIER -79.34 -13.91 59.33 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.426 0.631 . . . . 0.0 109.713 -179.922 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.685 ' HZ2' ' HB2' ' A' ' 70' ' ' LYS . 4.5 ttmp? -157.1 141.76 16.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.259 -179.233 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.569 ' HB2' HD13 ' A' ' 90' ' ' LEU . 10.0 tt -111.42 134.45 52.99 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 179.975 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.401 HG22 ' HA3' ' A' ' 87' ' ' GLY . 7.0 p -123.95 135.05 53.42 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 120.798 0.332 . . . . 0.0 111.156 179.852 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 26.9 p -159.52 168.8 25.28 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.134 -0.485 . . . . 0.0 109.998 179.988 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.525 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 56.6 ttt180 -99.66 101.97 15.34 Favored Pre-proline 0 C--N 1.314 -0.96 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.725 179.944 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.434 ' HD2' ' HA ' ' A' ' 85' ' ' ARG . 58.7 Cg_endo -71.43 123.14 9.26 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 122.535 2.156 . . . . 0.0 110.856 178.868 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.639 ' HA ' ' HB2' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -119.57 139.84 51.5 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.845 0.355 . . . . 0.0 111.053 -179.69 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.705 HG21 ' O ' ' A' ' 82' ' ' PHE . 12.3 t -75.47 140.65 42.98 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 116.176 -0.466 . . . . 0.0 109.752 -179.765 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 31.3 m -76.32 -5.97 8.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.488 -179.482 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 -64.75 -35.25 80.45 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-O 121.155 0.502 . . . . 0.0 110.234 179.145 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -154.01 -9.74 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.512 -0.851 . . . . 0.0 112.768 -179.925 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.32 17.51 52.73 Favored Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.641 -0.79 . . . . 0.0 111.862 179.976 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.705 ' O ' HG21 ' A' ' 77' ' ' THR . 34.0 p90 -111.23 151.2 28.56 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 119.17 -0.443 . . . . 0.0 109.974 -178.773 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.639 ' HB2' ' HA ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 169.78 -153.36 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.293 0 O-C-N 123.641 0.588 . . . . 0.0 111.052 179.107 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 49.9 mm-40 -122.21 -177.58 3.64 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.736 -178.037 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.525 ' HA ' ' HA ' ' A' ' 74' ' ' ARG . 52.7 ttt180 -106.03 153.45 22.01 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 177.396 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . 0.698 ' HG2' ' H ' ' A' ' 87' ' ' GLY . 8.3 tt0 -157.89 -174.98 5.11 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.662 -178.513 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.698 ' H ' ' HG2' ' A' ' 86' ' ' GLN . . . -148.92 140.54 8.28 Favored Glycine 0 N--CA 1.445 -0.704 0 N-CA-C 111.181 -0.767 . . . . 0.0 111.181 179.21 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 15.3 tt -119.28 131.41 72.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.544 0.688 . . . . 0.0 110.742 -179.548 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -75.94 140.7 42.22 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.401 -179.671 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.635 HD12 HD13 ' A' ' 19' ' ' LEU . 42.4 mt -109.84 44.19 1.24 Allowed 'General case' 0 C--O 1.234 0.253 0 N-CA-C 112.848 0.684 . . . . 0.0 112.848 -177.717 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.497 ' HA ' ' HG ' ' A' ' 2' ' ' SER . 3.9 m-80 -79.7 3.91 17.82 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-O 121.32 0.581 . . . . 0.0 110.834 178.759 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 36.6 mtp180 -95.86 -11.21 27.12 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.357 178.919 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 21.2 mm -100.8 109.08 24.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 -179.406 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -122.26 148.52 44.89 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.941 -178.108 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 27.2 p-10 -100.65 123.28 44.64 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.65 0.738 . . . . 0.0 110.268 178.448 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 59.5 t -114.73 114.3 46.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.672 -179.853 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 45.6 m-80 57.46 33.45 23.28 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.22 0.533 . . . . 0.0 110.562 -178.798 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 89.32 -15.24 58.92 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.867 -179.915 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 3.6 mpt_? -87.59 123.22 32.23 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 117.005 0.403 . . . . 0.0 110.048 -179.846 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.574 HD12 ' SG ' ' A' ' 23' ' ' CYS . 8.2 tp -77.16 115.05 16.61 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.474 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 11.3 t -122.73 140.37 46.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 120.964 0.411 . . . . 0.0 111.45 -178.271 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.628 ' HB2' HD11 ' A' ' 35' ' ' LEU . 3.9 t80 -84.65 132.85 34.43 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 177.401 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 3.9 tp-100 . . . . . 0 C--O 1.252 1.198 0 CA-C-O 118.545 -0.741 . . . . 0.0 110.794 -179.837 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 2' ' ' SER . . . . . 0.717 ' HG ' ' HA ' ' A' ' 91' ' ' ASN . 39.2 m . . . . . 0 N--CA 1.45 -0.439 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 . . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.5 ' HA ' ' OD1' ' A' ' 95' ' ' ASN . 14.6 p90 -65.73 -33.36 75.69 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.091 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.516 ' HA ' ' OG ' ' A' ' 7' ' ' SER . . . -57.69 -22.4 46.0 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.055 -0.52 . . . . 0.0 112.051 -179.368 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -65.4 -19.68 66.05 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 121.022 0.439 . . . . 0.0 110.629 179.217 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 7.4 p -145.9 39.53 1.13 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.645 179.938 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.516 ' OG ' ' HA ' ' A' ' 4' ' ' ALA . 87.0 p -145.89 167.73 22.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.205 179.085 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 4.9 ptp180 -150.49 162.84 39.83 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.733 -179.6 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 56.59 60.05 3.28 Favored 'General case' 0 C--N 1.331 -0.233 0 O-C-N 123.982 0.801 . . . . 0.0 111.769 177.657 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.4 ' HA ' ' HB1' ' A' ' 21' ' ' ALA . . . -91.94 119.49 31.74 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.703 179.775 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 27.4 m -119.81 169.55 10.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.475 -179.897 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.484 HD23 ' HG ' ' A' ' 64' ' ' LEU . 3.2 mm? -105.76 114.55 28.78 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.518 -179.211 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.454 ' OG1' ' HB ' ' A' ' 18' ' ' THR . 26.3 p -109.86 164.7 12.33 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.018 179.988 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 61.61 43.7 9.73 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.838 179.731 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 88.76 -37.84 3.27 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.792 -0.718 . . . . 0.0 111.975 179.827 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.417 ' O ' HG21 ' A' ' 62' ' ' ILE . . . 140.74 42.32 0.07 OUTLIER Glycine 0 N--CA 1.444 -0.808 0 N-CA-C 111.432 -0.667 . . . . 0.0 111.432 -179.529 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.441 ' HD2' ' CG ' ' A' ' 38' ' ' ASP . 18.2 ptt85 -127.19 -21.24 3.96 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.896 0.379 . . . . 0.0 111.126 -179.828 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.454 ' HB ' ' OG1' ' A' ' 13' ' ' THR . 3.8 m -106.63 131.29 53.95 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.374 179.889 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.682 HD13 HD11 ' A' ' 90' ' ' LEU . 57.3 mt -93.4 113.83 26.08 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.327 179.209 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 22.5 ttt180 -111.97 119.37 38.29 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 178.644 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.4 ' HB1' ' HA ' ' A' ' 10' ' ' ALA . . . -153.73 167.0 31.09 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.95 0.405 . . . . 0.0 111.362 -179.11 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -90.02 106.7 18.65 Favored 'General case' 0 CA--C 1.511 -0.523 0 N-CA-C 107.821 -1.178 . . . . 0.0 107.821 178.19 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.535 ' SG ' HD11 ' A' ' 100' ' ' LEU . 35.7 m -97.55 131.82 43.79 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.326 -178.627 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.503 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 13.1 ttp180 -76.25 119.45 20.16 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 116.174 -0.466 . . . . 0.0 109.945 179.38 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 36.9 p30 -81.75 168.83 17.64 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 179.535 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -52.93 -30.56 35.27 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 -179.013 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -72.57 -15.08 61.76 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.397 0.618 . . . . 0.0 110.483 179.982 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 92.18 24.5 24.41 Favored Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.549 179.985 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.503 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 8.2 t-20 -107.49 162.89 13.53 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.582 0.23 . . . . 0.0 110.476 -178.753 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.425 ' HZ3' ' HA ' ' A' ' 7' ' ' SER . 83.3 m95 -99.03 115.71 29.58 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.931 0.396 . . . . 0.0 111.694 -179.548 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.1 m -122.13 125.43 72.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.173 178.463 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 19.9 m -76.14 113.54 13.79 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.996 -179.559 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 57.8 m -120.43 155.91 32.52 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.74 179.887 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.628 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 46.7 mt-10 -131.46 136.95 48.36 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.191 -179.394 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.458 HD12 ' HB2' ' A' ' 102' ' ' PHE . 1.7 tm? -132.72 130.1 39.57 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 178.434 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.443 ' N ' HD11 ' A' ' 35' ' ' LEU . 9.0 m-20 -89.94 109.04 20.09 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 -179.997 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.478 HD12 HD13 ' A' ' 19' ' ' LEU . 3.3 mt -79.48 -20.63 46.87 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.57 -179.095 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.441 ' CG ' ' HD2' ' A' ' 17' ' ' ARG . 11.2 p-10 -65.78 -10.26 35.82 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.7 0.285 . . . . 0.0 111.713 -178.612 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 77.6 p -81.23 -11.91 59.27 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.996 0.427 . . . . 0.0 110.34 179.045 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 23.4 m -133.95 -15.92 2.28 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.982 -0.554 . . . . 0.0 112.4 -179.026 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 54.9 mt -99.84 135.29 36.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 O-C-N 122.093 -0.379 . . . . 0.0 109.991 179.081 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -143.65 156.7 26.73 Favored Glycine 0 N--CA 1.443 -0.878 0 C-N-CA 120.386 -0.911 . . . . 0.0 112.263 179.804 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.557 ' OD1' ' HB2' ' A' ' 58' ' ' SER . 25.4 p30 -153.47 40.38 0.16 Allowed Pre-proline 0 CA--C 1.54 0.568 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -179.785 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.41 ' CD ' ' N ' ' A' ' 43' ' ' ASN . 7.1 Cg_exo -71.77 -17.46 29.28 Favored 'Trans proline' 0 C--N 1.355 0.902 0 C-N-CA 121.74 1.627 . . . . 0.0 111.377 -179.213 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -91.58 -2.84 56.98 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.06 179.853 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.58 ' CA ' ' HG2' ' A' ' 83' ' ' ARG . . . 91.79 8.03 64.01 Favored Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.214 -179.439 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -126.11 139.38 53.43 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.667 0.27 . . . . 0.0 110.568 179.646 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 81.7 mt -84.48 148.7 26.4 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.723 179.862 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 165.42 171.11 31.24 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 121.036 -0.602 . . . . 0.0 111.921 179.244 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 89.0 m95 -95.28 125.66 40.06 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 179.676 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 163.21 -57.79 0.28 Allowed Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.192 -179.628 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.493 ' CE ' ' HA ' ' A' ' 52' ' ' MET . 0.0 OUTLIER -90.78 -166.01 1.49 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 179.719 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 28.2 pt20 -141.98 171.6 13.83 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.918 -0.313 . . . . 0.0 111.648 -179.047 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 29.0 m-80 63.12 36.3 12.27 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 115.493 -0.776 . . . . 0.0 112.628 178.749 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 12.4 p90 -61.21 -27.39 68.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.763 0.316 . . . . 0.0 111.371 -179.629 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 15.0 m -62.53 -30.58 71.4 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.038 0.384 . . . . 0.0 112.038 -178.958 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 35.7 m80 -82.04 -4.06 55.95 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.742 -0.383 . . . . 0.0 111.169 -179.14 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.557 ' HB2' ' OD1' ' A' ' 43' ' ' ASN . 30.3 m -130.77 29.85 4.71 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.347 0.594 . . . . 0.0 110.239 179.232 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 28.9 p -141.28 153.22 45.08 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.641 179.209 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 66.4 mt-10 -125.34 139.2 53.89 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.419 -179.687 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 36.0 t70 58.62 73.21 0.49 Allowed 'General case' 0 N--CA 1.466 0.363 0 O-C-N 123.83 0.706 . . . . 0.0 111.532 -179.766 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.527 HG23 HD21 ' A' ' 71' ' ' LEU . 77.4 mt -87.24 119.85 35.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 178.801 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.688 ' HB2' ' HZ2' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -148.87 159.79 43.84 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.843 -0.343 . . . . 0.0 111.033 -178.653 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.484 ' HG ' HD23 ' A' ' 12' ' ' LEU . 81.0 mt -99.94 123.54 44.3 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.845 0.355 . . . . 0.0 110.958 179.891 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.406 ' C ' ' H ' ' A' ' 67' ' ' GLY . 37.0 mm-40 -82.0 -61.48 1.9 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.502 -179.676 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.439 ' OE2' ' HB2' ' A' ' 70' ' ' LYS . 36.1 mt-10 -76.58 12.96 1.09 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.307 -179.658 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.406 ' H ' ' C ' ' A' ' 65' ' ' GLU . . . 76.5 18.79 78.81 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.348 -179.928 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.423 ' HA2' HD22 ' A' ' 64' ' ' LEU . . . 136.94 -17.16 3.66 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.0 -1.095 . . . . 0.0 112.924 179.384 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -83.01 -17.96 41.5 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.194 0.521 . . . . 0.0 109.72 -179.854 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.439 ' HB2' ' OE2' ' A' ' 66' ' ' GLU . 37.9 ttmt -150.73 136.87 18.46 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.891 -179.278 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.545 ' HB2' HD12 ' A' ' 90' ' ' LEU . 10.0 tt -114.73 129.3 56.67 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.491 179.714 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 8.2 p -116.57 140.01 49.86 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.155 0.502 . . . . 0.0 111.28 179.828 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 13.0 p -163.28 164.03 25.09 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.089 179.02 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.509 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 28.1 ttt180 -99.4 100.39 10.42 Favored Pre-proline 0 C--N 1.317 -0.822 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 179.103 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.07 117.39 5.01 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.383 2.055 . . . . 0.0 109.864 178.545 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.745 ' HA ' ' HB2' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -119.78 143.43 47.83 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.501 -178.978 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.668 HG22 ' O ' ' A' ' 82' ' ' PHE . 8.7 t -69.89 134.38 48.37 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.218 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 11.1 p -71.28 -12.43 16.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 O-C-N 124.088 0.867 . . . . 0.0 111.094 -179.284 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 32.8 m-20 -70.62 -16.72 62.86 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.506 -179.606 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.686 ' HA3' ' CE2' ' A' ' 82' ' ' PHE . . . -157.64 -30.2 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.441 -0.885 . . . . 0.0 112.628 179.215 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.464 ' HA2' ' CE ' ' A' ' 76' ' ' LYS . . . 101.83 16.13 24.71 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 121.024 -0.608 . . . . 0.0 111.916 -179.721 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.686 ' CE2' ' HA3' ' A' ' 80' ' ' GLY . 16.7 p90 -112.25 157.06 21.38 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 118.686 -0.673 . . . . 0.0 110.173 -178.622 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.745 ' HB2' ' HA ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 163.92 -151.03 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.556 0 O-C-N 124.253 0.971 . . . . 0.0 111.124 178.478 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -125.47 152.88 44.35 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.142 -177.927 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.509 ' HA ' ' HA ' ' A' ' 74' ' ' ARG . 39.7 ttt180 -83.91 145.8 28.39 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 179.621 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -150.63 -179.67 7.44 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.094 0.473 . . . . 0.0 111.756 -178.287 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -141.09 142.51 12.24 Favored Glycine 0 N--CA 1.451 -0.345 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.455 178.993 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 13.2 tt -125.09 136.58 60.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.028 0.442 . . . . 0.0 110.973 -179.199 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -80.59 141.28 35.19 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.467 -179.882 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.682 HD11 HD13 ' A' ' 19' ' ' LEU . 58.3 mt -107.59 46.36 0.95 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.674 0.749 . . . . 0.0 110.932 -179.816 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.717 ' HA ' ' HG ' ' A' ' 2' ' ' SER . 26.8 m-80 -79.9 3.67 19.11 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.634 179.762 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 12.9 mtp180 -98.47 -15.0 19.78 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.41 179.872 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 22.7 mm -94.37 98.07 7.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 121.356 0.598 . . . . 0.0 109.601 -179.029 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 22.3 tp60 -107.63 141.94 38.34 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.961 -178.443 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.5 ' OD1' ' HA ' ' A' ' 3' ' ' TYR . 16.1 p-10 -95.64 119.72 34.64 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.512 178.582 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 58.2 t -109.23 112.26 39.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.31 179.286 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 23.2 m-80 59.24 34.84 23.25 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-O 121.069 0.461 . . . . 0.0 110.56 -178.952 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 87.57 -8.96 75.51 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.757 -179.955 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.454 ' HD2' ' N ' ' A' ' 99' ' ' ARG . 7.9 mpt_? -94.65 134.43 37.24 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.661 0.267 . . . . 0.0 110.978 -179.052 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.535 HD11 ' SG ' ' A' ' 23' ' ' CYS . 2.9 tp -84.89 119.81 25.77 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.594 -0.276 . . . . 0.0 110.503 -179.681 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 20.8 t -129.28 141.53 46.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.609 -179.661 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.458 ' HB2' HD12 ' A' ' 35' ' ' LEU . 23.2 t80 -83.71 133.0 34.82 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 178.348 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 . . . . . 0 C--O 1.248 1.013 0 CA-C-O 118.336 -0.84 . . . . 0.0 110.108 179.271 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 2' ' ' SER . . . . . 0.573 ' OG ' ' HA ' ' A' ' 91' ' ' ASN . 21.0 m . . . . . 0 N--CA 1.453 -0.306 0 N-CA-C 110.474 -0.195 . . . . 0.0 110.474 . . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 11.7 p90 -55.32 -32.16 62.25 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.281 179.061 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -52.37 -20.89 3.07 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -178.801 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -55.93 -42.49 76.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.914 0.388 . . . . 0.0 110.959 178.743 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 47.7 m -132.01 36.02 3.69 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.001 179.828 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 16.7 m -144.57 153.24 41.6 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.483 179.531 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 7.9 ptp180 -149.53 172.7 14.58 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 110.317 -0.253 . . . . 0.0 110.317 179.951 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.456 ' N ' HD21 ' A' ' 9' ' ' ASN . 0.9 OUTLIER 67.02 44.63 1.92 Allowed 'General case' 0 N--CA 1.469 0.475 0 O-C-N 123.56 0.537 . . . . 0.0 110.5 -179.505 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -87.83 118.26 27.24 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.425 -179.879 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 30.6 m -121.57 176.15 4.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.871 179.308 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -104.98 114.09 28.09 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 -179.752 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.515 ' OG1' ' HB ' ' A' ' 18' ' ' THR . 24.1 p -106.1 163.38 12.82 Favored 'General case' 0 C--O 1.245 0.823 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.923 -179.641 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 62.16 36.2 15.18 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.706 -179.482 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 92.56 -40.28 2.88 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.7 179.431 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 147.72 56.07 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.499 0 N-CA-C 110.979 -0.849 . . . . 0.0 110.979 -179.723 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 10.0 ptm180 -140.87 -32.19 0.58 Allowed 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.066 0.46 . . . . 0.0 111.211 -179.394 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.515 ' HB ' ' OG1' ' A' ' 13' ' ' THR . 3.7 m -102.99 138.27 40.08 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.348 -179.53 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.603 ' O ' ' HA ' ' A' ' 34' ' ' GLU . 34.4 mt -98.6 113.34 25.35 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.865 179.428 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 5.2 ttp180 -106.3 120.61 42.32 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 178.489 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -152.88 166.24 32.92 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.938 0.399 . . . . 0.0 111.734 -179.245 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -90.65 107.27 19.07 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 178.467 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.457 ' SG ' HD11 ' A' ' 100' ' ' LEU . 27.2 m -98.78 127.49 44.72 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.457 -178.754 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 19.6 ttp180 -74.39 109.52 7.94 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 179.27 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -87.27 173.48 9.17 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.718 -178.96 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -46.63 -34.1 4.75 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 -178.692 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -67.56 -10.74 54.68 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 121.498 0.666 . . . . 0.0 111.105 -179.464 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.45 23.63 56.01 Favored Glycine 0 N--CA 1.446 -0.634 0 N-CA-C 111.233 -0.747 . . . . 0.0 111.233 -179.94 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 -123.74 160.4 27.37 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.797 0.332 . . . . 0.0 111.197 -178.836 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 75.3 m95 -87.57 131.56 34.35 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.24 -178.858 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 23' ' ' CYS . 6.2 m -126.29 137.0 59.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.745 178.118 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 37.6 m -75.53 109.24 8.93 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.133 179.775 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 49.9 m -122.8 144.59 49.08 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.932 -179.966 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.603 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 43.9 mt-10 -128.88 135.45 49.09 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.433 -179.729 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.511 HD13 ' HB2' ' A' ' 102' ' ' PHE . 2.4 tm? -128.64 131.69 48.07 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 178.808 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.452 ' N ' HD12 ' A' ' 35' ' ' LEU . 11.4 m-20 -89.29 110.77 21.51 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.297 -179.794 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.476 HD13 ' HG ' ' A' ' 19' ' ' LEU . 0.9 OUTLIER -86.87 -16.12 37.03 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.938 179.947 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.462 ' HA ' ' HD1' ' A' ' 55' ' ' PHE . 0.5 OUTLIER -66.06 -13.81 60.62 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 -177.508 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.424 HG23 ' O ' ' A' ' 36' ' ' ASP . 8.8 t -83.08 -7.82 59.6 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.895 0.378 . . . . 0.0 110.653 179.193 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.416 ' SG ' HG22 ' A' ' 39' ' ' THR . 58.0 m -130.94 -17.2 3.15 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 112.181 0.437 . . . . 0.0 112.181 -179.341 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 57.2 mt -104.98 137.05 36.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.684 0.278 . . . . 0.0 110.766 179.731 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -150.31 162.47 29.26 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 121.114 -0.565 . . . . 0.0 111.744 179.202 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.66 ' ND2' ' HB2' ' A' ' 55' ' ' PHE . 7.2 p30 -160.88 50.2 0.31 Allowed Pre-proline 0 CA--C 1.537 0.476 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -179.738 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -69.93 -13.07 33.77 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 121.658 1.572 . . . . 0.0 112.046 -179.653 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -101.94 5.02 40.62 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.735 179.83 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.538 ' CA ' ' HG2' ' A' ' 83' ' ' ARG . . . 85.43 11.66 74.59 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.362 -0.923 . . . . 0.0 112.37 -179.592 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.615 ' HA ' HE22 ' A' ' 86' ' ' GLN . 49.3 m-85 -125.31 131.81 52.98 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.013 0.435 . . . . 0.0 110.801 179.916 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 84.6 mt -86.31 135.57 33.48 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.461 -0.791 . . . . 0.0 111.722 -178.69 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -177.85 172.27 44.88 Favored Glycine 0 N--CA 1.447 -0.619 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.734 179.209 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 90.2 m95 -95.16 124.76 39.38 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 179.621 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 159.41 -54.71 0.35 Allowed Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.92 -0.657 . . . . 0.0 111.917 -179.26 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.56 -166.06 1.41 Allowed 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 179.649 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -146.03 173.63 12.0 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.64 -0.424 . . . . 0.0 111.634 -179.55 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 60.21 39.86 18.75 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.717 179.376 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.66 ' HB2' ' ND2' ' A' ' 43' ' ' ASN . 6.2 p90 -61.84 -28.61 69.61 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.167 179.488 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.444 ' HA ' ' CD1' ' A' ' 62' ' ' ILE . 24.5 t -58.83 -44.94 91.04 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.727 -179.942 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 34.0 m80 -81.31 -13.76 58.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.082 0.467 . . . . 0.0 111.037 -179.734 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 15.7 m -96.33 -1.47 47.77 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.77 -178.928 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 56.5 p -137.95 172.97 12.15 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 121.71 -0.619 . . . . 0.0 111.235 -179.0 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -131.13 147.57 52.62 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.011 179.909 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 39.0 t70 56.66 77.69 0.25 Allowed 'General case' 0 N--CA 1.467 0.396 0 O-C-N 123.877 0.736 . . . . 0.0 110.722 179.903 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.486 HG23 HD23 ' A' ' 71' ' ' LEU . 67.3 mt -99.94 120.38 49.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.841 -179.292 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 76.9 tttt -148.9 156.96 43.05 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.211 -0.45 . . . . 0.0 109.858 179.554 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 44.1 mt -82.66 140.12 33.32 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.139 0.495 . . . . 0.0 111.271 -178.848 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -90.81 -61.56 1.64 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.985 -178.792 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -82.2 13.01 3.73 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.127 0.489 . . . . 0.0 111.106 -179.767 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 78.4 17.16 78.35 Favored Glycine 0 N--CA 1.45 -0.403 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.413 179.8 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 143.24 -30.95 1.98 Allowed Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.309 -0.948 . . . . 0.0 112.552 179.469 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 4.6 tpp85 -75.45 -19.66 59.31 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.279 0.561 . . . . 0.0 110.565 -179.931 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -148.5 145.71 28.03 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.437 -178.33 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.583 ' HB2' HD12 ' A' ' 90' ' ' LEU . 10.2 tt -116.61 144.38 44.46 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.782 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.8 p -134.2 138.52 45.17 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 120.85 0.357 . . . . 0.0 110.697 179.747 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 26.5 p -162.55 174.58 12.45 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.85 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.45 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 4.1 tmt_? -109.29 97.46 26.31 Favored Pre-proline 0 C--N 1.315 -0.915 0 N-CA-C 109.111 -0.699 . . . . 0.0 109.111 179.087 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -64.58 129.55 24.03 Favored 'Trans proline' 0 CA--C 1.515 -0.473 0 C-N-CA 122.991 2.461 . . . . 0.0 110.807 -179.981 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.695 ' HA ' ' HB2' ' A' ' 83' ' ' ARG . 0.3 OUTLIER -121.22 149.78 42.32 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.217 0.532 . . . . 0.0 111.478 -179.569 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.645 HG22 ' O ' ' A' ' 82' ' ' PHE . 14.7 t -82.69 143.4 30.96 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 178.794 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 32.7 m -70.04 -9.33 12.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 O-C-N 123.862 0.727 . . . . 0.0 111.798 -179.494 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -62.57 -37.77 87.46 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-O 121.008 0.433 . . . . 0.0 110.374 179.246 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -160.38 -0.92 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.308 -0.949 . . . . 0.0 113.103 -179.519 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.88 21.52 55.46 Favored Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.488 -0.863 . . . . 0.0 112.041 179.304 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.645 ' O ' HG22 ' A' ' 77' ' ' THR . 40.2 p90 -111.07 154.91 23.57 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -179.588 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.788 ' HA ' ' HE ' ' A' ' 83' ' ' ARG . 0.0 OUTLIER 169.33 -145.34 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.241 0 O-C-N 123.805 0.691 . . . . 0.0 111.498 -179.999 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -129.53 157.46 41.97 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.688 -178.361 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.45 ' HA ' ' HA ' ' A' ' 74' ' ' ARG . 57.2 ttt180 -82.68 154.33 24.91 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 178.976 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . 0.615 HE22 ' HA ' ' A' ' 47' ' ' PHE . 7.6 tt0 -164.81 -179.36 5.79 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 120.986 0.422 . . . . 0.0 111.741 -177.939 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.531 ' H ' ' HG2' ' A' ' 86' ' ' GLN . . . -142.55 153.26 24.42 Favored Glycine 0 CA--C 1.521 0.455 0 N-CA-C 111.841 -0.504 . . . . 0.0 111.841 179.257 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 12.0 tt -131.33 143.98 39.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.11 0.481 . . . . 0.0 110.618 -179.876 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.599 ' OD2' ' HB2' ' A' ' 91' ' ' ASN . 20.8 t70 -82.99 133.55 35.1 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.345 -179.184 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.583 HD12 ' HB2' ' A' ' 71' ' ' LEU . 86.7 mt -109.46 38.35 2.36 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -179.214 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.599 ' HB2' ' OD2' ' A' ' 89' ' ' ASP . 6.6 m-80 -75.68 3.07 10.4 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-O 121.485 0.66 . . . . 0.0 110.256 178.621 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 24.9 mtp180 -96.08 -5.57 40.59 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.879 179.567 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.462 ' CD1' HD21 ' A' ' 37' ' ' LEU . 25.0 mm -103.02 100.95 11.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.265 0.555 . . . . 0.0 109.994 -179.413 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -110.24 156.34 20.8 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.725 -178.508 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 18.7 p-10 -110.07 113.18 25.67 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.378 178.172 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.7 p -109.9 114.99 48.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-O 121.339 0.59 . . . . 0.0 110.431 -179.777 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 65.12 23.54 12.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.559 179.697 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 95.45 -8.53 69.12 Favored Glycine 0 N--CA 1.447 -0.605 0 CA-C-N 115.481 -0.781 . . . . 0.0 112.404 -179.942 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 10.2 mtp180 -95.2 135.78 36.35 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -179.413 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.457 HD11 ' SG ' ' A' ' 23' ' ' CYS . 5.2 tp -88.22 116.11 26.19 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 -179.517 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 39.2 t -130.45 141.25 46.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.87 0.366 . . . . 0.0 110.65 -178.917 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.511 ' HB2' HD13 ' A' ' 35' ' ' LEU . 12.9 t80 -78.7 137.4 37.77 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.734 178.783 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 4.6 tp-100 . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.576 -0.726 . . . . 0.0 110.215 -179.994 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 2' ' ' SER . . . . . 0.432 ' HA ' HE22 ' A' ' 94' ' ' GLN . 39.0 m . . . . . 0 N--CA 1.451 -0.423 0 CA-C-O 120.893 0.377 . . . . 0.0 111.352 . . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.439 ' CB ' HD13 ' A' ' 100' ' ' LEU . 11.1 p90 -54.3 -32.63 56.9 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.518 178.062 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.536 ' HB2' ' HD2' ' A' ' 69' ' ' ARG . . . -57.43 -18.97 20.72 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 115.41 -0.814 . . . . 0.0 112.471 -179.056 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -69.41 -17.27 63.64 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 121.113 0.483 . . . . 0.0 110.891 179.641 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 74.6 m -144.27 37.05 1.24 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.076 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 23.2 t -150.83 157.17 42.6 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.686 -179.443 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 2.0 ptm180 -144.79 167.31 22.89 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 179.653 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 60.17 50.44 6.4 Favored 'General case' 0 N--CA 1.464 0.232 0 O-C-N 123.868 0.73 . . . . 0.0 111.186 179.492 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.473 ' HA ' ' HB3' ' A' ' 21' ' ' ALA . . . -84.81 117.36 23.81 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.467 179.721 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 33.5 m -122.42 168.77 14.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.916 -179.738 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.604 HD23 ' HG ' ' A' ' 64' ' ' LEU . 3.3 mm? -104.91 115.3 30.05 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.662 179.9 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 28.1 p -110.31 167.26 10.33 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.008 -179.891 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 59.83 46.78 10.94 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.089 179.398 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 85.5 -31.92 3.75 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 121.049 -0.596 . . . . 0.0 112.346 179.942 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 133.18 54.99 0.08 OUTLIER Glycine 0 N--CA 1.442 -0.905 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 -179.202 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.466 ' HD2' ' CG ' ' A' ' 38' ' ' ASP . 43.3 ptt85 -138.06 -32.73 0.72 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.889 0.376 . . . . 0.0 111.125 -179.664 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.2 m -98.56 132.32 44.07 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.479 179.93 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.712 HD13 HD11 ' A' ' 90' ' ' LEU . 69.5 mt -92.3 113.32 25.56 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.172 179.195 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 53.6 ttp180 -111.86 120.77 43.06 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 178.775 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.473 ' HB3' ' HA ' ' A' ' 10' ' ' ALA . . . -153.4 167.5 29.22 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.798 -179.271 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -90.36 106.15 18.3 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 178.437 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.544 ' SG ' HD12 ' A' ' 100' ' ' LEU . 58.5 m -93.15 130.59 38.75 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 -178.893 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 22.7 ttp85 -77.92 119.94 22.1 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 120.896 -0.322 . . . . 0.0 110.244 179.237 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 33.6 p30 -84.8 163.43 19.09 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.468 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.33 -15.43 25.47 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -178.232 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -82.21 -10.2 59.23 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.789 0.804 . . . . 0.0 109.289 179.168 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 87.23 35.36 9.7 Favored Glycine 0 N--CA 1.447 -0.605 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.702 -179.827 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 43.9 t30 -124.39 160.37 28.3 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.747 0.308 . . . . 0.0 111.316 -179.266 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 85.2 m95 -99.0 120.43 39.44 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.71 179.58 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.7 m -124.01 136.51 60.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.5 178.989 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 55.0 m -78.11 108.77 11.65 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 120.944 0.402 . . . . 0.0 110.135 179.696 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.469 ' HB2' ' SG ' ' A' ' 23' ' ' CYS . 70.6 m -119.26 142.46 48.03 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.383 -179.502 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.645 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 2.7 mp0 -128.38 152.6 47.99 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.344 -179.641 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.507 ' HB2' HD22 ' A' ' 100' ' ' LEU . 0.9 OUTLIER -143.53 126.96 16.81 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 178.292 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -87.26 109.65 19.64 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 -179.815 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.45 HD11 HD13 ' A' ' 19' ' ' LEU . 1.0 OUTLIER -86.94 -13.76 43.74 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.292 0.479 . . . . 0.0 112.292 -179.123 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.466 ' CG ' ' HD2' ' A' ' 17' ' ' ARG . 8.8 p-10 -64.98 -16.23 63.15 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 122.085 -0.384 . . . . 0.0 111.923 -178.314 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 15.1 t -91.15 0.79 57.46 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.119 0.485 . . . . 0.0 110.013 179.314 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 22.5 m -130.62 -19.5 3.0 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.993 -0.548 . . . . 0.0 111.783 -179.486 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 64.7 mt -112.79 139.95 35.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.823 0.344 . . . . 0.0 111.359 -179.287 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -148.81 158.62 27.73 Favored Glycine 0 N--CA 1.449 -0.493 0 N-CA-C 110.841 -0.903 . . . . 0.0 110.841 179.171 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.419 HD21 ' HG ' ' A' ' 48' ' ' LEU . 24.3 p30 -162.86 45.25 0.14 Allowed Pre-proline 0 CA--C 1.541 0.608 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 -179.317 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -71.84 -15.35 29.78 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 121.868 1.712 . . . . 0.0 111.277 179.959 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 70.9 m-20 -90.0 -0.75 57.75 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.703 -179.807 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.47 ' CA ' ' HG2' ' A' ' 83' ' ' ARG . . . 90.0 3.45 73.31 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.294 -0.955 . . . . 0.0 111.716 -179.167 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.679 ' HA ' HE22 ' A' ' 86' ' ' GLN . 64.7 m-85 -125.25 132.68 52.9 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.786 0.327 . . . . 0.0 110.449 179.988 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.557 HD23 HG23 ' A' ' 88' ' ' ILE . 11.1 mp -85.3 153.69 22.4 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.057 -179.273 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 170.99 171.97 36.77 Favored Glycine 0 N--CA 1.44 -1.094 0 C-N-CA 120.432 -0.89 . . . . 0.0 112.008 179.092 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 93.4 m95 -96.91 131.16 43.96 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.675 0.274 . . . . 0.0 110.506 -179.495 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 142.97 -62.47 0.51 Allowed Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 121.055 -0.593 . . . . 0.0 111.739 -179.866 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 2.4 ttt -72.07 -176.56 1.79 Allowed 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 179.345 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -142.84 169.16 18.09 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 121.517 -0.74 . . . . 0.0 112.605 -178.021 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 25.2 m-80 64.07 45.81 3.98 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.073 -0.967 . . . . 0.0 112.54 178.836 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 23.4 p90 -66.41 -32.71 74.26 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.837 179.512 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.432 ' HA ' HD13 ' A' ' 62' ' ' ILE . 4.3 m -63.09 -30.86 71.92 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.376 -179.169 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 28.1 m80 -81.76 -3.59 54.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.999 0.428 . . . . 0.0 111.025 -179.927 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 19.4 m -128.56 22.72 5.92 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.187 179.5 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 66.8 m -139.62 162.06 36.02 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.122 0.487 . . . . 0.0 111.671 -179.774 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -132.92 142.23 48.78 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.02 178.922 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 25.9 t70 60.0 73.52 0.48 Allowed 'General case' 0 N--CA 1.467 0.385 0 O-C-N 123.687 0.617 . . . . 0.0 110.707 -179.857 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.5 HG23 HD21 ' A' ' 71' ' ' LEU . 68.7 mt -93.19 114.42 29.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.415 -179.824 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -147.38 149.88 33.6 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.079 -179.055 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.604 ' HG ' HD23 ' A' ' 12' ' ' LEU . 79.3 mt -83.29 122.54 28.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.145 0.498 . . . . 0.0 111.37 -179.521 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -74.02 -63.27 1.25 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.379 -179.143 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.467 ' HB2' ' HB2' ' A' ' 69' ' ' ARG . 29.3 mt-10 -86.13 35.35 0.64 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.843 0.354 . . . . 0.0 111.462 -179.008 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 56.93 22.09 40.3 Favored Glycine 0 CA--C 1.519 0.319 0 CA-C-N 115.679 -0.691 . . . . 0.0 113.591 179.327 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 139.22 -23.97 2.84 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 119.887 -1.149 . . . . 0.0 113.091 179.275 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.536 ' HD2' ' HB2' ' A' ' 4' ' ' ALA . 0.2 OUTLIER -78.73 -17.12 56.34 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 117.251 0.526 . . . . 0.0 110.838 -179.788 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 33.3 ttmt -153.56 138.34 17.06 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.521 -177.938 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.524 ' HB2' HD12 ' A' ' 90' ' ' LEU . 10.5 tt -108.55 129.75 55.3 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.102 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 6.4 p -117.61 136.36 53.34 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.819 0.342 . . . . 0.0 111.528 179.969 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 28.2 p -162.67 163.45 26.99 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.479 179.895 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.4 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 78.8 ttt180 -99.47 103.93 24.03 Favored Pre-proline 0 C--N 1.32 -0.71 0 C-N-CA 120.341 -0.543 . . . . 0.0 110.458 179.061 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -71.95 123.46 9.33 Favored 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 122.848 2.365 . . . . 0.0 111.036 179.174 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.697 ' HA ' ' HB2' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -120.21 143.33 48.32 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.335 -179.589 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.728 HG21 ' O ' ' A' ' 82' ' ' PHE . 15.2 t -75.71 136.78 40.35 Favored 'General case' 0 CA--C 1.513 -0.471 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 179.334 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 35.0 m -76.35 -6.88 9.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.991 -179.784 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -68.59 -31.54 70.8 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.637 179.645 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.486 ' HA3' ' CE2' ' A' ' 82' ' ' PHE . . . -147.04 -23.34 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.717 179.568 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 101.18 12.54 36.06 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.997 -0.62 . . . . 0.0 112.146 -179.495 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.728 ' O ' HG21 ' A' ' 77' ' ' THR . 31.5 p90 -111.91 158.46 19.45 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 118.892 -0.575 . . . . 0.0 110.221 -178.349 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.697 ' HB2' ' HA ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 164.32 -161.47 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.436 0 O-C-N 123.861 0.725 . . . . 0.0 111.307 178.327 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -110.16 176.08 5.19 Favored 'General case' 0 C--O 1.222 -0.354 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.36 -176.904 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.4 ' HA ' ' HA ' ' A' ' 74' ' ' ARG . 74.9 ttt180 -102.65 153.73 19.84 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 177.967 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . 0.679 HE22 ' HA ' ' A' ' 47' ' ' PHE . 8.2 tt0 -166.09 179.2 5.89 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 120.361 -0.535 . . . . 0.0 111.848 -177.49 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.535 ' H ' ' HG2' ' A' ' 86' ' ' GLN . . . -145.54 155.16 26.37 Favored Glycine 0 N--CA 1.449 -0.493 0 N-CA-C 111.473 -0.651 . . . . 0.0 111.473 179.225 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.557 HG23 HD23 ' A' ' 48' ' ' LEU . 11.9 tt -132.06 134.84 59.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 110.105 -0.331 . . . . 0.0 110.105 179.883 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -77.78 139.09 39.31 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.221 0.534 . . . . 0.0 110.179 -179.949 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.712 HD11 HD13 ' A' ' 19' ' ' LEU . 68.3 mt -106.59 46.66 0.91 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.589 0.709 . . . . 0.0 111.201 -179.015 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 35.0 m-80 -79.16 3.19 18.41 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 115.344 -0.843 . . . . 0.0 110.176 179.555 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 17.8 mtp180 -97.09 -19.17 18.88 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.676 179.569 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.428 ' CD1' HD21 ' A' ' 37' ' ' LEU . 21.6 mm -91.56 100.76 11.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 -179.589 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.432 HE22 ' HA ' ' A' ' 2' ' ' SER . 21.1 mm-40 -109.48 165.92 11.28 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.285 -177.988 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.499 ' HA ' ' O ' ' A' ' 99' ' ' ARG . 18.4 p-10 -120.16 118.92 31.78 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.154 177.632 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.2 p -116.12 122.53 69.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 121.033 0.444 . . . . 0.0 110.339 -179.321 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 57.99 16.59 3.83 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.848 179.889 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 111.2 -12.15 28.82 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 121.076 -0.583 . . . . 0.0 113.707 178.859 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.499 ' O ' ' HA ' ' A' ' 95' ' ' ASN . 0.9 OUTLIER -101.0 147.06 26.62 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 117.422 0.611 . . . . 0.0 111.276 -178.906 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.544 HD12 ' SG ' ' A' ' 23' ' ' CYS . 5.2 tp -91.79 123.55 35.26 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.542 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 23.7 t -130.7 140.12 49.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.809 -178.951 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -85.65 125.07 32.87 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 177.397 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 . . . . . 0 C--N 1.309 -1.166 0 CA-C-O 118.46 -0.781 . . . . 0.0 110.862 179.675 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.9 m . . . . . 0 N--CA 1.45 -0.437 0 CA-C-O 120.536 0.208 . . . . 0.0 110.453 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.46 ' CZ ' HD12 ' A' ' 19' ' ' LEU . 18.0 p90 -55.43 -34.49 64.49 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.791 0.329 . . . . 0.0 111.114 178.555 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.521 ' HA ' ' OG ' ' A' ' 7' ' ' SER . . . -57.77 -18.69 23.08 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -178.546 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -69.48 -18.19 63.68 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 121.102 0.477 . . . . 0.0 111.168 179.875 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 50.7 m -141.64 36.51 1.64 Allowed 'General case' 0 N--CA 1.446 -0.646 0 CA-C-O 121.239 0.542 . . . . 0.0 109.899 179.361 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.521 ' OG ' ' HA ' ' A' ' 4' ' ' ALA . 77.8 p -148.7 165.47 31.26 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.36 179.205 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -148.22 165.57 30.53 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.068 179.918 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 62.09 42.44 9.81 Favored 'General case' 0 N--CA 1.464 0.237 0 O-C-N 123.594 0.559 . . . . 0.0 111.24 179.902 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.421 ' HA ' ' O ' ' A' ' 20' ' ' ARG . . . -80.13 117.21 20.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.153 179.627 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 28.2 m -126.41 172.38 13.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.708 -179.432 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.664 HD21 ' HG ' ' A' ' 64' ' ' LEU . 3.1 mm? -104.5 117.84 35.14 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.559 -179.216 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.439 ' OG1' ' HB ' ' A' ' 18' ' ' THR . 37.9 p -112.33 163.96 13.8 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.016 179.779 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 58.56 50.12 9.58 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.124 -179.909 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 84.63 -33.13 3.29 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.394 179.287 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 134.38 49.65 0.08 OUTLIER Glycine 0 N--CA 1.443 -0.855 0 N-CA-C 111.448 -0.661 . . . . 0.0 111.448 -179.652 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.606 ' HB2' ' HB2' ' A' ' 38' ' ' ASP . 20.4 ptt85 -133.79 -33.82 1.04 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.834 0.35 . . . . 0.0 111.021 179.96 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.439 ' HB ' ' OG1' ' A' ' 13' ' ' THR . 19.2 m -94.76 135.68 35.96 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.15 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.65 ' O ' ' HA ' ' A' ' 34' ' ' GLU . 79.9 mt -97.54 114.98 26.97 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.559 -179.589 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.432 ' HA ' ' HG2' ' A' ' 34' ' ' GLU . 16.8 ttm180 -104.57 120.24 40.84 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 178.661 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -153.84 160.39 42.19 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.776 0.322 . . . . 0.0 111.571 -179.982 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -90.32 106.08 18.25 Favored 'General case' 0 CA--C 1.513 -0.479 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 177.927 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.492 ' SG ' HD11 ' A' ' 100' ' ' LEU . 48.9 m -93.74 127.56 39.52 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 120.989 0.423 . . . . 0.0 111.053 -178.016 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 23.3 ttp180 -75.35 110.19 9.5 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.772 179.17 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -82.74 169.28 16.35 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 119.223 -0.418 . . . . 0.0 109.979 -179.525 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -47.83 -34.38 8.64 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -178.085 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -68.04 -12.71 61.32 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.473 0.654 . . . . 0.0 111.317 -179.58 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 85.72 26.17 36.1 Favored Glycine 0 N--CA 1.444 -0.83 0 N-CA-C 110.806 -0.918 . . . . 0.0 110.806 -179.202 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -115.95 153.54 31.42 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.718 0.294 . . . . 0.0 110.899 -179.288 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.439 ' HZ3' ' HA ' ' A' ' 7' ' ' SER . 88.6 m95 -89.29 125.58 35.17 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.395 -179.505 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 12.1 m -124.74 132.69 70.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 116.213 -0.449 . . . . 0.0 109.949 178.319 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 21.0 m -74.61 109.47 8.11 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.454 -179.904 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 68.7 m -123.18 142.94 50.37 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.358 179.826 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.65 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 49.1 mt-10 -128.38 134.93 48.93 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.31 -179.342 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.5 HD12 ' HB2' ' A' ' 102' ' ' PHE . 1.7 tm? -125.44 130.09 51.14 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 178.744 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -88.98 111.3 21.98 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 110.14 -0.318 . . . . 0.0 110.14 -179.914 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.479 HD11 HD13 ' A' ' 19' ' ' LEU . 0.9 OUTLIER -86.38 -12.62 48.75 Favored 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 120.937 -0.305 . . . . 0.0 110.906 179.828 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.691 ' OD2' ' HA ' ' A' ' 54' ' ' ASN . 10.1 t70 -61.66 -36.32 80.5 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.653 0.264 . . . . 0.0 111.225 -178.928 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.3 t -72.75 1.27 8.78 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.199 -0.455 . . . . 0.0 112.0 -179.877 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 78.5 m -135.45 -21.43 1.55 Allowed 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 179.943 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 68.7 mt -107.58 137.21 39.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 179.771 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -149.55 160.13 28.34 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.393 -0.908 . . . . 0.0 112.492 179.951 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.696 ' ND2' ' HB2' ' A' ' 55' ' ' PHE . 8.3 p30 -158.23 51.21 0.44 Allowed Pre-proline 0 CA--C 1.535 0.4 0 N-CA-C 111.664 0.246 . . . . 0.0 111.664 178.967 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -71.83 -19.69 26.97 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 121.944 1.763 . . . . 0.0 111.823 -179.347 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -91.19 -9.2 46.25 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.883 179.515 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.558 ' HA3' ' HG2' ' A' ' 83' ' ' ARG . . . 102.7 7.47 44.89 Favored Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.772 -179.917 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -125.3 137.45 54.07 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.018 0.437 . . . . 0.0 111.076 -179.674 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 86.9 mt -82.92 146.52 28.79 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.922 -178.457 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 168.32 171.48 34.23 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.2 178.743 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 91.6 m95 -95.27 128.01 41.77 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 -179.998 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 154.35 -51.66 0.46 Allowed Glycine 0 N--CA 1.453 -0.196 0 C-N-CA 120.856 -0.688 . . . . 0.0 111.95 -179.905 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 14.0 tpt -93.05 174.03 7.43 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 179.848 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -128.97 173.19 10.64 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.846 -0.342 . . . . 0.0 111.005 179.698 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.691 ' HA ' ' OD2' ' A' ' 38' ' ' ASP . 0.7 OUTLIER 65.52 47.23 2.29 Favored 'General case' 0 N--CA 1.466 0.352 0 O-C-N 123.701 0.626 . . . . 0.0 111.128 -179.806 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.696 ' HB2' ' ND2' ' A' ' 43' ' ' ASN . 15.7 p90 -74.19 -32.11 62.92 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.673 -179.756 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.508 ' HA ' HD13 ' A' ' 62' ' ' ILE . 20.1 m -63.75 -33.74 76.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.035 0.445 . . . . 0.0 111.128 -179.046 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 15.7 m-70 -82.15 -7.95 59.64 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.101 0.476 . . . . 0.0 110.27 179.578 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 15.1 m -112.0 4.23 17.98 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.387 -179.292 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 36.4 p -138.38 157.54 46.03 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 122.203 -0.31 . . . . 0.0 110.752 -179.222 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 38.0 mm-40 -117.46 148.42 41.83 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.014 -179.401 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 24.1 t70 52.05 83.35 0.06 Allowed 'General case' 0 N--CA 1.468 0.462 0 O-C-N 124.333 1.02 . . . . 0.0 111.644 178.957 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.508 HD13 ' HA ' ' A' ' 56' ' ' SER . 77.9 mt -97.79 124.1 50.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.78 -179.942 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 13.0 tmtt? -148.98 149.75 31.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.006 -179.857 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.664 ' HG ' HD21 ' A' ' 12' ' ' LEU . 76.2 mt -83.01 120.16 25.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.021 0.439 . . . . 0.0 111.532 -179.648 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -71.64 -60.2 2.36 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.267 -178.666 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.511 ' HB2' ' HB2' ' A' ' 69' ' ' ARG . 5.0 mm-40 -83.52 20.17 1.44 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.033 -178.767 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 68.66 19.23 72.88 Favored Glycine 0 N--CA 1.45 -0.425 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.923 179.701 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.517 ' HA2' HD12 ' A' ' 64' ' ' LEU . . . 144.18 -34.83 1.62 Allowed Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.315 -0.945 . . . . 0.0 113.251 179.697 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.511 ' HB2' ' HB2' ' A' ' 66' ' ' GLU . 5.4 mmt85 -71.57 -24.89 62.0 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.854 0.359 . . . . 0.0 111.829 -179.34 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 11.7 tttp -143.65 137.48 28.29 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.607 -177.81 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.571 ' HB2' HD11 ' A' ' 90' ' ' LEU . 10.5 tt -105.84 127.58 53.2 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 179.599 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.1 p -116.32 136.28 53.14 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 120.971 0.415 . . . . 0.0 111.233 179.967 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 21.0 p -162.58 175.87 10.98 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.747 -179.743 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.437 ' HA ' ' HD2' ' A' ' 75' ' ' PRO . 29.5 ttt180 -112.8 98.85 46.35 Favored Pre-proline 0 C--N 1.315 -0.902 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.303 178.97 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.437 ' HD2' ' HA ' ' A' ' 74' ' ' ARG . 34.9 Cg_endo -66.19 130.44 24.13 Favored 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 122.674 2.249 . . . . 0.0 110.791 178.953 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.579 ' HA ' ' HB2' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -119.71 152.88 36.47 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.167 0.508 . . . . 0.0 111.049 -179.681 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.654 ' HB ' ' HD2' ' A' ' 83' ' ' ARG . 10.9 t -88.84 144.78 25.99 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 178.902 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 34.7 m -71.61 -4.81 5.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 O-C-N 123.992 0.808 . . . . 0.0 112.152 -179.141 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 39.1 m-20 -63.93 -37.21 86.55 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-O 121.118 0.485 . . . . 0.0 109.793 178.928 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -164.76 -4.94 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 115.461 -0.79 . . . . 0.0 112.854 -179.841 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.38 22.9 25.67 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.089 179.731 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.619 ' O ' HG21 ' A' ' 77' ' ' THR . 34.2 p90 -111.46 148.02 34.03 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 -179.42 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.654 ' HD2' ' HB ' ' A' ' 77' ' ' THR . 0.0 OUTLIER 174.55 -143.75 0.01 OUTLIER 'General case' 0 C--O 1.233 0.195 0 O-C-N 123.465 0.478 . . . . 0.0 111.304 -179.915 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -125.31 176.6 6.66 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.923 0.392 . . . . 0.0 110.579 -179.49 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.431 ' HA ' ' HA ' ' A' ' 74' ' ' ARG . 62.8 ttt180 -108.66 147.82 31.32 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 177.849 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . 0.505 ' HG2' ' N ' ' A' ' 87' ' ' GLY . 9.0 tt0 -161.27 171.8 17.75 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.946 0.403 . . . . 0.0 111.79 -177.246 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.505 ' N ' ' HG2' ' A' ' 86' ' ' GLN . . . -132.12 141.65 13.01 Favored Glycine 0 N--CA 1.45 -0.387 0 N-CA-C 111.233 -0.747 . . . . 0.0 111.233 178.612 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 11.6 tt -120.45 138.74 49.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 120.976 0.417 . . . . 0.0 110.377 -179.221 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.6 m-20 -75.74 139.98 42.15 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.185 -179.472 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.582 HD13 HD13 ' A' ' 19' ' ' LEU . 29.8 mt -109.43 35.73 3.2 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.517 0.675 . . . . 0.0 110.376 179.317 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 13.5 m-80 -72.56 -5.41 36.92 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.594 -179.835 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 17.1 mtp180 -89.09 -7.74 55.21 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.001 178.731 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 27.5 mm -103.64 100.55 10.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -179.615 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 25.4 tp60 -117.55 146.76 43.37 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.342 -178.777 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 12.5 p-10 -95.16 117.11 29.66 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.48 179.18 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 48.5 t -101.36 107.03 20.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.788 179.727 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 56.16 41.86 28.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.675 -179.284 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 89.5 -18.4 46.4 Favored Glycine 0 N--CA 1.447 -0.624 0 CA-C-N 115.783 -0.644 . . . . 0.0 113.342 179.681 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 8.7 mpt_? -88.31 123.13 32.59 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 117.163 0.481 . . . . 0.0 110.921 -179.216 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.492 HD11 ' SG ' ' A' ' 23' ' ' CYS . 7.6 tp -76.65 114.46 15.41 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.443 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 40.7 t -128.98 144.7 37.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.09 0.472 . . . . 0.0 111.367 -178.488 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.5 ' HB2' HD12 ' A' ' 35' ' ' LEU . 22.3 t80 -83.26 130.92 35.11 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.63 178.442 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 . . . . . 0 C--N 1.317 -0.846 0 CA-C-O 118.325 -0.845 . . . . 0.0 110.216 -179.725 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.9 p . . . . . 0 N--CA 1.453 -0.3 0 N-CA-C 110.732 -0.099 . . . . 0.0 110.732 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 4.4 p90 -55.91 -38.09 69.79 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -178.555 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -56.35 -21.57 25.41 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 -177.882 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -66.4 -28.7 68.84 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.255 0.55 . . . . 0.0 110.392 179.971 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 41.4 m -133.44 36.22 3.39 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.687 179.204 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 8.6 t -140.29 160.11 40.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.945 -179.66 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 1.1 ptp180 -149.97 169.86 20.19 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.632 -179.593 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 58.23 45.48 17.21 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.129 177.934 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.513 ' HA ' ' HB1' ' A' ' 21' ' ' ALA . . . -81.66 118.34 22.73 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.055 0.455 . . . . 0.0 110.69 179.957 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 29.5 m -119.24 170.55 8.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.393 179.794 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.688 HD22 ' HG ' ' A' ' 64' ' ' LEU . 3.2 mm? -105.12 114.94 29.44 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.434 -179.47 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 38.8 p -115.01 167.66 10.6 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.808 179.752 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 57.64 50.56 10.71 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.154 179.653 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 83.88 -22.94 7.25 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 121.069 -0.586 . . . . 0.0 112.374 -179.808 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 119.71 38.23 0.73 Allowed Glycine 0 N--CA 1.447 -0.583 0 N-CA-C 111.662 -0.575 . . . . 0.0 111.662 179.976 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 14.3 ptt180 -121.86 -22.6 5.7 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.944 0.402 . . . . 0.0 110.758 -179.486 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 4.2 m -102.55 133.06 48.14 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.592 -179.607 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.797 HD13 HD12 ' A' ' 90' ' ' LEU . 69.5 mt -92.65 112.62 24.64 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.297 179.142 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.404 HH11 ' HD2' ' A' ' 20' ' ' ARG . 30.7 ttt85 -111.06 118.57 36.4 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 178.94 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.513 ' HB1' ' HA ' ' A' ' 10' ' ' ALA . . . -154.9 166.92 32.02 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.862 0.363 . . . . 0.0 111.964 -178.783 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -90.69 113.37 25.43 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 177.371 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.472 ' SG ' HD13 ' A' ' 100' ' ' LEU . 59.7 m -102.66 134.95 45.18 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 -179.806 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.543 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 7.3 ttt180 -82.12 104.66 12.61 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-O 120.917 0.389 . . . . 0.0 109.965 -179.804 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 37.8 p30 -67.01 170.84 6.17 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 115.619 -0.718 . . . . 0.0 111.162 -179.214 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.52 -31.16 61.84 Favored 'General case' 0 N--CA 1.464 0.269 0 O-C-N 123.431 0.457 . . . . 0.0 111.781 -178.781 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -71.56 -11.71 61.0 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.331 0.586 . . . . 0.0 110.421 179.878 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 87.55 24.64 35.47 Favored Glycine 0 N--CA 1.45 -0.404 0 N-CA-C 111.373 -0.691 . . . . 0.0 111.373 -179.839 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.543 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 10.7 t-20 -108.56 160.09 16.19 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.672 0.272 . . . . 0.0 110.718 -178.349 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 90.4 m95 -98.36 119.18 36.6 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.984 0.421 . . . . 0.0 110.8 179.745 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.2 m -123.43 130.9 73.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.098 179.11 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 28.0 m -79.69 109.12 13.8 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.057 0.455 . . . . 0.0 110.32 -179.889 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 70.3 m -115.89 161.33 18.96 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.439 -179.817 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.626 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 51.5 mt-10 -140.02 138.92 35.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.241 -178.908 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.402 HD22 ' O ' ' A' ' 100' ' ' LEU . 1.8 tm? -134.72 129.97 35.53 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 178.704 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.471 ' O ' HG21 ' A' ' 39' ' ' THR . 15.8 m-20 -88.64 109.64 20.28 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 179.971 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.446 HD12 HD22 ' A' ' 90' ' ' LEU . 1.4 mt -83.06 -12.42 57.16 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.831 -179.303 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.4 ' HA ' ' HD1' ' A' ' 55' ' ' PHE . 4.2 p-10 -66.23 -13.58 60.56 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 111.857 0.317 . . . . 0.0 111.857 -178.621 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.471 HG21 ' O ' ' A' ' 36' ' ' ASP . 12.1 t -87.97 -0.58 57.19 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.885 0.374 . . . . 0.0 110.296 179.387 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 67.2 m -136.58 -20.11 1.37 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.937 179.94 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 60.0 mt -107.96 132.49 55.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 178.877 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -141.49 158.69 26.61 Favored Glycine 0 N--CA 1.446 -0.667 0 N-CA-C 111.256 -0.738 . . . . 0.0 111.256 179.527 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.599 ' OD1' ' HB2' ' A' ' 58' ' ' SER . 32.6 p30 -156.29 40.82 0.12 Allowed Pre-proline 0 CA--C 1.54 0.592 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 179.792 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.403 ' CD ' ' N ' ' A' ' 43' ' ' ASN . 52.5 Cg_endo -69.65 -15.86 37.73 Favored 'Trans proline' 0 C--N 1.357 0.975 0 C-N-CA 121.331 1.354 . . . . 0.0 111.41 -179.933 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -89.74 -8.12 52.98 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.623 179.077 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.455 ' CA ' ' HG2' ' A' ' 83' ' ' ARG . . . 99.38 5.25 55.91 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.659 -179.575 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -126.92 139.79 52.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 117.045 0.422 . . . . 0.0 111.568 -179.587 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.531 ' H ' ' NE2' ' A' ' 86' ' ' GLN . 59.4 mt -84.5 138.86 32.54 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.735 -179.704 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 179.11 168.39 38.11 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.137 178.807 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 87.9 m95 -95.78 125.51 40.4 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.985 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 151.26 -42.61 0.72 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.895 -0.669 . . . . 0.0 111.519 -179.66 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 1.5 mtt -97.44 -172.07 2.33 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 179.399 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -142.96 169.81 16.88 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 119.757 -0.777 . . . . 0.0 112.343 -178.839 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 64.0 44.97 4.4 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.877 179.203 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.4 ' HD1' ' HA ' ' A' ' 38' ' ' ASP . 20.7 p90 -64.08 -33.6 76.13 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.464 -179.788 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 67.0 p -66.49 -23.84 66.32 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.208 0.527 . . . . 0.0 110.787 -179.36 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 16.1 m80 -76.97 -6.06 51.1 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.662 179.689 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.599 ' HB2' ' OD1' ' A' ' 43' ' ' ASN . 31.5 m -137.78 27.99 2.68 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.939 0.4 . . . . 0.0 110.782 179.492 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 35.6 p -141.73 149.81 40.98 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.169 0.509 . . . . 0.0 111.32 179.352 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -123.28 150.06 43.99 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.476 -179.626 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 27.6 t70 54.62 77.4 0.2 Allowed 'General case' 0 N--CA 1.47 0.546 0 O-C-N 123.778 0.674 . . . . 0.0 111.188 -179.922 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.491 HG22 HD23 ' A' ' 71' ' ' LEU . 69.4 mt -95.98 117.5 40.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.878 -179.404 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 41.6 tptt -142.25 150.45 40.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.699 -179.326 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.688 ' HG ' HD22 ' A' ' 12' ' ' LEU . 57.8 mt -92.93 144.7 25.01 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.362 179.432 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -101.42 -63.93 1.1 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.941 0.4 . . . . 0.0 111.963 -179.965 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -79.81 40.34 0.45 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.045 -178.098 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 64.11 22.09 66.61 Favored Glycine 0 C--N 1.314 -0.675 0 CA-C-N 115.229 -0.896 . . . . 0.0 113.123 178.858 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.536 ' HA2' HD12 ' A' ' 64' ' ' LEU . . . 120.56 -9.18 10.83 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 119.965 -1.112 . . . . 0.0 112.858 179.17 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 16.5 ttp85 -90.3 -3.06 58.01 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.665 0.745 . . . . 0.0 110.335 -179.794 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 5.6 tppp? -150.39 123.64 8.92 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.846 -179.77 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.597 ' HB2' HD13 ' A' ' 90' ' ' LEU . 9.5 tt -105.62 128.57 53.71 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 179.867 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 5.6 p -123.23 135.43 54.27 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.166 179.876 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 22.8 p -162.21 173.79 13.78 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 179.552 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.437 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 71.8 ttt180 -110.26 98.59 36.34 Favored Pre-proline 0 C--N 1.312 -1.035 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.276 179.606 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -69.92 132.65 23.5 Favored 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 122.342 2.028 . . . . 0.0 109.964 178.495 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.682 ' HA ' ' HB2' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -120.6 142.84 49.02 Favored 'General case' 0 C--N 1.32 -0.68 0 O-C-N 123.678 0.611 . . . . 0.0 111.452 -179.115 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.691 HG22 ' O ' ' A' ' 82' ' ' PHE . 14.6 t -76.81 143.31 39.87 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.614 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 22.5 m -77.4 1.07 2.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.573 -179.492 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -69.8 -34.26 73.48 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 121.371 0.605 . . . . 0.0 109.651 178.326 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -159.05 -12.77 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.517 0 CA-C-N 115.29 -0.868 . . . . 0.0 112.794 -179.814 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.23 20.21 23.72 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.108 179.983 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.691 ' O ' HG22 ' A' ' 77' ' ' THR . 33.8 p90 -111.83 155.42 23.62 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 118.996 -0.526 . . . . 0.0 109.904 -179.055 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.682 ' HB2' ' HA ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 171.49 -148.18 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 O-C-N 123.407 0.442 . . . . 0.0 111.48 179.651 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -134.99 153.51 52.06 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.157 -177.817 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.437 ' HA ' ' HA ' ' A' ' 74' ' ' ARG . 43.2 ttt85 -88.56 149.55 23.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.128 179.512 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . 0.531 ' NE2' ' H ' ' A' ' 48' ' ' LEU . 14.3 pt20 -165.28 177.51 7.54 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.146 -179.033 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -131.62 150.94 19.61 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.8 -0.715 . . . . 0.0 112.45 -179.994 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 9.5 tt -127.77 134.63 65.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 179.736 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.411 ' HB2' HD21 ' A' ' 91' ' ' ASN . 2.1 p-10 -76.94 140.27 40.42 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.997 0.427 . . . . 0.0 110.439 -179.178 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.797 HD12 HD13 ' A' ' 19' ' ' LEU . 62.2 mt -105.91 38.69 1.95 Allowed 'General case' 0 CA--C 1.512 -0.513 0 CA-C-O 121.412 0.625 . . . . 0.0 110.873 -178.892 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.411 HD21 ' HB2' ' A' ' 89' ' ' ASP . 30.2 m-80 -75.19 0.05 17.71 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.794 -179.759 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 14.7 mtp180 -92.05 -7.67 48.09 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.595 179.339 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.421 ' CD1' HD23 ' A' ' 37' ' ' LEU . 28.1 mm -98.5 104.57 16.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.518 0.675 . . . . 0.0 109.747 -179.334 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -106.56 157.36 17.73 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.36 -178.346 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.462 ' HA ' ' O ' ' A' ' 99' ' ' ARG . 20.4 p-10 -113.7 124.64 52.78 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.425 178.073 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 46.8 t -107.71 109.28 27.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 -179.237 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 11.3 m-80 57.79 22.14 8.21 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.937 0.398 . . . . 0.0 111.577 -179.326 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 113.66 -25.36 11.08 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.728 -0.748 . . . . 0.0 113.935 178.47 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.462 ' O ' ' HA ' ' A' ' 95' ' ' ASN . 1.4 ptm180 -86.5 147.76 25.83 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 117.416 0.608 . . . . 0.0 110.666 -178.85 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.472 HD13 ' SG ' ' A' ' 23' ' ' CYS . 2.1 tp -92.68 122.92 35.57 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.718 0.294 . . . . 0.0 110.335 -179.366 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 41.7 t -134.12 141.84 42.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.654 -179.869 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 16.9 t80 -78.44 136.39 37.61 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.979 0.419 . . . . 0.0 110.106 179.268 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.087 0 CA-C-O 118.462 -0.78 . . . . 0.0 110.39 179.949 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.453 -0.312 0 N-CA-C 111.729 0.27 . . . . 0.0 111.729 . . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.439 ' CB ' HD12 ' A' ' 100' ' ' LEU . 13.3 p90 -47.03 -36.07 7.49 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 123.09 0.556 . . . . 0.0 112.422 -179.51 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -54.13 -20.45 6.67 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -178.664 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -64.11 -33.65 76.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.218 0.533 . . . . 0.0 109.867 178.896 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 26.1 m -132.31 41.8 3.18 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.619 179.121 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 22.7 t -154.77 149.24 26.26 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.307 -179.591 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 11.6 ptp180 -136.62 175.7 9.37 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.827 -179.474 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 4.6 p30 45.58 60.39 3.12 Favored 'General case' 0 N--CA 1.474 0.774 0 O-C-N 124.298 0.999 . . . . 0.0 112.286 -179.233 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -87.28 117.73 26.23 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.376 179.519 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 33.9 m -115.92 170.64 5.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.821 -179.852 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.541 HD21 ' HG ' ' A' ' 64' ' ' LEU . 3.7 mm? -105.18 120.75 42.29 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.592 -179.62 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.43 HG23 ' NE ' ' A' ' 20' ' ' ARG . 17.7 p -119.96 161.42 20.92 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.825 179.542 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 59.8 38.27 21.55 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.14 179.679 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 93.86 -23.34 31.39 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.066 179.896 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 124.93 11.78 4.23 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.628 -0.796 . . . . 0.0 111.847 -179.939 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 16.9 ptt180 -92.46 -23.05 19.27 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.264 0.554 . . . . 0.0 110.067 -179.954 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 4.3 m -105.96 133.48 50.61 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.782 -179.535 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.727 HD12 HD12 ' A' ' 90' ' ' LEU . 59.9 mt -97.47 114.41 26.27 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.419 179.163 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.443 ' HA ' ' HG2' ' A' ' 34' ' ' GLU . 32.9 ttm180 -109.84 120.19 41.7 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 178.813 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -153.36 166.12 33.63 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.969 0.414 . . . . 0.0 111.455 -179.675 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -90.29 107.6 19.24 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 177.898 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.423 ' SG ' HD11 ' A' ' 100' ' ' LEU . 71.6 m -98.51 140.65 32.44 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.686 0.279 . . . . 0.0 110.69 -178.701 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.521 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 7.9 ttp180 -83.96 115.83 22.51 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-O 120.949 0.405 . . . . 0.0 110.2 179.412 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 37.0 p30 -76.55 174.2 10.62 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.262 179.919 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.74 -25.29 60.2 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -178.497 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -78.79 -9.81 59.57 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.65 0.738 . . . . 0.0 109.896 179.92 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 85.07 29.3 28.71 Favored Glycine 0 N--CA 1.445 -0.761 0 N-CA-C 110.718 -0.953 . . . . 0.0 110.718 -179.031 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.521 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 8.3 t-20 -111.53 158.45 19.17 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.74 -0.23 . . . . 0.0 110.687 -178.555 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 61.4 m95 -92.28 129.29 38.26 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.047 -179.899 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 15.6 m -132.9 141.42 44.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.668 179.346 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.2 m -81.7 111.75 18.25 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.228 179.86 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 54.7 m -127.53 150.18 49.81 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.655 179.779 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.656 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 45.1 mt-10 -134.25 148.32 50.81 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.03 -179.611 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.516 HD11 HD23 ' A' ' 37' ' ' LEU . 2.1 tm? -139.25 134.42 32.64 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.55 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.47 ' N ' HD12 ' A' ' 35' ' ' LEU . 29.6 m-20 -91.76 109.69 21.02 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.359 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.516 HD23 HD11 ' A' ' 35' ' ' LEU . 1.4 mt -83.01 -20.62 34.72 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.816 -178.543 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.406 ' HA ' ' HD1' ' A' ' 55' ' ' PHE . 4.3 p-10 -61.5 -15.41 37.61 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 111.717 0.266 . . . . 0.0 111.717 -178.423 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 60.0 p -72.48 -22.58 61.04 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.055 0.455 . . . . 0.0 110.716 179.737 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 27.3 m -128.86 0.25 5.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.06 -0.518 . . . . 0.0 112.022 -178.669 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 53.7 mt -116.57 131.35 69.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 120.636 0.255 . . . . 0.0 110.342 178.861 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -150.38 163.99 29.67 Favored Glycine 0 N--CA 1.445 -0.731 0 N-CA-C 111.328 -0.709 . . . . 0.0 111.328 179.445 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.59 ' ND2' ' HB2' ' A' ' 55' ' ' PHE . 7.3 p30 -161.91 51.08 0.32 Allowed Pre-proline 0 CA--C 1.535 0.386 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 179.813 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -63.5 -26.73 70.08 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 121.847 1.698 . . . . 0.0 111.75 -179.626 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -84.14 -12.59 54.73 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.797 179.898 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.518 ' CA ' ' HG2' ' A' ' 83' ' ' ARG . . . 103.36 7.96 41.92 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.283 -0.96 . . . . 0.0 112.954 -179.344 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.452 ' HA ' HE22 ' A' ' 86' ' ' GLN . 61.7 m-85 -124.88 133.62 53.01 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.003 0.43 . . . . 0.0 110.495 179.676 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 84.2 mt -83.09 138.0 33.87 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.498 -0.774 . . . . 0.0 112.251 -177.688 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -177.01 172.81 45.77 Favored Glycine 0 N--CA 1.447 -0.58 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.7 178.802 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 94.1 m95 -95.53 128.21 42.21 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.993 0.425 . . . . 0.0 110.321 -179.971 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 151.84 -62.69 0.39 Allowed Glycine 0 N--CA 1.449 -0.441 0 CA-C-N 116.019 -0.537 . . . . 0.0 112.076 -179.877 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.914 ' HA ' ' HE3' ' A' ' 52' ' ' MET . 1.0 OUTLIER -77.02 179.88 5.96 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 179.74 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -133.98 173.8 11.17 Favored 'General case' 0 C--N 1.326 -0.419 0 O-C-N 122.089 -0.382 . . . . 0.0 111.678 -178.982 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 61.74 45.99 7.4 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.642 -0.708 . . . . 0.0 112.33 179.174 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.59 ' HB2' ' ND2' ' A' ' 43' ' ' ASN . 8.5 p90 -65.83 -28.51 69.04 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 111.652 0.241 . . . . 0.0 111.652 -179.371 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 11.4 p -64.45 -28.4 69.65 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.917 0.389 . . . . 0.0 111.553 -179.104 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 50.5 m80 -82.27 -3.43 55.21 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.224 -179.433 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 14.9 m -126.52 13.53 7.57 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.792 179.793 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 63.9 m -135.49 151.94 50.85 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.382 0.61 . . . . 0.0 111.881 -178.891 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -121.55 141.46 51.05 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.404 179.279 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.405 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 31.4 t70 58.78 79.89 0.2 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.509 0.671 . . . . 0.0 111.39 179.704 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.517 HG23 HD23 ' A' ' 71' ' ' LEU . 74.3 mt -95.56 123.27 47.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.076 179.558 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.6 tptm -149.02 160.0 43.71 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 -179.769 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.541 ' HG ' HD21 ' A' ' 12' ' ' LEU . 44.7 mt -88.57 129.44 35.48 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.108 0.48 . . . . 0.0 109.973 178.965 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.1 tp10 -77.52 -69.47 0.53 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.264 -178.398 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.561 ' HB2' ' HB2' ' A' ' 69' ' ' ARG . 26.1 mt-10 -81.94 29.31 0.4 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.285 -179.284 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 68.11 14.64 66.36 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.903 -0.59 . . . . 0.0 113.282 179.757 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 145.98 -25.84 1.76 Allowed Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 119.591 -1.29 . . . . 0.0 113.373 179.361 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.561 ' HB2' ' HB2' ' A' ' 66' ' ' GLU . 9.6 mmt85 -76.19 -23.37 54.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.283 0.563 . . . . 0.0 110.431 -179.289 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -146.02 148.73 33.0 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.801 -177.883 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.614 ' HB2' HD13 ' A' ' 90' ' ' LEU . 9.8 tt -115.94 125.66 52.86 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 179.332 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.1 p -113.72 128.35 56.39 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.346 0.594 . . . . 0.0 111.241 179.43 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . 0.405 ' HA ' ' O ' ' A' ' 61' ' ' ASP . 25.6 p -149.88 171.32 16.97 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.659 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.511 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 4.1 tmt_? -104.37 98.31 14.02 Favored Pre-proline 0 C--N 1.315 -0.896 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 179.267 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -72.62 125.02 10.23 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 123.002 2.468 . . . . 0.0 111.506 179.79 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.668 ' HA ' ' HB2' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -121.82 139.92 53.02 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.867 179.819 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.713 HG22 ' O ' ' A' ' 82' ' ' PHE . 11.6 t -74.77 131.54 40.89 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 178.499 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.1 m -74.18 -2.22 3.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.488 -179.256 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -68.83 -33.71 74.28 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.185 0.517 . . . . 0.0 109.738 179.309 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -148.56 -23.96 0.08 OUTLIER Glycine 0 N--CA 1.449 -0.436 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.591 179.796 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.523 ' HA2' ' HE2' ' A' ' 76' ' ' LYS . . . 101.58 19.03 16.83 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.021 -179.793 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.713 ' O ' HG22 ' A' ' 77' ' ' THR . 26.3 p90 -110.71 151.05 28.19 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 118.821 -0.609 . . . . 0.0 109.993 -178.885 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.668 ' HB2' ' HA ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 167.49 -153.95 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.572 0 O-C-N 123.729 0.643 . . . . 0.0 111.213 179.236 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -135.55 167.41 21.14 Favored 'General case' 0 C--O 1.226 -0.17 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.051 -178.842 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.511 ' HA ' ' HA ' ' A' ' 74' ' ' ARG . 44.5 ttt180 -81.75 156.25 25.07 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 178.407 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . 0.595 ' HG2' ' H ' ' A' ' 87' ' ' GLY . 7.1 tt0 -161.04 -176.07 5.27 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.41 -0.516 . . . . 0.0 111.401 -178.161 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.595 ' H ' ' HG2' ' A' ' 86' ' ' GLN . . . -151.89 141.36 8.47 Favored Glycine 0 N--CA 1.449 -0.49 0 N-CA-C 111.778 -0.529 . . . . 0.0 111.778 179.379 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 10.4 tt -120.58 133.48 67.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.303 0.573 . . . . 0.0 110.77 -179.46 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.531 ' OD1' ' HB2' ' A' ' 91' ' ' ASN . 13.6 t70 -73.25 136.34 44.61 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.632 -179.868 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.727 HD12 HD12 ' A' ' 19' ' ' LEU . 63.8 mt -109.55 37.41 2.63 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -178.341 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.531 ' HB2' ' OD1' ' A' ' 89' ' ' ASP . 7.1 m-80 -75.05 2.59 10.23 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 121.368 0.604 . . . . 0.0 111.221 179.231 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 24.7 mtp180 -92.29 -12.49 32.37 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.243 179.104 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.448 ' CD1' HD22 ' A' ' 37' ' ' LEU . 24.6 mm -94.94 103.47 14.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 121.453 0.644 . . . . 0.0 109.563 -179.622 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 3.9 mm-40 -112.25 152.08 28.88 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.714 -178.368 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 18.3 p-10 -105.27 126.02 51.63 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.742 178.564 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 40.5 t -115.72 116.47 52.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 -179.562 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 54.4 25.39 6.0 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.601 -179.841 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 109.13 -27.45 12.72 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.806 -0.712 . . . . 0.0 114.004 179.155 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -86.8 146.19 26.33 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 117.687 0.744 . . . . 0.0 111.53 -178.48 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.494 ' O ' HD23 ' A' ' 35' ' ' LEU . 5.2 tp -92.14 121.52 33.76 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.906 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 24.1 t -129.73 140.88 47.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 120.804 0.335 . . . . 0.0 110.935 -178.821 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.4 ' HB2' HD13 ' A' ' 35' ' ' LEU . 20.7 t80 -79.21 130.73 35.77 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 178.475 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 . . . . . 0 C--N 1.312 -1.064 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.673 -179.57 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.9 mpp? . . . . . 0 N--CA 1.479 1.007 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.539 ' HG ' ' HA ' ' A' ' 91' ' ' ASN . 9.2 m -112.67 178.11 4.4 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.426 179.1 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 18.6 p90 -51.73 -34.18 37.98 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 123.448 0.468 . . . . 0.0 111.519 179.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -56.3 -18.8 11.77 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 -178.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -58.02 -32.91 68.4 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 121.261 0.553 . . . . 0.0 110.093 178.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 33.5 m -137.44 37.94 2.47 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.338 178.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.438 ' HA ' ' O ' ' A' ' 22' ' ' GLU . 20.3 t -147.23 147.97 30.99 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.271 -179.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 9.7 ptp180 -140.58 169.75 17.07 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.086 -179.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 65.7 m-80 57.39 52.32 8.8 Favored 'General case' 0 N--CA 1.465 0.296 0 O-C-N 123.93 0.769 . . . . 0.0 111.53 -179.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -82.47 118.12 23.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.465 179.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 27.0 m -121.55 170.8 11.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.67 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.594 HD22 ' HG ' ' A' ' 64' ' ' LEU . 3.3 mm? -105.14 114.57 28.85 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.118 -179.546 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.496 HG23 ' NE ' ' A' ' 20' ' ' ARG . 35.3 p -111.79 170.37 8.19 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.978 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 59.49 46.25 12.48 Favored 'General case' 0 CA--C 1.521 -0.137 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.289 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 86.01 -34.92 3.32 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 121.007 -0.616 . . . . 0.0 112.134 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.481 ' O ' HG22 ' A' ' 62' ' ' ILE . . . 136.2 38.02 0.17 Allowed Glycine 0 N--CA 1.447 -0.583 0 N-CA-C 111.437 -0.665 . . . . 0.0 111.437 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.646 ' HB2' ' HB2' ' A' ' 38' ' ' ASP . 3.3 ptp180 -125.23 -12.91 6.81 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.256 0.55 . . . . 0.0 110.98 -179.389 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.5 m -115.21 137.74 51.69 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.429 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.799 HD13 HD12 ' A' ' 90' ' ' LEU . 59.6 mt -96.13 118.66 33.16 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.734 179.565 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.496 ' NE ' HG23 ' A' ' 13' ' ' THR . 34.5 ttm180 -113.84 120.98 42.61 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 178.262 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.403 ' O ' ' HA ' ' A' ' 32' ' ' THR . . . -152.72 167.32 29.37 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.827 0.346 . . . . 0.0 111.532 -179.122 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.438 ' O ' ' HA ' ' A' ' 7' ' ' SER . 39.4 mt-10 -89.68 105.95 18.14 Favored 'General case' 0 CA--C 1.512 -0.516 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 178.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.53 ' SG ' HD11 ' A' ' 100' ' ' LEU . 56.0 m -96.23 119.22 34.33 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 -179.276 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.478 ' HB2' ' CZ3' ' A' ' 30' ' ' TRP . 45.9 ttp180 -72.85 111.28 7.83 Favored 'General case' 0 N--CA 1.437 -1.113 0 N-CA-C 110.197 -0.297 . . . . 0.0 110.197 179.386 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 31.9 p30 -81.18 168.9 18.03 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.669 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -51.54 -32.01 26.39 Favored 'General case' 0 N--CA 1.465 0.284 0 O-C-N 123.643 0.59 . . . . 0.0 112.096 -179.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -67.65 -14.12 62.67 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.404 0.621 . . . . 0.0 110.94 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 89.15 22.07 39.49 Favored Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.772 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.409 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 2.3 m-80 -111.77 150.38 30.37 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.838 0.351 . . . . 0.0 111.449 -179.101 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.478 ' CZ3' ' HB2' ' A' ' 24' ' ' ARG . 97.3 m95 -91.63 109.3 20.6 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.201 179.242 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.9 m -109.87 129.42 64.83 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 CA-C-O 120.965 0.412 . . . . 0.0 110.232 178.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.403 ' HA ' ' O ' ' A' ' 21' ' ' ALA . 27.7 m -78.98 113.16 16.87 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.854 -179.372 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 68.7 m -121.19 157.26 30.6 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.403 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.668 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 51.3 mt-10 -131.78 132.35 43.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.763 -179.583 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.455 ' HB2' HD21 ' A' ' 100' ' ' LEU . 1.9 tm? -124.91 132.63 53.27 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.571 -0.899 . . . . 0.0 108.571 178.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.444 ' N ' HD13 ' A' ' 35' ' ' LEU . 12.9 m-20 -91.45 109.95 21.25 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.76 0.314 . . . . 0.0 110.512 -179.113 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.437 HD21 ' CD1' ' A' ' 93' ' ' ILE . 0.9 OUTLIER -83.47 -15.99 47.43 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.296 -179.521 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.745 ' OD2' ' HA ' ' A' ' 54' ' ' ASN . 8.5 t70 -63.17 -8.48 8.11 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.071 0.462 . . . . 0.0 110.969 -179.297 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 73.0 p -87.14 -22.37 25.39 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.49 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 29.0 m -125.56 -5.04 7.1 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -178.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 56.7 mt -113.72 136.16 51.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.66 0.267 . . . . 0.0 110.407 179.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -146.65 157.35 27.37 Favored Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.86 -0.686 . . . . 0.0 111.855 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 21.8 p30 -159.53 46.28 0.21 Allowed Pre-proline 0 CA--C 1.539 0.534 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -70.84 -19.16 31.31 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 122.182 1.922 . . . . 0.0 112.012 -178.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -96.53 1.93 51.88 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.912 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.424 ' HA2' ' HB2' ' A' ' 75' ' ' PRO . . . 92.89 8.44 61.88 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.185 -1.007 . . . . 0.0 112.693 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.53 ' HA ' HE22 ' A' ' 86' ' ' GLN . 56.6 m-85 -125.88 134.49 51.59 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.952 0.376 . . . . 0.0 110.716 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.464 HD23 HG21 ' A' ' 88' ' ' ILE . 10.8 mp -88.6 147.26 24.66 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.904 -178.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 172.18 175.32 40.22 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.968 -0.634 . . . . 0.0 111.825 178.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.404 ' CD1' HD13 ' A' ' 88' ' ' ILE . 95.8 m95 -97.72 130.35 44.7 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.952 0.406 . . . . 0.0 110.346 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 147.31 -60.81 0.46 Allowed Glycine 0 N--CA 1.447 -0.593 0 N-CA-C 111.542 -0.623 . . . . 0.0 111.542 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.902 ' HE2' ' HA ' ' A' ' 52' ' ' MET . 1.7 tpt -77.85 171.61 14.71 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 179.09 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -132.19 171.23 13.93 Favored 'General case' 0 C--N 1.32 -0.715 0 O-C-N 121.845 -0.534 . . . . 0.0 110.907 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.745 ' HA ' ' OD2' ' A' ' 38' ' ' ASP . 13.6 m120 65.3 45.7 2.83 Favored 'General case' 0 C--N 1.328 -0.336 0 O-C-N 124.041 0.838 . . . . 0.0 111.77 178.657 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 25.5 p90 -65.65 -30.02 70.67 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.411 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 12.0 m -59.48 -26.81 65.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.297 0.57 . . . . 0.0 110.767 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 75.5 m80 -75.96 -13.59 60.24 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.635 -178.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 27.1 m -131.66 32.23 4.16 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 120.853 0.359 . . . . 0.0 110.978 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 29.2 p -145.58 154.1 41.79 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.611 -0.436 . . . . 0.0 111.328 179.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 68.3 mt-10 -131.47 148.75 52.67 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.368 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 60.29 59.65 2.25 Favored 'General case' 0 C--N 1.331 -0.229 0 O-C-N 123.848 0.718 . . . . 0.0 110.956 178.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.531 HG21 HD22 ' A' ' 71' ' ' LEU . 75.2 mt -83.45 113.83 23.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.116 -179.57 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 35.7 ttmt -149.74 154.73 38.98 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.994 179.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.594 ' HG ' HD22 ' A' ' 12' ' ' LEU . 72.6 mt -82.63 130.65 35.16 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.834 0.35 . . . . 0.0 110.509 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.408 ' C ' ' H ' ' A' ' 67' ' ' GLY . 20.9 tt0 -88.09 -58.52 2.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.634 -178.58 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.505 ' HB2' ' HB2' ' A' ' 69' ' ' ARG . 26.6 mt-10 -80.91 33.78 0.33 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.87 0.366 . . . . 0.0 111.318 -179.556 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.408 ' H ' ' C ' ' A' ' 65' ' ' GLU . . . 67.4 2.14 18.77 Favored Glycine 0 C--N 1.32 -0.342 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.879 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.522 ' HA2' HD13 ' A' ' 64' ' ' LEU . . . 145.37 -14.96 1.85 Allowed Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 120.095 -1.05 . . . . 0.0 112.669 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.505 ' HB2' ' HB2' ' A' ' 66' ' ' GLU . 19.1 mmt180 -79.67 -18.51 51.19 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 30.7 ttpt -149.22 140.24 22.94 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.123 -178.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.542 ' HB2' HD13 ' A' ' 90' ' ' LEU . 9.8 tt -109.49 124.26 50.76 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.306 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 6.6 p -111.41 137.01 49.74 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.232 0.539 . . . . 0.0 111.224 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 21.4 p -161.61 164.08 29.58 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.163 179.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.413 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 28.7 ttt180 -99.88 103.27 21.1 Favored Pre-proline 0 C--N 1.318 -0.78 0 CA-C-N 116.722 -0.217 . . . . 0.0 110.47 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.458 ' HD2' ' HA ' ' A' ' 85' ' ' ARG . 56.6 Cg_endo -70.02 116.03 4.4 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 122.403 2.069 . . . . 0.0 110.002 178.314 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.87 ' HE2' ' HA2' ' A' ' 81' ' ' GLY . 0.0 OUTLIER -119.34 141.61 48.87 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.301 -179.182 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.711 HG21 ' O ' ' A' ' 82' ' ' PHE . 12.2 t -67.57 132.6 47.87 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 179.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 14.0 p -68.58 -14.19 18.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 O-C-N 124.149 0.905 . . . . 0.0 111.128 -179.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -64.54 -28.03 69.37 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.72 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.481 ' HA3' ' CE1' ' A' ' 82' ' ' PHE . . . -155.12 -26.67 0.03 OUTLIER Glycine 0 CA--C 1.518 0.266 0 C-N-CA 120.138 -1.03 . . . . 0.0 113.858 -179.412 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.87 ' HA2' ' HE2' ' A' ' 76' ' ' LYS . . . 102.94 18.64 14.73 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.998 -0.62 . . . . 0.0 111.599 -179.31 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.711 ' O ' HG21 ' A' ' 77' ' ' THR . 18.9 p90 -112.36 145.52 39.93 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 119.274 -0.393 . . . . 0.0 110.053 -178.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.67 ' HB2' ' HA ' ' A' ' 76' ' ' LYS . 0.1 OUTLIER 173.9 -145.34 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.84 0.352 . . . . 0.0 111.62 -179.86 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -128.64 160.3 32.88 Favored 'General case' 0 C--O 1.222 -0.353 0 CA-C-N 115.586 -0.733 . . . . 0.0 109.52 -179.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.458 ' HA ' ' HD2' ' A' ' 75' ' ' PRO . 25.0 ttt180 -89.47 154.97 19.61 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.302 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.53 HE22 ' HA ' ' A' ' 47' ' ' PHE . 1.6 mt-30 -155.31 -169.55 3.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.333 0.587 . . . . 0.0 111.981 -178.581 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -163.08 142.97 8.25 Favored Glycine 0 N--CA 1.445 -0.709 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.771 179.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.464 HG21 HD23 ' A' ' 48' ' ' LEU . 10.9 tt -127.21 132.61 69.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.042 0.449 . . . . 0.0 110.548 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -75.23 141.29 43.55 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 179.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.799 HD12 HD13 ' A' ' 19' ' ' LEU . 63.4 mt -107.3 61.71 0.62 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.691 0.757 . . . . 0.0 110.854 -178.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.539 ' HA ' ' HG ' ' A' ' 2' ' ' SER . 25.0 m-80 -90.89 -0.07 57.63 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.354 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 9.8 mtp180 -96.01 -15.51 22.23 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.995 179.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.437 ' CD1' HD21 ' A' ' 37' ' ' LEU . 28.1 mm -89.88 110.03 21.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 -179.277 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.418 ' NE2' ' HA ' ' A' ' 2' ' ' SER . 23.5 mm-40 -111.17 167.16 10.49 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.425 -178.018 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 21.4 p-10 -126.67 112.42 15.44 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.574 178.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.7 p -111.55 116.66 53.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 120.96 0.409 . . . . 0.0 110.407 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 13.6 m-80 56.32 35.09 25.25 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.762 -178.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 87.02 -10.26 69.13 Favored Glycine 0 N--CA 1.442 -0.906 0 CA-C-N 115.65 -0.705 . . . . 0.0 113.311 179.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -94.11 123.14 37.29 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 117.459 0.63 . . . . 0.0 110.119 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.53 HD11 ' SG ' ' A' ' 23' ' ' CYS . 5.7 tp -79.69 119.21 22.31 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 54.1 t -133.23 145.6 33.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.398 -178.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 26.2 t80 -78.24 129.7 35.39 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 . . . . . 0 C--O 1.25 1.111 0 CA-C-O 117.986 -1.007 . . . . 0.0 110.802 -179.191 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 47.0 mtt . . . . . 0 N--CA 1.478 0.927 0 CA-C-O 120.655 0.264 . . . . 0.0 110.338 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.449 ' O ' ' HB2' ' A' ' 5' ' ' ASP . 17.1 m -118.99 177.8 4.73 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.108 179.183 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.421 ' HD1' ' O ' ' A' ' 93' ' ' ILE . 22.2 p90 -57.84 -36.77 72.75 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.083 0.468 . . . . 0.0 110.334 178.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -58.32 -18.71 29.29 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 115.446 -0.797 . . . . 0.0 112.523 -178.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.449 ' HB2' ' O ' ' A' ' 2' ' ' SER . 0.9 OUTLIER -62.41 -26.89 68.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.928 0.394 . . . . 0.0 110.298 179.161 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 27.1 m -134.63 30.08 3.49 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.819 179.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.406 ' HA ' ' HZ3' ' A' ' 30' ' ' TRP . 21.0 m -139.31 155.55 47.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.247 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.548 ' HG2' ' CZ3' ' A' ' 30' ' ' TRP . 2.3 ptp180 -142.1 169.84 16.84 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.869 -179.468 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 53.4 57.8 5.84 Favored 'General case' 0 C--O 1.232 0.179 0 O-C-N 123.769 0.668 . . . . 0.0 111.696 178.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -87.86 121.56 30.43 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.839 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 27.8 m -127.93 172.17 15.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.68 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.693 HD21 ' HG ' ' A' ' 64' ' ' LEU . 3.6 mm? -104.55 118.65 37.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.454 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 19.6 p -117.52 166.53 12.26 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.948 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 62.46 26.99 16.07 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.479 179.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 101.81 -22.68 37.49 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.485 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 124.51 21.49 2.21 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.703 -0.76 . . . . 0.0 111.981 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 11.5 ptm180 -106.41 -21.61 13.04 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.102 0.477 . . . . 0.0 110.031 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 3.6 m -111.89 136.11 51.64 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.953 -178.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.822 HD11 HD13 ' A' ' 90' ' ' LEU . 26.9 mt -96.95 117.06 30.31 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.18 179.08 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 24.5 ttm180 -109.9 121.01 44.25 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -152.58 166.62 31.5 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.645 -179.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -91.22 108.83 20.14 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 107.605 -1.258 . . . . 0.0 107.605 178.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.423 ' SG ' HD11 ' A' ' 100' ' ' LEU . 65.8 m -95.34 124.54 39.43 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 -179.065 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.484 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 38.4 ttt180 -76.11 112.34 12.46 Favored 'General case' 0 N--CA 1.439 -0.982 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 179.469 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 35.9 p30 -73.54 167.64 20.91 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.619 -179.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.06 -27.73 67.2 Favored 'General case' 0 C--N 1.33 -0.245 0 O-C-N 123.557 0.536 . . . . 0.0 111.507 -178.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -68.46 -18.21 64.36 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.22 0.533 . . . . 0.0 109.991 179.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 94.63 33.16 6.88 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.857 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.484 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 7.2 t-20 -123.92 164.38 19.41 Favored 'General case' 0 C--N 1.323 -0.571 0 O-C-N 122.773 -0.251 . . . . 0.0 110.734 -178.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.548 ' CZ3' ' HG2' ' A' ' 8' ' ' ARG . 98.4 m95 -100.51 120.41 39.97 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.385 -179.616 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 6.7 m -122.78 139.5 49.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.889 179.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 13.5 m -79.48 114.08 18.13 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.793 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 68.3 m -124.6 146.08 49.26 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.764 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.596 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 50.7 mt-10 -131.5 135.22 46.9 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.1 -179.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.519 ' HB2' HD21 ' A' ' 100' ' ' LEU . 1.6 tm? -130.08 131.67 45.85 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.166 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.447 ' N ' HD12 ' A' ' 35' ' ' LEU . 18.1 m-20 -87.11 110.23 19.97 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.842 0.353 . . . . 0.0 110.221 179.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.545 HD11 ' HG ' ' A' ' 19' ' ' LEU . 2.1 mt -86.54 -18.04 32.53 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.981 -179.479 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.417 ' HA ' ' HD1' ' A' ' 55' ' ' PHE . 0.5 OUTLIER -66.12 -13.91 60.91 Favored 'General case' 0 C--O 1.222 -0.357 0 C-N-CA 120.525 -0.47 . . . . 0.0 111.949 -177.72 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.406 HG23 ' HG ' ' A' ' 40' ' ' CYS . 14.6 t -87.0 -4.38 59.17 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.135 0.493 . . . . 0.0 110.233 179.42 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.406 ' HG ' HG23 ' A' ' 39' ' ' THR . 56.5 m -127.26 -22.73 3.67 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 120.872 0.367 . . . . 0.0 111.508 -179.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 65.3 mt -102.57 138.81 25.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 110.235 -0.283 . . . . 0.0 110.235 179.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -149.23 158.79 27.8 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.892 -0.67 . . . . 0.0 111.605 179.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.703 ' ND2' ' HB2' ' A' ' 55' ' ' PHE . 8.2 p30 -162.42 47.78 0.21 Allowed Pre-proline 0 CA--C 1.534 0.353 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -67.54 -21.73 45.72 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 121.501 1.467 . . . . 0.0 111.413 -179.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -84.53 -16.7 41.4 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.144 179.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.567 ' CA ' ' HG2' ' A' ' 83' ' ' ARG . . . 108.41 8.8 28.36 Favored Glycine 0 N--CA 1.442 -0.933 0 C-N-CA 120.341 -0.933 . . . . 0.0 113.374 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -125.73 134.88 51.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 117.1 0.45 . . . . 0.0 111.043 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 91.2 mt -83.33 131.8 35.05 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.889 -178.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -175.34 170.2 43.19 Favored Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.842 178.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 84.8 m95 -95.63 135.02 37.85 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 179.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 137.09 16.22 0.76 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.375 -0.917 . . . . 0.0 113.527 179.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 1.1 ttt -155.8 -165.79 2.05 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -147.3 167.88 23.15 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.307 -0.557 . . . . 0.0 111.718 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 67.14 41.67 2.53 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.061 -0.972 . . . . 0.0 112.254 178.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.703 ' HB2' ' ND2' ' A' ' 43' ' ' ASN . 3.2 p90 -70.15 -25.12 63.31 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.737 0.303 . . . . 0.0 111.07 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 44.9 t -60.76 -41.21 95.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.443 -178.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 8.5 m-70 -70.62 -14.85 62.64 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.459 -178.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.407 ' HA ' ' HD2' ' A' ' 76' ' ' LYS . 20.1 m -113.48 18.99 17.27 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 111.777 0.288 . . . . 0.0 111.777 -179.229 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 61.2 m -138.97 153.74 48.21 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 121.448 -0.783 . . . . 0.0 112.46 -179.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -118.83 142.76 47.43 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.343 179.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 56.25 77.12 0.26 Allowed 'General case' 0 N--CA 1.466 0.354 0 O-C-N 123.666 0.604 . . . . 0.0 112.127 178.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.497 HG21 HD23 ' A' ' 71' ' ' LEU . 88.2 mt -92.31 112.63 26.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 121.041 0.448 . . . . 0.0 110.278 179.515 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 34.3 ttmt -149.23 153.99 38.42 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.344 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.693 ' HG ' HD21 ' A' ' 12' ' ' LEU . 42.1 mt -81.91 126.44 31.92 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.462 0.649 . . . . 0.0 111.067 -179.046 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.478 ' HB2' ' CG2' ' A' ' 72' ' ' THR . 39.4 tt0 -74.52 -52.32 12.24 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 114.925 -1.034 . . . . 0.0 111.201 -179.151 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.486 ' HB2' ' HB2' ' A' ' 69' ' ' ARG . 21.0 mm-40 -89.37 0.91 56.48 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.003 179.671 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 77.09 32.36 49.15 Favored Glycine 0 N--CA 1.446 -0.692 0 CA-C-N 115.519 -0.764 . . . . 0.0 112.142 -179.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 142.79 -42.75 1.08 Allowed Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.391 -0.909 . . . . 0.0 112.422 179.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.486 ' HB2' ' HB2' ' A' ' 66' ' ' GLU . 13.3 mmt180 -70.02 -30.22 67.47 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.842 0.353 . . . . 0.0 111.117 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 46.2 tttt -144.36 145.97 32.27 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -177.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.528 ' HB2' HD11 ' A' ' 90' ' ' LEU . 10.5 tt -111.68 135.44 52.27 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.382 -0.826 . . . . 0.0 108.969 179.131 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.478 ' CG2' ' HB2' ' A' ' 65' ' ' GLU . 2.6 p -123.53 131.93 53.76 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.037 0.446 . . . . 0.0 111.501 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 26.0 p -158.99 164.46 35.54 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.338 -0.846 . . . . 0.0 108.717 179.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.416 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 31.6 ttt180 -99.76 103.55 22.54 Favored Pre-proline 0 C--N 1.317 -0.806 0 C-N-CA 120.424 -0.51 . . . . 0.0 110.394 179.548 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 85' ' ' ARG . 59.7 Cg_endo -71.31 127.91 13.97 Favored 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 122.543 2.162 . . . . 0.0 110.825 178.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.698 ' HA ' ' HB2' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -120.16 146.61 45.83 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.932 -179.81 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.698 HG23 ' O ' ' A' ' 82' ' ' PHE . 8.9 t -71.94 130.33 40.74 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 177.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 9.8 p -71.44 -8.16 10.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 O-C-N 123.619 0.574 . . . . 0.0 111.425 -178.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -70.71 -24.78 62.71 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.119 0.485 . . . . 0.0 110.612 179.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.543 ' HA3' ' CE2' ' A' ' 82' ' ' PHE . . . -151.58 -30.03 0.04 OUTLIER Glycine 0 CA--C 1.519 0.334 0 C-N-CA 120.623 -0.799 . . . . 0.0 113.015 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 104.54 17.16 15.78 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 121.051 -0.595 . . . . 0.0 112.112 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.698 ' O ' HG23 ' A' ' 77' ' ' THR . 17.2 p90 -112.72 153.71 27.29 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 118.904 -0.57 . . . . 0.0 109.766 -179.037 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.698 ' HB2' ' HA ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 169.3 -150.45 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.105 0.479 . . . . 0.0 112.138 179.481 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -129.29 154.9 46.39 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.355 -0.838 . . . . 0.0 110.428 -177.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.416 ' HA ' ' HA ' ' A' ' 74' ' ' ARG . 36.4 ttt180 -86.27 145.88 26.75 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 18.8 mt-30 -151.96 -171.3 3.89 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.565 -178.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -146.74 149.31 21.44 Favored Glycine 0 N--CA 1.448 -0.506 0 N-CA-C 111.261 -0.736 . . . . 0.0 111.261 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 12.0 tt -131.39 133.23 62.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 117.073 0.437 . . . . 0.0 110.877 -179.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -75.65 137.71 40.89 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.679 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.822 HD13 HD11 ' A' ' 19' ' ' LEU . 47.4 mt -101.52 40.23 1.33 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.48 0.657 . . . . 0.0 110.287 -179.513 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.478 ' N ' HD21 ' A' ' 91' ' ' ASN . 0.9 OUTLIER -74.12 0.04 15.11 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.657 -179.486 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 18.3 mtp180 -96.57 -12.63 23.74 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.926 179.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.421 ' O ' ' HD1' ' A' ' 3' ' ' TYR . 23.0 mm -99.02 114.65 37.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 -179.214 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 20.6 mt-30 -132.33 156.53 46.42 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.136 0.493 . . . . 0.0 111.712 -178.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.407 ' HA ' ' O ' ' A' ' 99' ' ' ARG . 20.4 p-10 -104.58 131.92 51.42 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.499 179.367 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 40.9 t -115.18 111.61 36.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 179.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 28.4 m-80 58.06 19.49 6.05 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.866 -179.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 117.46 -28.35 7.19 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.681 -0.771 . . . . 0.0 113.92 178.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.407 ' O ' ' HA ' ' A' ' 95' ' ' ASN . 0.2 OUTLIER -87.11 142.23 28.08 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 117.277 0.538 . . . . 0.0 110.991 -178.916 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.519 HD21 ' HB2' ' A' ' 35' ' ' LEU . 8.6 tp -87.74 125.78 34.62 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 24.6 t -131.36 140.35 48.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.014 -178.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.451 ' HB2' HD13 ' A' ' 35' ' ' LEU . 13.6 t80 -82.04 131.38 35.24 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 177.58 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 . . . . . 0 C--N 1.312 -1.024 0 CA-C-O 118.906 -0.568 . . . . 0.0 111.241 -179.259 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.3 ptp . . . . . 0 N--CA 1.482 1.134 0 CA-C-O 120.706 0.289 . . . . 0.0 110.269 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 38.0 m -119.24 179.16 4.27 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.996 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.477 ' HH ' ' HA2' ' A' ' 68' ' ' GLY . 9.3 p90 -54.23 -34.59 61.01 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.833 0.349 . . . . 0.0 110.867 178.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.576 ' HB1' ' HD2' ' A' ' 69' ' ' ARG . . . -57.27 -19.23 20.42 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.437 -179.029 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -70.75 -18.41 62.78 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.071 0.462 . . . . 0.0 110.867 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 41.6 m -140.67 33.8 1.81 Allowed 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 178.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 10.3 t -146.24 157.86 43.84 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.231 -179.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.413 ' HG2' ' CZ3' ' A' ' 30' ' ' TRP . 2.1 ptp180 -137.44 158.42 44.45 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.663 -0.244 . . . . 0.0 110.981 -179.748 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 57.54 61.62 2.41 Favored 'General case' 0 C--O 1.233 0.229 0 O-C-N 123.967 0.792 . . . . 0.0 111.127 178.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.527 ' HA ' ' HB1' ' A' ' 21' ' ' ALA . . . -89.83 118.52 29.48 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.917 -179.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 30.0 m -123.07 170.56 13.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.612 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.544 HD22 ' HG ' ' A' ' 64' ' ' LEU . 3.8 mm? -105.36 122.4 45.88 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.145 -179.57 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.411 ' OG1' ' HB ' ' A' ' 18' ' ' THR . 33.5 p -116.0 162.14 17.81 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.69 0.281 . . . . 0.0 110.892 179.543 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 63.51 29.29 15.38 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.904 -0.589 . . . . 0.0 112.078 179.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 97.09 -15.79 61.93 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.502 179.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 122.09 20.85 2.97 Favored Glycine 0 CA--C 1.507 -0.417 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.36 179.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 4.1 ptm180 -103.98 -22.64 13.44 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.029 0.442 . . . . 0.0 110.54 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.411 ' HB ' ' OG1' ' A' ' 13' ' ' THR . 5.5 m -113.48 137.89 50.89 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.893 -178.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.646 ' O ' ' HA ' ' A' ' 34' ' ' GLU . 83.8 mt -100.41 120.32 39.79 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.438 179.129 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 56.2 ttp180 -118.27 120.25 37.1 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.586 -0.446 . . . . 0.0 109.876 178.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.527 ' HB1' ' HA ' ' A' ' 10' ' ' ALA . . . -154.48 167.58 29.56 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.383 -179.416 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -89.43 105.96 18.14 Favored 'General case' 0 CA--C 1.51 -0.569 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 177.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 69.3 m -96.46 136.29 37.16 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 120.727 0.299 . . . . 0.0 110.625 -178.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.546 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 16.2 ttp180 -76.94 119.31 20.51 Favored 'General case' 0 N--CA 1.44 -0.934 0 CA-C-N 116.196 -0.457 . . . . 0.0 109.835 179.336 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 37.4 p30 -80.32 174.55 11.49 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.153 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.27 -30.87 63.03 Favored 'General case' 0 C--O 1.235 0.303 0 O-C-N 123.649 0.593 . . . . 0.0 112.516 -178.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -77.4 -10.51 59.5 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.319 0.58 . . . . 0.0 110.135 -179.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 89.82 29.36 15.96 Favored Glycine 0 N--CA 1.447 -0.597 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.472 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.546 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 4.8 t-20 -110.64 164.02 13.16 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 121.086 -0.246 . . . . 0.0 111.129 -178.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.413 ' CZ3' ' HG2' ' A' ' 8' ' ' ARG . 82.4 m95 -97.62 119.44 36.2 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.011 0.434 . . . . 0.0 111.954 -179.388 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 5.8 m -124.39 135.03 65.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.938 178.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 62.0 m -81.3 111.02 17.3 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.926 0.393 . . . . 0.0 110.506 -179.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 70.5 m -120.5 155.84 32.75 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.481 -179.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.646 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 41.6 mt-10 -135.12 142.65 46.25 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.564 179.319 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.495 HD13 ' HB2' ' A' ' 102' ' ' PHE . 1.4 tm? -138.92 131.39 28.68 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.304 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.442 ' N ' HD12 ' A' ' 35' ' ' LEU . 22.1 m-20 -89.83 110.89 21.79 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.425 HD13 ' HG ' ' A' ' 19' ' ' LEU . 1.1 mt -86.62 -19.42 29.35 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.659 -178.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.422 ' HA ' ' HD1' ' A' ' 55' ' ' PHE . 3.2 p-10 -68.45 -8.68 42.97 Favored 'General case' 0 C--O 1.221 -0.398 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -178.006 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.427 HG21 ' O ' ' A' ' 36' ' ' ASP . 13.7 t -87.27 -1.72 58.11 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 179.107 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 75.2 m -135.33 -23.32 1.47 Allowed 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 116.176 -0.465 . . . . 0.0 112.02 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 55.1 mt -96.91 145.03 9.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 O-C-N 122.222 -0.299 . . . . 0.0 110.476 -179.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -153.1 158.39 27.9 Favored Glycine 0 N--CA 1.447 -0.569 0 N-CA-C 111.277 -0.729 . . . . 0.0 111.277 179.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -159.91 53.91 0.58 Allowed Pre-proline 0 CA--C 1.538 0.511 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -179.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -71.54 -16.93 30.45 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 121.942 1.762 . . . . 0.0 112.216 -179.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -102.61 13.65 33.95 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.092 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.485 ' CA ' ' HG2' ' A' ' 83' ' ' ARG . . . 79.47 12.56 83.64 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.463 -0.875 . . . . 0.0 112.961 179.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.759 ' HA ' HE22 ' A' ' 86' ' ' GLN . 37.9 m-85 -125.31 130.74 52.59 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.879 0.371 . . . . 0.0 110.303 179.718 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 87.6 mt -84.33 132.51 34.6 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.745 -178.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -171.95 170.49 43.45 Favored Glycine 0 N--CA 1.443 -0.837 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.139 179.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 87.4 m95 -96.22 131.51 42.62 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 141.56 17.72 0.34 Allowed Glycine 0 CA--C 1.519 0.333 0 C-N-CA 120.46 -0.876 . . . . 0.0 113.821 179.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 5.3 ttt -153.57 -156.05 0.65 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 117.366 0.583 . . . . 0.0 109.801 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.404 ' HA ' ' O ' ' A' ' 38' ' ' ASP . 27.6 pt20 -148.04 167.62 24.49 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.705 0.288 . . . . 0.0 111.137 -179.341 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 35.9 m-80 61.63 44.74 8.69 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.452 -0.794 . . . . 0.0 112.938 178.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.422 ' HD1' ' HA ' ' A' ' 38' ' ' ASP . 1.2 p90 -71.01 -26.81 63.29 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.523 -0.471 . . . . 0.0 110.73 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.508 ' HA ' HD12 ' A' ' 62' ' ' ILE . 79.6 p -72.94 -29.35 63.04 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.035 0.445 . . . . 0.0 110.504 -179.413 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 41.8 m80 -82.81 -9.25 59.42 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.398 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.3 p -114.89 6.94 15.56 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.961 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 72.0 m -130.21 153.29 48.73 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.128 0.49 . . . . 0.0 110.745 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 86.7 mt-10 -119.09 134.67 55.06 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.403 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.5 t70 58.53 82.89 0.13 Allowed 'General case' 0 N--CA 1.465 0.317 0 O-C-N 123.938 0.774 . . . . 0.0 111.507 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.508 HD12 ' HA ' ' A' ' 56' ' ' SER . 72.0 mt -95.31 124.54 47.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.108 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.9 tptm -149.84 149.54 30.63 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.544 ' HG ' HD22 ' A' ' 12' ' ' LEU . 52.2 mt -83.39 135.94 34.52 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.823 0.344 . . . . 0.0 110.98 -179.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.407 ' C ' ' H ' ' A' ' 67' ' ' GLY . 34.4 tt0 -91.82 -59.03 2.22 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.958 -179.643 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.421 ' CB ' ' HB2' ' A' ' 69' ' ' ARG . 20.2 mm-40 -82.03 27.03 0.49 Allowed 'General case' 0 CA--C 1.516 -0.348 0 CA-C-O 121.106 0.479 . . . . 0.0 111.507 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.407 ' H ' ' C ' ' A' ' 65' ' ' GLU . . . 62.84 16.65 56.98 Favored Glycine 0 N--CA 1.448 -0.507 0 CA-C-N 115.278 -0.874 . . . . 0.0 112.722 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.477 ' HA2' ' HH ' ' A' ' 3' ' ' TYR . . . 144.08 -30.4 1.9 Allowed Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 120.104 -1.046 . . . . 0.0 113.189 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.576 ' HD2' ' HB1' ' A' ' 4' ' ' ALA . 7.2 mpt_? -74.37 -24.12 59.11 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 117.553 0.677 . . . . 0.0 111.12 -179.397 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 33.4 tttp -141.37 139.91 33.61 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.842 -178.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.526 ' HB2' HD11 ' A' ' 90' ' ' LEU . 10.1 tt -112.89 133.82 54.69 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.618 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.9 p -119.46 135.09 54.91 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.902 0.382 . . . . 0.0 111.083 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 25.3 p -162.49 172.23 15.83 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.37 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.557 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 32.2 ttt180 -106.98 99.38 25.9 Favored Pre-proline 0 C--N 1.319 -0.758 0 C-N-CA 120.356 -0.538 . . . . 0.0 110.741 178.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -67.4 123.86 11.35 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 122.784 2.323 . . . . 0.0 110.103 178.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.712 ' HA ' ' HB2' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -120.29 142.97 48.6 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.066 0.46 . . . . 0.0 111.956 -178.914 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.706 HG23 ' O ' ' A' ' 82' ' ' PHE . 14.8 t -75.38 138.69 41.89 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.027 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 11.1 p -76.18 -12.95 14.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.217 -179.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -66.05 -21.9 66.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.11 0.481 . . . . 0.0 111.002 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.699 ' HA3' ' CE2' ' A' ' 82' ' ' PHE . . . -155.63 -21.41 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.29 -0.957 . . . . 0.0 113.105 179.623 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.498 ' HA2' ' CE ' ' A' ' 76' ' ' LYS . . . 95.53 12.57 53.57 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.05 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.706 ' O ' HG23 ' A' ' 77' ' ' THR . 16.7 p90 -112.47 158.61 19.68 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 118.926 -0.559 . . . . 0.0 110.015 -178.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.775 ' HA ' ' HE ' ' A' ' 83' ' ' ARG . 0.0 OUTLIER 168.65 -152.42 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 O-C-N 123.805 0.691 . . . . 0.0 111.656 178.707 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -125.73 155.88 40.27 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.358 -177.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.557 ' HA ' ' HA ' ' A' ' 74' ' ' ARG . 32.2 ttt180 -80.3 155.52 27.23 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 179.476 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.759 HE22 ' HA ' ' A' ' 47' ' ' PHE . 8.8 tt0 -162.45 177.12 9.79 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 120.976 0.417 . . . . 0.0 111.407 -178.054 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.477 ' H ' ' HG2' ' A' ' 86' ' ' GLN . . . -140.2 143.82 14.13 Favored Glycine 0 N--CA 1.445 -0.711 0 N-CA-C 111.456 -0.657 . . . . 0.0 111.456 179.388 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 10.1 tt -124.38 140.69 46.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 109.751 -0.462 . . . . 0.0 109.751 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -82.46 136.47 34.9 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.861 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.596 HD13 HD12 ' A' ' 19' ' ' LEU . 83.2 mt -106.82 44.6 1.04 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.352 0.596 . . . . 0.0 110.861 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 18.5 m-80 -76.97 2.66 14.18 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.751 179.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 18.5 mtp180 -98.82 -15.05 19.4 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.087 -0.96 . . . . 0.0 110.316 179.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.556 HG21 HD13 ' A' ' 19' ' ' LEU . 29.3 mm -98.91 105.13 16.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 121.017 0.436 . . . . 0.0 109.993 -179.315 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -130.85 156.47 44.97 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.007 -179.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 13.1 p-10 -95.71 110.72 22.81 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.127 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 58.8 t -90.87 104.44 15.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 59.89 35.24 21.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.989 -179.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 98.45 -27.27 20.3 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.75 -0.738 . . . . 0.0 113.431 179.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.92 128.82 35.06 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.944 0.372 . . . . 0.0 110.136 -178.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.42 ' HA ' HD11 ' A' ' 100' ' ' LEU . 9.2 tp -75.72 120.33 20.96 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 -179.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 32.2 t -129.61 142.09 44.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.168 -178.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.495 ' HB2' HD13 ' A' ' 35' ' ' LEU . 18.1 t80 -82.28 124.61 30.11 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 177.384 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.421 -0.799 . . . . 0.0 110.877 -179.504 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 mpt? . . . . . 0 N--CA 1.48 1.028 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.45 ' OG ' ' HA ' ' A' ' 91' ' ' ASN . 9.5 m -117.83 178.92 4.23 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.071 179.559 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.522 ' HA ' ' OD1' ' A' ' 95' ' ' ASN . 13.2 p90 -58.7 -38.14 77.62 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.524 0.202 . . . . 0.0 111.322 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -57.84 -23.93 55.07 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.357 -0.383 . . . . 0.0 112.023 -179.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -69.97 -16.24 63.16 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.654 0.242 . . . . 0.0 111.654 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 20.8 m -141.22 30.09 1.79 Allowed 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 22.4 t -144.92 158.46 43.8 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 115.509 -0.768 . . . . 0.0 110.103 -179.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 18.3 ptt180 -140.3 165.49 27.27 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.441 -179.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 55.18 54.76 8.37 Favored 'General case' 0 N--CA 1.467 0.378 0 O-C-N 123.829 0.705 . . . . 0.0 111.404 179.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.413 ' HA ' ' HB3' ' A' ' 21' ' ' ALA . . . -81.08 117.32 21.56 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.59 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 33.8 m -122.56 168.86 14.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.686 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.632 HD22 ' HG ' ' A' ' 64' ' ' LEU . 3.9 mm? -105.15 117.08 33.1 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.005 -179.546 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.463 HG21 ' NE ' ' A' ' 20' ' ' ARG . 20.9 p -115.48 165.89 12.49 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.062 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.433 ' O ' ' HG2' ' A' ' 17' ' ' ARG . 93.9 m-20 60.35 31.14 20.31 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.8 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 96.3 -17.96 58.33 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.827 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 122.86 10.15 5.93 Favored Glycine 0 C--O 1.229 -0.197 0 C-N-CA 121.025 -0.607 . . . . 0.0 111.608 -179.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.433 ' HG2' ' O ' ' A' ' 14' ' ' ASN . 5.2 ptm180 -91.26 -24.17 19.94 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.257 0.551 . . . . 0.0 110.337 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 23.2 m -115.49 138.43 51.03 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.869 -178.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.705 HD13 HD12 ' A' ' 90' ' ' LEU . 92.1 mt -97.49 120.92 38.74 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.326 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.463 ' NE ' HG21 ' A' ' 13' ' ' THR . 34.5 ttm180 -114.12 120.46 40.62 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 178.252 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.413 ' HB3' ' HA ' ' A' ' 10' ' ' ALA . . . -153.11 167.71 28.35 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 120.938 0.399 . . . . 0.0 111.168 -178.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -88.9 105.95 18.09 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 178.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.419 ' SG ' ' HB2' ' A' ' 33' ' ' SER . 67.7 m -91.26 129.7 37.22 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.65 -178.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.504 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 24.7 ttp180 -75.69 116.38 16.35 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.521 179.124 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 36.2 p30 -82.16 173.3 12.25 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.177 179.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.18 -30.45 62.26 Favored 'General case' 0 N--CA 1.464 0.268 0 O-C-N 123.361 0.413 . . . . 0.0 112.084 -178.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -72.83 -13.5 61.31 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.662 0.744 . . . . 0.0 109.96 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 88.61 25.55 29.91 Favored Glycine 0 CA--C 1.503 -0.694 0 N-CA-C 110.8 -0.92 . . . . 0.0 110.8 -179.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.504 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 8.7 t-20 -106.6 161.97 14.16 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.575 -0.313 . . . . 0.0 110.323 -178.55 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 87.4 m95 -100.04 122.55 43.1 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.955 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 5.6 m -124.33 136.11 61.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.27 178.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 13.2 m -75.42 109.73 9.2 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.953 0.406 . . . . 0.0 110.958 -179.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.419 ' HB2' ' SG ' ' A' ' 23' ' ' CYS . 69.8 m -124.05 148.0 47.41 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.697 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.634 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 47.9 mt-10 -124.94 150.9 46.13 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.237 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.557 HD11 ' HB2' ' A' ' 102' ' ' PHE . 1.6 tm? -141.84 130.86 23.18 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 178.582 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.447 ' N ' HD13 ' A' ' 35' ' ' LEU . 2.1 p-10 -88.35 109.7 20.19 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.303 0.573 . . . . 0.0 110.605 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.494 HD12 ' HG ' ' A' ' 19' ' ' LEU . 1.0 OUTLIER -86.65 -21.05 26.95 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.965 179.532 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.411 ' HA ' ' HD1' ' A' ' 55' ' ' PHE . 5.1 p-10 -64.03 -13.73 49.02 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -178.445 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 64.1 p -83.63 -11.32 57.44 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 120.89 0.376 . . . . 0.0 110.801 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 35.5 m -130.41 -9.94 4.13 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.231 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.424 HD12 HD11 ' A' ' 88' ' ' ILE . 63.4 mt -113.26 137.05 47.67 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-O 120.682 0.277 . . . . 0.0 110.704 179.479 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -149.45 159.03 27.9 Favored Glycine 0 N--CA 1.446 -0.7 0 C-N-CA 120.967 -0.635 . . . . 0.0 111.581 179.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.433 ' OD1' ' HB2' ' A' ' 58' ' ' SER . 24.8 p30 -157.57 48.31 0.31 Allowed Pre-proline 0 CA--C 1.535 0.367 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -68.74 -22.21 37.53 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 121.829 1.686 . . . . 0.0 112.166 -178.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 70.6 m-20 -91.79 0.44 57.49 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.43 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.519 ' CA ' ' HG2' ' A' ' 83' ' ' ARG . . . 92.48 6.74 64.02 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.669 -0.776 . . . . 0.0 112.236 -179.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -120.78 132.25 54.93 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.938 0.399 . . . . 0.0 110.798 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 14.8 mt -84.31 146.79 27.55 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.399 -178.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 169.35 171.0 34.57 Favored Glycine 0 N--CA 1.442 -0.904 0 C-N-CA 120.254 -0.974 . . . . 0.0 112.64 178.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.413 ' HH2' HD11 ' A' ' 93' ' ' ILE . 90.8 m95 -96.1 126.17 41.14 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 149.82 -43.94 0.73 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.995 -0.621 . . . . 0.0 111.853 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.935 ' HE1' ' HA ' ' A' ' 52' ' ' MET . 0.7 OUTLIER -94.24 -177.04 4.15 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 179.104 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -143.14 170.19 16.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 119.076 0.853 . . . . 0.0 112.215 -178.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 30.0 m-80 66.11 36.68 5.54 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.091 -0.959 . . . . 0.0 112.307 179.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.411 ' HD1' ' HA ' ' A' ' 38' ' ' ASP . 9.1 p90 -62.86 -28.33 69.96 Favored 'General case' 0 C--O 1.221 -0.444 0 CA-C-O 120.651 0.262 . . . . 0.0 110.455 179.442 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 9.5 p -58.68 -34.34 71.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.351 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 26.5 m80 -80.06 -10.05 59.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.553 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.433 ' HB2' ' OD1' ' A' ' 43' ' ' ASN . 16.4 m -123.5 28.98 6.79 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.45 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 45.0 m -137.49 150.31 47.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.062 0.458 . . . . 0.0 111.079 179.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 71.5 mt-10 -129.86 134.01 47.26 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.677 179.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 38.5 t70 61.62 79.73 0.24 Allowed 'General case' 0 N--CA 1.468 0.455 0 O-C-N 123.705 0.628 . . . . 0.0 110.689 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.502 HG22 HD21 ' A' ' 71' ' ' LEU . 64.3 mt -98.67 125.06 52.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.037 -179.25 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.1 tptm -149.21 156.07 41.59 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.016 0.436 . . . . 0.0 111.285 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.632 ' HG ' HD22 ' A' ' 12' ' ' LEU . 83.0 mt -98.99 128.84 45.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.144 179.086 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -93.52 -65.7 0.97 Allowed 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -178.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.494 ' HB2' ' HB2' ' A' ' 69' ' ' ARG . 4.8 mm-40 -76.29 50.28 0.63 Allowed 'General case' 0 CA--C 1.516 -0.33 0 CA-C-O 121.117 0.484 . . . . 0.0 112.192 -178.013 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 59.94 16.35 39.32 Favored Glycine 0 C--N 1.318 -0.44 0 CA-C-N 115.117 -0.947 . . . . 0.0 112.795 179.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.507 ' HA2' HD11 ' A' ' 64' ' ' LEU . . . 121.11 -12.29 9.8 Favored Glycine 0 N--CA 1.442 -0.909 0 C-N-CA 120.394 -0.907 . . . . 0.0 113.241 179.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.494 ' HB2' ' HB2' ' A' ' 66' ' ' GLU . 2.8 mtt85 -77.69 -22.16 50.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 117.525 0.663 . . . . 0.0 110.721 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 33.0 tptt -131.63 127.56 37.27 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.294 -178.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.514 ' HB2' HD13 ' A' ' 90' ' ' LEU . 10.6 tt -110.04 121.2 44.7 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.442 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.4 p -109.66 136.61 48.74 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.176 0.513 . . . . 0.0 110.837 179.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.408 ' HG ' ' CD2' ' A' ' 71' ' ' LEU . 17.7 p -162.87 169.43 19.8 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.102 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.532 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 30.2 ttt180 -103.8 102.45 31.09 Favored Pre-proline 0 C--N 1.313 -0.979 0 C-N-CA 120.095 -0.642 . . . . 0.0 110.609 179.116 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.541 ' HD2' ' HA ' ' A' ' 85' ' ' ARG . 48.0 Cg_endo -67.77 116.15 4.13 Favored 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 122.539 2.159 . . . . 0.0 110.023 178.385 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.676 ' HA ' ' HB2' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -117.86 144.97 44.94 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.088 0.47 . . . . 0.0 111.455 -178.927 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.717 HG22 ' O ' ' A' ' 82' ' ' PHE . 15.3 t -77.86 140.73 39.37 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 179.402 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 32.2 m -74.52 -1.64 3.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 O-C-N 123.989 0.806 . . . . 0.0 111.145 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 -68.4 -32.01 71.76 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.174 0.511 . . . . 0.0 110.144 179.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -160.67 -9.51 0.04 OUTLIER Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.476 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.554 ' HA2' ' CE ' ' A' ' 76' ' ' LYS . . . 90.63 19.71 43.42 Favored Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 120.577 -0.821 . . . . 0.0 111.776 179.627 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.717 ' O ' HG22 ' A' ' 77' ' ' THR . 26.3 p90 -110.93 146.64 36.21 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 119.226 -0.416 . . . . 0.0 110.047 -179.028 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.676 ' HB2' ' HA ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 170.53 -154.92 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.224 0 O-C-N 123.925 0.766 . . . . 0.0 110.433 179.27 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -118.37 173.02 7.06 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.41 -178.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.541 ' HA ' ' HD2' ' A' ' 75' ' ' PRO . 31.3 ttt85 -104.3 153.43 21.03 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 178.244 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.688 ' HG2' ' H ' ' A' ' 87' ' ' GLY . 9.0 tt0 -165.61 -174.65 3.19 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 120.655 0.264 . . . . 0.0 110.698 -178.503 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.688 ' H ' ' HG2' ' A' ' 86' ' ' GLN . . . -141.11 151.9 22.86 Favored Glycine 0 N--CA 1.45 -0.369 0 N-CA-C 111.736 -0.545 . . . . 0.0 111.736 179.181 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.424 HD11 HD12 ' A' ' 41' ' ' ILE . 12.1 tt -125.49 145.6 32.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 120.965 0.412 . . . . 0.0 110.208 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -82.47 121.98 27.45 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.845 -179.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.705 HD12 HD13 ' A' ' 19' ' ' LEU . 59.8 mt -98.59 37.08 1.53 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.558 0.695 . . . . 0.0 110.632 179.476 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.45 ' HA ' ' OG ' ' A' ' 2' ' ' SER . 0.9 OUTLIER -75.27 -0.65 20.32 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 114.949 -1.023 . . . . 0.0 110.381 -179.958 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 20.1 mtp180 -92.09 -14.81 28.66 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.226 -179.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.413 HD11 ' HH2' ' A' ' 50' ' ' TRP . 21.0 mm -92.22 111.7 24.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 -179.445 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 21.9 tp60 -124.71 134.85 52.69 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.283 0.563 . . . . 0.0 111.315 -178.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.522 ' OD1' ' HA ' ' A' ' 3' ' ' TYR . 19.6 p-10 -95.45 119.82 34.62 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.843 178.105 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.3 p -114.95 119.2 61.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.177 0.513 . . . . 0.0 110.602 -179.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 58.54 30.22 19.49 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.002 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 94.87 -15.79 62.65 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.774 -0.727 . . . . 0.0 113.289 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -93.03 123.18 36.1 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 117.555 0.677 . . . . 0.0 110.089 -179.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 16.1 tp -82.57 117.22 22.39 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.8 t -128.6 149.98 33.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.769 0.319 . . . . 0.0 111.088 -179.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.557 ' HB2' HD11 ' A' ' 35' ' ' LEU . 8.5 t80 -89.61 126.0 35.45 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 178.113 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.316 -0.89 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.321 179.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.0 ttt . . . . . 0 N--CA 1.48 1.041 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.8 p -117.97 178.25 4.49 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.73 -0.388 . . . . 0.0 111.319 178.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.435 ' HA ' ' OD1' ' A' ' 95' ' ' ASN . 12.8 p90 -58.59 -38.61 78.31 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -179.615 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.578 ' HA ' ' OG ' ' A' ' 7' ' ' SER . . . -55.29 -19.09 7.52 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 -177.371 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -61.71 -37.07 82.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.963 0.411 . . . . 0.0 111.037 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 8.1 t -130.63 45.02 2.88 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 121.295 0.569 . . . . 0.0 109.754 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.578 ' OG ' ' HA ' ' A' ' 4' ' ' ALA . 86.4 p -147.06 165.54 29.6 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.225 179.017 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 11.9 ptm180 -149.24 166.6 28.42 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.661 -179.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 59.44 54.43 4.66 Favored 'General case' 0 C--O 1.234 0.254 0 O-C-N 123.93 0.769 . . . . 0.0 111.136 179.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -86.69 117.36 25.4 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.014 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 34.2 m -124.57 168.49 17.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.786 -179.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.725 HD23 ' HG ' ' A' ' 64' ' ' LEU . 3.5 mm? -105.21 114.9 29.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.121 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 19.2 p -110.06 167.2 10.35 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.166 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 60.64 49.94 6.04 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.778 -0.647 . . . . 0.0 111.449 179.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 83.76 -30.15 3.57 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.348 179.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 130.64 48.09 0.13 Allowed Glycine 0 N--CA 1.446 -0.689 0 N-CA-C 111.133 -0.787 . . . . 0.0 111.133 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 41.7 ptt85 -132.16 -27.07 1.85 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.017 0.436 . . . . 0.0 111.202 -179.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 4.2 m -100.94 133.88 44.76 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.828 -179.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.778 HD12 HD11 ' A' ' 90' ' ' LEU . 70.3 mt -94.17 115.95 28.3 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.275 179.084 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 53.3 ttp180 -114.36 121.28 43.12 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.504 -0.479 . . . . 0.0 109.983 178.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -153.43 166.05 33.89 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.845 0.355 . . . . 0.0 110.662 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -89.95 106.03 18.2 Favored 'General case' 0 CA--C 1.508 -0.643 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 178.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.45 ' SG ' HD12 ' A' ' 100' ' ' LEU . 45.3 m -98.81 132.17 44.37 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 120.876 -0.33 . . . . 0.0 110.191 -178.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.489 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 17.6 ttp85 -74.62 117.19 16.17 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.283 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 36.7 p30 -80.96 168.7 18.41 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.153 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.76 -33.21 55.06 Favored 'General case' 0 C--O 1.235 0.31 0 O-C-N 123.589 0.556 . . . . 0.0 112.118 -178.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -68.64 -17.88 64.18 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.289 0.566 . . . . 0.0 110.549 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 94.61 27.01 12.08 Favored Glycine 0 N--CA 1.446 -0.655 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.382 -179.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.489 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 62.0 t30 -111.09 164.06 13.23 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.547 0.213 . . . . 0.0 111.047 -178.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.406 ' HZ3' ' HA ' ' A' ' 7' ' ' SER . 89.8 m95 -100.36 113.84 26.88 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.534 179.318 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.9 m -116.55 131.03 70.36 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.877 179.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.3 m -74.93 109.22 8.22 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.445 179.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 66.9 m -119.26 146.62 45.09 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.408 -179.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.628 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 49.7 mt-10 -130.78 139.71 50.24 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.899 -179.301 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.486 HD13 HD23 ' A' ' 37' ' ' LEU . 1.4 tm? -132.81 129.12 38.12 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 178.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.451 ' N ' HD11 ' A' ' 35' ' ' LEU . 15.8 m-20 -88.88 108.93 19.81 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.486 HD23 HD13 ' A' ' 35' ' ' LEU . 0.5 OUTLIER -86.72 -9.11 56.66 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.363 -0.381 . . . . 0.0 112.017 -179.56 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -66.16 -14.93 62.64 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -178.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 8.9 t -87.47 0.48 55.48 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.974 0.416 . . . . 0.0 110.609 179.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.534 ' SG ' ' HZ3' ' A' ' 50' ' ' TRP . 1.7 p -140.63 -14.8 0.95 Allowed 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 54.5 mt -111.65 135.98 49.21 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-O 120.733 0.302 . . . . 0.0 110.502 179.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -152.93 158.33 27.84 Favored Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 111.468 -0.653 . . . . 0.0 111.468 179.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.678 ' ND2' ' HB2' ' A' ' 55' ' ' PHE . 3.7 p30 -161.72 52.03 0.37 Allowed Pre-proline 0 C--N 1.327 -0.412 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 179.556 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -78.03 -9.27 16.7 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.298 1.999 . . . . 0.0 111.647 -179.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 35.7 m-80 -99.35 2.04 44.96 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.618 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.458 ' CA ' ' HG2' ' A' ' 83' ' ' ARG . . . 93.33 0.74 67.27 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.402 -0.904 . . . . 0.0 112.093 -179.446 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.459 ' HA ' HE22 ' A' ' 86' ' ' GLN . 65.7 m-85 -125.47 131.37 52.86 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.986 0.422 . . . . 0.0 111.006 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.513 HD21 HG21 ' A' ' 88' ' ' ILE . 9.9 mp -84.58 153.99 22.89 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.479 -179.422 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 168.04 170.6 32.98 Favored Glycine 0 N--CA 1.443 -0.842 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.651 179.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.534 ' HZ3' ' SG ' ' A' ' 40' ' ' CYS . 90.5 m95 -95.86 125.24 40.29 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 149.24 -34.83 1.08 Allowed Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.804 -0.713 . . . . 0.0 112.405 -179.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 12.9 tpt -98.48 174.22 6.56 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 -179.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -128.71 168.97 15.05 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 117.93 0.332 . . . . 0.0 110.97 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 61.31 49.43 5.39 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.438 -0.801 . . . . 0.0 112.455 178.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.678 ' HB2' ' ND2' ' A' ' 43' ' ' ASN . 15.9 p90 -70.08 -25.72 63.66 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.104 179.157 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.476 ' HA ' HD11 ' A' ' 62' ' ' ILE . 10.6 p -60.93 -44.9 96.56 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.262 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 30.5 m80 -79.98 -11.36 59.79 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.999 0.428 . . . . 0.0 110.762 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 20.6 m -101.41 2.33 39.32 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.997 -178.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 62.3 p -144.57 160.82 40.52 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.548 -0.461 . . . . 0.0 111.421 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 59.1 mm-40 -117.23 152.23 35.27 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.966 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 50.22 76.36 0.15 Allowed 'General case' 0 N--CA 1.472 0.644 0 O-C-N 123.994 0.809 . . . . 0.0 111.777 179.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.522 HG22 HD23 ' A' ' 71' ' ' LEU . 83.8 mt -92.61 117.09 35.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.416 -179.334 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 32.1 ttmt -148.94 154.91 40.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.108 -0.497 . . . . 0.0 109.851 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.725 ' HG ' HD23 ' A' ' 12' ' ' LEU . 60.2 mt -83.73 135.95 34.36 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.193 0.52 . . . . 0.0 111.224 -179.616 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -92.17 -66.26 0.94 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.406 -0.815 . . . . 0.0 111.82 -178.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -78.6 40.98 0.39 Allowed 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 120.95 0.405 . . . . 0.0 111.671 -178.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 60.91 17.81 52.06 Favored Glycine 0 C--N 1.32 -0.324 0 CA-C-N 115.653 -0.703 . . . . 0.0 113.113 179.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.458 ' HA2' HD13 ' A' ' 64' ' ' LEU . . . 129.58 -16.06 5.67 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.222 -0.989 . . . . 0.0 112.668 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.466 ' HD2' ' HB2' ' A' ' 4' ' ' ALA . 0.1 OUTLIER -77.5 -19.17 56.26 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.134 0.492 . . . . 0.0 109.783 -179.796 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 65.3 tttt -150.35 144.33 25.43 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.936 -178.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.559 ' HB2' HD12 ' A' ' 90' ' ' LEU . 9.7 tt -112.29 126.66 55.48 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.56 179.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.5 p -114.04 137.71 51.36 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.099 0.476 . . . . 0.0 111.358 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 25.0 p -161.76 175.85 11.53 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.607 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.479 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 44.7 ttt180 -107.91 99.54 30.98 Favored Pre-proline 0 C--N 1.317 -0.833 0 N-CA-C 110.154 -0.313 . . . . 0.0 110.154 179.377 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.556 ' HD2' ' HA ' ' A' ' 85' ' ' ARG . 56.1 Cg_endo -67.06 122.91 10.29 Favored 'Trans proline' 0 CA--C 1.513 -0.564 0 C-N-CA 123.129 2.553 . . . . 0.0 111.332 -179.667 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.676 ' HA ' ' HB2' ' A' ' 83' ' ' ARG . 0.2 OUTLIER -120.13 147.03 45.39 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 120.947 0.403 . . . . 0.0 111.191 -179.85 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.721 HG22 ' O ' ' A' ' 82' ' ' PHE . 10.3 t -74.21 130.22 39.33 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 178.55 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.1 m -72.18 -3.39 3.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 O-C-N 123.629 0.581 . . . . 0.0 111.204 -179.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -70.52 -34.54 72.42 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.789 178.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.409 ' HA3' ' CE1' ' A' ' 82' ' ' PHE . . . -144.51 -24.72 0.13 Allowed Glycine 0 CA--C 1.521 0.441 0 C-N-CA 120.73 -0.747 . . . . 0.0 113.285 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 102.65 14.79 26.48 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 121.022 -0.609 . . . . 0.0 112.277 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.721 ' O ' HG22 ' A' ' 77' ' ' THR . 29.4 p90 -112.85 157.9 20.82 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 118.372 -0.823 . . . . 0.0 110.105 -179.206 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.817 ' HA ' ' HE ' ' A' ' 83' ' ' ARG . 0.0 OUTLIER 163.44 -154.03 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.75 0 O-C-N 123.932 0.77 . . . . 0.0 112.381 178.528 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 47.8 mm-40 -109.14 -173.96 2.39 Favored 'General case' 0 C--O 1.226 -0.161 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.468 -178.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.556 ' HA ' ' HD2' ' A' ' 75' ' ' PRO . 61.5 ttt180 -113.75 156.03 24.56 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 177.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.777 ' HG2' ' H ' ' A' ' 87' ' ' GLY . 6.8 tt0 -169.07 -165.78 0.57 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 120.526 -0.47 . . . . 0.0 111.462 -178.284 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.777 ' H ' ' HG2' ' A' ' 86' ' ' GLN . . . -162.15 154.42 25.38 Favored Glycine 0 N--CA 1.449 -0.434 0 N-CA-C 111.217 -0.753 . . . . 0.0 111.217 179.424 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.513 HG21 HD21 ' A' ' 48' ' ' LEU . 12.8 tt -130.78 137.54 55.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.952 0.376 . . . . 0.0 110.323 -179.558 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.409 ' HB2' ' ND2' ' A' ' 91' ' ' ASN . 1.8 p-10 -76.65 140.58 41.0 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.961 0.41 . . . . 0.0 109.92 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.778 HD11 HD12 ' A' ' 19' ' ' LEU . 55.8 mt -109.44 40.02 1.95 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.347 0.594 . . . . 0.0 110.834 -179.473 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.409 ' ND2' ' HB2' ' A' ' 89' ' ' ASP . 55.4 m-80 -75.45 2.36 11.69 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.806 -179.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 19.6 mtp180 -95.77 -11.25 27.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.015 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.403 ' CD1' HD22 ' A' ' 37' ' ' LEU . 23.1 mm -98.18 100.01 9.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 29.3 tp60 -107.21 145.6 32.42 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.953 -178.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.435 ' OD1' ' HA ' ' A' ' 3' ' ' TYR . 19.4 p-10 -94.78 118.82 32.38 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.54 178.144 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 47.5 t -106.28 107.78 23.52 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 27.8 m-80 59.46 32.51 21.78 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.022 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 97.99 -25.69 26.51 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.571 -0.823 . . . . 0.0 113.239 179.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -87.07 143.28 27.39 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 117.252 0.526 . . . . 0.0 110.603 -178.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.45 HD12 ' SG ' ' A' ' 23' ' ' CYS . 2.7 tp -87.42 124.23 33.2 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.78 0.324 . . . . 0.0 110.845 -179.25 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 21.7 t -131.19 138.15 53.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.419 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -83.14 130.95 35.15 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 177.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 22.0 tt0 . . . . . 0 C--O 1.25 1.119 0 CA-C-O 118.329 -0.844 . . . . 0.0 111.046 -179.076 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 85.5 mtp . . . . . 0 N--CA 1.479 0.999 0 CA-C-O 120.827 0.346 . . . . 0.0 110.439 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.401 ' HG ' ' HA ' ' A' ' 91' ' ' ASN . 13.4 m -118.21 178.44 4.43 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.46 179.135 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.472 ' CZ ' HD11 ' A' ' 19' ' ' LEU . 26.4 p90 -57.95 -38.5 76.12 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.672 0.273 . . . . 0.0 111.296 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.506 ' HA ' ' OG ' ' A' ' 7' ' ' SER . . . -58.97 -19.78 46.33 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -178.088 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -72.56 -17.78 61.68 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.297 0.57 . . . . 0.0 110.347 -179.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 48.8 m -136.74 36.42 2.64 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.333 179.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.506 ' OG ' ' HA ' ' A' ' 4' ' ' ALA . 68.6 p -149.61 171.43 16.67 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.485 179.373 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.483 ' HG2' ' CZ3' ' A' ' 30' ' ' TRP . 1.9 ptp180 -149.98 167.11 27.64 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.948 -179.532 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 53.73 56.05 7.71 Favored 'General case' 0 C--O 1.233 0.192 0 O-C-N 123.867 0.729 . . . . 0.0 111.322 178.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.474 ' HA ' ' HB1' ' A' ' 21' ' ' ALA . . . -88.24 117.32 27.06 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.181 179.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 35.9 m -124.13 170.22 14.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.596 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.828 HD21 ' HG ' ' A' ' 64' ' ' LEU . 3.3 mm? -104.68 114.17 28.21 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.832 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 18.7 p -108.88 166.63 10.67 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.622 -0.263 . . . . 0.0 110.95 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 59.37 48.5 9.94 Favored 'General case' 0 CA--C 1.522 -0.112 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.912 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 86.76 -39.35 3.08 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.953 -0.641 . . . . 0.0 112.35 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 140.01 38.32 0.1 OUTLIER Glycine 0 N--CA 1.445 -0.709 0 N-CA-C 111.305 -0.718 . . . . 0.0 111.305 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 39.2 ptt85 -122.14 -23.37 5.37 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.094 0.473 . . . . 0.0 110.779 -179.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 3.9 m -105.84 134.73 48.5 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.923 -179.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.666 HD12 HD11 ' A' ' 90' ' ' LEU . 81.9 mt -93.67 110.99 22.59 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.404 179.237 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 20.4 ttt180 -108.11 119.35 39.22 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 178.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.474 ' HB1' ' HA ' ' A' ' 10' ' ' ALA . . . -153.66 167.04 30.89 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.982 0.42 . . . . 0.0 111.483 -178.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -90.3 105.0 17.51 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 107.1 -1.445 . . . . 0.0 107.1 178.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.429 ' SG ' HD12 ' A' ' 100' ' ' LEU . 58.6 m -92.34 125.27 36.92 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.557 -178.218 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.418 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 33.8 ttp180 -73.3 117.82 15.51 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.582 179.055 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 35.1 p30 -82.35 167.62 18.35 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.62 -24.26 63.68 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 -178.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -75.08 -16.15 60.58 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.315 0.579 . . . . 0.0 109.727 179.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 93.32 36.32 5.97 Favored Glycine 0 N--CA 1.447 -0.624 0 CA-C-N 115.186 -0.915 . . . . 0.0 111.733 -179.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.418 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 9.2 t-20 -123.48 163.91 19.97 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.606 0.241 . . . . 0.0 110.417 -179.125 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.483 ' CZ3' ' HG2' ' A' ' 8' ' ' ARG . 89.2 m95 -101.16 118.47 37.05 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.381 -179.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.5 m -122.08 130.78 74.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.429 178.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 15.8 m -76.0 110.95 10.88 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.583 -179.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 67.8 m -123.25 154.65 38.52 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.745 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.642 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 50.4 mt-10 -135.02 143.08 46.58 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.055 -179.54 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.525 HD12 ' HB2' ' A' ' 102' ' ' PHE . 2.0 tm? -136.36 129.66 31.64 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 178.457 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.429 ' N ' HD11 ' A' ' 35' ' ' LEU . 15.1 m-20 -88.42 109.18 19.8 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 -179.576 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.478 HD23 HD13 ' A' ' 35' ' ' LEU . 3.8 mt -81.27 -20.01 41.82 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.764 -179.334 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -66.26 -5.33 10.06 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.874 0.369 . . . . 0.0 111.341 -178.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 77.6 p -82.9 -11.57 58.08 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.686 179.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 29.0 t -141.48 -3.86 1.15 Allowed 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 57.7 mt -109.59 135.06 49.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 178.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -146.0 155.63 26.6 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.93 -0.653 . . . . 0.0 111.519 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 23.6 p30 -159.69 45.19 0.19 Allowed Pre-proline 0 CA--C 1.538 0.486 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -179.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -66.66 -23.31 49.3 Favored 'Trans proline' 0 C--N 1.355 0.901 0 C-N-CA 121.793 1.662 . . . . 0.0 111.68 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 73.9 m-20 -83.95 -15.42 47.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.507 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 105.86 6.68 37.19 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.494 -0.86 . . . . 0.0 112.114 -179.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.726 ' HA ' HE22 ' A' ' 86' ' ' GLN . 55.7 m-85 -124.9 132.75 53.26 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.867 0.365 . . . . 0.0 110.171 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.471 HD23 ' SG ' ' A' ' 73' ' ' CYS . 11.0 mp -87.27 138.43 31.49 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.642 -0.708 . . . . 0.0 112.339 -178.173 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -177.37 171.14 43.87 Favored Glycine 0 N--CA 1.439 -1.14 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.611 178.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 91.6 m95 -94.99 125.39 39.63 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 156.11 -58.82 0.37 Allowed Glycine 0 N--CA 1.447 -0.58 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 -179.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 7.3 tpt -84.71 178.47 7.65 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 179.008 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.0 pt20 -137.2 177.7 7.66 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 118.596 0.635 . . . . 0.0 111.726 -179.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 44.9 m-80 62.73 39.68 10.78 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.408 -0.815 . . . . 0.0 112.083 179.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 10.1 p90 -66.26 -32.2 73.47 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 120.478 0.18 . . . . 0.0 111.296 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 42.3 p -61.81 -31.84 72.09 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.057 0.456 . . . . 0.0 111.118 -179.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 38.4 m80 -78.39 -12.0 59.98 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.08 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 43.9 m -119.6 23.63 11.07 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.956 0.408 . . . . 0.0 110.704 179.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 66.2 m -138.4 152.27 48.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.085 0.469 . . . . 0.0 111.09 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 78.6 mt-10 -130.18 136.41 49.23 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.119 179.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 29.7 t70 65.58 82.62 0.18 Allowed 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.329 0.585 . . . . 0.0 110.268 -178.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.489 HG21 HD23 ' A' ' 71' ' ' LEU . 64.2 mt -104.68 121.98 57.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.197 -179.248 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 27.8 tptt -147.33 153.7 40.01 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.828 ' HG ' HD21 ' A' ' 12' ' ' LEU . 73.4 mt -85.89 125.95 33.71 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.962 0.411 . . . . 0.0 110.764 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -78.56 -58.32 3.31 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.593 -178.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -89.02 39.13 0.92 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.94 0.4 . . . . 0.0 111.175 -179.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 61.92 10.9 28.42 Favored Glycine 0 N--CA 1.453 -0.225 0 CA-C-N 115.516 -0.765 . . . . 0.0 113.28 179.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.518 ' HA2' HD11 ' A' ' 64' ' ' LEU . . . 136.66 -14.6 3.89 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.415 -0.898 . . . . 0.0 112.705 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -79.07 -22.15 45.71 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.415 0.626 . . . . 0.0 109.349 -179.669 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.9 ttmp? -144.91 137.43 26.22 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.014 -179.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.55 ' HB2' HD12 ' A' ' 90' ' ' LEU . 10.6 tt -104.69 127.58 52.5 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.571 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.4 p -117.73 131.93 56.54 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.048 0.451 . . . . 0.0 111.405 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.471 ' SG ' HD23 ' A' ' 48' ' ' LEU . 28.4 p -158.2 165.57 34.56 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.569 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 12.0 ttt-85 -106.33 101.65 36.24 Favored Pre-proline 0 C--N 1.316 -0.885 0 C-N-CA 120.173 -0.611 . . . . 0.0 109.941 179.067 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.45 141.37 42.25 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 122.567 2.178 . . . . 0.0 110.417 178.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.628 ' HA ' ' HB2' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -121.66 143.62 49.23 Favored 'General case' 0 C--N 1.318 -0.8 0 O-C-N 123.567 0.542 . . . . 0.0 111.098 179.913 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.656 HG21 ' O ' ' A' ' 82' ' ' PHE . 11.4 t -79.83 143.14 34.64 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 178.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 8.8 p -70.4 -12.36 16.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 O-C-N 124.184 0.927 . . . . 0.0 111.577 -179.04 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 -63.43 -23.14 67.28 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.283 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -173.08 -14.62 0.02 OUTLIER Glycine 0 C--O 1.228 -0.255 0 C-N-CA 120.312 -0.947 . . . . 0.0 113.163 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 98.76 20.97 17.47 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.549 -0.834 . . . . 0.0 111.849 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.656 ' O ' HG21 ' A' ' 77' ' ' THR . 24.9 p90 -110.91 149.5 30.54 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -179.133 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.648 ' CD ' ' HB ' ' A' ' 77' ' ' THR . 0.0 OUTLIER 177.35 -143.15 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.763 -0.375 . . . . 0.0 111.896 -179.768 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -143.91 152.46 41.15 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.051 -178.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.569 ' HA ' ' HA ' ' A' ' 74' ' ' ARG . 31.6 ttt-85 -77.55 154.1 32.7 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 110.206 -0.294 . . . . 0.0 110.206 -179.68 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.726 HE22 ' HA ' ' A' ' 47' ' ' PHE . 8.1 tt0 -161.72 179.68 7.94 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 120.586 0.231 . . . . 0.0 110.587 -179.028 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.595 ' H ' ' HG2' ' A' ' 86' ' ' GLN . . . -145.51 148.56 20.37 Favored Glycine 0 N--CA 1.448 -0.545 0 N-CA-C 111.683 -0.567 . . . . 0.0 111.683 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.413 HG21 HD22 ' A' ' 48' ' ' LEU . 14.8 tt -126.18 137.84 56.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.199 0.523 . . . . 0.0 110.538 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -77.4 128.3 34.02 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.872 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.666 HD11 HD12 ' A' ' 19' ' ' LEU . 44.7 mt -96.7 42.06 1.1 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.613 0.721 . . . . 0.0 110.746 -179.163 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.401 ' HA ' ' HG ' ' A' ' 2' ' ' SER . 11.2 m-80 -78.86 3.2 17.56 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 115.053 -0.976 . . . . 0.0 111.041 -179.696 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 24.7 mtp180 -100.18 -3.98 30.52 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.677 178.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 22.1 mm -104.16 108.99 25.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 -179.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 26.6 tp60 -122.18 141.96 50.91 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.985 -178.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 17.0 p-10 -94.73 119.72 33.8 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.066 178.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 44.2 t -104.82 104.81 17.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.641 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 34.9 m-80 61.0 37.19 18.26 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 121.273 0.559 . . . . 0.0 110.651 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 91.05 -16.64 58.14 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.924 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 7.1 mpt_? -87.1 123.09 31.78 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.429 HD12 ' SG ' ' A' ' 23' ' ' CYS . 9.0 tp -81.6 114.9 20.61 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.684 -0.488 . . . . 0.0 109.684 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 39.5 t -128.7 143.11 42.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 120.933 0.397 . . . . 0.0 111.001 -178.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.525 ' HB2' HD12 ' A' ' 35' ' ' LEU . 6.7 t80 -81.47 136.05 35.64 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 178.36 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 . . . . . 0 C--O 1.245 0.85 0 CA-C-O 118.805 -0.617 . . . . 0.0 110.686 -179.976 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.04 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.58 ' OG ' ' HA ' ' A' ' 91' ' ' ASN . 5.5 m -119.66 -179.88 4.02 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.946 0.403 . . . . 0.0 111.45 -179.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.493 ' HA ' ' OD1' ' A' ' 95' ' ' ASN . 21.0 p90 -59.06 -33.92 71.34 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.857 178.388 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.482 ' HB2' ' HG2' ' A' ' 69' ' ' ARG . . . -56.34 -19.22 13.52 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 -178.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -69.43 -14.53 62.94 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 121.107 0.48 . . . . 0.0 110.808 179.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 14.9 p -149.5 33.7 0.71 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.655 0.741 . . . . 0.0 109.354 178.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 17.4 t -148.47 155.78 41.62 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.256 -0.884 . . . . 0.0 109.394 -179.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 1.5 ptp180 -148.74 170.24 18.63 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.76 -0.2 . . . . 0.0 110.858 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 62.56 44.6 6.79 Favored 'General case' 0 C--O 1.232 0.151 0 O-C-N 124.003 0.814 . . . . 0.0 111.18 178.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.418 ' HA ' ' HB3' ' A' ' 21' ' ' ALA . . . -80.33 126.34 31.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.88 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 35.5 m -126.77 172.62 13.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.552 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -105.94 114.88 29.3 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.68 -179.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 22.6 p -111.15 166.87 10.71 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.951 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.424 ' O ' ' HG2' ' A' ' 17' ' ' ARG . 83.9 m-20 56.83 42.28 26.78 Favored 'General case' 0 N--CA 1.461 0.108 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.604 -179.206 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 87.69 -41.03 3.07 Favored Glycine 0 CA--C 1.517 0.212 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.542 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 146.33 44.29 0.04 OUTLIER Glycine 0 N--CA 1.447 -0.617 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.424 ' HG2' ' O ' ' A' ' 14' ' ' ASN . 6.4 ptm180 -126.24 -26.18 3.4 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.894 0.378 . . . . 0.0 110.93 -179.191 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 3.7 m -107.08 135.97 47.73 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.971 -179.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.776 HD13 HD11 ' A' ' 90' ' ' LEU . 39.7 mt -94.62 115.87 28.08 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.209 178.708 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 78.0 ttt180 -112.98 119.04 36.53 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 178.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.43 ' O ' ' HA ' ' A' ' 32' ' ' THR . . . -154.08 166.78 31.98 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.728 0.299 . . . . 0.0 111.461 -179.139 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -90.99 106.64 18.66 Favored 'General case' 0 CA--C 1.513 -0.458 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 178.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.46 ' SG ' HD12 ' A' ' 100' ' ' LEU . 70.2 m -99.01 135.76 39.94 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 120.76 0.314 . . . . 0.0 110.765 -178.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 15.9 ttp180 -77.66 120.02 22.01 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.791 179.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 36.4 p30 -86.13 168.63 13.85 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.971 -0.291 . . . . 0.0 110.385 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -52.59 -36.28 55.78 Favored 'General case' 0 C--N 1.328 -0.369 0 O-C-N 123.837 0.71 . . . . 0.0 112.02 -179.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -67.45 -17.21 64.61 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.329 0.585 . . . . 0.0 111.041 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 92.6 34.98 6.68 Favored Glycine 0 N--CA 1.448 -0.528 0 N-CA-C 111.304 -0.718 . . . . 0.0 111.304 -179.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -119.77 158.08 27.27 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 110.237 -0.283 . . . . 0.0 110.237 -178.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 77.0 m95 -95.1 116.53 28.83 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.241 179.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.5 m -122.78 129.53 75.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.361 179.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.43 ' HA ' ' O ' ' A' ' 21' ' ' ALA . 21.0 m -74.77 114.5 13.29 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.202 0.525 . . . . 0.0 110.26 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 58.5 m -114.95 149.41 37.34 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.909 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.625 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 26.3 mt-10 -132.65 130.85 40.69 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.881 -178.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.571 HD13 ' HB2' ' A' ' 102' ' ' PHE . 2.1 tm? -132.64 132.83 42.87 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.449 ' N ' HD12 ' A' ' 35' ' ' LEU . 14.6 m-20 -88.96 110.19 20.9 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 -179.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.529 HD13 ' HG ' ' A' ' 19' ' ' LEU . 2.6 mt -81.11 -18.29 47.01 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.095 -179.123 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.45 ' HA ' ' HD1' ' A' ' 55' ' ' PHE . 5.7 p-10 -65.05 -7.22 11.08 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.28 -179.358 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 58.1 p -80.73 -13.04 59.34 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.271 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.405 ' SG ' ' HE3' ' A' ' 50' ' ' TRP . 18.8 t -139.96 -12.9 1.09 Allowed 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 112.138 0.422 . . . . 0.0 112.138 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 54.3 mt -97.55 135.46 31.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 O-C-N 121.814 -0.554 . . . . 0.0 110.057 179.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -142.15 144.64 14.44 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.731 -0.747 . . . . 0.0 111.743 179.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.482 ' OD1' ' HB2' ' A' ' 58' ' ' SER . 27.8 p30 -152.95 48.37 0.43 Allowed Pre-proline 0 CA--C 1.539 0.542 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 -179.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -76.78 -16.46 16.4 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 121.697 1.598 . . . . 0.0 112.339 -178.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -96.19 2.71 53.26 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.921 -179.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.578 ' CA ' ' HG2' ' A' ' 83' ' ' ARG . . . 92.48 5.58 65.02 Favored Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.295 -0.955 . . . . 0.0 112.26 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.455 ' HD1' ' NE2' ' A' ' 86' ' ' GLN . 31.9 m-85 -125.85 134.49 51.62 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.899 0.38 . . . . 0.0 110.497 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.461 HD22 HG21 ' A' ' 88' ' ' ILE . 9.5 mp -85.04 158.51 20.44 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.58 -0.737 . . . . 0.0 111.653 -178.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 159.55 167.26 19.94 Favored Glycine 0 N--CA 1.443 -0.864 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.95 178.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.442 ' CD1' HD12 ' A' ' 88' ' ' ILE . 85.2 m95 -95.33 125.12 39.73 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 166.29 -43.01 0.27 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.87 -179.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 8.4 ttp -107.86 -156.94 0.6 Allowed 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.4 pt20 -146.83 173.92 11.95 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 121.091 -0.244 . . . . 0.0 110.899 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 63.03 45.43 5.28 Favored 'General case' 0 N--CA 1.465 0.285 0 O-C-N 123.663 0.602 . . . . 0.0 112.351 178.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.45 ' HD1' ' HA ' ' A' ' 38' ' ' ASP . 10.1 p90 -71.63 -28.79 64.02 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.978 -0.289 . . . . 0.0 110.76 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.43 ' HA ' HD12 ' A' ' 62' ' ' ILE . 35.0 p -61.39 -37.61 84.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.079 0.466 . . . . 0.0 110.917 -179.333 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 27.2 m80 -81.06 -3.46 51.97 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.106 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.482 ' HB2' ' OD1' ' A' ' 43' ' ' ASN . 12.2 m -119.13 12.68 12.74 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.396 -179.436 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 22.0 p -145.88 155.3 42.79 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 120.995 0.426 . . . . 0.0 111.459 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -116.35 148.05 40.99 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.872 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 28.1 t70 54.0 78.44 0.16 Allowed 'General case' 0 N--CA 1.467 0.401 0 O-C-N 123.921 0.763 . . . . 0.0 111.168 -179.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.517 HG21 HD22 ' A' ' 71' ' ' LEU . 67.0 mt -97.04 117.64 42.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.784 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -148.03 153.78 39.41 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.825 0.345 . . . . 0.0 110.626 -179.159 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.421 HD22 ' HA2' ' A' ' 68' ' ' GLY . 43.0 mt -83.07 133.14 35.08 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.24 0.543 . . . . 0.0 111.041 -179.173 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -86.8 -61.44 1.73 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.68 -178.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.542 ' HB2' ' HB2' ' A' ' 69' ' ' ARG . 19.1 mt-10 -84.71 34.9 0.54 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.806 0.336 . . . . 0.0 111.42 -178.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 65.04 13.15 57.03 Favored Glycine 0 N--CA 1.452 -0.252 0 CA-C-N 115.972 -0.558 . . . . 0.0 113.504 179.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.421 ' HA2' HD22 ' A' ' 64' ' ' LEU . . . 140.26 -24.76 2.66 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.147 -1.025 . . . . 0.0 113.072 179.717 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.542 ' HB2' ' HB2' ' A' ' 66' ' ' GLU . 3.8 mmt85 -74.08 -21.34 59.95 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.967 0.413 . . . . 0.0 110.943 -179.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -146.17 143.05 29.03 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.743 -178.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.574 ' HB2' HD12 ' A' ' 90' ' ' LEU . 10.2 tt -113.19 135.32 53.94 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.013 -0.539 . . . . 0.0 109.617 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 8.9 p -127.16 139.13 53.17 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.018 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 26.4 p -162.54 172.0 16.14 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.269 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.617 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 75.1 ttt180 -108.86 98.87 31.88 Favored Pre-proline 0 C--N 1.321 -0.664 0 C-N-CA 120.562 -0.455 . . . . 0.0 110.349 178.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.502 ' HB2' ' HA2' ' A' ' 46' ' ' GLY . 41.4 Cg_endo -66.74 128.4 18.88 Favored 'Trans proline' 0 N--CA 1.459 -0.5 0 C-N-CA 122.847 2.365 . . . . 0.0 110.828 179.302 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.698 ' HA ' ' HB2' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -120.78 141.57 50.38 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.349 -179.268 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.708 HG21 ' O ' ' A' ' 82' ' ' PHE . 9.5 t -70.86 131.47 43.82 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 178.402 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.7 m -70.55 -6.84 7.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 123.818 0.699 . . . . 0.0 112.069 -178.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -69.29 -33.91 73.9 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.956 0.408 . . . . 0.0 110.313 179.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.428 ' HA3' ' CE1' ' A' ' 82' ' ' PHE . . . -143.98 -25.45 0.14 Allowed Glycine 0 N--CA 1.453 -0.187 0 C-N-CA 120.557 -0.83 . . . . 0.0 112.7 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 100.66 17.62 23.15 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 121.02 -0.609 . . . . 0.0 112.133 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.708 ' O ' HG21 ' A' ' 77' ' ' THR . 24.7 p90 -111.8 153.11 27.05 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 118.763 -0.637 . . . . 0.0 109.878 -178.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.698 ' HB2' ' HA ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 167.04 -154.88 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.582 0 O-C-N 123.697 0.623 . . . . 0.0 111.364 179.4 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -123.44 170.84 9.96 Favored 'General case' 0 C--O 1.223 -0.304 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.265 -178.023 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.617 ' HA ' ' HA ' ' A' ' 74' ' ' ARG . 30.1 ttt85 -96.81 157.97 15.65 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.246 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.455 ' NE2' ' HD1' ' A' ' 47' ' ' PHE . 6.4 tt0 -158.91 179.57 8.96 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.072 0.463 . . . . 0.0 111.58 -179.243 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.451 ' H ' ' HG2' ' A' ' 86' ' ' GLN . . . -144.54 143.82 12.53 Favored Glycine 0 N--CA 1.45 -0.426 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.612 179.22 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.461 HG21 HD22 ' A' ' 48' ' ' LEU . 13.9 tt -130.29 140.85 47.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.825 0.345 . . . . 0.0 110.556 -179.374 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -80.15 137.4 36.7 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.776 HD11 HD13 ' A' ' 19' ' ' LEU . 64.2 mt -104.71 41.28 1.35 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.292 0.568 . . . . 0.0 111.382 -179.285 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.58 ' HA ' ' OG ' ' A' ' 2' ' ' SER . 21.3 m-80 -76.0 3.31 10.55 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.976 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 8.4 mtp180 -96.7 -11.19 25.44 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.562 178.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.42 ' CD1' HD23 ' A' ' 37' ' ' LEU . 21.7 mm -98.38 95.91 4.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 21.6 tp60 -106.15 139.54 40.5 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.201 -177.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.493 ' OD1' ' HA ' ' A' ' 3' ' ' TYR . 16.8 p-10 -94.67 116.35 28.65 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.596 178.314 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.7 p -114.13 123.57 69.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 116.185 -0.461 . . . . 0.0 109.938 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 62.57 20.11 11.75 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.956 -179.156 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 95.84 -9.59 68.36 Favored Glycine 0 N--CA 1.446 -0.657 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.759 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.433 ' O ' ' HA ' ' A' ' 95' ' ' ASN . 0.0 OUTLIER -96.1 144.41 26.38 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-N 117.257 0.529 . . . . 0.0 110.826 -178.944 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.46 HD12 ' SG ' ' A' ' 23' ' ' CYS . 5.3 tp -89.55 116.38 27.66 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.145 -0.48 . . . . 0.0 109.796 -179.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 46.8 t -131.12 141.85 45.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.422 -179.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.571 ' HB2' HD13 ' A' ' 35' ' ' LEU . 22.8 t80 -80.27 128.68 33.82 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 179.153 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.163 -0.922 . . . . 0.0 110.864 -179.347 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.478 0.953 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -117.22 178.87 4.21 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.464 179.058 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.604 ' HA ' ' OD1' ' A' ' 95' ' ' ASN . 8.3 p90 -58.22 -41.41 84.02 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.772 -0.195 . . . . 0.0 111.399 -179.429 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -60.18 -19.37 53.78 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.849 -178.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -68.29 -21.81 64.76 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.146 0.498 . . . . 0.0 110.429 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 51.1 m -138.85 34.88 2.17 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.671 179.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.432 ' HG ' ' C ' ' A' ' 3' ' ' TYR . 92.8 p -149.96 167.67 26.02 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.182 179.258 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 16.0 ptm180 -149.9 169.11 21.9 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.648 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 60.4 52.87 4.52 Favored 'General case' 0 N--CA 1.465 0.296 0 O-C-N 123.646 0.591 . . . . 0.0 110.692 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -90.12 119.96 30.89 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.209 -179.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 35.3 m -122.49 170.71 12.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.165 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.686 HD21 ' HG ' ' A' ' 64' ' ' LEU . 3.4 mm? -104.81 116.29 31.76 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 -179.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.442 ' OG1' ' HB ' ' A' ' 18' ' ' THR . 29.4 p -110.7 167.62 10.09 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.072 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 56.95 55.62 5.99 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.93 179.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 82.24 -37.97 2.58 Favored Glycine 0 N--CA 1.453 -0.206 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.337 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 137.29 36.57 0.17 Allowed Glycine 0 N--CA 1.445 -0.757 0 N-CA-C 111.381 -0.688 . . . . 0.0 111.381 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.457 ' HD2' ' CG ' ' A' ' 38' ' ' ASP . 34.5 ptt85 -120.46 -23.11 6.22 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.93 0.395 . . . . 0.0 110.71 -179.222 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.442 ' HB ' ' OG1' ' A' ' 13' ' ' THR . 4.6 m -103.33 134.7 46.27 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.841 -179.258 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.64 ' O ' ' HA ' ' A' ' 34' ' ' GLU . 68.8 mt -95.26 116.18 28.41 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.395 179.19 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 39.0 ttt-85 -111.01 120.18 41.52 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 178.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -153.58 166.63 32.16 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.845 0.355 . . . . 0.0 111.488 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -89.9 105.68 17.97 Favored 'General case' 0 CA--C 1.512 -0.49 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 178.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.553 ' SG ' HD13 ' A' ' 100' ' ' LEU . 58.7 m -92.72 128.74 38.69 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.134 -177.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.424 ' HB2' ' CZ3' ' A' ' 30' ' ' TRP . 11.0 ttp180 -77.79 116.46 18.33 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.34 179.034 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 35.2 p30 -84.96 170.92 12.56 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -51.29 -31.41 21.28 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -179.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -73.88 -11.58 60.41 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.621 0.724 . . . . 0.0 110.601 -179.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 85.79 25.02 39.64 Favored Glycine 0 N--CA 1.447 -0.633 0 N-CA-C 110.629 -0.988 . . . . 0.0 110.629 -179.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.409 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 8.8 t-20 -104.73 156.12 18.27 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.459 -0.371 . . . . 0.0 110.243 -178.581 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.424 ' CZ3' ' HB2' ' A' ' 24' ' ' ARG . 90.7 m95 -97.6 116.02 29.01 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.775 -179.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.3 m -118.64 128.32 75.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.349 178.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 19.7 m -74.48 109.35 7.89 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.362 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 69.3 m -122.12 147.66 45.86 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.445 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.64 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 50.7 mt-10 -128.79 142.84 50.85 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.012 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.675 HD13 ' HB2' ' A' ' 102' ' ' PHE . 2.1 tm? -135.49 132.45 37.36 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.729 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.46 ' N ' HD12 ' A' ' 35' ' ' LEU . 16.2 m-20 -89.59 110.36 21.23 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.461 HD12 HD22 ' A' ' 90' ' ' LEU . 2.9 mt -82.25 -20.76 36.96 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.68 -178.644 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.457 ' CG ' ' HD2' ' A' ' 17' ' ' ARG . 5.1 p-10 -66.9 -5.2 11.58 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 121.008 -0.277 . . . . 0.0 111.272 -178.501 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 37.5 p -73.52 -28.12 61.72 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.055 0.455 . . . . 0.0 110.261 178.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 17.0 t -126.48 -4.39 6.62 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.909 -179.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 57.8 mt -104.7 134.65 45.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 O-C-N 121.718 -0.613 . . . . 0.0 110.655 179.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -149.98 158.85 27.85 Favored Glycine 0 N--CA 1.449 -0.456 0 N-CA-C 111.463 -0.655 . . . . 0.0 111.463 179.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.658 ' OD1' ' HB2' ' A' ' 55' ' ' PHE . 1.7 p-10 -163.64 56.37 0.54 Allowed Pre-proline 0 CA--C 1.538 0.484 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -66.64 -25.52 46.95 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.134 1.889 . . . . 0.0 112.068 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -96.54 3.94 52.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.03 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.631 ' HA2' ' HB2' ' A' ' 75' ' ' PRO . . . 89.9 11.99 62.76 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.305 -0.95 . . . . 0.0 113.288 179.453 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.485 ' HA ' HE22 ' A' ' 86' ' ' GLN . 27.1 m-85 -118.38 123.48 45.37 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 120.929 0.395 . . . . 0.0 109.987 179.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.525 HD21 ' SG ' ' A' ' 73' ' ' CYS . 8.0 mp -83.56 137.51 33.81 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.734 -178.427 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -179.97 172.62 44.18 Favored Glycine 0 N--CA 1.437 -1.254 0 C-N-CA 120.748 -0.739 . . . . 0.0 111.422 178.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 91.2 m95 -95.05 125.03 39.43 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 165.05 -55.25 0.27 Allowed Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.991 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 5.6 ttt -91.69 -158.07 0.55 Allowed 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.825 0.312 . . . . 0.0 110.226 -179.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -148.57 167.64 24.89 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 120.788 0.328 . . . . 0.0 111.466 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 23.8 m-80 63.6 48.61 3.31 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.303 -0.862 . . . . 0.0 112.82 178.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.658 ' HB2' ' OD1' ' A' ' 43' ' ' ASN . 8.8 p90 -69.73 -27.94 65.38 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.856 0.36 . . . . 0.0 110.423 179.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 21.7 t -61.26 -33.1 72.98 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.156 -179.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 24.3 m80 -78.37 -3.51 43.51 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.918 -179.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 40.0 m -133.94 24.56 3.94 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.956 0.408 . . . . 0.0 110.942 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 22.1 m -139.55 147.75 41.63 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.136 0.493 . . . . 0.0 111.465 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -123.06 151.5 41.91 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.59 179.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.438 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 28.2 t70 54.01 73.81 0.36 Allowed 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.356 0.598 . . . . 0.0 111.245 179.313 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.452 HG23 HD22 ' A' ' 71' ' ' LEU . 56.3 mt -98.48 116.13 40.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.887 -179.595 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.2 tptt -144.45 149.84 36.66 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.258 -179.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.686 ' HG ' HD21 ' A' ' 12' ' ' LEU . 65.0 mt -83.67 130.83 34.97 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 179.417 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 16.2 tp10 -83.13 -58.01 3.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.259 -178.134 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -85.59 23.14 1.43 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.158 0.504 . . . . 0.0 111.21 -179.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 76.49 3.38 77.8 Favored Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 115.487 -0.778 . . . . 0.0 112.963 179.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.447 ' HA2' HD21 ' A' ' 64' ' ' LEU . . . 147.62 -22.5 1.5 Allowed Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.671 -0.776 . . . . 0.0 111.997 -179.684 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 2.8 tpp180 -74.01 -12.53 60.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.267 0.556 . . . . 0.0 110.048 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 48.5 tttp -160.14 142.41 13.13 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.269 -178.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.583 ' HB2' HD13 ' A' ' 90' ' ' LEU . 10.3 tt -112.39 139.02 48.3 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.5 p -127.77 134.83 49.51 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.748 179.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.525 ' SG ' HD21 ' A' ' 48' ' ' LEU . 25.7 p -158.39 175.83 13.22 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.021 0.439 . . . . 0.0 110.259 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.541 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 2.8 tmt_? -110.92 98.79 39.99 Favored Pre-proline 0 C--N 1.316 -0.881 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 178.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.631 ' HB2' ' HA2' ' A' ' 46' ' ' GLY . 61.2 Cg_endo -71.18 124.98 10.96 Favored 'Trans proline' 0 CA--C 1.512 -0.604 0 C-N-CA 123.301 2.667 . . . . 0.0 111.468 179.612 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.641 ' HA ' ' HB2' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -120.63 138.47 53.9 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.942 179.56 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.708 HG22 ' O ' ' A' ' 82' ' ' PHE . 14.8 t -72.62 132.66 44.04 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.364 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.7 p -74.87 -10.0 13.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.84 -179.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -67.44 -29.51 69.0 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.233 179.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.592 ' HA3' ' CE2' ' A' ' 82' ' ' PHE . . . -146.49 -23.33 0.1 Allowed Glycine 0 C--O 1.228 -0.232 0 C-N-CA 120.342 -0.932 . . . . 0.0 113.676 -179.202 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.411 ' HA2' ' CE ' ' A' ' 76' ' ' LYS . . . 97.76 12.11 48.18 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.302 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.708 ' O ' HG22 ' A' ' 77' ' ' THR . 29.6 p90 -111.91 158.64 19.23 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 118.419 -0.8 . . . . 0.0 109.793 -178.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.641 ' HB2' ' HA ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 162.62 -158.94 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.588 0 O-C-N 123.956 0.785 . . . . 0.0 111.731 179.514 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -120.02 -171.09 2.08 Favored 'General case' 0 C--O 1.225 -0.189 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.625 -178.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.594 ' HA ' ' HD2' ' A' ' 75' ' ' PRO . 30.6 ttt180 -109.58 155.6 21.22 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 177.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.485 HE22 ' HA ' ' A' ' 47' ' ' PHE . 9.2 tt0 -169.1 162.06 10.69 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 120.407 -0.517 . . . . 0.0 112.265 -179.085 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -123.74 157.19 18.12 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 121.221 -0.514 . . . . 0.0 112.062 179.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 15.1 tt -131.43 143.82 39.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.027 0.441 . . . . 0.0 110.246 179.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.539 ' OD1' ' HB2' ' A' ' 91' ' ' ASN . 17.3 t70 -82.74 131.89 35.19 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.265 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.64 HD12 HD11 ' A' ' 19' ' ' LEU . 56.1 mt -105.34 34.15 3.37 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 112.943 0.719 . . . . 0.0 112.943 -177.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.539 ' HB2' ' OD1' ' A' ' 89' ' ' ASP . 10.8 m-80 -74.72 3.69 7.53 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 121.096 0.474 . . . . 0.0 111.464 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 32.3 mtp180 -92.86 -11.14 34.3 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.493 178.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 19.9 mm -99.59 106.46 19.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 19.9 tp60 -117.4 140.24 49.83 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.085 0.469 . . . . 0.0 111.269 -178.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.604 ' OD1' ' HA ' ' A' ' 3' ' ' TYR . 16.5 p-10 -95.14 101.28 13.02 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.399 0.619 . . . . 0.0 109.808 177.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.2 p -91.42 114.39 28.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 121.439 0.638 . . . . 0.0 110.424 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 61.24 29.75 18.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.57 -179.61 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 91.08 -10.82 73.96 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.038 -179.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.409 ' HD2' ' N ' ' A' ' 99' ' ' ARG . 9.6 mpt_? -92.11 123.54 35.54 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.684 0.278 . . . . 0.0 110.327 -179.33 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.553 HD13 ' SG ' ' A' ' 23' ' ' CYS . 5.5 tp -78.71 114.56 17.74 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 -179.537 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 53.4 t -132.14 140.98 46.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.189 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.675 ' HB2' HD13 ' A' ' 35' ' ' LEU . 8.3 t80 -83.06 133.75 35.06 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.137 179.327 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 . . . . . 0 C--O 1.248 1.008 0 CA-C-O 118.764 -0.636 . . . . 0.0 109.956 179.994 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.2 mpp? . . . . . 0 N--CA 1.483 1.217 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.67 ' OG ' ' HA ' ' A' ' 91' ' ' ASN . 12.3 m -117.21 179.22 4.1 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.616 -0.265 . . . . 0.0 110.903 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.413 ' CZ ' HD13 ' A' ' 19' ' ' LEU . 22.8 p90 -58.21 -36.92 73.84 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.257 179.652 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -56.68 -21.04 24.76 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -178.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -73.55 -9.74 58.99 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 120.991 0.424 . . . . 0.0 111.006 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 51.0 m -148.07 29.23 0.9 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.317 0.58 . . . . 0.0 109.529 178.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 36.7 m -143.29 164.48 30.1 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.576 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 2.3 ptm180 -148.57 165.97 29.66 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.327 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 57.83 57.29 4.26 Favored 'General case' 0 N--CA 1.462 0.174 0 O-C-N 123.647 0.592 . . . . 0.0 111.46 178.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -88.93 125.91 35.17 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.934 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 23.0 m -129.05 174.19 12.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.4 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.611 HD22 ' HG ' ' A' ' 64' ' ' LEU . 3.5 mm? -106.0 114.42 28.55 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.945 -179.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 28.3 p -111.54 171.24 7.6 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.126 -179.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 56.67 40.27 29.33 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.608 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 90.02 -20.43 36.39 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.677 179.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 121.73 34.92 0.82 Allowed Glycine 0 N--CA 1.443 -0.84 0 C-N-CA 120.926 -0.654 . . . . 0.0 111.727 -179.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 11.9 ptt180 -124.34 -15.41 6.7 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.218 0.533 . . . . 0.0 110.477 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 11.4 m -114.18 138.67 50.15 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.231 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.734 HD11 HD13 ' A' ' 90' ' ' LEU . 56.8 mt -95.17 113.71 25.43 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.93 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.413 ' C ' ' HD2' ' A' ' 20' ' ' ARG . 4.5 tmm_? -107.94 119.46 39.53 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 178.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -153.71 167.23 30.31 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.95 0.405 . . . . 0.0 111.401 -179.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -89.52 105.96 18.14 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 178.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.519 ' SG ' HD12 ' A' ' 100' ' ' LEU . 22.5 m -96.82 133.27 41.63 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.565 -0.288 . . . . 0.0 110.584 -177.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 16.7 ttp180 -76.4 116.63 17.27 Favored 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 179.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 36.1 p30 -81.75 165.01 21.31 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.14 -15.68 15.76 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -177.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -87.49 -6.22 58.47 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.745 0.783 . . . . 0.0 109.974 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 83.41 37.76 11.82 Favored Glycine 0 N--CA 1.448 -0.561 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.677 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -124.5 161.25 26.51 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 110.353 -0.24 . . . . 0.0 110.353 -179.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 72.8 m95 -98.56 120.87 39.72 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.72 179.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.6 m -124.67 134.87 65.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.979 179.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 46.1 m -75.76 109.38 9.31 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.756 179.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 55.4 m -122.83 153.51 39.48 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.755 -179.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.632 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 44.0 mt-10 -135.52 139.17 43.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.117 -179.483 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.678 HD13 ' HB2' ' A' ' 102' ' ' PHE . 2.5 tm? -131.71 131.95 43.5 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 179.049 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.494 ' O ' HG23 ' A' ' 39' ' ' THR . 38.8 m-20 -84.8 110.52 18.87 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.973 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.532 HD12 ' HG ' ' A' ' 19' ' ' LEU . 5.2 mt -81.2 -27.44 35.32 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.663 0.268 . . . . 0.0 111.385 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -65.65 -5.79 9.42 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.292 0.479 . . . . 0.0 112.292 -177.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.494 HG23 ' O ' ' A' ' 36' ' ' ASP . 14.0 t -78.75 -10.15 59.67 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 110.274 -0.269 . . . . 0.0 110.274 178.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 40.2 t -141.53 3.84 1.72 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.463 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 56.9 mt -113.88 132.58 62.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 O-C-N 121.95 -0.468 . . . . 0.0 110.621 179.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -146.47 155.48 26.55 Favored Glycine 0 N--CA 1.447 -0.568 0 N-CA-C 111.408 -0.677 . . . . 0.0 111.408 179.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.431 ' OD1' ' HB2' ' A' ' 55' ' ' PHE . 4.3 p-10 -153.3 45.16 0.27 Allowed Pre-proline 0 CA--C 1.541 0.626 0 N-CA-C 113.515 0.932 . . . . 0.0 113.515 -179.046 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -68.96 -20.38 38.77 Favored 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 121.522 1.481 . . . . 0.0 111.315 -179.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -81.07 -16.46 53.11 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.814 179.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 103.44 6.11 44.87 Favored Glycine 0 N--CA 1.443 -0.835 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.7 -178.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -122.26 135.04 54.68 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.826 0.346 . . . . 0.0 110.389 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 94.2 mt -83.53 130.96 35.02 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.8 -178.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -174.64 172.47 45.44 Favored Glycine 0 N--CA 1.441 -0.98 0 C-N-CA 120.699 -0.762 . . . . 0.0 111.807 179.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.414 ' HH2' HD11 ' A' ' 93' ' ' ILE . 81.5 m95 -94.36 125.93 39.3 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 179.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 170.66 -58.33 0.18 Allowed Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.516 -179.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 11.0 ttp -95.0 -153.12 0.38 Allowed 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -146.54 170.5 16.77 Favored 'General case' 0 C--N 1.33 -0.25 0 O-C-N 122.184 -0.322 . . . . 0.0 111.336 -179.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 62.29 41.84 9.91 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 113.153 0.797 . . . . 0.0 113.153 178.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.431 ' HB2' ' OD1' ' A' ' 43' ' ' ASN . 8.8 p90 -63.23 -26.77 68.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.13 0.49 . . . . 0.0 110.464 179.113 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 32.3 t -62.69 -32.6 73.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.499 -179.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 30.0 m80 -82.61 -4.07 57.13 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.846 0.355 . . . . 0.0 111.084 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 24.1 m -125.36 16.13 8.31 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.484 179.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 65.1 m -137.58 149.17 46.48 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.133 0.492 . . . . 0.0 111.041 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -128.95 158.12 39.7 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.469 179.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.501 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 36.5 t70 57.22 67.69 0.95 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.477 0.656 . . . . 0.0 110.405 179.226 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.511 HG21 HD23 ' A' ' 71' ' ' LEU . 71.6 mt -95.21 114.06 30.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.147 -178.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.8 tptm -145.33 143.91 30.42 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.317 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.611 ' HG ' HD22 ' A' ' 12' ' ' LEU . 79.2 mt -82.3 120.82 25.89 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.803 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -72.71 -56.35 5.41 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.778 -179.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.435 ' HB2' ' HB2' ' A' ' 69' ' ' ARG . 29.4 mt-10 -82.72 4.22 25.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.954 0.407 . . . . 0.0 110.64 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 81.19 13.78 80.19 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.293 -179.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.423 ' HA2' HD11 ' A' ' 64' ' ' LEU . . . 155.34 -31.51 0.64 Allowed Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 119.916 -1.135 . . . . 0.0 113.299 179.377 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.435 ' HB2' ' HB2' ' A' ' 66' ' ' GLU . 7.2 mmt85 -78.11 -33.15 50.72 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.022 0.439 . . . . 0.0 111.647 -179.47 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 28.6 tptt -131.65 135.23 46.75 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.437 -178.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.549 ' HB2' HD11 ' A' ' 90' ' ' LEU . 10.0 tt -110.68 124.5 52.05 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -112.2 128.14 56.15 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 120.972 0.415 . . . . 0.0 111.143 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.501 ' HA ' ' O ' ' A' ' 61' ' ' ASP . 24.5 p -155.0 166.21 34.29 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 179.53 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.518 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 29.3 ttt180 -101.29 100.61 14.0 Favored Pre-proline 0 C--N 1.314 -0.946 0 CA-C-O 120.797 0.332 . . . . 0.0 110.556 179.56 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.482 ' HD2' ' HA ' ' A' ' 85' ' ' ARG . 46.0 Cg_endo -69.7 120.88 7.6 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 122.48 2.12 . . . . 0.0 109.897 178.159 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.607 ' HA ' ' HB2' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -115.7 143.69 45.01 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.008 0.433 . . . . 0.0 110.884 -179.348 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.651 HG23 ' O ' ' A' ' 82' ' ' PHE . 13.1 t -78.49 142.0 37.79 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 179.505 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 28.9 m -70.59 -8.56 11.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 O-C-N 124.046 0.841 . . . . 0.0 112.002 -179.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -59.67 -35.11 73.8 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.046 0.45 . . . . 0.0 110.173 179.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -164.52 -13.08 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.56 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.611 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.504 ' HA2' ' CE ' ' A' ' 76' ' ' LYS . . . 99.73 23.0 11.29 Favored Glycine 0 N--CA 1.442 -0.961 0 C-N-CA 120.484 -0.865 . . . . 0.0 112.064 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.651 ' O ' HG23 ' A' ' 77' ' ' THR . 30.5 p90 -110.47 144.85 38.66 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 -178.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.607 ' HB2' ' HA ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 172.34 -151.82 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 O-C-N 123.645 0.591 . . . . 0.0 110.724 -179.676 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 23.9 mm-40 -122.41 176.56 5.82 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.09 -177.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.518 ' HA ' ' HA ' ' A' ' 74' ' ' ARG . 39.2 ttt-85 -112.74 151.01 30.77 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 177.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -166.52 -172.37 2.16 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.86 0.362 . . . . 0.0 111.472 -179.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -135.22 152.48 20.84 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.462 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 13.4 tt -122.81 149.94 26.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -86.61 124.79 33.29 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.77 0.319 . . . . 0.0 111.104 -179.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.734 HD13 HD11 ' A' ' 19' ' ' LEU . 44.3 mt -97.88 34.43 1.9 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.644 0.735 . . . . 0.0 110.134 179.254 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.67 ' HA ' ' OG ' ' A' ' 2' ' ' SER . 0.9 OUTLIER -75.17 2.03 11.87 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 114.806 -1.088 . . . . 0.0 110.704 -179.726 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 18.8 mtp180 -98.52 1.21 46.37 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.256 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.433 HD11 HD22 ' A' ' 37' ' ' LEU . 22.1 mm -105.65 112.96 41.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.144 0.497 . . . . 0.0 109.885 -179.228 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 5.1 mm-40 -117.69 145.56 44.33 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.996 -178.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -97.41 102.32 14.06 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.548 178.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 46.7 t -92.13 106.56 17.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.835 -178.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 61.08 25.29 15.32 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.161 179.469 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 106.0 -23.4 29.28 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.533 -0.842 . . . . 0.0 112.751 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.12 132.49 34.3 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.902 0.351 . . . . 0.0 110.062 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.519 HD12 ' SG ' ' A' ' 23' ' ' CYS . 7.9 tp -82.54 114.69 21.12 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 -179.474 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 5.5 t -125.93 146.41 31.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 120.937 0.399 . . . . 0.0 111.155 -178.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.678 ' HB2' HD13 ' A' ' 35' ' ' LEU . 18.6 t80 -79.8 138.22 37.18 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 178.314 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 . . . . . 0 C--N 1.316 -0.852 0 CA-C-O 118.81 -0.614 . . . . 0.0 110.427 -179.198 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 mpt? . . . . . 0 N--CA 1.482 1.13 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -103.81 178.41 4.57 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.563 -0.289 . . . . 0.0 111.548 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.502 ' HA ' ' OD1' ' A' ' 95' ' ' ASN . 11.8 p90 -48.73 -36.65 16.81 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -179.348 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -54.9 -19.32 6.37 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 -178.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -57.9 -39.19 77.3 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.237 0.541 . . . . 0.0 110.262 178.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 24.4 m -129.55 39.51 3.72 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.536 -0.757 . . . . 0.0 109.479 179.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 8.6 t -141.27 149.71 41.66 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.864 -179.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 10.6 ptm85 -138.16 158.55 44.08 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.633 -179.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 62.47 52.81 2.86 Favored 'General case' 0 N--CA 1.463 0.207 0 O-C-N 123.914 0.759 . . . . 0.0 111.374 179.035 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.47 ' HA ' ' HB2' ' A' ' 21' ' ' ALA . . . -82.25 117.58 22.46 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.239 179.69 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 36.0 m -124.18 169.17 15.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.05 -179.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.513 HD23 ' HG ' ' A' ' 64' ' ' LEU . 3.1 mm? -104.85 120.5 41.56 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.99 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 23.3 p -114.48 167.12 11.01 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 120.862 0.363 . . . . 0.0 111.277 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 64.03 31.4 13.59 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.402 179.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 92.36 -21.78 36.13 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.855 -0.688 . . . . 0.0 113.106 179.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 129.27 56.22 0.1 Allowed Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.775 -0.726 . . . . 0.0 111.407 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 2.4 ptm180 -143.13 -32.25 0.47 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.983 0.42 . . . . 0.0 111.077 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.8 m -103.11 135.25 45.14 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.952 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.643 HD12 HD11 ' A' ' 90' ' ' LEU . 62.5 mt -94.29 113.13 24.98 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.118 178.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 40.5 ttm180 -109.68 120.43 42.45 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 178.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.47 ' HB2' ' HA ' ' A' ' 10' ' ' ALA . . . -153.38 166.57 32.22 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.852 0.358 . . . . 0.0 111.048 -179.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -90.98 112.14 23.9 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 178.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.477 ' SG ' HD13 ' A' ' 100' ' ' LEU . 65.2 m -101.32 130.49 47.49 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.747 0.308 . . . . 0.0 110.816 -178.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.5 ttt180 -83.77 109.88 17.88 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 35.1 p30 -77.82 167.71 21.09 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.329 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -50.91 -33.07 22.68 Favored 'General case' 0 C--N 1.329 -0.292 0 O-C-N 123.674 0.609 . . . . 0.0 112.356 -179.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -67.24 -16.22 64.16 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.204 0.526 . . . . 0.0 110.825 -179.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 91.24 25.51 23.82 Favored Glycine 0 N--CA 1.446 -0.638 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.671 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -115.1 151.78 33.7 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.617 0.246 . . . . 0.0 111.074 -179.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -92.05 115.01 27.7 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.102 0.477 . . . . 0.0 110.911 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 5.0 m -113.38 132.79 61.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.561 179.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 53.2 m -79.58 110.19 14.68 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.037 0.446 . . . . 0.0 110.542 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 73.6 m -120.95 148.85 43.52 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.815 -179.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.557 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 46.3 mt-10 -130.92 138.55 49.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.832 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.551 HD11 ' HB2' ' A' ' 102' ' ' PHE . 1.9 tm? -132.38 130.2 40.37 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 179.026 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -88.86 109.58 20.33 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.969 0.414 . . . . 0.0 110.332 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.491 HD21 HD12 ' A' ' 35' ' ' LEU . 1.6 mt -84.67 -11.49 55.8 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.742 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -66.76 -6.0 14.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.156 -179.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 72.1 p -88.96 -13.09 39.75 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.018 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.534 ' SG ' ' HZ3' ' A' ' 50' ' ' TRP . 0.8 OUTLIER -136.05 -9.61 2.03 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -178.432 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 51.3 mt -107.16 132.17 55.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 O-C-N 122.241 -0.287 . . . . 0.0 110.455 178.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -151.97 162.01 29.56 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.199 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.643 ' ND2' ' HB2' ' A' ' 55' ' ' PHE . 5.3 p30 -159.4 57.98 1.13 Allowed Pre-proline 0 CA--C 1.535 0.382 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -72.39 -15.36 28.03 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.059 1.839 . . . . 0.0 112.374 -179.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 53.5 m-80 -100.26 -5.12 28.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.953 0.406 . . . . 0.0 110.466 179.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.51 ' CA ' ' HG2' ' A' ' 83' ' ' ARG . . . 98.99 9.48 51.95 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.41 -179.658 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -123.46 133.1 54.09 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.928 0.394 . . . . 0.0 110.852 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 79.0 mt -83.49 139.82 32.68 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.406 -178.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 178.33 172.58 42.88 Favored Glycine 0 N--CA 1.44 -1.095 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.437 179.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.534 ' HZ3' ' SG ' ' A' ' 40' ' ' CYS . 93.0 m95 -94.82 125.03 39.21 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 158.76 -63.94 0.3 Allowed Glycine 0 N--CA 1.45 -0.416 0 N-CA-C 111.588 -0.605 . . . . 0.0 111.588 -179.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 13.1 tpt -78.31 173.82 11.89 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -129.55 172.39 11.62 Favored 'General case' 0 C--N 1.322 -0.599 0 O-C-N 122.159 -0.338 . . . . 0.0 111.399 -179.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 20.9 m-80 61.07 48.81 6.11 Favored 'General case' 0 C--O 1.233 0.187 0 O-C-N 123.982 0.801 . . . . 0.0 111.967 179.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.643 ' HB2' ' ND2' ' A' ' 43' ' ' ASN . 18.8 p90 -67.91 -28.51 67.56 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.628 -179.502 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.1 m -63.47 -28.38 69.93 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.873 0.368 . . . . 0.0 111.125 -179.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 26.4 m80 -79.99 -9.04 59.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.001 0.429 . . . . 0.0 111.013 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 47.5 p -125.58 15.31 8.18 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.064 0.459 . . . . 0.0 110.659 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 68.2 m -133.61 150.5 51.6 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.302 0.572 . . . . 0.0 111.052 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 57.2 mt-10 -125.68 142.3 51.58 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.412 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.414 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 21.4 t70 60.01 78.41 0.27 Allowed 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 121.402 0.62 . . . . 0.0 110.367 -179.708 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.52 HG23 HD21 ' A' ' 71' ' ' LEU . 73.2 mt -101.73 115.47 43.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.36 -178.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 36.6 ttmt -148.96 156.99 43.08 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 179.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.513 ' HG ' HD23 ' A' ' 12' ' ' LEU . 42.5 mt -83.2 135.93 34.6 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.161 0.505 . . . . 0.0 110.947 -179.448 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 18.7 tp10 -90.23 -57.29 2.9 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.934 -178.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.476 ' HB2' ' HB2' ' A' ' 69' ' ' ARG . 20.5 mm-40 -84.15 24.11 0.98 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.158 0.504 . . . . 0.0 111.1 -179.336 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 68.24 16.72 69.36 Favored Glycine 0 N--CA 1.45 -0.39 0 CA-C-N 115.429 -0.805 . . . . 0.0 112.435 179.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.4 ' HA2' HD12 ' A' ' 64' ' ' LEU . . . 141.24 -28.12 2.37 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.013 -1.089 . . . . 0.0 112.806 179.556 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.476 ' HB2' ' HB2' ' A' ' 66' ' ' GLU . 12.6 mmt180 -73.07 -25.34 60.87 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.057 0.456 . . . . 0.0 110.582 -179.407 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -146.48 142.72 28.37 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.888 -178.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.588 ' HB2' HD12 ' A' ' 90' ' ' LEU . 8.9 tt -111.63 131.75 55.05 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.738 -0.468 . . . . 0.0 109.738 179.574 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.3 p -115.26 130.57 56.95 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.233 0.54 . . . . 0.0 111.066 179.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.414 ' HA ' ' O ' ' A' ' 61' ' ' ASP . 26.7 p -153.28 165.15 36.62 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.333 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.444 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 3.3 tmt_? -102.12 99.35 12.25 Favored Pre-proline 0 C--N 1.314 -0.958 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.418 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.55 ' HD2' ' HA ' ' A' ' 85' ' ' ARG . 61.7 Cg_endo -70.09 123.14 9.71 Favored 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 122.801 2.334 . . . . 0.0 111.443 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.669 ' HA ' ' HB2' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -119.67 144.21 47.31 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.76 -179.793 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.683 HG22 ' O ' ' A' ' 82' ' ' PHE . 14.6 t -76.92 140.78 40.63 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.547 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 8.9 p -73.8 -9.44 12.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.452 -0.794 . . . . 0.0 111.288 -179.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -64.2 -23.12 67.2 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.054 0.454 . . . . 0.0 110.872 179.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -166.26 -21.84 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.51 -0.852 . . . . 0.0 112.908 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.51 ' HA2' ' CE ' ' A' ' 76' ' ' LYS . . . 101.75 20.87 11.99 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.773 -0.727 . . . . 0.0 111.893 -179.544 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.683 ' O ' HG22 ' A' ' 77' ' ' THR . 22.2 p90 -111.15 147.7 34.35 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 119.031 -0.509 . . . . 0.0 109.766 -178.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.669 ' HB2' ' HA ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 169.26 -154.94 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.361 0 O-C-N 123.592 0.558 . . . . 0.0 111.315 179.716 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -117.62 -175.76 2.89 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.368 -178.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.55 ' HA ' ' HD2' ' A' ' 75' ' ' PRO . 31.6 ttt180 -110.59 155.68 22.01 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 177.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.518 ' HG2' ' H ' ' A' ' 87' ' ' GLY . 9.2 tt0 -165.17 176.69 8.25 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 120.512 -0.475 . . . . 0.0 111.712 -178.178 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.518 ' H ' ' HG2' ' A' ' 86' ' ' GLN . . . -137.91 140.83 11.54 Favored Glycine 0 N--CA 1.449 -0.466 0 N-CA-C 111.42 -0.672 . . . . 0.0 111.42 178.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 11.4 tt -118.44 133.84 63.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.371 0.605 . . . . 0.0 110.707 -179.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.468 ' OD1' ' HB2' ' A' ' 91' ' ' ASN . 14.5 t70 -74.79 136.48 41.66 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.809 -179.614 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.643 HD11 HD12 ' A' ' 19' ' ' LEU . 64.2 mt -110.77 37.34 2.81 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 -178.28 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.468 ' HB2' ' OD1' ' A' ' 89' ' ' ASP . 6.4 m-80 -73.92 -1.87 21.49 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-O 121.194 0.521 . . . . 0.0 111.037 179.373 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 21.0 mtp180 -88.11 -10.88 48.65 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.174 179.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.437 ' CD1' HD23 ' A' ' 37' ' ' LEU . 22.7 mm -99.15 98.59 7.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -179.383 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 1.2 mm-40 -107.68 152.21 24.62 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.743 -178.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.502 ' OD1' ' HA ' ' A' ' 3' ' ' TYR . 19.4 p-10 -106.82 105.54 15.63 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.106 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.2 p -98.42 113.85 34.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-O 121.286 0.565 . . . . 0.0 110.177 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 59.44 30.22 19.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.814 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 92.97 -13.54 67.41 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 121.005 -0.617 . . . . 0.0 113.276 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? -92.25 131.03 37.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 117.405 0.603 . . . . 0.0 110.257 -179.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.477 HD13 ' SG ' ' A' ' 23' ' ' CYS . 3.2 tp -84.16 115.54 22.46 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.08 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 46.5 t -129.98 142.66 43.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.333 -179.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.551 ' HB2' HD11 ' A' ' 35' ' ' LEU . 5.5 t80 -84.2 122.81 29.37 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.236 0.541 . . . . 0.0 110.089 178.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 . . . . . 0 C--N 1.312 -1.034 0 CA-C-O 118.193 -0.908 . . . . 0.0 110.408 179.737 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 mpt? . . . . . 0 N--CA 1.48 1.042 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.488 ' OG ' ' HA ' ' A' ' 91' ' ' ASN . 19.5 m -117.23 169.75 9.22 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 121.065 -0.254 . . . . 0.0 111.128 179.715 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.525 ' HA ' ' OD1' ' A' ' 95' ' ' ASN . 28.6 p90 -55.51 -34.09 64.33 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.724 179.742 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -54.46 -18.74 4.59 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -178.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -57.34 -41.71 80.53 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.151 0.501 . . . . 0.0 110.426 179.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 50.0 m -130.48 35.66 4.02 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.093 179.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 15.0 m -143.18 156.33 44.74 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.12 179.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.425 HH11 ' HD2' ' A' ' 8' ' ' ARG . 10.8 ptm85 -144.35 167.95 21.25 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.751 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 57.24 59.76 3.23 Favored 'General case' 0 C--O 1.235 0.337 0 O-C-N 123.736 0.648 . . . . 0.0 111.715 179.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.431 ' HA ' ' HB2' ' A' ' 21' ' ' ALA . . . -89.88 117.53 28.78 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.192 179.606 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 31.9 m -120.53 173.11 6.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.748 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.517 HD22 ' HG ' ' A' ' 64' ' ' LEU . 3.6 mm? -104.64 114.99 29.57 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.765 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.401 ' OG1' ' HB ' ' A' ' 18' ' ' THR . 21.0 p -108.53 164.65 12.16 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.479 179.786 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 62.16 43.67 8.45 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.412 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 87.73 -46.19 3.43 Favored Glycine 0 N--CA 1.449 -0.448 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.745 179.06 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 150.55 57.77 0.01 OUTLIER Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 110.404 -1.078 . . . . 0.0 110.404 -179.135 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 7.9 ptm180 -142.91 -30.37 0.53 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.947 0.403 . . . . 0.0 111.086 -179.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.401 ' HB ' ' OG1' ' A' ' 13' ' ' THR . 3.0 m -103.92 137.95 41.18 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.189 -178.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.714 HD11 HD11 ' A' ' 90' ' ' LEU . 58.3 mt -98.17 115.86 29.19 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.171 178.585 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 45.3 ttp180 -112.67 123.0 49.31 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 178.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.431 ' HB2' ' HA ' ' A' ' 10' ' ' ALA . . . -151.77 167.2 28.98 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.928 0.394 . . . . 0.0 111.408 -179.307 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -90.08 105.98 18.18 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 178.058 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 80.2 m -99.3 127.18 45.28 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.636 -178.557 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 9.4 ttp180 -77.42 115.09 16.9 Favored 'General case' 0 N--CA 1.436 -1.144 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.887 179.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 36.7 p30 -76.54 165.72 24.4 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.22 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.07 -27.75 54.83 Favored 'General case' 0 N--CA 1.464 0.235 0 O-C-N 123.61 0.569 . . . . 0.0 111.993 -179.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -69.26 -19.39 63.93 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.296 0.57 . . . . 0.0 110.327 179.433 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 96.11 30.25 7.98 Favored Glycine 0 N--CA 1.449 -0.488 0 CA-C-N 115.536 -0.756 . . . . 0.0 112.244 179.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -124.91 150.43 46.54 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.514 0.157 . . . . 0.0 110.773 -179.095 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 94.1 m95 -84.88 123.1 30.09 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.755 0.312 . . . . 0.0 111.391 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.0 m -124.77 134.72 66.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 121.089 0.471 . . . . 0.0 110.593 178.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 16.2 m -79.5 116.33 19.65 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.816 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 72.4 m -126.73 159.53 33.45 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.372 179.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.612 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 46.3 mt-10 -139.1 145.9 40.06 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-O 120.867 0.365 . . . . 0.0 111.444 -178.778 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.577 HD13 ' HB2' ' A' ' 102' ' ' PHE . 1.5 tm? -138.81 132.29 30.36 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.054 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.476 ' N ' HD12 ' A' ' 35' ' ' LEU . 27.3 m-20 -90.98 110.59 21.85 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.025 0.441 . . . . 0.0 110.391 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.444 HD11 HD11 ' A' ' 19' ' ' LEU . 1.5 mt -86.1 -16.66 37.31 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.572 -179.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.443 ' HA ' ' HD1' ' A' ' 55' ' ' PHE . 4.4 p-10 -63.65 -20.39 65.65 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -178.021 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 12.3 t -83.23 0.62 44.65 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.121 0.486 . . . . 0.0 110.87 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 57.6 m -136.32 -26.44 1.13 Allowed 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -179.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 61.7 mt -94.49 137.21 23.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 110.204 -0.295 . . . . 0.0 110.204 179.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.432 ' HA3' ' CB ' ' A' ' 52' ' ' MET . . . -153.72 156.2 26.64 Favored Glycine 0 N--CA 1.443 -0.885 0 C-N-CA 120.685 -0.769 . . . . 0.0 111.617 179.401 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.59 ' ND2' ' HB2' ' A' ' 55' ' ' PHE . 6.3 p30 -154.24 50.68 0.57 Allowed Pre-proline 0 C--N 1.326 -0.446 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.26 -18.93 39.12 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 121.712 1.608 . . . . 0.0 111.868 -179.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.437 ' N ' HD21 ' A' ' 45' ' ' ASN . 0.9 OUTLIER -90.77 -5.74 55.28 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.316 179.614 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.534 ' HA3' ' HG2' ' A' ' 83' ' ' ARG . . . 95.95 8.57 57.92 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.407 -179.485 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.403 ' HD1' HE22 ' A' ' 86' ' ' GLN . 51.7 m-85 -125.28 135.89 52.97 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.764 0.316 . . . . 0.0 110.314 179.795 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 72.7 mt -83.29 137.24 34.07 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.325 -178.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 179.11 171.74 42.61 Favored Glycine 0 N--CA 1.445 -0.717 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.832 179.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 83.4 m95 -95.35 125.46 39.99 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 161.24 -47.81 0.37 Allowed Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.309 -179.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.432 ' CB ' ' HA3' ' A' ' 42' ' ' GLY . 0.0 OUTLIER -90.41 -161.28 0.78 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.643 0.259 . . . . 0.0 110.836 -179.188 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -146.82 168.98 20.07 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.685 -0.234 . . . . 0.0 110.444 -179.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 18.7 m-80 56.77 45.74 21.2 Favored 'General case' 0 N--CA 1.465 0.32 0 O-C-N 123.796 0.685 . . . . 0.0 112.253 178.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.59 ' HB2' ' ND2' ' A' ' 43' ' ' ASN . 7.5 p90 -65.65 -28.64 69.25 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.902 -0.319 . . . . 0.0 110.793 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.534 ' HA ' HD12 ' A' ' 62' ' ' ILE . 13.8 m -58.13 -37.12 74.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.534 -179.62 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 17.8 m80 -73.18 -17.83 61.32 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.042 0.448 . . . . 0.0 111.446 179.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 47.9 m -112.89 14.9 19.86 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.497 -178.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 54.5 m -136.1 148.44 48.26 Favored 'General case' 0 C--N 1.32 -0.684 0 O-C-N 121.749 -0.595 . . . . 0.0 111.641 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 60.9 mm-40 -117.58 145.62 44.16 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.825 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 55.87 58.83 4.14 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 123.925 0.765 . . . . 0.0 111.687 178.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.534 HD12 ' HA ' ' A' ' 56' ' ' SER . 81.5 mt -75.95 113.6 15.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.512 179.767 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.41 ' HD2' HD21 ' A' ' 12' ' ' LEU . 15.2 tptm -147.74 154.84 41.05 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 -179.692 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.524 HD13 ' HA2' ' A' ' 68' ' ' GLY . 67.2 mt -82.41 138.9 34.3 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.314 0.578 . . . . 0.0 111.233 -179.161 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -89.17 -75.27 0.44 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 114.697 -1.138 . . . . 0.0 111.129 -178.492 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.584 ' HB2' ' HB2' ' A' ' 69' ' ' ARG . 19.7 mt-10 -77.87 45.53 0.52 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.754 -178.317 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 65.39 2.46 10.17 Favored Glycine 0 CA--C 1.518 0.255 0 CA-C-N 115.837 -0.619 . . . . 0.0 113.671 179.254 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.524 ' HA2' HD13 ' A' ' 64' ' ' LEU . . . 141.63 -13.81 2.69 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.081 -1.056 . . . . 0.0 112.985 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.584 ' HB2' ' HB2' ' A' ' 66' ' ' GLU . 14.3 mmt180 -78.27 -19.48 53.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.261 0.553 . . . . 0.0 109.825 179.746 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 40.7 tttt -144.46 143.54 30.93 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.596 -178.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.542 ' HB2' HD12 ' A' ' 90' ' ' LEU . 10.1 tt -110.5 132.81 53.86 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.753 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.9 p -121.0 132.42 54.89 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.03 0.443 . . . . 0.0 111.586 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 24.7 p -161.19 167.36 26.25 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.208 179.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 25.0 ttt180 -100.4 102.83 20.05 Favored Pre-proline 0 C--N 1.316 -0.85 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.343 179.012 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.425 ' HD2' ' HA ' ' A' ' 85' ' ' ARG . 39.0 Cg_endo -67.06 121.01 8.13 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 122.539 2.159 . . . . 0.0 110.58 178.649 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.603 ' HA ' ' HB2' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -119.25 146.58 45.1 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.764 -179.354 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.664 ' HB ' ' HD2' ' A' ' 83' ' ' ARG . 5.6 t -79.67 144.94 33.27 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 179.527 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.2 p -72.03 -9.47 12.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.436 -177.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -58.63 -29.37 66.45 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.224 0.535 . . . . 0.0 110.231 179.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -169.81 -24.62 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.304 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.869 -179.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 111.98 26.05 4.54 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.848 -0.692 . . . . 0.0 111.718 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.552 ' O ' HG22 ' A' ' 77' ' ' THR . 20.3 p90 -110.3 141.09 43.78 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 -178.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.664 ' HD2' ' HB ' ' A' ' 77' ' ' THR . 0.0 OUTLIER 174.13 -149.48 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 O-C-N 123.654 0.596 . . . . 0.0 110.027 -179.791 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -121.55 176.15 5.84 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 122.271 0.228 . . . . 0.0 110.982 -178.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.425 ' HA ' ' HD2' ' A' ' 75' ' ' PRO . 42.0 ttt-85 -98.35 156.81 16.55 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 178.075 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.403 HE22 ' HD1' ' A' ' 47' ' ' PHE . 9.2 tt0 -166.55 173.09 10.11 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 120.927 0.394 . . . . 0.0 111.524 -178.713 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.403 ' N ' ' HG2' ' A' ' 86' ' ' GLN . . . -135.8 144.42 16.23 Favored Glycine 0 N--CA 1.45 -0.388 0 N-CA-C 111.626 -0.589 . . . . 0.0 111.626 178.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 12.2 tt -121.57 134.67 64.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.093 0.473 . . . . 0.0 110.793 -179.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -77.73 136.76 38.2 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.113 -179.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.714 HD11 HD11 ' A' ' 19' ' ' LEU . 68.6 mt -108.38 56.48 0.63 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.735 0.778 . . . . 0.0 111.219 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.488 ' HA ' ' OG ' ' A' ' 2' ' ' SER . 19.7 m-80 -91.09 3.19 55.42 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.686 179.478 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 36.9 mtp180 -96.77 -6.69 35.63 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.846 179.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 16.4 mm -105.47 101.64 12.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -179.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 27.8 tp60 -113.95 145.09 42.01 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.022 -178.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.525 ' OD1' ' HA ' ' A' ' 3' ' ' TYR . 19.2 p-10 -95.44 115.7 27.79 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.157 178.817 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 57.8 t -106.24 110.78 32.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.04 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 30.7 m-80 58.48 28.8 17.45 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.995 -179.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 100.2 -23.55 35.48 Favored Glycine 0 N--CA 1.445 -0.748 0 C-N-CA 120.522 -0.847 . . . . 0.0 113.157 179.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.41 ' N ' ' HD2' ' A' ' 99' ' ' ARG . 3.3 mpt_? -86.95 138.18 31.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 117.242 0.521 . . . . 0.0 110.195 -179.367 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.449 HD21 ' HB2' ' A' ' 35' ' ' LEU . 4.9 tp -86.21 123.57 31.63 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 14.6 t -128.21 143.78 39.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.93 -179.027 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.577 ' HB2' HD13 ' A' ' 35' ' ' LEU . 9.9 t80 -92.66 128.3 38.47 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.161 0.505 . . . . 0.0 109.788 178.161 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 . . . . . 0 C--O 1.25 1.091 0 CA-C-O 118.181 -0.914 . . . . 0.0 110.651 179.742 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.7 mtt . . . . . 0 N--CA 1.481 1.12 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.463 ' HG ' ' HA ' ' A' ' 91' ' ' ASN . 19.9 m -116.99 167.13 11.41 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.781 178.75 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.431 ' CZ ' HD11 ' A' ' 19' ' ' LEU . 13.4 p90 -48.43 -37.53 17.38 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.42 ' HB1' ' HD2' ' A' ' 69' ' ' ARG . . . -53.18 -19.1 2.71 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -178.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -56.63 -42.62 79.16 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 121.335 0.588 . . . . 0.0 110.149 178.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 18.5 m -129.78 40.47 3.57 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.481 179.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 18.5 t -146.67 150.44 35.43 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.186 -179.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 9.3 ptp180 -136.87 175.29 9.74 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.279 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.581 HD22 ' HB2' ' A' ' 22' ' ' GLU . 8.9 p30 47.06 46.86 16.17 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 124.254 0.971 . . . . 0.0 112.107 -179.38 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.537 ' HA ' ' HB3' ' A' ' 21' ' ' ALA . . . -74.01 118.44 16.96 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.619 179.59 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 27.4 m -122.14 168.28 14.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.842 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.751 HD23 ' HG ' ' A' ' 64' ' ' LEU . 3.3 mm? -104.75 123.02 46.92 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.634 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.481 HG23 ' CZ ' ' A' ' 20' ' ' ARG . 20.6 p -123.19 168.71 12.07 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.811 0.338 . . . . 0.0 111.81 -178.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 59.94 42.75 15.7 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.003 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 92.17 -23.02 29.05 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.812 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.486 ' O ' HG22 ' A' ' 62' ' ' ILE . . . 122.32 41.23 0.48 Allowed Glycine 0 N--CA 1.445 -0.736 0 N-CA-C 111.39 -0.684 . . . . 0.0 111.39 179.837 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.632 ' HB2' ' HB2' ' A' ' 38' ' ' ASP . 15.9 ptt180 -126.14 -26.27 3.42 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.109 0.481 . . . . 0.0 110.582 -179.338 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.409 ' HB ' ' OG1' ' A' ' 13' ' ' THR . 2.8 m -101.11 130.32 47.14 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.48 -179.245 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.632 HD12 HD13 ' A' ' 90' ' ' LEU . 92.9 mt -91.23 112.22 24.04 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.01 179.529 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.481 ' CZ ' HG23 ' A' ' 13' ' ' THR . 43.9 ttm180 -109.07 119.39 39.42 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 179.375 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.537 ' HB3' ' HA ' ' A' ' 10' ' ' ALA . . . -154.79 167.38 30.41 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.818 0.342 . . . . 0.0 111.293 -179.434 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.581 ' HB2' HD22 ' A' ' 9' ' ' ASN . 0.4 OUTLIER -88.54 111.74 22.2 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 177.427 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 69.4 m -99.65 126.97 45.75 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 -179.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.446 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 34.3 ttt180 -76.1 114.07 14.35 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 116.3 -0.409 . . . . 0.0 109.936 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 35.1 p30 -77.95 170.23 16.95 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.372 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.75 -29.18 62.29 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 -178.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -73.98 -13.09 60.82 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.468 0.651 . . . . 0.0 110.253 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 91.21 27.89 16.84 Favored Glycine 0 N--CA 1.448 -0.54 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.629 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.446 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 10.7 t-20 -111.53 158.54 19.06 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 110.14 -0.319 . . . . 0.0 110.14 -178.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 98.9 m95 -99.57 119.43 38.04 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.953 0.406 . . . . 0.0 110.765 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 11.1 m -122.25 137.53 55.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.252 -179.461 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 16.8 m -75.92 109.57 9.65 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.105 179.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 69.3 m -122.43 137.13 54.97 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.41 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.599 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 3.0 mp0 -122.55 146.73 47.15 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.514 -179.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.452 ' HB2' HD23 ' A' ' 100' ' ' LEU . 1.2 tm? -138.53 126.83 22.97 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 178.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.413 ' N ' HD13 ' A' ' 35' ' ' LEU . 4.4 m-20 -85.95 110.07 19.2 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.868 0.366 . . . . 0.0 110.475 179.547 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.407 HD13 HD21 ' A' ' 90' ' ' LEU . 2.1 mt -83.91 -12.57 55.24 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.034 178.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.683 ' OD2' ' HA ' ' A' ' 54' ' ' ASN . 9.6 t70 -60.94 -29.23 69.51 Favored 'General case' 0 C--O 1.221 -0.426 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.89 -178.607 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.6 t -83.48 1.02 43.79 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.827 0.346 . . . . 0.0 111.459 -178.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 37.3 m -128.97 -24.68 2.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.829 0.347 . . . . 0.0 111.775 -179.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 71.9 mt -102.8 137.05 32.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.549 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -143.84 146.92 17.96 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.68 -0.771 . . . . 0.0 111.835 179.177 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.535 HD21 ' CB ' ' A' ' 75' ' ' PRO . 30.5 p-10 -152.44 48.86 0.48 Allowed Pre-proline 0 CA--C 1.539 0.557 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -178.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -71.79 -22.12 24.11 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 121.661 1.574 . . . . 0.0 111.747 -179.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -83.97 -14.54 50.53 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.885 179.173 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.535 ' CA ' ' HG2' ' A' ' 83' ' ' ARG . . . 106.26 8.62 33.14 Favored Glycine 0 N--CA 1.443 -0.874 0 C-N-CA 120.315 -0.945 . . . . 0.0 112.596 -179.149 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.531 ' HA ' HE22 ' A' ' 86' ' ' GLN . 66.5 m-85 -124.08 133.29 53.66 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.676 0.274 . . . . 0.0 110.282 179.476 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 95.3 mt -83.54 130.24 35.0 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.513 -178.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -173.5 172.65 45.36 Favored Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.097 179.029 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 88.3 m95 -95.03 125.1 39.47 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 168.64 -59.18 0.2 Allowed Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.493 -0.861 . . . . 0.0 112.602 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 6.1 ttp -96.75 -154.66 0.45 Allowed 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -146.79 173.75 12.1 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.43 0.157 . . . . 0.0 111.013 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.683 ' HA ' ' OD2' ' A' ' 38' ' ' ASP . 42.7 m-80 64.92 55.37 1.18 Allowed 'General case' 0 C--O 1.237 0.416 0 O-C-N 123.858 0.724 . . . . 0.0 111.52 179.523 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.476 ' CD1' ' HA ' ' A' ' 38' ' ' ASP . 11.8 p90 -87.46 -26.17 23.38 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.16 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 32.4 p -61.0 -35.89 78.04 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.998 0.428 . . . . 0.0 111.105 -178.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 26.7 m80 -77.49 -11.94 59.91 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.192 179.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.47 ' HB2' ' OD1' ' A' ' 43' ' ' ASN . 2.7 m -113.41 20.25 16.25 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.053 0.454 . . . . 0.0 110.353 -179.624 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 24.8 m -136.1 156.0 49.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.09 0.471 . . . . 0.0 111.46 -179.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -129.2 138.31 51.64 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.282 178.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.414 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 32.2 t70 58.22 79.31 0.21 Allowed 'General case' 0 N--CA 1.469 0.49 0 O-C-N 123.735 0.647 . . . . 0.0 110.721 -179.291 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.513 HG21 HD22 ' A' ' 71' ' ' LEU . 68.0 mt -98.74 112.74 31.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.548 -179.566 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.28 164.94 26.59 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.307 -179.057 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.751 ' HG ' HD23 ' A' ' 12' ' ' LEU . 55.9 mt -96.05 114.84 26.58 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 178.481 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -65.95 -54.34 27.58 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.12 -177.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 43.1 mm-40 -88.36 7.84 30.5 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.112 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 73.23 21.09 80.01 Favored Glycine 0 N--CA 1.447 -0.623 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.678 -179.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 156.53 -49.84 0.45 Allowed Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 120.131 -1.033 . . . . 0.0 112.946 179.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.42 ' HD2' ' HB1' ' A' ' 4' ' ' ALA . 5.1 mpt_? -66.31 -26.66 67.41 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -179.365 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 32.0 ttpt -141.91 144.62 33.88 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.651 -0.419 . . . . 0.0 111.677 -178.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.548 ' HB2' HD11 ' A' ' 90' ' ' LEU . 8.7 tt -115.45 124.08 50.24 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.305 -0.861 . . . . 0.0 108.983 179.286 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.415 HG23 ' HA3' ' A' ' 87' ' ' GLY . 1.1 p -115.8 133.4 56.07 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.375 0.607 . . . . 0.0 111.114 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.414 ' HA ' ' O ' ' A' ' 61' ' ' ASP . 26.3 p -156.2 172.32 18.66 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.336 -0.847 . . . . 0.0 108.868 -179.773 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.472 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 4.4 tmt_? -104.23 98.57 14.37 Favored Pre-proline 0 C--N 1.316 -0.861 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 179.283 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.535 ' CB ' HD21 ' A' ' 43' ' ' ASN . 54.9 Cg_endo -69.35 123.82 10.62 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 122.902 2.401 . . . . 0.0 110.653 179.026 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.651 ' HA ' ' HB2' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -120.91 149.41 42.67 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.619 -179.077 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.701 HG21 ' O ' ' A' ' 82' ' ' PHE . 13.2 t -79.59 134.5 36.47 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 177.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 31.3 m -72.44 -7.85 10.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 O-C-N 123.706 0.629 . . . . 0.0 111.402 -179.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -66.98 -33.63 75.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.533 179.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -150.0 -20.34 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.364 -0.922 . . . . 0.0 113.162 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.461 ' HA2' ' CE ' ' A' ' 76' ' ' LYS . . . 98.01 18.04 28.21 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.579 -0.82 . . . . 0.0 111.685 -179.712 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.701 ' O ' HG21 ' A' ' 77' ' ' THR . 32.0 p90 -111.55 153.18 26.62 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 118.872 -0.585 . . . . 0.0 109.891 -178.785 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.651 ' HB2' ' HA ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 167.84 -150.4 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.405 0 O-C-N 123.679 0.612 . . . . 0.0 111.442 179.502 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -127.58 154.92 44.62 Favored 'General case' 0 C--O 1.226 -0.142 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.7 -178.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.472 ' HA ' ' HA ' ' A' ' 74' ' ' ARG . 35.8 ttt180 -84.32 146.83 27.52 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 178.335 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.531 HE22 ' HA ' ' A' ' 47' ' ' PHE . 36.8 mt-30 -151.49 -170.17 3.58 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.619 0.723 . . . . 0.0 112.091 -177.702 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.415 ' HA3' HG23 ' A' ' 72' ' ' THR . . . -155.05 142.99 9.43 Favored Glycine 0 N--CA 1.442 -0.904 0 N-CA-C 110.23 -1.148 . . . . 0.0 110.23 178.645 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 13.0 tt -122.75 134.83 64.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.257 0.551 . . . . 0.0 110.734 -178.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -74.37 130.9 40.53 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.625 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.632 HD13 HD12 ' A' ' 19' ' ' LEU . 61.4 mt -102.04 46.55 0.93 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.676 0.751 . . . . 0.0 110.848 -179.746 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.463 ' HA ' ' HG ' ' A' ' 2' ' ' SER . 13.6 m-80 -81.3 4.63 19.91 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.317 179.665 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 19.1 mtp180 -100.54 -6.64 25.1 Favored 'General case' 0 C--O 1.226 -0.179 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.7 178.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 23.5 mm -106.15 108.03 24.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 -178.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 20.9 tp60 -125.98 145.93 50.08 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.783 -178.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 13.9 p-10 -95.08 115.31 27.27 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.331 0.586 . . . . 0.0 110.023 178.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 52.0 t -101.78 112.82 36.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.128 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 13.6 m-80 57.84 33.5 23.28 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.091 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 94.55 -23.87 30.33 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.837 179.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.24 124.89 33.81 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.945 0.372 . . . . 0.0 110.031 -179.486 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.452 HD23 ' HB2' ' A' ' 35' ' ' LEU . 11.8 tp -76.31 119.38 20.12 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 38.8 t -129.9 141.73 45.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.002 0.43 . . . . 0.0 111.154 -178.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.409 ' HB2' HD11 ' A' ' 35' ' ' LEU . 6.5 t80 -83.79 132.34 34.83 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 177.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 3.7 tp-100 . . . . . 0 C--N 1.314 -0.953 0 CA-C-O 118.745 -0.645 . . . . 0.0 110.231 179.946 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.1 mtt . . . . . 0 N--CA 1.483 1.19 0 CA-C-O 120.941 0.4 . . . . 0.0 110.295 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.59 ' OG ' ' HA ' ' A' ' 91' ' ' ASN . 8.7 m -120.67 -179.29 3.95 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.287 -179.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.428 ' CZ ' HD13 ' A' ' 19' ' ' LEU . 14.9 p90 -63.28 -34.46 77.73 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.667 0.27 . . . . 0.0 110.69 178.705 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -56.32 -24.26 42.42 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.806 -0.633 . . . . 0.0 112.597 -178.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -65.78 -16.51 63.86 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 121.205 0.526 . . . . 0.0 110.835 179.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 62.0 m -140.19 29.63 2.02 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.585 178.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 19.3 m -146.06 156.51 43.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.496 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 11.7 ptp180 -143.09 166.24 25.19 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.657 179.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 67.4 m-80 58.9 54.42 5.11 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.117 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.467 ' HA ' ' O ' ' A' ' 20' ' ' ARG . . . -88.65 118.47 28.34 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.311 179.555 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 27.3 m -118.93 171.58 6.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.193 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.536 HD22 ' HG ' ' A' ' 64' ' ' LEU . 3.3 mm? -104.99 115.0 29.54 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.147 -179.496 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.485 ' OG1' ' HB ' ' A' ' 18' ' ' THR . 21.9 p -110.06 167.73 9.96 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.931 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 57.97 53.27 6.97 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.948 -179.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 81.68 -35.36 2.48 Favored Glycine 0 CA--C 1.519 0.322 0 CA-C-N 116.035 -0.529 . . . . 0.0 112.686 179.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 136.75 49.22 0.07 OUTLIER Glycine 0 N--CA 1.447 -0.598 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 -179.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.47 ' HD2' ' CG ' ' A' ' 38' ' ' ASP . 15.7 ptt180 -133.91 -27.65 1.44 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.885 0.374 . . . . 0.0 111.317 -179.415 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.485 ' HB ' ' OG1' ' A' ' 13' ' ' THR . 3.9 m -99.04 135.73 40.03 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.794 -178.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.752 HD11 HD12 ' A' ' 90' ' ' LEU . 61.6 mt -94.3 114.65 26.76 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.628 179.337 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.467 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 1.6 tmt_? -110.47 120.51 42.66 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 178.589 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -153.2 167.23 30.01 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.835 0.35 . . . . 0.0 111.63 -179.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -90.73 105.63 17.95 Favored 'General case' 0 CA--C 1.512 -0.49 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 177.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.449 ' SG ' HD11 ' A' ' 100' ' ' LEU . 83.7 m -92.61 122.8 35.39 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 120.88 0.372 . . . . 0.0 110.963 -178.474 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.494 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 37.3 ttp180 -71.12 110.95 6.1 Favored 'General case' 0 N--CA 1.435 -1.208 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.64 178.609 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 37.4 p30 -76.84 167.19 22.26 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.12 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.42 -31.45 45.21 Favored 'General case' 0 C--N 1.329 -0.324 0 O-C-N 123.672 0.607 . . . . 0.0 112.289 -178.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -70.9 -17.64 62.7 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.306 0.574 . . . . 0.0 110.773 -179.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 95.08 28.39 9.98 Favored Glycine 0 CA--C 1.51 -0.243 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.551 -179.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.494 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 13.9 t-20 -113.08 164.03 13.99 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 -178.738 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.448 ' CZ3' ' HB2' ' A' ' 24' ' ' ARG . 96.6 m95 -105.21 116.82 32.59 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.77 0.319 . . . . 0.0 110.8 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.5 m -118.56 138.03 50.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.737 179.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 13.3 m -80.33 114.79 19.49 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.154 -179.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 75.5 m -126.13 147.6 49.58 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.244 179.268 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.655 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 50.9 mt-10 -131.7 141.39 49.55 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.887 -179.497 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.514 ' HB2' HD22 ' A' ' 100' ' ' LEU . 1.3 tm? -137.53 127.41 25.62 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.288 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.401 ' N ' HD12 ' A' ' 35' ' ' LEU . 18.6 m-20 -81.54 109.72 16.25 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.284 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.516 HD12 ' HG ' ' A' ' 19' ' ' LEU . 4.1 mt -82.01 -23.07 36.16 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 121.086 -0.246 . . . . 0.0 111.59 -178.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.47 ' CG ' ' HD2' ' A' ' 17' ' ' ARG . 6.5 p-10 -66.44 -6.16 13.61 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.796 0.332 . . . . 0.0 111.475 -178.421 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 55.7 p -76.55 -21.77 55.23 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.249 0.547 . . . . 0.0 109.727 178.361 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.456 ' SG ' ' HE3' ' A' ' 50' ' ' TRP . 29.0 t -128.79 -14.61 4.51 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.656 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 54.0 mt -99.42 133.98 40.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 O-C-N 122.149 -0.344 . . . . 0.0 110.136 178.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -152.28 165.33 30.81 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 121.011 -0.614 . . . . 0.0 111.857 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.712 ' ND2' ' HB2' ' A' ' 55' ' ' PHE . 5.3 p30 -163.86 54.35 0.4 Allowed Pre-proline 0 CA--C 1.537 0.442 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -179.503 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -73.13 -22.74 18.92 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 121.753 1.635 . . . . 0.0 111.241 179.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -85.07 -17.11 38.41 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.311 179.02 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.592 ' CA ' ' HG2' ' A' ' 83' ' ' ARG . . . 105.66 13.65 23.52 Favored Glycine 0 N--CA 1.441 -0.977 0 CA-C-N 115.459 -0.791 . . . . 0.0 113.152 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -125.3 134.2 52.35 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.831 0.348 . . . . 0.0 110.431 179.095 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 88.7 mt -82.79 129.85 35.05 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.107 -178.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -176.85 175.87 47.79 Favored Glycine 0 N--CA 1.442 -0.958 0 C-N-CA 120.663 -0.78 . . . . 0.0 111.873 179.241 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.456 ' HE3' ' SG ' ' A' ' 40' ' ' CYS . 88.1 m95 -96.22 125.45 40.75 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 159.88 -62.16 0.3 Allowed Glycine 0 N--CA 1.45 -0.373 0 N-CA-C 111.443 -0.663 . . . . 0.0 111.443 -179.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 42.4 tpp -80.67 173.82 12.22 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 179.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -129.44 166.85 18.78 Favored 'General case' 0 C--N 1.323 -0.558 0 O-C-N 122.147 -0.346 . . . . 0.0 111.629 -179.199 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 67.53 47.36 1.23 Allowed 'General case' 0 N--CA 1.463 0.212 0 O-C-N 124.175 0.922 . . . . 0.0 112.276 179.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.712 ' HB2' ' ND2' ' A' ' 43' ' ' ASN . 3.9 p90 -70.44 -26.19 63.54 Favored 'General case' 0 C--O 1.222 -0.343 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.589 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 32.9 t -60.34 -38.3 83.37 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.93 0.395 . . . . 0.0 110.834 -179.116 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 26.2 m80 -80.86 -2.81 48.92 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.57 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 49.8 m -124.91 16.28 8.59 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.648 0.261 . . . . 0.0 111.572 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 69.7 m -131.67 149.42 52.49 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.459 0.647 . . . . 0.0 111.981 -179.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -120.3 139.68 52.38 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.913 -1.04 . . . . 0.0 109.295 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.482 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 28.4 t70 61.34 72.07 0.53 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.482 0.658 . . . . 0.0 110.546 179.343 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.514 HG21 HD21 ' A' ' 71' ' ' LEU . 65.6 mt -96.3 113.48 30.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.242 -179.694 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 17.3 ttmt -150.33 149.99 30.86 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.859 0.361 . . . . 0.0 110.834 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.561 HD13 ' HA2' ' A' ' 68' ' ' GLY . 33.7 mt -88.67 136.83 32.8 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.849 -179.411 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.433 ' C ' ' H ' ' A' ' 67' ' ' GLY . 30.1 mt-10 -91.23 -67.08 0.87 Allowed 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.09 0.471 . . . . 0.0 110.988 179.436 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -74.88 42.29 0.17 Allowed 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 115.395 -0.82 . . . . 0.0 112.07 -178.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.433 ' H ' ' C ' ' A' ' 65' ' ' GLU . . . 60.9 13.92 35.56 Favored Glycine 0 C--N 1.314 -0.662 0 CA-C-N 115.249 -0.887 . . . . 0.0 113.426 179.091 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.561 ' HA2' HD13 ' A' ' 64' ' ' LEU . . . 130.92 -13.82 5.51 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.103 -1.046 . . . . 0.0 113.197 179.587 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 2.3 ttp85 -78.17 -20.04 52.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.343 0.592 . . . . 0.0 109.869 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -140.26 140.88 35.85 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.432 -179.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.549 ' HB2' HD13 ' A' ' 90' ' ' LEU . 10.3 tt -118.54 132.1 56.22 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.989 -0.551 . . . . 0.0 109.927 -179.414 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -118.19 129.91 55.78 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.634 178.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.482 ' HA ' ' O ' ' A' ' 61' ' ' ASP . 28.8 p -157.84 163.55 37.87 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.475 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.565 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 33.4 ttt180 -99.76 104.16 26.36 Favored Pre-proline 0 C--N 1.316 -0.886 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.32 179.488 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.566 ' HD2' ' HA ' ' A' ' 85' ' ' ARG . 43.5 Cg_endo -67.82 115.66 3.88 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 122.449 2.1 . . . . 0.0 109.802 178.202 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.645 ' HA ' ' HB2' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -119.3 140.33 50.47 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.65 -179.661 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.67 HG21 ' O ' ' A' ' 82' ' ' PHE . 15.3 t -75.85 130.14 38.09 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 17.3 m -72.59 -6.24 7.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.309 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -67.45 -34.01 76.31 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.845 179.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.581 ' HA3' ' CE2' ' A' ' 82' ' ' PHE . . . -143.26 -20.58 0.21 Allowed Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.902 179.769 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.498 ' HA2' ' CE ' ' A' ' 76' ' ' LYS . . . 95.23 12.54 54.51 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.363 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.67 ' O ' HG21 ' A' ' 77' ' ' THR . 21.3 p90 -111.96 157.68 20.4 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 118.83 -0.605 . . . . 0.0 110.64 -178.49 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.645 ' HB2' ' HA ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 165.54 -152.49 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.633 0 O-C-N 124.107 0.879 . . . . 0.0 111.862 178.238 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -132.6 151.3 51.98 Favored 'General case' 0 C--O 1.225 -0.192 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.189 -178.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.566 ' HA ' ' HD2' ' A' ' 75' ' ' PRO . 45.3 ttt-85 -85.95 151.48 23.71 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.547 0.213 . . . . 0.0 110.62 -179.39 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -154.05 -172.9 4.37 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.296 -178.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -141.54 144.47 14.46 Favored Glycine 0 N--CA 1.451 -0.34 0 N-CA-C 111.091 -0.804 . . . . 0.0 111.091 179.127 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 9.2 tt -131.77 137.53 54.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 120.935 0.398 . . . . 0.0 110.896 -179.144 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -82.03 136.88 35.18 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.269 179.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.752 HD12 HD11 ' A' ' 19' ' ' LEU . 50.8 mt -101.05 45.03 0.98 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.598 0.713 . . . . 0.0 110.587 -179.311 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.59 ' HA ' ' OG ' ' A' ' 2' ' ' SER . 0.9 OUTLIER -74.87 -0.94 20.16 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.931 -179.354 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 11.0 mtp180 -94.98 -11.98 27.53 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.809 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 23.5 mm -101.64 112.57 35.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 -179.268 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -129.1 162.21 28.24 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.589 0.709 . . . . 0.0 112.093 -178.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.481 ' HA ' ' O ' ' A' ' 99' ' ' ARG . 19.8 p-10 -106.94 124.55 49.78 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.728 -1.123 . . . . 0.0 110.308 179.144 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 46.1 t -106.69 104.02 16.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 33.9 m-80 59.78 19.39 8.21 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.71 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 119.44 -25.95 7.52 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.607 -0.806 . . . . 0.0 113.52 178.294 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.481 ' O ' ' HA ' ' A' ' 95' ' ' ASN . 1.9 ptm180 -86.76 144.7 26.95 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 117.092 0.446 . . . . 0.0 110.393 -179.267 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.514 HD22 ' HB2' ' A' ' 35' ' ' LEU . 6.9 tp -93.43 119.71 32.84 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 23.9 t -129.34 139.31 52.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.736 -178.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.414 ' HB2' HD13 ' A' ' 35' ' ' LEU . 13.7 t80 -82.98 130.68 35.17 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.873 -0.418 . . . . 0.0 109.873 178.508 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 . . . . . 0 C--N 1.316 -0.887 0 CA-C-O 118.37 -0.824 . . . . 0.0 110.117 179.63 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.3 mtt . . . . . 0 N--CA 1.479 0.975 0 CA-C-O 120.807 0.337 . . . . 0.0 110.494 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.514 ' HG ' ' HA ' ' A' ' 91' ' ' ASN . 13.2 m -118.24 168.89 10.18 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.13 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.443 ' CG ' HD13 ' A' ' 100' ' ' LEU . 18.9 p90 -57.6 -38.13 74.4 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.104 -0.498 . . . . 0.0 112.095 179.782 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.548 ' HB3' ' CG ' ' A' ' 69' ' ' ARG . . . -53.85 -18.72 3.55 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 -177.699 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -63.98 -30.41 71.49 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.381 0.61 . . . . 0.0 109.764 179.076 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 18.8 m -131.84 28.97 4.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.924 179.255 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.402 ' HA ' ' HZ3' ' A' ' 30' ' ' TRP . 13.6 m -143.33 155.98 44.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.921 -179.81 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.405 HH11 ' HD2' ' A' ' 8' ' ' ARG . 12.7 ptm180 -145.84 169.9 17.64 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 110.436 -0.209 . . . . 0.0 110.436 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 63.02 53.42 2.34 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 123.715 0.634 . . . . 0.0 110.803 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.474 ' HA ' ' HB1' ' A' ' 21' ' ' ALA . . . -92.06 119.86 32.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.201 -179.614 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 34.4 m -123.13 170.42 13.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.209 179.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.613 HD23 ' HG ' ' A' ' 64' ' ' LEU . 3.3 mm? -105.51 115.33 30.07 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.1 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.433 ' OG1' ' HB ' ' A' ' 18' ' ' THR . 21.8 p -112.26 171.23 7.64 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.35 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 58.9 45.88 14.57 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.486 179.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 88.56 -30.77 5.15 Favored Glycine 0 N--CA 1.451 -0.358 0 CA-C-N 115.892 -0.595 . . . . 0.0 112.366 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 131.31 53.72 0.09 OUTLIER Glycine 0 N--CA 1.445 -0.731 0 N-CA-C 111.059 -0.817 . . . . 0.0 111.059 -179.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.439 ' HD2' ' OD1' ' A' ' 38' ' ' ASP . 14.6 ptt180 -141.46 -29.28 0.64 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.864 0.364 . . . . 0.0 111.579 -179.712 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.433 ' HB ' ' OG1' ' A' ' 13' ' ' THR . 3.7 m -95.92 132.62 41.02 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.417 -179.631 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.704 HD11 HD12 ' A' ' 90' ' ' LEU . 87.5 mt -93.76 114.33 26.59 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.08 179.533 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 56.0 ttp180 -112.1 119.78 39.58 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 178.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.474 ' HB1' ' HA ' ' A' ' 10' ' ' ALA . . . -154.15 167.47 29.76 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.209 -179.317 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -89.89 108.94 20.01 Favored 'General case' 0 CA--C 1.513 -0.466 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 177.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.546 ' SG ' HD12 ' A' ' 100' ' ' LEU . 18.7 m -96.23 128.36 43.08 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.252 -178.641 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.492 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 25.0 ttp180 -72.87 116.73 13.72 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 179.411 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 36.3 p30 -84.16 171.58 12.7 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.052 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.44 -28.88 47.19 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 112.654 0.612 . . . . 0.0 112.654 -178.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -75.56 -10.59 59.58 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.394 0.616 . . . . 0.0 110.368 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 86.03 28.15 29.27 Favored Glycine 0 N--CA 1.447 -0.629 0 N-CA-C 110.916 -0.874 . . . . 0.0 110.916 -179.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.492 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 3.3 t-20 -110.31 160.35 16.63 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.572 0.225 . . . . 0.0 110.92 -178.479 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.402 ' HZ3' ' HA ' ' A' ' 7' ' ' SER . 84.1 m95 -99.98 112.9 25.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.074 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.1 m -115.79 131.88 66.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.365 178.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 21.6 m -77.46 109.02 11.04 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.943 0.401 . . . . 0.0 110.747 -179.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 70.3 m -118.29 151.69 37.21 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.726 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.604 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 45.1 mt-10 -128.89 144.5 51.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.817 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.61 HD11 ' HB2' ' A' ' 102' ' ' PHE . 1.4 tm? -138.86 128.84 25.19 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 178.472 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.402 ' N ' HD13 ' A' ' 35' ' ' LEU . 10.9 m-20 -90.31 109.85 20.94 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.479 -179.161 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.483 HD22 HD12 ' A' ' 35' ' ' LEU . 0.8 OUTLIER -87.21 -14.34 41.38 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -179.652 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.439 ' OD1' ' HD2' ' A' ' 17' ' ' ARG . 0.9 OUTLIER -64.64 -17.18 63.8 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -177.698 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.417 HG23 ' SG ' ' A' ' 40' ' ' CYS . 9.3 t -85.02 -2.63 58.19 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.894 0.378 . . . . 0.0 110.486 179.622 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.417 ' SG ' HG23 ' A' ' 39' ' ' THR . 35.8 m -132.28 -14.12 3.01 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.698 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 57.2 mt -116.41 134.89 58.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 CA-C-O 120.745 0.307 . . . . 0.0 110.402 179.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -153.16 164.64 30.99 Favored Glycine 0 N--CA 1.446 -0.635 0 N-CA-C 111.026 -0.83 . . . . 0.0 111.026 179.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.451 ' OD1' ' HB2' ' A' ' 55' ' ' PHE . 2.3 p-10 -157.14 52.44 0.6 Allowed Pre-proline 0 CA--C 1.537 0.468 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -179.586 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -69.4 -19.77 37.42 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 121.708 1.605 . . . . 0.0 111.899 -179.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -89.78 -2.84 58.33 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.463 179.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.531 ' CA ' ' HG2' ' A' ' 83' ' ' ARG . . . 95.32 4.86 60.82 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.477 -0.868 . . . . 0.0 112.699 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 52.6 m-85 -126.19 137.44 53.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.69 0.245 . . . . 0.0 110.648 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.449 HD23 HG21 ' A' ' 88' ' ' ILE . 5.5 mp -82.67 149.47 27.34 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.403 -179.313 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 171.4 171.98 37.07 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.396 178.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.47 ' CD1' HD13 ' A' ' 88' ' ' ILE . 91.8 m95 -95.62 133.8 39.26 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 138.65 -39.77 1.53 Allowed Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.879 -0.677 . . . . 0.0 111.636 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 4.4 tpt -94.03 -172.01 2.72 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -146.13 169.96 17.67 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.178 -0.609 . . . . 0.0 111.955 -179.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 45.5 m-80 62.41 42.71 8.7 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.062 -0.972 . . . . 0.0 112.39 179.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.451 ' HB2' ' OD1' ' A' ' 43' ' ' ASN . 20.9 p90 -63.34 -32.65 74.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.06 0.457 . . . . 0.0 110.302 179.337 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.475 ' HA ' HD11 ' A' ' 62' ' ' ILE . 8.8 m -64.05 -35.52 81.01 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.464 -179.399 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 27.3 m80 -79.15 -5.03 53.22 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.84 0.353 . . . . 0.0 111.173 -179.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 6.2 p -128.0 20.49 6.42 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.544 -179.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 66.9 m -135.8 152.41 51.06 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 121.26 0.552 . . . . 0.0 112.239 -179.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 -114.05 149.4 35.51 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.052 179.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 15.7 t70 47.25 72.51 0.24 Allowed 'General case' 0 N--CA 1.469 0.513 0 O-C-N 124.15 0.906 . . . . 0.0 111.526 179.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.514 HG23 HD21 ' A' ' 71' ' ' LEU . 73.1 mt -90.56 117.68 34.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.19 -179.595 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -149.12 164.62 34.17 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.074 179.452 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.613 ' HG ' HD23 ' A' ' 12' ' ' LEU . 62.7 mt -91.07 136.42 33.09 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.085 0.469 . . . . 0.0 110.954 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -92.76 -66.1 0.95 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.841 -178.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -81.65 46.1 0.94 Allowed 'General case' 0 CA--C 1.514 -0.424 0 CA-C-O 120.985 0.421 . . . . 0.0 111.709 -178.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 57.77 22.46 47.3 Favored Glycine 0 C--N 1.317 -0.525 0 CA-C-N 115.174 -0.921 . . . . 0.0 113.189 179.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.541 ' HA2' HD11 ' A' ' 64' ' ' LEU . . . 121.53 -12.59 9.5 Favored Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 120.225 -0.988 . . . . 0.0 113.575 179.616 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.548 ' CG ' ' HB3' ' A' ' 4' ' ' ALA . 17.9 mtm105 -92.68 1.9 57.02 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 117.806 0.803 . . . . 0.0 110.899 -179.498 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 17.8 tttp -157.65 133.22 9.09 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 -179.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.534 ' HB2' HD13 ' A' ' 90' ' ' LEU . 10.5 tt -109.35 129.14 55.54 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -179.803 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.519 HG21 ' HA3' ' A' ' 87' ' ' GLY . 2.4 p -121.07 131.22 54.14 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.355 0.597 . . . . 0.0 111.575 -179.476 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.408 ' SG ' HD21 ' A' ' 48' ' ' LEU . 25.0 p -158.03 174.26 15.5 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.786 -179.494 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.538 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 57.1 ttt180 -106.72 100.11 29.2 Favored Pre-proline 0 C--N 1.319 -0.735 0 C-N-CA 121.084 -0.246 . . . . 0.0 110.449 178.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.435 ' HD2' ' HA ' ' A' ' 85' ' ' ARG . 19.6 Cg_endo -65.39 126.12 15.68 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.493 2.129 . . . . 0.0 110.471 178.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.628 ' HA ' ' HB2' ' A' ' 83' ' ' ARG . 0.1 OUTLIER -120.26 145.01 47.47 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.987 0.423 . . . . 0.0 111.561 -179.806 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.634 HG22 ' O ' ' A' ' 82' ' ' PHE . 15.1 t -74.31 142.25 45.2 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.095 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.6 p -72.74 -12.05 15.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.525 -178.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -64.24 -28.52 69.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.558 179.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -161.24 -16.5 0.03 OUTLIER Glycine 0 CA--C 1.518 0.246 0 C-N-CA 120.065 -1.064 . . . . 0.0 113.496 -179.338 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.43 20.7 21.8 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.761 -0.733 . . . . 0.0 111.787 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.634 ' O ' HG22 ' A' ' 77' ' ' THR . 26.7 p90 -112.17 150.68 30.47 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 119.373 -0.346 . . . . 0.0 110.186 -179.202 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.628 ' HB2' ' HA ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 167.13 -152.86 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.302 0 O-C-N 123.953 0.783 . . . . 0.0 109.482 179.247 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 48.8 mm-40 -117.05 175.78 5.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.453 0.168 . . . . 0.0 111.427 -177.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.538 ' HA ' ' HA ' ' A' ' 74' ' ' ARG . 23.6 ttt180 -111.89 149.73 31.43 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 178.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -168.35 -161.9 0.38 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.642 -178.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.519 ' HA3' HG21 ' A' ' 72' ' ' THR . . . -153.25 161.74 29.84 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.785 179.742 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.47 HD13 ' CD1' ' A' ' 50' ' ' TRP . 13.9 tt -130.82 139.92 49.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 179.645 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -82.21 138.24 34.71 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.047 0.451 . . . . 0.0 110.812 -179.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.704 HD12 HD11 ' A' ' 19' ' ' LEU . 56.5 mt -104.94 50.32 0.79 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.618 0.723 . . . . 0.0 111.26 -178.655 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.514 ' HA ' ' HG ' ' A' ' 2' ' ' SER . 34.5 m-80 -82.96 3.34 30.41 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.324 179.027 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 40.3 mtp180 -98.85 -2.71 37.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.58 179.034 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 21.7 mm -110.4 96.26 4.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 24.9 tp60 -112.04 148.33 34.09 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.489 -178.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.441 ' OD1' ' HA ' ' A' ' 3' ' ' TYR . 17.7 p-10 -94.36 119.72 33.52 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.862 179.015 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.9 p -114.59 119.37 61.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.689 179.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 59.18 27.22 16.16 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.802 -179.486 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 92.43 -8.48 77.16 Favored Glycine 0 N--CA 1.447 -0.628 0 CA-C-N 115.971 -0.559 . . . . 0.0 113.155 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.21 135.08 43.27 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 117.409 0.604 . . . . 0.0 110.932 -179.154 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.546 HD12 ' SG ' ' A' ' 23' ' ' CYS . 3.9 tp -80.74 118.77 22.57 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.689 179.495 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 47.0 t -132.57 138.07 52.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 120.926 0.393 . . . . 0.0 110.79 -179.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.61 ' HB2' HD11 ' A' ' 35' ' ' LEU . 12.1 t80 -80.93 129.3 34.46 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 178.348 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 . . . . . 0 C--N 1.313 -0.993 0 CA-C-O 118.309 -0.853 . . . . 0.0 110.185 -179.604 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.179 0 CA-C-O 121.082 0.468 . . . . 0.0 110.994 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.552 ' OG ' ' HA ' ' A' ' 91' ' ' ASN . 3.8 m -119.1 171.54 8.2 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.17 179.141 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.42 ' HA ' ' OD1' ' A' ' 95' ' ' ASN . 21.4 p90 -59.54 -39.55 84.32 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.786 0.327 . . . . 0.0 110.915 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -56.24 -19.77 15.41 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 -178.328 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -69.69 -22.88 63.38 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.087 0.47 . . . . 0.0 110.35 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 24.0 m -138.36 35.6 2.28 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.456 0.646 . . . . 0.0 109.259 178.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.431 ' HA ' ' HZ3' ' A' ' 30' ' ' TRP . 9.0 t -138.18 161.03 37.87 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.477 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 25.0 ptt180 -149.49 165.58 31.73 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.496 -179.266 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 54.66 52.97 11.28 Favored 'General case' 0 C--N 1.331 -0.208 0 O-C-N 123.855 0.722 . . . . 0.0 111.704 178.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.407 ' HA ' ' HB2' ' A' ' 21' ' ' ALA . . . -86.51 117.83 25.54 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.095 179.61 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 34.5 m -118.22 169.08 9.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.328 -179.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.718 HD23 ' HG ' ' A' ' 64' ' ' LEU . 3.2 mm? -105.95 114.61 28.85 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.649 -179.115 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.423 ' OG1' ' HB ' ' A' ' 18' ' ' THR . 24.0 p -110.55 163.39 13.77 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.003 -179.733 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 62.7 27.76 16.26 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.043 179.342 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 98.8 -17.74 57.85 Favored Glycine 0 N--CA 1.454 -0.12 0 C-N-CA 120.457 -0.878 . . . . 0.0 112.583 179.459 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 121.86 35.13 0.8 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.802 -0.714 . . . . 0.0 112.09 179.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.5 ptm180 -118.76 -25.64 6.3 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.149 0.499 . . . . 0.0 110.551 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.423 ' HB ' ' OG1' ' A' ' 13' ' ' THR . 4.8 m -108.31 135.26 49.91 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.827 -179.686 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.643 HD13 HD13 ' A' ' 90' ' ' LEU . 63.0 mt -97.65 113.76 25.57 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.787 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.461 ' HA ' ' HG2' ' A' ' 34' ' ' GLU . 16.7 ttm180 -107.02 118.68 37.33 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 178.527 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.407 ' HB2' ' HA ' ' A' ' 10' ' ' ALA . . . -154.5 168.05 28.01 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.016 0.436 . . . . 0.0 111.853 -178.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -89.54 111.6 22.57 Favored 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 177.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.423 ' SG ' HD13 ' A' ' 100' ' ' LEU . 61.1 m -97.89 122.89 41.54 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 -179.36 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 19.0 ttt180 -77.23 111.07 12.46 Favored 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 179.073 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 34.9 p30 -74.96 168.0 20.81 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.168 179.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.68 -27.44 27.8 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -178.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -77.92 -4.56 47.44 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.342 0.591 . . . . 0.0 110.964 -179.099 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 81.28 29.5 40.55 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.962 -0.637 . . . . 0.0 111.568 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -112.95 153.03 28.65 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.431 ' HZ3' ' HA ' ' A' ' 7' ' ' SER . 99.1 m95 -99.14 114.5 27.29 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.149 0.499 . . . . 0.0 111.205 -179.156 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 6.9 m -114.17 131.89 64.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.385 179.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 17.3 m -79.41 109.57 13.9 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.894 0.378 . . . . 0.0 110.45 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 74.3 m -123.1 154.44 38.59 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.753 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.636 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 46.1 mt-10 -132.84 132.98 42.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.786 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.574 HD11 ' HB2' ' A' ' 102' ' ' PHE . 2.5 tm? -124.37 131.61 53.51 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.259 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.429 ' N ' HD13 ' A' ' 35' ' ' LEU . 8.4 m-20 -89.86 108.52 19.75 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.082 -179.666 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.496 HD23 HD12 ' A' ' 35' ' ' LEU . 1.6 mt -81.69 -16.93 49.7 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.894 -179.571 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -61.79 -11.88 14.49 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.442 -179.264 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 54.0 p -76.66 -24.68 53.24 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.431 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 34.8 t -128.64 -8.33 5.09 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.206 0.446 . . . . 0.0 112.206 -179.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 47.3 mt -103.44 132.67 49.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 O-C-N 121.851 -0.531 . . . . 0.0 110.046 178.324 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -149.71 159.51 28.11 Favored Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.799 -0.715 . . . . 0.0 111.538 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.413 HD21 ' CD1' ' A' ' 48' ' ' LEU . 19.1 p30 -163.35 50.17 0.25 Allowed Pre-proline 0 CA--C 1.537 0.47 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -179.689 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -68.46 -23.52 37.48 Favored 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 121.924 1.749 . . . . 0.0 112.227 -179.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -87.31 -15.96 36.5 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.537 179.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.483 ' HA2' ' HB2' ' A' ' 75' ' ' PRO . . . 108.6 11.68 22.7 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.461 -0.876 . . . . 0.0 112.741 -179.161 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -125.82 132.07 52.31 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.62 0.248 . . . . 0.0 110.392 179.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.439 HD21 ' SG ' ' A' ' 73' ' ' CYS . 9.2 mp -83.7 144.8 29.13 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.878 -178.807 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 171.76 170.38 35.68 Favored Glycine 0 N--CA 1.439 -1.134 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.11 178.245 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 90.3 m95 -94.88 125.8 39.78 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 153.43 -52.87 0.46 Allowed Glycine 0 N--CA 1.448 -0.56 0 N-CA-C 111.191 -0.764 . . . . 0.0 111.191 -179.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.867 ' HA ' ' HE3' ' A' ' 52' ' ' MET . 2.9 tpt -86.59 174.36 8.95 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.595 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -133.67 169.8 16.49 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 118.69 0.677 . . . . 0.0 111.85 -179.174 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 65.81 38.57 5.09 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.389 -0.823 . . . . 0.0 112.855 178.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 14.0 p90 -61.78 -29.85 70.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.721 0.296 . . . . 0.0 110.929 179.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 23.3 t -56.61 -36.12 69.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.158 -0.474 . . . . 0.0 112.042 -178.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 28.2 m80 -80.92 -18.43 47.17 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.899 -0.32 . . . . 0.0 111.543 -179.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 19.8 m -106.75 19.37 20.58 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.527 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 49.3 m -136.82 152.77 50.66 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.331 0.586 . . . . 0.0 111.628 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -129.06 136.27 50.04 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.197 178.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.407 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 33.6 m-20 63.63 83.65 0.16 Allowed 'General case' 0 N--CA 1.469 0.511 0 O-C-N 123.608 0.567 . . . . 0.0 111.304 -179.317 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.491 HG23 HD23 ' A' ' 71' ' ' LEU . 70.2 mt -101.51 124.19 55.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.285 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.8 tptt -145.03 154.61 42.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.766 0.317 . . . . 0.0 111.247 -179.396 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.718 ' HG ' HD23 ' A' ' 12' ' ' LEU . 86.1 mt -99.5 124.83 45.03 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.018 178.412 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.418 ' C ' ' H ' ' A' ' 67' ' ' GLY . 30.0 mt-10 -86.62 -60.26 2.04 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-O 121.194 0.521 . . . . 0.0 111.42 -179.61 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.407 ' OE1' ' HB2' ' A' ' 70' ' ' LYS . 20.3 mt-10 -78.19 38.44 0.29 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.665 -178.42 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.418 ' H ' ' C ' ' A' ' 65' ' ' GLU . . . 67.73 -4.76 3.87 Favored Glycine 0 N--CA 1.454 -0.117 0 CA-C-N 115.77 -0.65 . . . . 0.0 113.633 179.075 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.537 ' HA2' HD12 ' A' ' 64' ' ' LEU . . . 145.98 -6.96 1.4 Allowed Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.129 -179.429 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 5.5 tpp180 -81.7 -18.23 45.13 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.087 0.47 . . . . 0.0 109.807 179.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.407 ' HB2' ' OE1' ' A' ' 66' ' ' GLU . 35.6 ttmt -143.42 136.21 27.54 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.916 -179.234 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.565 ' HB2' HD11 ' A' ' 90' ' ' LEU . 10.5 tt -115.07 118.45 33.41 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.47 -0.787 . . . . 0.0 109.923 -179.709 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.482 HG23 ' HA3' ' A' ' 87' ' ' GLY . 3.6 p -108.82 134.13 51.93 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.241 0.543 . . . . 0.0 110.874 179.388 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.439 ' SG ' HD21 ' A' ' 48' ' ' LEU . 18.0 p -156.55 164.25 38.43 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.001 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.546 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 33.4 ttt-85 -100.87 101.87 17.51 Favored Pre-proline 0 C--N 1.316 -0.872 0 C-N-CA 120.424 -0.511 . . . . 0.0 110.254 178.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.581 ' HD2' ' HA ' ' A' ' 85' ' ' ARG . 57.9 Cg_endo -70.55 129.2 16.38 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.636 2.224 . . . . 0.0 110.167 178.631 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.64 ' HA ' ' HB2' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -121.2 140.99 51.28 Favored 'General case' 0 C--N 1.313 -1.009 0 O-C-N 123.28 0.362 . . . . 0.0 110.949 179.85 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.729 HG23 ' O ' ' A' ' 82' ' ' PHE . 14.0 t -76.86 130.73 38.01 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 178.478 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 35.3 m -72.66 -6.01 7.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 123.557 0.536 . . . . 0.0 111.492 -179.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -67.78 -35.97 79.62 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.229 178.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.432 ' HA3' ' CE2' ' A' ' 82' ' ' PHE . . . -145.3 -14.18 0.21 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.413 -0.898 . . . . 0.0 113.152 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 88.23 16.78 58.6 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.011 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.729 ' O ' HG23 ' A' ' 77' ' ' THR . 37.8 p90 -111.29 148.46 32.87 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 118.789 -0.624 . . . . 0.0 109.33 -179.195 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.665 ' HA ' ' HE ' ' A' ' 83' ' ' ARG . 0.0 OUTLIER 172.05 -160.14 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.987 0.423 . . . . 0.0 111.938 179.753 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 -125.74 173.22 9.19 Favored 'General case' 0 C--O 1.223 -0.317 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.006 -177.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.581 ' HA ' ' HD2' ' A' ' 75' ' ' PRO . 72.5 ttt180 -109.41 153.71 23.61 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 110.07 -0.344 . . . . 0.0 110.07 178.711 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -166.23 -170.24 1.64 Allowed 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.581 -179.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.482 ' HA3' HG23 ' A' ' 72' ' ' THR . . . -143.12 151.61 23.35 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.335 -0.936 . . . . 0.0 113.358 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.428 HG22 HD23 ' A' ' 48' ' ' LEU . 13.0 tt -123.31 137.49 56.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.025 0.441 . . . . 0.0 109.883 179.408 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -79.8 138.02 37.13 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.787 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.643 HD13 HD13 ' A' ' 19' ' ' LEU . 37.2 mt -106.08 40.88 1.5 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.499 0.666 . . . . 0.0 110.936 -179.014 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.552 ' HA ' ' OG ' ' A' ' 2' ' ' SER . 39.5 m-80 -76.03 3.55 10.15 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.079 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 20.9 mtp180 -96.95 -6.6 35.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.641 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 18.7 mm -98.78 116.75 42.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 -179.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 24.5 tp60 -126.81 143.36 51.28 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.275 0.559 . . . . 0.0 111.301 -178.229 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.42 ' OD1' ' HA ' ' A' ' 3' ' ' TYR . 12.9 p-10 -95.19 110.82 22.74 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.304 178.529 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 40.8 t -96.97 106.45 18.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.693 179.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 20.3 m-80 56.98 36.76 28.21 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.272 0.558 . . . . 0.0 111.304 -179.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 96.14 -22.05 41.82 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.828 -0.701 . . . . 0.0 113.388 179.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.413 ' HD2' ' N ' ' A' ' 99' ' ' ARG . 3.6 mpt_? -86.21 122.61 30.45 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 117.295 0.547 . . . . 0.0 110.211 -179.474 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.423 HD13 ' SG ' ' A' ' 23' ' ' CYS . 11.6 tp -79.63 114.59 18.67 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 32.7 t -128.15 140.71 48.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 120.984 0.421 . . . . 0.0 110.878 -178.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.574 ' HB2' HD11 ' A' ' 35' ' ' LEU . 8.3 t80 -83.93 129.3 34.93 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.121 -0.491 . . . . 0.0 109.81 178.665 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 2.7 tp-100 . . . . . 0 C--O 1.249 1.073 0 CA-C-O 119.031 -0.509 . . . . 0.0 110.451 179.396 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.0 ptp . . . . . 0 N--CA 1.483 1.204 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.8 m -118.33 178.04 4.59 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.779 -0.191 . . . . 0.0 110.98 179.294 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 9.8 p90 -59.62 -34.09 72.33 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.724 0.297 . . . . 0.0 111.543 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -55.35 -18.32 6.39 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 112.84 0.681 . . . . 0.0 112.84 -178.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -56.24 -38.29 70.91 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.326 0.584 . . . . 0.0 110.064 178.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 44.3 m -129.02 40.58 3.61 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.218 179.214 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.402 ' HA ' ' O ' ' A' ' 22' ' ' GLU . 29.3 t -148.1 148.44 30.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.264 -179.529 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -143.45 163.74 32.27 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.669 -179.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 64.22 49.04 2.71 Favored 'General case' 0 N--CA 1.465 0.318 0 O-C-N 123.718 0.636 . . . . 0.0 111.441 179.349 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.525 ' HA ' ' HB3' ' A' ' 21' ' ' ALA . . . -77.92 117.29 19.12 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.361 179.563 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 33.8 m -119.14 167.99 11.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.207 -179.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.578 HD22 ' HG ' ' A' ' 64' ' ' LEU . 3.3 mm? -104.38 114.53 28.82 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.661 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.468 HG23 ' NE ' ' A' ' 20' ' ' ARG . 28.4 p -112.4 166.69 11.07 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.548 -179.458 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 60.89 42.55 12.88 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.962 179.563 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 97.53 -48.03 1.54 Allowed Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 120.661 -0.781 . . . . 0.0 111.546 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 145.98 46.79 0.03 OUTLIER Glycine 0 N--CA 1.444 -0.824 0 N-CA-C 110.306 -1.117 . . . . 0.0 110.306 -179.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.549 ' HB2' ' HB2' ' A' ' 38' ' ' ASP . 7.1 ptp180 -132.95 -25.59 1.81 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.355 -0.423 . . . . 0.0 111.313 -178.595 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.456 ' HB ' ' OG1' ' A' ' 13' ' ' THR . 2.9 m -100.36 133.3 44.99 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.76 -179.688 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.779 HD13 HD12 ' A' ' 90' ' ' LEU . 68.8 mt -92.52 111.54 23.16 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.325 179.1 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.468 ' NE ' HG23 ' A' ' 13' ' ' THR . 37.4 ttm180 -110.42 120.22 41.73 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.721 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.525 ' HB3' ' HA ' ' A' ' 10' ' ' ALA . . . -152.96 167.24 29.83 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.76 0.314 . . . . 0.0 111.369 -179.125 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.402 ' O ' ' HA ' ' A' ' 7' ' ' SER . 37.1 mt-10 -91.01 107.76 19.41 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 178.262 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 65.9 m -100.32 133.11 45.23 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 120.914 0.387 . . . . 0.0 110.212 -179.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.422 HH11 ' HD2' ' A' ' 24' ' ' ARG . 6.7 ttp85 -80.78 117.63 21.61 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-O 120.918 0.39 . . . . 0.0 110.483 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 38.7 p30 -80.31 165.75 22.01 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.103 179.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.13 -18.69 38.04 Favored 'General case' 0 N--CA 1.464 0.266 0 O-C-N 123.807 0.692 . . . . 0.0 112.137 -179.012 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -75.85 -13.48 60.27 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.457 0.646 . . . . 0.0 109.716 179.192 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 91.0 23.83 28.9 Favored Glycine 0 N--CA 1.447 -0.58 0 CA-C-N 115.327 -0.851 . . . . 0.0 112.609 179.463 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -122.76 158.61 29.8 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.755 0.312 . . . . 0.0 111.67 -179.105 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 96.7 m95 -90.32 130.73 36.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.14 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.2 m -129.17 137.47 57.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.533 178.454 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 37.6 m -78.58 109.95 13.25 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.467 179.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 61.6 m -118.06 152.5 35.43 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.609 -179.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.596 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 44.9 mt-10 -132.5 154.41 49.96 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.156 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.531 ' HB2' HD21 ' A' ' 100' ' ' LEU . 1.1 tm? -150.5 126.31 10.38 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 178.78 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -88.77 109.21 19.98 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.482 HD22 HD11 ' A' ' 35' ' ' LEU . 2.2 mt -81.73 -12.73 58.48 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.329 -179.395 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.707 ' OD2' ' HA ' ' A' ' 54' ' ' ASN . 3.0 t70 -65.96 -5.85 10.71 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.115 0.484 . . . . 0.0 110.845 -179.271 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 49.6 p -85.45 -26.38 26.38 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.857 -0.61 . . . . 0.0 112.03 -179.383 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 16.1 t -127.19 -2.59 6.35 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.573 -0.451 . . . . 0.0 112.089 -178.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.438 ' HB ' ' CD1' ' A' ' 55' ' ' PHE . 54.8 mt -111.21 134.34 53.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 O-C-N 122.124 -0.36 . . . . 0.0 110.388 179.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -148.72 158.41 27.65 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 121.12 -0.562 . . . . 0.0 111.787 179.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.625 ' ND2' ' HB2' ' A' ' 55' ' ' PHE . 9.2 p30 -157.04 46.62 0.26 Allowed Pre-proline 0 CA--C 1.537 0.475 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 179.635 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.566 ' HG2' ' SD ' ' A' ' 52' ' ' MET . 14.0 Cg_exo -66.99 -19.67 51.64 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 121.75 1.634 . . . . 0.0 111.671 -179.678 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 73.9 m-20 -88.77 -8.89 53.63 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.559 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.589 ' CA ' ' HG2' ' A' ' 83' ' ' ARG . . . 98.52 7.71 55.47 Favored Glycine 0 N--CA 1.443 -0.885 0 C-N-CA 120.488 -0.863 . . . . 0.0 112.557 -179.309 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -125.57 135.61 52.41 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.753 0.311 . . . . 0.0 110.286 179.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 86.4 mt -83.66 141.84 31.21 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.532 -178.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 176.51 168.28 36.36 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.447 179.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 89.1 m95 -95.71 134.81 38.2 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 147.35 -52.25 0.56 Allowed Glycine 0 CA--C 1.508 -0.404 0 N-CA-C 111.676 -0.569 . . . . 0.0 111.676 179.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.566 ' SD ' ' HG2' ' A' ' 44' ' ' PRO . 36.7 ttm -95.74 172.12 8.23 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 178.783 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -123.7 173.23 8.25 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 118.824 0.738 . . . . 0.0 111.507 -178.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.707 ' HA ' ' OD2' ' A' ' 38' ' ' ASP . 13.9 m120 66.82 63.37 0.49 Allowed 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 114.926 -1.034 . . . . 0.0 111.68 178.59 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.625 ' HB2' ' ND2' ' A' ' 43' ' ' ASN . 20.7 p90 -87.11 -35.95 18.39 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.336 179.452 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 17.7 t -64.47 -27.56 69.06 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.353 -178.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 69.5 m80 -76.37 -12.81 60.12 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.881 -179.259 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 24.3 p -128.19 26.29 5.76 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.878 0.37 . . . . 0.0 111.303 -179.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 68.2 m -132.99 151.08 52.11 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 120.576 -0.45 . . . . 0.0 111.173 179.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -119.39 134.31 55.28 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.303 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.418 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 38.2 t70 61.1 84.65 0.13 Allowed 'General case' 0 N--CA 1.465 0.286 0 O-C-N 124.037 0.836 . . . . 0.0 110.934 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.472 HG21 HD21 ' A' ' 71' ' ' LEU . 72.2 mt -101.51 118.07 47.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.03 -179.127 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -145.44 150.21 36.11 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 -179.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.578 ' HG ' HD22 ' A' ' 12' ' ' LEU . 56.1 mt -83.01 123.19 29.22 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.315 0.579 . . . . 0.0 111.456 -179.517 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.446 ' C ' ' H ' ' A' ' 67' ' ' GLY . 33.0 tt0 -78.37 -61.79 1.89 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.13 -0.941 . . . . 0.0 111.973 -178.372 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 33.6 mm-40 -79.54 34.8 0.27 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.15 0.5 . . . . 0.0 111.433 -179.504 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.446 ' H ' ' C ' ' A' ' 65' ' ' GLU . . . 66.01 10.44 51.44 Favored Glycine 0 C--N 1.316 -0.575 0 CA-C-N 115.295 -0.866 . . . . 0.0 112.569 179.69 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.568 ' HA2' HD12 ' A' ' 64' ' ' LEU . . . 137.7 -16.95 3.5 Favored Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 120.348 -0.929 . . . . 0.0 112.963 179.807 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 27.2 mtt180 -83.23 -9.85 58.9 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 117.349 0.574 . . . . 0.0 110.779 -179.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 66.3 tttt -150.13 138.07 20.17 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.983 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.546 ' HB2' HD13 ' A' ' 90' ' ' LEU . 10.4 tt -107.2 126.44 52.41 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.958 -179.262 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.0 p -116.53 132.0 56.8 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.991 179.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.418 ' HA ' ' O ' ' A' ' 61' ' ' ASP . 26.8 p -159.97 175.4 13.06 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.065 -179.602 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.566 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 29.4 ttt180 -107.34 99.12 26.09 Favored Pre-proline 0 C--N 1.315 -0.892 0 C-N-CA 120.228 -0.589 . . . . 0.0 110.405 178.627 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.405 ' HD2' ' HA ' ' A' ' 74' ' ' ARG . 55.3 Cg_endo -69.38 125.44 12.35 Favored 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 122.713 2.275 . . . . 0.0 110.492 178.686 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.697 ' HA ' ' HB2' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -120.52 139.99 52.11 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.904 0.383 . . . . 0.0 111.422 -179.693 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.712 HG23 ' O ' ' A' ' 82' ' ' PHE . 15.2 t -73.39 135.63 44.26 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 179.649 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 26.9 m -76.22 -8.99 12.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.63 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.522 -179.35 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -68.57 -30.18 68.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.776 179.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.553 ' HA3' ' CE2' ' A' ' 82' ' ' PHE . . . -146.01 -19.26 0.14 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.502 -0.856 . . . . 0.0 113.281 179.431 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.97 14.05 55.47 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.931 -0.652 . . . . 0.0 111.86 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.712 ' O ' HG23 ' A' ' 77' ' ' THR . 37.6 p90 -111.8 157.37 20.63 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 118.901 -0.571 . . . . 0.0 110.173 -178.349 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.697 ' HB2' ' HA ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 166.6 -157.57 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.357 0 O-C-N 123.661 0.601 . . . . 0.0 112.258 178.456 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 41.5 mm-40 -123.42 176.57 6.08 Favored 'General case' 0 CA--C 1.521 -0.173 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.384 -177.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.566 ' HA ' ' HA ' ' A' ' 74' ' ' ARG . 30.9 ttt85 -98.85 154.75 17.79 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 178.009 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.406 ' HG2' ' N ' ' A' ' 87' ' ' GLY . 9.1 tt0 -161.92 171.48 17.61 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.533 -178.086 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.406 ' N ' ' HG2' ' A' ' 86' ' ' GLN . . . -134.12 138.25 9.93 Favored Glycine 0 N--CA 1.447 -0.622 0 N-CA-C 111.695 -0.562 . . . . 0.0 111.695 178.696 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 11.1 tt -118.4 134.82 60.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 121.052 0.453 . . . . 0.0 110.09 -179.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -76.1 136.98 39.86 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.232 -178.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.779 HD12 HD13 ' A' ' 19' ' ' LEU . 52.4 mt -105.74 40.46 1.56 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.382 0.611 . . . . 0.0 111.451 -179.128 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 29.5 m-80 -74.29 -2.91 27.12 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.27 179.413 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 8.4 mtp180 -91.79 -7.45 49.52 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.741 179.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 23.4 mm -105.47 112.1 37.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 -179.332 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -132.56 159.38 39.62 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.143 0.497 . . . . 0.0 111.477 -179.433 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.409 ' HA ' ' O ' ' A' ' 99' ' ' ARG . 13.2 p-10 -104.48 134.0 48.4 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.876 179.523 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 49.3 t -114.93 105.08 17.94 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.395 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -179.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 17.7 m-80 61.81 26.91 16.38 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.858 -179.021 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 113.88 -35.84 4.3 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.688 -0.767 . . . . 0.0 114.602 178.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.409 ' O ' ' HA ' ' A' ' 95' ' ' ASN . 0.0 OUTLIER -86.8 139.33 30.8 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 118.029 0.914 . . . . 0.0 112.817 -177.891 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.531 HD21 ' HB2' ' A' ' 35' ' ' LEU . 7.1 tp -81.29 120.05 24.42 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.968 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 26.2 t -128.29 141.52 46.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.308 -179.102 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.408 ' HB2' HD13 ' A' ' 35' ' ' LEU . 16.9 t80 -80.53 132.24 35.64 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 178.705 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 2.7 tp-100 . . . . . 0 C--O 1.253 1.25 0 CA-C-O 118.595 -0.717 . . . . 0.0 110.045 179.703 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.1 ptp . . . . . 0 N--CA 1.481 1.083 0 CA-C-O 121.007 0.432 . . . . 0.0 110.524 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.606 ' HB2' ' HG2' ' A' ' 69' ' ' ARG . 20.1 m -114.08 -179.31 3.6 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.042 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.479 ' HA ' ' OD1' ' A' ' 95' ' ' ASN . 12.6 p90 -54.89 -40.89 70.25 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -179.58 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.406 ' HB3' ' CG ' ' A' ' 69' ' ' ARG . . . -62.2 -18.45 61.08 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 -178.445 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.473 ' HB2' ' O ' ' A' ' 2' ' ' SER . 0.9 OUTLIER -64.43 -22.43 66.96 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 121.329 0.585 . . . . 0.0 110.572 179.626 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 49.6 m -140.92 39.21 1.8 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.274 179.075 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.406 ' HA ' ' HZ3' ' A' ' 30' ' ' TRP . 13.2 t -145.63 154.66 42.37 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.926 -1.034 . . . . 0.0 108.698 179.831 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 21.0 ptt180 -140.47 164.09 31.08 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.734 0.302 . . . . 0.0 111.26 -179.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 57.96 51.42 8.98 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.686 178.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.507 ' HA ' ' HB2' ' A' ' 21' ' ' ALA . . . -81.98 117.39 22.16 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.206 179.444 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 26.7 m -119.24 169.88 9.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.349 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.587 HD21 ' HG ' ' A' ' 64' ' ' LEU . 3.2 mm? -105.15 115.27 29.98 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.803 -179.478 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 23.5 p -111.74 169.6 8.72 Favored 'General case' 0 C--O 1.243 0.72 0 CA-C-O 121.115 0.483 . . . . 0.0 111.692 -179.43 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 62.67 26.87 15.88 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 115.285 -0.87 . . . . 0.0 112.56 179.218 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 101.8 -14.3 57.53 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.437 179.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 116.8 43.17 0.63 Allowed Glycine 0 N--CA 1.443 -0.869 0 N-CA-C 111.209 -0.756 . . . . 0.0 111.209 -179.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.654 ' HB2' ' HB2' ' A' ' 38' ' ' ASP . 14.0 ptm180 -130.6 -29.69 1.93 Allowed 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.301 -0.45 . . . . 0.0 111.26 -179.384 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.418 ' HA ' ' HA ' ' A' ' 36' ' ' ASP . 10.3 m -104.37 136.32 44.17 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.435 -179.628 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.651 ' O ' ' HA ' ' A' ' 34' ' ' GLU . 84.5 mt -93.3 117.61 30.28 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.369 179.698 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 44.3 ttt85 -113.81 119.85 38.76 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 178.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.507 ' HB2' ' HA ' ' A' ' 10' ' ' ALA . . . -153.76 167.14 30.63 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.924 0.393 . . . . 0.0 111.443 -178.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -90.98 109.13 20.37 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 177.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.494 ' SG ' HD12 ' A' ' 100' ' ' LEU . 68.5 m -100.09 135.64 41.2 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 120.897 0.38 . . . . 0.0 111.313 -178.122 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 17.3 ttp180 -80.02 115.55 19.66 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.99 179.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 34.3 p30 -80.29 167.62 20.05 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.789 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -52.04 -32.24 33.49 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 -178.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -71.35 -13.45 61.87 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.288 0.566 . . . . 0.0 111.004 -179.335 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 90.43 28.91 15.42 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.971 -0.633 . . . . 0.0 111.644 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -120.01 157.82 28.06 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.618 0.247 . . . . 0.0 110.834 -179.507 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.406 ' HZ3' ' HA ' ' A' ' 7' ' ' SER . 91.9 m95 -90.34 131.43 36.14 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.755 0.312 . . . . 0.0 111.362 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.9 m -133.32 130.6 57.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.116 178.164 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.4 m -77.11 112.87 14.23 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.573 -179.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 66.4 m -124.11 160.19 28.32 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.978 -179.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.651 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 47.4 mt-10 -139.32 143.77 37.98 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.104 -179.817 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.409 HD13 HD21 ' A' ' 37' ' ' LEU . 1.8 tm? -138.47 127.77 24.44 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 178.61 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.418 ' HA ' ' HA ' ' A' ' 18' ' ' THR . 27.1 t70 -91.01 109.79 21.04 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.94 0.4 . . . . 0.0 110.599 -179.177 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.482 HD12 HD11 ' A' ' 19' ' ' LEU . 1.5 mt -81.23 -14.24 57.69 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.747 -179.645 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.757 ' OD2' ' HA ' ' A' ' 54' ' ' ASN . 6.6 t70 -63.23 -15.71 57.92 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.291 0.567 . . . . 0.0 110.55 -179.301 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 68.1 p -80.21 -22.41 41.87 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.554 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 21.0 m -122.94 -8.68 8.33 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -177.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 65.4 mt -111.73 134.16 55.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 110.335 -0.246 . . . . 0.0 110.335 179.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -140.94 151.98 22.85 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.827 -0.702 . . . . 0.0 111.871 179.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 38.7 p-10 -160.57 48.53 0.25 Allowed Pre-proline 0 CA--C 1.54 0.561 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -179.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_exo -68.28 -18.21 44.68 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 121.883 1.722 . . . . 0.0 111.798 -179.164 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -93.28 -6.63 47.07 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.294 -0.866 . . . . 0.0 111.146 -179.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.479 ' HA3' ' HG2' ' A' ' 83' ' ' ARG . . . 100.22 9.33 48.29 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.11 -1.043 . . . . 0.0 112.926 -179.506 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.659 ' HA ' HE22 ' A' ' 86' ' ' GLN . 49.5 m-85 -125.08 128.98 49.32 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.119 0.485 . . . . 0.0 110.891 179.776 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.654 HD12 ' HG ' ' A' ' 73' ' ' CYS . 84.7 mt -83.41 137.87 33.74 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.782 -178.116 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -178.94 170.69 42.61 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 120.874 -0.679 . . . . 0.0 111.659 178.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 90.4 m95 -95.78 135.44 37.48 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.991 0.424 . . . . 0.0 110.153 -179.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 147.89 -67.12 0.39 Allowed Glycine 0 N--CA 1.445 -0.706 0 N-CA-C 111.498 -0.641 . . . . 0.0 111.498 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 14.7 ttt -80.35 -179.46 7.13 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -131.36 168.07 18.19 Favored 'General case' 0 C--N 1.321 -0.668 0 O-C-N 122.082 -0.386 . . . . 0.0 111.111 -179.327 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.757 ' HA ' ' OD2' ' A' ' 38' ' ' ASP . 0.9 OUTLIER 69.4 61.21 0.3 Allowed 'General case' 0 N--CA 1.461 0.087 0 O-C-N 124.079 0.862 . . . . 0.0 111.762 179.002 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.41 ' HD1' ' HA ' ' A' ' 38' ' ' ASP . 16.6 p90 -87.21 -37.35 17.35 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.319 179.484 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 72.2 p -64.74 -22.42 66.98 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.409 0.623 . . . . 0.0 110.501 -179.11 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 76.6 m80 -75.94 -11.53 59.98 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.096 -179.43 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.0 p -133.65 33.65 3.49 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.556 179.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 38.6 m -136.45 154.19 50.85 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.311 0.577 . . . . 0.0 111.678 -179.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -131.22 146.52 52.35 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.142 -0.935 . . . . 0.0 109.652 179.399 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.476 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 33.4 t70 58.72 66.86 1.0 Allowed 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 121.335 0.588 . . . . 0.0 110.917 178.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.507 HG21 HD21 ' A' ' 71' ' ' LEU . 74.5 mt -93.9 114.15 29.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.633 -179.583 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 29.0 tptt -144.54 147.65 33.47 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.992 0.425 . . . . 0.0 110.305 -179.574 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.587 ' HG ' HD21 ' A' ' 12' ' ' LEU . 65.6 mt -83.35 140.89 32.16 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.401 179.69 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -102.41 -55.27 2.5 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.023 -0.535 . . . . 0.0 112.232 -178.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -83.81 36.26 0.55 Allowed 'General case' 0 CA--C 1.515 -0.4 0 CA-C-O 121.061 0.457 . . . . 0.0 111.199 -179.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 70.49 -2.08 17.46 Favored Glycine 0 C--N 1.315 -0.589 0 CA-C-N 115.263 -0.881 . . . . 0.0 112.799 179.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.538 ' HA2' HD12 ' A' ' 64' ' ' LEU . . . 146.77 -12.84 1.51 Allowed Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.406 -0.902 . . . . 0.0 113.323 -179.712 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.606 ' HG2' ' HB2' ' A' ' 2' ' ' SER . 53.3 mtm180 -94.2 4.21 54.2 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 117.557 0.678 . . . . 0.0 111.174 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 39.9 tptt -151.45 119.74 6.37 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 -179.401 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.525 ' HB2' HD13 ' A' ' 90' ' ' LEU . 9.7 tt -104.29 120.07 40.36 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 -179.763 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.8 p -113.65 133.72 55.14 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.007 0.432 . . . . 0.0 110.798 179.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.654 ' HG ' HD12 ' A' ' 48' ' ' LEU . 26.2 p -159.98 175.61 12.82 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.887 -179.416 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.54 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 3.7 tmt_? -110.28 98.18 34.47 Favored Pre-proline 0 C--N 1.311 -1.084 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 178.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.409 ' HD2' ' HA ' ' A' ' 74' ' ' ARG . 59.1 Cg_endo -71.64 134.53 24.3 Favored 'Trans proline' 0 CA--C 1.515 -0.448 0 C-N-CA 123.221 2.614 . . . . 0.0 111.599 179.72 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.664 ' HA ' ' HB2' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -121.42 144.03 48.9 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 123.294 0.371 . . . . 0.0 111.347 179.44 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.755 HG23 ' O ' ' A' ' 82' ' ' PHE . 14.4 t -81.15 138.1 35.89 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.103 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 35.6 m -76.97 -4.68 6.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 O-C-N 124.057 0.848 . . . . 0.0 111.481 -179.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -69.95 -33.81 72.6 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.006 0.431 . . . . 0.0 110.352 178.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.449 ' HA3' ' CE2' ' A' ' 82' ' ' PHE . . . -148.25 -17.23 0.11 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.363 -0.922 . . . . 0.0 113.202 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.68 16.41 45.7 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.577 -0.82 . . . . 0.0 111.473 -179.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.755 ' O ' HG23 ' A' ' 77' ' ' THR . 33.2 p90 -112.2 154.16 25.98 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 118.754 -0.641 . . . . 0.0 109.478 -178.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.664 ' HB2' ' HA ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 170.8 -160.13 0.01 OUTLIER 'General case' 0 C--O 1.234 0.263 0 O-C-N 123.311 0.382 . . . . 0.0 111.772 179.477 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -124.77 -174.33 3.0 Favored 'General case' 0 C--O 1.226 -0.132 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.527 -177.489 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.54 ' HA ' ' HA ' ' A' ' 74' ' ' ARG . 35.1 ttt-85 -99.61 155.95 17.32 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 177.768 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.659 HE22 ' HA ' ' A' ' 47' ' ' PHE . 8.9 tt0 -163.73 165.78 22.8 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 121.088 0.47 . . . . 0.0 111.854 -178.766 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -134.95 144.3 16.22 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 121.066 -0.588 . . . . 0.0 111.636 179.413 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 12.1 tt -123.64 138.92 51.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 120.975 0.417 . . . . 0.0 110.312 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -78.63 129.69 35.04 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.561 -179.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.626 HD12 HD11 ' A' ' 19' ' ' LEU . 60.4 mt -99.44 45.69 0.99 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.711 0.767 . . . . 0.0 110.291 179.807 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.456 ' N ' HD21 ' A' ' 91' ' ' ASN . 0.8 OUTLIER -79.15 3.13 18.55 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 114.821 -1.081 . . . . 0.0 110.039 -179.609 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 11.7 mtp180 -101.89 0.18 35.05 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.267 -179.122 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.422 HD11 HD23 ' A' ' 37' ' ' LEU . 21.9 mm -107.19 114.96 47.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 -179.321 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 27.0 tp60 -125.78 144.59 50.57 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.908 -178.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.479 ' OD1' ' HA ' ' A' ' 3' ' ' TYR . 12.9 p-10 -95.36 102.02 13.8 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.276 178.758 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 54.1 t -86.37 109.3 18.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 179.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 26.3 m-80 57.64 31.6 20.62 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.02 0.438 . . . . 0.0 110.789 -178.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 95.1 -18.95 56.36 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.566 -0.826 . . . . 0.0 112.831 179.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 5.6 mpt_? -86.18 124.36 32.49 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 -179.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.494 HD12 ' SG ' ' A' ' 23' ' ' CYS . 6.7 tp -76.21 116.48 16.94 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 -179.648 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 44.9 t -130.99 143.19 41.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.622 -179.074 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.404 ' HB2' HD12 ' A' ' 35' ' ' LEU . 16.0 t80 -79.04 135.52 36.9 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.757 -0.461 . . . . 0.0 109.757 178.509 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.558 ' HA ' HE21 ' A' ' 103' ' ' GLN . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.653 -0.689 . . . . 0.0 110.163 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.5 mtt . . . . . 0 N--CA 1.484 1.241 0 CA-C-O 120.892 0.377 . . . . 0.0 110.415 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.558 ' OG ' ' HA ' ' A' ' 91' ' ' ASN . 3.6 m -118.52 179.18 4.2 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.46 179.464 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.436 ' CB ' HD11 ' A' ' 100' ' ' LEU . 13.6 p90 -57.25 -34.43 68.6 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.037 0.446 . . . . 0.0 110.411 178.335 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -57.29 -23.06 46.02 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 115.481 -0.781 . . . . 0.0 112.531 -179.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -64.98 -16.78 63.78 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 121.063 0.459 . . . . 0.0 110.815 179.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 49.7 m -146.66 35.48 0.95 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.712 178.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 44.5 m -145.48 163.55 34.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.879 179.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 6.1 ptp180 -148.05 165.12 31.75 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.596 -179.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 61.1 m-80 59.51 51.83 6.22 Favored 'General case' 0 N--CA 1.464 0.248 0 O-C-N 123.689 0.618 . . . . 0.0 111.376 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.45 ' HA ' ' HB3' ' A' ' 21' ' ' ALA . . . -83.89 117.38 23.29 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.391 179.418 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 31.2 m -123.0 168.9 14.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.481 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.796 HD23 ' HG ' ' A' ' 64' ' ' LEU . 3.4 mm? -104.45 114.32 28.48 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.68 -179.457 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 18.4 p -107.56 168.57 9.16 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.516 -179.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 60.4 39.8 18.13 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.039 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 89.62 -31.21 5.32 Favored Glycine 0 CA--C 1.519 0.335 0 CA-C-N 115.941 -0.572 . . . . 0.0 112.657 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 136.29 56.49 0.06 OUTLIER Glycine 0 N--CA 1.449 -0.472 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 -179.314 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.5 ptm180 -142.52 -31.89 0.51 Allowed 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.856 0.36 . . . . 0.0 111.078 -179.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.5 m -101.3 136.77 40.6 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.764 -179.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.735 HD12 HD12 ' A' ' 90' ' ' LEU . 67.8 mt -94.63 118.07 31.12 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.65 179.052 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 21.8 ttt180 -114.6 119.97 38.57 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 178.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.45 ' HB3' ' HA ' ' A' ' 10' ' ' ALA . . . -154.05 168.94 24.75 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.693 0.282 . . . . 0.0 111.317 -178.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -87.65 106.2 17.87 Favored 'General case' 0 CA--C 1.513 -0.461 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 178.048 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.544 ' SG ' HD13 ' A' ' 100' ' ' LEU . 30.4 m -93.25 121.26 34.43 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.451 -177.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.509 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 9.5 ttp180 -70.03 112.94 6.77 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.147 179.264 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 36.2 p30 -78.69 170.65 16.32 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.359 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.96 -27.4 52.36 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -178.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -80.31 -1.44 41.0 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.498 0.666 . . . . 0.0 110.409 -179.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.97 28.95 48.5 Favored Glycine 0 N--CA 1.448 -0.55 0 CA-C-N 115.534 -0.757 . . . . 0.0 112.107 179.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.509 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 57.7 t30 -110.98 163.02 14.25 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 121.212 -0.195 . . . . 0.0 110.818 -179.03 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 92.5 m95 -101.55 115.71 31.13 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.528 179.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.8 m -116.49 148.87 18.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 120.993 0.425 . . . . 0.0 110.835 179.224 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 28.3 m -86.11 110.52 19.6 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.269 179.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.473 ' HB2' ' SG ' ' A' ' 23' ' ' CYS . 70.1 m -128.99 147.22 50.84 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.682 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.64 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 51.9 mt-10 -129.84 148.72 51.74 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.548 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.56 HD13 ' HB2' ' A' ' 102' ' ' PHE . 1.8 tm? -140.51 129.34 23.15 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 178.753 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.423 ' N ' HD12 ' A' ' 35' ' ' LEU . 14.5 m-20 -87.13 109.21 19.29 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 -179.565 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.511 HD21 HD11 ' A' ' 35' ' ' LEU . 1.9 mt -85.12 -21.43 29.28 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -179.19 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -65.18 -6.96 10.65 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.744 0.307 . . . . 0.0 111.568 -178.386 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 69.0 p -81.09 -16.14 53.99 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.641 179.034 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 29.2 t -133.28 -10.02 2.91 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.718 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 51.1 mt -104.81 134.26 46.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 178.264 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -148.33 155.73 26.55 Favored Glycine 0 N--CA 1.442 -0.919 0 C-N-CA 120.577 -0.821 . . . . 0.0 112.112 -179.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 27.0 p30 -158.2 43.92 0.18 Allowed Pre-proline 0 CA--C 1.542 0.648 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -67.46 -23.06 44.24 Favored 'Trans proline' 0 C--N 1.356 0.952 0 C-N-CA 121.967 1.778 . . . . 0.0 111.683 -179.219 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 52.5 m-80 -89.3 -1.92 58.25 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.11 179.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.489 ' HA3' ' HG2' ' A' ' 83' ' ' ARG . . . 92.6 11.17 59.64 Favored Glycine 0 N--CA 1.443 -0.843 0 C-N-CA 120.385 -0.912 . . . . 0.0 112.657 -179.692 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 43.5 m-85 -125.19 132.44 53.02 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.767 0.318 . . . . 0.0 110.588 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.407 HD21 HG21 ' A' ' 88' ' ' ILE . 10.3 mp -86.0 146.03 26.84 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.892 -178.863 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 169.22 171.31 34.79 Favored Glycine 0 N--CA 1.442 -0.944 0 CA-C-N 115.476 -0.784 . . . . 0.0 112.066 178.156 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.432 ' CD1' HD13 ' A' ' 88' ' ' ILE . 90.3 m95 -95.48 125.18 39.91 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.496 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 153.29 -44.85 0.59 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.936 -0.649 . . . . 0.0 111.637 -179.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 12.7 tpt -94.2 174.61 7.06 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 -130.72 171.56 12.96 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.993 -179.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 64.23 37.41 8.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.991 177.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 11.7 p90 -62.33 -38.42 89.4 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.528 -0.469 . . . . 0.0 109.865 179.191 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 15.6 t -60.09 -29.98 68.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.12 -179.215 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 27.9 m80 -77.03 -12.62 59.96 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.815 0.341 . . . . 0.0 111.301 -179.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 19.7 m -126.54 27.77 6.06 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.078 0.466 . . . . 0.0 111.166 -179.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 38.6 m -132.41 147.56 52.38 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.195 0.522 . . . . 0.0 111.258 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -121.23 142.44 49.91 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.51 178.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.402 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 37.6 t70 58.43 80.39 0.18 Allowed 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.55 0.691 . . . . 0.0 110.477 -178.691 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.486 HG22 HD23 ' A' ' 71' ' ' LEU . 70.5 mt -102.77 119.66 51.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.997 -179.267 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.4 tpmt? -148.97 156.82 42.82 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 -179.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.796 ' HG ' HD23 ' A' ' 12' ' ' LEU . 71.9 mt -88.39 121.3 30.63 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.984 0.421 . . . . 0.0 110.099 178.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -71.88 -55.45 7.5 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.899 -178.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.518 ' CB ' ' HB2' ' A' ' 69' ' ' ARG . 8.8 mm-40 -87.08 13.57 9.09 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.884 -179.396 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 69.9 23.17 77.11 Favored Glycine 0 N--CA 1.448 -0.528 0 CA-C-N 115.7 -0.682 . . . . 0.0 112.578 179.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 145.27 -36.76 1.36 Allowed Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.029 -1.082 . . . . 0.0 112.956 179.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.518 ' HB2' ' CB ' ' A' ' 66' ' ' GLU . 8.3 mmt85 -72.39 -29.12 63.46 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.928 0.394 . . . . 0.0 111.396 -179.784 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 41.7 tttp -140.45 140.09 35.33 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.976 -177.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.556 ' HB2' HD13 ' A' ' 90' ' ' LEU . 9.9 tt -111.35 122.93 49.15 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 179.142 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.2 p -110.87 131.89 54.66 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.361 0.6 . . . . 0.0 110.873 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.402 ' HA ' ' O ' ' A' ' 61' ' ' ASP . 24.6 p -156.61 167.51 30.22 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.708 -179.659 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.507 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 67.5 ttt180 -103.81 101.3 23.99 Favored Pre-proline 0 C--N 1.314 -0.958 0 N-CA-C 109.865 -0.421 . . . . 0.0 109.865 178.807 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.633 ' HD2' ' HA ' ' A' ' 85' ' ' ARG . 61.5 Cg_endo -71.04 119.01 6.0 Favored 'Trans proline' 0 CA--C 1.513 -0.54 0 C-N-CA 122.871 2.381 . . . . 0.0 111.029 179.483 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.647 ' HA ' ' HB2' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -119.63 135.76 54.67 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 120.76 0.314 . . . . 0.0 110.486 179.795 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.728 HG23 ' O ' ' A' ' 82' ' ' PHE . 14.7 t -70.18 128.67 37.08 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 12.4 p -71.41 -12.57 16.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.474 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -60.24 -30.42 69.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.08 179.277 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.593 ' HA3' ' CE2' ' A' ' 82' ' ' PHE . . . -146.5 -35.68 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.433 0 CA-C-N 115.578 -0.737 . . . . 0.0 112.458 179.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 111.91 12.41 14.35 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 121.237 -0.506 . . . . 0.0 112.058 -179.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.728 ' O ' HG23 ' A' ' 77' ' ' THR . 16.1 p90 -112.66 152.82 28.54 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 118.782 -0.628 . . . . 0.0 110.37 -178.55 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.647 ' HB2' ' HA ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 167.52 -158.25 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.603 0 O-C-N 123.682 0.614 . . . . 0.0 111.994 178.675 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 57.4 mm-40 -117.62 -173.26 2.39 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.978 -178.088 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.633 ' HA ' ' HD2' ' A' ' 75' ' ' PRO . 73.2 ttt180 -115.93 151.38 35.5 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 178.524 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -157.95 -170.1 3.05 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.379 0.609 . . . . 0.0 112.335 -178.387 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -155.33 145.98 13.46 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.09 179.304 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.432 HD13 ' CD1' ' A' ' 50' ' ' TRP . 12.4 tt -128.46 142.17 44.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.953 0.377 . . . . 0.0 110.474 -179.628 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -82.5 133.82 35.2 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.184 0.516 . . . . 0.0 110.693 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.735 HD12 HD12 ' A' ' 19' ' ' LEU . 26.5 mt -101.02 39.64 1.37 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.616 -179.247 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.558 ' HA ' ' OG ' ' A' ' 2' ' ' SER . 9.4 m-80 -73.88 2.95 7.4 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.068 -0.969 . . . . 0.0 111.048 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 9.8 mtp180 -97.23 -11.07 24.63 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.459 179.316 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.432 ' CD1' HD23 ' A' ' 37' ' ' LEU . 23.3 mm -96.56 102.73 13.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 121.392 0.615 . . . . 0.0 109.449 -179.354 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 8.4 mm-40 -107.83 153.82 22.45 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.563 -178.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 22.8 p-10 -112.57 112.09 23.37 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.723 178.363 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 9.0 p -111.51 120.51 62.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.105 0.479 . . . . 0.0 110.176 -179.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 38.1 m-80 59.15 28.93 18.37 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.98 -178.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 88.09 -9.73 73.63 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.517 -179.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 10.5 mpt_? -91.4 124.8 35.86 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 -179.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.544 HD13 ' SG ' ' A' ' 23' ' ' CYS . 5.9 tp -82.16 117.11 22.06 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 16.6 t -129.24 138.07 55.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 120.651 0.262 . . . . 0.0 110.77 -179.136 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.56 ' HB2' HD13 ' A' ' 35' ' ' LEU . 6.8 t80 -80.91 125.72 30.48 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 177.829 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 . . . . . 0 C--N 1.311 -1.076 0 CA-C-O 118.077 -0.964 . . . . 0.0 110.856 179.848 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.435 ' HG2' HE22 ' A' ' 94' ' ' GLN . 16.5 ttt . . . . . 0 N--CA 1.479 1.0 0 CA-C-O 120.603 0.24 . . . . 0.0 110.471 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.491 ' OG ' ' HA ' ' A' ' 91' ' ' ASN . 11.8 m -104.67 178.07 4.67 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 179.56 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 34.6 p90 -59.86 -35.14 74.16 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 121.094 -0.242 . . . . 0.0 110.99 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -55.84 -22.09 23.21 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 112.114 0.412 . . . . 0.0 112.114 -179.356 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -68.27 -22.68 64.73 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 120.878 0.371 . . . . 0.0 110.716 179.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 9.6 p -139.73 29.97 2.1 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.31 0.576 . . . . 0.0 110.181 179.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 9.3 t -150.71 156.82 42.09 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -179.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 9.4 ptp180 -149.07 166.93 27.24 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.655 0.264 . . . . 0.0 111.127 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 57.3 m-80 57.85 60.71 2.65 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.967 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -90.48 125.47 35.6 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.853 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 34.0 m -122.62 170.65 12.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.8 179.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.606 HD21 ' HG ' ' A' ' 64' ' ' LEU . 3.2 mm? -104.8 114.21 28.29 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.355 -179.235 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 21.6 p -110.3 167.47 10.17 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.812 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 57.52 50.34 11.3 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.889 179.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 85.29 -37.95 3.01 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 121.01 -0.614 . . . . 0.0 112.516 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 138.59 38.83 0.11 Allowed Glycine 0 N--CA 1.447 -0.595 0 N-CA-C 111.284 -0.727 . . . . 0.0 111.284 -179.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 48.7 ptt85 -123.49 -23.23 4.84 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.939 0.4 . . . . 0.0 110.744 -179.267 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.3 m -105.28 137.5 42.96 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.027 -179.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.726 HD13 HD12 ' A' ' 90' ' ' LEU . 58.5 mt -97.05 116.17 28.78 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.576 179.294 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.82 119.68 40.12 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 178.242 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -152.33 168.07 26.6 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.979 0.419 . . . . 0.0 111.776 -178.348 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -89.99 106.09 18.25 Favored 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 178.513 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 58.1 m -97.95 130.68 44.8 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 120.761 0.315 . . . . 0.0 110.633 -178.218 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.508 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 10.5 ttp180 -78.37 122.2 25.47 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.497 179.831 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 35.6 p30 -86.83 168.36 13.53 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.827 179.415 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.84 -31.32 49.03 Favored 'General case' 0 N--CA 1.464 0.255 0 O-C-N 123.555 0.535 . . . . 0.0 112.356 -179.11 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -69.51 -17.84 63.63 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.446 0.641 . . . . 0.0 110.662 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 93.72 28.7 10.82 Favored Glycine 0 N--CA 1.446 -0.684 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.313 -179.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.508 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 43.9 t30 -112.91 160.97 17.52 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.644 0.259 . . . . 0.0 110.901 -179.106 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 94.6 m95 -100.37 114.33 27.77 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.93 0.395 . . . . 0.0 111.049 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.6 m -117.75 129.19 74.55 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.381 178.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 13.7 m -75.01 111.66 10.45 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.877 -0.602 . . . . 0.0 111.015 -179.415 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 73.5 m -121.58 153.3 38.22 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.609 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.593 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 42.8 mt-10 -129.4 141.46 51.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.206 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.589 HD13 ' HB2' ' A' ' 102' ' ' PHE . 1.9 tm? -136.54 131.96 34.58 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.387 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.406 ' N ' HD12 ' A' ' 35' ' ' LEU . 31.8 m-20 -88.58 109.8 20.38 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 -179.646 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.447 HD11 ' HG ' ' A' ' 19' ' ' LEU . 4.4 mt -79.64 -20.56 46.45 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.286 -179.636 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -65.99 -5.87 10.92 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.629 -0.259 . . . . 0.0 111.461 -178.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 72.9 p -81.08 -20.84 40.65 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.625 179.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.447 ' SG ' ' HE3' ' A' ' 50' ' ' TRP . 40.9 t -129.05 -11.51 4.72 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.616 -179.871 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 51.3 mt -100.14 128.8 51.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.083 178.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -139.34 154.34 23.44 Favored Glycine 0 N--CA 1.443 -0.876 0 C-N-CA 120.852 -0.69 . . . . 0.0 111.518 179.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.528 HD21 ' CB ' ' A' ' 75' ' ' PRO . 33.0 p-10 -160.95 44.24 0.15 Allowed Pre-proline 0 CA--C 1.539 0.533 0 N-CA-C 113.142 0.794 . . . . 0.0 113.142 -179.263 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -70.95 -16.76 32.5 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 121.404 1.403 . . . . 0.0 111.895 -179.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -89.07 -9.55 50.75 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.493 179.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.544 ' CA ' ' HG2' ' A' ' 83' ' ' ARG . . . 102.21 6.47 48.16 Favored Glycine 0 N--CA 1.443 -0.899 0 C-N-CA 120.482 -0.866 . . . . 0.0 112.503 -179.38 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.476 ' HD1' HE22 ' A' ' 86' ' ' GLN . 64.5 m-85 -125.14 134.42 52.44 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 122.732 -0.275 . . . . 0.0 110.85 179.808 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 88.0 mt -83.99 146.42 27.99 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.218 -179.166 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 170.82 169.99 34.52 Favored Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 120.539 -0.839 . . . . 0.0 112.361 178.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.447 ' HE3' ' SG ' ' A' ' 40' ' ' CYS . 90.8 m95 -95.3 124.98 39.62 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 110.048 -0.352 . . . . 0.0 110.048 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 160.73 -60.05 0.3 Allowed Glycine 0 N--CA 1.448 -0.558 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.791 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -86.69 -162.15 0.74 Allowed 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -147.25 175.19 10.95 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.768 -0.373 . . . . 0.0 111.708 -179.468 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 43.7 m-80 62.72 54.15 2.39 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 123.936 0.773 . . . . 0.0 112.236 179.278 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -87.5 -17.25 32.54 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.179 178.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.1 p -55.21 -55.65 28.87 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 -177.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 47.4 m80 -80.96 -10.23 59.74 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.926 0.393 . . . . 0.0 111.264 -179.179 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 15.0 m -96.01 14.41 23.78 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.942 0.401 . . . . 0.0 110.79 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 19.5 m -136.56 152.93 51.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.0 0.428 . . . . 0.0 111.551 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -119.1 145.69 45.73 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.477 178.19 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 35.9 t70 49.93 74.59 0.2 Allowed 'General case' 0 N--CA 1.47 0.561 0 O-C-N 123.787 0.679 . . . . 0.0 111.662 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.504 HG22 HD22 ' A' ' 71' ' ' LEU . 75.0 mt -91.51 115.46 30.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.489 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 15.0 tptm -149.07 150.97 33.64 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 121.031 0.443 . . . . 0.0 111.532 -179.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.606 ' HG ' HD21 ' A' ' 12' ' ' LEU . 64.1 mt -88.95 129.93 35.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.383 179.35 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -86.43 -57.22 3.09 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-O 121.126 0.488 . . . . 0.0 111.186 -179.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -71.9 -5.74 36.79 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.189 -179.183 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 95.51 -0.07 63.14 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 121.014 -0.612 . . . . 0.0 111.759 -179.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 164.34 -39.55 0.31 Allowed Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.434 -0.889 . . . . 0.0 112.555 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 7.9 mmt180 -62.31 -33.48 74.76 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 32.2 ttpt -135.44 139.09 43.84 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.915 0.388 . . . . 0.0 111.962 -178.292 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.522 ' HB2' HD13 ' A' ' 90' ' ' LEU . 10.5 tt -117.55 132.81 56.47 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.485 -0.779 . . . . 0.0 109.355 179.42 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.428 HG22 ' HA3' ' A' ' 87' ' ' GLY . 18.7 p -125.64 144.78 50.44 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.937 0.398 . . . . 0.0 111.04 179.437 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 24.0 p -162.6 175.45 11.4 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.544 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 52.9 ttt180 -109.3 98.25 30.5 Favored Pre-proline 0 C--N 1.311 -1.101 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 178.616 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.528 ' CB ' HD21 ' A' ' 43' ' ' ASN . 32.1 Cg_endo -64.3 127.21 18.6 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 122.866 2.377 . . . . 0.0 110.279 179.338 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.658 ' HA ' ' HB2' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -120.28 147.56 44.83 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.068 0.461 . . . . 0.0 111.619 -179.663 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.705 HG23 ' O ' ' A' ' 82' ' ' PHE . 14.5 t -81.61 141.47 33.67 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 179.007 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.1 m -73.87 -8.3 11.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 O-C-N 123.923 0.764 . . . . 0.0 111.321 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 53.0 m-20 -63.89 -34.04 77.06 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-O 120.955 0.407 . . . . 0.0 110.312 179.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -157.0 -10.92 0.05 OUTLIER Glycine 0 CA--C 1.519 0.298 0 C-N-CA 120.468 -0.872 . . . . 0.0 113.183 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.35 18.49 42.07 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.768 -0.729 . . . . 0.0 111.881 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.705 ' O ' HG23 ' A' ' 77' ' ' THR . 39.2 p90 -111.4 157.85 19.77 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 118.677 -0.678 . . . . 0.0 109.418 -179.144 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.658 ' HB2' ' HA ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 167.36 -149.08 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.428 0 O-C-N 123.543 0.527 . . . . 0.0 111.516 179.659 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -130.31 157.04 43.62 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.088 -178.184 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.544 ' HA ' ' HA ' ' A' ' 74' ' ' ARG . 38.8 ttt85 -82.85 154.03 24.86 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 179.181 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.476 HE22 ' HD1' ' A' ' 47' ' ' PHE . 8.8 tt0 -162.57 164.57 26.74 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.795 -0.362 . . . . 0.0 111.309 -177.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.428 ' HA3' HG22 ' A' ' 72' ' ' THR . . . -128.22 146.0 16.45 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.094 179.6 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 12.3 tt -128.74 136.01 60.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 120.977 0.417 . . . . 0.0 110.305 179.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -80.34 138.85 36.76 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.057 0.456 . . . . 0.0 110.348 179.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.726 HD12 HD13 ' A' ' 19' ' ' LEU . 50.0 mt -101.98 43.38 1.07 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.804 0.811 . . . . 0.0 109.857 -179.755 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.491 ' HA ' ' OG ' ' A' ' 2' ' ' SER . 0.9 OUTLIER -76.67 0.28 20.89 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 114.689 -1.142 . . . . 0.0 111.097 -179.347 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 14.6 mtp180 -98.12 -6.11 32.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.517 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 22.8 mm -101.48 118.89 48.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 -179.131 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.435 HE22 ' HG2' ' A' ' 1' ' ' MET . 7.4 tp-100 -132.1 143.89 50.33 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.004 -178.721 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -96.92 102.92 14.8 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.654 0.74 . . . . 0.0 110.487 178.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.2 p -87.81 117.84 32.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.232 0.539 . . . . 0.0 110.047 179.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 60.43 27.18 16.78 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.228 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 95.83 -9.42 68.37 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.813 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.473 ' HD2' ' N ' ' A' ' 99' ' ' ARG . 4.0 mpt_? -99.77 124.82 45.43 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 122.394 -0.474 . . . . 0.0 110.17 -179.642 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 12.2 tp -75.76 114.99 14.99 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.977 -179.247 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 45.7 t -130.4 145.73 35.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.25 -179.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.589 ' HB2' HD13 ' A' ' 35' ' ' LEU . 11.8 t80 -78.67 135.65 37.25 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 178.538 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.947 0 CA-C-O 118.774 -0.631 . . . . 0.0 109.996 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.7 mtt . . . . . 0 N--CA 1.481 1.093 0 CA-C-O 120.647 0.26 . . . . 0.0 110.446 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -82.31 178.11 8.42 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 178.699 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.425 ' CB ' HD11 ' A' ' 100' ' ' LEU . 6.7 p90 -54.71 -39.89 68.66 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 -177.799 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.596 ' HA ' ' OG ' ' A' ' 7' ' ' SER . . . -60.62 -20.42 60.65 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -178.266 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -68.42 -35.48 77.69 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.418 0.628 . . . . 0.0 109.808 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 8.1 m -120.38 34.8 5.08 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.855 -179.12 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.596 ' OG ' ' HA ' ' A' ' 4' ' ' ALA . 92.6 p -142.73 167.14 22.79 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 121.053 0.454 . . . . 0.0 110.161 178.826 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 13.5 ptp180 -152.19 166.46 31.66 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.018 -179.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 51.0 m-80 59.31 47.57 11.25 Favored 'General case' 0 N--CA 1.466 0.367 0 O-C-N 123.646 0.591 . . . . 0.0 110.959 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -80.53 118.45 22.14 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.823 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 29.6 m -126.52 170.52 16.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.12 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.768 HD22 ' HG ' ' A' ' 64' ' ' LEU . 3.1 mm? -104.53 114.77 29.21 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.237 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.425 ' OG1' ' HB ' ' A' ' 18' ' ' THR . 14.8 p -109.89 166.37 10.98 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.736 179.742 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.521 ' O ' ' HG2' ' A' ' 17' ' ' ARG . 90.4 m-20 57.15 50.28 12.1 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.13 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 83.42 -34.2 2.91 Favored Glycine 0 N--CA 1.452 -0.27 0 CA-C-N 115.962 -0.563 . . . . 0.0 112.841 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 135.59 42.44 0.12 Allowed Glycine 0 N--CA 1.447 -0.567 0 N-CA-C 111.194 -0.762 . . . . 0.0 111.194 -179.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.521 ' HG2' ' O ' ' A' ' 14' ' ' ASN . 5.4 ptm180 -124.55 -27.53 3.7 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.95 0.405 . . . . 0.0 110.712 -179.419 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.425 ' HB ' ' OG1' ' A' ' 13' ' ' THR . 2.3 m -102.63 134.52 45.87 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.192 -179.177 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.691 HD13 HD12 ' A' ' 90' ' ' LEU . 45.9 mt -94.43 111.08 22.82 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.05 178.75 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.432 ' HA ' ' HG2' ' A' ' 34' ' ' GLU . 25.7 ttt85 -106.98 120.03 40.96 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 179.421 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -155.06 167.03 31.73 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.873 0.368 . . . . 0.0 111.247 -179.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -89.09 108.03 19.37 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 177.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.584 ' SG ' HD13 ' A' ' 100' ' ' LEU . 46.8 m -95.93 129.73 43.11 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 120.778 0.323 . . . . 0.0 110.734 -178.376 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.559 ' HB2' ' CZ3' ' A' ' 30' ' ' TRP . 11.3 ttt85 -82.82 117.63 22.84 Favored 'General case' 0 N--CA 1.438 -1.06 0 N-CA-C 110.171 -0.307 . . . . 0.0 110.171 179.167 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 32.4 p30 -80.38 166.61 21.12 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.928 179.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.84 -26.03 44.82 Favored 'General case' 0 N--CA 1.465 0.285 0 O-C-N 123.702 0.626 . . . . 0.0 112.262 -178.59 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -71.12 -16.09 62.54 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.168 0.509 . . . . 0.0 110.091 179.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 93.21 24.67 21.48 Favored Glycine 0 N--CA 1.447 -0.567 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.22 179.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.414 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 32.7 m-20 -116.55 160.01 21.27 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.851 0.357 . . . . 0.0 111.449 -179.247 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.559 ' CZ3' ' HB2' ' A' ' 24' ' ' ARG . 93.5 m95 -95.73 122.62 38.7 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.067 0.46 . . . . 0.0 111.876 -179.305 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.4 m -122.8 134.08 67.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.59 178.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 23.1 m -75.23 113.09 12.19 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.05 179.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.4 ' HB2' ' SG ' ' A' ' 23' ' ' CYS . 74.4 m -128.43 153.57 46.96 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.08 -179.601 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.58 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 49.3 mt-10 -137.93 144.54 41.29 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.768 -179.582 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.439 HD13 ' N ' ' A' ' 36' ' ' ASP . 1.8 tm? -137.86 129.28 27.91 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 178.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.439 ' N ' HD13 ' A' ' 35' ' ' LEU . 13.6 m-20 -86.88 109.74 19.51 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.417 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.469 HD12 HD22 ' A' ' 90' ' ' LEU . 3.0 mt -82.02 -18.27 43.89 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 112.57 0.581 . . . . 0.0 112.57 -178.655 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.442 ' HA ' ' HD1' ' A' ' 55' ' ' PHE . 6.7 p-10 -65.7 -6.18 10.76 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.708 0.29 . . . . 0.0 111.522 -178.56 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 46.9 p -78.76 -23.25 45.46 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.836 179.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 17.2 t -130.31 -10.77 4.14 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -179.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 49.0 mt -99.77 128.76 51.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 178.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -142.47 150.9 22.57 Favored Glycine 0 N--CA 1.442 -0.952 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.119 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.482 ' OD1' ' HB2' ' A' ' 58' ' ' SER . 31.1 p-10 -157.11 47.94 0.31 Allowed Pre-proline 0 C--N 1.323 -0.579 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -179.713 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -73.01 -17.25 25.18 Favored 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 121.638 1.558 . . . . 0.0 111.87 -179.303 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -93.09 -5.84 49.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.467 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.547 ' HA3' ' HG2' ' A' ' 83' ' ' ARG . . . 101.56 7.15 49.13 Favored Glycine 0 N--CA 1.443 -0.871 0 C-N-CA 120.334 -0.936 . . . . 0.0 112.834 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -125.45 131.55 52.86 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.015 0.436 . . . . 0.0 111.309 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 81.7 mt -83.77 137.68 33.62 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.378 -178.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 177.62 171.66 41.32 Favored Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 120.861 -0.685 . . . . 0.0 111.854 179.08 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -96.29 125.04 40.52 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.997 0.427 . . . . 0.0 110.191 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 154.85 -58.3 0.39 Allowed Glycine 0 CA--C 1.507 -0.449 0 N-CA-C 110.916 -0.874 . . . . 0.0 110.916 -179.297 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 44.7 tpp -82.93 174.3 11.04 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 178.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -132.11 176.66 8.19 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 118.654 0.661 . . . . 0.0 111.798 -179.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 15.1 m-80 64.65 43.04 4.43 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.467 -0.788 . . . . 0.0 112.342 179.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.442 ' HD1' ' HA ' ' A' ' 38' ' ' ASP . 6.3 p90 -69.12 -25.5 64.43 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.997 -0.372 . . . . 0.0 109.997 179.217 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 9.4 p -58.24 -42.7 86.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.355 -179.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 41.4 m80 -80.26 -9.99 59.74 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.011 0.434 . . . . 0.0 111.215 -179.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.656 ' HA ' ' HD2' ' A' ' 76' ' ' LYS . 10.2 m -113.28 18.26 17.97 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.604 -178.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 23.5 m -131.85 143.64 50.32 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-O 121.158 0.504 . . . . 0.0 111.336 179.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 67.2 mm-40 -113.58 134.51 54.67 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.675 178.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 23.9 t70 57.34 79.6 0.19 Allowed 'General case' 0 C--N 1.322 -0.601 0 O-C-N 123.994 0.809 . . . . 0.0 111.33 -179.236 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.506 HG23 HD22 ' A' ' 71' ' ' LEU . 75.6 mt -91.6 123.57 43.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.882 179.691 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 27.8 tptt -149.05 149.88 31.85 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 110.156 -0.312 . . . . 0.0 110.156 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.768 ' HG ' HD22 ' A' ' 12' ' ' LEU . 70.3 mt -85.89 141.27 29.7 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.188 0.518 . . . . 0.0 110.608 179.233 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -100.68 -70.84 0.72 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.432 -0.804 . . . . 0.0 112.515 -178.283 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -74.67 49.0 0.38 Allowed 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -178.185 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 64.95 7.97 32.68 Favored Glycine 0 C--N 1.32 -0.326 0 CA-C-N 115.938 -0.574 . . . . 0.0 112.848 179.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.556 ' HA2' HD12 ' A' ' 64' ' ' LEU . . . 127.26 -3.3 7.24 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.645 -0.788 . . . . 0.0 113.122 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 29.9 ttp85 -95.43 0.38 53.31 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.793 0.806 . . . . 0.0 110.317 -179.448 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -147.69 129.49 15.21 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.403 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.536 ' HB2' HD13 ' A' ' 90' ' ' LEU . 10.0 tt -105.82 118.98 37.99 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 179.599 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.5 p -108.79 128.1 54.59 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.018 179.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 26.5 p -157.74 172.11 19.09 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.054 -179.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.496 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 78.9 ttt180 -108.16 100.44 36.82 Favored Pre-proline 0 C--N 1.31 -1.112 0 C-N-CA 120.225 -0.59 . . . . 0.0 109.971 178.614 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.477 ' CB ' HD21 ' A' ' 43' ' ' ASN . 19.2 Cg_endo -60.29 130.46 34.13 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 122.655 2.237 . . . . 0.0 110.246 178.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.656 ' HD2' ' HA ' ' A' ' 58' ' ' SER . 0.0 OUTLIER -119.97 154.14 34.93 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.256 0.551 . . . . 0.0 111.665 -179.133 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.691 ' HB ' ' CD ' ' A' ' 83' ' ' ARG . 6.3 t -94.08 147.64 22.94 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.69 -0.687 . . . . 0.0 109.551 179.131 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.4 p -72.34 -6.67 8.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 O-C-N 123.834 0.709 . . . . 0.0 111.941 -178.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -65.39 -23.15 66.89 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.108 0.48 . . . . 0.0 110.367 179.212 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -177.8 -8.99 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.987 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 94.42 22.1 25.27 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.707 -0.759 . . . . 0.0 111.72 179.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.606 ' O ' HG23 ' A' ' 77' ' ' THR . 26.7 p90 -111.33 153.1 26.45 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 -179.367 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.691 ' CD ' ' HB ' ' A' ' 77' ' ' THR . 0.0 OUTLIER 171.63 -148.39 0.0 OUTLIER 'General case' 0 C--O 1.233 0.224 0 O-C-N 123.683 0.614 . . . . 0.0 110.956 179.958 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -123.4 160.14 27.45 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.173 -177.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.496 ' HA ' ' HA ' ' A' ' 74' ' ' ARG . 41.8 ttt180 -86.66 155.09 20.54 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 179.562 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -163.99 169.32 18.16 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 121.091 0.472 . . . . 0.0 110.992 -178.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -136.85 133.06 6.29 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.841 -0.695 . . . . 0.0 111.686 179.169 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 10.1 tt -115.28 134.51 58.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-O 121.047 0.451 . . . . 0.0 110.18 -179.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -80.26 141.14 35.83 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.142 -179.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.691 HD12 HD13 ' A' ' 19' ' ' LEU . 16.6 mt -106.73 43.5 1.15 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.455 0.645 . . . . 0.0 110.887 -178.343 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 45.4 m-80 -79.63 3.28 19.52 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.463 -179.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 32.6 mtp180 -93.69 -9.89 36.28 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.576 178.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 17.2 mm -96.02 112.1 27.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 -179.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -119.1 147.01 44.63 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.149 -178.044 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 16.8 p-10 -95.6 102.89 14.73 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.51 0.671 . . . . 0.0 109.602 178.12 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 46.7 t -92.05 105.94 17.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.971 -179.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 60.7 33.88 20.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.842 -179.488 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 94.98 -23.03 35.03 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 121.037 -0.601 . . . . 0.0 113.007 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 3.7 mpt_? -87.13 129.39 34.95 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.945 0.373 . . . . 0.0 110.107 -179.181 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.584 HD13 ' SG ' ' A' ' 23' ' ' CYS . 6.7 tp -78.38 117.64 19.8 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -179.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 25.4 t -128.93 141.03 47.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.262 -179.155 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -86.55 135.0 33.61 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 178.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.596 ' HA ' HE21 ' A' ' 103' ' ' GLN . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.178 0 CA-C-O 118.506 -0.759 . . . . 0.0 110.234 179.43 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.0 mpp? . . . . . 0 N--CA 1.479 0.999 0 CA-C-O 120.921 0.391 . . . . 0.0 110.158 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.1 m -118.55 179.53 4.1 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.645 -179.482 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.501 ' HA ' ' OD1' ' A' ' 95' ' ' ASN . 11.0 p90 -57.49 -35.19 69.88 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.666 -0.243 . . . . 0.0 111.298 179.245 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -57.29 -22.24 40.37 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -178.978 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -66.27 -13.6 60.68 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.05 0.453 . . . . 0.0 110.977 179.565 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 11.0 p -149.25 33.98 0.73 Allowed 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 178.814 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 15.9 t -146.95 150.7 35.7 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.021 -179.268 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 34.6 ptt180 -129.55 164.5 23.67 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.666 -179.232 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 51.25 65.32 1.52 Allowed 'General case' 0 C--N 1.329 -0.299 0 O-C-N 123.826 0.704 . . . . 0.0 112.151 178.503 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.414 ' HA ' ' HB1' ' A' ' 21' ' ' ALA . . . -91.3 117.85 30.0 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.155 179.449 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 33.8 m -119.39 166.95 13.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.881 -179.372 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.617 HD23 ' HG ' ' A' ' 64' ' ' LEU . 3.1 mm? -105.22 117.14 33.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.014 -179.734 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.474 ' OG1' ' HB ' ' A' ' 18' ' ' THR . 23.5 p -111.29 164.21 13.14 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.639 -179.65 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 62.26 39.08 12.86 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.71 179.265 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 84.62 -8.47 68.77 Favored Glycine 0 CA--C 1.517 0.179 0 C-N-CA 120.742 -0.742 . . . . 0.0 113.325 179.144 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 114.09 53.88 0.43 Allowed Glycine 0 N--CA 1.443 -0.873 0 C-N-CA 120.527 -0.844 . . . . 0.0 111.383 179.421 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.4 ptm180 -137.78 -34.01 0.69 Allowed 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.088 0.471 . . . . 0.0 110.573 -179.91 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.474 ' HB ' ' OG1' ' A' ' 13' ' ' THR . 4.2 m -102.36 135.06 44.65 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.54 -179.798 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.725 HD13 HD12 ' A' ' 90' ' ' LEU . 62.6 mt -94.95 116.4 28.65 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.218 179.136 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 33.5 ttm180 -111.4 120.39 42.0 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 178.732 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.414 ' HB1' ' HA ' ' A' ' 10' ' ' ALA . . . -153.7 165.34 36.29 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.862 0.363 . . . . 0.0 111.418 -179.526 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -91.44 106.0 18.17 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 177.801 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 64.0 m -96.01 134.89 38.49 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 120.911 0.386 . . . . 0.0 110.984 -178.495 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.484 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 15.1 ttp180 -77.54 111.41 13.24 Favored 'General case' 0 N--CA 1.439 -0.999 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.052 179.558 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 38.2 p30 -75.71 169.38 18.22 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.48 -179.786 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.86 -33.29 64.42 Favored 'General case' 0 C--O 1.235 0.296 0 O-C-N 123.416 0.447 . . . . 0.0 111.718 -179.151 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -68.22 -14.69 63.17 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.327 0.584 . . . . 0.0 110.677 179.969 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 88.66 37.56 7.38 Favored Glycine 0 N--CA 1.447 -0.589 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 -179.504 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.484 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 53.7 t30 -124.81 164.16 20.6 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.496 0.189 . . . . 0.0 110.891 -179.082 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 91.1 m95 -98.05 124.89 42.77 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.885 179.587 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.4 m -128.42 137.88 56.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.028 178.544 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 37.4 m -84.1 109.32 17.61 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.002 0.43 . . . . 0.0 111.055 -179.048 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 69.6 m -119.09 148.8 42.64 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.138 179.409 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.638 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 45.4 mt-10 -127.86 145.33 50.97 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.867 -179.955 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.765 HD12 ' HB2' ' A' ' 102' ' ' PHE . 1.8 tm? -139.71 130.58 26.12 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 179.507 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.484 ' N ' HD11 ' A' ' 35' ' ' LEU . 39.7 m-20 -87.26 110.53 20.26 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.002 179.825 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.469 HD11 ' HG ' ' A' ' 19' ' ' LEU . 1.8 mt -84.86 -20.79 30.27 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.845 0.355 . . . . 0.0 110.871 -179.923 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.413 ' HA ' ' HD1' ' A' ' 55' ' ' PHE . 5.6 p-10 -67.35 -5.88 16.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.983 -178.195 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.43 HG22 ' O ' ' A' ' 36' ' ' ASP . 10.6 t -84.65 -8.51 58.85 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.867 0.365 . . . . 0.0 110.358 179.415 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 21.8 t -140.49 -5.41 1.22 Allowed 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 179.511 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 59.5 mt -106.95 136.7 41.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 O-C-N 122.036 -0.415 . . . . 0.0 109.882 178.957 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -146.72 154.38 25.94 Favored Glycine 0 N--CA 1.443 -0.846 0 C-N-CA 120.89 -0.671 . . . . 0.0 111.777 179.553 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 27.6 p30 -155.28 48.15 0.36 Allowed Pre-proline 0 CA--C 1.537 0.454 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 179.986 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -68.69 -23.75 35.83 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 121.722 1.614 . . . . 0.0 112.238 -179.084 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 72.0 m-20 -91.94 0.59 57.47 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.923 -179.582 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.526 ' CA ' ' HG2' ' A' ' 83' ' ' ARG . . . 93.05 7.28 62.59 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.287 -0.959 . . . . 0.0 112.049 -179.301 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.567 ' HA ' HE22 ' A' ' 86' ' ' GLN . 47.7 m-85 -122.55 133.95 54.55 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.851 0.357 . . . . 0.0 110.807 179.831 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 34.0 mt -84.5 147.89 26.81 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.536 -0.757 . . . . 0.0 111.664 -179.172 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 170.37 168.95 32.91 Favored Glycine 0 N--CA 1.441 -1.023 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.974 179.121 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 89.1 m95 -95.64 125.33 40.15 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 179.975 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 161.77 -53.72 0.32 Allowed Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 121.026 -0.607 . . . . 0.0 112.249 -179.696 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 4.1 tpt -90.92 -164.82 1.23 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 -179.952 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -146.3 170.58 16.5 Favored 'General case' 0 C--O 1.234 0.275 0 O-C-N 122.025 -0.422 . . . . 0.0 111.939 -178.815 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 42.2 m-80 64.0 36.13 10.17 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.454 -0.794 . . . . 0.0 112.599 178.991 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.413 ' HD1' ' HA ' ' A' ' 38' ' ' ASP . 8.0 p90 -65.23 -29.75 70.58 Favored 'General case' 0 C--O 1.224 -0.288 0 CA-C-O 120.684 0.278 . . . . 0.0 111.193 -179.896 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 13.4 t -57.07 -36.69 70.85 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -178.315 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 13.3 m-70 -80.82 -6.56 58.72 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.151 0.5 . . . . 0.0 110.984 -179.528 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 12.9 m -119.03 25.78 9.96 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.118 -179.987 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.513 ' HB2' HD11 ' A' ' 62' ' ' ILE . 11.6 m -137.3 140.23 41.4 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-O 121.059 0.457 . . . . 0.0 111.321 179.788 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -108.71 141.2 41.04 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.179 179.063 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 39.1 t70 52.35 75.94 0.21 Allowed 'General case' 0 C--N 1.32 -0.7 0 O-C-N 123.998 0.811 . . . . 0.0 111.402 179.95 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.514 HG22 HD23 ' A' ' 71' ' ' LEU . 81.6 mt -90.22 122.25 41.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.235 179.591 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.7 tptm -146.97 160.32 42.5 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.124 -178.892 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.617 ' HG ' HD23 ' A' ' 12' ' ' LEU . 55.8 mt -93.66 130.01 39.75 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.267 0.556 . . . . 0.0 110.012 178.602 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 45.2 tp10 -77.71 -66.33 0.85 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.39 -178.108 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -88.68 31.43 0.84 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.189 -178.889 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 68.04 17.91 70.3 Favored Glycine 0 N--CA 1.446 -0.638 0 CA-C-N 115.8 -0.636 . . . . 0.0 113.091 179.83 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.512 ' HA2' HD22 ' A' ' 64' ' ' LEU . . . 137.14 -21.96 3.28 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 119.828 -1.177 . . . . 0.0 113.3 179.184 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.444 HH11 ' HD2' ' A' ' 69' ' ' ARG . 0.8 OUTLIER -76.74 -21.05 55.81 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.579 0.704 . . . . 0.0 109.987 -179.642 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 2.6 ttmp? -148.43 138.46 22.42 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.094 -178.708 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.563 ' HB2' HD13 ' A' ' 90' ' ' LEU . 10.2 tt -108.89 124.96 51.46 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.309 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.1 p -116.16 127.77 55.08 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.544 0.687 . . . . 0.0 111.014 179.561 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 26.6 p -153.51 175.86 12.7 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.314 -179.721 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.571 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 12.0 ttt180 -108.33 98.74 28.77 Favored Pre-proline 0 C--N 1.31 -1.114 0 C-N-CA 120.623 -0.431 . . . . 0.0 110.007 178.654 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.436 ' HD2' ' HA ' ' A' ' 74' ' ' ARG . 49.4 Cg_endo -67.12 122.54 9.86 Favored 'Trans proline' 0 CA--C 1.516 -0.4 0 C-N-CA 122.835 2.357 . . . . 0.0 110.82 179.478 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.708 ' HA ' ' HB2' ' A' ' 83' ' ' ARG . 0.3 OUTLIER -120.29 147.04 45.5 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-O 120.914 0.388 . . . . 0.0 111.564 -179.333 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.736 HG22 ' O ' ' A' ' 82' ' ' PHE . 7.9 t -74.84 137.82 42.11 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 178.988 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 29.6 m -73.2 -12.33 15.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 123.82 0.7 . . . . 0.0 111.355 -179.635 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -63.55 -33.38 75.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.652 179.379 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.552 ' HA3' ' CE2' ' A' ' 82' ' ' PHE . . . -145.81 -23.07 0.12 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.42 -0.895 . . . . 0.0 113.088 179.73 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 98.68 14.7 36.6 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 121.049 -0.596 . . . . 0.0 111.877 -179.706 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.736 ' O ' HG22 ' A' ' 77' ' ' THR . 28.2 p90 -112.48 154.26 26.15 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 119.029 -0.51 . . . . 0.0 110.608 -178.492 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.708 ' HB2' ' HA ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 167.38 -153.13 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.461 0 O-C-N 123.745 0.653 . . . . 0.0 111.202 178.308 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -116.48 -177.34 3.16 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.143 -177.24 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.571 ' HA ' ' HA ' ' A' ' 74' ' ' ARG . 68.0 ttt180 -107.21 155.31 20.05 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 178.783 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.567 HE22 ' HA ' ' A' ' 47' ' ' PHE . 8.9 tt0 -166.37 167.74 15.57 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 120.87 0.366 . . . . 0.0 111.491 -178.976 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.45 ' N ' ' HG2' ' A' ' 86' ' ' GLN . . . -130.39 144.08 15.4 Favored Glycine 0 N--CA 1.45 -0.428 0 N-CA-C 111.564 -0.614 . . . . 0.0 111.564 178.601 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 9.4 tt -126.57 138.92 53.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 120.93 0.395 . . . . 0.0 110.517 -179.846 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -77.42 135.91 38.35 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.369 179.811 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.725 HD12 HD13 ' A' ' 19' ' ' LEU . 53.9 mt -105.38 39.43 1.74 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.688 -179.884 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 18.8 m-80 -75.35 2.53 11.03 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.104 -179.541 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 49.0 mtp180 -95.88 -10.48 28.72 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.657 -0.702 . . . . 0.0 109.967 178.33 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 20.9 mm -100.66 99.51 8.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -179.764 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 24.4 tp60 -115.98 143.14 45.85 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.089 -178.485 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.501 ' OD1' ' HA ' ' A' ' 3' ' ' TYR . 15.0 p-10 -95.18 122.81 38.25 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.008 178.728 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.3 p -115.04 115.75 50.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-O 121.16 0.505 . . . . 0.0 109.944 179.313 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 32.1 m-80 60.37 28.3 17.92 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.709 -179.166 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 94.77 -14.94 64.4 Favored Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 120.804 -0.712 . . . . 0.0 113.048 179.915 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.468 ' HD2' ' N ' ' A' ' 99' ' ' ARG . 3.3 mpt_? -91.7 131.93 36.74 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 117.158 0.479 . . . . 0.0 110.559 -179.12 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 8.5 tp -84.29 116.54 23.05 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.251 -179.28 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 24.4 t -125.54 140.3 48.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 120.798 0.332 . . . . 0.0 110.914 -179.287 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.765 ' HB2' HD12 ' A' ' 35' ' ' LEU . 3.9 t80 -91.67 124.37 35.76 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 178.396 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 . . . . . 0 C--N 1.314 -0.969 0 CA-C-O 118.002 -0.999 . . . . 0.0 110.955 179.82 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.8 mpp? . . . . . 0 N--CA 1.481 1.12 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.578 ' OG ' ' HA ' ' A' ' 91' ' ' ASN . 3.3 m -116.89 173.48 6.62 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.97 179.372 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.551 ' HA ' ' OD1' ' A' ' 95' ' ' ASN . 23.4 p90 -58.31 -37.65 75.5 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.53 0.205 . . . . 0.0 111.446 -179.892 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -55.09 -19.2 6.77 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.792 -0.64 . . . . 0.0 112.623 -178.794 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -59.15 -38.15 79.03 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.389 0.614 . . . . 0.0 109.956 179.168 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 49.2 m -133.08 46.5 2.6 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.15 179.086 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.424 ' HA ' ' HZ3' ' A' ' 30' ' ' TRP . 16.5 t -148.79 152.18 36.09 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.22 -179.329 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 3.9 ptp180 -149.39 171.69 16.14 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.314 -179.846 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 49.1 m-80 62.96 45.84 5.16 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 122.959 0.504 . . . . 0.0 110.437 -179.286 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -83.16 118.07 23.34 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.996 -179.718 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 27.1 m -126.24 170.69 15.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.193 179.519 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.51 HD22 ' HG ' ' A' ' 64' ' ' LEU . 3.0 mm? -105.37 117.64 34.53 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 -179.332 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 28.0 p -113.87 162.17 16.69 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.974 0.416 . . . . 0.0 111.508 -179.745 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 64.32 30.33 13.39 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.526 179.652 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 95.92 -18.87 56.64 Favored Glycine 0 C--O 1.228 -0.255 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.755 179.46 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 123.47 42.6 0.38 Allowed Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.508 -0.853 . . . . 0.0 111.768 179.78 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -126.77 -29.02 2.9 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.096 0.474 . . . . 0.0 110.541 -179.91 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 4.9 m -104.53 134.25 48.02 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.555 -179.877 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.776 HD13 HD13 ' A' ' 90' ' ' LEU . 33.6 mt -94.23 113.32 25.22 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.118 179.02 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 45.1 ttt180 -106.96 119.51 39.57 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 178.843 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -154.12 166.36 33.32 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.878 0.37 . . . . 0.0 111.151 -179.762 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 56.2 mm-40 -90.71 113.45 25.54 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 178.276 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.44 ' SG ' HD13 ' A' ' 100' ' ' LEU . 60.4 m -100.31 123.53 44.66 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 110.34 -0.245 . . . . 0.0 110.34 -178.957 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.495 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 11.7 ttp180 -72.6 114.47 10.77 Favored 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 179.015 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 35.4 p30 -77.66 171.04 15.54 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.85 -179.23 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.36 -33.87 63.77 Favored 'General case' 0 N--CA 1.464 0.252 0 O-C-N 123.675 0.609 . . . . 0.0 111.917 -178.776 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -67.92 -18.69 64.85 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.361 0.601 . . . . 0.0 110.613 -179.851 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 93.69 33.66 6.97 Favored Glycine 0 N--CA 1.443 -0.849 0 N-CA-C 111.085 -0.806 . . . . 0.0 111.085 -179.475 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.495 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 10.8 t-20 -118.49 159.89 22.71 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 110.013 -0.365 . . . . 0.0 110.013 -179.221 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.424 ' HZ3' ' HA ' ' A' ' 7' ' ' SER . 95.5 m95 -98.37 117.67 33.31 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.855 0.36 . . . . 0.0 110.6 179.918 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 12.5 m -119.23 132.27 69.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.38 178.773 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 27.9 m -74.86 110.36 9.09 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.021 0.439 . . . . 0.0 110.231 -179.624 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 60.7 m -121.29 145.62 47.68 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.599 -179.606 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.589 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 50.4 mt-10 -129.03 130.59 46.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.931 -179.505 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.417 HD12 ' N ' ' A' ' 36' ' ' ASP . 2.4 tm? -124.86 131.62 53.42 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.437 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.417 ' N ' HD12 ' A' ' 35' ' ' LEU . 9.0 m-20 -89.78 109.16 20.17 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.841 0.353 . . . . 0.0 110.189 -179.114 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.472 HD13 ' CD1' ' A' ' 19' ' ' LEU . 2.4 mt -81.87 -17.84 45.9 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.164 -179.494 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -62.18 -10.18 9.78 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.817 0.342 . . . . 0.0 111.149 -179.317 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 59.5 p -78.99 -20.4 49.18 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.191 179.585 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.425 ' SG ' ' HE3' ' A' ' 50' ' ' TRP . 20.5 t -132.36 -8.66 3.32 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -179.191 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 53.9 mt -104.69 133.45 48.79 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 O-C-N 122.132 -0.355 . . . . 0.0 110.225 178.777 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -147.84 160.28 28.27 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.921 -0.657 . . . . 0.0 111.823 179.91 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.419 HD21 ' CD1' ' A' ' 48' ' ' LEU . 21.6 p30 -162.3 54.15 0.46 Allowed Pre-proline 0 CA--C 1.537 0.45 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -179.799 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -72.16 -18.17 27.32 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 121.923 1.749 . . . . 0.0 112.311 -179.242 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -93.25 -16.51 24.69 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.437 179.822 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.496 ' HA3' ' HG2' ' A' ' 83' ' ' ARG . . . 109.82 9.64 24.3 Favored Glycine 0 N--CA 1.442 -0.964 0 C-N-CA 120.467 -0.873 . . . . 0.0 112.542 -179.333 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.488 ' HD1' HE22 ' A' ' 86' ' ' GLN . 54.6 m-85 -125.55 134.67 51.9 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.872 0.368 . . . . 0.0 110.623 179.716 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.575 HD22 HG22 ' A' ' 88' ' ' ILE . 10.5 mp -84.23 142.91 29.94 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.345 0.593 . . . . 0.0 111.848 -178.603 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 176.96 171.33 40.44 Favored Glycine 0 N--CA 1.439 -1.148 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.611 178.956 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.425 ' HE3' ' SG ' ' A' ' 40' ' ' CYS . 91.4 m95 -96.11 124.74 40.23 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 179.835 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 160.2 -58.81 0.31 Allowed Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 121.21 -0.519 . . . . 0.0 111.873 -179.708 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 12.8 tpt -85.89 175.2 8.77 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 -179.893 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -128.8 167.0 17.95 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.722 -0.391 . . . . 0.0 111.075 -179.712 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 11.3 m-80 64.56 49.79 2.3 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.449 179.026 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 21.1 p90 -68.48 -31.2 70.31 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.07 0.462 . . . . 0.0 110.187 179.021 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.412 ' HA ' HD13 ' A' ' 62' ' ' ILE . 3.5 p -56.53 -38.16 71.48 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.591 -178.699 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 22.4 m80 -72.49 -30.94 64.96 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.632 0.253 . . . . 0.0 111.331 -179.52 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 14.1 m -96.88 18.36 14.74 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.011 -179.488 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 45.4 m -130.79 165.31 23.25 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.199 0.523 . . . . 0.0 111.491 -179.756 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -137.64 136.14 37.19 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.245 -0.889 . . . . 0.0 108.95 178.589 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 37.0 t70 58.88 80.22 0.19 Allowed 'General case' 0 N--CA 1.467 0.425 0 O-C-N 123.649 0.593 . . . . 0.0 110.86 -179.705 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.473 HG23 HD21 ' A' ' 71' ' ' LEU . 59.9 mt -100.95 122.16 52.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.261 -179.13 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 72.9 tttt -149.22 165.1 32.89 Favored 'General case' 0 C--O 1.221 -0.407 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 179.466 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.51 ' HG ' HD22 ' A' ' 12' ' ' LEU . 71.2 mt -90.84 127.39 36.34 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.068 0.461 . . . . 0.0 111.072 -179.603 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -76.29 -57.97 3.55 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.443 -0.798 . . . . 0.0 110.676 -179.179 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -85.03 11.84 8.81 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.789 -179.521 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 71.61 28.07 69.98 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.383 179.973 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 136.86 -34.48 2.21 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.207 -0.996 . . . . 0.0 112.627 179.448 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 2.1 tpp180 -75.62 -18.47 59.69 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.116 0.484 . . . . 0.0 110.589 -179.551 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -151.42 141.88 22.53 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.067 -178.804 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.534 ' HB2' HD11 ' A' ' 90' ' ' LEU . 10.5 tt -110.52 128.62 55.72 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.104 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.2 p -123.16 128.11 49.6 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.317 0.58 . . . . 0.0 111.293 -179.905 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 20.5 p -151.94 169.91 21.15 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.516 179.875 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.596 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 29.4 ttt180 -106.35 99.73 25.64 Favored Pre-proline 0 C--N 1.321 -0.645 0 C-N-CA 120.263 -0.575 . . . . 0.0 110.492 179.126 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.429 ' HB2' ' HA2' ' A' ' 46' ' ' GLY . 60.5 Cg_endo -71.75 137.85 30.68 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 122.622 2.215 . . . . 0.0 110.273 178.718 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.658 ' HA ' ' HB2' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -121.39 140.68 51.82 Favored 'General case' 0 C--N 1.317 -0.807 0 O-C-N 123.483 0.49 . . . . 0.0 111.113 -179.883 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.725 HG23 ' O ' ' A' ' 82' ' ' PHE . 12.5 t -75.61 138.86 41.71 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 179.291 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 34.7 m -73.18 -9.78 13.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 O-C-N 124.122 0.889 . . . . 0.0 111.199 -179.826 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -66.92 -31.39 71.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.054 179.673 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.407 ' HA3' ' CE2' ' A' ' 82' ' ' PHE . . . -154.48 -12.49 0.06 OUTLIER Glycine 0 CA--C 1.521 0.428 0 C-N-CA 120.519 -0.848 . . . . 0.0 113.359 179.751 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.25 16.25 53.88 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.959 -0.639 . . . . 0.0 112.082 -179.792 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.725 ' O ' HG23 ' A' ' 77' ' ' THR . 35.4 p90 -111.76 158.35 19.45 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 118.694 -0.669 . . . . 0.0 109.612 -178.866 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.658 ' HB2' ' HA ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 171.37 -148.25 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 179.431 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -142.99 152.49 42.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.373 -0.831 . . . . 0.0 109.496 -178.195 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.596 ' HA ' ' HA ' ' A' ' 74' ' ' ARG . 27.8 ttt85 -77.84 150.43 34.22 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 123.229 0.331 . . . . 0.0 110.123 -179.794 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.488 HE22 ' HD1' ' A' ' 47' ' ' PHE . 8.9 tt0 -155.58 158.85 39.07 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.317 -178.806 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -123.32 144.34 15.58 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.088 179.412 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.575 HG22 HD22 ' A' ' 48' ' ' LEU . 12.8 tt -123.96 135.04 64.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 179.563 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -77.1 140.92 40.4 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.068 0.461 . . . . 0.0 110.017 -179.882 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.776 HD13 HD13 ' A' ' 19' ' ' LEU . 26.4 mt -106.35 41.17 1.47 Allowed 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.334 0.588 . . . . 0.0 110.765 -179.424 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.578 ' HA ' ' OG ' ' A' ' 2' ' ' SER . 28.8 m-80 -75.06 2.85 9.62 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.763 -179.96 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 9.7 mtp180 -96.72 -16.54 20.84 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.165 179.797 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 22.4 mm -92.73 114.36 29.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 109.684 -0.488 . . . . 0.0 109.684 -178.904 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 23.1 tp60 -124.6 141.46 52.08 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.356 0.598 . . . . 0.0 111.545 -178.157 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.551 ' OD1' ' HA ' ' A' ' 3' ' ' TYR . 13.1 p-10 -94.62 102.22 14.13 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.673 178.176 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.7 p -90.56 110.41 22.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.504 -179.348 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 60.42 27.32 16.92 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.14 -179.919 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 100.29 -17.04 57.48 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.735 -0.745 . . . . 0.0 113.225 179.739 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.412 ' HD2' ' N ' ' A' ' 99' ' ' ARG . 1.7 mpt_? -91.53 126.09 36.49 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 117.23 0.515 . . . . 0.0 109.871 -179.541 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.44 HD13 ' SG ' ' A' ' 23' ' ' CYS . 11.2 tp -82.84 114.03 20.87 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.233 -179.203 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 38.4 t -131.47 146.48 33.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 120.694 0.283 . . . . 0.0 110.321 -179.338 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.417 ' HB2' HD13 ' A' ' 35' ' ' LEU . 11.7 t80 -78.67 133.94 37.17 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 178.771 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 . . . . . 0 C--O 1.247 0.951 0 CA-C-O 118.632 -0.699 . . . . 0.0 110.067 179.824 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.8 ptp . . . . . 0 N--CA 1.482 1.168 0 CA-C-O 120.724 0.297 . . . . 0.0 110.548 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.839 ' HB2' ' HG2' ' A' ' 69' ' ' ARG . 4.7 m -116.75 174.67 5.95 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.848 179.441 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.421 ' CD2' HD13 ' A' ' 100' ' ' LEU . 4.2 p90 -59.85 -33.27 71.56 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.228 -0.442 . . . . 0.0 112.032 -179.713 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.581 ' HA ' ' OG ' ' A' ' 7' ' ' SER . . . -55.16 -18.41 5.72 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -178.167 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -58.32 -42.85 87.65 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.976 0.417 . . . . 0.0 111.166 179.727 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 25.6 m -123.02 38.44 4.19 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 121.044 0.45 . . . . 0.0 110.903 -179.486 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.581 ' OG ' ' HA ' ' A' ' 4' ' ' ALA . 52.5 p -141.28 168.19 20.37 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.21 179.143 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 37.1 ptt180 -149.76 168.23 24.27 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.005 -178.564 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 55.25 43.24 29.52 Favored 'General case' 0 C--N 1.33 -0.244 0 O-C-N 124.089 0.868 . . . . 0.0 112.203 178.078 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -72.28 117.0 13.38 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 179.251 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.447 HG21 HH21 ' A' ' 20' ' ' ARG . 27.8 m -124.0 172.74 11.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.713 -179.423 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.558 HD22 ' HG ' ' A' ' 64' ' ' LEU . 3.7 mm? -104.74 115.81 30.95 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.775 -179.311 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 27.9 p -112.45 161.08 17.11 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.666 179.387 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 59.25 44.58 15.35 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.17 179.553 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 87.35 -23.61 11.62 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.218 -179.715 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 124.85 17.01 2.88 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 121.109 -0.567 . . . . 0.0 111.894 -179.867 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.684 ' HB2' ' HB2' ' A' ' 38' ' ' ASP . 3.6 ptm180 -95.78 -22.05 17.75 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.227 0.537 . . . . 0.0 110.375 -179.609 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.7 m -111.29 135.99 51.03 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.788 -178.978 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.679 HD12 HD13 ' A' ' 90' ' ' LEU . 41.8 mt -97.46 112.55 24.35 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.768 179.361 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.447 HH21 HG21 ' A' ' 11' ' ' VAL . 30.5 ttp180 -105.1 120.65 42.03 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 178.439 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -152.97 162.41 41.35 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.906 0.384 . . . . 0.0 111.062 -179.878 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -90.84 105.75 18.04 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 178.439 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.55 ' SG ' HD12 ' A' ' 100' ' ' LEU . 40.2 m -94.21 132.09 39.12 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 -179.449 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 8.0 ttp180 -84.28 116.46 23.0 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-O 120.776 0.322 . . . . 0.0 110.747 -179.886 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 31.4 p30 -82.07 162.23 22.63 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.086 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.49 -21.72 17.78 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -178.68 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -74.69 -13.77 60.66 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.317 0.58 . . . . 0.0 110.195 179.764 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 89.74 32.13 10.47 Favored Glycine 0 N--CA 1.449 -0.456 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.93 179.987 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 -124.47 151.62 44.34 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.826 0.346 . . . . 0.0 111.364 -179.519 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 93.9 m95 -90.96 120.59 32.09 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.568 179.384 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -118.56 127.3 75.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 116.247 -0.433 . . . . 0.0 109.918 178.079 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 25.5 m -76.48 111.52 12.04 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.194 179.935 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 66.7 m -123.06 145.66 48.35 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.906 -179.376 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.592 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 44.8 mt-10 -124.91 133.07 53.19 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.882 179.708 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.699 HD13 ' HB2' ' A' ' 102' ' ' PHE . 1.5 tm? -125.42 131.59 52.89 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.167 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.45 ' O ' HG21 ' A' ' 39' ' ' THR . 14.5 m-20 -90.05 110.27 21.27 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.012 0.434 . . . . 0.0 110.241 -179.779 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.486 HD12 ' HG ' ' A' ' 19' ' ' LEU . 1.5 mt -83.8 -23.89 31.25 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.031 -179.749 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.719 ' OD2' ' HA ' ' A' ' 54' ' ' ASN . 20.9 t70 -60.49 -15.14 24.06 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.19 -0.459 . . . . 0.0 112.151 -178.647 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.45 HG21 ' O ' ' A' ' 36' ' ' ASP . 11.6 t -77.44 -14.48 59.69 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.721 -0.218 . . . . 0.0 111.387 -179.656 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.413 ' SG ' ' HE3' ' A' ' 50' ' ' TRP . 42.5 t -134.33 -0.79 2.94 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -179.609 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.443 ' HB ' ' CD1' ' A' ' 55' ' ' PHE . 60.4 mt -108.84 135.24 48.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 178.589 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -138.61 156.53 24.2 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.095 -179.826 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 39.9 p-10 -164.81 43.79 0.09 OUTLIER Pre-proline 0 CA--C 1.542 0.664 0 N-CA-C 113.102 0.778 . . . . 0.0 113.102 -179.377 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -73.17 -22.65 18.92 Favored 'Trans proline' 0 C--N 1.354 0.858 0 C-N-CA 121.661 1.574 . . . . 0.0 112.346 -178.913 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -84.4 -14.11 50.31 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.819 179.923 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.487 ' CA ' ' HG2' ' A' ' 83' ' ' ARG . . . 107.29 8.17 31.49 Favored Glycine 0 N--CA 1.444 -0.81 0 C-N-CA 120.301 -0.952 . . . . 0.0 111.994 -178.866 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.56 ' HA ' HE22 ' A' ' 86' ' ' GLN . 71.3 m-85 -125.91 139.1 53.73 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 110.391 -0.226 . . . . 0.0 110.391 179.82 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 7.8 mp -89.89 151.04 21.94 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.225 0.536 . . . . 0.0 111.975 -178.931 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 167.24 170.99 32.79 Favored Glycine 0 N--CA 1.444 -0.782 0 CA-C-N 115.601 -0.727 . . . . 0.0 112.122 178.469 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.417 ' CD1' HD13 ' A' ' 88' ' ' ILE . 90.8 m95 -95.73 132.24 41.15 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 179.98 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 156.42 -63.08 0.33 Allowed Glycine 0 N--CA 1.451 -0.355 0 N-CA-C 111.573 -0.611 . . . . 0.0 111.573 179.915 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 39.7 ttm -88.63 176.63 7.04 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 179.34 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -130.65 172.41 11.98 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 118.288 0.495 . . . . 0.0 111.654 -179.294 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.719 ' HA ' ' OD2' ' A' ' 38' ' ' ASP . 36.0 m-80 68.54 46.85 0.95 Allowed 'General case' 0 C--O 1.234 0.263 0 O-C-N 123.945 0.778 . . . . 0.0 111.697 179.129 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.443 ' CD1' ' HB ' ' A' ' 41' ' ' ILE . 13.7 p90 -76.6 -26.88 55.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.517 179.78 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 7.1 m -62.69 -30.45 71.41 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.199 0.523 . . . . 0.0 110.97 -178.694 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 17.7 m-70 -82.11 -3.54 55.0 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.754 -179.519 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 42.4 m -128.29 28.69 5.45 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.112 0.482 . . . . 0.0 110.358 179.333 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.43 ' HA ' ' O ' ' A' ' 74' ' ' ARG . 15.4 p -143.61 157.85 44.11 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.105 179.829 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -127.0 136.86 52.82 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.991 179.663 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.414 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 36.5 t70 60.29 84.48 0.12 Allowed 'General case' 0 N--CA 1.467 0.381 0 O-C-N 123.608 0.568 . . . . 0.0 111.68 179.511 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 75.4 mt -97.92 120.38 47.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.103 179.547 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.6 tptm -147.33 148.19 31.13 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.123 -179.79 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.564 HD11 HD22 ' A' ' 19' ' ' LEU . 36.3 mt -88.56 145.23 25.84 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.868 -179.474 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -105.34 -62.14 1.39 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.044 -0.525 . . . . 0.0 112.107 -179.046 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.542 ' HB2' ' HB2' ' A' ' 69' ' ' ARG . 44.6 mm-40 -79.21 42.93 0.51 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.831 -178.527 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 62.49 20.41 61.27 Favored Glycine 0 C--N 1.317 -0.525 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.594 179.33 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.538 ' HA2' HD13 ' A' ' 64' ' ' LEU . . . 121.4 -14.88 9.31 Favored Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.388 -179.996 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.839 ' HG2' ' HB2' ' A' ' 2' ' ' SER . 48.3 mtm105 -84.02 2.27 39.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.13 0.491 . . . . 0.0 110.804 -179.718 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -155.26 134.36 12.27 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.975 179.917 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.601 ' HB2' HD11 ' A' ' 90' ' ' LEU . 9.8 tt -116.77 125.71 52.03 Favored 'General case' 0 C--N 1.318 -0.794 0 O-C-N 123.576 0.548 . . . . 0.0 109.94 -179.723 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.7 p -113.97 136.29 53.06 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.769 179.208 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.414 ' HA ' ' O ' ' A' ' 61' ' ' ASP . 25.8 p -162.26 165.57 26.55 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.252 179.84 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.502 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 31.9 ttt180 -99.48 103.44 21.05 Favored Pre-proline 0 C--N 1.319 -0.745 0 C-N-CA 120.676 -0.409 . . . . 0.0 110.733 179.496 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.554 ' HD2' ' HA ' ' A' ' 85' ' ' ARG . 43.8 Cg_endo -67.64 119.63 6.64 Favored 'Trans proline' 0 CA--C 1.512 -0.58 0 C-N-CA 122.569 2.18 . . . . 0.0 110.149 178.564 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.636 ' HA ' ' HB2' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -119.91 140.61 50.61 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 120.764 0.316 . . . . 0.0 111.682 -178.808 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.713 HG22 ' O ' ' A' ' 82' ' ' PHE . 12.9 t -72.52 135.22 45.59 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.695 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 26.7 m -73.33 -4.33 5.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 123.943 0.777 . . . . 0.0 112.056 -178.938 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -68.95 -32.9 72.83 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.13 0.49 . . . . 0.0 109.902 179.342 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -151.65 -20.23 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.678 179.819 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.22 20.73 22.25 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.751 -0.738 . . . . 0.0 111.949 -179.887 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.713 ' O ' HG22 ' A' ' 77' ' ' THR . 27.6 p90 -111.88 143.22 43.21 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 -178.876 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.636 ' HB2' ' HA ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 175.06 -154.21 0.01 OUTLIER 'General case' 0 C--O 1.234 0.241 0 CA-C-O 120.796 0.332 . . . . 0.0 111.702 179.881 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -113.84 177.16 4.73 Favored 'General case' 0 C--O 1.225 -0.207 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.486 -178.708 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.554 ' HA ' ' HD2' ' A' ' 75' ' ' PRO . 59.1 ttt180 -110.39 150.86 28.2 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 178.77 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.56 HE22 ' HA ' ' A' ' 47' ' ' PHE . 22.1 mt-30 -156.84 -175.25 5.32 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -178.152 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -150.3 142.89 10.06 Favored Glycine 0 N--CA 1.45 -0.423 0 CA-C-N 114.803 -1.09 . . . . 0.0 111.108 179.09 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.417 HD13 ' CD1' ' A' ' 50' ' ' TRP . 13.2 tt -123.97 142.73 39.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 121.052 0.453 . . . . 0.0 110.649 -178.683 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -79.14 133.61 36.73 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.623 179.807 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.679 HD13 HD12 ' A' ' 19' ' ' LEU . 74.9 mt -106.27 41.25 1.45 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.324 0.583 . . . . 0.0 111.286 -179.44 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.551 ' HA ' ' OG ' ' A' ' 2' ' ' SER . 22.8 m-80 -76.12 2.05 14.01 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.192 179.575 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 13.3 mtp180 -94.03 -6.98 44.02 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.783 179.392 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 17.7 mm -101.92 106.36 19.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -179.782 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 21.7 tp60 -118.93 149.35 41.74 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.994 -178.008 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.409 ' OD1' ' HA ' ' A' ' 3' ' ' TYR . 14.7 p-10 -99.3 117.94 34.86 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.29 0.567 . . . . 0.0 110.435 178.858 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 48.1 t -103.71 100.4 10.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.5 179.191 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 7.3 m-80 58.69 43.5 18.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.858 -179.197 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 89.99 -23.42 20.76 Favored Glycine 0 N--CA 1.444 -0.792 0 CA-C-N 115.512 -0.767 . . . . 0.0 113.496 179.48 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.421 ' HD2' ' N ' ' A' ' 99' ' ' ARG . 4.4 mpt_? -86.78 123.39 31.87 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 117.116 0.458 . . . . 0.0 110.574 -179.271 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.55 HD12 ' SG ' ' A' ' 23' ' ' CYS . 5.6 tp -76.01 122.15 23.79 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.166 -179.403 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 24.1 t -129.35 138.95 53.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.933 -179.183 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.699 ' HB2' HD13 ' A' ' 35' ' ' LEU . 12.5 t80 -85.51 131.92 34.29 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.052 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 17.3 tt0 . . . . . 0 C--N 1.315 -0.892 0 CA-C-O 117.968 -1.015 . . . . 0.0 110.44 -179.954 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mpt? . . . . . 0 N--CA 1.481 1.075 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.497 ' HG ' ' HA ' ' A' ' 91' ' ' ASN . 17.7 m -116.55 169.07 9.62 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.708 -0.224 . . . . 0.0 110.663 179.304 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.436 ' CG ' HD13 ' A' ' 100' ' ' LEU . 25.2 p90 -57.17 -30.64 64.67 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.201 179.362 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.425 ' HB1' ' HD2' ' A' ' 69' ' ' ARG . . . -53.7 -18.86 3.42 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.33 -179.363 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -61.06 -36.27 79.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.296 0.57 . . . . 0.0 109.977 179.043 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 24.5 m -133.95 36.46 3.27 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.805 179.691 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.413 ' HA ' ' HZ3' ' A' ' 30' ' ' TRP . 23.2 t -148.75 145.77 27.76 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.399 -179.987 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 4.5 ptp180 -136.61 167.9 20.52 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.585 -0.279 . . . . 0.0 111.646 -178.874 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 67.1 m-80 55.78 65.21 1.51 Allowed 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.435 179.893 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -92.55 120.03 32.61 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.661 179.622 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 26.6 m -120.41 169.11 12.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.317 -179.731 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.727 HD22 ' HG ' ' A' ' 64' ' ' LEU . 3.1 mm? -104.67 116.91 32.86 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.24 -179.634 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.478 ' OG1' ' HB ' ' A' ' 18' ' ' THR . 18.9 p -109.81 161.94 14.96 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.452 179.48 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 62.15 40.87 11.34 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.945 -179.803 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 91.02 -45.38 2.85 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 121.034 -0.603 . . . . 0.0 112.459 179.62 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 149.77 52.42 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.506 0 N-CA-C 111.481 -0.648 . . . . 0.0 111.481 -179.469 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.44 ' HB2' ' HB2' ' A' ' 38' ' ' ASP . 3.7 ptm180 -135.57 -33.46 0.87 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.146 0.498 . . . . 0.0 110.808 -179.811 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.478 ' HB ' ' OG1' ' A' ' 13' ' ' THR . 3.0 m -97.53 133.5 42.01 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.524 -179.968 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.635 HD13 HD12 ' A' ' 90' ' ' LEU . 44.1 mt -95.89 113.65 25.29 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.231 179.349 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 17.9 ttm180 -107.86 120.68 42.94 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 178.76 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -152.77 167.85 27.64 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.929 0.395 . . . . 0.0 111.365 -178.896 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -89.63 106.09 18.23 Favored 'General case' 0 CA--C 1.512 -0.491 0 N-CA-C 107.969 -1.122 . . . . 0.0 107.969 178.405 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.574 ' SG ' HD12 ' A' ' 100' ' ' LEU . 58.5 m -96.39 125.91 41.22 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 120.713 0.292 . . . . 0.0 110.225 -178.959 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.596 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 22.4 ttt180 -77.94 111.83 14.2 Favored 'General case' 0 N--CA 1.44 -0.933 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.087 179.639 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 36.0 p30 -74.18 170.65 15.1 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.318 -179.62 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.26 -11.73 23.68 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -177.806 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -88.15 -10.23 50.62 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 178.676 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 88.45 27.94 23.59 Favored Glycine 0 N--CA 1.448 -0.511 0 CA-C-N 114.956 -1.02 . . . . 0.0 111.535 -179.522 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.596 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 51.9 t30 -112.75 161.45 16.88 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.526 0.203 . . . . 0.0 111.162 -178.661 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.439 ' CZ3' ' HB2' ' A' ' 24' ' ' ARG . 95.4 m95 -102.5 116.85 33.46 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.715 179.596 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 6.2 m -118.82 141.1 40.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.608 179.309 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 61.6 m -81.1 108.62 14.92 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 179.209 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 50.3 m -120.34 150.43 40.76 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.351 -179.536 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.592 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 48.3 mt-10 -131.2 145.6 52.0 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.915 -179.893 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.628 HD11 ' HB2' ' A' ' 102' ' ' PHE . 2.2 tm? -139.45 132.0 28.75 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 178.777 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.476 ' N ' HD13 ' A' ' 35' ' ' LEU . 5.7 m-20 -90.33 110.25 21.32 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.919 0.39 . . . . 0.0 110.992 179.967 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.473 HD13 HD22 ' A' ' 90' ' ' LEU . 2.4 mt -80.67 -19.73 44.57 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.705 179.268 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.528 ' OD1' ' HA ' ' A' ' 54' ' ' ASN . 22.4 t70 -58.74 -18.7 33.85 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.389 -0.823 . . . . 0.0 112.339 -178.812 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.436 HG21 ' O ' ' A' ' 36' ' ' ASP . 14.6 t -82.61 -6.74 59.52 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 121.103 -0.239 . . . . 0.0 111.449 -179.639 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.522 ' SG ' ' HE3' ' A' ' 50' ' ' TRP . 25.8 t -135.0 -18.63 1.81 Allowed 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.816 -0.354 . . . . 0.0 111.467 179.556 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 56.0 mt -98.28 129.13 48.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 178.359 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -141.11 164.69 26.45 Favored Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 120.64 -0.791 . . . . 0.0 111.67 179.784 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.517 ' OD1' ' HB2' ' A' ' 58' ' ' SER . 32.1 p-10 -161.92 47.26 0.21 Allowed Pre-proline 0 CA--C 1.538 0.487 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 -179.144 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -71.9 -23.21 22.39 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 121.562 1.508 . . . . 0.0 111.625 -179.536 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -84.26 -14.95 48.51 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.588 -179.893 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 103.98 8.22 39.66 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.051 -178.831 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -125.21 140.07 53.18 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 179.43 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 92.3 mt -86.68 145.64 26.61 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.012 -179.712 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 171.39 172.33 37.4 Favored Glycine 0 N--CA 1.444 -0.784 0 C-N-CA 120.785 -0.722 . . . . 0.0 111.745 179.207 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.522 ' HE3' ' SG ' ' A' ' 40' ' ' CYS . 87.2 m95 -95.53 125.2 39.96 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.826 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 159.99 -52.16 0.36 Allowed Glycine 0 CA--C 1.518 0.25 0 C-N-CA 121.129 -0.557 . . . . 0.0 112.453 -179.997 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.625 ' HA ' ' HE3' ' A' ' 52' ' ' MET . 0.1 OUTLIER -97.15 178.03 5.39 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.29 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -129.99 171.78 12.42 Favored 'General case' 0 C--N 1.318 -0.798 0 O-C-N 122.04 -0.412 . . . . 0.0 111.295 -179.18 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.528 ' HA ' ' OD1' ' A' ' 38' ' ' ASP . 21.7 m-80 64.31 59.98 0.98 Allowed 'General case' 0 C--O 1.235 0.311 0 O-C-N 123.963 0.789 . . . . 0.0 111.285 179.458 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.441 ' HA ' ' OD1' ' A' ' 43' ' ' ASN . 18.6 p90 -86.56 -32.24 20.79 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.645 -179.991 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 13.3 m -62.05 -36.9 83.01 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.269 -179.024 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 38.2 m80 -81.28 -3.59 52.95 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.728 179.218 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.517 ' HB2' ' OD1' ' A' ' 43' ' ' ASN . 4.7 m -121.33 18.67 11.44 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.551 -179.676 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 58.1 p -145.55 171.69 14.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.097 0.475 . . . . 0.0 111.096 179.882 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -140.85 154.03 46.02 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.065 179.433 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 62.3 63.04 1.09 Allowed 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.022 0.439 . . . . 0.0 110.929 -179.703 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.467 HG21 HD22 ' A' ' 71' ' ' LEU . 63.6 mt -90.7 117.27 33.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.973 -179.681 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 42.5 tptt -148.85 149.45 31.32 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.772 -179.895 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.727 ' HG ' HD22 ' A' ' 12' ' ' LEU . 76.5 mt -82.46 132.57 35.2 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.931 0.396 . . . . 0.0 110.106 179.317 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -80.25 -62.61 1.63 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.488 -178.862 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -85.49 28.05 0.78 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.584 -179.86 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 64.97 15.95 61.12 Favored Glycine 0 N--CA 1.448 -0.545 0 CA-C-N 115.624 -0.717 . . . . 0.0 113.066 179.812 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.509 ' HA2' HD12 ' A' ' 64' ' ' LEU . . . 142.66 -21.98 2.35 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 119.904 -1.141 . . . . 0.0 113.091 179.459 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.425 ' HD2' ' HB1' ' A' ' 4' ' ' ALA . 0.2 OUTLIER -79.34 -13.91 59.33 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.426 0.631 . . . . 0.0 109.713 -179.922 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.685 ' HZ2' ' HB2' ' A' ' 70' ' ' LYS . 4.5 ttmp? -157.1 141.76 16.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.259 -179.233 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.569 ' HB2' HD13 ' A' ' 90' ' ' LEU . 10.0 tt -111.42 134.45 52.99 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 179.975 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.401 HG22 ' HA3' ' A' ' 87' ' ' GLY . 7.0 p -123.95 135.05 53.42 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 120.798 0.332 . . . . 0.0 111.156 179.852 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 26.9 p -159.52 168.8 25.28 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.134 -0.485 . . . . 0.0 109.998 179.988 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.525 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 56.6 ttt180 -99.66 101.97 15.34 Favored Pre-proline 0 C--N 1.314 -0.96 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.725 179.944 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.434 ' HD2' ' HA ' ' A' ' 85' ' ' ARG . 58.7 Cg_endo -71.43 123.14 9.26 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 122.535 2.156 . . . . 0.0 110.856 178.868 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.639 ' HA ' ' HB2' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -119.57 139.84 51.5 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.845 0.355 . . . . 0.0 111.053 -179.69 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.705 HG21 ' O ' ' A' ' 82' ' ' PHE . 12.3 t -75.47 140.65 42.98 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 116.176 -0.466 . . . . 0.0 109.752 -179.765 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 31.3 m -76.32 -5.97 8.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.488 -179.482 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 -64.75 -35.25 80.45 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-O 121.155 0.502 . . . . 0.0 110.234 179.145 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -154.01 -9.74 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.512 -0.851 . . . . 0.0 112.768 -179.925 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.32 17.51 52.73 Favored Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.641 -0.79 . . . . 0.0 111.862 179.976 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.705 ' O ' HG21 ' A' ' 77' ' ' THR . 34.0 p90 -111.23 151.2 28.56 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 119.17 -0.443 . . . . 0.0 109.974 -178.773 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.639 ' HB2' ' HA ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 169.78 -153.36 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.293 0 O-C-N 123.641 0.588 . . . . 0.0 111.052 179.107 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 49.9 mm-40 -122.21 -177.58 3.64 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.736 -178.037 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.525 ' HA ' ' HA ' ' A' ' 74' ' ' ARG . 52.7 ttt180 -106.03 153.45 22.01 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 177.396 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.698 ' HG2' ' H ' ' A' ' 87' ' ' GLY . 8.3 tt0 -157.89 -174.98 5.11 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.662 -178.513 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.698 ' H ' ' HG2' ' A' ' 86' ' ' GLN . . . -148.92 140.54 8.28 Favored Glycine 0 N--CA 1.445 -0.704 0 N-CA-C 111.181 -0.767 . . . . 0.0 111.181 179.21 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 15.3 tt -119.28 131.41 72.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.544 0.688 . . . . 0.0 110.742 -179.548 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -75.94 140.7 42.22 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.401 -179.671 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.635 HD12 HD13 ' A' ' 19' ' ' LEU . 42.4 mt -109.84 44.19 1.24 Allowed 'General case' 0 C--O 1.234 0.253 0 N-CA-C 112.848 0.684 . . . . 0.0 112.848 -177.717 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.497 ' HA ' ' HG ' ' A' ' 2' ' ' SER . 3.9 m-80 -79.7 3.91 17.82 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-O 121.32 0.581 . . . . 0.0 110.834 178.759 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 36.6 mtp180 -95.86 -11.21 27.12 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.357 178.919 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 21.2 mm -100.8 109.08 24.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 -179.406 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -122.26 148.52 44.89 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.941 -178.108 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 27.2 p-10 -100.65 123.28 44.64 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.65 0.738 . . . . 0.0 110.268 178.448 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 59.5 t -114.73 114.3 46.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.672 -179.853 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 45.6 m-80 57.46 33.45 23.28 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.22 0.533 . . . . 0.0 110.562 -178.798 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 89.32 -15.24 58.92 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.867 -179.915 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 3.6 mpt_? -87.59 123.22 32.23 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 117.005 0.403 . . . . 0.0 110.048 -179.846 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.574 HD12 ' SG ' ' A' ' 23' ' ' CYS . 8.2 tp -77.16 115.05 16.61 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.474 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 11.3 t -122.73 140.37 46.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 120.964 0.411 . . . . 0.0 111.45 -178.271 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.628 ' HB2' HD11 ' A' ' 35' ' ' LEU . 3.9 t80 -84.65 132.85 34.43 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 177.401 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 3.9 tp-100 . . . . . 0 C--O 1.252 1.198 0 CA-C-O 118.545 -0.741 . . . . 0.0 110.794 -179.837 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.1 ttt . . . . . 0 N--CA 1.48 1.054 0 N-CA-C 110.089 -0.338 . . . . 0.0 110.089 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.717 ' HG ' ' HA ' ' A' ' 91' ' ' ASN . 39.2 m -114.03 177.09 4.76 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.468 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.5 ' HA ' ' OD1' ' A' ' 95' ' ' ASN . 14.6 p90 -65.73 -33.36 75.69 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.091 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.516 ' HA ' ' OG ' ' A' ' 7' ' ' SER . . . -57.69 -22.4 46.0 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.055 -0.52 . . . . 0.0 112.051 -179.368 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -65.4 -19.68 66.05 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 121.022 0.439 . . . . 0.0 110.629 179.217 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 7.4 p -145.9 39.53 1.13 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.645 179.938 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.516 ' OG ' ' HA ' ' A' ' 4' ' ' ALA . 87.0 p -145.89 167.73 22.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.205 179.085 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 4.9 ptp180 -150.49 162.84 39.83 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.733 -179.6 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 56.59 60.05 3.28 Favored 'General case' 0 C--N 1.331 -0.233 0 O-C-N 123.982 0.801 . . . . 0.0 111.769 177.657 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.4 ' HA ' ' HB1' ' A' ' 21' ' ' ALA . . . -91.94 119.49 31.74 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.703 179.775 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 27.4 m -119.81 169.55 10.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.475 -179.897 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.484 HD23 ' HG ' ' A' ' 64' ' ' LEU . 3.2 mm? -105.76 114.55 28.78 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.518 -179.211 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.454 ' OG1' ' HB ' ' A' ' 18' ' ' THR . 26.3 p -109.86 164.7 12.33 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.018 179.988 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 61.61 43.7 9.73 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.838 179.731 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 88.76 -37.84 3.27 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.792 -0.718 . . . . 0.0 111.975 179.827 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.417 ' O ' HG21 ' A' ' 62' ' ' ILE . . . 140.74 42.32 0.07 OUTLIER Glycine 0 N--CA 1.444 -0.808 0 N-CA-C 111.432 -0.667 . . . . 0.0 111.432 -179.529 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.441 ' HD2' ' CG ' ' A' ' 38' ' ' ASP . 18.2 ptt85 -127.19 -21.24 3.96 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.896 0.379 . . . . 0.0 111.126 -179.828 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.454 ' HB ' ' OG1' ' A' ' 13' ' ' THR . 3.8 m -106.63 131.29 53.95 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.374 179.889 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.682 HD13 HD11 ' A' ' 90' ' ' LEU . 57.3 mt -93.4 113.83 26.08 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.327 179.209 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 22.5 ttt180 -111.97 119.37 38.29 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 178.644 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.4 ' HB1' ' HA ' ' A' ' 10' ' ' ALA . . . -153.73 167.0 31.09 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.95 0.405 . . . . 0.0 111.362 -179.11 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -90.02 106.7 18.65 Favored 'General case' 0 CA--C 1.511 -0.523 0 N-CA-C 107.821 -1.178 . . . . 0.0 107.821 178.19 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.535 ' SG ' HD11 ' A' ' 100' ' ' LEU . 35.7 m -97.55 131.82 43.79 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.326 -178.627 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.503 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 13.1 ttp180 -76.25 119.45 20.16 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 116.174 -0.466 . . . . 0.0 109.945 179.38 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 36.9 p30 -81.75 168.83 17.64 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 179.535 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -52.93 -30.56 35.27 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 -179.013 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -72.57 -15.08 61.76 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.397 0.618 . . . . 0.0 110.483 179.982 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 92.18 24.5 24.41 Favored Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.549 179.985 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.503 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 8.2 t-20 -107.49 162.89 13.53 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.582 0.23 . . . . 0.0 110.476 -178.753 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.425 ' HZ3' ' HA ' ' A' ' 7' ' ' SER . 83.3 m95 -99.03 115.71 29.58 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.931 0.396 . . . . 0.0 111.694 -179.548 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.1 m -122.13 125.43 72.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.173 178.463 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 19.9 m -76.14 113.54 13.79 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.996 -179.559 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 57.8 m -120.43 155.91 32.52 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.74 179.887 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.628 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 46.7 mt-10 -131.46 136.95 48.36 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.191 -179.394 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.458 HD12 ' HB2' ' A' ' 102' ' ' PHE . 1.7 tm? -132.72 130.1 39.57 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 178.434 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.443 ' N ' HD11 ' A' ' 35' ' ' LEU . 9.0 m-20 -89.94 109.04 20.09 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 -179.997 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.478 HD12 HD13 ' A' ' 19' ' ' LEU . 3.3 mt -79.48 -20.63 46.87 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.57 -179.095 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.441 ' CG ' ' HD2' ' A' ' 17' ' ' ARG . 11.2 p-10 -65.78 -10.26 35.82 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.7 0.285 . . . . 0.0 111.713 -178.612 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 77.6 p -81.23 -11.91 59.27 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.996 0.427 . . . . 0.0 110.34 179.045 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 23.4 m -133.95 -15.92 2.28 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.982 -0.554 . . . . 0.0 112.4 -179.026 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 54.9 mt -99.84 135.29 36.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 O-C-N 122.093 -0.379 . . . . 0.0 109.991 179.081 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -143.65 156.7 26.73 Favored Glycine 0 N--CA 1.443 -0.878 0 C-N-CA 120.386 -0.911 . . . . 0.0 112.263 179.804 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.557 ' OD1' ' HB2' ' A' ' 58' ' ' SER . 25.4 p30 -153.47 40.38 0.16 Allowed Pre-proline 0 CA--C 1.54 0.568 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -179.785 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.41 ' CD ' ' N ' ' A' ' 43' ' ' ASN . 7.1 Cg_exo -71.77 -17.46 29.28 Favored 'Trans proline' 0 C--N 1.355 0.902 0 C-N-CA 121.74 1.627 . . . . 0.0 111.377 -179.213 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -91.58 -2.84 56.98 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.06 179.853 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.58 ' CA ' ' HG2' ' A' ' 83' ' ' ARG . . . 91.79 8.03 64.01 Favored Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.214 -179.439 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -126.11 139.38 53.43 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.667 0.27 . . . . 0.0 110.568 179.646 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 81.7 mt -84.48 148.7 26.4 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.723 179.862 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 165.42 171.11 31.24 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 121.036 -0.602 . . . . 0.0 111.921 179.244 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 89.0 m95 -95.28 125.66 40.06 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 179.676 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 163.21 -57.79 0.28 Allowed Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.192 -179.628 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.493 ' CE ' ' HA ' ' A' ' 52' ' ' MET . 0.0 OUTLIER -90.78 -166.01 1.49 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 179.719 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 28.2 pt20 -141.98 171.6 13.83 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.918 -0.313 . . . . 0.0 111.648 -179.047 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 29.0 m-80 63.12 36.3 12.27 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 115.493 -0.776 . . . . 0.0 112.628 178.749 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 12.4 p90 -61.21 -27.39 68.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.763 0.316 . . . . 0.0 111.371 -179.629 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 15.0 m -62.53 -30.58 71.4 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.038 0.384 . . . . 0.0 112.038 -178.958 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 35.7 m80 -82.04 -4.06 55.95 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.742 -0.383 . . . . 0.0 111.169 -179.14 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.557 ' HB2' ' OD1' ' A' ' 43' ' ' ASN . 30.3 m -130.77 29.85 4.71 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.347 0.594 . . . . 0.0 110.239 179.232 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 28.9 p -141.28 153.22 45.08 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.641 179.209 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 66.4 mt-10 -125.34 139.2 53.89 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.419 -179.687 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 36.0 t70 58.62 73.21 0.49 Allowed 'General case' 0 N--CA 1.466 0.363 0 O-C-N 123.83 0.706 . . . . 0.0 111.532 -179.766 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.527 HG23 HD21 ' A' ' 71' ' ' LEU . 77.4 mt -87.24 119.85 35.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 178.801 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.688 ' HB2' ' HZ2' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -148.87 159.79 43.84 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.843 -0.343 . . . . 0.0 111.033 -178.653 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.484 ' HG ' HD23 ' A' ' 12' ' ' LEU . 81.0 mt -99.94 123.54 44.3 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.845 0.355 . . . . 0.0 110.958 179.891 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.406 ' C ' ' H ' ' A' ' 67' ' ' GLY . 37.0 mm-40 -82.0 -61.48 1.9 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.502 -179.676 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.439 ' OE2' ' HB2' ' A' ' 70' ' ' LYS . 36.1 mt-10 -76.58 12.96 1.09 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.307 -179.658 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.406 ' H ' ' C ' ' A' ' 65' ' ' GLU . . . 76.5 18.79 78.81 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.348 -179.928 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.423 ' HA2' HD22 ' A' ' 64' ' ' LEU . . . 136.94 -17.16 3.66 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.0 -1.095 . . . . 0.0 112.924 179.384 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -83.01 -17.96 41.5 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.194 0.521 . . . . 0.0 109.72 -179.854 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.439 ' HB2' ' OE2' ' A' ' 66' ' ' GLU . 37.9 ttmt -150.73 136.87 18.46 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.891 -179.278 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.545 ' HB2' HD12 ' A' ' 90' ' ' LEU . 10.0 tt -114.73 129.3 56.67 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.491 179.714 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 8.2 p -116.57 140.01 49.86 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.155 0.502 . . . . 0.0 111.28 179.828 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 13.0 p -163.28 164.03 25.09 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.089 179.02 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.509 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 28.1 ttt180 -99.4 100.39 10.42 Favored Pre-proline 0 C--N 1.317 -0.822 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 179.103 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.07 117.39 5.01 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.383 2.055 . . . . 0.0 109.864 178.545 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.745 ' HA ' ' HB2' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -119.78 143.43 47.83 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.501 -178.978 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.668 HG22 ' O ' ' A' ' 82' ' ' PHE . 8.7 t -69.89 134.38 48.37 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.218 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 11.1 p -71.28 -12.43 16.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 O-C-N 124.088 0.867 . . . . 0.0 111.094 -179.284 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 32.8 m-20 -70.62 -16.72 62.86 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.506 -179.606 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.686 ' HA3' ' CE2' ' A' ' 82' ' ' PHE . . . -157.64 -30.2 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.441 -0.885 . . . . 0.0 112.628 179.215 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.464 ' HA2' ' CE ' ' A' ' 76' ' ' LYS . . . 101.83 16.13 24.71 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 121.024 -0.608 . . . . 0.0 111.916 -179.721 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.686 ' CE2' ' HA3' ' A' ' 80' ' ' GLY . 16.7 p90 -112.25 157.06 21.38 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 118.686 -0.673 . . . . 0.0 110.173 -178.622 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.745 ' HB2' ' HA ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 163.92 -151.03 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.556 0 O-C-N 124.253 0.971 . . . . 0.0 111.124 178.478 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -125.47 152.88 44.35 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.142 -177.927 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.509 ' HA ' ' HA ' ' A' ' 74' ' ' ARG . 39.7 ttt180 -83.91 145.8 28.39 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 179.621 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -150.63 -179.67 7.44 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.094 0.473 . . . . 0.0 111.756 -178.287 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -141.09 142.51 12.24 Favored Glycine 0 N--CA 1.451 -0.345 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.455 178.993 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 13.2 tt -125.09 136.58 60.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.028 0.442 . . . . 0.0 110.973 -179.199 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -80.59 141.28 35.19 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.467 -179.882 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.682 HD11 HD13 ' A' ' 19' ' ' LEU . 58.3 mt -107.59 46.36 0.95 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.674 0.749 . . . . 0.0 110.932 -179.816 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.717 ' HA ' ' HG ' ' A' ' 2' ' ' SER . 26.8 m-80 -79.9 3.67 19.11 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.634 179.762 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 12.9 mtp180 -98.47 -15.0 19.78 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.41 179.872 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 22.7 mm -94.37 98.07 7.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 121.356 0.598 . . . . 0.0 109.601 -179.029 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 22.3 tp60 -107.63 141.94 38.34 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.961 -178.443 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.5 ' OD1' ' HA ' ' A' ' 3' ' ' TYR . 16.1 p-10 -95.64 119.72 34.64 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.512 178.582 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 58.2 t -109.23 112.26 39.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.31 179.286 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 23.2 m-80 59.24 34.84 23.25 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-O 121.069 0.461 . . . . 0.0 110.56 -178.952 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 87.57 -8.96 75.51 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.757 -179.955 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.454 ' HD2' ' N ' ' A' ' 99' ' ' ARG . 7.9 mpt_? -94.65 134.43 37.24 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.661 0.267 . . . . 0.0 110.978 -179.052 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.535 HD11 ' SG ' ' A' ' 23' ' ' CYS . 2.9 tp -84.89 119.81 25.77 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.594 -0.276 . . . . 0.0 110.503 -179.681 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 20.8 t -129.28 141.53 46.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.609 -179.661 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.458 ' HB2' HD12 ' A' ' 35' ' ' LEU . 23.2 t80 -83.71 133.0 34.82 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 178.348 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 . . . . . 0 C--O 1.248 1.013 0 CA-C-O 118.336 -0.84 . . . . 0.0 110.108 179.271 . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.2 mmt . . . . . 0 N--CA 1.481 1.077 0 CA-C-O 120.621 0.248 . . . . 0.0 110.562 . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.573 ' OG ' ' HA ' ' A' ' 91' ' ' ASN . 21.0 m -117.72 175.04 5.84 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.723 -0.217 . . . . 0.0 110.474 179.082 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 11.7 p90 -55.32 -32.16 62.25 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.281 179.061 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -52.37 -20.89 3.07 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -178.801 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -55.93 -42.49 76.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.914 0.388 . . . . 0.0 110.959 178.743 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 47.7 m -132.01 36.02 3.69 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.001 179.828 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 16.7 m -144.57 153.24 41.6 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.483 179.531 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 7.9 ptp180 -149.53 172.7 14.58 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 110.317 -0.253 . . . . 0.0 110.317 179.951 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.456 ' N ' HD21 ' A' ' 9' ' ' ASN . 0.9 OUTLIER 67.02 44.63 1.92 Allowed 'General case' 0 N--CA 1.469 0.475 0 O-C-N 123.56 0.537 . . . . 0.0 110.5 -179.505 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -87.83 118.26 27.24 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.425 -179.879 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 30.6 m -121.57 176.15 4.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.871 179.308 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -104.98 114.09 28.09 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 -179.752 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.515 ' OG1' ' HB ' ' A' ' 18' ' ' THR . 24.1 p -106.1 163.38 12.82 Favored 'General case' 0 C--O 1.245 0.823 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.923 -179.641 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 62.16 36.2 15.18 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.706 -179.482 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 92.56 -40.28 2.88 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.7 179.431 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 147.72 56.07 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.499 0 N-CA-C 110.979 -0.849 . . . . 0.0 110.979 -179.723 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 10.0 ptm180 -140.87 -32.19 0.58 Allowed 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.066 0.46 . . . . 0.0 111.211 -179.394 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.515 ' HB ' ' OG1' ' A' ' 13' ' ' THR . 3.7 m -102.99 138.27 40.08 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.348 -179.53 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.603 ' O ' ' HA ' ' A' ' 34' ' ' GLU . 34.4 mt -98.6 113.34 25.35 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.865 179.428 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 5.2 ttp180 -106.3 120.61 42.32 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 178.489 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -152.88 166.24 32.92 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.938 0.399 . . . . 0.0 111.734 -179.245 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -90.65 107.27 19.07 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 178.467 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.457 ' SG ' HD11 ' A' ' 100' ' ' LEU . 27.2 m -98.78 127.49 44.72 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.457 -178.754 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 19.6 ttp180 -74.39 109.52 7.94 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 179.27 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -87.27 173.48 9.17 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.718 -178.96 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -46.63 -34.1 4.75 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 -178.692 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -67.56 -10.74 54.68 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 121.498 0.666 . . . . 0.0 111.105 -179.464 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.45 23.63 56.01 Favored Glycine 0 N--CA 1.446 -0.634 0 N-CA-C 111.233 -0.747 . . . . 0.0 111.233 -179.94 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 -123.74 160.4 27.37 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.797 0.332 . . . . 0.0 111.197 -178.836 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 75.3 m95 -87.57 131.56 34.35 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.24 -178.858 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 23' ' ' CYS . 6.2 m -126.29 137.0 59.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.745 178.118 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 37.6 m -75.53 109.24 8.93 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.133 179.775 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 49.9 m -122.8 144.59 49.08 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.932 -179.966 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.603 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 43.9 mt-10 -128.88 135.45 49.09 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.433 -179.729 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.511 HD13 ' HB2' ' A' ' 102' ' ' PHE . 2.4 tm? -128.64 131.69 48.07 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 178.808 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.452 ' N ' HD12 ' A' ' 35' ' ' LEU . 11.4 m-20 -89.29 110.77 21.51 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.297 -179.794 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.476 HD13 ' HG ' ' A' ' 19' ' ' LEU . 0.9 OUTLIER -86.87 -16.12 37.03 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.938 179.947 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.462 ' HA ' ' HD1' ' A' ' 55' ' ' PHE . 0.5 OUTLIER -66.06 -13.81 60.62 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 -177.508 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.424 HG23 ' O ' ' A' ' 36' ' ' ASP . 8.8 t -83.08 -7.82 59.6 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.895 0.378 . . . . 0.0 110.653 179.193 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.416 ' SG ' HG22 ' A' ' 39' ' ' THR . 58.0 m -130.94 -17.2 3.15 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 112.181 0.437 . . . . 0.0 112.181 -179.341 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 57.2 mt -104.98 137.05 36.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.684 0.278 . . . . 0.0 110.766 179.731 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -150.31 162.47 29.26 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 121.114 -0.565 . . . . 0.0 111.744 179.202 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.66 ' ND2' ' HB2' ' A' ' 55' ' ' PHE . 7.2 p30 -160.88 50.2 0.31 Allowed Pre-proline 0 CA--C 1.537 0.476 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -179.738 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -69.93 -13.07 33.77 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 121.658 1.572 . . . . 0.0 112.046 -179.653 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -101.94 5.02 40.62 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.735 179.83 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.538 ' CA ' ' HG2' ' A' ' 83' ' ' ARG . . . 85.43 11.66 74.59 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.362 -0.923 . . . . 0.0 112.37 -179.592 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.615 ' HA ' HE22 ' A' ' 86' ' ' GLN . 49.3 m-85 -125.31 131.81 52.98 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.013 0.435 . . . . 0.0 110.801 179.916 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 84.6 mt -86.31 135.57 33.48 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.461 -0.791 . . . . 0.0 111.722 -178.69 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -177.85 172.27 44.88 Favored Glycine 0 N--CA 1.447 -0.619 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.734 179.209 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 90.2 m95 -95.16 124.76 39.38 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 179.621 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 159.41 -54.71 0.35 Allowed Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.92 -0.657 . . . . 0.0 111.917 -179.26 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.56 -166.06 1.41 Allowed 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 179.649 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -146.03 173.63 12.0 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.64 -0.424 . . . . 0.0 111.634 -179.55 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 60.21 39.86 18.75 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.717 179.376 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.66 ' HB2' ' ND2' ' A' ' 43' ' ' ASN . 6.2 p90 -61.84 -28.61 69.61 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.167 179.488 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.444 ' HA ' ' CD1' ' A' ' 62' ' ' ILE . 24.5 t -58.83 -44.94 91.04 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.727 -179.942 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 34.0 m80 -81.31 -13.76 58.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.082 0.467 . . . . 0.0 111.037 -179.734 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 15.7 m -96.33 -1.47 47.77 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.77 -178.928 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 56.5 p -137.95 172.97 12.15 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 121.71 -0.619 . . . . 0.0 111.235 -179.0 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -131.13 147.57 52.62 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.011 179.909 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 39.0 t70 56.66 77.69 0.25 Allowed 'General case' 0 N--CA 1.467 0.396 0 O-C-N 123.877 0.736 . . . . 0.0 110.722 179.903 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.486 HG23 HD23 ' A' ' 71' ' ' LEU . 67.3 mt -99.94 120.38 49.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.841 -179.292 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 76.9 tttt -148.9 156.96 43.05 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.211 -0.45 . . . . 0.0 109.858 179.554 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 44.1 mt -82.66 140.12 33.32 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.139 0.495 . . . . 0.0 111.271 -178.848 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -90.81 -61.56 1.64 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.985 -178.792 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -82.2 13.01 3.73 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.127 0.489 . . . . 0.0 111.106 -179.767 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 78.4 17.16 78.35 Favored Glycine 0 N--CA 1.45 -0.403 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.413 179.8 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 143.24 -30.95 1.98 Allowed Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.309 -0.948 . . . . 0.0 112.552 179.469 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 4.6 tpp85 -75.45 -19.66 59.31 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.279 0.561 . . . . 0.0 110.565 -179.931 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -148.5 145.71 28.03 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.437 -178.33 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.583 ' HB2' HD12 ' A' ' 90' ' ' LEU . 10.2 tt -116.61 144.38 44.46 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.782 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.8 p -134.2 138.52 45.17 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 120.85 0.357 . . . . 0.0 110.697 179.747 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 26.5 p -162.55 174.58 12.45 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.85 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.45 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 4.1 tmt_? -109.29 97.46 26.31 Favored Pre-proline 0 C--N 1.315 -0.915 0 N-CA-C 109.111 -0.699 . . . . 0.0 109.111 179.087 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -64.58 129.55 24.03 Favored 'Trans proline' 0 CA--C 1.515 -0.473 0 C-N-CA 122.991 2.461 . . . . 0.0 110.807 -179.981 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.695 ' HA ' ' HB2' ' A' ' 83' ' ' ARG . 0.3 OUTLIER -121.22 149.78 42.32 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.217 0.532 . . . . 0.0 111.478 -179.569 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.645 HG22 ' O ' ' A' ' 82' ' ' PHE . 14.7 t -82.69 143.4 30.96 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 178.794 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 32.7 m -70.04 -9.33 12.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 O-C-N 123.862 0.727 . . . . 0.0 111.798 -179.494 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -62.57 -37.77 87.46 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-O 121.008 0.433 . . . . 0.0 110.374 179.246 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -160.38 -0.92 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.308 -0.949 . . . . 0.0 113.103 -179.519 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.88 21.52 55.46 Favored Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.488 -0.863 . . . . 0.0 112.041 179.304 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.645 ' O ' HG22 ' A' ' 77' ' ' THR . 40.2 p90 -111.07 154.91 23.57 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -179.588 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.788 ' HA ' ' HE ' ' A' ' 83' ' ' ARG . 0.0 OUTLIER 169.33 -145.34 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.241 0 O-C-N 123.805 0.691 . . . . 0.0 111.498 -179.999 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -129.53 157.46 41.97 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.688 -178.361 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.45 ' HA ' ' HA ' ' A' ' 74' ' ' ARG . 57.2 ttt180 -82.68 154.33 24.91 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 178.976 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.615 HE22 ' HA ' ' A' ' 47' ' ' PHE . 7.6 tt0 -164.81 -179.36 5.79 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 120.986 0.422 . . . . 0.0 111.741 -177.939 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.531 ' H ' ' HG2' ' A' ' 86' ' ' GLN . . . -142.55 153.26 24.42 Favored Glycine 0 CA--C 1.521 0.455 0 N-CA-C 111.841 -0.504 . . . . 0.0 111.841 179.257 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 12.0 tt -131.33 143.98 39.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.11 0.481 . . . . 0.0 110.618 -179.876 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.599 ' OD2' ' HB2' ' A' ' 91' ' ' ASN . 20.8 t70 -82.99 133.55 35.1 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.345 -179.184 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.583 HD12 ' HB2' ' A' ' 71' ' ' LEU . 86.7 mt -109.46 38.35 2.36 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -179.214 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.599 ' HB2' ' OD2' ' A' ' 89' ' ' ASP . 6.6 m-80 -75.68 3.07 10.4 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-O 121.485 0.66 . . . . 0.0 110.256 178.621 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 24.9 mtp180 -96.08 -5.57 40.59 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.879 179.567 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.462 ' CD1' HD21 ' A' ' 37' ' ' LEU . 25.0 mm -103.02 100.95 11.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.265 0.555 . . . . 0.0 109.994 -179.413 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -110.24 156.34 20.8 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.725 -178.508 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 18.7 p-10 -110.07 113.18 25.67 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.378 178.172 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.7 p -109.9 114.99 48.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-O 121.339 0.59 . . . . 0.0 110.431 -179.777 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 65.12 23.54 12.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.559 179.697 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 95.45 -8.53 69.12 Favored Glycine 0 N--CA 1.447 -0.605 0 CA-C-N 115.481 -0.781 . . . . 0.0 112.404 -179.942 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 10.2 mtp180 -95.2 135.78 36.35 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -179.413 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.457 HD11 ' SG ' ' A' ' 23' ' ' CYS . 5.2 tp -88.22 116.11 26.19 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 -179.517 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 39.2 t -130.45 141.25 46.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.87 0.366 . . . . 0.0 110.65 -178.917 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.511 ' HB2' HD13 ' A' ' 35' ' ' LEU . 12.9 t80 -78.7 137.4 37.77 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.734 178.783 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 4.6 tp-100 . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.576 -0.726 . . . . 0.0 110.215 -179.994 . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.0 mpp? . . . . . 0 N--CA 1.481 1.082 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.432 ' HA ' HE22 ' A' ' 94' ' ' GLN . 39.0 m -119.52 179.2 4.29 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.893 0.377 . . . . 0.0 111.352 -179.506 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.439 ' CB ' HD13 ' A' ' 100' ' ' LEU . 11.1 p90 -54.3 -32.63 56.9 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.518 178.062 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.536 ' HB2' ' HD2' ' A' ' 69' ' ' ARG . . . -57.43 -18.97 20.72 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 115.41 -0.814 . . . . 0.0 112.471 -179.056 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -69.41 -17.27 63.64 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 121.113 0.483 . . . . 0.0 110.891 179.641 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 74.6 m -144.27 37.05 1.24 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.076 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 23.2 t -150.83 157.17 42.6 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.686 -179.443 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 2.0 ptm180 -144.79 167.31 22.89 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 179.653 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 60.17 50.44 6.4 Favored 'General case' 0 N--CA 1.464 0.232 0 O-C-N 123.868 0.73 . . . . 0.0 111.186 179.492 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.473 ' HA ' ' HB3' ' A' ' 21' ' ' ALA . . . -84.81 117.36 23.81 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.467 179.721 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 33.5 m -122.42 168.77 14.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.916 -179.738 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.604 HD23 ' HG ' ' A' ' 64' ' ' LEU . 3.3 mm? -104.91 115.3 30.05 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.662 179.9 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 28.1 p -110.31 167.26 10.33 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.008 -179.891 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 59.83 46.78 10.94 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.089 179.398 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 85.5 -31.92 3.75 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 121.049 -0.596 . . . . 0.0 112.346 179.942 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 133.18 54.99 0.08 OUTLIER Glycine 0 N--CA 1.442 -0.905 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 -179.202 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.466 ' HD2' ' CG ' ' A' ' 38' ' ' ASP . 43.3 ptt85 -138.06 -32.73 0.72 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.889 0.376 . . . . 0.0 111.125 -179.664 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.2 m -98.56 132.32 44.07 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.479 179.93 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.712 HD13 HD11 ' A' ' 90' ' ' LEU . 69.5 mt -92.3 113.32 25.56 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.172 179.195 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 53.6 ttp180 -111.86 120.77 43.06 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 178.775 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.473 ' HB3' ' HA ' ' A' ' 10' ' ' ALA . . . -153.4 167.5 29.22 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.798 -179.271 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -90.36 106.15 18.3 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 178.437 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.544 ' SG ' HD12 ' A' ' 100' ' ' LEU . 58.5 m -93.15 130.59 38.75 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 -178.893 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 22.7 ttp85 -77.92 119.94 22.1 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 120.896 -0.322 . . . . 0.0 110.244 179.237 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 33.6 p30 -84.8 163.43 19.09 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.468 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.33 -15.43 25.47 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -178.232 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -82.21 -10.2 59.23 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.789 0.804 . . . . 0.0 109.289 179.168 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 87.23 35.36 9.7 Favored Glycine 0 N--CA 1.447 -0.605 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.702 -179.827 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 43.9 t30 -124.39 160.37 28.3 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.747 0.308 . . . . 0.0 111.316 -179.266 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 85.2 m95 -99.0 120.43 39.44 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.71 179.58 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.7 m -124.01 136.51 60.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.5 178.989 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 55.0 m -78.11 108.77 11.65 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 120.944 0.402 . . . . 0.0 110.135 179.696 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.469 ' HB2' ' SG ' ' A' ' 23' ' ' CYS . 70.6 m -119.26 142.46 48.03 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.383 -179.502 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.645 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 2.7 mp0 -128.38 152.6 47.99 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.344 -179.641 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.507 ' HB2' HD22 ' A' ' 100' ' ' LEU . 0.9 OUTLIER -143.53 126.96 16.81 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 178.292 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -87.26 109.65 19.64 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 -179.815 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.45 HD11 HD13 ' A' ' 19' ' ' LEU . 1.0 OUTLIER -86.94 -13.76 43.74 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.292 0.479 . . . . 0.0 112.292 -179.123 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.466 ' CG ' ' HD2' ' A' ' 17' ' ' ARG . 8.8 p-10 -64.98 -16.23 63.15 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 122.085 -0.384 . . . . 0.0 111.923 -178.314 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 15.1 t -91.15 0.79 57.46 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.119 0.485 . . . . 0.0 110.013 179.314 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 22.5 m -130.62 -19.5 3.0 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.993 -0.548 . . . . 0.0 111.783 -179.486 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 64.7 mt -112.79 139.95 35.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.823 0.344 . . . . 0.0 111.359 -179.287 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -148.81 158.62 27.73 Favored Glycine 0 N--CA 1.449 -0.493 0 N-CA-C 110.841 -0.903 . . . . 0.0 110.841 179.171 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.419 HD21 ' HG ' ' A' ' 48' ' ' LEU . 24.3 p30 -162.86 45.25 0.14 Allowed Pre-proline 0 CA--C 1.541 0.608 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 -179.317 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -71.84 -15.35 29.78 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 121.868 1.712 . . . . 0.0 111.277 179.959 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 70.9 m-20 -90.0 -0.75 57.75 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.703 -179.807 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.47 ' CA ' ' HG2' ' A' ' 83' ' ' ARG . . . 90.0 3.45 73.31 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.294 -0.955 . . . . 0.0 111.716 -179.167 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.679 ' HA ' HE22 ' A' ' 86' ' ' GLN . 64.7 m-85 -125.25 132.68 52.9 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.786 0.327 . . . . 0.0 110.449 179.988 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.557 HD23 HG23 ' A' ' 88' ' ' ILE . 11.1 mp -85.3 153.69 22.4 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.057 -179.273 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 170.99 171.97 36.77 Favored Glycine 0 N--CA 1.44 -1.094 0 C-N-CA 120.432 -0.89 . . . . 0.0 112.008 179.092 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 93.4 m95 -96.91 131.16 43.96 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.675 0.274 . . . . 0.0 110.506 -179.495 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 142.97 -62.47 0.51 Allowed Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 121.055 -0.593 . . . . 0.0 111.739 -179.866 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 2.4 ttt -72.07 -176.56 1.79 Allowed 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 179.345 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -142.84 169.16 18.09 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 121.517 -0.74 . . . . 0.0 112.605 -178.021 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 25.2 m-80 64.07 45.81 3.98 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.073 -0.967 . . . . 0.0 112.54 178.836 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 23.4 p90 -66.41 -32.71 74.26 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.837 179.512 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.432 ' HA ' HD13 ' A' ' 62' ' ' ILE . 4.3 m -63.09 -30.86 71.92 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.376 -179.169 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 28.1 m80 -81.76 -3.59 54.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.999 0.428 . . . . 0.0 111.025 -179.927 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 19.4 m -128.56 22.72 5.92 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.187 179.5 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 66.8 m -139.62 162.06 36.02 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.122 0.487 . . . . 0.0 111.671 -179.774 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -132.92 142.23 48.78 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.02 178.922 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 25.9 t70 60.0 73.52 0.48 Allowed 'General case' 0 N--CA 1.467 0.385 0 O-C-N 123.687 0.617 . . . . 0.0 110.707 -179.857 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.5 HG23 HD21 ' A' ' 71' ' ' LEU . 68.7 mt -93.19 114.42 29.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.415 -179.824 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -147.38 149.88 33.6 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.079 -179.055 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.604 ' HG ' HD23 ' A' ' 12' ' ' LEU . 79.3 mt -83.29 122.54 28.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.145 0.498 . . . . 0.0 111.37 -179.521 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -74.02 -63.27 1.25 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.379 -179.143 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.467 ' HB2' ' HB2' ' A' ' 69' ' ' ARG . 29.3 mt-10 -86.13 35.35 0.64 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.843 0.354 . . . . 0.0 111.462 -179.008 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 56.93 22.09 40.3 Favored Glycine 0 CA--C 1.519 0.319 0 CA-C-N 115.679 -0.691 . . . . 0.0 113.591 179.327 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 139.22 -23.97 2.84 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 119.887 -1.149 . . . . 0.0 113.091 179.275 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.536 ' HD2' ' HB2' ' A' ' 4' ' ' ALA . 0.2 OUTLIER -78.73 -17.12 56.34 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 117.251 0.526 . . . . 0.0 110.838 -179.788 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 33.3 ttmt -153.56 138.34 17.06 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.521 -177.938 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.524 ' HB2' HD12 ' A' ' 90' ' ' LEU . 10.5 tt -108.55 129.75 55.3 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.102 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 6.4 p -117.61 136.36 53.34 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.819 0.342 . . . . 0.0 111.528 179.969 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 28.2 p -162.67 163.45 26.99 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.479 179.895 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.4 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 78.8 ttt180 -99.47 103.93 24.03 Favored Pre-proline 0 C--N 1.32 -0.71 0 C-N-CA 120.341 -0.543 . . . . 0.0 110.458 179.061 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -71.95 123.46 9.33 Favored 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 122.848 2.365 . . . . 0.0 111.036 179.174 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.697 ' HA ' ' HB2' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -120.21 143.33 48.32 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.335 -179.589 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.728 HG21 ' O ' ' A' ' 82' ' ' PHE . 15.2 t -75.71 136.78 40.35 Favored 'General case' 0 CA--C 1.513 -0.471 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 179.334 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 35.0 m -76.35 -6.88 9.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.991 -179.784 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -68.59 -31.54 70.8 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.637 179.645 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.486 ' HA3' ' CE2' ' A' ' 82' ' ' PHE . . . -147.04 -23.34 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.717 179.568 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 101.18 12.54 36.06 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.997 -0.62 . . . . 0.0 112.146 -179.495 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.728 ' O ' HG21 ' A' ' 77' ' ' THR . 31.5 p90 -111.91 158.46 19.45 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 118.892 -0.575 . . . . 0.0 110.221 -178.349 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.697 ' HB2' ' HA ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 164.32 -161.47 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.436 0 O-C-N 123.861 0.725 . . . . 0.0 111.307 178.327 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -110.16 176.08 5.19 Favored 'General case' 0 C--O 1.222 -0.354 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.36 -176.904 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.4 ' HA ' ' HA ' ' A' ' 74' ' ' ARG . 74.9 ttt180 -102.65 153.73 19.84 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 177.967 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.679 HE22 ' HA ' ' A' ' 47' ' ' PHE . 8.2 tt0 -166.09 179.2 5.89 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 120.361 -0.535 . . . . 0.0 111.848 -177.49 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.535 ' H ' ' HG2' ' A' ' 86' ' ' GLN . . . -145.54 155.16 26.37 Favored Glycine 0 N--CA 1.449 -0.493 0 N-CA-C 111.473 -0.651 . . . . 0.0 111.473 179.225 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.557 HG23 HD23 ' A' ' 48' ' ' LEU . 11.9 tt -132.06 134.84 59.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 110.105 -0.331 . . . . 0.0 110.105 179.883 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -77.78 139.09 39.31 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.221 0.534 . . . . 0.0 110.179 -179.949 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.712 HD11 HD13 ' A' ' 19' ' ' LEU . 68.3 mt -106.59 46.66 0.91 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.589 0.709 . . . . 0.0 111.201 -179.015 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 35.0 m-80 -79.16 3.19 18.41 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 115.344 -0.843 . . . . 0.0 110.176 179.555 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 17.8 mtp180 -97.09 -19.17 18.88 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.676 179.569 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.428 ' CD1' HD21 ' A' ' 37' ' ' LEU . 21.6 mm -91.56 100.76 11.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 -179.589 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.432 HE22 ' HA ' ' A' ' 2' ' ' SER . 21.1 mm-40 -109.48 165.92 11.28 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.285 -177.988 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.499 ' HA ' ' O ' ' A' ' 99' ' ' ARG . 18.4 p-10 -120.16 118.92 31.78 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.154 177.632 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.2 p -116.12 122.53 69.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 121.033 0.444 . . . . 0.0 110.339 -179.321 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 57.99 16.59 3.83 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.848 179.889 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 111.2 -12.15 28.82 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 121.076 -0.583 . . . . 0.0 113.707 178.859 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.499 ' O ' ' HA ' ' A' ' 95' ' ' ASN . 0.9 OUTLIER -101.0 147.06 26.62 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 117.422 0.611 . . . . 0.0 111.276 -178.906 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.544 HD12 ' SG ' ' A' ' 23' ' ' CYS . 5.2 tp -91.79 123.55 35.26 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.542 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 23.7 t -130.7 140.12 49.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.809 -178.951 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -85.65 125.07 32.87 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 177.397 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 . . . . . 0 C--N 1.309 -1.166 0 CA-C-O 118.46 -0.781 . . . . 0.0 110.862 179.675 . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.9 mpp? . . . . . 0 N--CA 1.481 1.099 0 CA-C-O 120.989 0.424 . . . . 0.0 110.375 . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.9 m -119.29 -179.73 3.94 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.453 -179.78 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.46 ' CZ ' HD12 ' A' ' 19' ' ' LEU . 18.0 p90 -55.43 -34.49 64.49 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.791 0.329 . . . . 0.0 111.114 178.555 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.521 ' HA ' ' OG ' ' A' ' 7' ' ' SER . . . -57.77 -18.69 23.08 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -178.546 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -69.48 -18.19 63.68 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 121.102 0.477 . . . . 0.0 111.168 179.875 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 50.7 m -141.64 36.51 1.64 Allowed 'General case' 0 N--CA 1.446 -0.646 0 CA-C-O 121.239 0.542 . . . . 0.0 109.899 179.361 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.521 ' OG ' ' HA ' ' A' ' 4' ' ' ALA . 77.8 p -148.7 165.47 31.26 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.36 179.205 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -148.22 165.57 30.53 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.068 179.918 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 62.09 42.44 9.81 Favored 'General case' 0 N--CA 1.464 0.237 0 O-C-N 123.594 0.559 . . . . 0.0 111.24 179.902 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.421 ' HA ' ' O ' ' A' ' 20' ' ' ARG . . . -80.13 117.21 20.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.153 179.627 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 28.2 m -126.41 172.38 13.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.708 -179.432 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.664 HD21 ' HG ' ' A' ' 64' ' ' LEU . 3.1 mm? -104.5 117.84 35.14 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.559 -179.216 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.439 ' OG1' ' HB ' ' A' ' 18' ' ' THR . 37.9 p -112.33 163.96 13.8 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.016 179.779 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 58.56 50.12 9.58 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.124 -179.909 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 84.63 -33.13 3.29 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.394 179.287 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 134.38 49.65 0.08 OUTLIER Glycine 0 N--CA 1.443 -0.855 0 N-CA-C 111.448 -0.661 . . . . 0.0 111.448 -179.652 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.606 ' HB2' ' HB2' ' A' ' 38' ' ' ASP . 20.4 ptt85 -133.79 -33.82 1.04 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.834 0.35 . . . . 0.0 111.021 179.96 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.439 ' HB ' ' OG1' ' A' ' 13' ' ' THR . 19.2 m -94.76 135.68 35.96 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.15 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.65 ' O ' ' HA ' ' A' ' 34' ' ' GLU . 79.9 mt -97.54 114.98 26.97 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.559 -179.589 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.432 ' HA ' ' HG2' ' A' ' 34' ' ' GLU . 16.8 ttm180 -104.57 120.24 40.84 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 178.661 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -153.84 160.39 42.19 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.776 0.322 . . . . 0.0 111.571 -179.982 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -90.32 106.08 18.25 Favored 'General case' 0 CA--C 1.513 -0.479 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 177.927 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.492 ' SG ' HD11 ' A' ' 100' ' ' LEU . 48.9 m -93.74 127.56 39.52 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 120.989 0.423 . . . . 0.0 111.053 -178.016 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 23.3 ttp180 -75.35 110.19 9.5 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.772 179.17 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -82.74 169.28 16.35 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 119.223 -0.418 . . . . 0.0 109.979 -179.525 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -47.83 -34.38 8.64 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -178.085 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -68.04 -12.71 61.32 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.473 0.654 . . . . 0.0 111.317 -179.58 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 85.72 26.17 36.1 Favored Glycine 0 N--CA 1.444 -0.83 0 N-CA-C 110.806 -0.918 . . . . 0.0 110.806 -179.202 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -115.95 153.54 31.42 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.718 0.294 . . . . 0.0 110.899 -179.288 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.439 ' HZ3' ' HA ' ' A' ' 7' ' ' SER . 88.6 m95 -89.29 125.58 35.17 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.395 -179.505 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 12.1 m -124.74 132.69 70.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 116.213 -0.449 . . . . 0.0 109.949 178.319 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 21.0 m -74.61 109.47 8.11 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.454 -179.904 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 68.7 m -123.18 142.94 50.37 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.358 179.826 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.65 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 49.1 mt-10 -128.38 134.93 48.93 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.31 -179.342 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.5 HD12 ' HB2' ' A' ' 102' ' ' PHE . 1.7 tm? -125.44 130.09 51.14 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 178.744 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -88.98 111.3 21.98 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 110.14 -0.318 . . . . 0.0 110.14 -179.914 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.479 HD11 HD13 ' A' ' 19' ' ' LEU . 0.9 OUTLIER -86.38 -12.62 48.75 Favored 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 120.937 -0.305 . . . . 0.0 110.906 179.828 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.691 ' OD2' ' HA ' ' A' ' 54' ' ' ASN . 10.1 t70 -61.66 -36.32 80.5 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.653 0.264 . . . . 0.0 111.225 -178.928 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.3 t -72.75 1.27 8.78 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.199 -0.455 . . . . 0.0 112.0 -179.877 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 78.5 m -135.45 -21.43 1.55 Allowed 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 179.943 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 68.7 mt -107.58 137.21 39.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 179.771 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -149.55 160.13 28.34 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.393 -0.908 . . . . 0.0 112.492 179.951 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.696 ' ND2' ' HB2' ' A' ' 55' ' ' PHE . 8.3 p30 -158.23 51.21 0.44 Allowed Pre-proline 0 CA--C 1.535 0.4 0 N-CA-C 111.664 0.246 . . . . 0.0 111.664 178.967 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -71.83 -19.69 26.97 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 121.944 1.763 . . . . 0.0 111.823 -179.347 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -91.19 -9.2 46.25 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.883 179.515 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.558 ' HA3' ' HG2' ' A' ' 83' ' ' ARG . . . 102.7 7.47 44.89 Favored Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.772 -179.917 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -125.3 137.45 54.07 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.018 0.437 . . . . 0.0 111.076 -179.674 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 86.9 mt -82.92 146.52 28.79 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.922 -178.457 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 168.32 171.48 34.23 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.2 178.743 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 91.6 m95 -95.27 128.01 41.77 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 -179.998 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 154.35 -51.66 0.46 Allowed Glycine 0 N--CA 1.453 -0.196 0 C-N-CA 120.856 -0.688 . . . . 0.0 111.95 -179.905 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 14.0 tpt -93.05 174.03 7.43 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 179.848 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -128.97 173.19 10.64 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.846 -0.342 . . . . 0.0 111.005 179.698 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.691 ' HA ' ' OD2' ' A' ' 38' ' ' ASP . 0.7 OUTLIER 65.52 47.23 2.29 Favored 'General case' 0 N--CA 1.466 0.352 0 O-C-N 123.701 0.626 . . . . 0.0 111.128 -179.806 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.696 ' HB2' ' ND2' ' A' ' 43' ' ' ASN . 15.7 p90 -74.19 -32.11 62.92 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.673 -179.756 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.508 ' HA ' HD13 ' A' ' 62' ' ' ILE . 20.1 m -63.75 -33.74 76.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.035 0.445 . . . . 0.0 111.128 -179.046 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 15.7 m-70 -82.15 -7.95 59.64 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.101 0.476 . . . . 0.0 110.27 179.578 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 15.1 m -112.0 4.23 17.98 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.387 -179.292 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 36.4 p -138.38 157.54 46.03 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 122.203 -0.31 . . . . 0.0 110.752 -179.222 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 38.0 mm-40 -117.46 148.42 41.83 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.014 -179.401 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 24.1 t70 52.05 83.35 0.06 Allowed 'General case' 0 N--CA 1.468 0.462 0 O-C-N 124.333 1.02 . . . . 0.0 111.644 178.957 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.508 HD13 ' HA ' ' A' ' 56' ' ' SER . 77.9 mt -97.79 124.1 50.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.78 -179.942 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 13.0 tmtt? -148.98 149.75 31.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.006 -179.857 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.664 ' HG ' HD21 ' A' ' 12' ' ' LEU . 76.2 mt -83.01 120.16 25.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.021 0.439 . . . . 0.0 111.532 -179.648 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -71.64 -60.2 2.36 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.267 -178.666 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.511 ' HB2' ' HB2' ' A' ' 69' ' ' ARG . 5.0 mm-40 -83.52 20.17 1.44 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.033 -178.767 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 68.66 19.23 72.88 Favored Glycine 0 N--CA 1.45 -0.425 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.923 179.701 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.517 ' HA2' HD12 ' A' ' 64' ' ' LEU . . . 144.18 -34.83 1.62 Allowed Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.315 -0.945 . . . . 0.0 113.251 179.697 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.511 ' HB2' ' HB2' ' A' ' 66' ' ' GLU . 5.4 mmt85 -71.57 -24.89 62.0 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.854 0.359 . . . . 0.0 111.829 -179.34 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 11.7 tttp -143.65 137.48 28.29 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.607 -177.81 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.571 ' HB2' HD11 ' A' ' 90' ' ' LEU . 10.5 tt -105.84 127.58 53.2 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 179.599 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.1 p -116.32 136.28 53.14 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 120.971 0.415 . . . . 0.0 111.233 179.967 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 21.0 p -162.58 175.87 10.98 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.747 -179.743 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.437 ' HA ' ' HD2' ' A' ' 75' ' ' PRO . 29.5 ttt180 -112.8 98.85 46.35 Favored Pre-proline 0 C--N 1.315 -0.902 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.303 178.97 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.437 ' HD2' ' HA ' ' A' ' 74' ' ' ARG . 34.9 Cg_endo -66.19 130.44 24.13 Favored 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 122.674 2.249 . . . . 0.0 110.791 178.953 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.579 ' HA ' ' HB2' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -119.71 152.88 36.47 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.167 0.508 . . . . 0.0 111.049 -179.681 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.654 ' HB ' ' HD2' ' A' ' 83' ' ' ARG . 10.9 t -88.84 144.78 25.99 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 178.902 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 34.7 m -71.61 -4.81 5.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 O-C-N 123.992 0.808 . . . . 0.0 112.152 -179.141 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 39.1 m-20 -63.93 -37.21 86.55 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-O 121.118 0.485 . . . . 0.0 109.793 178.928 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -164.76 -4.94 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 115.461 -0.79 . . . . 0.0 112.854 -179.841 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.38 22.9 25.67 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.089 179.731 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.619 ' O ' HG21 ' A' ' 77' ' ' THR . 34.2 p90 -111.46 148.02 34.03 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 -179.42 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.654 ' HD2' ' HB ' ' A' ' 77' ' ' THR . 0.0 OUTLIER 174.55 -143.75 0.01 OUTLIER 'General case' 0 C--O 1.233 0.195 0 O-C-N 123.465 0.478 . . . . 0.0 111.304 -179.915 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -125.31 176.6 6.66 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.923 0.392 . . . . 0.0 110.579 -179.49 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.431 ' HA ' ' HA ' ' A' ' 74' ' ' ARG . 62.8 ttt180 -108.66 147.82 31.32 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 177.849 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.505 ' HG2' ' N ' ' A' ' 87' ' ' GLY . 9.0 tt0 -161.27 171.8 17.75 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.946 0.403 . . . . 0.0 111.79 -177.246 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.505 ' N ' ' HG2' ' A' ' 86' ' ' GLN . . . -132.12 141.65 13.01 Favored Glycine 0 N--CA 1.45 -0.387 0 N-CA-C 111.233 -0.747 . . . . 0.0 111.233 178.612 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 11.6 tt -120.45 138.74 49.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 120.976 0.417 . . . . 0.0 110.377 -179.221 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.6 m-20 -75.74 139.98 42.15 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.185 -179.472 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.582 HD13 HD13 ' A' ' 19' ' ' LEU . 29.8 mt -109.43 35.73 3.2 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.517 0.675 . . . . 0.0 110.376 179.317 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 13.5 m-80 -72.56 -5.41 36.92 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.594 -179.835 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 17.1 mtp180 -89.09 -7.74 55.21 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.001 178.731 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 27.5 mm -103.64 100.55 10.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -179.615 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 25.4 tp60 -117.55 146.76 43.37 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.342 -178.777 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 12.5 p-10 -95.16 117.11 29.66 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.48 179.18 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 48.5 t -101.36 107.03 20.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.788 179.727 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 56.16 41.86 28.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.675 -179.284 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 89.5 -18.4 46.4 Favored Glycine 0 N--CA 1.447 -0.624 0 CA-C-N 115.783 -0.644 . . . . 0.0 113.342 179.681 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 8.7 mpt_? -88.31 123.13 32.59 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 117.163 0.481 . . . . 0.0 110.921 -179.216 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.492 HD11 ' SG ' ' A' ' 23' ' ' CYS . 7.6 tp -76.65 114.46 15.41 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.443 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 40.7 t -128.98 144.7 37.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.09 0.472 . . . . 0.0 111.367 -178.488 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.5 ' HB2' HD12 ' A' ' 35' ' ' LEU . 22.3 t80 -83.26 130.92 35.11 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.63 178.442 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 . . . . . 0 C--N 1.317 -0.846 0 CA-C-O 118.325 -0.845 . . . . 0.0 110.216 -179.725 . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 tmt? . . . . . 0 N--CA 1.481 1.102 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.9 p -112.98 177.58 4.58 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.732 179.525 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 4.4 p90 -55.91 -38.09 69.79 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -178.555 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -56.35 -21.57 25.41 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 -177.882 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -66.4 -28.7 68.84 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.255 0.55 . . . . 0.0 110.392 179.971 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 41.4 m -133.44 36.22 3.39 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.687 179.204 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 8.6 t -140.29 160.11 40.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.945 -179.66 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 1.1 ptp180 -149.97 169.86 20.19 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.632 -179.593 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 58.23 45.48 17.21 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.129 177.934 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.513 ' HA ' ' HB1' ' A' ' 21' ' ' ALA . . . -81.66 118.34 22.73 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.055 0.455 . . . . 0.0 110.69 179.957 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 29.5 m -119.24 170.55 8.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.393 179.794 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.688 HD22 ' HG ' ' A' ' 64' ' ' LEU . 3.2 mm? -105.12 114.94 29.44 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.434 -179.47 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 38.8 p -115.01 167.66 10.6 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.808 179.752 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 57.64 50.56 10.71 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.154 179.653 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 83.88 -22.94 7.25 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 121.069 -0.586 . . . . 0.0 112.374 -179.808 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 119.71 38.23 0.73 Allowed Glycine 0 N--CA 1.447 -0.583 0 N-CA-C 111.662 -0.575 . . . . 0.0 111.662 179.976 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 14.3 ptt180 -121.86 -22.6 5.7 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.944 0.402 . . . . 0.0 110.758 -179.486 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 4.2 m -102.55 133.06 48.14 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.592 -179.607 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.797 HD13 HD12 ' A' ' 90' ' ' LEU . 69.5 mt -92.65 112.62 24.64 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.297 179.142 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.404 HH11 ' HD2' ' A' ' 20' ' ' ARG . 30.7 ttt85 -111.06 118.57 36.4 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 178.94 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.513 ' HB1' ' HA ' ' A' ' 10' ' ' ALA . . . -154.9 166.92 32.02 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.862 0.363 . . . . 0.0 111.964 -178.783 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -90.69 113.37 25.43 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 177.371 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.472 ' SG ' HD13 ' A' ' 100' ' ' LEU . 59.7 m -102.66 134.95 45.18 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 -179.806 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.543 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 7.3 ttt180 -82.12 104.66 12.61 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-O 120.917 0.389 . . . . 0.0 109.965 -179.804 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 37.8 p30 -67.01 170.84 6.17 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 115.619 -0.718 . . . . 0.0 111.162 -179.214 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.52 -31.16 61.84 Favored 'General case' 0 N--CA 1.464 0.269 0 O-C-N 123.431 0.457 . . . . 0.0 111.781 -178.781 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -71.56 -11.71 61.0 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.331 0.586 . . . . 0.0 110.421 179.878 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 87.55 24.64 35.47 Favored Glycine 0 N--CA 1.45 -0.404 0 N-CA-C 111.373 -0.691 . . . . 0.0 111.373 -179.839 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.543 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 10.7 t-20 -108.56 160.09 16.19 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.672 0.272 . . . . 0.0 110.718 -178.349 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 90.4 m95 -98.36 119.18 36.6 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.984 0.421 . . . . 0.0 110.8 179.745 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.2 m -123.43 130.9 73.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.098 179.11 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 28.0 m -79.69 109.12 13.8 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.057 0.455 . . . . 0.0 110.32 -179.889 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 70.3 m -115.89 161.33 18.96 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.439 -179.817 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.626 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 51.5 mt-10 -140.02 138.92 35.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.241 -178.908 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.402 HD22 ' O ' ' A' ' 100' ' ' LEU . 1.8 tm? -134.72 129.97 35.53 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 178.704 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.471 ' O ' HG21 ' A' ' 39' ' ' THR . 15.8 m-20 -88.64 109.64 20.28 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 179.971 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.446 HD12 HD22 ' A' ' 90' ' ' LEU . 1.4 mt -83.06 -12.42 57.16 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.831 -179.303 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.4 ' HA ' ' HD1' ' A' ' 55' ' ' PHE . 4.2 p-10 -66.23 -13.58 60.56 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 111.857 0.317 . . . . 0.0 111.857 -178.621 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.471 HG21 ' O ' ' A' ' 36' ' ' ASP . 12.1 t -87.97 -0.58 57.19 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.885 0.374 . . . . 0.0 110.296 179.387 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 67.2 m -136.58 -20.11 1.37 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.937 179.94 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 60.0 mt -107.96 132.49 55.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 178.877 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -141.49 158.69 26.61 Favored Glycine 0 N--CA 1.446 -0.667 0 N-CA-C 111.256 -0.738 . . . . 0.0 111.256 179.527 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.599 ' OD1' ' HB2' ' A' ' 58' ' ' SER . 32.6 p30 -156.29 40.82 0.12 Allowed Pre-proline 0 CA--C 1.54 0.592 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 179.792 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.403 ' CD ' ' N ' ' A' ' 43' ' ' ASN . 52.5 Cg_endo -69.65 -15.86 37.73 Favored 'Trans proline' 0 C--N 1.357 0.975 0 C-N-CA 121.331 1.354 . . . . 0.0 111.41 -179.933 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -89.74 -8.12 52.98 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.623 179.077 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.455 ' CA ' ' HG2' ' A' ' 83' ' ' ARG . . . 99.38 5.25 55.91 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.659 -179.575 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -126.92 139.79 52.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 117.045 0.422 . . . . 0.0 111.568 -179.587 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.531 ' H ' ' NE2' ' A' ' 86' ' ' GLN . 59.4 mt -84.5 138.86 32.54 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.735 -179.704 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 179.11 168.39 38.11 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.137 178.807 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 87.9 m95 -95.78 125.51 40.4 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.985 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 151.26 -42.61 0.72 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.895 -0.669 . . . . 0.0 111.519 -179.66 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 1.5 mtt -97.44 -172.07 2.33 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 179.399 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -142.96 169.81 16.88 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 119.757 -0.777 . . . . 0.0 112.343 -178.839 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 64.0 44.97 4.4 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.877 179.203 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.4 ' HD1' ' HA ' ' A' ' 38' ' ' ASP . 20.7 p90 -64.08 -33.6 76.13 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.464 -179.788 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 67.0 p -66.49 -23.84 66.32 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.208 0.527 . . . . 0.0 110.787 -179.36 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 16.1 m80 -76.97 -6.06 51.1 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.662 179.689 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.599 ' HB2' ' OD1' ' A' ' 43' ' ' ASN . 31.5 m -137.78 27.99 2.68 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.939 0.4 . . . . 0.0 110.782 179.492 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 35.6 p -141.73 149.81 40.98 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.169 0.509 . . . . 0.0 111.32 179.352 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -123.28 150.06 43.99 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.476 -179.626 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 27.6 t70 54.62 77.4 0.2 Allowed 'General case' 0 N--CA 1.47 0.546 0 O-C-N 123.778 0.674 . . . . 0.0 111.188 -179.922 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.491 HG22 HD23 ' A' ' 71' ' ' LEU . 69.4 mt -95.98 117.5 40.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.878 -179.404 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 41.6 tptt -142.25 150.45 40.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.699 -179.326 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.688 ' HG ' HD22 ' A' ' 12' ' ' LEU . 57.8 mt -92.93 144.7 25.01 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.362 179.432 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -101.42 -63.93 1.1 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.941 0.4 . . . . 0.0 111.963 -179.965 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -79.81 40.34 0.45 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.045 -178.098 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 64.11 22.09 66.61 Favored Glycine 0 C--N 1.314 -0.675 0 CA-C-N 115.229 -0.896 . . . . 0.0 113.123 178.858 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.536 ' HA2' HD12 ' A' ' 64' ' ' LEU . . . 120.56 -9.18 10.83 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 119.965 -1.112 . . . . 0.0 112.858 179.17 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 16.5 ttp85 -90.3 -3.06 58.01 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.665 0.745 . . . . 0.0 110.335 -179.794 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 5.6 tppp? -150.39 123.64 8.92 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.846 -179.77 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.597 ' HB2' HD13 ' A' ' 90' ' ' LEU . 9.5 tt -105.62 128.57 53.71 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 179.867 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 5.6 p -123.23 135.43 54.27 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.166 179.876 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 22.8 p -162.21 173.79 13.78 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 179.552 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.437 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 71.8 ttt180 -110.26 98.59 36.34 Favored Pre-proline 0 C--N 1.312 -1.035 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.276 179.606 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -69.92 132.65 23.5 Favored 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 122.342 2.028 . . . . 0.0 109.964 178.495 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.682 ' HA ' ' HB2' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -120.6 142.84 49.02 Favored 'General case' 0 C--N 1.32 -0.68 0 O-C-N 123.678 0.611 . . . . 0.0 111.452 -179.115 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.691 HG22 ' O ' ' A' ' 82' ' ' PHE . 14.6 t -76.81 143.31 39.87 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.614 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 22.5 m -77.4 1.07 2.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.573 -179.492 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -69.8 -34.26 73.48 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 121.371 0.605 . . . . 0.0 109.651 178.326 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -159.05 -12.77 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.517 0 CA-C-N 115.29 -0.868 . . . . 0.0 112.794 -179.814 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.23 20.21 23.72 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.108 179.983 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.691 ' O ' HG22 ' A' ' 77' ' ' THR . 33.8 p90 -111.83 155.42 23.62 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 118.996 -0.526 . . . . 0.0 109.904 -179.055 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.682 ' HB2' ' HA ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 171.49 -148.18 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 O-C-N 123.407 0.442 . . . . 0.0 111.48 179.651 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -134.99 153.51 52.06 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.157 -177.817 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.437 ' HA ' ' HA ' ' A' ' 74' ' ' ARG . 43.2 ttt85 -88.56 149.55 23.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.128 179.512 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.531 ' NE2' ' H ' ' A' ' 48' ' ' LEU . 14.3 pt20 -165.28 177.51 7.54 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.146 -179.033 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -131.62 150.94 19.61 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.8 -0.715 . . . . 0.0 112.45 -179.994 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 9.5 tt -127.77 134.63 65.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 179.736 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.411 ' HB2' HD21 ' A' ' 91' ' ' ASN . 2.1 p-10 -76.94 140.27 40.42 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.997 0.427 . . . . 0.0 110.439 -179.178 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.797 HD12 HD13 ' A' ' 19' ' ' LEU . 62.2 mt -105.91 38.69 1.95 Allowed 'General case' 0 CA--C 1.512 -0.513 0 CA-C-O 121.412 0.625 . . . . 0.0 110.873 -178.892 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.411 HD21 ' HB2' ' A' ' 89' ' ' ASP . 30.2 m-80 -75.19 0.05 17.71 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.794 -179.759 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 14.7 mtp180 -92.05 -7.67 48.09 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.595 179.339 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.421 ' CD1' HD23 ' A' ' 37' ' ' LEU . 28.1 mm -98.5 104.57 16.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.518 0.675 . . . . 0.0 109.747 -179.334 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -106.56 157.36 17.73 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.36 -178.346 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.462 ' HA ' ' O ' ' A' ' 99' ' ' ARG . 20.4 p-10 -113.7 124.64 52.78 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.425 178.073 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 46.8 t -107.71 109.28 27.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 -179.237 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 11.3 m-80 57.79 22.14 8.21 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.937 0.398 . . . . 0.0 111.577 -179.326 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 113.66 -25.36 11.08 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.728 -0.748 . . . . 0.0 113.935 178.47 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.462 ' O ' ' HA ' ' A' ' 95' ' ' ASN . 1.4 ptm180 -86.5 147.76 25.83 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 117.416 0.608 . . . . 0.0 110.666 -178.85 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.472 HD13 ' SG ' ' A' ' 23' ' ' CYS . 2.1 tp -92.68 122.92 35.57 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.718 0.294 . . . . 0.0 110.335 -179.366 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 41.7 t -134.12 141.84 42.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.654 -179.869 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 16.9 t80 -78.44 136.39 37.61 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.979 0.419 . . . . 0.0 110.106 179.268 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.087 0 CA-C-O 118.462 -0.78 . . . . 0.0 110.39 179.949 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 70.5 mtm . . . . . 0 N--CA 1.482 1.173 0 CA-C-O 120.842 0.353 . . . . 0.0 110.297 . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.93 179.91 4.63 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.729 179.92 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.439 ' CB ' HD12 ' A' ' 100' ' ' LEU . 13.3 p90 -47.03 -36.07 7.49 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 123.09 0.556 . . . . 0.0 112.422 -179.51 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -54.13 -20.45 6.67 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -178.664 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -64.11 -33.65 76.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.218 0.533 . . . . 0.0 109.867 178.896 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 26.1 m -132.31 41.8 3.18 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.619 179.121 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 22.7 t -154.77 149.24 26.26 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.307 -179.591 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 11.6 ptp180 -136.62 175.7 9.37 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.827 -179.474 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 4.6 p30 45.58 60.39 3.12 Favored 'General case' 0 N--CA 1.474 0.774 0 O-C-N 124.298 0.999 . . . . 0.0 112.286 -179.233 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -87.28 117.73 26.23 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.376 179.519 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 33.9 m -115.92 170.64 5.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.821 -179.852 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.541 HD21 ' HG ' ' A' ' 64' ' ' LEU . 3.7 mm? -105.18 120.75 42.29 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.592 -179.62 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.43 HG23 ' NE ' ' A' ' 20' ' ' ARG . 17.7 p -119.96 161.42 20.92 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.825 179.542 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 59.8 38.27 21.55 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.14 179.679 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 93.86 -23.34 31.39 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.066 179.896 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 124.93 11.78 4.23 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.628 -0.796 . . . . 0.0 111.847 -179.939 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 16.9 ptt180 -92.46 -23.05 19.27 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.264 0.554 . . . . 0.0 110.067 -179.954 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 4.3 m -105.96 133.48 50.61 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.782 -179.535 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.727 HD12 HD12 ' A' ' 90' ' ' LEU . 59.9 mt -97.47 114.41 26.27 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.419 179.163 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.443 ' HA ' ' HG2' ' A' ' 34' ' ' GLU . 32.9 ttm180 -109.84 120.19 41.7 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 178.813 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -153.36 166.12 33.63 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.969 0.414 . . . . 0.0 111.455 -179.675 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -90.29 107.6 19.24 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 177.898 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.423 ' SG ' HD11 ' A' ' 100' ' ' LEU . 71.6 m -98.51 140.65 32.44 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.686 0.279 . . . . 0.0 110.69 -178.701 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.521 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 7.9 ttp180 -83.96 115.83 22.51 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-O 120.949 0.405 . . . . 0.0 110.2 179.412 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 37.0 p30 -76.55 174.2 10.62 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.262 179.919 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.74 -25.29 60.2 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -178.497 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -78.79 -9.81 59.57 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.65 0.738 . . . . 0.0 109.896 179.92 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 85.07 29.3 28.71 Favored Glycine 0 N--CA 1.445 -0.761 0 N-CA-C 110.718 -0.953 . . . . 0.0 110.718 -179.031 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.521 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 8.3 t-20 -111.53 158.45 19.17 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.74 -0.23 . . . . 0.0 110.687 -178.555 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 61.4 m95 -92.28 129.29 38.26 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.047 -179.899 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 15.6 m -132.9 141.42 44.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.668 179.346 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.2 m -81.7 111.75 18.25 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.228 179.86 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 54.7 m -127.53 150.18 49.81 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.655 179.779 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.656 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 45.1 mt-10 -134.25 148.32 50.81 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.03 -179.611 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.516 HD11 HD23 ' A' ' 37' ' ' LEU . 2.1 tm? -139.25 134.42 32.64 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.55 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.47 ' N ' HD12 ' A' ' 35' ' ' LEU . 29.6 m-20 -91.76 109.69 21.02 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.359 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.516 HD23 HD11 ' A' ' 35' ' ' LEU . 1.4 mt -83.01 -20.62 34.72 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.816 -178.543 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.406 ' HA ' ' HD1' ' A' ' 55' ' ' PHE . 4.3 p-10 -61.5 -15.41 37.61 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 111.717 0.266 . . . . 0.0 111.717 -178.423 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 60.0 p -72.48 -22.58 61.04 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.055 0.455 . . . . 0.0 110.716 179.737 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 27.3 m -128.86 0.25 5.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.06 -0.518 . . . . 0.0 112.022 -178.669 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 53.7 mt -116.57 131.35 69.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 120.636 0.255 . . . . 0.0 110.342 178.861 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -150.38 163.99 29.67 Favored Glycine 0 N--CA 1.445 -0.731 0 N-CA-C 111.328 -0.709 . . . . 0.0 111.328 179.445 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.59 ' ND2' ' HB2' ' A' ' 55' ' ' PHE . 7.3 p30 -161.91 51.08 0.32 Allowed Pre-proline 0 CA--C 1.535 0.386 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 179.813 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -63.5 -26.73 70.08 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 121.847 1.698 . . . . 0.0 111.75 -179.626 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -84.14 -12.59 54.73 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.797 179.898 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.518 ' CA ' ' HG2' ' A' ' 83' ' ' ARG . . . 103.36 7.96 41.92 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.283 -0.96 . . . . 0.0 112.954 -179.344 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.452 ' HA ' HE22 ' A' ' 86' ' ' GLN . 61.7 m-85 -124.88 133.62 53.01 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.003 0.43 . . . . 0.0 110.495 179.676 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 84.2 mt -83.09 138.0 33.87 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.498 -0.774 . . . . 0.0 112.251 -177.688 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -177.01 172.81 45.77 Favored Glycine 0 N--CA 1.447 -0.58 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.7 178.802 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 94.1 m95 -95.53 128.21 42.21 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.993 0.425 . . . . 0.0 110.321 -179.971 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 151.84 -62.69 0.39 Allowed Glycine 0 N--CA 1.449 -0.441 0 CA-C-N 116.019 -0.537 . . . . 0.0 112.076 -179.877 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.914 ' HA ' ' HE3' ' A' ' 52' ' ' MET . 1.0 OUTLIER -77.02 179.88 5.96 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 179.74 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -133.98 173.8 11.17 Favored 'General case' 0 C--N 1.326 -0.419 0 O-C-N 122.089 -0.382 . . . . 0.0 111.678 -178.982 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 61.74 45.99 7.4 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.642 -0.708 . . . . 0.0 112.33 179.174 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.59 ' HB2' ' ND2' ' A' ' 43' ' ' ASN . 8.5 p90 -65.83 -28.51 69.04 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 111.652 0.241 . . . . 0.0 111.652 -179.371 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 11.4 p -64.45 -28.4 69.65 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.917 0.389 . . . . 0.0 111.553 -179.104 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 50.5 m80 -82.27 -3.43 55.21 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.224 -179.433 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 14.9 m -126.52 13.53 7.57 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.792 179.793 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 63.9 m -135.49 151.94 50.85 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.382 0.61 . . . . 0.0 111.881 -178.891 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -121.55 141.46 51.05 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.404 179.279 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.405 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 31.4 t70 58.78 79.89 0.2 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.509 0.671 . . . . 0.0 111.39 179.704 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.517 HG23 HD23 ' A' ' 71' ' ' LEU . 74.3 mt -95.56 123.27 47.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.076 179.558 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.6 tptm -149.02 160.0 43.71 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 -179.769 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.541 ' HG ' HD21 ' A' ' 12' ' ' LEU . 44.7 mt -88.57 129.44 35.48 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.108 0.48 . . . . 0.0 109.973 178.965 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.1 tp10 -77.52 -69.47 0.53 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.264 -178.398 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.561 ' HB2' ' HB2' ' A' ' 69' ' ' ARG . 26.1 mt-10 -81.94 29.31 0.4 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.285 -179.284 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 68.11 14.64 66.36 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.903 -0.59 . . . . 0.0 113.282 179.757 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 145.98 -25.84 1.76 Allowed Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 119.591 -1.29 . . . . 0.0 113.373 179.361 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.561 ' HB2' ' HB2' ' A' ' 66' ' ' GLU . 9.6 mmt85 -76.19 -23.37 54.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.283 0.563 . . . . 0.0 110.431 -179.289 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -146.02 148.73 33.0 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.801 -177.883 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.614 ' HB2' HD13 ' A' ' 90' ' ' LEU . 9.8 tt -115.94 125.66 52.86 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 179.332 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.1 p -113.72 128.35 56.39 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.346 0.594 . . . . 0.0 111.241 179.43 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . 0.405 ' HA ' ' O ' ' A' ' 61' ' ' ASP . 25.6 p -149.88 171.32 16.97 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.659 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.511 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 4.1 tmt_? -104.37 98.31 14.02 Favored Pre-proline 0 C--N 1.315 -0.896 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 179.267 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -72.62 125.02 10.23 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 123.002 2.468 . . . . 0.0 111.506 179.79 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.668 ' HA ' ' HB2' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -121.82 139.92 53.02 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.867 179.819 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.713 HG22 ' O ' ' A' ' 82' ' ' PHE . 11.6 t -74.77 131.54 40.89 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 178.499 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.1 m -74.18 -2.22 3.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.488 -179.256 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -68.83 -33.71 74.28 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.185 0.517 . . . . 0.0 109.738 179.309 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -148.56 -23.96 0.08 OUTLIER Glycine 0 N--CA 1.449 -0.436 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.591 179.796 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.523 ' HA2' ' HE2' ' A' ' 76' ' ' LYS . . . 101.58 19.03 16.83 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.021 -179.793 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.713 ' O ' HG22 ' A' ' 77' ' ' THR . 26.3 p90 -110.71 151.05 28.19 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 118.821 -0.609 . . . . 0.0 109.993 -178.885 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.668 ' HB2' ' HA ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 167.49 -153.95 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.572 0 O-C-N 123.729 0.643 . . . . 0.0 111.213 179.236 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -135.55 167.41 21.14 Favored 'General case' 0 C--O 1.226 -0.17 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.051 -178.842 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.511 ' HA ' ' HA ' ' A' ' 74' ' ' ARG . 44.5 ttt180 -81.75 156.25 25.07 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 178.407 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.595 ' HG2' ' H ' ' A' ' 87' ' ' GLY . 7.1 tt0 -161.04 -176.07 5.27 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.41 -0.516 . . . . 0.0 111.401 -178.161 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.595 ' H ' ' HG2' ' A' ' 86' ' ' GLN . . . -151.89 141.36 8.47 Favored Glycine 0 N--CA 1.449 -0.49 0 N-CA-C 111.778 -0.529 . . . . 0.0 111.778 179.379 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 10.4 tt -120.58 133.48 67.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.303 0.573 . . . . 0.0 110.77 -179.46 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.531 ' OD1' ' HB2' ' A' ' 91' ' ' ASN . 13.6 t70 -73.25 136.34 44.61 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.632 -179.868 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.727 HD12 HD12 ' A' ' 19' ' ' LEU . 63.8 mt -109.55 37.41 2.63 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -178.341 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.531 ' HB2' ' OD1' ' A' ' 89' ' ' ASP . 7.1 m-80 -75.05 2.59 10.23 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 121.368 0.604 . . . . 0.0 111.221 179.231 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 24.7 mtp180 -92.29 -12.49 32.37 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.243 179.104 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.448 ' CD1' HD22 ' A' ' 37' ' ' LEU . 24.6 mm -94.94 103.47 14.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 121.453 0.644 . . . . 0.0 109.563 -179.622 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 3.9 mm-40 -112.25 152.08 28.88 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.714 -178.368 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 18.3 p-10 -105.27 126.02 51.63 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.742 178.564 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 40.5 t -115.72 116.47 52.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 -179.562 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 54.4 25.39 6.0 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.601 -179.841 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 109.13 -27.45 12.72 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.806 -0.712 . . . . 0.0 114.004 179.155 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -86.8 146.19 26.33 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 117.687 0.744 . . . . 0.0 111.53 -178.48 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.494 ' O ' HD23 ' A' ' 35' ' ' LEU . 5.2 tp -92.14 121.52 33.76 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.906 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 24.1 t -129.73 140.88 47.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 120.804 0.335 . . . . 0.0 110.935 -178.821 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.4 ' HB2' HD13 ' A' ' 35' ' ' LEU . 20.7 t80 -79.21 130.73 35.77 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 178.475 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 . . . . . 0 C--N 1.312 -1.064 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.673 -179.57 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' SER . . . . . 0.537 ' OG ' ' HA ' ' A' ' 91' ' ' ASN . 9.2 m . . . . . 0 N--CA 1.449 -0.485 0 N-CA-C 110.426 -0.213 . . . . 0.0 110.426 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 18.6 p90 -51.73 -34.18 37.98 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 123.448 0.468 . . . . 0.0 111.519 179.143 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -56.3 -18.8 11.77 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 -178.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -58.02 -32.91 68.4 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 121.261 0.553 . . . . 0.0 110.093 178.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 33.5 m -137.44 37.94 2.47 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.338 178.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.456 ' HA ' ' O ' ' A' ' 22' ' ' GLU . 20.3 t -147.23 147.97 30.99 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.271 -179.661 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 9.7 ptp180 -140.58 169.75 17.07 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.086 -179.625 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 65.7 m-80 57.39 52.32 8.8 Favored 'General case' 0 N--CA 1.465 0.296 0 O-C-N 123.93 0.769 . . . . 0.0 111.53 -179.419 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -82.47 118.12 23.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.465 179.361 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 27.0 m -121.55 170.8 11.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.67 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.641 HD21 ' HG ' ' A' ' 64' ' ' LEU . 3.3 mm? -105.14 114.57 28.85 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.118 -179.546 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.504 HG21 ' NE ' ' A' ' 20' ' ' ARG . 35.3 p -111.79 170.37 8.19 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.978 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 59.49 46.25 12.48 Favored 'General case' 0 CA--C 1.521 -0.137 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.289 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 86.01 -34.92 3.32 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 121.007 -0.616 . . . . 0.0 112.134 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.592 ' HA2' ' HB3' ' A' ' 12' ' ' LEU . . . 136.2 38.02 0.17 Allowed Glycine 0 N--CA 1.447 -0.583 0 N-CA-C 111.437 -0.665 . . . . 0.0 111.437 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.692 ' HB2' ' HB2' ' A' ' 38' ' ' ASP . 3.3 ptp180 -125.23 -12.91 6.81 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.256 0.55 . . . . 0.0 110.98 -179.389 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.519 ' CG2' ' HB3' ' A' ' 34' ' ' GLU . 9.5 m -115.21 137.74 51.69 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.429 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.831 HD11 HD13 ' A' ' 90' ' ' LEU . 59.6 mt -96.13 118.66 33.16 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.734 179.565 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.504 ' NE ' HG21 ' A' ' 13' ' ' THR . 34.5 ttm180 -113.84 120.98 42.61 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 178.262 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.413 ' O ' ' HA ' ' A' ' 32' ' ' THR . . . -152.72 167.32 29.37 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.827 0.346 . . . . 0.0 111.532 -179.122 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.697 ' HB3' ' HB3' ' A' ' 30' ' ' TRP . 39.4 mt-10 -89.68 105.95 18.14 Favored 'General case' 0 CA--C 1.512 -0.516 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 178.819 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.533 ' SG ' HD13 ' A' ' 100' ' ' LEU . 56.0 m -96.23 119.22 34.33 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 -179.276 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.486 ' HB2' ' CZ3' ' A' ' 30' ' ' TRP . 45.9 ttp180 -72.85 111.28 7.83 Favored 'General case' 0 N--CA 1.437 -1.113 0 N-CA-C 110.197 -0.297 . . . . 0.0 110.197 179.386 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 31.9 p30 -81.18 168.9 18.03 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.669 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -51.54 -32.01 26.39 Favored 'General case' 0 N--CA 1.465 0.284 0 O-C-N 123.643 0.59 . . . . 0.0 112.096 -179.192 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -67.65 -14.12 62.67 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.404 0.621 . . . . 0.0 110.94 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 89.15 22.07 39.49 Favored Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.772 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.431 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 2.3 m-80 -111.77 150.38 30.37 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.838 0.351 . . . . 0.0 111.449 -179.101 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.697 ' HB3' ' HB3' ' A' ' 22' ' ' GLU . 97.3 m95 -91.63 109.3 20.6 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.201 179.242 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.9 m -109.87 129.42 64.83 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 CA-C-O 120.965 0.412 . . . . 0.0 110.232 178.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.413 ' HA ' ' O ' ' A' ' 21' ' ' ALA . 27.7 m -78.98 113.16 16.87 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.854 -179.372 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 68.7 m -121.19 157.26 30.6 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.403 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.676 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 51.3 mt-10 -131.78 132.35 43.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.763 -179.583 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.472 ' HB2' HD23 ' A' ' 100' ' ' LEU . 1.9 tm? -124.91 132.63 53.27 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.571 -0.899 . . . . 0.0 108.571 178.771 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.449 ' N ' HD13 ' A' ' 35' ' ' LEU . 12.9 m-20 -91.45 109.95 21.25 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.76 0.314 . . . . 0.0 110.512 -179.113 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.451 HD13 HD22 ' A' ' 90' ' ' LEU . 0.9 OUTLIER -83.47 -15.99 47.43 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.296 -179.521 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.75 ' OD2' ' HA ' ' A' ' 54' ' ' ASN . 8.5 t70 -63.17 -8.48 8.11 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.071 0.462 . . . . 0.0 110.969 -179.297 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 73.0 p -87.14 -22.37 25.39 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.49 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.404 ' HB2' ' CZ3' ' A' ' 50' ' ' TRP . 29.0 m -125.56 -5.04 7.1 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -178.056 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 56.7 mt -113.72 136.16 51.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.66 0.267 . . . . 0.0 110.407 179.295 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.521 ' HA3' ' HB3' ' A' ' 52' ' ' MET . . . -146.65 157.35 27.37 Favored Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.86 -0.686 . . . . 0.0 111.855 179.769 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.618 ' N ' ' HD3' ' A' ' 44' ' ' PRO . 21.8 p30 -159.53 46.28 0.21 Allowed Pre-proline 0 CA--C 1.539 0.534 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.618 ' HD3' ' N ' ' A' ' 43' ' ' ASN . 7.0 Cg_exo -70.84 -19.16 31.31 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 122.182 1.922 . . . . 0.0 112.012 -178.757 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -96.53 1.93 51.88 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.912 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.433 ' HA2' ' HB2' ' A' ' 75' ' ' PRO . . . 92.89 8.44 61.88 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.185 -1.007 . . . . 0.0 112.693 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.545 ' HA ' HE22 ' A' ' 86' ' ' GLN . 56.6 m-85 -125.88 134.49 51.59 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.952 0.376 . . . . 0.0 110.716 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.491 HD23 HG22 ' A' ' 88' ' ' ILE . 10.8 mp -88.6 147.26 24.66 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.904 -178.883 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 172.18 175.32 40.22 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.968 -0.634 . . . . 0.0 111.825 178.434 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.45 ' HH2' HD11 ' A' ' 93' ' ' ILE . 95.8 m95 -97.72 130.35 44.7 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.952 0.406 . . . . 0.0 110.346 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 147.31 -60.81 0.46 Allowed Glycine 0 N--CA 1.447 -0.593 0 N-CA-C 111.542 -0.623 . . . . 0.0 111.542 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.588 ' CE ' ' HA ' ' A' ' 52' ' ' MET . 1.7 tpt -77.85 171.61 14.71 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 179.09 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -132.19 171.23 13.93 Favored 'General case' 0 C--N 1.32 -0.715 0 O-C-N 121.845 -0.534 . . . . 0.0 110.907 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.75 ' HA ' ' OD2' ' A' ' 38' ' ' ASP . 13.6 m120 65.3 45.7 2.83 Favored 'General case' 0 C--N 1.328 -0.336 0 O-C-N 124.041 0.838 . . . . 0.0 111.77 178.657 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.409 ' HB3' ' HA2' ' A' ' 42' ' ' GLY . 25.5 p90 -65.65 -30.02 70.67 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.411 179.658 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.419 ' OG ' ' HB3' ' A' ' 17' ' ' ARG . 12.0 m -59.48 -26.81 65.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.297 0.57 . . . . 0.0 110.767 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 75.5 m80 -75.96 -13.59 60.24 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.635 -178.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 27.1 m -131.66 32.23 4.16 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 120.853 0.359 . . . . 0.0 110.978 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 29.2 p -145.58 154.1 41.79 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.611 -0.436 . . . . 0.0 111.328 179.443 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.485 ' HG3' ' HG2' ' A' ' 76' ' ' LYS . 68.3 mt-10 -131.47 148.75 52.67 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.368 179.769 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 60.29 59.65 2.25 Favored 'General case' 0 C--N 1.331 -0.229 0 O-C-N 123.848 0.718 . . . . 0.0 110.956 178.844 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.576 HG23 HD21 ' A' ' 71' ' ' LEU . 75.2 mt -83.45 113.83 23.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.116 -179.57 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 35.7 ttmt -149.74 154.73 38.98 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.994 179.487 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.641 ' HG ' HD21 ' A' ' 12' ' ' LEU . 72.6 mt -82.63 130.65 35.16 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.834 0.35 . . . . 0.0 110.509 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -88.09 -58.52 2.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.634 -178.58 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.532 ' HB2' ' HB2' ' A' ' 69' ' ' ARG . 26.6 mt-10 -80.91 33.78 0.33 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.87 0.366 . . . . 0.0 111.318 -179.556 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 67.4 2.14 18.77 Favored Glycine 0 C--N 1.32 -0.342 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.879 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.546 ' HA2' HD13 ' A' ' 64' ' ' LEU . . . 145.37 -14.96 1.85 Allowed Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 120.095 -1.05 . . . . 0.0 112.669 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.532 ' HB2' ' HB2' ' A' ' 66' ' ' GLU . 19.1 mmt180 -79.67 -18.51 51.19 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.47 ' HB3' ' HG3' ' A' ' 66' ' ' GLU . 30.7 ttpt -149.22 140.24 22.94 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.123 -178.556 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.597 ' HB2' HD11 ' A' ' 90' ' ' LEU . 9.8 tt -109.49 124.26 50.76 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.306 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 6.6 p -111.41 137.01 49.74 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.232 0.539 . . . . 0.0 111.224 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.502 ' HB3' ' HA ' ' A' ' 62' ' ' ILE . 21.4 p -161.61 164.08 29.58 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.163 179.522 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.437 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 28.7 ttt180 -99.88 103.27 21.1 Favored Pre-proline 0 C--N 1.318 -0.78 0 CA-C-N 116.722 -0.217 . . . . 0.0 110.47 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.614 ' O ' ' HB3' ' A' ' 83' ' ' ARG . 56.6 Cg_endo -70.02 116.03 4.4 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 122.403 2.069 . . . . 0.0 110.002 178.314 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.906 ' HE2' ' HA2' ' A' ' 81' ' ' GLY . 0.0 OUTLIER -119.34 141.61 48.87 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.301 -179.182 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.695 HG22 ' O ' ' A' ' 82' ' ' PHE . 12.2 t -67.57 132.6 47.87 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 179.642 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 14.0 p -68.58 -14.19 18.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 O-C-N 124.149 0.905 . . . . 0.0 111.128 -179.296 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -64.54 -28.03 69.37 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.72 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.481 ' HA3' ' CE1' ' A' ' 82' ' ' PHE . . . -155.12 -26.67 0.03 OUTLIER Glycine 0 CA--C 1.518 0.266 0 C-N-CA 120.138 -1.03 . . . . 0.0 113.858 -179.412 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.906 ' HA2' ' HE2' ' A' ' 76' ' ' LYS . . . 102.94 18.64 14.73 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.998 -0.62 . . . . 0.0 111.599 -179.31 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.695 ' O ' HG22 ' A' ' 77' ' ' THR . 18.9 p90 -112.36 145.52 39.93 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 119.274 -0.393 . . . . 0.0 110.053 -178.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.739 ' HB2' ' HA ' ' A' ' 76' ' ' LYS . 0.1 OUTLIER 173.9 -145.34 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.84 0.352 . . . . 0.0 111.62 -179.86 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -128.64 160.3 32.88 Favored 'General case' 0 C--O 1.222 -0.353 0 CA-C-N 115.586 -0.733 . . . . 0.0 109.52 -179.033 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.47 ' HA ' ' HD2' ' A' ' 75' ' ' PRO . 25.0 ttt180 -89.47 154.97 19.61 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.302 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLN . . . . . 0.545 HE22 ' HA ' ' A' ' 47' ' ' PHE . 1.6 mt-30 -155.31 -169.55 3.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.333 0.587 . . . . 0.0 111.981 -178.581 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -163.08 142.97 8.25 Favored Glycine 0 N--CA 1.445 -0.709 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.771 179.153 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.491 HG22 HD23 ' A' ' 48' ' ' LEU . 10.9 tt -127.21 132.61 69.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.042 0.449 . . . . 0.0 110.548 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -75.23 141.29 43.55 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 179.741 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.831 HD13 HD11 ' A' ' 19' ' ' LEU . 63.4 mt -107.3 61.71 0.62 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.691 0.757 . . . . 0.0 110.854 -178.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.537 ' HA ' ' OG ' ' A' ' 2' ' ' SER . 25.0 m-80 -90.89 -0.07 57.63 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.354 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 9.8 mtp180 -96.01 -15.51 22.23 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.995 179.316 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.45 HD11 ' HH2' ' A' ' 50' ' ' TRP . 28.1 mm -89.88 110.03 21.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 -179.277 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 12.4 mm100 -111.17 167.16 10.49 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.425 -178.018 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 21.4 p-10 -126.67 112.42 15.44 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.574 178.228 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.7 p -111.55 116.66 53.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 120.96 0.409 . . . . 0.0 110.407 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 13.6 m-80 56.32 35.09 25.25 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.762 -178.717 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 87.02 -10.26 69.13 Favored Glycine 0 N--CA 1.442 -0.906 0 CA-C-N 115.65 -0.705 . . . . 0.0 113.311 179.417 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -94.11 123.14 37.29 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 117.459 0.63 . . . . 0.0 110.119 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.533 HD13 ' SG ' ' A' ' 23' ' ' CYS . 5.7 tp -79.69 119.21 22.31 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 54.1 t -133.23 145.6 33.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.398 -178.817 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.411 ' HB2' HD11 ' A' ' 35' ' ' LEU . 26.2 t80 -78.24 129.7 35.39 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.005 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 47.4 tt0 . . . . . 0 C--O 1.25 1.111 0 CA-C-O 117.986 -1.007 . . . . 0.0 110.802 -179.191 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' SER . . . . . 0.443 ' O ' ' HB2' ' A' ' 5' ' ' ASP . 17.1 m . . . . . 0 N--CA 1.452 -0.365 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.566 ' HB3' ' HA ' ' A' ' 94' ' ' GLN . 22.2 p90 -57.84 -36.77 72.75 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.083 0.468 . . . . 0.0 110.334 178.585 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.5 ' HB3' ' HD3' ' A' ' 69' ' ' ARG . . . -58.32 -18.71 29.29 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 115.446 -0.797 . . . . 0.0 112.523 -178.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.443 ' HB2' ' O ' ' A' ' 2' ' ' SER . 0.9 OUTLIER -62.41 -26.89 68.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.928 0.394 . . . . 0.0 110.298 179.161 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 27.1 m -134.63 30.08 3.49 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.819 179.11 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.413 ' HA ' ' HZ3' ' A' ' 30' ' ' TRP . 21.0 m -139.31 155.55 47.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.247 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.557 ' HG2' ' CZ3' ' A' ' 30' ' ' TRP . 2.3 ptp180 -142.1 169.84 16.84 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.869 -179.468 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 53.4 57.8 5.84 Favored 'General case' 0 C--O 1.232 0.179 0 O-C-N 123.769 0.668 . . . . 0.0 111.696 178.58 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -87.86 121.56 30.43 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.839 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 27.8 m -127.93 172.17 15.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.68 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.688 HD21 ' HG ' ' A' ' 64' ' ' LEU . 3.6 mm? -104.55 118.65 37.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.454 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 19.6 p -117.52 166.53 12.26 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.948 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 62.46 26.99 16.07 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.479 179.298 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 101.81 -22.68 37.49 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.485 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.578 ' HA2' ' HB3' ' A' ' 12' ' ' LEU . . . 124.51 21.49 2.21 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.703 -0.76 . . . . 0.0 111.981 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.564 ' HB2' ' HB3' ' A' ' 38' ' ' ASP . 11.5 ptm180 -106.41 -21.61 13.04 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.102 0.477 . . . . 0.0 110.031 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.482 ' CG2' ' HB3' ' A' ' 34' ' ' GLU . 3.6 m -111.89 136.11 51.64 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.953 -178.869 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.838 HD11 HD13 ' A' ' 90' ' ' LEU . 26.9 mt -96.95 117.06 30.31 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.18 179.08 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 24.5 ttm180 -109.9 121.01 44.25 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.334 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -152.58 166.62 31.5 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.645 -179.727 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -91.22 108.83 20.14 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 107.605 -1.258 . . . . 0.0 107.605 178.342 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.429 ' SG ' HD13 ' A' ' 100' ' ' LEU . 65.8 m -95.34 124.54 39.43 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 -179.065 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.51 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 38.4 ttt180 -76.11 112.34 12.46 Favored 'General case' 0 N--CA 1.439 -0.982 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 179.469 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 35.9 p30 -73.54 167.64 20.91 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.619 -179.47 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.06 -27.73 67.2 Favored 'General case' 0 C--N 1.33 -0.245 0 O-C-N 123.557 0.536 . . . . 0.0 111.507 -178.8 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -68.46 -18.21 64.36 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.22 0.533 . . . . 0.0 109.991 179.325 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 94.63 33.16 6.88 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.857 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.51 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 7.2 t-20 -123.92 164.38 19.41 Favored 'General case' 0 C--N 1.323 -0.571 0 O-C-N 122.773 -0.251 . . . . 0.0 110.734 -178.733 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.557 ' CZ3' ' HG2' ' A' ' 8' ' ' ARG . 98.4 m95 -100.51 120.41 39.97 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.385 -179.616 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 6.7 m -122.78 139.5 49.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.889 179.215 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 13.5 m -79.48 114.08 18.13 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.793 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 68.3 m -124.6 146.08 49.26 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.764 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.603 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 50.7 mt-10 -131.5 135.22 46.9 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.1 -179.676 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.534 ' HB2' HD23 ' A' ' 100' ' ' LEU . 1.6 tm? -130.08 131.67 45.85 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.166 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.452 ' N ' HD13 ' A' ' 35' ' ' LEU . 18.1 m-20 -87.11 110.23 19.97 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.842 0.353 . . . . 0.0 110.221 179.783 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.539 HD11 ' HG ' ' A' ' 19' ' ' LEU . 2.1 mt -86.54 -18.04 32.53 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.981 -179.479 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.564 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 0.5 OUTLIER -66.12 -13.91 60.91 Favored 'General case' 0 C--O 1.222 -0.357 0 C-N-CA 120.525 -0.47 . . . . 0.0 111.949 -177.72 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.403 HG22 ' O ' ' A' ' 36' ' ' ASP . 14.6 t -87.0 -4.38 59.17 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.135 0.493 . . . . 0.0 110.233 179.42 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 56.5 m -127.26 -22.73 3.67 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 120.872 0.367 . . . . 0.0 111.508 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.528 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 65.3 mt -102.57 138.81 25.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 110.235 -0.283 . . . . 0.0 110.235 179.405 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.572 ' HA3' ' HB3' ' A' ' 52' ' ' MET . . . -149.23 158.79 27.8 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.892 -0.67 . . . . 0.0 111.605 179.222 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.559 ' OD1' ' HB2' ' A' ' 55' ' ' PHE . 2.6 p-10 -162.42 47.78 0.21 Allowed Pre-proline 0 CA--C 1.534 0.353 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -67.54 -21.73 45.72 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 121.501 1.467 . . . . 0.0 111.413 -179.612 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -84.53 -16.7 41.4 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.144 179.121 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.604 ' HA3' ' HG2' ' A' ' 83' ' ' ARG . . . 108.41 8.8 28.36 Favored Glycine 0 N--CA 1.442 -0.933 0 C-N-CA 120.341 -0.933 . . . . 0.0 113.374 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -125.73 134.88 51.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 117.1 0.45 . . . . 0.0 111.043 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 91.2 mt -83.33 131.8 35.05 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.889 -178.136 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -175.34 170.2 43.19 Favored Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.842 178.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.415 ' CD2' ' HD3' ' A' ' 92' ' ' ARG . 84.8 m95 -95.63 135.02 37.85 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 179.668 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 137.09 16.22 0.76 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.375 -0.917 . . . . 0.0 113.527 179.233 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.572 ' HB3' ' HA3' ' A' ' 42' ' ' GLY . 1.1 ttt -155.8 -165.79 2.05 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -147.3 167.88 23.15 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.307 -0.557 . . . . 0.0 111.718 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 13.9 m120 67.14 41.67 2.53 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.061 -0.972 . . . . 0.0 112.254 178.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.559 ' HB2' ' OD1' ' A' ' 43' ' ' ASN . 3.2 p90 -70.15 -25.12 63.31 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.737 0.303 . . . . 0.0 111.07 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 44.9 t -60.76 -41.21 95.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.443 -178.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 46.1 m170 -70.62 -14.85 62.64 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.459 -178.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.417 ' HA ' ' HD2' ' A' ' 76' ' ' LYS . 20.1 m -113.48 18.99 17.27 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 111.777 0.288 . . . . 0.0 111.777 -179.229 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 61.2 m -138.97 153.74 48.21 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 121.448 -0.783 . . . . 0.0 112.46 -179.395 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -118.83 142.76 47.43 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.343 179.147 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 56.25 77.12 0.26 Allowed 'General case' 0 N--CA 1.466 0.354 0 O-C-N 123.666 0.604 . . . . 0.0 112.127 178.38 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.505 HG23 HD21 ' A' ' 71' ' ' LEU . 88.2 mt -92.31 112.63 26.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 121.041 0.448 . . . . 0.0 110.278 179.515 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 34.3 ttmt -149.23 153.99 38.42 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.344 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.688 ' HG ' HD21 ' A' ' 12' ' ' LEU . 42.1 mt -81.91 126.44 31.92 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.462 0.649 . . . . 0.0 111.067 -179.046 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.491 ' HB2' ' CG2' ' A' ' 72' ' ' THR . 39.4 tt0 -74.52 -52.32 12.24 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 114.925 -1.034 . . . . 0.0 111.201 -179.151 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.503 ' HB2' ' HB2' ' A' ' 69' ' ' ARG . 21.0 mm-40 -89.37 0.91 56.48 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.003 179.671 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 77.09 32.36 49.15 Favored Glycine 0 N--CA 1.446 -0.692 0 CA-C-N 115.519 -0.764 . . . . 0.0 112.142 -179.5 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 142.79 -42.75 1.08 Allowed Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.391 -0.909 . . . . 0.0 112.422 179.382 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.503 ' HB2' ' HB2' ' A' ' 66' ' ' GLU . 13.3 mmt180 -70.02 -30.22 67.47 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.842 0.353 . . . . 0.0 111.117 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 46.2 tttt -144.36 145.97 32.27 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -177.741 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.549 ' HB2' HD11 ' A' ' 90' ' ' LEU . 10.5 tt -111.68 135.44 52.27 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.382 -0.826 . . . . 0.0 108.969 179.131 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.491 ' CG2' ' HB2' ' A' ' 65' ' ' GLU . 2.6 p -123.53 131.93 53.76 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.037 0.446 . . . . 0.0 111.501 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 26.0 p -158.99 164.46 35.54 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.338 -0.846 . . . . 0.0 108.717 179.262 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.443 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 31.6 ttt180 -99.76 103.55 22.54 Favored Pre-proline 0 C--N 1.317 -0.806 0 C-N-CA 120.424 -0.51 . . . . 0.0 110.394 179.548 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.621 ' O ' ' HB3' ' A' ' 83' ' ' ARG . 59.7 Cg_endo -71.31 127.91 13.97 Favored 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 122.543 2.162 . . . . 0.0 110.825 178.882 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.764 ' HA ' ' HB2' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -120.16 146.61 45.83 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.932 -179.81 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.719 HG22 ' O ' ' A' ' 82' ' ' PHE . 8.9 t -71.94 130.33 40.74 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 177.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 9.8 p -71.44 -8.16 10.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 O-C-N 123.619 0.574 . . . . 0.0 111.425 -178.566 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -70.71 -24.78 62.71 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.119 0.485 . . . . 0.0 110.612 179.512 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.544 ' HA3' ' CE2' ' A' ' 82' ' ' PHE . . . -151.58 -30.03 0.04 OUTLIER Glycine 0 CA--C 1.519 0.334 0 C-N-CA 120.623 -0.799 . . . . 0.0 113.015 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 104.54 17.16 15.78 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 121.051 -0.595 . . . . 0.0 112.112 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.719 ' O ' HG22 ' A' ' 77' ' ' THR . 17.2 p90 -112.72 153.71 27.29 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 118.904 -0.57 . . . . 0.0 109.766 -179.037 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.764 ' HB2' ' HA ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 169.3 -150.45 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.105 0.479 . . . . 0.0 112.138 179.481 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -129.29 154.9 46.39 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.355 -0.838 . . . . 0.0 110.428 -177.75 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.443 ' HA ' ' HA ' ' A' ' 74' ' ' ARG . 36.4 ttt180 -86.27 145.88 26.75 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -151.96 -171.3 3.89 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.565 -178.615 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -146.74 149.31 21.44 Favored Glycine 0 N--CA 1.448 -0.506 0 N-CA-C 111.261 -0.736 . . . . 0.0 111.261 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.403 HD11 ' CD1' ' A' ' 50' ' ' TRP . 12.0 tt -131.39 133.23 62.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 117.073 0.437 . . . . 0.0 110.877 -179.255 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -75.65 137.71 40.89 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.679 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.838 HD13 HD11 ' A' ' 19' ' ' LEU . 47.4 mt -101.52 40.23 1.33 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.48 0.657 . . . . 0.0 110.287 -179.513 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.436 ' HA ' ' OG ' ' A' ' 2' ' ' SER . 5.6 m-20 -74.12 0.04 15.11 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.657 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.415 ' HD3' ' CD2' ' A' ' 50' ' ' TRP . 18.3 mtp180 -96.57 -12.63 23.74 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.926 179.614 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.45 HG13 HD22 ' A' ' 37' ' ' LEU . 23.0 mm -99.02 114.65 37.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 -179.214 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.566 ' HA ' ' HB3' ' A' ' 3' ' ' TYR . 20.6 mt-30 -132.33 156.53 46.42 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.136 0.493 . . . . 0.0 111.712 -178.682 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.411 ' HA ' ' O ' ' A' ' 99' ' ' ARG . 20.4 p-10 -104.58 131.92 51.42 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.499 179.367 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 40.9 t -115.18 111.61 36.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 179.658 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 10.3 m120 58.06 19.49 6.05 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.866 -179.082 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 117.46 -28.35 7.19 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.681 -0.771 . . . . 0.0 113.92 178.828 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.411 ' O ' ' HA ' ' A' ' 95' ' ' ASN . 0.2 OUTLIER -87.11 142.23 28.08 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 117.277 0.538 . . . . 0.0 110.991 -178.916 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.534 HD23 ' HB2' ' A' ' 35' ' ' LEU . 8.6 tp -87.74 125.78 34.62 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 24.6 t -131.36 140.35 48.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.014 -178.69 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.491 ' HB2' HD11 ' A' ' 35' ' ' LEU . 13.6 t80 -82.04 131.38 35.24 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 177.58 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 20.2 tt0 . . . . . 0 C--N 1.312 -1.024 0 CA-C-O 118.906 -0.568 . . . . 0.0 111.241 -179.259 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' SER . . . . . 0.456 ' HB2' ' HG3' ' A' ' 69' ' ' ARG . 38.0 m . . . . . 0 N--CA 1.449 -0.483 0 CA-C-O 120.364 0.126 . . . . 0.0 110.996 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.412 ' CZ ' HD13 ' A' ' 19' ' ' LEU . 9.3 p90 -54.23 -34.59 61.01 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.833 0.349 . . . . 0.0 110.867 178.735 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.589 ' HB3' ' HD2' ' A' ' 69' ' ' ARG . . . -57.27 -19.23 20.42 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.437 -179.029 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -70.75 -18.41 62.78 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.071 0.462 . . . . 0.0 110.867 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 41.6 m -140.67 33.8 1.81 Allowed 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 178.705 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 10.3 t -146.24 157.86 43.84 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.231 -179.444 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.422 ' HG2' ' CZ3' ' A' ' 30' ' ' TRP . 2.1 ptp180 -137.44 158.42 44.45 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.663 -0.244 . . . . 0.0 110.981 -179.748 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 57.54 61.62 2.41 Favored 'General case' 0 C--O 1.233 0.229 0 O-C-N 123.967 0.792 . . . . 0.0 111.127 178.459 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.603 ' HA ' ' HB2' ' A' ' 21' ' ' ALA . . . -89.83 118.52 29.48 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.917 -179.787 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 30.0 m -123.07 170.56 13.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.612 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.62 ' HB3' ' HA2' ' A' ' 16' ' ' GLY . 3.8 mm? -105.36 122.4 45.88 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.145 -179.57 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.426 ' OG1' ' HB ' ' A' ' 18' ' ' THR . 33.5 p -116.0 162.14 17.81 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.69 0.281 . . . . 0.0 110.892 179.543 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 63.51 29.29 15.38 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.904 -0.589 . . . . 0.0 112.078 179.306 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 97.09 -15.79 61.93 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.502 179.425 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.62 ' HA2' ' HB3' ' A' ' 12' ' ' LEU . . . 122.09 20.85 2.97 Favored Glycine 0 CA--C 1.507 -0.417 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.36 179.528 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 4.1 ptm180 -103.98 -22.64 13.44 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.029 0.442 . . . . 0.0 110.54 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.426 ' HB ' ' OG1' ' A' ' 13' ' ' THR . 5.5 m -113.48 137.89 50.89 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.893 -178.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.653 ' O ' ' HA ' ' A' ' 34' ' ' GLU . 83.8 mt -100.41 120.32 39.79 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.438 179.129 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 56.2 ttp180 -118.27 120.25 37.1 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.586 -0.446 . . . . 0.0 109.876 178.718 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.603 ' HB2' ' HA ' ' A' ' 10' ' ' ALA . . . -154.48 167.58 29.56 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.383 -179.416 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -89.43 105.96 18.14 Favored 'General case' 0 CA--C 1.51 -0.569 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 177.238 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 69.3 m -96.46 136.29 37.16 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 120.727 0.299 . . . . 0.0 110.625 -178.535 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.564 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 16.2 ttp180 -76.94 119.31 20.51 Favored 'General case' 0 N--CA 1.44 -0.934 0 CA-C-N 116.196 -0.457 . . . . 0.0 109.835 179.336 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 37.4 p30 -80.32 174.55 11.49 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.153 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.27 -30.87 63.03 Favored 'General case' 0 C--O 1.235 0.303 0 O-C-N 123.649 0.593 . . . . 0.0 112.516 -178.273 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -77.4 -10.51 59.5 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.319 0.58 . . . . 0.0 110.135 -179.489 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 89.82 29.36 15.96 Favored Glycine 0 N--CA 1.447 -0.597 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.472 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.564 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 4.8 t-20 -110.64 164.02 13.16 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 121.086 -0.246 . . . . 0.0 111.129 -178.545 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.422 ' CZ3' ' HG2' ' A' ' 8' ' ' ARG . 82.4 m95 -97.62 119.44 36.2 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.011 0.434 . . . . 0.0 111.954 -179.388 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 5.8 m -124.39 135.03 65.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.938 178.496 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 62.0 m -81.3 111.02 17.3 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.926 0.393 . . . . 0.0 110.506 -179.393 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 70.5 m -120.5 155.84 32.75 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.481 -179.269 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.653 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 41.6 mt-10 -135.12 142.65 46.25 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.564 179.319 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.547 HD11 ' HB2' ' A' ' 102' ' ' PHE . 1.4 tm? -138.92 131.39 28.68 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.304 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.441 ' O ' HG22 ' A' ' 39' ' ' THR . 22.1 m-20 -89.83 110.89 21.79 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.509 HD22 HG13 ' A' ' 93' ' ' ILE . 1.1 mt -86.62 -19.42 29.35 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.659 -178.858 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.434 ' HA ' ' HD1' ' A' ' 55' ' ' PHE . 3.2 p-10 -68.45 -8.68 42.97 Favored 'General case' 0 C--O 1.221 -0.398 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -178.006 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.441 HG22 ' O ' ' A' ' 36' ' ' ASP . 13.7 t -87.27 -1.72 58.11 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 179.107 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 75.2 m -135.33 -23.32 1.47 Allowed 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 116.176 -0.465 . . . . 0.0 112.02 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.505 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 55.1 mt -96.91 145.03 9.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 O-C-N 122.222 -0.299 . . . . 0.0 110.476 -179.699 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.638 ' HA3' ' HB3' ' A' ' 52' ' ' MET . . . -153.1 158.39 27.9 Favored Glycine 0 N--CA 1.447 -0.569 0 N-CA-C 111.277 -0.729 . . . . 0.0 111.277 179.056 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.491 ' HB3' HD23 ' A' ' 48' ' ' LEU . 6.0 p30 -159.91 53.91 0.58 Allowed Pre-proline 0 CA--C 1.538 0.511 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -179.277 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -71.54 -16.93 30.45 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 121.942 1.762 . . . . 0.0 112.216 -179.402 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -102.61 13.65 33.95 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.092 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.504 ' CA ' ' HG2' ' A' ' 83' ' ' ARG . . . 79.47 12.56 83.64 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.463 -0.875 . . . . 0.0 112.961 179.626 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.419 ' HA ' ' OE1' ' A' ' 86' ' ' GLN . 37.9 m-85 -125.31 130.74 52.59 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.879 0.371 . . . . 0.0 110.303 179.718 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.558 ' HB3' ' HB ' ' A' ' 88' ' ' ILE . 87.6 mt -84.33 132.51 34.6 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.745 -178.413 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -171.95 170.49 43.45 Favored Glycine 0 N--CA 1.443 -0.837 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.139 179.165 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.414 ' HH2' HD11 ' A' ' 93' ' ' ILE . 87.4 m95 -96.22 131.51 42.62 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 141.56 17.72 0.34 Allowed Glycine 0 CA--C 1.519 0.333 0 C-N-CA 120.46 -0.876 . . . . 0.0 113.821 179.6 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.638 ' HB3' ' HA3' ' A' ' 42' ' ' GLY . 5.3 ttt -153.57 -156.05 0.65 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 117.366 0.583 . . . . 0.0 109.801 179.764 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.416 ' HA ' ' O ' ' A' ' 38' ' ' ASP . 27.6 pt20 -148.04 167.62 24.49 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.705 0.288 . . . . 0.0 111.137 -179.341 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 12.6 m120 61.63 44.74 8.69 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.452 -0.794 . . . . 0.0 112.938 178.328 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.505 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 1.2 p90 -71.01 -26.81 63.29 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.523 -0.471 . . . . 0.0 110.73 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.533 ' HA ' HD11 ' A' ' 62' ' ' ILE . 79.6 p -72.94 -29.35 63.04 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.035 0.445 . . . . 0.0 110.504 -179.413 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 41.8 m80 -82.81 -9.25 59.42 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.398 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.3 p -114.89 6.94 15.56 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.961 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 72.0 m -130.21 153.29 48.73 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.128 0.49 . . . . 0.0 110.745 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 86.7 mt-10 -119.09 134.67 55.06 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.403 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.5 t70 58.53 82.89 0.13 Allowed 'General case' 0 N--CA 1.465 0.317 0 O-C-N 123.938 0.774 . . . . 0.0 111.507 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.534 HG23 HD21 ' A' ' 71' ' ' LEU . 72.0 mt -95.31 124.54 47.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.108 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.9 tptm -149.84 149.54 30.63 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.271 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.565 ' HG ' HD21 ' A' ' 12' ' ' LEU . 52.2 mt -83.39 135.94 34.52 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.823 0.344 . . . . 0.0 110.98 -179.673 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -91.82 -59.03 2.22 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.958 -179.643 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.433 ' CB ' ' HB2' ' A' ' 69' ' ' ARG . 20.2 mm-40 -82.03 27.03 0.49 Allowed 'General case' 0 CA--C 1.516 -0.348 0 CA-C-O 121.106 0.479 . . . . 0.0 111.507 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 62.84 16.65 56.98 Favored Glycine 0 N--CA 1.448 -0.507 0 CA-C-N 115.278 -0.874 . . . . 0.0 112.722 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.449 ' HA3' ' HB2' ' A' ' 4' ' ' ALA . . . 144.08 -30.4 1.9 Allowed Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 120.104 -1.046 . . . . 0.0 113.189 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.589 ' HD2' ' HB3' ' A' ' 4' ' ' ALA . 7.2 mpt_? -74.37 -24.12 59.11 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 117.553 0.677 . . . . 0.0 111.12 -179.397 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 33.4 tttp -141.37 139.91 33.61 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.842 -178.518 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.637 ' HB2' HD11 ' A' ' 90' ' ' LEU . 10.1 tt -112.89 133.82 54.69 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.618 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.9 p -119.46 135.09 54.91 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.902 0.382 . . . . 0.0 111.083 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 25.3 p -162.49 172.23 15.83 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.37 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.589 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 32.2 ttt180 -106.98 99.38 25.9 Favored Pre-proline 0 C--N 1.319 -0.758 0 C-N-CA 120.356 -0.538 . . . . 0.0 110.741 178.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.647 ' O ' ' HB3' ' A' ' 83' ' ' ARG . 46.0 Cg_endo -67.4 123.86 11.35 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 122.784 2.323 . . . . 0.0 110.103 178.692 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.863 ' HE3' ' HA2' ' A' ' 81' ' ' GLY . 0.0 OUTLIER -120.29 142.97 48.6 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.066 0.46 . . . . 0.0 111.956 -178.914 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.711 HG22 ' O ' ' A' ' 82' ' ' PHE . 14.8 t -75.38 138.69 41.89 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.027 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 11.1 p -76.18 -12.95 14.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.217 -179.067 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -66.05 -21.9 66.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.11 0.481 . . . . 0.0 111.002 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.703 ' HA3' ' CE2' ' A' ' 82' ' ' PHE . . . -155.63 -21.41 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.29 -0.957 . . . . 0.0 113.105 179.623 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.863 ' HA2' ' HE3' ' A' ' 76' ' ' LYS . . . 95.53 12.57 53.57 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.05 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.711 ' O ' HG22 ' A' ' 77' ' ' THR . 16.7 p90 -112.47 158.61 19.68 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 118.926 -0.559 . . . . 0.0 110.015 -178.676 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.782 ' HA ' ' HE ' ' A' ' 83' ' ' ARG . 0.0 OUTLIER 168.65 -152.42 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 O-C-N 123.805 0.691 . . . . 0.0 111.656 178.707 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -125.73 155.88 40.27 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.358 -177.706 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.589 ' HA ' ' HA ' ' A' ' 74' ' ' ARG . 32.2 ttt180 -80.3 155.52 27.23 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 179.476 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLN . . . . . 0.485 ' HG2' ' H ' ' A' ' 87' ' ' GLY . 47.7 tt0 -162.45 177.12 9.79 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 120.976 0.417 . . . . 0.0 111.407 -178.054 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.485 ' H ' ' HG2' ' A' ' 86' ' ' GLN . . . -140.2 143.82 14.13 Favored Glycine 0 N--CA 1.445 -0.711 0 N-CA-C 111.456 -0.657 . . . . 0.0 111.456 179.388 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.558 ' HB ' ' HB3' ' A' ' 48' ' ' LEU . 10.1 tt -124.38 140.69 46.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 109.751 -0.462 . . . . 0.0 109.751 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -82.46 136.47 34.9 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.861 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.637 HD11 ' HB2' ' A' ' 71' ' ' LEU . 83.2 mt -106.82 44.6 1.04 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.352 0.596 . . . . 0.0 110.861 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -76.97 2.66 14.18 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.751 179.415 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 18.5 mtp180 -98.82 -15.05 19.4 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.087 -0.96 . . . . 0.0 110.316 179.32 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.584 HG21 HD12 ' A' ' 19' ' ' LEU . 29.3 mm -98.91 105.13 16.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 121.017 0.436 . . . . 0.0 109.993 -179.315 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.401 ' HA ' ' HB3' ' A' ' 3' ' ' TYR . 9.0 mt-30 -130.85 156.47 44.97 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.007 -179.262 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 13.1 p-10 -95.71 110.72 22.81 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.127 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 58.8 t -90.87 104.44 15.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.031 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 59.89 35.24 21.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.989 -179.62 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 98.45 -27.27 20.3 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.75 -0.738 . . . . 0.0 113.431 179.402 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.422 ' HD3' ' H ' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -86.92 128.82 35.06 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.944 0.372 . . . . 0.0 110.136 -178.936 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.424 HD12 ' HA ' ' A' ' 100' ' ' LEU . 9.2 tp -75.72 120.33 20.96 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 -179.733 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 32.2 t -129.61 142.09 44.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.168 -178.2 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.547 ' HB2' HD11 ' A' ' 35' ' ' LEU . 18.1 t80 -82.28 124.61 30.11 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 177.384 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.421 -0.799 . . . . 0.0 110.877 -179.504 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' SER . . . . . 0.462 ' OG ' ' HA ' ' A' ' 91' ' ' ASN . 9.5 m . . . . . 0 N--CA 1.451 -0.383 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.532 ' HA ' ' OD1' ' A' ' 95' ' ' ASN . 13.2 p90 -58.7 -38.14 77.62 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.524 0.202 . . . . 0.0 111.322 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -57.84 -23.93 55.07 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.357 -0.383 . . . . 0.0 112.023 -179.064 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -69.97 -16.24 63.16 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.654 0.242 . . . . 0.0 111.654 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 20.8 m -141.22 30.09 1.79 Allowed 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.173 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 22.4 t -144.92 158.46 43.8 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 115.509 -0.768 . . . . 0.0 110.103 -179.444 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 18.3 ptt180 -140.3 165.49 27.27 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.441 -179.528 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 55.18 54.76 8.37 Favored 'General case' 0 N--CA 1.467 0.378 0 O-C-N 123.829 0.705 . . . . 0.0 111.404 179.178 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.49 ' HA ' ' HB2' ' A' ' 21' ' ' ALA . . . -81.08 117.32 21.56 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.59 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 33.8 m -122.56 168.86 14.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.686 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.65 HD21 ' HG ' ' A' ' 64' ' ' LEU . 3.9 mm? -105.15 117.08 33.1 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.005 -179.546 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.478 HG21 ' NE ' ' A' ' 20' ' ' ARG . 20.9 p -115.48 165.89 12.49 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.062 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.436 ' O ' ' HG2' ' A' ' 17' ' ' ARG . 93.9 m-20 60.35 31.14 20.31 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.8 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 96.3 -17.96 58.33 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.827 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.576 ' HA2' ' HB3' ' A' ' 12' ' ' LEU . . . 122.86 10.15 5.93 Favored Glycine 0 C--O 1.229 -0.197 0 C-N-CA 121.025 -0.607 . . . . 0.0 111.608 -179.648 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.538 ' HB2' ' HB3' ' A' ' 38' ' ' ASP . 5.2 ptm180 -91.26 -24.17 19.94 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.257 0.551 . . . . 0.0 110.337 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.5 ' CG2' ' HB3' ' A' ' 34' ' ' GLU . 23.2 m -115.49 138.43 51.03 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.869 -178.674 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.739 HD11 HD13 ' A' ' 90' ' ' LEU . 92.1 mt -97.49 120.92 38.74 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.326 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.478 ' NE ' HG21 ' A' ' 13' ' ' THR . 34.5 ttm180 -114.12 120.46 40.62 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 178.252 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.49 ' HB2' ' HA ' ' A' ' 10' ' ' ALA . . . -153.11 167.71 28.35 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 120.938 0.399 . . . . 0.0 111.168 -178.916 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.649 ' HB3' ' HB3' ' A' ' 30' ' ' TRP . 10.4 mm-40 -88.9 105.95 18.09 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 178.784 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.423 ' SG ' ' HB2' ' A' ' 33' ' ' SER . 67.7 m -91.26 129.7 37.22 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.65 -178.671 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.528 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 24.7 ttp180 -75.69 116.38 16.35 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.521 179.124 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.411 HD21 ' HB3' ' A' ' 29' ' ' ASN . 36.2 p30 -82.16 173.3 12.25 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.177 179.545 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.18 -30.45 62.26 Favored 'General case' 0 N--CA 1.464 0.268 0 O-C-N 123.361 0.413 . . . . 0.0 112.084 -178.586 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -72.83 -13.5 61.31 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.662 0.744 . . . . 0.0 109.96 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 88.61 25.55 29.91 Favored Glycine 0 CA--C 1.503 -0.694 0 N-CA-C 110.8 -0.92 . . . . 0.0 110.8 -179.372 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.528 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 8.7 t-20 -106.6 161.97 14.16 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.575 -0.313 . . . . 0.0 110.323 -178.55 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.649 ' HB3' ' HB3' ' A' ' 22' ' ' GLU . 87.4 m95 -100.04 122.55 43.1 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.955 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 5.6 m -124.33 136.11 61.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.27 178.742 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 13.2 m -75.42 109.73 9.2 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.953 0.406 . . . . 0.0 110.958 -179.189 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.423 ' HB2' ' SG ' ' A' ' 23' ' ' CYS . 69.8 m -124.05 148.0 47.41 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.697 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.638 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 47.9 mt-10 -124.94 150.9 46.13 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.237 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.597 HD11 ' HB2' ' A' ' 102' ' ' PHE . 1.6 tm? -141.84 130.86 23.18 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 178.582 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.452 ' N ' HD13 ' A' ' 35' ' ' LEU . 2.1 p-10 -88.35 109.7 20.19 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.303 0.573 . . . . 0.0 110.605 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.477 HD11 ' HG ' ' A' ' 19' ' ' LEU . 1.0 OUTLIER -86.65 -21.05 26.95 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.965 179.532 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.538 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 5.1 p-10 -64.03 -13.73 49.02 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -178.445 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 64.1 p -83.63 -11.32 57.44 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 120.89 0.376 . . . . 0.0 110.801 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 35.5 m -130.41 -9.94 4.13 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.231 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.427 HD13 HD13 ' A' ' 88' ' ' ILE . 63.4 mt -113.26 137.05 47.67 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-O 120.682 0.277 . . . . 0.0 110.704 179.479 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.594 ' HA3' ' HB3' ' A' ' 52' ' ' MET . . . -149.45 159.03 27.9 Favored Glycine 0 N--CA 1.446 -0.7 0 C-N-CA 120.967 -0.635 . . . . 0.0 111.581 179.089 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.454 ' OD1' ' HB2' ' A' ' 58' ' ' SER . 24.8 p30 -157.57 48.31 0.31 Allowed Pre-proline 0 CA--C 1.535 0.367 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -68.74 -22.21 37.53 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 121.829 1.686 . . . . 0.0 112.166 -178.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 70.6 m-20 -91.79 0.44 57.49 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.43 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.539 ' CA ' ' HG2' ' A' ' 83' ' ' ARG . . . 92.48 6.74 64.02 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.669 -0.776 . . . . 0.0 112.236 -179.67 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -120.78 132.25 54.93 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.938 0.399 . . . . 0.0 110.798 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.452 HD12 ' HB3' ' A' ' 86' ' ' GLN . 14.8 mt -84.31 146.79 27.55 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.399 -178.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 169.35 171.0 34.57 Favored Glycine 0 N--CA 1.442 -0.904 0 C-N-CA 120.254 -0.974 . . . . 0.0 112.64 178.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.466 ' HH2' HD11 ' A' ' 93' ' ' ILE . 90.8 m95 -96.1 126.17 41.14 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 149.82 -43.94 0.73 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.995 -0.621 . . . . 0.0 111.853 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.63 ' CE ' ' HA ' ' A' ' 52' ' ' MET . 0.7 OUTLIER -94.24 -177.04 4.15 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 179.104 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.4 ' H ' ' HG3' ' A' ' 52' ' ' MET . 13.4 pt20 -143.14 170.19 16.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 119.076 0.853 . . . . 0.0 112.215 -178.94 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 9.6 m120 66.11 36.68 5.54 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.091 -0.959 . . . . 0.0 112.307 179.278 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.531 ' HB3' ' HA2' ' A' ' 42' ' ' GLY . 9.1 p90 -62.86 -28.33 69.96 Favored 'General case' 0 C--O 1.221 -0.444 0 CA-C-O 120.651 0.262 . . . . 0.0 110.455 179.442 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.468 ' HB3' ' HB3' ' A' ' 17' ' ' ARG . 9.5 p -58.68 -34.34 71.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.351 -179.626 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 26.5 m80 -80.06 -10.05 59.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.553 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.454 ' HB2' ' OD1' ' A' ' 43' ' ' ASN . 16.4 m -123.5 28.98 6.79 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.45 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 45.0 m -137.49 150.31 47.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.062 0.458 . . . . 0.0 111.079 179.58 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.447 ' HG3' ' HG2' ' A' ' 76' ' ' LYS . 71.5 mt-10 -129.86 134.01 47.26 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.677 179.281 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 38.5 t70 61.62 79.73 0.24 Allowed 'General case' 0 N--CA 1.468 0.455 0 O-C-N 123.705 0.628 . . . . 0.0 110.689 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.524 HG23 HD21 ' A' ' 71' ' ' LEU . 64.3 mt -98.67 125.06 52.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.037 -179.25 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.1 tptm -149.21 156.07 41.59 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.016 0.436 . . . . 0.0 111.285 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.65 ' HG ' HD21 ' A' ' 12' ' ' LEU . 83.0 mt -98.99 128.84 45.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.144 179.086 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -93.52 -65.7 0.97 Allowed 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -178.191 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.527 ' HB2' ' HB2' ' A' ' 69' ' ' ARG . 4.8 mm-40 -76.29 50.28 0.63 Allowed 'General case' 0 CA--C 1.516 -0.33 0 CA-C-O 121.117 0.484 . . . . 0.0 112.192 -178.013 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 59.94 16.35 39.32 Favored Glycine 0 C--N 1.318 -0.44 0 CA-C-N 115.117 -0.947 . . . . 0.0 112.795 179.146 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.534 ' HA2' HD13 ' A' ' 64' ' ' LEU . . . 121.11 -12.29 9.8 Favored Glycine 0 N--CA 1.442 -0.909 0 C-N-CA 120.394 -0.907 . . . . 0.0 113.241 179.693 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.527 ' HB2' ' HB2' ' A' ' 66' ' ' GLU . 2.8 mtt85 -77.69 -22.16 50.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 117.525 0.663 . . . . 0.0 110.721 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 33.0 tptt -131.63 127.56 37.27 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.294 -178.581 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.668 ' HB2' HD11 ' A' ' 90' ' ' LEU . 10.6 tt -110.04 121.2 44.7 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.442 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.4 p -109.66 136.61 48.74 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.176 0.513 . . . . 0.0 110.837 179.568 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 17.7 p -162.87 169.43 19.8 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.102 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.562 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 30.2 ttt180 -103.8 102.45 31.09 Favored Pre-proline 0 C--N 1.313 -0.979 0 C-N-CA 120.095 -0.642 . . . . 0.0 110.609 179.116 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.645 ' O ' ' HB3' ' A' ' 83' ' ' ARG . 48.0 Cg_endo -67.77 116.15 4.13 Favored 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 122.539 2.159 . . . . 0.0 110.023 178.385 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.942 ' HE3' ' HA2' ' A' ' 81' ' ' GLY . 0.0 OUTLIER -117.86 144.97 44.94 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.088 0.47 . . . . 0.0 111.455 -178.927 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.71 HG22 ' O ' ' A' ' 82' ' ' PHE . 15.3 t -77.86 140.73 39.37 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 179.402 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 32.2 m -74.52 -1.64 3.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 O-C-N 123.989 0.806 . . . . 0.0 111.145 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 -68.4 -32.01 71.76 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.174 0.511 . . . . 0.0 110.144 179.281 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -160.67 -9.51 0.04 OUTLIER Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.476 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.942 ' HA2' ' HE3' ' A' ' 76' ' ' LYS . . . 90.63 19.71 43.42 Favored Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 120.577 -0.821 . . . . 0.0 111.776 179.627 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.71 ' O ' HG22 ' A' ' 77' ' ' THR . 26.3 p90 -110.93 146.64 36.21 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 119.226 -0.416 . . . . 0.0 110.047 -179.028 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.732 ' HB2' ' HA ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 170.53 -154.92 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.224 0 O-C-N 123.925 0.766 . . . . 0.0 110.433 179.27 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -118.37 173.02 7.06 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.41 -178.05 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.562 ' HA ' ' HA ' ' A' ' 74' ' ' ARG . 31.3 ttt85 -104.3 153.43 21.03 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 178.244 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLN . . . . . 0.704 ' HG2' ' H ' ' A' ' 87' ' ' GLY . 56.5 tt0 -165.61 -174.65 3.19 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 120.655 0.264 . . . . 0.0 110.698 -178.503 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.704 ' H ' ' HG2' ' A' ' 86' ' ' GLN . . . -141.11 151.9 22.86 Favored Glycine 0 N--CA 1.45 -0.369 0 N-CA-C 111.736 -0.545 . . . . 0.0 111.736 179.181 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.427 HD13 HD13 ' A' ' 41' ' ' ILE . 12.1 tt -125.49 145.6 32.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 120.965 0.412 . . . . 0.0 110.208 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -82.47 121.98 27.45 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.845 -179.17 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.739 HD13 HD11 ' A' ' 19' ' ' LEU . 59.8 mt -98.59 37.08 1.53 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.558 0.695 . . . . 0.0 110.632 179.476 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.462 ' HA ' ' OG ' ' A' ' 2' ' ' SER . 5.0 m-20 -75.27 -0.65 20.32 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 114.949 -1.023 . . . . 0.0 110.381 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 20.1 mtp180 -92.09 -14.81 28.66 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.226 -179.449 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.466 HD11 ' HH2' ' A' ' 50' ' ' TRP . 21.0 mm -92.22 111.7 24.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 -179.445 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 21.9 tp60 -124.71 134.85 52.69 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.283 0.563 . . . . 0.0 111.315 -178.091 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.532 ' OD1' ' HA ' ' A' ' 3' ' ' TYR . 19.6 p-10 -95.45 119.82 34.62 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.843 178.105 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.3 p -114.95 119.2 61.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.177 0.513 . . . . 0.0 110.602 -179.508 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 58.54 30.22 19.49 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.002 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 94.87 -15.79 62.65 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.774 -0.727 . . . . 0.0 113.289 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -93.03 123.18 36.1 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 117.555 0.677 . . . . 0.0 110.089 -179.268 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 16.1 tp -82.57 117.22 22.39 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.8 t -128.6 149.98 33.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.769 0.319 . . . . 0.0 111.088 -179.033 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.597 ' HB2' HD11 ' A' ' 35' ' ' LEU . 8.5 t80 -89.61 126.0 35.45 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 178.113 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.316 -0.89 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.321 179.372 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' SER . . . . . 0.565 ' HB3' ' HA ' ' A' ' 91' ' ' ASN . 10.8 p . . . . . 0 N--CA 1.45 -0.436 0 CA-C-O 120.429 0.157 . . . . 0.0 111.319 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.443 ' HA ' ' OD1' ' A' ' 95' ' ' ASN . 12.8 p90 -58.59 -38.61 78.31 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -179.615 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.61 ' HA ' ' OG ' ' A' ' 7' ' ' SER . . . -55.29 -19.09 7.52 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 -177.371 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -61.71 -37.07 82.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.963 0.411 . . . . 0.0 111.037 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 8.1 t -130.63 45.02 2.88 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 121.295 0.569 . . . . 0.0 109.754 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.61 ' OG ' ' HA ' ' A' ' 4' ' ' ALA . 86.4 p -147.06 165.54 29.6 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.225 179.017 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 11.9 ptm180 -149.24 166.6 28.42 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.661 -179.534 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 59.44 54.43 4.66 Favored 'General case' 0 C--O 1.234 0.254 0 O-C-N 123.93 0.769 . . . . 0.0 111.136 179.498 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.404 ' HA ' ' HB2' ' A' ' 21' ' ' ALA . . . -86.69 117.36 25.4 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.014 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 34.2 m -124.57 168.49 17.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.786 -179.469 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.752 HD21 ' HG ' ' A' ' 64' ' ' LEU . 3.5 mm? -105.21 114.9 29.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.121 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 19.2 p -110.06 167.2 10.35 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.166 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 60.64 49.94 6.04 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.778 -0.647 . . . . 0.0 111.449 179.454 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 83.76 -30.15 3.57 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.348 179.633 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.557 ' HA2' ' HB3' ' A' ' 12' ' ' LEU . . . 130.64 48.09 0.13 Allowed Glycine 0 N--CA 1.446 -0.689 0 N-CA-C 111.133 -0.787 . . . . 0.0 111.133 -179.796 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.616 ' HB2' ' HB3' ' A' ' 38' ' ' ASP . 41.7 ptt85 -132.16 -27.07 1.85 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.017 0.436 . . . . 0.0 111.202 -179.403 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.449 ' CG2' ' HB3' ' A' ' 34' ' ' GLU . 4.2 m -100.94 133.88 44.76 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.828 -179.269 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.791 HD11 HD13 ' A' ' 90' ' ' LEU . 70.3 mt -94.17 115.95 28.3 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.275 179.084 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 53.3 ttp180 -114.36 121.28 43.12 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.504 -0.479 . . . . 0.0 109.983 178.604 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.404 ' HB2' ' HA ' ' A' ' 10' ' ' ALA . . . -153.43 166.05 33.89 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.845 0.355 . . . . 0.0 110.662 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -89.95 106.03 18.2 Favored 'General case' 0 CA--C 1.508 -0.643 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 178.308 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.457 ' SG ' HD13 ' A' ' 100' ' ' LEU . 45.3 m -98.81 132.17 44.37 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 120.876 -0.33 . . . . 0.0 110.191 -178.809 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.512 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 17.6 ttp85 -74.62 117.19 16.17 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.283 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.492 HD21 ' HB3' ' A' ' 29' ' ' ASN . 36.7 p30 -80.96 168.7 18.41 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.153 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.76 -33.21 55.06 Favored 'General case' 0 C--O 1.235 0.31 0 O-C-N 123.589 0.556 . . . . 0.0 112.118 -178.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -68.64 -17.88 64.18 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.289 0.566 . . . . 0.0 110.549 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 94.61 27.01 12.08 Favored Glycine 0 N--CA 1.446 -0.655 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.382 -179.442 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.512 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 62.0 t30 -111.09 164.06 13.23 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.547 0.213 . . . . 0.0 111.047 -178.722 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.413 ' HZ3' ' HA ' ' A' ' 7' ' ' SER . 89.8 m95 -100.36 113.84 26.88 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.534 179.318 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.9 m -116.55 131.03 70.36 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.877 179.407 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.3 m -74.93 109.22 8.22 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.445 179.272 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 66.9 m -119.26 146.62 45.09 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.408 -179.559 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.637 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 49.7 mt-10 -130.78 139.71 50.24 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.899 -179.301 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.521 HD12 HD23 ' A' ' 37' ' ' LEU . 1.4 tm? -132.81 129.12 38.12 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 178.706 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.449 ' N ' HD13 ' A' ' 35' ' ' LEU . 15.8 m-20 -88.88 108.93 19.81 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.521 HD23 HD12 ' A' ' 35' ' ' LEU . 0.5 OUTLIER -86.72 -9.11 56.66 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.363 -0.381 . . . . 0.0 112.017 -179.56 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.616 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 6.7 p-10 -66.16 -14.93 62.64 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -178.356 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 8.9 t -87.47 0.48 55.48 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.974 0.416 . . . . 0.0 110.609 179.225 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.538 ' SG ' ' HZ3' ' A' ' 50' ' ' TRP . 1.7 p -140.63 -14.8 0.95 Allowed 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 54.5 mt -111.65 135.98 49.21 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-O 120.733 0.302 . . . . 0.0 110.502 179.363 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.529 ' HA3' ' HB3' ' A' ' 52' ' ' MET . . . -152.93 158.33 27.84 Favored Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 111.468 -0.653 . . . . 0.0 111.468 179.383 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.694 ' ND2' ' HB2' ' A' ' 55' ' ' PHE . 3.7 p30 -161.72 52.03 0.37 Allowed Pre-proline 0 C--N 1.327 -0.412 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 179.556 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.559 ' HD3' ' N ' ' A' ' 43' ' ' ASN . 5.4 Cg_exo -78.03 -9.27 16.7 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.298 1.999 . . . . 0.0 111.647 -179.432 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 35.7 m-80 -99.35 2.04 44.96 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.618 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.478 ' CA ' ' HG2' ' A' ' 83' ' ' ARG . . . 93.33 0.74 67.27 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.402 -0.904 . . . . 0.0 112.093 -179.446 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -125.47 131.37 52.86 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.986 0.422 . . . . 0.0 111.006 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.582 HD13 ' HB3' ' A' ' 86' ' ' GLN . 9.9 mp -84.58 153.99 22.89 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.479 -179.422 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 168.04 170.6 32.98 Favored Glycine 0 N--CA 1.443 -0.842 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.651 179.424 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.538 ' HZ3' ' SG ' ' A' ' 40' ' ' CYS . 90.5 m95 -95.86 125.24 40.29 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 149.24 -34.83 1.08 Allowed Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.804 -0.713 . . . . 0.0 112.405 -179.621 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.529 ' HB3' ' HA3' ' A' ' 42' ' ' GLY . 12.9 tpt -98.48 174.22 6.56 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 -179.319 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -128.71 168.97 15.05 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 117.93 0.332 . . . . 0.0 110.97 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 61.31 49.43 5.39 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.438 -0.801 . . . . 0.0 112.455 178.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.694 ' HB2' ' ND2' ' A' ' 43' ' ' ASN . 15.9 p90 -70.08 -25.72 63.66 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.104 179.157 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.5 ' HA ' HD11 ' A' ' 62' ' ' ILE . 10.6 p -60.93 -44.9 96.56 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.262 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 30.5 m80 -79.98 -11.36 59.79 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.999 0.428 . . . . 0.0 110.762 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 20.6 m -101.41 2.33 39.32 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.997 -178.611 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 62.3 p -144.57 160.82 40.52 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.548 -0.461 . . . . 0.0 111.421 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 59.1 mm-40 -117.23 152.23 35.27 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.966 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 50.22 76.36 0.15 Allowed 'General case' 0 N--CA 1.472 0.644 0 O-C-N 123.994 0.809 . . . . 0.0 111.777 179.445 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.562 HG23 HD21 ' A' ' 71' ' ' LEU . 83.8 mt -92.61 117.09 35.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.416 -179.334 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 32.1 ttmt -148.94 154.91 40.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.108 -0.497 . . . . 0.0 109.851 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.752 ' HG ' HD21 ' A' ' 12' ' ' LEU . 60.2 mt -83.73 135.95 34.36 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.193 0.52 . . . . 0.0 111.224 -179.616 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -92.17 -66.26 0.94 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.406 -0.815 . . . . 0.0 111.82 -178.819 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -78.6 40.98 0.39 Allowed 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 120.95 0.405 . . . . 0.0 111.671 -178.659 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 60.91 17.81 52.06 Favored Glycine 0 C--N 1.32 -0.324 0 CA-C-N 115.653 -0.703 . . . . 0.0 113.113 179.553 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.47 ' HA2' HD13 ' A' ' 64' ' ' LEU . . . 129.58 -16.06 5.67 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.222 -0.989 . . . . 0.0 112.668 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.52 ' HD2' ' HB3' ' A' ' 4' ' ' ALA . 0.1 OUTLIER -77.5 -19.17 56.26 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.134 0.492 . . . . 0.0 109.783 -179.796 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.47 ' HG3' ' HA ' ' A' ' 89' ' ' ASP . 65.3 tttt -150.35 144.33 25.43 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.936 -178.391 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.61 ' HB2' HD11 ' A' ' 90' ' ' LEU . 9.7 tt -112.29 126.66 55.48 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.56 179.744 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.5 p -114.04 137.71 51.36 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.099 0.476 . . . . 0.0 111.358 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.423 ' HB3' ' HA ' ' A' ' 62' ' ' ILE . 25.0 p -161.76 175.85 11.53 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.607 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.511 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 44.7 ttt180 -107.91 99.54 30.98 Favored Pre-proline 0 C--N 1.317 -0.833 0 N-CA-C 110.154 -0.313 . . . . 0.0 110.154 179.377 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.672 ' O ' ' HB3' ' A' ' 83' ' ' ARG . 56.1 Cg_endo -67.06 122.91 10.29 Favored 'Trans proline' 0 CA--C 1.513 -0.564 0 C-N-CA 123.129 2.553 . . . . 0.0 111.332 -179.667 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.74 ' HA ' ' HB2' ' A' ' 83' ' ' ARG . 0.2 OUTLIER -120.13 147.03 45.39 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 120.947 0.403 . . . . 0.0 111.191 -179.85 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.743 HG22 ' O ' ' A' ' 82' ' ' PHE . 10.3 t -74.21 130.22 39.33 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 178.55 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.1 m -72.18 -3.39 3.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 O-C-N 123.629 0.581 . . . . 0.0 111.204 -179.484 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -70.52 -34.54 72.42 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.789 178.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.41 ' HA3' ' CE1' ' A' ' 82' ' ' PHE . . . -144.51 -24.72 0.13 Allowed Glycine 0 CA--C 1.521 0.441 0 C-N-CA 120.73 -0.747 . . . . 0.0 113.285 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 102.65 14.79 26.48 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 121.022 -0.609 . . . . 0.0 112.277 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.743 ' O ' HG22 ' A' ' 77' ' ' THR . 29.4 p90 -112.85 157.9 20.82 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 118.372 -0.823 . . . . 0.0 110.105 -179.206 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.844 ' HA ' ' HE ' ' A' ' 83' ' ' ARG . 0.0 OUTLIER 163.44 -154.03 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.75 0 O-C-N 123.932 0.77 . . . . 0.0 112.381 178.528 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 47.8 mm-40 -109.14 -173.96 2.39 Favored 'General case' 0 C--O 1.226 -0.161 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.468 -178.136 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.535 ' HA ' ' HD2' ' A' ' 75' ' ' PRO . 61.5 ttt180 -113.75 156.03 24.56 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 177.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLN . . . . . 0.787 ' HG2' ' H ' ' A' ' 87' ' ' GLY . 34.9 tt0 -169.07 -165.78 0.57 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 120.526 -0.47 . . . . 0.0 111.462 -178.284 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.787 ' H ' ' HG2' ' A' ' 86' ' ' GLN . . . -162.15 154.42 25.38 Favored Glycine 0 N--CA 1.449 -0.434 0 N-CA-C 111.217 -0.753 . . . . 0.0 111.217 179.424 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.485 HG22 HD23 ' A' ' 48' ' ' LEU . 12.8 tt -130.78 137.54 55.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.952 0.376 . . . . 0.0 110.323 -179.558 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.47 ' HA ' ' HG3' ' A' ' 70' ' ' LYS . 1.8 p-10 -76.65 140.58 41.0 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.961 0.41 . . . . 0.0 109.92 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.791 HD13 HD11 ' A' ' 19' ' ' LEU . 55.8 mt -109.44 40.02 1.95 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.347 0.594 . . . . 0.0 110.834 -179.473 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.565 ' HA ' ' HB3' ' A' ' 2' ' ' SER . 22.2 m120 -75.45 2.36 11.69 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.806 -179.732 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 19.6 mtp180 -95.77 -11.25 27.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.015 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.407 ' CD1' HD22 ' A' ' 37' ' ' LEU . 23.1 mm -98.18 100.01 9.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 29.3 tp60 -107.21 145.6 32.42 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.953 -178.101 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.443 ' OD1' ' HA ' ' A' ' 3' ' ' TYR . 19.4 p-10 -94.78 118.82 32.38 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.54 178.144 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 47.5 t -106.28 107.78 23.52 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 27.8 m-80 59.46 32.51 21.78 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.022 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.407 ' O ' ' HB2' ' A' ' 23' ' ' CYS . . . 97.99 -25.69 26.51 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.571 -0.823 . . . . 0.0 113.239 179.397 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.408 ' HD2' ' H ' ' A' ' 99' ' ' ARG . 1.7 mpt_? -87.07 143.28 27.39 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 117.252 0.526 . . . . 0.0 110.603 -178.832 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.485 ' HB3' ' HB2' ' A' ' 35' ' ' LEU . 2.7 tp -87.42 124.23 33.2 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.78 0.324 . . . . 0.0 110.845 -179.25 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 21.7 t -131.19 138.15 53.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.419 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.425 ' HB2' HD11 ' A' ' 35' ' ' LEU . 10.3 t80 -83.14 130.95 35.15 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 177.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 22.0 tt0 . . . . . 0 C--O 1.25 1.119 0 CA-C-O 118.329 -0.844 . . . . 0.0 111.046 -179.076 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' SER . . . . . 0.406 ' OG ' ' HA ' ' A' ' 91' ' ' ASN . 13.4 m . . . . . 0 N--CA 1.453 -0.302 0 N-CA-C 110.46 -0.2 . . . . 0.0 110.46 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.482 ' CZ ' HD13 ' A' ' 19' ' ' LEU . 26.4 p90 -57.95 -38.5 76.12 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.672 0.273 . . . . 0.0 111.296 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.533 ' HA ' ' OG ' ' A' ' 7' ' ' SER . . . -58.97 -19.78 46.33 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -178.088 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -72.56 -17.78 61.68 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.297 0.57 . . . . 0.0 110.347 -179.492 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 48.8 m -136.74 36.42 2.64 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.333 179.429 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.533 ' OG ' ' HA ' ' A' ' 4' ' ' ALA . 68.6 p -149.61 171.43 16.67 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.485 179.373 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.553 ' HG3' ' HB2' ' A' ' 22' ' ' GLU . 1.9 ptp180 -149.98 167.11 27.64 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.948 -179.532 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 53.73 56.05 7.71 Favored 'General case' 0 C--O 1.233 0.192 0 O-C-N 123.867 0.729 . . . . 0.0 111.322 178.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.503 ' HA ' ' HB2' ' A' ' 21' ' ' ALA . . . -88.24 117.32 27.06 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.181 179.702 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 35.9 m -124.13 170.22 14.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.596 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.848 HD21 ' HG ' ' A' ' 64' ' ' LEU . 3.3 mm? -104.68 114.17 28.21 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.832 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 18.7 p -108.88 166.63 10.67 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.622 -0.263 . . . . 0.0 110.95 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 59.37 48.5 9.94 Favored 'General case' 0 CA--C 1.522 -0.112 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.912 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 86.76 -39.35 3.08 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.953 -0.641 . . . . 0.0 112.35 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.637 ' HA2' ' HB3' ' A' ' 12' ' ' LEU . . . 140.01 38.32 0.1 OUTLIER Glycine 0 N--CA 1.445 -0.709 0 N-CA-C 111.305 -0.718 . . . . 0.0 111.305 -179.708 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.552 ' HB2' ' HB3' ' A' ' 38' ' ' ASP . 39.2 ptt85 -122.14 -23.37 5.37 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.094 0.473 . . . . 0.0 110.779 -179.326 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.432 HG22 ' HB3' ' A' ' 34' ' ' GLU . 3.9 m -105.84 134.73 48.5 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.923 -179.166 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.665 HD11 HD13 ' A' ' 90' ' ' LEU . 81.9 mt -93.67 110.99 22.59 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.404 179.237 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 20.4 ttt180 -108.11 119.35 39.22 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 178.714 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.503 ' HB2' ' HA ' ' A' ' 10' ' ' ALA . . . -153.66 167.04 30.89 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.982 0.42 . . . . 0.0 111.483 -178.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.553 ' HB2' ' HG3' ' A' ' 8' ' ' ARG . 7.3 mm-40 -90.3 105.0 17.51 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 107.1 -1.445 . . . . 0.0 107.1 178.293 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.442 ' SG ' HD13 ' A' ' 100' ' ' LEU . 58.6 m -92.34 125.27 36.92 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.557 -178.218 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.437 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 33.8 ttp180 -73.3 117.82 15.51 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.582 179.055 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.406 HD21 ' HB3' ' A' ' 29' ' ' ASN . 35.1 p30 -82.35 167.62 18.35 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.62 -24.26 63.68 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 -178.274 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -75.08 -16.15 60.58 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.315 0.579 . . . . 0.0 109.727 179.614 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 93.32 36.32 5.97 Favored Glycine 0 N--CA 1.447 -0.624 0 CA-C-N 115.186 -0.915 . . . . 0.0 111.733 -179.374 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.437 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 9.2 t-20 -123.48 163.91 19.97 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.606 0.241 . . . . 0.0 110.417 -179.125 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.498 ' CZ3' ' HG2' ' A' ' 8' ' ' ARG . 89.2 m95 -101.16 118.47 37.05 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.381 -179.599 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.5 m -122.08 130.78 74.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.429 178.37 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 15.8 m -76.0 110.95 10.88 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.583 -179.517 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 67.8 m -123.25 154.65 38.52 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.745 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.647 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 50.4 mt-10 -135.02 143.08 46.58 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.055 -179.54 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.549 HD11 ' HB2' ' A' ' 102' ' ' PHE . 2.0 tm? -136.36 129.66 31.64 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 178.457 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.443 ' N ' HD13 ' A' ' 35' ' ' LEU . 15.1 m-20 -88.42 109.18 19.8 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 -179.576 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.554 HD13 HD22 ' A' ' 90' ' ' LEU . 3.8 mt -81.27 -20.01 41.82 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.764 -179.334 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.552 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 5.7 p-10 -66.26 -5.33 10.06 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.874 0.369 . . . . 0.0 111.341 -178.772 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 77.6 p -82.9 -11.57 58.08 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.686 179.289 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 29.0 t -141.48 -3.86 1.15 Allowed 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 57.7 mt -109.59 135.06 49.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 178.712 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.556 ' HA3' ' HB3' ' A' ' 52' ' ' MET . . . -146.0 155.63 26.6 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.93 -0.653 . . . . 0.0 111.519 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 23.6 p30 -159.69 45.19 0.19 Allowed Pre-proline 0 CA--C 1.538 0.486 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -179.742 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -66.66 -23.31 49.3 Favored 'Trans proline' 0 C--N 1.355 0.901 0 C-N-CA 121.793 1.662 . . . . 0.0 111.68 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 73.9 m-20 -83.95 -15.42 47.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.507 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 105.86 6.68 37.19 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.494 -0.86 . . . . 0.0 112.114 -179.143 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.475 ' HA ' ' OE1' ' A' ' 86' ' ' GLN . 55.7 m-85 -124.9 132.75 53.26 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.867 0.365 . . . . 0.0 110.171 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.591 ' HB3' ' HB ' ' A' ' 88' ' ' ILE . 11.0 mp -87.27 138.43 31.49 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.642 -0.708 . . . . 0.0 112.339 -178.173 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -177.37 171.14 43.87 Favored Glycine 0 N--CA 1.439 -1.14 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.611 178.754 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.427 ' HH2' HD11 ' A' ' 93' ' ' ILE . 91.6 m95 -94.99 125.39 39.63 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 156.11 -58.82 0.37 Allowed Glycine 0 N--CA 1.447 -0.58 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 -179.345 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.556 ' HB3' ' HA3' ' A' ' 42' ' ' GLY . 7.3 tpt -84.71 178.47 7.65 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 179.008 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.0 pt20 -137.2 177.7 7.66 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 118.596 0.635 . . . . 0.0 111.726 -179.408 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 15.5 m120 62.73 39.68 10.78 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.408 -0.815 . . . . 0.0 112.083 179.617 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.443 ' HB3' ' HA2' ' A' ' 42' ' ' GLY . 10.1 p90 -66.26 -32.2 73.47 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 120.478 0.18 . . . . 0.0 111.296 -179.583 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.434 ' HB3' ' HB3' ' A' ' 17' ' ' ARG . 42.3 p -61.81 -31.84 72.09 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.057 0.456 . . . . 0.0 111.118 -179.005 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 38.4 m80 -78.39 -12.0 59.98 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.08 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 43.9 m -119.6 23.63 11.07 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.956 0.408 . . . . 0.0 110.704 179.624 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 66.2 m -138.4 152.27 48.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.085 0.469 . . . . 0.0 111.09 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 78.6 mt-10 -130.18 136.41 49.23 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.119 179.53 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 29.7 t70 65.58 82.62 0.18 Allowed 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.329 0.585 . . . . 0.0 110.268 -178.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.478 HG23 HD21 ' A' ' 71' ' ' LEU . 64.2 mt -104.68 121.98 57.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.197 -179.248 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 27.8 tptt -147.33 153.7 40.01 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.848 ' HG ' HD21 ' A' ' 12' ' ' LEU . 73.4 mt -85.89 125.95 33.71 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.962 0.411 . . . . 0.0 110.764 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -78.56 -58.32 3.31 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.593 -178.673 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.545 ' HB2' ' HB3' ' A' ' 69' ' ' ARG . 35.9 mt-10 -89.02 39.13 0.92 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.94 0.4 . . . . 0.0 111.175 -179.119 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 61.92 10.9 28.42 Favored Glycine 0 N--CA 1.453 -0.225 0 CA-C-N 115.516 -0.765 . . . . 0.0 113.28 179.4 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.516 ' HA2' HD13 ' A' ' 64' ' ' LEU . . . 136.66 -14.6 3.89 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.415 -0.898 . . . . 0.0 112.705 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.545 ' HB3' ' HB2' ' A' ' 66' ' ' GLU . 0.6 OUTLIER -79.07 -22.15 45.71 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.415 0.626 . . . . 0.0 109.349 -179.669 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.9 ttmp? -144.91 137.43 26.22 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.014 -179.435 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.598 ' HB2' HD11 ' A' ' 90' ' ' LEU . 10.6 tt -104.69 127.58 52.5 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.571 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.4 p -117.73 131.93 56.54 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.048 0.451 . . . . 0.0 111.405 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.481 ' SG ' HD21 ' A' ' 48' ' ' LEU . 28.4 p -158.2 165.57 34.56 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.604 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 12.0 ttt-85 -106.33 101.65 36.24 Favored Pre-proline 0 C--N 1.316 -0.885 0 C-N-CA 120.173 -0.611 . . . . 0.0 109.941 179.067 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.672 ' O ' ' HB3' ' A' ' 83' ' ' ARG . 55.8 Cg_endo -70.45 141.37 42.25 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 122.567 2.178 . . . . 0.0 110.417 178.618 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.785 ' HE3' ' HA2' ' A' ' 81' ' ' GLY . 0.0 OUTLIER -121.66 143.62 49.23 Favored 'General case' 0 C--N 1.318 -0.8 0 O-C-N 123.567 0.542 . . . . 0.0 111.098 179.913 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.678 ' HB ' ' HD2' ' A' ' 83' ' ' ARG . 11.4 t -79.83 143.14 34.64 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 178.852 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 8.8 p -70.4 -12.36 16.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 O-C-N 124.184 0.927 . . . . 0.0 111.577 -179.04 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 -63.43 -23.14 67.28 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.283 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -173.08 -14.62 0.02 OUTLIER Glycine 0 C--O 1.228 -0.255 0 C-N-CA 120.312 -0.947 . . . . 0.0 113.163 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.785 ' HA2' ' HE3' ' A' ' 76' ' ' LYS . . . 98.76 20.97 17.47 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.549 -0.834 . . . . 0.0 111.849 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.678 ' O ' HG22 ' A' ' 77' ' ' THR . 24.9 p90 -110.91 149.5 30.54 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -179.133 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.688 ' HB2' ' HA ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 177.35 -143.15 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.763 -0.375 . . . . 0.0 111.896 -179.768 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -143.91 152.46 41.15 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.051 -178.141 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.604 ' HA ' ' HA ' ' A' ' 74' ' ' ARG . 31.6 ttt-85 -77.55 154.1 32.7 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 110.206 -0.294 . . . . 0.0 110.206 -179.68 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLN . . . . . 0.608 ' HG2' ' H ' ' A' ' 87' ' ' GLY . 43.2 tt0 -161.72 179.68 7.94 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 120.586 0.231 . . . . 0.0 110.587 -179.028 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.608 ' H ' ' HG2' ' A' ' 86' ' ' GLN . . . -145.51 148.56 20.37 Favored Glycine 0 N--CA 1.448 -0.545 0 N-CA-C 111.683 -0.567 . . . . 0.0 111.683 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.591 ' HB ' ' HB3' ' A' ' 48' ' ' LEU . 14.8 tt -126.18 137.84 56.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.199 0.523 . . . . 0.0 110.538 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -77.4 128.3 34.02 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.872 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.665 HD13 HD11 ' A' ' 19' ' ' LEU . 44.7 mt -96.7 42.06 1.1 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.613 0.721 . . . . 0.0 110.746 -179.163 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.406 ' HA ' ' OG ' ' A' ' 2' ' ' SER . 4.6 m120 -78.86 3.2 17.56 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 115.053 -0.976 . . . . 0.0 111.041 -179.696 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 24.7 mtp180 -100.18 -3.98 30.52 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.677 178.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.427 HD11 ' HH2' ' A' ' 50' ' ' TRP . 22.1 mm -104.16 108.99 25.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 -179.377 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 26.6 tp60 -122.18 141.96 50.91 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.985 -178.242 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 17.0 p-10 -94.73 119.72 33.8 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.066 178.596 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 44.2 t -104.82 104.81 17.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.641 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 12.9 m120 61.0 37.19 18.26 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 121.273 0.559 . . . . 0.0 110.651 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 91.05 -16.64 58.14 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.924 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 7.1 mpt_? -87.1 123.09 31.78 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.442 HD13 ' SG ' ' A' ' 23' ' ' CYS . 9.0 tp -81.6 114.9 20.61 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.684 -0.488 . . . . 0.0 109.684 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 39.5 t -128.7 143.11 42.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 120.933 0.397 . . . . 0.0 111.001 -178.773 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.549 ' HB2' HD11 ' A' ' 35' ' ' LEU . 6.7 t80 -81.47 136.05 35.64 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 178.36 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 54.2 tp60 . . . . . 0 C--O 1.245 0.85 0 CA-C-O 118.805 -0.617 . . . . 0.0 110.686 -179.976 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' SER . . . . . 0.581 ' OG ' ' HA ' ' A' ' 91' ' ' ASN . 5.5 m . . . . . 0 N--CA 1.454 -0.23 0 CA-C-O 120.946 0.403 . . . . 0.0 111.45 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.503 ' HA ' ' OD1' ' A' ' 95' ' ' ASN . 21.0 p90 -59.06 -33.92 71.34 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.857 178.388 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.491 ' HB3' ' HG2' ' A' ' 69' ' ' ARG . . . -56.34 -19.22 13.52 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 -178.738 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -69.43 -14.53 62.94 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 121.107 0.48 . . . . 0.0 110.808 179.758 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 14.9 p -149.5 33.7 0.71 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.655 0.741 . . . . 0.0 109.354 178.672 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 17.4 t -148.47 155.78 41.62 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.256 -0.884 . . . . 0.0 109.394 -179.509 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 1.5 ptp180 -148.74 170.24 18.63 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.76 -0.2 . . . . 0.0 110.858 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 62.56 44.6 6.79 Favored 'General case' 0 C--O 1.232 0.151 0 O-C-N 124.003 0.814 . . . . 0.0 111.18 178.625 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.413 ' HA ' ' HB2' ' A' ' 21' ' ' ALA . . . -80.33 126.34 31.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.88 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 35.5 m -126.77 172.62 13.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.552 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -105.94 114.88 29.3 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.68 -179.479 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 22.6 p -111.15 166.87 10.71 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.951 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.432 ' O ' ' HG2' ' A' ' 17' ' ' ARG . 83.9 m-20 56.83 42.28 26.78 Favored 'General case' 0 N--CA 1.461 0.108 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.604 -179.206 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 87.69 -41.03 3.07 Favored Glycine 0 CA--C 1.517 0.212 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.542 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 146.33 44.29 0.04 OUTLIER Glycine 0 N--CA 1.447 -0.617 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.432 ' HG2' ' O ' ' A' ' 14' ' ' ASN . 6.4 ptm180 -126.24 -26.18 3.4 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.894 0.378 . . . . 0.0 110.93 -179.191 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 3.7 m -107.08 135.97 47.73 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.971 -179.0 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.815 HD11 HD13 ' A' ' 90' ' ' LEU . 39.7 mt -94.62 115.87 28.08 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.209 178.708 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 78.0 ttt180 -112.98 119.04 36.53 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 178.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.432 ' O ' ' HA ' ' A' ' 32' ' ' THR . . . -154.08 166.78 31.98 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.728 0.299 . . . . 0.0 111.461 -179.139 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -90.99 106.64 18.66 Favored 'General case' 0 CA--C 1.513 -0.458 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 178.315 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.468 ' SG ' HD13 ' A' ' 100' ' ' LEU . 70.2 m -99.01 135.76 39.94 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 120.76 0.314 . . . . 0.0 110.765 -178.751 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.4 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 15.9 ttp180 -77.66 120.02 22.01 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.791 179.334 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.43 HD21 ' HB3' ' A' ' 29' ' ' ASN . 36.4 p30 -86.13 168.63 13.85 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.971 -0.291 . . . . 0.0 110.385 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -52.59 -36.28 55.78 Favored 'General case' 0 C--N 1.328 -0.369 0 O-C-N 123.837 0.71 . . . . 0.0 112.02 -179.097 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -67.45 -17.21 64.61 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.329 0.585 . . . . 0.0 111.041 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 92.6 34.98 6.68 Favored Glycine 0 N--CA 1.448 -0.528 0 N-CA-C 111.304 -0.718 . . . . 0.0 111.304 -179.586 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.43 ' HB3' HD21 ' A' ' 25' ' ' ASN . 9.9 t-20 -119.77 158.08 27.27 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 110.237 -0.283 . . . . 0.0 110.237 -178.839 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 77.0 m95 -95.1 116.53 28.83 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.241 179.065 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.5 m -122.78 129.53 75.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.361 179.195 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.432 ' HA ' ' O ' ' A' ' 21' ' ' ALA . 21.0 m -74.77 114.5 13.29 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.202 0.525 . . . . 0.0 110.26 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.55 ' HB3' ' HB2' ' A' ' 100' ' ' LEU . 58.5 m -114.95 149.41 37.34 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.909 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.641 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 26.3 mt-10 -132.65 130.85 40.69 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.881 -178.801 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.591 HD11 ' HB2' ' A' ' 102' ' ' PHE . 2.1 tm? -132.64 132.83 42.87 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.461 ' N ' HD13 ' A' ' 35' ' ' LEU . 14.6 m-20 -88.96 110.19 20.9 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 -179.726 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.505 HD11 ' HG ' ' A' ' 19' ' ' LEU . 2.6 mt -81.11 -18.29 47.01 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.095 -179.123 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.465 ' HA ' ' HD1' ' A' ' 55' ' ' PHE . 5.7 p-10 -65.05 -7.22 11.08 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.28 -179.358 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 58.1 p -80.73 -13.04 59.34 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.271 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.457 ' HG ' ' HZ ' ' A' ' 102' ' ' PHE . 18.8 t -139.96 -12.9 1.09 Allowed 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 112.138 0.422 . . . . 0.0 112.138 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 54.3 mt -97.55 135.46 31.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 O-C-N 121.814 -0.554 . . . . 0.0 110.057 179.361 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -142.15 144.64 14.44 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.731 -0.747 . . . . 0.0 111.743 179.648 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.503 ' OD1' ' HB2' ' A' ' 58' ' ' SER . 27.8 p30 -152.95 48.37 0.43 Allowed Pre-proline 0 CA--C 1.539 0.542 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 -179.696 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -76.78 -16.46 16.4 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 121.697 1.598 . . . . 0.0 112.339 -178.881 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -96.19 2.71 53.26 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.921 -179.457 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.604 ' CA ' ' HG2' ' A' ' 83' ' ' ARG . . . 92.48 5.58 65.02 Favored Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.295 -0.955 . . . . 0.0 112.26 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.451 ' HD1' ' NE2' ' A' ' 86' ' ' GLN . 31.9 m-85 -125.85 134.49 51.62 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.899 0.38 . . . . 0.0 110.497 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.467 HD23 HG22 ' A' ' 88' ' ' ILE . 9.5 mp -85.04 158.51 20.44 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.58 -0.737 . . . . 0.0 111.653 -178.713 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 159.55 167.26 19.94 Favored Glycine 0 N--CA 1.443 -0.864 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.95 178.901 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.451 ' CD1' HD11 ' A' ' 88' ' ' ILE . 85.2 m95 -95.33 125.12 39.73 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 166.29 -43.01 0.27 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.87 -179.462 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 8.4 ttp -107.86 -156.94 0.6 Allowed 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.4 pt20 -146.83 173.92 11.95 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 121.091 -0.244 . . . . 0.0 110.899 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 63.03 45.43 5.28 Favored 'General case' 0 N--CA 1.465 0.285 0 O-C-N 123.663 0.602 . . . . 0.0 112.351 178.266 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.465 ' HD1' ' HA ' ' A' ' 38' ' ' ASP . 10.1 p90 -71.63 -28.79 64.02 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.978 -0.289 . . . . 0.0 110.76 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.45 ' HA ' HD11 ' A' ' 62' ' ' ILE . 35.0 p -61.39 -37.61 84.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.079 0.466 . . . . 0.0 110.917 -179.333 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 27.2 m80 -81.06 -3.46 51.97 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.106 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.503 ' HB2' ' OD1' ' A' ' 43' ' ' ASN . 12.2 m -119.13 12.68 12.74 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.396 -179.436 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 22.0 p -145.88 155.3 42.79 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 120.995 0.426 . . . . 0.0 111.459 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -116.35 148.05 40.99 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.872 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.405 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 28.1 t70 54.0 78.44 0.16 Allowed 'General case' 0 N--CA 1.467 0.401 0 O-C-N 123.921 0.763 . . . . 0.0 111.168 -179.614 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.586 ' HA ' ' HB3' ' A' ' 73' ' ' CYS . 67.0 mt -97.04 117.64 42.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.784 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -148.03 153.78 39.41 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.825 0.345 . . . . 0.0 110.626 -179.159 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.432 HD22 ' HA2' ' A' ' 68' ' ' GLY . 43.0 mt -83.07 133.14 35.08 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.24 0.543 . . . . 0.0 111.041 -179.173 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.439 ' OE2' ' HD3' ' A' ' 70' ' ' LYS . 35.4 tt0 -86.8 -61.44 1.73 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.68 -178.772 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.595 ' HB2' ' HB2' ' A' ' 69' ' ' ARG . 19.1 mt-10 -84.71 34.9 0.54 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.806 0.336 . . . . 0.0 111.42 -178.79 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 65.04 13.15 57.03 Favored Glycine 0 N--CA 1.452 -0.252 0 CA-C-N 115.972 -0.558 . . . . 0.0 113.504 179.406 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.432 ' HA2' HD22 ' A' ' 64' ' ' LEU . . . 140.26 -24.76 2.66 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.147 -1.025 . . . . 0.0 113.072 179.717 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.595 ' HB2' ' HB2' ' A' ' 66' ' ' GLU . 3.8 mmt85 -74.08 -21.34 59.95 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.967 0.413 . . . . 0.0 110.943 -179.765 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.591 ' HB3' ' HG3' ' A' ' 66' ' ' GLU . 81.9 tttt -146.17 143.05 29.03 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.743 -178.509 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.685 ' HB2' HD11 ' A' ' 90' ' ' LEU . 10.2 tt -113.19 135.32 53.94 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.013 -0.539 . . . . 0.0 109.617 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 8.9 p -127.16 139.13 53.17 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.018 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.586 ' HB3' ' HA ' ' A' ' 62' ' ' ILE . 26.4 p -162.54 172.0 16.14 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.269 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.664 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 75.1 ttt180 -108.86 98.87 31.88 Favored Pre-proline 0 C--N 1.321 -0.664 0 C-N-CA 120.562 -0.455 . . . . 0.0 110.349 178.737 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.689 ' O ' ' HB3' ' A' ' 83' ' ' ARG . 41.4 Cg_endo -66.74 128.4 18.88 Favored 'Trans proline' 0 N--CA 1.459 -0.5 0 C-N-CA 122.847 2.365 . . . . 0.0 110.828 179.302 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.763 ' HA ' ' HB2' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -120.78 141.57 50.38 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.349 -179.268 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.699 HG22 ' O ' ' A' ' 82' ' ' PHE . 9.5 t -70.86 131.47 43.82 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 178.402 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.7 m -70.55 -6.84 7.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 123.818 0.699 . . . . 0.0 112.069 -178.764 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -69.29 -33.91 73.9 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.956 0.408 . . . . 0.0 110.313 179.271 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.431 ' HA3' ' CE1' ' A' ' 82' ' ' PHE . . . -143.98 -25.45 0.14 Allowed Glycine 0 N--CA 1.453 -0.187 0 C-N-CA 120.557 -0.83 . . . . 0.0 112.7 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 100.66 17.62 23.15 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 121.02 -0.609 . . . . 0.0 112.133 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.699 ' O ' HG22 ' A' ' 77' ' ' THR . 24.7 p90 -111.8 153.11 27.05 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 118.763 -0.637 . . . . 0.0 109.878 -178.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.763 ' HB2' ' HA ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 167.04 -154.88 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.582 0 O-C-N 123.697 0.623 . . . . 0.0 111.364 179.4 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -123.44 170.84 9.96 Favored 'General case' 0 C--O 1.223 -0.304 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.265 -178.023 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.664 ' HA ' ' HA ' ' A' ' 74' ' ' ARG . 30.1 ttt85 -96.81 157.97 15.65 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.246 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLN . . . . . 0.455 ' HG2' ' H ' ' A' ' 87' ' ' GLY . 6.4 tt0 -158.91 179.57 8.96 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.072 0.463 . . . . 0.0 111.58 -179.243 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.455 ' H ' ' HG2' ' A' ' 86' ' ' GLN . . . -144.54 143.82 12.53 Favored Glycine 0 N--CA 1.45 -0.426 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.612 179.22 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.467 HG22 HD23 ' A' ' 48' ' ' LEU . 13.9 tt -130.29 140.85 47.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.825 0.345 . . . . 0.0 110.556 -179.374 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -80.15 137.4 36.7 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.815 HD13 HD11 ' A' ' 19' ' ' LEU . 64.2 mt -104.71 41.28 1.35 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.292 0.568 . . . . 0.0 111.382 -179.285 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.581 ' HA ' ' OG ' ' A' ' 2' ' ' SER . 7.3 m120 -76.0 3.31 10.55 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.976 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.407 HH11 ' HD2' ' A' ' 92' ' ' ARG . 8.4 mtp180 -96.7 -11.19 25.44 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.562 178.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.492 HG13 HD22 ' A' ' 37' ' ' LEU . 21.7 mm -98.38 95.91 4.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 21.6 tp60 -106.15 139.54 40.5 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.201 -177.812 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.503 ' OD1' ' HA ' ' A' ' 3' ' ' TYR . 16.8 p-10 -94.67 116.35 28.65 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.596 178.314 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.7 p -114.13 123.57 69.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 116.185 -0.461 . . . . 0.0 109.938 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 62.57 20.11 11.75 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.956 -179.156 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 95.84 -9.59 68.36 Favored Glycine 0 N--CA 1.446 -0.657 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.759 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.446 ' O ' ' HA ' ' A' ' 95' ' ' ASN . 0.0 OUTLIER -96.1 144.41 26.38 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-N 117.257 0.529 . . . . 0.0 110.826 -178.944 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.55 ' HB2' ' HB3' ' A' ' 33' ' ' SER . 5.3 tp -89.55 116.38 27.66 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.145 -0.48 . . . . 0.0 109.796 -179.789 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 46.8 t -131.12 141.85 45.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.422 -179.353 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.591 ' HB2' HD11 ' A' ' 35' ' ' LEU . 22.8 t80 -80.27 128.68 33.82 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 179.153 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.163 -0.922 . . . . 0.0 110.864 -179.347 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' SER . . . . . 0.623 ' HB3' ' HA ' ' A' ' 91' ' ' ASN . 1.0 OUTLIER . . . . . 0 N--CA 1.448 -0.533 0 N-CA-C 110.464 -0.198 . . . . 0.0 110.464 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.619 ' HA ' ' OD1' ' A' ' 95' ' ' ASN . 8.3 p90 -58.22 -41.41 84.02 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.772 -0.195 . . . . 0.0 111.399 -179.429 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -60.18 -19.37 53.78 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.849 -178.809 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -68.29 -21.81 64.76 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.146 0.498 . . . . 0.0 110.429 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.405 ' HB2' HD21 ' A' ' 95' ' ' ASN . 51.1 m -138.85 34.88 2.17 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.671 179.593 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.433 ' HA ' ' HZ3' ' A' ' 30' ' ' TRP . 92.8 p -149.96 167.67 26.02 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.182 179.258 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 16.0 ptm180 -149.9 169.11 21.9 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.648 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 60.4 52.87 4.52 Favored 'General case' 0 N--CA 1.465 0.296 0 O-C-N 123.646 0.591 . . . . 0.0 110.692 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -90.12 119.96 30.89 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.209 -179.515 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 35.3 m -122.49 170.71 12.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.165 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.707 HD21 ' HG ' ' A' ' 64' ' ' LEU . 3.4 mm? -104.81 116.29 31.76 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 -179.704 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.456 ' OG1' ' HB ' ' A' ' 18' ' ' THR . 29.4 p -110.7 167.62 10.09 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.072 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 56.95 55.62 5.99 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.93 179.704 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 82.24 -37.97 2.58 Favored Glycine 0 N--CA 1.453 -0.206 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.337 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.602 ' HA2' ' HB3' ' A' ' 12' ' ' LEU . . . 137.29 36.57 0.17 Allowed Glycine 0 N--CA 1.445 -0.757 0 N-CA-C 111.381 -0.688 . . . . 0.0 111.381 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.534 ' HB2' ' HB3' ' A' ' 38' ' ' ASP . 34.5 ptt85 -120.46 -23.11 6.22 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.93 0.395 . . . . 0.0 110.71 -179.222 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.456 ' HB ' ' OG1' ' A' ' 13' ' ' THR . 4.6 m -103.33 134.7 46.27 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.841 -179.258 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.65 ' O ' ' HA ' ' A' ' 34' ' ' GLU . 68.8 mt -95.26 116.18 28.41 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.395 179.19 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 39.0 ttt-85 -111.01 120.18 41.52 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 178.807 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -153.58 166.63 32.16 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.845 0.355 . . . . 0.0 111.488 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.468 ' HB3' ' HB3' ' A' ' 30' ' ' TRP . 49.8 mt-10 -89.9 105.68 17.97 Favored 'General case' 0 CA--C 1.512 -0.49 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 178.117 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.561 ' SG ' HD13 ' A' ' 100' ' ' LEU . 58.7 m -92.72 128.74 38.69 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.134 -177.766 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.434 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 11.0 ttp180 -77.79 116.46 18.33 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.34 179.034 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.439 HD21 ' HB3' ' A' ' 29' ' ' ASN . 35.2 p30 -84.96 170.92 12.56 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.231 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -51.29 -31.41 21.28 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -179.283 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -73.88 -11.58 60.41 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.621 0.724 . . . . 0.0 110.601 -179.183 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 85.79 25.02 39.64 Favored Glycine 0 N--CA 1.447 -0.633 0 N-CA-C 110.629 -0.988 . . . . 0.0 110.629 -179.21 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.439 ' HB3' HD21 ' A' ' 25' ' ' ASN . 8.8 t-20 -104.73 156.12 18.27 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.459 -0.371 . . . . 0.0 110.243 -178.581 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.468 ' HB3' ' HB3' ' A' ' 22' ' ' GLU . 90.7 m95 -97.6 116.02 29.01 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.775 -179.737 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.3 m -118.64 128.32 75.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.349 178.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 19.7 m -74.48 109.35 7.89 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.362 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.44 ' HB3' ' HB2' ' A' ' 100' ' ' LEU . 69.3 m -122.12 147.66 45.86 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.445 -179.813 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.65 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 50.7 mt-10 -128.79 142.84 50.85 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.012 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.722 HD11 ' HB2' ' A' ' 102' ' ' PHE . 2.1 tm? -135.49 132.45 37.36 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.729 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.463 ' N ' HD13 ' A' ' 35' ' ' LEU . 16.2 m-20 -89.59 110.36 21.23 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.542 HD13 HD22 ' A' ' 90' ' ' LEU . 2.9 mt -82.25 -20.76 36.96 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.68 -178.644 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.534 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 5.1 p-10 -66.9 -5.2 11.58 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 121.008 -0.277 . . . . 0.0 111.272 -178.501 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 37.5 p -73.52 -28.12 61.72 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.055 0.455 . . . . 0.0 110.261 178.425 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 17.0 t -126.48 -4.39 6.62 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.909 -179.342 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.403 HD13 HD13 ' A' ' 88' ' ' ILE . 57.8 mt -104.7 134.65 45.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 O-C-N 121.718 -0.613 . . . . 0.0 110.655 179.145 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.503 ' HA3' ' HB3' ' A' ' 52' ' ' MET . . . -149.98 158.85 27.85 Favored Glycine 0 N--CA 1.449 -0.456 0 N-CA-C 111.463 -0.655 . . . . 0.0 111.463 179.51 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.672 ' OD1' ' HB2' ' A' ' 55' ' ' PHE . 1.7 p-10 -163.64 56.37 0.54 Allowed Pre-proline 0 CA--C 1.538 0.484 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -66.64 -25.52 46.95 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.134 1.889 . . . . 0.0 112.068 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -96.54 3.94 52.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.03 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.641 ' HA2' ' HB2' ' A' ' 75' ' ' PRO . . . 89.9 11.99 62.76 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.305 -0.95 . . . . 0.0 113.288 179.453 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -118.38 123.48 45.37 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 120.929 0.395 . . . . 0.0 109.987 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.535 HD21 ' SG ' ' A' ' 73' ' ' CYS . 8.0 mp -83.56 137.51 33.81 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.734 -178.427 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -179.97 172.62 44.18 Favored Glycine 0 N--CA 1.437 -1.254 0 C-N-CA 120.748 -0.739 . . . . 0.0 111.422 178.72 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.43 ' CD2' ' HD3' ' A' ' 92' ' ' ARG . 91.2 m95 -95.05 125.03 39.43 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 -179.813 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 165.05 -55.25 0.27 Allowed Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.991 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.503 ' HB3' ' HA3' ' A' ' 42' ' ' GLY . 5.6 ttt -91.69 -158.07 0.55 Allowed 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.825 0.312 . . . . 0.0 110.226 -179.176 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 17.7 pt20 -148.57 167.64 24.89 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 120.788 0.328 . . . . 0.0 111.466 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 8.1 m120 63.6 48.61 3.31 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.303 -0.862 . . . . 0.0 112.82 178.621 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.672 ' HB2' ' OD1' ' A' ' 43' ' ' ASN . 8.8 p90 -69.73 -27.94 65.38 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.856 0.36 . . . . 0.0 110.423 179.438 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.453 ' HB2' ' HB3' ' A' ' 17' ' ' ARG . 21.7 t -61.26 -33.1 72.98 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.156 -179.762 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 24.3 m80 -78.37 -3.51 43.51 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.918 -179.457 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 40.0 m -133.94 24.56 3.94 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.956 0.408 . . . . 0.0 110.942 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 22.1 m -139.55 147.75 41.63 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.136 0.493 . . . . 0.0 111.465 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -123.06 151.5 41.91 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.59 179.48 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.452 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 28.2 t70 54.01 73.81 0.36 Allowed 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.356 0.598 . . . . 0.0 111.245 179.313 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.472 HG23 HD21 ' A' ' 71' ' ' LEU . 56.3 mt -98.48 116.13 40.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.887 -179.595 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.2 tptt -144.45 149.84 36.66 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.258 -179.503 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.707 ' HG ' HD21 ' A' ' 12' ' ' LEU . 65.0 mt -83.67 130.83 34.97 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 179.417 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 16.2 tp10 -83.13 -58.01 3.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.259 -178.134 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.514 ' HB2' ' HB3' ' A' ' 69' ' ' ARG . 7.2 mm-40 -85.59 23.14 1.43 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.158 0.504 . . . . 0.0 111.21 -179.046 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 76.49 3.38 77.8 Favored Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 115.487 -0.778 . . . . 0.0 112.963 179.373 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.451 ' HA2' HD22 ' A' ' 64' ' ' LEU . . . 147.62 -22.5 1.5 Allowed Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.671 -0.776 . . . . 0.0 111.997 -179.684 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.514 ' HB3' ' HB2' ' A' ' 66' ' ' GLU . 2.8 tpp180 -74.01 -12.53 60.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.267 0.556 . . . . 0.0 110.048 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 48.5 tttp -160.14 142.41 13.13 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.269 -178.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.649 ' HB2' HD11 ' A' ' 90' ' ' LEU . 10.3 tt -112.39 139.02 48.3 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.5 p -127.77 134.83 49.51 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.748 179.591 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.535 ' SG ' HD21 ' A' ' 48' ' ' LEU . 25.7 p -158.39 175.83 13.22 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.021 0.439 . . . . 0.0 110.259 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.589 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 2.8 tmt_? -110.92 98.79 39.99 Favored Pre-proline 0 C--N 1.316 -0.881 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 178.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.65 ' O ' ' HB3' ' A' ' 83' ' ' ARG . 61.2 Cg_endo -71.18 124.98 10.96 Favored 'Trans proline' 0 CA--C 1.512 -0.604 0 C-N-CA 123.301 2.667 . . . . 0.0 111.468 179.612 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.691 ' HA ' ' HB2' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -120.63 138.47 53.9 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.942 179.56 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.715 HG22 ' O ' ' A' ' 82' ' ' PHE . 14.8 t -72.62 132.66 44.04 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.364 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.7 p -74.87 -10.0 13.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.84 -179.087 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -67.44 -29.51 69.0 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.233 179.608 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.596 ' HA3' ' CE2' ' A' ' 82' ' ' PHE . . . -146.49 -23.33 0.1 Allowed Glycine 0 C--O 1.228 -0.232 0 C-N-CA 120.342 -0.932 . . . . 0.0 113.676 -179.202 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.68 ' HA2' ' HE3' ' A' ' 76' ' ' LYS . . . 97.76 12.11 48.18 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.302 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.715 ' O ' HG22 ' A' ' 77' ' ' THR . 29.6 p90 -111.91 158.64 19.23 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 118.419 -0.8 . . . . 0.0 109.793 -178.799 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.691 ' HB2' ' HA ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 162.62 -158.94 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.588 0 O-C-N 123.956 0.785 . . . . 0.0 111.731 179.514 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -120.02 -171.09 2.08 Favored 'General case' 0 C--O 1.225 -0.189 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.625 -178.684 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.589 ' HA ' ' HA ' ' A' ' 74' ' ' ARG . 30.6 ttt180 -109.58 155.6 21.22 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 177.534 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -169.1 162.06 10.69 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 120.407 -0.517 . . . . 0.0 112.265 -179.085 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -123.74 157.19 18.12 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 121.221 -0.514 . . . . 0.0 112.062 179.438 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.474 ' HB ' ' HB3' ' A' ' 48' ' ' LEU . 15.1 tt -131.43 143.82 39.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.027 0.441 . . . . 0.0 110.246 179.738 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.525 ' OD1' ' HB2' ' A' ' 91' ' ' ASN . 17.3 t70 -82.74 131.89 35.19 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.265 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.649 HD11 ' HB2' ' A' ' 71' ' ' LEU . 56.1 mt -105.34 34.15 3.37 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 112.943 0.719 . . . . 0.0 112.943 -177.916 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.623 ' HA ' ' HB3' ' A' ' 2' ' ' SER . 3.8 m120 -74.72 3.69 7.53 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 121.096 0.474 . . . . 0.0 111.464 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.43 ' HD3' ' CD2' ' A' ' 50' ' ' TRP . 32.3 mtp180 -92.86 -11.14 34.3 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.493 178.678 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.509 HG13 HD22 ' A' ' 37' ' ' LEU . 19.9 mm -99.59 106.46 19.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -179.653 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -117.4 140.24 49.83 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.085 0.469 . . . . 0.0 111.269 -178.508 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.619 ' OD1' ' HA ' ' A' ' 3' ' ' TYR . 16.5 p-10 -95.14 101.28 13.02 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.399 0.619 . . . . 0.0 109.808 177.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.2 p -91.42 114.39 28.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 121.439 0.638 . . . . 0.0 110.424 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 61.24 29.75 18.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.57 -179.61 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 91.08 -10.82 73.96 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.038 -179.195 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.417 ' HD2' ' N ' ' A' ' 99' ' ' ARG . 9.6 mpt_? -92.11 123.54 35.54 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.684 0.278 . . . . 0.0 110.327 -179.33 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.561 HD13 ' SG ' ' A' ' 23' ' ' CYS . 5.5 tp -78.71 114.56 17.74 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 -179.537 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 53.4 t -132.14 140.98 46.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.189 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.722 ' HB2' HD11 ' A' ' 35' ' ' LEU . 8.3 t80 -83.06 133.75 35.06 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.137 179.327 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 35.3 tp60 . . . . . 0 C--O 1.248 1.008 0 CA-C-O 118.764 -0.636 . . . . 0.0 109.956 179.994 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' SER . . . . . 0.683 ' OG ' ' HA ' ' A' ' 91' ' ' ASN . 12.3 m . . . . . 0 N--CA 1.451 -0.408 0 CA-C-O 120.533 0.206 . . . . 0.0 110.903 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.424 ' CZ ' HD13 ' A' ' 19' ' ' LEU . 22.8 p90 -58.21 -36.92 73.84 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.257 179.652 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -56.68 -21.04 24.76 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -178.399 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -73.55 -9.74 58.99 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 120.991 0.424 . . . . 0.0 111.006 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 51.0 m -148.07 29.23 0.9 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.317 0.58 . . . . 0.0 109.529 178.695 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 36.7 m -143.29 164.48 30.1 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.576 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 2.3 ptm180 -148.57 165.97 29.66 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.327 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 57.83 57.29 4.26 Favored 'General case' 0 N--CA 1.462 0.174 0 O-C-N 123.647 0.592 . . . . 0.0 111.46 178.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.421 ' HA ' ' HB2' ' A' ' 21' ' ' ALA . . . -88.93 125.91 35.17 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.934 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 23.0 m -129.05 174.19 12.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.4 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.671 HD21 ' HG ' ' A' ' 64' ' ' LEU . 3.5 mm? -106.0 114.42 28.55 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.945 -179.743 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 28.3 p -111.54 171.24 7.6 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.126 -179.43 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 56.67 40.27 29.33 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.608 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 90.02 -20.43 36.39 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.677 179.322 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.629 ' HA2' ' HB3' ' A' ' 12' ' ' LEU . . . 121.73 34.92 0.82 Allowed Glycine 0 N--CA 1.443 -0.84 0 C-N-CA 120.926 -0.654 . . . . 0.0 111.727 -179.732 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.563 ' HB2' ' HB3' ' A' ' 38' ' ' ASP . 11.9 ptt180 -124.34 -15.41 6.7 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.218 0.533 . . . . 0.0 110.477 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.428 ' CG2' ' HB3' ' A' ' 34' ' ' GLU . 11.4 m -114.18 138.67 50.15 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.231 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.698 HD11 HD13 ' A' ' 90' ' ' LEU . 56.8 mt -95.17 113.71 25.43 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.93 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.516 ' HD3' HG23 ' A' ' 32' ' ' THR . 4.5 tmm_? -107.94 119.46 39.53 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 178.629 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.421 ' HB2' ' HA ' ' A' ' 10' ' ' ALA . . . -153.71 167.23 30.31 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.95 0.405 . . . . 0.0 111.401 -179.158 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -89.52 105.96 18.14 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 178.064 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.529 ' SG ' HD13 ' A' ' 100' ' ' LEU . 22.5 m -96.82 133.27 41.63 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.565 -0.288 . . . . 0.0 110.584 -177.824 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 16.7 ttp180 -76.4 116.63 17.27 Favored 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 179.111 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.403 HD21 ' HB3' ' A' ' 29' ' ' ASN . 36.1 p30 -81.75 165.01 21.31 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 179.69 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.14 -15.68 15.76 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -177.837 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -87.49 -6.22 58.47 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.745 0.783 . . . . 0.0 109.974 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 83.41 37.76 11.82 Favored Glycine 0 N--CA 1.448 -0.561 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.677 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.403 ' HB3' HD21 ' A' ' 25' ' ' ASN . 9.8 t-20 -124.5 161.25 26.51 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 110.353 -0.24 . . . . 0.0 110.353 -179.329 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 72.8 m95 -98.56 120.87 39.72 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.72 179.662 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.6 m -124.67 134.87 65.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.979 179.208 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.516 HG23 ' HD3' ' A' ' 20' ' ' ARG . 46.1 m -75.76 109.38 9.31 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.756 179.066 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 55.4 m -122.83 153.51 39.48 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.755 -179.651 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.638 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 44.0 mt-10 -135.52 139.17 43.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.117 -179.483 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.701 HD11 ' HB2' ' A' ' 102' ' ' PHE . 2.5 tm? -131.71 131.95 43.5 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 179.049 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.478 ' O ' HG22 ' A' ' 39' ' ' THR . 38.8 m-20 -84.8 110.52 18.87 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.973 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.603 HD13 HD22 ' A' ' 90' ' ' LEU . 5.2 mt -81.2 -27.44 35.32 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.663 0.268 . . . . 0.0 111.385 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.563 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 4.6 p-10 -65.65 -5.79 9.42 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.292 0.479 . . . . 0.0 112.292 -177.818 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.478 HG22 ' O ' ' A' ' 36' ' ' ASP . 14.0 t -78.75 -10.15 59.67 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 110.274 -0.269 . . . . 0.0 110.274 178.899 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 40.2 t -141.53 3.84 1.72 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.463 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.407 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 56.9 mt -113.88 132.58 62.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 O-C-N 121.95 -0.468 . . . . 0.0 110.621 179.327 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.486 ' HA3' ' HB3' ' A' ' 52' ' ' MET . . . -146.47 155.48 26.55 Favored Glycine 0 N--CA 1.447 -0.568 0 N-CA-C 111.408 -0.677 . . . . 0.0 111.408 179.278 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.437 ' OD1' ' HB2' ' A' ' 55' ' ' PHE . 4.3 p-10 -153.3 45.16 0.27 Allowed Pre-proline 0 CA--C 1.541 0.626 0 N-CA-C 113.515 0.932 . . . . 0.0 113.515 -179.046 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.437 ' HG3' ' SD ' ' A' ' 52' ' ' MET . 57.5 Cg_endo -68.96 -20.38 38.77 Favored 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 121.522 1.481 . . . . 0.0 111.315 -179.535 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -81.07 -16.46 53.11 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.814 179.264 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 103.44 6.11 44.87 Favored Glycine 0 N--CA 1.443 -0.835 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.7 -178.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.428 ' HD1' HE22 ' A' ' 86' ' ' GLN . 67.4 m-85 -122.26 135.04 54.68 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.826 0.346 . . . . 0.0 110.389 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.623 HD12 ' HG3' ' A' ' 86' ' ' GLN . 94.2 mt -83.53 130.96 35.02 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.8 -178.771 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -174.64 172.47 45.44 Favored Glycine 0 N--CA 1.441 -0.98 0 C-N-CA 120.699 -0.762 . . . . 0.0 111.807 179.189 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.478 ' HH2' HD11 ' A' ' 93' ' ' ILE . 81.5 m95 -94.36 125.93 39.3 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 179.68 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 170.66 -58.33 0.18 Allowed Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.516 -179.394 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.486 ' HB3' ' HA3' ' A' ' 42' ' ' GLY . 11.0 ttp -95.0 -153.12 0.38 Allowed 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -146.54 170.5 16.77 Favored 'General case' 0 C--N 1.33 -0.25 0 O-C-N 122.184 -0.322 . . . . 0.0 111.336 -179.273 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 8.4 m120 62.29 41.84 9.91 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 113.153 0.797 . . . . 0.0 113.153 178.537 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.437 ' HB2' ' OD1' ' A' ' 43' ' ' ASN . 8.8 p90 -63.23 -26.77 68.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.13 0.49 . . . . 0.0 110.464 179.113 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.556 ' HB2' ' HB3' ' A' ' 17' ' ' ARG . 32.3 t -62.69 -32.6 73.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.499 -179.253 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 30.0 m80 -82.61 -4.07 57.13 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.846 0.355 . . . . 0.0 111.084 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 24.1 m -125.36 16.13 8.31 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.484 179.401 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 65.1 m -137.58 149.17 46.48 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.133 0.492 . . . . 0.0 111.041 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -128.95 158.12 39.7 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.469 179.54 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.522 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 36.5 t70 57.22 67.69 0.95 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.477 0.656 . . . . 0.0 110.405 179.226 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.536 HG23 HD21 ' A' ' 71' ' ' LEU . 71.6 mt -95.21 114.06 30.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.147 -178.888 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.8 tptm -145.33 143.91 30.42 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.317 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.671 ' HG ' HD21 ' A' ' 12' ' ' LEU . 79.2 mt -82.3 120.82 25.89 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.803 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -72.71 -56.35 5.41 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.778 -179.202 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.46 ' HB2' ' HB2' ' A' ' 69' ' ' ARG . 29.4 mt-10 -82.72 4.22 25.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.954 0.407 . . . . 0.0 110.64 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 81.19 13.78 80.19 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.293 -179.594 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.43 ' HA2' HD13 ' A' ' 64' ' ' LEU . . . 155.34 -31.51 0.64 Allowed Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 119.916 -1.135 . . . . 0.0 113.299 179.377 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.547 ' HD3' ' HB2' ' A' ' 2' ' ' SER . 7.2 mmt85 -78.11 -33.15 50.72 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.022 0.439 . . . . 0.0 111.647 -179.47 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 28.6 tptt -131.65 135.23 46.75 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.437 -178.401 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.715 ' HB2' HD11 ' A' ' 90' ' ' LEU . 10.0 tt -110.68 124.5 52.05 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -112.2 128.14 56.15 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 120.972 0.415 . . . . 0.0 111.143 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.522 ' HA ' ' O ' ' A' ' 61' ' ' ASP . 24.5 p -155.0 166.21 34.29 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 179.53 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.545 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 29.3 ttt180 -101.29 100.61 14.0 Favored Pre-proline 0 C--N 1.314 -0.946 0 CA-C-O 120.797 0.332 . . . . 0.0 110.556 179.56 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.644 ' O ' ' HB3' ' A' ' 83' ' ' ARG . 46.0 Cg_endo -69.7 120.88 7.6 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 122.48 2.12 . . . . 0.0 109.897 178.159 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.999 ' HE3' ' HA2' ' A' ' 81' ' ' GLY . 0.0 OUTLIER -115.7 143.69 45.01 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.008 0.433 . . . . 0.0 110.884 -179.348 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.661 HG22 ' O ' ' A' ' 82' ' ' PHE . 13.1 t -78.49 142.0 37.79 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 179.505 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 28.9 m -70.59 -8.56 11.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 O-C-N 124.046 0.841 . . . . 0.0 112.002 -179.335 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -59.67 -35.11 73.8 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.046 0.45 . . . . 0.0 110.173 179.15 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.409 ' H ' ' H ' ' A' ' 81' ' ' GLY . . . -164.52 -13.08 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.56 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.611 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.999 ' HA2' ' HE3' ' A' ' 76' ' ' LYS . . . 99.73 23.0 11.29 Favored Glycine 0 N--CA 1.442 -0.961 0 C-N-CA 120.484 -0.865 . . . . 0.0 112.064 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.661 ' O ' HG22 ' A' ' 77' ' ' THR . 30.5 p90 -110.47 144.85 38.66 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 -178.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.659 ' HB2' ' HA ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 172.34 -151.82 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 O-C-N 123.645 0.591 . . . . 0.0 110.724 -179.676 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 23.9 mm-40 -122.41 176.56 5.82 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.09 -177.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.545 ' HA ' ' HA ' ' A' ' 74' ' ' ARG . 39.2 ttt-85 -112.74 151.01 30.77 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 177.836 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLN . . . . . 0.623 ' HG3' HD12 ' A' ' 48' ' ' LEU . 10.4 pt20 -166.52 -172.37 2.16 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.86 0.362 . . . . 0.0 111.472 -179.263 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -135.22 152.48 20.84 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.462 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.4 HD13 HD13 ' A' ' 41' ' ' ILE . 13.4 tt -122.81 149.94 26.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -86.61 124.79 33.29 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.77 0.319 . . . . 0.0 111.104 -179.069 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.715 HD11 ' HB2' ' A' ' 71' ' ' LEU . 44.3 mt -97.88 34.43 1.9 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.644 0.735 . . . . 0.0 110.134 179.254 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.683 ' HA ' ' OG ' ' A' ' 2' ' ' SER . 5.0 m-20 -75.17 2.03 11.87 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 114.806 -1.088 . . . . 0.0 110.704 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 18.8 mtp180 -98.52 1.21 46.37 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.256 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.507 HD12 HD12 ' A' ' 35' ' ' LEU . 22.1 mm -105.65 112.96 41.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.144 0.497 . . . . 0.0 109.885 -179.228 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.4 mm100 -117.69 145.56 44.33 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.996 -178.27 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -97.41 102.32 14.06 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.548 178.051 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 46.7 t -92.13 106.56 17.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.835 -178.845 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 61.08 25.29 15.32 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.161 179.469 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 106.0 -23.4 29.28 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.533 -0.842 . . . . 0.0 112.751 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.12 132.49 34.3 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.902 0.351 . . . . 0.0 110.062 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.529 HD13 ' SG ' ' A' ' 23' ' ' CYS . 7.9 tp -82.54 114.69 21.12 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 -179.474 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 5.5 t -125.93 146.41 31.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 120.937 0.399 . . . . 0.0 111.155 -178.518 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.701 ' HB2' HD11 ' A' ' 35' ' ' LEU . 18.6 t80 -79.8 138.22 37.18 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 178.314 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 . . . . . 0 C--N 1.316 -0.852 0 CA-C-O 118.81 -0.614 . . . . 0.0 110.427 -179.198 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' SER . . . . . 0.549 ' HB3' ' HA ' ' A' ' 91' ' ' ASN . 0.5 OUTLIER . . . . . 0 N--CA 1.449 -0.479 0 N-CA-C 111.548 0.203 . . . . 0.0 111.548 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.51 ' HA ' ' OD1' ' A' ' 95' ' ' ASN . 11.8 p90 -48.73 -36.65 16.81 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -179.348 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.479 ' HB3' ' HD3' ' A' ' 69' ' ' ARG . . . -54.9 -19.32 6.37 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 -178.253 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -57.9 -39.19 77.3 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.237 0.541 . . . . 0.0 110.262 178.751 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.41 ' HB2' HD21 ' A' ' 95' ' ' ASN . 24.4 m -129.55 39.51 3.72 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.536 -0.757 . . . . 0.0 109.479 179.285 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.424 ' HB3' ' HA ' ' A' ' 4' ' ' ALA . 8.6 t -141.27 149.71 41.66 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.864 -179.603 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.407 HH11 ' HD2' ' A' ' 8' ' ' ARG . 10.6 ptm85 -138.16 158.55 44.08 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.633 -179.607 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 62.47 52.81 2.86 Favored 'General case' 0 N--CA 1.463 0.207 0 O-C-N 123.914 0.759 . . . . 0.0 111.374 179.035 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.507 ' HA ' ' HB2' ' A' ' 21' ' ' ALA . . . -82.25 117.58 22.46 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.239 179.69 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 36.0 m -124.18 169.17 15.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.05 -179.51 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.524 HD21 ' HG ' ' A' ' 64' ' ' LEU . 3.1 mm? -104.85 120.5 41.56 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.99 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 23.3 p -114.48 167.12 11.01 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 120.862 0.363 . . . . 0.0 111.277 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 64.03 31.4 13.59 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.402 179.383 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 92.36 -21.78 36.13 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.855 -0.688 . . . . 0.0 113.106 179.261 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.413 ' HA2' ' HB3' ' A' ' 12' ' ' LEU . . . 129.27 56.22 0.1 Allowed Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.775 -0.726 . . . . 0.0 111.407 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.411 ' HB3' ' OG ' ' A' ' 56' ' ' SER . 2.4 ptm180 -143.13 -32.25 0.47 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.983 0.42 . . . . 0.0 111.077 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.437 ' CG2' ' HB3' ' A' ' 34' ' ' GLU . 2.8 m -103.11 135.25 45.14 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.952 -179.553 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.654 HD11 HD13 ' A' ' 90' ' ' LEU . 62.5 mt -94.29 113.13 24.98 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.118 178.87 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.421 ' HE ' ' CD ' ' A' ' 34' ' ' GLU . 40.5 ttm180 -109.68 120.43 42.45 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 178.751 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.507 ' HB2' ' HA ' ' A' ' 10' ' ' ALA . . . -153.38 166.57 32.22 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.852 0.358 . . . . 0.0 111.048 -179.844 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -90.98 112.14 23.9 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 178.349 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.485 ' SG ' HD13 ' A' ' 100' ' ' LEU . 65.2 m -101.32 130.49 47.49 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.747 0.308 . . . . 0.0 110.816 -178.835 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.5 ttt180 -83.77 109.88 17.88 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 35.1 p30 -77.82 167.71 21.09 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.329 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -50.91 -33.07 22.68 Favored 'General case' 0 C--N 1.329 -0.292 0 O-C-N 123.674 0.609 . . . . 0.0 112.356 -179.137 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -67.24 -16.22 64.16 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.204 0.526 . . . . 0.0 110.825 -179.181 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 91.24 25.51 23.82 Favored Glycine 0 N--CA 1.446 -0.638 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.671 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -115.1 151.78 33.7 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.617 0.246 . . . . 0.0 111.074 -179.325 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -92.05 115.01 27.7 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.102 0.477 . . . . 0.0 110.911 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 5.0 m -113.38 132.79 61.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.561 179.106 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 53.2 m -79.58 110.19 14.68 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.037 0.446 . . . . 0.0 110.542 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 73.6 m -120.95 148.85 43.52 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.815 -179.697 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.566 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 46.3 mt-10 -130.92 138.55 49.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.832 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.565 HD11 ' HB2' ' A' ' 102' ' ' PHE . 1.9 tm? -132.38 130.2 40.37 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 179.026 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.412 ' N ' HD13 ' A' ' 35' ' ' LEU . 23.9 m-20 -88.86 109.58 20.33 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.969 0.414 . . . . 0.0 110.332 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.495 HD11 HD11 ' A' ' 19' ' ' LEU . 1.6 mt -84.67 -11.49 55.8 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.742 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -66.76 -6.0 14.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.156 -179.621 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 72.1 p -88.96 -13.09 39.75 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.018 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.537 ' SG ' ' HZ3' ' A' ' 50' ' ' TRP . 0.8 OUTLIER -136.05 -9.61 2.03 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -178.432 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.427 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 51.3 mt -107.16 132.17 55.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 O-C-N 122.241 -0.287 . . . . 0.0 110.455 178.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.528 ' HA3' ' HB3' ' A' ' 52' ' ' MET . . . -151.97 162.01 29.56 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.199 179.591 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.511 ' OD1' ' HB2' ' A' ' 55' ' ' PHE . 2.3 p-10 -159.4 57.98 1.13 Allowed Pre-proline 0 CA--C 1.535 0.382 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -72.39 -15.36 28.03 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.059 1.839 . . . . 0.0 112.374 -179.337 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 53.5 m-80 -100.26 -5.12 28.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.953 0.406 . . . . 0.0 110.466 179.675 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.527 ' HA3' ' HG2' ' A' ' 83' ' ' ARG . . . 98.99 9.48 51.95 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.41 -179.658 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -123.46 133.1 54.09 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.928 0.394 . . . . 0.0 110.852 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.5 ' HB3' ' HB ' ' A' ' 88' ' ' ILE . 79.0 mt -83.49 139.82 32.68 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.406 -178.775 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 178.33 172.58 42.88 Favored Glycine 0 N--CA 1.44 -1.095 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.437 179.005 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.537 ' HZ3' ' SG ' ' A' ' 40' ' ' CYS . 93.0 m95 -94.82 125.03 39.21 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 158.76 -63.94 0.3 Allowed Glycine 0 N--CA 1.45 -0.416 0 N-CA-C 111.588 -0.605 . . . . 0.0 111.588 -179.354 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.528 ' HB3' ' HA3' ' A' ' 42' ' ' GLY . 13.1 tpt -78.31 173.82 11.89 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.627 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -129.55 172.39 11.62 Favored 'General case' 0 C--N 1.322 -0.599 0 O-C-N 122.159 -0.338 . . . . 0.0 111.399 -179.275 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 6.9 m120 61.07 48.81 6.11 Favored 'General case' 0 C--O 1.233 0.187 0 O-C-N 123.982 0.801 . . . . 0.0 111.967 179.427 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.511 ' HB2' ' OD1' ' A' ' 43' ' ' ASN . 18.8 p90 -67.91 -28.51 67.56 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.628 -179.502 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.411 ' OG ' ' HB3' ' A' ' 17' ' ' ARG . 3.1 m -63.47 -28.38 69.93 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.873 0.368 . . . . 0.0 111.125 -179.312 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 26.4 m80 -79.99 -9.04 59.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.001 0.429 . . . . 0.0 111.013 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 47.5 p -125.58 15.31 8.18 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.064 0.459 . . . . 0.0 110.659 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 68.2 m -133.61 150.5 51.6 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.302 0.572 . . . . 0.0 111.052 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 57.2 mt-10 -125.68 142.3 51.58 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.412 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.433 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 21.4 t70 60.01 78.41 0.27 Allowed 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 121.402 0.62 . . . . 0.0 110.367 -179.708 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.541 HG23 HD21 ' A' ' 71' ' ' LEU . 73.2 mt -101.73 115.47 43.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.36 -178.775 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 36.6 ttmt -148.96 156.99 43.08 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 179.576 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.524 ' HG ' HD21 ' A' ' 12' ' ' LEU . 42.5 mt -83.2 135.93 34.6 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.161 0.505 . . . . 0.0 110.947 -179.448 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 18.7 tp10 -90.23 -57.29 2.9 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.934 -178.804 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.494 ' HB2' ' HB2' ' A' ' 69' ' ' ARG . 20.5 mm-40 -84.15 24.11 0.98 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.158 0.504 . . . . 0.0 111.1 -179.336 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 68.24 16.72 69.36 Favored Glycine 0 N--CA 1.45 -0.39 0 CA-C-N 115.429 -0.805 . . . . 0.0 112.435 179.656 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 141.24 -28.12 2.37 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.013 -1.089 . . . . 0.0 112.806 179.556 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.494 ' HB2' ' HB2' ' A' ' 66' ' ' GLU . 12.6 mmt180 -73.07 -25.34 60.87 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.057 0.456 . . . . 0.0 110.582 -179.407 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.436 ' HG3' ' HA ' ' A' ' 89' ' ' ASP . 36.6 ttpt -146.48 142.72 28.37 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.888 -178.185 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.677 ' HB2' HD11 ' A' ' 90' ' ' LEU . 8.9 tt -111.63 131.75 55.05 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.738 -0.468 . . . . 0.0 109.738 179.574 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.3 p -115.26 130.57 56.95 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.233 0.54 . . . . 0.0 111.066 179.604 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.433 ' HA ' ' O ' ' A' ' 61' ' ' ASP . 26.7 p -153.28 165.15 36.62 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.333 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.49 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 3.3 tmt_? -102.12 99.35 12.25 Favored Pre-proline 0 C--N 1.314 -0.958 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.418 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.67 ' O ' ' HB3' ' A' ' 83' ' ' ARG . 61.7 Cg_endo -70.09 123.14 9.71 Favored 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 122.801 2.334 . . . . 0.0 111.443 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.924 ' HE3' ' HA2' ' A' ' 81' ' ' GLY . 0.0 OUTLIER -119.67 144.21 47.31 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.76 -179.793 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.685 HG22 ' O ' ' A' ' 82' ' ' PHE . 14.6 t -76.92 140.78 40.63 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.547 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 8.9 p -73.8 -9.44 12.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.452 -0.794 . . . . 0.0 111.288 -179.042 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -64.2 -23.12 67.2 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.054 0.454 . . . . 0.0 110.872 179.342 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -166.26 -21.84 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.51 -0.852 . . . . 0.0 112.908 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.924 ' HA2' ' HE3' ' A' ' 76' ' ' LYS . . . 101.75 20.87 11.99 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.773 -0.727 . . . . 0.0 111.893 -179.544 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.685 ' O ' HG22 ' A' ' 77' ' ' THR . 22.2 p90 -111.15 147.7 34.35 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 119.031 -0.509 . . . . 0.0 109.766 -178.916 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.723 ' HB2' ' HA ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 169.26 -154.94 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.361 0 O-C-N 123.592 0.558 . . . . 0.0 111.315 179.716 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -117.62 -175.76 2.89 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.368 -178.261 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.544 ' HA ' ' HD2' ' A' ' 75' ' ' PRO . 31.6 ttt180 -110.59 155.68 22.01 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 177.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLN . . . . . 0.534 ' HG2' ' H ' ' A' ' 87' ' ' GLY . 50.7 tt0 -165.17 176.69 8.25 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 120.512 -0.475 . . . . 0.0 111.712 -178.178 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.534 ' H ' ' HG2' ' A' ' 86' ' ' GLN . . . -137.91 140.83 11.54 Favored Glycine 0 N--CA 1.449 -0.466 0 N-CA-C 111.42 -0.672 . . . . 0.0 111.42 178.637 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.5 ' HB ' ' HB3' ' A' ' 48' ' ' LEU . 11.4 tt -118.44 133.84 63.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.371 0.605 . . . . 0.0 110.707 -179.619 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.457 ' OD1' ' HB2' ' A' ' 91' ' ' ASN . 14.5 t70 -74.79 136.48 41.66 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.809 -179.614 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.677 HD11 ' HB2' ' A' ' 71' ' ' LEU . 64.2 mt -110.77 37.34 2.81 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 -178.28 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.549 ' HA ' ' HB3' ' A' ' 2' ' ' SER . 2.5 m120 -73.92 -1.87 21.49 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-O 121.194 0.521 . . . . 0.0 111.037 179.373 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 21.0 mtp180 -88.11 -10.88 48.65 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.174 179.07 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.442 ' CD1' HD22 ' A' ' 37' ' ' LEU . 22.7 mm -99.15 98.59 7.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -179.383 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -107.68 152.21 24.62 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.743 -178.017 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.51 ' OD1' ' HA ' ' A' ' 3' ' ' TYR . 19.4 p-10 -106.82 105.54 15.63 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.106 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.2 p -98.42 113.85 34.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-O 121.286 0.565 . . . . 0.0 110.177 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 59.44 30.22 19.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.814 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 92.97 -13.54 67.41 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 121.005 -0.617 . . . . 0.0 113.276 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.401 HH11 ' HD3' ' A' ' 99' ' ' ARG . 3.0 mpt_? -92.25 131.03 37.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 117.405 0.603 . . . . 0.0 110.257 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.485 HD13 ' SG ' ' A' ' 23' ' ' CYS . 3.2 tp -84.16 115.54 22.46 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.08 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 46.5 t -129.98 142.66 43.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.333 -179.594 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.565 ' HB2' HD11 ' A' ' 35' ' ' LEU . 5.5 t80 -84.2 122.81 29.37 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.236 0.541 . . . . 0.0 110.089 178.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 . . . . . 0 C--N 1.312 -1.034 0 CA-C-O 118.193 -0.908 . . . . 0.0 110.408 179.737 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' SER . . . . . 0.495 ' OG ' ' HA ' ' A' ' 91' ' ' ASN . 19.5 m . . . . . 0 N--CA 1.453 -0.28 0 CA-C-O 120.535 0.207 . . . . 0.0 111.128 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.536 ' HA ' ' OD1' ' A' ' 95' ' ' ASN . 28.6 p90 -55.51 -34.09 64.33 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.724 179.742 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -54.46 -18.74 4.59 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -178.811 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -57.34 -41.71 80.53 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.151 0.501 . . . . 0.0 110.426 179.018 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.426 ' HB2' HD21 ' A' ' 95' ' ' ASN . 50.0 m -130.48 35.66 4.02 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.093 179.52 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.4 ' HA ' ' HZ3' ' A' ' 30' ' ' TRP . 15.0 m -143.18 156.33 44.74 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.12 179.55 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.425 HH11 ' HD2' ' A' ' 8' ' ' ARG . 10.8 ptm85 -144.35 167.95 21.25 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.751 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 57.24 59.76 3.23 Favored 'General case' 0 C--O 1.235 0.337 0 O-C-N 123.736 0.648 . . . . 0.0 111.715 179.345 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.445 ' HA ' ' HB2' ' A' ' 21' ' ' ALA . . . -89.88 117.53 28.78 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.192 179.606 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 31.9 m -120.53 173.11 6.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.748 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.52 HD21 ' HG ' ' A' ' 64' ' ' LEU . 3.6 mm? -104.64 114.99 29.57 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.765 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.413 ' OG1' ' HB ' ' A' ' 18' ' ' THR . 21.0 p -108.53 164.65 12.16 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.479 179.786 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 62.16 43.67 8.45 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.412 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 87.73 -46.19 3.43 Favored Glycine 0 N--CA 1.449 -0.448 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.745 179.06 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 150.55 57.77 0.01 OUTLIER Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 110.404 -1.078 . . . . 0.0 110.404 -179.135 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.445 ' HB2' ' HB3' ' A' ' 38' ' ' ASP . 7.9 ptm180 -142.91 -30.37 0.53 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.947 0.403 . . . . 0.0 111.086 -179.024 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.453 ' CG2' ' HB3' ' A' ' 34' ' ' GLU . 3.0 m -103.92 137.95 41.18 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.189 -178.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.727 HD11 HD13 ' A' ' 90' ' ' LEU . 58.3 mt -98.17 115.86 29.19 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.171 178.585 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 45.3 ttp180 -112.67 123.0 49.31 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 178.854 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.445 ' HB2' ' HA ' ' A' ' 10' ' ' ALA . . . -151.77 167.2 28.98 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.928 0.394 . . . . 0.0 111.408 -179.307 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -90.08 105.98 18.18 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 178.058 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 80.2 m -99.3 127.18 45.28 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.636 -178.557 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 9.4 ttp180 -77.42 115.09 16.9 Favored 'General case' 0 N--CA 1.436 -1.144 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.887 179.325 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 36.7 p30 -76.54 165.72 24.4 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.22 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.07 -27.75 54.83 Favored 'General case' 0 N--CA 1.464 0.235 0 O-C-N 123.61 0.569 . . . . 0.0 111.993 -179.113 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -69.26 -19.39 63.93 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.296 0.57 . . . . 0.0 110.327 179.433 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 96.11 30.25 7.98 Favored Glycine 0 N--CA 1.449 -0.488 0 CA-C-N 115.536 -0.756 . . . . 0.0 112.244 179.661 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -124.91 150.43 46.54 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.514 0.157 . . . . 0.0 110.773 -179.095 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.4 ' HZ3' ' HA ' ' A' ' 7' ' ' SER . 94.1 m95 -84.88 123.1 30.09 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.755 0.312 . . . . 0.0 111.391 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.0 m -124.77 134.72 66.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 121.089 0.471 . . . . 0.0 110.593 178.29 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 16.2 m -79.5 116.33 19.65 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.816 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 72.4 m -126.73 159.53 33.45 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.372 179.723 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.623 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 46.3 mt-10 -139.1 145.9 40.06 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-O 120.867 0.365 . . . . 0.0 111.444 -178.778 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.622 HD11 ' HB2' ' A' ' 102' ' ' PHE . 1.5 tm? -138.81 132.29 30.36 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.054 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.477 ' N ' HD13 ' A' ' 35' ' ' LEU . 27.3 m-20 -90.98 110.59 21.85 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.025 0.441 . . . . 0.0 110.391 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.524 HD11 HD11 ' A' ' 19' ' ' LEU . 1.5 mt -86.1 -16.66 37.31 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.572 -179.826 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.453 ' HA ' ' HD1' ' A' ' 55' ' ' PHE . 4.4 p-10 -63.65 -20.39 65.65 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -178.021 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.417 HG23 ' SG ' ' A' ' 40' ' ' CYS . 12.3 t -83.23 0.62 44.65 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.121 0.486 . . . . 0.0 110.87 -179.83 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.417 ' SG ' HG23 ' A' ' 39' ' ' THR . 57.6 m -136.32 -26.44 1.13 Allowed 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -179.571 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.47 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 61.7 mt -94.49 137.21 23.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 110.204 -0.295 . . . . 0.0 110.204 179.405 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.593 ' HA3' ' HB3' ' A' ' 52' ' ' MET . . . -153.72 156.2 26.64 Favored Glycine 0 N--CA 1.443 -0.885 0 C-N-CA 120.685 -0.769 . . . . 0.0 111.617 179.401 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.461 ' HB3' HD23 ' A' ' 48' ' ' LEU . 2.9 p-10 -154.24 50.68 0.57 Allowed Pre-proline 0 C--N 1.326 -0.446 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.26 -18.93 39.12 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 121.712 1.608 . . . . 0.0 111.868 -179.633 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 6.9 m-20 -90.77 -5.74 55.28 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.316 179.614 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.57 ' HA3' ' HG2' ' A' ' 83' ' ' ARG . . . 95.95 8.57 57.92 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.407 -179.485 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -125.28 135.89 52.97 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.764 0.316 . . . . 0.0 110.314 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.469 ' HB3' ' HB ' ' A' ' 88' ' ' ILE . 72.7 mt -83.29 137.24 34.07 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.325 -178.601 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 179.11 171.74 42.61 Favored Glycine 0 N--CA 1.445 -0.717 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.832 179.388 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.459 ' CD2' ' HD3' ' A' ' 92' ' ' ARG . 83.4 m95 -95.35 125.46 39.99 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.624 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 161.24 -47.81 0.37 Allowed Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.309 -179.475 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.593 ' HB3' ' HA3' ' A' ' 42' ' ' GLY . 0.0 OUTLIER -90.41 -161.28 0.78 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.643 0.259 . . . . 0.0 110.836 -179.188 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 -146.82 168.98 20.07 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.685 -0.234 . . . . 0.0 110.444 -179.495 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 6.3 m120 56.77 45.74 21.2 Favored 'General case' 0 N--CA 1.465 0.32 0 O-C-N 123.796 0.685 . . . . 0.0 112.253 178.785 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.47 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 7.5 p90 -65.65 -28.64 69.25 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.902 -0.319 . . . . 0.0 110.793 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.56 ' HA ' HD11 ' A' ' 62' ' ' ILE . 13.8 m -58.13 -37.12 74.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.534 -179.62 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 17.8 m80 -73.18 -17.83 61.32 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.042 0.448 . . . . 0.0 111.446 179.68 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 47.9 m -112.89 14.9 19.86 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.497 -178.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 54.5 m -136.1 148.44 48.26 Favored 'General case' 0 C--N 1.32 -0.684 0 O-C-N 121.749 -0.595 . . . . 0.0 111.641 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 60.9 mm-40 -117.58 145.62 44.16 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.825 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 55.87 58.83 4.14 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 123.925 0.765 . . . . 0.0 111.687 178.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.56 HD11 ' HA ' ' A' ' 56' ' ' SER . 81.5 mt -75.95 113.6 15.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.512 179.767 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.411 ' HD2' HD23 ' A' ' 12' ' ' LEU . 15.2 tptm -147.74 154.84 41.05 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 -179.692 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.536 HD13 ' HA2' ' A' ' 68' ' ' GLY . 67.2 mt -82.41 138.9 34.3 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.314 0.578 . . . . 0.0 111.233 -179.161 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -89.17 -75.27 0.44 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 114.697 -1.138 . . . . 0.0 111.129 -178.492 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.604 ' HB2' ' HB2' ' A' ' 69' ' ' ARG . 19.7 mt-10 -77.87 45.53 0.52 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.754 -178.317 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 65.39 2.46 10.17 Favored Glycine 0 CA--C 1.518 0.255 0 CA-C-N 115.837 -0.619 . . . . 0.0 113.671 179.254 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.536 ' HA2' HD13 ' A' ' 64' ' ' LEU . . . 141.63 -13.81 2.69 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.081 -1.056 . . . . 0.0 112.985 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.604 ' HB2' ' HB2' ' A' ' 66' ' ' GLU . 14.3 mmt180 -78.27 -19.48 53.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.261 0.553 . . . . 0.0 109.825 179.746 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.461 ' HB3' ' HG3' ' A' ' 66' ' ' GLU . 40.7 tttt -144.46 143.54 30.93 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.596 -178.623 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.625 ' HB2' HD11 ' A' ' 90' ' ' LEU . 10.1 tt -110.5 132.81 53.86 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.753 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.9 p -121.0 132.42 54.89 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.03 0.443 . . . . 0.0 111.586 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.537 ' HB3' ' HA ' ' A' ' 62' ' ' ILE . 24.7 p -161.19 167.36 26.25 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.208 179.526 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.407 ' HA ' ' HD2' ' A' ' 75' ' ' PRO . 25.0 ttt180 -100.4 102.83 20.05 Favored Pre-proline 0 C--N 1.316 -0.85 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.343 179.012 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.645 ' O ' ' HB3' ' A' ' 83' ' ' ARG . 39.0 Cg_endo -67.06 121.01 8.13 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 122.539 2.159 . . . . 0.0 110.58 178.649 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.649 ' HA ' ' HB2' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -119.25 146.58 45.1 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.764 -179.354 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.707 ' HB ' ' HD2' ' A' ' 83' ' ' ARG . 5.6 t -79.67 144.94 33.27 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 179.527 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.2 p -72.03 -9.47 12.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.436 -177.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -58.63 -29.37 66.45 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.224 0.535 . . . . 0.0 110.231 179.206 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -169.81 -24.62 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.304 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.869 -179.674 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.617 ' HA2' ' HD3' ' A' ' 76' ' ' LYS . . . 111.98 26.05 4.54 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.848 -0.692 . . . . 0.0 111.718 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.564 ' O ' HG22 ' A' ' 77' ' ' THR . 20.3 p90 -110.3 141.09 43.78 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 -178.98 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.707 ' HD2' ' HB ' ' A' ' 77' ' ' THR . 0.0 OUTLIER 174.13 -149.48 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 O-C-N 123.654 0.596 . . . . 0.0 110.027 -179.791 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -121.55 176.15 5.84 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 122.271 0.228 . . . . 0.0 110.982 -178.397 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.416 ' HA ' ' HD2' ' A' ' 75' ' ' PRO . 42.0 ttt-85 -98.35 156.81 16.55 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 178.075 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLN . . . . . 0.413 ' HG2' ' N ' ' A' ' 87' ' ' GLY . 49.4 tt0 -166.55 173.09 10.11 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 120.927 0.394 . . . . 0.0 111.524 -178.713 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.413 ' N ' ' HG2' ' A' ' 86' ' ' GLN . . . -135.8 144.42 16.23 Favored Glycine 0 N--CA 1.45 -0.388 0 N-CA-C 111.626 -0.589 . . . . 0.0 111.626 178.895 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.469 ' HB ' ' HB3' ' A' ' 48' ' ' LEU . 12.2 tt -121.57 134.67 64.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.093 0.473 . . . . 0.0 110.793 -179.439 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -77.73 136.76 38.2 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.113 -179.416 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.727 HD13 HD11 ' A' ' 19' ' ' LEU . 68.6 mt -108.38 56.48 0.63 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.735 0.778 . . . . 0.0 111.219 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.495 ' HA ' ' OG ' ' A' ' 2' ' ' SER . 8.1 m120 -91.09 3.19 55.42 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.686 179.478 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.459 ' HD3' ' CD2' ' A' ' 50' ' ' TRP . 36.9 mtp180 -96.77 -6.69 35.63 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.846 179.274 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.425 HD11 ' HH2' ' A' ' 50' ' ' TRP . 16.4 mm -105.47 101.64 12.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -179.525 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 27.8 tp60 -113.95 145.09 42.01 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.022 -178.152 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.536 ' OD1' ' HA ' ' A' ' 3' ' ' TYR . 19.2 p-10 -95.44 115.7 27.79 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.157 178.817 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 57.8 t -106.24 110.78 32.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.04 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 10.3 m120 58.48 28.8 17.45 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.995 -179.533 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 100.2 -23.55 35.48 Favored Glycine 0 N--CA 1.445 -0.748 0 C-N-CA 120.522 -0.847 . . . . 0.0 113.157 179.475 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.413 ' N ' ' HD2' ' A' ' 99' ' ' ARG . 3.3 mpt_? -86.95 138.18 31.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 117.242 0.521 . . . . 0.0 110.195 -179.367 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.463 HD23 ' HB2' ' A' ' 35' ' ' LEU . 4.9 tp -86.21 123.57 31.63 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 14.6 t -128.21 143.78 39.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.93 -179.027 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.622 ' HB2' HD11 ' A' ' 35' ' ' LEU . 9.9 t80 -92.66 128.3 38.47 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.161 0.505 . . . . 0.0 109.788 178.161 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 . . . . . 0 C--O 1.25 1.091 0 CA-C-O 118.181 -0.914 . . . . 0.0 110.651 179.742 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' SER . . . . . 0.436 ' OG ' ' HA ' ' A' ' 91' ' ' ASN . 19.9 m . . . . . 0 N--CA 1.448 -0.533 0 N-CA-C 110.781 -0.081 . . . . 0.0 110.781 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.448 ' HB3' HD11 ' A' ' 100' ' ' LEU . 13.4 p90 -48.43 -37.53 17.38 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.476 ' HB3' ' HD2' ' A' ' 69' ' ' ARG . . . -53.18 -19.1 2.71 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -178.892 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -56.63 -42.62 79.16 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 121.335 0.588 . . . . 0.0 110.149 178.682 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.418 ' HB2' HD21 ' A' ' 95' ' ' ASN . 18.5 m -129.78 40.47 3.57 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.481 179.654 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.406 ' HA ' ' HZ3' ' A' ' 30' ' ' TRP . 18.5 t -146.67 150.44 35.43 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.186 -179.501 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 9.3 ptp180 -136.87 175.29 9.74 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.279 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 47.06 46.86 16.17 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 124.254 0.971 . . . . 0.0 112.107 -179.38 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.604 ' HA ' ' HB2' ' A' ' 21' ' ' ALA . . . -74.01 118.44 16.96 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.619 179.59 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 27.4 m -122.14 168.28 14.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.842 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.754 HD21 ' HG ' ' A' ' 64' ' ' LEU . 3.3 mm? -104.75 123.02 46.92 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.634 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.479 HG21 ' CZ ' ' A' ' 20' ' ' ARG . 20.6 p -123.19 168.71 12.07 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.811 0.338 . . . . 0.0 111.81 -178.865 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 59.94 42.75 15.7 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.003 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 92.17 -23.02 29.05 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.812 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.627 ' HA2' ' HB3' ' A' ' 12' ' ' LEU . . . 122.32 41.23 0.48 Allowed Glycine 0 N--CA 1.445 -0.736 0 N-CA-C 111.39 -0.684 . . . . 0.0 111.39 179.837 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.657 ' HB2' ' HB2' ' A' ' 38' ' ' ASP . 15.9 ptt180 -126.14 -26.27 3.42 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.109 0.481 . . . . 0.0 110.582 -179.338 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.493 HG22 ' HB3' ' A' ' 34' ' ' GLU . 2.8 m -101.11 130.32 47.14 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.48 -179.245 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.638 HD11 HD13 ' A' ' 90' ' ' LEU . 92.9 mt -91.23 112.22 24.04 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.01 179.529 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.479 ' CZ ' HG21 ' A' ' 13' ' ' THR . 43.9 ttm180 -109.07 119.39 39.42 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 179.375 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.604 ' HB2' ' HA ' ' A' ' 10' ' ' ALA . . . -154.79 167.38 30.41 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.818 0.342 . . . . 0.0 111.293 -179.434 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.611 ' HG3' ' HB3' ' A' ' 30' ' ' TRP . 0.4 OUTLIER -88.54 111.74 22.2 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 177.427 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 69.4 m -99.65 126.97 45.75 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 -179.709 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.469 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 34.3 ttt180 -76.1 114.07 14.35 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 116.3 -0.409 . . . . 0.0 109.936 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.429 HD21 ' HB3' ' A' ' 29' ' ' ASN . 35.1 p30 -77.95 170.23 16.95 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.372 -179.616 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.75 -29.18 62.29 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 -178.288 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -73.98 -13.09 60.82 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.468 0.651 . . . . 0.0 110.253 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 91.21 27.89 16.84 Favored Glycine 0 N--CA 1.448 -0.54 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.629 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.469 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 10.7 t-20 -111.53 158.54 19.06 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 110.14 -0.319 . . . . 0.0 110.14 -178.939 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.611 ' HB3' ' HG3' ' A' ' 22' ' ' GLU . 98.9 m95 -99.57 119.43 38.04 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.953 0.406 . . . . 0.0 110.765 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 11.1 m -122.25 137.53 55.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.252 -179.461 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 16.8 m -75.92 109.57 9.65 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.105 179.306 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 69.3 m -122.43 137.13 54.97 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.41 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.609 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 3.0 mp0 -122.55 146.73 47.15 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.514 -179.814 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.462 HD11 ' HB2' ' A' ' 102' ' ' PHE . 1.2 tm? -138.53 126.83 22.97 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 178.895 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.409 ' N ' HD13 ' A' ' 35' ' ' LEU . 4.4 m-20 -85.95 110.07 19.2 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.868 0.366 . . . . 0.0 110.475 179.547 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.445 HD13 HD22 ' A' ' 90' ' ' LEU . 2.1 mt -83.91 -12.57 55.24 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.034 178.958 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.689 ' OD2' ' HA ' ' A' ' 54' ' ' ASN . 9.6 t70 -60.94 -29.23 69.51 Favored 'General case' 0 C--O 1.221 -0.426 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.89 -178.607 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.6 t -83.48 1.02 43.79 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.827 0.346 . . . . 0.0 111.459 -178.817 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 37.3 m -128.97 -24.68 2.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.829 0.347 . . . . 0.0 111.775 -179.765 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 71.9 mt -102.8 137.05 32.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.549 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -143.84 146.92 17.96 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.68 -0.771 . . . . 0.0 111.835 179.177 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.764 HD22 ' HB3' ' A' ' 75' ' ' PRO . 30.5 p-10 -152.44 48.86 0.48 Allowed Pre-proline 0 CA--C 1.539 0.557 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -178.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -71.79 -22.12 24.11 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 121.661 1.574 . . . . 0.0 111.747 -179.357 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -83.97 -14.54 50.53 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.885 179.173 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.544 ' CA ' ' HG2' ' A' ' 83' ' ' ARG . . . 106.26 8.62 33.14 Favored Glycine 0 N--CA 1.443 -0.874 0 C-N-CA 120.315 -0.945 . . . . 0.0 112.596 -179.149 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -124.08 133.29 53.66 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.676 0.274 . . . . 0.0 110.282 179.476 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 95.3 mt -83.54 130.24 35.0 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.513 -178.412 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -173.5 172.65 45.36 Favored Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.097 179.029 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.408 ' HH2' HD11 ' A' ' 93' ' ' ILE . 88.3 m95 -95.03 125.1 39.47 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.758 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 168.64 -59.18 0.2 Allowed Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.493 -0.861 . . . . 0.0 112.602 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 6.1 ttp -96.75 -154.66 0.45 Allowed 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 25.5 pt20 -146.79 173.75 12.1 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.43 0.157 . . . . 0.0 111.013 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.689 ' HA ' ' OD2' ' A' ' 38' ' ' ASP . 16.2 m120 64.92 55.37 1.18 Allowed 'General case' 0 C--O 1.237 0.416 0 O-C-N 123.858 0.724 . . . . 0.0 111.52 179.523 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.495 ' HD1' ' HA ' ' A' ' 38' ' ' ASP . 11.8 p90 -87.46 -26.17 23.38 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.16 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.411 ' HB3' ' HB3' ' A' ' 17' ' ' ARG . 32.4 p -61.0 -35.89 78.04 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.998 0.428 . . . . 0.0 111.105 -178.745 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 26.7 m80 -77.49 -11.94 59.91 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.192 179.621 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.483 ' HB2' ' OD1' ' A' ' 43' ' ' ASN . 2.7 m -113.41 20.25 16.25 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.053 0.454 . . . . 0.0 110.353 -179.624 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 24.8 m -136.1 156.0 49.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.09 0.471 . . . . 0.0 111.46 -179.371 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -129.2 138.31 51.64 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.282 178.732 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.44 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 32.2 t70 58.22 79.31 0.21 Allowed 'General case' 0 N--CA 1.469 0.49 0 O-C-N 123.735 0.647 . . . . 0.0 110.721 -179.291 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.55 HG23 HD21 ' A' ' 71' ' ' LEU . 68.0 mt -98.74 112.74 31.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.548 -179.566 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.28 164.94 26.59 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.307 -179.057 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.754 ' HG ' HD21 ' A' ' 12' ' ' LEU . 55.9 mt -96.05 114.84 26.58 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 178.481 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -65.95 -54.34 27.58 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.12 -177.627 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 43.1 mm-40 -88.36 7.84 30.5 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.112 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 73.23 21.09 80.01 Favored Glycine 0 N--CA 1.447 -0.623 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.678 -179.442 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 156.53 -49.84 0.45 Allowed Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 120.131 -1.033 . . . . 0.0 112.946 179.706 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.476 ' HD2' ' HB3' ' A' ' 4' ' ' ALA . 5.1 mpt_? -66.31 -26.66 67.41 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -179.365 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 32.0 ttpt -141.91 144.62 33.88 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.651 -0.419 . . . . 0.0 111.677 -178.471 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.628 ' HB2' HD11 ' A' ' 90' ' ' LEU . 8.7 tt -115.45 124.08 50.24 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.305 -0.861 . . . . 0.0 108.983 179.286 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.447 HG22 ' HA3' ' A' ' 87' ' ' GLY . 1.1 p -115.8 133.4 56.07 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.375 0.607 . . . . 0.0 111.114 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.546 ' HB3' ' HA ' ' A' ' 62' ' ' ILE . 26.3 p -156.2 172.32 18.66 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.336 -0.847 . . . . 0.0 108.868 -179.773 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.513 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 4.4 tmt_? -104.23 98.57 14.37 Favored Pre-proline 0 C--N 1.316 -0.861 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 179.283 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.764 ' HB3' HD22 ' A' ' 43' ' ' ASN . 54.9 Cg_endo -69.35 123.82 10.62 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 122.902 2.401 . . . . 0.0 110.653 179.026 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.963 ' HE3' ' HA2' ' A' ' 81' ' ' GLY . 0.0 OUTLIER -120.91 149.41 42.67 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.619 -179.077 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.709 HG22 ' O ' ' A' ' 82' ' ' PHE . 13.2 t -79.59 134.5 36.47 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 177.947 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 31.3 m -72.44 -7.85 10.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 O-C-N 123.706 0.629 . . . . 0.0 111.402 -179.22 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -66.98 -33.63 75.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.533 179.43 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -150.0 -20.34 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.364 -0.922 . . . . 0.0 113.162 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.963 ' HA2' ' HE3' ' A' ' 76' ' ' LYS . . . 98.01 18.04 28.21 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.579 -0.82 . . . . 0.0 111.685 -179.712 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.709 ' O ' HG22 ' A' ' 77' ' ' THR . 32.0 p90 -111.55 153.18 26.62 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 118.872 -0.585 . . . . 0.0 109.891 -178.785 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.716 ' HB2' ' HA ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 167.84 -150.4 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.405 0 O-C-N 123.679 0.612 . . . . 0.0 111.442 179.502 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -127.58 154.92 44.62 Favored 'General case' 0 C--O 1.226 -0.142 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.7 -178.471 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.513 ' HA ' ' HA ' ' A' ' 74' ' ' ARG . 35.8 ttt180 -84.32 146.83 27.52 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 178.335 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -151.49 -170.17 3.58 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.619 0.723 . . . . 0.0 112.091 -177.702 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.447 ' HA3' HG22 ' A' ' 72' ' ' THR . . . -155.05 142.99 9.43 Favored Glycine 0 N--CA 1.442 -0.904 0 N-CA-C 110.23 -1.148 . . . . 0.0 110.23 178.645 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 13.0 tt -122.75 134.83 64.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.257 0.551 . . . . 0.0 110.734 -178.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -74.37 130.9 40.53 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.625 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.638 HD13 HD11 ' A' ' 19' ' ' LEU . 61.4 mt -102.04 46.55 0.93 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.676 0.751 . . . . 0.0 110.848 -179.746 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.436 ' HA ' ' OG ' ' A' ' 2' ' ' SER . 5.8 m120 -81.3 4.63 19.91 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.317 179.665 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 19.1 mtp180 -100.54 -6.64 25.1 Favored 'General case' 0 C--O 1.226 -0.179 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.7 178.789 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.408 HD11 ' HH2' ' A' ' 50' ' ' TRP . 23.5 mm -106.15 108.03 24.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 -178.891 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 20.9 tp60 -125.98 145.93 50.08 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.783 -178.584 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.418 HD21 ' HB2' ' A' ' 6' ' ' SER . 13.9 p-10 -95.08 115.31 27.27 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.331 0.586 . . . . 0.0 110.023 178.475 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 52.0 t -101.78 112.82 36.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.128 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 13.6 m-80 57.84 33.5 23.28 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.091 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 94.55 -23.87 30.33 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.837 179.599 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.24 124.89 33.81 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.945 0.372 . . . . 0.0 110.031 -179.486 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.46 HD23 ' HB2' ' A' ' 35' ' ' LEU . 11.8 tp -76.31 119.38 20.12 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 38.8 t -129.9 141.73 45.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.002 0.43 . . . . 0.0 111.154 -178.669 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.462 ' HB2' HD11 ' A' ' 35' ' ' LEU . 6.5 t80 -83.79 132.34 34.83 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 177.885 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 3.7 tp-100 . . . . . 0 C--N 1.314 -0.953 0 CA-C-O 118.745 -0.645 . . . . 0.0 110.231 179.946 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' SER . . . . . 0.602 ' OG ' ' HA ' ' A' ' 91' ' ' ASN . 8.7 m . . . . . 0 N--CA 1.452 -0.364 0 CA-C-O 120.687 0.279 . . . . 0.0 111.287 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.434 ' CZ ' HD13 ' A' ' 19' ' ' LEU . 14.9 p90 -63.28 -34.46 77.73 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.667 0.27 . . . . 0.0 110.69 178.705 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -56.32 -24.26 42.42 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.806 -0.633 . . . . 0.0 112.597 -178.582 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -65.78 -16.51 63.86 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 121.205 0.526 . . . . 0.0 110.835 179.679 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 62.0 m -140.19 29.63 2.02 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.585 178.722 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 19.3 m -146.06 156.51 43.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.496 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 11.7 ptp180 -143.09 166.24 25.19 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.657 179.618 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 67.4 m-80 58.9 54.42 5.11 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.117 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.479 ' HA ' ' O ' ' A' ' 20' ' ' ARG . . . -88.65 118.47 28.34 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.311 179.555 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.407 HG22 ' HD2' ' A' ' 20' ' ' ARG . 27.3 m -118.93 171.58 6.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.193 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.581 HD21 ' HG ' ' A' ' 64' ' ' LEU . 3.3 mm? -104.99 115.0 29.54 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.147 -179.496 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.5 ' OG1' ' HB ' ' A' ' 18' ' ' THR . 21.9 p -110.06 167.73 9.96 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.931 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 57.97 53.27 6.97 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.948 -179.677 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 81.68 -35.36 2.48 Favored Glycine 0 CA--C 1.519 0.322 0 CA-C-N 116.035 -0.529 . . . . 0.0 112.686 179.646 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.564 ' HA2' ' HB3' ' A' ' 12' ' ' LEU . . . 136.75 49.22 0.07 OUTLIER Glycine 0 N--CA 1.447 -0.598 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 -179.504 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.555 ' HB3' ' HB2' ' A' ' 56' ' ' SER . 15.7 ptt180 -133.91 -27.65 1.44 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.885 0.374 . . . . 0.0 111.317 -179.415 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.5 ' HB ' ' OG1' ' A' ' 13' ' ' THR . 3.9 m -99.04 135.73 40.03 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.794 -178.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.762 HD11 HD13 ' A' ' 90' ' ' LEU . 61.6 mt -94.3 114.65 26.76 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.628 179.337 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.479 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 1.6 tmt_? -110.47 120.51 42.66 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 178.589 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -153.2 167.23 30.01 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.835 0.35 . . . . 0.0 111.63 -179.562 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.494 ' HB3' ' HB3' ' A' ' 30' ' ' TRP . 45.4 mt-10 -90.73 105.63 17.95 Favored 'General case' 0 CA--C 1.512 -0.49 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 177.603 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.456 ' SG ' HD13 ' A' ' 100' ' ' LEU . 83.7 m -92.61 122.8 35.39 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 120.88 0.372 . . . . 0.0 110.963 -178.474 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.514 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 37.3 ttp180 -71.12 110.95 6.1 Favored 'General case' 0 N--CA 1.435 -1.208 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.64 178.609 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.418 HD21 ' HB3' ' A' ' 29' ' ' ASN . 37.4 p30 -76.84 167.19 22.26 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.12 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.42 -31.45 45.21 Favored 'General case' 0 C--N 1.329 -0.324 0 O-C-N 123.672 0.607 . . . . 0.0 112.289 -178.691 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -70.9 -17.64 62.7 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.306 0.574 . . . . 0.0 110.773 -179.392 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 95.08 28.39 9.98 Favored Glycine 0 CA--C 1.51 -0.243 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.551 -179.555 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.514 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 13.9 t-20 -113.08 164.03 13.99 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 -178.738 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.494 ' HB3' ' HB3' ' A' ' 22' ' ' GLU . 96.6 m95 -105.21 116.82 32.59 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.77 0.319 . . . . 0.0 110.8 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.5 m -118.56 138.03 50.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.737 179.421 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 13.3 m -80.33 114.79 19.49 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.154 -179.609 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.493 ' HB3' ' HB2' ' A' ' 100' ' ' LEU . 75.5 m -126.13 147.6 49.58 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.244 179.268 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.663 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 50.9 mt-10 -131.7 141.39 49.55 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.887 -179.497 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.523 ' HB2' HD23 ' A' ' 100' ' ' LEU . 1.3 tm? -137.53 127.41 25.62 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.288 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.404 ' N ' HD13 ' A' ' 35' ' ' LEU . 18.6 m-20 -81.54 109.72 16.25 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.284 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.601 HD22 HG13 ' A' ' 93' ' ' ILE . 4.1 mt -82.01 -23.07 36.16 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 121.086 -0.246 . . . . 0.0 111.59 -178.907 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.523 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 6.5 p-10 -66.44 -6.16 13.61 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.796 0.332 . . . . 0.0 111.475 -178.421 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 55.7 p -76.55 -21.77 55.23 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.249 0.547 . . . . 0.0 109.727 178.361 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.456 ' SG ' ' HE3' ' A' ' 50' ' ' TRP . 29.0 t -128.79 -14.61 4.51 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.656 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.463 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 54.0 mt -99.42 133.98 40.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 O-C-N 122.149 -0.344 . . . . 0.0 110.136 178.802 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.526 ' HA3' ' HB3' ' A' ' 52' ' ' MET . . . -152.28 165.33 30.81 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 121.011 -0.614 . . . . 0.0 111.857 179.602 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.559 ' OD1' ' HB2' ' A' ' 55' ' ' PHE . 2.1 p-10 -163.86 54.35 0.4 Allowed Pre-proline 0 CA--C 1.537 0.442 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -179.503 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.41 ' HG3' ' HG2' ' A' ' 52' ' ' MET . 58.4 Cg_endo -73.13 -22.74 18.92 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 121.753 1.635 . . . . 0.0 111.241 179.506 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -85.07 -17.11 38.41 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.311 179.02 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.612 ' CA ' ' HG2' ' A' ' 83' ' ' ARG . . . 105.66 13.65 23.52 Favored Glycine 0 N--CA 1.441 -0.977 0 CA-C-N 115.459 -0.791 . . . . 0.0 113.152 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.409 ' HA ' HE22 ' A' ' 86' ' ' GLN . 59.0 m-85 -125.3 134.2 52.35 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.831 0.348 . . . . 0.0 110.431 179.095 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 88.7 mt -82.79 129.85 35.05 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.107 -178.695 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -176.85 175.87 47.79 Favored Glycine 0 N--CA 1.442 -0.958 0 C-N-CA 120.663 -0.78 . . . . 0.0 111.873 179.241 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.456 ' HE3' ' SG ' ' A' ' 40' ' ' CYS . 88.1 m95 -96.22 125.45 40.75 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 159.88 -62.16 0.3 Allowed Glycine 0 N--CA 1.45 -0.373 0 N-CA-C 111.443 -0.663 . . . . 0.0 111.443 -179.726 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.526 ' HB3' ' HA3' ' A' ' 42' ' ' GLY . 42.4 tpp -80.67 173.82 12.22 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 179.755 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -129.44 166.85 18.78 Favored 'General case' 0 C--N 1.323 -0.558 0 O-C-N 122.147 -0.346 . . . . 0.0 111.629 -179.199 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 67.53 47.36 1.23 Allowed 'General case' 0 N--CA 1.463 0.212 0 O-C-N 124.175 0.922 . . . . 0.0 112.276 179.605 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.559 ' HB2' ' OD1' ' A' ' 43' ' ' ASN . 3.9 p90 -70.44 -26.19 63.54 Favored 'General case' 0 C--O 1.222 -0.343 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.589 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.555 ' HB2' ' HB3' ' A' ' 17' ' ' ARG . 32.9 t -60.34 -38.3 83.37 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.93 0.395 . . . . 0.0 110.834 -179.116 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 26.2 m80 -80.86 -2.81 48.92 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.57 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 49.8 m -124.91 16.28 8.59 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.648 0.261 . . . . 0.0 111.572 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 69.7 m -131.67 149.42 52.49 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.459 0.647 . . . . 0.0 111.981 -179.592 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.467 ' HG3' ' HG2' ' A' ' 76' ' ' LYS . 39.8 mt-10 -120.3 139.68 52.38 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.913 -1.04 . . . . 0.0 109.295 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.505 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 28.4 t70 61.34 72.07 0.53 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.482 0.658 . . . . 0.0 110.546 179.343 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.536 HG23 HD21 ' A' ' 71' ' ' LEU . 65.6 mt -96.3 113.48 30.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.242 -179.694 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.456 ' HE3' ' HB2' ' A' ' 63' ' ' LYS . 17.3 ttmt -150.33 149.99 30.86 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.859 0.361 . . . . 0.0 110.834 -179.776 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.604 HD13 ' HA2' ' A' ' 68' ' ' GLY . 33.7 mt -88.67 136.83 32.8 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.849 -179.411 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -91.23 -67.08 0.87 Allowed 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.09 0.471 . . . . 0.0 110.988 179.436 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.547 ' HB2' ' HB3' ' A' ' 69' ' ' ARG . 21.9 mm-40 -74.88 42.29 0.17 Allowed 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 115.395 -0.82 . . . . 0.0 112.07 -178.618 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 60.9 13.92 35.56 Favored Glycine 0 C--N 1.314 -0.662 0 CA-C-N 115.249 -0.887 . . . . 0.0 113.426 179.091 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.604 ' HA2' HD13 ' A' ' 64' ' ' LEU . . . 130.92 -13.82 5.51 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.103 -1.046 . . . . 0.0 113.197 179.587 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.547 ' HB3' ' HB2' ' A' ' 66' ' ' GLU . 2.3 ttp85 -78.17 -20.04 52.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.343 0.592 . . . . 0.0 109.869 179.735 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -140.26 140.88 35.85 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.432 -179.722 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.61 ' HB2' HD11 ' A' ' 90' ' ' LEU . 10.3 tt -118.54 132.1 56.22 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.989 -0.551 . . . . 0.0 109.927 -179.414 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -118.19 129.91 55.78 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.634 178.924 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.505 ' HA ' ' O ' ' A' ' 61' ' ' ASP . 28.8 p -157.84 163.55 37.87 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.475 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.592 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 33.4 ttt180 -99.76 104.16 26.36 Favored Pre-proline 0 C--N 1.316 -0.886 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.32 179.488 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.589 ' O ' ' HB3' ' A' ' 83' ' ' ARG . 43.5 Cg_endo -67.82 115.66 3.88 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 122.449 2.1 . . . . 0.0 109.802 178.202 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.736 ' HE3' ' HA2' ' A' ' 81' ' ' GLY . 0.0 OUTLIER -119.3 140.33 50.47 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.65 -179.661 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.667 HG22 ' O ' ' A' ' 82' ' ' PHE . 15.3 t -75.85 130.14 38.09 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 17.3 m -72.59 -6.24 7.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.309 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -67.45 -34.01 76.31 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.845 179.493 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.584 ' HA3' ' CE2' ' A' ' 82' ' ' PHE . . . -143.26 -20.58 0.21 Allowed Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.902 179.769 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.736 ' HA2' ' HE3' ' A' ' 76' ' ' LYS . . . 95.23 12.54 54.51 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.363 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.667 ' O ' HG22 ' A' ' 77' ' ' THR . 21.3 p90 -111.96 157.68 20.4 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 118.83 -0.605 . . . . 0.0 110.64 -178.49 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.701 ' HB2' ' HA ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 165.54 -152.49 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.633 0 O-C-N 124.107 0.879 . . . . 0.0 111.862 178.238 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -132.6 151.3 51.98 Favored 'General case' 0 C--O 1.225 -0.192 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.189 -178.258 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.592 ' HA ' ' HA ' ' A' ' 74' ' ' ARG . 45.3 ttt-85 -85.95 151.48 23.71 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.547 0.213 . . . . 0.0 110.62 -179.39 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' GLN . . . . . 0.42 ' HG3' ' O ' ' A' ' 85' ' ' ARG . 35.6 mt-30 -154.05 -172.9 4.37 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.296 -178.76 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -141.54 144.47 14.46 Favored Glycine 0 N--CA 1.451 -0.34 0 N-CA-C 111.091 -0.804 . . . . 0.0 111.091 179.127 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 9.2 tt -131.77 137.53 54.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 120.935 0.398 . . . . 0.0 110.896 -179.144 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -82.03 136.88 35.18 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.269 179.546 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.762 HD13 HD11 ' A' ' 19' ' ' LEU . 50.8 mt -101.05 45.03 0.98 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.598 0.713 . . . . 0.0 110.587 -179.311 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.602 ' HA ' ' OG ' ' A' ' 2' ' ' SER . 4.4 m-20 -74.87 -0.94 20.16 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.931 -179.354 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 11.0 mtp180 -94.98 -11.98 27.53 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.809 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.601 HG13 HD22 ' A' ' 37' ' ' LEU . 23.5 mm -101.64 112.57 35.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 -179.268 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -129.1 162.21 28.24 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.589 0.709 . . . . 0.0 112.093 -178.875 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.489 ' HA ' ' O ' ' A' ' 99' ' ' ARG . 19.8 p-10 -106.94 124.55 49.78 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.728 -1.123 . . . . 0.0 110.308 179.144 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 46.1 t -106.69 104.02 16.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.784 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 33.9 m-80 59.78 19.39 8.21 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.71 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 119.44 -25.95 7.52 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.607 -0.806 . . . . 0.0 113.52 178.294 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.489 ' O ' ' HA ' ' A' ' 95' ' ' ASN . 1.9 ptm180 -86.76 144.7 26.95 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 117.092 0.446 . . . . 0.0 110.393 -179.267 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.523 HD23 ' HB2' ' A' ' 35' ' ' LEU . 6.9 tp -93.43 119.71 32.84 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 23.9 t -129.34 139.31 52.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.736 -178.786 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.453 ' HB2' HD11 ' A' ' 35' ' ' LEU . 13.7 t80 -82.98 130.68 35.17 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.873 -0.418 . . . . 0.0 109.873 178.508 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 46.5 tp60 . . . . . 0 C--N 1.316 -0.887 0 CA-C-O 118.37 -0.824 . . . . 0.0 110.117 179.63 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' SER . . . . . 0.475 ' HB2' ' HD2' ' A' ' 69' ' ' ARG . 13.2 m . . . . . 0 N--CA 1.449 -0.486 0 CA-C-O 120.746 0.307 . . . . 0.0 111.13 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.455 ' CG ' HD11 ' A' ' 100' ' ' LEU . 18.9 p90 -57.6 -38.13 74.4 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.104 -0.498 . . . . 0.0 112.095 179.782 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.571 ' HB3' ' CG ' ' A' ' 69' ' ' ARG . . . -53.85 -18.72 3.55 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 -177.699 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -63.98 -30.41 71.49 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.381 0.61 . . . . 0.0 109.764 179.076 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 18.8 m -131.84 28.97 4.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.924 179.255 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.412 ' HA ' ' HZ3' ' A' ' 30' ' ' TRP . 13.6 m -143.33 155.98 44.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.921 -179.81 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.42 HH11 ' HD2' ' A' ' 8' ' ' ARG . 12.7 ptm180 -145.84 169.9 17.64 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 110.436 -0.209 . . . . 0.0 110.436 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 63.02 53.42 2.34 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 123.715 0.634 . . . . 0.0 110.803 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.478 ' HA ' ' HB2' ' A' ' 21' ' ' ALA . . . -92.06 119.86 32.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.201 -179.614 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 34.4 m -123.13 170.42 13.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.209 179.687 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.632 HD21 ' HG ' ' A' ' 64' ' ' LEU . 3.3 mm? -105.51 115.33 30.07 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.1 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.447 ' OG1' ' HB ' ' A' ' 18' ' ' THR . 21.8 p -112.26 171.23 7.64 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.35 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.45 ' HB3' ' HE ' ' A' ' 17' ' ' ARG . 87.1 m-20 58.9 45.88 14.57 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.486 179.509 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 88.56 -30.77 5.15 Favored Glycine 0 N--CA 1.451 -0.358 0 CA-C-N 115.892 -0.595 . . . . 0.0 112.366 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.554 ' HA2' ' HB3' ' A' ' 12' ' ' LEU . . . 131.31 53.72 0.09 OUTLIER Glycine 0 N--CA 1.445 -0.731 0 N-CA-C 111.059 -0.817 . . . . 0.0 111.059 -179.477 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.638 ' HB2' ' HB3' ' A' ' 38' ' ' ASP . 14.6 ptt180 -141.46 -29.28 0.64 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.864 0.364 . . . . 0.0 111.579 -179.712 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.485 ' CG2' ' HB3' ' A' ' 34' ' ' GLU . 3.7 m -95.92 132.62 41.02 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.417 -179.631 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.734 HD11 HD13 ' A' ' 90' ' ' LEU . 87.5 mt -93.76 114.33 26.59 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.08 179.533 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 56.0 ttp180 -112.1 119.78 39.58 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 178.82 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.478 ' HB2' ' HA ' ' A' ' 10' ' ' ALA . . . -154.15 167.47 29.76 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.209 -179.317 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.629 ' HB3' ' HB3' ' A' ' 30' ' ' TRP . 40.8 mt-10 -89.89 108.94 20.01 Favored 'General case' 0 CA--C 1.513 -0.466 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 177.781 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.557 ' SG ' HD13 ' A' ' 100' ' ' LEU . 18.7 m -96.23 128.36 43.08 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.252 -178.641 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.511 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 25.0 ttp180 -72.87 116.73 13.72 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 179.411 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.429 HD21 ' HB3' ' A' ' 29' ' ' ASN . 36.3 p30 -84.16 171.58 12.7 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.052 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.44 -28.88 47.19 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 112.654 0.612 . . . . 0.0 112.654 -178.923 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -75.56 -10.59 59.58 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.394 0.616 . . . . 0.0 110.368 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 86.03 28.15 29.27 Favored Glycine 0 N--CA 1.447 -0.629 0 N-CA-C 110.916 -0.874 . . . . 0.0 110.916 -179.264 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.511 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 3.3 t-20 -110.31 160.35 16.63 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.572 0.225 . . . . 0.0 110.92 -178.479 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.629 ' HB3' ' HB3' ' A' ' 22' ' ' GLU . 84.1 m95 -99.98 112.9 25.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.074 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.1 m -115.79 131.88 66.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.365 178.863 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 21.6 m -77.46 109.02 11.04 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.943 0.401 . . . . 0.0 110.747 -179.323 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 70.3 m -118.29 151.69 37.21 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.726 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.611 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 45.1 mt-10 -128.89 144.5 51.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.817 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.628 HD11 ' HB2' ' A' ' 102' ' ' PHE . 1.4 tm? -138.86 128.84 25.19 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 178.472 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.423 ' N ' HD13 ' A' ' 35' ' ' LEU . 10.9 m-20 -90.31 109.85 20.94 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.479 -179.161 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.483 HD23 HD12 ' A' ' 35' ' ' LEU . 0.8 OUTLIER -87.21 -14.34 41.38 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -179.652 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.638 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 0.9 OUTLIER -64.64 -17.18 63.8 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -177.698 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.426 HG23 ' SG ' ' A' ' 40' ' ' CYS . 9.3 t -85.02 -2.63 58.19 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.894 0.378 . . . . 0.0 110.486 179.622 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.426 ' SG ' HG23 ' A' ' 39' ' ' THR . 35.8 m -132.28 -14.12 3.01 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.698 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 57.2 mt -116.41 134.89 58.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 CA-C-O 120.745 0.307 . . . . 0.0 110.402 179.636 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.572 ' HA3' ' HB3' ' A' ' 52' ' ' MET . . . -153.16 164.64 30.99 Favored Glycine 0 N--CA 1.446 -0.635 0 N-CA-C 111.026 -0.83 . . . . 0.0 111.026 179.261 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.467 ' OD1' ' HB2' ' A' ' 55' ' ' PHE . 2.3 p-10 -157.14 52.44 0.6 Allowed Pre-proline 0 CA--C 1.537 0.468 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -179.586 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -69.4 -19.77 37.42 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 121.708 1.605 . . . . 0.0 111.899 -179.614 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -89.78 -2.84 58.33 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.463 179.635 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.552 ' HA3' ' HG2' ' A' ' 83' ' ' ARG . . . 95.32 4.86 60.82 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.477 -0.868 . . . . 0.0 112.699 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 52.6 m-85 -126.19 137.44 53.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.69 0.245 . . . . 0.0 110.648 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.465 HD23 HG22 ' A' ' 88' ' ' ILE . 5.5 mp -82.67 149.47 27.34 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.403 -179.313 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 171.4 171.98 37.07 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.396 178.922 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.48 ' CD1' HD11 ' A' ' 88' ' ' ILE . 91.8 m95 -95.62 133.8 39.26 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 138.65 -39.77 1.53 Allowed Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.879 -0.677 . . . . 0.0 111.636 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.572 ' HB3' ' HA3' ' A' ' 42' ' ' GLY . 4.4 tpt -94.03 -172.01 2.72 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -146.13 169.96 17.67 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.178 -0.609 . . . . 0.0 111.955 -179.282 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 14.9 m120 62.41 42.71 8.7 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.062 -0.972 . . . . 0.0 112.39 179.311 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.467 ' HB2' ' OD1' ' A' ' 43' ' ' ASN . 20.9 p90 -63.34 -32.65 74.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.06 0.457 . . . . 0.0 110.302 179.337 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.603 ' OG ' ' HB3' ' A' ' 17' ' ' ARG . 8.8 m -64.05 -35.52 81.01 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.464 -179.399 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 27.3 m80 -79.15 -5.03 53.22 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.84 0.353 . . . . 0.0 111.173 -179.491 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 6.2 p -128.0 20.49 6.42 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.544 -179.634 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 66.9 m -135.8 152.41 51.06 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 121.26 0.552 . . . . 0.0 112.239 -179.504 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 -114.05 149.4 35.51 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.052 179.126 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 15.7 t70 47.25 72.51 0.24 Allowed 'General case' 0 N--CA 1.469 0.513 0 O-C-N 124.15 0.906 . . . . 0.0 111.526 179.549 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.536 HG23 HD21 ' A' ' 71' ' ' LEU . 73.1 mt -90.56 117.68 34.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.19 -179.595 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -149.12 164.62 34.17 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.074 179.452 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.632 ' HG ' HD21 ' A' ' 12' ' ' LEU . 62.7 mt -91.07 136.42 33.09 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.085 0.469 . . . . 0.0 110.954 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -92.76 -66.1 0.95 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.841 -178.38 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -81.65 46.1 0.94 Allowed 'General case' 0 CA--C 1.514 -0.424 0 CA-C-O 120.985 0.421 . . . . 0.0 111.709 -178.58 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 57.77 22.46 47.3 Favored Glycine 0 C--N 1.317 -0.525 0 CA-C-N 115.174 -0.921 . . . . 0.0 113.189 179.474 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.606 ' HA2' HD13 ' A' ' 64' ' ' LEU . . . 121.53 -12.59 9.5 Favored Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 120.225 -0.988 . . . . 0.0 113.575 179.616 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.571 ' CG ' ' HB3' ' A' ' 4' ' ' ALA . 17.9 mtm105 -92.68 1.9 57.02 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 117.806 0.803 . . . . 0.0 110.899 -179.498 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 17.8 tttp -157.65 133.22 9.09 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 -179.595 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.591 ' HB2' HD11 ' A' ' 90' ' ' LEU . 10.5 tt -109.35 129.14 55.54 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -179.803 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.551 HG22 ' HA3' ' A' ' 87' ' ' GLY . 2.4 p -121.07 131.22 54.14 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.355 0.597 . . . . 0.0 111.575 -179.476 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.526 ' HB3' ' HA ' ' A' ' 62' ' ' ILE . 25.0 p -158.03 174.26 15.5 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.786 -179.494 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.567 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 57.1 ttt180 -106.72 100.11 29.2 Favored Pre-proline 0 C--N 1.319 -0.735 0 C-N-CA 121.084 -0.246 . . . . 0.0 110.449 178.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.693 ' O ' ' HB3' ' A' ' 83' ' ' ARG . 19.6 Cg_endo -65.39 126.12 15.68 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.493 2.129 . . . . 0.0 110.471 178.881 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.679 ' HA ' ' HB2' ' A' ' 83' ' ' ARG . 0.1 OUTLIER -120.26 145.01 47.47 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.987 0.423 . . . . 0.0 111.561 -179.806 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.644 HG22 ' O ' ' A' ' 82' ' ' PHE . 15.1 t -74.31 142.25 45.2 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.095 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.6 p -72.74 -12.05 15.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.525 -178.76 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -64.24 -28.52 69.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.558 179.643 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -161.24 -16.5 0.03 OUTLIER Glycine 0 CA--C 1.518 0.246 0 C-N-CA 120.065 -1.064 . . . . 0.0 113.496 -179.338 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.63 ' HA2' ' HD3' ' A' ' 76' ' ' LYS . . . 97.43 20.7 21.8 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.761 -0.733 . . . . 0.0 111.787 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.644 ' O ' HG22 ' A' ' 77' ' ' THR . 26.7 p90 -112.17 150.68 30.47 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 119.373 -0.346 . . . . 0.0 110.186 -179.202 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.693 ' HB3' ' O ' ' A' ' 75' ' ' PRO . 0.0 OUTLIER 167.13 -152.86 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.302 0 O-C-N 123.953 0.783 . . . . 0.0 109.482 179.247 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 48.8 mm-40 -117.05 175.78 5.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.453 0.168 . . . . 0.0 111.427 -177.89 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.567 ' HA ' ' HA ' ' A' ' 74' ' ' ARG . 23.6 ttt180 -111.89 149.73 31.43 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 178.966 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -168.35 -161.9 0.38 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.642 -178.637 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.551 ' HA3' HG22 ' A' ' 72' ' ' THR . . . -153.25 161.74 29.84 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.785 179.742 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.48 HD11 ' CD1' ' A' ' 50' ' ' TRP . 13.9 tt -130.82 139.92 49.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 179.645 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -82.21 138.24 34.71 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.047 0.451 . . . . 0.0 110.812 -179.57 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.734 HD13 HD11 ' A' ' 19' ' ' LEU . 56.5 mt -104.94 50.32 0.79 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.618 0.723 . . . . 0.0 111.26 -178.655 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.42 ' HA ' ' OG ' ' A' ' 2' ' ' SER . 11.4 m120 -82.96 3.34 30.41 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.324 179.027 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 40.3 mtp180 -98.85 -2.71 37.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.58 179.034 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.401 HG13 HD22 ' A' ' 37' ' ' LEU . 21.7 mm -110.4 96.26 4.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 24.9 tp60 -112.04 148.33 34.09 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.489 -178.706 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.439 ' OD1' ' HA ' ' A' ' 3' ' ' TYR . 17.7 p-10 -94.36 119.72 33.52 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.862 179.015 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.9 p -114.59 119.37 61.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.689 179.392 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 59.18 27.22 16.16 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.802 -179.486 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 92.43 -8.48 77.16 Favored Glycine 0 N--CA 1.447 -0.628 0 CA-C-N 115.971 -0.559 . . . . 0.0 113.155 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.21 135.08 43.27 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 117.409 0.604 . . . . 0.0 110.932 -179.154 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.557 HD13 ' SG ' ' A' ' 23' ' ' CYS . 3.9 tp -80.74 118.77 22.57 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.689 179.495 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 47.0 t -132.57 138.07 52.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 120.926 0.393 . . . . 0.0 110.79 -179.604 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.628 ' HB2' HD11 ' A' ' 35' ' ' LEU . 12.1 t80 -80.93 129.3 34.46 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 178.348 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 60.1 tt0 . . . . . 0 C--N 1.313 -0.993 0 CA-C-O 118.309 -0.853 . . . . 0.0 110.185 -179.604 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' SER . . . . . 0.564 ' OG ' ' HA ' ' A' ' 91' ' ' ASN . 3.8 m . . . . . 0 N--CA 1.449 -0.475 0 N-CA-C 110.17 -0.307 . . . . 0.0 110.17 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.43 ' HA ' ' OD1' ' A' ' 95' ' ' ASN . 21.4 p90 -59.54 -39.55 84.32 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.786 0.327 . . . . 0.0 110.915 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -56.24 -19.77 15.41 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 -178.328 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -69.69 -22.88 63.38 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.087 0.47 . . . . 0.0 110.35 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 24.0 m -138.36 35.6 2.28 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.456 0.646 . . . . 0.0 109.259 178.869 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.438 ' HA ' ' HZ3' ' A' ' 30' ' ' TRP . 9.0 t -138.18 161.03 37.87 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.477 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 25.0 ptt180 -149.49 165.58 31.73 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.496 -179.266 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 54.66 52.97 11.28 Favored 'General case' 0 C--N 1.331 -0.208 0 O-C-N 123.855 0.722 . . . . 0.0 111.704 178.901 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.436 ' HA ' ' HB2' ' A' ' 21' ' ' ALA . . . -86.51 117.83 25.54 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.095 179.61 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 34.5 m -118.22 169.08 9.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.328 -179.427 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.731 HD21 ' HG ' ' A' ' 64' ' ' LEU . 3.2 mm? -105.95 114.61 28.85 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.649 -179.115 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.436 ' OG1' ' HB ' ' A' ' 18' ' ' THR . 24.0 p -110.55 163.39 13.77 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.003 -179.733 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 62.7 27.76 16.26 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.043 179.342 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 98.8 -17.74 57.85 Favored Glycine 0 N--CA 1.454 -0.12 0 C-N-CA 120.457 -0.878 . . . . 0.0 112.583 179.459 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.634 ' HA2' ' HB3' ' A' ' 12' ' ' LEU . . . 121.86 35.13 0.8 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.802 -0.714 . . . . 0.0 112.09 179.514 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.461 ' HB2' ' HB3' ' A' ' 38' ' ' ASP . 3.5 ptm180 -118.76 -25.64 6.3 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.149 0.499 . . . . 0.0 110.551 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.436 ' HB ' ' OG1' ' A' ' 13' ' ' THR . 4.8 m -108.31 135.26 49.91 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.827 -179.686 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.667 HD11 HD13 ' A' ' 90' ' ' LEU . 63.0 mt -97.65 113.76 25.57 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.787 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.498 ' HA ' ' HG2' ' A' ' 34' ' ' GLU . 16.7 ttm180 -107.02 118.68 37.33 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 178.527 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.436 ' HB2' ' HA ' ' A' ' 10' ' ' ALA . . . -154.5 168.05 28.01 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.016 0.436 . . . . 0.0 111.853 -178.916 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -89.54 111.6 22.57 Favored 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 177.485 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.439 ' SG ' HD13 ' A' ' 100' ' ' LEU . 61.1 m -97.89 122.89 41.54 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 -179.36 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.411 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 19.0 ttt180 -77.23 111.07 12.46 Favored 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 179.073 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.449 HD21 ' HB3' ' A' ' 29' ' ' ASN . 34.9 p30 -74.96 168.0 20.81 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.168 179.713 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.68 -27.44 27.8 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -178.719 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -77.92 -4.56 47.44 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.342 0.591 . . . . 0.0 110.964 -179.099 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 81.28 29.5 40.55 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.962 -0.637 . . . . 0.0 111.568 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.449 ' HB3' HD21 ' A' ' 25' ' ' ASN . 8.0 t-20 -112.95 153.03 28.65 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.438 ' HZ3' ' HA ' ' A' ' 7' ' ' SER . 99.1 m95 -99.14 114.5 27.29 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.149 0.499 . . . . 0.0 111.205 -179.156 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 6.9 m -114.17 131.89 64.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.385 179.334 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 17.3 m -79.41 109.57 13.9 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.894 0.378 . . . . 0.0 110.45 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 74.3 m -123.1 154.44 38.59 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.753 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.645 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 46.1 mt-10 -132.84 132.98 42.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.786 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.575 HD11 ' HB2' ' A' ' 102' ' ' PHE . 2.5 tm? -124.37 131.61 53.51 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.259 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.45 ' N ' HD13 ' A' ' 35' ' ' LEU . 8.4 m-20 -89.86 108.52 19.75 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.082 -179.666 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.502 HD13 HD22 ' A' ' 90' ' ' LEU . 1.6 mt -81.69 -16.93 49.7 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.894 -179.571 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.461 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 4.7 p-10 -61.79 -11.88 14.49 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.442 -179.264 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 54.0 p -76.66 -24.68 53.24 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.431 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 34.8 t -128.64 -8.33 5.09 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.206 0.446 . . . . 0.0 112.206 -179.351 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 47.3 mt -103.44 132.67 49.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 O-C-N 121.851 -0.531 . . . . 0.0 110.046 178.324 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.564 ' HA3' ' HB3' ' A' ' 52' ' ' MET . . . -149.71 159.51 28.11 Favored Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.799 -0.715 . . . . 0.0 111.538 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.457 HD22 ' CD1' ' A' ' 48' ' ' LEU . 19.1 p30 -163.35 50.17 0.25 Allowed Pre-proline 0 CA--C 1.537 0.47 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -179.689 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -68.46 -23.52 37.48 Favored 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 121.924 1.749 . . . . 0.0 112.227 -179.03 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.425 ' O ' ' HD3' ' A' ' 83' ' ' ARG . 3.3 m-20 -87.31 -15.96 36.5 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.537 179.739 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.52 ' HA3' ' HG2' ' A' ' 83' ' ' ARG . . . 108.6 11.68 22.7 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.461 -0.876 . . . . 0.0 112.741 -179.161 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -125.82 132.07 52.31 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.62 0.248 . . . . 0.0 110.392 179.563 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.497 HD23 HG22 ' A' ' 88' ' ' ILE . 9.2 mp -83.7 144.8 29.13 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.878 -178.807 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 171.76 170.38 35.68 Favored Glycine 0 N--CA 1.439 -1.134 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.11 178.245 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 90.3 m95 -94.88 125.8 39.78 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.703 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 153.43 -52.87 0.46 Allowed Glycine 0 N--CA 1.448 -0.56 0 N-CA-C 111.191 -0.764 . . . . 0.0 111.191 -179.784 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.564 ' HB3' ' HA3' ' A' ' 42' ' ' GLY . 2.9 tpt -86.59 174.36 8.95 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.595 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.453 ' H ' ' HE2' ' A' ' 52' ' ' MET . 14.1 pt20 -133.67 169.8 16.49 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 118.69 0.677 . . . . 0.0 111.85 -179.174 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 65.81 38.57 5.09 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.389 -0.823 . . . . 0.0 112.855 178.651 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.515 ' HB3' ' HA2' ' A' ' 42' ' ' GLY . 14.0 p90 -61.78 -29.85 70.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.721 0.296 . . . . 0.0 110.929 179.644 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.45 ' HB2' ' HB3' ' A' ' 17' ' ' ARG . 23.3 t -56.61 -36.12 69.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.158 -0.474 . . . . 0.0 112.042 -178.876 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 28.2 m80 -80.92 -18.43 47.17 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.899 -0.32 . . . . 0.0 111.543 -179.207 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 19.8 m -106.75 19.37 20.58 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.527 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 49.3 m -136.82 152.77 50.66 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.331 0.586 . . . . 0.0 111.628 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -129.06 136.27 50.04 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.197 178.758 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.427 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 33.6 m-20 63.63 83.65 0.16 Allowed 'General case' 0 N--CA 1.469 0.511 0 O-C-N 123.608 0.567 . . . . 0.0 111.304 -179.317 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.504 HG23 HD21 ' A' ' 71' ' ' LEU . 70.2 mt -101.51 124.19 55.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.285 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.8 tptt -145.03 154.61 42.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.766 0.317 . . . . 0.0 111.247 -179.396 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.731 ' HG ' HD21 ' A' ' 12' ' ' LEU . 86.1 mt -99.5 124.83 45.03 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.018 178.412 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -86.62 -60.26 2.04 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-O 121.194 0.521 . . . . 0.0 111.42 -179.61 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.607 ' HB2' ' HB3' ' A' ' 69' ' ' ARG . 20.3 mt-10 -78.19 38.44 0.29 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.665 -178.42 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 67.73 -4.76 3.87 Favored Glycine 0 N--CA 1.454 -0.117 0 CA-C-N 115.77 -0.65 . . . . 0.0 113.633 179.075 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.57 ' HA2' HD13 ' A' ' 64' ' ' LEU . . . 145.98 -6.96 1.4 Allowed Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.129 -179.429 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.607 ' HB3' ' HB2' ' A' ' 66' ' ' GLU . 5.5 tpp180 -81.7 -18.23 45.13 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.087 0.47 . . . . 0.0 109.807 179.668 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.429 ' HE3' ' HB2' ' A' ' 70' ' ' LYS . 35.6 ttmt -143.42 136.21 27.54 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.916 -179.234 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.668 ' HB2' HD11 ' A' ' 90' ' ' LEU . 10.5 tt -115.07 118.45 33.41 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.47 -0.787 . . . . 0.0 109.923 -179.709 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.493 HG22 ' HA3' ' A' ' 87' ' ' GLY . 3.6 p -108.82 134.13 51.93 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.241 0.543 . . . . 0.0 110.874 179.388 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.451 ' SG ' HD21 ' A' ' 48' ' ' LEU . 18.0 p -156.55 164.25 38.43 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.001 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.583 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 33.4 ttt-85 -100.87 101.87 17.51 Favored Pre-proline 0 C--N 1.316 -0.872 0 C-N-CA 120.424 -0.511 . . . . 0.0 110.254 178.915 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.639 ' O ' ' HB3' ' A' ' 83' ' ' ARG . 57.9 Cg_endo -70.55 129.2 16.38 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.636 2.224 . . . . 0.0 110.167 178.631 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.69 ' HA ' ' HB2' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -121.2 140.99 51.28 Favored 'General case' 0 C--N 1.313 -1.009 0 O-C-N 123.28 0.362 . . . . 0.0 110.949 179.85 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.723 HG22 ' O ' ' A' ' 82' ' ' PHE . 14.0 t -76.86 130.73 38.01 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 178.478 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 35.3 m -72.66 -6.01 7.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 123.557 0.536 . . . . 0.0 111.492 -179.415 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -67.78 -35.97 79.62 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.229 178.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.431 ' HA3' ' CE2' ' A' ' 82' ' ' PHE . . . -145.3 -14.18 0.21 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.413 -0.898 . . . . 0.0 113.152 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.582 ' HA2' ' HE3' ' A' ' 76' ' ' LYS . . . 88.23 16.78 58.6 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.011 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.723 ' O ' HG22 ' A' ' 77' ' ' THR . 37.8 p90 -111.29 148.46 32.87 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 118.789 -0.624 . . . . 0.0 109.33 -179.195 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.69 ' HB2' ' HA ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 172.05 -160.14 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.987 0.423 . . . . 0.0 111.938 179.753 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 -125.74 173.22 9.19 Favored 'General case' 0 C--O 1.223 -0.317 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.006 -177.473 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.594 ' HA ' ' HD2' ' A' ' 75' ' ' PRO . 72.5 ttt180 -109.41 153.71 23.61 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 110.07 -0.344 . . . . 0.0 110.07 178.711 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -166.23 -170.24 1.64 Allowed 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.581 -179.561 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.493 ' HA3' HG22 ' A' ' 72' ' ' THR . . . -143.12 151.61 23.35 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.335 -0.936 . . . . 0.0 113.358 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.497 HG22 HD23 ' A' ' 48' ' ' LEU . 13.0 tt -123.31 137.49 56.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.025 0.441 . . . . 0.0 109.883 179.408 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -79.8 138.02 37.13 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.787 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.668 HD11 ' HB2' ' A' ' 71' ' ' LEU . 37.2 mt -106.08 40.88 1.5 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.499 0.666 . . . . 0.0 110.936 -179.014 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.564 ' HA ' ' OG ' ' A' ' 2' ' ' SER . 39.5 m-80 -76.03 3.55 10.15 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.079 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 20.9 mtp180 -96.95 -6.6 35.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.641 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 18.7 mm -98.78 116.75 42.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 -179.355 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 24.5 tp60 -126.81 143.36 51.28 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.275 0.559 . . . . 0.0 111.301 -178.229 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.43 ' OD1' ' HA ' ' A' ' 3' ' ' TYR . 12.9 p-10 -95.19 110.82 22.74 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.304 178.529 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 40.8 t -96.97 106.45 18.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.693 179.586 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 20.3 m-80 56.98 36.76 28.21 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.272 0.558 . . . . 0.0 111.304 -179.341 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 96.14 -22.05 41.82 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.828 -0.701 . . . . 0.0 113.388 179.444 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.426 HH11 ' HD3' ' A' ' 99' ' ' ARG . 3.6 mpt_? -86.21 122.61 30.45 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 117.295 0.547 . . . . 0.0 110.211 -179.474 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.439 HD13 ' SG ' ' A' ' 23' ' ' CYS . 11.6 tp -79.63 114.59 18.67 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 32.7 t -128.15 140.71 48.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 120.984 0.421 . . . . 0.0 110.878 -178.778 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.575 ' HB2' HD11 ' A' ' 35' ' ' LEU . 8.3 t80 -83.93 129.3 34.93 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.121 -0.491 . . . . 0.0 109.81 178.665 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 2.7 tp-100 . . . . . 0 C--O 1.249 1.073 0 CA-C-O 119.031 -0.509 . . . . 0.0 110.451 179.396 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.8 m . . . . . 0 N--CA 1.454 -0.274 0 CA-C-O 120.276 0.084 . . . . 0.0 110.98 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.589 ' HB3' ' HA ' ' A' ' 94' ' ' GLN . 9.8 p90 -59.62 -34.09 72.33 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.724 0.297 . . . . 0.0 111.543 179.781 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.475 ' HA ' ' HB3' ' A' ' 7' ' ' SER . . . -55.35 -18.32 6.39 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 112.84 0.681 . . . . 0.0 112.84 -178.649 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -56.24 -38.29 70.91 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.326 0.584 . . . . 0.0 110.064 178.758 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 44.3 m -129.02 40.58 3.61 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.218 179.214 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.475 ' HB3' ' HA ' ' A' ' 4' ' ' ALA . 29.3 t -148.1 148.44 30.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.264 -179.529 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -143.45 163.74 32.27 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.669 -179.671 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 64.22 49.04 2.71 Favored 'General case' 0 N--CA 1.465 0.318 0 O-C-N 123.718 0.636 . . . . 0.0 111.441 179.349 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.543 ' HA ' ' HB2' ' A' ' 21' ' ' ALA . . . -77.92 117.29 19.12 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.361 179.563 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 33.8 m -119.14 167.99 11.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.207 -179.8 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.599 ' HB3' ' HA2' ' A' ' 16' ' ' GLY . 3.3 mm? -104.38 114.53 28.82 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.661 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.476 HG21 ' NE ' ' A' ' 20' ' ' ARG . 28.4 p -112.4 166.69 11.07 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.548 -179.458 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 60.89 42.55 12.88 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.962 179.563 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 97.53 -48.03 1.54 Allowed Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 120.661 -0.781 . . . . 0.0 111.546 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.599 ' HA2' ' HB3' ' A' ' 12' ' ' LEU . . . 145.98 46.79 0.03 OUTLIER Glycine 0 N--CA 1.444 -0.824 0 N-CA-C 110.306 -1.117 . . . . 0.0 110.306 -179.388 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.573 ' HB2' ' HB2' ' A' ' 38' ' ' ASP . 7.1 ptp180 -132.95 -25.59 1.81 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.355 -0.423 . . . . 0.0 111.313 -178.595 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.47 ' HB ' ' OG1' ' A' ' 13' ' ' THR . 2.9 m -100.36 133.3 44.99 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.76 -179.688 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.792 HD11 HD13 ' A' ' 90' ' ' LEU . 68.8 mt -92.52 111.54 23.16 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.325 179.1 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.476 ' NE ' HG21 ' A' ' 13' ' ' THR . 37.4 ttm180 -110.42 120.22 41.73 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.721 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.543 ' HB2' ' HA ' ' A' ' 10' ' ' ALA . . . -152.96 167.24 29.83 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.76 0.314 . . . . 0.0 111.369 -179.125 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.423 ' O ' ' HA ' ' A' ' 7' ' ' SER . 37.1 mt-10 -91.01 107.76 19.41 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 178.262 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 65.9 m -100.32 133.11 45.23 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 120.914 0.387 . . . . 0.0 110.212 -179.285 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.44 HH11 ' HD2' ' A' ' 24' ' ' ARG . 6.7 ttp85 -80.78 117.63 21.61 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-O 120.918 0.39 . . . . 0.0 110.483 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 38.7 p30 -80.31 165.75 22.01 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.103 179.685 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.13 -18.69 38.04 Favored 'General case' 0 N--CA 1.464 0.266 0 O-C-N 123.807 0.692 . . . . 0.0 112.137 -179.012 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -75.85 -13.48 60.27 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.457 0.646 . . . . 0.0 109.716 179.192 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 91.0 23.83 28.9 Favored Glycine 0 N--CA 1.447 -0.58 0 CA-C-N 115.327 -0.851 . . . . 0.0 112.609 179.463 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -122.76 158.61 29.8 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.755 0.312 . . . . 0.0 111.67 -179.105 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 96.7 m95 -90.32 130.73 36.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.14 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.2 m -129.17 137.47 57.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.533 178.454 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 37.6 m -78.58 109.95 13.25 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.467 179.786 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 61.6 m -118.06 152.5 35.43 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.609 -179.844 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.599 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 44.9 mt-10 -132.5 154.41 49.96 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.156 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.555 ' HB2' HD23 ' A' ' 100' ' ' LEU . 1.1 tm? -150.5 126.31 10.38 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 178.78 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -88.77 109.21 19.98 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.583 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.54 HD13 HD22 ' A' ' 90' ' ' LEU . 2.2 mt -81.73 -12.73 58.48 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.329 -179.395 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.712 ' OD2' ' HA ' ' A' ' 54' ' ' ASN . 3.0 t70 -65.96 -5.85 10.71 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.115 0.484 . . . . 0.0 110.845 -179.271 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 49.6 p -85.45 -26.38 26.38 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.857 -0.61 . . . . 0.0 112.03 -179.383 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 16.1 t -127.19 -2.59 6.35 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.573 -0.451 . . . . 0.0 112.089 -178.635 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.433 ' HB ' ' CD1' ' A' ' 55' ' ' PHE . 54.8 mt -111.21 134.34 53.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 O-C-N 122.124 -0.36 . . . . 0.0 110.388 179.0 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -148.72 158.41 27.65 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 121.12 -0.562 . . . . 0.0 111.787 179.522 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.573 ' N ' ' HD3' ' A' ' 44' ' ' PRO . 2.1 p-10 -157.04 46.62 0.26 Allowed Pre-proline 0 CA--C 1.537 0.475 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 179.635 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.575 ' HG2' ' SD ' ' A' ' 52' ' ' MET . 14.0 Cg_exo -66.99 -19.67 51.64 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 121.75 1.634 . . . . 0.0 111.671 -179.678 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 73.9 m-20 -88.77 -8.89 53.63 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.559 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.601 ' CA ' ' HG2' ' A' ' 83' ' ' ARG . . . 98.52 7.71 55.47 Favored Glycine 0 N--CA 1.443 -0.885 0 C-N-CA 120.488 -0.863 . . . . 0.0 112.557 -179.309 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -125.57 135.61 52.41 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.753 0.311 . . . . 0.0 110.286 179.695 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.475 ' HB3' ' HB ' ' A' ' 88' ' ' ILE . 86.4 mt -83.66 141.84 31.21 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.532 -178.532 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 176.51 168.28 36.36 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.447 179.193 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.424 ' HH2' HD11 ' A' ' 93' ' ' ILE . 89.1 m95 -95.71 134.81 38.2 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 147.35 -52.25 0.56 Allowed Glycine 0 CA--C 1.508 -0.404 0 N-CA-C 111.676 -0.569 . . . . 0.0 111.676 179.45 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.575 ' SD ' ' HG2' ' A' ' 44' ' ' PRO . 36.7 ttm -95.74 172.12 8.23 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 178.783 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -123.7 173.23 8.25 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 118.824 0.738 . . . . 0.0 111.507 -178.538 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.712 ' HA ' ' OD2' ' A' ' 38' ' ' ASP . 13.9 m120 66.82 63.37 0.49 Allowed 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 114.926 -1.034 . . . . 0.0 111.68 178.59 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.493 ' HB2' ' OD1' ' A' ' 43' ' ' ASN . 20.7 p90 -87.11 -35.95 18.39 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.336 179.452 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 17.7 t -64.47 -27.56 69.06 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.353 -178.943 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 69.5 m80 -76.37 -12.81 60.12 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.881 -179.259 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.519 ' O ' ' HG3' ' A' ' 76' ' ' LYS . 24.3 p -128.19 26.29 5.76 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.878 0.37 . . . . 0.0 111.303 -179.745 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 68.2 m -132.99 151.08 52.11 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 120.576 -0.45 . . . . 0.0 111.173 179.686 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -119.39 134.31 55.28 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.303 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.437 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 38.2 t70 61.1 84.65 0.13 Allowed 'General case' 0 N--CA 1.465 0.286 0 O-C-N 124.037 0.836 . . . . 0.0 110.934 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.488 HG23 HD21 ' A' ' 71' ' ' LEU . 72.2 mt -101.51 118.07 47.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.03 -179.127 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.456 ' HD3' ' N ' ' A' ' 64' ' ' LEU . 1.2 tmtp? -145.44 150.21 36.11 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 -179.792 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.606 HD13 ' HA2' ' A' ' 68' ' ' GLY . 56.1 mt -83.01 123.19 29.22 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.315 0.579 . . . . 0.0 111.456 -179.517 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -78.37 -61.79 1.89 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.13 -0.941 . . . . 0.0 111.973 -178.372 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 33.6 mm-40 -79.54 34.8 0.27 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.15 0.5 . . . . 0.0 111.433 -179.504 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 66.01 10.44 51.44 Favored Glycine 0 C--N 1.316 -0.575 0 CA-C-N 115.295 -0.866 . . . . 0.0 112.569 179.69 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.606 ' HA2' HD13 ' A' ' 64' ' ' LEU . . . 137.7 -16.95 3.5 Favored Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 120.348 -0.929 . . . . 0.0 112.963 179.807 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 27.2 mtt180 -83.23 -9.85 58.9 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 117.349 0.574 . . . . 0.0 110.779 -179.71 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 66.3 tttt -150.13 138.07 20.17 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.983 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.567 ' HB2' HD11 ' A' ' 90' ' ' LEU . 10.4 tt -107.2 126.44 52.41 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.958 -179.262 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.0 p -116.53 132.0 56.8 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.991 179.723 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.437 ' HA ' ' O ' ' A' ' 61' ' ' ASP . 26.8 p -159.97 175.4 13.06 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.065 -179.602 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.606 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 29.4 ttt180 -107.34 99.12 26.09 Favored Pre-proline 0 C--N 1.315 -0.892 0 C-N-CA 120.228 -0.589 . . . . 0.0 110.405 178.627 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.614 ' O ' ' HB3' ' A' ' 83' ' ' ARG . 55.3 Cg_endo -69.38 125.44 12.35 Favored 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 122.713 2.275 . . . . 0.0 110.492 178.686 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.746 ' HA ' ' HB2' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -120.52 139.99 52.11 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.904 0.383 . . . . 0.0 111.422 -179.693 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.723 HG22 ' O ' ' A' ' 82' ' ' PHE . 15.2 t -73.39 135.63 44.26 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 179.649 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 26.9 m -76.22 -8.99 12.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.63 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.522 -179.35 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -68.57 -30.18 68.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.776 179.531 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.555 ' HA3' ' CE2' ' A' ' 82' ' ' PHE . . . -146.01 -19.26 0.14 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.502 -0.856 . . . . 0.0 113.281 179.431 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.498 ' HA2' ' HE3' ' A' ' 76' ' ' LYS . . . 92.97 14.05 55.47 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.931 -0.652 . . . . 0.0 111.86 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.723 ' O ' HG22 ' A' ' 77' ' ' THR . 37.6 p90 -111.8 157.37 20.63 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 118.901 -0.571 . . . . 0.0 110.173 -178.349 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.746 ' HB2' ' HA ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 166.6 -157.57 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.357 0 O-C-N 123.661 0.601 . . . . 0.0 112.258 178.456 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 41.5 mm-40 -123.42 176.57 6.08 Favored 'General case' 0 CA--C 1.521 -0.173 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.384 -177.687 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.606 ' HA ' ' HA ' ' A' ' 74' ' ' ARG . 30.9 ttt85 -98.85 154.75 17.79 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 178.009 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' GLN . . . . . 0.42 ' HG2' ' N ' ' A' ' 87' ' ' GLY . 49.1 tt0 -161.92 171.48 17.61 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.533 -178.086 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.42 ' N ' ' HG2' ' A' ' 86' ' ' GLN . . . -134.12 138.25 9.93 Favored Glycine 0 N--CA 1.447 -0.622 0 N-CA-C 111.695 -0.562 . . . . 0.0 111.695 178.696 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.475 ' HB ' ' HB3' ' A' ' 48' ' ' LEU . 11.1 tt -118.4 134.82 60.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 121.052 0.453 . . . . 0.0 110.09 -179.667 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -76.1 136.98 39.86 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.232 -178.868 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.792 HD13 HD11 ' A' ' 19' ' ' LEU . 52.4 mt -105.74 40.46 1.56 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.382 0.611 . . . . 0.0 111.451 -179.128 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -74.29 -2.91 27.12 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.27 179.413 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 8.4 mtp180 -91.79 -7.45 49.52 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.741 179.677 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.424 HD11 ' HH2' ' A' ' 50' ' ' TRP . 23.4 mm -105.47 112.1 37.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 -179.332 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.589 ' HA ' ' HB3' ' A' ' 3' ' ' TYR . 7.9 mt-30 -132.56 159.38 39.62 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.143 0.497 . . . . 0.0 111.477 -179.433 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.421 ' HA ' ' O ' ' A' ' 99' ' ' ARG . 13.2 p-10 -104.48 134.0 48.4 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.876 179.523 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 49.3 t -114.93 105.08 17.94 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.395 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -179.496 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 17.7 m-80 61.81 26.91 16.38 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.858 -179.021 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 113.88 -35.84 4.3 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.688 -0.767 . . . . 0.0 114.602 178.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.421 ' O ' ' HA ' ' A' ' 95' ' ' ASN . 0.0 OUTLIER -86.8 139.33 30.8 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 118.029 0.914 . . . . 0.0 112.817 -177.891 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.555 HD23 ' HB2' ' A' ' 35' ' ' LEU . 7.1 tp -81.29 120.05 24.42 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.968 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 26.2 t -128.29 141.52 46.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.308 -179.102 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.444 ' HB2' HD11 ' A' ' 35' ' ' LEU . 16.9 t80 -80.53 132.24 35.64 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 178.705 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 2.7 tp-100 . . . . . 0 C--O 1.253 1.25 0 CA-C-O 118.595 -0.717 . . . . 0.0 110.045 179.703 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' SER . . . . . 0.624 ' HB2' ' HG2' ' A' ' 69' ' ' ARG . 20.1 m . . . . . 0 N--CA 1.451 -0.379 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.483 ' HA ' ' OD1' ' A' ' 95' ' ' ASN . 12.6 p90 -54.89 -40.89 70.25 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -179.58 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.803 ' HB3' ' HG3' ' A' ' 69' ' ' ARG . . . -62.2 -18.45 61.08 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 -178.445 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.469 ' HB2' ' O ' ' A' ' 2' ' ' SER . 0.9 OUTLIER -64.43 -22.43 66.96 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 121.329 0.585 . . . . 0.0 110.572 179.626 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 49.6 m -140.92 39.21 1.8 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.274 179.075 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.478 ' HB3' ' HA ' ' A' ' 4' ' ' ALA . 13.2 t -145.63 154.66 42.37 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.926 -1.034 . . . . 0.0 108.698 179.831 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 21.0 ptt180 -140.47 164.09 31.08 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.734 0.302 . . . . 0.0 111.26 -179.205 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 57.96 51.42 8.98 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.686 178.867 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.514 ' HA ' ' HB2' ' A' ' 21' ' ' ALA . . . -81.98 117.39 22.16 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.206 179.444 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 26.7 m -119.24 169.88 9.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.349 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.643 ' HB3' ' HA2' ' A' ' 16' ' ' GLY . 3.2 mm? -105.15 115.27 29.98 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.803 -179.478 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 23.5 p -111.74 169.6 8.72 Favored 'General case' 0 C--O 1.243 0.72 0 CA-C-O 121.115 0.483 . . . . 0.0 111.692 -179.43 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 62.67 26.87 15.88 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 115.285 -0.87 . . . . 0.0 112.56 179.218 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 101.8 -14.3 57.53 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.437 179.274 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.643 ' HA2' ' HB3' ' A' ' 12' ' ' LEU . . . 116.8 43.17 0.63 Allowed Glycine 0 N--CA 1.443 -0.869 0 N-CA-C 111.209 -0.756 . . . . 0.0 111.209 -179.659 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.711 ' HB2' ' HB2' ' A' ' 38' ' ' ASP . 14.0 ptm180 -130.6 -29.69 1.93 Allowed 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.301 -0.45 . . . . 0.0 111.26 -179.384 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.431 ' HA ' ' HA ' ' A' ' 36' ' ' ASP . 10.3 m -104.37 136.32 44.17 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.435 -179.628 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.655 ' O ' ' HA ' ' A' ' 34' ' ' GLU . 84.5 mt -93.3 117.61 30.28 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.369 179.698 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 44.3 ttt85 -113.81 119.85 38.76 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 178.733 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.514 ' HB2' ' HA ' ' A' ' 10' ' ' ALA . . . -153.76 167.14 30.63 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.924 0.393 . . . . 0.0 111.443 -178.955 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -90.98 109.13 20.37 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 177.65 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.505 ' SG ' HD13 ' A' ' 100' ' ' LEU . 68.5 m -100.09 135.64 41.2 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 120.897 0.38 . . . . 0.0 111.313 -178.122 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 17.3 ttp180 -80.02 115.55 19.66 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.99 179.309 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 34.3 p30 -80.29 167.62 20.05 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.789 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -52.04 -32.24 33.49 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 -178.891 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -71.35 -13.45 61.87 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.288 0.566 . . . . 0.0 111.004 -179.335 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 90.43 28.91 15.42 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.971 -0.633 . . . . 0.0 111.644 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -120.01 157.82 28.06 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.618 0.247 . . . . 0.0 110.834 -179.507 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 91.9 m95 -90.34 131.43 36.14 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.755 0.312 . . . . 0.0 111.362 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.9 m -133.32 130.6 57.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.116 178.164 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.4 m -77.11 112.87 14.23 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.573 -179.716 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 66.4 m -124.11 160.19 28.32 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.978 -179.535 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.655 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 47.4 mt-10 -139.32 143.77 37.98 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.104 -179.817 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.456 HD11 ' HB2' ' A' ' 102' ' ' PHE . 1.8 tm? -138.47 127.77 24.44 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 178.61 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.431 ' HA ' ' HA ' ' A' ' 18' ' ' THR . 27.1 t70 -91.01 109.79 21.04 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.94 0.4 . . . . 0.0 110.599 -179.177 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.553 HD11 HD11 ' A' ' 19' ' ' LEU . 1.5 mt -81.23 -14.24 57.69 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.747 -179.645 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.763 ' OD2' ' HA ' ' A' ' 54' ' ' ASN . 6.6 t70 -63.23 -15.71 57.92 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.291 0.567 . . . . 0.0 110.55 -179.301 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 68.1 p -80.21 -22.41 41.87 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.554 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 21.0 m -122.94 -8.68 8.33 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -177.628 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 65.4 mt -111.73 134.16 55.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 110.335 -0.246 . . . . 0.0 110.335 179.768 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.465 ' HA3' ' HB3' ' A' ' 52' ' ' MET . . . -140.94 151.98 22.85 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.827 -0.702 . . . . 0.0 111.871 179.445 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.851 HD22 ' HB3' ' A' ' 75' ' ' PRO . 38.7 p-10 -160.57 48.53 0.25 Allowed Pre-proline 0 CA--C 1.54 0.561 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -179.308 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.562 ' HD3' ' N ' ' A' ' 43' ' ' ASN . 10.1 Cg_exo -68.28 -18.21 44.68 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 121.883 1.722 . . . . 0.0 111.798 -179.164 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -93.28 -6.63 47.07 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.294 -0.866 . . . . 0.0 111.146 -179.755 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.532 ' HA3' ' HD3' ' A' ' 83' ' ' ARG . . . 100.22 9.33 48.29 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.11 -1.043 . . . . 0.0 112.926 -179.506 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -125.08 128.98 49.32 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.119 0.485 . . . . 0.0 110.891 179.776 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.47 HD11 ' SG ' ' A' ' 73' ' ' CYS . 84.7 mt -83.41 137.87 33.74 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.782 -178.116 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -178.94 170.69 42.61 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 120.874 -0.679 . . . . 0.0 111.659 178.897 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.417 ' HH2' HD11 ' A' ' 93' ' ' ILE . 90.4 m95 -95.78 135.44 37.48 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.991 0.424 . . . . 0.0 110.153 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 147.89 -67.12 0.39 Allowed Glycine 0 N--CA 1.445 -0.706 0 N-CA-C 111.498 -0.641 . . . . 0.0 111.498 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.465 ' HB3' ' HA3' ' A' ' 42' ' ' GLY . 14.7 ttt -80.35 -179.46 7.13 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.458 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -131.36 168.07 18.19 Favored 'General case' 0 C--N 1.321 -0.668 0 O-C-N 122.082 -0.386 . . . . 0.0 111.111 -179.327 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.763 ' HA ' ' OD2' ' A' ' 38' ' ' ASP . 6.8 m-20 69.4 61.21 0.3 Allowed 'General case' 0 N--CA 1.461 0.087 0 O-C-N 124.079 0.862 . . . . 0.0 111.762 179.002 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.43 ' HD1' ' HA ' ' A' ' 38' ' ' ASP . 16.6 p90 -87.21 -37.35 17.35 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.319 179.484 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 72.2 p -64.74 -22.42 66.98 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.409 0.623 . . . . 0.0 110.501 -179.11 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 76.6 m80 -75.94 -11.53 59.98 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.096 -179.43 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.406 ' O ' ' HG3' ' A' ' 76' ' ' LYS . 3.0 p -133.65 33.65 3.49 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.556 179.201 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 38.6 m -136.45 154.19 50.85 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.311 0.577 . . . . 0.0 111.678 -179.818 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -131.22 146.52 52.35 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.142 -0.935 . . . . 0.0 109.652 179.399 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.49 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 33.4 t70 58.72 66.86 1.0 Allowed 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 121.335 0.588 . . . . 0.0 110.917 178.961 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.563 ' HA ' ' HB3' ' A' ' 73' ' ' CYS . 74.5 mt -93.9 114.15 29.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.633 -179.583 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 29.0 tptt -144.54 147.65 33.47 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.992 0.425 . . . . 0.0 110.305 -179.574 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.62 ' HG ' HD21 ' A' ' 12' ' ' LEU . 65.6 mt -83.35 140.89 32.16 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.401 179.69 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -102.41 -55.27 2.5 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.023 -0.535 . . . . 0.0 112.232 -178.78 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.429 ' H ' ' HB3' ' A' ' 70' ' ' LYS . 62.9 mm-40 -83.81 36.26 0.55 Allowed 'General case' 0 CA--C 1.515 -0.4 0 CA-C-O 121.061 0.457 . . . . 0.0 111.199 -179.667 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 70.49 -2.08 17.46 Favored Glycine 0 C--N 1.315 -0.589 0 CA-C-N 115.263 -0.881 . . . . 0.0 112.799 179.821 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.587 ' HA2' HD13 ' A' ' 64' ' ' LEU . . . 146.77 -12.84 1.51 Allowed Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.406 -0.902 . . . . 0.0 113.323 -179.712 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.803 ' HG3' ' HB3' ' A' ' 4' ' ' ALA . 53.3 mtm180 -94.2 4.21 54.2 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 117.557 0.678 . . . . 0.0 111.174 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.429 ' HB3' ' H ' ' A' ' 66' ' ' GLU . 39.9 tptt -151.45 119.74 6.37 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 -179.401 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.592 ' HB2' HD11 ' A' ' 90' ' ' LEU . 9.7 tt -104.29 120.07 40.36 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 -179.763 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.8 p -113.65 133.72 55.14 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.007 0.432 . . . . 0.0 110.798 179.64 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.563 ' HB3' ' HA ' ' A' ' 62' ' ' ILE . 26.2 p -159.98 175.61 12.82 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.887 -179.416 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.586 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 3.7 tmt_? -110.28 98.18 34.47 Favored Pre-proline 0 C--N 1.311 -1.084 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 178.989 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.851 ' HB3' HD22 ' A' ' 43' ' ' ASN . 59.1 Cg_endo -71.64 134.53 24.3 Favored 'Trans proline' 0 CA--C 1.515 -0.448 0 C-N-CA 123.221 2.614 . . . . 0.0 111.599 179.72 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.717 ' HA ' ' HB2' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -121.42 144.03 48.9 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 123.294 0.371 . . . . 0.0 111.347 179.44 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.763 HG22 ' O ' ' A' ' 82' ' ' PHE . 14.4 t -81.15 138.1 35.89 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.103 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 35.6 m -76.97 -4.68 6.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 O-C-N 124.057 0.848 . . . . 0.0 111.481 -179.53 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -69.95 -33.81 72.6 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.006 0.431 . . . . 0.0 110.352 178.765 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.45 ' HA3' ' CE2' ' A' ' 82' ' ' PHE . . . -148.25 -17.23 0.11 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.363 -0.922 . . . . 0.0 113.202 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.626 ' HA2' ' HE3' ' A' ' 76' ' ' LYS . . . 93.68 16.41 45.7 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.577 -0.82 . . . . 0.0 111.473 -179.431 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.763 ' O ' HG22 ' A' ' 77' ' ' THR . 33.2 p90 -112.2 154.16 25.98 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 118.754 -0.641 . . . . 0.0 109.478 -178.926 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.717 ' HB2' ' HA ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 170.8 -160.13 0.01 OUTLIER 'General case' 0 C--O 1.234 0.263 0 O-C-N 123.311 0.382 . . . . 0.0 111.772 179.477 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -124.77 -174.33 3.0 Favored 'General case' 0 C--O 1.226 -0.132 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.527 -177.489 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.586 ' HA ' ' HA ' ' A' ' 74' ' ' ARG . 35.1 ttt-85 -99.61 155.95 17.32 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 177.768 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -163.73 165.78 22.8 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 121.088 0.47 . . . . 0.0 111.854 -178.766 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -134.95 144.3 16.22 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 121.066 -0.588 . . . . 0.0 111.636 179.413 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 12.1 tt -123.64 138.92 51.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 120.975 0.417 . . . . 0.0 110.312 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -78.63 129.69 35.04 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.561 -179.688 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.623 HD13 HD11 ' A' ' 19' ' ' LEU . 60.4 mt -99.44 45.69 0.99 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.711 0.767 . . . . 0.0 110.291 179.807 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -79.15 3.13 18.55 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 114.821 -1.081 . . . . 0.0 110.039 -179.609 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 11.7 mtp180 -101.89 0.18 35.05 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.267 -179.122 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.426 ' CD1' HD22 ' A' ' 37' ' ' LEU . 21.9 mm -107.19 114.96 47.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 -179.321 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 27.0 tp60 -125.78 144.59 50.57 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.908 -178.416 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.483 ' OD1' ' HA ' ' A' ' 3' ' ' TYR . 12.9 p-10 -95.36 102.02 13.8 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.276 178.758 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 54.1 t -86.37 109.3 18.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 179.564 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 9.4 m120 57.64 31.6 20.62 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.02 0.438 . . . . 0.0 110.789 -178.873 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 95.1 -18.95 56.36 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.566 -0.826 . . . . 0.0 112.831 179.768 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 5.6 mpt_? -86.18 124.36 32.49 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 -179.7 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.505 HD13 ' SG ' ' A' ' 23' ' ' CYS . 6.7 tp -76.21 116.48 16.94 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 -179.648 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 44.9 t -130.99 143.19 41.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.622 -179.074 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.456 ' HB2' HD11 ' A' ' 35' ' ' LEU . 16.0 t80 -79.04 135.52 36.9 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.757 -0.461 . . . . 0.0 109.757 178.509 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 6.0 tp60 . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.653 -0.689 . . . . 0.0 110.163 -179.965 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' SER . . . . . 0.565 ' OG ' ' HA ' ' A' ' 91' ' ' ASN . 3.6 m . . . . . 0 N--CA 1.449 -0.522 0 CA-C-O 120.621 0.248 . . . . 0.0 110.46 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.446 ' CZ ' HD13 ' A' ' 19' ' ' LEU . 13.6 p90 -57.25 -34.43 68.6 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.037 0.446 . . . . 0.0 110.411 178.335 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -57.29 -23.06 46.02 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 115.481 -0.781 . . . . 0.0 112.531 -179.003 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -64.98 -16.78 63.78 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 121.063 0.459 . . . . 0.0 110.815 179.666 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 49.7 m -146.66 35.48 0.95 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.712 178.882 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 44.5 m -145.48 163.55 34.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.879 179.789 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 6.1 ptp180 -148.05 165.12 31.75 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.596 -179.606 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 61.1 m-80 59.51 51.83 6.22 Favored 'General case' 0 N--CA 1.464 0.248 0 O-C-N 123.689 0.618 . . . . 0.0 111.376 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.484 ' HA ' ' HB2' ' A' ' 21' ' ' ALA . . . -83.89 117.38 23.29 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.391 179.418 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 31.2 m -123.0 168.9 14.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.481 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.81 HD21 ' HG ' ' A' ' 64' ' ' LEU . 3.4 mm? -104.45 114.32 28.48 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.68 -179.457 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 18.4 p -107.56 168.57 9.16 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.516 -179.381 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 60.4 39.8 18.13 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.039 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 89.62 -31.21 5.32 Favored Glycine 0 CA--C 1.519 0.335 0 CA-C-N 115.941 -0.572 . . . . 0.0 112.657 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.577 ' HA2' ' HB3' ' A' ' 12' ' ' LEU . . . 136.29 56.49 0.06 OUTLIER Glycine 0 N--CA 1.449 -0.472 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 -179.314 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.5 ptm180 -142.52 -31.89 0.51 Allowed 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.856 0.36 . . . . 0.0 111.078 -179.379 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.444 HG22 ' HB3' ' A' ' 34' ' ' GLU . 5.5 m -101.3 136.77 40.6 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.764 -179.538 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.751 HD11 HD13 ' A' ' 90' ' ' LEU . 67.8 mt -94.63 118.07 31.12 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.65 179.052 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.402 ' HD2' HH11 ' A' ' 20' ' ' ARG . 21.8 ttt180 -114.6 119.97 38.57 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 178.708 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.484 ' HB2' ' HA ' ' A' ' 10' ' ' ALA . . . -154.05 168.94 24.75 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.693 0.282 . . . . 0.0 111.317 -178.897 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.453 ' HB3' ' HB3' ' A' ' 30' ' ' TRP . 43.4 mt-10 -87.65 106.2 17.87 Favored 'General case' 0 CA--C 1.513 -0.461 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 178.048 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.553 ' SG ' HD13 ' A' ' 100' ' ' LEU . 30.4 m -93.25 121.26 34.43 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.451 -177.928 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.529 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 9.5 ttp180 -70.03 112.94 6.77 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.147 179.264 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.457 ' ND2' ' HB3' ' A' ' 29' ' ' ASN . 36.2 p30 -78.69 170.65 16.32 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.359 -179.776 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.96 -27.4 52.36 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -178.899 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -80.31 -1.44 41.0 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.498 0.666 . . . . 0.0 110.409 -179.607 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.97 28.95 48.5 Favored Glycine 0 N--CA 1.448 -0.55 0 CA-C-N 115.534 -0.757 . . . . 0.0 112.107 179.599 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.529 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 57.7 t30 -110.98 163.02 14.25 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 121.212 -0.195 . . . . 0.0 110.818 -179.03 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.453 ' HB3' ' HB3' ' A' ' 22' ' ' GLU . 92.5 m95 -101.55 115.71 31.13 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.528 179.616 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.8 m -116.49 148.87 18.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 120.993 0.425 . . . . 0.0 110.835 179.224 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 28.3 m -86.11 110.52 19.6 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.269 179.803 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.482 ' HB2' ' SG ' ' A' ' 23' ' ' CYS . 70.1 m -128.99 147.22 50.84 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.682 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.648 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 51.9 mt-10 -129.84 148.72 51.74 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.548 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.553 HD11 ' HB2' ' A' ' 102' ' ' PHE . 1.8 tm? -140.51 129.34 23.15 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 178.753 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.456 ' N ' HD13 ' A' ' 35' ' ' LEU . 14.5 m-20 -87.13 109.21 19.29 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 -179.565 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.506 HD13 HD22 ' A' ' 90' ' ' LEU . 1.9 mt -85.12 -21.43 29.28 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -179.19 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.4 ' HA ' ' HD1' ' A' ' 55' ' ' PHE . 5.9 p-10 -65.18 -6.96 10.65 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.744 0.307 . . . . 0.0 111.568 -178.386 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 69.0 p -81.09 -16.14 53.99 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.641 179.034 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.409 ' HG ' ' HZ ' ' A' ' 102' ' ' PHE . 29.2 t -133.28 -10.02 2.91 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.718 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 51.1 mt -104.81 134.26 46.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 178.264 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.52 ' HA3' ' HB3' ' A' ' 52' ' ' MET . . . -148.33 155.73 26.55 Favored Glycine 0 N--CA 1.442 -0.919 0 C-N-CA 120.577 -0.821 . . . . 0.0 112.112 -179.643 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.628 ' N ' ' HD3' ' A' ' 44' ' ' PRO . 27.0 p30 -158.2 43.92 0.18 Allowed Pre-proline 0 CA--C 1.542 0.648 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.628 ' HD3' ' N ' ' A' ' 43' ' ' ASN . 16.2 Cg_exo -67.46 -23.06 44.24 Favored 'Trans proline' 0 C--N 1.356 0.952 0 C-N-CA 121.967 1.778 . . . . 0.0 111.683 -179.219 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 52.5 m-80 -89.3 -1.92 58.25 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.11 179.563 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.534 ' HA3' ' HG2' ' A' ' 83' ' ' ARG . . . 92.6 11.17 59.64 Favored Glycine 0 N--CA 1.443 -0.843 0 C-N-CA 120.385 -0.912 . . . . 0.0 112.657 -179.692 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 43.5 m-85 -125.19 132.44 53.02 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.767 0.318 . . . . 0.0 110.588 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.424 HD23 HG22 ' A' ' 88' ' ' ILE . 10.3 mp -86.0 146.03 26.84 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.892 -178.863 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 169.22 171.31 34.79 Favored Glycine 0 N--CA 1.442 -0.944 0 CA-C-N 115.476 -0.784 . . . . 0.0 112.066 178.156 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.438 ' CD1' HD11 ' A' ' 88' ' ' ILE . 90.3 m95 -95.48 125.18 39.91 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.496 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 153.29 -44.85 0.59 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.936 -0.649 . . . . 0.0 111.637 -179.561 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.52 ' HB3' ' HA3' ' A' ' 42' ' ' GLY . 12.7 tpt -94.2 174.61 7.06 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.784 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 -130.72 171.56 12.96 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.993 -179.659 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 64.23 37.41 8.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.991 177.883 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.498 ' HB3' ' HA2' ' A' ' 42' ' ' GLY . 11.7 p90 -62.33 -38.42 89.4 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.528 -0.469 . . . . 0.0 109.865 179.191 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 15.6 t -60.09 -29.98 68.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.12 -179.215 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 27.9 m80 -77.03 -12.62 59.96 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.815 0.341 . . . . 0.0 111.301 -179.657 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 19.7 m -126.54 27.77 6.06 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.078 0.466 . . . . 0.0 111.166 -179.714 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 38.6 m -132.41 147.56 52.38 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.195 0.522 . . . . 0.0 111.258 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.668 ' HG3' ' HB3' ' A' ' 74' ' ' ARG . 7.0 pt-20 -121.23 142.44 49.91 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.51 178.571 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.419 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 37.6 t70 58.43 80.39 0.18 Allowed 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.55 0.691 . . . . 0.0 110.477 -178.691 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.542 HG23 HD21 ' A' ' 71' ' ' LEU . 70.5 mt -102.77 119.66 51.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.997 -179.267 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.4 tpmt? -148.97 156.82 42.82 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 -179.754 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.81 ' HG ' HD21 ' A' ' 12' ' ' LEU . 71.9 mt -88.39 121.3 30.63 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.984 0.421 . . . . 0.0 110.099 178.904 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -71.88 -55.45 7.5 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.899 -178.817 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.534 ' CB ' ' HB2' ' A' ' 69' ' ' ARG . 8.8 mm-40 -87.08 13.57 9.09 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.884 -179.396 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 69.9 23.17 77.11 Favored Glycine 0 N--CA 1.448 -0.528 0 CA-C-N 115.7 -0.682 . . . . 0.0 112.578 179.79 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 145.27 -36.76 1.36 Allowed Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.029 -1.082 . . . . 0.0 112.956 179.332 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.534 ' HB2' ' CB ' ' A' ' 66' ' ' GLU . 8.3 mmt85 -72.39 -29.12 63.46 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.928 0.394 . . . . 0.0 111.396 -179.784 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 41.7 tttp -140.45 140.09 35.33 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.976 -177.868 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.616 ' HB2' HD11 ' A' ' 90' ' ' LEU . 9.9 tt -111.35 122.93 49.15 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 179.142 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.2 p -110.87 131.89 54.66 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.361 0.6 . . . . 0.0 110.873 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.419 ' HA ' ' O ' ' A' ' 61' ' ' ASP . 24.6 p -156.61 167.51 30.22 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.708 -179.659 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.668 ' HB3' ' HG3' ' A' ' 60' ' ' GLU . 67.5 ttt180 -103.81 101.3 23.99 Favored Pre-proline 0 C--N 1.314 -0.958 0 N-CA-C 109.865 -0.421 . . . . 0.0 109.865 178.807 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.64 ' O ' ' HB3' ' A' ' 83' ' ' ARG . 61.5 Cg_endo -71.04 119.01 6.0 Favored 'Trans proline' 0 CA--C 1.513 -0.54 0 C-N-CA 122.871 2.381 . . . . 0.0 111.029 179.483 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.699 ' HA ' ' HB2' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -119.63 135.76 54.67 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 120.76 0.314 . . . . 0.0 110.486 179.795 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.715 HG22 ' O ' ' A' ' 82' ' ' PHE . 14.7 t -70.18 128.67 37.08 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 12.4 p -71.41 -12.57 16.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.474 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -60.24 -30.42 69.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.08 179.277 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.597 ' HA3' ' CE2' ' A' ' 82' ' ' PHE . . . -146.5 -35.68 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.433 0 CA-C-N 115.578 -0.737 . . . . 0.0 112.458 179.85 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 111.91 12.41 14.35 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 121.237 -0.506 . . . . 0.0 112.058 -179.522 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.715 ' O ' HG22 ' A' ' 77' ' ' THR . 16.1 p90 -112.66 152.82 28.54 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 118.782 -0.628 . . . . 0.0 110.37 -178.55 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.699 ' HB2' ' HA ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 167.52 -158.25 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.603 0 O-C-N 123.682 0.614 . . . . 0.0 111.994 178.675 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 57.4 mm-40 -117.62 -173.26 2.39 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.978 -178.088 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.632 ' HA ' ' HD2' ' A' ' 75' ' ' PRO . 73.2 ttt180 -115.93 151.38 35.5 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 178.524 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' GLN . . . . . 0.463 ' HG3' ' O ' ' A' ' 85' ' ' ARG . 31.1 mt-30 -157.95 -170.1 3.05 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.379 0.609 . . . . 0.0 112.335 -178.387 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -155.33 145.98 13.46 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.09 179.304 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.438 HD11 ' CD1' ' A' ' 50' ' ' TRP . 12.4 tt -128.46 142.17 44.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.953 0.377 . . . . 0.0 110.474 -179.628 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -82.5 133.82 35.2 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.184 0.516 . . . . 0.0 110.693 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.751 HD13 HD11 ' A' ' 19' ' ' LEU . 26.5 mt -101.02 39.64 1.37 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.616 -179.247 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.565 ' HA ' ' OG ' ' A' ' 2' ' ' SER . 3.4 m120 -73.88 2.95 7.4 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.068 -0.969 . . . . 0.0 111.048 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 9.8 mtp180 -97.23 -11.07 24.63 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.459 179.316 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.436 ' CD1' HD22 ' A' ' 37' ' ' LEU . 23.3 mm -96.56 102.73 13.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 121.392 0.615 . . . . 0.0 109.449 -179.354 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 6.6 mm100 -107.83 153.82 22.45 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.563 -178.598 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.432 ' HB3' HD12 ' A' ' 100' ' ' LEU . 22.8 p-10 -112.57 112.09 23.37 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.723 178.363 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 9.0 p -111.51 120.51 62.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.105 0.479 . . . . 0.0 110.176 -179.695 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 12.4 m120 59.15 28.93 18.37 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.98 -178.623 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 88.09 -9.73 73.63 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.517 -179.36 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 10.5 mpt_? -91.4 124.8 35.86 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 -179.804 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.553 HD13 ' SG ' ' A' ' 23' ' ' CYS . 5.9 tp -82.16 117.11 22.06 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 16.6 t -129.24 138.07 55.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 120.651 0.262 . . . . 0.0 110.77 -179.136 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.553 ' HB2' HD11 ' A' ' 35' ' ' LEU . 6.8 t80 -80.91 125.72 30.48 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 177.829 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 . . . . . 0 C--N 1.311 -1.076 0 CA-C-O 118.077 -0.964 . . . . 0.0 110.856 179.848 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' SER . . . . . 0.5 ' OG ' ' HA ' ' A' ' 91' ' ' ASN . 11.8 m . . . . . 0 N--CA 1.452 -0.344 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 34.6 p90 -59.86 -35.14 74.16 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 121.094 -0.242 . . . . 0.0 110.99 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -55.84 -22.09 23.21 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 112.114 0.412 . . . . 0.0 112.114 -179.356 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -68.27 -22.68 64.73 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 120.878 0.371 . . . . 0.0 110.716 179.463 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 9.6 p -139.73 29.97 2.1 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.31 0.576 . . . . 0.0 110.181 179.603 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 9.3 t -150.71 156.82 42.09 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -179.692 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 9.4 ptp180 -149.07 166.93 27.24 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.655 0.264 . . . . 0.0 111.127 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 29.6 m120 57.85 60.71 2.65 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.967 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -90.48 125.47 35.6 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.853 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 34.0 m -122.62 170.65 12.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.8 179.807 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.63 HD21 ' HG ' ' A' ' 64' ' ' LEU . 3.2 mm? -104.8 114.21 28.29 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.355 -179.235 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 21.6 p -110.3 167.47 10.17 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.812 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 57.52 50.34 11.3 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.889 179.779 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 85.29 -37.95 3.01 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 121.01 -0.614 . . . . 0.0 112.516 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.618 ' HA2' ' HB3' ' A' ' 12' ' ' LEU . . . 138.59 38.83 0.11 Allowed Glycine 0 N--CA 1.447 -0.595 0 N-CA-C 111.284 -0.727 . . . . 0.0 111.284 -179.709 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.64 ' HB3' ' HB3' ' A' ' 56' ' ' SER . 48.7 ptt85 -123.49 -23.23 4.84 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.939 0.4 . . . . 0.0 110.744 -179.267 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.3 m -105.28 137.5 42.96 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.027 -179.384 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.743 HD11 HD13 ' A' ' 90' ' ' LEU . 58.5 mt -97.05 116.17 28.78 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.576 179.294 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.82 119.68 40.12 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 178.242 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -152.33 168.07 26.6 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.979 0.419 . . . . 0.0 111.776 -178.348 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -89.99 106.09 18.25 Favored 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 178.513 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 58.1 m -97.95 130.68 44.8 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 120.761 0.315 . . . . 0.0 110.633 -178.218 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.527 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 10.5 ttp180 -78.37 122.2 25.47 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.497 179.831 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.448 HD21 ' HB3' ' A' ' 29' ' ' ASN . 35.6 p30 -86.83 168.36 13.53 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.827 179.415 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.84 -31.32 49.03 Favored 'General case' 0 N--CA 1.464 0.255 0 O-C-N 123.555 0.535 . . . . 0.0 112.356 -179.11 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -69.51 -17.84 63.63 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.446 0.641 . . . . 0.0 110.662 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 93.72 28.7 10.82 Favored Glycine 0 N--CA 1.446 -0.684 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.313 -179.542 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.527 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 43.9 t30 -112.91 160.97 17.52 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.644 0.259 . . . . 0.0 110.901 -179.106 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 94.6 m95 -100.37 114.33 27.77 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.93 0.395 . . . . 0.0 111.049 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.6 m -117.75 129.19 74.55 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.381 178.908 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 13.7 m -75.01 111.66 10.45 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.877 -0.602 . . . . 0.0 111.015 -179.415 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.417 ' HB3' ' H ' ' A' ' 100' ' ' LEU . 73.5 m -121.58 153.3 38.22 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.609 179.827 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.601 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 42.8 mt-10 -129.4 141.46 51.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.206 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.615 HD11 ' HB2' ' A' ' 102' ' ' PHE . 1.9 tm? -136.54 131.96 34.58 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.387 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.416 ' N ' HD13 ' A' ' 35' ' ' LEU . 31.8 m-20 -88.58 109.8 20.38 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 -179.646 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.527 HD13 HD22 ' A' ' 90' ' ' LEU . 4.4 mt -79.64 -20.56 46.45 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.286 -179.636 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.543 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 5.1 p-10 -65.99 -5.87 10.92 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.629 -0.259 . . . . 0.0 111.461 -178.897 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 72.9 p -81.08 -20.84 40.65 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.625 179.472 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.446 ' SG ' ' HE3' ' A' ' 50' ' ' TRP . 40.9 t -129.05 -11.51 4.72 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.616 -179.871 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 51.3 mt -100.14 128.8 51.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.083 178.819 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.517 ' HA3' ' HB3' ' A' ' 52' ' ' MET . . . -139.34 154.34 23.44 Favored Glycine 0 N--CA 1.443 -0.876 0 C-N-CA 120.852 -0.69 . . . . 0.0 111.518 179.497 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.939 HD22 ' HB3' ' A' ' 75' ' ' PRO . 33.0 p-10 -160.95 44.24 0.15 Allowed Pre-proline 0 CA--C 1.539 0.533 0 N-CA-C 113.142 0.794 . . . . 0.0 113.142 -179.263 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -70.95 -16.76 32.5 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 121.404 1.403 . . . . 0.0 111.895 -179.387 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -89.07 -9.55 50.75 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.493 179.74 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.562 ' CA ' ' HG2' ' A' ' 83' ' ' ARG . . . 102.21 6.47 48.16 Favored Glycine 0 N--CA 1.443 -0.899 0 C-N-CA 120.482 -0.866 . . . . 0.0 112.503 -179.38 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -125.14 134.42 52.44 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 122.732 -0.275 . . . . 0.0 110.85 179.808 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.51 HD23 ' HB3' ' A' ' 43' ' ' ASN . 88.0 mt -83.99 146.42 27.99 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.218 -179.166 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 170.82 169.99 34.52 Favored Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 120.539 -0.839 . . . . 0.0 112.361 178.822 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.446 ' HE3' ' SG ' ' A' ' 40' ' ' CYS . 90.8 m95 -95.3 124.98 39.62 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 110.048 -0.352 . . . . 0.0 110.048 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 160.73 -60.05 0.3 Allowed Glycine 0 N--CA 1.448 -0.558 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.791 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.517 ' HB3' ' HA3' ' A' ' 42' ' ' GLY . 0.4 OUTLIER -86.69 -162.15 0.74 Allowed 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 -179.902 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -147.25 175.19 10.95 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.768 -0.373 . . . . 0.0 111.708 -179.468 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 14.6 m120 62.72 54.15 2.39 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 123.936 0.773 . . . . 0.0 112.236 179.278 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -87.5 -17.25 32.54 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.179 178.786 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.64 ' HB3' ' HB3' ' A' ' 17' ' ' ARG . 6.1 p -55.21 -55.65 28.87 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 -177.741 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 47.4 m80 -80.96 -10.23 59.74 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.926 0.393 . . . . 0.0 111.264 -179.179 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.4 ' HB2' ' OD1' ' A' ' 43' ' ' ASN . 15.0 m -96.01 14.41 23.78 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.942 0.401 . . . . 0.0 110.79 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 19.5 m -136.56 152.93 51.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.0 0.428 . . . . 0.0 111.551 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -119.1 145.69 45.73 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.477 178.19 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 35.9 t70 49.93 74.59 0.2 Allowed 'General case' 0 N--CA 1.47 0.561 0 O-C-N 123.787 0.679 . . . . 0.0 111.662 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.518 HG23 HD21 ' A' ' 71' ' ' LEU . 75.0 mt -91.51 115.46 30.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.489 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 15.0 tptm -149.07 150.97 33.64 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 121.031 0.443 . . . . 0.0 111.532 -179.521 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.63 ' HG ' HD21 ' A' ' 12' ' ' LEU . 64.1 mt -88.95 129.93 35.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.383 179.35 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -86.43 -57.22 3.09 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-O 121.126 0.488 . . . . 0.0 111.186 -179.594 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.516 ' HG2' ' HB3' ' A' ' 70' ' ' LYS . 16.3 mm-40 -71.9 -5.74 36.79 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.189 -179.183 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 95.51 -0.07 63.14 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 121.014 -0.612 . . . . 0.0 111.759 -179.525 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 164.34 -39.55 0.31 Allowed Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.434 -0.889 . . . . 0.0 112.555 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 7.9 mmt180 -62.31 -33.48 74.76 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.516 ' HB3' ' HG2' ' A' ' 66' ' ' GLU . 32.2 ttpt -135.44 139.09 43.84 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.915 0.388 . . . . 0.0 111.962 -178.292 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.607 ' HB2' HD11 ' A' ' 90' ' ' LEU . 10.5 tt -117.55 132.81 56.47 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.485 -0.779 . . . . 0.0 109.355 179.42 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.454 HG22 ' HA3' ' A' ' 87' ' ' GLY . 18.7 p -125.64 144.78 50.44 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.937 0.398 . . . . 0.0 111.04 179.437 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.468 ' HB3' ' HA ' ' A' ' 62' ' ' ILE . 24.0 p -162.6 175.45 11.4 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.582 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 52.9 ttt180 -109.3 98.25 30.5 Favored Pre-proline 0 C--N 1.311 -1.101 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 178.616 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.939 ' HB3' HD22 ' A' ' 43' ' ' ASN . 32.1 Cg_endo -64.3 127.21 18.6 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 122.866 2.377 . . . . 0.0 110.279 179.338 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.721 ' HA ' ' HB2' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -120.28 147.56 44.83 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.068 0.461 . . . . 0.0 111.619 -179.663 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.713 HG22 ' O ' ' A' ' 82' ' ' PHE . 14.5 t -81.61 141.47 33.67 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 179.007 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.1 m -73.87 -8.3 11.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 O-C-N 123.923 0.764 . . . . 0.0 111.321 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 53.0 m-20 -63.89 -34.04 77.06 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-O 120.955 0.407 . . . . 0.0 110.312 179.311 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -157.0 -10.92 0.05 OUTLIER Glycine 0 CA--C 1.519 0.298 0 C-N-CA 120.468 -0.872 . . . . 0.0 113.183 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.35 18.49 42.07 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.768 -0.729 . . . . 0.0 111.881 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.713 ' O ' HG22 ' A' ' 77' ' ' THR . 39.2 p90 -111.4 157.85 19.77 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 118.677 -0.678 . . . . 0.0 109.418 -179.144 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.721 ' HB2' ' HA ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 167.36 -149.08 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.428 0 O-C-N 123.543 0.527 . . . . 0.0 111.516 179.659 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -130.31 157.04 43.62 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.088 -178.184 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.582 ' HA ' ' HA ' ' A' ' 74' ' ' ARG . 38.8 ttt85 -82.85 154.03 24.86 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 179.181 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -162.57 164.57 26.74 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.795 -0.362 . . . . 0.0 111.309 -177.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.454 ' HA3' HG22 ' A' ' 72' ' ' THR . . . -128.22 146.0 16.45 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.094 179.6 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 12.3 tt -128.74 136.01 60.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 120.977 0.417 . . . . 0.0 110.305 179.776 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -80.34 138.85 36.76 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.057 0.456 . . . . 0.0 110.348 179.727 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.743 HD13 HD11 ' A' ' 19' ' ' LEU . 50.0 mt -101.98 43.38 1.07 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.804 0.811 . . . . 0.0 109.857 -179.755 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.5 ' HA ' ' OG ' ' A' ' 2' ' ' SER . 5.1 m-20 -76.67 0.28 20.89 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 114.689 -1.142 . . . . 0.0 111.097 -179.347 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 14.6 mtp180 -98.12 -6.11 32.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.517 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.415 HG13 HD22 ' A' ' 37' ' ' LEU . 22.8 mm -101.48 118.89 48.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 -179.131 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -132.1 143.89 50.33 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.004 -178.721 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -96.92 102.92 14.8 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.654 0.74 . . . . 0.0 110.487 178.863 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.2 p -87.81 117.84 32.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.232 0.539 . . . . 0.0 110.047 179.434 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 60.43 27.18 16.78 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.228 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 95.83 -9.42 68.37 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.813 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.483 ' HD2' ' N ' ' A' ' 99' ' ' ARG . 4.0 mpt_? -99.77 124.82 45.43 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 122.394 -0.474 . . . . 0.0 110.17 -179.642 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.417 ' H ' ' HB3' ' A' ' 33' ' ' SER . 12.2 tp -75.76 114.99 14.99 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.977 -179.247 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 45.7 t -130.4 145.73 35.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.25 -179.066 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.615 ' HB2' HD11 ' A' ' 35' ' ' LEU . 11.8 t80 -78.67 135.65 37.25 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 178.538 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 2.3 tp60 . . . . . 0 C--O 1.247 0.947 0 CA-C-O 118.774 -0.631 . . . . 0.0 109.996 -179.959 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.448 -0.54 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.44 ' CB ' HD11 ' A' ' 100' ' ' LEU . 6.7 p90 -54.71 -39.89 68.66 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 -177.799 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.614 ' HA ' ' OG ' ' A' ' 7' ' ' SER . . . -60.62 -20.42 60.65 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -178.266 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -68.42 -35.48 77.69 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.418 0.628 . . . . 0.0 109.808 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 8.1 m -120.38 34.8 5.08 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.855 -179.12 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.614 ' OG ' ' HA ' ' A' ' 4' ' ' ALA . 92.6 p -142.73 167.14 22.79 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 121.053 0.454 . . . . 0.0 110.161 178.826 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 13.5 ptp180 -152.19 166.46 31.66 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.018 -179.752 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 24.6 m120 59.31 47.57 11.25 Favored 'General case' 0 N--CA 1.466 0.367 0 O-C-N 123.646 0.591 . . . . 0.0 110.959 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.4 ' HA ' ' HB2' ' A' ' 21' ' ' ALA . . . -80.53 118.45 22.14 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.823 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 29.6 m -126.52 170.52 16.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.12 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.781 HD21 ' HG ' ' A' ' 64' ' ' LEU . 3.1 mm? -104.53 114.77 29.21 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.237 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.436 ' OG1' ' HB ' ' A' ' 18' ' ' THR . 14.8 p -109.89 166.37 10.98 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.736 179.742 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.528 ' O ' ' HG2' ' A' ' 17' ' ' ARG . 90.4 m-20 57.15 50.28 12.1 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.13 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 83.42 -34.2 2.91 Favored Glycine 0 N--CA 1.452 -0.27 0 CA-C-N 115.962 -0.563 . . . . 0.0 112.841 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.612 ' HA2' ' HB3' ' A' ' 12' ' ' LEU . . . 135.59 42.44 0.12 Allowed Glycine 0 N--CA 1.447 -0.567 0 N-CA-C 111.194 -0.762 . . . . 0.0 111.194 -179.348 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.528 ' HG2' ' O ' ' A' ' 14' ' ' ASN . 5.4 ptm180 -124.55 -27.53 3.7 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.95 0.405 . . . . 0.0 110.712 -179.419 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.467 HG22 ' HB3' ' A' ' 34' ' ' GLU . 2.3 m -102.63 134.52 45.87 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.192 -179.177 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.742 HD11 HD13 ' A' ' 90' ' ' LEU . 45.9 mt -94.43 111.08 22.82 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.05 178.75 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.457 ' HA ' ' HG2' ' A' ' 34' ' ' GLU . 25.7 ttt85 -106.98 120.03 40.96 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 179.421 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.4 ' HB2' ' HA ' ' A' ' 10' ' ' ALA . . . -155.06 167.03 31.73 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.873 0.368 . . . . 0.0 111.247 -179.706 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -89.09 108.03 19.37 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 177.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.592 ' SG ' HD13 ' A' ' 100' ' ' LEU . 46.8 m -95.93 129.73 43.11 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 120.778 0.323 . . . . 0.0 110.734 -178.376 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.571 ' HB2' ' CZ3' ' A' ' 30' ' ' TRP . 11.3 ttt85 -82.82 117.63 22.84 Favored 'General case' 0 N--CA 1.438 -1.06 0 N-CA-C 110.171 -0.307 . . . . 0.0 110.171 179.167 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 32.4 p30 -80.38 166.61 21.12 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.928 179.682 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.84 -26.03 44.82 Favored 'General case' 0 N--CA 1.465 0.285 0 O-C-N 123.702 0.626 . . . . 0.0 112.262 -178.59 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -71.12 -16.09 62.54 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.168 0.509 . . . . 0.0 110.091 179.663 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 93.21 24.67 21.48 Favored Glycine 0 N--CA 1.447 -0.567 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.22 179.75 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.44 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 32.7 m-20 -116.55 160.01 21.27 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.851 0.357 . . . . 0.0 111.449 -179.247 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.571 ' CZ3' ' HB2' ' A' ' 24' ' ' ARG . 93.5 m95 -95.73 122.62 38.7 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.067 0.46 . . . . 0.0 111.876 -179.305 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.4 m -122.8 134.08 67.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.59 178.56 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 23.1 m -75.23 113.09 12.19 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.05 179.459 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.407 ' HB2' ' SG ' ' A' ' 23' ' ' CYS . 74.4 m -128.43 153.57 46.96 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.08 -179.601 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.587 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 49.3 mt-10 -137.93 144.54 41.29 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.768 -179.582 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.455 HD12 HD23 ' A' ' 37' ' ' LEU . 1.8 tm? -137.86 129.28 27.91 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 178.917 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.435 ' N ' HD13 ' A' ' 35' ' ' LEU . 13.6 m-20 -86.88 109.74 19.51 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.417 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.534 HD13 HD22 ' A' ' 90' ' ' LEU . 3.0 mt -82.02 -18.27 43.89 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 112.57 0.581 . . . . 0.0 112.57 -178.655 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.459 ' HA ' ' HD1' ' A' ' 55' ' ' PHE . 6.7 p-10 -65.7 -6.18 10.76 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.708 0.29 . . . . 0.0 111.522 -178.56 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 46.9 p -78.76 -23.25 45.46 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.836 179.431 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.542 ' HG ' ' HZ ' ' A' ' 102' ' ' PHE . 17.2 t -130.31 -10.77 4.14 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -179.468 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.406 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 49.0 mt -99.77 128.76 51.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 178.504 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.533 ' HA3' ' HB3' ' A' ' 52' ' ' MET . . . -142.47 150.9 22.57 Favored Glycine 0 N--CA 1.442 -0.952 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.119 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.922 HD22 ' HB3' ' A' ' 75' ' ' PRO . 31.1 p-10 -157.11 47.94 0.31 Allowed Pre-proline 0 C--N 1.323 -0.579 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -179.713 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -73.01 -17.25 25.18 Favored 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 121.638 1.558 . . . . 0.0 111.87 -179.303 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -93.09 -5.84 49.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.467 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.593 ' HA3' ' HG2' ' A' ' 83' ' ' ARG . . . 101.56 7.15 49.13 Favored Glycine 0 N--CA 1.443 -0.871 0 C-N-CA 120.334 -0.936 . . . . 0.0 112.834 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -125.45 131.55 52.86 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.015 0.436 . . . . 0.0 111.309 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.451 HD23 ' HB3' ' A' ' 43' ' ' ASN . 81.7 mt -83.77 137.68 33.62 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.378 -178.925 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 177.62 171.66 41.32 Favored Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 120.861 -0.685 . . . . 0.0 111.854 179.08 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.48 ' CD2' ' HD3' ' A' ' 92' ' ' ARG . 90.6 m95 -96.29 125.04 40.52 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.997 0.427 . . . . 0.0 110.191 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 154.85 -58.3 0.39 Allowed Glycine 0 CA--C 1.507 -0.449 0 N-CA-C 110.916 -0.874 . . . . 0.0 110.916 -179.297 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.533 ' HB3' ' HA3' ' A' ' 42' ' ' GLY . 44.7 tpp -82.93 174.3 11.04 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 178.661 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -132.11 176.66 8.19 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 118.654 0.661 . . . . 0.0 111.798 -179.794 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 4.9 m120 64.65 43.04 4.43 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.467 -0.788 . . . . 0.0 112.342 179.759 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.459 ' HD1' ' HA ' ' A' ' 38' ' ' ASP . 6.3 p90 -69.12 -25.5 64.43 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.997 -0.372 . . . . 0.0 109.997 179.217 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 9.4 p -58.24 -42.7 86.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.355 -179.431 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 41.4 m80 -80.26 -9.99 59.74 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.011 0.434 . . . . 0.0 111.215 -179.619 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.684 ' HA ' ' HD2' ' A' ' 76' ' ' LYS . 10.2 m -113.28 18.26 17.97 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.604 -178.912 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 23.5 m -131.85 143.64 50.32 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-O 121.158 0.504 . . . . 0.0 111.336 179.759 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 67.2 mm-40 -113.58 134.51 54.67 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.675 178.497 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 23.9 t70 57.34 79.6 0.19 Allowed 'General case' 0 C--N 1.322 -0.601 0 O-C-N 123.994 0.809 . . . . 0.0 111.33 -179.236 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.53 HG23 HD21 ' A' ' 71' ' ' LEU . 75.6 mt -91.6 123.57 43.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.882 179.691 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 27.8 tptt -149.05 149.88 31.85 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 110.156 -0.312 . . . . 0.0 110.156 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.781 ' HG ' HD21 ' A' ' 12' ' ' LEU . 70.3 mt -85.89 141.27 29.7 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.188 0.518 . . . . 0.0 110.608 179.233 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -100.68 -70.84 0.72 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.432 -0.804 . . . . 0.0 112.515 -178.283 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.452 ' HG3' ' HB3' ' A' ' 70' ' ' LYS . 31.3 mt-10 -74.67 49.0 0.38 Allowed 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -178.185 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 64.95 7.97 32.68 Favored Glycine 0 C--N 1.32 -0.326 0 CA-C-N 115.938 -0.574 . . . . 0.0 112.848 179.581 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.606 ' HA2' HD13 ' A' ' 64' ' ' LEU . . . 127.26 -3.3 7.24 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.645 -0.788 . . . . 0.0 113.122 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 29.9 ttp85 -95.43 0.38 53.31 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.793 0.806 . . . . 0.0 110.317 -179.448 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.452 ' HB3' ' HG3' ' A' ' 66' ' ' GLU . 0.5 OUTLIER -147.69 129.49 15.21 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.403 -179.984 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.575 ' HB2' HD11 ' A' ' 90' ' ' LEU . 10.0 tt -105.82 118.98 37.99 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 179.599 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.5 p -108.79 128.1 54.59 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.018 179.78 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.446 ' HB3' ' HA ' ' A' ' 62' ' ' ILE . 26.5 p -157.74 172.11 19.09 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.054 -179.727 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.531 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 78.9 ttt180 -108.16 100.44 36.82 Favored Pre-proline 0 C--N 1.31 -1.112 0 C-N-CA 120.225 -0.59 . . . . 0.0 109.971 178.614 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.922 ' HB3' HD22 ' A' ' 43' ' ' ASN . 19.2 Cg_endo -60.29 130.46 34.13 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 122.655 2.237 . . . . 0.0 110.246 178.96 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.684 ' HD2' ' HA ' ' A' ' 58' ' ' SER . 0.0 OUTLIER -119.97 154.14 34.93 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.256 0.551 . . . . 0.0 111.665 -179.133 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.716 ' HB ' ' HD2' ' A' ' 83' ' ' ARG . 6.3 t -94.08 147.64 22.94 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.69 -0.687 . . . . 0.0 109.551 179.131 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.4 p -72.34 -6.67 8.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 O-C-N 123.834 0.709 . . . . 0.0 111.941 -178.992 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -65.39 -23.15 66.89 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.108 0.48 . . . . 0.0 110.367 179.212 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -177.8 -8.99 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.987 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 94.42 22.1 25.27 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.707 -0.759 . . . . 0.0 111.72 179.726 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.627 ' O ' HG22 ' A' ' 77' ' ' THR . 26.7 p90 -111.33 153.1 26.45 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 -179.367 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.716 ' HD2' ' HB ' ' A' ' 77' ' ' THR . 0.0 OUTLIER 171.63 -148.39 0.0 OUTLIER 'General case' 0 C--O 1.233 0.224 0 O-C-N 123.683 0.614 . . . . 0.0 110.956 179.958 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -123.4 160.14 27.45 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.173 -177.885 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.531 ' HA ' ' HA ' ' A' ' 74' ' ' ARG . 41.8 ttt180 -86.66 155.09 20.54 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 179.562 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 44.8 tt0 -163.99 169.32 18.16 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 121.091 0.472 . . . . 0.0 110.992 -178.817 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -136.85 133.06 6.29 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.841 -0.695 . . . . 0.0 111.686 179.169 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 10.1 tt -115.28 134.51 58.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-O 121.047 0.451 . . . . 0.0 110.18 -179.644 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -80.26 141.14 35.83 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.142 -179.688 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.742 HD13 HD11 ' A' ' 19' ' ' LEU . 16.6 mt -106.73 43.5 1.15 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.455 0.645 . . . . 0.0 110.887 -178.343 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 45.4 m-80 -79.63 3.28 19.52 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.463 -179.506 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.48 ' HD3' ' CD2' ' A' ' 50' ' ' TRP . 32.6 mtp180 -93.69 -9.89 36.28 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.576 178.847 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 17.2 mm -96.02 112.1 27.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 -179.57 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -119.1 147.01 44.63 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.149 -178.044 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 16.8 p-10 -95.6 102.89 14.73 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.51 0.671 . . . . 0.0 109.602 178.12 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 46.7 t -92.05 105.94 17.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.971 -179.351 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 60.7 33.88 20.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.842 -179.488 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 94.98 -23.03 35.03 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 121.037 -0.601 . . . . 0.0 113.007 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 3.7 mpt_? -87.13 129.39 34.95 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.945 0.373 . . . . 0.0 110.107 -179.181 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.592 HD13 ' SG ' ' A' ' 23' ' ' CYS . 6.7 tp -78.38 117.64 19.8 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -179.807 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 25.4 t -128.93 141.03 47.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.262 -179.155 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.542 ' HZ ' ' HG ' ' A' ' 40' ' ' CYS . 5.9 t80 -86.55 135.0 33.61 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 178.53 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 5.1 tp60 . . . . . 0 C--O 1.251 1.178 0 CA-C-O 118.506 -0.759 . . . . 0.0 110.234 179.43 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.1 m . . . . . 0 N--CA 1.448 -0.527 0 CA-C-O 120.439 0.161 . . . . 0.0 110.645 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.511 ' HA ' ' OD1' ' A' ' 95' ' ' ASN . 11.0 p90 -57.49 -35.19 69.88 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.666 -0.243 . . . . 0.0 111.298 179.245 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -57.29 -22.24 40.37 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -178.978 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -66.27 -13.6 60.68 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.05 0.453 . . . . 0.0 110.977 179.565 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 11.0 p -149.25 33.98 0.73 Allowed 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 178.814 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 15.9 t -146.95 150.7 35.7 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.021 -179.268 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 34.6 ptt180 -129.55 164.5 23.67 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.666 -179.232 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 51.25 65.32 1.52 Allowed 'General case' 0 C--N 1.329 -0.299 0 O-C-N 123.826 0.704 . . . . 0.0 112.151 178.503 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.446 ' HA ' ' HB2' ' A' ' 21' ' ' ALA . . . -91.3 117.85 30.0 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.155 179.449 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 33.8 m -119.39 166.95 13.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.881 -179.372 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.636 HD21 ' HG ' ' A' ' 64' ' ' LEU . 3.1 mm? -105.22 117.14 33.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.014 -179.734 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.49 ' OG1' ' HB ' ' A' ' 18' ' ' THR . 23.5 p -111.29 164.21 13.14 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.639 -179.65 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.49 ' HB3' ' HD3' ' A' ' 17' ' ' ARG . 89.6 m-20 62.26 39.08 12.86 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.71 179.265 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 84.62 -8.47 68.77 Favored Glycine 0 CA--C 1.517 0.179 0 C-N-CA 120.742 -0.742 . . . . 0.0 113.325 179.144 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.495 ' HA2' ' HB3' ' A' ' 12' ' ' LEU . . . 114.09 53.88 0.43 Allowed Glycine 0 N--CA 1.443 -0.873 0 C-N-CA 120.527 -0.844 . . . . 0.0 111.383 179.421 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.49 ' HD3' ' HB3' ' A' ' 14' ' ' ASN . 3.4 ptm180 -137.78 -34.01 0.69 Allowed 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.088 0.471 . . . . 0.0 110.573 -179.91 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.49 ' HB ' ' OG1' ' A' ' 13' ' ' THR . 4.2 m -102.36 135.06 44.65 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.54 -179.798 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.713 HD11 HD13 ' A' ' 90' ' ' LEU . 62.6 mt -94.95 116.4 28.65 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.218 179.136 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.411 ' NE ' HG21 ' A' ' 13' ' ' THR . 33.5 ttm180 -111.4 120.39 42.0 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 178.732 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.446 ' HB2' ' HA ' ' A' ' 10' ' ' ALA . . . -153.7 165.34 36.29 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.862 0.363 . . . . 0.0 111.418 -179.526 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -91.44 106.0 18.17 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 177.801 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.404 ' HB3' HD22 ' A' ' 95' ' ' ASN . 64.0 m -96.01 134.89 38.49 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 120.911 0.386 . . . . 0.0 110.984 -178.495 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.511 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 15.1 ttp180 -77.54 111.41 13.24 Favored 'General case' 0 N--CA 1.439 -0.999 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.052 179.558 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.463 HD21 ' HB3' ' A' ' 29' ' ' ASN . 38.2 p30 -75.71 169.38 18.22 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.48 -179.786 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.86 -33.29 64.42 Favored 'General case' 0 C--O 1.235 0.296 0 O-C-N 123.416 0.447 . . . . 0.0 111.718 -179.151 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -68.22 -14.69 63.17 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.327 0.584 . . . . 0.0 110.677 179.969 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 88.66 37.56 7.38 Favored Glycine 0 N--CA 1.447 -0.589 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 -179.504 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.511 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 53.7 t30 -124.81 164.16 20.6 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.496 0.189 . . . . 0.0 110.891 -179.082 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 91.1 m95 -98.05 124.89 42.77 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.885 179.587 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.4 m -128.42 137.88 56.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.028 178.544 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 37.4 m -84.1 109.32 17.61 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.002 0.43 . . . . 0.0 111.055 -179.048 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 69.6 m -119.09 148.8 42.64 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.138 179.409 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.646 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 45.4 mt-10 -127.86 145.33 50.97 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.867 -179.955 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.798 HD11 ' HB2' ' A' ' 102' ' ' PHE . 1.8 tm? -139.71 130.58 26.12 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 179.507 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.49 ' N ' HD13 ' A' ' 35' ' ' LEU . 39.7 m-20 -87.26 110.53 20.26 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.002 179.825 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.524 HD13 HD22 ' A' ' 90' ' ' LEU . 1.8 mt -84.86 -20.79 30.27 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.845 0.355 . . . . 0.0 110.871 -179.923 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.423 ' HA ' ' HD1' ' A' ' 55' ' ' PHE . 5.6 p-10 -67.35 -5.88 16.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.983 -178.195 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.416 HG22 ' O ' ' A' ' 36' ' ' ASP . 10.6 t -84.65 -8.51 58.85 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.867 0.365 . . . . 0.0 110.358 179.415 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 21.8 t -140.49 -5.41 1.22 Allowed 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 179.511 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 59.5 mt -106.95 136.7 41.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 O-C-N 122.036 -0.415 . . . . 0.0 109.882 178.957 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.656 ' HA3' ' HB3' ' A' ' 52' ' ' MET . . . -146.72 154.38 25.94 Favored Glycine 0 N--CA 1.443 -0.846 0 C-N-CA 120.89 -0.671 . . . . 0.0 111.777 179.553 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.4 HD22 ' CD2' ' A' ' 48' ' ' LEU . 27.6 p30 -155.28 48.15 0.36 Allowed Pre-proline 0 CA--C 1.537 0.454 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 179.986 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -68.69 -23.75 35.83 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 121.722 1.614 . . . . 0.0 112.238 -179.084 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 72.0 m-20 -91.94 0.59 57.47 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.923 -179.582 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.546 ' CA ' ' HG2' ' A' ' 83' ' ' ARG . . . 93.05 7.28 62.59 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.287 -0.959 . . . . 0.0 112.049 -179.301 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -122.55 133.95 54.55 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.851 0.357 . . . . 0.0 110.807 179.831 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.433 ' HB3' ' HB ' ' A' ' 88' ' ' ILE . 34.0 mt -84.5 147.89 26.81 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.536 -0.757 . . . . 0.0 111.664 -179.172 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 170.37 168.95 32.91 Favored Glycine 0 N--CA 1.441 -1.023 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.974 179.121 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.403 ' HH2' HD11 ' A' ' 93' ' ' ILE . 89.1 m95 -95.64 125.33 40.15 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 179.975 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 161.77 -53.72 0.32 Allowed Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 121.026 -0.607 . . . . 0.0 112.249 -179.696 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.656 ' HB3' ' HA3' ' A' ' 42' ' ' GLY . 4.1 tpt -90.92 -164.82 1.23 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 -179.952 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -146.3 170.58 16.5 Favored 'General case' 0 C--O 1.234 0.275 0 O-C-N 122.025 -0.422 . . . . 0.0 111.939 -178.815 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 14.9 m120 64.0 36.13 10.17 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.454 -0.794 . . . . 0.0 112.599 178.991 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.454 ' HB3' ' HA2' ' A' ' 42' ' ' GLY . 8.0 p90 -65.23 -29.75 70.58 Favored 'General case' 0 C--O 1.224 -0.288 0 CA-C-O 120.684 0.278 . . . . 0.0 111.193 -179.896 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.454 ' HB2' ' HB3' ' A' ' 17' ' ' ARG . 13.4 t -57.07 -36.69 70.85 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -178.315 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 13.3 m-70 -80.82 -6.56 58.72 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.151 0.5 . . . . 0.0 110.984 -179.528 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 12.9 m -119.03 25.78 9.96 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.118 -179.987 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.532 ' HB2' HD11 ' A' ' 62' ' ' ILE . 11.6 m -137.3 140.23 41.4 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-O 121.059 0.457 . . . . 0.0 111.321 179.788 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -108.71 141.2 41.04 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.179 179.063 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 39.1 t70 52.35 75.94 0.21 Allowed 'General case' 0 C--N 1.32 -0.7 0 O-C-N 123.998 0.811 . . . . 0.0 111.402 179.95 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.533 HG23 HD21 ' A' ' 71' ' ' LEU . 81.6 mt -90.22 122.25 41.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.235 179.591 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.7 tptm -146.97 160.32 42.5 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.124 -178.892 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.636 ' HG ' HD21 ' A' ' 12' ' ' LEU . 55.8 mt -93.66 130.01 39.75 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.267 0.556 . . . . 0.0 110.012 178.602 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.462 ' HB3' ' HB3' ' A' ' 70' ' ' LYS . 45.2 tp10 -77.71 -66.33 0.85 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.39 -178.108 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.534 ' HB2' ' HB3' ' A' ' 69' ' ' ARG . 23.7 mt-10 -88.68 31.43 0.84 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.189 -178.889 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 68.04 17.91 70.3 Favored Glycine 0 N--CA 1.446 -0.638 0 CA-C-N 115.8 -0.636 . . . . 0.0 113.091 179.83 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.517 ' HA2' HD22 ' A' ' 64' ' ' LEU . . . 137.14 -21.96 3.28 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 119.828 -1.177 . . . . 0.0 113.3 179.184 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.534 ' HB3' ' HB2' ' A' ' 66' ' ' GLU . 0.8 OUTLIER -76.74 -21.05 55.81 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.579 0.704 . . . . 0.0 109.987 -179.642 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.462 ' HB3' ' HB3' ' A' ' 65' ' ' GLU . 2.6 ttmp? -148.43 138.46 22.42 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.094 -178.708 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.641 ' HB2' HD11 ' A' ' 90' ' ' LEU . 10.2 tt -108.89 124.96 51.46 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.309 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.1 p -116.16 127.77 55.08 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.544 0.687 . . . . 0.0 111.014 179.561 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.496 ' HB3' ' HA ' ' A' ' 62' ' ' ILE . 26.6 p -153.51 175.86 12.7 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.314 -179.721 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.615 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 12.0 ttt180 -108.33 98.74 28.77 Favored Pre-proline 0 C--N 1.31 -1.114 0 C-N-CA 120.623 -0.431 . . . . 0.0 110.007 178.654 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.665 ' O ' ' HB3' ' A' ' 83' ' ' ARG . 49.4 Cg_endo -67.12 122.54 9.86 Favored 'Trans proline' 0 CA--C 1.516 -0.4 0 C-N-CA 122.835 2.357 . . . . 0.0 110.82 179.478 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.778 ' HA ' ' HB2' ' A' ' 83' ' ' ARG . 0.3 OUTLIER -120.29 147.04 45.5 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-O 120.914 0.388 . . . . 0.0 111.564 -179.333 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.771 HG22 ' O ' ' A' ' 82' ' ' PHE . 7.9 t -74.84 137.82 42.11 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 178.988 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 29.6 m -73.2 -12.33 15.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 123.82 0.7 . . . . 0.0 111.355 -179.635 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -63.55 -33.38 75.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.652 179.379 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.553 ' HA3' ' CE2' ' A' ' 82' ' ' PHE . . . -145.81 -23.07 0.12 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.42 -0.895 . . . . 0.0 113.088 179.73 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.616 ' HA2' ' HD3' ' A' ' 76' ' ' LYS . . . 98.68 14.7 36.6 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 121.049 -0.596 . . . . 0.0 111.877 -179.706 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.771 ' O ' HG22 ' A' ' 77' ' ' THR . 28.2 p90 -112.48 154.26 26.15 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 119.029 -0.51 . . . . 0.0 110.608 -178.492 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.778 ' HB2' ' HA ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 167.38 -153.13 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.461 0 O-C-N 123.745 0.653 . . . . 0.0 111.202 178.308 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.408 ' O ' ' HG3' ' A' ' 74' ' ' ARG . 18.7 mm-40 -116.48 -177.34 3.16 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.143 -177.24 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.615 ' HA ' ' HA ' ' A' ' 74' ' ' ARG . 68.0 ttt180 -107.21 155.31 20.05 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 178.783 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 86' ' ' GLN . . . . . 0.459 ' HG2' ' N ' ' A' ' 87' ' ' GLY . 50.9 tt0 -166.37 167.74 15.57 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 120.87 0.366 . . . . 0.0 111.491 -178.976 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.459 ' N ' ' HG2' ' A' ' 86' ' ' GLN . . . -130.39 144.08 15.4 Favored Glycine 0 N--CA 1.45 -0.428 0 N-CA-C 111.564 -0.614 . . . . 0.0 111.564 178.601 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.433 ' HB ' ' HB3' ' A' ' 48' ' ' LEU . 9.4 tt -126.57 138.92 53.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 120.93 0.395 . . . . 0.0 110.517 -179.846 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -77.42 135.91 38.35 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.369 179.811 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.713 HD13 HD11 ' A' ' 19' ' ' LEU . 53.9 mt -105.38 39.43 1.74 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.688 -179.884 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -75.35 2.53 11.03 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.104 -179.541 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 49.0 mtp180 -95.88 -10.48 28.72 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.657 -0.702 . . . . 0.0 109.967 178.33 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.476 HG13 HD22 ' A' ' 37' ' ' LEU . 20.9 mm -100.66 99.51 8.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -179.764 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 24.4 tp60 -115.98 143.14 45.85 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.089 -178.485 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.511 ' OD1' ' HA ' ' A' ' 3' ' ' TYR . 15.0 p-10 -95.18 122.81 38.25 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.008 178.728 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.3 p -115.04 115.75 50.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-O 121.16 0.505 . . . . 0.0 109.944 179.313 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 10.9 m120 60.37 28.3 17.92 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.709 -179.166 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 94.77 -14.94 64.4 Favored Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 120.804 -0.712 . . . . 0.0 113.048 179.915 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.47 ' HD2' ' N ' ' A' ' 99' ' ' ARG . 3.3 mpt_? -91.7 131.93 36.74 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 117.158 0.479 . . . . 0.0 110.559 -179.12 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.41 ' HA ' HD12 ' A' ' 100' ' ' LEU . 8.5 tp -84.29 116.54 23.05 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.251 -179.28 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 24.4 t -125.54 140.3 48.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 120.798 0.332 . . . . 0.0 110.914 -179.287 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.798 ' HB2' HD11 ' A' ' 35' ' ' LEU . 3.9 t80 -91.67 124.37 35.76 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 178.396 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 . . . . . 0 C--N 1.314 -0.969 0 CA-C-O 118.002 -0.999 . . . . 0.0 110.955 179.82 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 2' ' ' SER . . . . . 0.591 ' OG ' ' HA ' ' A' ' 91' ' ' ASN . 3.3 m . . . . . 0 N--CA 1.452 -0.355 0 N-CA-C 109.97 -0.382 . . . . 0.0 109.97 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.557 ' HA ' ' OD1' ' A' ' 95' ' ' ASN . 23.4 p90 -58.31 -37.65 75.5 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.53 0.205 . . . . 0.0 111.446 -179.892 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -55.09 -19.2 6.77 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.792 -0.64 . . . . 0.0 112.623 -178.794 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -59.15 -38.15 79.03 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.389 0.614 . . . . 0.0 109.956 179.168 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 49.2 m -133.08 46.5 2.6 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.15 179.086 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.431 ' HA ' ' HZ3' ' A' ' 30' ' ' TRP . 16.5 t -148.79 152.18 36.09 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.22 -179.329 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 3.9 ptp180 -149.39 171.69 16.14 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.314 -179.846 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.426 ' HB2' ' HG2' ' A' ' 22' ' ' GLU . 24.1 m120 62.96 45.84 5.16 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 122.959 0.504 . . . . 0.0 110.437 -179.286 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -83.16 118.07 23.34 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.996 -179.718 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 27.1 m -126.24 170.69 15.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.193 179.519 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.565 ' HB3' ' HA2' ' A' ' 16' ' ' GLY . 3.0 mm? -105.37 117.64 34.53 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 -179.332 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.409 ' OG1' ' HB ' ' A' ' 18' ' ' THR . 28.0 p -113.87 162.17 16.69 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.974 0.416 . . . . 0.0 111.508 -179.745 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 64.32 30.33 13.39 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.526 179.652 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 95.92 -18.87 56.64 Favored Glycine 0 C--O 1.228 -0.255 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.755 179.46 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.565 ' HA2' ' HB3' ' A' ' 12' ' ' LEU . . . 123.47 42.6 0.38 Allowed Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.508 -0.853 . . . . 0.0 111.768 179.78 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -126.77 -29.02 2.9 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.096 0.474 . . . . 0.0 110.541 -179.91 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.409 ' HB ' ' OG1' ' A' ' 13' ' ' THR . 4.9 m -104.53 134.25 48.02 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.555 -179.877 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.803 HD11 HD13 ' A' ' 90' ' ' LEU . 33.6 mt -94.23 113.32 25.22 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.118 179.02 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 45.1 ttt180 -106.96 119.51 39.57 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 178.843 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -154.12 166.36 33.32 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.878 0.37 . . . . 0.0 111.151 -179.762 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.426 ' HG2' ' HB2' ' A' ' 9' ' ' ASN . 56.2 mm-40 -90.71 113.45 25.54 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 178.276 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.45 ' SG ' HD13 ' A' ' 100' ' ' LEU . 60.4 m -100.31 123.53 44.66 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 110.34 -0.245 . . . . 0.0 110.34 -178.957 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.514 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 11.7 ttp180 -72.6 114.47 10.77 Favored 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 179.015 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.407 HD21 ' HB3' ' A' ' 29' ' ' ASN . 35.4 p30 -77.66 171.04 15.54 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.85 -179.23 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.36 -33.87 63.77 Favored 'General case' 0 N--CA 1.464 0.252 0 O-C-N 123.675 0.609 . . . . 0.0 111.917 -178.776 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -67.92 -18.69 64.85 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.361 0.601 . . . . 0.0 110.613 -179.851 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 93.69 33.66 6.97 Favored Glycine 0 N--CA 1.443 -0.849 0 N-CA-C 111.085 -0.806 . . . . 0.0 111.085 -179.475 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.514 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 10.8 t-20 -118.49 159.89 22.71 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 110.013 -0.365 . . . . 0.0 110.013 -179.221 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.431 ' HZ3' ' HA ' ' A' ' 7' ' ' SER . 95.5 m95 -98.37 117.67 33.31 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.855 0.36 . . . . 0.0 110.6 179.918 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 12.5 m -119.23 132.27 69.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.38 178.773 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 27.9 m -74.86 110.36 9.09 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.021 0.439 . . . . 0.0 110.231 -179.624 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 60.7 m -121.29 145.62 47.68 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.599 -179.606 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.598 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 50.4 mt-10 -129.03 130.59 46.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.931 -179.505 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.449 HD11 ' HB2' ' A' ' 102' ' ' PHE . 2.4 tm? -124.86 131.62 53.42 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.437 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.423 ' N ' HD13 ' A' ' 35' ' ' LEU . 9.0 m-20 -89.78 109.16 20.17 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.841 0.353 . . . . 0.0 110.189 -179.114 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.529 HD13 HD22 ' A' ' 90' ' ' LEU . 2.4 mt -81.87 -17.84 45.9 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.164 -179.494 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -62.18 -10.18 9.78 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.817 0.342 . . . . 0.0 111.149 -179.317 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 59.5 p -78.99 -20.4 49.18 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.191 179.585 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.424 ' SG ' ' HE3' ' A' ' 50' ' ' TRP . 20.5 t -132.36 -8.66 3.32 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -179.191 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 53.9 mt -104.69 133.45 48.79 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 O-C-N 122.132 -0.355 . . . . 0.0 110.225 178.777 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.525 ' HA3' ' HB3' ' A' ' 52' ' ' MET . . . -147.84 160.28 28.27 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.921 -0.657 . . . . 0.0 111.823 179.91 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.464 HD22 ' CD1' ' A' ' 48' ' ' LEU . 21.6 p30 -162.3 54.15 0.46 Allowed Pre-proline 0 CA--C 1.537 0.45 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -179.799 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -72.16 -18.17 27.32 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 121.923 1.749 . . . . 0.0 112.311 -179.242 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.449 ' O ' ' HD3' ' A' ' 83' ' ' ARG . 93.0 m-20 -93.25 -16.51 24.69 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.437 179.822 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.538 ' HA3' ' HG2' ' A' ' 83' ' ' ARG . . . 109.82 9.64 24.3 Favored Glycine 0 N--CA 1.442 -0.964 0 C-N-CA 120.467 -0.873 . . . . 0.0 112.542 -179.333 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -125.55 134.67 51.9 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.872 0.368 . . . . 0.0 110.623 179.716 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.595 HD23 HG22 ' A' ' 88' ' ' ILE . 10.5 mp -84.23 142.91 29.94 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.345 0.593 . . . . 0.0 111.848 -178.603 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 176.96 171.33 40.44 Favored Glycine 0 N--CA 1.439 -1.148 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.611 178.956 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.424 ' HE3' ' SG ' ' A' ' 40' ' ' CYS . 91.4 m95 -96.11 124.74 40.23 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 179.835 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 160.2 -58.81 0.31 Allowed Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 121.21 -0.519 . . . . 0.0 111.873 -179.708 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.525 ' HB3' ' HA3' ' A' ' 42' ' ' GLY . 12.8 tpt -85.89 175.2 8.77 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 -179.893 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -128.8 167.0 17.95 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.722 -0.391 . . . . 0.0 111.075 -179.712 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 11.3 m-80 64.56 49.79 2.3 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.449 179.026 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.453 ' HB3' ' HA2' ' A' ' 42' ' ' GLY . 21.1 p90 -68.48 -31.2 70.31 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.07 0.462 . . . . 0.0 110.187 179.021 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.443 ' HA ' HD11 ' A' ' 62' ' ' ILE . 3.5 p -56.53 -38.16 71.48 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.591 -178.699 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 22.4 m80 -72.49 -30.94 64.96 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.632 0.253 . . . . 0.0 111.331 -179.52 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 14.1 m -96.88 18.36 14.74 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.011 -179.488 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 45.4 m -130.79 165.31 23.25 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.199 0.523 . . . . 0.0 111.491 -179.756 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -137.64 136.14 37.19 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.245 -0.889 . . . . 0.0 108.95 178.589 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 37.0 t70 58.88 80.22 0.19 Allowed 'General case' 0 N--CA 1.467 0.425 0 O-C-N 123.649 0.593 . . . . 0.0 110.86 -179.705 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.525 ' HA ' ' HB3' ' A' ' 73' ' ' CYS . 59.9 mt -100.95 122.16 52.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.261 -179.13 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 72.9 tttt -149.22 165.1 32.89 Favored 'General case' 0 C--O 1.221 -0.407 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 179.466 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.525 ' HG ' HD21 ' A' ' 12' ' ' LEU . 71.2 mt -90.84 127.39 36.34 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.068 0.461 . . . . 0.0 111.072 -179.603 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -76.29 -57.97 3.55 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.443 -0.798 . . . . 0.0 110.676 -179.179 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.477 ' CB ' ' HB3' ' A' ' 69' ' ' ARG . 15.4 mm-40 -85.03 11.84 8.81 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.789 -179.521 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 71.61 28.07 69.98 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.383 179.973 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 136.86 -34.48 2.21 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.207 -0.996 . . . . 0.0 112.627 179.448 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.477 ' HB3' ' CB ' ' A' ' 66' ' ' GLU . 2.1 tpp180 -75.62 -18.47 59.69 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.116 0.484 . . . . 0.0 110.589 -179.551 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.45 ' HB3' ' HG2' ' A' ' 66' ' ' GLU . 38.9 ttmt -151.42 141.88 22.53 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.067 -178.804 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.562 ' HB2' HD11 ' A' ' 90' ' ' LEU . 10.5 tt -110.52 128.62 55.72 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.104 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.2 p -123.16 128.11 49.6 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.317 0.58 . . . . 0.0 111.293 -179.905 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.525 ' HB3' ' HA ' ' A' ' 62' ' ' ILE . 20.5 p -151.94 169.91 21.15 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.516 179.875 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.635 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 29.4 ttt180 -106.35 99.73 25.64 Favored Pre-proline 0 C--N 1.321 -0.645 0 C-N-CA 120.263 -0.575 . . . . 0.0 110.492 179.126 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.647 ' O ' ' HB3' ' A' ' 83' ' ' ARG . 60.5 Cg_endo -71.75 137.85 30.68 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 122.622 2.215 . . . . 0.0 110.273 178.718 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.712 ' HA ' ' HB2' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -121.39 140.68 51.82 Favored 'General case' 0 C--N 1.317 -0.807 0 O-C-N 123.483 0.49 . . . . 0.0 111.113 -179.883 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.732 HG22 ' O ' ' A' ' 82' ' ' PHE . 12.5 t -75.61 138.86 41.71 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 179.291 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 34.7 m -73.18 -9.78 13.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 O-C-N 124.122 0.889 . . . . 0.0 111.199 -179.826 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -66.92 -31.39 71.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.054 179.673 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.406 ' HA3' ' CE2' ' A' ' 82' ' ' PHE . . . -154.48 -12.49 0.06 OUTLIER Glycine 0 CA--C 1.521 0.428 0 C-N-CA 120.519 -0.848 . . . . 0.0 113.359 179.751 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.615 ' HA2' ' HE3' ' A' ' 76' ' ' LYS . . . 91.25 16.25 53.88 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.959 -0.639 . . . . 0.0 112.082 -179.792 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.732 ' O ' HG22 ' A' ' 77' ' ' THR . 35.4 p90 -111.76 158.35 19.45 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 118.694 -0.669 . . . . 0.0 109.612 -178.866 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.712 ' HB2' ' HA ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 171.37 -148.25 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 179.431 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -142.99 152.49 42.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.373 -0.831 . . . . 0.0 109.496 -178.195 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.635 ' HA ' ' HA ' ' A' ' 74' ' ' ARG . 27.8 ttt85 -77.84 150.43 34.22 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 123.229 0.331 . . . . 0.0 110.123 -179.794 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 86' ' ' GLN . . . . . 0.431 ' HB3' HD13 ' A' ' 48' ' ' LEU . 52.4 tt0 -155.58 158.85 39.07 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.317 -178.806 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -123.32 144.34 15.58 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.088 179.412 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.595 HG22 HD23 ' A' ' 48' ' ' LEU . 12.8 tt -123.96 135.04 64.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 179.563 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -77.1 140.92 40.4 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.068 0.461 . . . . 0.0 110.017 -179.882 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.803 HD13 HD11 ' A' ' 19' ' ' LEU . 26.4 mt -106.35 41.17 1.47 Allowed 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.334 0.588 . . . . 0.0 110.765 -179.424 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.591 ' HA ' ' OG ' ' A' ' 2' ' ' SER . 10.6 m120 -75.06 2.85 9.62 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.763 -179.96 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 9.7 mtp180 -96.72 -16.54 20.84 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.165 179.797 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.434 HG13 HD22 ' A' ' 37' ' ' LEU . 22.4 mm -92.73 114.36 29.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 109.684 -0.488 . . . . 0.0 109.684 -178.904 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 23.1 tp60 -124.6 141.46 52.08 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.356 0.598 . . . . 0.0 111.545 -178.157 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.557 ' OD1' ' HA ' ' A' ' 3' ' ' TYR . 13.1 p-10 -94.62 102.22 14.13 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.673 178.176 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.7 p -90.56 110.41 22.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.504 -179.348 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 60.42 27.32 16.92 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.14 -179.919 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 100.29 -17.04 57.48 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.735 -0.745 . . . . 0.0 113.225 179.739 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.41 ' HD2' ' N ' ' A' ' 99' ' ' ARG . 1.7 mpt_? -91.53 126.09 36.49 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 117.23 0.515 . . . . 0.0 109.871 -179.541 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.45 HD13 ' SG ' ' A' ' 23' ' ' CYS . 11.2 tp -82.84 114.03 20.87 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.233 -179.203 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 38.4 t -131.47 146.48 33.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 120.694 0.283 . . . . 0.0 110.321 -179.338 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.449 ' HB2' HD11 ' A' ' 35' ' ' LEU . 11.7 t80 -78.67 133.94 37.17 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 178.771 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 . . . . . 0 C--O 1.247 0.951 0 CA-C-O 118.632 -0.699 . . . . 0.0 110.067 179.824 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 2' ' ' SER . . . . . 0.848 ' HB2' ' HG2' ' A' ' 69' ' ' ARG . 4.7 m . . . . . 0 N--CA 1.452 -0.328 0 CA-C-O 120.639 0.257 . . . . 0.0 110.848 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.422 ' CD2' HD11 ' A' ' 100' ' ' LEU . 4.2 p90 -59.85 -33.27 71.56 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.228 -0.442 . . . . 0.0 112.032 -179.713 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.606 ' HA ' ' OG ' ' A' ' 7' ' ' SER . . . -55.16 -18.41 5.72 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -178.167 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -58.32 -42.85 87.65 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.976 0.417 . . . . 0.0 111.166 179.727 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.416 ' HB2' HD21 ' A' ' 95' ' ' ASN . 25.6 m -123.02 38.44 4.19 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 121.044 0.45 . . . . 0.0 110.903 -179.486 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.606 ' OG ' ' HA ' ' A' ' 4' ' ' ALA . 52.5 p -141.28 168.19 20.37 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.21 179.143 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 37.1 ptt180 -149.76 168.23 24.27 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.005 -178.564 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 55.25 43.24 29.52 Favored 'General case' 0 C--N 1.33 -0.244 0 O-C-N 124.089 0.868 . . . . 0.0 112.203 178.078 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.442 ' HA ' ' HB2' ' A' ' 21' ' ' ALA . . . -72.28 117.0 13.38 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 179.251 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.463 HG21 HH21 ' A' ' 20' ' ' ARG . 27.8 m -124.0 172.74 11.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.713 -179.423 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.637 ' HB3' ' HA2' ' A' ' 16' ' ' GLY . 3.7 mm? -104.74 115.81 30.95 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.775 -179.311 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 27.9 p -112.45 161.08 17.11 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.666 179.387 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 59.25 44.58 15.35 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.17 179.553 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 87.35 -23.61 11.62 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.218 -179.715 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.637 ' HA2' ' HB3' ' A' ' 12' ' ' LEU . . . 124.85 17.01 2.88 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 121.109 -0.567 . . . . 0.0 111.894 -179.867 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.749 ' HB2' ' HB2' ' A' ' 38' ' ' ASP . 3.6 ptm180 -95.78 -22.05 17.75 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.227 0.537 . . . . 0.0 110.375 -179.609 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.482 ' CG2' ' HB3' ' A' ' 34' ' ' GLU . 2.7 m -111.29 135.99 51.03 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.788 -178.978 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.727 HD11 HD13 ' A' ' 90' ' ' LEU . 41.8 mt -97.46 112.55 24.35 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.768 179.361 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.463 HH21 HG21 ' A' ' 11' ' ' VAL . 30.5 ttp180 -105.1 120.65 42.03 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 178.439 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.442 ' HB2' ' HA ' ' A' ' 10' ' ' ALA . . . -152.97 162.41 41.35 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.906 0.384 . . . . 0.0 111.062 -179.878 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -90.84 105.75 18.04 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 178.439 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.56 ' SG ' HD13 ' A' ' 100' ' ' LEU . 40.2 m -94.21 132.09 39.12 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 -179.449 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 8.0 ttp180 -84.28 116.46 23.0 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-O 120.776 0.322 . . . . 0.0 110.747 -179.886 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 31.4 p30 -82.07 162.23 22.63 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.086 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.49 -21.72 17.78 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -178.68 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -74.69 -13.77 60.66 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.317 0.58 . . . . 0.0 110.195 179.764 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 89.74 32.13 10.47 Favored Glycine 0 N--CA 1.449 -0.456 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.93 179.987 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 -124.47 151.62 44.34 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.826 0.346 . . . . 0.0 111.364 -179.519 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 93.9 m95 -90.96 120.59 32.09 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.568 179.384 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -118.56 127.3 75.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 116.247 -0.433 . . . . 0.0 109.918 178.079 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 25.5 m -76.48 111.52 12.04 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.194 179.935 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 66.7 m -123.06 145.66 48.35 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.906 -179.376 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.602 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 44.8 mt-10 -124.91 133.07 53.19 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.882 179.708 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.724 HD11 ' HB2' ' A' ' 102' ' ' PHE . 1.5 tm? -125.42 131.59 52.89 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.167 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.456 ' O ' HG22 ' A' ' 39' ' ' THR . 14.5 m-20 -90.05 110.27 21.27 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.012 0.434 . . . . 0.0 110.241 -179.779 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.495 HD13 HD22 ' A' ' 90' ' ' LEU . 1.5 mt -83.8 -23.89 31.25 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.031 -179.749 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.749 ' HB2' ' HB2' ' A' ' 17' ' ' ARG . 20.9 t70 -60.49 -15.14 24.06 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.19 -0.459 . . . . 0.0 112.151 -178.647 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.456 HG22 ' O ' ' A' ' 36' ' ' ASP . 11.6 t -77.44 -14.48 59.69 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.721 -0.218 . . . . 0.0 111.387 -179.656 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.411 ' SG ' ' HE3' ' A' ' 50' ' ' TRP . 42.5 t -134.33 -0.79 2.94 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -179.609 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.443 ' HB ' ' CD1' ' A' ' 55' ' ' PHE . 60.4 mt -108.84 135.24 48.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 178.589 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.486 ' HA3' ' HB3' ' A' ' 52' ' ' MET . . . -138.61 156.53 24.2 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.095 -179.826 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.494 ' N ' HD21 ' A' ' 43' ' ' ASN . 0.0 OUTLIER -164.81 43.79 0.09 OUTLIER Pre-proline 0 CA--C 1.542 0.664 0 N-CA-C 113.102 0.778 . . . . 0.0 113.102 -179.377 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.446 ' HG3' ' SD ' ' A' ' 52' ' ' MET . 74.4 Cg_endo -73.17 -22.65 18.92 Favored 'Trans proline' 0 C--N 1.354 0.858 0 C-N-CA 121.661 1.574 . . . . 0.0 112.346 -178.913 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -84.4 -14.11 50.31 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.819 179.923 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.5 ' CA ' ' HG2' ' A' ' 83' ' ' ARG . . . 107.29 8.17 31.49 Favored Glycine 0 N--CA 1.444 -0.81 0 C-N-CA 120.301 -0.952 . . . . 0.0 111.994 -178.866 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -125.91 139.1 53.73 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 110.391 -0.226 . . . . 0.0 110.391 179.82 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 7.8 mp -89.89 151.04 21.94 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.225 0.536 . . . . 0.0 111.975 -178.931 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 167.24 170.99 32.79 Favored Glycine 0 N--CA 1.444 -0.782 0 CA-C-N 115.601 -0.727 . . . . 0.0 112.122 178.469 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.428 ' CD1' HD11 ' A' ' 88' ' ' ILE . 90.8 m95 -95.73 132.24 41.15 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 179.98 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 156.42 -63.08 0.33 Allowed Glycine 0 N--CA 1.451 -0.355 0 N-CA-C 111.573 -0.611 . . . . 0.0 111.573 179.915 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.486 ' HB3' ' HA3' ' A' ' 42' ' ' GLY . 39.7 ttm -88.63 176.63 7.04 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 179.34 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -130.65 172.41 11.98 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 118.288 0.495 . . . . 0.0 111.654 -179.294 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.715 ' HA ' ' OD2' ' A' ' 38' ' ' ASP . 13.2 m120 68.54 46.85 0.95 Allowed 'General case' 0 C--O 1.234 0.263 0 O-C-N 123.945 0.778 . . . . 0.0 111.697 179.129 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.443 ' CD1' ' HB ' ' A' ' 41' ' ' ILE . 13.7 p90 -76.6 -26.88 55.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.517 179.78 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 7.1 m -62.69 -30.45 71.41 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.199 0.523 . . . . 0.0 110.97 -178.694 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 30.9 m170 -82.11 -3.54 55.0 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.754 -179.519 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.405 ' HB2' ' ND2' ' A' ' 43' ' ' ASN . 42.4 m -128.29 28.69 5.45 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.112 0.482 . . . . 0.0 110.358 179.333 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.447 ' HA ' ' O ' ' A' ' 74' ' ' ARG . 15.4 p -143.61 157.85 44.11 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.105 179.829 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.438 ' HG3' ' HG2' ' A' ' 76' ' ' LYS . 50.6 mt-10 -127.0 136.86 52.82 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.991 179.663 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.43 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 36.5 t70 60.29 84.48 0.12 Allowed 'General case' 0 N--CA 1.467 0.381 0 O-C-N 123.608 0.568 . . . . 0.0 111.68 179.511 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 75.4 mt -97.92 120.38 47.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.103 179.547 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.6 tptm -147.33 148.19 31.13 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.123 -179.79 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.584 ' HG ' HD21 ' A' ' 12' ' ' LEU . 36.3 mt -88.56 145.23 25.84 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.868 -179.474 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -105.34 -62.14 1.39 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.044 -0.525 . . . . 0.0 112.107 -179.046 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.577 ' HB2' ' HB2' ' A' ' 69' ' ' ARG . 44.6 mm-40 -79.21 42.93 0.51 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.831 -178.527 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 62.49 20.41 61.27 Favored Glycine 0 C--N 1.317 -0.525 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.594 179.33 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.57 ' HA2' HD13 ' A' ' 64' ' ' LEU . . . 121.4 -14.88 9.31 Favored Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.388 -179.996 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.848 ' HG2' ' HB2' ' A' ' 2' ' ' SER . 48.3 mtm105 -84.02 2.27 39.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.13 0.491 . . . . 0.0 110.804 -179.718 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.492 ' HB3' ' HG2' ' A' ' 66' ' ' GLU . 37.3 ttmt -155.26 134.36 12.27 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.975 179.917 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.75 ' HB2' HD11 ' A' ' 90' ' ' LEU . 9.8 tt -116.77 125.71 52.03 Favored 'General case' 0 C--N 1.318 -0.794 0 O-C-N 123.576 0.548 . . . . 0.0 109.94 -179.723 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.7 p -113.97 136.29 53.06 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.769 179.208 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.43 ' HA ' ' O ' ' A' ' 61' ' ' ASP . 25.8 p -162.26 165.57 26.55 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.252 179.84 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.538 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 31.9 ttt180 -99.48 103.44 21.05 Favored Pre-proline 0 C--N 1.319 -0.745 0 C-N-CA 120.676 -0.409 . . . . 0.0 110.733 179.496 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.692 ' O ' ' HB3' ' A' ' 83' ' ' ARG . 43.8 Cg_endo -67.64 119.63 6.64 Favored 'Trans proline' 0 CA--C 1.512 -0.58 0 C-N-CA 122.569 2.18 . . . . 0.0 110.149 178.564 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.686 ' HA ' ' HB2' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -119.91 140.61 50.61 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 120.764 0.316 . . . . 0.0 111.682 -178.808 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.708 HG22 ' O ' ' A' ' 82' ' ' PHE . 12.9 t -72.52 135.22 45.59 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.695 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 26.7 m -73.33 -4.33 5.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 123.943 0.777 . . . . 0.0 112.056 -178.938 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -68.95 -32.9 72.83 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.13 0.49 . . . . 0.0 109.902 179.342 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -151.65 -20.23 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.678 179.819 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.22 20.73 22.25 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.751 -0.738 . . . . 0.0 111.949 -179.887 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.708 ' O ' HG22 ' A' ' 77' ' ' THR . 27.6 p90 -111.88 143.22 43.21 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 -178.876 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.692 ' HB3' ' O ' ' A' ' 75' ' ' PRO . 0.0 OUTLIER 175.06 -154.21 0.01 OUTLIER 'General case' 0 C--O 1.234 0.241 0 CA-C-O 120.796 0.332 . . . . 0.0 111.702 179.881 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -113.84 177.16 4.73 Favored 'General case' 0 C--O 1.225 -0.207 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.486 -178.708 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.558 ' HA ' ' HD2' ' A' ' 75' ' ' PRO . 59.1 ttt180 -110.39 150.86 28.2 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 178.77 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 86' ' ' GLN . . . . . 0.406 ' HG3' ' O ' ' A' ' 85' ' ' ARG . 26.6 mt-30 -156.84 -175.25 5.32 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -178.152 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -150.3 142.89 10.06 Favored Glycine 0 N--CA 1.45 -0.423 0 CA-C-N 114.803 -1.09 . . . . 0.0 111.108 179.09 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.428 HD11 ' CD1' ' A' ' 50' ' ' TRP . 13.2 tt -123.97 142.73 39.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 121.052 0.453 . . . . 0.0 110.649 -178.683 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -79.14 133.61 36.73 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.623 179.807 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.75 HD11 ' HB2' ' A' ' 71' ' ' LEU . 74.9 mt -106.27 41.25 1.45 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.324 0.583 . . . . 0.0 111.286 -179.44 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.563 ' HA ' ' OG ' ' A' ' 2' ' ' SER . 8.3 m120 -76.12 2.05 14.01 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.192 179.575 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 13.3 mtp180 -94.03 -6.98 44.02 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.783 179.392 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.432 HG13 HD22 ' A' ' 37' ' ' LEU . 17.7 mm -101.92 106.36 19.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -179.782 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 21.7 tp60 -118.93 149.35 41.74 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.994 -178.008 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.416 HD21 ' HB2' ' A' ' 6' ' ' SER . 14.7 p-10 -99.3 117.94 34.86 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.29 0.567 . . . . 0.0 110.435 178.858 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 48.1 t -103.71 100.4 10.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.5 179.191 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 7.3 m-80 58.69 43.5 18.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.858 -179.197 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 89.99 -23.42 20.76 Favored Glycine 0 N--CA 1.444 -0.792 0 CA-C-N 115.512 -0.767 . . . . 0.0 113.496 179.48 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.425 ' HD2' ' N ' ' A' ' 99' ' ' ARG . 4.4 mpt_? -86.78 123.39 31.87 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 117.116 0.458 . . . . 0.0 110.574 -179.271 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.56 HD13 ' SG ' ' A' ' 23' ' ' CYS . 5.6 tp -76.01 122.15 23.79 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.166 -179.403 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 24.1 t -129.35 138.95 53.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.933 -179.183 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.724 ' HB2' HD11 ' A' ' 35' ' ' LEU . 12.5 t80 -85.51 131.92 34.29 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.052 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 17.3 tt0 . . . . . 0 C--N 1.315 -0.892 0 CA-C-O 117.968 -1.015 . . . . 0.0 110.44 -179.954 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 2' ' ' SER . . . . . 0.486 ' OG ' ' HA ' ' A' ' 91' ' ' ASN . 17.7 m . . . . . 0 N--CA 1.448 -0.539 0 CA-C-O 120.564 0.221 . . . . 0.0 110.663 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.444 ' CG ' HD11 ' A' ' 100' ' ' LEU . 25.2 p90 -57.17 -30.64 64.67 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.201 179.362 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.463 ' HB3' ' HD2' ' A' ' 69' ' ' ARG . . . -53.7 -18.86 3.42 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.33 -179.363 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -61.06 -36.27 79.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.296 0.57 . . . . 0.0 109.977 179.043 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 24.5 m -133.95 36.46 3.27 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.805 179.691 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.411 ' HA ' ' HZ3' ' A' ' 30' ' ' TRP . 23.2 t -148.75 145.77 27.76 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.399 -179.987 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 4.5 ptp180 -136.61 167.9 20.52 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.585 -0.279 . . . . 0.0 111.646 -178.874 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 67.1 m-80 55.78 65.21 1.51 Allowed 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.435 179.893 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.404 ' HB3' ' O ' ' A' ' 67' ' ' GLY . . . -92.55 120.03 32.61 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.661 179.622 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 26.6 m -120.41 169.11 12.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.317 -179.731 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.742 HD21 ' HG ' ' A' ' 64' ' ' LEU . 3.1 mm? -104.67 116.91 32.86 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.24 -179.634 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.49 ' OG1' ' HB ' ' A' ' 18' ' ' THR . 18.9 p -109.81 161.94 14.96 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.452 179.48 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 62.15 40.87 11.34 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.945 -179.803 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 91.02 -45.38 2.85 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 121.034 -0.603 . . . . 0.0 112.459 179.62 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.571 ' HA2' ' HB3' ' A' ' 12' ' ' LEU . . . 149.77 52.42 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.506 0 N-CA-C 111.481 -0.648 . . . . 0.0 111.481 -179.469 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.505 ' HB3' ' OG ' ' A' ' 56' ' ' SER . 3.7 ptm180 -135.57 -33.46 0.87 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.146 0.498 . . . . 0.0 110.808 -179.811 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.49 ' HB ' ' OG1' ' A' ' 13' ' ' THR . 3.0 m -97.53 133.5 42.01 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.524 -179.968 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.653 HD11 HD13 ' A' ' 90' ' ' LEU . 44.1 mt -95.89 113.65 25.29 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.231 179.349 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 17.9 ttm180 -107.86 120.68 42.94 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 178.76 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -152.77 167.85 27.64 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.929 0.395 . . . . 0.0 111.365 -178.896 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -89.63 106.09 18.23 Favored 'General case' 0 CA--C 1.512 -0.491 0 N-CA-C 107.969 -1.122 . . . . 0.0 107.969 178.405 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.579 ' SG ' HD13 ' A' ' 100' ' ' LEU . 58.5 m -96.39 125.91 41.22 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 120.713 0.292 . . . . 0.0 110.225 -178.959 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.622 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 22.4 ttt180 -77.94 111.83 14.2 Favored 'General case' 0 N--CA 1.44 -0.933 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.087 179.639 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.454 HD21 ' HB3' ' A' ' 29' ' ' ASN . 36.0 p30 -74.18 170.65 15.1 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.318 -179.62 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.26 -11.73 23.68 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -177.806 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -88.15 -10.23 50.62 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 178.676 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 88.45 27.94 23.59 Favored Glycine 0 N--CA 1.448 -0.511 0 CA-C-N 114.956 -1.02 . . . . 0.0 111.535 -179.522 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.622 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 51.9 t30 -112.75 161.45 16.88 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.526 0.203 . . . . 0.0 111.162 -178.661 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.449 ' CZ3' ' HB2' ' A' ' 24' ' ' ARG . 95.4 m95 -102.5 116.85 33.46 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.715 179.596 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 6.2 m -118.82 141.1 40.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.608 179.309 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 61.6 m -81.1 108.62 14.92 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 179.209 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 50.3 m -120.34 150.43 40.76 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.351 -179.536 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.601 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 48.3 mt-10 -131.2 145.6 52.0 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.915 -179.893 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.669 HD11 ' HB2' ' A' ' 102' ' ' PHE . 2.2 tm? -139.45 132.0 28.75 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 178.777 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.479 ' N ' HD13 ' A' ' 35' ' ' LEU . 5.7 m-20 -90.33 110.25 21.32 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.919 0.39 . . . . 0.0 110.992 179.967 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.531 HD11 HD11 ' A' ' 19' ' ' LEU . 2.4 mt -80.67 -19.73 44.57 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.705 179.268 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.523 ' OD1' ' HA ' ' A' ' 54' ' ' ASN . 22.4 t70 -58.74 -18.7 33.85 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.389 -0.823 . . . . 0.0 112.339 -178.812 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.449 HG22 ' O ' ' A' ' 36' ' ' ASP . 14.6 t -82.61 -6.74 59.52 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 121.103 -0.239 . . . . 0.0 111.449 -179.639 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.521 ' SG ' ' HE3' ' A' ' 50' ' ' TRP . 25.8 t -135.0 -18.63 1.81 Allowed 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.816 -0.354 . . . . 0.0 111.467 179.556 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 56.0 mt -98.28 129.13 48.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 178.359 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.615 ' HA3' ' HB3' ' A' ' 52' ' ' MET . . . -141.11 164.69 26.45 Favored Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 120.64 -0.791 . . . . 0.0 111.67 179.784 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.788 HD21 ' HB3' ' A' ' 59' ' ' SER . 32.1 p-10 -161.92 47.26 0.21 Allowed Pre-proline 0 CA--C 1.538 0.487 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 -179.144 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -71.9 -23.21 22.39 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 121.562 1.508 . . . . 0.0 111.625 -179.536 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -84.26 -14.95 48.51 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.588 -179.893 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.404 ' CA ' ' HG2' ' A' ' 83' ' ' ARG . . . 103.98 8.22 39.66 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.051 -178.831 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -125.21 140.07 53.18 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 179.43 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.559 HD23 ' HB3' ' A' ' 43' ' ' ASN . 92.3 mt -86.68 145.64 26.61 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.012 -179.712 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 171.39 172.33 37.4 Favored Glycine 0 N--CA 1.444 -0.784 0 C-N-CA 120.785 -0.722 . . . . 0.0 111.745 179.207 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.521 ' HE3' ' SG ' ' A' ' 40' ' ' CYS . 87.2 m95 -95.53 125.2 39.96 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.826 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 159.99 -52.16 0.36 Allowed Glycine 0 CA--C 1.518 0.25 0 C-N-CA 121.129 -0.557 . . . . 0.0 112.453 -179.997 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.615 ' HB3' ' HA3' ' A' ' 42' ' ' GLY . 0.1 OUTLIER -97.15 178.03 5.39 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.29 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -129.99 171.78 12.42 Favored 'General case' 0 C--N 1.318 -0.798 0 O-C-N 122.04 -0.412 . . . . 0.0 111.295 -179.18 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.523 ' HA ' ' OD1' ' A' ' 38' ' ' ASP . 21.7 m-80 64.31 59.98 0.98 Allowed 'General case' 0 C--O 1.235 0.311 0 O-C-N 123.963 0.789 . . . . 0.0 111.285 179.458 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.452 ' HA ' ' OD1' ' A' ' 43' ' ' ASN . 18.6 p90 -86.56 -32.24 20.79 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.645 -179.991 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.505 ' OG ' ' HB3' ' A' ' 17' ' ' ARG . 13.3 m -62.05 -36.9 83.01 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.269 -179.024 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 38.2 m80 -81.28 -3.59 52.95 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.728 179.218 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.531 ' HB2' ' OD1' ' A' ' 43' ' ' ASN . 4.7 m -121.33 18.67 11.44 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.551 -179.676 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.788 ' HB3' HD21 ' A' ' 43' ' ' ASN . 58.1 p -145.55 171.69 14.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.097 0.475 . . . . 0.0 111.096 179.882 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.494 ' HG3' ' HD3' ' A' ' 74' ' ' ARG . 2.3 pt-20 -140.85 154.03 46.02 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.065 179.433 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.406 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 43.2 m-20 62.3 63.04 1.09 Allowed 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.022 0.439 . . . . 0.0 110.929 -179.703 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.482 HG23 HD21 ' A' ' 71' ' ' LEU . 63.6 mt -90.7 117.27 33.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.973 -179.681 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 42.5 tptt -148.85 149.45 31.32 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.772 -179.895 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.742 ' HG ' HD21 ' A' ' 12' ' ' LEU . 76.5 mt -82.46 132.57 35.2 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.931 0.396 . . . . 0.0 110.106 179.317 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -80.25 -62.61 1.63 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.488 -178.862 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.509 ' HB2' ' HB3' ' A' ' 69' ' ' ARG . 30.3 mt-10 -85.49 28.05 0.78 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.584 -179.86 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.404 ' O ' ' HB3' ' A' ' 10' ' ' ALA . . . 64.97 15.95 61.12 Favored Glycine 0 N--CA 1.448 -0.545 0 CA-C-N 115.624 -0.717 . . . . 0.0 113.066 179.812 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.539 ' HA2' HD13 ' A' ' 64' ' ' LEU . . . 142.66 -21.98 2.35 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 119.904 -1.141 . . . . 0.0 113.091 179.459 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.509 ' HB3' ' HB2' ' A' ' 66' ' ' GLU . 0.2 OUTLIER -79.34 -13.91 59.33 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.426 0.631 . . . . 0.0 109.713 -179.922 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.534 ' HG3' ' HA ' ' A' ' 89' ' ' ASP . 4.5 ttmp? -157.1 141.76 16.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.259 -179.233 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.604 ' HB2' HD11 ' A' ' 90' ' ' LEU . 10.0 tt -111.42 134.45 52.99 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 179.975 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.431 HG22 ' HA3' ' A' ' 87' ' ' GLY . 7.0 p -123.95 135.05 53.42 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 120.798 0.332 . . . . 0.0 111.156 179.852 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.437 ' HB3' ' HA ' ' A' ' 62' ' ' ILE . 26.9 p -159.52 168.8 25.28 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.134 -0.485 . . . . 0.0 109.998 179.988 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.566 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 56.6 ttt180 -99.66 101.97 15.34 Favored Pre-proline 0 C--N 1.314 -0.96 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.725 179.944 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.625 ' O ' ' HB3' ' A' ' 83' ' ' ARG . 58.7 Cg_endo -71.43 123.14 9.26 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 122.535 2.156 . . . . 0.0 110.856 178.868 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.697 ' HA ' ' HB2' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -119.57 139.84 51.5 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.845 0.355 . . . . 0.0 111.053 -179.69 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.705 HG22 ' O ' ' A' ' 82' ' ' PHE . 12.3 t -75.47 140.65 42.98 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 116.176 -0.466 . . . . 0.0 109.752 -179.765 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 31.3 m -76.32 -5.97 8.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.488 -179.482 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 -64.75 -35.25 80.45 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-O 121.155 0.502 . . . . 0.0 110.234 179.145 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -154.01 -9.74 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.512 -0.851 . . . . 0.0 112.768 -179.925 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.602 ' HA2' ' HE3' ' A' ' 76' ' ' LYS . . . 90.32 17.51 52.73 Favored Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.641 -0.79 . . . . 0.0 111.862 179.976 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.705 ' O ' HG22 ' A' ' 77' ' ' THR . 34.0 p90 -111.23 151.2 28.56 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 119.17 -0.443 . . . . 0.0 109.974 -178.773 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.697 ' HB2' ' HA ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 169.78 -153.36 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.293 0 O-C-N 123.641 0.588 . . . . 0.0 111.052 179.107 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 49.9 mm-40 -122.21 -177.58 3.64 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.736 -178.037 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.566 ' HA ' ' HA ' ' A' ' 74' ' ' ARG . 52.7 ttt180 -106.03 153.45 22.01 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 177.396 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 86' ' ' GLN . . . . . 0.705 ' HG2' ' H ' ' A' ' 87' ' ' GLY . 41.8 tt0 -157.89 -174.98 5.11 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.662 -178.513 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.705 ' H ' ' HG2' ' A' ' 86' ' ' GLN . . . -148.92 140.54 8.28 Favored Glycine 0 N--CA 1.445 -0.704 0 N-CA-C 111.181 -0.767 . . . . 0.0 111.181 179.21 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 15.3 tt -119.28 131.41 72.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.544 0.688 . . . . 0.0 110.742 -179.548 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.534 ' HA ' ' HG3' ' A' ' 70' ' ' LYS . 16.0 t70 -75.94 140.7 42.22 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.401 -179.671 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.653 HD13 HD11 ' A' ' 19' ' ' LEU . 42.4 mt -109.84 44.19 1.24 Allowed 'General case' 0 C--O 1.234 0.253 0 N-CA-C 112.848 0.684 . . . . 0.0 112.848 -177.717 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.486 ' HA ' ' OG ' ' A' ' 2' ' ' SER . 3.9 m-80 -79.7 3.91 17.82 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-O 121.32 0.581 . . . . 0.0 110.834 178.759 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.48 ' HD3' ' CD2' ' A' ' 50' ' ' TRP . 36.6 mtp180 -95.86 -11.21 27.12 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.357 178.919 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.431 HG13 HD22 ' A' ' 37' ' ' LEU . 21.2 mm -100.8 109.08 24.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 -179.406 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -122.26 148.52 44.89 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.941 -178.108 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 27.2 p-10 -100.65 123.28 44.64 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.65 0.738 . . . . 0.0 110.268 178.448 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 59.5 t -114.73 114.3 46.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.672 -179.853 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 16.7 m120 57.46 33.45 23.28 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.22 0.533 . . . . 0.0 110.562 -178.798 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 89.32 -15.24 58.92 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.867 -179.915 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 3.6 mpt_? -87.59 123.22 32.23 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 117.005 0.403 . . . . 0.0 110.048 -179.846 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.579 HD13 ' SG ' ' A' ' 23' ' ' CYS . 8.2 tp -77.16 115.05 16.61 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.474 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 11.3 t -122.73 140.37 46.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 120.964 0.411 . . . . 0.0 111.45 -178.271 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.669 ' HB2' HD11 ' A' ' 35' ' ' LEU . 3.9 t80 -84.65 132.85 34.43 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 177.401 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 3.9 tp-100 . . . . . 0 C--O 1.252 1.198 0 CA-C-O 118.545 -0.741 . . . . 0.0 110.794 -179.837 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 2' ' ' SER . . . . . 0.652 ' OG ' ' HA ' ' A' ' 91' ' ' ASN . 39.2 m . . . . . 0 N--CA 1.45 -0.439 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.518 ' HA ' ' OD1' ' A' ' 95' ' ' ASN . 14.6 p90 -65.73 -33.36 75.69 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.091 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.529 ' HA ' ' OG ' ' A' ' 7' ' ' SER . . . -57.69 -22.4 46.0 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.055 -0.52 . . . . 0.0 112.051 -179.368 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -65.4 -19.68 66.05 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 121.022 0.439 . . . . 0.0 110.629 179.217 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 7.4 p -145.9 39.53 1.13 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.645 179.938 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.529 ' OG ' ' HA ' ' A' ' 4' ' ' ALA . 87.0 p -145.89 167.73 22.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.205 179.085 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 4.9 ptp180 -150.49 162.84 39.83 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.733 -179.6 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 56.59 60.05 3.28 Favored 'General case' 0 C--N 1.331 -0.233 0 O-C-N 123.982 0.801 . . . . 0.0 111.769 177.657 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.434 ' HA ' ' HB2' ' A' ' 21' ' ' ALA . . . -91.94 119.49 31.74 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.703 179.775 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 27.4 m -119.81 169.55 10.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.475 -179.897 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.58 ' HB3' ' HA2' ' A' ' 16' ' ' GLY . 3.2 mm? -105.76 114.55 28.78 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.518 -179.211 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.468 ' OG1' ' HB ' ' A' ' 18' ' ' THR . 26.3 p -109.86 164.7 12.33 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.018 179.988 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 61.61 43.7 9.73 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.838 179.731 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 88.76 -37.84 3.27 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.792 -0.718 . . . . 0.0 111.975 179.827 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.58 ' HA2' ' HB3' ' A' ' 12' ' ' LEU . . . 140.74 42.32 0.07 OUTLIER Glycine 0 N--CA 1.444 -0.808 0 N-CA-C 111.432 -0.667 . . . . 0.0 111.432 -179.529 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.566 ' HB2' ' HB3' ' A' ' 38' ' ' ASP . 18.2 ptt85 -127.19 -21.24 3.96 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.896 0.379 . . . . 0.0 111.126 -179.828 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.468 ' HB ' ' OG1' ' A' ' 13' ' ' THR . 3.8 m -106.63 131.29 53.95 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.374 179.889 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.712 HD11 HD13 ' A' ' 90' ' ' LEU . 57.3 mt -93.4 113.83 26.08 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.327 179.209 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 22.5 ttt180 -111.97 119.37 38.29 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 178.644 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.434 ' HB2' ' HA ' ' A' ' 10' ' ' ALA . . . -153.73 167.0 31.09 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.95 0.405 . . . . 0.0 111.362 -179.11 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -90.02 106.7 18.65 Favored 'General case' 0 CA--C 1.511 -0.523 0 N-CA-C 107.821 -1.178 . . . . 0.0 107.821 178.19 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.543 ' SG ' HD13 ' A' ' 100' ' ' LEU . 35.7 m -97.55 131.82 43.79 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.326 -178.627 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.52 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 13.1 ttp180 -76.25 119.45 20.16 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 116.174 -0.466 . . . . 0.0 109.945 179.38 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 36.9 p30 -81.75 168.83 17.64 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 179.535 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -52.93 -30.56 35.27 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 -179.013 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -72.57 -15.08 61.76 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.397 0.618 . . . . 0.0 110.483 179.982 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 92.18 24.5 24.41 Favored Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.549 179.985 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.52 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 8.2 t-20 -107.49 162.89 13.53 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.582 0.23 . . . . 0.0 110.476 -178.753 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.429 ' HZ3' ' HA ' ' A' ' 7' ' ' SER . 83.3 m95 -99.03 115.71 29.58 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.931 0.396 . . . . 0.0 111.694 -179.548 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.1 m -122.13 125.43 72.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.173 178.463 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 19.9 m -76.14 113.54 13.79 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.996 -179.559 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 57.8 m -120.43 155.91 32.52 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.74 179.887 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.634 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 46.7 mt-10 -131.46 136.95 48.36 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.191 -179.394 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.502 ' HB2' ' HB3' ' A' ' 100' ' ' LEU . 1.7 tm? -132.72 130.1 39.57 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 178.434 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.443 ' N ' HD13 ' A' ' 35' ' ' LEU . 9.0 m-20 -89.94 109.04 20.09 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 -179.997 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.568 HD11 HD11 ' A' ' 19' ' ' LEU . 3.3 mt -79.48 -20.63 46.87 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.57 -179.095 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.566 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 11.2 p-10 -65.78 -10.26 35.82 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.7 0.285 . . . . 0.0 111.713 -178.612 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 77.6 p -81.23 -11.91 59.27 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.996 0.427 . . . . 0.0 110.34 179.045 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 23.4 m -133.95 -15.92 2.28 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.982 -0.554 . . . . 0.0 112.4 -179.026 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 54.9 mt -99.84 135.29 36.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 O-C-N 122.093 -0.379 . . . . 0.0 109.991 179.081 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.629 ' HA3' ' HB3' ' A' ' 52' ' ' MET . . . -143.65 156.7 26.73 Favored Glycine 0 N--CA 1.443 -0.878 0 C-N-CA 120.386 -0.911 . . . . 0.0 112.263 179.804 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.662 ' N ' ' HD3' ' A' ' 44' ' ' PRO . 25.4 p30 -153.47 40.38 0.16 Allowed Pre-proline 0 CA--C 1.54 0.568 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -179.785 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.662 ' HD3' ' N ' ' A' ' 43' ' ' ASN . 7.1 Cg_exo -71.77 -17.46 29.28 Favored 'Trans proline' 0 C--N 1.355 0.902 0 C-N-CA 121.74 1.627 . . . . 0.0 111.377 -179.213 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -91.58 -2.84 56.98 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.06 179.853 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.597 ' CA ' ' HG2' ' A' ' 83' ' ' ARG . . . 91.79 8.03 64.01 Favored Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.214 -179.439 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -126.11 139.38 53.43 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.667 0.27 . . . . 0.0 110.568 179.646 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.518 HD23 ' HB3' ' A' ' 43' ' ' ASN . 81.7 mt -84.48 148.7 26.4 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.723 179.862 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 165.42 171.11 31.24 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 121.036 -0.602 . . . . 0.0 111.921 179.244 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 89.0 m95 -95.28 125.66 40.06 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 179.676 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 163.21 -57.79 0.28 Allowed Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.192 -179.628 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.629 ' HB3' ' HA3' ' A' ' 42' ' ' GLY . 0.0 OUTLIER -90.78 -166.01 1.49 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 179.719 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 28.2 pt20 -141.98 171.6 13.83 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.918 -0.313 . . . . 0.0 111.648 -179.047 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 10.1 m120 63.12 36.3 12.27 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 115.493 -0.776 . . . . 0.0 112.628 178.749 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.43 ' HB3' ' HA2' ' A' ' 42' ' ' GLY . 12.4 p90 -61.21 -27.39 68.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.763 0.316 . . . . 0.0 111.371 -179.629 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.525 ' OG ' ' HB3' ' A' ' 17' ' ' ARG . 15.0 m -62.53 -30.58 71.4 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.038 0.384 . . . . 0.0 112.038 -178.958 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 35.7 m80 -82.04 -4.06 55.95 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.742 -0.383 . . . . 0.0 111.169 -179.14 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.575 ' HB2' ' OD1' ' A' ' 43' ' ' ASN . 30.3 m -130.77 29.85 4.71 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.347 0.594 . . . . 0.0 110.239 179.232 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.643 ' HB3' HD21 ' A' ' 43' ' ' ASN . 28.9 p -141.28 153.22 45.08 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.641 179.209 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 66.4 mt-10 -125.34 139.2 53.89 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.419 -179.687 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 36.0 t70 58.62 73.21 0.49 Allowed 'General case' 0 N--CA 1.466 0.363 0 O-C-N 123.83 0.706 . . . . 0.0 111.532 -179.766 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.548 HG23 HD21 ' A' ' 71' ' ' LEU . 77.4 mt -87.24 119.85 35.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 178.801 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.493 ' HB2' ' NZ ' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -148.87 159.79 43.84 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.843 -0.343 . . . . 0.0 111.033 -178.653 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.48 ' HG ' HD21 ' A' ' 12' ' ' LEU . 81.0 mt -99.94 123.54 44.3 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.845 0.355 . . . . 0.0 110.958 179.891 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 37.0 mm-40 -82.0 -61.48 1.9 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.502 -179.676 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.5 ' OE2' ' HE3' ' A' ' 70' ' ' LYS . 36.1 mt-10 -76.58 12.96 1.09 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.307 -179.658 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 76.5 18.79 78.81 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.348 -179.928 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.405 ' HA2' HD22 ' A' ' 64' ' ' LEU . . . 136.94 -17.16 3.66 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.0 -1.095 . . . . 0.0 112.924 179.384 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.45 ' HB3' ' HB2' ' A' ' 66' ' ' GLU . 0.1 OUTLIER -83.01 -17.96 41.5 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.194 0.521 . . . . 0.0 109.72 -179.854 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.5 ' HE3' ' OE2' ' A' ' 66' ' ' GLU . 37.9 ttmt -150.73 136.87 18.46 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.891 -179.278 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.609 ' HB2' HD11 ' A' ' 90' ' ' LEU . 10.0 tt -114.73 129.3 56.67 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.491 179.714 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 8.2 p -116.57 140.01 49.86 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.155 0.502 . . . . 0.0 111.28 179.828 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.489 ' HB3' ' HA ' ' A' ' 62' ' ' ILE . 13.0 p -163.28 164.03 25.09 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.089 179.02 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.537 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 28.1 ttt180 -99.4 100.39 10.42 Favored Pre-proline 0 C--N 1.317 -0.822 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 179.103 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.609 ' O ' ' HB3' ' A' ' 83' ' ' ARG . 53.2 Cg_endo -69.07 117.39 5.01 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.383 2.055 . . . . 0.0 109.864 178.545 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.868 ' HE3' ' HA2' ' A' ' 81' ' ' GLY . 0.0 OUTLIER -119.78 143.43 47.83 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.501 -178.978 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.684 HG22 ' O ' ' A' ' 82' ' ' PHE . 8.7 t -69.89 134.38 48.37 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.218 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 11.1 p -71.28 -12.43 16.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 O-C-N 124.088 0.867 . . . . 0.0 111.094 -179.284 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 32.8 m-20 -70.62 -16.72 62.86 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.506 -179.606 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.693 ' HA3' ' CE2' ' A' ' 82' ' ' PHE . . . -157.64 -30.2 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.441 -0.885 . . . . 0.0 112.628 179.215 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.868 ' HA2' ' HE3' ' A' ' 76' ' ' LYS . . . 101.83 16.13 24.71 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 121.024 -0.608 . . . . 0.0 111.916 -179.721 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.693 ' CE2' ' HA3' ' A' ' 80' ' ' GLY . 16.7 p90 -112.25 157.06 21.38 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 118.686 -0.673 . . . . 0.0 110.173 -178.622 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.813 ' HB2' ' HA ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 163.92 -151.03 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.556 0 O-C-N 124.253 0.971 . . . . 0.0 111.124 178.478 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -125.47 152.88 44.35 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.142 -177.927 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.537 ' HA ' ' HA ' ' A' ' 74' ' ' ARG . 39.7 ttt180 -83.91 145.8 28.39 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 179.621 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -150.63 -179.67 7.44 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.094 0.473 . . . . 0.0 111.756 -178.287 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -141.09 142.51 12.24 Favored Glycine 0 N--CA 1.451 -0.345 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.455 178.993 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 13.2 tt -125.09 136.58 60.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.028 0.442 . . . . 0.0 110.973 -179.199 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -80.59 141.28 35.19 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.467 -179.882 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.712 HD13 HD11 ' A' ' 19' ' ' LEU . 58.3 mt -107.59 46.36 0.95 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.674 0.749 . . . . 0.0 110.932 -179.816 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.652 ' HA ' ' OG ' ' A' ' 2' ' ' SER . 11.4 m120 -79.9 3.67 19.11 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.634 179.762 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 12.9 mtp180 -98.47 -15.0 19.78 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.41 179.872 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 22.7 mm -94.37 98.07 7.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 121.356 0.598 . . . . 0.0 109.601 -179.029 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 22.3 tp60 -107.63 141.94 38.34 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.961 -178.443 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.518 ' OD1' ' HA ' ' A' ' 3' ' ' TYR . 16.1 p-10 -95.64 119.72 34.64 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.512 178.582 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 58.2 t -109.23 112.26 39.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.31 179.286 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 23.2 m-80 59.24 34.84 23.25 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-O 121.069 0.461 . . . . 0.0 110.56 -178.952 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 87.57 -8.96 75.51 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.757 -179.955 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.458 ' HD2' ' N ' ' A' ' 99' ' ' ARG . 7.9 mpt_? -94.65 134.43 37.24 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.661 0.267 . . . . 0.0 110.978 -179.052 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.543 HD13 ' SG ' ' A' ' 23' ' ' CYS . 2.9 tp -84.89 119.81 25.77 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.594 -0.276 . . . . 0.0 110.503 -179.681 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 20.8 t -129.28 141.53 46.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.609 -179.661 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.495 ' HB2' HD11 ' A' ' 35' ' ' LEU . 23.2 t80 -83.71 133.0 34.82 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 178.348 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 . . . . . 0 C--O 1.248 1.013 0 CA-C-O 118.336 -0.84 . . . . 0.0 110.108 179.271 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 2' ' ' SER . . . . . 0.58 ' OG ' ' HA ' ' A' ' 91' ' ' ASN . 21.0 m . . . . . 0 N--CA 1.453 -0.306 0 N-CA-C 110.474 -0.195 . . . . 0.0 110.474 . . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.405 ' CG ' HD11 ' A' ' 100' ' ' LEU . 11.7 p90 -55.32 -32.16 62.25 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.281 179.061 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -52.37 -20.89 3.07 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -178.801 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -55.93 -42.49 76.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.914 0.388 . . . . 0.0 110.959 178.743 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 47.7 m -132.01 36.02 3.69 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.001 179.828 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 16.7 m -144.57 153.24 41.6 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.483 179.531 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 7.9 ptp180 -149.53 172.7 14.58 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 110.317 -0.253 . . . . 0.0 110.317 179.951 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 67.02 44.63 1.92 Allowed 'General case' 0 N--CA 1.469 0.475 0 O-C-N 123.56 0.537 . . . . 0.0 110.5 -179.505 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.412 ' HA ' ' O ' ' A' ' 20' ' ' ARG . . . -87.83 118.26 27.24 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.425 -179.879 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 30.6 m -121.57 176.15 4.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.871 179.308 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.523 ' HB3' ' HA2' ' A' ' 16' ' ' GLY . 3.2 mm? -104.98 114.09 28.09 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 -179.752 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.529 ' OG1' ' HB ' ' A' ' 18' ' ' THR . 24.1 p -106.1 163.38 12.82 Favored 'General case' 0 C--O 1.245 0.823 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.923 -179.641 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 62.16 36.2 15.18 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.706 -179.482 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 92.56 -40.28 2.88 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.7 179.431 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.523 ' HA2' ' HB3' ' A' ' 12' ' ' LEU . . . 147.72 56.07 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.499 0 N-CA-C 110.979 -0.849 . . . . 0.0 110.979 -179.723 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.534 ' HB2' ' HB3' ' A' ' 38' ' ' ASP . 10.0 ptm180 -140.87 -32.19 0.58 Allowed 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.066 0.46 . . . . 0.0 111.211 -179.394 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.529 ' HB ' ' OG1' ' A' ' 13' ' ' THR . 3.7 m -102.99 138.27 40.08 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.348 -179.53 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.611 ' O ' ' HA ' ' A' ' 34' ' ' GLU . 34.4 mt -98.6 113.34 25.35 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.865 179.428 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.412 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 5.2 ttp180 -106.3 120.61 42.32 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 178.489 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -152.88 166.24 32.92 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.938 0.399 . . . . 0.0 111.734 -179.245 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.788 ' HB3' ' HB3' ' A' ' 30' ' ' TRP . 20.8 mm-40 -90.65 107.27 19.07 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 178.467 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.467 ' SG ' HD13 ' A' ' 100' ' ' LEU . 27.2 m -98.78 127.49 44.72 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.457 -178.754 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 19.6 ttp180 -74.39 109.52 7.94 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 179.27 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -87.27 173.48 9.17 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.718 -178.96 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -46.63 -34.1 4.75 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 -178.692 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -67.56 -10.74 54.68 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 121.498 0.666 . . . . 0.0 111.105 -179.464 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.45 23.63 56.01 Favored Glycine 0 N--CA 1.446 -0.634 0 N-CA-C 111.233 -0.747 . . . . 0.0 111.233 -179.94 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 -123.74 160.4 27.37 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.797 0.332 . . . . 0.0 111.197 -178.836 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.788 ' HB3' ' HB3' ' A' ' 22' ' ' GLU . 75.3 m95 -87.57 131.56 34.35 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.24 -178.858 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.414 HG22 ' O ' ' A' ' 23' ' ' CYS . 6.2 m -126.29 137.0 59.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.745 178.118 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 37.6 m -75.53 109.24 8.93 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.133 179.775 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 49.9 m -122.8 144.59 49.08 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.932 -179.966 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.611 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 43.9 mt-10 -128.88 135.45 49.09 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.433 -179.729 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.573 HD11 ' HB2' ' A' ' 102' ' ' PHE . 2.4 tm? -128.64 131.69 48.07 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 178.808 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.45 ' N ' HD13 ' A' ' 35' ' ' LEU . 11.4 m-20 -89.29 110.77 21.51 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.297 -179.794 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.476 HD23 HD12 ' A' ' 35' ' ' LEU . 0.9 OUTLIER -86.87 -16.12 37.03 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.938 179.947 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.534 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 0.5 OUTLIER -66.06 -13.81 60.62 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 -177.508 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.435 HG22 ' O ' ' A' ' 36' ' ' ASP . 8.8 t -83.08 -7.82 59.6 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.895 0.378 . . . . 0.0 110.653 179.193 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.427 ' SG ' HG23 ' A' ' 39' ' ' THR . 58.0 m -130.94 -17.2 3.15 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 112.181 0.437 . . . . 0.0 112.181 -179.341 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.46 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 57.2 mt -104.98 137.05 36.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.684 0.278 . . . . 0.0 110.766 179.731 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.576 ' HA3' ' HB3' ' A' ' 52' ' ' MET . . . -150.31 162.47 29.26 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 121.114 -0.565 . . . . 0.0 111.744 179.202 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.67 ' ND2' ' HB2' ' A' ' 55' ' ' PHE . 7.2 p30 -160.88 50.2 0.31 Allowed Pre-proline 0 CA--C 1.537 0.476 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -179.738 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -69.93 -13.07 33.77 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 121.658 1.572 . . . . 0.0 112.046 -179.653 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -101.94 5.02 40.62 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.735 179.83 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.559 ' CA ' ' HG2' ' A' ' 83' ' ' ARG . . . 85.43 11.66 74.59 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.362 -0.923 . . . . 0.0 112.37 -179.592 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -125.31 131.81 52.98 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.013 0.435 . . . . 0.0 110.801 179.916 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.522 ' HB3' ' HB ' ' A' ' 88' ' ' ILE . 84.6 mt -86.31 135.57 33.48 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.461 -0.791 . . . . 0.0 111.722 -178.69 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -177.85 172.27 44.88 Favored Glycine 0 N--CA 1.447 -0.619 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.734 179.209 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.44 ' HH2' HD11 ' A' ' 93' ' ' ILE . 90.2 m95 -95.16 124.76 39.38 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 179.621 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 159.41 -54.71 0.35 Allowed Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.92 -0.657 . . . . 0.0 111.917 -179.26 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.576 ' HB3' ' HA3' ' A' ' 42' ' ' GLY . 0.0 OUTLIER -85.56 -166.06 1.41 Allowed 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 179.649 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -146.03 173.63 12.0 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.64 -0.424 . . . . 0.0 111.634 -179.55 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 60.21 39.86 18.75 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.717 179.376 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.67 ' HB2' ' ND2' ' A' ' 43' ' ' ASN . 6.2 p90 -61.84 -28.61 69.61 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.167 179.488 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.493 ' HB2' ' HB3' ' A' ' 17' ' ' ARG . 24.5 t -58.83 -44.94 91.04 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.727 -179.942 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 34.0 m80 -81.31 -13.76 58.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.082 0.467 . . . . 0.0 111.037 -179.734 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 15.7 m -96.33 -1.47 47.77 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.77 -178.928 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.421 ' HB3' ' HA ' ' A' ' 75' ' ' PRO . 56.5 p -137.95 172.97 12.15 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 121.71 -0.619 . . . . 0.0 111.235 -179.0 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.402 ' HG3' ' HG2' ' A' ' 76' ' ' LYS . 44.3 mt-10 -131.13 147.57 52.62 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.011 179.909 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 39.0 t70 56.66 77.69 0.25 Allowed 'General case' 0 N--CA 1.467 0.396 0 O-C-N 123.877 0.736 . . . . 0.0 110.722 179.903 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.542 ' HA ' ' HB3' ' A' ' 73' ' ' CYS . 67.3 mt -99.94 120.38 49.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.841 -179.292 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 76.9 tttt -148.9 156.96 43.05 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.211 -0.45 . . . . 0.0 109.858 179.554 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 44.1 mt -82.66 140.12 33.32 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.139 0.495 . . . . 0.0 111.271 -178.848 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -90.81 -61.56 1.64 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.985 -178.792 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.492 ' HB2' ' HB3' ' A' ' 69' ' ' ARG . 30.1 mm-40 -82.2 13.01 3.73 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.127 0.489 . . . . 0.0 111.106 -179.767 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 78.4 17.16 78.35 Favored Glycine 0 N--CA 1.45 -0.403 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.413 179.8 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 143.24 -30.95 1.98 Allowed Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.309 -0.948 . . . . 0.0 112.552 179.469 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.513 ' HD3' ' HB2' ' A' ' 2' ' ' SER . 4.6 tpp85 -75.45 -19.66 59.31 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.279 0.561 . . . . 0.0 110.565 -179.931 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.428 ' HB3' ' HG2' ' A' ' 66' ' ' GLU . 86.5 tttt -148.5 145.71 28.03 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.437 -178.33 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.733 ' HB2' HD11 ' A' ' 90' ' ' LEU . 10.2 tt -116.61 144.38 44.46 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.782 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.8 p -134.2 138.52 45.17 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 120.85 0.357 . . . . 0.0 110.697 179.747 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.542 ' HB3' ' HA ' ' A' ' 62' ' ' ILE . 26.5 p -162.55 174.58 12.45 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.85 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.495 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 4.1 tmt_? -109.29 97.46 26.31 Favored Pre-proline 0 C--N 1.315 -0.915 0 N-CA-C 109.111 -0.699 . . . . 0.0 109.111 179.087 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.65 ' O ' ' HB3' ' A' ' 83' ' ' ARG . 32.4 Cg_endo -64.58 129.55 24.03 Favored 'Trans proline' 0 CA--C 1.515 -0.473 0 C-N-CA 122.991 2.461 . . . . 0.0 110.807 -179.981 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.765 ' HA ' ' HB2' ' A' ' 83' ' ' ARG . 0.3 OUTLIER -121.22 149.78 42.32 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.217 0.532 . . . . 0.0 111.478 -179.569 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.655 HG22 ' O ' ' A' ' 82' ' ' PHE . 14.7 t -82.69 143.4 30.96 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 178.794 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 32.7 m -70.04 -9.33 12.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 O-C-N 123.862 0.727 . . . . 0.0 111.798 -179.494 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -62.57 -37.77 87.46 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-O 121.008 0.433 . . . . 0.0 110.374 179.246 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -160.38 -0.92 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.308 -0.949 . . . . 0.0 113.103 -179.519 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.591 ' HA2' ' HD3' ' A' ' 76' ' ' LYS . . . 84.88 21.52 55.46 Favored Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.488 -0.863 . . . . 0.0 112.041 179.304 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.655 ' O ' HG22 ' A' ' 77' ' ' THR . 40.2 p90 -111.07 154.91 23.57 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -179.588 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.805 ' HA ' ' HE ' ' A' ' 83' ' ' ARG . 0.0 OUTLIER 169.33 -145.34 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.241 0 O-C-N 123.805 0.691 . . . . 0.0 111.498 -179.999 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -129.53 157.46 41.97 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.688 -178.361 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.495 ' HA ' ' HA ' ' A' ' 74' ' ' ARG . 57.2 ttt180 -82.68 154.33 24.91 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 178.976 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 86' ' ' GLN . . . . . 0.546 ' HG2' ' H ' ' A' ' 87' ' ' GLY . 39.6 tt0 -164.81 -179.36 5.79 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 120.986 0.422 . . . . 0.0 111.741 -177.939 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.546 ' H ' ' HG2' ' A' ' 86' ' ' GLN . . . -142.55 153.26 24.42 Favored Glycine 0 CA--C 1.521 0.455 0 N-CA-C 111.841 -0.504 . . . . 0.0 111.841 179.257 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.522 ' HB ' ' HB3' ' A' ' 48' ' ' LEU . 12.0 tt -131.33 143.98 39.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.11 0.481 . . . . 0.0 110.618 -179.876 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.589 ' OD2' ' HB2' ' A' ' 91' ' ' ASN . 20.8 t70 -82.99 133.55 35.1 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.345 -179.184 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.733 HD11 ' HB2' ' A' ' 71' ' ' LEU . 86.7 mt -109.46 38.35 2.36 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -179.214 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.589 ' HB2' ' OD2' ' A' ' 89' ' ' ASP . 6.6 m-80 -75.68 3.07 10.4 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-O 121.485 0.66 . . . . 0.0 110.256 178.621 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 24.9 mtp180 -96.08 -5.57 40.59 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.879 179.567 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.471 ' CD1' HD22 ' A' ' 37' ' ' LEU . 25.0 mm -103.02 100.95 11.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.265 0.555 . . . . 0.0 109.994 -179.413 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 19.1 mm-40 -110.24 156.34 20.8 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.725 -178.508 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 18.7 p-10 -110.07 113.18 25.67 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.378 178.172 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.7 p -109.9 114.99 48.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-O 121.339 0.59 . . . . 0.0 110.431 -179.777 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 65.12 23.54 12.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.559 179.697 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 95.45 -8.53 69.12 Favored Glycine 0 N--CA 1.447 -0.605 0 CA-C-N 115.481 -0.781 . . . . 0.0 112.404 -179.942 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 10.2 mtp180 -95.2 135.78 36.35 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -179.413 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.467 HD13 ' SG ' ' A' ' 23' ' ' CYS . 5.2 tp -88.22 116.11 26.19 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 -179.517 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 39.2 t -130.45 141.25 46.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.87 0.366 . . . . 0.0 110.65 -178.917 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.573 ' HB2' HD11 ' A' ' 35' ' ' LEU . 12.9 t80 -78.7 137.4 37.77 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.734 178.783 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 23.8 tp60 . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.576 -0.726 . . . . 0.0 110.215 -179.994 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 39.0 m . . . . . 0 N--CA 1.451 -0.423 0 CA-C-O 120.893 0.377 . . . . 0.0 111.352 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.444 ' CB ' HD11 ' A' ' 100' ' ' LEU . 11.1 p90 -54.3 -32.63 56.9 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.518 178.062 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.558 ' HB3' ' HD2' ' A' ' 69' ' ' ARG . . . -57.43 -18.97 20.72 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 115.41 -0.814 . . . . 0.0 112.471 -179.056 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -69.41 -17.27 63.64 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 121.113 0.483 . . . . 0.0 110.891 179.641 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.413 ' HB2' HD21 ' A' ' 95' ' ' ASN . 74.6 m -144.27 37.05 1.24 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.076 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 23.2 t -150.83 157.17 42.6 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.686 -179.443 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 2.0 ptm180 -144.79 167.31 22.89 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 179.653 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 60.17 50.44 6.4 Favored 'General case' 0 N--CA 1.464 0.232 0 O-C-N 123.868 0.73 . . . . 0.0 111.186 179.492 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.505 ' HA ' ' HB2' ' A' ' 21' ' ' ALA . . . -84.81 117.36 23.81 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.467 179.721 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 33.5 m -122.42 168.77 14.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.916 -179.738 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.631 HD21 ' HG ' ' A' ' 64' ' ' LEU . 3.3 mm? -104.91 115.3 30.05 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.662 179.9 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 28.1 p -110.31 167.26 10.33 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.008 -179.891 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 59.83 46.78 10.94 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.089 179.398 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 85.5 -31.92 3.75 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 121.049 -0.596 . . . . 0.0 112.346 179.942 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.574 ' HA2' ' HB3' ' A' ' 12' ' ' LEU . . . 133.18 54.99 0.08 OUTLIER Glycine 0 N--CA 1.442 -0.905 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 -179.202 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.616 ' HB2' ' HB3' ' A' ' 38' ' ' ASP . 43.3 ptt85 -138.06 -32.73 0.72 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.889 0.376 . . . . 0.0 111.125 -179.664 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.451 HG22 ' HB3' ' A' ' 34' ' ' GLU . 5.2 m -98.56 132.32 44.07 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.479 179.93 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.744 HD11 HD13 ' A' ' 90' ' ' LEU . 69.5 mt -92.3 113.32 25.56 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.172 179.195 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 53.6 ttp180 -111.86 120.77 43.06 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 178.775 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.505 ' HB2' ' HA ' ' A' ' 10' ' ' ALA . . . -153.4 167.5 29.22 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.798 -179.271 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -90.36 106.15 18.3 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 178.437 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.556 ' SG ' HD13 ' A' ' 100' ' ' LEU . 58.5 m -93.15 130.59 38.75 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 -178.893 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 22.7 ttp85 -77.92 119.94 22.1 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 120.896 -0.322 . . . . 0.0 110.244 179.237 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.48 HD21 ' HB3' ' A' ' 29' ' ' ASN . 33.6 p30 -84.8 163.43 19.09 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.468 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.33 -15.43 25.47 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -178.232 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -82.21 -10.2 59.23 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.789 0.804 . . . . 0.0 109.289 179.168 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 87.23 35.36 9.7 Favored Glycine 0 N--CA 1.447 -0.605 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.702 -179.827 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.48 ' HB3' HD21 ' A' ' 25' ' ' ASN . 43.9 t30 -124.39 160.37 28.3 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.747 0.308 . . . . 0.0 111.316 -179.266 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 85.2 m95 -99.0 120.43 39.44 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.71 179.58 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.7 m -124.01 136.51 60.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.5 178.989 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 55.0 m -78.11 108.77 11.65 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 120.944 0.402 . . . . 0.0 110.135 179.696 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.478 ' HB2' ' SG ' ' A' ' 23' ' ' CYS . 70.6 m -119.26 142.46 48.03 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.383 -179.502 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.649 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 2.7 mp0 -128.38 152.6 47.99 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.344 -179.641 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.525 ' HB2' HD23 ' A' ' 100' ' ' LEU . 0.9 OUTLIER -143.53 126.96 16.81 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 178.292 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -87.26 109.65 19.64 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 -179.815 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.467 HD11 HD11 ' A' ' 19' ' ' LEU . 1.0 OUTLIER -86.94 -13.76 43.74 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.292 0.479 . . . . 0.0 112.292 -179.123 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.616 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 8.8 p-10 -64.98 -16.23 63.15 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 122.085 -0.384 . . . . 0.0 111.923 -178.314 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 15.1 t -91.15 0.79 57.46 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.119 0.485 . . . . 0.0 110.013 179.314 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 22.5 m -130.62 -19.5 3.0 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.993 -0.548 . . . . 0.0 111.783 -179.486 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 64.7 mt -112.79 139.95 35.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.823 0.344 . . . . 0.0 111.359 -179.287 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.577 ' HA3' ' HB3' ' A' ' 52' ' ' MET . . . -148.81 158.62 27.73 Favored Glycine 0 N--CA 1.449 -0.493 0 N-CA-C 110.841 -0.903 . . . . 0.0 110.841 179.171 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.6 ' N ' ' HD3' ' A' ' 44' ' ' PRO . 24.3 p30 -162.86 45.25 0.14 Allowed Pre-proline 0 CA--C 1.541 0.608 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 -179.317 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.6 ' HD3' ' N ' ' A' ' 43' ' ' ASN . 7.8 Cg_exo -71.84 -15.35 29.78 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 121.868 1.712 . . . . 0.0 111.277 179.959 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 70.9 m-20 -90.0 -0.75 57.75 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.703 -179.807 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.491 ' CA ' ' HG2' ' A' ' 83' ' ' ARG . . . 90.0 3.45 73.31 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.294 -0.955 . . . . 0.0 111.716 -179.167 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -125.25 132.68 52.9 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.786 0.327 . . . . 0.0 110.449 179.988 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.545 HD23 HG22 ' A' ' 88' ' ' ILE . 11.1 mp -85.3 153.69 22.4 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.057 -179.273 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 170.99 171.97 36.77 Favored Glycine 0 N--CA 1.44 -1.094 0 C-N-CA 120.432 -0.89 . . . . 0.0 112.008 179.092 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.51 ' CD2' ' HD3' ' A' ' 92' ' ' ARG . 93.4 m95 -96.91 131.16 43.96 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.675 0.274 . . . . 0.0 110.506 -179.495 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 142.97 -62.47 0.51 Allowed Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 121.055 -0.593 . . . . 0.0 111.739 -179.866 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.577 ' HB3' ' HA3' ' A' ' 42' ' ' GLY . 2.4 ttt -72.07 -176.56 1.79 Allowed 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 179.345 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -142.84 169.16 18.09 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 121.517 -0.74 . . . . 0.0 112.605 -178.021 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 8.2 m120 64.07 45.81 3.98 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.073 -0.967 . . . . 0.0 112.54 178.836 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 23.4 p90 -66.41 -32.71 74.26 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.837 179.512 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.448 ' HA ' HD11 ' A' ' 62' ' ' ILE . 4.3 m -63.09 -30.86 71.92 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.376 -179.169 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 28.1 m80 -81.76 -3.59 54.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.999 0.428 . . . . 0.0 111.025 -179.927 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 19.4 m -128.56 22.72 5.92 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.187 179.5 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 66.8 m -139.62 162.06 36.02 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.122 0.487 . . . . 0.0 111.671 -179.774 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -132.92 142.23 48.78 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.02 178.922 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 25.9 t70 60.0 73.52 0.48 Allowed 'General case' 0 N--CA 1.467 0.385 0 O-C-N 123.687 0.617 . . . . 0.0 110.707 -179.857 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.519 HG23 HD21 ' A' ' 71' ' ' LEU . 68.7 mt -93.19 114.42 29.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.415 -179.824 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.472 ' HD3' ' N ' ' A' ' 64' ' ' LEU . 13.7 tmtt? -147.38 149.88 33.6 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.079 -179.055 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.631 ' HG ' HD21 ' A' ' 12' ' ' LEU . 79.3 mt -83.29 122.54 28.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.145 0.498 . . . . 0.0 111.37 -179.521 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -74.02 -63.27 1.25 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.379 -179.143 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.515 ' HB2' ' HB2' ' A' ' 69' ' ' ARG . 29.3 mt-10 -86.13 35.35 0.64 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.843 0.354 . . . . 0.0 111.462 -179.008 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 56.93 22.09 40.3 Favored Glycine 0 CA--C 1.519 0.319 0 CA-C-N 115.679 -0.691 . . . . 0.0 113.591 179.327 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 139.22 -23.97 2.84 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 119.887 -1.149 . . . . 0.0 113.091 179.275 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.558 ' HD2' ' HB3' ' A' ' 4' ' ' ALA . 0.2 OUTLIER -78.73 -17.12 56.34 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 117.251 0.526 . . . . 0.0 110.838 -179.788 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.459 ' HE3' ' OE1' ' A' ' 66' ' ' GLU . 33.3 ttmt -153.56 138.34 17.06 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.521 -177.938 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.586 ' HB2' HD11 ' A' ' 90' ' ' LEU . 10.5 tt -108.55 129.75 55.3 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.102 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 6.4 p -117.61 136.36 53.34 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.819 0.342 . . . . 0.0 111.528 179.969 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 28.2 p -162.67 163.45 26.99 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.479 179.895 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.44 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 78.8 ttt180 -99.47 103.93 24.03 Favored Pre-proline 0 C--N 1.32 -0.71 0 C-N-CA 120.341 -0.543 . . . . 0.0 110.458 179.061 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.709 ' O ' ' HB3' ' A' ' 83' ' ' ARG . 69.2 Cg_endo -71.95 123.46 9.33 Favored 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 122.848 2.365 . . . . 0.0 111.036 179.174 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.758 ' HA ' ' HB2' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -120.21 143.33 48.32 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.335 -179.589 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.738 HG22 ' O ' ' A' ' 82' ' ' PHE . 15.2 t -75.71 136.78 40.35 Favored 'General case' 0 CA--C 1.513 -0.471 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 179.334 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 35.0 m -76.35 -6.88 9.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.991 -179.784 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -68.59 -31.54 70.8 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.637 179.645 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.486 ' HA3' ' CE2' ' A' ' 82' ' ' PHE . . . -147.04 -23.34 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.717 179.568 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 101.18 12.54 36.06 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.997 -0.62 . . . . 0.0 112.146 -179.495 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.738 ' O ' HG22 ' A' ' 77' ' ' THR . 31.5 p90 -111.91 158.46 19.45 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 118.892 -0.575 . . . . 0.0 110.221 -178.349 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.758 ' HB2' ' HA ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 164.32 -161.47 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.436 0 O-C-N 123.861 0.725 . . . . 0.0 111.307 178.327 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -110.16 176.08 5.19 Favored 'General case' 0 C--O 1.222 -0.354 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.36 -176.904 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.44 ' HA ' ' HA ' ' A' ' 74' ' ' ARG . 74.9 ttt180 -102.65 153.73 19.84 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 177.967 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 86' ' ' GLN . . . . . 0.539 ' HB3' HD13 ' A' ' 48' ' ' LEU . 43.4 tt0 -166.09 179.2 5.89 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 120.361 -0.535 . . . . 0.0 111.848 -177.49 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.539 ' H ' ' HG2' ' A' ' 86' ' ' GLN . . . -145.54 155.16 26.37 Favored Glycine 0 N--CA 1.449 -0.493 0 N-CA-C 111.473 -0.651 . . . . 0.0 111.473 179.225 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.545 HG22 HD23 ' A' ' 48' ' ' LEU . 11.9 tt -132.06 134.84 59.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 110.105 -0.331 . . . . 0.0 110.105 179.883 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -77.78 139.09 39.31 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.221 0.534 . . . . 0.0 110.179 -179.949 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.744 HD13 HD11 ' A' ' 19' ' ' LEU . 68.3 mt -106.59 46.66 0.91 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.589 0.709 . . . . 0.0 111.201 -179.015 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -79.16 3.19 18.41 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 115.344 -0.843 . . . . 0.0 110.176 179.555 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.51 ' HD3' ' CD2' ' A' ' 50' ' ' TRP . 17.8 mtp180 -97.09 -19.17 18.88 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.676 179.569 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.435 ' CD1' HD22 ' A' ' 37' ' ' LEU . 21.6 mm -91.56 100.76 11.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 -179.589 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 9.3 mm100 -109.48 165.92 11.28 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.285 -177.988 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.511 ' HA ' ' O ' ' A' ' 99' ' ' ARG . 18.4 p-10 -120.16 118.92 31.78 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.154 177.632 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.2 p -116.12 122.53 69.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 121.033 0.444 . . . . 0.0 110.339 -179.321 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 57.99 16.59 3.83 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.848 179.889 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 111.2 -12.15 28.82 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 121.076 -0.583 . . . . 0.0 113.707 178.859 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.511 ' O ' ' HA ' ' A' ' 95' ' ' ASN . 0.9 OUTLIER -101.0 147.06 26.62 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 117.422 0.611 . . . . 0.0 111.276 -178.906 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.556 HD13 ' SG ' ' A' ' 23' ' ' CYS . 5.2 tp -91.79 123.55 35.26 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.542 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 23.7 t -130.7 140.12 49.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.809 -178.951 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -85.65 125.07 32.87 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 177.397 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 . . . . . 0 C--N 1.309 -1.166 0 CA-C-O 118.46 -0.781 . . . . 0.0 110.862 179.675 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.9 m . . . . . 0 N--CA 1.45 -0.437 0 CA-C-O 120.536 0.208 . . . . 0.0 110.453 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.475 ' CZ ' HD13 ' A' ' 19' ' ' LEU . 18.0 p90 -55.43 -34.49 64.49 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.791 0.329 . . . . 0.0 111.114 178.555 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.546 ' HA ' ' OG ' ' A' ' 7' ' ' SER . . . -57.77 -18.69 23.08 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -178.546 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -69.48 -18.19 63.68 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 121.102 0.477 . . . . 0.0 111.168 179.875 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.419 ' HB2' HD21 ' A' ' 95' ' ' ASN . 50.7 m -141.64 36.51 1.64 Allowed 'General case' 0 N--CA 1.446 -0.646 0 CA-C-O 121.239 0.542 . . . . 0.0 109.899 179.361 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.546 ' OG ' ' HA ' ' A' ' 4' ' ' ALA . 77.8 p -148.7 165.47 31.26 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.36 179.205 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -148.22 165.57 30.53 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.068 179.918 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 62.09 42.44 9.81 Favored 'General case' 0 N--CA 1.464 0.237 0 O-C-N 123.594 0.559 . . . . 0.0 111.24 179.902 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.432 ' HA ' ' O ' ' A' ' 20' ' ' ARG . . . -80.13 117.21 20.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.153 179.627 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 28.2 m -126.41 172.38 13.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.708 -179.432 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.655 HD21 ' HG ' ' A' ' 64' ' ' LEU . 3.1 mm? -104.5 117.84 35.14 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.559 -179.216 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.45 ' OG1' ' HB ' ' A' ' 18' ' ' THR . 37.9 p -112.33 163.96 13.8 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.016 179.779 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 58.56 50.12 9.58 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.124 -179.909 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 84.63 -33.13 3.29 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.394 179.287 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.599 ' HA2' ' HB3' ' A' ' 12' ' ' LEU . . . 134.38 49.65 0.08 OUTLIER Glycine 0 N--CA 1.443 -0.855 0 N-CA-C 111.448 -0.661 . . . . 0.0 111.448 -179.652 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.681 ' HB2' ' HB2' ' A' ' 38' ' ' ASP . 20.4 ptt85 -133.79 -33.82 1.04 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.834 0.35 . . . . 0.0 111.021 179.96 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.509 ' CG2' ' HB3' ' A' ' 34' ' ' GLU . 19.2 m -94.76 135.68 35.96 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.15 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.656 ' O ' ' HA ' ' A' ' 34' ' ' GLU . 79.9 mt -97.54 114.98 26.97 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.559 -179.589 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.468 ' HA ' ' HG2' ' A' ' 34' ' ' GLU . 16.8 ttm180 -104.57 120.24 40.84 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 178.661 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -153.84 160.39 42.19 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.776 0.322 . . . . 0.0 111.571 -179.982 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.585 ' HB3' ' HB3' ' A' ' 30' ' ' TRP . 15.9 mm-40 -90.32 106.08 18.25 Favored 'General case' 0 CA--C 1.513 -0.479 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 177.927 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.505 ' SG ' HD13 ' A' ' 100' ' ' LEU . 48.9 m -93.74 127.56 39.52 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 120.989 0.423 . . . . 0.0 111.053 -178.016 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 23.3 ttp180 -75.35 110.19 9.5 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.772 179.17 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -82.74 169.28 16.35 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 119.223 -0.418 . . . . 0.0 109.979 -179.525 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -47.83 -34.38 8.64 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -178.085 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -68.04 -12.71 61.32 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.473 0.654 . . . . 0.0 111.317 -179.58 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 85.72 26.17 36.1 Favored Glycine 0 N--CA 1.444 -0.83 0 N-CA-C 110.806 -0.918 . . . . 0.0 110.806 -179.202 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -115.95 153.54 31.42 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.718 0.294 . . . . 0.0 110.899 -179.288 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.585 ' HB3' ' HB3' ' A' ' 22' ' ' GLU . 88.6 m95 -89.29 125.58 35.17 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.395 -179.505 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.409 HG22 ' O ' ' A' ' 23' ' ' CYS . 12.1 m -124.74 132.69 70.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 116.213 -0.449 . . . . 0.0 109.949 178.319 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 21.0 m -74.61 109.47 8.11 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.454 -179.904 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 68.7 m -123.18 142.94 50.37 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.358 179.826 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.656 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 49.1 mt-10 -128.38 134.93 48.93 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.31 -179.342 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.519 HD11 ' HB2' ' A' ' 102' ' ' PHE . 1.7 tm? -125.44 130.09 51.14 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 178.744 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.413 ' N ' HD13 ' A' ' 35' ' ' LEU . 15.2 t70 -88.98 111.3 21.98 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 110.14 -0.318 . . . . 0.0 110.14 -179.914 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.548 HD13 HD22 ' A' ' 90' ' ' LEU . 0.9 OUTLIER -86.38 -12.62 48.75 Favored 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 120.937 -0.305 . . . . 0.0 110.906 179.828 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.681 ' HB2' ' HB2' ' A' ' 17' ' ' ARG . 10.1 t70 -61.66 -36.32 80.5 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.653 0.264 . . . . 0.0 111.225 -178.928 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.3 t -72.75 1.27 8.78 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.199 -0.455 . . . . 0.0 112.0 -179.877 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 78.5 m -135.45 -21.43 1.55 Allowed 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 179.943 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.459 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 68.7 mt -107.58 137.21 39.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 179.771 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.491 ' HA2' ' HB3' ' A' ' 55' ' ' PHE . . . -149.55 160.13 28.34 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.393 -0.908 . . . . 0.0 112.492 179.951 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.705 ' ND2' ' HB2' ' A' ' 55' ' ' PHE . 8.3 p30 -158.23 51.21 0.44 Allowed Pre-proline 0 CA--C 1.535 0.4 0 N-CA-C 111.664 0.246 . . . . 0.0 111.664 178.967 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.402 ' HG3' ' HG2' ' A' ' 52' ' ' MET . 60.6 Cg_endo -71.83 -19.69 26.97 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 121.944 1.763 . . . . 0.0 111.823 -179.347 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -91.19 -9.2 46.25 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.883 179.515 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.594 ' HA3' ' HG2' ' A' ' 83' ' ' ARG . . . 102.7 7.47 44.89 Favored Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.772 -179.917 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -125.3 137.45 54.07 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.018 0.437 . . . . 0.0 111.076 -179.674 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.439 HD23 ' HB3' ' A' ' 43' ' ' ASN . 86.9 mt -82.92 146.52 28.79 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.922 -178.457 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 168.32 171.48 34.23 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.2 178.743 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.409 ' HH2' HD11 ' A' ' 93' ' ' ILE . 91.6 m95 -95.27 128.01 41.77 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 -179.998 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 154.35 -51.66 0.46 Allowed Glycine 0 N--CA 1.453 -0.196 0 C-N-CA 120.856 -0.688 . . . . 0.0 111.95 -179.905 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.449 ' HB3' ' HA3' ' A' ' 42' ' ' GLY . 14.0 tpt -93.05 174.03 7.43 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 179.848 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -128.97 173.19 10.64 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.846 -0.342 . . . . 0.0 111.005 179.698 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.678 ' HA ' ' OD2' ' A' ' 38' ' ' ASP . 0.7 OUTLIER 65.52 47.23 2.29 Favored 'General case' 0 N--CA 1.466 0.352 0 O-C-N 123.701 0.626 . . . . 0.0 111.128 -179.806 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.705 ' HB2' ' ND2' ' A' ' 43' ' ' ASN . 15.7 p90 -74.19 -32.11 62.92 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.673 -179.756 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.614 ' OG ' ' HB3' ' A' ' 17' ' ' ARG . 20.1 m -63.75 -33.74 76.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.035 0.445 . . . . 0.0 111.128 -179.046 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 15.7 m-70 -82.15 -7.95 59.64 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.101 0.476 . . . . 0.0 110.27 179.578 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 15.1 m -112.0 4.23 17.98 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.387 -179.292 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 36.4 p -138.38 157.54 46.03 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 122.203 -0.31 . . . . 0.0 110.752 -179.222 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 38.0 mm-40 -117.46 148.42 41.83 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.014 -179.401 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 24.1 t70 52.05 83.35 0.06 Allowed 'General case' 0 N--CA 1.468 0.462 0 O-C-N 124.333 1.02 . . . . 0.0 111.644 178.957 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.538 HD11 ' HA ' ' A' ' 56' ' ' SER . 77.9 mt -97.79 124.1 50.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.78 -179.942 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.455 ' HD3' ' N ' ' A' ' 64' ' ' LEU . 13.0 tmtt? -148.98 149.75 31.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.006 -179.857 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.655 ' HG ' HD21 ' A' ' 12' ' ' LEU . 76.2 mt -83.01 120.16 25.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.021 0.439 . . . . 0.0 111.532 -179.648 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -71.64 -60.2 2.36 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.267 -178.666 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.548 ' HB2' ' HB2' ' A' ' 69' ' ' ARG . 5.0 mm-40 -83.52 20.17 1.44 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.033 -178.767 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 68.66 19.23 72.88 Favored Glycine 0 N--CA 1.45 -0.425 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.923 179.701 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.519 ' HA2' HD13 ' A' ' 64' ' ' LEU . . . 144.18 -34.83 1.62 Allowed Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.315 -0.945 . . . . 0.0 113.251 179.697 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.548 ' HB2' ' HB2' ' A' ' 66' ' ' GLU . 5.4 mmt85 -71.57 -24.89 62.0 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.854 0.359 . . . . 0.0 111.829 -179.34 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 11.7 tttp -143.65 137.48 28.29 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.607 -177.81 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.606 ' HB2' HD11 ' A' ' 90' ' ' LEU . 10.5 tt -105.84 127.58 53.2 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 179.599 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.1 p -116.32 136.28 53.14 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 120.971 0.415 . . . . 0.0 111.233 179.967 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.403 ' HB3' ' HA ' ' A' ' 62' ' ' ILE . 21.0 p -162.58 175.87 10.98 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.747 -179.743 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.464 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 29.5 ttt180 -112.8 98.85 46.35 Favored Pre-proline 0 C--N 1.315 -0.902 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.303 178.97 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.647 ' O ' ' HB3' ' A' ' 83' ' ' ARG . 34.9 Cg_endo -66.19 130.44 24.13 Favored 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 122.674 2.249 . . . . 0.0 110.791 178.953 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.626 ' HA ' ' HB2' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -119.71 152.88 36.47 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.167 0.508 . . . . 0.0 111.049 -179.681 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.696 ' HB ' ' HD2' ' A' ' 83' ' ' ARG . 10.9 t -88.84 144.78 25.99 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 178.902 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 34.7 m -71.61 -4.81 5.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 O-C-N 123.992 0.808 . . . . 0.0 112.152 -179.141 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 39.1 m-20 -63.93 -37.21 86.55 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-O 121.118 0.485 . . . . 0.0 109.793 178.928 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.405 ' H ' ' H ' ' A' ' 81' ' ' GLY . . . -164.76 -4.94 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 115.461 -0.79 . . . . 0.0 112.854 -179.841 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.405 ' H ' ' H ' ' A' ' 80' ' ' GLY . . . 93.38 22.9 25.67 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.089 179.731 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.649 ' O ' HG22 ' A' ' 77' ' ' THR . 34.2 p90 -111.46 148.02 34.03 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 -179.42 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.696 ' HD2' ' HB ' ' A' ' 77' ' ' THR . 0.0 OUTLIER 174.55 -143.75 0.01 OUTLIER 'General case' 0 C--O 1.233 0.195 0 O-C-N 123.465 0.478 . . . . 0.0 111.304 -179.915 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -125.31 176.6 6.66 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.923 0.392 . . . . 0.0 110.579 -179.49 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.464 ' HA ' ' HA ' ' A' ' 74' ' ' ARG . 62.8 ttt180 -108.66 147.82 31.32 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 177.849 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 86' ' ' GLN . . . . . 0.519 ' HG2' ' N ' ' A' ' 87' ' ' GLY . 9.0 tt0 -161.27 171.8 17.75 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.946 0.403 . . . . 0.0 111.79 -177.246 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.519 ' N ' ' HG2' ' A' ' 86' ' ' GLN . . . -132.12 141.65 13.01 Favored Glycine 0 N--CA 1.45 -0.387 0 N-CA-C 111.233 -0.747 . . . . 0.0 111.233 178.612 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 11.6 tt -120.45 138.74 49.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 120.976 0.417 . . . . 0.0 110.377 -179.221 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.6 m-20 -75.74 139.98 42.15 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.185 -179.472 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.612 HD13 HD11 ' A' ' 19' ' ' LEU . 29.8 mt -109.43 35.73 3.2 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.517 0.675 . . . . 0.0 110.376 179.317 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -72.56 -5.41 36.92 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.594 -179.835 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 17.1 mtp180 -89.09 -7.74 55.21 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.001 178.731 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.438 HG13 HD22 ' A' ' 37' ' ' LEU . 27.5 mm -103.64 100.55 10.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -179.615 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 25.4 tp60 -117.55 146.76 43.37 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.342 -178.777 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.419 HD21 ' HB2' ' A' ' 6' ' ' SER . 12.5 p-10 -95.16 117.11 29.66 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.48 179.18 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 48.5 t -101.36 107.03 20.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.788 179.727 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 56.16 41.86 28.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.675 -179.284 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 89.5 -18.4 46.4 Favored Glycine 0 N--CA 1.447 -0.624 0 CA-C-N 115.783 -0.644 . . . . 0.0 113.342 179.681 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 8.7 mpt_? -88.31 123.13 32.59 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 117.163 0.481 . . . . 0.0 110.921 -179.216 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.505 HD13 ' SG ' ' A' ' 23' ' ' CYS . 7.6 tp -76.65 114.46 15.41 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.443 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 40.7 t -128.98 144.7 37.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.09 0.472 . . . . 0.0 111.367 -178.488 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.519 ' HB2' HD11 ' A' ' 35' ' ' LEU . 22.3 t80 -83.26 130.92 35.11 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.63 178.442 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 . . . . . 0 C--N 1.317 -0.846 0 CA-C-O 118.325 -0.845 . . . . 0.0 110.216 -179.725 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 2' ' ' SER . . . . . 0.536 ' HB3' ' HA ' ' A' ' 91' ' ' ASN . 15.9 p . . . . . 0 N--CA 1.453 -0.3 0 N-CA-C 110.732 -0.099 . . . . 0.0 110.732 . . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 4.4 p90 -55.91 -38.09 69.79 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -178.555 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -56.35 -21.57 25.41 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 -177.882 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -66.4 -28.7 68.84 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.255 0.55 . . . . 0.0 110.392 179.971 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 41.4 m -133.44 36.22 3.39 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.687 179.204 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 8.6 t -140.29 160.11 40.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.945 -179.66 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 1.1 ptp180 -149.97 169.86 20.19 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.632 -179.593 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 58.23 45.48 17.21 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.129 177.934 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.567 ' HA ' ' HB2' ' A' ' 21' ' ' ALA . . . -81.66 118.34 22.73 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.055 0.455 . . . . 0.0 110.69 179.957 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 29.5 m -119.24 170.55 8.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.393 179.794 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.712 HD21 ' HG ' ' A' ' 64' ' ' LEU . 3.2 mm? -105.12 114.94 29.44 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.434 -179.47 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 38.8 p -115.01 167.66 10.6 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.808 179.752 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 57.64 50.56 10.71 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.154 179.653 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 83.88 -22.94 7.25 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 121.069 -0.586 . . . . 0.0 112.374 -179.808 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.613 ' HA2' ' HB3' ' A' ' 12' ' ' LEU . . . 119.71 38.23 0.73 Allowed Glycine 0 N--CA 1.447 -0.583 0 N-CA-C 111.662 -0.575 . . . . 0.0 111.662 179.976 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.626 ' HB2' ' HB3' ' A' ' 38' ' ' ASP . 14.3 ptt180 -121.86 -22.6 5.7 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.944 0.402 . . . . 0.0 110.758 -179.486 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 4.2 m -102.55 133.06 48.14 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.592 -179.607 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.811 HD11 HD13 ' A' ' 90' ' ' LEU . 69.5 mt -92.65 112.62 24.64 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.297 179.142 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.411 HH11 ' HD2' ' A' ' 20' ' ' ARG . 30.7 ttt85 -111.06 118.57 36.4 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 178.94 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.567 ' HB2' ' HA ' ' A' ' 10' ' ' ALA . . . -154.9 166.92 32.02 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.862 0.363 . . . . 0.0 111.964 -178.783 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -90.69 113.37 25.43 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 177.371 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.477 ' SG ' HD13 ' A' ' 100' ' ' LEU . 59.7 m -102.66 134.95 45.18 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 -179.806 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.563 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 7.3 ttt180 -82.12 104.66 12.61 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-O 120.917 0.389 . . . . 0.0 109.965 -179.804 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.431 HD21 ' HB3' ' A' ' 29' ' ' ASN . 37.8 p30 -67.01 170.84 6.17 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 115.619 -0.718 . . . . 0.0 111.162 -179.214 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.52 -31.16 61.84 Favored 'General case' 0 N--CA 1.464 0.269 0 O-C-N 123.431 0.457 . . . . 0.0 111.781 -178.781 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -71.56 -11.71 61.0 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.331 0.586 . . . . 0.0 110.421 179.878 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 87.55 24.64 35.47 Favored Glycine 0 N--CA 1.45 -0.404 0 N-CA-C 111.373 -0.691 . . . . 0.0 111.373 -179.839 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.563 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 10.7 t-20 -108.56 160.09 16.19 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.672 0.272 . . . . 0.0 110.718 -178.349 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 90.4 m95 -98.36 119.18 36.6 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.984 0.421 . . . . 0.0 110.8 179.745 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.2 m -123.43 130.9 73.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.098 179.11 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 28.0 m -79.69 109.12 13.8 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.057 0.455 . . . . 0.0 110.32 -179.889 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 70.3 m -115.89 161.33 18.96 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.439 -179.817 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.636 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 51.5 mt-10 -140.02 138.92 35.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.241 -178.908 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.6 ' HB2' ' HB3' ' A' ' 100' ' ' LEU . 1.8 tm? -134.72 129.97 35.53 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 178.704 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.476 ' O ' HG22 ' A' ' 39' ' ' THR . 15.8 m-20 -88.64 109.64 20.28 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 179.971 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.534 HD13 HD22 ' A' ' 90' ' ' LEU . 1.4 mt -83.06 -12.42 57.16 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.831 -179.303 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.626 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 4.2 p-10 -66.23 -13.58 60.56 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 111.857 0.317 . . . . 0.0 111.857 -178.621 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.476 HG22 ' O ' ' A' ' 36' ' ' ASP . 12.1 t -87.97 -0.58 57.19 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.885 0.374 . . . . 0.0 110.296 179.387 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 67.2 m -136.58 -20.11 1.37 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.937 179.94 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 60.0 mt -107.96 132.49 55.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 178.877 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.557 ' HA3' ' HB3' ' A' ' 52' ' ' MET . . . -141.49 158.69 26.61 Favored Glycine 0 N--CA 1.446 -0.667 0 N-CA-C 111.256 -0.738 . . . . 0.0 111.256 179.527 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.613 ' OD1' ' HB2' ' A' ' 58' ' ' SER . 32.6 p30 -156.29 40.82 0.12 Allowed Pre-proline 0 CA--C 1.54 0.592 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 179.792 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.403 ' CD ' ' N ' ' A' ' 43' ' ' ASN . 52.5 Cg_endo -69.65 -15.86 37.73 Favored 'Trans proline' 0 C--N 1.357 0.975 0 C-N-CA 121.331 1.354 . . . . 0.0 111.41 -179.933 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -89.74 -8.12 52.98 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.623 179.077 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.589 ' HA3' ' HD3' ' A' ' 83' ' ' ARG . . . 99.38 5.25 55.91 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.659 -179.575 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.702 ' HD1' HE22 ' A' ' 86' ' ' GLN . 63.2 m-85 -126.92 139.79 52.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 117.045 0.422 . . . . 0.0 111.568 -179.587 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.625 HD12 ' HG3' ' A' ' 86' ' ' GLN . 59.4 mt -84.5 138.86 32.54 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.735 -179.704 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 179.11 168.39 38.11 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.137 178.807 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 87.9 m95 -95.78 125.51 40.4 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.985 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 151.26 -42.61 0.72 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.895 -0.669 . . . . 0.0 111.519 -179.66 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.557 ' HB3' ' HA3' ' A' ' 42' ' ' GLY . 1.5 mtt -97.44 -172.07 2.33 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 179.399 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -142.96 169.81 16.88 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 119.757 -0.777 . . . . 0.0 112.343 -178.839 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 64.0 44.97 4.4 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.877 179.203 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.41 ' HD1' ' HA ' ' A' ' 38' ' ' ASP . 20.7 p90 -64.08 -33.6 76.13 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.464 -179.788 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 67.0 p -66.49 -23.84 66.32 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.208 0.527 . . . . 0.0 110.787 -179.36 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 16.1 m80 -76.97 -6.06 51.1 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.662 179.689 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.613 ' HB2' ' OD1' ' A' ' 43' ' ' ASN . 31.5 m -137.78 27.99 2.68 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.939 0.4 . . . . 0.0 110.782 179.492 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.554 ' HB3' HD21 ' A' ' 43' ' ' ASN . 35.6 p -141.73 149.81 40.98 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.169 0.509 . . . . 0.0 111.32 179.352 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -123.28 150.06 43.99 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.476 -179.626 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 27.6 t70 54.62 77.4 0.2 Allowed 'General case' 0 N--CA 1.47 0.546 0 O-C-N 123.778 0.674 . . . . 0.0 111.188 -179.922 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.51 ' HA ' ' HB3' ' A' ' 73' ' ' CYS . 69.4 mt -95.98 117.5 40.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.878 -179.404 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 41.6 tptt -142.25 150.45 40.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.699 -179.326 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.712 ' HG ' HD21 ' A' ' 12' ' ' LEU . 57.8 mt -92.93 144.7 25.01 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.362 179.432 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -101.42 -63.93 1.1 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.941 0.4 . . . . 0.0 111.963 -179.965 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.537 ' HB2' ' HB3' ' A' ' 69' ' ' ARG . 10.6 mm-40 -79.81 40.34 0.45 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.045 -178.098 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 64.11 22.09 66.61 Favored Glycine 0 C--N 1.314 -0.675 0 CA-C-N 115.229 -0.896 . . . . 0.0 113.123 178.858 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.598 ' HA2' HD13 ' A' ' 64' ' ' LEU . . . 120.56 -9.18 10.83 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 119.965 -1.112 . . . . 0.0 112.858 179.17 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.537 ' HB3' ' HB2' ' A' ' 66' ' ' GLU . 16.5 ttp85 -90.3 -3.06 58.01 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.665 0.745 . . . . 0.0 110.335 -179.794 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.517 ' HD3' ' HA ' ' A' ' 89' ' ' ASP . 5.6 tppp? -150.39 123.64 8.92 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.846 -179.77 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.677 ' HB2' HD11 ' A' ' 90' ' ' LEU . 9.5 tt -105.62 128.57 53.71 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 179.867 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 5.6 p -123.23 135.43 54.27 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.166 179.876 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.51 ' HB3' ' HA ' ' A' ' 62' ' ' ILE . 22.8 p -162.21 173.79 13.78 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 179.552 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.47 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 71.8 ttt180 -110.26 98.59 36.34 Favored Pre-proline 0 C--N 1.312 -1.035 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.276 179.606 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.646 ' O ' ' HB3' ' A' ' 83' ' ' ARG . 37.1 Cg_endo -69.92 132.65 23.5 Favored 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 122.342 2.028 . . . . 0.0 109.964 178.495 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.743 ' HA ' ' HB2' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -120.6 142.84 49.02 Favored 'General case' 0 C--N 1.32 -0.68 0 O-C-N 123.678 0.611 . . . . 0.0 111.452 -179.115 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.706 HG22 ' O ' ' A' ' 82' ' ' PHE . 14.6 t -76.81 143.31 39.87 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.614 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 22.5 m -77.4 1.07 2.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.573 -179.492 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -69.8 -34.26 73.48 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 121.371 0.605 . . . . 0.0 109.651 178.326 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -159.05 -12.77 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.517 0 CA-C-N 115.29 -0.868 . . . . 0.0 112.794 -179.814 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.704 ' HA2' ' HE3' ' A' ' 76' ' ' LYS . . . 97.23 20.21 23.72 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.108 179.983 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.706 ' O ' HG22 ' A' ' 77' ' ' THR . 33.8 p90 -111.83 155.42 23.62 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 118.996 -0.526 . . . . 0.0 109.904 -179.055 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.743 ' HB2' ' HA ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 171.49 -148.18 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 O-C-N 123.407 0.442 . . . . 0.0 111.48 179.651 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -134.99 153.51 52.06 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.157 -177.817 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.47 ' HA ' ' HA ' ' A' ' 74' ' ' ARG . 43.2 ttt85 -88.56 149.55 23.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.128 179.512 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 86' ' ' GLN . . . . . 0.702 HE22 ' HD1' ' A' ' 47' ' ' PHE . 8.2 pt20 -165.28 177.51 7.54 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.146 -179.033 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -131.62 150.94 19.61 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.8 -0.715 . . . . 0.0 112.45 -179.994 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 9.5 tt -127.77 134.63 65.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 179.736 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.517 ' HA ' ' HD3' ' A' ' 70' ' ' LYS . 2.1 p-10 -76.94 140.27 40.42 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.997 0.427 . . . . 0.0 110.439 -179.178 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.811 HD13 HD11 ' A' ' 19' ' ' LEU . 62.2 mt -105.91 38.69 1.95 Allowed 'General case' 0 CA--C 1.512 -0.513 0 CA-C-O 121.412 0.625 . . . . 0.0 110.873 -178.892 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.536 ' HA ' ' HB3' ' A' ' 2' ' ' SER . 11.1 m120 -75.19 0.05 17.71 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.794 -179.759 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 14.7 mtp180 -92.05 -7.67 48.09 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.595 179.339 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.424 ' CD1' HD22 ' A' ' 37' ' ' LEU . 28.1 mm -98.5 104.57 16.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.518 0.675 . . . . 0.0 109.747 -179.334 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -106.56 157.36 17.73 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.36 -178.346 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.477 ' HA ' ' O ' ' A' ' 99' ' ' ARG . 20.4 p-10 -113.7 124.64 52.78 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.425 178.073 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 46.8 t -107.71 109.28 27.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 -179.237 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 11.3 m-80 57.79 22.14 8.21 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.937 0.398 . . . . 0.0 111.577 -179.326 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 113.66 -25.36 11.08 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.728 -0.748 . . . . 0.0 113.935 178.47 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.477 ' O ' ' HA ' ' A' ' 95' ' ' ASN . 1.4 ptm180 -86.5 147.76 25.83 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 117.416 0.608 . . . . 0.0 110.666 -178.85 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.6 ' HB3' ' HB2' ' A' ' 35' ' ' LEU . 2.1 tp -92.68 122.92 35.57 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.718 0.294 . . . . 0.0 110.335 -179.366 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 41.7 t -134.12 141.84 42.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.654 -179.869 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.416 ' HB2' HD11 ' A' ' 35' ' ' LEU . 16.9 t80 -78.44 136.39 37.61 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.979 0.419 . . . . 0.0 110.106 179.268 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 . . . . . 0 C--O 1.25 1.087 0 CA-C-O 118.462 -0.78 . . . . 0.0 110.39 179.949 . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 2' ' ' SER . . . . . 0.582 ' HB3' ' HA ' ' A' ' 91' ' ' ASN . 0.3 OUTLIER . . . . . 0 N--CA 1.453 -0.312 0 N-CA-C 111.729 0.27 . . . . 0.0 111.729 . . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.442 ' CB ' HD11 ' A' ' 100' ' ' LEU . 13.3 p90 -47.03 -36.07 7.49 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 123.09 0.556 . . . . 0.0 112.422 -179.51 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.434 ' HB3' ' HD3' ' A' ' 69' ' ' ARG . . . -54.13 -20.45 6.67 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -178.664 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -64.11 -33.65 76.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.218 0.533 . . . . 0.0 109.867 178.896 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 26.1 m -132.31 41.8 3.18 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.619 179.121 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 22.7 t -154.77 149.24 26.26 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.307 -179.591 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.459 ' HG3' ' ND2' ' A' ' 9' ' ' ASN . 11.6 ptp180 -136.62 175.7 9.37 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.827 -179.474 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.459 ' ND2' ' HG3' ' A' ' 8' ' ' ARG . 4.6 p30 45.58 60.39 3.12 Favored 'General case' 0 N--CA 1.474 0.774 0 O-C-N 124.298 0.999 . . . . 0.0 112.286 -179.233 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.422 ' HA ' ' HB2' ' A' ' 21' ' ' ALA . . . -87.28 117.73 26.23 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.376 179.519 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 33.9 m -115.92 170.64 5.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.821 -179.852 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.582 ' HB3' ' HA2' ' A' ' 16' ' ' GLY . 3.7 mm? -105.18 120.75 42.29 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.592 -179.62 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.437 HG21 ' NE ' ' A' ' 20' ' ' ARG . 17.7 p -119.96 161.42 20.92 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.825 179.542 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 59.8 38.27 21.55 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.14 179.679 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 93.86 -23.34 31.39 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.066 179.896 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.582 ' HA2' ' HB3' ' A' ' 12' ' ' LEU . . . 124.93 11.78 4.23 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.628 -0.796 . . . . 0.0 111.847 -179.939 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.585 ' HB2' ' HB3' ' A' ' 38' ' ' ASP . 16.9 ptt180 -92.46 -23.05 19.27 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.264 0.554 . . . . 0.0 110.067 -179.954 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.463 HG22 ' HB3' ' A' ' 34' ' ' GLU . 4.3 m -105.96 133.48 50.61 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.782 -179.535 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.766 HD11 HD13 ' A' ' 90' ' ' LEU . 59.9 mt -97.47 114.41 26.27 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.419 179.163 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.481 ' HA ' ' HG2' ' A' ' 34' ' ' GLU . 32.9 ttm180 -109.84 120.19 41.7 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 178.813 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.422 ' HB2' ' HA ' ' A' ' 10' ' ' ALA . . . -153.36 166.12 33.63 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.969 0.414 . . . . 0.0 111.455 -179.675 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.714 ' HG3' ' HB3' ' A' ' 30' ' ' TRP . 1.0 OUTLIER -90.29 107.6 19.24 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 177.898 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.43 ' SG ' HD13 ' A' ' 100' ' ' LEU . 71.6 m -98.51 140.65 32.44 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.686 0.279 . . . . 0.0 110.69 -178.701 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.532 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 7.9 ttp180 -83.96 115.83 22.51 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-O 120.949 0.405 . . . . 0.0 110.2 179.412 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.423 HD21 ' HB3' ' A' ' 29' ' ' ASN . 37.0 p30 -76.55 174.2 10.62 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.262 179.919 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.74 -25.29 60.2 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -178.497 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -78.79 -9.81 59.57 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.65 0.738 . . . . 0.0 109.896 179.92 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 85.07 29.3 28.71 Favored Glycine 0 N--CA 1.445 -0.761 0 N-CA-C 110.718 -0.953 . . . . 0.0 110.718 -179.031 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.532 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 8.3 t-20 -111.53 158.45 19.17 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.74 -0.23 . . . . 0.0 110.687 -178.555 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.714 ' HB3' ' HG3' ' A' ' 22' ' ' GLU . 61.4 m95 -92.28 129.29 38.26 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.047 -179.899 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.4 HG22 ' O ' ' A' ' 23' ' ' CYS . 15.6 m -132.9 141.42 44.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.668 179.346 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.2 m -81.7 111.75 18.25 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.228 179.86 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 54.7 m -127.53 150.18 49.81 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.655 179.779 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.667 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 45.1 mt-10 -134.25 148.32 50.81 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.03 -179.611 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.544 HD12 HD23 ' A' ' 37' ' ' LEU . 2.1 tm? -139.25 134.42 32.64 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.55 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.478 ' N ' HD13 ' A' ' 35' ' ' LEU . 29.6 m-20 -91.76 109.69 21.02 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.359 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.544 HD23 HD12 ' A' ' 35' ' ' LEU . 1.4 mt -83.01 -20.62 34.72 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.816 -178.543 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.585 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 4.3 p-10 -61.5 -15.41 37.61 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 111.717 0.266 . . . . 0.0 111.717 -178.423 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 60.0 p -72.48 -22.58 61.04 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.055 0.455 . . . . 0.0 110.716 179.737 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 27.3 m -128.86 0.25 5.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.06 -0.518 . . . . 0.0 112.022 -178.669 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.438 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 53.7 mt -116.57 131.35 69.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 120.636 0.255 . . . . 0.0 110.342 178.861 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.562 ' HA3' ' HB3' ' A' ' 52' ' ' MET . . . -150.38 163.99 29.67 Favored Glycine 0 N--CA 1.445 -0.731 0 N-CA-C 111.328 -0.709 . . . . 0.0 111.328 179.445 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.451 ' OD1' ' HB2' ' A' ' 55' ' ' PHE . 3.7 p-10 -161.91 51.08 0.32 Allowed Pre-proline 0 CA--C 1.535 0.386 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 179.813 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -63.5 -26.73 70.08 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 121.847 1.698 . . . . 0.0 111.75 -179.626 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -84.14 -12.59 54.73 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.797 179.898 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.599 ' HA3' ' HD3' ' A' ' 83' ' ' ARG . . . 103.36 7.96 41.92 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.283 -0.96 . . . . 0.0 112.954 -179.344 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -124.88 133.62 53.01 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.003 0.43 . . . . 0.0 110.495 179.676 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.503 ' HB3' ' HB ' ' A' ' 88' ' ' ILE . 84.2 mt -83.09 138.0 33.87 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.498 -0.774 . . . . 0.0 112.251 -177.688 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -177.01 172.81 45.77 Favored Glycine 0 N--CA 1.447 -0.58 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.7 178.802 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.421 ' CD2' ' HD3' ' A' ' 92' ' ' ARG . 94.1 m95 -95.53 128.21 42.21 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.993 0.425 . . . . 0.0 110.321 -179.971 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 151.84 -62.69 0.39 Allowed Glycine 0 N--CA 1.449 -0.441 0 CA-C-N 116.019 -0.537 . . . . 0.0 112.076 -179.877 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.608 ' CE ' ' HA ' ' A' ' 52' ' ' MET . 1.0 OUTLIER -77.02 179.88 5.96 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 179.74 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -133.98 173.8 11.17 Favored 'General case' 0 C--N 1.326 -0.419 0 O-C-N 122.089 -0.382 . . . . 0.0 111.678 -178.982 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 61.74 45.99 7.4 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.642 -0.708 . . . . 0.0 112.33 179.174 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.451 ' HB2' ' OD1' ' A' ' 43' ' ' ASN . 8.5 p90 -65.83 -28.51 69.04 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 111.652 0.241 . . . . 0.0 111.652 -179.371 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 11.4 p -64.45 -28.4 69.65 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.917 0.389 . . . . 0.0 111.553 -179.104 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 50.5 m80 -82.27 -3.43 55.21 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.224 -179.433 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 14.9 m -126.52 13.53 7.57 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.792 179.793 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 63.9 m -135.49 151.94 50.85 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.382 0.61 . . . . 0.0 111.881 -178.891 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -121.55 141.46 51.05 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.404 179.279 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.43 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 31.4 t70 58.78 79.89 0.2 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.509 0.671 . . . . 0.0 111.39 179.704 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.535 HG23 HD21 ' A' ' 71' ' ' LEU . 74.3 mt -95.56 123.27 47.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.076 179.558 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.6 tptm -149.02 160.0 43.71 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 -179.769 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.547 ' HG ' HD21 ' A' ' 12' ' ' LEU . 44.7 mt -88.57 129.44 35.48 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.108 0.48 . . . . 0.0 109.973 178.965 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.415 ' HB3' ' HB3' ' A' ' 70' ' ' LYS . 34.1 tp10 -77.52 -69.47 0.53 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.264 -178.398 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.57 ' HB2' ' HB2' ' A' ' 69' ' ' ARG . 26.1 mt-10 -81.94 29.31 0.4 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.285 -179.284 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 68.11 14.64 66.36 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.903 -0.59 . . . . 0.0 113.282 179.757 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 145.98 -25.84 1.76 Allowed Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 119.591 -1.29 . . . . 0.0 113.373 179.361 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.57 ' HB2' ' HB2' ' A' ' 66' ' ' GLU . 9.6 mmt85 -76.19 -23.37 54.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.283 0.563 . . . . 0.0 110.431 -179.289 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.415 ' HB3' ' HB3' ' A' ' 65' ' ' GLU . 39.9 ttmt -146.02 148.73 33.0 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.801 -177.883 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.716 ' HB2' HD11 ' A' ' 90' ' ' LEU . 9.8 tt -115.94 125.66 52.86 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 179.332 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.1 p -113.72 128.35 56.39 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.346 0.594 . . . . 0.0 111.241 179.43 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 73' ' ' CYS . . . . . 0.43 ' HA ' ' O ' ' A' ' 61' ' ' ASP . 25.6 p -149.88 171.32 16.97 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.659 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.56 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 4.1 tmt_? -104.37 98.31 14.02 Favored Pre-proline 0 C--N 1.315 -0.896 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 179.267 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.591 ' O ' ' HB3' ' A' ' 83' ' ' ARG . 64.9 Cg_endo -72.62 125.02 10.23 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 123.002 2.468 . . . . 0.0 111.506 179.79 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.718 ' HA ' ' HB2' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -121.82 139.92 53.02 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.867 179.819 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.721 HG22 ' O ' ' A' ' 82' ' ' PHE . 11.6 t -74.77 131.54 40.89 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 178.499 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.1 m -74.18 -2.22 3.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.488 -179.256 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -68.83 -33.71 74.28 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.185 0.517 . . . . 0.0 109.738 179.309 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -148.56 -23.96 0.08 OUTLIER Glycine 0 N--CA 1.449 -0.436 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.591 179.796 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.527 ' HA2' ' HE2' ' A' ' 76' ' ' LYS . . . 101.58 19.03 16.83 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.021 -179.793 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.721 ' O ' HG22 ' A' ' 77' ' ' THR . 26.3 p90 -110.71 151.05 28.19 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 118.821 -0.609 . . . . 0.0 109.993 -178.885 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.718 ' HB2' ' HA ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 167.49 -153.95 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.572 0 O-C-N 123.729 0.643 . . . . 0.0 111.213 179.236 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -135.55 167.41 21.14 Favored 'General case' 0 C--O 1.226 -0.17 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.051 -178.842 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.56 ' HA ' ' HA ' ' A' ' 74' ' ' ARG . 44.5 ttt180 -81.75 156.25 25.07 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 178.407 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 86' ' ' GLN . . . . . 0.61 ' HG2' ' H ' ' A' ' 87' ' ' GLY . 36.8 tt0 -161.04 -176.07 5.27 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.41 -0.516 . . . . 0.0 111.401 -178.161 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.61 ' H ' ' HG2' ' A' ' 86' ' ' GLN . . . -151.89 141.36 8.47 Favored Glycine 0 N--CA 1.449 -0.49 0 N-CA-C 111.778 -0.529 . . . . 0.0 111.778 179.379 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.503 ' HB ' ' HB3' ' A' ' 48' ' ' LEU . 10.4 tt -120.58 133.48 67.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.303 0.573 . . . . 0.0 110.77 -179.46 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.515 ' OD1' ' HB2' ' A' ' 91' ' ' ASN . 13.6 t70 -73.25 136.34 44.61 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.632 -179.868 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.766 HD13 HD11 ' A' ' 19' ' ' LEU . 63.8 mt -109.55 37.41 2.63 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -178.341 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.582 ' HA ' ' HB3' ' A' ' 2' ' ' SER . 2.6 m120 -75.05 2.59 10.23 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 121.368 0.604 . . . . 0.0 111.221 179.231 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.421 ' HD3' ' CD2' ' A' ' 50' ' ' TRP . 24.7 mtp180 -92.29 -12.49 32.37 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.243 179.104 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.471 HG13 HD22 ' A' ' 37' ' ' LEU . 24.6 mm -94.94 103.47 14.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 121.453 0.644 . . . . 0.0 109.563 -179.622 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 3.5 mm100 -112.25 152.08 28.88 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.714 -178.368 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 18.3 p-10 -105.27 126.02 51.63 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.742 178.564 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 40.5 t -115.72 116.47 52.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 -179.562 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 54.4 25.39 6.0 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.601 -179.841 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 109.13 -27.45 12.72 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.806 -0.712 . . . . 0.0 114.004 179.155 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -86.8 146.19 26.33 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 117.687 0.744 . . . . 0.0 111.53 -178.48 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.523 ' HB3' ' HB2' ' A' ' 35' ' ' LEU . 5.2 tp -92.14 121.52 33.76 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.906 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 24.1 t -129.73 140.88 47.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 120.804 0.335 . . . . 0.0 110.935 -178.821 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.432 ' HB2' HD11 ' A' ' 35' ' ' LEU . 20.7 t80 -79.21 130.73 35.77 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 178.475 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 . . . . . 0 C--N 1.312 -1.064 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.673 -179.57 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.9 mpp? . . . . . 0 N--CA 1.479 1.007 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.537 ' OG ' ' HA ' ' A' ' 91' ' ' ASN . 9.2 m -112.67 178.11 4.4 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.426 179.1 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 18.6 p90 -51.73 -34.18 37.98 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 123.448 0.468 . . . . 0.0 111.519 179.143 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -56.3 -18.8 11.77 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 -178.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -58.02 -32.91 68.4 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 121.261 0.553 . . . . 0.0 110.093 178.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 33.5 m -137.44 37.94 2.47 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.338 178.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.456 ' HA ' ' O ' ' A' ' 22' ' ' GLU . 20.3 t -147.23 147.97 30.99 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.271 -179.661 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 9.7 ptp180 -140.58 169.75 17.07 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.086 -179.625 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 65.7 m-80 57.39 52.32 8.8 Favored 'General case' 0 N--CA 1.465 0.296 0 O-C-N 123.93 0.769 . . . . 0.0 111.53 -179.419 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -82.47 118.12 23.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.465 179.361 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 27.0 m -121.55 170.8 11.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.67 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.641 HD21 ' HG ' ' A' ' 64' ' ' LEU . 3.3 mm? -105.14 114.57 28.85 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.118 -179.546 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.504 HG21 ' NE ' ' A' ' 20' ' ' ARG . 35.3 p -111.79 170.37 8.19 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.978 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 59.49 46.25 12.48 Favored 'General case' 0 CA--C 1.521 -0.137 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.289 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 86.01 -34.92 3.32 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 121.007 -0.616 . . . . 0.0 112.134 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.592 ' HA2' ' HB3' ' A' ' 12' ' ' LEU . . . 136.2 38.02 0.17 Allowed Glycine 0 N--CA 1.447 -0.583 0 N-CA-C 111.437 -0.665 . . . . 0.0 111.437 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.692 ' HB2' ' HB2' ' A' ' 38' ' ' ASP . 3.3 ptp180 -125.23 -12.91 6.81 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.256 0.55 . . . . 0.0 110.98 -179.389 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.519 ' CG2' ' HB3' ' A' ' 34' ' ' GLU . 9.5 m -115.21 137.74 51.69 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.429 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.831 HD11 HD13 ' A' ' 90' ' ' LEU . 59.6 mt -96.13 118.66 33.16 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.734 179.565 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.504 ' NE ' HG21 ' A' ' 13' ' ' THR . 34.5 ttm180 -113.84 120.98 42.61 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 178.262 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.413 ' O ' ' HA ' ' A' ' 32' ' ' THR . . . -152.72 167.32 29.37 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.827 0.346 . . . . 0.0 111.532 -179.122 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.697 ' HB3' ' HB3' ' A' ' 30' ' ' TRP . 39.4 mt-10 -89.68 105.95 18.14 Favored 'General case' 0 CA--C 1.512 -0.516 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 178.819 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.533 ' SG ' HD13 ' A' ' 100' ' ' LEU . 56.0 m -96.23 119.22 34.33 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 -179.276 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.486 ' HB2' ' CZ3' ' A' ' 30' ' ' TRP . 45.9 ttp180 -72.85 111.28 7.83 Favored 'General case' 0 N--CA 1.437 -1.113 0 N-CA-C 110.197 -0.297 . . . . 0.0 110.197 179.386 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 31.9 p30 -81.18 168.9 18.03 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.669 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -51.54 -32.01 26.39 Favored 'General case' 0 N--CA 1.465 0.284 0 O-C-N 123.643 0.59 . . . . 0.0 112.096 -179.192 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -67.65 -14.12 62.67 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.404 0.621 . . . . 0.0 110.94 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 89.15 22.07 39.49 Favored Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.772 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.431 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 2.3 m-80 -111.77 150.38 30.37 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.838 0.351 . . . . 0.0 111.449 -179.101 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.697 ' HB3' ' HB3' ' A' ' 22' ' ' GLU . 97.3 m95 -91.63 109.3 20.6 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.201 179.242 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.9 m -109.87 129.42 64.83 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 CA-C-O 120.965 0.412 . . . . 0.0 110.232 178.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.413 ' HA ' ' O ' ' A' ' 21' ' ' ALA . 27.7 m -78.98 113.16 16.87 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.854 -179.372 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 68.7 m -121.19 157.26 30.6 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.403 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.676 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 51.3 mt-10 -131.78 132.35 43.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.763 -179.583 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.472 ' HB2' HD23 ' A' ' 100' ' ' LEU . 1.9 tm? -124.91 132.63 53.27 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.571 -0.899 . . . . 0.0 108.571 178.771 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.449 ' N ' HD13 ' A' ' 35' ' ' LEU . 12.9 m-20 -91.45 109.95 21.25 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.76 0.314 . . . . 0.0 110.512 -179.113 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.451 HD13 HD22 ' A' ' 90' ' ' LEU . 0.9 OUTLIER -83.47 -15.99 47.43 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.296 -179.521 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.75 ' OD2' ' HA ' ' A' ' 54' ' ' ASN . 8.5 t70 -63.17 -8.48 8.11 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.071 0.462 . . . . 0.0 110.969 -179.297 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 73.0 p -87.14 -22.37 25.39 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.49 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.404 ' HB2' ' CZ3' ' A' ' 50' ' ' TRP . 29.0 m -125.56 -5.04 7.1 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -178.056 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 56.7 mt -113.72 136.16 51.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.66 0.267 . . . . 0.0 110.407 179.295 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.521 ' HA3' ' HB3' ' A' ' 52' ' ' MET . . . -146.65 157.35 27.37 Favored Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.86 -0.686 . . . . 0.0 111.855 179.769 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.618 ' N ' ' HD3' ' A' ' 44' ' ' PRO . 21.8 p30 -159.53 46.28 0.21 Allowed Pre-proline 0 CA--C 1.539 0.534 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.618 ' HD3' ' N ' ' A' ' 43' ' ' ASN . 7.0 Cg_exo -70.84 -19.16 31.31 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 122.182 1.922 . . . . 0.0 112.012 -178.757 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -96.53 1.93 51.88 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.912 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.433 ' HA2' ' HB2' ' A' ' 75' ' ' PRO . . . 92.89 8.44 61.88 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.185 -1.007 . . . . 0.0 112.693 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.545 ' HA ' HE22 ' A' ' 86' ' ' GLN . 56.6 m-85 -125.88 134.49 51.59 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.952 0.376 . . . . 0.0 110.716 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.491 HD23 HG22 ' A' ' 88' ' ' ILE . 10.8 mp -88.6 147.26 24.66 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.904 -178.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 172.18 175.32 40.22 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.968 -0.634 . . . . 0.0 111.825 178.434 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.45 ' HH2' HD11 ' A' ' 93' ' ' ILE . 95.8 m95 -97.72 130.35 44.7 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.952 0.406 . . . . 0.0 110.346 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 147.31 -60.81 0.46 Allowed Glycine 0 N--CA 1.447 -0.593 0 N-CA-C 111.542 -0.623 . . . . 0.0 111.542 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.588 ' CE ' ' HA ' ' A' ' 52' ' ' MET . 1.7 tpt -77.85 171.61 14.71 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 179.09 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -132.19 171.23 13.93 Favored 'General case' 0 C--N 1.32 -0.715 0 O-C-N 121.845 -0.534 . . . . 0.0 110.907 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.75 ' HA ' ' OD2' ' A' ' 38' ' ' ASP . 13.6 m120 65.3 45.7 2.83 Favored 'General case' 0 C--N 1.328 -0.336 0 O-C-N 124.041 0.838 . . . . 0.0 111.77 178.657 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.409 ' HB3' ' HA2' ' A' ' 42' ' ' GLY . 25.5 p90 -65.65 -30.02 70.67 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.411 179.658 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.419 ' OG ' ' HB3' ' A' ' 17' ' ' ARG . 12.0 m -59.48 -26.81 65.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.297 0.57 . . . . 0.0 110.767 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 75.5 m80 -75.96 -13.59 60.24 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.635 -178.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 27.1 m -131.66 32.23 4.16 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 120.853 0.359 . . . . 0.0 110.978 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 29.2 p -145.58 154.1 41.79 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.611 -0.436 . . . . 0.0 111.328 179.443 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.485 ' HG3' ' HG2' ' A' ' 76' ' ' LYS . 68.3 mt-10 -131.47 148.75 52.67 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.368 179.769 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 60.29 59.65 2.25 Favored 'General case' 0 C--N 1.331 -0.229 0 O-C-N 123.848 0.718 . . . . 0.0 110.956 178.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.576 HG23 HD21 ' A' ' 71' ' ' LEU . 75.2 mt -83.45 113.83 23.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.116 -179.57 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 35.7 ttmt -149.74 154.73 38.98 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.994 179.487 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.641 ' HG ' HD21 ' A' ' 12' ' ' LEU . 72.6 mt -82.63 130.65 35.16 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.834 0.35 . . . . 0.0 110.509 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -88.09 -58.52 2.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.634 -178.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.532 ' HB2' ' HB2' ' A' ' 69' ' ' ARG . 26.6 mt-10 -80.91 33.78 0.33 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.87 0.366 . . . . 0.0 111.318 -179.556 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 67.4 2.14 18.77 Favored Glycine 0 C--N 1.32 -0.342 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.879 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.546 ' HA2' HD13 ' A' ' 64' ' ' LEU . . . 145.37 -14.96 1.85 Allowed Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 120.095 -1.05 . . . . 0.0 112.669 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.532 ' HB2' ' HB2' ' A' ' 66' ' ' GLU . 19.1 mmt180 -79.67 -18.51 51.19 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.47 ' HB3' ' HG3' ' A' ' 66' ' ' GLU . 30.7 ttpt -149.22 140.24 22.94 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.123 -178.556 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.597 ' HB2' HD11 ' A' ' 90' ' ' LEU . 9.8 tt -109.49 124.26 50.76 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.306 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 6.6 p -111.41 137.01 49.74 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.232 0.539 . . . . 0.0 111.224 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.502 ' HB3' ' HA ' ' A' ' 62' ' ' ILE . 21.4 p -161.61 164.08 29.58 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.163 179.522 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.437 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 28.7 ttt180 -99.88 103.27 21.1 Favored Pre-proline 0 C--N 1.318 -0.78 0 CA-C-N 116.722 -0.217 . . . . 0.0 110.47 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.614 ' O ' ' HB3' ' A' ' 83' ' ' ARG . 56.6 Cg_endo -70.02 116.03 4.4 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 122.403 2.069 . . . . 0.0 110.002 178.314 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.906 ' HE2' ' HA2' ' A' ' 81' ' ' GLY . 0.0 OUTLIER -119.34 141.61 48.87 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.301 -179.182 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.695 HG22 ' O ' ' A' ' 82' ' ' PHE . 12.2 t -67.57 132.6 47.87 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 179.642 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 14.0 p -68.58 -14.19 18.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 O-C-N 124.149 0.905 . . . . 0.0 111.128 -179.296 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -64.54 -28.03 69.37 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.72 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.481 ' HA3' ' CE1' ' A' ' 82' ' ' PHE . . . -155.12 -26.67 0.03 OUTLIER Glycine 0 CA--C 1.518 0.266 0 C-N-CA 120.138 -1.03 . . . . 0.0 113.858 -179.412 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.906 ' HA2' ' HE2' ' A' ' 76' ' ' LYS . . . 102.94 18.64 14.73 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.998 -0.62 . . . . 0.0 111.599 -179.31 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.695 ' O ' HG22 ' A' ' 77' ' ' THR . 18.9 p90 -112.36 145.52 39.93 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 119.274 -0.393 . . . . 0.0 110.053 -178.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.739 ' HB2' ' HA ' ' A' ' 76' ' ' LYS . 0.1 OUTLIER 173.9 -145.34 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.84 0.352 . . . . 0.0 111.62 -179.86 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -128.64 160.3 32.88 Favored 'General case' 0 C--O 1.222 -0.353 0 CA-C-N 115.586 -0.733 . . . . 0.0 109.52 -179.033 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.47 ' HA ' ' HD2' ' A' ' 75' ' ' PRO . 25.0 ttt180 -89.47 154.97 19.61 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.302 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.545 HE22 ' HA ' ' A' ' 47' ' ' PHE . 1.6 mt-30 -155.31 -169.55 3.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.333 0.587 . . . . 0.0 111.981 -178.581 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -163.08 142.97 8.25 Favored Glycine 0 N--CA 1.445 -0.709 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.771 179.153 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.491 HG22 HD23 ' A' ' 48' ' ' LEU . 10.9 tt -127.21 132.61 69.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.042 0.449 . . . . 0.0 110.548 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -75.23 141.29 43.55 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 179.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.831 HD13 HD11 ' A' ' 19' ' ' LEU . 63.4 mt -107.3 61.71 0.62 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.691 0.757 . . . . 0.0 110.854 -178.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.537 ' HA ' ' OG ' ' A' ' 2' ' ' SER . 25.0 m-80 -90.89 -0.07 57.63 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.354 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 9.8 mtp180 -96.01 -15.51 22.23 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.995 179.316 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.45 HD11 ' HH2' ' A' ' 50' ' ' TRP . 28.1 mm -89.88 110.03 21.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 -179.277 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.463 HE22 ' HA ' ' A' ' 2' ' ' SER . 23.5 mm-40 -111.17 167.16 10.49 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.425 -178.018 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 21.4 p-10 -126.67 112.42 15.44 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.574 178.228 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.7 p -111.55 116.66 53.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 120.96 0.409 . . . . 0.0 110.407 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 13.6 m-80 56.32 35.09 25.25 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.762 -178.717 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 87.02 -10.26 69.13 Favored Glycine 0 N--CA 1.442 -0.906 0 CA-C-N 115.65 -0.705 . . . . 0.0 113.311 179.417 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -94.11 123.14 37.29 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 117.459 0.63 . . . . 0.0 110.119 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.533 HD13 ' SG ' ' A' ' 23' ' ' CYS . 5.7 tp -79.69 119.21 22.31 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 54.1 t -133.23 145.6 33.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.398 -178.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.411 ' HB2' HD11 ' A' ' 35' ' ' LEU . 26.2 t80 -78.24 129.7 35.39 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.005 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 47.4 tt0 . . . . . 0 C--O 1.25 1.111 0 CA-C-O 117.986 -1.007 . . . . 0.0 110.802 -179.191 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 47.0 mtt . . . . . 0 N--CA 1.478 0.927 0 CA-C-O 120.655 0.264 . . . . 0.0 110.338 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.443 ' O ' ' HB2' ' A' ' 5' ' ' ASP . 17.1 m -118.99 177.8 4.73 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.108 179.183 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.566 ' HB3' ' HA ' ' A' ' 94' ' ' GLN . 22.2 p90 -57.84 -36.77 72.75 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.083 0.468 . . . . 0.0 110.334 178.585 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.5 ' HB3' ' HD3' ' A' ' 69' ' ' ARG . . . -58.32 -18.71 29.29 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 115.446 -0.797 . . . . 0.0 112.523 -178.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.443 ' HB2' ' O ' ' A' ' 2' ' ' SER . 0.9 OUTLIER -62.41 -26.89 68.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.928 0.394 . . . . 0.0 110.298 179.161 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 27.1 m -134.63 30.08 3.49 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.819 179.11 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.413 ' HA ' ' HZ3' ' A' ' 30' ' ' TRP . 21.0 m -139.31 155.55 47.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.247 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.557 ' HG2' ' CZ3' ' A' ' 30' ' ' TRP . 2.3 ptp180 -142.1 169.84 16.84 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.869 -179.468 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 53.4 57.8 5.84 Favored 'General case' 0 C--O 1.232 0.179 0 O-C-N 123.769 0.668 . . . . 0.0 111.696 178.58 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -87.86 121.56 30.43 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.839 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 27.8 m -127.93 172.17 15.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.68 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.688 HD21 ' HG ' ' A' ' 64' ' ' LEU . 3.6 mm? -104.55 118.65 37.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.454 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 19.6 p -117.52 166.53 12.26 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.948 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 62.46 26.99 16.07 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.479 179.298 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 101.81 -22.68 37.49 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.485 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.578 ' HA2' ' HB3' ' A' ' 12' ' ' LEU . . . 124.51 21.49 2.21 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.703 -0.76 . . . . 0.0 111.981 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.564 ' HB2' ' HB3' ' A' ' 38' ' ' ASP . 11.5 ptm180 -106.41 -21.61 13.04 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.102 0.477 . . . . 0.0 110.031 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.482 ' CG2' ' HB3' ' A' ' 34' ' ' GLU . 3.6 m -111.89 136.11 51.64 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.953 -178.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.838 HD11 HD13 ' A' ' 90' ' ' LEU . 26.9 mt -96.95 117.06 30.31 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.18 179.08 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 24.5 ttm180 -109.9 121.01 44.25 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.334 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -152.58 166.62 31.5 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.645 -179.727 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -91.22 108.83 20.14 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 107.605 -1.258 . . . . 0.0 107.605 178.342 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.429 ' SG ' HD13 ' A' ' 100' ' ' LEU . 65.8 m -95.34 124.54 39.43 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 -179.065 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.51 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 38.4 ttt180 -76.11 112.34 12.46 Favored 'General case' 0 N--CA 1.439 -0.982 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 179.469 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 35.9 p30 -73.54 167.64 20.91 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.619 -179.47 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.06 -27.73 67.2 Favored 'General case' 0 C--N 1.33 -0.245 0 O-C-N 123.557 0.536 . . . . 0.0 111.507 -178.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -68.46 -18.21 64.36 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.22 0.533 . . . . 0.0 109.991 179.325 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 94.63 33.16 6.88 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.857 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.51 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 7.2 t-20 -123.92 164.38 19.41 Favored 'General case' 0 C--N 1.323 -0.571 0 O-C-N 122.773 -0.251 . . . . 0.0 110.734 -178.733 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.557 ' CZ3' ' HG2' ' A' ' 8' ' ' ARG . 98.4 m95 -100.51 120.41 39.97 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.385 -179.616 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 6.7 m -122.78 139.5 49.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.889 179.215 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 13.5 m -79.48 114.08 18.13 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.793 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 68.3 m -124.6 146.08 49.26 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.764 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.603 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 50.7 mt-10 -131.5 135.22 46.9 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.1 -179.676 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.534 ' HB2' HD23 ' A' ' 100' ' ' LEU . 1.6 tm? -130.08 131.67 45.85 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.166 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.452 ' N ' HD13 ' A' ' 35' ' ' LEU . 18.1 m-20 -87.11 110.23 19.97 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.842 0.353 . . . . 0.0 110.221 179.783 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.539 HD11 ' HG ' ' A' ' 19' ' ' LEU . 2.1 mt -86.54 -18.04 32.53 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.981 -179.479 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.564 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 0.5 OUTLIER -66.12 -13.91 60.91 Favored 'General case' 0 C--O 1.222 -0.357 0 C-N-CA 120.525 -0.47 . . . . 0.0 111.949 -177.72 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.403 HG22 ' O ' ' A' ' 36' ' ' ASP . 14.6 t -87.0 -4.38 59.17 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.135 0.493 . . . . 0.0 110.233 179.42 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 56.5 m -127.26 -22.73 3.67 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 120.872 0.367 . . . . 0.0 111.508 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.528 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 65.3 mt -102.57 138.81 25.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 110.235 -0.283 . . . . 0.0 110.235 179.405 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.572 ' HA3' ' HB3' ' A' ' 52' ' ' MET . . . -149.23 158.79 27.8 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.892 -0.67 . . . . 0.0 111.605 179.222 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.559 ' OD1' ' HB2' ' A' ' 55' ' ' PHE . 2.6 p-10 -162.42 47.78 0.21 Allowed Pre-proline 0 CA--C 1.534 0.353 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -67.54 -21.73 45.72 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 121.501 1.467 . . . . 0.0 111.413 -179.612 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -84.53 -16.7 41.4 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.144 179.121 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.604 ' HA3' ' HG2' ' A' ' 83' ' ' ARG . . . 108.41 8.8 28.36 Favored Glycine 0 N--CA 1.442 -0.933 0 C-N-CA 120.341 -0.933 . . . . 0.0 113.374 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -125.73 134.88 51.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 117.1 0.45 . . . . 0.0 111.043 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 91.2 mt -83.33 131.8 35.05 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.889 -178.136 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -175.34 170.2 43.19 Favored Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.842 178.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.415 ' CD2' ' HD3' ' A' ' 92' ' ' ARG . 84.8 m95 -95.63 135.02 37.85 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 179.668 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 137.09 16.22 0.76 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.375 -0.917 . . . . 0.0 113.527 179.233 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.572 ' HB3' ' HA3' ' A' ' 42' ' ' GLY . 1.1 ttt -155.8 -165.79 2.05 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -147.3 167.88 23.15 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.307 -0.557 . . . . 0.0 111.718 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 13.9 m120 67.14 41.67 2.53 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.061 -0.972 . . . . 0.0 112.254 178.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.559 ' HB2' ' OD1' ' A' ' 43' ' ' ASN . 3.2 p90 -70.15 -25.12 63.31 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.737 0.303 . . . . 0.0 111.07 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 44.9 t -60.76 -41.21 95.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.443 -178.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 46.1 m170 -70.62 -14.85 62.64 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.459 -178.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.417 ' HA ' ' HD2' ' A' ' 76' ' ' LYS . 20.1 m -113.48 18.99 17.27 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 111.777 0.288 . . . . 0.0 111.777 -179.229 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 61.2 m -138.97 153.74 48.21 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 121.448 -0.783 . . . . 0.0 112.46 -179.395 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -118.83 142.76 47.43 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.343 179.147 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 56.25 77.12 0.26 Allowed 'General case' 0 N--CA 1.466 0.354 0 O-C-N 123.666 0.604 . . . . 0.0 112.127 178.38 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.505 HG23 HD21 ' A' ' 71' ' ' LEU . 88.2 mt -92.31 112.63 26.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 121.041 0.448 . . . . 0.0 110.278 179.515 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 34.3 ttmt -149.23 153.99 38.42 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.344 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.688 ' HG ' HD21 ' A' ' 12' ' ' LEU . 42.1 mt -81.91 126.44 31.92 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.462 0.649 . . . . 0.0 111.067 -179.046 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.491 ' HB2' ' CG2' ' A' ' 72' ' ' THR . 39.4 tt0 -74.52 -52.32 12.24 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 114.925 -1.034 . . . . 0.0 111.201 -179.151 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.503 ' HB2' ' HB2' ' A' ' 69' ' ' ARG . 21.0 mm-40 -89.37 0.91 56.48 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.003 179.671 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 77.09 32.36 49.15 Favored Glycine 0 N--CA 1.446 -0.692 0 CA-C-N 115.519 -0.764 . . . . 0.0 112.142 -179.5 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 142.79 -42.75 1.08 Allowed Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.391 -0.909 . . . . 0.0 112.422 179.382 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.503 ' HB2' ' HB2' ' A' ' 66' ' ' GLU . 13.3 mmt180 -70.02 -30.22 67.47 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.842 0.353 . . . . 0.0 111.117 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 46.2 tttt -144.36 145.97 32.27 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -177.741 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.549 ' HB2' HD11 ' A' ' 90' ' ' LEU . 10.5 tt -111.68 135.44 52.27 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.382 -0.826 . . . . 0.0 108.969 179.131 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.491 ' CG2' ' HB2' ' A' ' 65' ' ' GLU . 2.6 p -123.53 131.93 53.76 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.037 0.446 . . . . 0.0 111.501 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 26.0 p -158.99 164.46 35.54 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.338 -0.846 . . . . 0.0 108.717 179.262 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.443 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 31.6 ttt180 -99.76 103.55 22.54 Favored Pre-proline 0 C--N 1.317 -0.806 0 C-N-CA 120.424 -0.51 . . . . 0.0 110.394 179.548 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.621 ' O ' ' HB3' ' A' ' 83' ' ' ARG . 59.7 Cg_endo -71.31 127.91 13.97 Favored 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 122.543 2.162 . . . . 0.0 110.825 178.882 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.764 ' HA ' ' HB2' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -120.16 146.61 45.83 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.932 -179.81 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.719 HG22 ' O ' ' A' ' 82' ' ' PHE . 8.9 t -71.94 130.33 40.74 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 177.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 9.8 p -71.44 -8.16 10.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 O-C-N 123.619 0.574 . . . . 0.0 111.425 -178.566 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -70.71 -24.78 62.71 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.119 0.485 . . . . 0.0 110.612 179.512 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.544 ' HA3' ' CE2' ' A' ' 82' ' ' PHE . . . -151.58 -30.03 0.04 OUTLIER Glycine 0 CA--C 1.519 0.334 0 C-N-CA 120.623 -0.799 . . . . 0.0 113.015 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 104.54 17.16 15.78 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 121.051 -0.595 . . . . 0.0 112.112 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.719 ' O ' HG22 ' A' ' 77' ' ' THR . 17.2 p90 -112.72 153.71 27.29 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 118.904 -0.57 . . . . 0.0 109.766 -179.037 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.764 ' HB2' ' HA ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 169.3 -150.45 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.105 0.479 . . . . 0.0 112.138 179.481 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -129.29 154.9 46.39 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.355 -0.838 . . . . 0.0 110.428 -177.75 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.443 ' HA ' ' HA ' ' A' ' 74' ' ' ARG . 36.4 ttt180 -86.27 145.88 26.75 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -151.96 -171.3 3.89 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.565 -178.615 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -146.74 149.31 21.44 Favored Glycine 0 N--CA 1.448 -0.506 0 N-CA-C 111.261 -0.736 . . . . 0.0 111.261 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.403 HD11 ' CD1' ' A' ' 50' ' ' TRP . 12.0 tt -131.39 133.23 62.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 117.073 0.437 . . . . 0.0 110.877 -179.255 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -75.65 137.71 40.89 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.679 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.838 HD13 HD11 ' A' ' 19' ' ' LEU . 47.4 mt -101.52 40.23 1.33 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.48 0.657 . . . . 0.0 110.287 -179.513 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.436 ' HA ' ' OG ' ' A' ' 2' ' ' SER . 5.6 m-20 -74.12 0.04 15.11 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.657 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.415 ' HD3' ' CD2' ' A' ' 50' ' ' TRP . 18.3 mtp180 -96.57 -12.63 23.74 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.926 179.614 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.45 HG13 HD22 ' A' ' 37' ' ' LEU . 23.0 mm -99.02 114.65 37.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 -179.214 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.566 ' HA ' ' HB3' ' A' ' 3' ' ' TYR . 20.6 mt-30 -132.33 156.53 46.42 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.136 0.493 . . . . 0.0 111.712 -178.682 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.411 ' HA ' ' O ' ' A' ' 99' ' ' ARG . 20.4 p-10 -104.58 131.92 51.42 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.499 179.367 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 40.9 t -115.18 111.61 36.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 179.658 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 10.3 m120 58.06 19.49 6.05 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.866 -179.082 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 117.46 -28.35 7.19 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.681 -0.771 . . . . 0.0 113.92 178.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.411 ' O ' ' HA ' ' A' ' 95' ' ' ASN . 0.2 OUTLIER -87.11 142.23 28.08 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 117.277 0.538 . . . . 0.0 110.991 -178.916 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.534 HD23 ' HB2' ' A' ' 35' ' ' LEU . 8.6 tp -87.74 125.78 34.62 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 24.6 t -131.36 140.35 48.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.014 -178.69 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.491 ' HB2' HD11 ' A' ' 35' ' ' LEU . 13.6 t80 -82.04 131.38 35.24 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 177.58 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 20.2 tt0 . . . . . 0 C--N 1.312 -1.024 0 CA-C-O 118.906 -0.568 . . . . 0.0 111.241 -179.259 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.3 ptp . . . . . 0 N--CA 1.482 1.134 0 CA-C-O 120.706 0.289 . . . . 0.0 110.269 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.456 ' HB2' ' HG3' ' A' ' 69' ' ' ARG . 38.0 m -119.24 179.16 4.27 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.996 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.412 ' CZ ' HD13 ' A' ' 19' ' ' LEU . 9.3 p90 -54.23 -34.59 61.01 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.833 0.349 . . . . 0.0 110.867 178.735 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.589 ' HB3' ' HD2' ' A' ' 69' ' ' ARG . . . -57.27 -19.23 20.42 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.437 -179.029 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -70.75 -18.41 62.78 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.071 0.462 . . . . 0.0 110.867 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 41.6 m -140.67 33.8 1.81 Allowed 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 178.705 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 10.3 t -146.24 157.86 43.84 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.231 -179.444 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.422 ' HG2' ' CZ3' ' A' ' 30' ' ' TRP . 2.1 ptp180 -137.44 158.42 44.45 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.663 -0.244 . . . . 0.0 110.981 -179.748 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 57.54 61.62 2.41 Favored 'General case' 0 C--O 1.233 0.229 0 O-C-N 123.967 0.792 . . . . 0.0 111.127 178.459 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.603 ' HA ' ' HB2' ' A' ' 21' ' ' ALA . . . -89.83 118.52 29.48 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.917 -179.787 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 30.0 m -123.07 170.56 13.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.612 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.62 ' HB3' ' HA2' ' A' ' 16' ' ' GLY . 3.8 mm? -105.36 122.4 45.88 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.145 -179.57 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.426 ' OG1' ' HB ' ' A' ' 18' ' ' THR . 33.5 p -116.0 162.14 17.81 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.69 0.281 . . . . 0.0 110.892 179.543 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 63.51 29.29 15.38 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.904 -0.589 . . . . 0.0 112.078 179.306 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 97.09 -15.79 61.93 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.502 179.425 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.62 ' HA2' ' HB3' ' A' ' 12' ' ' LEU . . . 122.09 20.85 2.97 Favored Glycine 0 CA--C 1.507 -0.417 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.36 179.528 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 4.1 ptm180 -103.98 -22.64 13.44 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.029 0.442 . . . . 0.0 110.54 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.426 ' HB ' ' OG1' ' A' ' 13' ' ' THR . 5.5 m -113.48 137.89 50.89 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.893 -178.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.653 ' O ' ' HA ' ' A' ' 34' ' ' GLU . 83.8 mt -100.41 120.32 39.79 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.438 179.129 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 56.2 ttp180 -118.27 120.25 37.1 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.586 -0.446 . . . . 0.0 109.876 178.718 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.603 ' HB2' ' HA ' ' A' ' 10' ' ' ALA . . . -154.48 167.58 29.56 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.383 -179.416 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -89.43 105.96 18.14 Favored 'General case' 0 CA--C 1.51 -0.569 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 177.238 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 69.3 m -96.46 136.29 37.16 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 120.727 0.299 . . . . 0.0 110.625 -178.535 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.564 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 16.2 ttp180 -76.94 119.31 20.51 Favored 'General case' 0 N--CA 1.44 -0.934 0 CA-C-N 116.196 -0.457 . . . . 0.0 109.835 179.336 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 37.4 p30 -80.32 174.55 11.49 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.153 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.27 -30.87 63.03 Favored 'General case' 0 C--O 1.235 0.303 0 O-C-N 123.649 0.593 . . . . 0.0 112.516 -178.273 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -77.4 -10.51 59.5 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.319 0.58 . . . . 0.0 110.135 -179.489 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 89.82 29.36 15.96 Favored Glycine 0 N--CA 1.447 -0.597 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.472 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.564 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 4.8 t-20 -110.64 164.02 13.16 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 121.086 -0.246 . . . . 0.0 111.129 -178.545 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.422 ' CZ3' ' HG2' ' A' ' 8' ' ' ARG . 82.4 m95 -97.62 119.44 36.2 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.011 0.434 . . . . 0.0 111.954 -179.388 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 5.8 m -124.39 135.03 65.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.938 178.496 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 62.0 m -81.3 111.02 17.3 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.926 0.393 . . . . 0.0 110.506 -179.393 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 70.5 m -120.5 155.84 32.75 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.481 -179.269 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.653 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 41.6 mt-10 -135.12 142.65 46.25 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.564 179.319 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.547 HD11 ' HB2' ' A' ' 102' ' ' PHE . 1.4 tm? -138.92 131.39 28.68 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.304 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.441 ' O ' HG22 ' A' ' 39' ' ' THR . 22.1 m-20 -89.83 110.89 21.79 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.509 HD22 HG13 ' A' ' 93' ' ' ILE . 1.1 mt -86.62 -19.42 29.35 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.659 -178.858 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.434 ' HA ' ' HD1' ' A' ' 55' ' ' PHE . 3.2 p-10 -68.45 -8.68 42.97 Favored 'General case' 0 C--O 1.221 -0.398 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -178.006 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.441 HG22 ' O ' ' A' ' 36' ' ' ASP . 13.7 t -87.27 -1.72 58.11 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 179.107 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 75.2 m -135.33 -23.32 1.47 Allowed 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 116.176 -0.465 . . . . 0.0 112.02 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.505 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 55.1 mt -96.91 145.03 9.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 O-C-N 122.222 -0.299 . . . . 0.0 110.476 -179.699 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.638 ' HA3' ' HB3' ' A' ' 52' ' ' MET . . . -153.1 158.39 27.9 Favored Glycine 0 N--CA 1.447 -0.569 0 N-CA-C 111.277 -0.729 . . . . 0.0 111.277 179.056 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.491 ' HB3' HD23 ' A' ' 48' ' ' LEU . 6.0 p30 -159.91 53.91 0.58 Allowed Pre-proline 0 CA--C 1.538 0.511 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -179.277 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -71.54 -16.93 30.45 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 121.942 1.762 . . . . 0.0 112.216 -179.402 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -102.61 13.65 33.95 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.092 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.504 ' CA ' ' HG2' ' A' ' 83' ' ' ARG . . . 79.47 12.56 83.64 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.463 -0.875 . . . . 0.0 112.961 179.626 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.419 ' HA ' ' OE1' ' A' ' 86' ' ' GLN . 37.9 m-85 -125.31 130.74 52.59 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.879 0.371 . . . . 0.0 110.303 179.718 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.558 ' HB3' ' HB ' ' A' ' 88' ' ' ILE . 87.6 mt -84.33 132.51 34.6 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.745 -178.413 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -171.95 170.49 43.45 Favored Glycine 0 N--CA 1.443 -0.837 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.139 179.165 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.414 ' HH2' HD11 ' A' ' 93' ' ' ILE . 87.4 m95 -96.22 131.51 42.62 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 141.56 17.72 0.34 Allowed Glycine 0 CA--C 1.519 0.333 0 C-N-CA 120.46 -0.876 . . . . 0.0 113.821 179.6 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.638 ' HB3' ' HA3' ' A' ' 42' ' ' GLY . 5.3 ttt -153.57 -156.05 0.65 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 117.366 0.583 . . . . 0.0 109.801 179.764 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.416 ' HA ' ' O ' ' A' ' 38' ' ' ASP . 27.6 pt20 -148.04 167.62 24.49 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.705 0.288 . . . . 0.0 111.137 -179.341 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 12.6 m120 61.63 44.74 8.69 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.452 -0.794 . . . . 0.0 112.938 178.328 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.505 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 1.2 p90 -71.01 -26.81 63.29 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.523 -0.471 . . . . 0.0 110.73 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.533 ' HA ' HD11 ' A' ' 62' ' ' ILE . 79.6 p -72.94 -29.35 63.04 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.035 0.445 . . . . 0.0 110.504 -179.413 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 41.8 m80 -82.81 -9.25 59.42 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.398 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.3 p -114.89 6.94 15.56 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.961 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 72.0 m -130.21 153.29 48.73 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.128 0.49 . . . . 0.0 110.745 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 86.7 mt-10 -119.09 134.67 55.06 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.403 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.5 t70 58.53 82.89 0.13 Allowed 'General case' 0 N--CA 1.465 0.317 0 O-C-N 123.938 0.774 . . . . 0.0 111.507 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.534 HG23 HD21 ' A' ' 71' ' ' LEU . 72.0 mt -95.31 124.54 47.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.108 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.9 tptm -149.84 149.54 30.63 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.271 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.565 ' HG ' HD21 ' A' ' 12' ' ' LEU . 52.2 mt -83.39 135.94 34.52 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.823 0.344 . . . . 0.0 110.98 -179.673 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -91.82 -59.03 2.22 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.958 -179.643 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.433 ' CB ' ' HB2' ' A' ' 69' ' ' ARG . 20.2 mm-40 -82.03 27.03 0.49 Allowed 'General case' 0 CA--C 1.516 -0.348 0 CA-C-O 121.106 0.479 . . . . 0.0 111.507 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 62.84 16.65 56.98 Favored Glycine 0 N--CA 1.448 -0.507 0 CA-C-N 115.278 -0.874 . . . . 0.0 112.722 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.449 ' HA3' ' HB2' ' A' ' 4' ' ' ALA . . . 144.08 -30.4 1.9 Allowed Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 120.104 -1.046 . . . . 0.0 113.189 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.589 ' HD2' ' HB3' ' A' ' 4' ' ' ALA . 7.2 mpt_? -74.37 -24.12 59.11 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 117.553 0.677 . . . . 0.0 111.12 -179.397 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 33.4 tttp -141.37 139.91 33.61 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.842 -178.518 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.637 ' HB2' HD11 ' A' ' 90' ' ' LEU . 10.1 tt -112.89 133.82 54.69 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.618 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.9 p -119.46 135.09 54.91 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.902 0.382 . . . . 0.0 111.083 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 25.3 p -162.49 172.23 15.83 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.37 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.589 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 32.2 ttt180 -106.98 99.38 25.9 Favored Pre-proline 0 C--N 1.319 -0.758 0 C-N-CA 120.356 -0.538 . . . . 0.0 110.741 178.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.647 ' O ' ' HB3' ' A' ' 83' ' ' ARG . 46.0 Cg_endo -67.4 123.86 11.35 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 122.784 2.323 . . . . 0.0 110.103 178.692 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.863 ' HE3' ' HA2' ' A' ' 81' ' ' GLY . 0.0 OUTLIER -120.29 142.97 48.6 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.066 0.46 . . . . 0.0 111.956 -178.914 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.711 HG22 ' O ' ' A' ' 82' ' ' PHE . 14.8 t -75.38 138.69 41.89 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.027 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 11.1 p -76.18 -12.95 14.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.217 -179.067 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -66.05 -21.9 66.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.11 0.481 . . . . 0.0 111.002 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.703 ' HA3' ' CE2' ' A' ' 82' ' ' PHE . . . -155.63 -21.41 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.29 -0.957 . . . . 0.0 113.105 179.623 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.863 ' HA2' ' HE3' ' A' ' 76' ' ' LYS . . . 95.53 12.57 53.57 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.05 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.711 ' O ' HG22 ' A' ' 77' ' ' THR . 16.7 p90 -112.47 158.61 19.68 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 118.926 -0.559 . . . . 0.0 110.015 -178.676 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.782 ' HA ' ' HE ' ' A' ' 83' ' ' ARG . 0.0 OUTLIER 168.65 -152.42 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 O-C-N 123.805 0.691 . . . . 0.0 111.656 178.707 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -125.73 155.88 40.27 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.358 -177.706 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.589 ' HA ' ' HA ' ' A' ' 74' ' ' ARG . 32.2 ttt180 -80.3 155.52 27.23 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 179.476 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.485 ' HG2' ' H ' ' A' ' 87' ' ' GLY . 47.7 tt0 -162.45 177.12 9.79 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 120.976 0.417 . . . . 0.0 111.407 -178.054 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.485 ' H ' ' HG2' ' A' ' 86' ' ' GLN . . . -140.2 143.82 14.13 Favored Glycine 0 N--CA 1.445 -0.711 0 N-CA-C 111.456 -0.657 . . . . 0.0 111.456 179.388 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.558 ' HB ' ' HB3' ' A' ' 48' ' ' LEU . 10.1 tt -124.38 140.69 46.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 109.751 -0.462 . . . . 0.0 109.751 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.459 ' HB3' HD22 ' A' ' 91' ' ' ASN . 61.9 m-20 -82.46 136.47 34.9 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.861 -179.528 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.637 HD11 ' HB2' ' A' ' 71' ' ' LEU . 83.2 mt -106.82 44.6 1.04 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.352 0.596 . . . . 0.0 110.861 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.459 HD22 ' HB3' ' A' ' 89' ' ' ASP . 18.5 m-80 -76.97 2.66 14.18 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.751 179.415 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 18.5 mtp180 -98.82 -15.05 19.4 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.087 -0.96 . . . . 0.0 110.316 179.32 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.584 HG21 HD12 ' A' ' 19' ' ' LEU . 29.3 mm -98.91 105.13 16.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 121.017 0.436 . . . . 0.0 109.993 -179.315 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.401 ' HA ' ' HB3' ' A' ' 3' ' ' TYR . 9.0 mt-30 -130.85 156.47 44.97 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.007 -179.262 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 13.1 p-10 -95.71 110.72 22.81 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.127 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 58.8 t -90.87 104.44 15.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.031 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 59.89 35.24 21.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.989 -179.62 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 98.45 -27.27 20.3 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.75 -0.738 . . . . 0.0 113.431 179.402 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.422 ' HD3' ' H ' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -86.92 128.82 35.06 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.944 0.372 . . . . 0.0 110.136 -178.936 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.424 HD12 ' HA ' ' A' ' 100' ' ' LEU . 9.2 tp -75.72 120.33 20.96 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 -179.733 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 32.2 t -129.61 142.09 44.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.168 -178.2 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.547 ' HB2' HD11 ' A' ' 35' ' ' LEU . 18.1 t80 -82.28 124.61 30.11 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 177.384 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.421 -0.799 . . . . 0.0 110.877 -179.504 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 mpt? . . . . . 0 N--CA 1.48 1.028 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.462 ' OG ' ' HA ' ' A' ' 91' ' ' ASN . 9.5 m -117.83 178.92 4.23 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.071 179.559 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.532 ' HA ' ' OD1' ' A' ' 95' ' ' ASN . 13.2 p90 -58.7 -38.14 77.62 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.524 0.202 . . . . 0.0 111.322 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -57.84 -23.93 55.07 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.357 -0.383 . . . . 0.0 112.023 -179.064 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -69.97 -16.24 63.16 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.654 0.242 . . . . 0.0 111.654 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 20.8 m -141.22 30.09 1.79 Allowed 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.173 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 22.4 t -144.92 158.46 43.8 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 115.509 -0.768 . . . . 0.0 110.103 -179.444 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 18.3 ptt180 -140.3 165.49 27.27 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.441 -179.528 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 55.18 54.76 8.37 Favored 'General case' 0 N--CA 1.467 0.378 0 O-C-N 123.829 0.705 . . . . 0.0 111.404 179.178 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.49 ' HA ' ' HB2' ' A' ' 21' ' ' ALA . . . -81.08 117.32 21.56 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.59 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 33.8 m -122.56 168.86 14.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.686 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.65 HD21 ' HG ' ' A' ' 64' ' ' LEU . 3.9 mm? -105.15 117.08 33.1 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.005 -179.546 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.478 HG21 ' NE ' ' A' ' 20' ' ' ARG . 20.9 p -115.48 165.89 12.49 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.062 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.436 ' O ' ' HG2' ' A' ' 17' ' ' ARG . 93.9 m-20 60.35 31.14 20.31 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.8 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 96.3 -17.96 58.33 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.827 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.576 ' HA2' ' HB3' ' A' ' 12' ' ' LEU . . . 122.86 10.15 5.93 Favored Glycine 0 C--O 1.229 -0.197 0 C-N-CA 121.025 -0.607 . . . . 0.0 111.608 -179.648 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.538 ' HB2' ' HB3' ' A' ' 38' ' ' ASP . 5.2 ptm180 -91.26 -24.17 19.94 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.257 0.551 . . . . 0.0 110.337 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.5 ' CG2' ' HB3' ' A' ' 34' ' ' GLU . 23.2 m -115.49 138.43 51.03 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.869 -178.674 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.739 HD11 HD13 ' A' ' 90' ' ' LEU . 92.1 mt -97.49 120.92 38.74 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.326 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.478 ' NE ' HG21 ' A' ' 13' ' ' THR . 34.5 ttm180 -114.12 120.46 40.62 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 178.252 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.49 ' HB2' ' HA ' ' A' ' 10' ' ' ALA . . . -153.11 167.71 28.35 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 120.938 0.399 . . . . 0.0 111.168 -178.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.649 ' HB3' ' HB3' ' A' ' 30' ' ' TRP . 10.4 mm-40 -88.9 105.95 18.09 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 178.784 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.423 ' SG ' ' HB2' ' A' ' 33' ' ' SER . 67.7 m -91.26 129.7 37.22 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.65 -178.671 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.528 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 24.7 ttp180 -75.69 116.38 16.35 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.521 179.124 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.411 HD21 ' HB3' ' A' ' 29' ' ' ASN . 36.2 p30 -82.16 173.3 12.25 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.177 179.545 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.18 -30.45 62.26 Favored 'General case' 0 N--CA 1.464 0.268 0 O-C-N 123.361 0.413 . . . . 0.0 112.084 -178.586 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -72.83 -13.5 61.31 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.662 0.744 . . . . 0.0 109.96 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 88.61 25.55 29.91 Favored Glycine 0 CA--C 1.503 -0.694 0 N-CA-C 110.8 -0.92 . . . . 0.0 110.8 -179.372 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.528 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 8.7 t-20 -106.6 161.97 14.16 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.575 -0.313 . . . . 0.0 110.323 -178.55 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.649 ' HB3' ' HB3' ' A' ' 22' ' ' GLU . 87.4 m95 -100.04 122.55 43.1 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.955 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 5.6 m -124.33 136.11 61.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.27 178.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 13.2 m -75.42 109.73 9.2 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.953 0.406 . . . . 0.0 110.958 -179.189 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.423 ' HB2' ' SG ' ' A' ' 23' ' ' CYS . 69.8 m -124.05 148.0 47.41 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.697 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.638 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 47.9 mt-10 -124.94 150.9 46.13 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.237 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.597 HD11 ' HB2' ' A' ' 102' ' ' PHE . 1.6 tm? -141.84 130.86 23.18 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 178.582 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.452 ' N ' HD13 ' A' ' 35' ' ' LEU . 2.1 p-10 -88.35 109.7 20.19 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.303 0.573 . . . . 0.0 110.605 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.477 HD11 ' HG ' ' A' ' 19' ' ' LEU . 1.0 OUTLIER -86.65 -21.05 26.95 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.965 179.532 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.538 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 5.1 p-10 -64.03 -13.73 49.02 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -178.445 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 64.1 p -83.63 -11.32 57.44 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 120.89 0.376 . . . . 0.0 110.801 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 35.5 m -130.41 -9.94 4.13 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.231 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.427 HD13 HD13 ' A' ' 88' ' ' ILE . 63.4 mt -113.26 137.05 47.67 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-O 120.682 0.277 . . . . 0.0 110.704 179.479 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.594 ' HA3' ' HB3' ' A' ' 52' ' ' MET . . . -149.45 159.03 27.9 Favored Glycine 0 N--CA 1.446 -0.7 0 C-N-CA 120.967 -0.635 . . . . 0.0 111.581 179.089 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.454 ' OD1' ' HB2' ' A' ' 58' ' ' SER . 24.8 p30 -157.57 48.31 0.31 Allowed Pre-proline 0 CA--C 1.535 0.367 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -68.74 -22.21 37.53 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 121.829 1.686 . . . . 0.0 112.166 -178.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 70.6 m-20 -91.79 0.44 57.49 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.43 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.539 ' CA ' ' HG2' ' A' ' 83' ' ' ARG . . . 92.48 6.74 64.02 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.669 -0.776 . . . . 0.0 112.236 -179.67 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -120.78 132.25 54.93 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.938 0.399 . . . . 0.0 110.798 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.452 HD12 ' HB3' ' A' ' 86' ' ' GLN . 14.8 mt -84.31 146.79 27.55 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.399 -178.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 169.35 171.0 34.57 Favored Glycine 0 N--CA 1.442 -0.904 0 C-N-CA 120.254 -0.974 . . . . 0.0 112.64 178.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.466 ' HH2' HD11 ' A' ' 93' ' ' ILE . 90.8 m95 -96.1 126.17 41.14 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 149.82 -43.94 0.73 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.995 -0.621 . . . . 0.0 111.853 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.63 ' CE ' ' HA ' ' A' ' 52' ' ' MET . 0.7 OUTLIER -94.24 -177.04 4.15 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 179.104 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.4 ' H ' ' HG3' ' A' ' 52' ' ' MET . 13.4 pt20 -143.14 170.19 16.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 119.076 0.853 . . . . 0.0 112.215 -178.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 9.6 m120 66.11 36.68 5.54 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.091 -0.959 . . . . 0.0 112.307 179.278 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.531 ' HB3' ' HA2' ' A' ' 42' ' ' GLY . 9.1 p90 -62.86 -28.33 69.96 Favored 'General case' 0 C--O 1.221 -0.444 0 CA-C-O 120.651 0.262 . . . . 0.0 110.455 179.442 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.468 ' HB3' ' HB3' ' A' ' 17' ' ' ARG . 9.5 p -58.68 -34.34 71.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.351 -179.626 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 26.5 m80 -80.06 -10.05 59.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.553 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.454 ' HB2' ' OD1' ' A' ' 43' ' ' ASN . 16.4 m -123.5 28.98 6.79 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.45 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 45.0 m -137.49 150.31 47.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.062 0.458 . . . . 0.0 111.079 179.58 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.447 ' HG3' ' HG2' ' A' ' 76' ' ' LYS . 71.5 mt-10 -129.86 134.01 47.26 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.677 179.281 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 38.5 t70 61.62 79.73 0.24 Allowed 'General case' 0 N--CA 1.468 0.455 0 O-C-N 123.705 0.628 . . . . 0.0 110.689 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.524 HG23 HD21 ' A' ' 71' ' ' LEU . 64.3 mt -98.67 125.06 52.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.037 -179.25 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.1 tptm -149.21 156.07 41.59 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.016 0.436 . . . . 0.0 111.285 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.65 ' HG ' HD21 ' A' ' 12' ' ' LEU . 83.0 mt -98.99 128.84 45.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.144 179.086 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -93.52 -65.7 0.97 Allowed 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -178.191 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.527 ' HB2' ' HB2' ' A' ' 69' ' ' ARG . 4.8 mm-40 -76.29 50.28 0.63 Allowed 'General case' 0 CA--C 1.516 -0.33 0 CA-C-O 121.117 0.484 . . . . 0.0 112.192 -178.013 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 59.94 16.35 39.32 Favored Glycine 0 C--N 1.318 -0.44 0 CA-C-N 115.117 -0.947 . . . . 0.0 112.795 179.146 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.534 ' HA2' HD13 ' A' ' 64' ' ' LEU . . . 121.11 -12.29 9.8 Favored Glycine 0 N--CA 1.442 -0.909 0 C-N-CA 120.394 -0.907 . . . . 0.0 113.241 179.693 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.527 ' HB2' ' HB2' ' A' ' 66' ' ' GLU . 2.8 mtt85 -77.69 -22.16 50.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 117.525 0.663 . . . . 0.0 110.721 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 33.0 tptt -131.63 127.56 37.27 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.294 -178.581 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.668 ' HB2' HD11 ' A' ' 90' ' ' LEU . 10.6 tt -110.04 121.2 44.7 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.442 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.4 p -109.66 136.61 48.74 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.176 0.513 . . . . 0.0 110.837 179.568 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 17.7 p -162.87 169.43 19.8 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.102 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.562 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 30.2 ttt180 -103.8 102.45 31.09 Favored Pre-proline 0 C--N 1.313 -0.979 0 C-N-CA 120.095 -0.642 . . . . 0.0 110.609 179.116 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.645 ' O ' ' HB3' ' A' ' 83' ' ' ARG . 48.0 Cg_endo -67.77 116.15 4.13 Favored 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 122.539 2.159 . . . . 0.0 110.023 178.385 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.942 ' HE3' ' HA2' ' A' ' 81' ' ' GLY . 0.0 OUTLIER -117.86 144.97 44.94 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.088 0.47 . . . . 0.0 111.455 -178.927 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.71 HG22 ' O ' ' A' ' 82' ' ' PHE . 15.3 t -77.86 140.73 39.37 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 179.402 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 32.2 m -74.52 -1.64 3.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 O-C-N 123.989 0.806 . . . . 0.0 111.145 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 -68.4 -32.01 71.76 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.174 0.511 . . . . 0.0 110.144 179.281 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -160.67 -9.51 0.04 OUTLIER Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.476 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.942 ' HA2' ' HE3' ' A' ' 76' ' ' LYS . . . 90.63 19.71 43.42 Favored Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 120.577 -0.821 . . . . 0.0 111.776 179.627 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.71 ' O ' HG22 ' A' ' 77' ' ' THR . 26.3 p90 -110.93 146.64 36.21 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 119.226 -0.416 . . . . 0.0 110.047 -179.028 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.732 ' HB2' ' HA ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 170.53 -154.92 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.224 0 O-C-N 123.925 0.766 . . . . 0.0 110.433 179.27 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -118.37 173.02 7.06 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.41 -178.05 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.562 ' HA ' ' HA ' ' A' ' 74' ' ' ARG . 31.3 ttt85 -104.3 153.43 21.03 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 178.244 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.704 ' HG2' ' H ' ' A' ' 87' ' ' GLY . 56.5 tt0 -165.61 -174.65 3.19 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 120.655 0.264 . . . . 0.0 110.698 -178.503 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.704 ' H ' ' HG2' ' A' ' 86' ' ' GLN . . . -141.11 151.9 22.86 Favored Glycine 0 N--CA 1.45 -0.369 0 N-CA-C 111.736 -0.545 . . . . 0.0 111.736 179.181 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.427 HD13 HD13 ' A' ' 41' ' ' ILE . 12.1 tt -125.49 145.6 32.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 120.965 0.412 . . . . 0.0 110.208 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -82.47 121.98 27.45 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.845 -179.17 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.739 HD13 HD11 ' A' ' 19' ' ' LEU . 59.8 mt -98.59 37.08 1.53 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.558 0.695 . . . . 0.0 110.632 179.476 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.462 ' HA ' ' OG ' ' A' ' 2' ' ' SER . 5.0 m-20 -75.27 -0.65 20.32 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 114.949 -1.023 . . . . 0.0 110.381 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 20.1 mtp180 -92.09 -14.81 28.66 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.226 -179.449 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.466 HD11 ' HH2' ' A' ' 50' ' ' TRP . 21.0 mm -92.22 111.7 24.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 -179.445 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 21.9 tp60 -124.71 134.85 52.69 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.283 0.563 . . . . 0.0 111.315 -178.091 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.532 ' OD1' ' HA ' ' A' ' 3' ' ' TYR . 19.6 p-10 -95.45 119.82 34.62 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.843 178.105 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.3 p -114.95 119.2 61.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.177 0.513 . . . . 0.0 110.602 -179.508 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 58.54 30.22 19.49 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.002 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 94.87 -15.79 62.65 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.774 -0.727 . . . . 0.0 113.289 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -93.03 123.18 36.1 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 117.555 0.677 . . . . 0.0 110.089 -179.268 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 16.1 tp -82.57 117.22 22.39 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.8 t -128.6 149.98 33.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.769 0.319 . . . . 0.0 111.088 -179.033 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.597 ' HB2' HD11 ' A' ' 35' ' ' LEU . 8.5 t80 -89.61 126.0 35.45 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 178.113 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.316 -0.89 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.321 179.372 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.0 ttt . . . . . 0 N--CA 1.48 1.041 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.565 ' HB3' ' HA ' ' A' ' 91' ' ' ASN . 10.8 p -117.97 178.25 4.49 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.73 -0.388 . . . . 0.0 111.319 178.67 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.443 ' HA ' ' OD1' ' A' ' 95' ' ' ASN . 12.8 p90 -58.59 -38.61 78.31 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -179.615 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.61 ' HA ' ' OG ' ' A' ' 7' ' ' SER . . . -55.29 -19.09 7.52 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 -177.371 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -61.71 -37.07 82.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.963 0.411 . . . . 0.0 111.037 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 8.1 t -130.63 45.02 2.88 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 121.295 0.569 . . . . 0.0 109.754 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.61 ' OG ' ' HA ' ' A' ' 4' ' ' ALA . 86.4 p -147.06 165.54 29.6 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.225 179.017 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 11.9 ptm180 -149.24 166.6 28.42 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.661 -179.534 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 59.44 54.43 4.66 Favored 'General case' 0 C--O 1.234 0.254 0 O-C-N 123.93 0.769 . . . . 0.0 111.136 179.498 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.404 ' HA ' ' HB2' ' A' ' 21' ' ' ALA . . . -86.69 117.36 25.4 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.014 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 34.2 m -124.57 168.49 17.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.786 -179.469 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.752 HD21 ' HG ' ' A' ' 64' ' ' LEU . 3.5 mm? -105.21 114.9 29.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.121 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 19.2 p -110.06 167.2 10.35 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.166 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 60.64 49.94 6.04 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.778 -0.647 . . . . 0.0 111.449 179.454 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 83.76 -30.15 3.57 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.348 179.633 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.557 ' HA2' ' HB3' ' A' ' 12' ' ' LEU . . . 130.64 48.09 0.13 Allowed Glycine 0 N--CA 1.446 -0.689 0 N-CA-C 111.133 -0.787 . . . . 0.0 111.133 -179.796 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.616 ' HB2' ' HB3' ' A' ' 38' ' ' ASP . 41.7 ptt85 -132.16 -27.07 1.85 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.017 0.436 . . . . 0.0 111.202 -179.403 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.449 ' CG2' ' HB3' ' A' ' 34' ' ' GLU . 4.2 m -100.94 133.88 44.76 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.828 -179.269 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.791 HD11 HD13 ' A' ' 90' ' ' LEU . 70.3 mt -94.17 115.95 28.3 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.275 179.084 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 53.3 ttp180 -114.36 121.28 43.12 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.504 -0.479 . . . . 0.0 109.983 178.604 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.404 ' HB2' ' HA ' ' A' ' 10' ' ' ALA . . . -153.43 166.05 33.89 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.845 0.355 . . . . 0.0 110.662 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -89.95 106.03 18.2 Favored 'General case' 0 CA--C 1.508 -0.643 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 178.308 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.457 ' SG ' HD13 ' A' ' 100' ' ' LEU . 45.3 m -98.81 132.17 44.37 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 120.876 -0.33 . . . . 0.0 110.191 -178.809 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.512 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 17.6 ttp85 -74.62 117.19 16.17 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.283 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.492 HD21 ' HB3' ' A' ' 29' ' ' ASN . 36.7 p30 -80.96 168.7 18.41 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.153 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.76 -33.21 55.06 Favored 'General case' 0 C--O 1.235 0.31 0 O-C-N 123.589 0.556 . . . . 0.0 112.118 -178.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -68.64 -17.88 64.18 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.289 0.566 . . . . 0.0 110.549 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 94.61 27.01 12.08 Favored Glycine 0 N--CA 1.446 -0.655 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.382 -179.442 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.512 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 62.0 t30 -111.09 164.06 13.23 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.547 0.213 . . . . 0.0 111.047 -178.722 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.413 ' HZ3' ' HA ' ' A' ' 7' ' ' SER . 89.8 m95 -100.36 113.84 26.88 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.534 179.318 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.9 m -116.55 131.03 70.36 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.877 179.407 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.3 m -74.93 109.22 8.22 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.445 179.272 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 66.9 m -119.26 146.62 45.09 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.408 -179.559 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.637 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 49.7 mt-10 -130.78 139.71 50.24 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.899 -179.301 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.521 HD12 HD23 ' A' ' 37' ' ' LEU . 1.4 tm? -132.81 129.12 38.12 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 178.706 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.449 ' N ' HD13 ' A' ' 35' ' ' LEU . 15.8 m-20 -88.88 108.93 19.81 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.521 HD23 HD12 ' A' ' 35' ' ' LEU . 0.5 OUTLIER -86.72 -9.11 56.66 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.363 -0.381 . . . . 0.0 112.017 -179.56 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.616 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 6.7 p-10 -66.16 -14.93 62.64 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -178.356 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 8.9 t -87.47 0.48 55.48 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.974 0.416 . . . . 0.0 110.609 179.225 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.538 ' SG ' ' HZ3' ' A' ' 50' ' ' TRP . 1.7 p -140.63 -14.8 0.95 Allowed 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 54.5 mt -111.65 135.98 49.21 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-O 120.733 0.302 . . . . 0.0 110.502 179.363 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.529 ' HA3' ' HB3' ' A' ' 52' ' ' MET . . . -152.93 158.33 27.84 Favored Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 111.468 -0.653 . . . . 0.0 111.468 179.383 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.694 ' ND2' ' HB2' ' A' ' 55' ' ' PHE . 3.7 p30 -161.72 52.03 0.37 Allowed Pre-proline 0 C--N 1.327 -0.412 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 179.556 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.559 ' HD3' ' N ' ' A' ' 43' ' ' ASN . 5.4 Cg_exo -78.03 -9.27 16.7 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.298 1.999 . . . . 0.0 111.647 -179.432 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 35.7 m-80 -99.35 2.04 44.96 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.618 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.478 ' CA ' ' HG2' ' A' ' 83' ' ' ARG . . . 93.33 0.74 67.27 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.402 -0.904 . . . . 0.0 112.093 -179.446 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -125.47 131.37 52.86 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.986 0.422 . . . . 0.0 111.006 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.582 HD13 ' HB3' ' A' ' 86' ' ' GLN . 9.9 mp -84.58 153.99 22.89 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.479 -179.422 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 168.04 170.6 32.98 Favored Glycine 0 N--CA 1.443 -0.842 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.651 179.424 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.538 ' HZ3' ' SG ' ' A' ' 40' ' ' CYS . 90.5 m95 -95.86 125.24 40.29 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 149.24 -34.83 1.08 Allowed Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.804 -0.713 . . . . 0.0 112.405 -179.621 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.529 ' HB3' ' HA3' ' A' ' 42' ' ' GLY . 12.9 tpt -98.48 174.22 6.56 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 -179.319 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -128.71 168.97 15.05 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 117.93 0.332 . . . . 0.0 110.97 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 61.31 49.43 5.39 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.438 -0.801 . . . . 0.0 112.455 178.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.694 ' HB2' ' ND2' ' A' ' 43' ' ' ASN . 15.9 p90 -70.08 -25.72 63.66 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.104 179.157 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.5 ' HA ' HD11 ' A' ' 62' ' ' ILE . 10.6 p -60.93 -44.9 96.56 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.262 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 30.5 m80 -79.98 -11.36 59.79 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.999 0.428 . . . . 0.0 110.762 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 20.6 m -101.41 2.33 39.32 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.997 -178.611 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 62.3 p -144.57 160.82 40.52 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.548 -0.461 . . . . 0.0 111.421 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 59.1 mm-40 -117.23 152.23 35.27 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.966 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 50.22 76.36 0.15 Allowed 'General case' 0 N--CA 1.472 0.644 0 O-C-N 123.994 0.809 . . . . 0.0 111.777 179.445 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.562 HG23 HD21 ' A' ' 71' ' ' LEU . 83.8 mt -92.61 117.09 35.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.416 -179.334 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 32.1 ttmt -148.94 154.91 40.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.108 -0.497 . . . . 0.0 109.851 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.752 ' HG ' HD21 ' A' ' 12' ' ' LEU . 60.2 mt -83.73 135.95 34.36 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.193 0.52 . . . . 0.0 111.224 -179.616 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -92.17 -66.26 0.94 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.406 -0.815 . . . . 0.0 111.82 -178.819 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -78.6 40.98 0.39 Allowed 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 120.95 0.405 . . . . 0.0 111.671 -178.659 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 60.91 17.81 52.06 Favored Glycine 0 C--N 1.32 -0.324 0 CA-C-N 115.653 -0.703 . . . . 0.0 113.113 179.553 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.47 ' HA2' HD13 ' A' ' 64' ' ' LEU . . . 129.58 -16.06 5.67 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.222 -0.989 . . . . 0.0 112.668 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.52 ' HD2' ' HB3' ' A' ' 4' ' ' ALA . 0.1 OUTLIER -77.5 -19.17 56.26 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.134 0.492 . . . . 0.0 109.783 -179.796 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.47 ' HG3' ' HA ' ' A' ' 89' ' ' ASP . 65.3 tttt -150.35 144.33 25.43 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.936 -178.391 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.61 ' HB2' HD11 ' A' ' 90' ' ' LEU . 9.7 tt -112.29 126.66 55.48 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.56 179.744 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.5 p -114.04 137.71 51.36 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.099 0.476 . . . . 0.0 111.358 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.423 ' HB3' ' HA ' ' A' ' 62' ' ' ILE . 25.0 p -161.76 175.85 11.53 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.607 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.511 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 44.7 ttt180 -107.91 99.54 30.98 Favored Pre-proline 0 C--N 1.317 -0.833 0 N-CA-C 110.154 -0.313 . . . . 0.0 110.154 179.377 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.672 ' O ' ' HB3' ' A' ' 83' ' ' ARG . 56.1 Cg_endo -67.06 122.91 10.29 Favored 'Trans proline' 0 CA--C 1.513 -0.564 0 C-N-CA 123.129 2.553 . . . . 0.0 111.332 -179.667 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.74 ' HA ' ' HB2' ' A' ' 83' ' ' ARG . 0.2 OUTLIER -120.13 147.03 45.39 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 120.947 0.403 . . . . 0.0 111.191 -179.85 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.743 HG22 ' O ' ' A' ' 82' ' ' PHE . 10.3 t -74.21 130.22 39.33 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 178.55 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.1 m -72.18 -3.39 3.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 O-C-N 123.629 0.581 . . . . 0.0 111.204 -179.484 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -70.52 -34.54 72.42 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.789 178.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.41 ' HA3' ' CE1' ' A' ' 82' ' ' PHE . . . -144.51 -24.72 0.13 Allowed Glycine 0 CA--C 1.521 0.441 0 C-N-CA 120.73 -0.747 . . . . 0.0 113.285 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 102.65 14.79 26.48 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 121.022 -0.609 . . . . 0.0 112.277 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.743 ' O ' HG22 ' A' ' 77' ' ' THR . 29.4 p90 -112.85 157.9 20.82 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 118.372 -0.823 . . . . 0.0 110.105 -179.206 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.844 ' HA ' ' HE ' ' A' ' 83' ' ' ARG . 0.0 OUTLIER 163.44 -154.03 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.75 0 O-C-N 123.932 0.77 . . . . 0.0 112.381 178.528 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 47.8 mm-40 -109.14 -173.96 2.39 Favored 'General case' 0 C--O 1.226 -0.161 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.468 -178.136 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.535 ' HA ' ' HD2' ' A' ' 75' ' ' PRO . 61.5 ttt180 -113.75 156.03 24.56 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 177.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.787 ' HG2' ' H ' ' A' ' 87' ' ' GLY . 34.9 tt0 -169.07 -165.78 0.57 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 120.526 -0.47 . . . . 0.0 111.462 -178.284 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.787 ' H ' ' HG2' ' A' ' 86' ' ' GLN . . . -162.15 154.42 25.38 Favored Glycine 0 N--CA 1.449 -0.434 0 N-CA-C 111.217 -0.753 . . . . 0.0 111.217 179.424 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.485 HG22 HD23 ' A' ' 48' ' ' LEU . 12.8 tt -130.78 137.54 55.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.952 0.376 . . . . 0.0 110.323 -179.558 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.47 ' HA ' ' HG3' ' A' ' 70' ' ' LYS . 1.8 p-10 -76.65 140.58 41.0 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.961 0.41 . . . . 0.0 109.92 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.791 HD13 HD11 ' A' ' 19' ' ' LEU . 55.8 mt -109.44 40.02 1.95 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.347 0.594 . . . . 0.0 110.834 -179.473 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.565 ' HA ' ' HB3' ' A' ' 2' ' ' SER . 22.2 m120 -75.45 2.36 11.69 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.806 -179.732 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 19.6 mtp180 -95.77 -11.25 27.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.015 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.407 ' CD1' HD22 ' A' ' 37' ' ' LEU . 23.1 mm -98.18 100.01 9.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 29.3 tp60 -107.21 145.6 32.42 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.953 -178.101 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.443 ' OD1' ' HA ' ' A' ' 3' ' ' TYR . 19.4 p-10 -94.78 118.82 32.38 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.54 178.144 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 47.5 t -106.28 107.78 23.52 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 27.8 m-80 59.46 32.51 21.78 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.022 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.407 ' O ' ' HB2' ' A' ' 23' ' ' CYS . . . 97.99 -25.69 26.51 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.571 -0.823 . . . . 0.0 113.239 179.397 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.408 ' HD2' ' H ' ' A' ' 99' ' ' ARG . 1.7 mpt_? -87.07 143.28 27.39 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 117.252 0.526 . . . . 0.0 110.603 -178.832 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.485 ' HB3' ' HB2' ' A' ' 35' ' ' LEU . 2.7 tp -87.42 124.23 33.2 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.78 0.324 . . . . 0.0 110.845 -179.25 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 21.7 t -131.19 138.15 53.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.419 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.425 ' HB2' HD11 ' A' ' 35' ' ' LEU . 10.3 t80 -83.14 130.95 35.15 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 177.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 22.0 tt0 . . . . . 0 C--O 1.25 1.119 0 CA-C-O 118.329 -0.844 . . . . 0.0 111.046 -179.076 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 85.5 mtp . . . . . 0 N--CA 1.479 0.999 0 CA-C-O 120.827 0.346 . . . . 0.0 110.439 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.406 ' OG ' ' HA ' ' A' ' 91' ' ' ASN . 13.4 m -118.21 178.44 4.43 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.46 179.135 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.482 ' CZ ' HD13 ' A' ' 19' ' ' LEU . 26.4 p90 -57.95 -38.5 76.12 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.672 0.273 . . . . 0.0 111.296 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.533 ' HA ' ' OG ' ' A' ' 7' ' ' SER . . . -58.97 -19.78 46.33 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -178.088 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -72.56 -17.78 61.68 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.297 0.57 . . . . 0.0 110.347 -179.492 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 48.8 m -136.74 36.42 2.64 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.333 179.429 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.533 ' OG ' ' HA ' ' A' ' 4' ' ' ALA . 68.6 p -149.61 171.43 16.67 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.485 179.373 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.553 ' HG3' ' HB2' ' A' ' 22' ' ' GLU . 1.9 ptp180 -149.98 167.11 27.64 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.948 -179.532 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 53.73 56.05 7.71 Favored 'General case' 0 C--O 1.233 0.192 0 O-C-N 123.867 0.729 . . . . 0.0 111.322 178.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.503 ' HA ' ' HB2' ' A' ' 21' ' ' ALA . . . -88.24 117.32 27.06 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.181 179.702 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 35.9 m -124.13 170.22 14.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.596 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.848 HD21 ' HG ' ' A' ' 64' ' ' LEU . 3.3 mm? -104.68 114.17 28.21 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.832 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 18.7 p -108.88 166.63 10.67 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.622 -0.263 . . . . 0.0 110.95 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 59.37 48.5 9.94 Favored 'General case' 0 CA--C 1.522 -0.112 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.912 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 86.76 -39.35 3.08 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.953 -0.641 . . . . 0.0 112.35 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.637 ' HA2' ' HB3' ' A' ' 12' ' ' LEU . . . 140.01 38.32 0.1 OUTLIER Glycine 0 N--CA 1.445 -0.709 0 N-CA-C 111.305 -0.718 . . . . 0.0 111.305 -179.708 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.552 ' HB2' ' HB3' ' A' ' 38' ' ' ASP . 39.2 ptt85 -122.14 -23.37 5.37 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.094 0.473 . . . . 0.0 110.779 -179.326 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.432 HG22 ' HB3' ' A' ' 34' ' ' GLU . 3.9 m -105.84 134.73 48.5 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.923 -179.166 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.665 HD11 HD13 ' A' ' 90' ' ' LEU . 81.9 mt -93.67 110.99 22.59 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.404 179.237 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 20.4 ttt180 -108.11 119.35 39.22 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 178.714 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.503 ' HB2' ' HA ' ' A' ' 10' ' ' ALA . . . -153.66 167.04 30.89 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.982 0.42 . . . . 0.0 111.483 -178.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.553 ' HB2' ' HG3' ' A' ' 8' ' ' ARG . 7.3 mm-40 -90.3 105.0 17.51 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 107.1 -1.445 . . . . 0.0 107.1 178.293 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.442 ' SG ' HD13 ' A' ' 100' ' ' LEU . 58.6 m -92.34 125.27 36.92 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.557 -178.218 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.437 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 33.8 ttp180 -73.3 117.82 15.51 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.582 179.055 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.406 HD21 ' HB3' ' A' ' 29' ' ' ASN . 35.1 p30 -82.35 167.62 18.35 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.62 -24.26 63.68 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 -178.274 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -75.08 -16.15 60.58 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.315 0.579 . . . . 0.0 109.727 179.614 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 93.32 36.32 5.97 Favored Glycine 0 N--CA 1.447 -0.624 0 CA-C-N 115.186 -0.915 . . . . 0.0 111.733 -179.374 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.437 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 9.2 t-20 -123.48 163.91 19.97 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.606 0.241 . . . . 0.0 110.417 -179.125 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.498 ' CZ3' ' HG2' ' A' ' 8' ' ' ARG . 89.2 m95 -101.16 118.47 37.05 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.381 -179.599 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.5 m -122.08 130.78 74.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.429 178.37 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 15.8 m -76.0 110.95 10.88 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.583 -179.517 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 67.8 m -123.25 154.65 38.52 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.745 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.647 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 50.4 mt-10 -135.02 143.08 46.58 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.055 -179.54 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.549 HD11 ' HB2' ' A' ' 102' ' ' PHE . 2.0 tm? -136.36 129.66 31.64 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 178.457 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.443 ' N ' HD13 ' A' ' 35' ' ' LEU . 15.1 m-20 -88.42 109.18 19.8 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 -179.576 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.554 HD13 HD22 ' A' ' 90' ' ' LEU . 3.8 mt -81.27 -20.01 41.82 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.764 -179.334 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.552 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 5.7 p-10 -66.26 -5.33 10.06 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.874 0.369 . . . . 0.0 111.341 -178.772 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 77.6 p -82.9 -11.57 58.08 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.686 179.289 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 29.0 t -141.48 -3.86 1.15 Allowed 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 57.7 mt -109.59 135.06 49.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 178.712 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.556 ' HA3' ' HB3' ' A' ' 52' ' ' MET . . . -146.0 155.63 26.6 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.93 -0.653 . . . . 0.0 111.519 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 23.6 p30 -159.69 45.19 0.19 Allowed Pre-proline 0 CA--C 1.538 0.486 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -179.742 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -66.66 -23.31 49.3 Favored 'Trans proline' 0 C--N 1.355 0.901 0 C-N-CA 121.793 1.662 . . . . 0.0 111.68 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 73.9 m-20 -83.95 -15.42 47.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.507 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 105.86 6.68 37.19 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.494 -0.86 . . . . 0.0 112.114 -179.143 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.475 ' HA ' ' OE1' ' A' ' 86' ' ' GLN . 55.7 m-85 -124.9 132.75 53.26 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.867 0.365 . . . . 0.0 110.171 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.591 ' HB3' ' HB ' ' A' ' 88' ' ' ILE . 11.0 mp -87.27 138.43 31.49 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.642 -0.708 . . . . 0.0 112.339 -178.173 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -177.37 171.14 43.87 Favored Glycine 0 N--CA 1.439 -1.14 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.611 178.754 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.427 ' HH2' HD11 ' A' ' 93' ' ' ILE . 91.6 m95 -94.99 125.39 39.63 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 156.11 -58.82 0.37 Allowed Glycine 0 N--CA 1.447 -0.58 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 -179.345 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.556 ' HB3' ' HA3' ' A' ' 42' ' ' GLY . 7.3 tpt -84.71 178.47 7.65 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 179.008 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.0 pt20 -137.2 177.7 7.66 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 118.596 0.635 . . . . 0.0 111.726 -179.408 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 15.5 m120 62.73 39.68 10.78 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.408 -0.815 . . . . 0.0 112.083 179.617 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.443 ' HB3' ' HA2' ' A' ' 42' ' ' GLY . 10.1 p90 -66.26 -32.2 73.47 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 120.478 0.18 . . . . 0.0 111.296 -179.583 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.434 ' HB3' ' HB3' ' A' ' 17' ' ' ARG . 42.3 p -61.81 -31.84 72.09 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.057 0.456 . . . . 0.0 111.118 -179.005 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 38.4 m80 -78.39 -12.0 59.98 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.08 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 43.9 m -119.6 23.63 11.07 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.956 0.408 . . . . 0.0 110.704 179.624 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 66.2 m -138.4 152.27 48.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.085 0.469 . . . . 0.0 111.09 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 78.6 mt-10 -130.18 136.41 49.23 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.119 179.53 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 29.7 t70 65.58 82.62 0.18 Allowed 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.329 0.585 . . . . 0.0 110.268 -178.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.478 HG23 HD21 ' A' ' 71' ' ' LEU . 64.2 mt -104.68 121.98 57.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.197 -179.248 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 27.8 tptt -147.33 153.7 40.01 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.848 ' HG ' HD21 ' A' ' 12' ' ' LEU . 73.4 mt -85.89 125.95 33.71 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.962 0.411 . . . . 0.0 110.764 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -78.56 -58.32 3.31 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.593 -178.673 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.545 ' HB2' ' HB3' ' A' ' 69' ' ' ARG . 35.9 mt-10 -89.02 39.13 0.92 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.94 0.4 . . . . 0.0 111.175 -179.119 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 61.92 10.9 28.42 Favored Glycine 0 N--CA 1.453 -0.225 0 CA-C-N 115.516 -0.765 . . . . 0.0 113.28 179.4 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.516 ' HA2' HD13 ' A' ' 64' ' ' LEU . . . 136.66 -14.6 3.89 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.415 -0.898 . . . . 0.0 112.705 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.545 ' HB3' ' HB2' ' A' ' 66' ' ' GLU . 0.6 OUTLIER -79.07 -22.15 45.71 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.415 0.626 . . . . 0.0 109.349 -179.669 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.9 ttmp? -144.91 137.43 26.22 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.014 -179.435 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.598 ' HB2' HD11 ' A' ' 90' ' ' LEU . 10.6 tt -104.69 127.58 52.5 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.571 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.4 p -117.73 131.93 56.54 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.048 0.451 . . . . 0.0 111.405 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.481 ' SG ' HD21 ' A' ' 48' ' ' LEU . 28.4 p -158.2 165.57 34.56 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.604 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 12.0 ttt-85 -106.33 101.65 36.24 Favored Pre-proline 0 C--N 1.316 -0.885 0 C-N-CA 120.173 -0.611 . . . . 0.0 109.941 179.067 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.672 ' O ' ' HB3' ' A' ' 83' ' ' ARG . 55.8 Cg_endo -70.45 141.37 42.25 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 122.567 2.178 . . . . 0.0 110.417 178.618 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.785 ' HE3' ' HA2' ' A' ' 81' ' ' GLY . 0.0 OUTLIER -121.66 143.62 49.23 Favored 'General case' 0 C--N 1.318 -0.8 0 O-C-N 123.567 0.542 . . . . 0.0 111.098 179.913 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.678 ' HB ' ' HD2' ' A' ' 83' ' ' ARG . 11.4 t -79.83 143.14 34.64 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 178.852 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 8.8 p -70.4 -12.36 16.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 O-C-N 124.184 0.927 . . . . 0.0 111.577 -179.04 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 -63.43 -23.14 67.28 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.283 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -173.08 -14.62 0.02 OUTLIER Glycine 0 C--O 1.228 -0.255 0 C-N-CA 120.312 -0.947 . . . . 0.0 113.163 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.785 ' HA2' ' HE3' ' A' ' 76' ' ' LYS . . . 98.76 20.97 17.47 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.549 -0.834 . . . . 0.0 111.849 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.678 ' O ' HG22 ' A' ' 77' ' ' THR . 24.9 p90 -110.91 149.5 30.54 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -179.133 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.688 ' HB2' ' HA ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 177.35 -143.15 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.763 -0.375 . . . . 0.0 111.896 -179.768 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -143.91 152.46 41.15 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.051 -178.141 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.604 ' HA ' ' HA ' ' A' ' 74' ' ' ARG . 31.6 ttt-85 -77.55 154.1 32.7 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 110.206 -0.294 . . . . 0.0 110.206 -179.68 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.608 ' HG2' ' H ' ' A' ' 87' ' ' GLY . 43.2 tt0 -161.72 179.68 7.94 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 120.586 0.231 . . . . 0.0 110.587 -179.028 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.608 ' H ' ' HG2' ' A' ' 86' ' ' GLN . . . -145.51 148.56 20.37 Favored Glycine 0 N--CA 1.448 -0.545 0 N-CA-C 111.683 -0.567 . . . . 0.0 111.683 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.591 ' HB ' ' HB3' ' A' ' 48' ' ' LEU . 14.8 tt -126.18 137.84 56.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.199 0.523 . . . . 0.0 110.538 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -77.4 128.3 34.02 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.872 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.665 HD13 HD11 ' A' ' 19' ' ' LEU . 44.7 mt -96.7 42.06 1.1 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.613 0.721 . . . . 0.0 110.746 -179.163 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.406 ' HA ' ' OG ' ' A' ' 2' ' ' SER . 4.6 m120 -78.86 3.2 17.56 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 115.053 -0.976 . . . . 0.0 111.041 -179.696 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 24.7 mtp180 -100.18 -3.98 30.52 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.677 178.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.427 HD11 ' HH2' ' A' ' 50' ' ' TRP . 22.1 mm -104.16 108.99 25.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 -179.377 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 26.6 tp60 -122.18 141.96 50.91 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.985 -178.242 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 17.0 p-10 -94.73 119.72 33.8 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.066 178.596 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 44.2 t -104.82 104.81 17.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.641 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 12.9 m120 61.0 37.19 18.26 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 121.273 0.559 . . . . 0.0 110.651 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 91.05 -16.64 58.14 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.924 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 7.1 mpt_? -87.1 123.09 31.78 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.442 HD13 ' SG ' ' A' ' 23' ' ' CYS . 9.0 tp -81.6 114.9 20.61 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.684 -0.488 . . . . 0.0 109.684 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 39.5 t -128.7 143.11 42.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 120.933 0.397 . . . . 0.0 111.001 -178.773 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.549 ' HB2' HD11 ' A' ' 35' ' ' LEU . 6.7 t80 -81.47 136.05 35.64 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 178.36 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 54.2 tp60 . . . . . 0 C--O 1.245 0.85 0 CA-C-O 118.805 -0.617 . . . . 0.0 110.686 -179.976 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.04 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.581 ' OG ' ' HA ' ' A' ' 91' ' ' ASN . 5.5 m -119.66 -179.88 4.02 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.946 0.403 . . . . 0.0 111.45 -179.709 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.503 ' HA ' ' OD1' ' A' ' 95' ' ' ASN . 21.0 p90 -59.06 -33.92 71.34 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.857 178.388 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.491 ' HB3' ' HG2' ' A' ' 69' ' ' ARG . . . -56.34 -19.22 13.52 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 -178.738 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -69.43 -14.53 62.94 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 121.107 0.48 . . . . 0.0 110.808 179.758 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 14.9 p -149.5 33.7 0.71 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.655 0.741 . . . . 0.0 109.354 178.672 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 17.4 t -148.47 155.78 41.62 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.256 -0.884 . . . . 0.0 109.394 -179.509 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 1.5 ptp180 -148.74 170.24 18.63 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.76 -0.2 . . . . 0.0 110.858 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 62.56 44.6 6.79 Favored 'General case' 0 C--O 1.232 0.151 0 O-C-N 124.003 0.814 . . . . 0.0 111.18 178.625 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.413 ' HA ' ' HB2' ' A' ' 21' ' ' ALA . . . -80.33 126.34 31.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.88 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 35.5 m -126.77 172.62 13.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.552 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -105.94 114.88 29.3 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.68 -179.479 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 22.6 p -111.15 166.87 10.71 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.951 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.432 ' O ' ' HG2' ' A' ' 17' ' ' ARG . 83.9 m-20 56.83 42.28 26.78 Favored 'General case' 0 N--CA 1.461 0.108 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.604 -179.206 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 87.69 -41.03 3.07 Favored Glycine 0 CA--C 1.517 0.212 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.542 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 146.33 44.29 0.04 OUTLIER Glycine 0 N--CA 1.447 -0.617 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.432 ' HG2' ' O ' ' A' ' 14' ' ' ASN . 6.4 ptm180 -126.24 -26.18 3.4 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.894 0.378 . . . . 0.0 110.93 -179.191 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 3.7 m -107.08 135.97 47.73 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.971 -179.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.815 HD11 HD13 ' A' ' 90' ' ' LEU . 39.7 mt -94.62 115.87 28.08 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.209 178.708 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 78.0 ttt180 -112.98 119.04 36.53 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 178.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.432 ' O ' ' HA ' ' A' ' 32' ' ' THR . . . -154.08 166.78 31.98 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.728 0.299 . . . . 0.0 111.461 -179.139 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -90.99 106.64 18.66 Favored 'General case' 0 CA--C 1.513 -0.458 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 178.315 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.468 ' SG ' HD13 ' A' ' 100' ' ' LEU . 70.2 m -99.01 135.76 39.94 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 120.76 0.314 . . . . 0.0 110.765 -178.751 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.4 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 15.9 ttp180 -77.66 120.02 22.01 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.791 179.334 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.43 HD21 ' HB3' ' A' ' 29' ' ' ASN . 36.4 p30 -86.13 168.63 13.85 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.971 -0.291 . . . . 0.0 110.385 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -52.59 -36.28 55.78 Favored 'General case' 0 C--N 1.328 -0.369 0 O-C-N 123.837 0.71 . . . . 0.0 112.02 -179.097 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -67.45 -17.21 64.61 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.329 0.585 . . . . 0.0 111.041 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 92.6 34.98 6.68 Favored Glycine 0 N--CA 1.448 -0.528 0 N-CA-C 111.304 -0.718 . . . . 0.0 111.304 -179.586 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.43 ' HB3' HD21 ' A' ' 25' ' ' ASN . 9.9 t-20 -119.77 158.08 27.27 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 110.237 -0.283 . . . . 0.0 110.237 -178.839 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 77.0 m95 -95.1 116.53 28.83 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.241 179.065 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.5 m -122.78 129.53 75.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.361 179.195 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.432 ' HA ' ' O ' ' A' ' 21' ' ' ALA . 21.0 m -74.77 114.5 13.29 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.202 0.525 . . . . 0.0 110.26 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.55 ' HB3' ' HB2' ' A' ' 100' ' ' LEU . 58.5 m -114.95 149.41 37.34 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.909 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.641 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 26.3 mt-10 -132.65 130.85 40.69 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.881 -178.801 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.591 HD11 ' HB2' ' A' ' 102' ' ' PHE . 2.1 tm? -132.64 132.83 42.87 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.461 ' N ' HD13 ' A' ' 35' ' ' LEU . 14.6 m-20 -88.96 110.19 20.9 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 -179.726 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.505 HD11 ' HG ' ' A' ' 19' ' ' LEU . 2.6 mt -81.11 -18.29 47.01 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.095 -179.123 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.465 ' HA ' ' HD1' ' A' ' 55' ' ' PHE . 5.7 p-10 -65.05 -7.22 11.08 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.28 -179.358 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 58.1 p -80.73 -13.04 59.34 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.271 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.457 ' HG ' ' HZ ' ' A' ' 102' ' ' PHE . 18.8 t -139.96 -12.9 1.09 Allowed 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 112.138 0.422 . . . . 0.0 112.138 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 54.3 mt -97.55 135.46 31.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 O-C-N 121.814 -0.554 . . . . 0.0 110.057 179.361 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -142.15 144.64 14.44 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.731 -0.747 . . . . 0.0 111.743 179.648 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.503 ' OD1' ' HB2' ' A' ' 58' ' ' SER . 27.8 p30 -152.95 48.37 0.43 Allowed Pre-proline 0 CA--C 1.539 0.542 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 -179.696 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -76.78 -16.46 16.4 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 121.697 1.598 . . . . 0.0 112.339 -178.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -96.19 2.71 53.26 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.921 -179.457 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.604 ' CA ' ' HG2' ' A' ' 83' ' ' ARG . . . 92.48 5.58 65.02 Favored Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.295 -0.955 . . . . 0.0 112.26 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.451 ' HD1' ' NE2' ' A' ' 86' ' ' GLN . 31.9 m-85 -125.85 134.49 51.62 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.899 0.38 . . . . 0.0 110.497 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.467 HD23 HG22 ' A' ' 88' ' ' ILE . 9.5 mp -85.04 158.51 20.44 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.58 -0.737 . . . . 0.0 111.653 -178.713 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 159.55 167.26 19.94 Favored Glycine 0 N--CA 1.443 -0.864 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.95 178.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.451 ' CD1' HD11 ' A' ' 88' ' ' ILE . 85.2 m95 -95.33 125.12 39.73 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 166.29 -43.01 0.27 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.87 -179.462 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 8.4 ttp -107.86 -156.94 0.6 Allowed 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.4 pt20 -146.83 173.92 11.95 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 121.091 -0.244 . . . . 0.0 110.899 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 63.03 45.43 5.28 Favored 'General case' 0 N--CA 1.465 0.285 0 O-C-N 123.663 0.602 . . . . 0.0 112.351 178.266 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.465 ' HD1' ' HA ' ' A' ' 38' ' ' ASP . 10.1 p90 -71.63 -28.79 64.02 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.978 -0.289 . . . . 0.0 110.76 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.45 ' HA ' HD11 ' A' ' 62' ' ' ILE . 35.0 p -61.39 -37.61 84.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.079 0.466 . . . . 0.0 110.917 -179.333 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 27.2 m80 -81.06 -3.46 51.97 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.106 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.503 ' HB2' ' OD1' ' A' ' 43' ' ' ASN . 12.2 m -119.13 12.68 12.74 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.396 -179.436 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 22.0 p -145.88 155.3 42.79 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 120.995 0.426 . . . . 0.0 111.459 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -116.35 148.05 40.99 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.872 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.405 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 28.1 t70 54.0 78.44 0.16 Allowed 'General case' 0 N--CA 1.467 0.401 0 O-C-N 123.921 0.763 . . . . 0.0 111.168 -179.614 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.586 ' HA ' ' HB3' ' A' ' 73' ' ' CYS . 67.0 mt -97.04 117.64 42.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.784 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -148.03 153.78 39.41 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.825 0.345 . . . . 0.0 110.626 -179.159 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.432 HD22 ' HA2' ' A' ' 68' ' ' GLY . 43.0 mt -83.07 133.14 35.08 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.24 0.543 . . . . 0.0 111.041 -179.173 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.439 ' OE2' ' HD3' ' A' ' 70' ' ' LYS . 35.4 tt0 -86.8 -61.44 1.73 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.68 -178.772 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.595 ' HB2' ' HB2' ' A' ' 69' ' ' ARG . 19.1 mt-10 -84.71 34.9 0.54 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.806 0.336 . . . . 0.0 111.42 -178.79 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 65.04 13.15 57.03 Favored Glycine 0 N--CA 1.452 -0.252 0 CA-C-N 115.972 -0.558 . . . . 0.0 113.504 179.406 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.432 ' HA2' HD22 ' A' ' 64' ' ' LEU . . . 140.26 -24.76 2.66 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.147 -1.025 . . . . 0.0 113.072 179.717 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.595 ' HB2' ' HB2' ' A' ' 66' ' ' GLU . 3.8 mmt85 -74.08 -21.34 59.95 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.967 0.413 . . . . 0.0 110.943 -179.765 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.591 ' HB3' ' HG3' ' A' ' 66' ' ' GLU . 81.9 tttt -146.17 143.05 29.03 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.743 -178.509 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.685 ' HB2' HD11 ' A' ' 90' ' ' LEU . 10.2 tt -113.19 135.32 53.94 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.013 -0.539 . . . . 0.0 109.617 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 8.9 p -127.16 139.13 53.17 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.018 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.586 ' HB3' ' HA ' ' A' ' 62' ' ' ILE . 26.4 p -162.54 172.0 16.14 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.269 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.664 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 75.1 ttt180 -108.86 98.87 31.88 Favored Pre-proline 0 C--N 1.321 -0.664 0 C-N-CA 120.562 -0.455 . . . . 0.0 110.349 178.737 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.689 ' O ' ' HB3' ' A' ' 83' ' ' ARG . 41.4 Cg_endo -66.74 128.4 18.88 Favored 'Trans proline' 0 N--CA 1.459 -0.5 0 C-N-CA 122.847 2.365 . . . . 0.0 110.828 179.302 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.763 ' HA ' ' HB2' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -120.78 141.57 50.38 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.349 -179.268 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.699 HG22 ' O ' ' A' ' 82' ' ' PHE . 9.5 t -70.86 131.47 43.82 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 178.402 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.7 m -70.55 -6.84 7.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 123.818 0.699 . . . . 0.0 112.069 -178.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -69.29 -33.91 73.9 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.956 0.408 . . . . 0.0 110.313 179.271 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.431 ' HA3' ' CE1' ' A' ' 82' ' ' PHE . . . -143.98 -25.45 0.14 Allowed Glycine 0 N--CA 1.453 -0.187 0 C-N-CA 120.557 -0.83 . . . . 0.0 112.7 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 100.66 17.62 23.15 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 121.02 -0.609 . . . . 0.0 112.133 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.699 ' O ' HG22 ' A' ' 77' ' ' THR . 24.7 p90 -111.8 153.11 27.05 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 118.763 -0.637 . . . . 0.0 109.878 -178.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.763 ' HB2' ' HA ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 167.04 -154.88 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.582 0 O-C-N 123.697 0.623 . . . . 0.0 111.364 179.4 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -123.44 170.84 9.96 Favored 'General case' 0 C--O 1.223 -0.304 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.265 -178.023 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.664 ' HA ' ' HA ' ' A' ' 74' ' ' ARG . 30.1 ttt85 -96.81 157.97 15.65 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.246 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.455 ' HG2' ' H ' ' A' ' 87' ' ' GLY . 6.4 tt0 -158.91 179.57 8.96 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.072 0.463 . . . . 0.0 111.58 -179.243 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.455 ' H ' ' HG2' ' A' ' 86' ' ' GLN . . . -144.54 143.82 12.53 Favored Glycine 0 N--CA 1.45 -0.426 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.612 179.22 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.467 HG22 HD23 ' A' ' 48' ' ' LEU . 13.9 tt -130.29 140.85 47.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.825 0.345 . . . . 0.0 110.556 -179.374 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.467 ' HB3' HD22 ' A' ' 91' ' ' ASN . 6.9 m-20 -80.15 137.4 36.7 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.815 HD13 HD11 ' A' ' 19' ' ' LEU . 64.2 mt -104.71 41.28 1.35 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.292 0.568 . . . . 0.0 111.382 -179.285 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.581 ' HA ' ' OG ' ' A' ' 2' ' ' SER . 21.3 m-80 -76.0 3.31 10.55 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.976 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.407 HH11 ' HD2' ' A' ' 92' ' ' ARG . 8.4 mtp180 -96.7 -11.19 25.44 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.562 178.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.492 HG13 HD22 ' A' ' 37' ' ' LEU . 21.7 mm -98.38 95.91 4.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 21.6 tp60 -106.15 139.54 40.5 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.201 -177.812 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.503 ' OD1' ' HA ' ' A' ' 3' ' ' TYR . 16.8 p-10 -94.67 116.35 28.65 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.596 178.314 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.7 p -114.13 123.57 69.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 116.185 -0.461 . . . . 0.0 109.938 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 62.57 20.11 11.75 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.956 -179.156 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 95.84 -9.59 68.36 Favored Glycine 0 N--CA 1.446 -0.657 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.759 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.446 ' O ' ' HA ' ' A' ' 95' ' ' ASN . 0.0 OUTLIER -96.1 144.41 26.38 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-N 117.257 0.529 . . . . 0.0 110.826 -178.944 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.55 ' HB2' ' HB3' ' A' ' 33' ' ' SER . 5.3 tp -89.55 116.38 27.66 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.145 -0.48 . . . . 0.0 109.796 -179.789 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 46.8 t -131.12 141.85 45.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.422 -179.353 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.591 ' HB2' HD11 ' A' ' 35' ' ' LEU . 22.8 t80 -80.27 128.68 33.82 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 179.153 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.163 -0.922 . . . . 0.0 110.864 -179.347 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.478 0.953 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.623 ' HB3' ' HA ' ' A' ' 91' ' ' ASN . 1.0 OUTLIER -117.22 178.87 4.21 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.464 179.058 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.619 ' HA ' ' OD1' ' A' ' 95' ' ' ASN . 8.3 p90 -58.22 -41.41 84.02 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.772 -0.195 . . . . 0.0 111.399 -179.429 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -60.18 -19.37 53.78 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.849 -178.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -68.29 -21.81 64.76 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.146 0.498 . . . . 0.0 110.429 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.405 ' HB2' HD21 ' A' ' 95' ' ' ASN . 51.1 m -138.85 34.88 2.17 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.671 179.593 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.433 ' HA ' ' HZ3' ' A' ' 30' ' ' TRP . 92.8 p -149.96 167.67 26.02 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.182 179.258 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 16.0 ptm180 -149.9 169.11 21.9 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.648 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 60.4 52.87 4.52 Favored 'General case' 0 N--CA 1.465 0.296 0 O-C-N 123.646 0.591 . . . . 0.0 110.692 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -90.12 119.96 30.89 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.209 -179.515 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 35.3 m -122.49 170.71 12.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.165 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.707 HD21 ' HG ' ' A' ' 64' ' ' LEU . 3.4 mm? -104.81 116.29 31.76 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 -179.704 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.456 ' OG1' ' HB ' ' A' ' 18' ' ' THR . 29.4 p -110.7 167.62 10.09 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.072 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 56.95 55.62 5.99 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.93 179.704 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 82.24 -37.97 2.58 Favored Glycine 0 N--CA 1.453 -0.206 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.337 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.602 ' HA2' ' HB3' ' A' ' 12' ' ' LEU . . . 137.29 36.57 0.17 Allowed Glycine 0 N--CA 1.445 -0.757 0 N-CA-C 111.381 -0.688 . . . . 0.0 111.381 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.534 ' HB2' ' HB3' ' A' ' 38' ' ' ASP . 34.5 ptt85 -120.46 -23.11 6.22 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.93 0.395 . . . . 0.0 110.71 -179.222 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.456 ' HB ' ' OG1' ' A' ' 13' ' ' THR . 4.6 m -103.33 134.7 46.27 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.841 -179.258 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.65 ' O ' ' HA ' ' A' ' 34' ' ' GLU . 68.8 mt -95.26 116.18 28.41 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.395 179.19 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 39.0 ttt-85 -111.01 120.18 41.52 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 178.807 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -153.58 166.63 32.16 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.845 0.355 . . . . 0.0 111.488 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.468 ' HB3' ' HB3' ' A' ' 30' ' ' TRP . 49.8 mt-10 -89.9 105.68 17.97 Favored 'General case' 0 CA--C 1.512 -0.49 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 178.117 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.561 ' SG ' HD13 ' A' ' 100' ' ' LEU . 58.7 m -92.72 128.74 38.69 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.134 -177.766 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.434 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 11.0 ttp180 -77.79 116.46 18.33 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.34 179.034 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.439 HD21 ' HB3' ' A' ' 29' ' ' ASN . 35.2 p30 -84.96 170.92 12.56 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.231 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -51.29 -31.41 21.28 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -179.283 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -73.88 -11.58 60.41 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.621 0.724 . . . . 0.0 110.601 -179.183 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 85.79 25.02 39.64 Favored Glycine 0 N--CA 1.447 -0.633 0 N-CA-C 110.629 -0.988 . . . . 0.0 110.629 -179.21 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.439 ' HB3' HD21 ' A' ' 25' ' ' ASN . 8.8 t-20 -104.73 156.12 18.27 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.459 -0.371 . . . . 0.0 110.243 -178.581 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.468 ' HB3' ' HB3' ' A' ' 22' ' ' GLU . 90.7 m95 -97.6 116.02 29.01 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.775 -179.737 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.3 m -118.64 128.32 75.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.349 178.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 19.7 m -74.48 109.35 7.89 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.362 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.44 ' HB3' ' HB2' ' A' ' 100' ' ' LEU . 69.3 m -122.12 147.66 45.86 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.445 -179.813 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.65 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 50.7 mt-10 -128.79 142.84 50.85 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.012 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.722 HD11 ' HB2' ' A' ' 102' ' ' PHE . 2.1 tm? -135.49 132.45 37.36 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.729 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.463 ' N ' HD13 ' A' ' 35' ' ' LEU . 16.2 m-20 -89.59 110.36 21.23 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.542 HD13 HD22 ' A' ' 90' ' ' LEU . 2.9 mt -82.25 -20.76 36.96 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.68 -178.644 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.534 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 5.1 p-10 -66.9 -5.2 11.58 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 121.008 -0.277 . . . . 0.0 111.272 -178.501 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 37.5 p -73.52 -28.12 61.72 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.055 0.455 . . . . 0.0 110.261 178.425 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 17.0 t -126.48 -4.39 6.62 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.909 -179.342 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.403 HD13 HD13 ' A' ' 88' ' ' ILE . 57.8 mt -104.7 134.65 45.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 O-C-N 121.718 -0.613 . . . . 0.0 110.655 179.145 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.503 ' HA3' ' HB3' ' A' ' 52' ' ' MET . . . -149.98 158.85 27.85 Favored Glycine 0 N--CA 1.449 -0.456 0 N-CA-C 111.463 -0.655 . . . . 0.0 111.463 179.51 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.672 ' OD1' ' HB2' ' A' ' 55' ' ' PHE . 1.7 p-10 -163.64 56.37 0.54 Allowed Pre-proline 0 CA--C 1.538 0.484 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -66.64 -25.52 46.95 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.134 1.889 . . . . 0.0 112.068 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -96.54 3.94 52.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.03 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.641 ' HA2' ' HB2' ' A' ' 75' ' ' PRO . . . 89.9 11.99 62.76 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.305 -0.95 . . . . 0.0 113.288 179.453 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -118.38 123.48 45.37 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 120.929 0.395 . . . . 0.0 109.987 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.535 HD21 ' SG ' ' A' ' 73' ' ' CYS . 8.0 mp -83.56 137.51 33.81 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.734 -178.427 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -179.97 172.62 44.18 Favored Glycine 0 N--CA 1.437 -1.254 0 C-N-CA 120.748 -0.739 . . . . 0.0 111.422 178.72 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.43 ' CD2' ' HD3' ' A' ' 92' ' ' ARG . 91.2 m95 -95.05 125.03 39.43 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 -179.813 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 165.05 -55.25 0.27 Allowed Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.991 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.503 ' HB3' ' HA3' ' A' ' 42' ' ' GLY . 5.6 ttt -91.69 -158.07 0.55 Allowed 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.825 0.312 . . . . 0.0 110.226 -179.176 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 17.7 pt20 -148.57 167.64 24.89 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 120.788 0.328 . . . . 0.0 111.466 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 8.1 m120 63.6 48.61 3.31 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.303 -0.862 . . . . 0.0 112.82 178.621 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.672 ' HB2' ' OD1' ' A' ' 43' ' ' ASN . 8.8 p90 -69.73 -27.94 65.38 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.856 0.36 . . . . 0.0 110.423 179.438 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.453 ' HB2' ' HB3' ' A' ' 17' ' ' ARG . 21.7 t -61.26 -33.1 72.98 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.156 -179.762 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 24.3 m80 -78.37 -3.51 43.51 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.918 -179.457 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 40.0 m -133.94 24.56 3.94 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.956 0.408 . . . . 0.0 110.942 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 22.1 m -139.55 147.75 41.63 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.136 0.493 . . . . 0.0 111.465 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -123.06 151.5 41.91 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.59 179.48 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.452 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 28.2 t70 54.01 73.81 0.36 Allowed 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.356 0.598 . . . . 0.0 111.245 179.313 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.472 HG23 HD21 ' A' ' 71' ' ' LEU . 56.3 mt -98.48 116.13 40.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.887 -179.595 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.2 tptt -144.45 149.84 36.66 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.258 -179.503 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.707 ' HG ' HD21 ' A' ' 12' ' ' LEU . 65.0 mt -83.67 130.83 34.97 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 179.417 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 16.2 tp10 -83.13 -58.01 3.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.259 -178.134 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.514 ' HB2' ' HB3' ' A' ' 69' ' ' ARG . 7.2 mm-40 -85.59 23.14 1.43 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.158 0.504 . . . . 0.0 111.21 -179.046 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 76.49 3.38 77.8 Favored Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 115.487 -0.778 . . . . 0.0 112.963 179.373 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.451 ' HA2' HD22 ' A' ' 64' ' ' LEU . . . 147.62 -22.5 1.5 Allowed Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.671 -0.776 . . . . 0.0 111.997 -179.684 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.514 ' HB3' ' HB2' ' A' ' 66' ' ' GLU . 2.8 tpp180 -74.01 -12.53 60.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.267 0.556 . . . . 0.0 110.048 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 48.5 tttp -160.14 142.41 13.13 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.269 -178.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.649 ' HB2' HD11 ' A' ' 90' ' ' LEU . 10.3 tt -112.39 139.02 48.3 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.5 p -127.77 134.83 49.51 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.748 179.591 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.535 ' SG ' HD21 ' A' ' 48' ' ' LEU . 25.7 p -158.39 175.83 13.22 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.021 0.439 . . . . 0.0 110.259 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.589 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 2.8 tmt_? -110.92 98.79 39.99 Favored Pre-proline 0 C--N 1.316 -0.881 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 178.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.65 ' O ' ' HB3' ' A' ' 83' ' ' ARG . 61.2 Cg_endo -71.18 124.98 10.96 Favored 'Trans proline' 0 CA--C 1.512 -0.604 0 C-N-CA 123.301 2.667 . . . . 0.0 111.468 179.612 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.691 ' HA ' ' HB2' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -120.63 138.47 53.9 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.942 179.56 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.715 HG22 ' O ' ' A' ' 82' ' ' PHE . 14.8 t -72.62 132.66 44.04 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.364 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.7 p -74.87 -10.0 13.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.84 -179.087 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -67.44 -29.51 69.0 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.233 179.608 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.596 ' HA3' ' CE2' ' A' ' 82' ' ' PHE . . . -146.49 -23.33 0.1 Allowed Glycine 0 C--O 1.228 -0.232 0 C-N-CA 120.342 -0.932 . . . . 0.0 113.676 -179.202 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.68 ' HA2' ' HE3' ' A' ' 76' ' ' LYS . . . 97.76 12.11 48.18 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.302 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.715 ' O ' HG22 ' A' ' 77' ' ' THR . 29.6 p90 -111.91 158.64 19.23 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 118.419 -0.8 . . . . 0.0 109.793 -178.799 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.691 ' HB2' ' HA ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 162.62 -158.94 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.588 0 O-C-N 123.956 0.785 . . . . 0.0 111.731 179.514 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -120.02 -171.09 2.08 Favored 'General case' 0 C--O 1.225 -0.189 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.625 -178.684 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.589 ' HA ' ' HA ' ' A' ' 74' ' ' ARG . 30.6 ttt180 -109.58 155.6 21.22 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 177.534 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -169.1 162.06 10.69 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 120.407 -0.517 . . . . 0.0 112.265 -179.085 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -123.74 157.19 18.12 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 121.221 -0.514 . . . . 0.0 112.062 179.438 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.474 ' HB ' ' HB3' ' A' ' 48' ' ' LEU . 15.1 tt -131.43 143.82 39.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.027 0.441 . . . . 0.0 110.246 179.738 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.525 ' OD1' ' HB2' ' A' ' 91' ' ' ASN . 17.3 t70 -82.74 131.89 35.19 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.265 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.649 HD11 ' HB2' ' A' ' 71' ' ' LEU . 56.1 mt -105.34 34.15 3.37 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 112.943 0.719 . . . . 0.0 112.943 -177.916 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.623 ' HA ' ' HB3' ' A' ' 2' ' ' SER . 3.8 m120 -74.72 3.69 7.53 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 121.096 0.474 . . . . 0.0 111.464 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.43 ' HD3' ' CD2' ' A' ' 50' ' ' TRP . 32.3 mtp180 -92.86 -11.14 34.3 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.493 178.678 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.509 HG13 HD22 ' A' ' 37' ' ' LEU . 19.9 mm -99.59 106.46 19.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -179.653 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 19.9 tp60 -117.4 140.24 49.83 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.085 0.469 . . . . 0.0 111.269 -178.508 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.619 ' OD1' ' HA ' ' A' ' 3' ' ' TYR . 16.5 p-10 -95.14 101.28 13.02 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.399 0.619 . . . . 0.0 109.808 177.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.2 p -91.42 114.39 28.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 121.439 0.638 . . . . 0.0 110.424 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 61.24 29.75 18.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.57 -179.61 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 91.08 -10.82 73.96 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.038 -179.195 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.417 ' HD2' ' N ' ' A' ' 99' ' ' ARG . 9.6 mpt_? -92.11 123.54 35.54 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.684 0.278 . . . . 0.0 110.327 -179.33 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.561 HD13 ' SG ' ' A' ' 23' ' ' CYS . 5.5 tp -78.71 114.56 17.74 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 -179.537 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 53.4 t -132.14 140.98 46.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.189 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.722 ' HB2' HD11 ' A' ' 35' ' ' LEU . 8.3 t80 -83.06 133.75 35.06 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.137 179.327 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 35.3 tp60 . . . . . 0 C--O 1.248 1.008 0 CA-C-O 118.764 -0.636 . . . . 0.0 109.956 179.994 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.2 mpp? . . . . . 0 N--CA 1.483 1.217 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.683 ' OG ' ' HA ' ' A' ' 91' ' ' ASN . 12.3 m -117.21 179.22 4.1 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.616 -0.265 . . . . 0.0 110.903 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.424 ' CZ ' HD13 ' A' ' 19' ' ' LEU . 22.8 p90 -58.21 -36.92 73.84 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.257 179.652 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -56.68 -21.04 24.76 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -178.399 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -73.55 -9.74 58.99 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 120.991 0.424 . . . . 0.0 111.006 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 51.0 m -148.07 29.23 0.9 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.317 0.58 . . . . 0.0 109.529 178.695 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 36.7 m -143.29 164.48 30.1 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.576 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 2.3 ptm180 -148.57 165.97 29.66 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.327 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 57.83 57.29 4.26 Favored 'General case' 0 N--CA 1.462 0.174 0 O-C-N 123.647 0.592 . . . . 0.0 111.46 178.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.421 ' HA ' ' HB2' ' A' ' 21' ' ' ALA . . . -88.93 125.91 35.17 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.934 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 23.0 m -129.05 174.19 12.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.4 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.671 HD21 ' HG ' ' A' ' 64' ' ' LEU . 3.5 mm? -106.0 114.42 28.55 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.945 -179.743 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 28.3 p -111.54 171.24 7.6 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.126 -179.43 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 56.67 40.27 29.33 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.608 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 90.02 -20.43 36.39 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.677 179.322 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.629 ' HA2' ' HB3' ' A' ' 12' ' ' LEU . . . 121.73 34.92 0.82 Allowed Glycine 0 N--CA 1.443 -0.84 0 C-N-CA 120.926 -0.654 . . . . 0.0 111.727 -179.732 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.563 ' HB2' ' HB3' ' A' ' 38' ' ' ASP . 11.9 ptt180 -124.34 -15.41 6.7 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.218 0.533 . . . . 0.0 110.477 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.428 ' CG2' ' HB3' ' A' ' 34' ' ' GLU . 11.4 m -114.18 138.67 50.15 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.231 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.698 HD11 HD13 ' A' ' 90' ' ' LEU . 56.8 mt -95.17 113.71 25.43 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.93 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.516 ' HD3' HG23 ' A' ' 32' ' ' THR . 4.5 tmm_? -107.94 119.46 39.53 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 178.629 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.421 ' HB2' ' HA ' ' A' ' 10' ' ' ALA . . . -153.71 167.23 30.31 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.95 0.405 . . . . 0.0 111.401 -179.158 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -89.52 105.96 18.14 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 178.064 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.529 ' SG ' HD13 ' A' ' 100' ' ' LEU . 22.5 m -96.82 133.27 41.63 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.565 -0.288 . . . . 0.0 110.584 -177.824 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 16.7 ttp180 -76.4 116.63 17.27 Favored 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 179.111 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.403 HD21 ' HB3' ' A' ' 29' ' ' ASN . 36.1 p30 -81.75 165.01 21.31 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 179.69 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.14 -15.68 15.76 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -177.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -87.49 -6.22 58.47 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.745 0.783 . . . . 0.0 109.974 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 83.41 37.76 11.82 Favored Glycine 0 N--CA 1.448 -0.561 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.677 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.403 ' HB3' HD21 ' A' ' 25' ' ' ASN . 9.8 t-20 -124.5 161.25 26.51 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 110.353 -0.24 . . . . 0.0 110.353 -179.329 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 72.8 m95 -98.56 120.87 39.72 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.72 179.662 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.6 m -124.67 134.87 65.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.979 179.208 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.516 HG23 ' HD3' ' A' ' 20' ' ' ARG . 46.1 m -75.76 109.38 9.31 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.756 179.066 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 55.4 m -122.83 153.51 39.48 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.755 -179.651 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.638 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 44.0 mt-10 -135.52 139.17 43.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.117 -179.483 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.701 HD11 ' HB2' ' A' ' 102' ' ' PHE . 2.5 tm? -131.71 131.95 43.5 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 179.049 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.478 ' O ' HG22 ' A' ' 39' ' ' THR . 38.8 m-20 -84.8 110.52 18.87 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.973 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.603 HD13 HD22 ' A' ' 90' ' ' LEU . 5.2 mt -81.2 -27.44 35.32 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.663 0.268 . . . . 0.0 111.385 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.563 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 4.6 p-10 -65.65 -5.79 9.42 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.292 0.479 . . . . 0.0 112.292 -177.818 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.478 HG22 ' O ' ' A' ' 36' ' ' ASP . 14.0 t -78.75 -10.15 59.67 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 110.274 -0.269 . . . . 0.0 110.274 178.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 40.2 t -141.53 3.84 1.72 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.463 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.407 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 56.9 mt -113.88 132.58 62.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 O-C-N 121.95 -0.468 . . . . 0.0 110.621 179.327 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.486 ' HA3' ' HB3' ' A' ' 52' ' ' MET . . . -146.47 155.48 26.55 Favored Glycine 0 N--CA 1.447 -0.568 0 N-CA-C 111.408 -0.677 . . . . 0.0 111.408 179.278 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.437 ' OD1' ' HB2' ' A' ' 55' ' ' PHE . 4.3 p-10 -153.3 45.16 0.27 Allowed Pre-proline 0 CA--C 1.541 0.626 0 N-CA-C 113.515 0.932 . . . . 0.0 113.515 -179.046 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.437 ' HG3' ' SD ' ' A' ' 52' ' ' MET . 57.5 Cg_endo -68.96 -20.38 38.77 Favored 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 121.522 1.481 . . . . 0.0 111.315 -179.535 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -81.07 -16.46 53.11 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.814 179.264 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 103.44 6.11 44.87 Favored Glycine 0 N--CA 1.443 -0.835 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.7 -178.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.428 ' HD1' HE22 ' A' ' 86' ' ' GLN . 67.4 m-85 -122.26 135.04 54.68 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.826 0.346 . . . . 0.0 110.389 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.623 HD12 ' HG3' ' A' ' 86' ' ' GLN . 94.2 mt -83.53 130.96 35.02 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.8 -178.771 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -174.64 172.47 45.44 Favored Glycine 0 N--CA 1.441 -0.98 0 C-N-CA 120.699 -0.762 . . . . 0.0 111.807 179.189 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.478 ' HH2' HD11 ' A' ' 93' ' ' ILE . 81.5 m95 -94.36 125.93 39.3 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 179.68 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 170.66 -58.33 0.18 Allowed Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.516 -179.394 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.486 ' HB3' ' HA3' ' A' ' 42' ' ' GLY . 11.0 ttp -95.0 -153.12 0.38 Allowed 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -146.54 170.5 16.77 Favored 'General case' 0 C--N 1.33 -0.25 0 O-C-N 122.184 -0.322 . . . . 0.0 111.336 -179.273 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 8.4 m120 62.29 41.84 9.91 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 113.153 0.797 . . . . 0.0 113.153 178.537 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.437 ' HB2' ' OD1' ' A' ' 43' ' ' ASN . 8.8 p90 -63.23 -26.77 68.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.13 0.49 . . . . 0.0 110.464 179.113 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.556 ' HB2' ' HB3' ' A' ' 17' ' ' ARG . 32.3 t -62.69 -32.6 73.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.499 -179.253 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 30.0 m80 -82.61 -4.07 57.13 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.846 0.355 . . . . 0.0 111.084 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 24.1 m -125.36 16.13 8.31 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.484 179.401 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 65.1 m -137.58 149.17 46.48 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.133 0.492 . . . . 0.0 111.041 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -128.95 158.12 39.7 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.469 179.54 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.522 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 36.5 t70 57.22 67.69 0.95 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.477 0.656 . . . . 0.0 110.405 179.226 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.536 HG23 HD21 ' A' ' 71' ' ' LEU . 71.6 mt -95.21 114.06 30.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.147 -178.888 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.8 tptm -145.33 143.91 30.42 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.317 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.671 ' HG ' HD21 ' A' ' 12' ' ' LEU . 79.2 mt -82.3 120.82 25.89 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.803 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -72.71 -56.35 5.41 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.778 -179.202 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.46 ' HB2' ' HB2' ' A' ' 69' ' ' ARG . 29.4 mt-10 -82.72 4.22 25.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.954 0.407 . . . . 0.0 110.64 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 81.19 13.78 80.19 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.293 -179.594 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.43 ' HA2' HD13 ' A' ' 64' ' ' LEU . . . 155.34 -31.51 0.64 Allowed Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 119.916 -1.135 . . . . 0.0 113.299 179.377 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.547 ' HD3' ' HB2' ' A' ' 2' ' ' SER . 7.2 mmt85 -78.11 -33.15 50.72 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.022 0.439 . . . . 0.0 111.647 -179.47 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 28.6 tptt -131.65 135.23 46.75 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.437 -178.401 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.715 ' HB2' HD11 ' A' ' 90' ' ' LEU . 10.0 tt -110.68 124.5 52.05 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -112.2 128.14 56.15 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 120.972 0.415 . . . . 0.0 111.143 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.522 ' HA ' ' O ' ' A' ' 61' ' ' ASP . 24.5 p -155.0 166.21 34.29 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 179.53 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.545 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 29.3 ttt180 -101.29 100.61 14.0 Favored Pre-proline 0 C--N 1.314 -0.946 0 CA-C-O 120.797 0.332 . . . . 0.0 110.556 179.56 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.644 ' O ' ' HB3' ' A' ' 83' ' ' ARG . 46.0 Cg_endo -69.7 120.88 7.6 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 122.48 2.12 . . . . 0.0 109.897 178.159 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.999 ' HE3' ' HA2' ' A' ' 81' ' ' GLY . 0.0 OUTLIER -115.7 143.69 45.01 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.008 0.433 . . . . 0.0 110.884 -179.348 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.661 HG22 ' O ' ' A' ' 82' ' ' PHE . 13.1 t -78.49 142.0 37.79 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 179.505 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 28.9 m -70.59 -8.56 11.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 O-C-N 124.046 0.841 . . . . 0.0 112.002 -179.335 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -59.67 -35.11 73.8 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.046 0.45 . . . . 0.0 110.173 179.15 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.409 ' H ' ' H ' ' A' ' 81' ' ' GLY . . . -164.52 -13.08 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.56 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.611 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.999 ' HA2' ' HE3' ' A' ' 76' ' ' LYS . . . 99.73 23.0 11.29 Favored Glycine 0 N--CA 1.442 -0.961 0 C-N-CA 120.484 -0.865 . . . . 0.0 112.064 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.661 ' O ' HG22 ' A' ' 77' ' ' THR . 30.5 p90 -110.47 144.85 38.66 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 -178.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.659 ' HB2' ' HA ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 172.34 -151.82 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 O-C-N 123.645 0.591 . . . . 0.0 110.724 -179.676 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 23.9 mm-40 -122.41 176.56 5.82 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.09 -177.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.545 ' HA ' ' HA ' ' A' ' 74' ' ' ARG . 39.2 ttt-85 -112.74 151.01 30.77 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 177.836 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.623 ' HG3' HD12 ' A' ' 48' ' ' LEU . 10.4 pt20 -166.52 -172.37 2.16 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.86 0.362 . . . . 0.0 111.472 -179.263 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -135.22 152.48 20.84 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.462 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.4 HD13 HD13 ' A' ' 41' ' ' ILE . 13.4 tt -122.81 149.94 26.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -86.61 124.79 33.29 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.77 0.319 . . . . 0.0 111.104 -179.069 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.715 HD11 ' HB2' ' A' ' 71' ' ' LEU . 44.3 mt -97.88 34.43 1.9 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.644 0.735 . . . . 0.0 110.134 179.254 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.683 ' HA ' ' OG ' ' A' ' 2' ' ' SER . 5.0 m-20 -75.17 2.03 11.87 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 114.806 -1.088 . . . . 0.0 110.704 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 18.8 mtp180 -98.52 1.21 46.37 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.256 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.507 HD12 HD12 ' A' ' 35' ' ' LEU . 22.1 mm -105.65 112.96 41.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.144 0.497 . . . . 0.0 109.885 -179.228 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.4 mm100 -117.69 145.56 44.33 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.996 -178.27 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -97.41 102.32 14.06 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.548 178.051 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 46.7 t -92.13 106.56 17.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.835 -178.845 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 61.08 25.29 15.32 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.161 179.469 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 106.0 -23.4 29.28 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.533 -0.842 . . . . 0.0 112.751 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.12 132.49 34.3 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.902 0.351 . . . . 0.0 110.062 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.529 HD13 ' SG ' ' A' ' 23' ' ' CYS . 7.9 tp -82.54 114.69 21.12 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 -179.474 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 5.5 t -125.93 146.41 31.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 120.937 0.399 . . . . 0.0 111.155 -178.518 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.701 ' HB2' HD11 ' A' ' 35' ' ' LEU . 18.6 t80 -79.8 138.22 37.18 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 178.314 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 . . . . . 0 C--N 1.316 -0.852 0 CA-C-O 118.81 -0.614 . . . . 0.0 110.427 -179.198 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 mpt? . . . . . 0 N--CA 1.482 1.13 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.549 ' HB3' ' HA ' ' A' ' 91' ' ' ASN . 0.5 OUTLIER -103.81 178.41 4.57 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.563 -0.289 . . . . 0.0 111.548 179.676 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.51 ' HA ' ' OD1' ' A' ' 95' ' ' ASN . 11.8 p90 -48.73 -36.65 16.81 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -179.348 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.479 ' HB3' ' HD3' ' A' ' 69' ' ' ARG . . . -54.9 -19.32 6.37 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 -178.253 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -57.9 -39.19 77.3 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.237 0.541 . . . . 0.0 110.262 178.751 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.41 ' HB2' HD21 ' A' ' 95' ' ' ASN . 24.4 m -129.55 39.51 3.72 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.536 -0.757 . . . . 0.0 109.479 179.285 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.424 ' HB3' ' HA ' ' A' ' 4' ' ' ALA . 8.6 t -141.27 149.71 41.66 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.864 -179.603 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.407 HH11 ' HD2' ' A' ' 8' ' ' ARG . 10.6 ptm85 -138.16 158.55 44.08 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.633 -179.607 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 62.47 52.81 2.86 Favored 'General case' 0 N--CA 1.463 0.207 0 O-C-N 123.914 0.759 . . . . 0.0 111.374 179.035 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.507 ' HA ' ' HB2' ' A' ' 21' ' ' ALA . . . -82.25 117.58 22.46 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.239 179.69 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 36.0 m -124.18 169.17 15.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.05 -179.51 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.524 HD21 ' HG ' ' A' ' 64' ' ' LEU . 3.1 mm? -104.85 120.5 41.56 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.99 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 23.3 p -114.48 167.12 11.01 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 120.862 0.363 . . . . 0.0 111.277 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 64.03 31.4 13.59 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.402 179.383 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 92.36 -21.78 36.13 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.855 -0.688 . . . . 0.0 113.106 179.261 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.413 ' HA2' ' HB3' ' A' ' 12' ' ' LEU . . . 129.27 56.22 0.1 Allowed Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.775 -0.726 . . . . 0.0 111.407 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.411 ' HB3' ' OG ' ' A' ' 56' ' ' SER . 2.4 ptm180 -143.13 -32.25 0.47 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.983 0.42 . . . . 0.0 111.077 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.437 ' CG2' ' HB3' ' A' ' 34' ' ' GLU . 2.8 m -103.11 135.25 45.14 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.952 -179.553 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.654 HD11 HD13 ' A' ' 90' ' ' LEU . 62.5 mt -94.29 113.13 24.98 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.118 178.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.421 ' HE ' ' CD ' ' A' ' 34' ' ' GLU . 40.5 ttm180 -109.68 120.43 42.45 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 178.751 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.507 ' HB2' ' HA ' ' A' ' 10' ' ' ALA . . . -153.38 166.57 32.22 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.852 0.358 . . . . 0.0 111.048 -179.844 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -90.98 112.14 23.9 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 178.349 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.485 ' SG ' HD13 ' A' ' 100' ' ' LEU . 65.2 m -101.32 130.49 47.49 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.747 0.308 . . . . 0.0 110.816 -178.835 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.5 ttt180 -83.77 109.88 17.88 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 35.1 p30 -77.82 167.71 21.09 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.329 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -50.91 -33.07 22.68 Favored 'General case' 0 C--N 1.329 -0.292 0 O-C-N 123.674 0.609 . . . . 0.0 112.356 -179.137 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -67.24 -16.22 64.16 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.204 0.526 . . . . 0.0 110.825 -179.181 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 91.24 25.51 23.82 Favored Glycine 0 N--CA 1.446 -0.638 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.671 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -115.1 151.78 33.7 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.617 0.246 . . . . 0.0 111.074 -179.325 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -92.05 115.01 27.7 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.102 0.477 . . . . 0.0 110.911 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 5.0 m -113.38 132.79 61.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.561 179.106 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 53.2 m -79.58 110.19 14.68 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.037 0.446 . . . . 0.0 110.542 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 73.6 m -120.95 148.85 43.52 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.815 -179.697 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.566 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 46.3 mt-10 -130.92 138.55 49.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.832 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.565 HD11 ' HB2' ' A' ' 102' ' ' PHE . 1.9 tm? -132.38 130.2 40.37 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 179.026 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.412 ' N ' HD13 ' A' ' 35' ' ' LEU . 23.9 m-20 -88.86 109.58 20.33 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.969 0.414 . . . . 0.0 110.332 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.495 HD11 HD11 ' A' ' 19' ' ' LEU . 1.6 mt -84.67 -11.49 55.8 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.742 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -66.76 -6.0 14.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.156 -179.621 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 72.1 p -88.96 -13.09 39.75 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.018 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.537 ' SG ' ' HZ3' ' A' ' 50' ' ' TRP . 0.8 OUTLIER -136.05 -9.61 2.03 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -178.432 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.427 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 51.3 mt -107.16 132.17 55.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 O-C-N 122.241 -0.287 . . . . 0.0 110.455 178.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.528 ' HA3' ' HB3' ' A' ' 52' ' ' MET . . . -151.97 162.01 29.56 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.199 179.591 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.511 ' OD1' ' HB2' ' A' ' 55' ' ' PHE . 2.3 p-10 -159.4 57.98 1.13 Allowed Pre-proline 0 CA--C 1.535 0.382 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -72.39 -15.36 28.03 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.059 1.839 . . . . 0.0 112.374 -179.337 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 53.5 m-80 -100.26 -5.12 28.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.953 0.406 . . . . 0.0 110.466 179.675 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.527 ' HA3' ' HG2' ' A' ' 83' ' ' ARG . . . 98.99 9.48 51.95 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.41 -179.658 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -123.46 133.1 54.09 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.928 0.394 . . . . 0.0 110.852 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.5 ' HB3' ' HB ' ' A' ' 88' ' ' ILE . 79.0 mt -83.49 139.82 32.68 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.406 -178.775 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 178.33 172.58 42.88 Favored Glycine 0 N--CA 1.44 -1.095 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.437 179.005 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.537 ' HZ3' ' SG ' ' A' ' 40' ' ' CYS . 93.0 m95 -94.82 125.03 39.21 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 158.76 -63.94 0.3 Allowed Glycine 0 N--CA 1.45 -0.416 0 N-CA-C 111.588 -0.605 . . . . 0.0 111.588 -179.354 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.528 ' HB3' ' HA3' ' A' ' 42' ' ' GLY . 13.1 tpt -78.31 173.82 11.89 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.627 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -129.55 172.39 11.62 Favored 'General case' 0 C--N 1.322 -0.599 0 O-C-N 122.159 -0.338 . . . . 0.0 111.399 -179.275 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 6.9 m120 61.07 48.81 6.11 Favored 'General case' 0 C--O 1.233 0.187 0 O-C-N 123.982 0.801 . . . . 0.0 111.967 179.427 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.511 ' HB2' ' OD1' ' A' ' 43' ' ' ASN . 18.8 p90 -67.91 -28.51 67.56 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.628 -179.502 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.411 ' OG ' ' HB3' ' A' ' 17' ' ' ARG . 3.1 m -63.47 -28.38 69.93 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.873 0.368 . . . . 0.0 111.125 -179.312 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 26.4 m80 -79.99 -9.04 59.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.001 0.429 . . . . 0.0 111.013 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 47.5 p -125.58 15.31 8.18 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.064 0.459 . . . . 0.0 110.659 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 68.2 m -133.61 150.5 51.6 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.302 0.572 . . . . 0.0 111.052 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 57.2 mt-10 -125.68 142.3 51.58 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.412 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.433 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 21.4 t70 60.01 78.41 0.27 Allowed 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 121.402 0.62 . . . . 0.0 110.367 -179.708 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.541 HG23 HD21 ' A' ' 71' ' ' LEU . 73.2 mt -101.73 115.47 43.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.36 -178.775 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 36.6 ttmt -148.96 156.99 43.08 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 179.576 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.524 ' HG ' HD21 ' A' ' 12' ' ' LEU . 42.5 mt -83.2 135.93 34.6 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.161 0.505 . . . . 0.0 110.947 -179.448 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 18.7 tp10 -90.23 -57.29 2.9 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.934 -178.804 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.494 ' HB2' ' HB2' ' A' ' 69' ' ' ARG . 20.5 mm-40 -84.15 24.11 0.98 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.158 0.504 . . . . 0.0 111.1 -179.336 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 68.24 16.72 69.36 Favored Glycine 0 N--CA 1.45 -0.39 0 CA-C-N 115.429 -0.805 . . . . 0.0 112.435 179.656 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 141.24 -28.12 2.37 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.013 -1.089 . . . . 0.0 112.806 179.556 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.494 ' HB2' ' HB2' ' A' ' 66' ' ' GLU . 12.6 mmt180 -73.07 -25.34 60.87 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.057 0.456 . . . . 0.0 110.582 -179.407 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.436 ' HG3' ' HA ' ' A' ' 89' ' ' ASP . 36.6 ttpt -146.48 142.72 28.37 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.888 -178.185 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.677 ' HB2' HD11 ' A' ' 90' ' ' LEU . 8.9 tt -111.63 131.75 55.05 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.738 -0.468 . . . . 0.0 109.738 179.574 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.3 p -115.26 130.57 56.95 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.233 0.54 . . . . 0.0 111.066 179.604 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.433 ' HA ' ' O ' ' A' ' 61' ' ' ASP . 26.7 p -153.28 165.15 36.62 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.333 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.49 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 3.3 tmt_? -102.12 99.35 12.25 Favored Pre-proline 0 C--N 1.314 -0.958 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.418 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.67 ' O ' ' HB3' ' A' ' 83' ' ' ARG . 61.7 Cg_endo -70.09 123.14 9.71 Favored 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 122.801 2.334 . . . . 0.0 111.443 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.924 ' HE3' ' HA2' ' A' ' 81' ' ' GLY . 0.0 OUTLIER -119.67 144.21 47.31 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.76 -179.793 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.685 HG22 ' O ' ' A' ' 82' ' ' PHE . 14.6 t -76.92 140.78 40.63 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.547 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 8.9 p -73.8 -9.44 12.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.452 -0.794 . . . . 0.0 111.288 -179.042 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -64.2 -23.12 67.2 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.054 0.454 . . . . 0.0 110.872 179.342 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -166.26 -21.84 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.51 -0.852 . . . . 0.0 112.908 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.924 ' HA2' ' HE3' ' A' ' 76' ' ' LYS . . . 101.75 20.87 11.99 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.773 -0.727 . . . . 0.0 111.893 -179.544 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.685 ' O ' HG22 ' A' ' 77' ' ' THR . 22.2 p90 -111.15 147.7 34.35 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 119.031 -0.509 . . . . 0.0 109.766 -178.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.723 ' HB2' ' HA ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 169.26 -154.94 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.361 0 O-C-N 123.592 0.558 . . . . 0.0 111.315 179.716 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -117.62 -175.76 2.89 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.368 -178.261 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.544 ' HA ' ' HD2' ' A' ' 75' ' ' PRO . 31.6 ttt180 -110.59 155.68 22.01 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 177.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.534 ' HG2' ' H ' ' A' ' 87' ' ' GLY . 50.7 tt0 -165.17 176.69 8.25 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 120.512 -0.475 . . . . 0.0 111.712 -178.178 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.534 ' H ' ' HG2' ' A' ' 86' ' ' GLN . . . -137.91 140.83 11.54 Favored Glycine 0 N--CA 1.449 -0.466 0 N-CA-C 111.42 -0.672 . . . . 0.0 111.42 178.637 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.5 ' HB ' ' HB3' ' A' ' 48' ' ' LEU . 11.4 tt -118.44 133.84 63.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.371 0.605 . . . . 0.0 110.707 -179.619 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.457 ' OD1' ' HB2' ' A' ' 91' ' ' ASN . 14.5 t70 -74.79 136.48 41.66 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.809 -179.614 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.677 HD11 ' HB2' ' A' ' 71' ' ' LEU . 64.2 mt -110.77 37.34 2.81 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 -178.28 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.549 ' HA ' ' HB3' ' A' ' 2' ' ' SER . 6.4 m-80 -73.92 -1.87 21.49 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-O 121.194 0.521 . . . . 0.0 111.037 179.373 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 21.0 mtp180 -88.11 -10.88 48.65 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.174 179.07 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.442 ' CD1' HD22 ' A' ' 37' ' ' LEU . 22.7 mm -99.15 98.59 7.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -179.383 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -107.68 152.21 24.62 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.743 -178.017 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.51 ' OD1' ' HA ' ' A' ' 3' ' ' TYR . 19.4 p-10 -106.82 105.54 15.63 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.106 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.2 p -98.42 113.85 34.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-O 121.286 0.565 . . . . 0.0 110.177 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 59.44 30.22 19.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.814 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 92.97 -13.54 67.41 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 121.005 -0.617 . . . . 0.0 113.276 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.401 HH11 ' HD3' ' A' ' 99' ' ' ARG . 3.0 mpt_? -92.25 131.03 37.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 117.405 0.603 . . . . 0.0 110.257 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.485 HD13 ' SG ' ' A' ' 23' ' ' CYS . 3.2 tp -84.16 115.54 22.46 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.08 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 46.5 t -129.98 142.66 43.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.333 -179.594 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.565 ' HB2' HD11 ' A' ' 35' ' ' LEU . 5.5 t80 -84.2 122.81 29.37 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.236 0.541 . . . . 0.0 110.089 178.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 . . . . . 0 C--N 1.312 -1.034 0 CA-C-O 118.193 -0.908 . . . . 0.0 110.408 179.737 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 mpt? . . . . . 0 N--CA 1.48 1.042 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.495 ' OG ' ' HA ' ' A' ' 91' ' ' ASN . 19.5 m -117.23 169.75 9.22 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 121.065 -0.254 . . . . 0.0 111.128 179.715 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.536 ' HA ' ' OD1' ' A' ' 95' ' ' ASN . 28.6 p90 -55.51 -34.09 64.33 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.724 179.742 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -54.46 -18.74 4.59 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -178.811 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -57.34 -41.71 80.53 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.151 0.501 . . . . 0.0 110.426 179.018 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.426 ' HB2' HD21 ' A' ' 95' ' ' ASN . 50.0 m -130.48 35.66 4.02 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.093 179.52 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.4 ' HA ' ' HZ3' ' A' ' 30' ' ' TRP . 15.0 m -143.18 156.33 44.74 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.12 179.55 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.425 HH11 ' HD2' ' A' ' 8' ' ' ARG . 10.8 ptm85 -144.35 167.95 21.25 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.751 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 57.24 59.76 3.23 Favored 'General case' 0 C--O 1.235 0.337 0 O-C-N 123.736 0.648 . . . . 0.0 111.715 179.345 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.445 ' HA ' ' HB2' ' A' ' 21' ' ' ALA . . . -89.88 117.53 28.78 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.192 179.606 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 31.9 m -120.53 173.11 6.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.748 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.52 HD21 ' HG ' ' A' ' 64' ' ' LEU . 3.6 mm? -104.64 114.99 29.57 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.765 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.413 ' OG1' ' HB ' ' A' ' 18' ' ' THR . 21.0 p -108.53 164.65 12.16 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.479 179.786 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 62.16 43.67 8.45 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.412 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 87.73 -46.19 3.43 Favored Glycine 0 N--CA 1.449 -0.448 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.745 179.06 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 150.55 57.77 0.01 OUTLIER Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 110.404 -1.078 . . . . 0.0 110.404 -179.135 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.445 ' HB2' ' HB3' ' A' ' 38' ' ' ASP . 7.9 ptm180 -142.91 -30.37 0.53 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.947 0.403 . . . . 0.0 111.086 -179.024 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.453 ' CG2' ' HB3' ' A' ' 34' ' ' GLU . 3.0 m -103.92 137.95 41.18 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.189 -178.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.727 HD11 HD13 ' A' ' 90' ' ' LEU . 58.3 mt -98.17 115.86 29.19 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.171 178.585 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 45.3 ttp180 -112.67 123.0 49.31 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 178.854 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.445 ' HB2' ' HA ' ' A' ' 10' ' ' ALA . . . -151.77 167.2 28.98 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.928 0.394 . . . . 0.0 111.408 -179.307 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -90.08 105.98 18.18 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 178.058 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 80.2 m -99.3 127.18 45.28 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.636 -178.557 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 9.4 ttp180 -77.42 115.09 16.9 Favored 'General case' 0 N--CA 1.436 -1.144 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.887 179.325 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 36.7 p30 -76.54 165.72 24.4 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.22 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.07 -27.75 54.83 Favored 'General case' 0 N--CA 1.464 0.235 0 O-C-N 123.61 0.569 . . . . 0.0 111.993 -179.113 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -69.26 -19.39 63.93 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.296 0.57 . . . . 0.0 110.327 179.433 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 96.11 30.25 7.98 Favored Glycine 0 N--CA 1.449 -0.488 0 CA-C-N 115.536 -0.756 . . . . 0.0 112.244 179.661 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -124.91 150.43 46.54 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.514 0.157 . . . . 0.0 110.773 -179.095 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.4 ' HZ3' ' HA ' ' A' ' 7' ' ' SER . 94.1 m95 -84.88 123.1 30.09 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.755 0.312 . . . . 0.0 111.391 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.0 m -124.77 134.72 66.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 121.089 0.471 . . . . 0.0 110.593 178.29 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 16.2 m -79.5 116.33 19.65 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.816 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 72.4 m -126.73 159.53 33.45 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.372 179.723 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.623 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 46.3 mt-10 -139.1 145.9 40.06 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-O 120.867 0.365 . . . . 0.0 111.444 -178.778 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.622 HD11 ' HB2' ' A' ' 102' ' ' PHE . 1.5 tm? -138.81 132.29 30.36 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.054 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.477 ' N ' HD13 ' A' ' 35' ' ' LEU . 27.3 m-20 -90.98 110.59 21.85 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.025 0.441 . . . . 0.0 110.391 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.524 HD11 HD11 ' A' ' 19' ' ' LEU . 1.5 mt -86.1 -16.66 37.31 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.572 -179.826 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.453 ' HA ' ' HD1' ' A' ' 55' ' ' PHE . 4.4 p-10 -63.65 -20.39 65.65 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -178.021 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.417 HG23 ' SG ' ' A' ' 40' ' ' CYS . 12.3 t -83.23 0.62 44.65 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.121 0.486 . . . . 0.0 110.87 -179.83 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.417 ' SG ' HG23 ' A' ' 39' ' ' THR . 57.6 m -136.32 -26.44 1.13 Allowed 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -179.571 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.47 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 61.7 mt -94.49 137.21 23.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 110.204 -0.295 . . . . 0.0 110.204 179.405 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.593 ' HA3' ' HB3' ' A' ' 52' ' ' MET . . . -153.72 156.2 26.64 Favored Glycine 0 N--CA 1.443 -0.885 0 C-N-CA 120.685 -0.769 . . . . 0.0 111.617 179.401 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.461 ' HB3' HD23 ' A' ' 48' ' ' LEU . 2.9 p-10 -154.24 50.68 0.57 Allowed Pre-proline 0 C--N 1.326 -0.446 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.26 -18.93 39.12 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 121.712 1.608 . . . . 0.0 111.868 -179.633 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 6.9 m-20 -90.77 -5.74 55.28 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.316 179.614 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.57 ' HA3' ' HG2' ' A' ' 83' ' ' ARG . . . 95.95 8.57 57.92 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.407 -179.485 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -125.28 135.89 52.97 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.764 0.316 . . . . 0.0 110.314 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.469 ' HB3' ' HB ' ' A' ' 88' ' ' ILE . 72.7 mt -83.29 137.24 34.07 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.325 -178.601 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 179.11 171.74 42.61 Favored Glycine 0 N--CA 1.445 -0.717 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.832 179.388 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.459 ' CD2' ' HD3' ' A' ' 92' ' ' ARG . 83.4 m95 -95.35 125.46 39.99 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.624 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 161.24 -47.81 0.37 Allowed Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.309 -179.475 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.593 ' HB3' ' HA3' ' A' ' 42' ' ' GLY . 0.0 OUTLIER -90.41 -161.28 0.78 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.643 0.259 . . . . 0.0 110.836 -179.188 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 -146.82 168.98 20.07 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.685 -0.234 . . . . 0.0 110.444 -179.495 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 6.3 m120 56.77 45.74 21.2 Favored 'General case' 0 N--CA 1.465 0.32 0 O-C-N 123.796 0.685 . . . . 0.0 112.253 178.785 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.47 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 7.5 p90 -65.65 -28.64 69.25 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.902 -0.319 . . . . 0.0 110.793 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.56 ' HA ' HD11 ' A' ' 62' ' ' ILE . 13.8 m -58.13 -37.12 74.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.534 -179.62 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 17.8 m80 -73.18 -17.83 61.32 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.042 0.448 . . . . 0.0 111.446 179.68 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 47.9 m -112.89 14.9 19.86 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.497 -178.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 54.5 m -136.1 148.44 48.26 Favored 'General case' 0 C--N 1.32 -0.684 0 O-C-N 121.749 -0.595 . . . . 0.0 111.641 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 60.9 mm-40 -117.58 145.62 44.16 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.825 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 55.87 58.83 4.14 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 123.925 0.765 . . . . 0.0 111.687 178.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.56 HD11 ' HA ' ' A' ' 56' ' ' SER . 81.5 mt -75.95 113.6 15.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.512 179.767 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.411 ' HD2' HD23 ' A' ' 12' ' ' LEU . 15.2 tptm -147.74 154.84 41.05 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 -179.692 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.536 HD13 ' HA2' ' A' ' 68' ' ' GLY . 67.2 mt -82.41 138.9 34.3 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.314 0.578 . . . . 0.0 111.233 -179.161 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -89.17 -75.27 0.44 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 114.697 -1.138 . . . . 0.0 111.129 -178.492 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.604 ' HB2' ' HB2' ' A' ' 69' ' ' ARG . 19.7 mt-10 -77.87 45.53 0.52 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.754 -178.317 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 65.39 2.46 10.17 Favored Glycine 0 CA--C 1.518 0.255 0 CA-C-N 115.837 -0.619 . . . . 0.0 113.671 179.254 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.536 ' HA2' HD13 ' A' ' 64' ' ' LEU . . . 141.63 -13.81 2.69 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.081 -1.056 . . . . 0.0 112.985 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.604 ' HB2' ' HB2' ' A' ' 66' ' ' GLU . 14.3 mmt180 -78.27 -19.48 53.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.261 0.553 . . . . 0.0 109.825 179.746 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.461 ' HB3' ' HG3' ' A' ' 66' ' ' GLU . 40.7 tttt -144.46 143.54 30.93 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.596 -178.623 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.625 ' HB2' HD11 ' A' ' 90' ' ' LEU . 10.1 tt -110.5 132.81 53.86 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.753 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.9 p -121.0 132.42 54.89 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.03 0.443 . . . . 0.0 111.586 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.537 ' HB3' ' HA ' ' A' ' 62' ' ' ILE . 24.7 p -161.19 167.36 26.25 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.208 179.526 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.407 ' HA ' ' HD2' ' A' ' 75' ' ' PRO . 25.0 ttt180 -100.4 102.83 20.05 Favored Pre-proline 0 C--N 1.316 -0.85 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.343 179.012 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.645 ' O ' ' HB3' ' A' ' 83' ' ' ARG . 39.0 Cg_endo -67.06 121.01 8.13 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 122.539 2.159 . . . . 0.0 110.58 178.649 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.649 ' HA ' ' HB2' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -119.25 146.58 45.1 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.764 -179.354 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.707 ' HB ' ' HD2' ' A' ' 83' ' ' ARG . 5.6 t -79.67 144.94 33.27 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 179.527 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.2 p -72.03 -9.47 12.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.436 -177.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -58.63 -29.37 66.45 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.224 0.535 . . . . 0.0 110.231 179.206 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -169.81 -24.62 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.304 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.869 -179.674 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.617 ' HA2' ' HD3' ' A' ' 76' ' ' LYS . . . 111.98 26.05 4.54 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.848 -0.692 . . . . 0.0 111.718 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.564 ' O ' HG22 ' A' ' 77' ' ' THR . 20.3 p90 -110.3 141.09 43.78 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 -178.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.707 ' HD2' ' HB ' ' A' ' 77' ' ' THR . 0.0 OUTLIER 174.13 -149.48 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 O-C-N 123.654 0.596 . . . . 0.0 110.027 -179.791 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -121.55 176.15 5.84 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 122.271 0.228 . . . . 0.0 110.982 -178.397 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.416 ' HA ' ' HD2' ' A' ' 75' ' ' PRO . 42.0 ttt-85 -98.35 156.81 16.55 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 178.075 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.413 ' HG2' ' N ' ' A' ' 87' ' ' GLY . 49.4 tt0 -166.55 173.09 10.11 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 120.927 0.394 . . . . 0.0 111.524 -178.713 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.413 ' N ' ' HG2' ' A' ' 86' ' ' GLN . . . -135.8 144.42 16.23 Favored Glycine 0 N--CA 1.45 -0.388 0 N-CA-C 111.626 -0.589 . . . . 0.0 111.626 178.895 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.469 ' HB ' ' HB3' ' A' ' 48' ' ' LEU . 12.2 tt -121.57 134.67 64.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.093 0.473 . . . . 0.0 110.793 -179.439 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -77.73 136.76 38.2 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.113 -179.416 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.727 HD13 HD11 ' A' ' 19' ' ' LEU . 68.6 mt -108.38 56.48 0.63 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.735 0.778 . . . . 0.0 111.219 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.495 ' HA ' ' OG ' ' A' ' 2' ' ' SER . 8.1 m120 -91.09 3.19 55.42 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.686 179.478 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.459 ' HD3' ' CD2' ' A' ' 50' ' ' TRP . 36.9 mtp180 -96.77 -6.69 35.63 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.846 179.274 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.425 HD11 ' HH2' ' A' ' 50' ' ' TRP . 16.4 mm -105.47 101.64 12.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -179.525 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 27.8 tp60 -113.95 145.09 42.01 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.022 -178.152 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.536 ' OD1' ' HA ' ' A' ' 3' ' ' TYR . 19.2 p-10 -95.44 115.7 27.79 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.157 178.817 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 57.8 t -106.24 110.78 32.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.04 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 10.3 m120 58.48 28.8 17.45 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.995 -179.533 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 100.2 -23.55 35.48 Favored Glycine 0 N--CA 1.445 -0.748 0 C-N-CA 120.522 -0.847 . . . . 0.0 113.157 179.475 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.413 ' N ' ' HD2' ' A' ' 99' ' ' ARG . 3.3 mpt_? -86.95 138.18 31.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 117.242 0.521 . . . . 0.0 110.195 -179.367 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.463 HD23 ' HB2' ' A' ' 35' ' ' LEU . 4.9 tp -86.21 123.57 31.63 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 14.6 t -128.21 143.78 39.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.93 -179.027 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.622 ' HB2' HD11 ' A' ' 35' ' ' LEU . 9.9 t80 -92.66 128.3 38.47 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.161 0.505 . . . . 0.0 109.788 178.161 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 . . . . . 0 C--O 1.25 1.091 0 CA-C-O 118.181 -0.914 . . . . 0.0 110.651 179.742 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.7 mtt . . . . . 0 N--CA 1.481 1.12 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.436 ' OG ' ' HA ' ' A' ' 91' ' ' ASN . 19.9 m -116.99 167.13 11.41 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.781 178.75 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.448 ' HB3' HD11 ' A' ' 100' ' ' LEU . 13.4 p90 -48.43 -37.53 17.38 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.476 ' HB3' ' HD2' ' A' ' 69' ' ' ARG . . . -53.18 -19.1 2.71 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -178.892 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -56.63 -42.62 79.16 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 121.335 0.588 . . . . 0.0 110.149 178.682 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.418 ' HB2' HD21 ' A' ' 95' ' ' ASN . 18.5 m -129.78 40.47 3.57 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.481 179.654 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.406 ' HA ' ' HZ3' ' A' ' 30' ' ' TRP . 18.5 t -146.67 150.44 35.43 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.186 -179.501 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 9.3 ptp180 -136.87 175.29 9.74 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.279 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 47.06 46.86 16.17 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 124.254 0.971 . . . . 0.0 112.107 -179.38 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.604 ' HA ' ' HB2' ' A' ' 21' ' ' ALA . . . -74.01 118.44 16.96 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.619 179.59 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 27.4 m -122.14 168.28 14.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.842 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.754 HD21 ' HG ' ' A' ' 64' ' ' LEU . 3.3 mm? -104.75 123.02 46.92 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.634 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.479 HG21 ' CZ ' ' A' ' 20' ' ' ARG . 20.6 p -123.19 168.71 12.07 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.811 0.338 . . . . 0.0 111.81 -178.865 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 59.94 42.75 15.7 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.003 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 92.17 -23.02 29.05 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.812 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.627 ' HA2' ' HB3' ' A' ' 12' ' ' LEU . . . 122.32 41.23 0.48 Allowed Glycine 0 N--CA 1.445 -0.736 0 N-CA-C 111.39 -0.684 . . . . 0.0 111.39 179.837 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.657 ' HB2' ' HB2' ' A' ' 38' ' ' ASP . 15.9 ptt180 -126.14 -26.27 3.42 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.109 0.481 . . . . 0.0 110.582 -179.338 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.493 HG22 ' HB3' ' A' ' 34' ' ' GLU . 2.8 m -101.11 130.32 47.14 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.48 -179.245 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.638 HD11 HD13 ' A' ' 90' ' ' LEU . 92.9 mt -91.23 112.22 24.04 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.01 179.529 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.479 ' CZ ' HG21 ' A' ' 13' ' ' THR . 43.9 ttm180 -109.07 119.39 39.42 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 179.375 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.604 ' HB2' ' HA ' ' A' ' 10' ' ' ALA . . . -154.79 167.38 30.41 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.818 0.342 . . . . 0.0 111.293 -179.434 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.611 ' HG3' ' HB3' ' A' ' 30' ' ' TRP . 0.4 OUTLIER -88.54 111.74 22.2 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 177.427 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 69.4 m -99.65 126.97 45.75 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 -179.709 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.469 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 34.3 ttt180 -76.1 114.07 14.35 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 116.3 -0.409 . . . . 0.0 109.936 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.429 HD21 ' HB3' ' A' ' 29' ' ' ASN . 35.1 p30 -77.95 170.23 16.95 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.372 -179.616 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.75 -29.18 62.29 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 -178.288 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -73.98 -13.09 60.82 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.468 0.651 . . . . 0.0 110.253 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 91.21 27.89 16.84 Favored Glycine 0 N--CA 1.448 -0.54 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.629 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.469 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 10.7 t-20 -111.53 158.54 19.06 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 110.14 -0.319 . . . . 0.0 110.14 -178.939 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.611 ' HB3' ' HG3' ' A' ' 22' ' ' GLU . 98.9 m95 -99.57 119.43 38.04 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.953 0.406 . . . . 0.0 110.765 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 11.1 m -122.25 137.53 55.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.252 -179.461 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 16.8 m -75.92 109.57 9.65 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.105 179.306 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 69.3 m -122.43 137.13 54.97 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.41 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.609 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 3.0 mp0 -122.55 146.73 47.15 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.514 -179.814 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.462 HD11 ' HB2' ' A' ' 102' ' ' PHE . 1.2 tm? -138.53 126.83 22.97 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 178.895 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.409 ' N ' HD13 ' A' ' 35' ' ' LEU . 4.4 m-20 -85.95 110.07 19.2 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.868 0.366 . . . . 0.0 110.475 179.547 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.445 HD13 HD22 ' A' ' 90' ' ' LEU . 2.1 mt -83.91 -12.57 55.24 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.034 178.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.689 ' OD2' ' HA ' ' A' ' 54' ' ' ASN . 9.6 t70 -60.94 -29.23 69.51 Favored 'General case' 0 C--O 1.221 -0.426 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.89 -178.607 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.6 t -83.48 1.02 43.79 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.827 0.346 . . . . 0.0 111.459 -178.817 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 37.3 m -128.97 -24.68 2.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.829 0.347 . . . . 0.0 111.775 -179.765 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 71.9 mt -102.8 137.05 32.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.549 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -143.84 146.92 17.96 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.68 -0.771 . . . . 0.0 111.835 179.177 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.764 HD22 ' HB3' ' A' ' 75' ' ' PRO . 30.5 p-10 -152.44 48.86 0.48 Allowed Pre-proline 0 CA--C 1.539 0.557 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -178.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -71.79 -22.12 24.11 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 121.661 1.574 . . . . 0.0 111.747 -179.357 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -83.97 -14.54 50.53 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.885 179.173 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.544 ' CA ' ' HG2' ' A' ' 83' ' ' ARG . . . 106.26 8.62 33.14 Favored Glycine 0 N--CA 1.443 -0.874 0 C-N-CA 120.315 -0.945 . . . . 0.0 112.596 -179.149 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -124.08 133.29 53.66 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.676 0.274 . . . . 0.0 110.282 179.476 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 95.3 mt -83.54 130.24 35.0 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.513 -178.412 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -173.5 172.65 45.36 Favored Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.097 179.029 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.408 ' HH2' HD11 ' A' ' 93' ' ' ILE . 88.3 m95 -95.03 125.1 39.47 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.758 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 168.64 -59.18 0.2 Allowed Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.493 -0.861 . . . . 0.0 112.602 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 6.1 ttp -96.75 -154.66 0.45 Allowed 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 25.5 pt20 -146.79 173.75 12.1 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.43 0.157 . . . . 0.0 111.013 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.689 ' HA ' ' OD2' ' A' ' 38' ' ' ASP . 16.2 m120 64.92 55.37 1.18 Allowed 'General case' 0 C--O 1.237 0.416 0 O-C-N 123.858 0.724 . . . . 0.0 111.52 179.523 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.495 ' HD1' ' HA ' ' A' ' 38' ' ' ASP . 11.8 p90 -87.46 -26.17 23.38 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.16 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.411 ' HB3' ' HB3' ' A' ' 17' ' ' ARG . 32.4 p -61.0 -35.89 78.04 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.998 0.428 . . . . 0.0 111.105 -178.745 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 26.7 m80 -77.49 -11.94 59.91 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.192 179.621 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.483 ' HB2' ' OD1' ' A' ' 43' ' ' ASN . 2.7 m -113.41 20.25 16.25 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.053 0.454 . . . . 0.0 110.353 -179.624 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 24.8 m -136.1 156.0 49.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.09 0.471 . . . . 0.0 111.46 -179.371 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -129.2 138.31 51.64 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.282 178.732 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.44 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 32.2 t70 58.22 79.31 0.21 Allowed 'General case' 0 N--CA 1.469 0.49 0 O-C-N 123.735 0.647 . . . . 0.0 110.721 -179.291 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.55 HG23 HD21 ' A' ' 71' ' ' LEU . 68.0 mt -98.74 112.74 31.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.548 -179.566 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.28 164.94 26.59 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.307 -179.057 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.754 ' HG ' HD21 ' A' ' 12' ' ' LEU . 55.9 mt -96.05 114.84 26.58 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 178.481 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -65.95 -54.34 27.58 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.12 -177.627 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 43.1 mm-40 -88.36 7.84 30.5 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.112 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 73.23 21.09 80.01 Favored Glycine 0 N--CA 1.447 -0.623 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.678 -179.442 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 156.53 -49.84 0.45 Allowed Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 120.131 -1.033 . . . . 0.0 112.946 179.706 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.476 ' HD2' ' HB3' ' A' ' 4' ' ' ALA . 5.1 mpt_? -66.31 -26.66 67.41 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -179.365 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 32.0 ttpt -141.91 144.62 33.88 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.651 -0.419 . . . . 0.0 111.677 -178.471 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.628 ' HB2' HD11 ' A' ' 90' ' ' LEU . 8.7 tt -115.45 124.08 50.24 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.305 -0.861 . . . . 0.0 108.983 179.286 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.447 HG22 ' HA3' ' A' ' 87' ' ' GLY . 1.1 p -115.8 133.4 56.07 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.375 0.607 . . . . 0.0 111.114 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.546 ' HB3' ' HA ' ' A' ' 62' ' ' ILE . 26.3 p -156.2 172.32 18.66 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.336 -0.847 . . . . 0.0 108.868 -179.773 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.513 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 4.4 tmt_? -104.23 98.57 14.37 Favored Pre-proline 0 C--N 1.316 -0.861 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 179.283 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.764 ' HB3' HD22 ' A' ' 43' ' ' ASN . 54.9 Cg_endo -69.35 123.82 10.62 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 122.902 2.401 . . . . 0.0 110.653 179.026 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.963 ' HE3' ' HA2' ' A' ' 81' ' ' GLY . 0.0 OUTLIER -120.91 149.41 42.67 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.619 -179.077 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.709 HG22 ' O ' ' A' ' 82' ' ' PHE . 13.2 t -79.59 134.5 36.47 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 177.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 31.3 m -72.44 -7.85 10.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 O-C-N 123.706 0.629 . . . . 0.0 111.402 -179.22 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -66.98 -33.63 75.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.533 179.43 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -150.0 -20.34 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.364 -0.922 . . . . 0.0 113.162 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.963 ' HA2' ' HE3' ' A' ' 76' ' ' LYS . . . 98.01 18.04 28.21 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.579 -0.82 . . . . 0.0 111.685 -179.712 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.709 ' O ' HG22 ' A' ' 77' ' ' THR . 32.0 p90 -111.55 153.18 26.62 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 118.872 -0.585 . . . . 0.0 109.891 -178.785 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.716 ' HB2' ' HA ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 167.84 -150.4 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.405 0 O-C-N 123.679 0.612 . . . . 0.0 111.442 179.502 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -127.58 154.92 44.62 Favored 'General case' 0 C--O 1.226 -0.142 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.7 -178.471 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.513 ' HA ' ' HA ' ' A' ' 74' ' ' ARG . 35.8 ttt180 -84.32 146.83 27.52 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 178.335 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -151.49 -170.17 3.58 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.619 0.723 . . . . 0.0 112.091 -177.702 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.447 ' HA3' HG22 ' A' ' 72' ' ' THR . . . -155.05 142.99 9.43 Favored Glycine 0 N--CA 1.442 -0.904 0 N-CA-C 110.23 -1.148 . . . . 0.0 110.23 178.645 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 13.0 tt -122.75 134.83 64.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.257 0.551 . . . . 0.0 110.734 -178.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -74.37 130.9 40.53 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.625 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.638 HD13 HD11 ' A' ' 19' ' ' LEU . 61.4 mt -102.04 46.55 0.93 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.676 0.751 . . . . 0.0 110.848 -179.746 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.436 ' HA ' ' OG ' ' A' ' 2' ' ' SER . 5.8 m120 -81.3 4.63 19.91 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.317 179.665 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 19.1 mtp180 -100.54 -6.64 25.1 Favored 'General case' 0 C--O 1.226 -0.179 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.7 178.789 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.408 HD11 ' HH2' ' A' ' 50' ' ' TRP . 23.5 mm -106.15 108.03 24.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 -178.891 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 20.9 tp60 -125.98 145.93 50.08 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.783 -178.584 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.418 HD21 ' HB2' ' A' ' 6' ' ' SER . 13.9 p-10 -95.08 115.31 27.27 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.331 0.586 . . . . 0.0 110.023 178.475 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 52.0 t -101.78 112.82 36.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.128 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 13.6 m-80 57.84 33.5 23.28 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.091 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 94.55 -23.87 30.33 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.837 179.599 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.24 124.89 33.81 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.945 0.372 . . . . 0.0 110.031 -179.486 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.46 HD23 ' HB2' ' A' ' 35' ' ' LEU . 11.8 tp -76.31 119.38 20.12 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 38.8 t -129.9 141.73 45.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.002 0.43 . . . . 0.0 111.154 -178.669 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.462 ' HB2' HD11 ' A' ' 35' ' ' LEU . 6.5 t80 -83.79 132.34 34.83 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 177.885 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 3.7 tp-100 . . . . . 0 C--N 1.314 -0.953 0 CA-C-O 118.745 -0.645 . . . . 0.0 110.231 179.946 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.1 mtt . . . . . 0 N--CA 1.483 1.19 0 CA-C-O 120.941 0.4 . . . . 0.0 110.295 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.602 ' OG ' ' HA ' ' A' ' 91' ' ' ASN . 8.7 m -120.67 -179.29 3.95 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.287 -179.802 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.434 ' CZ ' HD13 ' A' ' 19' ' ' LEU . 14.9 p90 -63.28 -34.46 77.73 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.667 0.27 . . . . 0.0 110.69 178.705 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -56.32 -24.26 42.42 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.806 -0.633 . . . . 0.0 112.597 -178.582 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -65.78 -16.51 63.86 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 121.205 0.526 . . . . 0.0 110.835 179.679 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 62.0 m -140.19 29.63 2.02 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.585 178.722 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 19.3 m -146.06 156.51 43.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.496 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 11.7 ptp180 -143.09 166.24 25.19 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.657 179.618 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 67.4 m-80 58.9 54.42 5.11 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.117 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.479 ' HA ' ' O ' ' A' ' 20' ' ' ARG . . . -88.65 118.47 28.34 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.311 179.555 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.407 HG22 ' HD2' ' A' ' 20' ' ' ARG . 27.3 m -118.93 171.58 6.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.193 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.581 HD21 ' HG ' ' A' ' 64' ' ' LEU . 3.3 mm? -104.99 115.0 29.54 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.147 -179.496 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.5 ' OG1' ' HB ' ' A' ' 18' ' ' THR . 21.9 p -110.06 167.73 9.96 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.931 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 57.97 53.27 6.97 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.948 -179.677 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 81.68 -35.36 2.48 Favored Glycine 0 CA--C 1.519 0.322 0 CA-C-N 116.035 -0.529 . . . . 0.0 112.686 179.646 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.564 ' HA2' ' HB3' ' A' ' 12' ' ' LEU . . . 136.75 49.22 0.07 OUTLIER Glycine 0 N--CA 1.447 -0.598 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 -179.504 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.555 ' HB3' ' HB2' ' A' ' 56' ' ' SER . 15.7 ptt180 -133.91 -27.65 1.44 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.885 0.374 . . . . 0.0 111.317 -179.415 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.5 ' HB ' ' OG1' ' A' ' 13' ' ' THR . 3.9 m -99.04 135.73 40.03 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.794 -178.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.762 HD11 HD13 ' A' ' 90' ' ' LEU . 61.6 mt -94.3 114.65 26.76 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.628 179.337 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.479 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 1.6 tmt_? -110.47 120.51 42.66 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 178.589 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -153.2 167.23 30.01 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.835 0.35 . . . . 0.0 111.63 -179.562 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.494 ' HB3' ' HB3' ' A' ' 30' ' ' TRP . 45.4 mt-10 -90.73 105.63 17.95 Favored 'General case' 0 CA--C 1.512 -0.49 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 177.603 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.456 ' SG ' HD13 ' A' ' 100' ' ' LEU . 83.7 m -92.61 122.8 35.39 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 120.88 0.372 . . . . 0.0 110.963 -178.474 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.514 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 37.3 ttp180 -71.12 110.95 6.1 Favored 'General case' 0 N--CA 1.435 -1.208 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.64 178.609 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.418 HD21 ' HB3' ' A' ' 29' ' ' ASN . 37.4 p30 -76.84 167.19 22.26 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.12 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.42 -31.45 45.21 Favored 'General case' 0 C--N 1.329 -0.324 0 O-C-N 123.672 0.607 . . . . 0.0 112.289 -178.691 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -70.9 -17.64 62.7 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.306 0.574 . . . . 0.0 110.773 -179.392 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 95.08 28.39 9.98 Favored Glycine 0 CA--C 1.51 -0.243 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.551 -179.555 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.514 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 13.9 t-20 -113.08 164.03 13.99 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 -178.738 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.494 ' HB3' ' HB3' ' A' ' 22' ' ' GLU . 96.6 m95 -105.21 116.82 32.59 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.77 0.319 . . . . 0.0 110.8 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.5 m -118.56 138.03 50.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.737 179.421 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 13.3 m -80.33 114.79 19.49 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.154 -179.609 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.493 ' HB3' ' HB2' ' A' ' 100' ' ' LEU . 75.5 m -126.13 147.6 49.58 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.244 179.268 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.663 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 50.9 mt-10 -131.7 141.39 49.55 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.887 -179.497 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.523 ' HB2' HD23 ' A' ' 100' ' ' LEU . 1.3 tm? -137.53 127.41 25.62 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.288 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.404 ' N ' HD13 ' A' ' 35' ' ' LEU . 18.6 m-20 -81.54 109.72 16.25 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.284 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.601 HD22 HG13 ' A' ' 93' ' ' ILE . 4.1 mt -82.01 -23.07 36.16 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 121.086 -0.246 . . . . 0.0 111.59 -178.907 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.523 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 6.5 p-10 -66.44 -6.16 13.61 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.796 0.332 . . . . 0.0 111.475 -178.421 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 55.7 p -76.55 -21.77 55.23 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.249 0.547 . . . . 0.0 109.727 178.361 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.456 ' SG ' ' HE3' ' A' ' 50' ' ' TRP . 29.0 t -128.79 -14.61 4.51 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.656 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.463 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 54.0 mt -99.42 133.98 40.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 O-C-N 122.149 -0.344 . . . . 0.0 110.136 178.802 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.526 ' HA3' ' HB3' ' A' ' 52' ' ' MET . . . -152.28 165.33 30.81 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 121.011 -0.614 . . . . 0.0 111.857 179.602 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.559 ' OD1' ' HB2' ' A' ' 55' ' ' PHE . 2.1 p-10 -163.86 54.35 0.4 Allowed Pre-proline 0 CA--C 1.537 0.442 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -179.503 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.41 ' HG3' ' HG2' ' A' ' 52' ' ' MET . 58.4 Cg_endo -73.13 -22.74 18.92 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 121.753 1.635 . . . . 0.0 111.241 179.506 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -85.07 -17.11 38.41 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.311 179.02 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.612 ' CA ' ' HG2' ' A' ' 83' ' ' ARG . . . 105.66 13.65 23.52 Favored Glycine 0 N--CA 1.441 -0.977 0 CA-C-N 115.459 -0.791 . . . . 0.0 113.152 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.409 ' HA ' HE22 ' A' ' 86' ' ' GLN . 59.0 m-85 -125.3 134.2 52.35 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.831 0.348 . . . . 0.0 110.431 179.095 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 88.7 mt -82.79 129.85 35.05 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.107 -178.695 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -176.85 175.87 47.79 Favored Glycine 0 N--CA 1.442 -0.958 0 C-N-CA 120.663 -0.78 . . . . 0.0 111.873 179.241 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.456 ' HE3' ' SG ' ' A' ' 40' ' ' CYS . 88.1 m95 -96.22 125.45 40.75 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 159.88 -62.16 0.3 Allowed Glycine 0 N--CA 1.45 -0.373 0 N-CA-C 111.443 -0.663 . . . . 0.0 111.443 -179.726 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.526 ' HB3' ' HA3' ' A' ' 42' ' ' GLY . 42.4 tpp -80.67 173.82 12.22 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 179.755 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -129.44 166.85 18.78 Favored 'General case' 0 C--N 1.323 -0.558 0 O-C-N 122.147 -0.346 . . . . 0.0 111.629 -179.199 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 67.53 47.36 1.23 Allowed 'General case' 0 N--CA 1.463 0.212 0 O-C-N 124.175 0.922 . . . . 0.0 112.276 179.605 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.559 ' HB2' ' OD1' ' A' ' 43' ' ' ASN . 3.9 p90 -70.44 -26.19 63.54 Favored 'General case' 0 C--O 1.222 -0.343 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.589 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.555 ' HB2' ' HB3' ' A' ' 17' ' ' ARG . 32.9 t -60.34 -38.3 83.37 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.93 0.395 . . . . 0.0 110.834 -179.116 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 26.2 m80 -80.86 -2.81 48.92 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.57 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 49.8 m -124.91 16.28 8.59 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.648 0.261 . . . . 0.0 111.572 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 69.7 m -131.67 149.42 52.49 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.459 0.647 . . . . 0.0 111.981 -179.592 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.467 ' HG3' ' HG2' ' A' ' 76' ' ' LYS . 39.8 mt-10 -120.3 139.68 52.38 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.913 -1.04 . . . . 0.0 109.295 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.505 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 28.4 t70 61.34 72.07 0.53 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.482 0.658 . . . . 0.0 110.546 179.343 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.536 HG23 HD21 ' A' ' 71' ' ' LEU . 65.6 mt -96.3 113.48 30.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.242 -179.694 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.456 ' HE3' ' HB2' ' A' ' 63' ' ' LYS . 17.3 ttmt -150.33 149.99 30.86 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.859 0.361 . . . . 0.0 110.834 -179.776 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.604 HD13 ' HA2' ' A' ' 68' ' ' GLY . 33.7 mt -88.67 136.83 32.8 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.849 -179.411 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -91.23 -67.08 0.87 Allowed 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.09 0.471 . . . . 0.0 110.988 179.436 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.547 ' HB2' ' HB3' ' A' ' 69' ' ' ARG . 21.9 mm-40 -74.88 42.29 0.17 Allowed 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 115.395 -0.82 . . . . 0.0 112.07 -178.618 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 60.9 13.92 35.56 Favored Glycine 0 C--N 1.314 -0.662 0 CA-C-N 115.249 -0.887 . . . . 0.0 113.426 179.091 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.604 ' HA2' HD13 ' A' ' 64' ' ' LEU . . . 130.92 -13.82 5.51 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.103 -1.046 . . . . 0.0 113.197 179.587 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.547 ' HB3' ' HB2' ' A' ' 66' ' ' GLU . 2.3 ttp85 -78.17 -20.04 52.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.343 0.592 . . . . 0.0 109.869 179.735 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -140.26 140.88 35.85 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.432 -179.722 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.61 ' HB2' HD11 ' A' ' 90' ' ' LEU . 10.3 tt -118.54 132.1 56.22 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.989 -0.551 . . . . 0.0 109.927 -179.414 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -118.19 129.91 55.78 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.634 178.924 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.505 ' HA ' ' O ' ' A' ' 61' ' ' ASP . 28.8 p -157.84 163.55 37.87 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.475 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.592 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 33.4 ttt180 -99.76 104.16 26.36 Favored Pre-proline 0 C--N 1.316 -0.886 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.32 179.488 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.589 ' O ' ' HB3' ' A' ' 83' ' ' ARG . 43.5 Cg_endo -67.82 115.66 3.88 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 122.449 2.1 . . . . 0.0 109.802 178.202 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.736 ' HE3' ' HA2' ' A' ' 81' ' ' GLY . 0.0 OUTLIER -119.3 140.33 50.47 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.65 -179.661 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.667 HG22 ' O ' ' A' ' 82' ' ' PHE . 15.3 t -75.85 130.14 38.09 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 17.3 m -72.59 -6.24 7.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.309 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -67.45 -34.01 76.31 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.845 179.493 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.584 ' HA3' ' CE2' ' A' ' 82' ' ' PHE . . . -143.26 -20.58 0.21 Allowed Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.902 179.769 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.736 ' HA2' ' HE3' ' A' ' 76' ' ' LYS . . . 95.23 12.54 54.51 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.363 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.667 ' O ' HG22 ' A' ' 77' ' ' THR . 21.3 p90 -111.96 157.68 20.4 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 118.83 -0.605 . . . . 0.0 110.64 -178.49 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.701 ' HB2' ' HA ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 165.54 -152.49 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.633 0 O-C-N 124.107 0.879 . . . . 0.0 111.862 178.238 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -132.6 151.3 51.98 Favored 'General case' 0 C--O 1.225 -0.192 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.189 -178.258 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.592 ' HA ' ' HA ' ' A' ' 74' ' ' ARG . 45.3 ttt-85 -85.95 151.48 23.71 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.547 0.213 . . . . 0.0 110.62 -179.39 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.42 ' HG3' ' O ' ' A' ' 85' ' ' ARG . 35.6 mt-30 -154.05 -172.9 4.37 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.296 -178.76 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -141.54 144.47 14.46 Favored Glycine 0 N--CA 1.451 -0.34 0 N-CA-C 111.091 -0.804 . . . . 0.0 111.091 179.127 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 9.2 tt -131.77 137.53 54.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 120.935 0.398 . . . . 0.0 110.896 -179.144 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -82.03 136.88 35.18 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.269 179.546 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.762 HD13 HD11 ' A' ' 19' ' ' LEU . 50.8 mt -101.05 45.03 0.98 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.598 0.713 . . . . 0.0 110.587 -179.311 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.602 ' HA ' ' OG ' ' A' ' 2' ' ' SER . 4.4 m-20 -74.87 -0.94 20.16 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.931 -179.354 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 11.0 mtp180 -94.98 -11.98 27.53 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.809 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.601 HG13 HD22 ' A' ' 37' ' ' LEU . 23.5 mm -101.64 112.57 35.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 -179.268 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -129.1 162.21 28.24 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.589 0.709 . . . . 0.0 112.093 -178.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.489 ' HA ' ' O ' ' A' ' 99' ' ' ARG . 19.8 p-10 -106.94 124.55 49.78 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.728 -1.123 . . . . 0.0 110.308 179.144 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 46.1 t -106.69 104.02 16.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.784 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 33.9 m-80 59.78 19.39 8.21 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.71 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 119.44 -25.95 7.52 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.607 -0.806 . . . . 0.0 113.52 178.294 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.489 ' O ' ' HA ' ' A' ' 95' ' ' ASN . 1.9 ptm180 -86.76 144.7 26.95 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 117.092 0.446 . . . . 0.0 110.393 -179.267 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.523 HD23 ' HB2' ' A' ' 35' ' ' LEU . 6.9 tp -93.43 119.71 32.84 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 23.9 t -129.34 139.31 52.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.736 -178.786 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.453 ' HB2' HD11 ' A' ' 35' ' ' LEU . 13.7 t80 -82.98 130.68 35.17 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.873 -0.418 . . . . 0.0 109.873 178.508 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 46.5 tp60 . . . . . 0 C--N 1.316 -0.887 0 CA-C-O 118.37 -0.824 . . . . 0.0 110.117 179.63 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.3 mtt . . . . . 0 N--CA 1.479 0.975 0 CA-C-O 120.807 0.337 . . . . 0.0 110.494 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.475 ' HB2' ' HD2' ' A' ' 69' ' ' ARG . 13.2 m -118.24 168.89 10.18 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.13 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.455 ' CG ' HD11 ' A' ' 100' ' ' LEU . 18.9 p90 -57.6 -38.13 74.4 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.104 -0.498 . . . . 0.0 112.095 179.782 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.571 ' HB3' ' CG ' ' A' ' 69' ' ' ARG . . . -53.85 -18.72 3.55 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 -177.699 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -63.98 -30.41 71.49 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.381 0.61 . . . . 0.0 109.764 179.076 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 18.8 m -131.84 28.97 4.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.924 179.255 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.412 ' HA ' ' HZ3' ' A' ' 30' ' ' TRP . 13.6 m -143.33 155.98 44.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.921 -179.81 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.42 HH11 ' HD2' ' A' ' 8' ' ' ARG . 12.7 ptm180 -145.84 169.9 17.64 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 110.436 -0.209 . . . . 0.0 110.436 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 63.02 53.42 2.34 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 123.715 0.634 . . . . 0.0 110.803 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.478 ' HA ' ' HB2' ' A' ' 21' ' ' ALA . . . -92.06 119.86 32.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.201 -179.614 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 34.4 m -123.13 170.42 13.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.209 179.687 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.632 HD21 ' HG ' ' A' ' 64' ' ' LEU . 3.3 mm? -105.51 115.33 30.07 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.1 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.447 ' OG1' ' HB ' ' A' ' 18' ' ' THR . 21.8 p -112.26 171.23 7.64 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.35 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.45 ' HB3' ' HE ' ' A' ' 17' ' ' ARG . 87.1 m-20 58.9 45.88 14.57 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.486 179.509 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 88.56 -30.77 5.15 Favored Glycine 0 N--CA 1.451 -0.358 0 CA-C-N 115.892 -0.595 . . . . 0.0 112.366 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.554 ' HA2' ' HB3' ' A' ' 12' ' ' LEU . . . 131.31 53.72 0.09 OUTLIER Glycine 0 N--CA 1.445 -0.731 0 N-CA-C 111.059 -0.817 . . . . 0.0 111.059 -179.477 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.638 ' HB2' ' HB3' ' A' ' 38' ' ' ASP . 14.6 ptt180 -141.46 -29.28 0.64 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.864 0.364 . . . . 0.0 111.579 -179.712 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.485 ' CG2' ' HB3' ' A' ' 34' ' ' GLU . 3.7 m -95.92 132.62 41.02 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.417 -179.631 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.734 HD11 HD13 ' A' ' 90' ' ' LEU . 87.5 mt -93.76 114.33 26.59 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.08 179.533 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 56.0 ttp180 -112.1 119.78 39.58 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 178.82 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.478 ' HB2' ' HA ' ' A' ' 10' ' ' ALA . . . -154.15 167.47 29.76 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.209 -179.317 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.629 ' HB3' ' HB3' ' A' ' 30' ' ' TRP . 40.8 mt-10 -89.89 108.94 20.01 Favored 'General case' 0 CA--C 1.513 -0.466 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 177.781 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.557 ' SG ' HD13 ' A' ' 100' ' ' LEU . 18.7 m -96.23 128.36 43.08 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.252 -178.641 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.511 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 25.0 ttp180 -72.87 116.73 13.72 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 179.411 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.429 HD21 ' HB3' ' A' ' 29' ' ' ASN . 36.3 p30 -84.16 171.58 12.7 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.052 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.44 -28.88 47.19 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 112.654 0.612 . . . . 0.0 112.654 -178.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -75.56 -10.59 59.58 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.394 0.616 . . . . 0.0 110.368 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 86.03 28.15 29.27 Favored Glycine 0 N--CA 1.447 -0.629 0 N-CA-C 110.916 -0.874 . . . . 0.0 110.916 -179.264 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.511 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 3.3 t-20 -110.31 160.35 16.63 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.572 0.225 . . . . 0.0 110.92 -178.479 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.629 ' HB3' ' HB3' ' A' ' 22' ' ' GLU . 84.1 m95 -99.98 112.9 25.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.074 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.1 m -115.79 131.88 66.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.365 178.863 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 21.6 m -77.46 109.02 11.04 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.943 0.401 . . . . 0.0 110.747 -179.323 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 70.3 m -118.29 151.69 37.21 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.726 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.611 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 45.1 mt-10 -128.89 144.5 51.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.817 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.628 HD11 ' HB2' ' A' ' 102' ' ' PHE . 1.4 tm? -138.86 128.84 25.19 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 178.472 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.423 ' N ' HD13 ' A' ' 35' ' ' LEU . 10.9 m-20 -90.31 109.85 20.94 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.479 -179.161 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.483 HD23 HD12 ' A' ' 35' ' ' LEU . 0.8 OUTLIER -87.21 -14.34 41.38 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -179.652 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.638 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 0.9 OUTLIER -64.64 -17.18 63.8 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -177.698 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.426 HG23 ' SG ' ' A' ' 40' ' ' CYS . 9.3 t -85.02 -2.63 58.19 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.894 0.378 . . . . 0.0 110.486 179.622 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.426 ' SG ' HG23 ' A' ' 39' ' ' THR . 35.8 m -132.28 -14.12 3.01 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.698 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 57.2 mt -116.41 134.89 58.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 CA-C-O 120.745 0.307 . . . . 0.0 110.402 179.636 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.572 ' HA3' ' HB3' ' A' ' 52' ' ' MET . . . -153.16 164.64 30.99 Favored Glycine 0 N--CA 1.446 -0.635 0 N-CA-C 111.026 -0.83 . . . . 0.0 111.026 179.261 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.467 ' OD1' ' HB2' ' A' ' 55' ' ' PHE . 2.3 p-10 -157.14 52.44 0.6 Allowed Pre-proline 0 CA--C 1.537 0.468 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -179.586 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -69.4 -19.77 37.42 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 121.708 1.605 . . . . 0.0 111.899 -179.614 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -89.78 -2.84 58.33 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.463 179.635 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.552 ' HA3' ' HG2' ' A' ' 83' ' ' ARG . . . 95.32 4.86 60.82 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.477 -0.868 . . . . 0.0 112.699 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 52.6 m-85 -126.19 137.44 53.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.69 0.245 . . . . 0.0 110.648 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.465 HD23 HG22 ' A' ' 88' ' ' ILE . 5.5 mp -82.67 149.47 27.34 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.403 -179.313 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 171.4 171.98 37.07 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.396 178.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.48 ' CD1' HD11 ' A' ' 88' ' ' ILE . 91.8 m95 -95.62 133.8 39.26 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 138.65 -39.77 1.53 Allowed Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.879 -0.677 . . . . 0.0 111.636 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.572 ' HB3' ' HA3' ' A' ' 42' ' ' GLY . 4.4 tpt -94.03 -172.01 2.72 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -146.13 169.96 17.67 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.178 -0.609 . . . . 0.0 111.955 -179.282 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 14.9 m120 62.41 42.71 8.7 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.062 -0.972 . . . . 0.0 112.39 179.311 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.467 ' HB2' ' OD1' ' A' ' 43' ' ' ASN . 20.9 p90 -63.34 -32.65 74.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.06 0.457 . . . . 0.0 110.302 179.337 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.603 ' OG ' ' HB3' ' A' ' 17' ' ' ARG . 8.8 m -64.05 -35.52 81.01 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.464 -179.399 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 27.3 m80 -79.15 -5.03 53.22 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.84 0.353 . . . . 0.0 111.173 -179.491 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 6.2 p -128.0 20.49 6.42 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.544 -179.634 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 66.9 m -135.8 152.41 51.06 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 121.26 0.552 . . . . 0.0 112.239 -179.504 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 -114.05 149.4 35.51 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.052 179.126 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 15.7 t70 47.25 72.51 0.24 Allowed 'General case' 0 N--CA 1.469 0.513 0 O-C-N 124.15 0.906 . . . . 0.0 111.526 179.549 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.536 HG23 HD21 ' A' ' 71' ' ' LEU . 73.1 mt -90.56 117.68 34.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.19 -179.595 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -149.12 164.62 34.17 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.074 179.452 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.632 ' HG ' HD21 ' A' ' 12' ' ' LEU . 62.7 mt -91.07 136.42 33.09 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.085 0.469 . . . . 0.0 110.954 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -92.76 -66.1 0.95 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.841 -178.38 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -81.65 46.1 0.94 Allowed 'General case' 0 CA--C 1.514 -0.424 0 CA-C-O 120.985 0.421 . . . . 0.0 111.709 -178.58 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 57.77 22.46 47.3 Favored Glycine 0 C--N 1.317 -0.525 0 CA-C-N 115.174 -0.921 . . . . 0.0 113.189 179.474 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.606 ' HA2' HD13 ' A' ' 64' ' ' LEU . . . 121.53 -12.59 9.5 Favored Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 120.225 -0.988 . . . . 0.0 113.575 179.616 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.571 ' CG ' ' HB3' ' A' ' 4' ' ' ALA . 17.9 mtm105 -92.68 1.9 57.02 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 117.806 0.803 . . . . 0.0 110.899 -179.498 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 17.8 tttp -157.65 133.22 9.09 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 -179.595 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.591 ' HB2' HD11 ' A' ' 90' ' ' LEU . 10.5 tt -109.35 129.14 55.54 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -179.803 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.551 HG22 ' HA3' ' A' ' 87' ' ' GLY . 2.4 p -121.07 131.22 54.14 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.355 0.597 . . . . 0.0 111.575 -179.476 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.526 ' HB3' ' HA ' ' A' ' 62' ' ' ILE . 25.0 p -158.03 174.26 15.5 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.786 -179.494 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.567 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 57.1 ttt180 -106.72 100.11 29.2 Favored Pre-proline 0 C--N 1.319 -0.735 0 C-N-CA 121.084 -0.246 . . . . 0.0 110.449 178.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.693 ' O ' ' HB3' ' A' ' 83' ' ' ARG . 19.6 Cg_endo -65.39 126.12 15.68 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.493 2.129 . . . . 0.0 110.471 178.881 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.679 ' HA ' ' HB2' ' A' ' 83' ' ' ARG . 0.1 OUTLIER -120.26 145.01 47.47 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.987 0.423 . . . . 0.0 111.561 -179.806 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.644 HG22 ' O ' ' A' ' 82' ' ' PHE . 15.1 t -74.31 142.25 45.2 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.095 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.6 p -72.74 -12.05 15.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.525 -178.76 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -64.24 -28.52 69.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.558 179.643 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -161.24 -16.5 0.03 OUTLIER Glycine 0 CA--C 1.518 0.246 0 C-N-CA 120.065 -1.064 . . . . 0.0 113.496 -179.338 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.63 ' HA2' ' HD3' ' A' ' 76' ' ' LYS . . . 97.43 20.7 21.8 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.761 -0.733 . . . . 0.0 111.787 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.644 ' O ' HG22 ' A' ' 77' ' ' THR . 26.7 p90 -112.17 150.68 30.47 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 119.373 -0.346 . . . . 0.0 110.186 -179.202 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.693 ' HB3' ' O ' ' A' ' 75' ' ' PRO . 0.0 OUTLIER 167.13 -152.86 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.302 0 O-C-N 123.953 0.783 . . . . 0.0 109.482 179.247 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 48.8 mm-40 -117.05 175.78 5.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.453 0.168 . . . . 0.0 111.427 -177.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.567 ' HA ' ' HA ' ' A' ' 74' ' ' ARG . 23.6 ttt180 -111.89 149.73 31.43 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 178.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -168.35 -161.9 0.38 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.642 -178.637 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.551 ' HA3' HG22 ' A' ' 72' ' ' THR . . . -153.25 161.74 29.84 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.785 179.742 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.48 HD11 ' CD1' ' A' ' 50' ' ' TRP . 13.9 tt -130.82 139.92 49.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 179.645 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.48 ' HB3' HD22 ' A' ' 91' ' ' ASN . 18.1 m-20 -82.21 138.24 34.71 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.047 0.451 . . . . 0.0 110.812 -179.57 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.734 HD13 HD11 ' A' ' 19' ' ' LEU . 56.5 mt -104.94 50.32 0.79 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.618 0.723 . . . . 0.0 111.26 -178.655 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.48 HD22 ' HB3' ' A' ' 89' ' ' ASP . 34.5 m-80 -82.96 3.34 30.41 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.324 179.027 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 40.3 mtp180 -98.85 -2.71 37.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.58 179.034 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.401 HG13 HD22 ' A' ' 37' ' ' LEU . 21.7 mm -110.4 96.26 4.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 24.9 tp60 -112.04 148.33 34.09 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.489 -178.706 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.439 ' OD1' ' HA ' ' A' ' 3' ' ' TYR . 17.7 p-10 -94.36 119.72 33.52 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.862 179.015 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.9 p -114.59 119.37 61.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.689 179.392 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 59.18 27.22 16.16 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.802 -179.486 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 92.43 -8.48 77.16 Favored Glycine 0 N--CA 1.447 -0.628 0 CA-C-N 115.971 -0.559 . . . . 0.0 113.155 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.21 135.08 43.27 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 117.409 0.604 . . . . 0.0 110.932 -179.154 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.557 HD13 ' SG ' ' A' ' 23' ' ' CYS . 3.9 tp -80.74 118.77 22.57 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.689 179.495 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 47.0 t -132.57 138.07 52.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 120.926 0.393 . . . . 0.0 110.79 -179.604 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.628 ' HB2' HD11 ' A' ' 35' ' ' LEU . 12.1 t80 -80.93 129.3 34.46 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 178.348 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 60.1 tt0 . . . . . 0 C--N 1.313 -0.993 0 CA-C-O 118.309 -0.853 . . . . 0.0 110.185 -179.604 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.179 0 CA-C-O 121.082 0.468 . . . . 0.0 110.994 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.564 ' OG ' ' HA ' ' A' ' 91' ' ' ASN . 3.8 m -119.1 171.54 8.2 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.17 179.141 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.43 ' HA ' ' OD1' ' A' ' 95' ' ' ASN . 21.4 p90 -59.54 -39.55 84.32 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.786 0.327 . . . . 0.0 110.915 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -56.24 -19.77 15.41 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 -178.328 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -69.69 -22.88 63.38 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.087 0.47 . . . . 0.0 110.35 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 24.0 m -138.36 35.6 2.28 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.456 0.646 . . . . 0.0 109.259 178.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.438 ' HA ' ' HZ3' ' A' ' 30' ' ' TRP . 9.0 t -138.18 161.03 37.87 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.477 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 25.0 ptt180 -149.49 165.58 31.73 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.496 -179.266 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 54.66 52.97 11.28 Favored 'General case' 0 C--N 1.331 -0.208 0 O-C-N 123.855 0.722 . . . . 0.0 111.704 178.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.436 ' HA ' ' HB2' ' A' ' 21' ' ' ALA . . . -86.51 117.83 25.54 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.095 179.61 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 34.5 m -118.22 169.08 9.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.328 -179.427 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.731 HD21 ' HG ' ' A' ' 64' ' ' LEU . 3.2 mm? -105.95 114.61 28.85 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.649 -179.115 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.436 ' OG1' ' HB ' ' A' ' 18' ' ' THR . 24.0 p -110.55 163.39 13.77 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.003 -179.733 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 62.7 27.76 16.26 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.043 179.342 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 98.8 -17.74 57.85 Favored Glycine 0 N--CA 1.454 -0.12 0 C-N-CA 120.457 -0.878 . . . . 0.0 112.583 179.459 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.634 ' HA2' ' HB3' ' A' ' 12' ' ' LEU . . . 121.86 35.13 0.8 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.802 -0.714 . . . . 0.0 112.09 179.514 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.461 ' HB2' ' HB3' ' A' ' 38' ' ' ASP . 3.5 ptm180 -118.76 -25.64 6.3 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.149 0.499 . . . . 0.0 110.551 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.436 ' HB ' ' OG1' ' A' ' 13' ' ' THR . 4.8 m -108.31 135.26 49.91 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.827 -179.686 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.667 HD11 HD13 ' A' ' 90' ' ' LEU . 63.0 mt -97.65 113.76 25.57 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.787 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.498 ' HA ' ' HG2' ' A' ' 34' ' ' GLU . 16.7 ttm180 -107.02 118.68 37.33 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 178.527 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.436 ' HB2' ' HA ' ' A' ' 10' ' ' ALA . . . -154.5 168.05 28.01 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.016 0.436 . . . . 0.0 111.853 -178.916 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -89.54 111.6 22.57 Favored 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 177.485 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.439 ' SG ' HD13 ' A' ' 100' ' ' LEU . 61.1 m -97.89 122.89 41.54 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 -179.36 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.411 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 19.0 ttt180 -77.23 111.07 12.46 Favored 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 179.073 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.449 HD21 ' HB3' ' A' ' 29' ' ' ASN . 34.9 p30 -74.96 168.0 20.81 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.168 179.713 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.68 -27.44 27.8 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -178.719 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -77.92 -4.56 47.44 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.342 0.591 . . . . 0.0 110.964 -179.099 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 81.28 29.5 40.55 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.962 -0.637 . . . . 0.0 111.568 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.449 ' HB3' HD21 ' A' ' 25' ' ' ASN . 8.0 t-20 -112.95 153.03 28.65 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.438 ' HZ3' ' HA ' ' A' ' 7' ' ' SER . 99.1 m95 -99.14 114.5 27.29 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.149 0.499 . . . . 0.0 111.205 -179.156 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 6.9 m -114.17 131.89 64.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.385 179.334 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 17.3 m -79.41 109.57 13.9 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.894 0.378 . . . . 0.0 110.45 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 74.3 m -123.1 154.44 38.59 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.753 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.645 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 46.1 mt-10 -132.84 132.98 42.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.786 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.575 HD11 ' HB2' ' A' ' 102' ' ' PHE . 2.5 tm? -124.37 131.61 53.51 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.259 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.45 ' N ' HD13 ' A' ' 35' ' ' LEU . 8.4 m-20 -89.86 108.52 19.75 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.082 -179.666 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.502 HD13 HD22 ' A' ' 90' ' ' LEU . 1.6 mt -81.69 -16.93 49.7 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.894 -179.571 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.461 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 4.7 p-10 -61.79 -11.88 14.49 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.442 -179.264 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 54.0 p -76.66 -24.68 53.24 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.431 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 34.8 t -128.64 -8.33 5.09 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.206 0.446 . . . . 0.0 112.206 -179.351 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 47.3 mt -103.44 132.67 49.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 O-C-N 121.851 -0.531 . . . . 0.0 110.046 178.324 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.564 ' HA3' ' HB3' ' A' ' 52' ' ' MET . . . -149.71 159.51 28.11 Favored Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.799 -0.715 . . . . 0.0 111.538 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.457 HD22 ' CD1' ' A' ' 48' ' ' LEU . 19.1 p30 -163.35 50.17 0.25 Allowed Pre-proline 0 CA--C 1.537 0.47 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -179.689 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -68.46 -23.52 37.48 Favored 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 121.924 1.749 . . . . 0.0 112.227 -179.03 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.425 ' O ' ' HD3' ' A' ' 83' ' ' ARG . 3.3 m-20 -87.31 -15.96 36.5 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.537 179.739 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.52 ' HA3' ' HG2' ' A' ' 83' ' ' ARG . . . 108.6 11.68 22.7 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.461 -0.876 . . . . 0.0 112.741 -179.161 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -125.82 132.07 52.31 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.62 0.248 . . . . 0.0 110.392 179.563 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.497 HD23 HG22 ' A' ' 88' ' ' ILE . 9.2 mp -83.7 144.8 29.13 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.878 -178.807 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 171.76 170.38 35.68 Favored Glycine 0 N--CA 1.439 -1.134 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.11 178.245 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 90.3 m95 -94.88 125.8 39.78 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.703 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 153.43 -52.87 0.46 Allowed Glycine 0 N--CA 1.448 -0.56 0 N-CA-C 111.191 -0.764 . . . . 0.0 111.191 -179.784 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.564 ' HB3' ' HA3' ' A' ' 42' ' ' GLY . 2.9 tpt -86.59 174.36 8.95 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.595 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.453 ' H ' ' HE2' ' A' ' 52' ' ' MET . 14.1 pt20 -133.67 169.8 16.49 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 118.69 0.677 . . . . 0.0 111.85 -179.174 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 65.81 38.57 5.09 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.389 -0.823 . . . . 0.0 112.855 178.651 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.515 ' HB3' ' HA2' ' A' ' 42' ' ' GLY . 14.0 p90 -61.78 -29.85 70.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.721 0.296 . . . . 0.0 110.929 179.644 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.45 ' HB2' ' HB3' ' A' ' 17' ' ' ARG . 23.3 t -56.61 -36.12 69.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.158 -0.474 . . . . 0.0 112.042 -178.876 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 28.2 m80 -80.92 -18.43 47.17 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.899 -0.32 . . . . 0.0 111.543 -179.207 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 19.8 m -106.75 19.37 20.58 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.527 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 49.3 m -136.82 152.77 50.66 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.331 0.586 . . . . 0.0 111.628 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -129.06 136.27 50.04 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.197 178.758 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.427 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 33.6 m-20 63.63 83.65 0.16 Allowed 'General case' 0 N--CA 1.469 0.511 0 O-C-N 123.608 0.567 . . . . 0.0 111.304 -179.317 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.504 HG23 HD21 ' A' ' 71' ' ' LEU . 70.2 mt -101.51 124.19 55.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.285 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.8 tptt -145.03 154.61 42.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.766 0.317 . . . . 0.0 111.247 -179.396 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.731 ' HG ' HD21 ' A' ' 12' ' ' LEU . 86.1 mt -99.5 124.83 45.03 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.018 178.412 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -86.62 -60.26 2.04 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-O 121.194 0.521 . . . . 0.0 111.42 -179.61 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.607 ' HB2' ' HB3' ' A' ' 69' ' ' ARG . 20.3 mt-10 -78.19 38.44 0.29 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.665 -178.42 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 67.73 -4.76 3.87 Favored Glycine 0 N--CA 1.454 -0.117 0 CA-C-N 115.77 -0.65 . . . . 0.0 113.633 179.075 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.57 ' HA2' HD13 ' A' ' 64' ' ' LEU . . . 145.98 -6.96 1.4 Allowed Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.129 -179.429 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.607 ' HB3' ' HB2' ' A' ' 66' ' ' GLU . 5.5 tpp180 -81.7 -18.23 45.13 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.087 0.47 . . . . 0.0 109.807 179.668 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.429 ' HE3' ' HB2' ' A' ' 70' ' ' LYS . 35.6 ttmt -143.42 136.21 27.54 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.916 -179.234 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.668 ' HB2' HD11 ' A' ' 90' ' ' LEU . 10.5 tt -115.07 118.45 33.41 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.47 -0.787 . . . . 0.0 109.923 -179.709 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.493 HG22 ' HA3' ' A' ' 87' ' ' GLY . 3.6 p -108.82 134.13 51.93 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.241 0.543 . . . . 0.0 110.874 179.388 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.451 ' SG ' HD21 ' A' ' 48' ' ' LEU . 18.0 p -156.55 164.25 38.43 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.001 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.583 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 33.4 ttt-85 -100.87 101.87 17.51 Favored Pre-proline 0 C--N 1.316 -0.872 0 C-N-CA 120.424 -0.511 . . . . 0.0 110.254 178.915 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.639 ' O ' ' HB3' ' A' ' 83' ' ' ARG . 57.9 Cg_endo -70.55 129.2 16.38 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.636 2.224 . . . . 0.0 110.167 178.631 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.69 ' HA ' ' HB2' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -121.2 140.99 51.28 Favored 'General case' 0 C--N 1.313 -1.009 0 O-C-N 123.28 0.362 . . . . 0.0 110.949 179.85 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.723 HG22 ' O ' ' A' ' 82' ' ' PHE . 14.0 t -76.86 130.73 38.01 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 178.478 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 35.3 m -72.66 -6.01 7.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 123.557 0.536 . . . . 0.0 111.492 -179.415 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -67.78 -35.97 79.62 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.229 178.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.431 ' HA3' ' CE2' ' A' ' 82' ' ' PHE . . . -145.3 -14.18 0.21 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.413 -0.898 . . . . 0.0 113.152 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.582 ' HA2' ' HE3' ' A' ' 76' ' ' LYS . . . 88.23 16.78 58.6 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.011 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.723 ' O ' HG22 ' A' ' 77' ' ' THR . 37.8 p90 -111.29 148.46 32.87 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 118.789 -0.624 . . . . 0.0 109.33 -179.195 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.69 ' HB2' ' HA ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 172.05 -160.14 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.987 0.423 . . . . 0.0 111.938 179.753 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 -125.74 173.22 9.19 Favored 'General case' 0 C--O 1.223 -0.317 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.006 -177.473 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.594 ' HA ' ' HD2' ' A' ' 75' ' ' PRO . 72.5 ttt180 -109.41 153.71 23.61 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 110.07 -0.344 . . . . 0.0 110.07 178.711 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -166.23 -170.24 1.64 Allowed 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.581 -179.561 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.493 ' HA3' HG22 ' A' ' 72' ' ' THR . . . -143.12 151.61 23.35 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.335 -0.936 . . . . 0.0 113.358 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.497 HG22 HD23 ' A' ' 48' ' ' LEU . 13.0 tt -123.31 137.49 56.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.025 0.441 . . . . 0.0 109.883 179.408 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -79.8 138.02 37.13 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.787 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.668 HD11 ' HB2' ' A' ' 71' ' ' LEU . 37.2 mt -106.08 40.88 1.5 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.499 0.666 . . . . 0.0 110.936 -179.014 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.564 ' HA ' ' OG ' ' A' ' 2' ' ' SER . 39.5 m-80 -76.03 3.55 10.15 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.079 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 20.9 mtp180 -96.95 -6.6 35.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.641 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 18.7 mm -98.78 116.75 42.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 -179.355 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 24.5 tp60 -126.81 143.36 51.28 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.275 0.559 . . . . 0.0 111.301 -178.229 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.43 ' OD1' ' HA ' ' A' ' 3' ' ' TYR . 12.9 p-10 -95.19 110.82 22.74 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.304 178.529 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 40.8 t -96.97 106.45 18.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.693 179.586 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 20.3 m-80 56.98 36.76 28.21 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.272 0.558 . . . . 0.0 111.304 -179.341 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 96.14 -22.05 41.82 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.828 -0.701 . . . . 0.0 113.388 179.444 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.426 HH11 ' HD3' ' A' ' 99' ' ' ARG . 3.6 mpt_? -86.21 122.61 30.45 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 117.295 0.547 . . . . 0.0 110.211 -179.474 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.439 HD13 ' SG ' ' A' ' 23' ' ' CYS . 11.6 tp -79.63 114.59 18.67 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 32.7 t -128.15 140.71 48.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 120.984 0.421 . . . . 0.0 110.878 -178.778 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.575 ' HB2' HD11 ' A' ' 35' ' ' LEU . 8.3 t80 -83.93 129.3 34.93 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.121 -0.491 . . . . 0.0 109.81 178.665 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 2.7 tp-100 . . . . . 0 C--O 1.249 1.073 0 CA-C-O 119.031 -0.509 . . . . 0.0 110.451 179.396 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.0 ptp . . . . . 0 N--CA 1.483 1.204 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.8 m -118.33 178.04 4.59 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.779 -0.191 . . . . 0.0 110.98 179.294 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.589 ' HB3' ' HA ' ' A' ' 94' ' ' GLN . 9.8 p90 -59.62 -34.09 72.33 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.724 0.297 . . . . 0.0 111.543 179.781 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.475 ' HA ' ' HB3' ' A' ' 7' ' ' SER . . . -55.35 -18.32 6.39 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 112.84 0.681 . . . . 0.0 112.84 -178.649 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -56.24 -38.29 70.91 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.326 0.584 . . . . 0.0 110.064 178.758 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 44.3 m -129.02 40.58 3.61 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.218 179.214 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.475 ' HB3' ' HA ' ' A' ' 4' ' ' ALA . 29.3 t -148.1 148.44 30.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.264 -179.529 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -143.45 163.74 32.27 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.669 -179.671 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 64.22 49.04 2.71 Favored 'General case' 0 N--CA 1.465 0.318 0 O-C-N 123.718 0.636 . . . . 0.0 111.441 179.349 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.543 ' HA ' ' HB2' ' A' ' 21' ' ' ALA . . . -77.92 117.29 19.12 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.361 179.563 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 33.8 m -119.14 167.99 11.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.207 -179.8 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.599 ' HB3' ' HA2' ' A' ' 16' ' ' GLY . 3.3 mm? -104.38 114.53 28.82 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.661 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.476 HG21 ' NE ' ' A' ' 20' ' ' ARG . 28.4 p -112.4 166.69 11.07 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.548 -179.458 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 60.89 42.55 12.88 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.962 179.563 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 97.53 -48.03 1.54 Allowed Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 120.661 -0.781 . . . . 0.0 111.546 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.599 ' HA2' ' HB3' ' A' ' 12' ' ' LEU . . . 145.98 46.79 0.03 OUTLIER Glycine 0 N--CA 1.444 -0.824 0 N-CA-C 110.306 -1.117 . . . . 0.0 110.306 -179.388 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.573 ' HB2' ' HB2' ' A' ' 38' ' ' ASP . 7.1 ptp180 -132.95 -25.59 1.81 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.355 -0.423 . . . . 0.0 111.313 -178.595 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.47 ' HB ' ' OG1' ' A' ' 13' ' ' THR . 2.9 m -100.36 133.3 44.99 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.76 -179.688 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.792 HD11 HD13 ' A' ' 90' ' ' LEU . 68.8 mt -92.52 111.54 23.16 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.325 179.1 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.476 ' NE ' HG21 ' A' ' 13' ' ' THR . 37.4 ttm180 -110.42 120.22 41.73 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.721 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.543 ' HB2' ' HA ' ' A' ' 10' ' ' ALA . . . -152.96 167.24 29.83 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.76 0.314 . . . . 0.0 111.369 -179.125 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.423 ' O ' ' HA ' ' A' ' 7' ' ' SER . 37.1 mt-10 -91.01 107.76 19.41 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 178.262 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 65.9 m -100.32 133.11 45.23 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 120.914 0.387 . . . . 0.0 110.212 -179.285 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.44 HH11 ' HD2' ' A' ' 24' ' ' ARG . 6.7 ttp85 -80.78 117.63 21.61 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-O 120.918 0.39 . . . . 0.0 110.483 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 38.7 p30 -80.31 165.75 22.01 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.103 179.685 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.13 -18.69 38.04 Favored 'General case' 0 N--CA 1.464 0.266 0 O-C-N 123.807 0.692 . . . . 0.0 112.137 -179.012 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -75.85 -13.48 60.27 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.457 0.646 . . . . 0.0 109.716 179.192 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 91.0 23.83 28.9 Favored Glycine 0 N--CA 1.447 -0.58 0 CA-C-N 115.327 -0.851 . . . . 0.0 112.609 179.463 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -122.76 158.61 29.8 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.755 0.312 . . . . 0.0 111.67 -179.105 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 96.7 m95 -90.32 130.73 36.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.14 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.2 m -129.17 137.47 57.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.533 178.454 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 37.6 m -78.58 109.95 13.25 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.467 179.786 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 61.6 m -118.06 152.5 35.43 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.609 -179.844 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.599 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 44.9 mt-10 -132.5 154.41 49.96 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.156 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.555 ' HB2' HD23 ' A' ' 100' ' ' LEU . 1.1 tm? -150.5 126.31 10.38 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 178.78 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -88.77 109.21 19.98 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.583 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.54 HD13 HD22 ' A' ' 90' ' ' LEU . 2.2 mt -81.73 -12.73 58.48 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.329 -179.395 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.712 ' OD2' ' HA ' ' A' ' 54' ' ' ASN . 3.0 t70 -65.96 -5.85 10.71 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.115 0.484 . . . . 0.0 110.845 -179.271 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 49.6 p -85.45 -26.38 26.38 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.857 -0.61 . . . . 0.0 112.03 -179.383 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 16.1 t -127.19 -2.59 6.35 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.573 -0.451 . . . . 0.0 112.089 -178.635 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.433 ' HB ' ' CD1' ' A' ' 55' ' ' PHE . 54.8 mt -111.21 134.34 53.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 O-C-N 122.124 -0.36 . . . . 0.0 110.388 179.0 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -148.72 158.41 27.65 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 121.12 -0.562 . . . . 0.0 111.787 179.522 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.573 ' N ' ' HD3' ' A' ' 44' ' ' PRO . 2.1 p-10 -157.04 46.62 0.26 Allowed Pre-proline 0 CA--C 1.537 0.475 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 179.635 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.575 ' HG2' ' SD ' ' A' ' 52' ' ' MET . 14.0 Cg_exo -66.99 -19.67 51.64 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 121.75 1.634 . . . . 0.0 111.671 -179.678 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 73.9 m-20 -88.77 -8.89 53.63 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.559 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.601 ' CA ' ' HG2' ' A' ' 83' ' ' ARG . . . 98.52 7.71 55.47 Favored Glycine 0 N--CA 1.443 -0.885 0 C-N-CA 120.488 -0.863 . . . . 0.0 112.557 -179.309 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -125.57 135.61 52.41 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.753 0.311 . . . . 0.0 110.286 179.695 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.475 ' HB3' ' HB ' ' A' ' 88' ' ' ILE . 86.4 mt -83.66 141.84 31.21 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.532 -178.532 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 176.51 168.28 36.36 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.447 179.193 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.424 ' HH2' HD11 ' A' ' 93' ' ' ILE . 89.1 m95 -95.71 134.81 38.2 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 147.35 -52.25 0.56 Allowed Glycine 0 CA--C 1.508 -0.404 0 N-CA-C 111.676 -0.569 . . . . 0.0 111.676 179.45 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.575 ' SD ' ' HG2' ' A' ' 44' ' ' PRO . 36.7 ttm -95.74 172.12 8.23 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 178.783 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -123.7 173.23 8.25 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 118.824 0.738 . . . . 0.0 111.507 -178.538 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.712 ' HA ' ' OD2' ' A' ' 38' ' ' ASP . 13.9 m120 66.82 63.37 0.49 Allowed 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 114.926 -1.034 . . . . 0.0 111.68 178.59 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.493 ' HB2' ' OD1' ' A' ' 43' ' ' ASN . 20.7 p90 -87.11 -35.95 18.39 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.336 179.452 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 17.7 t -64.47 -27.56 69.06 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.353 -178.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 69.5 m80 -76.37 -12.81 60.12 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.881 -179.259 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.519 ' O ' ' HG3' ' A' ' 76' ' ' LYS . 24.3 p -128.19 26.29 5.76 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.878 0.37 . . . . 0.0 111.303 -179.745 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 68.2 m -132.99 151.08 52.11 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 120.576 -0.45 . . . . 0.0 111.173 179.686 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -119.39 134.31 55.28 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.303 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.437 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 38.2 t70 61.1 84.65 0.13 Allowed 'General case' 0 N--CA 1.465 0.286 0 O-C-N 124.037 0.836 . . . . 0.0 110.934 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.488 HG23 HD21 ' A' ' 71' ' ' LEU . 72.2 mt -101.51 118.07 47.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.03 -179.127 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.456 ' HD3' ' N ' ' A' ' 64' ' ' LEU . 1.2 tmtp? -145.44 150.21 36.11 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 -179.792 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.606 HD13 ' HA2' ' A' ' 68' ' ' GLY . 56.1 mt -83.01 123.19 29.22 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.315 0.579 . . . . 0.0 111.456 -179.517 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -78.37 -61.79 1.89 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.13 -0.941 . . . . 0.0 111.973 -178.372 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 33.6 mm-40 -79.54 34.8 0.27 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.15 0.5 . . . . 0.0 111.433 -179.504 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 66.01 10.44 51.44 Favored Glycine 0 C--N 1.316 -0.575 0 CA-C-N 115.295 -0.866 . . . . 0.0 112.569 179.69 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.606 ' HA2' HD13 ' A' ' 64' ' ' LEU . . . 137.7 -16.95 3.5 Favored Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 120.348 -0.929 . . . . 0.0 112.963 179.807 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 27.2 mtt180 -83.23 -9.85 58.9 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 117.349 0.574 . . . . 0.0 110.779 -179.71 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 66.3 tttt -150.13 138.07 20.17 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.983 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.567 ' HB2' HD11 ' A' ' 90' ' ' LEU . 10.4 tt -107.2 126.44 52.41 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.958 -179.262 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.0 p -116.53 132.0 56.8 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.991 179.723 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.437 ' HA ' ' O ' ' A' ' 61' ' ' ASP . 26.8 p -159.97 175.4 13.06 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.065 -179.602 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.606 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 29.4 ttt180 -107.34 99.12 26.09 Favored Pre-proline 0 C--N 1.315 -0.892 0 C-N-CA 120.228 -0.589 . . . . 0.0 110.405 178.627 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.614 ' O ' ' HB3' ' A' ' 83' ' ' ARG . 55.3 Cg_endo -69.38 125.44 12.35 Favored 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 122.713 2.275 . . . . 0.0 110.492 178.686 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.746 ' HA ' ' HB2' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -120.52 139.99 52.11 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.904 0.383 . . . . 0.0 111.422 -179.693 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.723 HG22 ' O ' ' A' ' 82' ' ' PHE . 15.2 t -73.39 135.63 44.26 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 179.649 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 26.9 m -76.22 -8.99 12.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.63 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.522 -179.35 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -68.57 -30.18 68.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.776 179.531 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.555 ' HA3' ' CE2' ' A' ' 82' ' ' PHE . . . -146.01 -19.26 0.14 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.502 -0.856 . . . . 0.0 113.281 179.431 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.498 ' HA2' ' HE3' ' A' ' 76' ' ' LYS . . . 92.97 14.05 55.47 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.931 -0.652 . . . . 0.0 111.86 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.723 ' O ' HG22 ' A' ' 77' ' ' THR . 37.6 p90 -111.8 157.37 20.63 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 118.901 -0.571 . . . . 0.0 110.173 -178.349 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.746 ' HB2' ' HA ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 166.6 -157.57 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.357 0 O-C-N 123.661 0.601 . . . . 0.0 112.258 178.456 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 41.5 mm-40 -123.42 176.57 6.08 Favored 'General case' 0 CA--C 1.521 -0.173 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.384 -177.687 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.606 ' HA ' ' HA ' ' A' ' 74' ' ' ARG . 30.9 ttt85 -98.85 154.75 17.79 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 178.009 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.42 ' HG2' ' N ' ' A' ' 87' ' ' GLY . 49.1 tt0 -161.92 171.48 17.61 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.533 -178.086 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.42 ' N ' ' HG2' ' A' ' 86' ' ' GLN . . . -134.12 138.25 9.93 Favored Glycine 0 N--CA 1.447 -0.622 0 N-CA-C 111.695 -0.562 . . . . 0.0 111.695 178.696 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.475 ' HB ' ' HB3' ' A' ' 48' ' ' LEU . 11.1 tt -118.4 134.82 60.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 121.052 0.453 . . . . 0.0 110.09 -179.667 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -76.1 136.98 39.86 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.232 -178.868 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.792 HD13 HD11 ' A' ' 19' ' ' LEU . 52.4 mt -105.74 40.46 1.56 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.382 0.611 . . . . 0.0 111.451 -179.128 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -74.29 -2.91 27.12 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.27 179.413 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 8.4 mtp180 -91.79 -7.45 49.52 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.741 179.677 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.424 HD11 ' HH2' ' A' ' 50' ' ' TRP . 23.4 mm -105.47 112.1 37.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 -179.332 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.589 ' HA ' ' HB3' ' A' ' 3' ' ' TYR . 17.3 mt-30 -132.56 159.38 39.62 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.143 0.497 . . . . 0.0 111.477 -179.433 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.421 ' HA ' ' O ' ' A' ' 99' ' ' ARG . 13.2 p-10 -104.48 134.0 48.4 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.876 179.523 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 49.3 t -114.93 105.08 17.94 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.395 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -179.496 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 17.7 m-80 61.81 26.91 16.38 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.858 -179.021 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 113.88 -35.84 4.3 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.688 -0.767 . . . . 0.0 114.602 178.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.421 ' O ' ' HA ' ' A' ' 95' ' ' ASN . 0.0 OUTLIER -86.8 139.33 30.8 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 118.029 0.914 . . . . 0.0 112.817 -177.891 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.555 HD23 ' HB2' ' A' ' 35' ' ' LEU . 7.1 tp -81.29 120.05 24.42 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.968 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 26.2 t -128.29 141.52 46.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.308 -179.102 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.444 ' HB2' HD11 ' A' ' 35' ' ' LEU . 16.9 t80 -80.53 132.24 35.64 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 178.705 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 2.7 tp-100 . . . . . 0 C--O 1.253 1.25 0 CA-C-O 118.595 -0.717 . . . . 0.0 110.045 179.703 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.1 ptp . . . . . 0 N--CA 1.481 1.083 0 CA-C-O 121.007 0.432 . . . . 0.0 110.524 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.624 ' HB2' ' HG2' ' A' ' 69' ' ' ARG . 20.1 m -114.08 -179.31 3.6 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.042 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.483 ' HA ' ' OD1' ' A' ' 95' ' ' ASN . 12.6 p90 -54.89 -40.89 70.25 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -179.58 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.803 ' HB3' ' HG3' ' A' ' 69' ' ' ARG . . . -62.2 -18.45 61.08 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 -178.445 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.469 ' HB2' ' O ' ' A' ' 2' ' ' SER . 0.9 OUTLIER -64.43 -22.43 66.96 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 121.329 0.585 . . . . 0.0 110.572 179.626 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 49.6 m -140.92 39.21 1.8 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.274 179.075 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.478 ' HB3' ' HA ' ' A' ' 4' ' ' ALA . 13.2 t -145.63 154.66 42.37 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.926 -1.034 . . . . 0.0 108.698 179.831 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 21.0 ptt180 -140.47 164.09 31.08 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.734 0.302 . . . . 0.0 111.26 -179.205 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 57.96 51.42 8.98 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.686 178.867 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.514 ' HA ' ' HB2' ' A' ' 21' ' ' ALA . . . -81.98 117.39 22.16 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.206 179.444 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 26.7 m -119.24 169.88 9.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.349 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.643 ' HB3' ' HA2' ' A' ' 16' ' ' GLY . 3.2 mm? -105.15 115.27 29.98 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.803 -179.478 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 23.5 p -111.74 169.6 8.72 Favored 'General case' 0 C--O 1.243 0.72 0 CA-C-O 121.115 0.483 . . . . 0.0 111.692 -179.43 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 62.67 26.87 15.88 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 115.285 -0.87 . . . . 0.0 112.56 179.218 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 101.8 -14.3 57.53 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.437 179.274 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.643 ' HA2' ' HB3' ' A' ' 12' ' ' LEU . . . 116.8 43.17 0.63 Allowed Glycine 0 N--CA 1.443 -0.869 0 N-CA-C 111.209 -0.756 . . . . 0.0 111.209 -179.659 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.711 ' HB2' ' HB2' ' A' ' 38' ' ' ASP . 14.0 ptm180 -130.6 -29.69 1.93 Allowed 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.301 -0.45 . . . . 0.0 111.26 -179.384 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.431 ' HA ' ' HA ' ' A' ' 36' ' ' ASP . 10.3 m -104.37 136.32 44.17 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.435 -179.628 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.655 ' O ' ' HA ' ' A' ' 34' ' ' GLU . 84.5 mt -93.3 117.61 30.28 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.369 179.698 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 44.3 ttt85 -113.81 119.85 38.76 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 178.733 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.514 ' HB2' ' HA ' ' A' ' 10' ' ' ALA . . . -153.76 167.14 30.63 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.924 0.393 . . . . 0.0 111.443 -178.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -90.98 109.13 20.37 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 177.65 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.505 ' SG ' HD13 ' A' ' 100' ' ' LEU . 68.5 m -100.09 135.64 41.2 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 120.897 0.38 . . . . 0.0 111.313 -178.122 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 17.3 ttp180 -80.02 115.55 19.66 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.99 179.309 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 34.3 p30 -80.29 167.62 20.05 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.789 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -52.04 -32.24 33.49 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 -178.891 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -71.35 -13.45 61.87 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.288 0.566 . . . . 0.0 111.004 -179.335 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 90.43 28.91 15.42 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.971 -0.633 . . . . 0.0 111.644 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -120.01 157.82 28.06 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.618 0.247 . . . . 0.0 110.834 -179.507 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 91.9 m95 -90.34 131.43 36.14 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.755 0.312 . . . . 0.0 111.362 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.9 m -133.32 130.6 57.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.116 178.164 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.4 m -77.11 112.87 14.23 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.573 -179.716 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 66.4 m -124.11 160.19 28.32 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.978 -179.535 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.655 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 47.4 mt-10 -139.32 143.77 37.98 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.104 -179.817 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.456 HD11 ' HB2' ' A' ' 102' ' ' PHE . 1.8 tm? -138.47 127.77 24.44 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 178.61 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.431 ' HA ' ' HA ' ' A' ' 18' ' ' THR . 27.1 t70 -91.01 109.79 21.04 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.94 0.4 . . . . 0.0 110.599 -179.177 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.553 HD11 HD11 ' A' ' 19' ' ' LEU . 1.5 mt -81.23 -14.24 57.69 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.747 -179.645 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.763 ' OD2' ' HA ' ' A' ' 54' ' ' ASN . 6.6 t70 -63.23 -15.71 57.92 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.291 0.567 . . . . 0.0 110.55 -179.301 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 68.1 p -80.21 -22.41 41.87 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.554 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 21.0 m -122.94 -8.68 8.33 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -177.628 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 65.4 mt -111.73 134.16 55.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 110.335 -0.246 . . . . 0.0 110.335 179.768 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.465 ' HA3' ' HB3' ' A' ' 52' ' ' MET . . . -140.94 151.98 22.85 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.827 -0.702 . . . . 0.0 111.871 179.445 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.851 HD22 ' HB3' ' A' ' 75' ' ' PRO . 38.7 p-10 -160.57 48.53 0.25 Allowed Pre-proline 0 CA--C 1.54 0.561 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -179.308 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.562 ' HD3' ' N ' ' A' ' 43' ' ' ASN . 10.1 Cg_exo -68.28 -18.21 44.68 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 121.883 1.722 . . . . 0.0 111.798 -179.164 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -93.28 -6.63 47.07 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.294 -0.866 . . . . 0.0 111.146 -179.755 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.532 ' HA3' ' HD3' ' A' ' 83' ' ' ARG . . . 100.22 9.33 48.29 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.11 -1.043 . . . . 0.0 112.926 -179.506 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -125.08 128.98 49.32 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.119 0.485 . . . . 0.0 110.891 179.776 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.47 HD11 ' SG ' ' A' ' 73' ' ' CYS . 84.7 mt -83.41 137.87 33.74 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.782 -178.116 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -178.94 170.69 42.61 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 120.874 -0.679 . . . . 0.0 111.659 178.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.417 ' HH2' HD11 ' A' ' 93' ' ' ILE . 90.4 m95 -95.78 135.44 37.48 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.991 0.424 . . . . 0.0 110.153 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 147.89 -67.12 0.39 Allowed Glycine 0 N--CA 1.445 -0.706 0 N-CA-C 111.498 -0.641 . . . . 0.0 111.498 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.465 ' HB3' ' HA3' ' A' ' 42' ' ' GLY . 14.7 ttt -80.35 -179.46 7.13 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.458 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -131.36 168.07 18.19 Favored 'General case' 0 C--N 1.321 -0.668 0 O-C-N 122.082 -0.386 . . . . 0.0 111.111 -179.327 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.763 ' HA ' ' OD2' ' A' ' 38' ' ' ASP . 6.8 m-20 69.4 61.21 0.3 Allowed 'General case' 0 N--CA 1.461 0.087 0 O-C-N 124.079 0.862 . . . . 0.0 111.762 179.002 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.43 ' HD1' ' HA ' ' A' ' 38' ' ' ASP . 16.6 p90 -87.21 -37.35 17.35 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.319 179.484 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 72.2 p -64.74 -22.42 66.98 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.409 0.623 . . . . 0.0 110.501 -179.11 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 76.6 m80 -75.94 -11.53 59.98 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.096 -179.43 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.406 ' O ' ' HG3' ' A' ' 76' ' ' LYS . 3.0 p -133.65 33.65 3.49 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.556 179.201 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 38.6 m -136.45 154.19 50.85 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.311 0.577 . . . . 0.0 111.678 -179.818 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -131.22 146.52 52.35 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.142 -0.935 . . . . 0.0 109.652 179.399 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.49 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 33.4 t70 58.72 66.86 1.0 Allowed 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 121.335 0.588 . . . . 0.0 110.917 178.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.563 ' HA ' ' HB3' ' A' ' 73' ' ' CYS . 74.5 mt -93.9 114.15 29.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.633 -179.583 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 29.0 tptt -144.54 147.65 33.47 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.992 0.425 . . . . 0.0 110.305 -179.574 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.62 ' HG ' HD21 ' A' ' 12' ' ' LEU . 65.6 mt -83.35 140.89 32.16 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.401 179.69 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -102.41 -55.27 2.5 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.023 -0.535 . . . . 0.0 112.232 -178.78 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.429 ' H ' ' HB3' ' A' ' 70' ' ' LYS . 62.9 mm-40 -83.81 36.26 0.55 Allowed 'General case' 0 CA--C 1.515 -0.4 0 CA-C-O 121.061 0.457 . . . . 0.0 111.199 -179.667 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 70.49 -2.08 17.46 Favored Glycine 0 C--N 1.315 -0.589 0 CA-C-N 115.263 -0.881 . . . . 0.0 112.799 179.821 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.587 ' HA2' HD13 ' A' ' 64' ' ' LEU . . . 146.77 -12.84 1.51 Allowed Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.406 -0.902 . . . . 0.0 113.323 -179.712 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.803 ' HG3' ' HB3' ' A' ' 4' ' ' ALA . 53.3 mtm180 -94.2 4.21 54.2 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 117.557 0.678 . . . . 0.0 111.174 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.429 ' HB3' ' H ' ' A' ' 66' ' ' GLU . 39.9 tptt -151.45 119.74 6.37 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 -179.401 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.592 ' HB2' HD11 ' A' ' 90' ' ' LEU . 9.7 tt -104.29 120.07 40.36 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 -179.763 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.8 p -113.65 133.72 55.14 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.007 0.432 . . . . 0.0 110.798 179.64 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.563 ' HB3' ' HA ' ' A' ' 62' ' ' ILE . 26.2 p -159.98 175.61 12.82 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.887 -179.416 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.586 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 3.7 tmt_? -110.28 98.18 34.47 Favored Pre-proline 0 C--N 1.311 -1.084 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 178.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.851 ' HB3' HD22 ' A' ' 43' ' ' ASN . 59.1 Cg_endo -71.64 134.53 24.3 Favored 'Trans proline' 0 CA--C 1.515 -0.448 0 C-N-CA 123.221 2.614 . . . . 0.0 111.599 179.72 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.717 ' HA ' ' HB2' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -121.42 144.03 48.9 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 123.294 0.371 . . . . 0.0 111.347 179.44 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.763 HG22 ' O ' ' A' ' 82' ' ' PHE . 14.4 t -81.15 138.1 35.89 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.103 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 35.6 m -76.97 -4.68 6.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 O-C-N 124.057 0.848 . . . . 0.0 111.481 -179.53 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -69.95 -33.81 72.6 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.006 0.431 . . . . 0.0 110.352 178.765 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.45 ' HA3' ' CE2' ' A' ' 82' ' ' PHE . . . -148.25 -17.23 0.11 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.363 -0.922 . . . . 0.0 113.202 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.626 ' HA2' ' HE3' ' A' ' 76' ' ' LYS . . . 93.68 16.41 45.7 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.577 -0.82 . . . . 0.0 111.473 -179.431 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.763 ' O ' HG22 ' A' ' 77' ' ' THR . 33.2 p90 -112.2 154.16 25.98 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 118.754 -0.641 . . . . 0.0 109.478 -178.926 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.717 ' HB2' ' HA ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 170.8 -160.13 0.01 OUTLIER 'General case' 0 C--O 1.234 0.263 0 O-C-N 123.311 0.382 . . . . 0.0 111.772 179.477 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -124.77 -174.33 3.0 Favored 'General case' 0 C--O 1.226 -0.132 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.527 -177.489 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.586 ' HA ' ' HA ' ' A' ' 74' ' ' ARG . 35.1 ttt-85 -99.61 155.95 17.32 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 177.768 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -163.73 165.78 22.8 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 121.088 0.47 . . . . 0.0 111.854 -178.766 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -134.95 144.3 16.22 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 121.066 -0.588 . . . . 0.0 111.636 179.413 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 12.1 tt -123.64 138.92 51.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 120.975 0.417 . . . . 0.0 110.312 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -78.63 129.69 35.04 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.561 -179.688 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.623 HD13 HD11 ' A' ' 19' ' ' LEU . 60.4 mt -99.44 45.69 0.99 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.711 0.767 . . . . 0.0 110.291 179.807 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -79.15 3.13 18.55 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 114.821 -1.081 . . . . 0.0 110.039 -179.609 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 11.7 mtp180 -101.89 0.18 35.05 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.267 -179.122 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.426 ' CD1' HD22 ' A' ' 37' ' ' LEU . 21.9 mm -107.19 114.96 47.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 -179.321 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 27.0 tp60 -125.78 144.59 50.57 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.908 -178.416 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.483 ' OD1' ' HA ' ' A' ' 3' ' ' TYR . 12.9 p-10 -95.36 102.02 13.8 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.276 178.758 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 54.1 t -86.37 109.3 18.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 179.564 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 9.4 m120 57.64 31.6 20.62 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.02 0.438 . . . . 0.0 110.789 -178.873 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 95.1 -18.95 56.36 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.566 -0.826 . . . . 0.0 112.831 179.768 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 5.6 mpt_? -86.18 124.36 32.49 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 -179.7 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.505 HD13 ' SG ' ' A' ' 23' ' ' CYS . 6.7 tp -76.21 116.48 16.94 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 -179.648 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 44.9 t -130.99 143.19 41.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.622 -179.074 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.456 ' HB2' HD11 ' A' ' 35' ' ' LEU . 16.0 t80 -79.04 135.52 36.9 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.757 -0.461 . . . . 0.0 109.757 178.509 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 6.0 tp60 . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.653 -0.689 . . . . 0.0 110.163 -179.965 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.5 mtt . . . . . 0 N--CA 1.484 1.241 0 CA-C-O 120.892 0.377 . . . . 0.0 110.415 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.565 ' OG ' ' HA ' ' A' ' 91' ' ' ASN . 3.6 m -118.52 179.18 4.2 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.46 179.464 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.446 ' CZ ' HD13 ' A' ' 19' ' ' LEU . 13.6 p90 -57.25 -34.43 68.6 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.037 0.446 . . . . 0.0 110.411 178.335 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -57.29 -23.06 46.02 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 115.481 -0.781 . . . . 0.0 112.531 -179.003 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -64.98 -16.78 63.78 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 121.063 0.459 . . . . 0.0 110.815 179.666 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 49.7 m -146.66 35.48 0.95 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.712 178.882 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 44.5 m -145.48 163.55 34.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.879 179.789 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 6.1 ptp180 -148.05 165.12 31.75 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.596 -179.606 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 61.1 m-80 59.51 51.83 6.22 Favored 'General case' 0 N--CA 1.464 0.248 0 O-C-N 123.689 0.618 . . . . 0.0 111.376 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.484 ' HA ' ' HB2' ' A' ' 21' ' ' ALA . . . -83.89 117.38 23.29 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.391 179.418 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 31.2 m -123.0 168.9 14.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.481 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.81 HD21 ' HG ' ' A' ' 64' ' ' LEU . 3.4 mm? -104.45 114.32 28.48 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.68 -179.457 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 18.4 p -107.56 168.57 9.16 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.516 -179.381 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 60.4 39.8 18.13 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.039 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 89.62 -31.21 5.32 Favored Glycine 0 CA--C 1.519 0.335 0 CA-C-N 115.941 -0.572 . . . . 0.0 112.657 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.577 ' HA2' ' HB3' ' A' ' 12' ' ' LEU . . . 136.29 56.49 0.06 OUTLIER Glycine 0 N--CA 1.449 -0.472 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 -179.314 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.5 ptm180 -142.52 -31.89 0.51 Allowed 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.856 0.36 . . . . 0.0 111.078 -179.379 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.444 HG22 ' HB3' ' A' ' 34' ' ' GLU . 5.5 m -101.3 136.77 40.6 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.764 -179.538 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.751 HD11 HD13 ' A' ' 90' ' ' LEU . 67.8 mt -94.63 118.07 31.12 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.65 179.052 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.402 ' HD2' HH11 ' A' ' 20' ' ' ARG . 21.8 ttt180 -114.6 119.97 38.57 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 178.708 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.484 ' HB2' ' HA ' ' A' ' 10' ' ' ALA . . . -154.05 168.94 24.75 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.693 0.282 . . . . 0.0 111.317 -178.897 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.453 ' HB3' ' HB3' ' A' ' 30' ' ' TRP . 43.4 mt-10 -87.65 106.2 17.87 Favored 'General case' 0 CA--C 1.513 -0.461 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 178.048 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.553 ' SG ' HD13 ' A' ' 100' ' ' LEU . 30.4 m -93.25 121.26 34.43 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.451 -177.928 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.529 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 9.5 ttp180 -70.03 112.94 6.77 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.147 179.264 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.457 ' ND2' ' HB3' ' A' ' 29' ' ' ASN . 36.2 p30 -78.69 170.65 16.32 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.359 -179.776 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.96 -27.4 52.36 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -178.899 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -80.31 -1.44 41.0 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.498 0.666 . . . . 0.0 110.409 -179.607 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.97 28.95 48.5 Favored Glycine 0 N--CA 1.448 -0.55 0 CA-C-N 115.534 -0.757 . . . . 0.0 112.107 179.599 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.529 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 57.7 t30 -110.98 163.02 14.25 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 121.212 -0.195 . . . . 0.0 110.818 -179.03 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.453 ' HB3' ' HB3' ' A' ' 22' ' ' GLU . 92.5 m95 -101.55 115.71 31.13 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.528 179.616 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.8 m -116.49 148.87 18.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 120.993 0.425 . . . . 0.0 110.835 179.224 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 28.3 m -86.11 110.52 19.6 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.269 179.803 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.482 ' HB2' ' SG ' ' A' ' 23' ' ' CYS . 70.1 m -128.99 147.22 50.84 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.682 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.648 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 51.9 mt-10 -129.84 148.72 51.74 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.548 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.553 HD11 ' HB2' ' A' ' 102' ' ' PHE . 1.8 tm? -140.51 129.34 23.15 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 178.753 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.456 ' N ' HD13 ' A' ' 35' ' ' LEU . 14.5 m-20 -87.13 109.21 19.29 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 -179.565 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.506 HD13 HD22 ' A' ' 90' ' ' LEU . 1.9 mt -85.12 -21.43 29.28 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -179.19 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.4 ' HA ' ' HD1' ' A' ' 55' ' ' PHE . 5.9 p-10 -65.18 -6.96 10.65 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.744 0.307 . . . . 0.0 111.568 -178.386 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 69.0 p -81.09 -16.14 53.99 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.641 179.034 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.409 ' HG ' ' HZ ' ' A' ' 102' ' ' PHE . 29.2 t -133.28 -10.02 2.91 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.718 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 51.1 mt -104.81 134.26 46.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 178.264 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.52 ' HA3' ' HB3' ' A' ' 52' ' ' MET . . . -148.33 155.73 26.55 Favored Glycine 0 N--CA 1.442 -0.919 0 C-N-CA 120.577 -0.821 . . . . 0.0 112.112 -179.643 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.628 ' N ' ' HD3' ' A' ' 44' ' ' PRO . 27.0 p30 -158.2 43.92 0.18 Allowed Pre-proline 0 CA--C 1.542 0.648 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.628 ' HD3' ' N ' ' A' ' 43' ' ' ASN . 16.2 Cg_exo -67.46 -23.06 44.24 Favored 'Trans proline' 0 C--N 1.356 0.952 0 C-N-CA 121.967 1.778 . . . . 0.0 111.683 -179.219 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 52.5 m-80 -89.3 -1.92 58.25 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.11 179.563 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.534 ' HA3' ' HG2' ' A' ' 83' ' ' ARG . . . 92.6 11.17 59.64 Favored Glycine 0 N--CA 1.443 -0.843 0 C-N-CA 120.385 -0.912 . . . . 0.0 112.657 -179.692 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 43.5 m-85 -125.19 132.44 53.02 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.767 0.318 . . . . 0.0 110.588 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.424 HD23 HG22 ' A' ' 88' ' ' ILE . 10.3 mp -86.0 146.03 26.84 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.892 -178.863 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 169.22 171.31 34.79 Favored Glycine 0 N--CA 1.442 -0.944 0 CA-C-N 115.476 -0.784 . . . . 0.0 112.066 178.156 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.438 ' CD1' HD11 ' A' ' 88' ' ' ILE . 90.3 m95 -95.48 125.18 39.91 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.496 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 153.29 -44.85 0.59 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.936 -0.649 . . . . 0.0 111.637 -179.561 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.52 ' HB3' ' HA3' ' A' ' 42' ' ' GLY . 12.7 tpt -94.2 174.61 7.06 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.784 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 -130.72 171.56 12.96 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.993 -179.659 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 64.23 37.41 8.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.991 177.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.498 ' HB3' ' HA2' ' A' ' 42' ' ' GLY . 11.7 p90 -62.33 -38.42 89.4 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.528 -0.469 . . . . 0.0 109.865 179.191 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 15.6 t -60.09 -29.98 68.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.12 -179.215 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 27.9 m80 -77.03 -12.62 59.96 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.815 0.341 . . . . 0.0 111.301 -179.657 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 19.7 m -126.54 27.77 6.06 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.078 0.466 . . . . 0.0 111.166 -179.714 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 38.6 m -132.41 147.56 52.38 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.195 0.522 . . . . 0.0 111.258 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.668 ' HG3' ' HB3' ' A' ' 74' ' ' ARG . 7.0 pt-20 -121.23 142.44 49.91 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.51 178.571 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.419 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 37.6 t70 58.43 80.39 0.18 Allowed 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.55 0.691 . . . . 0.0 110.477 -178.691 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.542 HG23 HD21 ' A' ' 71' ' ' LEU . 70.5 mt -102.77 119.66 51.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.997 -179.267 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.4 tpmt? -148.97 156.82 42.82 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 -179.754 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.81 ' HG ' HD21 ' A' ' 12' ' ' LEU . 71.9 mt -88.39 121.3 30.63 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.984 0.421 . . . . 0.0 110.099 178.904 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -71.88 -55.45 7.5 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.899 -178.817 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.534 ' CB ' ' HB2' ' A' ' 69' ' ' ARG . 8.8 mm-40 -87.08 13.57 9.09 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.884 -179.396 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 69.9 23.17 77.11 Favored Glycine 0 N--CA 1.448 -0.528 0 CA-C-N 115.7 -0.682 . . . . 0.0 112.578 179.79 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 145.27 -36.76 1.36 Allowed Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.029 -1.082 . . . . 0.0 112.956 179.332 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.534 ' HB2' ' CB ' ' A' ' 66' ' ' GLU . 8.3 mmt85 -72.39 -29.12 63.46 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.928 0.394 . . . . 0.0 111.396 -179.784 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 41.7 tttp -140.45 140.09 35.33 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.976 -177.868 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.616 ' HB2' HD11 ' A' ' 90' ' ' LEU . 9.9 tt -111.35 122.93 49.15 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 179.142 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.2 p -110.87 131.89 54.66 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.361 0.6 . . . . 0.0 110.873 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.419 ' HA ' ' O ' ' A' ' 61' ' ' ASP . 24.6 p -156.61 167.51 30.22 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.708 -179.659 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.668 ' HB3' ' HG3' ' A' ' 60' ' ' GLU . 67.5 ttt180 -103.81 101.3 23.99 Favored Pre-proline 0 C--N 1.314 -0.958 0 N-CA-C 109.865 -0.421 . . . . 0.0 109.865 178.807 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.64 ' O ' ' HB3' ' A' ' 83' ' ' ARG . 61.5 Cg_endo -71.04 119.01 6.0 Favored 'Trans proline' 0 CA--C 1.513 -0.54 0 C-N-CA 122.871 2.381 . . . . 0.0 111.029 179.483 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.699 ' HA ' ' HB2' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -119.63 135.76 54.67 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 120.76 0.314 . . . . 0.0 110.486 179.795 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.715 HG22 ' O ' ' A' ' 82' ' ' PHE . 14.7 t -70.18 128.67 37.08 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 12.4 p -71.41 -12.57 16.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.474 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -60.24 -30.42 69.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.08 179.277 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.597 ' HA3' ' CE2' ' A' ' 82' ' ' PHE . . . -146.5 -35.68 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.433 0 CA-C-N 115.578 -0.737 . . . . 0.0 112.458 179.85 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 111.91 12.41 14.35 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 121.237 -0.506 . . . . 0.0 112.058 -179.522 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.715 ' O ' HG22 ' A' ' 77' ' ' THR . 16.1 p90 -112.66 152.82 28.54 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 118.782 -0.628 . . . . 0.0 110.37 -178.55 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.699 ' HB2' ' HA ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 167.52 -158.25 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.603 0 O-C-N 123.682 0.614 . . . . 0.0 111.994 178.675 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 57.4 mm-40 -117.62 -173.26 2.39 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.978 -178.088 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.632 ' HA ' ' HD2' ' A' ' 75' ' ' PRO . 73.2 ttt180 -115.93 151.38 35.5 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 178.524 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.463 ' HG3' ' O ' ' A' ' 85' ' ' ARG . 31.1 mt-30 -157.95 -170.1 3.05 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.379 0.609 . . . . 0.0 112.335 -178.387 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -155.33 145.98 13.46 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.09 179.304 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.438 HD11 ' CD1' ' A' ' 50' ' ' TRP . 12.4 tt -128.46 142.17 44.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.953 0.377 . . . . 0.0 110.474 -179.628 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.408 ' HB3' HD22 ' A' ' 91' ' ' ASN . 3.8 m-20 -82.5 133.82 35.2 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.184 0.516 . . . . 0.0 110.693 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.751 HD13 HD11 ' A' ' 19' ' ' LEU . 26.5 mt -101.02 39.64 1.37 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.616 -179.247 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.565 ' HA ' ' OG ' ' A' ' 2' ' ' SER . 9.4 m-80 -73.88 2.95 7.4 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.068 -0.969 . . . . 0.0 111.048 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 9.8 mtp180 -97.23 -11.07 24.63 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.459 179.316 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.436 ' CD1' HD22 ' A' ' 37' ' ' LEU . 23.3 mm -96.56 102.73 13.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 121.392 0.615 . . . . 0.0 109.449 -179.354 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 6.6 mm100 -107.83 153.82 22.45 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.563 -178.598 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.432 ' HB3' HD12 ' A' ' 100' ' ' LEU . 22.8 p-10 -112.57 112.09 23.37 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.723 178.363 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 9.0 p -111.51 120.51 62.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.105 0.479 . . . . 0.0 110.176 -179.695 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 12.4 m120 59.15 28.93 18.37 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.98 -178.623 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 88.09 -9.73 73.63 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.517 -179.36 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 10.5 mpt_? -91.4 124.8 35.86 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 -179.804 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.553 HD13 ' SG ' ' A' ' 23' ' ' CYS . 5.9 tp -82.16 117.11 22.06 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 16.6 t -129.24 138.07 55.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 120.651 0.262 . . . . 0.0 110.77 -179.136 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.553 ' HB2' HD11 ' A' ' 35' ' ' LEU . 6.8 t80 -80.91 125.72 30.48 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 177.829 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 . . . . . 0 C--N 1.311 -1.076 0 CA-C-O 118.077 -0.964 . . . . 0.0 110.856 179.848 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.456 ' HG2' HE22 ' A' ' 94' ' ' GLN . 16.5 ttt . . . . . 0 N--CA 1.479 1.0 0 CA-C-O 120.603 0.24 . . . . 0.0 110.471 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.5 ' OG ' ' HA ' ' A' ' 91' ' ' ASN . 11.8 m -104.67 178.07 4.67 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 179.56 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 34.6 p90 -59.86 -35.14 74.16 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 121.094 -0.242 . . . . 0.0 110.99 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -55.84 -22.09 23.21 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 112.114 0.412 . . . . 0.0 112.114 -179.356 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -68.27 -22.68 64.73 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 120.878 0.371 . . . . 0.0 110.716 179.463 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 9.6 p -139.73 29.97 2.1 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.31 0.576 . . . . 0.0 110.181 179.603 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 9.3 t -150.71 156.82 42.09 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -179.692 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 9.4 ptp180 -149.07 166.93 27.24 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.655 0.264 . . . . 0.0 111.127 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 29.6 m120 57.85 60.71 2.65 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.967 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -90.48 125.47 35.6 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.853 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 34.0 m -122.62 170.65 12.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.8 179.807 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.63 HD21 ' HG ' ' A' ' 64' ' ' LEU . 3.2 mm? -104.8 114.21 28.29 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.355 -179.235 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 21.6 p -110.3 167.47 10.17 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.812 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 57.52 50.34 11.3 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.889 179.779 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 85.29 -37.95 3.01 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 121.01 -0.614 . . . . 0.0 112.516 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.618 ' HA2' ' HB3' ' A' ' 12' ' ' LEU . . . 138.59 38.83 0.11 Allowed Glycine 0 N--CA 1.447 -0.595 0 N-CA-C 111.284 -0.727 . . . . 0.0 111.284 -179.709 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.64 ' HB3' ' HB3' ' A' ' 56' ' ' SER . 48.7 ptt85 -123.49 -23.23 4.84 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.939 0.4 . . . . 0.0 110.744 -179.267 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.3 m -105.28 137.5 42.96 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.027 -179.384 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.743 HD11 HD13 ' A' ' 90' ' ' LEU . 58.5 mt -97.05 116.17 28.78 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.576 179.294 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.82 119.68 40.12 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 178.242 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -152.33 168.07 26.6 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.979 0.419 . . . . 0.0 111.776 -178.348 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -89.99 106.09 18.25 Favored 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 178.513 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 58.1 m -97.95 130.68 44.8 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 120.761 0.315 . . . . 0.0 110.633 -178.218 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.527 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 10.5 ttp180 -78.37 122.2 25.47 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.497 179.831 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.448 HD21 ' HB3' ' A' ' 29' ' ' ASN . 35.6 p30 -86.83 168.36 13.53 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.827 179.415 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.84 -31.32 49.03 Favored 'General case' 0 N--CA 1.464 0.255 0 O-C-N 123.555 0.535 . . . . 0.0 112.356 -179.11 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -69.51 -17.84 63.63 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.446 0.641 . . . . 0.0 110.662 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 93.72 28.7 10.82 Favored Glycine 0 N--CA 1.446 -0.684 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.313 -179.542 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.527 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 43.9 t30 -112.91 160.97 17.52 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.644 0.259 . . . . 0.0 110.901 -179.106 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 94.6 m95 -100.37 114.33 27.77 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.93 0.395 . . . . 0.0 111.049 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.6 m -117.75 129.19 74.55 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.381 178.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 13.7 m -75.01 111.66 10.45 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.877 -0.602 . . . . 0.0 111.015 -179.415 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.417 ' HB3' ' H ' ' A' ' 100' ' ' LEU . 73.5 m -121.58 153.3 38.22 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.609 179.827 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.601 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 42.8 mt-10 -129.4 141.46 51.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.206 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.615 HD11 ' HB2' ' A' ' 102' ' ' PHE . 1.9 tm? -136.54 131.96 34.58 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.387 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.416 ' N ' HD13 ' A' ' 35' ' ' LEU . 31.8 m-20 -88.58 109.8 20.38 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 -179.646 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.527 HD13 HD22 ' A' ' 90' ' ' LEU . 4.4 mt -79.64 -20.56 46.45 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.286 -179.636 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.543 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 5.1 p-10 -65.99 -5.87 10.92 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.629 -0.259 . . . . 0.0 111.461 -178.897 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 72.9 p -81.08 -20.84 40.65 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.625 179.472 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.446 ' SG ' ' HE3' ' A' ' 50' ' ' TRP . 40.9 t -129.05 -11.51 4.72 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.616 -179.871 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 51.3 mt -100.14 128.8 51.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.083 178.819 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.517 ' HA3' ' HB3' ' A' ' 52' ' ' MET . . . -139.34 154.34 23.44 Favored Glycine 0 N--CA 1.443 -0.876 0 C-N-CA 120.852 -0.69 . . . . 0.0 111.518 179.497 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.939 HD22 ' HB3' ' A' ' 75' ' ' PRO . 33.0 p-10 -160.95 44.24 0.15 Allowed Pre-proline 0 CA--C 1.539 0.533 0 N-CA-C 113.142 0.794 . . . . 0.0 113.142 -179.263 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -70.95 -16.76 32.5 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 121.404 1.403 . . . . 0.0 111.895 -179.387 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -89.07 -9.55 50.75 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.493 179.74 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.562 ' CA ' ' HG2' ' A' ' 83' ' ' ARG . . . 102.21 6.47 48.16 Favored Glycine 0 N--CA 1.443 -0.899 0 C-N-CA 120.482 -0.866 . . . . 0.0 112.503 -179.38 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -125.14 134.42 52.44 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 122.732 -0.275 . . . . 0.0 110.85 179.808 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.51 HD23 ' HB3' ' A' ' 43' ' ' ASN . 88.0 mt -83.99 146.42 27.99 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.218 -179.166 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 170.82 169.99 34.52 Favored Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 120.539 -0.839 . . . . 0.0 112.361 178.822 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.446 ' HE3' ' SG ' ' A' ' 40' ' ' CYS . 90.8 m95 -95.3 124.98 39.62 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 110.048 -0.352 . . . . 0.0 110.048 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 160.73 -60.05 0.3 Allowed Glycine 0 N--CA 1.448 -0.558 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.791 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.517 ' HB3' ' HA3' ' A' ' 42' ' ' GLY . 0.4 OUTLIER -86.69 -162.15 0.74 Allowed 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 -179.902 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -147.25 175.19 10.95 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.768 -0.373 . . . . 0.0 111.708 -179.468 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 14.6 m120 62.72 54.15 2.39 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 123.936 0.773 . . . . 0.0 112.236 179.278 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -87.5 -17.25 32.54 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.179 178.786 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.64 ' HB3' ' HB3' ' A' ' 17' ' ' ARG . 6.1 p -55.21 -55.65 28.87 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 -177.741 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 47.4 m80 -80.96 -10.23 59.74 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.926 0.393 . . . . 0.0 111.264 -179.179 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.4 ' HB2' ' OD1' ' A' ' 43' ' ' ASN . 15.0 m -96.01 14.41 23.78 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.942 0.401 . . . . 0.0 110.79 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 19.5 m -136.56 152.93 51.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.0 0.428 . . . . 0.0 111.551 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -119.1 145.69 45.73 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.477 178.19 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 35.9 t70 49.93 74.59 0.2 Allowed 'General case' 0 N--CA 1.47 0.561 0 O-C-N 123.787 0.679 . . . . 0.0 111.662 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.518 HG23 HD21 ' A' ' 71' ' ' LEU . 75.0 mt -91.51 115.46 30.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.489 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 15.0 tptm -149.07 150.97 33.64 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 121.031 0.443 . . . . 0.0 111.532 -179.521 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.63 ' HG ' HD21 ' A' ' 12' ' ' LEU . 64.1 mt -88.95 129.93 35.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.383 179.35 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -86.43 -57.22 3.09 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-O 121.126 0.488 . . . . 0.0 111.186 -179.594 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.516 ' HG2' ' HB3' ' A' ' 70' ' ' LYS . 16.3 mm-40 -71.9 -5.74 36.79 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.189 -179.183 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 95.51 -0.07 63.14 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 121.014 -0.612 . . . . 0.0 111.759 -179.525 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 164.34 -39.55 0.31 Allowed Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.434 -0.889 . . . . 0.0 112.555 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 7.9 mmt180 -62.31 -33.48 74.76 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.516 ' HB3' ' HG2' ' A' ' 66' ' ' GLU . 32.2 ttpt -135.44 139.09 43.84 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.915 0.388 . . . . 0.0 111.962 -178.292 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.607 ' HB2' HD11 ' A' ' 90' ' ' LEU . 10.5 tt -117.55 132.81 56.47 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.485 -0.779 . . . . 0.0 109.355 179.42 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.454 HG22 ' HA3' ' A' ' 87' ' ' GLY . 18.7 p -125.64 144.78 50.44 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.937 0.398 . . . . 0.0 111.04 179.437 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.468 ' HB3' ' HA ' ' A' ' 62' ' ' ILE . 24.0 p -162.6 175.45 11.4 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.582 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 52.9 ttt180 -109.3 98.25 30.5 Favored Pre-proline 0 C--N 1.311 -1.101 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 178.616 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.939 ' HB3' HD22 ' A' ' 43' ' ' ASN . 32.1 Cg_endo -64.3 127.21 18.6 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 122.866 2.377 . . . . 0.0 110.279 179.338 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.721 ' HA ' ' HB2' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -120.28 147.56 44.83 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.068 0.461 . . . . 0.0 111.619 -179.663 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.713 HG22 ' O ' ' A' ' 82' ' ' PHE . 14.5 t -81.61 141.47 33.67 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 179.007 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.1 m -73.87 -8.3 11.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 O-C-N 123.923 0.764 . . . . 0.0 111.321 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 53.0 m-20 -63.89 -34.04 77.06 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-O 120.955 0.407 . . . . 0.0 110.312 179.311 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -157.0 -10.92 0.05 OUTLIER Glycine 0 CA--C 1.519 0.298 0 C-N-CA 120.468 -0.872 . . . . 0.0 113.183 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.35 18.49 42.07 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.768 -0.729 . . . . 0.0 111.881 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.713 ' O ' HG22 ' A' ' 77' ' ' THR . 39.2 p90 -111.4 157.85 19.77 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 118.677 -0.678 . . . . 0.0 109.418 -179.144 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.721 ' HB2' ' HA ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 167.36 -149.08 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.428 0 O-C-N 123.543 0.527 . . . . 0.0 111.516 179.659 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -130.31 157.04 43.62 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.088 -178.184 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.582 ' HA ' ' HA ' ' A' ' 74' ' ' ARG . 38.8 ttt85 -82.85 154.03 24.86 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 179.181 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -162.57 164.57 26.74 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.795 -0.362 . . . . 0.0 111.309 -177.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.454 ' HA3' HG22 ' A' ' 72' ' ' THR . . . -128.22 146.0 16.45 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.094 179.6 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 12.3 tt -128.74 136.01 60.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 120.977 0.417 . . . . 0.0 110.305 179.776 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -80.34 138.85 36.76 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.057 0.456 . . . . 0.0 110.348 179.727 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.743 HD13 HD11 ' A' ' 19' ' ' LEU . 50.0 mt -101.98 43.38 1.07 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.804 0.811 . . . . 0.0 109.857 -179.755 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.5 ' HA ' ' OG ' ' A' ' 2' ' ' SER . 5.1 m-20 -76.67 0.28 20.89 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 114.689 -1.142 . . . . 0.0 111.097 -179.347 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 14.6 mtp180 -98.12 -6.11 32.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.517 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.415 HG13 HD22 ' A' ' 37' ' ' LEU . 22.8 mm -101.48 118.89 48.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 -179.131 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.456 HE22 ' HG2' ' A' ' 1' ' ' MET . 7.4 tp-100 -132.1 143.89 50.33 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.004 -178.721 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -96.92 102.92 14.8 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.654 0.74 . . . . 0.0 110.487 178.863 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.2 p -87.81 117.84 32.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.232 0.539 . . . . 0.0 110.047 179.434 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 60.43 27.18 16.78 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.228 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 95.83 -9.42 68.37 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.813 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.483 ' HD2' ' N ' ' A' ' 99' ' ' ARG . 4.0 mpt_? -99.77 124.82 45.43 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 122.394 -0.474 . . . . 0.0 110.17 -179.642 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.417 ' H ' ' HB3' ' A' ' 33' ' ' SER . 12.2 tp -75.76 114.99 14.99 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.977 -179.247 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 45.7 t -130.4 145.73 35.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.25 -179.066 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.615 ' HB2' HD11 ' A' ' 35' ' ' LEU . 11.8 t80 -78.67 135.65 37.25 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 178.538 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 2.3 tp60 . . . . . 0 C--O 1.247 0.947 0 CA-C-O 118.774 -0.631 . . . . 0.0 109.996 -179.959 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.7 mtt . . . . . 0 N--CA 1.481 1.093 0 CA-C-O 120.647 0.26 . . . . 0.0 110.446 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -82.31 178.11 8.42 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 178.699 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.44 ' CB ' HD11 ' A' ' 100' ' ' LEU . 6.7 p90 -54.71 -39.89 68.66 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 -177.799 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.614 ' HA ' ' OG ' ' A' ' 7' ' ' SER . . . -60.62 -20.42 60.65 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -178.266 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -68.42 -35.48 77.69 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.418 0.628 . . . . 0.0 109.808 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 8.1 m -120.38 34.8 5.08 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.855 -179.12 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.614 ' OG ' ' HA ' ' A' ' 4' ' ' ALA . 92.6 p -142.73 167.14 22.79 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 121.053 0.454 . . . . 0.0 110.161 178.826 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 13.5 ptp180 -152.19 166.46 31.66 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.018 -179.752 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 24.6 m120 59.31 47.57 11.25 Favored 'General case' 0 N--CA 1.466 0.367 0 O-C-N 123.646 0.591 . . . . 0.0 110.959 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.4 ' HA ' ' HB2' ' A' ' 21' ' ' ALA . . . -80.53 118.45 22.14 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.823 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 29.6 m -126.52 170.52 16.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.12 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.781 HD21 ' HG ' ' A' ' 64' ' ' LEU . 3.1 mm? -104.53 114.77 29.21 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.237 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.436 ' OG1' ' HB ' ' A' ' 18' ' ' THR . 14.8 p -109.89 166.37 10.98 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.736 179.742 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.528 ' O ' ' HG2' ' A' ' 17' ' ' ARG . 90.4 m-20 57.15 50.28 12.1 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.13 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 83.42 -34.2 2.91 Favored Glycine 0 N--CA 1.452 -0.27 0 CA-C-N 115.962 -0.563 . . . . 0.0 112.841 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.612 ' HA2' ' HB3' ' A' ' 12' ' ' LEU . . . 135.59 42.44 0.12 Allowed Glycine 0 N--CA 1.447 -0.567 0 N-CA-C 111.194 -0.762 . . . . 0.0 111.194 -179.348 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.528 ' HG2' ' O ' ' A' ' 14' ' ' ASN . 5.4 ptm180 -124.55 -27.53 3.7 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.95 0.405 . . . . 0.0 110.712 -179.419 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.467 HG22 ' HB3' ' A' ' 34' ' ' GLU . 2.3 m -102.63 134.52 45.87 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.192 -179.177 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.742 HD11 HD13 ' A' ' 90' ' ' LEU . 45.9 mt -94.43 111.08 22.82 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.05 178.75 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.457 ' HA ' ' HG2' ' A' ' 34' ' ' GLU . 25.7 ttt85 -106.98 120.03 40.96 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 179.421 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.4 ' HB2' ' HA ' ' A' ' 10' ' ' ALA . . . -155.06 167.03 31.73 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.873 0.368 . . . . 0.0 111.247 -179.706 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -89.09 108.03 19.37 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 177.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.592 ' SG ' HD13 ' A' ' 100' ' ' LEU . 46.8 m -95.93 129.73 43.11 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 120.778 0.323 . . . . 0.0 110.734 -178.376 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.571 ' HB2' ' CZ3' ' A' ' 30' ' ' TRP . 11.3 ttt85 -82.82 117.63 22.84 Favored 'General case' 0 N--CA 1.438 -1.06 0 N-CA-C 110.171 -0.307 . . . . 0.0 110.171 179.167 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 32.4 p30 -80.38 166.61 21.12 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.928 179.682 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.84 -26.03 44.82 Favored 'General case' 0 N--CA 1.465 0.285 0 O-C-N 123.702 0.626 . . . . 0.0 112.262 -178.59 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -71.12 -16.09 62.54 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.168 0.509 . . . . 0.0 110.091 179.663 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 93.21 24.67 21.48 Favored Glycine 0 N--CA 1.447 -0.567 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.22 179.75 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.44 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 32.7 m-20 -116.55 160.01 21.27 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.851 0.357 . . . . 0.0 111.449 -179.247 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.571 ' CZ3' ' HB2' ' A' ' 24' ' ' ARG . 93.5 m95 -95.73 122.62 38.7 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.067 0.46 . . . . 0.0 111.876 -179.305 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.4 m -122.8 134.08 67.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.59 178.56 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 23.1 m -75.23 113.09 12.19 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.05 179.459 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.407 ' HB2' ' SG ' ' A' ' 23' ' ' CYS . 74.4 m -128.43 153.57 46.96 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.08 -179.601 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.587 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 49.3 mt-10 -137.93 144.54 41.29 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.768 -179.582 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.455 HD12 HD23 ' A' ' 37' ' ' LEU . 1.8 tm? -137.86 129.28 27.91 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 178.917 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.435 ' N ' HD13 ' A' ' 35' ' ' LEU . 13.6 m-20 -86.88 109.74 19.51 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.417 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.534 HD13 HD22 ' A' ' 90' ' ' LEU . 3.0 mt -82.02 -18.27 43.89 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 112.57 0.581 . . . . 0.0 112.57 -178.655 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.459 ' HA ' ' HD1' ' A' ' 55' ' ' PHE . 6.7 p-10 -65.7 -6.18 10.76 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.708 0.29 . . . . 0.0 111.522 -178.56 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 46.9 p -78.76 -23.25 45.46 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.836 179.431 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.542 ' HG ' ' HZ ' ' A' ' 102' ' ' PHE . 17.2 t -130.31 -10.77 4.14 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -179.468 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.406 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 49.0 mt -99.77 128.76 51.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 178.504 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.533 ' HA3' ' HB3' ' A' ' 52' ' ' MET . . . -142.47 150.9 22.57 Favored Glycine 0 N--CA 1.442 -0.952 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.119 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.922 HD22 ' HB3' ' A' ' 75' ' ' PRO . 31.1 p-10 -157.11 47.94 0.31 Allowed Pre-proline 0 C--N 1.323 -0.579 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -179.713 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -73.01 -17.25 25.18 Favored 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 121.638 1.558 . . . . 0.0 111.87 -179.303 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -93.09 -5.84 49.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.467 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.593 ' HA3' ' HG2' ' A' ' 83' ' ' ARG . . . 101.56 7.15 49.13 Favored Glycine 0 N--CA 1.443 -0.871 0 C-N-CA 120.334 -0.936 . . . . 0.0 112.834 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -125.45 131.55 52.86 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.015 0.436 . . . . 0.0 111.309 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.451 HD23 ' HB3' ' A' ' 43' ' ' ASN . 81.7 mt -83.77 137.68 33.62 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.378 -178.925 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 177.62 171.66 41.32 Favored Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 120.861 -0.685 . . . . 0.0 111.854 179.08 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.48 ' CD2' ' HD3' ' A' ' 92' ' ' ARG . 90.6 m95 -96.29 125.04 40.52 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.997 0.427 . . . . 0.0 110.191 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 154.85 -58.3 0.39 Allowed Glycine 0 CA--C 1.507 -0.449 0 N-CA-C 110.916 -0.874 . . . . 0.0 110.916 -179.297 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.533 ' HB3' ' HA3' ' A' ' 42' ' ' GLY . 44.7 tpp -82.93 174.3 11.04 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 178.661 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -132.11 176.66 8.19 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 118.654 0.661 . . . . 0.0 111.798 -179.794 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 4.9 m120 64.65 43.04 4.43 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.467 -0.788 . . . . 0.0 112.342 179.759 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.459 ' HD1' ' HA ' ' A' ' 38' ' ' ASP . 6.3 p90 -69.12 -25.5 64.43 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.997 -0.372 . . . . 0.0 109.997 179.217 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 9.4 p -58.24 -42.7 86.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.355 -179.431 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 41.4 m80 -80.26 -9.99 59.74 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.011 0.434 . . . . 0.0 111.215 -179.619 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.684 ' HA ' ' HD2' ' A' ' 76' ' ' LYS . 10.2 m -113.28 18.26 17.97 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.604 -178.912 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 23.5 m -131.85 143.64 50.32 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-O 121.158 0.504 . . . . 0.0 111.336 179.759 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 67.2 mm-40 -113.58 134.51 54.67 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.675 178.497 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 23.9 t70 57.34 79.6 0.19 Allowed 'General case' 0 C--N 1.322 -0.601 0 O-C-N 123.994 0.809 . . . . 0.0 111.33 -179.236 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.53 HG23 HD21 ' A' ' 71' ' ' LEU . 75.6 mt -91.6 123.57 43.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.882 179.691 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 27.8 tptt -149.05 149.88 31.85 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 110.156 -0.312 . . . . 0.0 110.156 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.781 ' HG ' HD21 ' A' ' 12' ' ' LEU . 70.3 mt -85.89 141.27 29.7 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.188 0.518 . . . . 0.0 110.608 179.233 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -100.68 -70.84 0.72 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.432 -0.804 . . . . 0.0 112.515 -178.283 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.452 ' HG3' ' HB3' ' A' ' 70' ' ' LYS . 31.3 mt-10 -74.67 49.0 0.38 Allowed 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -178.185 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 64.95 7.97 32.68 Favored Glycine 0 C--N 1.32 -0.326 0 CA-C-N 115.938 -0.574 . . . . 0.0 112.848 179.581 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.606 ' HA2' HD13 ' A' ' 64' ' ' LEU . . . 127.26 -3.3 7.24 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.645 -0.788 . . . . 0.0 113.122 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 29.9 ttp85 -95.43 0.38 53.31 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.793 0.806 . . . . 0.0 110.317 -179.448 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.452 ' HB3' ' HG3' ' A' ' 66' ' ' GLU . 0.5 OUTLIER -147.69 129.49 15.21 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.403 -179.984 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.575 ' HB2' HD11 ' A' ' 90' ' ' LEU . 10.0 tt -105.82 118.98 37.99 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 179.599 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.5 p -108.79 128.1 54.59 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.018 179.78 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.446 ' HB3' ' HA ' ' A' ' 62' ' ' ILE . 26.5 p -157.74 172.11 19.09 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.054 -179.727 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.531 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 78.9 ttt180 -108.16 100.44 36.82 Favored Pre-proline 0 C--N 1.31 -1.112 0 C-N-CA 120.225 -0.59 . . . . 0.0 109.971 178.614 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.922 ' HB3' HD22 ' A' ' 43' ' ' ASN . 19.2 Cg_endo -60.29 130.46 34.13 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 122.655 2.237 . . . . 0.0 110.246 178.96 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.684 ' HD2' ' HA ' ' A' ' 58' ' ' SER . 0.0 OUTLIER -119.97 154.14 34.93 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.256 0.551 . . . . 0.0 111.665 -179.133 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.716 ' HB ' ' HD2' ' A' ' 83' ' ' ARG . 6.3 t -94.08 147.64 22.94 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.69 -0.687 . . . . 0.0 109.551 179.131 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.4 p -72.34 -6.67 8.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 O-C-N 123.834 0.709 . . . . 0.0 111.941 -178.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -65.39 -23.15 66.89 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.108 0.48 . . . . 0.0 110.367 179.212 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -177.8 -8.99 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.987 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 94.42 22.1 25.27 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.707 -0.759 . . . . 0.0 111.72 179.726 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.627 ' O ' HG22 ' A' ' 77' ' ' THR . 26.7 p90 -111.33 153.1 26.45 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 -179.367 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.716 ' HD2' ' HB ' ' A' ' 77' ' ' THR . 0.0 OUTLIER 171.63 -148.39 0.0 OUTLIER 'General case' 0 C--O 1.233 0.224 0 O-C-N 123.683 0.614 . . . . 0.0 110.956 179.958 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -123.4 160.14 27.45 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.173 -177.885 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.531 ' HA ' ' HA ' ' A' ' 74' ' ' ARG . 41.8 ttt180 -86.66 155.09 20.54 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 179.562 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 44.8 tt0 -163.99 169.32 18.16 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 121.091 0.472 . . . . 0.0 110.992 -178.817 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -136.85 133.06 6.29 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.841 -0.695 . . . . 0.0 111.686 179.169 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 10.1 tt -115.28 134.51 58.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-O 121.047 0.451 . . . . 0.0 110.18 -179.644 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -80.26 141.14 35.83 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.142 -179.688 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.742 HD13 HD11 ' A' ' 19' ' ' LEU . 16.6 mt -106.73 43.5 1.15 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.455 0.645 . . . . 0.0 110.887 -178.343 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 45.4 m-80 -79.63 3.28 19.52 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.463 -179.506 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.48 ' HD3' ' CD2' ' A' ' 50' ' ' TRP . 32.6 mtp180 -93.69 -9.89 36.28 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.576 178.847 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 17.2 mm -96.02 112.1 27.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 -179.57 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -119.1 147.01 44.63 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.149 -178.044 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 16.8 p-10 -95.6 102.89 14.73 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.51 0.671 . . . . 0.0 109.602 178.12 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 46.7 t -92.05 105.94 17.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.971 -179.351 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 60.7 33.88 20.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.842 -179.488 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 94.98 -23.03 35.03 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 121.037 -0.601 . . . . 0.0 113.007 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 3.7 mpt_? -87.13 129.39 34.95 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.945 0.373 . . . . 0.0 110.107 -179.181 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.592 HD13 ' SG ' ' A' ' 23' ' ' CYS . 6.7 tp -78.38 117.64 19.8 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -179.807 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 25.4 t -128.93 141.03 47.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.262 -179.155 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.542 ' HZ ' ' HG ' ' A' ' 40' ' ' CYS . 5.9 t80 -86.55 135.0 33.61 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 178.53 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 5.1 tp60 . . . . . 0 C--O 1.251 1.178 0 CA-C-O 118.506 -0.759 . . . . 0.0 110.234 179.43 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.0 mpp? . . . . . 0 N--CA 1.479 0.999 0 CA-C-O 120.921 0.391 . . . . 0.0 110.158 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.1 m -118.55 179.53 4.1 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.645 -179.482 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.511 ' HA ' ' OD1' ' A' ' 95' ' ' ASN . 11.0 p90 -57.49 -35.19 69.88 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.666 -0.243 . . . . 0.0 111.298 179.245 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -57.29 -22.24 40.37 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -178.978 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -66.27 -13.6 60.68 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.05 0.453 . . . . 0.0 110.977 179.565 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 11.0 p -149.25 33.98 0.73 Allowed 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 178.814 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 15.9 t -146.95 150.7 35.7 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.021 -179.268 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 34.6 ptt180 -129.55 164.5 23.67 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.666 -179.232 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 51.25 65.32 1.52 Allowed 'General case' 0 C--N 1.329 -0.299 0 O-C-N 123.826 0.704 . . . . 0.0 112.151 178.503 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.446 ' HA ' ' HB2' ' A' ' 21' ' ' ALA . . . -91.3 117.85 30.0 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.155 179.449 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 33.8 m -119.39 166.95 13.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.881 -179.372 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.636 HD21 ' HG ' ' A' ' 64' ' ' LEU . 3.1 mm? -105.22 117.14 33.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.014 -179.734 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.49 ' OG1' ' HB ' ' A' ' 18' ' ' THR . 23.5 p -111.29 164.21 13.14 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.639 -179.65 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.49 ' HB3' ' HD3' ' A' ' 17' ' ' ARG . 89.6 m-20 62.26 39.08 12.86 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.71 179.265 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 84.62 -8.47 68.77 Favored Glycine 0 CA--C 1.517 0.179 0 C-N-CA 120.742 -0.742 . . . . 0.0 113.325 179.144 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.495 ' HA2' ' HB3' ' A' ' 12' ' ' LEU . . . 114.09 53.88 0.43 Allowed Glycine 0 N--CA 1.443 -0.873 0 C-N-CA 120.527 -0.844 . . . . 0.0 111.383 179.421 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.49 ' HD3' ' HB3' ' A' ' 14' ' ' ASN . 3.4 ptm180 -137.78 -34.01 0.69 Allowed 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.088 0.471 . . . . 0.0 110.573 -179.91 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.49 ' HB ' ' OG1' ' A' ' 13' ' ' THR . 4.2 m -102.36 135.06 44.65 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.54 -179.798 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.713 HD11 HD13 ' A' ' 90' ' ' LEU . 62.6 mt -94.95 116.4 28.65 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.218 179.136 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.411 ' NE ' HG21 ' A' ' 13' ' ' THR . 33.5 ttm180 -111.4 120.39 42.0 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 178.732 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.446 ' HB2' ' HA ' ' A' ' 10' ' ' ALA . . . -153.7 165.34 36.29 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.862 0.363 . . . . 0.0 111.418 -179.526 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -91.44 106.0 18.17 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 177.801 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.404 ' HB3' HD22 ' A' ' 95' ' ' ASN . 64.0 m -96.01 134.89 38.49 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 120.911 0.386 . . . . 0.0 110.984 -178.495 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.511 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 15.1 ttp180 -77.54 111.41 13.24 Favored 'General case' 0 N--CA 1.439 -0.999 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.052 179.558 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.463 HD21 ' HB3' ' A' ' 29' ' ' ASN . 38.2 p30 -75.71 169.38 18.22 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.48 -179.786 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.86 -33.29 64.42 Favored 'General case' 0 C--O 1.235 0.296 0 O-C-N 123.416 0.447 . . . . 0.0 111.718 -179.151 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -68.22 -14.69 63.17 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.327 0.584 . . . . 0.0 110.677 179.969 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 88.66 37.56 7.38 Favored Glycine 0 N--CA 1.447 -0.589 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 -179.504 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.511 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 53.7 t30 -124.81 164.16 20.6 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.496 0.189 . . . . 0.0 110.891 -179.082 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 91.1 m95 -98.05 124.89 42.77 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.885 179.587 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.4 m -128.42 137.88 56.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.028 178.544 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 37.4 m -84.1 109.32 17.61 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.002 0.43 . . . . 0.0 111.055 -179.048 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 69.6 m -119.09 148.8 42.64 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.138 179.409 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.646 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 45.4 mt-10 -127.86 145.33 50.97 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.867 -179.955 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.798 HD11 ' HB2' ' A' ' 102' ' ' PHE . 1.8 tm? -139.71 130.58 26.12 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 179.507 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.49 ' N ' HD13 ' A' ' 35' ' ' LEU . 39.7 m-20 -87.26 110.53 20.26 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.002 179.825 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.524 HD13 HD22 ' A' ' 90' ' ' LEU . 1.8 mt -84.86 -20.79 30.27 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.845 0.355 . . . . 0.0 110.871 -179.923 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.423 ' HA ' ' HD1' ' A' ' 55' ' ' PHE . 5.6 p-10 -67.35 -5.88 16.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.983 -178.195 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.416 HG22 ' O ' ' A' ' 36' ' ' ASP . 10.6 t -84.65 -8.51 58.85 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.867 0.365 . . . . 0.0 110.358 179.415 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 21.8 t -140.49 -5.41 1.22 Allowed 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 179.511 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 59.5 mt -106.95 136.7 41.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 O-C-N 122.036 -0.415 . . . . 0.0 109.882 178.957 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.656 ' HA3' ' HB3' ' A' ' 52' ' ' MET . . . -146.72 154.38 25.94 Favored Glycine 0 N--CA 1.443 -0.846 0 C-N-CA 120.89 -0.671 . . . . 0.0 111.777 179.553 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.4 HD22 ' CD2' ' A' ' 48' ' ' LEU . 27.6 p30 -155.28 48.15 0.36 Allowed Pre-proline 0 CA--C 1.537 0.454 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 179.986 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -68.69 -23.75 35.83 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 121.722 1.614 . . . . 0.0 112.238 -179.084 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 72.0 m-20 -91.94 0.59 57.47 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.923 -179.582 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.546 ' CA ' ' HG2' ' A' ' 83' ' ' ARG . . . 93.05 7.28 62.59 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.287 -0.959 . . . . 0.0 112.049 -179.301 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -122.55 133.95 54.55 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.851 0.357 . . . . 0.0 110.807 179.831 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.433 ' HB3' ' HB ' ' A' ' 88' ' ' ILE . 34.0 mt -84.5 147.89 26.81 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.536 -0.757 . . . . 0.0 111.664 -179.172 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 170.37 168.95 32.91 Favored Glycine 0 N--CA 1.441 -1.023 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.974 179.121 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.403 ' HH2' HD11 ' A' ' 93' ' ' ILE . 89.1 m95 -95.64 125.33 40.15 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 179.975 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 161.77 -53.72 0.32 Allowed Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 121.026 -0.607 . . . . 0.0 112.249 -179.696 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.656 ' HB3' ' HA3' ' A' ' 42' ' ' GLY . 4.1 tpt -90.92 -164.82 1.23 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 -179.952 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -146.3 170.58 16.5 Favored 'General case' 0 C--O 1.234 0.275 0 O-C-N 122.025 -0.422 . . . . 0.0 111.939 -178.815 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 14.9 m120 64.0 36.13 10.17 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.454 -0.794 . . . . 0.0 112.599 178.991 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.454 ' HB3' ' HA2' ' A' ' 42' ' ' GLY . 8.0 p90 -65.23 -29.75 70.58 Favored 'General case' 0 C--O 1.224 -0.288 0 CA-C-O 120.684 0.278 . . . . 0.0 111.193 -179.896 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.454 ' HB2' ' HB3' ' A' ' 17' ' ' ARG . 13.4 t -57.07 -36.69 70.85 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -178.315 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 13.3 m-70 -80.82 -6.56 58.72 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.151 0.5 . . . . 0.0 110.984 -179.528 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 12.9 m -119.03 25.78 9.96 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.118 -179.987 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.532 ' HB2' HD11 ' A' ' 62' ' ' ILE . 11.6 m -137.3 140.23 41.4 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-O 121.059 0.457 . . . . 0.0 111.321 179.788 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -108.71 141.2 41.04 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.179 179.063 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 39.1 t70 52.35 75.94 0.21 Allowed 'General case' 0 C--N 1.32 -0.7 0 O-C-N 123.998 0.811 . . . . 0.0 111.402 179.95 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.533 HG23 HD21 ' A' ' 71' ' ' LEU . 81.6 mt -90.22 122.25 41.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.235 179.591 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.7 tptm -146.97 160.32 42.5 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.124 -178.892 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.636 ' HG ' HD21 ' A' ' 12' ' ' LEU . 55.8 mt -93.66 130.01 39.75 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.267 0.556 . . . . 0.0 110.012 178.602 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.462 ' HB3' ' HB3' ' A' ' 70' ' ' LYS . 45.2 tp10 -77.71 -66.33 0.85 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.39 -178.108 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.534 ' HB2' ' HB3' ' A' ' 69' ' ' ARG . 23.7 mt-10 -88.68 31.43 0.84 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.189 -178.889 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 68.04 17.91 70.3 Favored Glycine 0 N--CA 1.446 -0.638 0 CA-C-N 115.8 -0.636 . . . . 0.0 113.091 179.83 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.517 ' HA2' HD22 ' A' ' 64' ' ' LEU . . . 137.14 -21.96 3.28 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 119.828 -1.177 . . . . 0.0 113.3 179.184 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.534 ' HB3' ' HB2' ' A' ' 66' ' ' GLU . 0.8 OUTLIER -76.74 -21.05 55.81 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.579 0.704 . . . . 0.0 109.987 -179.642 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.462 ' HB3' ' HB3' ' A' ' 65' ' ' GLU . 2.6 ttmp? -148.43 138.46 22.42 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.094 -178.708 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.641 ' HB2' HD11 ' A' ' 90' ' ' LEU . 10.2 tt -108.89 124.96 51.46 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.309 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.1 p -116.16 127.77 55.08 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.544 0.687 . . . . 0.0 111.014 179.561 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.496 ' HB3' ' HA ' ' A' ' 62' ' ' ILE . 26.6 p -153.51 175.86 12.7 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.314 -179.721 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.615 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 12.0 ttt180 -108.33 98.74 28.77 Favored Pre-proline 0 C--N 1.31 -1.114 0 C-N-CA 120.623 -0.431 . . . . 0.0 110.007 178.654 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.665 ' O ' ' HB3' ' A' ' 83' ' ' ARG . 49.4 Cg_endo -67.12 122.54 9.86 Favored 'Trans proline' 0 CA--C 1.516 -0.4 0 C-N-CA 122.835 2.357 . . . . 0.0 110.82 179.478 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.778 ' HA ' ' HB2' ' A' ' 83' ' ' ARG . 0.3 OUTLIER -120.29 147.04 45.5 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-O 120.914 0.388 . . . . 0.0 111.564 -179.333 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.771 HG22 ' O ' ' A' ' 82' ' ' PHE . 7.9 t -74.84 137.82 42.11 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 178.988 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 29.6 m -73.2 -12.33 15.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 123.82 0.7 . . . . 0.0 111.355 -179.635 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -63.55 -33.38 75.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.652 179.379 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.553 ' HA3' ' CE2' ' A' ' 82' ' ' PHE . . . -145.81 -23.07 0.12 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.42 -0.895 . . . . 0.0 113.088 179.73 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.616 ' HA2' ' HD3' ' A' ' 76' ' ' LYS . . . 98.68 14.7 36.6 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 121.049 -0.596 . . . . 0.0 111.877 -179.706 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.771 ' O ' HG22 ' A' ' 77' ' ' THR . 28.2 p90 -112.48 154.26 26.15 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 119.029 -0.51 . . . . 0.0 110.608 -178.492 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.778 ' HB2' ' HA ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 167.38 -153.13 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.461 0 O-C-N 123.745 0.653 . . . . 0.0 111.202 178.308 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.408 ' O ' ' HG3' ' A' ' 74' ' ' ARG . 18.7 mm-40 -116.48 -177.34 3.16 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.143 -177.24 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.615 ' HA ' ' HA ' ' A' ' 74' ' ' ARG . 68.0 ttt180 -107.21 155.31 20.05 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 178.783 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.459 ' HG2' ' N ' ' A' ' 87' ' ' GLY . 50.9 tt0 -166.37 167.74 15.57 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 120.87 0.366 . . . . 0.0 111.491 -178.976 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.459 ' N ' ' HG2' ' A' ' 86' ' ' GLN . . . -130.39 144.08 15.4 Favored Glycine 0 N--CA 1.45 -0.428 0 N-CA-C 111.564 -0.614 . . . . 0.0 111.564 178.601 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.433 ' HB ' ' HB3' ' A' ' 48' ' ' LEU . 9.4 tt -126.57 138.92 53.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 120.93 0.395 . . . . 0.0 110.517 -179.846 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -77.42 135.91 38.35 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.369 179.811 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.713 HD13 HD11 ' A' ' 19' ' ' LEU . 53.9 mt -105.38 39.43 1.74 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.688 -179.884 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -75.35 2.53 11.03 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.104 -179.541 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 49.0 mtp180 -95.88 -10.48 28.72 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.657 -0.702 . . . . 0.0 109.967 178.33 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.476 HG13 HD22 ' A' ' 37' ' ' LEU . 20.9 mm -100.66 99.51 8.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -179.764 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 24.4 tp60 -115.98 143.14 45.85 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.089 -178.485 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.511 ' OD1' ' HA ' ' A' ' 3' ' ' TYR . 15.0 p-10 -95.18 122.81 38.25 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.008 178.728 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.3 p -115.04 115.75 50.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-O 121.16 0.505 . . . . 0.0 109.944 179.313 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 10.9 m120 60.37 28.3 17.92 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.709 -179.166 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 94.77 -14.94 64.4 Favored Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 120.804 -0.712 . . . . 0.0 113.048 179.915 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.47 ' HD2' ' N ' ' A' ' 99' ' ' ARG . 3.3 mpt_? -91.7 131.93 36.74 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 117.158 0.479 . . . . 0.0 110.559 -179.12 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.41 ' HA ' HD12 ' A' ' 100' ' ' LEU . 8.5 tp -84.29 116.54 23.05 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.251 -179.28 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 24.4 t -125.54 140.3 48.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 120.798 0.332 . . . . 0.0 110.914 -179.287 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.798 ' HB2' HD11 ' A' ' 35' ' ' LEU . 3.9 t80 -91.67 124.37 35.76 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 178.396 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 . . . . . 0 C--N 1.314 -0.969 0 CA-C-O 118.002 -0.999 . . . . 0.0 110.955 179.82 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.8 mpp? . . . . . 0 N--CA 1.481 1.12 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.591 ' OG ' ' HA ' ' A' ' 91' ' ' ASN . 3.3 m -116.89 173.48 6.62 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.97 179.372 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.557 ' HA ' ' OD1' ' A' ' 95' ' ' ASN . 23.4 p90 -58.31 -37.65 75.5 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.53 0.205 . . . . 0.0 111.446 -179.892 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -55.09 -19.2 6.77 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.792 -0.64 . . . . 0.0 112.623 -178.794 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -59.15 -38.15 79.03 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.389 0.614 . . . . 0.0 109.956 179.168 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 49.2 m -133.08 46.5 2.6 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.15 179.086 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.431 ' HA ' ' HZ3' ' A' ' 30' ' ' TRP . 16.5 t -148.79 152.18 36.09 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.22 -179.329 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 3.9 ptp180 -149.39 171.69 16.14 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.314 -179.846 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.426 ' HB2' ' HG2' ' A' ' 22' ' ' GLU . 24.1 m120 62.96 45.84 5.16 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 122.959 0.504 . . . . 0.0 110.437 -179.286 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -83.16 118.07 23.34 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.996 -179.718 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 27.1 m -126.24 170.69 15.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.193 179.519 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.565 ' HB3' ' HA2' ' A' ' 16' ' ' GLY . 3.0 mm? -105.37 117.64 34.53 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 -179.332 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.409 ' OG1' ' HB ' ' A' ' 18' ' ' THR . 28.0 p -113.87 162.17 16.69 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.974 0.416 . . . . 0.0 111.508 -179.745 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 64.32 30.33 13.39 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.526 179.652 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 95.92 -18.87 56.64 Favored Glycine 0 C--O 1.228 -0.255 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.755 179.46 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.565 ' HA2' ' HB3' ' A' ' 12' ' ' LEU . . . 123.47 42.6 0.38 Allowed Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.508 -0.853 . . . . 0.0 111.768 179.78 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -126.77 -29.02 2.9 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.096 0.474 . . . . 0.0 110.541 -179.91 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.409 ' HB ' ' OG1' ' A' ' 13' ' ' THR . 4.9 m -104.53 134.25 48.02 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.555 -179.877 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.803 HD11 HD13 ' A' ' 90' ' ' LEU . 33.6 mt -94.23 113.32 25.22 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.118 179.02 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 45.1 ttt180 -106.96 119.51 39.57 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 178.843 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -154.12 166.36 33.32 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.878 0.37 . . . . 0.0 111.151 -179.762 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.426 ' HG2' ' HB2' ' A' ' 9' ' ' ASN . 56.2 mm-40 -90.71 113.45 25.54 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 178.276 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.45 ' SG ' HD13 ' A' ' 100' ' ' LEU . 60.4 m -100.31 123.53 44.66 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 110.34 -0.245 . . . . 0.0 110.34 -178.957 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.514 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 11.7 ttp180 -72.6 114.47 10.77 Favored 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 179.015 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.407 HD21 ' HB3' ' A' ' 29' ' ' ASN . 35.4 p30 -77.66 171.04 15.54 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.85 -179.23 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.36 -33.87 63.77 Favored 'General case' 0 N--CA 1.464 0.252 0 O-C-N 123.675 0.609 . . . . 0.0 111.917 -178.776 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -67.92 -18.69 64.85 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.361 0.601 . . . . 0.0 110.613 -179.851 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 93.69 33.66 6.97 Favored Glycine 0 N--CA 1.443 -0.849 0 N-CA-C 111.085 -0.806 . . . . 0.0 111.085 -179.475 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.514 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 10.8 t-20 -118.49 159.89 22.71 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 110.013 -0.365 . . . . 0.0 110.013 -179.221 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.431 ' HZ3' ' HA ' ' A' ' 7' ' ' SER . 95.5 m95 -98.37 117.67 33.31 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.855 0.36 . . . . 0.0 110.6 179.918 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 12.5 m -119.23 132.27 69.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.38 178.773 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 27.9 m -74.86 110.36 9.09 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.021 0.439 . . . . 0.0 110.231 -179.624 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 60.7 m -121.29 145.62 47.68 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.599 -179.606 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.598 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 50.4 mt-10 -129.03 130.59 46.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.931 -179.505 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.449 HD11 ' HB2' ' A' ' 102' ' ' PHE . 2.4 tm? -124.86 131.62 53.42 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.437 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.423 ' N ' HD13 ' A' ' 35' ' ' LEU . 9.0 m-20 -89.78 109.16 20.17 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.841 0.353 . . . . 0.0 110.189 -179.114 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.529 HD13 HD22 ' A' ' 90' ' ' LEU . 2.4 mt -81.87 -17.84 45.9 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.164 -179.494 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -62.18 -10.18 9.78 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.817 0.342 . . . . 0.0 111.149 -179.317 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 59.5 p -78.99 -20.4 49.18 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.191 179.585 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.424 ' SG ' ' HE3' ' A' ' 50' ' ' TRP . 20.5 t -132.36 -8.66 3.32 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -179.191 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 53.9 mt -104.69 133.45 48.79 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 O-C-N 122.132 -0.355 . . . . 0.0 110.225 178.777 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.525 ' HA3' ' HB3' ' A' ' 52' ' ' MET . . . -147.84 160.28 28.27 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.921 -0.657 . . . . 0.0 111.823 179.91 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.464 HD22 ' CD1' ' A' ' 48' ' ' LEU . 21.6 p30 -162.3 54.15 0.46 Allowed Pre-proline 0 CA--C 1.537 0.45 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -179.799 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -72.16 -18.17 27.32 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 121.923 1.749 . . . . 0.0 112.311 -179.242 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.449 ' O ' ' HD3' ' A' ' 83' ' ' ARG . 93.0 m-20 -93.25 -16.51 24.69 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.437 179.822 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.538 ' HA3' ' HG2' ' A' ' 83' ' ' ARG . . . 109.82 9.64 24.3 Favored Glycine 0 N--CA 1.442 -0.964 0 C-N-CA 120.467 -0.873 . . . . 0.0 112.542 -179.333 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -125.55 134.67 51.9 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.872 0.368 . . . . 0.0 110.623 179.716 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.595 HD23 HG22 ' A' ' 88' ' ' ILE . 10.5 mp -84.23 142.91 29.94 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.345 0.593 . . . . 0.0 111.848 -178.603 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 176.96 171.33 40.44 Favored Glycine 0 N--CA 1.439 -1.148 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.611 178.956 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.424 ' HE3' ' SG ' ' A' ' 40' ' ' CYS . 91.4 m95 -96.11 124.74 40.23 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 179.835 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 160.2 -58.81 0.31 Allowed Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 121.21 -0.519 . . . . 0.0 111.873 -179.708 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.525 ' HB3' ' HA3' ' A' ' 42' ' ' GLY . 12.8 tpt -85.89 175.2 8.77 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 -179.893 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -128.8 167.0 17.95 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.722 -0.391 . . . . 0.0 111.075 -179.712 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 11.3 m-80 64.56 49.79 2.3 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.449 179.026 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.453 ' HB3' ' HA2' ' A' ' 42' ' ' GLY . 21.1 p90 -68.48 -31.2 70.31 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.07 0.462 . . . . 0.0 110.187 179.021 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.443 ' HA ' HD11 ' A' ' 62' ' ' ILE . 3.5 p -56.53 -38.16 71.48 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.591 -178.699 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 22.4 m80 -72.49 -30.94 64.96 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.632 0.253 . . . . 0.0 111.331 -179.52 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 14.1 m -96.88 18.36 14.74 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.011 -179.488 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 45.4 m -130.79 165.31 23.25 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.199 0.523 . . . . 0.0 111.491 -179.756 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -137.64 136.14 37.19 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.245 -0.889 . . . . 0.0 108.95 178.589 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 37.0 t70 58.88 80.22 0.19 Allowed 'General case' 0 N--CA 1.467 0.425 0 O-C-N 123.649 0.593 . . . . 0.0 110.86 -179.705 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.525 ' HA ' ' HB3' ' A' ' 73' ' ' CYS . 59.9 mt -100.95 122.16 52.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.261 -179.13 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 72.9 tttt -149.22 165.1 32.89 Favored 'General case' 0 C--O 1.221 -0.407 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 179.466 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.525 ' HG ' HD21 ' A' ' 12' ' ' LEU . 71.2 mt -90.84 127.39 36.34 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.068 0.461 . . . . 0.0 111.072 -179.603 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -76.29 -57.97 3.55 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.443 -0.798 . . . . 0.0 110.676 -179.179 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.477 ' CB ' ' HB3' ' A' ' 69' ' ' ARG . 15.4 mm-40 -85.03 11.84 8.81 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.789 -179.521 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 71.61 28.07 69.98 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.383 179.973 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 136.86 -34.48 2.21 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.207 -0.996 . . . . 0.0 112.627 179.448 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.477 ' HB3' ' CB ' ' A' ' 66' ' ' GLU . 2.1 tpp180 -75.62 -18.47 59.69 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.116 0.484 . . . . 0.0 110.589 -179.551 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.45 ' HB3' ' HG2' ' A' ' 66' ' ' GLU . 38.9 ttmt -151.42 141.88 22.53 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.067 -178.804 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.562 ' HB2' HD11 ' A' ' 90' ' ' LEU . 10.5 tt -110.52 128.62 55.72 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.104 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.2 p -123.16 128.11 49.6 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.317 0.58 . . . . 0.0 111.293 -179.905 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.525 ' HB3' ' HA ' ' A' ' 62' ' ' ILE . 20.5 p -151.94 169.91 21.15 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.516 179.875 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.635 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 29.4 ttt180 -106.35 99.73 25.64 Favored Pre-proline 0 C--N 1.321 -0.645 0 C-N-CA 120.263 -0.575 . . . . 0.0 110.492 179.126 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.647 ' O ' ' HB3' ' A' ' 83' ' ' ARG . 60.5 Cg_endo -71.75 137.85 30.68 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 122.622 2.215 . . . . 0.0 110.273 178.718 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.712 ' HA ' ' HB2' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -121.39 140.68 51.82 Favored 'General case' 0 C--N 1.317 -0.807 0 O-C-N 123.483 0.49 . . . . 0.0 111.113 -179.883 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.732 HG22 ' O ' ' A' ' 82' ' ' PHE . 12.5 t -75.61 138.86 41.71 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 179.291 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 34.7 m -73.18 -9.78 13.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 O-C-N 124.122 0.889 . . . . 0.0 111.199 -179.826 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -66.92 -31.39 71.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.054 179.673 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.406 ' HA3' ' CE2' ' A' ' 82' ' ' PHE . . . -154.48 -12.49 0.06 OUTLIER Glycine 0 CA--C 1.521 0.428 0 C-N-CA 120.519 -0.848 . . . . 0.0 113.359 179.751 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.615 ' HA2' ' HE3' ' A' ' 76' ' ' LYS . . . 91.25 16.25 53.88 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.959 -0.639 . . . . 0.0 112.082 -179.792 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.732 ' O ' HG22 ' A' ' 77' ' ' THR . 35.4 p90 -111.76 158.35 19.45 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 118.694 -0.669 . . . . 0.0 109.612 -178.866 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.712 ' HB2' ' HA ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 171.37 -148.25 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 179.431 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -142.99 152.49 42.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.373 -0.831 . . . . 0.0 109.496 -178.195 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.635 ' HA ' ' HA ' ' A' ' 74' ' ' ARG . 27.8 ttt85 -77.84 150.43 34.22 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 123.229 0.331 . . . . 0.0 110.123 -179.794 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.431 ' HB3' HD13 ' A' ' 48' ' ' LEU . 52.4 tt0 -155.58 158.85 39.07 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.317 -178.806 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -123.32 144.34 15.58 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.088 179.412 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.595 HG22 HD23 ' A' ' 48' ' ' LEU . 12.8 tt -123.96 135.04 64.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 179.563 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -77.1 140.92 40.4 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.068 0.461 . . . . 0.0 110.017 -179.882 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.803 HD13 HD11 ' A' ' 19' ' ' LEU . 26.4 mt -106.35 41.17 1.47 Allowed 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.334 0.588 . . . . 0.0 110.765 -179.424 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.591 ' HA ' ' OG ' ' A' ' 2' ' ' SER . 10.6 m120 -75.06 2.85 9.62 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.763 -179.96 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 9.7 mtp180 -96.72 -16.54 20.84 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.165 179.797 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.434 HG13 HD22 ' A' ' 37' ' ' LEU . 22.4 mm -92.73 114.36 29.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 109.684 -0.488 . . . . 0.0 109.684 -178.904 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 23.1 tp60 -124.6 141.46 52.08 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.356 0.598 . . . . 0.0 111.545 -178.157 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.557 ' OD1' ' HA ' ' A' ' 3' ' ' TYR . 13.1 p-10 -94.62 102.22 14.13 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.673 178.176 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.7 p -90.56 110.41 22.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.504 -179.348 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 60.42 27.32 16.92 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.14 -179.919 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 100.29 -17.04 57.48 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.735 -0.745 . . . . 0.0 113.225 179.739 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.41 ' HD2' ' N ' ' A' ' 99' ' ' ARG . 1.7 mpt_? -91.53 126.09 36.49 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 117.23 0.515 . . . . 0.0 109.871 -179.541 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.45 HD13 ' SG ' ' A' ' 23' ' ' CYS . 11.2 tp -82.84 114.03 20.87 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.233 -179.203 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 38.4 t -131.47 146.48 33.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 120.694 0.283 . . . . 0.0 110.321 -179.338 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.449 ' HB2' HD11 ' A' ' 35' ' ' LEU . 11.7 t80 -78.67 133.94 37.17 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 178.771 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 . . . . . 0 C--O 1.247 0.951 0 CA-C-O 118.632 -0.699 . . . . 0.0 110.067 179.824 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.8 ptp . . . . . 0 N--CA 1.482 1.168 0 CA-C-O 120.724 0.297 . . . . 0.0 110.548 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.848 ' HB2' ' HG2' ' A' ' 69' ' ' ARG . 4.7 m -116.75 174.67 5.95 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.848 179.441 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.422 ' CD2' HD11 ' A' ' 100' ' ' LEU . 4.2 p90 -59.85 -33.27 71.56 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.228 -0.442 . . . . 0.0 112.032 -179.713 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.606 ' HA ' ' OG ' ' A' ' 7' ' ' SER . . . -55.16 -18.41 5.72 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -178.167 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -58.32 -42.85 87.65 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.976 0.417 . . . . 0.0 111.166 179.727 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.416 ' HB2' HD21 ' A' ' 95' ' ' ASN . 25.6 m -123.02 38.44 4.19 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 121.044 0.45 . . . . 0.0 110.903 -179.486 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.606 ' OG ' ' HA ' ' A' ' 4' ' ' ALA . 52.5 p -141.28 168.19 20.37 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.21 179.143 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 37.1 ptt180 -149.76 168.23 24.27 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.005 -178.564 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 55.25 43.24 29.52 Favored 'General case' 0 C--N 1.33 -0.244 0 O-C-N 124.089 0.868 . . . . 0.0 112.203 178.078 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.442 ' HA ' ' HB2' ' A' ' 21' ' ' ALA . . . -72.28 117.0 13.38 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 179.251 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.463 HG21 HH21 ' A' ' 20' ' ' ARG . 27.8 m -124.0 172.74 11.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.713 -179.423 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.637 ' HB3' ' HA2' ' A' ' 16' ' ' GLY . 3.7 mm? -104.74 115.81 30.95 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.775 -179.311 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 27.9 p -112.45 161.08 17.11 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.666 179.387 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 59.25 44.58 15.35 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.17 179.553 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 87.35 -23.61 11.62 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.218 -179.715 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.637 ' HA2' ' HB3' ' A' ' 12' ' ' LEU . . . 124.85 17.01 2.88 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 121.109 -0.567 . . . . 0.0 111.894 -179.867 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.749 ' HB2' ' HB2' ' A' ' 38' ' ' ASP . 3.6 ptm180 -95.78 -22.05 17.75 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.227 0.537 . . . . 0.0 110.375 -179.609 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.482 ' CG2' ' HB3' ' A' ' 34' ' ' GLU . 2.7 m -111.29 135.99 51.03 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.788 -178.978 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.727 HD11 HD13 ' A' ' 90' ' ' LEU . 41.8 mt -97.46 112.55 24.35 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.768 179.361 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.463 HH21 HG21 ' A' ' 11' ' ' VAL . 30.5 ttp180 -105.1 120.65 42.03 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 178.439 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.442 ' HB2' ' HA ' ' A' ' 10' ' ' ALA . . . -152.97 162.41 41.35 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.906 0.384 . . . . 0.0 111.062 -179.878 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -90.84 105.75 18.04 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 178.439 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.56 ' SG ' HD13 ' A' ' 100' ' ' LEU . 40.2 m -94.21 132.09 39.12 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 -179.449 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 8.0 ttp180 -84.28 116.46 23.0 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-O 120.776 0.322 . . . . 0.0 110.747 -179.886 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 31.4 p30 -82.07 162.23 22.63 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.086 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.49 -21.72 17.78 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -178.68 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -74.69 -13.77 60.66 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.317 0.58 . . . . 0.0 110.195 179.764 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 89.74 32.13 10.47 Favored Glycine 0 N--CA 1.449 -0.456 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.93 179.987 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 -124.47 151.62 44.34 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.826 0.346 . . . . 0.0 111.364 -179.519 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 93.9 m95 -90.96 120.59 32.09 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.568 179.384 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -118.56 127.3 75.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 116.247 -0.433 . . . . 0.0 109.918 178.079 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 25.5 m -76.48 111.52 12.04 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.194 179.935 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 66.7 m -123.06 145.66 48.35 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.906 -179.376 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.602 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 44.8 mt-10 -124.91 133.07 53.19 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.882 179.708 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.724 HD11 ' HB2' ' A' ' 102' ' ' PHE . 1.5 tm? -125.42 131.59 52.89 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.167 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.456 ' O ' HG22 ' A' ' 39' ' ' THR . 14.5 m-20 -90.05 110.27 21.27 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.012 0.434 . . . . 0.0 110.241 -179.779 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.495 HD13 HD22 ' A' ' 90' ' ' LEU . 1.5 mt -83.8 -23.89 31.25 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.031 -179.749 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.749 ' HB2' ' HB2' ' A' ' 17' ' ' ARG . 20.9 t70 -60.49 -15.14 24.06 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.19 -0.459 . . . . 0.0 112.151 -178.647 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.456 HG22 ' O ' ' A' ' 36' ' ' ASP . 11.6 t -77.44 -14.48 59.69 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.721 -0.218 . . . . 0.0 111.387 -179.656 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.411 ' SG ' ' HE3' ' A' ' 50' ' ' TRP . 42.5 t -134.33 -0.79 2.94 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -179.609 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.443 ' HB ' ' CD1' ' A' ' 55' ' ' PHE . 60.4 mt -108.84 135.24 48.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 178.589 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.486 ' HA3' ' HB3' ' A' ' 52' ' ' MET . . . -138.61 156.53 24.2 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.095 -179.826 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.494 ' N ' HD21 ' A' ' 43' ' ' ASN . 0.0 OUTLIER -164.81 43.79 0.09 OUTLIER Pre-proline 0 CA--C 1.542 0.664 0 N-CA-C 113.102 0.778 . . . . 0.0 113.102 -179.377 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.446 ' HG3' ' SD ' ' A' ' 52' ' ' MET . 74.4 Cg_endo -73.17 -22.65 18.92 Favored 'Trans proline' 0 C--N 1.354 0.858 0 C-N-CA 121.661 1.574 . . . . 0.0 112.346 -178.913 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -84.4 -14.11 50.31 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.819 179.923 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.5 ' CA ' ' HG2' ' A' ' 83' ' ' ARG . . . 107.29 8.17 31.49 Favored Glycine 0 N--CA 1.444 -0.81 0 C-N-CA 120.301 -0.952 . . . . 0.0 111.994 -178.866 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -125.91 139.1 53.73 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 110.391 -0.226 . . . . 0.0 110.391 179.82 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 7.8 mp -89.89 151.04 21.94 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.225 0.536 . . . . 0.0 111.975 -178.931 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 167.24 170.99 32.79 Favored Glycine 0 N--CA 1.444 -0.782 0 CA-C-N 115.601 -0.727 . . . . 0.0 112.122 178.469 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.428 ' CD1' HD11 ' A' ' 88' ' ' ILE . 90.8 m95 -95.73 132.24 41.15 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 179.98 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 156.42 -63.08 0.33 Allowed Glycine 0 N--CA 1.451 -0.355 0 N-CA-C 111.573 -0.611 . . . . 0.0 111.573 179.915 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.486 ' HB3' ' HA3' ' A' ' 42' ' ' GLY . 39.7 ttm -88.63 176.63 7.04 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 179.34 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -130.65 172.41 11.98 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 118.288 0.495 . . . . 0.0 111.654 -179.294 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.715 ' HA ' ' OD2' ' A' ' 38' ' ' ASP . 13.2 m120 68.54 46.85 0.95 Allowed 'General case' 0 C--O 1.234 0.263 0 O-C-N 123.945 0.778 . . . . 0.0 111.697 179.129 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.443 ' CD1' ' HB ' ' A' ' 41' ' ' ILE . 13.7 p90 -76.6 -26.88 55.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.517 179.78 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 7.1 m -62.69 -30.45 71.41 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.199 0.523 . . . . 0.0 110.97 -178.694 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 30.9 m170 -82.11 -3.54 55.0 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.754 -179.519 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.405 ' HB2' ' ND2' ' A' ' 43' ' ' ASN . 42.4 m -128.29 28.69 5.45 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.112 0.482 . . . . 0.0 110.358 179.333 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.447 ' HA ' ' O ' ' A' ' 74' ' ' ARG . 15.4 p -143.61 157.85 44.11 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.105 179.829 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.438 ' HG3' ' HG2' ' A' ' 76' ' ' LYS . 50.6 mt-10 -127.0 136.86 52.82 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.991 179.663 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.43 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 36.5 t70 60.29 84.48 0.12 Allowed 'General case' 0 N--CA 1.467 0.381 0 O-C-N 123.608 0.568 . . . . 0.0 111.68 179.511 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 75.4 mt -97.92 120.38 47.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.103 179.547 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.6 tptm -147.33 148.19 31.13 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.123 -179.79 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.584 ' HG ' HD21 ' A' ' 12' ' ' LEU . 36.3 mt -88.56 145.23 25.84 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.868 -179.474 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -105.34 -62.14 1.39 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.044 -0.525 . . . . 0.0 112.107 -179.046 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.577 ' HB2' ' HB2' ' A' ' 69' ' ' ARG . 44.6 mm-40 -79.21 42.93 0.51 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.831 -178.527 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 62.49 20.41 61.27 Favored Glycine 0 C--N 1.317 -0.525 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.594 179.33 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.57 ' HA2' HD13 ' A' ' 64' ' ' LEU . . . 121.4 -14.88 9.31 Favored Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.388 -179.996 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.848 ' HG2' ' HB2' ' A' ' 2' ' ' SER . 48.3 mtm105 -84.02 2.27 39.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.13 0.491 . . . . 0.0 110.804 -179.718 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.492 ' HB3' ' HG2' ' A' ' 66' ' ' GLU . 37.3 ttmt -155.26 134.36 12.27 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.975 179.917 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.75 ' HB2' HD11 ' A' ' 90' ' ' LEU . 9.8 tt -116.77 125.71 52.03 Favored 'General case' 0 C--N 1.318 -0.794 0 O-C-N 123.576 0.548 . . . . 0.0 109.94 -179.723 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.7 p -113.97 136.29 53.06 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.769 179.208 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.43 ' HA ' ' O ' ' A' ' 61' ' ' ASP . 25.8 p -162.26 165.57 26.55 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.252 179.84 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.538 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 31.9 ttt180 -99.48 103.44 21.05 Favored Pre-proline 0 C--N 1.319 -0.745 0 C-N-CA 120.676 -0.409 . . . . 0.0 110.733 179.496 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.692 ' O ' ' HB3' ' A' ' 83' ' ' ARG . 43.8 Cg_endo -67.64 119.63 6.64 Favored 'Trans proline' 0 CA--C 1.512 -0.58 0 C-N-CA 122.569 2.18 . . . . 0.0 110.149 178.564 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.686 ' HA ' ' HB2' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -119.91 140.61 50.61 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 120.764 0.316 . . . . 0.0 111.682 -178.808 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.708 HG22 ' O ' ' A' ' 82' ' ' PHE . 12.9 t -72.52 135.22 45.59 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.695 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 26.7 m -73.33 -4.33 5.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 123.943 0.777 . . . . 0.0 112.056 -178.938 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -68.95 -32.9 72.83 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.13 0.49 . . . . 0.0 109.902 179.342 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -151.65 -20.23 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.678 179.819 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.22 20.73 22.25 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.751 -0.738 . . . . 0.0 111.949 -179.887 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.708 ' O ' HG22 ' A' ' 77' ' ' THR . 27.6 p90 -111.88 143.22 43.21 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 -178.876 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.692 ' HB3' ' O ' ' A' ' 75' ' ' PRO . 0.0 OUTLIER 175.06 -154.21 0.01 OUTLIER 'General case' 0 C--O 1.234 0.241 0 CA-C-O 120.796 0.332 . . . . 0.0 111.702 179.881 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -113.84 177.16 4.73 Favored 'General case' 0 C--O 1.225 -0.207 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.486 -178.708 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.558 ' HA ' ' HD2' ' A' ' 75' ' ' PRO . 59.1 ttt180 -110.39 150.86 28.2 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 178.77 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.406 ' HG3' ' O ' ' A' ' 85' ' ' ARG . 26.6 mt-30 -156.84 -175.25 5.32 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -178.152 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -150.3 142.89 10.06 Favored Glycine 0 N--CA 1.45 -0.423 0 CA-C-N 114.803 -1.09 . . . . 0.0 111.108 179.09 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.428 HD11 ' CD1' ' A' ' 50' ' ' TRP . 13.2 tt -123.97 142.73 39.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 121.052 0.453 . . . . 0.0 110.649 -178.683 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -79.14 133.61 36.73 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.623 179.807 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.75 HD11 ' HB2' ' A' ' 71' ' ' LEU . 74.9 mt -106.27 41.25 1.45 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.324 0.583 . . . . 0.0 111.286 -179.44 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.563 ' HA ' ' OG ' ' A' ' 2' ' ' SER . 8.3 m120 -76.12 2.05 14.01 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.192 179.575 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 13.3 mtp180 -94.03 -6.98 44.02 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.783 179.392 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.432 HG13 HD22 ' A' ' 37' ' ' LEU . 17.7 mm -101.92 106.36 19.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -179.782 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 21.7 tp60 -118.93 149.35 41.74 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.994 -178.008 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.416 HD21 ' HB2' ' A' ' 6' ' ' SER . 14.7 p-10 -99.3 117.94 34.86 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.29 0.567 . . . . 0.0 110.435 178.858 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 48.1 t -103.71 100.4 10.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.5 179.191 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 7.3 m-80 58.69 43.5 18.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.858 -179.197 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 89.99 -23.42 20.76 Favored Glycine 0 N--CA 1.444 -0.792 0 CA-C-N 115.512 -0.767 . . . . 0.0 113.496 179.48 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.425 ' HD2' ' N ' ' A' ' 99' ' ' ARG . 4.4 mpt_? -86.78 123.39 31.87 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 117.116 0.458 . . . . 0.0 110.574 -179.271 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.56 HD13 ' SG ' ' A' ' 23' ' ' CYS . 5.6 tp -76.01 122.15 23.79 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.166 -179.403 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 24.1 t -129.35 138.95 53.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.933 -179.183 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.724 ' HB2' HD11 ' A' ' 35' ' ' LEU . 12.5 t80 -85.51 131.92 34.29 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.052 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 17.3 tt0 . . . . . 0 C--N 1.315 -0.892 0 CA-C-O 117.968 -1.015 . . . . 0.0 110.44 -179.954 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mpt? . . . . . 0 N--CA 1.481 1.075 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.486 ' OG ' ' HA ' ' A' ' 91' ' ' ASN . 17.7 m -116.55 169.07 9.62 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.708 -0.224 . . . . 0.0 110.663 179.304 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.444 ' CG ' HD11 ' A' ' 100' ' ' LEU . 25.2 p90 -57.17 -30.64 64.67 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.201 179.362 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.463 ' HB3' ' HD2' ' A' ' 69' ' ' ARG . . . -53.7 -18.86 3.42 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.33 -179.363 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -61.06 -36.27 79.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.296 0.57 . . . . 0.0 109.977 179.043 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 24.5 m -133.95 36.46 3.27 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.805 179.691 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.411 ' HA ' ' HZ3' ' A' ' 30' ' ' TRP . 23.2 t -148.75 145.77 27.76 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.399 -179.987 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 4.5 ptp180 -136.61 167.9 20.52 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.585 -0.279 . . . . 0.0 111.646 -178.874 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 67.1 m-80 55.78 65.21 1.51 Allowed 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.435 179.893 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.404 ' HB3' ' O ' ' A' ' 67' ' ' GLY . . . -92.55 120.03 32.61 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.661 179.622 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 26.6 m -120.41 169.11 12.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.317 -179.731 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.742 HD21 ' HG ' ' A' ' 64' ' ' LEU . 3.1 mm? -104.67 116.91 32.86 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.24 -179.634 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.49 ' OG1' ' HB ' ' A' ' 18' ' ' THR . 18.9 p -109.81 161.94 14.96 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.452 179.48 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 62.15 40.87 11.34 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.945 -179.803 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 91.02 -45.38 2.85 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 121.034 -0.603 . . . . 0.0 112.459 179.62 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.571 ' HA2' ' HB3' ' A' ' 12' ' ' LEU . . . 149.77 52.42 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.506 0 N-CA-C 111.481 -0.648 . . . . 0.0 111.481 -179.469 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.505 ' HB3' ' OG ' ' A' ' 56' ' ' SER . 3.7 ptm180 -135.57 -33.46 0.87 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.146 0.498 . . . . 0.0 110.808 -179.811 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.49 ' HB ' ' OG1' ' A' ' 13' ' ' THR . 3.0 m -97.53 133.5 42.01 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.524 -179.968 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.653 HD11 HD13 ' A' ' 90' ' ' LEU . 44.1 mt -95.89 113.65 25.29 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.231 179.349 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 17.9 ttm180 -107.86 120.68 42.94 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 178.76 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -152.77 167.85 27.64 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.929 0.395 . . . . 0.0 111.365 -178.896 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -89.63 106.09 18.23 Favored 'General case' 0 CA--C 1.512 -0.491 0 N-CA-C 107.969 -1.122 . . . . 0.0 107.969 178.405 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.579 ' SG ' HD13 ' A' ' 100' ' ' LEU . 58.5 m -96.39 125.91 41.22 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 120.713 0.292 . . . . 0.0 110.225 -178.959 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.622 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 22.4 ttt180 -77.94 111.83 14.2 Favored 'General case' 0 N--CA 1.44 -0.933 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.087 179.639 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.454 HD21 ' HB3' ' A' ' 29' ' ' ASN . 36.0 p30 -74.18 170.65 15.1 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.318 -179.62 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.26 -11.73 23.68 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -177.806 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -88.15 -10.23 50.62 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 178.676 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 88.45 27.94 23.59 Favored Glycine 0 N--CA 1.448 -0.511 0 CA-C-N 114.956 -1.02 . . . . 0.0 111.535 -179.522 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.622 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 51.9 t30 -112.75 161.45 16.88 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.526 0.203 . . . . 0.0 111.162 -178.661 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.449 ' CZ3' ' HB2' ' A' ' 24' ' ' ARG . 95.4 m95 -102.5 116.85 33.46 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.715 179.596 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 6.2 m -118.82 141.1 40.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.608 179.309 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 61.6 m -81.1 108.62 14.92 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 179.209 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 50.3 m -120.34 150.43 40.76 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.351 -179.536 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.601 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 48.3 mt-10 -131.2 145.6 52.0 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.915 -179.893 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.669 HD11 ' HB2' ' A' ' 102' ' ' PHE . 2.2 tm? -139.45 132.0 28.75 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 178.777 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.479 ' N ' HD13 ' A' ' 35' ' ' LEU . 5.7 m-20 -90.33 110.25 21.32 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.919 0.39 . . . . 0.0 110.992 179.967 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.531 HD11 HD11 ' A' ' 19' ' ' LEU . 2.4 mt -80.67 -19.73 44.57 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.705 179.268 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.523 ' OD1' ' HA ' ' A' ' 54' ' ' ASN . 22.4 t70 -58.74 -18.7 33.85 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.389 -0.823 . . . . 0.0 112.339 -178.812 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.449 HG22 ' O ' ' A' ' 36' ' ' ASP . 14.6 t -82.61 -6.74 59.52 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 121.103 -0.239 . . . . 0.0 111.449 -179.639 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.521 ' SG ' ' HE3' ' A' ' 50' ' ' TRP . 25.8 t -135.0 -18.63 1.81 Allowed 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.816 -0.354 . . . . 0.0 111.467 179.556 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 56.0 mt -98.28 129.13 48.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 178.359 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.615 ' HA3' ' HB3' ' A' ' 52' ' ' MET . . . -141.11 164.69 26.45 Favored Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 120.64 -0.791 . . . . 0.0 111.67 179.784 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.788 HD21 ' HB3' ' A' ' 59' ' ' SER . 32.1 p-10 -161.92 47.26 0.21 Allowed Pre-proline 0 CA--C 1.538 0.487 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 -179.144 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -71.9 -23.21 22.39 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 121.562 1.508 . . . . 0.0 111.625 -179.536 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -84.26 -14.95 48.51 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.588 -179.893 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.404 ' CA ' ' HG2' ' A' ' 83' ' ' ARG . . . 103.98 8.22 39.66 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.051 -178.831 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -125.21 140.07 53.18 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 179.43 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.559 HD23 ' HB3' ' A' ' 43' ' ' ASN . 92.3 mt -86.68 145.64 26.61 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.012 -179.712 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 171.39 172.33 37.4 Favored Glycine 0 N--CA 1.444 -0.784 0 C-N-CA 120.785 -0.722 . . . . 0.0 111.745 179.207 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.521 ' HE3' ' SG ' ' A' ' 40' ' ' CYS . 87.2 m95 -95.53 125.2 39.96 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.826 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 159.99 -52.16 0.36 Allowed Glycine 0 CA--C 1.518 0.25 0 C-N-CA 121.129 -0.557 . . . . 0.0 112.453 -179.997 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.615 ' HB3' ' HA3' ' A' ' 42' ' ' GLY . 0.1 OUTLIER -97.15 178.03 5.39 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.29 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -129.99 171.78 12.42 Favored 'General case' 0 C--N 1.318 -0.798 0 O-C-N 122.04 -0.412 . . . . 0.0 111.295 -179.18 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.523 ' HA ' ' OD1' ' A' ' 38' ' ' ASP . 21.7 m-80 64.31 59.98 0.98 Allowed 'General case' 0 C--O 1.235 0.311 0 O-C-N 123.963 0.789 . . . . 0.0 111.285 179.458 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.452 ' HA ' ' OD1' ' A' ' 43' ' ' ASN . 18.6 p90 -86.56 -32.24 20.79 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.645 -179.991 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.505 ' OG ' ' HB3' ' A' ' 17' ' ' ARG . 13.3 m -62.05 -36.9 83.01 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.269 -179.024 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 38.2 m80 -81.28 -3.59 52.95 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.728 179.218 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.531 ' HB2' ' OD1' ' A' ' 43' ' ' ASN . 4.7 m -121.33 18.67 11.44 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.551 -179.676 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.788 ' HB3' HD21 ' A' ' 43' ' ' ASN . 58.1 p -145.55 171.69 14.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.097 0.475 . . . . 0.0 111.096 179.882 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.494 ' HG3' ' HD3' ' A' ' 74' ' ' ARG . 2.3 pt-20 -140.85 154.03 46.02 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.065 179.433 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.406 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 43.2 m-20 62.3 63.04 1.09 Allowed 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.022 0.439 . . . . 0.0 110.929 -179.703 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.482 HG23 HD21 ' A' ' 71' ' ' LEU . 63.6 mt -90.7 117.27 33.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.973 -179.681 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 42.5 tptt -148.85 149.45 31.32 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.772 -179.895 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.742 ' HG ' HD21 ' A' ' 12' ' ' LEU . 76.5 mt -82.46 132.57 35.2 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.931 0.396 . . . . 0.0 110.106 179.317 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -80.25 -62.61 1.63 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.488 -178.862 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.509 ' HB2' ' HB3' ' A' ' 69' ' ' ARG . 30.3 mt-10 -85.49 28.05 0.78 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.584 -179.86 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.404 ' O ' ' HB3' ' A' ' 10' ' ' ALA . . . 64.97 15.95 61.12 Favored Glycine 0 N--CA 1.448 -0.545 0 CA-C-N 115.624 -0.717 . . . . 0.0 113.066 179.812 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.539 ' HA2' HD13 ' A' ' 64' ' ' LEU . . . 142.66 -21.98 2.35 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 119.904 -1.141 . . . . 0.0 113.091 179.459 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.509 ' HB3' ' HB2' ' A' ' 66' ' ' GLU . 0.2 OUTLIER -79.34 -13.91 59.33 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.426 0.631 . . . . 0.0 109.713 -179.922 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.534 ' HG3' ' HA ' ' A' ' 89' ' ' ASP . 4.5 ttmp? -157.1 141.76 16.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.259 -179.233 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.604 ' HB2' HD11 ' A' ' 90' ' ' LEU . 10.0 tt -111.42 134.45 52.99 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 179.975 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.431 HG22 ' HA3' ' A' ' 87' ' ' GLY . 7.0 p -123.95 135.05 53.42 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 120.798 0.332 . . . . 0.0 111.156 179.852 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.437 ' HB3' ' HA ' ' A' ' 62' ' ' ILE . 26.9 p -159.52 168.8 25.28 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.134 -0.485 . . . . 0.0 109.998 179.988 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.566 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 56.6 ttt180 -99.66 101.97 15.34 Favored Pre-proline 0 C--N 1.314 -0.96 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.725 179.944 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.625 ' O ' ' HB3' ' A' ' 83' ' ' ARG . 58.7 Cg_endo -71.43 123.14 9.26 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 122.535 2.156 . . . . 0.0 110.856 178.868 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.697 ' HA ' ' HB2' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -119.57 139.84 51.5 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.845 0.355 . . . . 0.0 111.053 -179.69 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.705 HG22 ' O ' ' A' ' 82' ' ' PHE . 12.3 t -75.47 140.65 42.98 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 116.176 -0.466 . . . . 0.0 109.752 -179.765 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 31.3 m -76.32 -5.97 8.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.488 -179.482 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 -64.75 -35.25 80.45 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-O 121.155 0.502 . . . . 0.0 110.234 179.145 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -154.01 -9.74 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.512 -0.851 . . . . 0.0 112.768 -179.925 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.602 ' HA2' ' HE3' ' A' ' 76' ' ' LYS . . . 90.32 17.51 52.73 Favored Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.641 -0.79 . . . . 0.0 111.862 179.976 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.705 ' O ' HG22 ' A' ' 77' ' ' THR . 34.0 p90 -111.23 151.2 28.56 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 119.17 -0.443 . . . . 0.0 109.974 -178.773 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.697 ' HB2' ' HA ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 169.78 -153.36 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.293 0 O-C-N 123.641 0.588 . . . . 0.0 111.052 179.107 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 49.9 mm-40 -122.21 -177.58 3.64 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.736 -178.037 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.566 ' HA ' ' HA ' ' A' ' 74' ' ' ARG . 52.7 ttt180 -106.03 153.45 22.01 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 177.396 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.705 ' HG2' ' H ' ' A' ' 87' ' ' GLY . 41.8 tt0 -157.89 -174.98 5.11 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.662 -178.513 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.705 ' H ' ' HG2' ' A' ' 86' ' ' GLN . . . -148.92 140.54 8.28 Favored Glycine 0 N--CA 1.445 -0.704 0 N-CA-C 111.181 -0.767 . . . . 0.0 111.181 179.21 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 15.3 tt -119.28 131.41 72.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.544 0.688 . . . . 0.0 110.742 -179.548 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.534 ' HA ' ' HG3' ' A' ' 70' ' ' LYS . 16.0 t70 -75.94 140.7 42.22 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.401 -179.671 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.653 HD13 HD11 ' A' ' 19' ' ' LEU . 42.4 mt -109.84 44.19 1.24 Allowed 'General case' 0 C--O 1.234 0.253 0 N-CA-C 112.848 0.684 . . . . 0.0 112.848 -177.717 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.486 ' HA ' ' OG ' ' A' ' 2' ' ' SER . 3.9 m-80 -79.7 3.91 17.82 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-O 121.32 0.581 . . . . 0.0 110.834 178.759 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.48 ' HD3' ' CD2' ' A' ' 50' ' ' TRP . 36.6 mtp180 -95.86 -11.21 27.12 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.357 178.919 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.431 HG13 HD22 ' A' ' 37' ' ' LEU . 21.2 mm -100.8 109.08 24.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 -179.406 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -122.26 148.52 44.89 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.941 -178.108 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 27.2 p-10 -100.65 123.28 44.64 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.65 0.738 . . . . 0.0 110.268 178.448 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 59.5 t -114.73 114.3 46.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.672 -179.853 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 16.7 m120 57.46 33.45 23.28 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.22 0.533 . . . . 0.0 110.562 -178.798 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 89.32 -15.24 58.92 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.867 -179.915 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 3.6 mpt_? -87.59 123.22 32.23 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 117.005 0.403 . . . . 0.0 110.048 -179.846 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.579 HD13 ' SG ' ' A' ' 23' ' ' CYS . 8.2 tp -77.16 115.05 16.61 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.474 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 11.3 t -122.73 140.37 46.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 120.964 0.411 . . . . 0.0 111.45 -178.271 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.669 ' HB2' HD11 ' A' ' 35' ' ' LEU . 3.9 t80 -84.65 132.85 34.43 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 177.401 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 3.9 tp-100 . . . . . 0 C--O 1.252 1.198 0 CA-C-O 118.545 -0.741 . . . . 0.0 110.794 -179.837 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.1 ttt . . . . . 0 N--CA 1.48 1.054 0 N-CA-C 110.089 -0.338 . . . . 0.0 110.089 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.652 ' OG ' ' HA ' ' A' ' 91' ' ' ASN . 39.2 m -114.03 177.09 4.76 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.468 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.518 ' HA ' ' OD1' ' A' ' 95' ' ' ASN . 14.6 p90 -65.73 -33.36 75.69 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.091 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.529 ' HA ' ' OG ' ' A' ' 7' ' ' SER . . . -57.69 -22.4 46.0 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.055 -0.52 . . . . 0.0 112.051 -179.368 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -65.4 -19.68 66.05 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 121.022 0.439 . . . . 0.0 110.629 179.217 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 7.4 p -145.9 39.53 1.13 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.645 179.938 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.529 ' OG ' ' HA ' ' A' ' 4' ' ' ALA . 87.0 p -145.89 167.73 22.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.205 179.085 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 4.9 ptp180 -150.49 162.84 39.83 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.733 -179.6 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 56.59 60.05 3.28 Favored 'General case' 0 C--N 1.331 -0.233 0 O-C-N 123.982 0.801 . . . . 0.0 111.769 177.657 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.434 ' HA ' ' HB2' ' A' ' 21' ' ' ALA . . . -91.94 119.49 31.74 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.703 179.775 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 27.4 m -119.81 169.55 10.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.475 -179.897 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.58 ' HB3' ' HA2' ' A' ' 16' ' ' GLY . 3.2 mm? -105.76 114.55 28.78 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.518 -179.211 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.468 ' OG1' ' HB ' ' A' ' 18' ' ' THR . 26.3 p -109.86 164.7 12.33 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.018 179.988 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 61.61 43.7 9.73 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.838 179.731 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 88.76 -37.84 3.27 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.792 -0.718 . . . . 0.0 111.975 179.827 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.58 ' HA2' ' HB3' ' A' ' 12' ' ' LEU . . . 140.74 42.32 0.07 OUTLIER Glycine 0 N--CA 1.444 -0.808 0 N-CA-C 111.432 -0.667 . . . . 0.0 111.432 -179.529 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.566 ' HB2' ' HB3' ' A' ' 38' ' ' ASP . 18.2 ptt85 -127.19 -21.24 3.96 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.896 0.379 . . . . 0.0 111.126 -179.828 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.468 ' HB ' ' OG1' ' A' ' 13' ' ' THR . 3.8 m -106.63 131.29 53.95 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.374 179.889 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.712 HD11 HD13 ' A' ' 90' ' ' LEU . 57.3 mt -93.4 113.83 26.08 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.327 179.209 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 22.5 ttt180 -111.97 119.37 38.29 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 178.644 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.434 ' HB2' ' HA ' ' A' ' 10' ' ' ALA . . . -153.73 167.0 31.09 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.95 0.405 . . . . 0.0 111.362 -179.11 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -90.02 106.7 18.65 Favored 'General case' 0 CA--C 1.511 -0.523 0 N-CA-C 107.821 -1.178 . . . . 0.0 107.821 178.19 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.543 ' SG ' HD13 ' A' ' 100' ' ' LEU . 35.7 m -97.55 131.82 43.79 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.326 -178.627 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.52 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 13.1 ttp180 -76.25 119.45 20.16 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 116.174 -0.466 . . . . 0.0 109.945 179.38 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 36.9 p30 -81.75 168.83 17.64 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 179.535 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -52.93 -30.56 35.27 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 -179.013 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -72.57 -15.08 61.76 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.397 0.618 . . . . 0.0 110.483 179.982 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 92.18 24.5 24.41 Favored Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.549 179.985 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.52 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 8.2 t-20 -107.49 162.89 13.53 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.582 0.23 . . . . 0.0 110.476 -178.753 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.429 ' HZ3' ' HA ' ' A' ' 7' ' ' SER . 83.3 m95 -99.03 115.71 29.58 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.931 0.396 . . . . 0.0 111.694 -179.548 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.1 m -122.13 125.43 72.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.173 178.463 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 19.9 m -76.14 113.54 13.79 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.996 -179.559 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 57.8 m -120.43 155.91 32.52 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.74 179.887 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.634 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 46.7 mt-10 -131.46 136.95 48.36 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.191 -179.394 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.502 ' HB2' ' HB3' ' A' ' 100' ' ' LEU . 1.7 tm? -132.72 130.1 39.57 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 178.434 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.443 ' N ' HD13 ' A' ' 35' ' ' LEU . 9.0 m-20 -89.94 109.04 20.09 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 -179.997 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.568 HD11 HD11 ' A' ' 19' ' ' LEU . 3.3 mt -79.48 -20.63 46.87 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.57 -179.095 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.566 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 11.2 p-10 -65.78 -10.26 35.82 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.7 0.285 . . . . 0.0 111.713 -178.612 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 77.6 p -81.23 -11.91 59.27 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.996 0.427 . . . . 0.0 110.34 179.045 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 23.4 m -133.95 -15.92 2.28 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.982 -0.554 . . . . 0.0 112.4 -179.026 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 54.9 mt -99.84 135.29 36.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 O-C-N 122.093 -0.379 . . . . 0.0 109.991 179.081 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.629 ' HA3' ' HB3' ' A' ' 52' ' ' MET . . . -143.65 156.7 26.73 Favored Glycine 0 N--CA 1.443 -0.878 0 C-N-CA 120.386 -0.911 . . . . 0.0 112.263 179.804 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.662 ' N ' ' HD3' ' A' ' 44' ' ' PRO . 25.4 p30 -153.47 40.38 0.16 Allowed Pre-proline 0 CA--C 1.54 0.568 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -179.785 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.662 ' HD3' ' N ' ' A' ' 43' ' ' ASN . 7.1 Cg_exo -71.77 -17.46 29.28 Favored 'Trans proline' 0 C--N 1.355 0.902 0 C-N-CA 121.74 1.627 . . . . 0.0 111.377 -179.213 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -91.58 -2.84 56.98 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.06 179.853 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.597 ' CA ' ' HG2' ' A' ' 83' ' ' ARG . . . 91.79 8.03 64.01 Favored Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.214 -179.439 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -126.11 139.38 53.43 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.667 0.27 . . . . 0.0 110.568 179.646 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.518 HD23 ' HB3' ' A' ' 43' ' ' ASN . 81.7 mt -84.48 148.7 26.4 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.723 179.862 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 165.42 171.11 31.24 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 121.036 -0.602 . . . . 0.0 111.921 179.244 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 89.0 m95 -95.28 125.66 40.06 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 179.676 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 163.21 -57.79 0.28 Allowed Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.192 -179.628 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.629 ' HB3' ' HA3' ' A' ' 42' ' ' GLY . 0.0 OUTLIER -90.78 -166.01 1.49 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 179.719 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 28.2 pt20 -141.98 171.6 13.83 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.918 -0.313 . . . . 0.0 111.648 -179.047 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 10.1 m120 63.12 36.3 12.27 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 115.493 -0.776 . . . . 0.0 112.628 178.749 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.43 ' HB3' ' HA2' ' A' ' 42' ' ' GLY . 12.4 p90 -61.21 -27.39 68.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.763 0.316 . . . . 0.0 111.371 -179.629 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.525 ' OG ' ' HB3' ' A' ' 17' ' ' ARG . 15.0 m -62.53 -30.58 71.4 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.038 0.384 . . . . 0.0 112.038 -178.958 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 35.7 m80 -82.04 -4.06 55.95 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.742 -0.383 . . . . 0.0 111.169 -179.14 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.575 ' HB2' ' OD1' ' A' ' 43' ' ' ASN . 30.3 m -130.77 29.85 4.71 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.347 0.594 . . . . 0.0 110.239 179.232 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.643 ' HB3' HD21 ' A' ' 43' ' ' ASN . 28.9 p -141.28 153.22 45.08 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.641 179.209 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 66.4 mt-10 -125.34 139.2 53.89 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.419 -179.687 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 36.0 t70 58.62 73.21 0.49 Allowed 'General case' 0 N--CA 1.466 0.363 0 O-C-N 123.83 0.706 . . . . 0.0 111.532 -179.766 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.548 HG23 HD21 ' A' ' 71' ' ' LEU . 77.4 mt -87.24 119.85 35.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 178.801 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.493 ' HB2' ' NZ ' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -148.87 159.79 43.84 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.843 -0.343 . . . . 0.0 111.033 -178.653 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.48 ' HG ' HD21 ' A' ' 12' ' ' LEU . 81.0 mt -99.94 123.54 44.3 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.845 0.355 . . . . 0.0 110.958 179.891 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 37.0 mm-40 -82.0 -61.48 1.9 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.502 -179.676 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.5 ' OE2' ' HE3' ' A' ' 70' ' ' LYS . 36.1 mt-10 -76.58 12.96 1.09 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.307 -179.658 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 76.5 18.79 78.81 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.348 -179.928 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.405 ' HA2' HD22 ' A' ' 64' ' ' LEU . . . 136.94 -17.16 3.66 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.0 -1.095 . . . . 0.0 112.924 179.384 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.45 ' HB3' ' HB2' ' A' ' 66' ' ' GLU . 0.1 OUTLIER -83.01 -17.96 41.5 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.194 0.521 . . . . 0.0 109.72 -179.854 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.5 ' HE3' ' OE2' ' A' ' 66' ' ' GLU . 37.9 ttmt -150.73 136.87 18.46 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.891 -179.278 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.609 ' HB2' HD11 ' A' ' 90' ' ' LEU . 10.0 tt -114.73 129.3 56.67 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.491 179.714 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 8.2 p -116.57 140.01 49.86 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.155 0.502 . . . . 0.0 111.28 179.828 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.489 ' HB3' ' HA ' ' A' ' 62' ' ' ILE . 13.0 p -163.28 164.03 25.09 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.089 179.02 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.537 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 28.1 ttt180 -99.4 100.39 10.42 Favored Pre-proline 0 C--N 1.317 -0.822 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 179.103 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.609 ' O ' ' HB3' ' A' ' 83' ' ' ARG . 53.2 Cg_endo -69.07 117.39 5.01 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.383 2.055 . . . . 0.0 109.864 178.545 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.868 ' HE3' ' HA2' ' A' ' 81' ' ' GLY . 0.0 OUTLIER -119.78 143.43 47.83 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.501 -178.978 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.684 HG22 ' O ' ' A' ' 82' ' ' PHE . 8.7 t -69.89 134.38 48.37 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.218 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 11.1 p -71.28 -12.43 16.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 O-C-N 124.088 0.867 . . . . 0.0 111.094 -179.284 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 32.8 m-20 -70.62 -16.72 62.86 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.506 -179.606 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.693 ' HA3' ' CE2' ' A' ' 82' ' ' PHE . . . -157.64 -30.2 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.441 -0.885 . . . . 0.0 112.628 179.215 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.868 ' HA2' ' HE3' ' A' ' 76' ' ' LYS . . . 101.83 16.13 24.71 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 121.024 -0.608 . . . . 0.0 111.916 -179.721 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.693 ' CE2' ' HA3' ' A' ' 80' ' ' GLY . 16.7 p90 -112.25 157.06 21.38 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 118.686 -0.673 . . . . 0.0 110.173 -178.622 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.813 ' HB2' ' HA ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 163.92 -151.03 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.556 0 O-C-N 124.253 0.971 . . . . 0.0 111.124 178.478 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -125.47 152.88 44.35 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.142 -177.927 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.537 ' HA ' ' HA ' ' A' ' 74' ' ' ARG . 39.7 ttt180 -83.91 145.8 28.39 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 179.621 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -150.63 -179.67 7.44 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.094 0.473 . . . . 0.0 111.756 -178.287 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -141.09 142.51 12.24 Favored Glycine 0 N--CA 1.451 -0.345 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.455 178.993 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 13.2 tt -125.09 136.58 60.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.028 0.442 . . . . 0.0 110.973 -179.199 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -80.59 141.28 35.19 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.467 -179.882 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.712 HD13 HD11 ' A' ' 19' ' ' LEU . 58.3 mt -107.59 46.36 0.95 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.674 0.749 . . . . 0.0 110.932 -179.816 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.652 ' HA ' ' OG ' ' A' ' 2' ' ' SER . 11.4 m120 -79.9 3.67 19.11 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.634 179.762 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 12.9 mtp180 -98.47 -15.0 19.78 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.41 179.872 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 22.7 mm -94.37 98.07 7.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 121.356 0.598 . . . . 0.0 109.601 -179.029 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 22.3 tp60 -107.63 141.94 38.34 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.961 -178.443 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.518 ' OD1' ' HA ' ' A' ' 3' ' ' TYR . 16.1 p-10 -95.64 119.72 34.64 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.512 178.582 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 58.2 t -109.23 112.26 39.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.31 179.286 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 23.2 m-80 59.24 34.84 23.25 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-O 121.069 0.461 . . . . 0.0 110.56 -178.952 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 87.57 -8.96 75.51 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.757 -179.955 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.458 ' HD2' ' N ' ' A' ' 99' ' ' ARG . 7.9 mpt_? -94.65 134.43 37.24 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.661 0.267 . . . . 0.0 110.978 -179.052 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.543 HD13 ' SG ' ' A' ' 23' ' ' CYS . 2.9 tp -84.89 119.81 25.77 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.594 -0.276 . . . . 0.0 110.503 -179.681 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 20.8 t -129.28 141.53 46.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.609 -179.661 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.495 ' HB2' HD11 ' A' ' 35' ' ' LEU . 23.2 t80 -83.71 133.0 34.82 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 178.348 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 . . . . . 0 C--O 1.248 1.013 0 CA-C-O 118.336 -0.84 . . . . 0.0 110.108 179.271 . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.2 mmt . . . . . 0 N--CA 1.481 1.077 0 CA-C-O 120.621 0.248 . . . . 0.0 110.562 . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.58 ' OG ' ' HA ' ' A' ' 91' ' ' ASN . 21.0 m -117.72 175.04 5.84 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.723 -0.217 . . . . 0.0 110.474 179.082 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.405 ' CG ' HD11 ' A' ' 100' ' ' LEU . 11.7 p90 -55.32 -32.16 62.25 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.281 179.061 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -52.37 -20.89 3.07 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -178.801 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -55.93 -42.49 76.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.914 0.388 . . . . 0.0 110.959 178.743 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 47.7 m -132.01 36.02 3.69 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.001 179.828 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 16.7 m -144.57 153.24 41.6 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.483 179.531 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 7.9 ptp180 -149.53 172.7 14.58 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 110.317 -0.253 . . . . 0.0 110.317 179.951 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 67.02 44.63 1.92 Allowed 'General case' 0 N--CA 1.469 0.475 0 O-C-N 123.56 0.537 . . . . 0.0 110.5 -179.505 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.412 ' HA ' ' O ' ' A' ' 20' ' ' ARG . . . -87.83 118.26 27.24 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.425 -179.879 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 30.6 m -121.57 176.15 4.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.871 179.308 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.523 ' HB3' ' HA2' ' A' ' 16' ' ' GLY . 3.2 mm? -104.98 114.09 28.09 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 -179.752 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.529 ' OG1' ' HB ' ' A' ' 18' ' ' THR . 24.1 p -106.1 163.38 12.82 Favored 'General case' 0 C--O 1.245 0.823 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.923 -179.641 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 62.16 36.2 15.18 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.706 -179.482 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 92.56 -40.28 2.88 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.7 179.431 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.523 ' HA2' ' HB3' ' A' ' 12' ' ' LEU . . . 147.72 56.07 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.499 0 N-CA-C 110.979 -0.849 . . . . 0.0 110.979 -179.723 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.534 ' HB2' ' HB3' ' A' ' 38' ' ' ASP . 10.0 ptm180 -140.87 -32.19 0.58 Allowed 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.066 0.46 . . . . 0.0 111.211 -179.394 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.529 ' HB ' ' OG1' ' A' ' 13' ' ' THR . 3.7 m -102.99 138.27 40.08 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.348 -179.53 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.611 ' O ' ' HA ' ' A' ' 34' ' ' GLU . 34.4 mt -98.6 113.34 25.35 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.865 179.428 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.412 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 5.2 ttp180 -106.3 120.61 42.32 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 178.489 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -152.88 166.24 32.92 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.938 0.399 . . . . 0.0 111.734 -179.245 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.788 ' HB3' ' HB3' ' A' ' 30' ' ' TRP . 20.8 mm-40 -90.65 107.27 19.07 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 178.467 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.467 ' SG ' HD13 ' A' ' 100' ' ' LEU . 27.2 m -98.78 127.49 44.72 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.457 -178.754 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 19.6 ttp180 -74.39 109.52 7.94 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 179.27 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -87.27 173.48 9.17 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.718 -178.96 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -46.63 -34.1 4.75 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 -178.692 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -67.56 -10.74 54.68 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 121.498 0.666 . . . . 0.0 111.105 -179.464 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.45 23.63 56.01 Favored Glycine 0 N--CA 1.446 -0.634 0 N-CA-C 111.233 -0.747 . . . . 0.0 111.233 -179.94 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 -123.74 160.4 27.37 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.797 0.332 . . . . 0.0 111.197 -178.836 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.788 ' HB3' ' HB3' ' A' ' 22' ' ' GLU . 75.3 m95 -87.57 131.56 34.35 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.24 -178.858 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.414 HG22 ' O ' ' A' ' 23' ' ' CYS . 6.2 m -126.29 137.0 59.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.745 178.118 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 37.6 m -75.53 109.24 8.93 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.133 179.775 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 49.9 m -122.8 144.59 49.08 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.932 -179.966 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.611 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 43.9 mt-10 -128.88 135.45 49.09 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.433 -179.729 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.573 HD11 ' HB2' ' A' ' 102' ' ' PHE . 2.4 tm? -128.64 131.69 48.07 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 178.808 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.45 ' N ' HD13 ' A' ' 35' ' ' LEU . 11.4 m-20 -89.29 110.77 21.51 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.297 -179.794 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.476 HD23 HD12 ' A' ' 35' ' ' LEU . 0.9 OUTLIER -86.87 -16.12 37.03 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.938 179.947 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.534 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 0.5 OUTLIER -66.06 -13.81 60.62 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 -177.508 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.435 HG22 ' O ' ' A' ' 36' ' ' ASP . 8.8 t -83.08 -7.82 59.6 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.895 0.378 . . . . 0.0 110.653 179.193 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.427 ' SG ' HG23 ' A' ' 39' ' ' THR . 58.0 m -130.94 -17.2 3.15 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 112.181 0.437 . . . . 0.0 112.181 -179.341 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.46 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 57.2 mt -104.98 137.05 36.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.684 0.278 . . . . 0.0 110.766 179.731 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.576 ' HA3' ' HB3' ' A' ' 52' ' ' MET . . . -150.31 162.47 29.26 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 121.114 -0.565 . . . . 0.0 111.744 179.202 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.67 ' ND2' ' HB2' ' A' ' 55' ' ' PHE . 7.2 p30 -160.88 50.2 0.31 Allowed Pre-proline 0 CA--C 1.537 0.476 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -179.738 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -69.93 -13.07 33.77 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 121.658 1.572 . . . . 0.0 112.046 -179.653 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -101.94 5.02 40.62 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.735 179.83 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.559 ' CA ' ' HG2' ' A' ' 83' ' ' ARG . . . 85.43 11.66 74.59 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.362 -0.923 . . . . 0.0 112.37 -179.592 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -125.31 131.81 52.98 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.013 0.435 . . . . 0.0 110.801 179.916 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.522 ' HB3' ' HB ' ' A' ' 88' ' ' ILE . 84.6 mt -86.31 135.57 33.48 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.461 -0.791 . . . . 0.0 111.722 -178.69 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -177.85 172.27 44.88 Favored Glycine 0 N--CA 1.447 -0.619 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.734 179.209 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.44 ' HH2' HD11 ' A' ' 93' ' ' ILE . 90.2 m95 -95.16 124.76 39.38 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 179.621 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 159.41 -54.71 0.35 Allowed Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.92 -0.657 . . . . 0.0 111.917 -179.26 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.576 ' HB3' ' HA3' ' A' ' 42' ' ' GLY . 0.0 OUTLIER -85.56 -166.06 1.41 Allowed 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 179.649 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -146.03 173.63 12.0 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.64 -0.424 . . . . 0.0 111.634 -179.55 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 60.21 39.86 18.75 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.717 179.376 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.67 ' HB2' ' ND2' ' A' ' 43' ' ' ASN . 6.2 p90 -61.84 -28.61 69.61 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.167 179.488 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.493 ' HB2' ' HB3' ' A' ' 17' ' ' ARG . 24.5 t -58.83 -44.94 91.04 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.727 -179.942 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 34.0 m80 -81.31 -13.76 58.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.082 0.467 . . . . 0.0 111.037 -179.734 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 15.7 m -96.33 -1.47 47.77 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.77 -178.928 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.421 ' HB3' ' HA ' ' A' ' 75' ' ' PRO . 56.5 p -137.95 172.97 12.15 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 121.71 -0.619 . . . . 0.0 111.235 -179.0 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.402 ' HG3' ' HG2' ' A' ' 76' ' ' LYS . 44.3 mt-10 -131.13 147.57 52.62 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.011 179.909 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 39.0 t70 56.66 77.69 0.25 Allowed 'General case' 0 N--CA 1.467 0.396 0 O-C-N 123.877 0.736 . . . . 0.0 110.722 179.903 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.542 ' HA ' ' HB3' ' A' ' 73' ' ' CYS . 67.3 mt -99.94 120.38 49.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.841 -179.292 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 76.9 tttt -148.9 156.96 43.05 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.211 -0.45 . . . . 0.0 109.858 179.554 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 44.1 mt -82.66 140.12 33.32 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.139 0.495 . . . . 0.0 111.271 -178.848 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -90.81 -61.56 1.64 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.985 -178.792 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.492 ' HB2' ' HB3' ' A' ' 69' ' ' ARG . 30.1 mm-40 -82.2 13.01 3.73 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.127 0.489 . . . . 0.0 111.106 -179.767 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 78.4 17.16 78.35 Favored Glycine 0 N--CA 1.45 -0.403 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.413 179.8 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 143.24 -30.95 1.98 Allowed Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.309 -0.948 . . . . 0.0 112.552 179.469 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.513 ' HD3' ' HB2' ' A' ' 2' ' ' SER . 4.6 tpp85 -75.45 -19.66 59.31 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.279 0.561 . . . . 0.0 110.565 -179.931 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.428 ' HB3' ' HG2' ' A' ' 66' ' ' GLU . 86.5 tttt -148.5 145.71 28.03 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.437 -178.33 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.733 ' HB2' HD11 ' A' ' 90' ' ' LEU . 10.2 tt -116.61 144.38 44.46 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.782 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.8 p -134.2 138.52 45.17 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 120.85 0.357 . . . . 0.0 110.697 179.747 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.542 ' HB3' ' HA ' ' A' ' 62' ' ' ILE . 26.5 p -162.55 174.58 12.45 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.85 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.495 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 4.1 tmt_? -109.29 97.46 26.31 Favored Pre-proline 0 C--N 1.315 -0.915 0 N-CA-C 109.111 -0.699 . . . . 0.0 109.111 179.087 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.65 ' O ' ' HB3' ' A' ' 83' ' ' ARG . 32.4 Cg_endo -64.58 129.55 24.03 Favored 'Trans proline' 0 CA--C 1.515 -0.473 0 C-N-CA 122.991 2.461 . . . . 0.0 110.807 -179.981 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.765 ' HA ' ' HB2' ' A' ' 83' ' ' ARG . 0.3 OUTLIER -121.22 149.78 42.32 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.217 0.532 . . . . 0.0 111.478 -179.569 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.655 HG22 ' O ' ' A' ' 82' ' ' PHE . 14.7 t -82.69 143.4 30.96 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 178.794 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 32.7 m -70.04 -9.33 12.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 O-C-N 123.862 0.727 . . . . 0.0 111.798 -179.494 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -62.57 -37.77 87.46 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-O 121.008 0.433 . . . . 0.0 110.374 179.246 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -160.38 -0.92 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.308 -0.949 . . . . 0.0 113.103 -179.519 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.591 ' HA2' ' HD3' ' A' ' 76' ' ' LYS . . . 84.88 21.52 55.46 Favored Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.488 -0.863 . . . . 0.0 112.041 179.304 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.655 ' O ' HG22 ' A' ' 77' ' ' THR . 40.2 p90 -111.07 154.91 23.57 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -179.588 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.805 ' HA ' ' HE ' ' A' ' 83' ' ' ARG . 0.0 OUTLIER 169.33 -145.34 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.241 0 O-C-N 123.805 0.691 . . . . 0.0 111.498 -179.999 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -129.53 157.46 41.97 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.688 -178.361 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.495 ' HA ' ' HA ' ' A' ' 74' ' ' ARG . 57.2 ttt180 -82.68 154.33 24.91 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 178.976 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.546 ' HG2' ' H ' ' A' ' 87' ' ' GLY . 39.6 tt0 -164.81 -179.36 5.79 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 120.986 0.422 . . . . 0.0 111.741 -177.939 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.546 ' H ' ' HG2' ' A' ' 86' ' ' GLN . . . -142.55 153.26 24.42 Favored Glycine 0 CA--C 1.521 0.455 0 N-CA-C 111.841 -0.504 . . . . 0.0 111.841 179.257 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.522 ' HB ' ' HB3' ' A' ' 48' ' ' LEU . 12.0 tt -131.33 143.98 39.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.11 0.481 . . . . 0.0 110.618 -179.876 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.589 ' OD2' ' HB2' ' A' ' 91' ' ' ASN . 20.8 t70 -82.99 133.55 35.1 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.345 -179.184 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.733 HD11 ' HB2' ' A' ' 71' ' ' LEU . 86.7 mt -109.46 38.35 2.36 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -179.214 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.589 ' HB2' ' OD2' ' A' ' 89' ' ' ASP . 6.6 m-80 -75.68 3.07 10.4 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-O 121.485 0.66 . . . . 0.0 110.256 178.621 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 24.9 mtp180 -96.08 -5.57 40.59 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.879 179.567 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.471 ' CD1' HD22 ' A' ' 37' ' ' LEU . 25.0 mm -103.02 100.95 11.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.265 0.555 . . . . 0.0 109.994 -179.413 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 19.1 mm-40 -110.24 156.34 20.8 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.725 -178.508 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 18.7 p-10 -110.07 113.18 25.67 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.378 178.172 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.7 p -109.9 114.99 48.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-O 121.339 0.59 . . . . 0.0 110.431 -179.777 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 65.12 23.54 12.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.559 179.697 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 95.45 -8.53 69.12 Favored Glycine 0 N--CA 1.447 -0.605 0 CA-C-N 115.481 -0.781 . . . . 0.0 112.404 -179.942 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 10.2 mtp180 -95.2 135.78 36.35 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -179.413 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.467 HD13 ' SG ' ' A' ' 23' ' ' CYS . 5.2 tp -88.22 116.11 26.19 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 -179.517 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 39.2 t -130.45 141.25 46.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.87 0.366 . . . . 0.0 110.65 -178.917 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.573 ' HB2' HD11 ' A' ' 35' ' ' LEU . 12.9 t80 -78.7 137.4 37.77 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.734 178.783 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 23.8 tp60 . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.576 -0.726 . . . . 0.0 110.215 -179.994 . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.0 mpp? . . . . . 0 N--CA 1.481 1.082 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 39.0 m -119.52 179.2 4.29 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.893 0.377 . . . . 0.0 111.352 -179.506 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.444 ' CB ' HD11 ' A' ' 100' ' ' LEU . 11.1 p90 -54.3 -32.63 56.9 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.518 178.062 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.558 ' HB3' ' HD2' ' A' ' 69' ' ' ARG . . . -57.43 -18.97 20.72 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 115.41 -0.814 . . . . 0.0 112.471 -179.056 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -69.41 -17.27 63.64 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 121.113 0.483 . . . . 0.0 110.891 179.641 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.413 ' HB2' HD21 ' A' ' 95' ' ' ASN . 74.6 m -144.27 37.05 1.24 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.076 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 23.2 t -150.83 157.17 42.6 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.686 -179.443 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 2.0 ptm180 -144.79 167.31 22.89 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 179.653 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 60.17 50.44 6.4 Favored 'General case' 0 N--CA 1.464 0.232 0 O-C-N 123.868 0.73 . . . . 0.0 111.186 179.492 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.505 ' HA ' ' HB2' ' A' ' 21' ' ' ALA . . . -84.81 117.36 23.81 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.467 179.721 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 33.5 m -122.42 168.77 14.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.916 -179.738 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.631 HD21 ' HG ' ' A' ' 64' ' ' LEU . 3.3 mm? -104.91 115.3 30.05 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.662 179.9 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 28.1 p -110.31 167.26 10.33 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.008 -179.891 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 59.83 46.78 10.94 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.089 179.398 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 85.5 -31.92 3.75 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 121.049 -0.596 . . . . 0.0 112.346 179.942 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.574 ' HA2' ' HB3' ' A' ' 12' ' ' LEU . . . 133.18 54.99 0.08 OUTLIER Glycine 0 N--CA 1.442 -0.905 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 -179.202 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.616 ' HB2' ' HB3' ' A' ' 38' ' ' ASP . 43.3 ptt85 -138.06 -32.73 0.72 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.889 0.376 . . . . 0.0 111.125 -179.664 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.451 HG22 ' HB3' ' A' ' 34' ' ' GLU . 5.2 m -98.56 132.32 44.07 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.479 179.93 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.744 HD11 HD13 ' A' ' 90' ' ' LEU . 69.5 mt -92.3 113.32 25.56 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.172 179.195 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 53.6 ttp180 -111.86 120.77 43.06 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 178.775 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.505 ' HB2' ' HA ' ' A' ' 10' ' ' ALA . . . -153.4 167.5 29.22 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.798 -179.271 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -90.36 106.15 18.3 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 178.437 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.556 ' SG ' HD13 ' A' ' 100' ' ' LEU . 58.5 m -93.15 130.59 38.75 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 -178.893 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 22.7 ttp85 -77.92 119.94 22.1 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 120.896 -0.322 . . . . 0.0 110.244 179.237 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.48 HD21 ' HB3' ' A' ' 29' ' ' ASN . 33.6 p30 -84.8 163.43 19.09 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.468 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.33 -15.43 25.47 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -178.232 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -82.21 -10.2 59.23 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.789 0.804 . . . . 0.0 109.289 179.168 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 87.23 35.36 9.7 Favored Glycine 0 N--CA 1.447 -0.605 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.702 -179.827 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.48 ' HB3' HD21 ' A' ' 25' ' ' ASN . 43.9 t30 -124.39 160.37 28.3 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.747 0.308 . . . . 0.0 111.316 -179.266 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 85.2 m95 -99.0 120.43 39.44 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.71 179.58 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.7 m -124.01 136.51 60.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.5 178.989 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 55.0 m -78.11 108.77 11.65 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 120.944 0.402 . . . . 0.0 110.135 179.696 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.478 ' HB2' ' SG ' ' A' ' 23' ' ' CYS . 70.6 m -119.26 142.46 48.03 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.383 -179.502 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.649 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 2.7 mp0 -128.38 152.6 47.99 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.344 -179.641 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.525 ' HB2' HD23 ' A' ' 100' ' ' LEU . 0.9 OUTLIER -143.53 126.96 16.81 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 178.292 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -87.26 109.65 19.64 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 -179.815 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.467 HD11 HD11 ' A' ' 19' ' ' LEU . 1.0 OUTLIER -86.94 -13.76 43.74 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.292 0.479 . . . . 0.0 112.292 -179.123 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.616 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 8.8 p-10 -64.98 -16.23 63.15 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 122.085 -0.384 . . . . 0.0 111.923 -178.314 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 15.1 t -91.15 0.79 57.46 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.119 0.485 . . . . 0.0 110.013 179.314 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 22.5 m -130.62 -19.5 3.0 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.993 -0.548 . . . . 0.0 111.783 -179.486 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 64.7 mt -112.79 139.95 35.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.823 0.344 . . . . 0.0 111.359 -179.287 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.577 ' HA3' ' HB3' ' A' ' 52' ' ' MET . . . -148.81 158.62 27.73 Favored Glycine 0 N--CA 1.449 -0.493 0 N-CA-C 110.841 -0.903 . . . . 0.0 110.841 179.171 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.6 ' N ' ' HD3' ' A' ' 44' ' ' PRO . 24.3 p30 -162.86 45.25 0.14 Allowed Pre-proline 0 CA--C 1.541 0.608 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 -179.317 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.6 ' HD3' ' N ' ' A' ' 43' ' ' ASN . 7.8 Cg_exo -71.84 -15.35 29.78 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 121.868 1.712 . . . . 0.0 111.277 179.959 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 70.9 m-20 -90.0 -0.75 57.75 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.703 -179.807 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.491 ' CA ' ' HG2' ' A' ' 83' ' ' ARG . . . 90.0 3.45 73.31 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.294 -0.955 . . . . 0.0 111.716 -179.167 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -125.25 132.68 52.9 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.786 0.327 . . . . 0.0 110.449 179.988 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.545 HD23 HG22 ' A' ' 88' ' ' ILE . 11.1 mp -85.3 153.69 22.4 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.057 -179.273 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 170.99 171.97 36.77 Favored Glycine 0 N--CA 1.44 -1.094 0 C-N-CA 120.432 -0.89 . . . . 0.0 112.008 179.092 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.51 ' CD2' ' HD3' ' A' ' 92' ' ' ARG . 93.4 m95 -96.91 131.16 43.96 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.675 0.274 . . . . 0.0 110.506 -179.495 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 142.97 -62.47 0.51 Allowed Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 121.055 -0.593 . . . . 0.0 111.739 -179.866 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.577 ' HB3' ' HA3' ' A' ' 42' ' ' GLY . 2.4 ttt -72.07 -176.56 1.79 Allowed 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 179.345 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -142.84 169.16 18.09 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 121.517 -0.74 . . . . 0.0 112.605 -178.021 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 8.2 m120 64.07 45.81 3.98 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.073 -0.967 . . . . 0.0 112.54 178.836 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 23.4 p90 -66.41 -32.71 74.26 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.837 179.512 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.448 ' HA ' HD11 ' A' ' 62' ' ' ILE . 4.3 m -63.09 -30.86 71.92 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.376 -179.169 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 28.1 m80 -81.76 -3.59 54.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.999 0.428 . . . . 0.0 111.025 -179.927 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 19.4 m -128.56 22.72 5.92 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.187 179.5 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 66.8 m -139.62 162.06 36.02 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.122 0.487 . . . . 0.0 111.671 -179.774 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -132.92 142.23 48.78 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.02 178.922 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 25.9 t70 60.0 73.52 0.48 Allowed 'General case' 0 N--CA 1.467 0.385 0 O-C-N 123.687 0.617 . . . . 0.0 110.707 -179.857 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.519 HG23 HD21 ' A' ' 71' ' ' LEU . 68.7 mt -93.19 114.42 29.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.415 -179.824 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.472 ' HD3' ' N ' ' A' ' 64' ' ' LEU . 13.7 tmtt? -147.38 149.88 33.6 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.079 -179.055 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.631 ' HG ' HD21 ' A' ' 12' ' ' LEU . 79.3 mt -83.29 122.54 28.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.145 0.498 . . . . 0.0 111.37 -179.521 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -74.02 -63.27 1.25 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.379 -179.143 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.515 ' HB2' ' HB2' ' A' ' 69' ' ' ARG . 29.3 mt-10 -86.13 35.35 0.64 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.843 0.354 . . . . 0.0 111.462 -179.008 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 56.93 22.09 40.3 Favored Glycine 0 CA--C 1.519 0.319 0 CA-C-N 115.679 -0.691 . . . . 0.0 113.591 179.327 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 139.22 -23.97 2.84 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 119.887 -1.149 . . . . 0.0 113.091 179.275 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.558 ' HD2' ' HB3' ' A' ' 4' ' ' ALA . 0.2 OUTLIER -78.73 -17.12 56.34 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 117.251 0.526 . . . . 0.0 110.838 -179.788 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.459 ' HE3' ' OE1' ' A' ' 66' ' ' GLU . 33.3 ttmt -153.56 138.34 17.06 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.521 -177.938 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.586 ' HB2' HD11 ' A' ' 90' ' ' LEU . 10.5 tt -108.55 129.75 55.3 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.102 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 6.4 p -117.61 136.36 53.34 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.819 0.342 . . . . 0.0 111.528 179.969 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 28.2 p -162.67 163.45 26.99 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.479 179.895 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.44 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 78.8 ttt180 -99.47 103.93 24.03 Favored Pre-proline 0 C--N 1.32 -0.71 0 C-N-CA 120.341 -0.543 . . . . 0.0 110.458 179.061 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.709 ' O ' ' HB3' ' A' ' 83' ' ' ARG . 69.2 Cg_endo -71.95 123.46 9.33 Favored 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 122.848 2.365 . . . . 0.0 111.036 179.174 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.758 ' HA ' ' HB2' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -120.21 143.33 48.32 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.335 -179.589 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.738 HG22 ' O ' ' A' ' 82' ' ' PHE . 15.2 t -75.71 136.78 40.35 Favored 'General case' 0 CA--C 1.513 -0.471 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 179.334 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 35.0 m -76.35 -6.88 9.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.991 -179.784 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -68.59 -31.54 70.8 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.637 179.645 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.486 ' HA3' ' CE2' ' A' ' 82' ' ' PHE . . . -147.04 -23.34 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.717 179.568 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 101.18 12.54 36.06 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.997 -0.62 . . . . 0.0 112.146 -179.495 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.738 ' O ' HG22 ' A' ' 77' ' ' THR . 31.5 p90 -111.91 158.46 19.45 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 118.892 -0.575 . . . . 0.0 110.221 -178.349 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.758 ' HB2' ' HA ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 164.32 -161.47 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.436 0 O-C-N 123.861 0.725 . . . . 0.0 111.307 178.327 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -110.16 176.08 5.19 Favored 'General case' 0 C--O 1.222 -0.354 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.36 -176.904 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.44 ' HA ' ' HA ' ' A' ' 74' ' ' ARG . 74.9 ttt180 -102.65 153.73 19.84 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 177.967 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.539 ' HB3' HD13 ' A' ' 48' ' ' LEU . 43.4 tt0 -166.09 179.2 5.89 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 120.361 -0.535 . . . . 0.0 111.848 -177.49 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.539 ' H ' ' HG2' ' A' ' 86' ' ' GLN . . . -145.54 155.16 26.37 Favored Glycine 0 N--CA 1.449 -0.493 0 N-CA-C 111.473 -0.651 . . . . 0.0 111.473 179.225 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.545 HG22 HD23 ' A' ' 48' ' ' LEU . 11.9 tt -132.06 134.84 59.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 110.105 -0.331 . . . . 0.0 110.105 179.883 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -77.78 139.09 39.31 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.221 0.534 . . . . 0.0 110.179 -179.949 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.744 HD13 HD11 ' A' ' 19' ' ' LEU . 68.3 mt -106.59 46.66 0.91 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.589 0.709 . . . . 0.0 111.201 -179.015 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 35.0 m-80 -79.16 3.19 18.41 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 115.344 -0.843 . . . . 0.0 110.176 179.555 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.51 ' HD3' ' CD2' ' A' ' 50' ' ' TRP . 17.8 mtp180 -97.09 -19.17 18.88 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.676 179.569 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.435 ' CD1' HD22 ' A' ' 37' ' ' LEU . 21.6 mm -91.56 100.76 11.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 -179.589 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 9.3 mm100 -109.48 165.92 11.28 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.285 -177.988 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.511 ' HA ' ' O ' ' A' ' 99' ' ' ARG . 18.4 p-10 -120.16 118.92 31.78 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.154 177.632 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.2 p -116.12 122.53 69.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 121.033 0.444 . . . . 0.0 110.339 -179.321 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 57.99 16.59 3.83 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.848 179.889 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 111.2 -12.15 28.82 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 121.076 -0.583 . . . . 0.0 113.707 178.859 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.511 ' O ' ' HA ' ' A' ' 95' ' ' ASN . 0.9 OUTLIER -101.0 147.06 26.62 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 117.422 0.611 . . . . 0.0 111.276 -178.906 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.556 HD13 ' SG ' ' A' ' 23' ' ' CYS . 5.2 tp -91.79 123.55 35.26 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.542 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 23.7 t -130.7 140.12 49.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.809 -178.951 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -85.65 125.07 32.87 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 177.397 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 . . . . . 0 C--N 1.309 -1.166 0 CA-C-O 118.46 -0.781 . . . . 0.0 110.862 179.675 . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.9 mpp? . . . . . 0 N--CA 1.481 1.099 0 CA-C-O 120.989 0.424 . . . . 0.0 110.375 . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.9 m -119.29 -179.73 3.94 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.453 -179.78 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.475 ' CZ ' HD13 ' A' ' 19' ' ' LEU . 18.0 p90 -55.43 -34.49 64.49 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.791 0.329 . . . . 0.0 111.114 178.555 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.546 ' HA ' ' OG ' ' A' ' 7' ' ' SER . . . -57.77 -18.69 23.08 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -178.546 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -69.48 -18.19 63.68 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 121.102 0.477 . . . . 0.0 111.168 179.875 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.419 ' HB2' HD21 ' A' ' 95' ' ' ASN . 50.7 m -141.64 36.51 1.64 Allowed 'General case' 0 N--CA 1.446 -0.646 0 CA-C-O 121.239 0.542 . . . . 0.0 109.899 179.361 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.546 ' OG ' ' HA ' ' A' ' 4' ' ' ALA . 77.8 p -148.7 165.47 31.26 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.36 179.205 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -148.22 165.57 30.53 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.068 179.918 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 62.09 42.44 9.81 Favored 'General case' 0 N--CA 1.464 0.237 0 O-C-N 123.594 0.559 . . . . 0.0 111.24 179.902 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.432 ' HA ' ' O ' ' A' ' 20' ' ' ARG . . . -80.13 117.21 20.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.153 179.627 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 28.2 m -126.41 172.38 13.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.708 -179.432 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.655 HD21 ' HG ' ' A' ' 64' ' ' LEU . 3.1 mm? -104.5 117.84 35.14 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.559 -179.216 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.45 ' OG1' ' HB ' ' A' ' 18' ' ' THR . 37.9 p -112.33 163.96 13.8 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.016 179.779 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 58.56 50.12 9.58 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.124 -179.909 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 84.63 -33.13 3.29 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.394 179.287 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.599 ' HA2' ' HB3' ' A' ' 12' ' ' LEU . . . 134.38 49.65 0.08 OUTLIER Glycine 0 N--CA 1.443 -0.855 0 N-CA-C 111.448 -0.661 . . . . 0.0 111.448 -179.652 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.681 ' HB2' ' HB2' ' A' ' 38' ' ' ASP . 20.4 ptt85 -133.79 -33.82 1.04 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.834 0.35 . . . . 0.0 111.021 179.96 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.509 ' CG2' ' HB3' ' A' ' 34' ' ' GLU . 19.2 m -94.76 135.68 35.96 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.15 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.656 ' O ' ' HA ' ' A' ' 34' ' ' GLU . 79.9 mt -97.54 114.98 26.97 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.559 -179.589 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.468 ' HA ' ' HG2' ' A' ' 34' ' ' GLU . 16.8 ttm180 -104.57 120.24 40.84 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 178.661 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -153.84 160.39 42.19 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.776 0.322 . . . . 0.0 111.571 -179.982 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.585 ' HB3' ' HB3' ' A' ' 30' ' ' TRP . 15.9 mm-40 -90.32 106.08 18.25 Favored 'General case' 0 CA--C 1.513 -0.479 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 177.927 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.505 ' SG ' HD13 ' A' ' 100' ' ' LEU . 48.9 m -93.74 127.56 39.52 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 120.989 0.423 . . . . 0.0 111.053 -178.016 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 23.3 ttp180 -75.35 110.19 9.5 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.772 179.17 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -82.74 169.28 16.35 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 119.223 -0.418 . . . . 0.0 109.979 -179.525 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -47.83 -34.38 8.64 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -178.085 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -68.04 -12.71 61.32 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.473 0.654 . . . . 0.0 111.317 -179.58 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 85.72 26.17 36.1 Favored Glycine 0 N--CA 1.444 -0.83 0 N-CA-C 110.806 -0.918 . . . . 0.0 110.806 -179.202 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -115.95 153.54 31.42 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.718 0.294 . . . . 0.0 110.899 -179.288 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.585 ' HB3' ' HB3' ' A' ' 22' ' ' GLU . 88.6 m95 -89.29 125.58 35.17 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.395 -179.505 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.409 HG22 ' O ' ' A' ' 23' ' ' CYS . 12.1 m -124.74 132.69 70.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 116.213 -0.449 . . . . 0.0 109.949 178.319 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 21.0 m -74.61 109.47 8.11 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.454 -179.904 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 68.7 m -123.18 142.94 50.37 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.358 179.826 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.656 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 49.1 mt-10 -128.38 134.93 48.93 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.31 -179.342 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.519 HD11 ' HB2' ' A' ' 102' ' ' PHE . 1.7 tm? -125.44 130.09 51.14 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 178.744 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.413 ' N ' HD13 ' A' ' 35' ' ' LEU . 15.2 t70 -88.98 111.3 21.98 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 110.14 -0.318 . . . . 0.0 110.14 -179.914 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.548 HD13 HD22 ' A' ' 90' ' ' LEU . 0.9 OUTLIER -86.38 -12.62 48.75 Favored 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 120.937 -0.305 . . . . 0.0 110.906 179.828 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.681 ' HB2' ' HB2' ' A' ' 17' ' ' ARG . 10.1 t70 -61.66 -36.32 80.5 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.653 0.264 . . . . 0.0 111.225 -178.928 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.3 t -72.75 1.27 8.78 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.199 -0.455 . . . . 0.0 112.0 -179.877 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 78.5 m -135.45 -21.43 1.55 Allowed 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 179.943 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.459 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 68.7 mt -107.58 137.21 39.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 179.771 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.491 ' HA2' ' HB3' ' A' ' 55' ' ' PHE . . . -149.55 160.13 28.34 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.393 -0.908 . . . . 0.0 112.492 179.951 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.705 ' ND2' ' HB2' ' A' ' 55' ' ' PHE . 8.3 p30 -158.23 51.21 0.44 Allowed Pre-proline 0 CA--C 1.535 0.4 0 N-CA-C 111.664 0.246 . . . . 0.0 111.664 178.967 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.402 ' HG3' ' HG2' ' A' ' 52' ' ' MET . 60.6 Cg_endo -71.83 -19.69 26.97 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 121.944 1.763 . . . . 0.0 111.823 -179.347 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -91.19 -9.2 46.25 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.883 179.515 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.594 ' HA3' ' HG2' ' A' ' 83' ' ' ARG . . . 102.7 7.47 44.89 Favored Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.772 -179.917 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -125.3 137.45 54.07 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.018 0.437 . . . . 0.0 111.076 -179.674 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.439 HD23 ' HB3' ' A' ' 43' ' ' ASN . 86.9 mt -82.92 146.52 28.79 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.922 -178.457 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 168.32 171.48 34.23 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.2 178.743 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.409 ' HH2' HD11 ' A' ' 93' ' ' ILE . 91.6 m95 -95.27 128.01 41.77 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 -179.998 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 154.35 -51.66 0.46 Allowed Glycine 0 N--CA 1.453 -0.196 0 C-N-CA 120.856 -0.688 . . . . 0.0 111.95 -179.905 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.449 ' HB3' ' HA3' ' A' ' 42' ' ' GLY . 14.0 tpt -93.05 174.03 7.43 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 179.848 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -128.97 173.19 10.64 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.846 -0.342 . . . . 0.0 111.005 179.698 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.678 ' HA ' ' OD2' ' A' ' 38' ' ' ASP . 0.7 OUTLIER 65.52 47.23 2.29 Favored 'General case' 0 N--CA 1.466 0.352 0 O-C-N 123.701 0.626 . . . . 0.0 111.128 -179.806 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.705 ' HB2' ' ND2' ' A' ' 43' ' ' ASN . 15.7 p90 -74.19 -32.11 62.92 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.673 -179.756 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.614 ' OG ' ' HB3' ' A' ' 17' ' ' ARG . 20.1 m -63.75 -33.74 76.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.035 0.445 . . . . 0.0 111.128 -179.046 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 15.7 m-70 -82.15 -7.95 59.64 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.101 0.476 . . . . 0.0 110.27 179.578 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 15.1 m -112.0 4.23 17.98 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.387 -179.292 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 36.4 p -138.38 157.54 46.03 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 122.203 -0.31 . . . . 0.0 110.752 -179.222 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 38.0 mm-40 -117.46 148.42 41.83 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.014 -179.401 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 24.1 t70 52.05 83.35 0.06 Allowed 'General case' 0 N--CA 1.468 0.462 0 O-C-N 124.333 1.02 . . . . 0.0 111.644 178.957 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.538 HD11 ' HA ' ' A' ' 56' ' ' SER . 77.9 mt -97.79 124.1 50.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.78 -179.942 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.455 ' HD3' ' N ' ' A' ' 64' ' ' LEU . 13.0 tmtt? -148.98 149.75 31.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.006 -179.857 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.655 ' HG ' HD21 ' A' ' 12' ' ' LEU . 76.2 mt -83.01 120.16 25.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.021 0.439 . . . . 0.0 111.532 -179.648 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -71.64 -60.2 2.36 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.267 -178.666 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.548 ' HB2' ' HB2' ' A' ' 69' ' ' ARG . 5.0 mm-40 -83.52 20.17 1.44 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.033 -178.767 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 68.66 19.23 72.88 Favored Glycine 0 N--CA 1.45 -0.425 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.923 179.701 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.519 ' HA2' HD13 ' A' ' 64' ' ' LEU . . . 144.18 -34.83 1.62 Allowed Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.315 -0.945 . . . . 0.0 113.251 179.697 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.548 ' HB2' ' HB2' ' A' ' 66' ' ' GLU . 5.4 mmt85 -71.57 -24.89 62.0 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.854 0.359 . . . . 0.0 111.829 -179.34 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 11.7 tttp -143.65 137.48 28.29 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.607 -177.81 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.606 ' HB2' HD11 ' A' ' 90' ' ' LEU . 10.5 tt -105.84 127.58 53.2 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 179.599 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.1 p -116.32 136.28 53.14 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 120.971 0.415 . . . . 0.0 111.233 179.967 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.403 ' HB3' ' HA ' ' A' ' 62' ' ' ILE . 21.0 p -162.58 175.87 10.98 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.747 -179.743 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.464 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 29.5 ttt180 -112.8 98.85 46.35 Favored Pre-proline 0 C--N 1.315 -0.902 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.303 178.97 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.647 ' O ' ' HB3' ' A' ' 83' ' ' ARG . 34.9 Cg_endo -66.19 130.44 24.13 Favored 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 122.674 2.249 . . . . 0.0 110.791 178.953 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.626 ' HA ' ' HB2' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -119.71 152.88 36.47 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.167 0.508 . . . . 0.0 111.049 -179.681 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.696 ' HB ' ' HD2' ' A' ' 83' ' ' ARG . 10.9 t -88.84 144.78 25.99 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 178.902 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 34.7 m -71.61 -4.81 5.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 O-C-N 123.992 0.808 . . . . 0.0 112.152 -179.141 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 39.1 m-20 -63.93 -37.21 86.55 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-O 121.118 0.485 . . . . 0.0 109.793 178.928 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.405 ' H ' ' H ' ' A' ' 81' ' ' GLY . . . -164.76 -4.94 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 115.461 -0.79 . . . . 0.0 112.854 -179.841 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.405 ' H ' ' H ' ' A' ' 80' ' ' GLY . . . 93.38 22.9 25.67 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.089 179.731 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.649 ' O ' HG22 ' A' ' 77' ' ' THR . 34.2 p90 -111.46 148.02 34.03 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 -179.42 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.696 ' HD2' ' HB ' ' A' ' 77' ' ' THR . 0.0 OUTLIER 174.55 -143.75 0.01 OUTLIER 'General case' 0 C--O 1.233 0.195 0 O-C-N 123.465 0.478 . . . . 0.0 111.304 -179.915 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -125.31 176.6 6.66 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.923 0.392 . . . . 0.0 110.579 -179.49 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.464 ' HA ' ' HA ' ' A' ' 74' ' ' ARG . 62.8 ttt180 -108.66 147.82 31.32 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 177.849 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.519 ' HG2' ' N ' ' A' ' 87' ' ' GLY . 9.0 tt0 -161.27 171.8 17.75 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.946 0.403 . . . . 0.0 111.79 -177.246 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.519 ' N ' ' HG2' ' A' ' 86' ' ' GLN . . . -132.12 141.65 13.01 Favored Glycine 0 N--CA 1.45 -0.387 0 N-CA-C 111.233 -0.747 . . . . 0.0 111.233 178.612 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 11.6 tt -120.45 138.74 49.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 120.976 0.417 . . . . 0.0 110.377 -179.221 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 39.6 m-20 -75.74 139.98 42.15 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.185 -179.472 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.612 HD13 HD11 ' A' ' 19' ' ' LEU . 29.8 mt -109.43 35.73 3.2 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.517 0.675 . . . . 0.0 110.376 179.317 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -72.56 -5.41 36.92 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.594 -179.835 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 17.1 mtp180 -89.09 -7.74 55.21 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.001 178.731 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.438 HG13 HD22 ' A' ' 37' ' ' LEU . 27.5 mm -103.64 100.55 10.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -179.615 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 25.4 tp60 -117.55 146.76 43.37 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.342 -178.777 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.419 HD21 ' HB2' ' A' ' 6' ' ' SER . 12.5 p-10 -95.16 117.11 29.66 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.48 179.18 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 48.5 t -101.36 107.03 20.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.788 179.727 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 56.16 41.86 28.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.675 -179.284 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 89.5 -18.4 46.4 Favored Glycine 0 N--CA 1.447 -0.624 0 CA-C-N 115.783 -0.644 . . . . 0.0 113.342 179.681 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 8.7 mpt_? -88.31 123.13 32.59 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 117.163 0.481 . . . . 0.0 110.921 -179.216 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.505 HD13 ' SG ' ' A' ' 23' ' ' CYS . 7.6 tp -76.65 114.46 15.41 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.443 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 40.7 t -128.98 144.7 37.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.09 0.472 . . . . 0.0 111.367 -178.488 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.519 ' HB2' HD11 ' A' ' 35' ' ' LEU . 22.3 t80 -83.26 130.92 35.11 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.63 178.442 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 . . . . . 0 C--N 1.317 -0.846 0 CA-C-O 118.325 -0.845 . . . . 0.0 110.216 -179.725 . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 tmt? . . . . . 0 N--CA 1.481 1.102 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.536 ' HB3' ' HA ' ' A' ' 91' ' ' ASN . 15.9 p -112.98 177.58 4.58 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.732 179.525 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 4.4 p90 -55.91 -38.09 69.79 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -178.555 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -56.35 -21.57 25.41 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 -177.882 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -66.4 -28.7 68.84 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.255 0.55 . . . . 0.0 110.392 179.971 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 41.4 m -133.44 36.22 3.39 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.687 179.204 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 8.6 t -140.29 160.11 40.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.945 -179.66 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 1.1 ptp180 -149.97 169.86 20.19 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.632 -179.593 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 58.23 45.48 17.21 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.129 177.934 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.567 ' HA ' ' HB2' ' A' ' 21' ' ' ALA . . . -81.66 118.34 22.73 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.055 0.455 . . . . 0.0 110.69 179.957 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 29.5 m -119.24 170.55 8.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.393 179.794 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.712 HD21 ' HG ' ' A' ' 64' ' ' LEU . 3.2 mm? -105.12 114.94 29.44 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.434 -179.47 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 38.8 p -115.01 167.66 10.6 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.808 179.752 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 57.64 50.56 10.71 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.154 179.653 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 83.88 -22.94 7.25 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 121.069 -0.586 . . . . 0.0 112.374 -179.808 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.613 ' HA2' ' HB3' ' A' ' 12' ' ' LEU . . . 119.71 38.23 0.73 Allowed Glycine 0 N--CA 1.447 -0.583 0 N-CA-C 111.662 -0.575 . . . . 0.0 111.662 179.976 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.626 ' HB2' ' HB3' ' A' ' 38' ' ' ASP . 14.3 ptt180 -121.86 -22.6 5.7 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.944 0.402 . . . . 0.0 110.758 -179.486 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 4.2 m -102.55 133.06 48.14 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.592 -179.607 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.811 HD11 HD13 ' A' ' 90' ' ' LEU . 69.5 mt -92.65 112.62 24.64 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.297 179.142 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.411 HH11 ' HD2' ' A' ' 20' ' ' ARG . 30.7 ttt85 -111.06 118.57 36.4 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 178.94 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.567 ' HB2' ' HA ' ' A' ' 10' ' ' ALA . . . -154.9 166.92 32.02 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.862 0.363 . . . . 0.0 111.964 -178.783 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -90.69 113.37 25.43 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 177.371 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.477 ' SG ' HD13 ' A' ' 100' ' ' LEU . 59.7 m -102.66 134.95 45.18 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 -179.806 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.563 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 7.3 ttt180 -82.12 104.66 12.61 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-O 120.917 0.389 . . . . 0.0 109.965 -179.804 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.431 HD21 ' HB3' ' A' ' 29' ' ' ASN . 37.8 p30 -67.01 170.84 6.17 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 115.619 -0.718 . . . . 0.0 111.162 -179.214 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.52 -31.16 61.84 Favored 'General case' 0 N--CA 1.464 0.269 0 O-C-N 123.431 0.457 . . . . 0.0 111.781 -178.781 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -71.56 -11.71 61.0 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.331 0.586 . . . . 0.0 110.421 179.878 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 87.55 24.64 35.47 Favored Glycine 0 N--CA 1.45 -0.404 0 N-CA-C 111.373 -0.691 . . . . 0.0 111.373 -179.839 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.563 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 10.7 t-20 -108.56 160.09 16.19 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.672 0.272 . . . . 0.0 110.718 -178.349 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 90.4 m95 -98.36 119.18 36.6 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.984 0.421 . . . . 0.0 110.8 179.745 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.2 m -123.43 130.9 73.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.098 179.11 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 28.0 m -79.69 109.12 13.8 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.057 0.455 . . . . 0.0 110.32 -179.889 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 70.3 m -115.89 161.33 18.96 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.439 -179.817 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.636 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 51.5 mt-10 -140.02 138.92 35.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.241 -178.908 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.6 ' HB2' ' HB3' ' A' ' 100' ' ' LEU . 1.8 tm? -134.72 129.97 35.53 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 178.704 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.476 ' O ' HG22 ' A' ' 39' ' ' THR . 15.8 m-20 -88.64 109.64 20.28 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 179.971 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.534 HD13 HD22 ' A' ' 90' ' ' LEU . 1.4 mt -83.06 -12.42 57.16 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.831 -179.303 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.626 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 4.2 p-10 -66.23 -13.58 60.56 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 111.857 0.317 . . . . 0.0 111.857 -178.621 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.476 HG22 ' O ' ' A' ' 36' ' ' ASP . 12.1 t -87.97 -0.58 57.19 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.885 0.374 . . . . 0.0 110.296 179.387 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 67.2 m -136.58 -20.11 1.37 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.937 179.94 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 60.0 mt -107.96 132.49 55.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 178.877 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.557 ' HA3' ' HB3' ' A' ' 52' ' ' MET . . . -141.49 158.69 26.61 Favored Glycine 0 N--CA 1.446 -0.667 0 N-CA-C 111.256 -0.738 . . . . 0.0 111.256 179.527 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.613 ' OD1' ' HB2' ' A' ' 58' ' ' SER . 32.6 p30 -156.29 40.82 0.12 Allowed Pre-proline 0 CA--C 1.54 0.592 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 179.792 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.403 ' CD ' ' N ' ' A' ' 43' ' ' ASN . 52.5 Cg_endo -69.65 -15.86 37.73 Favored 'Trans proline' 0 C--N 1.357 0.975 0 C-N-CA 121.331 1.354 . . . . 0.0 111.41 -179.933 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -89.74 -8.12 52.98 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.623 179.077 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.589 ' HA3' ' HD3' ' A' ' 83' ' ' ARG . . . 99.38 5.25 55.91 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.659 -179.575 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.702 ' HD1' HE22 ' A' ' 86' ' ' GLN . 63.2 m-85 -126.92 139.79 52.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 117.045 0.422 . . . . 0.0 111.568 -179.587 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.625 HD12 ' HG3' ' A' ' 86' ' ' GLN . 59.4 mt -84.5 138.86 32.54 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.735 -179.704 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 179.11 168.39 38.11 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.137 178.807 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 87.9 m95 -95.78 125.51 40.4 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.985 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 151.26 -42.61 0.72 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.895 -0.669 . . . . 0.0 111.519 -179.66 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.557 ' HB3' ' HA3' ' A' ' 42' ' ' GLY . 1.5 mtt -97.44 -172.07 2.33 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 179.399 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -142.96 169.81 16.88 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 119.757 -0.777 . . . . 0.0 112.343 -178.839 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 64.0 44.97 4.4 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.877 179.203 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.41 ' HD1' ' HA ' ' A' ' 38' ' ' ASP . 20.7 p90 -64.08 -33.6 76.13 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.464 -179.788 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 67.0 p -66.49 -23.84 66.32 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.208 0.527 . . . . 0.0 110.787 -179.36 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 16.1 m80 -76.97 -6.06 51.1 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.662 179.689 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.613 ' HB2' ' OD1' ' A' ' 43' ' ' ASN . 31.5 m -137.78 27.99 2.68 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.939 0.4 . . . . 0.0 110.782 179.492 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.554 ' HB3' HD21 ' A' ' 43' ' ' ASN . 35.6 p -141.73 149.81 40.98 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.169 0.509 . . . . 0.0 111.32 179.352 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -123.28 150.06 43.99 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.476 -179.626 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 27.6 t70 54.62 77.4 0.2 Allowed 'General case' 0 N--CA 1.47 0.546 0 O-C-N 123.778 0.674 . . . . 0.0 111.188 -179.922 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.51 ' HA ' ' HB3' ' A' ' 73' ' ' CYS . 69.4 mt -95.98 117.5 40.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.878 -179.404 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 41.6 tptt -142.25 150.45 40.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.699 -179.326 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.712 ' HG ' HD21 ' A' ' 12' ' ' LEU . 57.8 mt -92.93 144.7 25.01 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.362 179.432 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -101.42 -63.93 1.1 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.941 0.4 . . . . 0.0 111.963 -179.965 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.537 ' HB2' ' HB3' ' A' ' 69' ' ' ARG . 10.6 mm-40 -79.81 40.34 0.45 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.045 -178.098 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 64.11 22.09 66.61 Favored Glycine 0 C--N 1.314 -0.675 0 CA-C-N 115.229 -0.896 . . . . 0.0 113.123 178.858 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.598 ' HA2' HD13 ' A' ' 64' ' ' LEU . . . 120.56 -9.18 10.83 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 119.965 -1.112 . . . . 0.0 112.858 179.17 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.537 ' HB3' ' HB2' ' A' ' 66' ' ' GLU . 16.5 ttp85 -90.3 -3.06 58.01 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.665 0.745 . . . . 0.0 110.335 -179.794 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.517 ' HD3' ' HA ' ' A' ' 89' ' ' ASP . 5.6 tppp? -150.39 123.64 8.92 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.846 -179.77 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.677 ' HB2' HD11 ' A' ' 90' ' ' LEU . 9.5 tt -105.62 128.57 53.71 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 179.867 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 5.6 p -123.23 135.43 54.27 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.166 179.876 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.51 ' HB3' ' HA ' ' A' ' 62' ' ' ILE . 22.8 p -162.21 173.79 13.78 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 179.552 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.47 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 71.8 ttt180 -110.26 98.59 36.34 Favored Pre-proline 0 C--N 1.312 -1.035 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.276 179.606 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.646 ' O ' ' HB3' ' A' ' 83' ' ' ARG . 37.1 Cg_endo -69.92 132.65 23.5 Favored 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 122.342 2.028 . . . . 0.0 109.964 178.495 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.743 ' HA ' ' HB2' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -120.6 142.84 49.02 Favored 'General case' 0 C--N 1.32 -0.68 0 O-C-N 123.678 0.611 . . . . 0.0 111.452 -179.115 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.706 HG22 ' O ' ' A' ' 82' ' ' PHE . 14.6 t -76.81 143.31 39.87 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.614 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 22.5 m -77.4 1.07 2.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.573 -179.492 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -69.8 -34.26 73.48 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 121.371 0.605 . . . . 0.0 109.651 178.326 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -159.05 -12.77 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.517 0 CA-C-N 115.29 -0.868 . . . . 0.0 112.794 -179.814 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.704 ' HA2' ' HE3' ' A' ' 76' ' ' LYS . . . 97.23 20.21 23.72 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.108 179.983 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.706 ' O ' HG22 ' A' ' 77' ' ' THR . 33.8 p90 -111.83 155.42 23.62 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 118.996 -0.526 . . . . 0.0 109.904 -179.055 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.743 ' HB2' ' HA ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 171.49 -148.18 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 O-C-N 123.407 0.442 . . . . 0.0 111.48 179.651 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -134.99 153.51 52.06 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.157 -177.817 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.47 ' HA ' ' HA ' ' A' ' 74' ' ' ARG . 43.2 ttt85 -88.56 149.55 23.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.128 179.512 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.702 HE22 ' HD1' ' A' ' 47' ' ' PHE . 8.2 pt20 -165.28 177.51 7.54 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.146 -179.033 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -131.62 150.94 19.61 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.8 -0.715 . . . . 0.0 112.45 -179.994 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 9.5 tt -127.77 134.63 65.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 179.736 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.517 ' HA ' ' HD3' ' A' ' 70' ' ' LYS . 2.1 p-10 -76.94 140.27 40.42 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.997 0.427 . . . . 0.0 110.439 -179.178 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.811 HD13 HD11 ' A' ' 19' ' ' LEU . 62.2 mt -105.91 38.69 1.95 Allowed 'General case' 0 CA--C 1.512 -0.513 0 CA-C-O 121.412 0.625 . . . . 0.0 110.873 -178.892 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.536 ' HA ' ' HB3' ' A' ' 2' ' ' SER . 11.1 m120 -75.19 0.05 17.71 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.794 -179.759 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 14.7 mtp180 -92.05 -7.67 48.09 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.595 179.339 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.424 ' CD1' HD22 ' A' ' 37' ' ' LEU . 28.1 mm -98.5 104.57 16.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.518 0.675 . . . . 0.0 109.747 -179.334 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -106.56 157.36 17.73 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.36 -178.346 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.477 ' HA ' ' O ' ' A' ' 99' ' ' ARG . 20.4 p-10 -113.7 124.64 52.78 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.425 178.073 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 46.8 t -107.71 109.28 27.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 -179.237 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 11.3 m-80 57.79 22.14 8.21 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.937 0.398 . . . . 0.0 111.577 -179.326 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 113.66 -25.36 11.08 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.728 -0.748 . . . . 0.0 113.935 178.47 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.477 ' O ' ' HA ' ' A' ' 95' ' ' ASN . 1.4 ptm180 -86.5 147.76 25.83 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 117.416 0.608 . . . . 0.0 110.666 -178.85 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.6 ' HB3' ' HB2' ' A' ' 35' ' ' LEU . 2.1 tp -92.68 122.92 35.57 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.718 0.294 . . . . 0.0 110.335 -179.366 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 41.7 t -134.12 141.84 42.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.654 -179.869 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.416 ' HB2' HD11 ' A' ' 35' ' ' LEU . 16.9 t80 -78.44 136.39 37.61 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.979 0.419 . . . . 0.0 110.106 179.268 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 . . . . . 0 C--O 1.25 1.087 0 CA-C-O 118.462 -0.78 . . . . 0.0 110.39 179.949 . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 70.5 mtm . . . . . 0 N--CA 1.482 1.173 0 CA-C-O 120.842 0.353 . . . . 0.0 110.297 . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.582 ' HB3' ' HA ' ' A' ' 91' ' ' ASN . 0.3 OUTLIER -97.93 179.91 4.63 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.729 179.92 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.442 ' CB ' HD11 ' A' ' 100' ' ' LEU . 13.3 p90 -47.03 -36.07 7.49 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 123.09 0.556 . . . . 0.0 112.422 -179.51 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.434 ' HB3' ' HD3' ' A' ' 69' ' ' ARG . . . -54.13 -20.45 6.67 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -178.664 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -64.11 -33.65 76.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.218 0.533 . . . . 0.0 109.867 178.896 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 26.1 m -132.31 41.8 3.18 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.619 179.121 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 22.7 t -154.77 149.24 26.26 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.307 -179.591 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.459 ' HG3' ' ND2' ' A' ' 9' ' ' ASN . 11.6 ptp180 -136.62 175.7 9.37 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.827 -179.474 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.459 ' ND2' ' HG3' ' A' ' 8' ' ' ARG . 4.6 p30 45.58 60.39 3.12 Favored 'General case' 0 N--CA 1.474 0.774 0 O-C-N 124.298 0.999 . . . . 0.0 112.286 -179.233 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.422 ' HA ' ' HB2' ' A' ' 21' ' ' ALA . . . -87.28 117.73 26.23 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.376 179.519 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 33.9 m -115.92 170.64 5.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.821 -179.852 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.582 ' HB3' ' HA2' ' A' ' 16' ' ' GLY . 3.7 mm? -105.18 120.75 42.29 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.592 -179.62 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.437 HG21 ' NE ' ' A' ' 20' ' ' ARG . 17.7 p -119.96 161.42 20.92 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.825 179.542 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 59.8 38.27 21.55 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.14 179.679 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 93.86 -23.34 31.39 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.066 179.896 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.582 ' HA2' ' HB3' ' A' ' 12' ' ' LEU . . . 124.93 11.78 4.23 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.628 -0.796 . . . . 0.0 111.847 -179.939 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.585 ' HB2' ' HB3' ' A' ' 38' ' ' ASP . 16.9 ptt180 -92.46 -23.05 19.27 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.264 0.554 . . . . 0.0 110.067 -179.954 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.463 HG22 ' HB3' ' A' ' 34' ' ' GLU . 4.3 m -105.96 133.48 50.61 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.782 -179.535 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.766 HD11 HD13 ' A' ' 90' ' ' LEU . 59.9 mt -97.47 114.41 26.27 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.419 179.163 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.481 ' HA ' ' HG2' ' A' ' 34' ' ' GLU . 32.9 ttm180 -109.84 120.19 41.7 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 178.813 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.422 ' HB2' ' HA ' ' A' ' 10' ' ' ALA . . . -153.36 166.12 33.63 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.969 0.414 . . . . 0.0 111.455 -179.675 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.714 ' HG3' ' HB3' ' A' ' 30' ' ' TRP . 1.0 OUTLIER -90.29 107.6 19.24 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 177.898 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.43 ' SG ' HD13 ' A' ' 100' ' ' LEU . 71.6 m -98.51 140.65 32.44 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.686 0.279 . . . . 0.0 110.69 -178.701 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.532 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 7.9 ttp180 -83.96 115.83 22.51 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-O 120.949 0.405 . . . . 0.0 110.2 179.412 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.423 HD21 ' HB3' ' A' ' 29' ' ' ASN . 37.0 p30 -76.55 174.2 10.62 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.262 179.919 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.74 -25.29 60.2 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -178.497 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -78.79 -9.81 59.57 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.65 0.738 . . . . 0.0 109.896 179.92 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 85.07 29.3 28.71 Favored Glycine 0 N--CA 1.445 -0.761 0 N-CA-C 110.718 -0.953 . . . . 0.0 110.718 -179.031 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.532 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 8.3 t-20 -111.53 158.45 19.17 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.74 -0.23 . . . . 0.0 110.687 -178.555 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.714 ' HB3' ' HG3' ' A' ' 22' ' ' GLU . 61.4 m95 -92.28 129.29 38.26 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.047 -179.899 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.4 HG22 ' O ' ' A' ' 23' ' ' CYS . 15.6 m -132.9 141.42 44.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.668 179.346 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.2 m -81.7 111.75 18.25 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.228 179.86 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 54.7 m -127.53 150.18 49.81 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.655 179.779 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.667 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 45.1 mt-10 -134.25 148.32 50.81 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.03 -179.611 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.544 HD12 HD23 ' A' ' 37' ' ' LEU . 2.1 tm? -139.25 134.42 32.64 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.55 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.478 ' N ' HD13 ' A' ' 35' ' ' LEU . 29.6 m-20 -91.76 109.69 21.02 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.359 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.544 HD23 HD12 ' A' ' 35' ' ' LEU . 1.4 mt -83.01 -20.62 34.72 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.816 -178.543 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.585 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 4.3 p-10 -61.5 -15.41 37.61 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 111.717 0.266 . . . . 0.0 111.717 -178.423 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 60.0 p -72.48 -22.58 61.04 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.055 0.455 . . . . 0.0 110.716 179.737 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 27.3 m -128.86 0.25 5.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.06 -0.518 . . . . 0.0 112.022 -178.669 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.438 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 53.7 mt -116.57 131.35 69.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 120.636 0.255 . . . . 0.0 110.342 178.861 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.562 ' HA3' ' HB3' ' A' ' 52' ' ' MET . . . -150.38 163.99 29.67 Favored Glycine 0 N--CA 1.445 -0.731 0 N-CA-C 111.328 -0.709 . . . . 0.0 111.328 179.445 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.451 ' OD1' ' HB2' ' A' ' 55' ' ' PHE . 3.7 p-10 -161.91 51.08 0.32 Allowed Pre-proline 0 CA--C 1.535 0.386 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 179.813 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -63.5 -26.73 70.08 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 121.847 1.698 . . . . 0.0 111.75 -179.626 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -84.14 -12.59 54.73 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.797 179.898 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.599 ' HA3' ' HD3' ' A' ' 83' ' ' ARG . . . 103.36 7.96 41.92 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.283 -0.96 . . . . 0.0 112.954 -179.344 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -124.88 133.62 53.01 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.003 0.43 . . . . 0.0 110.495 179.676 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.503 ' HB3' ' HB ' ' A' ' 88' ' ' ILE . 84.2 mt -83.09 138.0 33.87 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.498 -0.774 . . . . 0.0 112.251 -177.688 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -177.01 172.81 45.77 Favored Glycine 0 N--CA 1.447 -0.58 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.7 178.802 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.421 ' CD2' ' HD3' ' A' ' 92' ' ' ARG . 94.1 m95 -95.53 128.21 42.21 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.993 0.425 . . . . 0.0 110.321 -179.971 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 151.84 -62.69 0.39 Allowed Glycine 0 N--CA 1.449 -0.441 0 CA-C-N 116.019 -0.537 . . . . 0.0 112.076 -179.877 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.608 ' CE ' ' HA ' ' A' ' 52' ' ' MET . 1.0 OUTLIER -77.02 179.88 5.96 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 179.74 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -133.98 173.8 11.17 Favored 'General case' 0 C--N 1.326 -0.419 0 O-C-N 122.089 -0.382 . . . . 0.0 111.678 -178.982 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 61.74 45.99 7.4 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.642 -0.708 . . . . 0.0 112.33 179.174 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.451 ' HB2' ' OD1' ' A' ' 43' ' ' ASN . 8.5 p90 -65.83 -28.51 69.04 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 111.652 0.241 . . . . 0.0 111.652 -179.371 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 11.4 p -64.45 -28.4 69.65 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.917 0.389 . . . . 0.0 111.553 -179.104 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 50.5 m80 -82.27 -3.43 55.21 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.224 -179.433 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 14.9 m -126.52 13.53 7.57 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.792 179.793 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 63.9 m -135.49 151.94 50.85 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.382 0.61 . . . . 0.0 111.881 -178.891 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -121.55 141.46 51.05 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.404 179.279 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.43 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 31.4 t70 58.78 79.89 0.2 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.509 0.671 . . . . 0.0 111.39 179.704 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.535 HG23 HD21 ' A' ' 71' ' ' LEU . 74.3 mt -95.56 123.27 47.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.076 179.558 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.6 tptm -149.02 160.0 43.71 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 -179.769 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.547 ' HG ' HD21 ' A' ' 12' ' ' LEU . 44.7 mt -88.57 129.44 35.48 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.108 0.48 . . . . 0.0 109.973 178.965 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.415 ' HB3' ' HB3' ' A' ' 70' ' ' LYS . 34.1 tp10 -77.52 -69.47 0.53 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.264 -178.398 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.57 ' HB2' ' HB2' ' A' ' 69' ' ' ARG . 26.1 mt-10 -81.94 29.31 0.4 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.285 -179.284 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 68.11 14.64 66.36 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.903 -0.59 . . . . 0.0 113.282 179.757 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 145.98 -25.84 1.76 Allowed Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 119.591 -1.29 . . . . 0.0 113.373 179.361 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.57 ' HB2' ' HB2' ' A' ' 66' ' ' GLU . 9.6 mmt85 -76.19 -23.37 54.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.283 0.563 . . . . 0.0 110.431 -179.289 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.415 ' HB3' ' HB3' ' A' ' 65' ' ' GLU . 39.9 ttmt -146.02 148.73 33.0 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.801 -177.883 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.716 ' HB2' HD11 ' A' ' 90' ' ' LEU . 9.8 tt -115.94 125.66 52.86 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 179.332 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.1 p -113.72 128.35 56.39 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.346 0.594 . . . . 0.0 111.241 179.43 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 73' ' ' CYS . . . . . 0.43 ' HA ' ' O ' ' A' ' 61' ' ' ASP . 25.6 p -149.88 171.32 16.97 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.659 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.56 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 4.1 tmt_? -104.37 98.31 14.02 Favored Pre-proline 0 C--N 1.315 -0.896 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 179.267 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.591 ' O ' ' HB3' ' A' ' 83' ' ' ARG . 64.9 Cg_endo -72.62 125.02 10.23 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 123.002 2.468 . . . . 0.0 111.506 179.79 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.718 ' HA ' ' HB2' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -121.82 139.92 53.02 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.867 179.819 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.721 HG22 ' O ' ' A' ' 82' ' ' PHE . 11.6 t -74.77 131.54 40.89 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 178.499 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.1 m -74.18 -2.22 3.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.488 -179.256 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -68.83 -33.71 74.28 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.185 0.517 . . . . 0.0 109.738 179.309 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -148.56 -23.96 0.08 OUTLIER Glycine 0 N--CA 1.449 -0.436 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.591 179.796 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.527 ' HA2' ' HE2' ' A' ' 76' ' ' LYS . . . 101.58 19.03 16.83 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.021 -179.793 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.721 ' O ' HG22 ' A' ' 77' ' ' THR . 26.3 p90 -110.71 151.05 28.19 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 118.821 -0.609 . . . . 0.0 109.993 -178.885 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.718 ' HB2' ' HA ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 167.49 -153.95 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.572 0 O-C-N 123.729 0.643 . . . . 0.0 111.213 179.236 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -135.55 167.41 21.14 Favored 'General case' 0 C--O 1.226 -0.17 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.051 -178.842 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.56 ' HA ' ' HA ' ' A' ' 74' ' ' ARG . 44.5 ttt180 -81.75 156.25 25.07 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 178.407 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.61 ' HG2' ' H ' ' A' ' 87' ' ' GLY . 36.8 tt0 -161.04 -176.07 5.27 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.41 -0.516 . . . . 0.0 111.401 -178.161 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.61 ' H ' ' HG2' ' A' ' 86' ' ' GLN . . . -151.89 141.36 8.47 Favored Glycine 0 N--CA 1.449 -0.49 0 N-CA-C 111.778 -0.529 . . . . 0.0 111.778 179.379 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.503 ' HB ' ' HB3' ' A' ' 48' ' ' LEU . 10.4 tt -120.58 133.48 67.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.303 0.573 . . . . 0.0 110.77 -179.46 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.515 ' OD1' ' HB2' ' A' ' 91' ' ' ASN . 13.6 t70 -73.25 136.34 44.61 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.632 -179.868 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.766 HD13 HD11 ' A' ' 19' ' ' LEU . 63.8 mt -109.55 37.41 2.63 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -178.341 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.582 ' HA ' ' HB3' ' A' ' 2' ' ' SER . 7.1 m-80 -75.05 2.59 10.23 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 121.368 0.604 . . . . 0.0 111.221 179.231 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.421 ' HD3' ' CD2' ' A' ' 50' ' ' TRP . 24.7 mtp180 -92.29 -12.49 32.37 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.243 179.104 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.471 HG13 HD22 ' A' ' 37' ' ' LEU . 24.6 mm -94.94 103.47 14.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 121.453 0.644 . . . . 0.0 109.563 -179.622 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 3.5 mm100 -112.25 152.08 28.88 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.714 -178.368 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 18.3 p-10 -105.27 126.02 51.63 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.742 178.564 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 40.5 t -115.72 116.47 52.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 -179.562 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 54.4 25.39 6.0 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.601 -179.841 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 109.13 -27.45 12.72 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.806 -0.712 . . . . 0.0 114.004 179.155 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -86.8 146.19 26.33 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 117.687 0.744 . . . . 0.0 111.53 -178.48 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.523 ' HB3' ' HB2' ' A' ' 35' ' ' LEU . 5.2 tp -92.14 121.52 33.76 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.906 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 24.1 t -129.73 140.88 47.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 120.804 0.335 . . . . 0.0 110.935 -178.821 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.432 ' HB2' HD11 ' A' ' 35' ' ' LEU . 20.7 t80 -79.21 130.73 35.77 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 178.475 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 . . . . . 0 C--N 1.312 -1.064 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.673 -179.57 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . 0.537 ' OG ' ' HA ' ' A' ' 91' ' ' ASN . 9.2 m . . . . . 0 N--CA 1.449 -0.485 0 N-CA-C 110.426 -0.213 . . . . 0.0 110.426 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 18.6 p90 -51.73 -34.18 37.98 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 123.448 0.468 . . . . 0.0 111.519 179.143 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -56.3 -18.8 11.77 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 -178.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -58.02 -32.91 68.4 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 121.261 0.553 . . . . 0.0 110.093 178.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 33.5 m -137.44 37.94 2.47 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.338 178.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.456 ' HA ' ' O ' ' A' ' 22' ' ' GLU . 20.3 t -147.23 147.97 30.99 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.271 -179.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 9.7 ptp180 -140.58 169.75 17.07 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.086 -179.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 65.7 m-80 57.39 52.32 8.8 Favored 'General case' 0 N--CA 1.465 0.296 0 O-C-N 123.93 0.769 . . . . 0.0 111.53 -179.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -82.47 118.12 23.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.465 179.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 27.0 m -121.55 170.8 11.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.67 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.641 HD21 ' HG ' ' A' ' 64' ' ' LEU . 3.3 mm? -105.14 114.57 28.85 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.118 -179.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.504 HG21 ' NE ' ' A' ' 20' ' ' ARG . 35.3 p -111.79 170.37 8.19 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.978 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 59.49 46.25 12.48 Favored 'General case' 0 CA--C 1.521 -0.137 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.289 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 86.01 -34.92 3.32 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 121.007 -0.616 . . . . 0.0 112.134 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.592 ' HA2' ' HB3' ' A' ' 12' ' ' LEU . . . 136.2 38.02 0.17 Allowed Glycine 0 N--CA 1.447 -0.583 0 N-CA-C 111.437 -0.665 . . . . 0.0 111.437 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.692 ' HB2' ' HB2' ' A' ' 38' ' ' ASP . 3.3 ptp180 -125.23 -12.91 6.81 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.256 0.55 . . . . 0.0 110.98 -179.389 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.519 ' CG2' ' HB3' ' A' ' 34' ' ' GLU . 9.5 m -115.21 137.74 51.69 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.429 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.831 HD11 HD13 ' A' ' 90' ' ' LEU . 59.6 mt -96.13 118.66 33.16 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.734 179.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.504 ' NE ' HG21 ' A' ' 13' ' ' THR . 34.5 ttm180 -113.84 120.98 42.61 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 178.262 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.413 ' O ' ' HA ' ' A' ' 32' ' ' THR . . . -152.72 167.32 29.37 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.827 0.346 . . . . 0.0 111.532 -179.122 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.697 ' HB3' ' HB3' ' A' ' 30' ' ' TRP . 39.4 mt-10 -89.68 105.95 18.14 Favored 'General case' 0 CA--C 1.512 -0.516 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 178.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.533 ' SG ' HD13 ' A' ' 100' ' ' LEU . 56.0 m -96.23 119.22 34.33 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 -179.276 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.486 ' HB2' ' CZ3' ' A' ' 30' ' ' TRP . 45.9 ttp180 -72.85 111.28 7.83 Favored 'General case' 0 N--CA 1.437 -1.113 0 N-CA-C 110.197 -0.297 . . . . 0.0 110.197 179.386 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 31.9 p30 -81.18 168.9 18.03 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.669 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -51.54 -32.01 26.39 Favored 'General case' 0 N--CA 1.465 0.284 0 O-C-N 123.643 0.59 . . . . 0.0 112.096 -179.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -67.65 -14.12 62.67 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.404 0.621 . . . . 0.0 110.94 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 89.15 22.07 39.49 Favored Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.772 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.431 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 2.3 m-80 -111.77 150.38 30.37 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.838 0.351 . . . . 0.0 111.449 -179.101 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.697 ' HB3' ' HB3' ' A' ' 22' ' ' GLU . 97.3 m95 -91.63 109.3 20.6 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.201 179.242 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.9 m -109.87 129.42 64.83 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 CA-C-O 120.965 0.412 . . . . 0.0 110.232 178.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.413 ' HA ' ' O ' ' A' ' 21' ' ' ALA . 27.7 m -78.98 113.16 16.87 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.854 -179.372 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 68.7 m -121.19 157.26 30.6 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.403 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.676 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 51.3 mt-10 -131.78 132.35 43.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.763 -179.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.472 ' HB2' HD23 ' A' ' 100' ' ' LEU . 1.9 tm? -124.91 132.63 53.27 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.571 -0.899 . . . . 0.0 108.571 178.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.449 ' N ' HD13 ' A' ' 35' ' ' LEU . 12.9 m-20 -91.45 109.95 21.25 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.76 0.314 . . . . 0.0 110.512 -179.113 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.451 HD13 HD22 ' A' ' 90' ' ' LEU . 0.9 OUTLIER -83.47 -15.99 47.43 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.296 -179.521 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.75 ' OD2' ' HA ' ' A' ' 54' ' ' ASN . 8.5 t70 -63.17 -8.48 8.11 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.071 0.462 . . . . 0.0 110.969 -179.297 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 73.0 p -87.14 -22.37 25.39 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.49 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.404 ' HB2' ' CZ3' ' A' ' 50' ' ' TRP . 29.0 m -125.56 -5.04 7.1 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -178.056 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 56.7 mt -113.72 136.16 51.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.66 0.267 . . . . 0.0 110.407 179.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.521 ' HA3' ' HB3' ' A' ' 52' ' ' MET . . . -146.65 157.35 27.37 Favored Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.86 -0.686 . . . . 0.0 111.855 179.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.618 ' N ' ' HD3' ' A' ' 44' ' ' PRO . 21.8 p30 -159.53 46.28 0.21 Allowed Pre-proline 0 CA--C 1.539 0.534 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.618 ' HD3' ' N ' ' A' ' 43' ' ' ASN . 7.0 Cg_exo -70.84 -19.16 31.31 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 122.182 1.922 . . . . 0.0 112.012 -178.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -96.53 1.93 51.88 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.912 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.433 ' HA2' ' HB2' ' A' ' 75' ' ' PRO . . . 92.89 8.44 61.88 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.185 -1.007 . . . . 0.0 112.693 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.545 ' HA ' HE22 ' A' ' 86' ' ' GLN . 56.6 m-85 -125.88 134.49 51.59 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.952 0.376 . . . . 0.0 110.716 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.491 HD23 HG22 ' A' ' 88' ' ' ILE . 10.8 mp -88.6 147.26 24.66 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.904 -178.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 172.18 175.32 40.22 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.968 -0.634 . . . . 0.0 111.825 178.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.45 ' HH2' HD11 ' A' ' 93' ' ' ILE . 95.8 m95 -97.72 130.35 44.7 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.952 0.406 . . . . 0.0 110.346 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 147.31 -60.81 0.46 Allowed Glycine 0 N--CA 1.447 -0.593 0 N-CA-C 111.542 -0.623 . . . . 0.0 111.542 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.588 ' HA ' ' CE ' ' A' ' 52' ' ' MET . 1.7 tpt -77.85 171.61 14.71 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 179.09 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -132.19 171.23 13.93 Favored 'General case' 0 C--N 1.32 -0.715 0 O-C-N 121.845 -0.534 . . . . 0.0 110.907 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.75 ' HA ' ' OD2' ' A' ' 38' ' ' ASP . 13.6 m120 65.3 45.7 2.83 Favored 'General case' 0 C--N 1.328 -0.336 0 O-C-N 124.041 0.838 . . . . 0.0 111.77 178.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.409 ' HB3' ' HA2' ' A' ' 42' ' ' GLY . 25.5 p90 -65.65 -30.02 70.67 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.411 179.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.419 ' OG ' ' HB3' ' A' ' 17' ' ' ARG . 12.0 m -59.48 -26.81 65.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.297 0.57 . . . . 0.0 110.767 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 75.5 m80 -75.96 -13.59 60.24 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.635 -178.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 27.1 m -131.66 32.23 4.16 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 120.853 0.359 . . . . 0.0 110.978 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 29.2 p -145.58 154.1 41.79 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.611 -0.436 . . . . 0.0 111.328 179.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.485 ' HG3' ' HG2' ' A' ' 76' ' ' LYS . 68.3 mt-10 -131.47 148.75 52.67 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.368 179.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 60.29 59.65 2.25 Favored 'General case' 0 C--N 1.331 -0.229 0 O-C-N 123.848 0.718 . . . . 0.0 110.956 178.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.576 HG23 HD21 ' A' ' 71' ' ' LEU . 75.2 mt -83.45 113.83 23.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.116 -179.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 35.7 ttmt -149.74 154.73 38.98 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.994 179.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.641 ' HG ' HD21 ' A' ' 12' ' ' LEU . 72.6 mt -82.63 130.65 35.16 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.834 0.35 . . . . 0.0 110.509 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -88.09 -58.52 2.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.634 -178.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.532 ' HB2' ' HB2' ' A' ' 69' ' ' ARG . 26.6 mt-10 -80.91 33.78 0.33 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.87 0.366 . . . . 0.0 111.318 -179.556 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 67.4 2.14 18.77 Favored Glycine 0 C--N 1.32 -0.342 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.879 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.546 ' HA2' HD13 ' A' ' 64' ' ' LEU . . . 145.37 -14.96 1.85 Allowed Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 120.095 -1.05 . . . . 0.0 112.669 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.532 ' HB2' ' HB2' ' A' ' 66' ' ' GLU . 19.1 mmt180 -79.67 -18.51 51.19 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.47 ' HB3' ' HG3' ' A' ' 66' ' ' GLU . 30.7 ttpt -149.22 140.24 22.94 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.123 -178.556 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.597 ' HB2' HD11 ' A' ' 90' ' ' LEU . 9.8 tt -109.49 124.26 50.76 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.306 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 6.6 p -111.41 137.01 49.74 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.232 0.539 . . . . 0.0 111.224 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.502 ' HB3' ' HA ' ' A' ' 62' ' ' ILE . 21.4 p -161.61 164.08 29.58 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.163 179.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.437 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 28.7 ttt180 -99.88 103.27 21.1 Favored Pre-proline 0 C--N 1.318 -0.78 0 CA-C-N 116.722 -0.217 . . . . 0.0 110.47 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.614 ' O ' ' HB3' ' A' ' 83' ' ' ARG . 56.6 Cg_endo -70.02 116.03 4.4 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 122.403 2.069 . . . . 0.0 110.002 178.314 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.906 ' HE2' ' HA2' ' A' ' 81' ' ' GLY . 0.0 OUTLIER -119.34 141.61 48.87 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.301 -179.182 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.695 HG22 ' O ' ' A' ' 82' ' ' PHE . 12.2 t -67.57 132.6 47.87 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 179.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 14.0 p -68.58 -14.19 18.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 O-C-N 124.149 0.905 . . . . 0.0 111.128 -179.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -64.54 -28.03 69.37 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.72 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.481 ' HA3' ' CE1' ' A' ' 82' ' ' PHE . . . -155.12 -26.67 0.03 OUTLIER Glycine 0 CA--C 1.518 0.266 0 C-N-CA 120.138 -1.03 . . . . 0.0 113.858 -179.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.906 ' HA2' ' HE2' ' A' ' 76' ' ' LYS . . . 102.94 18.64 14.73 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.998 -0.62 . . . . 0.0 111.599 -179.31 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.695 ' O ' HG22 ' A' ' 77' ' ' THR . 18.9 p90 -112.36 145.52 39.93 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 119.274 -0.393 . . . . 0.0 110.053 -178.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.739 ' HB2' ' HA ' ' A' ' 76' ' ' LYS . 0.1 OUTLIER 173.9 -145.34 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.84 0.352 . . . . 0.0 111.62 -179.86 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -128.64 160.3 32.88 Favored 'General case' 0 C--O 1.222 -0.353 0 CA-C-N 115.586 -0.733 . . . . 0.0 109.52 -179.033 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.47 ' HA ' ' HD2' ' A' ' 75' ' ' PRO . 25.0 ttt180 -89.47 154.97 19.61 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.302 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.545 HE22 ' HA ' ' A' ' 47' ' ' PHE . 1.6 mt-30 -155.31 -169.55 3.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.333 0.587 . . . . 0.0 111.981 -178.581 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -163.08 142.97 8.25 Favored Glycine 0 N--CA 1.445 -0.709 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.771 179.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.491 HG22 HD23 ' A' ' 48' ' ' LEU . 10.9 tt -127.21 132.61 69.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.042 0.449 . . . . 0.0 110.548 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -75.23 141.29 43.55 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 179.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.831 HD13 HD11 ' A' ' 19' ' ' LEU . 63.4 mt -107.3 61.71 0.62 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.691 0.757 . . . . 0.0 110.854 -178.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.537 ' HA ' ' OG ' ' A' ' 2' ' ' SER . 25.0 m-80 -90.89 -0.07 57.63 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.354 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 9.8 mtp180 -96.01 -15.51 22.23 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.995 179.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.45 HD11 ' HH2' ' A' ' 50' ' ' TRP . 28.1 mm -89.88 110.03 21.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 -179.277 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.463 HE22 ' HA ' ' A' ' 2' ' ' SER . 23.5 mm-40 -111.17 167.16 10.49 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.425 -178.018 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 21.4 p-10 -126.67 112.42 15.44 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.574 178.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.7 p -111.55 116.66 53.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 120.96 0.409 . . . . 0.0 110.407 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 13.6 m-80 56.32 35.09 25.25 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.762 -178.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 87.02 -10.26 69.13 Favored Glycine 0 N--CA 1.442 -0.906 0 CA-C-N 115.65 -0.705 . . . . 0.0 113.311 179.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -94.11 123.14 37.29 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 117.459 0.63 . . . . 0.0 110.119 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.533 HD13 ' SG ' ' A' ' 23' ' ' CYS . 5.7 tp -79.69 119.21 22.31 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 54.1 t -133.23 145.6 33.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.398 -178.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.411 ' HB2' HD11 ' A' ' 35' ' ' LEU . 26.2 t80 -78.24 129.7 35.39 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.005 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 . . . . . 0 C--O 1.25 1.111 0 CA-C-O 117.986 -1.007 . . . . 0.0 110.802 -179.191 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . 0.443 ' O ' ' HB2' ' A' ' 5' ' ' ASP . 17.1 m . . . . . 0 N--CA 1.452 -0.365 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.566 ' HB3' ' HA ' ' A' ' 94' ' ' GLN . 22.2 p90 -57.84 -36.77 72.75 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.083 0.468 . . . . 0.0 110.334 178.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.5 ' HB3' ' HD3' ' A' ' 69' ' ' ARG . . . -58.32 -18.71 29.29 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 115.446 -0.797 . . . . 0.0 112.523 -178.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.443 ' HB2' ' O ' ' A' ' 2' ' ' SER . 0.9 OUTLIER -62.41 -26.89 68.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.928 0.394 . . . . 0.0 110.298 179.161 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 27.1 m -134.63 30.08 3.49 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.819 179.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.413 ' HA ' ' HZ3' ' A' ' 30' ' ' TRP . 21.0 m -139.31 155.55 47.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.247 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.557 ' HG2' ' CZ3' ' A' ' 30' ' ' TRP . 2.3 ptp180 -142.1 169.84 16.84 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.869 -179.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 53.4 57.8 5.84 Favored 'General case' 0 C--O 1.232 0.179 0 O-C-N 123.769 0.668 . . . . 0.0 111.696 178.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -87.86 121.56 30.43 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.839 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 27.8 m -127.93 172.17 15.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.68 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.688 HD21 ' HG ' ' A' ' 64' ' ' LEU . 3.6 mm? -104.55 118.65 37.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.454 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 19.6 p -117.52 166.53 12.26 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.948 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 62.46 26.99 16.07 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.479 179.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 101.81 -22.68 37.49 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.485 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.578 ' HA2' ' HB3' ' A' ' 12' ' ' LEU . . . 124.51 21.49 2.21 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.703 -0.76 . . . . 0.0 111.981 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.564 ' HB2' ' HB3' ' A' ' 38' ' ' ASP . 11.5 ptm180 -106.41 -21.61 13.04 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.102 0.477 . . . . 0.0 110.031 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.482 ' CG2' ' HB3' ' A' ' 34' ' ' GLU . 3.6 m -111.89 136.11 51.64 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.953 -178.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.838 HD11 HD13 ' A' ' 90' ' ' LEU . 26.9 mt -96.95 117.06 30.31 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.18 179.08 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 24.5 ttm180 -109.9 121.01 44.25 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -152.58 166.62 31.5 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.645 -179.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -91.22 108.83 20.14 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 107.605 -1.258 . . . . 0.0 107.605 178.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.429 ' SG ' HD13 ' A' ' 100' ' ' LEU . 65.8 m -95.34 124.54 39.43 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 -179.065 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.51 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 38.4 ttt180 -76.11 112.34 12.46 Favored 'General case' 0 N--CA 1.439 -0.982 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 179.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 35.9 p30 -73.54 167.64 20.91 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.619 -179.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.06 -27.73 67.2 Favored 'General case' 0 C--N 1.33 -0.245 0 O-C-N 123.557 0.536 . . . . 0.0 111.507 -178.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -68.46 -18.21 64.36 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.22 0.533 . . . . 0.0 109.991 179.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 94.63 33.16 6.88 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.857 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.51 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 7.2 t-20 -123.92 164.38 19.41 Favored 'General case' 0 C--N 1.323 -0.571 0 O-C-N 122.773 -0.251 . . . . 0.0 110.734 -178.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.557 ' CZ3' ' HG2' ' A' ' 8' ' ' ARG . 98.4 m95 -100.51 120.41 39.97 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.385 -179.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 6.7 m -122.78 139.5 49.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.889 179.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 13.5 m -79.48 114.08 18.13 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.793 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 68.3 m -124.6 146.08 49.26 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.764 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.603 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 50.7 mt-10 -131.5 135.22 46.9 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.1 -179.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.534 ' HB2' HD23 ' A' ' 100' ' ' LEU . 1.6 tm? -130.08 131.67 45.85 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.166 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.452 ' N ' HD13 ' A' ' 35' ' ' LEU . 18.1 m-20 -87.11 110.23 19.97 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.842 0.353 . . . . 0.0 110.221 179.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.539 HD11 ' HG ' ' A' ' 19' ' ' LEU . 2.1 mt -86.54 -18.04 32.53 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.981 -179.479 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.564 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 0.5 OUTLIER -66.12 -13.91 60.91 Favored 'General case' 0 C--O 1.222 -0.357 0 C-N-CA 120.525 -0.47 . . . . 0.0 111.949 -177.72 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.403 HG22 ' O ' ' A' ' 36' ' ' ASP . 14.6 t -87.0 -4.38 59.17 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.135 0.493 . . . . 0.0 110.233 179.42 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 56.5 m -127.26 -22.73 3.67 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 120.872 0.367 . . . . 0.0 111.508 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.528 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 65.3 mt -102.57 138.81 25.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 110.235 -0.283 . . . . 0.0 110.235 179.405 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.572 ' HA3' ' HB3' ' A' ' 52' ' ' MET . . . -149.23 158.79 27.8 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.892 -0.67 . . . . 0.0 111.605 179.222 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.709 ' ND2' ' HB2' ' A' ' 55' ' ' PHE . 8.2 p30 -162.42 47.78 0.21 Allowed Pre-proline 0 CA--C 1.534 0.353 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -67.54 -21.73 45.72 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 121.501 1.467 . . . . 0.0 111.413 -179.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -84.53 -16.7 41.4 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.144 179.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.604 ' HA3' ' HG2' ' A' ' 83' ' ' ARG . . . 108.41 8.8 28.36 Favored Glycine 0 N--CA 1.442 -0.933 0 C-N-CA 120.341 -0.933 . . . . 0.0 113.374 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.465 ' HA ' HE22 ' A' ' 86' ' ' GLN . 71.6 m-85 -125.73 134.88 51.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 117.1 0.45 . . . . 0.0 111.043 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 91.2 mt -83.33 131.8 35.05 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.889 -178.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -175.34 170.2 43.19 Favored Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.842 178.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.415 ' CD2' ' HD3' ' A' ' 92' ' ' ARG . 84.8 m95 -95.63 135.02 37.85 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 179.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 137.09 16.22 0.76 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.375 -0.917 . . . . 0.0 113.527 179.233 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.572 ' HB3' ' HA3' ' A' ' 42' ' ' GLY . 1.1 ttt -155.8 -165.79 2.05 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.407 ' HG3' HD22 ' A' ' 54' ' ' ASN . 10.8 pt20 -147.3 167.88 23.15 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.307 -0.557 . . . . 0.0 111.718 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.407 HD22 ' HG3' ' A' ' 53' ' ' GLN . 39.0 m-80 67.14 41.67 2.53 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.061 -0.972 . . . . 0.0 112.254 178.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.709 ' HB2' ' ND2' ' A' ' 43' ' ' ASN . 3.2 p90 -70.15 -25.12 63.31 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.737 0.303 . . . . 0.0 111.07 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 44.9 t -60.76 -41.21 95.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.443 -178.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 8.5 m-70 -70.62 -14.85 62.64 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.459 -178.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.417 ' HA ' ' HD2' ' A' ' 76' ' ' LYS . 20.1 m -113.48 18.99 17.27 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 111.777 0.288 . . . . 0.0 111.777 -179.229 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 61.2 m -138.97 153.74 48.21 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 121.448 -0.783 . . . . 0.0 112.46 -179.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -118.83 142.76 47.43 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.343 179.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 56.25 77.12 0.26 Allowed 'General case' 0 N--CA 1.466 0.354 0 O-C-N 123.666 0.604 . . . . 0.0 112.127 178.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.505 HG23 HD21 ' A' ' 71' ' ' LEU . 88.2 mt -92.31 112.63 26.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 121.041 0.448 . . . . 0.0 110.278 179.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 34.3 ttmt -149.23 153.99 38.42 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.344 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.688 ' HG ' HD21 ' A' ' 12' ' ' LEU . 42.1 mt -81.91 126.44 31.92 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.462 0.649 . . . . 0.0 111.067 -179.046 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.491 ' HB2' ' CG2' ' A' ' 72' ' ' THR . 39.4 tt0 -74.52 -52.32 12.24 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 114.925 -1.034 . . . . 0.0 111.201 -179.151 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.503 ' HB2' ' HB2' ' A' ' 69' ' ' ARG . 21.0 mm-40 -89.37 0.91 56.48 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.003 179.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 77.09 32.36 49.15 Favored Glycine 0 N--CA 1.446 -0.692 0 CA-C-N 115.519 -0.764 . . . . 0.0 112.142 -179.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 142.79 -42.75 1.08 Allowed Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.391 -0.909 . . . . 0.0 112.422 179.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.503 ' HB2' ' HB2' ' A' ' 66' ' ' GLU . 13.3 mmt180 -70.02 -30.22 67.47 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.842 0.353 . . . . 0.0 111.117 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 46.2 tttt -144.36 145.97 32.27 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -177.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.549 ' HB2' HD11 ' A' ' 90' ' ' LEU . 10.5 tt -111.68 135.44 52.27 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.382 -0.826 . . . . 0.0 108.969 179.131 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.491 ' CG2' ' HB2' ' A' ' 65' ' ' GLU . 2.6 p -123.53 131.93 53.76 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.037 0.446 . . . . 0.0 111.501 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 26.0 p -158.99 164.46 35.54 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.338 -0.846 . . . . 0.0 108.717 179.262 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.443 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 31.6 ttt180 -99.76 103.55 22.54 Favored Pre-proline 0 C--N 1.317 -0.806 0 C-N-CA 120.424 -0.51 . . . . 0.0 110.394 179.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.621 ' O ' ' HB3' ' A' ' 83' ' ' ARG . 59.7 Cg_endo -71.31 127.91 13.97 Favored 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 122.543 2.162 . . . . 0.0 110.825 178.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.764 ' HA ' ' HB2' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -120.16 146.61 45.83 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.932 -179.81 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.719 HG22 ' O ' ' A' ' 82' ' ' PHE . 8.9 t -71.94 130.33 40.74 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 177.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 9.8 p -71.44 -8.16 10.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 O-C-N 123.619 0.574 . . . . 0.0 111.425 -178.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -70.71 -24.78 62.71 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.119 0.485 . . . . 0.0 110.612 179.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.544 ' HA3' ' CE2' ' A' ' 82' ' ' PHE . . . -151.58 -30.03 0.04 OUTLIER Glycine 0 CA--C 1.519 0.334 0 C-N-CA 120.623 -0.799 . . . . 0.0 113.015 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 104.54 17.16 15.78 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 121.051 -0.595 . . . . 0.0 112.112 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.719 ' O ' HG22 ' A' ' 77' ' ' THR . 17.2 p90 -112.72 153.71 27.29 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 118.904 -0.57 . . . . 0.0 109.766 -179.037 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.764 ' HB2' ' HA ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 169.3 -150.45 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.105 0.479 . . . . 0.0 112.138 179.481 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -129.29 154.9 46.39 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.355 -0.838 . . . . 0.0 110.428 -177.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.443 ' HA ' ' HA ' ' A' ' 74' ' ' ARG . 36.4 ttt180 -86.27 145.88 26.75 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.465 HE22 ' HA ' ' A' ' 47' ' ' PHE . 18.8 mt-30 -151.96 -171.3 3.89 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.565 -178.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -146.74 149.31 21.44 Favored Glycine 0 N--CA 1.448 -0.506 0 N-CA-C 111.261 -0.736 . . . . 0.0 111.261 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.403 HD11 ' CD1' ' A' ' 50' ' ' TRP . 12.0 tt -131.39 133.23 62.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 117.073 0.437 . . . . 0.0 110.877 -179.255 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -75.65 137.71 40.89 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.679 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.838 HD13 HD11 ' A' ' 19' ' ' LEU . 47.4 mt -101.52 40.23 1.33 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.48 0.657 . . . . 0.0 110.287 -179.513 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.482 HD22 ' N ' ' A' ' 91' ' ' ASN . 0.9 OUTLIER -74.12 0.04 15.11 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.657 -179.486 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.415 ' HD3' ' CD2' ' A' ' 50' ' ' TRP . 18.3 mtp180 -96.57 -12.63 23.74 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.926 179.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.45 HG13 HD22 ' A' ' 37' ' ' LEU . 23.0 mm -99.02 114.65 37.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 -179.214 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.566 ' HA ' ' HB3' ' A' ' 3' ' ' TYR . 20.6 mt-30 -132.33 156.53 46.42 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.136 0.493 . . . . 0.0 111.712 -178.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.411 ' HA ' ' O ' ' A' ' 99' ' ' ARG . 20.4 p-10 -104.58 131.92 51.42 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.499 179.367 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 40.9 t -115.18 111.61 36.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 179.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 28.4 m-80 58.06 19.49 6.05 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.866 -179.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 117.46 -28.35 7.19 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.681 -0.771 . . . . 0.0 113.92 178.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.411 ' O ' ' HA ' ' A' ' 95' ' ' ASN . 0.2 OUTLIER -87.11 142.23 28.08 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 117.277 0.538 . . . . 0.0 110.991 -178.916 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.534 HD23 ' HB2' ' A' ' 35' ' ' LEU . 8.6 tp -87.74 125.78 34.62 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 24.6 t -131.36 140.35 48.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.014 -178.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.491 ' HB2' HD11 ' A' ' 35' ' ' LEU . 13.6 t80 -82.04 131.38 35.24 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 177.58 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 . . . . . 0 C--N 1.312 -1.024 0 CA-C-O 118.906 -0.568 . . . . 0.0 111.241 -179.259 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . 0.456 ' HB2' ' HG3' ' A' ' 69' ' ' ARG . 38.0 m . . . . . 0 N--CA 1.449 -0.483 0 CA-C-O 120.364 0.126 . . . . 0.0 110.996 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.412 ' CZ ' HD13 ' A' ' 19' ' ' LEU . 9.3 p90 -54.23 -34.59 61.01 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.833 0.349 . . . . 0.0 110.867 178.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.589 ' HB3' ' HD2' ' A' ' 69' ' ' ARG . . . -57.27 -19.23 20.42 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.437 -179.029 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -70.75 -18.41 62.78 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.071 0.462 . . . . 0.0 110.867 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 41.6 m -140.67 33.8 1.81 Allowed 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 178.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 10.3 t -146.24 157.86 43.84 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.231 -179.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.422 ' HG2' ' CZ3' ' A' ' 30' ' ' TRP . 2.1 ptp180 -137.44 158.42 44.45 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.663 -0.244 . . . . 0.0 110.981 -179.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 57.54 61.62 2.41 Favored 'General case' 0 C--O 1.233 0.229 0 O-C-N 123.967 0.792 . . . . 0.0 111.127 178.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.603 ' HA ' ' HB2' ' A' ' 21' ' ' ALA . . . -89.83 118.52 29.48 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.917 -179.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 30.0 m -123.07 170.56 13.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.612 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.62 ' HB3' ' HA2' ' A' ' 16' ' ' GLY . 3.8 mm? -105.36 122.4 45.88 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.145 -179.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.426 ' OG1' ' HB ' ' A' ' 18' ' ' THR . 33.5 p -116.0 162.14 17.81 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.69 0.281 . . . . 0.0 110.892 179.543 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 63.51 29.29 15.38 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.904 -0.589 . . . . 0.0 112.078 179.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 97.09 -15.79 61.93 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.502 179.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.62 ' HA2' ' HB3' ' A' ' 12' ' ' LEU . . . 122.09 20.85 2.97 Favored Glycine 0 CA--C 1.507 -0.417 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.36 179.528 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 4.1 ptm180 -103.98 -22.64 13.44 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.029 0.442 . . . . 0.0 110.54 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.426 ' HB ' ' OG1' ' A' ' 13' ' ' THR . 5.5 m -113.48 137.89 50.89 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.893 -178.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.653 ' O ' ' HA ' ' A' ' 34' ' ' GLU . 83.8 mt -100.41 120.32 39.79 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.438 179.129 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 56.2 ttp180 -118.27 120.25 37.1 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.586 -0.446 . . . . 0.0 109.876 178.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.603 ' HB2' ' HA ' ' A' ' 10' ' ' ALA . . . -154.48 167.58 29.56 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.383 -179.416 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -89.43 105.96 18.14 Favored 'General case' 0 CA--C 1.51 -0.569 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 177.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 69.3 m -96.46 136.29 37.16 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 120.727 0.299 . . . . 0.0 110.625 -178.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.564 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 16.2 ttp180 -76.94 119.31 20.51 Favored 'General case' 0 N--CA 1.44 -0.934 0 CA-C-N 116.196 -0.457 . . . . 0.0 109.835 179.336 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 37.4 p30 -80.32 174.55 11.49 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.153 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.27 -30.87 63.03 Favored 'General case' 0 C--O 1.235 0.303 0 O-C-N 123.649 0.593 . . . . 0.0 112.516 -178.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -77.4 -10.51 59.5 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.319 0.58 . . . . 0.0 110.135 -179.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 89.82 29.36 15.96 Favored Glycine 0 N--CA 1.447 -0.597 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.472 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.564 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 4.8 t-20 -110.64 164.02 13.16 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 121.086 -0.246 . . . . 0.0 111.129 -178.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.422 ' CZ3' ' HG2' ' A' ' 8' ' ' ARG . 82.4 m95 -97.62 119.44 36.2 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.011 0.434 . . . . 0.0 111.954 -179.388 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 5.8 m -124.39 135.03 65.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.938 178.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 62.0 m -81.3 111.02 17.3 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.926 0.393 . . . . 0.0 110.506 -179.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 70.5 m -120.5 155.84 32.75 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.481 -179.269 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.653 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 41.6 mt-10 -135.12 142.65 46.25 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.564 179.319 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.547 HD11 ' HB2' ' A' ' 102' ' ' PHE . 1.4 tm? -138.92 131.39 28.68 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.304 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.441 ' O ' HG22 ' A' ' 39' ' ' THR . 22.1 m-20 -89.83 110.89 21.79 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.509 HD22 HG13 ' A' ' 93' ' ' ILE . 1.1 mt -86.62 -19.42 29.35 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.659 -178.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.434 ' HA ' ' HD1' ' A' ' 55' ' ' PHE . 3.2 p-10 -68.45 -8.68 42.97 Favored 'General case' 0 C--O 1.221 -0.398 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -178.006 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.441 HG22 ' O ' ' A' ' 36' ' ' ASP . 13.7 t -87.27 -1.72 58.11 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 179.107 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 75.2 m -135.33 -23.32 1.47 Allowed 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 116.176 -0.465 . . . . 0.0 112.02 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.505 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 55.1 mt -96.91 145.03 9.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 O-C-N 122.222 -0.299 . . . . 0.0 110.476 -179.699 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.638 ' HA3' ' HB3' ' A' ' 52' ' ' MET . . . -153.1 158.39 27.9 Favored Glycine 0 N--CA 1.447 -0.569 0 N-CA-C 111.277 -0.729 . . . . 0.0 111.277 179.056 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.491 ' HB3' HD23 ' A' ' 48' ' ' LEU . 6.0 p30 -159.91 53.91 0.58 Allowed Pre-proline 0 CA--C 1.538 0.511 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -179.277 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -71.54 -16.93 30.45 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 121.942 1.762 . . . . 0.0 112.216 -179.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -102.61 13.65 33.95 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.092 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.504 ' CA ' ' HG2' ' A' ' 83' ' ' ARG . . . 79.47 12.56 83.64 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.463 -0.875 . . . . 0.0 112.961 179.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.81 ' HA ' HE22 ' A' ' 86' ' ' GLN . 37.9 m-85 -125.31 130.74 52.59 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.879 0.371 . . . . 0.0 110.303 179.718 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.558 ' HB3' ' HB ' ' A' ' 88' ' ' ILE . 87.6 mt -84.33 132.51 34.6 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.745 -178.413 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -171.95 170.49 43.45 Favored Glycine 0 N--CA 1.443 -0.837 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.139 179.165 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.414 ' HH2' HD11 ' A' ' 93' ' ' ILE . 87.4 m95 -96.22 131.51 42.62 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 141.56 17.72 0.34 Allowed Glycine 0 CA--C 1.519 0.333 0 C-N-CA 120.46 -0.876 . . . . 0.0 113.821 179.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.638 ' HB3' ' HA3' ' A' ' 42' ' ' GLY . 5.3 ttt -153.57 -156.05 0.65 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 117.366 0.583 . . . . 0.0 109.801 179.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.416 ' HA ' ' O ' ' A' ' 38' ' ' ASP . 27.6 pt20 -148.04 167.62 24.49 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.705 0.288 . . . . 0.0 111.137 -179.341 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 35.9 m-80 61.63 44.74 8.69 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.452 -0.794 . . . . 0.0 112.938 178.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.505 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 1.2 p90 -71.01 -26.81 63.29 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.523 -0.471 . . . . 0.0 110.73 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.533 ' HA ' HD11 ' A' ' 62' ' ' ILE . 79.6 p -72.94 -29.35 63.04 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.035 0.445 . . . . 0.0 110.504 -179.413 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 41.8 m80 -82.81 -9.25 59.42 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.398 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.3 p -114.89 6.94 15.56 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.961 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 72.0 m -130.21 153.29 48.73 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.128 0.49 . . . . 0.0 110.745 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 86.7 mt-10 -119.09 134.67 55.06 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.403 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.5 t70 58.53 82.89 0.13 Allowed 'General case' 0 N--CA 1.465 0.317 0 O-C-N 123.938 0.774 . . . . 0.0 111.507 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.534 HG23 HD21 ' A' ' 71' ' ' LEU . 72.0 mt -95.31 124.54 47.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.108 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.9 tptm -149.84 149.54 30.63 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.565 ' HG ' HD21 ' A' ' 12' ' ' LEU . 52.2 mt -83.39 135.94 34.52 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.823 0.344 . . . . 0.0 110.98 -179.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -91.82 -59.03 2.22 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.958 -179.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.433 ' CB ' ' HB2' ' A' ' 69' ' ' ARG . 20.2 mm-40 -82.03 27.03 0.49 Allowed 'General case' 0 CA--C 1.516 -0.348 0 CA-C-O 121.106 0.479 . . . . 0.0 111.507 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 62.84 16.65 56.98 Favored Glycine 0 N--CA 1.448 -0.507 0 CA-C-N 115.278 -0.874 . . . . 0.0 112.722 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.449 ' HA3' ' HB2' ' A' ' 4' ' ' ALA . . . 144.08 -30.4 1.9 Allowed Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 120.104 -1.046 . . . . 0.0 113.189 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.589 ' HD2' ' HB3' ' A' ' 4' ' ' ALA . 7.2 mpt_? -74.37 -24.12 59.11 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 117.553 0.677 . . . . 0.0 111.12 -179.397 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 33.4 tttp -141.37 139.91 33.61 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.842 -178.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.637 ' HB2' HD11 ' A' ' 90' ' ' LEU . 10.1 tt -112.89 133.82 54.69 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.618 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.9 p -119.46 135.09 54.91 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.902 0.382 . . . . 0.0 111.083 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 25.3 p -162.49 172.23 15.83 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.37 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.589 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 32.2 ttt180 -106.98 99.38 25.9 Favored Pre-proline 0 C--N 1.319 -0.758 0 C-N-CA 120.356 -0.538 . . . . 0.0 110.741 178.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.647 ' O ' ' HB3' ' A' ' 83' ' ' ARG . 46.0 Cg_endo -67.4 123.86 11.35 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 122.784 2.323 . . . . 0.0 110.103 178.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.863 ' HE3' ' HA2' ' A' ' 81' ' ' GLY . 0.0 OUTLIER -120.29 142.97 48.6 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.066 0.46 . . . . 0.0 111.956 -178.914 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.711 HG22 ' O ' ' A' ' 82' ' ' PHE . 14.8 t -75.38 138.69 41.89 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.027 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 11.1 p -76.18 -12.95 14.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.217 -179.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -66.05 -21.9 66.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.11 0.481 . . . . 0.0 111.002 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.703 ' HA3' ' CE2' ' A' ' 82' ' ' PHE . . . -155.63 -21.41 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.29 -0.957 . . . . 0.0 113.105 179.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.863 ' HA2' ' HE3' ' A' ' 76' ' ' LYS . . . 95.53 12.57 53.57 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.05 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.711 ' O ' HG22 ' A' ' 77' ' ' THR . 16.7 p90 -112.47 158.61 19.68 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 118.926 -0.559 . . . . 0.0 110.015 -178.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.782 ' HA ' ' HE ' ' A' ' 83' ' ' ARG . 0.0 OUTLIER 168.65 -152.42 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 O-C-N 123.805 0.691 . . . . 0.0 111.656 178.707 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -125.73 155.88 40.27 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.358 -177.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.589 ' HA ' ' HA ' ' A' ' 74' ' ' ARG . 32.2 ttt180 -80.3 155.52 27.23 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 179.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.81 HE22 ' HA ' ' A' ' 47' ' ' PHE . 8.8 tt0 -162.45 177.12 9.79 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 120.976 0.417 . . . . 0.0 111.407 -178.054 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.485 ' H ' ' HG2' ' A' ' 86' ' ' GLN . . . -140.2 143.82 14.13 Favored Glycine 0 N--CA 1.445 -0.711 0 N-CA-C 111.456 -0.657 . . . . 0.0 111.456 179.388 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.558 ' HB ' ' HB3' ' A' ' 48' ' ' LEU . 10.1 tt -124.38 140.69 46.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 109.751 -0.462 . . . . 0.0 109.751 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.459 ' HB3' HD22 ' A' ' 91' ' ' ASN . 61.9 m-20 -82.46 136.47 34.9 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.861 -179.528 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.637 HD11 ' HB2' ' A' ' 71' ' ' LEU . 83.2 mt -106.82 44.6 1.04 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.352 0.596 . . . . 0.0 110.861 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.459 HD22 ' HB3' ' A' ' 89' ' ' ASP . 18.5 m-80 -76.97 2.66 14.18 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.751 179.415 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 18.5 mtp180 -98.82 -15.05 19.4 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.087 -0.96 . . . . 0.0 110.316 179.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.584 HG21 HD12 ' A' ' 19' ' ' LEU . 29.3 mm -98.91 105.13 16.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 121.017 0.436 . . . . 0.0 109.993 -179.315 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.401 ' HA ' ' HB3' ' A' ' 3' ' ' TYR . 4.0 mt-30 -130.85 156.47 44.97 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.007 -179.262 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 13.1 p-10 -95.71 110.72 22.81 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.127 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 58.8 t -90.87 104.44 15.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.031 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 59.89 35.24 21.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.989 -179.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 98.45 -27.27 20.3 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.75 -0.738 . . . . 0.0 113.431 179.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.422 ' HD3' ' H ' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -86.92 128.82 35.06 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.944 0.372 . . . . 0.0 110.136 -178.936 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.424 HD12 ' HA ' ' A' ' 100' ' ' LEU . 9.2 tp -75.72 120.33 20.96 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 -179.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 32.2 t -129.61 142.09 44.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.168 -178.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.547 ' HB2' HD11 ' A' ' 35' ' ' LEU . 18.1 t80 -82.28 124.61 30.11 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 177.384 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.421 -0.799 . . . . 0.0 110.877 -179.504 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . 0.462 ' OG ' ' HA ' ' A' ' 91' ' ' ASN . 9.5 m . . . . . 0 N--CA 1.451 -0.383 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.532 ' HA ' ' OD1' ' A' ' 95' ' ' ASN . 13.2 p90 -58.7 -38.14 77.62 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.524 0.202 . . . . 0.0 111.322 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -57.84 -23.93 55.07 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.357 -0.383 . . . . 0.0 112.023 -179.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -69.97 -16.24 63.16 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.654 0.242 . . . . 0.0 111.654 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 20.8 m -141.22 30.09 1.79 Allowed 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 22.4 t -144.92 158.46 43.8 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 115.509 -0.768 . . . . 0.0 110.103 -179.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 18.3 ptt180 -140.3 165.49 27.27 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.441 -179.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 55.18 54.76 8.37 Favored 'General case' 0 N--CA 1.467 0.378 0 O-C-N 123.829 0.705 . . . . 0.0 111.404 179.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.49 ' HA ' ' HB2' ' A' ' 21' ' ' ALA . . . -81.08 117.32 21.56 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.59 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 33.8 m -122.56 168.86 14.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.686 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.65 HD21 ' HG ' ' A' ' 64' ' ' LEU . 3.9 mm? -105.15 117.08 33.1 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.005 -179.546 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.478 HG21 ' NE ' ' A' ' 20' ' ' ARG . 20.9 p -115.48 165.89 12.49 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.062 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.436 ' O ' ' HG2' ' A' ' 17' ' ' ARG . 93.9 m-20 60.35 31.14 20.31 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.8 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 96.3 -17.96 58.33 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.827 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.576 ' HA2' ' HB3' ' A' ' 12' ' ' LEU . . . 122.86 10.15 5.93 Favored Glycine 0 C--O 1.229 -0.197 0 C-N-CA 121.025 -0.607 . . . . 0.0 111.608 -179.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.538 ' HB2' ' HB3' ' A' ' 38' ' ' ASP . 5.2 ptm180 -91.26 -24.17 19.94 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.257 0.551 . . . . 0.0 110.337 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.5 ' CG2' ' HB3' ' A' ' 34' ' ' GLU . 23.2 m -115.49 138.43 51.03 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.869 -178.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.739 HD11 HD13 ' A' ' 90' ' ' LEU . 92.1 mt -97.49 120.92 38.74 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.326 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.478 ' NE ' HG21 ' A' ' 13' ' ' THR . 34.5 ttm180 -114.12 120.46 40.62 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 178.252 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.49 ' HB2' ' HA ' ' A' ' 10' ' ' ALA . . . -153.11 167.71 28.35 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 120.938 0.399 . . . . 0.0 111.168 -178.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.649 ' HB3' ' HB3' ' A' ' 30' ' ' TRP . 10.4 mm-40 -88.9 105.95 18.09 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 178.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.423 ' SG ' ' HB2' ' A' ' 33' ' ' SER . 67.7 m -91.26 129.7 37.22 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.65 -178.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.528 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 24.7 ttp180 -75.69 116.38 16.35 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.521 179.124 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.411 HD21 ' HB3' ' A' ' 29' ' ' ASN . 36.2 p30 -82.16 173.3 12.25 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.177 179.545 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.18 -30.45 62.26 Favored 'General case' 0 N--CA 1.464 0.268 0 O-C-N 123.361 0.413 . . . . 0.0 112.084 -178.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -72.83 -13.5 61.31 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.662 0.744 . . . . 0.0 109.96 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 88.61 25.55 29.91 Favored Glycine 0 CA--C 1.503 -0.694 0 N-CA-C 110.8 -0.92 . . . . 0.0 110.8 -179.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.528 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 8.7 t-20 -106.6 161.97 14.16 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.575 -0.313 . . . . 0.0 110.323 -178.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.649 ' HB3' ' HB3' ' A' ' 22' ' ' GLU . 87.4 m95 -100.04 122.55 43.1 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.955 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 5.6 m -124.33 136.11 61.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.27 178.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 13.2 m -75.42 109.73 9.2 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.953 0.406 . . . . 0.0 110.958 -179.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.423 ' HB2' ' SG ' ' A' ' 23' ' ' CYS . 69.8 m -124.05 148.0 47.41 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.697 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.638 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 47.9 mt-10 -124.94 150.9 46.13 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.237 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.597 HD11 ' HB2' ' A' ' 102' ' ' PHE . 1.6 tm? -141.84 130.86 23.18 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 178.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.452 ' N ' HD13 ' A' ' 35' ' ' LEU . 2.1 p-10 -88.35 109.7 20.19 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.303 0.573 . . . . 0.0 110.605 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.477 HD11 ' HG ' ' A' ' 19' ' ' LEU . 1.0 OUTLIER -86.65 -21.05 26.95 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.965 179.532 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.538 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 5.1 p-10 -64.03 -13.73 49.02 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -178.445 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 64.1 p -83.63 -11.32 57.44 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 120.89 0.376 . . . . 0.0 110.801 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 35.5 m -130.41 -9.94 4.13 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.231 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.427 HD13 HD13 ' A' ' 88' ' ' ILE . 63.4 mt -113.26 137.05 47.67 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-O 120.682 0.277 . . . . 0.0 110.704 179.479 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.594 ' HA3' ' HB3' ' A' ' 52' ' ' MET . . . -149.45 159.03 27.9 Favored Glycine 0 N--CA 1.446 -0.7 0 C-N-CA 120.967 -0.635 . . . . 0.0 111.581 179.089 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.454 ' OD1' ' HB2' ' A' ' 58' ' ' SER . 24.8 p30 -157.57 48.31 0.31 Allowed Pre-proline 0 CA--C 1.535 0.367 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -68.74 -22.21 37.53 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 121.829 1.686 . . . . 0.0 112.166 -178.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 70.6 m-20 -91.79 0.44 57.49 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.43 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.539 ' CA ' ' HG2' ' A' ' 83' ' ' ARG . . . 92.48 6.74 64.02 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.669 -0.776 . . . . 0.0 112.236 -179.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -120.78 132.25 54.93 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.938 0.399 . . . . 0.0 110.798 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.452 HD12 ' HB3' ' A' ' 86' ' ' GLN . 14.8 mt -84.31 146.79 27.55 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.399 -178.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 169.35 171.0 34.57 Favored Glycine 0 N--CA 1.442 -0.904 0 C-N-CA 120.254 -0.974 . . . . 0.0 112.64 178.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.466 ' HH2' HD11 ' A' ' 93' ' ' ILE . 90.8 m95 -96.1 126.17 41.14 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 149.82 -43.94 0.73 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.995 -0.621 . . . . 0.0 111.853 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.63 ' HA ' ' CE ' ' A' ' 52' ' ' MET . 0.7 OUTLIER -94.24 -177.04 4.15 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 179.104 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.4 ' H ' ' HG3' ' A' ' 52' ' ' MET . 13.4 pt20 -143.14 170.19 16.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 119.076 0.853 . . . . 0.0 112.215 -178.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 30.0 m-80 66.11 36.68 5.54 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.091 -0.959 . . . . 0.0 112.307 179.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.531 ' HB3' ' HA2' ' A' ' 42' ' ' GLY . 9.1 p90 -62.86 -28.33 69.96 Favored 'General case' 0 C--O 1.221 -0.444 0 CA-C-O 120.651 0.262 . . . . 0.0 110.455 179.442 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.468 ' HB3' ' HB3' ' A' ' 17' ' ' ARG . 9.5 p -58.68 -34.34 71.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.351 -179.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 26.5 m80 -80.06 -10.05 59.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.553 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.454 ' HB2' ' OD1' ' A' ' 43' ' ' ASN . 16.4 m -123.5 28.98 6.79 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.45 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 45.0 m -137.49 150.31 47.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.062 0.458 . . . . 0.0 111.079 179.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.447 ' HG3' ' HG2' ' A' ' 76' ' ' LYS . 71.5 mt-10 -129.86 134.01 47.26 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.677 179.281 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 38.5 t70 61.62 79.73 0.24 Allowed 'General case' 0 N--CA 1.468 0.455 0 O-C-N 123.705 0.628 . . . . 0.0 110.689 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.524 HG23 HD21 ' A' ' 71' ' ' LEU . 64.3 mt -98.67 125.06 52.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.037 -179.25 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.1 tptm -149.21 156.07 41.59 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.016 0.436 . . . . 0.0 111.285 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.65 ' HG ' HD21 ' A' ' 12' ' ' LEU . 83.0 mt -98.99 128.84 45.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.144 179.086 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -93.52 -65.7 0.97 Allowed 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -178.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.527 ' HB2' ' HB2' ' A' ' 69' ' ' ARG . 4.8 mm-40 -76.29 50.28 0.63 Allowed 'General case' 0 CA--C 1.516 -0.33 0 CA-C-O 121.117 0.484 . . . . 0.0 112.192 -178.013 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 59.94 16.35 39.32 Favored Glycine 0 C--N 1.318 -0.44 0 CA-C-N 115.117 -0.947 . . . . 0.0 112.795 179.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.534 ' HA2' HD13 ' A' ' 64' ' ' LEU . . . 121.11 -12.29 9.8 Favored Glycine 0 N--CA 1.442 -0.909 0 C-N-CA 120.394 -0.907 . . . . 0.0 113.241 179.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.527 ' HB2' ' HB2' ' A' ' 66' ' ' GLU . 2.8 mtt85 -77.69 -22.16 50.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 117.525 0.663 . . . . 0.0 110.721 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 33.0 tptt -131.63 127.56 37.27 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.294 -178.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.668 ' HB2' HD11 ' A' ' 90' ' ' LEU . 10.6 tt -110.04 121.2 44.7 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.442 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.4 p -109.66 136.61 48.74 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.176 0.513 . . . . 0.0 110.837 179.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 17.7 p -162.87 169.43 19.8 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.102 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.562 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 30.2 ttt180 -103.8 102.45 31.09 Favored Pre-proline 0 C--N 1.313 -0.979 0 C-N-CA 120.095 -0.642 . . . . 0.0 110.609 179.116 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.645 ' O ' ' HB3' ' A' ' 83' ' ' ARG . 48.0 Cg_endo -67.77 116.15 4.13 Favored 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 122.539 2.159 . . . . 0.0 110.023 178.385 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.942 ' HE3' ' HA2' ' A' ' 81' ' ' GLY . 0.0 OUTLIER -117.86 144.97 44.94 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.088 0.47 . . . . 0.0 111.455 -178.927 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.71 HG22 ' O ' ' A' ' 82' ' ' PHE . 15.3 t -77.86 140.73 39.37 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 179.402 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 32.2 m -74.52 -1.64 3.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 O-C-N 123.989 0.806 . . . . 0.0 111.145 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 -68.4 -32.01 71.76 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.174 0.511 . . . . 0.0 110.144 179.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -160.67 -9.51 0.04 OUTLIER Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.476 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.942 ' HA2' ' HE3' ' A' ' 76' ' ' LYS . . . 90.63 19.71 43.42 Favored Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 120.577 -0.821 . . . . 0.0 111.776 179.627 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.71 ' O ' HG22 ' A' ' 77' ' ' THR . 26.3 p90 -110.93 146.64 36.21 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 119.226 -0.416 . . . . 0.0 110.047 -179.028 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.732 ' HB2' ' HA ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 170.53 -154.92 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.224 0 O-C-N 123.925 0.766 . . . . 0.0 110.433 179.27 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -118.37 173.02 7.06 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.41 -178.05 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.562 ' HA ' ' HA ' ' A' ' 74' ' ' ARG . 31.3 ttt85 -104.3 153.43 21.03 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 178.244 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.704 ' HG2' ' H ' ' A' ' 87' ' ' GLY . 9.0 tt0 -165.61 -174.65 3.19 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 120.655 0.264 . . . . 0.0 110.698 -178.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.704 ' H ' ' HG2' ' A' ' 86' ' ' GLN . . . -141.11 151.9 22.86 Favored Glycine 0 N--CA 1.45 -0.369 0 N-CA-C 111.736 -0.545 . . . . 0.0 111.736 179.181 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.427 HD13 HD13 ' A' ' 41' ' ' ILE . 12.1 tt -125.49 145.6 32.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 120.965 0.412 . . . . 0.0 110.208 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -82.47 121.98 27.45 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.845 -179.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.739 HD13 HD11 ' A' ' 19' ' ' LEU . 59.8 mt -98.59 37.08 1.53 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.558 0.695 . . . . 0.0 110.632 179.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.462 ' HA ' ' OG ' ' A' ' 2' ' ' SER . 0.9 OUTLIER -75.27 -0.65 20.32 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 114.949 -1.023 . . . . 0.0 110.381 -179.958 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 20.1 mtp180 -92.09 -14.81 28.66 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.226 -179.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.466 HD11 ' HH2' ' A' ' 50' ' ' TRP . 21.0 mm -92.22 111.7 24.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 -179.445 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 21.9 tp60 -124.71 134.85 52.69 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.283 0.563 . . . . 0.0 111.315 -178.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.532 ' OD1' ' HA ' ' A' ' 3' ' ' TYR . 19.6 p-10 -95.45 119.82 34.62 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.843 178.105 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.3 p -114.95 119.2 61.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.177 0.513 . . . . 0.0 110.602 -179.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 58.54 30.22 19.49 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.002 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 94.87 -15.79 62.65 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.774 -0.727 . . . . 0.0 113.289 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -93.03 123.18 36.1 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 117.555 0.677 . . . . 0.0 110.089 -179.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 16.1 tp -82.57 117.22 22.39 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.8 t -128.6 149.98 33.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.769 0.319 . . . . 0.0 111.088 -179.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.597 ' HB2' HD11 ' A' ' 35' ' ' LEU . 8.5 t80 -89.61 126.0 35.45 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 178.113 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.316 -0.89 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.321 179.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . 0.565 ' HB3' ' HA ' ' A' ' 91' ' ' ASN . 10.8 p . . . . . 0 N--CA 1.45 -0.436 0 CA-C-O 120.429 0.157 . . . . 0.0 111.319 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.443 ' HA ' ' OD1' ' A' ' 95' ' ' ASN . 12.8 p90 -58.59 -38.61 78.31 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -179.615 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.61 ' HA ' ' OG ' ' A' ' 7' ' ' SER . . . -55.29 -19.09 7.52 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 -177.371 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -61.71 -37.07 82.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.963 0.411 . . . . 0.0 111.037 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 8.1 t -130.63 45.02 2.88 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 121.295 0.569 . . . . 0.0 109.754 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.61 ' OG ' ' HA ' ' A' ' 4' ' ' ALA . 86.4 p -147.06 165.54 29.6 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.225 179.017 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 11.9 ptm180 -149.24 166.6 28.42 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.661 -179.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 59.44 54.43 4.66 Favored 'General case' 0 C--O 1.234 0.254 0 O-C-N 123.93 0.769 . . . . 0.0 111.136 179.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.404 ' HA ' ' HB2' ' A' ' 21' ' ' ALA . . . -86.69 117.36 25.4 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.014 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 34.2 m -124.57 168.49 17.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.786 -179.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.752 HD21 ' HG ' ' A' ' 64' ' ' LEU . 3.5 mm? -105.21 114.9 29.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.121 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 19.2 p -110.06 167.2 10.35 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.166 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 60.64 49.94 6.04 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.778 -0.647 . . . . 0.0 111.449 179.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 83.76 -30.15 3.57 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.348 179.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.557 ' HA2' ' HB3' ' A' ' 12' ' ' LEU . . . 130.64 48.09 0.13 Allowed Glycine 0 N--CA 1.446 -0.689 0 N-CA-C 111.133 -0.787 . . . . 0.0 111.133 -179.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.616 ' HB2' ' HB3' ' A' ' 38' ' ' ASP . 41.7 ptt85 -132.16 -27.07 1.85 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.017 0.436 . . . . 0.0 111.202 -179.403 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.449 ' CG2' ' HB3' ' A' ' 34' ' ' GLU . 4.2 m -100.94 133.88 44.76 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.828 -179.269 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.791 HD11 HD13 ' A' ' 90' ' ' LEU . 70.3 mt -94.17 115.95 28.3 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.275 179.084 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 53.3 ttp180 -114.36 121.28 43.12 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.504 -0.479 . . . . 0.0 109.983 178.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.404 ' HB2' ' HA ' ' A' ' 10' ' ' ALA . . . -153.43 166.05 33.89 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.845 0.355 . . . . 0.0 110.662 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -89.95 106.03 18.2 Favored 'General case' 0 CA--C 1.508 -0.643 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 178.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.457 ' SG ' HD13 ' A' ' 100' ' ' LEU . 45.3 m -98.81 132.17 44.37 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 120.876 -0.33 . . . . 0.0 110.191 -178.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.512 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 17.6 ttp85 -74.62 117.19 16.17 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.283 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.492 HD21 ' HB3' ' A' ' 29' ' ' ASN . 36.7 p30 -80.96 168.7 18.41 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.153 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.76 -33.21 55.06 Favored 'General case' 0 C--O 1.235 0.31 0 O-C-N 123.589 0.556 . . . . 0.0 112.118 -178.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -68.64 -17.88 64.18 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.289 0.566 . . . . 0.0 110.549 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 94.61 27.01 12.08 Favored Glycine 0 N--CA 1.446 -0.655 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.382 -179.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.512 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 62.0 t30 -111.09 164.06 13.23 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.547 0.213 . . . . 0.0 111.047 -178.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.413 ' HZ3' ' HA ' ' A' ' 7' ' ' SER . 89.8 m95 -100.36 113.84 26.88 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.534 179.318 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.9 m -116.55 131.03 70.36 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.877 179.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.3 m -74.93 109.22 8.22 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.445 179.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 66.9 m -119.26 146.62 45.09 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.408 -179.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.637 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 49.7 mt-10 -130.78 139.71 50.24 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.899 -179.301 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.521 HD12 HD23 ' A' ' 37' ' ' LEU . 1.4 tm? -132.81 129.12 38.12 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 178.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.449 ' N ' HD13 ' A' ' 35' ' ' LEU . 15.8 m-20 -88.88 108.93 19.81 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.521 HD23 HD12 ' A' ' 35' ' ' LEU . 0.5 OUTLIER -86.72 -9.11 56.66 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.363 -0.381 . . . . 0.0 112.017 -179.56 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.616 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 6.7 p-10 -66.16 -14.93 62.64 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -178.356 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 8.9 t -87.47 0.48 55.48 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.974 0.416 . . . . 0.0 110.609 179.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.538 ' SG ' ' HZ3' ' A' ' 50' ' ' TRP . 1.7 p -140.63 -14.8 0.95 Allowed 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 54.5 mt -111.65 135.98 49.21 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-O 120.733 0.302 . . . . 0.0 110.502 179.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.529 ' HA3' ' HB3' ' A' ' 52' ' ' MET . . . -152.93 158.33 27.84 Favored Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 111.468 -0.653 . . . . 0.0 111.468 179.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.694 ' ND2' ' HB2' ' A' ' 55' ' ' PHE . 3.7 p30 -161.72 52.03 0.37 Allowed Pre-proline 0 C--N 1.327 -0.412 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 179.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.559 ' HD3' ' N ' ' A' ' 43' ' ' ASN . 5.4 Cg_exo -78.03 -9.27 16.7 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.298 1.999 . . . . 0.0 111.647 -179.432 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 35.7 m-80 -99.35 2.04 44.96 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.618 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.478 ' CA ' ' HG2' ' A' ' 83' ' ' ARG . . . 93.33 0.74 67.27 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.402 -0.904 . . . . 0.0 112.093 -179.446 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.499 ' HA ' HE22 ' A' ' 86' ' ' GLN . 65.7 m-85 -125.47 131.37 52.86 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.986 0.422 . . . . 0.0 111.006 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.582 HD13 ' HB3' ' A' ' 86' ' ' GLN . 9.9 mp -84.58 153.99 22.89 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.479 -179.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 168.04 170.6 32.98 Favored Glycine 0 N--CA 1.443 -0.842 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.651 179.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.538 ' HZ3' ' SG ' ' A' ' 40' ' ' CYS . 90.5 m95 -95.86 125.24 40.29 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 149.24 -34.83 1.08 Allowed Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.804 -0.713 . . . . 0.0 112.405 -179.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.529 ' HB3' ' HA3' ' A' ' 42' ' ' GLY . 12.9 tpt -98.48 174.22 6.56 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 -179.319 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -128.71 168.97 15.05 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 117.93 0.332 . . . . 0.0 110.97 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 61.31 49.43 5.39 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.438 -0.801 . . . . 0.0 112.455 178.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.694 ' HB2' ' ND2' ' A' ' 43' ' ' ASN . 15.9 p90 -70.08 -25.72 63.66 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.104 179.157 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.5 ' HA ' HD11 ' A' ' 62' ' ' ILE . 10.6 p -60.93 -44.9 96.56 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.262 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 30.5 m80 -79.98 -11.36 59.79 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.999 0.428 . . . . 0.0 110.762 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 20.6 m -101.41 2.33 39.32 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.997 -178.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 62.3 p -144.57 160.82 40.52 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.548 -0.461 . . . . 0.0 111.421 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 59.1 mm-40 -117.23 152.23 35.27 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.966 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 50.22 76.36 0.15 Allowed 'General case' 0 N--CA 1.472 0.644 0 O-C-N 123.994 0.809 . . . . 0.0 111.777 179.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.562 HG23 HD21 ' A' ' 71' ' ' LEU . 83.8 mt -92.61 117.09 35.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.416 -179.334 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 32.1 ttmt -148.94 154.91 40.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.108 -0.497 . . . . 0.0 109.851 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.752 ' HG ' HD21 ' A' ' 12' ' ' LEU . 60.2 mt -83.73 135.95 34.36 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.193 0.52 . . . . 0.0 111.224 -179.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -92.17 -66.26 0.94 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.406 -0.815 . . . . 0.0 111.82 -178.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -78.6 40.98 0.39 Allowed 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 120.95 0.405 . . . . 0.0 111.671 -178.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 60.91 17.81 52.06 Favored Glycine 0 C--N 1.32 -0.324 0 CA-C-N 115.653 -0.703 . . . . 0.0 113.113 179.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.47 ' HA2' HD13 ' A' ' 64' ' ' LEU . . . 129.58 -16.06 5.67 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.222 -0.989 . . . . 0.0 112.668 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.52 ' HD2' ' HB3' ' A' ' 4' ' ' ALA . 0.1 OUTLIER -77.5 -19.17 56.26 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.134 0.492 . . . . 0.0 109.783 -179.796 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.47 ' HG3' ' HA ' ' A' ' 89' ' ' ASP . 65.3 tttt -150.35 144.33 25.43 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.936 -178.391 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.61 ' HB2' HD11 ' A' ' 90' ' ' LEU . 9.7 tt -112.29 126.66 55.48 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.56 179.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.5 p -114.04 137.71 51.36 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.099 0.476 . . . . 0.0 111.358 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.423 ' HB3' ' HA ' ' A' ' 62' ' ' ILE . 25.0 p -161.76 175.85 11.53 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.607 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.511 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 44.7 ttt180 -107.91 99.54 30.98 Favored Pre-proline 0 C--N 1.317 -0.833 0 N-CA-C 110.154 -0.313 . . . . 0.0 110.154 179.377 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.672 ' O ' ' HB3' ' A' ' 83' ' ' ARG . 56.1 Cg_endo -67.06 122.91 10.29 Favored 'Trans proline' 0 CA--C 1.513 -0.564 0 C-N-CA 123.129 2.553 . . . . 0.0 111.332 -179.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.74 ' HA ' ' HB2' ' A' ' 83' ' ' ARG . 0.2 OUTLIER -120.13 147.03 45.39 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 120.947 0.403 . . . . 0.0 111.191 -179.85 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.743 HG22 ' O ' ' A' ' 82' ' ' PHE . 10.3 t -74.21 130.22 39.33 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 178.55 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.1 m -72.18 -3.39 3.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 O-C-N 123.629 0.581 . . . . 0.0 111.204 -179.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -70.52 -34.54 72.42 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.789 178.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.41 ' HA3' ' CE1' ' A' ' 82' ' ' PHE . . . -144.51 -24.72 0.13 Allowed Glycine 0 CA--C 1.521 0.441 0 C-N-CA 120.73 -0.747 . . . . 0.0 113.285 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 102.65 14.79 26.48 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 121.022 -0.609 . . . . 0.0 112.277 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.743 ' O ' HG22 ' A' ' 77' ' ' THR . 29.4 p90 -112.85 157.9 20.82 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 118.372 -0.823 . . . . 0.0 110.105 -179.206 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.844 ' HA ' ' HE ' ' A' ' 83' ' ' ARG . 0.0 OUTLIER 163.44 -154.03 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.75 0 O-C-N 123.932 0.77 . . . . 0.0 112.381 178.528 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 47.8 mm-40 -109.14 -173.96 2.39 Favored 'General case' 0 C--O 1.226 -0.161 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.468 -178.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.535 ' HA ' ' HD2' ' A' ' 75' ' ' PRO . 61.5 ttt180 -113.75 156.03 24.56 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 177.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.787 ' HG2' ' H ' ' A' ' 87' ' ' GLY . 6.8 tt0 -169.07 -165.78 0.57 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 120.526 -0.47 . . . . 0.0 111.462 -178.284 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.787 ' H ' ' HG2' ' A' ' 86' ' ' GLN . . . -162.15 154.42 25.38 Favored Glycine 0 N--CA 1.449 -0.434 0 N-CA-C 111.217 -0.753 . . . . 0.0 111.217 179.424 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.485 HG22 HD23 ' A' ' 48' ' ' LEU . 12.8 tt -130.78 137.54 55.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.952 0.376 . . . . 0.0 110.323 -179.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.47 ' HA ' ' HG3' ' A' ' 70' ' ' LYS . 1.8 p-10 -76.65 140.58 41.0 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.961 0.41 . . . . 0.0 109.92 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.791 HD13 HD11 ' A' ' 19' ' ' LEU . 55.8 mt -109.44 40.02 1.95 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.347 0.594 . . . . 0.0 110.834 -179.473 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.565 ' HA ' ' HB3' ' A' ' 2' ' ' SER . 55.4 m-80 -75.45 2.36 11.69 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.806 -179.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 19.6 mtp180 -95.77 -11.25 27.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.015 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.407 ' CD1' HD22 ' A' ' 37' ' ' LEU . 23.1 mm -98.18 100.01 9.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 29.3 tp60 -107.21 145.6 32.42 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.953 -178.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.443 ' OD1' ' HA ' ' A' ' 3' ' ' TYR . 19.4 p-10 -94.78 118.82 32.38 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.54 178.144 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 47.5 t -106.28 107.78 23.52 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 27.8 m-80 59.46 32.51 21.78 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.022 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.407 ' O ' ' HB2' ' A' ' 23' ' ' CYS . . . 97.99 -25.69 26.51 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.571 -0.823 . . . . 0.0 113.239 179.397 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.408 ' HD2' ' H ' ' A' ' 99' ' ' ARG . 1.7 mpt_? -87.07 143.28 27.39 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 117.252 0.526 . . . . 0.0 110.603 -178.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.485 ' HB3' ' HB2' ' A' ' 35' ' ' LEU . 2.7 tp -87.42 124.23 33.2 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.78 0.324 . . . . 0.0 110.845 -179.25 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 21.7 t -131.19 138.15 53.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.419 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.425 ' HB2' HD11 ' A' ' 35' ' ' LEU . 10.3 t80 -83.14 130.95 35.15 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 177.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 22.0 tt0 . . . . . 0 C--O 1.25 1.119 0 CA-C-O 118.329 -0.844 . . . . 0.0 111.046 -179.076 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . 0.406 ' OG ' ' HA ' ' A' ' 91' ' ' ASN . 13.4 m . . . . . 0 N--CA 1.453 -0.302 0 N-CA-C 110.46 -0.2 . . . . 0.0 110.46 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.482 ' CZ ' HD13 ' A' ' 19' ' ' LEU . 26.4 p90 -57.95 -38.5 76.12 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.672 0.273 . . . . 0.0 111.296 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.533 ' HA ' ' OG ' ' A' ' 7' ' ' SER . . . -58.97 -19.78 46.33 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -178.088 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -72.56 -17.78 61.68 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.297 0.57 . . . . 0.0 110.347 -179.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 48.8 m -136.74 36.42 2.64 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.333 179.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.533 ' OG ' ' HA ' ' A' ' 4' ' ' ALA . 68.6 p -149.61 171.43 16.67 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.485 179.373 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.553 ' HG3' ' HB2' ' A' ' 22' ' ' GLU . 1.9 ptp180 -149.98 167.11 27.64 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.948 -179.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 53.73 56.05 7.71 Favored 'General case' 0 C--O 1.233 0.192 0 O-C-N 123.867 0.729 . . . . 0.0 111.322 178.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.503 ' HA ' ' HB2' ' A' ' 21' ' ' ALA . . . -88.24 117.32 27.06 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.181 179.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 35.9 m -124.13 170.22 14.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.596 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.848 HD21 ' HG ' ' A' ' 64' ' ' LEU . 3.3 mm? -104.68 114.17 28.21 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.832 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 18.7 p -108.88 166.63 10.67 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.622 -0.263 . . . . 0.0 110.95 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 59.37 48.5 9.94 Favored 'General case' 0 CA--C 1.522 -0.112 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.912 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 86.76 -39.35 3.08 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.953 -0.641 . . . . 0.0 112.35 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.637 ' HA2' ' HB3' ' A' ' 12' ' ' LEU . . . 140.01 38.32 0.1 OUTLIER Glycine 0 N--CA 1.445 -0.709 0 N-CA-C 111.305 -0.718 . . . . 0.0 111.305 -179.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.552 ' HB2' ' HB3' ' A' ' 38' ' ' ASP . 39.2 ptt85 -122.14 -23.37 5.37 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.094 0.473 . . . . 0.0 110.779 -179.326 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.432 HG22 ' HB3' ' A' ' 34' ' ' GLU . 3.9 m -105.84 134.73 48.5 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.923 -179.166 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.665 HD11 HD13 ' A' ' 90' ' ' LEU . 81.9 mt -93.67 110.99 22.59 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.404 179.237 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 20.4 ttt180 -108.11 119.35 39.22 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 178.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.503 ' HB2' ' HA ' ' A' ' 10' ' ' ALA . . . -153.66 167.04 30.89 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.982 0.42 . . . . 0.0 111.483 -178.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.553 ' HB2' ' HG3' ' A' ' 8' ' ' ARG . 7.3 mm-40 -90.3 105.0 17.51 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 107.1 -1.445 . . . . 0.0 107.1 178.293 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.442 ' SG ' HD13 ' A' ' 100' ' ' LEU . 58.6 m -92.34 125.27 36.92 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.557 -178.218 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.437 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 33.8 ttp180 -73.3 117.82 15.51 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.582 179.055 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.406 HD21 ' HB3' ' A' ' 29' ' ' ASN . 35.1 p30 -82.35 167.62 18.35 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.62 -24.26 63.68 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 -178.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -75.08 -16.15 60.58 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.315 0.579 . . . . 0.0 109.727 179.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 93.32 36.32 5.97 Favored Glycine 0 N--CA 1.447 -0.624 0 CA-C-N 115.186 -0.915 . . . . 0.0 111.733 -179.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.437 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 9.2 t-20 -123.48 163.91 19.97 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.606 0.241 . . . . 0.0 110.417 -179.125 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.498 ' CZ3' ' HG2' ' A' ' 8' ' ' ARG . 89.2 m95 -101.16 118.47 37.05 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.381 -179.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.5 m -122.08 130.78 74.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.429 178.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 15.8 m -76.0 110.95 10.88 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.583 -179.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 67.8 m -123.25 154.65 38.52 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.745 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.647 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 50.4 mt-10 -135.02 143.08 46.58 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.055 -179.54 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.549 HD11 ' HB2' ' A' ' 102' ' ' PHE . 2.0 tm? -136.36 129.66 31.64 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 178.457 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.443 ' N ' HD13 ' A' ' 35' ' ' LEU . 15.1 m-20 -88.42 109.18 19.8 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 -179.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.554 HD13 HD22 ' A' ' 90' ' ' LEU . 3.8 mt -81.27 -20.01 41.82 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.764 -179.334 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.552 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 5.7 p-10 -66.26 -5.33 10.06 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.874 0.369 . . . . 0.0 111.341 -178.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 77.6 p -82.9 -11.57 58.08 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.686 179.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 29.0 t -141.48 -3.86 1.15 Allowed 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 57.7 mt -109.59 135.06 49.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 178.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.556 ' HA3' ' HB3' ' A' ' 52' ' ' MET . . . -146.0 155.63 26.6 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.93 -0.653 . . . . 0.0 111.519 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 23.6 p30 -159.69 45.19 0.19 Allowed Pre-proline 0 CA--C 1.538 0.486 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -179.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -66.66 -23.31 49.3 Favored 'Trans proline' 0 C--N 1.355 0.901 0 C-N-CA 121.793 1.662 . . . . 0.0 111.68 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 73.9 m-20 -83.95 -15.42 47.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.507 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 105.86 6.68 37.19 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.494 -0.86 . . . . 0.0 112.114 -179.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.793 ' HA ' HE22 ' A' ' 86' ' ' GLN . 55.7 m-85 -124.9 132.75 53.26 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.867 0.365 . . . . 0.0 110.171 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.591 ' HB3' ' HB ' ' A' ' 88' ' ' ILE . 11.0 mp -87.27 138.43 31.49 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.642 -0.708 . . . . 0.0 112.339 -178.173 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -177.37 171.14 43.87 Favored Glycine 0 N--CA 1.439 -1.14 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.611 178.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.427 ' HH2' HD11 ' A' ' 93' ' ' ILE . 91.6 m95 -94.99 125.39 39.63 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 156.11 -58.82 0.37 Allowed Glycine 0 N--CA 1.447 -0.58 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 -179.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.556 ' HB3' ' HA3' ' A' ' 42' ' ' GLY . 7.3 tpt -84.71 178.47 7.65 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 179.008 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.428 ' HG3' HD22 ' A' ' 54' ' ' ASN . 27.0 pt20 -137.2 177.7 7.66 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 118.596 0.635 . . . . 0.0 111.726 -179.408 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.428 HD22 ' HG3' ' A' ' 53' ' ' GLN . 44.9 m-80 62.73 39.68 10.78 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.408 -0.815 . . . . 0.0 112.083 179.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.443 ' HB3' ' HA2' ' A' ' 42' ' ' GLY . 10.1 p90 -66.26 -32.2 73.47 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 120.478 0.18 . . . . 0.0 111.296 -179.583 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.434 ' HB3' ' HB3' ' A' ' 17' ' ' ARG . 42.3 p -61.81 -31.84 72.09 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.057 0.456 . . . . 0.0 111.118 -179.005 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 38.4 m80 -78.39 -12.0 59.98 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.08 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 43.9 m -119.6 23.63 11.07 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.956 0.408 . . . . 0.0 110.704 179.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 66.2 m -138.4 152.27 48.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.085 0.469 . . . . 0.0 111.09 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 78.6 mt-10 -130.18 136.41 49.23 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.119 179.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 29.7 t70 65.58 82.62 0.18 Allowed 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.329 0.585 . . . . 0.0 110.268 -178.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.478 HG23 HD21 ' A' ' 71' ' ' LEU . 64.2 mt -104.68 121.98 57.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.197 -179.248 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 27.8 tptt -147.33 153.7 40.01 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.848 ' HG ' HD21 ' A' ' 12' ' ' LEU . 73.4 mt -85.89 125.95 33.71 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.962 0.411 . . . . 0.0 110.764 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -78.56 -58.32 3.31 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.593 -178.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.545 ' HB2' ' HB3' ' A' ' 69' ' ' ARG . 35.9 mt-10 -89.02 39.13 0.92 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.94 0.4 . . . . 0.0 111.175 -179.119 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 61.92 10.9 28.42 Favored Glycine 0 N--CA 1.453 -0.225 0 CA-C-N 115.516 -0.765 . . . . 0.0 113.28 179.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.516 ' HA2' HD13 ' A' ' 64' ' ' LEU . . . 136.66 -14.6 3.89 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.415 -0.898 . . . . 0.0 112.705 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.545 ' HB3' ' HB2' ' A' ' 66' ' ' GLU . 0.6 OUTLIER -79.07 -22.15 45.71 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.415 0.626 . . . . 0.0 109.349 -179.669 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.9 ttmp? -144.91 137.43 26.22 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.014 -179.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.598 ' HB2' HD11 ' A' ' 90' ' ' LEU . 10.6 tt -104.69 127.58 52.5 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.571 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.4 p -117.73 131.93 56.54 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.048 0.451 . . . . 0.0 111.405 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.481 ' SG ' HD21 ' A' ' 48' ' ' LEU . 28.4 p -158.2 165.57 34.56 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.604 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 12.0 ttt-85 -106.33 101.65 36.24 Favored Pre-proline 0 C--N 1.316 -0.885 0 C-N-CA 120.173 -0.611 . . . . 0.0 109.941 179.067 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.672 ' O ' ' HB3' ' A' ' 83' ' ' ARG . 55.8 Cg_endo -70.45 141.37 42.25 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 122.567 2.178 . . . . 0.0 110.417 178.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.785 ' HE3' ' HA2' ' A' ' 81' ' ' GLY . 0.0 OUTLIER -121.66 143.62 49.23 Favored 'General case' 0 C--N 1.318 -0.8 0 O-C-N 123.567 0.542 . . . . 0.0 111.098 179.913 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.678 ' HB ' ' HD2' ' A' ' 83' ' ' ARG . 11.4 t -79.83 143.14 34.64 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 178.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 8.8 p -70.4 -12.36 16.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 O-C-N 124.184 0.927 . . . . 0.0 111.577 -179.04 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 -63.43 -23.14 67.28 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.283 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -173.08 -14.62 0.02 OUTLIER Glycine 0 C--O 1.228 -0.255 0 C-N-CA 120.312 -0.947 . . . . 0.0 113.163 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.785 ' HA2' ' HE3' ' A' ' 76' ' ' LYS . . . 98.76 20.97 17.47 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.549 -0.834 . . . . 0.0 111.849 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.678 ' O ' HG22 ' A' ' 77' ' ' THR . 24.9 p90 -110.91 149.5 30.54 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -179.133 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.688 ' HB2' ' HA ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 177.35 -143.15 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.763 -0.375 . . . . 0.0 111.896 -179.768 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -143.91 152.46 41.15 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.051 -178.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.604 ' HA ' ' HA ' ' A' ' 74' ' ' ARG . 31.6 ttt-85 -77.55 154.1 32.7 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 110.206 -0.294 . . . . 0.0 110.206 -179.68 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.793 HE22 ' HA ' ' A' ' 47' ' ' PHE . 8.1 tt0 -161.72 179.68 7.94 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 120.586 0.231 . . . . 0.0 110.587 -179.028 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.608 ' H ' ' HG2' ' A' ' 86' ' ' GLN . . . -145.51 148.56 20.37 Favored Glycine 0 N--CA 1.448 -0.545 0 N-CA-C 111.683 -0.567 . . . . 0.0 111.683 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.591 ' HB ' ' HB3' ' A' ' 48' ' ' LEU . 14.8 tt -126.18 137.84 56.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.199 0.523 . . . . 0.0 110.538 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.445 ' HB3' HD22 ' A' ' 91' ' ' ASN . 4.0 m-20 -77.4 128.3 34.02 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.872 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.665 HD13 HD11 ' A' ' 19' ' ' LEU . 44.7 mt -96.7 42.06 1.1 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.613 0.721 . . . . 0.0 110.746 -179.163 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.445 HD22 ' HB3' ' A' ' 89' ' ' ASP . 11.2 m-80 -78.86 3.2 17.56 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 115.053 -0.976 . . . . 0.0 111.041 -179.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 24.7 mtp180 -100.18 -3.98 30.52 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.677 178.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.427 HD11 ' HH2' ' A' ' 50' ' ' TRP . 22.1 mm -104.16 108.99 25.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 -179.377 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 26.6 tp60 -122.18 141.96 50.91 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.985 -178.242 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 17.0 p-10 -94.73 119.72 33.8 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.066 178.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 44.2 t -104.82 104.81 17.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.641 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 34.9 m-80 61.0 37.19 18.26 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 121.273 0.559 . . . . 0.0 110.651 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 91.05 -16.64 58.14 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.924 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 7.1 mpt_? -87.1 123.09 31.78 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.442 HD13 ' SG ' ' A' ' 23' ' ' CYS . 9.0 tp -81.6 114.9 20.61 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.684 -0.488 . . . . 0.0 109.684 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 39.5 t -128.7 143.11 42.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 120.933 0.397 . . . . 0.0 111.001 -178.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.549 ' HB2' HD11 ' A' ' 35' ' ' LEU . 6.7 t80 -81.47 136.05 35.64 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 178.36 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 . . . . . 0 C--O 1.245 0.85 0 CA-C-O 118.805 -0.617 . . . . 0.0 110.686 -179.976 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . 0.581 ' OG ' ' HA ' ' A' ' 91' ' ' ASN . 5.5 m . . . . . 0 N--CA 1.454 -0.23 0 CA-C-O 120.946 0.403 . . . . 0.0 111.45 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.503 ' HA ' ' OD1' ' A' ' 95' ' ' ASN . 21.0 p90 -59.06 -33.92 71.34 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.857 178.388 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.491 ' HB3' ' HG2' ' A' ' 69' ' ' ARG . . . -56.34 -19.22 13.52 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 -178.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -69.43 -14.53 62.94 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 121.107 0.48 . . . . 0.0 110.808 179.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 14.9 p -149.5 33.7 0.71 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.655 0.741 . . . . 0.0 109.354 178.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 17.4 t -148.47 155.78 41.62 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.256 -0.884 . . . . 0.0 109.394 -179.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 1.5 ptp180 -148.74 170.24 18.63 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.76 -0.2 . . . . 0.0 110.858 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 62.56 44.6 6.79 Favored 'General case' 0 C--O 1.232 0.151 0 O-C-N 124.003 0.814 . . . . 0.0 111.18 178.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.413 ' HA ' ' HB2' ' A' ' 21' ' ' ALA . . . -80.33 126.34 31.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.88 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 35.5 m -126.77 172.62 13.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.552 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -105.94 114.88 29.3 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.68 -179.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 22.6 p -111.15 166.87 10.71 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.951 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.432 ' O ' ' HG2' ' A' ' 17' ' ' ARG . 83.9 m-20 56.83 42.28 26.78 Favored 'General case' 0 N--CA 1.461 0.108 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.604 -179.206 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 87.69 -41.03 3.07 Favored Glycine 0 CA--C 1.517 0.212 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.542 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 146.33 44.29 0.04 OUTLIER Glycine 0 N--CA 1.447 -0.617 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.432 ' HG2' ' O ' ' A' ' 14' ' ' ASN . 6.4 ptm180 -126.24 -26.18 3.4 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.894 0.378 . . . . 0.0 110.93 -179.191 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 3.7 m -107.08 135.97 47.73 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.971 -179.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.815 HD11 HD13 ' A' ' 90' ' ' LEU . 39.7 mt -94.62 115.87 28.08 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.209 178.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 78.0 ttt180 -112.98 119.04 36.53 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 178.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.432 ' O ' ' HA ' ' A' ' 32' ' ' THR . . . -154.08 166.78 31.98 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.728 0.299 . . . . 0.0 111.461 -179.139 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -90.99 106.64 18.66 Favored 'General case' 0 CA--C 1.513 -0.458 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 178.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.468 ' SG ' HD13 ' A' ' 100' ' ' LEU . 70.2 m -99.01 135.76 39.94 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 120.76 0.314 . . . . 0.0 110.765 -178.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.4 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 15.9 ttp180 -77.66 120.02 22.01 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.791 179.334 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.43 HD21 ' HB3' ' A' ' 29' ' ' ASN . 36.4 p30 -86.13 168.63 13.85 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.971 -0.291 . . . . 0.0 110.385 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -52.59 -36.28 55.78 Favored 'General case' 0 C--N 1.328 -0.369 0 O-C-N 123.837 0.71 . . . . 0.0 112.02 -179.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -67.45 -17.21 64.61 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.329 0.585 . . . . 0.0 111.041 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 92.6 34.98 6.68 Favored Glycine 0 N--CA 1.448 -0.528 0 N-CA-C 111.304 -0.718 . . . . 0.0 111.304 -179.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.43 ' HB3' HD21 ' A' ' 25' ' ' ASN . 9.9 t-20 -119.77 158.08 27.27 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 110.237 -0.283 . . . . 0.0 110.237 -178.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 77.0 m95 -95.1 116.53 28.83 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.241 179.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.5 m -122.78 129.53 75.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.361 179.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.432 ' HA ' ' O ' ' A' ' 21' ' ' ALA . 21.0 m -74.77 114.5 13.29 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.202 0.525 . . . . 0.0 110.26 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.55 ' HB3' ' HB2' ' A' ' 100' ' ' LEU . 58.5 m -114.95 149.41 37.34 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.909 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.641 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 26.3 mt-10 -132.65 130.85 40.69 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.881 -178.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.591 HD11 ' HB2' ' A' ' 102' ' ' PHE . 2.1 tm? -132.64 132.83 42.87 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.461 ' N ' HD13 ' A' ' 35' ' ' LEU . 14.6 m-20 -88.96 110.19 20.9 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 -179.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.505 HD11 ' HG ' ' A' ' 19' ' ' LEU . 2.6 mt -81.11 -18.29 47.01 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.095 -179.123 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.465 ' HA ' ' HD1' ' A' ' 55' ' ' PHE . 5.7 p-10 -65.05 -7.22 11.08 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.28 -179.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 58.1 p -80.73 -13.04 59.34 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.271 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.457 ' HG ' ' HZ ' ' A' ' 102' ' ' PHE . 18.8 t -139.96 -12.9 1.09 Allowed 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 112.138 0.422 . . . . 0.0 112.138 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 54.3 mt -97.55 135.46 31.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 O-C-N 121.814 -0.554 . . . . 0.0 110.057 179.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -142.15 144.64 14.44 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.731 -0.747 . . . . 0.0 111.743 179.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.503 ' OD1' ' HB2' ' A' ' 58' ' ' SER . 27.8 p30 -152.95 48.37 0.43 Allowed Pre-proline 0 CA--C 1.539 0.542 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 -179.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -76.78 -16.46 16.4 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 121.697 1.598 . . . . 0.0 112.339 -178.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -96.19 2.71 53.26 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.921 -179.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.604 ' CA ' ' HG2' ' A' ' 83' ' ' ARG . . . 92.48 5.58 65.02 Favored Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.295 -0.955 . . . . 0.0 112.26 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.451 ' HD1' ' NE2' ' A' ' 86' ' ' GLN . 31.9 m-85 -125.85 134.49 51.62 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.899 0.38 . . . . 0.0 110.497 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.467 HD23 HG22 ' A' ' 88' ' ' ILE . 9.5 mp -85.04 158.51 20.44 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.58 -0.737 . . . . 0.0 111.653 -178.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 159.55 167.26 19.94 Favored Glycine 0 N--CA 1.443 -0.864 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.95 178.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.451 ' CD1' HD11 ' A' ' 88' ' ' ILE . 85.2 m95 -95.33 125.12 39.73 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 166.29 -43.01 0.27 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.87 -179.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 8.4 ttp -107.86 -156.94 0.6 Allowed 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.4 pt20 -146.83 173.92 11.95 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 121.091 -0.244 . . . . 0.0 110.899 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 63.03 45.43 5.28 Favored 'General case' 0 N--CA 1.465 0.285 0 O-C-N 123.663 0.602 . . . . 0.0 112.351 178.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.465 ' HD1' ' HA ' ' A' ' 38' ' ' ASP . 10.1 p90 -71.63 -28.79 64.02 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.978 -0.289 . . . . 0.0 110.76 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.45 ' HA ' HD11 ' A' ' 62' ' ' ILE . 35.0 p -61.39 -37.61 84.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.079 0.466 . . . . 0.0 110.917 -179.333 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 27.2 m80 -81.06 -3.46 51.97 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.106 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.503 ' HB2' ' OD1' ' A' ' 43' ' ' ASN . 12.2 m -119.13 12.68 12.74 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.396 -179.436 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 22.0 p -145.88 155.3 42.79 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 120.995 0.426 . . . . 0.0 111.459 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -116.35 148.05 40.99 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.872 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.405 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 28.1 t70 54.0 78.44 0.16 Allowed 'General case' 0 N--CA 1.467 0.401 0 O-C-N 123.921 0.763 . . . . 0.0 111.168 -179.614 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.586 ' HA ' ' HB3' ' A' ' 73' ' ' CYS . 67.0 mt -97.04 117.64 42.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.784 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -148.03 153.78 39.41 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.825 0.345 . . . . 0.0 110.626 -179.159 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.432 HD22 ' HA2' ' A' ' 68' ' ' GLY . 43.0 mt -83.07 133.14 35.08 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.24 0.543 . . . . 0.0 111.041 -179.173 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.439 ' OE2' ' HD3' ' A' ' 70' ' ' LYS . 35.4 tt0 -86.8 -61.44 1.73 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.68 -178.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.595 ' HB2' ' HB2' ' A' ' 69' ' ' ARG . 19.1 mt-10 -84.71 34.9 0.54 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.806 0.336 . . . . 0.0 111.42 -178.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 65.04 13.15 57.03 Favored Glycine 0 N--CA 1.452 -0.252 0 CA-C-N 115.972 -0.558 . . . . 0.0 113.504 179.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.432 ' HA2' HD22 ' A' ' 64' ' ' LEU . . . 140.26 -24.76 2.66 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.147 -1.025 . . . . 0.0 113.072 179.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.595 ' HB2' ' HB2' ' A' ' 66' ' ' GLU . 3.8 mmt85 -74.08 -21.34 59.95 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.967 0.413 . . . . 0.0 110.943 -179.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.591 ' HB3' ' HG3' ' A' ' 66' ' ' GLU . 81.9 tttt -146.17 143.05 29.03 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.743 -178.509 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.685 ' HB2' HD11 ' A' ' 90' ' ' LEU . 10.2 tt -113.19 135.32 53.94 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.013 -0.539 . . . . 0.0 109.617 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 8.9 p -127.16 139.13 53.17 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.018 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.586 ' HB3' ' HA ' ' A' ' 62' ' ' ILE . 26.4 p -162.54 172.0 16.14 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.269 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.664 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 75.1 ttt180 -108.86 98.87 31.88 Favored Pre-proline 0 C--N 1.321 -0.664 0 C-N-CA 120.562 -0.455 . . . . 0.0 110.349 178.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.689 ' O ' ' HB3' ' A' ' 83' ' ' ARG . 41.4 Cg_endo -66.74 128.4 18.88 Favored 'Trans proline' 0 N--CA 1.459 -0.5 0 C-N-CA 122.847 2.365 . . . . 0.0 110.828 179.302 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.763 ' HA ' ' HB2' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -120.78 141.57 50.38 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.349 -179.268 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.699 HG22 ' O ' ' A' ' 82' ' ' PHE . 9.5 t -70.86 131.47 43.82 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 178.402 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.7 m -70.55 -6.84 7.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 123.818 0.699 . . . . 0.0 112.069 -178.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -69.29 -33.91 73.9 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.956 0.408 . . . . 0.0 110.313 179.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.431 ' HA3' ' CE1' ' A' ' 82' ' ' PHE . . . -143.98 -25.45 0.14 Allowed Glycine 0 N--CA 1.453 -0.187 0 C-N-CA 120.557 -0.83 . . . . 0.0 112.7 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 100.66 17.62 23.15 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 121.02 -0.609 . . . . 0.0 112.133 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.699 ' O ' HG22 ' A' ' 77' ' ' THR . 24.7 p90 -111.8 153.11 27.05 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 118.763 -0.637 . . . . 0.0 109.878 -178.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.763 ' HB2' ' HA ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 167.04 -154.88 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.582 0 O-C-N 123.697 0.623 . . . . 0.0 111.364 179.4 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -123.44 170.84 9.96 Favored 'General case' 0 C--O 1.223 -0.304 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.265 -178.023 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.664 ' HA ' ' HA ' ' A' ' 74' ' ' ARG . 30.1 ttt85 -96.81 157.97 15.65 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.246 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.455 ' HG2' ' H ' ' A' ' 87' ' ' GLY . 6.4 tt0 -158.91 179.57 8.96 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.072 0.463 . . . . 0.0 111.58 -179.243 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.455 ' H ' ' HG2' ' A' ' 86' ' ' GLN . . . -144.54 143.82 12.53 Favored Glycine 0 N--CA 1.45 -0.426 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.612 179.22 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.467 HG22 HD23 ' A' ' 48' ' ' LEU . 13.9 tt -130.29 140.85 47.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.825 0.345 . . . . 0.0 110.556 -179.374 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.467 ' HB3' HD22 ' A' ' 91' ' ' ASN . 6.9 m-20 -80.15 137.4 36.7 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.815 HD13 HD11 ' A' ' 19' ' ' LEU . 64.2 mt -104.71 41.28 1.35 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.292 0.568 . . . . 0.0 111.382 -179.285 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.581 ' HA ' ' OG ' ' A' ' 2' ' ' SER . 21.3 m-80 -76.0 3.31 10.55 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.976 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.407 HH11 ' HD2' ' A' ' 92' ' ' ARG . 8.4 mtp180 -96.7 -11.19 25.44 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.562 178.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.492 HG13 HD22 ' A' ' 37' ' ' LEU . 21.7 mm -98.38 95.91 4.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 21.6 tp60 -106.15 139.54 40.5 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.201 -177.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.503 ' OD1' ' HA ' ' A' ' 3' ' ' TYR . 16.8 p-10 -94.67 116.35 28.65 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.596 178.314 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.7 p -114.13 123.57 69.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 116.185 -0.461 . . . . 0.0 109.938 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 62.57 20.11 11.75 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.956 -179.156 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 95.84 -9.59 68.36 Favored Glycine 0 N--CA 1.446 -0.657 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.759 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.446 ' O ' ' HA ' ' A' ' 95' ' ' ASN . 0.0 OUTLIER -96.1 144.41 26.38 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-N 117.257 0.529 . . . . 0.0 110.826 -178.944 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.55 ' HB2' ' HB3' ' A' ' 33' ' ' SER . 5.3 tp -89.55 116.38 27.66 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.145 -0.48 . . . . 0.0 109.796 -179.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 46.8 t -131.12 141.85 45.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.422 -179.353 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.591 ' HB2' HD11 ' A' ' 35' ' ' LEU . 22.8 t80 -80.27 128.68 33.82 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 179.153 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.163 -0.922 . . . . 0.0 110.864 -179.347 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . 0.623 ' HB3' ' HA ' ' A' ' 91' ' ' ASN . 1.0 OUTLIER . . . . . 0 N--CA 1.448 -0.533 0 N-CA-C 110.464 -0.198 . . . . 0.0 110.464 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.619 ' HA ' ' OD1' ' A' ' 95' ' ' ASN . 8.3 p90 -58.22 -41.41 84.02 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.772 -0.195 . . . . 0.0 111.399 -179.429 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -60.18 -19.37 53.78 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.849 -178.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -68.29 -21.81 64.76 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.146 0.498 . . . . 0.0 110.429 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.405 ' HB2' HD21 ' A' ' 95' ' ' ASN . 51.1 m -138.85 34.88 2.17 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.671 179.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.433 ' HA ' ' HZ3' ' A' ' 30' ' ' TRP . 92.8 p -149.96 167.67 26.02 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.182 179.258 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 16.0 ptm180 -149.9 169.11 21.9 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.648 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 60.4 52.87 4.52 Favored 'General case' 0 N--CA 1.465 0.296 0 O-C-N 123.646 0.591 . . . . 0.0 110.692 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -90.12 119.96 30.89 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.209 -179.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 35.3 m -122.49 170.71 12.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.165 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.707 HD21 ' HG ' ' A' ' 64' ' ' LEU . 3.4 mm? -104.81 116.29 31.76 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 -179.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.456 ' OG1' ' HB ' ' A' ' 18' ' ' THR . 29.4 p -110.7 167.62 10.09 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.072 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 56.95 55.62 5.99 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.93 179.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 82.24 -37.97 2.58 Favored Glycine 0 N--CA 1.453 -0.206 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.337 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.602 ' HA2' ' HB3' ' A' ' 12' ' ' LEU . . . 137.29 36.57 0.17 Allowed Glycine 0 N--CA 1.445 -0.757 0 N-CA-C 111.381 -0.688 . . . . 0.0 111.381 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.534 ' HB2' ' HB3' ' A' ' 38' ' ' ASP . 34.5 ptt85 -120.46 -23.11 6.22 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.93 0.395 . . . . 0.0 110.71 -179.222 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.456 ' HB ' ' OG1' ' A' ' 13' ' ' THR . 4.6 m -103.33 134.7 46.27 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.841 -179.258 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.65 ' O ' ' HA ' ' A' ' 34' ' ' GLU . 68.8 mt -95.26 116.18 28.41 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.395 179.19 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 39.0 ttt-85 -111.01 120.18 41.52 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 178.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -153.58 166.63 32.16 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.845 0.355 . . . . 0.0 111.488 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.468 ' HB3' ' HB3' ' A' ' 30' ' ' TRP . 49.8 mt-10 -89.9 105.68 17.97 Favored 'General case' 0 CA--C 1.512 -0.49 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 178.117 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.561 ' SG ' HD13 ' A' ' 100' ' ' LEU . 58.7 m -92.72 128.74 38.69 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.134 -177.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.434 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 11.0 ttp180 -77.79 116.46 18.33 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.34 179.034 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.439 HD21 ' HB3' ' A' ' 29' ' ' ASN . 35.2 p30 -84.96 170.92 12.56 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.231 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -51.29 -31.41 21.28 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -179.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -73.88 -11.58 60.41 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.621 0.724 . . . . 0.0 110.601 -179.183 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 85.79 25.02 39.64 Favored Glycine 0 N--CA 1.447 -0.633 0 N-CA-C 110.629 -0.988 . . . . 0.0 110.629 -179.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.439 ' HB3' HD21 ' A' ' 25' ' ' ASN . 8.8 t-20 -104.73 156.12 18.27 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.459 -0.371 . . . . 0.0 110.243 -178.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.468 ' HB3' ' HB3' ' A' ' 22' ' ' GLU . 90.7 m95 -97.6 116.02 29.01 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.775 -179.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.3 m -118.64 128.32 75.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.349 178.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 19.7 m -74.48 109.35 7.89 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.362 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.44 ' HB3' ' HB2' ' A' ' 100' ' ' LEU . 69.3 m -122.12 147.66 45.86 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.445 -179.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.65 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 50.7 mt-10 -128.79 142.84 50.85 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.012 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.722 HD11 ' HB2' ' A' ' 102' ' ' PHE . 2.1 tm? -135.49 132.45 37.36 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.463 ' N ' HD13 ' A' ' 35' ' ' LEU . 16.2 m-20 -89.59 110.36 21.23 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.542 HD13 HD22 ' A' ' 90' ' ' LEU . 2.9 mt -82.25 -20.76 36.96 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.68 -178.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.534 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 5.1 p-10 -66.9 -5.2 11.58 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 121.008 -0.277 . . . . 0.0 111.272 -178.501 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 37.5 p -73.52 -28.12 61.72 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.055 0.455 . . . . 0.0 110.261 178.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 17.0 t -126.48 -4.39 6.62 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.909 -179.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.403 HD13 HD13 ' A' ' 88' ' ' ILE . 57.8 mt -104.7 134.65 45.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 O-C-N 121.718 -0.613 . . . . 0.0 110.655 179.145 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.503 ' HA3' ' HB3' ' A' ' 52' ' ' MET . . . -149.98 158.85 27.85 Favored Glycine 0 N--CA 1.449 -0.456 0 N-CA-C 111.463 -0.655 . . . . 0.0 111.463 179.51 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.672 ' OD1' ' HB2' ' A' ' 55' ' ' PHE . 1.7 p-10 -163.64 56.37 0.54 Allowed Pre-proline 0 CA--C 1.538 0.484 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -66.64 -25.52 46.95 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.134 1.889 . . . . 0.0 112.068 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -96.54 3.94 52.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.03 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.641 ' HA2' ' HB2' ' A' ' 75' ' ' PRO . . . 89.9 11.99 62.76 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.305 -0.95 . . . . 0.0 113.288 179.453 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.534 ' HA ' HE22 ' A' ' 86' ' ' GLN . 27.1 m-85 -118.38 123.48 45.37 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 120.929 0.395 . . . . 0.0 109.987 179.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.535 HD21 ' SG ' ' A' ' 73' ' ' CYS . 8.0 mp -83.56 137.51 33.81 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.734 -178.427 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -179.97 172.62 44.18 Favored Glycine 0 N--CA 1.437 -1.254 0 C-N-CA 120.748 -0.739 . . . . 0.0 111.422 178.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.43 ' CD2' ' HD3' ' A' ' 92' ' ' ARG . 91.2 m95 -95.05 125.03 39.43 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 -179.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 165.05 -55.25 0.27 Allowed Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.991 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.503 ' HB3' ' HA3' ' A' ' 42' ' ' GLY . 5.6 ttt -91.69 -158.07 0.55 Allowed 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.825 0.312 . . . . 0.0 110.226 -179.176 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -148.57 167.64 24.89 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 120.788 0.328 . . . . 0.0 111.466 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 23.8 m-80 63.6 48.61 3.31 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.303 -0.862 . . . . 0.0 112.82 178.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.672 ' HB2' ' OD1' ' A' ' 43' ' ' ASN . 8.8 p90 -69.73 -27.94 65.38 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.856 0.36 . . . . 0.0 110.423 179.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.453 ' HB2' ' HB3' ' A' ' 17' ' ' ARG . 21.7 t -61.26 -33.1 72.98 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.156 -179.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 24.3 m80 -78.37 -3.51 43.51 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.918 -179.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 40.0 m -133.94 24.56 3.94 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.956 0.408 . . . . 0.0 110.942 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 22.1 m -139.55 147.75 41.63 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.136 0.493 . . . . 0.0 111.465 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -123.06 151.5 41.91 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.59 179.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.452 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 28.2 t70 54.01 73.81 0.36 Allowed 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.356 0.598 . . . . 0.0 111.245 179.313 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.472 HG23 HD21 ' A' ' 71' ' ' LEU . 56.3 mt -98.48 116.13 40.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.887 -179.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.2 tptt -144.45 149.84 36.66 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.258 -179.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.707 ' HG ' HD21 ' A' ' 12' ' ' LEU . 65.0 mt -83.67 130.83 34.97 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 179.417 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 16.2 tp10 -83.13 -58.01 3.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.259 -178.134 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.514 ' HB2' ' HB3' ' A' ' 69' ' ' ARG . 7.2 mm-40 -85.59 23.14 1.43 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.158 0.504 . . . . 0.0 111.21 -179.046 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 76.49 3.38 77.8 Favored Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 115.487 -0.778 . . . . 0.0 112.963 179.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.451 ' HA2' HD22 ' A' ' 64' ' ' LEU . . . 147.62 -22.5 1.5 Allowed Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.671 -0.776 . . . . 0.0 111.997 -179.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.514 ' HB3' ' HB2' ' A' ' 66' ' ' GLU . 2.8 tpp180 -74.01 -12.53 60.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.267 0.556 . . . . 0.0 110.048 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 48.5 tttp -160.14 142.41 13.13 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.269 -178.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.649 ' HB2' HD11 ' A' ' 90' ' ' LEU . 10.3 tt -112.39 139.02 48.3 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.5 p -127.77 134.83 49.51 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.748 179.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.535 ' SG ' HD21 ' A' ' 48' ' ' LEU . 25.7 p -158.39 175.83 13.22 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.021 0.439 . . . . 0.0 110.259 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.589 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 2.8 tmt_? -110.92 98.79 39.99 Favored Pre-proline 0 C--N 1.316 -0.881 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 178.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.65 ' O ' ' HB3' ' A' ' 83' ' ' ARG . 61.2 Cg_endo -71.18 124.98 10.96 Favored 'Trans proline' 0 CA--C 1.512 -0.604 0 C-N-CA 123.301 2.667 . . . . 0.0 111.468 179.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.691 ' HA ' ' HB2' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -120.63 138.47 53.9 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.942 179.56 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.715 HG22 ' O ' ' A' ' 82' ' ' PHE . 14.8 t -72.62 132.66 44.04 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.364 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.7 p -74.87 -10.0 13.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.84 -179.087 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -67.44 -29.51 69.0 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.233 179.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.596 ' HA3' ' CE2' ' A' ' 82' ' ' PHE . . . -146.49 -23.33 0.1 Allowed Glycine 0 C--O 1.228 -0.232 0 C-N-CA 120.342 -0.932 . . . . 0.0 113.676 -179.202 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.68 ' HA2' ' HE3' ' A' ' 76' ' ' LYS . . . 97.76 12.11 48.18 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.302 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.715 ' O ' HG22 ' A' ' 77' ' ' THR . 29.6 p90 -111.91 158.64 19.23 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 118.419 -0.8 . . . . 0.0 109.793 -178.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.691 ' HB2' ' HA ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 162.62 -158.94 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.588 0 O-C-N 123.956 0.785 . . . . 0.0 111.731 179.514 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -120.02 -171.09 2.08 Favored 'General case' 0 C--O 1.225 -0.189 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.625 -178.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.589 ' HA ' ' HA ' ' A' ' 74' ' ' ARG . 30.6 ttt180 -109.58 155.6 21.22 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 177.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.534 HE22 ' HA ' ' A' ' 47' ' ' PHE . 9.2 tt0 -169.1 162.06 10.69 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 120.407 -0.517 . . . . 0.0 112.265 -179.085 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -123.74 157.19 18.12 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 121.221 -0.514 . . . . 0.0 112.062 179.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.474 ' HB ' ' HB3' ' A' ' 48' ' ' LEU . 15.1 tt -131.43 143.82 39.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.027 0.441 . . . . 0.0 110.246 179.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.525 ' OD1' ' HB2' ' A' ' 91' ' ' ASN . 17.3 t70 -82.74 131.89 35.19 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.265 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.649 HD13 HD11 ' A' ' 19' ' ' LEU . 56.1 mt -105.34 34.15 3.37 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 112.943 0.719 . . . . 0.0 112.943 -177.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.623 ' HA ' ' HB3' ' A' ' 2' ' ' SER . 10.8 m-80 -74.72 3.69 7.53 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 121.096 0.474 . . . . 0.0 111.464 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.43 ' HD3' ' CD2' ' A' ' 50' ' ' TRP . 32.3 mtp180 -92.86 -11.14 34.3 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.493 178.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.509 HG13 HD22 ' A' ' 37' ' ' LEU . 19.9 mm -99.59 106.46 19.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -179.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 19.9 tp60 -117.4 140.24 49.83 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.085 0.469 . . . . 0.0 111.269 -178.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.619 ' OD1' ' HA ' ' A' ' 3' ' ' TYR . 16.5 p-10 -95.14 101.28 13.02 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.399 0.619 . . . . 0.0 109.808 177.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.2 p -91.42 114.39 28.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 121.439 0.638 . . . . 0.0 110.424 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 61.24 29.75 18.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.57 -179.61 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 91.08 -10.82 73.96 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.038 -179.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.417 ' N ' ' HD2' ' A' ' 99' ' ' ARG . 9.6 mpt_? -92.11 123.54 35.54 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.684 0.278 . . . . 0.0 110.327 -179.33 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.561 HD13 ' SG ' ' A' ' 23' ' ' CYS . 5.5 tp -78.71 114.56 17.74 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 -179.537 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 53.4 t -132.14 140.98 46.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.189 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.722 ' HB2' HD11 ' A' ' 35' ' ' LEU . 8.3 t80 -83.06 133.75 35.06 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.137 179.327 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 . . . . . 0 C--O 1.248 1.008 0 CA-C-O 118.764 -0.636 . . . . 0.0 109.956 179.994 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . 0.683 ' OG ' ' HA ' ' A' ' 91' ' ' ASN . 12.3 m . . . . . 0 N--CA 1.451 -0.408 0 CA-C-O 120.533 0.206 . . . . 0.0 110.903 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.424 ' CZ ' HD13 ' A' ' 19' ' ' LEU . 22.8 p90 -58.21 -36.92 73.84 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.257 179.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -56.68 -21.04 24.76 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -178.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -73.55 -9.74 58.99 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 120.991 0.424 . . . . 0.0 111.006 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 51.0 m -148.07 29.23 0.9 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.317 0.58 . . . . 0.0 109.529 178.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 36.7 m -143.29 164.48 30.1 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.576 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 2.3 ptm180 -148.57 165.97 29.66 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.327 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 57.83 57.29 4.26 Favored 'General case' 0 N--CA 1.462 0.174 0 O-C-N 123.647 0.592 . . . . 0.0 111.46 178.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.421 ' HA ' ' HB2' ' A' ' 21' ' ' ALA . . . -88.93 125.91 35.17 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.934 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 23.0 m -129.05 174.19 12.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.4 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.671 HD21 ' HG ' ' A' ' 64' ' ' LEU . 3.5 mm? -106.0 114.42 28.55 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.945 -179.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 28.3 p -111.54 171.24 7.6 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.126 -179.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 56.67 40.27 29.33 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.608 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 90.02 -20.43 36.39 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.677 179.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.629 ' HA2' ' HB3' ' A' ' 12' ' ' LEU . . . 121.73 34.92 0.82 Allowed Glycine 0 N--CA 1.443 -0.84 0 C-N-CA 120.926 -0.654 . . . . 0.0 111.727 -179.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.563 ' HB2' ' HB3' ' A' ' 38' ' ' ASP . 11.9 ptt180 -124.34 -15.41 6.7 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.218 0.533 . . . . 0.0 110.477 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.428 ' CG2' ' HB3' ' A' ' 34' ' ' GLU . 11.4 m -114.18 138.67 50.15 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.231 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.698 HD11 HD13 ' A' ' 90' ' ' LEU . 56.8 mt -95.17 113.71 25.43 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.93 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.516 ' HD3' HG23 ' A' ' 32' ' ' THR . 4.5 tmm_? -107.94 119.46 39.53 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 178.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.421 ' HB2' ' HA ' ' A' ' 10' ' ' ALA . . . -153.71 167.23 30.31 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.95 0.405 . . . . 0.0 111.401 -179.158 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -89.52 105.96 18.14 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 178.064 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.529 ' SG ' HD13 ' A' ' 100' ' ' LEU . 22.5 m -96.82 133.27 41.63 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.565 -0.288 . . . . 0.0 110.584 -177.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 16.7 ttp180 -76.4 116.63 17.27 Favored 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 179.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.403 HD21 ' HB3' ' A' ' 29' ' ' ASN . 36.1 p30 -81.75 165.01 21.31 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 179.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.14 -15.68 15.76 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -177.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -87.49 -6.22 58.47 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.745 0.783 . . . . 0.0 109.974 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 83.41 37.76 11.82 Favored Glycine 0 N--CA 1.448 -0.561 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.677 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.403 ' HB3' HD21 ' A' ' 25' ' ' ASN . 9.8 t-20 -124.5 161.25 26.51 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 110.353 -0.24 . . . . 0.0 110.353 -179.329 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 72.8 m95 -98.56 120.87 39.72 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.72 179.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.6 m -124.67 134.87 65.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.979 179.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.516 HG23 ' HD3' ' A' ' 20' ' ' ARG . 46.1 m -75.76 109.38 9.31 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.756 179.066 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 55.4 m -122.83 153.51 39.48 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.755 -179.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.638 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 44.0 mt-10 -135.52 139.17 43.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.117 -179.483 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.701 HD11 ' HB2' ' A' ' 102' ' ' PHE . 2.5 tm? -131.71 131.95 43.5 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 179.049 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.478 ' O ' HG22 ' A' ' 39' ' ' THR . 38.8 m-20 -84.8 110.52 18.87 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.973 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.603 HD13 HD22 ' A' ' 90' ' ' LEU . 5.2 mt -81.2 -27.44 35.32 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.663 0.268 . . . . 0.0 111.385 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.563 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 4.6 p-10 -65.65 -5.79 9.42 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.292 0.479 . . . . 0.0 112.292 -177.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.478 HG22 ' O ' ' A' ' 36' ' ' ASP . 14.0 t -78.75 -10.15 59.67 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 110.274 -0.269 . . . . 0.0 110.274 178.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 40.2 t -141.53 3.84 1.72 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.463 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.407 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 56.9 mt -113.88 132.58 62.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 O-C-N 121.95 -0.468 . . . . 0.0 110.621 179.327 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.486 ' HA3' ' HB3' ' A' ' 52' ' ' MET . . . -146.47 155.48 26.55 Favored Glycine 0 N--CA 1.447 -0.568 0 N-CA-C 111.408 -0.677 . . . . 0.0 111.408 179.278 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.437 ' OD1' ' HB2' ' A' ' 55' ' ' PHE . 4.3 p-10 -153.3 45.16 0.27 Allowed Pre-proline 0 CA--C 1.541 0.626 0 N-CA-C 113.515 0.932 . . . . 0.0 113.515 -179.046 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.437 ' HG3' ' SD ' ' A' ' 52' ' ' MET . 57.5 Cg_endo -68.96 -20.38 38.77 Favored 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 121.522 1.481 . . . . 0.0 111.315 -179.535 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -81.07 -16.46 53.11 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.814 179.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 103.44 6.11 44.87 Favored Glycine 0 N--CA 1.443 -0.835 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.7 -178.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.428 ' HD1' HE22 ' A' ' 86' ' ' GLN . 67.4 m-85 -122.26 135.04 54.68 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.826 0.346 . . . . 0.0 110.389 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.623 HD12 ' HG3' ' A' ' 86' ' ' GLN . 94.2 mt -83.53 130.96 35.02 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.8 -178.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -174.64 172.47 45.44 Favored Glycine 0 N--CA 1.441 -0.98 0 C-N-CA 120.699 -0.762 . . . . 0.0 111.807 179.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.478 ' HH2' HD11 ' A' ' 93' ' ' ILE . 81.5 m95 -94.36 125.93 39.3 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 179.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 170.66 -58.33 0.18 Allowed Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.516 -179.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.486 ' HB3' ' HA3' ' A' ' 42' ' ' GLY . 11.0 ttp -95.0 -153.12 0.38 Allowed 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -146.54 170.5 16.77 Favored 'General case' 0 C--N 1.33 -0.25 0 O-C-N 122.184 -0.322 . . . . 0.0 111.336 -179.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 62.29 41.84 9.91 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 113.153 0.797 . . . . 0.0 113.153 178.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.437 ' HB2' ' OD1' ' A' ' 43' ' ' ASN . 8.8 p90 -63.23 -26.77 68.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.13 0.49 . . . . 0.0 110.464 179.113 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.556 ' HB2' ' HB3' ' A' ' 17' ' ' ARG . 32.3 t -62.69 -32.6 73.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.499 -179.253 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 30.0 m80 -82.61 -4.07 57.13 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.846 0.355 . . . . 0.0 111.084 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 24.1 m -125.36 16.13 8.31 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.484 179.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 65.1 m -137.58 149.17 46.48 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.133 0.492 . . . . 0.0 111.041 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -128.95 158.12 39.7 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.469 179.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.522 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 36.5 t70 57.22 67.69 0.95 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.477 0.656 . . . . 0.0 110.405 179.226 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.536 HG23 HD21 ' A' ' 71' ' ' LEU . 71.6 mt -95.21 114.06 30.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.147 -178.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.8 tptm -145.33 143.91 30.42 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.317 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.671 ' HG ' HD21 ' A' ' 12' ' ' LEU . 79.2 mt -82.3 120.82 25.89 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.803 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -72.71 -56.35 5.41 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.778 -179.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.46 ' HB2' ' HB2' ' A' ' 69' ' ' ARG . 29.4 mt-10 -82.72 4.22 25.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.954 0.407 . . . . 0.0 110.64 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 81.19 13.78 80.19 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.293 -179.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.43 ' HA2' HD13 ' A' ' 64' ' ' LEU . . . 155.34 -31.51 0.64 Allowed Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 119.916 -1.135 . . . . 0.0 113.299 179.377 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.547 ' HD3' ' HB2' ' A' ' 2' ' ' SER . 7.2 mmt85 -78.11 -33.15 50.72 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.022 0.439 . . . . 0.0 111.647 -179.47 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 28.6 tptt -131.65 135.23 46.75 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.437 -178.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.715 ' HB2' HD11 ' A' ' 90' ' ' LEU . 10.0 tt -110.68 124.5 52.05 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -112.2 128.14 56.15 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 120.972 0.415 . . . . 0.0 111.143 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.522 ' HA ' ' O ' ' A' ' 61' ' ' ASP . 24.5 p -155.0 166.21 34.29 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 179.53 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.545 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 29.3 ttt180 -101.29 100.61 14.0 Favored Pre-proline 0 C--N 1.314 -0.946 0 CA-C-O 120.797 0.332 . . . . 0.0 110.556 179.56 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.644 ' O ' ' HB3' ' A' ' 83' ' ' ARG . 46.0 Cg_endo -69.7 120.88 7.6 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 122.48 2.12 . . . . 0.0 109.897 178.159 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.999 ' HE3' ' HA2' ' A' ' 81' ' ' GLY . 0.0 OUTLIER -115.7 143.69 45.01 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.008 0.433 . . . . 0.0 110.884 -179.348 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.661 HG22 ' O ' ' A' ' 82' ' ' PHE . 13.1 t -78.49 142.0 37.79 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 179.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 28.9 m -70.59 -8.56 11.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 O-C-N 124.046 0.841 . . . . 0.0 112.002 -179.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -59.67 -35.11 73.8 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.046 0.45 . . . . 0.0 110.173 179.15 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.409 ' H ' ' H ' ' A' ' 81' ' ' GLY . . . -164.52 -13.08 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.56 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.611 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.999 ' HA2' ' HE3' ' A' ' 76' ' ' LYS . . . 99.73 23.0 11.29 Favored Glycine 0 N--CA 1.442 -0.961 0 C-N-CA 120.484 -0.865 . . . . 0.0 112.064 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.661 ' O ' HG22 ' A' ' 77' ' ' THR . 30.5 p90 -110.47 144.85 38.66 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 -178.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.659 ' HB2' ' HA ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 172.34 -151.82 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 O-C-N 123.645 0.591 . . . . 0.0 110.724 -179.676 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 23.9 mm-40 -122.41 176.56 5.82 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.09 -177.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.545 ' HA ' ' HA ' ' A' ' 74' ' ' ARG . 39.2 ttt-85 -112.74 151.01 30.77 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 177.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.623 ' HG3' HD12 ' A' ' 48' ' ' LEU . 10.4 pt20 -166.52 -172.37 2.16 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.86 0.362 . . . . 0.0 111.472 -179.263 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -135.22 152.48 20.84 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.462 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.4 HD13 HD13 ' A' ' 41' ' ' ILE . 13.4 tt -122.81 149.94 26.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -86.61 124.79 33.29 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.77 0.319 . . . . 0.0 111.104 -179.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.715 HD11 ' HB2' ' A' ' 71' ' ' LEU . 44.3 mt -97.88 34.43 1.9 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.644 0.735 . . . . 0.0 110.134 179.254 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.683 ' HA ' ' OG ' ' A' ' 2' ' ' SER . 0.9 OUTLIER -75.17 2.03 11.87 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 114.806 -1.088 . . . . 0.0 110.704 -179.726 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 18.8 mtp180 -98.52 1.21 46.37 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.256 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.507 HD12 HD12 ' A' ' 35' ' ' LEU . 22.1 mm -105.65 112.96 41.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.144 0.497 . . . . 0.0 109.885 -179.228 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 5.1 mm-40 -117.69 145.56 44.33 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.996 -178.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -97.41 102.32 14.06 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.548 178.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 46.7 t -92.13 106.56 17.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.835 -178.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 61.08 25.29 15.32 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.161 179.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 106.0 -23.4 29.28 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.533 -0.842 . . . . 0.0 112.751 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.12 132.49 34.3 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.902 0.351 . . . . 0.0 110.062 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.529 HD13 ' SG ' ' A' ' 23' ' ' CYS . 7.9 tp -82.54 114.69 21.12 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 -179.474 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 5.5 t -125.93 146.41 31.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 120.937 0.399 . . . . 0.0 111.155 -178.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.701 ' HB2' HD11 ' A' ' 35' ' ' LEU . 18.6 t80 -79.8 138.22 37.18 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 178.314 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 . . . . . 0 C--N 1.316 -0.852 0 CA-C-O 118.81 -0.614 . . . . 0.0 110.427 -179.198 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . 0.549 ' HB3' ' HA ' ' A' ' 91' ' ' ASN . 0.5 OUTLIER . . . . . 0 N--CA 1.449 -0.479 0 N-CA-C 111.548 0.203 . . . . 0.0 111.548 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.51 ' HA ' ' OD1' ' A' ' 95' ' ' ASN . 11.8 p90 -48.73 -36.65 16.81 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -179.348 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.479 ' HB3' ' HD3' ' A' ' 69' ' ' ARG . . . -54.9 -19.32 6.37 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 -178.253 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -57.9 -39.19 77.3 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.237 0.541 . . . . 0.0 110.262 178.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.41 ' HB2' HD21 ' A' ' 95' ' ' ASN . 24.4 m -129.55 39.51 3.72 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.536 -0.757 . . . . 0.0 109.479 179.285 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.424 ' HB3' ' HA ' ' A' ' 4' ' ' ALA . 8.6 t -141.27 149.71 41.66 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.864 -179.603 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.407 HH11 ' HD2' ' A' ' 8' ' ' ARG . 10.6 ptm85 -138.16 158.55 44.08 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.633 -179.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 62.47 52.81 2.86 Favored 'General case' 0 N--CA 1.463 0.207 0 O-C-N 123.914 0.759 . . . . 0.0 111.374 179.035 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.507 ' HA ' ' HB2' ' A' ' 21' ' ' ALA . . . -82.25 117.58 22.46 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.239 179.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 36.0 m -124.18 169.17 15.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.05 -179.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.524 HD21 ' HG ' ' A' ' 64' ' ' LEU . 3.1 mm? -104.85 120.5 41.56 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.99 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 23.3 p -114.48 167.12 11.01 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 120.862 0.363 . . . . 0.0 111.277 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 64.03 31.4 13.59 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.402 179.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 92.36 -21.78 36.13 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.855 -0.688 . . . . 0.0 113.106 179.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.413 ' HA2' ' HB3' ' A' ' 12' ' ' LEU . . . 129.27 56.22 0.1 Allowed Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.775 -0.726 . . . . 0.0 111.407 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.411 ' HB3' ' OG ' ' A' ' 56' ' ' SER . 2.4 ptm180 -143.13 -32.25 0.47 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.983 0.42 . . . . 0.0 111.077 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.437 ' CG2' ' HB3' ' A' ' 34' ' ' GLU . 2.8 m -103.11 135.25 45.14 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.952 -179.553 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.654 HD11 HD13 ' A' ' 90' ' ' LEU . 62.5 mt -94.29 113.13 24.98 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.118 178.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.421 ' HE ' ' CD ' ' A' ' 34' ' ' GLU . 40.5 ttm180 -109.68 120.43 42.45 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 178.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.507 ' HB2' ' HA ' ' A' ' 10' ' ' ALA . . . -153.38 166.57 32.22 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.852 0.358 . . . . 0.0 111.048 -179.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -90.98 112.14 23.9 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 178.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.485 ' SG ' HD13 ' A' ' 100' ' ' LEU . 65.2 m -101.32 130.49 47.49 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.747 0.308 . . . . 0.0 110.816 -178.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.5 ttt180 -83.77 109.88 17.88 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 35.1 p30 -77.82 167.71 21.09 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.329 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -50.91 -33.07 22.68 Favored 'General case' 0 C--N 1.329 -0.292 0 O-C-N 123.674 0.609 . . . . 0.0 112.356 -179.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -67.24 -16.22 64.16 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.204 0.526 . . . . 0.0 110.825 -179.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 91.24 25.51 23.82 Favored Glycine 0 N--CA 1.446 -0.638 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.671 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -115.1 151.78 33.7 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.617 0.246 . . . . 0.0 111.074 -179.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -92.05 115.01 27.7 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.102 0.477 . . . . 0.0 110.911 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 5.0 m -113.38 132.79 61.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.561 179.106 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 53.2 m -79.58 110.19 14.68 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.037 0.446 . . . . 0.0 110.542 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 73.6 m -120.95 148.85 43.52 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.815 -179.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.566 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 46.3 mt-10 -130.92 138.55 49.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.832 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.565 HD11 ' HB2' ' A' ' 102' ' ' PHE . 1.9 tm? -132.38 130.2 40.37 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 179.026 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.412 ' N ' HD13 ' A' ' 35' ' ' LEU . 23.9 m-20 -88.86 109.58 20.33 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.969 0.414 . . . . 0.0 110.332 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.495 HD11 HD11 ' A' ' 19' ' ' LEU . 1.6 mt -84.67 -11.49 55.8 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.742 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -66.76 -6.0 14.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.156 -179.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 72.1 p -88.96 -13.09 39.75 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.018 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.537 ' SG ' ' HZ3' ' A' ' 50' ' ' TRP . 0.8 OUTLIER -136.05 -9.61 2.03 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -178.432 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.427 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 51.3 mt -107.16 132.17 55.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 O-C-N 122.241 -0.287 . . . . 0.0 110.455 178.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.528 ' HA3' ' HB3' ' A' ' 52' ' ' MET . . . -151.97 162.01 29.56 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.199 179.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.66 ' ND2' ' HB2' ' A' ' 55' ' ' PHE . 5.3 p30 -159.4 57.98 1.13 Allowed Pre-proline 0 CA--C 1.535 0.382 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -72.39 -15.36 28.03 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.059 1.839 . . . . 0.0 112.374 -179.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 53.5 m-80 -100.26 -5.12 28.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.953 0.406 . . . . 0.0 110.466 179.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.527 ' HA3' ' HG2' ' A' ' 83' ' ' ARG . . . 98.99 9.48 51.95 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.41 -179.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -123.46 133.1 54.09 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.928 0.394 . . . . 0.0 110.852 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.5 ' HB3' ' HB ' ' A' ' 88' ' ' ILE . 79.0 mt -83.49 139.82 32.68 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.406 -178.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 178.33 172.58 42.88 Favored Glycine 0 N--CA 1.44 -1.095 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.437 179.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.537 ' HZ3' ' SG ' ' A' ' 40' ' ' CYS . 93.0 m95 -94.82 125.03 39.21 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 158.76 -63.94 0.3 Allowed Glycine 0 N--CA 1.45 -0.416 0 N-CA-C 111.588 -0.605 . . . . 0.0 111.588 -179.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.528 ' HB3' ' HA3' ' A' ' 42' ' ' GLY . 13.1 tpt -78.31 173.82 11.89 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -129.55 172.39 11.62 Favored 'General case' 0 C--N 1.322 -0.599 0 O-C-N 122.159 -0.338 . . . . 0.0 111.399 -179.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 20.9 m-80 61.07 48.81 6.11 Favored 'General case' 0 C--O 1.233 0.187 0 O-C-N 123.982 0.801 . . . . 0.0 111.967 179.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.66 ' HB2' ' ND2' ' A' ' 43' ' ' ASN . 18.8 p90 -67.91 -28.51 67.56 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.628 -179.502 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.411 ' OG ' ' HB3' ' A' ' 17' ' ' ARG . 3.1 m -63.47 -28.38 69.93 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.873 0.368 . . . . 0.0 111.125 -179.312 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 26.4 m80 -79.99 -9.04 59.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.001 0.429 . . . . 0.0 111.013 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 47.5 p -125.58 15.31 8.18 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.064 0.459 . . . . 0.0 110.659 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 68.2 m -133.61 150.5 51.6 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.302 0.572 . . . . 0.0 111.052 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 57.2 mt-10 -125.68 142.3 51.58 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.412 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.433 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 21.4 t70 60.01 78.41 0.27 Allowed 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 121.402 0.62 . . . . 0.0 110.367 -179.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.541 HG23 HD21 ' A' ' 71' ' ' LEU . 73.2 mt -101.73 115.47 43.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.36 -178.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 36.6 ttmt -148.96 156.99 43.08 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 179.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.524 ' HG ' HD21 ' A' ' 12' ' ' LEU . 42.5 mt -83.2 135.93 34.6 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.161 0.505 . . . . 0.0 110.947 -179.448 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 18.7 tp10 -90.23 -57.29 2.9 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.934 -178.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.494 ' HB2' ' HB2' ' A' ' 69' ' ' ARG . 20.5 mm-40 -84.15 24.11 0.98 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.158 0.504 . . . . 0.0 111.1 -179.336 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 68.24 16.72 69.36 Favored Glycine 0 N--CA 1.45 -0.39 0 CA-C-N 115.429 -0.805 . . . . 0.0 112.435 179.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 141.24 -28.12 2.37 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.013 -1.089 . . . . 0.0 112.806 179.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.494 ' HB2' ' HB2' ' A' ' 66' ' ' GLU . 12.6 mmt180 -73.07 -25.34 60.87 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.057 0.456 . . . . 0.0 110.582 -179.407 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.436 ' HG3' ' HA ' ' A' ' 89' ' ' ASP . 36.6 ttpt -146.48 142.72 28.37 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.888 -178.185 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.677 ' HB2' HD11 ' A' ' 90' ' ' LEU . 8.9 tt -111.63 131.75 55.05 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.738 -0.468 . . . . 0.0 109.738 179.574 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.3 p -115.26 130.57 56.95 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.233 0.54 . . . . 0.0 111.066 179.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.433 ' HA ' ' O ' ' A' ' 61' ' ' ASP . 26.7 p -153.28 165.15 36.62 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.333 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.49 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 3.3 tmt_? -102.12 99.35 12.25 Favored Pre-proline 0 C--N 1.314 -0.958 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.418 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.67 ' O ' ' HB3' ' A' ' 83' ' ' ARG . 61.7 Cg_endo -70.09 123.14 9.71 Favored 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 122.801 2.334 . . . . 0.0 111.443 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.924 ' HE3' ' HA2' ' A' ' 81' ' ' GLY . 0.0 OUTLIER -119.67 144.21 47.31 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.76 -179.793 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.685 HG22 ' O ' ' A' ' 82' ' ' PHE . 14.6 t -76.92 140.78 40.63 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.547 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 8.9 p -73.8 -9.44 12.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.452 -0.794 . . . . 0.0 111.288 -179.042 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -64.2 -23.12 67.2 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.054 0.454 . . . . 0.0 110.872 179.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -166.26 -21.84 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.51 -0.852 . . . . 0.0 112.908 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.924 ' HA2' ' HE3' ' A' ' 76' ' ' LYS . . . 101.75 20.87 11.99 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.773 -0.727 . . . . 0.0 111.893 -179.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.685 ' O ' HG22 ' A' ' 77' ' ' THR . 22.2 p90 -111.15 147.7 34.35 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 119.031 -0.509 . . . . 0.0 109.766 -178.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.723 ' HB2' ' HA ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 169.26 -154.94 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.361 0 O-C-N 123.592 0.558 . . . . 0.0 111.315 179.716 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -117.62 -175.76 2.89 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.368 -178.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.544 ' HA ' ' HD2' ' A' ' 75' ' ' PRO . 31.6 ttt180 -110.59 155.68 22.01 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 177.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.534 ' HG2' ' H ' ' A' ' 87' ' ' GLY . 9.2 tt0 -165.17 176.69 8.25 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 120.512 -0.475 . . . . 0.0 111.712 -178.178 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.534 ' H ' ' HG2' ' A' ' 86' ' ' GLN . . . -137.91 140.83 11.54 Favored Glycine 0 N--CA 1.449 -0.466 0 N-CA-C 111.42 -0.672 . . . . 0.0 111.42 178.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.5 ' HB ' ' HB3' ' A' ' 48' ' ' LEU . 11.4 tt -118.44 133.84 63.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.371 0.605 . . . . 0.0 110.707 -179.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.457 ' OD1' ' HB2' ' A' ' 91' ' ' ASN . 14.5 t70 -74.79 136.48 41.66 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.809 -179.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.677 HD11 ' HB2' ' A' ' 71' ' ' LEU . 64.2 mt -110.77 37.34 2.81 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 -178.28 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.549 ' HA ' ' HB3' ' A' ' 2' ' ' SER . 6.4 m-80 -73.92 -1.87 21.49 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-O 121.194 0.521 . . . . 0.0 111.037 179.373 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 21.0 mtp180 -88.11 -10.88 48.65 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.174 179.07 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.442 ' CD1' HD22 ' A' ' 37' ' ' LEU . 22.7 mm -99.15 98.59 7.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -179.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 1.2 mm-40 -107.68 152.21 24.62 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.743 -178.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.51 ' OD1' ' HA ' ' A' ' 3' ' ' TYR . 19.4 p-10 -106.82 105.54 15.63 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.106 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.2 p -98.42 113.85 34.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-O 121.286 0.565 . . . . 0.0 110.177 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 59.44 30.22 19.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.814 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 92.97 -13.54 67.41 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 121.005 -0.617 . . . . 0.0 113.276 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.401 HH11 ' HD3' ' A' ' 99' ' ' ARG . 3.0 mpt_? -92.25 131.03 37.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 117.405 0.603 . . . . 0.0 110.257 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.485 HD13 ' SG ' ' A' ' 23' ' ' CYS . 3.2 tp -84.16 115.54 22.46 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.08 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 46.5 t -129.98 142.66 43.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.333 -179.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.565 ' HB2' HD11 ' A' ' 35' ' ' LEU . 5.5 t80 -84.2 122.81 29.37 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.236 0.541 . . . . 0.0 110.089 178.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 . . . . . 0 C--N 1.312 -1.034 0 CA-C-O 118.193 -0.908 . . . . 0.0 110.408 179.737 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . 0.495 ' OG ' ' HA ' ' A' ' 91' ' ' ASN . 19.5 m . . . . . 0 N--CA 1.453 -0.28 0 CA-C-O 120.535 0.207 . . . . 0.0 111.128 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.536 ' HA ' ' OD1' ' A' ' 95' ' ' ASN . 28.6 p90 -55.51 -34.09 64.33 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.724 179.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -54.46 -18.74 4.59 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -178.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -57.34 -41.71 80.53 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.151 0.501 . . . . 0.0 110.426 179.018 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.426 ' HB2' HD21 ' A' ' 95' ' ' ASN . 50.0 m -130.48 35.66 4.02 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.093 179.52 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.4 ' HA ' ' HZ3' ' A' ' 30' ' ' TRP . 15.0 m -143.18 156.33 44.74 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.12 179.55 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.425 HH11 ' HD2' ' A' ' 8' ' ' ARG . 10.8 ptm85 -144.35 167.95 21.25 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.751 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 57.24 59.76 3.23 Favored 'General case' 0 C--O 1.235 0.337 0 O-C-N 123.736 0.648 . . . . 0.0 111.715 179.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.445 ' HA ' ' HB2' ' A' ' 21' ' ' ALA . . . -89.88 117.53 28.78 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.192 179.606 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 31.9 m -120.53 173.11 6.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.748 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.52 HD21 ' HG ' ' A' ' 64' ' ' LEU . 3.6 mm? -104.64 114.99 29.57 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.765 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.413 ' OG1' ' HB ' ' A' ' 18' ' ' THR . 21.0 p -108.53 164.65 12.16 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.479 179.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 62.16 43.67 8.45 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.412 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 87.73 -46.19 3.43 Favored Glycine 0 N--CA 1.449 -0.448 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.745 179.06 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 150.55 57.77 0.01 OUTLIER Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 110.404 -1.078 . . . . 0.0 110.404 -179.135 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.445 ' HB2' ' HB3' ' A' ' 38' ' ' ASP . 7.9 ptm180 -142.91 -30.37 0.53 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.947 0.403 . . . . 0.0 111.086 -179.024 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.453 ' CG2' ' HB3' ' A' ' 34' ' ' GLU . 3.0 m -103.92 137.95 41.18 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.189 -178.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.727 HD11 HD13 ' A' ' 90' ' ' LEU . 58.3 mt -98.17 115.86 29.19 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.171 178.585 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 45.3 ttp180 -112.67 123.0 49.31 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 178.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.445 ' HB2' ' HA ' ' A' ' 10' ' ' ALA . . . -151.77 167.2 28.98 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.928 0.394 . . . . 0.0 111.408 -179.307 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -90.08 105.98 18.18 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 178.058 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 80.2 m -99.3 127.18 45.28 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.636 -178.557 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 9.4 ttp180 -77.42 115.09 16.9 Favored 'General case' 0 N--CA 1.436 -1.144 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.887 179.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 36.7 p30 -76.54 165.72 24.4 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.22 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.07 -27.75 54.83 Favored 'General case' 0 N--CA 1.464 0.235 0 O-C-N 123.61 0.569 . . . . 0.0 111.993 -179.113 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -69.26 -19.39 63.93 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.296 0.57 . . . . 0.0 110.327 179.433 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 96.11 30.25 7.98 Favored Glycine 0 N--CA 1.449 -0.488 0 CA-C-N 115.536 -0.756 . . . . 0.0 112.244 179.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -124.91 150.43 46.54 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.514 0.157 . . . . 0.0 110.773 -179.095 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.4 ' HZ3' ' HA ' ' A' ' 7' ' ' SER . 94.1 m95 -84.88 123.1 30.09 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.755 0.312 . . . . 0.0 111.391 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.0 m -124.77 134.72 66.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 121.089 0.471 . . . . 0.0 110.593 178.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 16.2 m -79.5 116.33 19.65 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.816 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 72.4 m -126.73 159.53 33.45 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.372 179.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.623 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 46.3 mt-10 -139.1 145.9 40.06 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-O 120.867 0.365 . . . . 0.0 111.444 -178.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.622 HD11 ' HB2' ' A' ' 102' ' ' PHE . 1.5 tm? -138.81 132.29 30.36 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.054 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.477 ' N ' HD13 ' A' ' 35' ' ' LEU . 27.3 m-20 -90.98 110.59 21.85 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.025 0.441 . . . . 0.0 110.391 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.524 HD11 HD11 ' A' ' 19' ' ' LEU . 1.5 mt -86.1 -16.66 37.31 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.572 -179.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.453 ' HA ' ' HD1' ' A' ' 55' ' ' PHE . 4.4 p-10 -63.65 -20.39 65.65 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -178.021 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.417 HG23 ' SG ' ' A' ' 40' ' ' CYS . 12.3 t -83.23 0.62 44.65 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.121 0.486 . . . . 0.0 110.87 -179.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.417 ' SG ' HG23 ' A' ' 39' ' ' THR . 57.6 m -136.32 -26.44 1.13 Allowed 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -179.571 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.47 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 61.7 mt -94.49 137.21 23.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 110.204 -0.295 . . . . 0.0 110.204 179.405 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.593 ' HA3' ' HB3' ' A' ' 52' ' ' MET . . . -153.72 156.2 26.64 Favored Glycine 0 N--CA 1.443 -0.885 0 C-N-CA 120.685 -0.769 . . . . 0.0 111.617 179.401 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.599 ' ND2' ' HB2' ' A' ' 55' ' ' PHE . 6.3 p30 -154.24 50.68 0.57 Allowed Pre-proline 0 C--N 1.326 -0.446 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.26 -18.93 39.12 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 121.712 1.608 . . . . 0.0 111.868 -179.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.457 HD22 ' N ' ' A' ' 45' ' ' ASN . 0.9 OUTLIER -90.77 -5.74 55.28 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.316 179.614 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.57 ' HA3' ' HG2' ' A' ' 83' ' ' ARG . . . 95.95 8.57 57.92 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.407 -179.485 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.435 ' HD1' HE22 ' A' ' 86' ' ' GLN . 51.7 m-85 -125.28 135.89 52.97 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.764 0.316 . . . . 0.0 110.314 179.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.469 ' HB3' ' HB ' ' A' ' 88' ' ' ILE . 72.7 mt -83.29 137.24 34.07 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.325 -178.601 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 179.11 171.74 42.61 Favored Glycine 0 N--CA 1.445 -0.717 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.832 179.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.459 ' CD2' ' HD3' ' A' ' 92' ' ' ARG . 83.4 m95 -95.35 125.46 39.99 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.624 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 161.24 -47.81 0.37 Allowed Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.309 -179.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.593 ' HB3' ' HA3' ' A' ' 42' ' ' GLY . 0.0 OUTLIER -90.41 -161.28 0.78 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.643 0.259 . . . . 0.0 110.836 -179.188 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -146.82 168.98 20.07 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.685 -0.234 . . . . 0.0 110.444 -179.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 18.7 m-80 56.77 45.74 21.2 Favored 'General case' 0 N--CA 1.465 0.32 0 O-C-N 123.796 0.685 . . . . 0.0 112.253 178.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.599 ' HB2' ' ND2' ' A' ' 43' ' ' ASN . 7.5 p90 -65.65 -28.64 69.25 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.902 -0.319 . . . . 0.0 110.793 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.56 ' HA ' HD11 ' A' ' 62' ' ' ILE . 13.8 m -58.13 -37.12 74.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.534 -179.62 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 17.8 m80 -73.18 -17.83 61.32 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.042 0.448 . . . . 0.0 111.446 179.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 47.9 m -112.89 14.9 19.86 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.497 -178.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 54.5 m -136.1 148.44 48.26 Favored 'General case' 0 C--N 1.32 -0.684 0 O-C-N 121.749 -0.595 . . . . 0.0 111.641 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 60.9 mm-40 -117.58 145.62 44.16 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.825 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 55.87 58.83 4.14 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 123.925 0.765 . . . . 0.0 111.687 178.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.56 HD11 ' HA ' ' A' ' 56' ' ' SER . 81.5 mt -75.95 113.6 15.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.512 179.767 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.411 ' HD2' HD23 ' A' ' 12' ' ' LEU . 15.2 tptm -147.74 154.84 41.05 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 -179.692 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.536 HD13 ' HA2' ' A' ' 68' ' ' GLY . 67.2 mt -82.41 138.9 34.3 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.314 0.578 . . . . 0.0 111.233 -179.161 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -89.17 -75.27 0.44 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 114.697 -1.138 . . . . 0.0 111.129 -178.492 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.604 ' HB2' ' HB2' ' A' ' 69' ' ' ARG . 19.7 mt-10 -77.87 45.53 0.52 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.754 -178.317 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 65.39 2.46 10.17 Favored Glycine 0 CA--C 1.518 0.255 0 CA-C-N 115.837 -0.619 . . . . 0.0 113.671 179.254 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.536 ' HA2' HD13 ' A' ' 64' ' ' LEU . . . 141.63 -13.81 2.69 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.081 -1.056 . . . . 0.0 112.985 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.604 ' HB2' ' HB2' ' A' ' 66' ' ' GLU . 14.3 mmt180 -78.27 -19.48 53.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.261 0.553 . . . . 0.0 109.825 179.746 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.461 ' HB3' ' HG3' ' A' ' 66' ' ' GLU . 40.7 tttt -144.46 143.54 30.93 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.596 -178.623 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.625 ' HB2' HD11 ' A' ' 90' ' ' LEU . 10.1 tt -110.5 132.81 53.86 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.753 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.9 p -121.0 132.42 54.89 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.03 0.443 . . . . 0.0 111.586 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.537 ' HB3' ' HA ' ' A' ' 62' ' ' ILE . 24.7 p -161.19 167.36 26.25 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.208 179.526 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.407 ' HA ' ' HD2' ' A' ' 75' ' ' PRO . 25.0 ttt180 -100.4 102.83 20.05 Favored Pre-proline 0 C--N 1.316 -0.85 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.343 179.012 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.645 ' O ' ' HB3' ' A' ' 83' ' ' ARG . 39.0 Cg_endo -67.06 121.01 8.13 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 122.539 2.159 . . . . 0.0 110.58 178.649 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.649 ' HA ' ' HB2' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -119.25 146.58 45.1 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.764 -179.354 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.707 ' HB ' ' HD2' ' A' ' 83' ' ' ARG . 5.6 t -79.67 144.94 33.27 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 179.527 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.2 p -72.03 -9.47 12.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.436 -177.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -58.63 -29.37 66.45 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.224 0.535 . . . . 0.0 110.231 179.206 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -169.81 -24.62 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.304 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.869 -179.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.617 ' HA2' ' HD3' ' A' ' 76' ' ' LYS . . . 111.98 26.05 4.54 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.848 -0.692 . . . . 0.0 111.718 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.564 ' O ' HG22 ' A' ' 77' ' ' THR . 20.3 p90 -110.3 141.09 43.78 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 -178.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.707 ' HD2' ' HB ' ' A' ' 77' ' ' THR . 0.0 OUTLIER 174.13 -149.48 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 O-C-N 123.654 0.596 . . . . 0.0 110.027 -179.791 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -121.55 176.15 5.84 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 122.271 0.228 . . . . 0.0 110.982 -178.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.416 ' HA ' ' HD2' ' A' ' 75' ' ' PRO . 42.0 ttt-85 -98.35 156.81 16.55 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 178.075 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.435 HE22 ' HD1' ' A' ' 47' ' ' PHE . 9.2 tt0 -166.55 173.09 10.11 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 120.927 0.394 . . . . 0.0 111.524 -178.713 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.413 ' N ' ' HG2' ' A' ' 86' ' ' GLN . . . -135.8 144.42 16.23 Favored Glycine 0 N--CA 1.45 -0.388 0 N-CA-C 111.626 -0.589 . . . . 0.0 111.626 178.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.469 ' HB ' ' HB3' ' A' ' 48' ' ' LEU . 12.2 tt -121.57 134.67 64.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.093 0.473 . . . . 0.0 110.793 -179.439 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.479 ' HB3' HD22 ' A' ' 91' ' ' ASN . 4.2 m-20 -77.73 136.76 38.2 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.113 -179.416 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.727 HD13 HD11 ' A' ' 19' ' ' LEU . 68.6 mt -108.38 56.48 0.63 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.735 0.778 . . . . 0.0 111.219 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.495 ' HA ' ' OG ' ' A' ' 2' ' ' SER . 19.7 m-80 -91.09 3.19 55.42 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.686 179.478 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.459 ' HD3' ' CD2' ' A' ' 50' ' ' TRP . 36.9 mtp180 -96.77 -6.69 35.63 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.846 179.274 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.425 HD11 ' HH2' ' A' ' 50' ' ' TRP . 16.4 mm -105.47 101.64 12.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -179.525 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 27.8 tp60 -113.95 145.09 42.01 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.022 -178.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.536 ' OD1' ' HA ' ' A' ' 3' ' ' TYR . 19.2 p-10 -95.44 115.7 27.79 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.157 178.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 57.8 t -106.24 110.78 32.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.04 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 30.7 m-80 58.48 28.8 17.45 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.995 -179.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 100.2 -23.55 35.48 Favored Glycine 0 N--CA 1.445 -0.748 0 C-N-CA 120.522 -0.847 . . . . 0.0 113.157 179.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.413 ' N ' ' HD2' ' A' ' 99' ' ' ARG . 3.3 mpt_? -86.95 138.18 31.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 117.242 0.521 . . . . 0.0 110.195 -179.367 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.463 HD23 ' HB2' ' A' ' 35' ' ' LEU . 4.9 tp -86.21 123.57 31.63 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 14.6 t -128.21 143.78 39.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.93 -179.027 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.622 ' HB2' HD11 ' A' ' 35' ' ' LEU . 9.9 t80 -92.66 128.3 38.47 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.161 0.505 . . . . 0.0 109.788 178.161 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 . . . . . 0 C--O 1.25 1.091 0 CA-C-O 118.181 -0.914 . . . . 0.0 110.651 179.742 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . 0.436 ' OG ' ' HA ' ' A' ' 91' ' ' ASN . 19.9 m . . . . . 0 N--CA 1.448 -0.533 0 N-CA-C 110.781 -0.081 . . . . 0.0 110.781 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.448 ' HB3' HD11 ' A' ' 100' ' ' LEU . 13.4 p90 -48.43 -37.53 17.38 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.476 ' HB3' ' HD2' ' A' ' 69' ' ' ARG . . . -53.18 -19.1 2.71 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -178.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -56.63 -42.62 79.16 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 121.335 0.588 . . . . 0.0 110.149 178.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.418 ' HB2' HD21 ' A' ' 95' ' ' ASN . 18.5 m -129.78 40.47 3.57 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.481 179.654 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.406 ' HA ' ' HZ3' ' A' ' 30' ' ' TRP . 18.5 t -146.67 150.44 35.43 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.186 -179.501 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.45 ' HG3' ' ND2' ' A' ' 9' ' ' ASN . 9.3 ptp180 -136.87 175.29 9.74 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.279 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.589 HD21 ' HB2' ' A' ' 22' ' ' GLU . 8.9 p30 47.06 46.86 16.17 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 124.254 0.971 . . . . 0.0 112.107 -179.38 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.604 ' HA ' ' HB2' ' A' ' 21' ' ' ALA . . . -74.01 118.44 16.96 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.619 179.59 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 27.4 m -122.14 168.28 14.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.842 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.754 HD21 ' HG ' ' A' ' 64' ' ' LEU . 3.3 mm? -104.75 123.02 46.92 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.634 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.479 HG21 ' CZ ' ' A' ' 20' ' ' ARG . 20.6 p -123.19 168.71 12.07 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.811 0.338 . . . . 0.0 111.81 -178.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 59.94 42.75 15.7 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.003 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 92.17 -23.02 29.05 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.812 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.627 ' HA2' ' HB3' ' A' ' 12' ' ' LEU . . . 122.32 41.23 0.48 Allowed Glycine 0 N--CA 1.445 -0.736 0 N-CA-C 111.39 -0.684 . . . . 0.0 111.39 179.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.657 ' HB2' ' HB2' ' A' ' 38' ' ' ASP . 15.9 ptt180 -126.14 -26.27 3.42 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.109 0.481 . . . . 0.0 110.582 -179.338 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.493 HG22 ' HB3' ' A' ' 34' ' ' GLU . 2.8 m -101.11 130.32 47.14 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.48 -179.245 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.638 HD11 HD13 ' A' ' 90' ' ' LEU . 92.9 mt -91.23 112.22 24.04 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.01 179.529 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.479 ' CZ ' HG21 ' A' ' 13' ' ' THR . 43.9 ttm180 -109.07 119.39 39.42 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 179.375 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.604 ' HB2' ' HA ' ' A' ' 10' ' ' ALA . . . -154.79 167.38 30.41 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.818 0.342 . . . . 0.0 111.293 -179.434 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.611 ' HG3' ' HB3' ' A' ' 30' ' ' TRP . 0.4 OUTLIER -88.54 111.74 22.2 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 177.427 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 69.4 m -99.65 126.97 45.75 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 -179.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.469 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 34.3 ttt180 -76.1 114.07 14.35 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 116.3 -0.409 . . . . 0.0 109.936 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.429 HD21 ' HB3' ' A' ' 29' ' ' ASN . 35.1 p30 -77.95 170.23 16.95 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.372 -179.616 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.75 -29.18 62.29 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 -178.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -73.98 -13.09 60.82 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.468 0.651 . . . . 0.0 110.253 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 91.21 27.89 16.84 Favored Glycine 0 N--CA 1.448 -0.54 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.629 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.469 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 10.7 t-20 -111.53 158.54 19.06 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 110.14 -0.319 . . . . 0.0 110.14 -178.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.611 ' HB3' ' HG3' ' A' ' 22' ' ' GLU . 98.9 m95 -99.57 119.43 38.04 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.953 0.406 . . . . 0.0 110.765 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 11.1 m -122.25 137.53 55.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.252 -179.461 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 16.8 m -75.92 109.57 9.65 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.105 179.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 69.3 m -122.43 137.13 54.97 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.41 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.609 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 3.0 mp0 -122.55 146.73 47.15 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.514 -179.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.462 HD11 ' HB2' ' A' ' 102' ' ' PHE . 1.2 tm? -138.53 126.83 22.97 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 178.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.409 ' N ' HD13 ' A' ' 35' ' ' LEU . 4.4 m-20 -85.95 110.07 19.2 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.868 0.366 . . . . 0.0 110.475 179.547 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.445 HD13 HD22 ' A' ' 90' ' ' LEU . 2.1 mt -83.91 -12.57 55.24 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.034 178.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.689 ' OD2' ' HA ' ' A' ' 54' ' ' ASN . 9.6 t70 -60.94 -29.23 69.51 Favored 'General case' 0 C--O 1.221 -0.426 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.89 -178.607 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.6 t -83.48 1.02 43.79 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.827 0.346 . . . . 0.0 111.459 -178.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 37.3 m -128.97 -24.68 2.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.829 0.347 . . . . 0.0 111.775 -179.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 71.9 mt -102.8 137.05 32.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.549 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -143.84 146.92 17.96 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.68 -0.771 . . . . 0.0 111.835 179.177 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.764 HD22 ' HB3' ' A' ' 75' ' ' PRO . 30.5 p-10 -152.44 48.86 0.48 Allowed Pre-proline 0 CA--C 1.539 0.557 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -178.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -71.79 -22.12 24.11 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 121.661 1.574 . . . . 0.0 111.747 -179.357 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -83.97 -14.54 50.53 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.885 179.173 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.544 ' CA ' ' HG2' ' A' ' 83' ' ' ARG . . . 106.26 8.62 33.14 Favored Glycine 0 N--CA 1.443 -0.874 0 C-N-CA 120.315 -0.945 . . . . 0.0 112.596 -179.149 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.576 ' HA ' HE22 ' A' ' 86' ' ' GLN . 66.5 m-85 -124.08 133.29 53.66 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.676 0.274 . . . . 0.0 110.282 179.476 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 95.3 mt -83.54 130.24 35.0 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.513 -178.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -173.5 172.65 45.36 Favored Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.097 179.029 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.408 ' HH2' HD11 ' A' ' 93' ' ' ILE . 88.3 m95 -95.03 125.1 39.47 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.758 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 168.64 -59.18 0.2 Allowed Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.493 -0.861 . . . . 0.0 112.602 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 6.1 ttp -96.75 -154.66 0.45 Allowed 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.46 ' HG3' HD22 ' A' ' 54' ' ' ASN . 3.4 pt20 -146.79 173.75 12.1 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.43 0.157 . . . . 0.0 111.013 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.689 ' HA ' ' OD2' ' A' ' 38' ' ' ASP . 42.7 m-80 64.92 55.37 1.18 Allowed 'General case' 0 C--O 1.237 0.416 0 O-C-N 123.858 0.724 . . . . 0.0 111.52 179.523 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.495 ' HD1' ' HA ' ' A' ' 38' ' ' ASP . 11.8 p90 -87.46 -26.17 23.38 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.16 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.411 ' HB3' ' HB3' ' A' ' 17' ' ' ARG . 32.4 p -61.0 -35.89 78.04 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.998 0.428 . . . . 0.0 111.105 -178.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 26.7 m80 -77.49 -11.94 59.91 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.192 179.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.483 ' HB2' ' OD1' ' A' ' 43' ' ' ASN . 2.7 m -113.41 20.25 16.25 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.053 0.454 . . . . 0.0 110.353 -179.624 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 24.8 m -136.1 156.0 49.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.09 0.471 . . . . 0.0 111.46 -179.371 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -129.2 138.31 51.64 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.282 178.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.44 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 32.2 t70 58.22 79.31 0.21 Allowed 'General case' 0 N--CA 1.469 0.49 0 O-C-N 123.735 0.647 . . . . 0.0 110.721 -179.291 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.55 HG23 HD21 ' A' ' 71' ' ' LEU . 68.0 mt -98.74 112.74 31.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.548 -179.566 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.28 164.94 26.59 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.307 -179.057 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.754 ' HG ' HD21 ' A' ' 12' ' ' LEU . 55.9 mt -96.05 114.84 26.58 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 178.481 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -65.95 -54.34 27.58 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.12 -177.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 43.1 mm-40 -88.36 7.84 30.5 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.112 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 73.23 21.09 80.01 Favored Glycine 0 N--CA 1.447 -0.623 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.678 -179.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 156.53 -49.84 0.45 Allowed Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 120.131 -1.033 . . . . 0.0 112.946 179.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.476 ' HD2' ' HB3' ' A' ' 4' ' ' ALA . 5.1 mpt_? -66.31 -26.66 67.41 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -179.365 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 32.0 ttpt -141.91 144.62 33.88 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.651 -0.419 . . . . 0.0 111.677 -178.471 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.628 ' HB2' HD11 ' A' ' 90' ' ' LEU . 8.7 tt -115.45 124.08 50.24 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.305 -0.861 . . . . 0.0 108.983 179.286 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.447 HG22 ' HA3' ' A' ' 87' ' ' GLY . 1.1 p -115.8 133.4 56.07 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.375 0.607 . . . . 0.0 111.114 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.546 ' HB3' ' HA ' ' A' ' 62' ' ' ILE . 26.3 p -156.2 172.32 18.66 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.336 -0.847 . . . . 0.0 108.868 -179.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.513 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 4.4 tmt_? -104.23 98.57 14.37 Favored Pre-proline 0 C--N 1.316 -0.861 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 179.283 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.764 ' HB3' HD22 ' A' ' 43' ' ' ASN . 54.9 Cg_endo -69.35 123.82 10.62 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 122.902 2.401 . . . . 0.0 110.653 179.026 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.963 ' HE3' ' HA2' ' A' ' 81' ' ' GLY . 0.0 OUTLIER -120.91 149.41 42.67 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.619 -179.077 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.709 HG22 ' O ' ' A' ' 82' ' ' PHE . 13.2 t -79.59 134.5 36.47 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 177.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 31.3 m -72.44 -7.85 10.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 O-C-N 123.706 0.629 . . . . 0.0 111.402 -179.22 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -66.98 -33.63 75.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.533 179.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -150.0 -20.34 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.364 -0.922 . . . . 0.0 113.162 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.963 ' HA2' ' HE3' ' A' ' 76' ' ' LYS . . . 98.01 18.04 28.21 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.579 -0.82 . . . . 0.0 111.685 -179.712 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.709 ' O ' HG22 ' A' ' 77' ' ' THR . 32.0 p90 -111.55 153.18 26.62 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 118.872 -0.585 . . . . 0.0 109.891 -178.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.716 ' HB2' ' HA ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 167.84 -150.4 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.405 0 O-C-N 123.679 0.612 . . . . 0.0 111.442 179.502 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -127.58 154.92 44.62 Favored 'General case' 0 C--O 1.226 -0.142 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.7 -178.471 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.513 ' HA ' ' HA ' ' A' ' 74' ' ' ARG . 35.8 ttt180 -84.32 146.83 27.52 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 178.335 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.576 HE22 ' HA ' ' A' ' 47' ' ' PHE . 36.8 mt-30 -151.49 -170.17 3.58 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.619 0.723 . . . . 0.0 112.091 -177.702 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.447 ' HA3' HG22 ' A' ' 72' ' ' THR . . . -155.05 142.99 9.43 Favored Glycine 0 N--CA 1.442 -0.904 0 N-CA-C 110.23 -1.148 . . . . 0.0 110.23 178.645 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 13.0 tt -122.75 134.83 64.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.257 0.551 . . . . 0.0 110.734 -178.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.446 ' HB3' HD22 ' A' ' 91' ' ' ASN . 7.5 m-20 -74.37 130.9 40.53 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.625 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.638 HD13 HD11 ' A' ' 19' ' ' LEU . 61.4 mt -102.04 46.55 0.93 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.676 0.751 . . . . 0.0 110.848 -179.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.446 HD22 ' HB3' ' A' ' 89' ' ' ASP . 13.6 m-80 -81.3 4.63 19.91 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.317 179.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 19.1 mtp180 -100.54 -6.64 25.1 Favored 'General case' 0 C--O 1.226 -0.179 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.7 178.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.408 HD11 ' HH2' ' A' ' 50' ' ' TRP . 23.5 mm -106.15 108.03 24.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 -178.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 20.9 tp60 -125.98 145.93 50.08 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.783 -178.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.418 HD21 ' HB2' ' A' ' 6' ' ' SER . 13.9 p-10 -95.08 115.31 27.27 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.331 0.586 . . . . 0.0 110.023 178.475 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 52.0 t -101.78 112.82 36.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.128 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 13.6 m-80 57.84 33.5 23.28 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.091 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 94.55 -23.87 30.33 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.837 179.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.24 124.89 33.81 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.945 0.372 . . . . 0.0 110.031 -179.486 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.46 HD23 ' HB2' ' A' ' 35' ' ' LEU . 11.8 tp -76.31 119.38 20.12 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 38.8 t -129.9 141.73 45.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.002 0.43 . . . . 0.0 111.154 -178.669 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.462 ' HB2' HD11 ' A' ' 35' ' ' LEU . 6.5 t80 -83.79 132.34 34.83 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 177.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 3.7 tp-100 . . . . . 0 C--N 1.314 -0.953 0 CA-C-O 118.745 -0.645 . . . . 0.0 110.231 179.946 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . 0.602 ' OG ' ' HA ' ' A' ' 91' ' ' ASN . 8.7 m . . . . . 0 N--CA 1.452 -0.364 0 CA-C-O 120.687 0.279 . . . . 0.0 111.287 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.434 ' CZ ' HD13 ' A' ' 19' ' ' LEU . 14.9 p90 -63.28 -34.46 77.73 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.667 0.27 . . . . 0.0 110.69 178.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -56.32 -24.26 42.42 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.806 -0.633 . . . . 0.0 112.597 -178.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -65.78 -16.51 63.86 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 121.205 0.526 . . . . 0.0 110.835 179.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 62.0 m -140.19 29.63 2.02 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.585 178.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 19.3 m -146.06 156.51 43.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.496 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 11.7 ptp180 -143.09 166.24 25.19 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.657 179.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 67.4 m-80 58.9 54.42 5.11 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.117 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.479 ' HA ' ' O ' ' A' ' 20' ' ' ARG . . . -88.65 118.47 28.34 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.311 179.555 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.407 HG22 ' HD2' ' A' ' 20' ' ' ARG . 27.3 m -118.93 171.58 6.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.193 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.581 HD21 ' HG ' ' A' ' 64' ' ' LEU . 3.3 mm? -104.99 115.0 29.54 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.147 -179.496 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.5 ' OG1' ' HB ' ' A' ' 18' ' ' THR . 21.9 p -110.06 167.73 9.96 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.931 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 57.97 53.27 6.97 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.948 -179.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 81.68 -35.36 2.48 Favored Glycine 0 CA--C 1.519 0.322 0 CA-C-N 116.035 -0.529 . . . . 0.0 112.686 179.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.564 ' HA2' ' HB3' ' A' ' 12' ' ' LEU . . . 136.75 49.22 0.07 OUTLIER Glycine 0 N--CA 1.447 -0.598 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 -179.504 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.555 ' HB3' ' HB2' ' A' ' 56' ' ' SER . 15.7 ptt180 -133.91 -27.65 1.44 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.885 0.374 . . . . 0.0 111.317 -179.415 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.5 ' HB ' ' OG1' ' A' ' 13' ' ' THR . 3.9 m -99.04 135.73 40.03 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.794 -178.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.762 HD11 HD13 ' A' ' 90' ' ' LEU . 61.6 mt -94.3 114.65 26.76 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.628 179.337 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.479 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 1.6 tmt_? -110.47 120.51 42.66 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 178.589 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -153.2 167.23 30.01 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.835 0.35 . . . . 0.0 111.63 -179.562 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.494 ' HB3' ' HB3' ' A' ' 30' ' ' TRP . 45.4 mt-10 -90.73 105.63 17.95 Favored 'General case' 0 CA--C 1.512 -0.49 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 177.603 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.456 ' SG ' HD13 ' A' ' 100' ' ' LEU . 83.7 m -92.61 122.8 35.39 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 120.88 0.372 . . . . 0.0 110.963 -178.474 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.514 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 37.3 ttp180 -71.12 110.95 6.1 Favored 'General case' 0 N--CA 1.435 -1.208 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.64 178.609 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.418 HD21 ' HB3' ' A' ' 29' ' ' ASN . 37.4 p30 -76.84 167.19 22.26 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.12 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.42 -31.45 45.21 Favored 'General case' 0 C--N 1.329 -0.324 0 O-C-N 123.672 0.607 . . . . 0.0 112.289 -178.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -70.9 -17.64 62.7 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.306 0.574 . . . . 0.0 110.773 -179.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 95.08 28.39 9.98 Favored Glycine 0 CA--C 1.51 -0.243 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.551 -179.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.514 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 13.9 t-20 -113.08 164.03 13.99 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 -178.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.494 ' HB3' ' HB3' ' A' ' 22' ' ' GLU . 96.6 m95 -105.21 116.82 32.59 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.77 0.319 . . . . 0.0 110.8 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.5 m -118.56 138.03 50.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.737 179.421 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 13.3 m -80.33 114.79 19.49 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.154 -179.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.493 ' HB3' ' HB2' ' A' ' 100' ' ' LEU . 75.5 m -126.13 147.6 49.58 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.244 179.268 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.663 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 50.9 mt-10 -131.7 141.39 49.55 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.887 -179.497 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.523 ' HB2' HD23 ' A' ' 100' ' ' LEU . 1.3 tm? -137.53 127.41 25.62 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.288 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.404 ' N ' HD13 ' A' ' 35' ' ' LEU . 18.6 m-20 -81.54 109.72 16.25 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.284 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.601 HD22 HG13 ' A' ' 93' ' ' ILE . 4.1 mt -82.01 -23.07 36.16 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 121.086 -0.246 . . . . 0.0 111.59 -178.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.523 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 6.5 p-10 -66.44 -6.16 13.61 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.796 0.332 . . . . 0.0 111.475 -178.421 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 55.7 p -76.55 -21.77 55.23 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.249 0.547 . . . . 0.0 109.727 178.361 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.456 ' SG ' ' HE3' ' A' ' 50' ' ' TRP . 29.0 t -128.79 -14.61 4.51 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.656 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.463 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 54.0 mt -99.42 133.98 40.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 O-C-N 122.149 -0.344 . . . . 0.0 110.136 178.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.526 ' HA3' ' HB3' ' A' ' 52' ' ' MET . . . -152.28 165.33 30.81 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 121.011 -0.614 . . . . 0.0 111.857 179.602 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.724 ' ND2' ' HB2' ' A' ' 55' ' ' PHE . 5.3 p30 -163.86 54.35 0.4 Allowed Pre-proline 0 CA--C 1.537 0.442 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -179.503 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.41 ' HG3' ' HG2' ' A' ' 52' ' ' MET . 58.4 Cg_endo -73.13 -22.74 18.92 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 121.753 1.635 . . . . 0.0 111.241 179.506 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -85.07 -17.11 38.41 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.311 179.02 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.612 ' CA ' ' HG2' ' A' ' 83' ' ' ARG . . . 105.66 13.65 23.52 Favored Glycine 0 N--CA 1.441 -0.977 0 CA-C-N 115.459 -0.791 . . . . 0.0 113.152 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.409 ' HA ' HE22 ' A' ' 86' ' ' GLN . 59.0 m-85 -125.3 134.2 52.35 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.831 0.348 . . . . 0.0 110.431 179.095 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 88.7 mt -82.79 129.85 35.05 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.107 -178.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -176.85 175.87 47.79 Favored Glycine 0 N--CA 1.442 -0.958 0 C-N-CA 120.663 -0.78 . . . . 0.0 111.873 179.241 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.456 ' HE3' ' SG ' ' A' ' 40' ' ' CYS . 88.1 m95 -96.22 125.45 40.75 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 159.88 -62.16 0.3 Allowed Glycine 0 N--CA 1.45 -0.373 0 N-CA-C 111.443 -0.663 . . . . 0.0 111.443 -179.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.526 ' HB3' ' HA3' ' A' ' 42' ' ' GLY . 42.4 tpp -80.67 173.82 12.22 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 179.755 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -129.44 166.85 18.78 Favored 'General case' 0 C--N 1.323 -0.558 0 O-C-N 122.147 -0.346 . . . . 0.0 111.629 -179.199 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 67.53 47.36 1.23 Allowed 'General case' 0 N--CA 1.463 0.212 0 O-C-N 124.175 0.922 . . . . 0.0 112.276 179.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.724 ' HB2' ' ND2' ' A' ' 43' ' ' ASN . 3.9 p90 -70.44 -26.19 63.54 Favored 'General case' 0 C--O 1.222 -0.343 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.589 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.555 ' HB2' ' HB3' ' A' ' 17' ' ' ARG . 32.9 t -60.34 -38.3 83.37 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.93 0.395 . . . . 0.0 110.834 -179.116 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 26.2 m80 -80.86 -2.81 48.92 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.57 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 49.8 m -124.91 16.28 8.59 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.648 0.261 . . . . 0.0 111.572 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 69.7 m -131.67 149.42 52.49 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.459 0.647 . . . . 0.0 111.981 -179.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.467 ' HG3' ' HG2' ' A' ' 76' ' ' LYS . 39.8 mt-10 -120.3 139.68 52.38 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.913 -1.04 . . . . 0.0 109.295 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.505 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 28.4 t70 61.34 72.07 0.53 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.482 0.658 . . . . 0.0 110.546 179.343 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.536 HG23 HD21 ' A' ' 71' ' ' LEU . 65.6 mt -96.3 113.48 30.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.242 -179.694 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.456 ' HE3' ' HB2' ' A' ' 63' ' ' LYS . 17.3 ttmt -150.33 149.99 30.86 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.859 0.361 . . . . 0.0 110.834 -179.776 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.604 HD13 ' HA2' ' A' ' 68' ' ' GLY . 33.7 mt -88.67 136.83 32.8 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.849 -179.411 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -91.23 -67.08 0.87 Allowed 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.09 0.471 . . . . 0.0 110.988 179.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.547 ' HB2' ' HB3' ' A' ' 69' ' ' ARG . 21.9 mm-40 -74.88 42.29 0.17 Allowed 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 115.395 -0.82 . . . . 0.0 112.07 -178.618 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 60.9 13.92 35.56 Favored Glycine 0 C--N 1.314 -0.662 0 CA-C-N 115.249 -0.887 . . . . 0.0 113.426 179.091 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.604 ' HA2' HD13 ' A' ' 64' ' ' LEU . . . 130.92 -13.82 5.51 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.103 -1.046 . . . . 0.0 113.197 179.587 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.547 ' HB3' ' HB2' ' A' ' 66' ' ' GLU . 2.3 ttp85 -78.17 -20.04 52.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.343 0.592 . . . . 0.0 109.869 179.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -140.26 140.88 35.85 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.432 -179.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.61 ' HB2' HD11 ' A' ' 90' ' ' LEU . 10.3 tt -118.54 132.1 56.22 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.989 -0.551 . . . . 0.0 109.927 -179.414 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -118.19 129.91 55.78 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.634 178.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.505 ' HA ' ' O ' ' A' ' 61' ' ' ASP . 28.8 p -157.84 163.55 37.87 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.475 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.592 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 33.4 ttt180 -99.76 104.16 26.36 Favored Pre-proline 0 C--N 1.316 -0.886 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.32 179.488 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.589 ' O ' ' HB3' ' A' ' 83' ' ' ARG . 43.5 Cg_endo -67.82 115.66 3.88 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 122.449 2.1 . . . . 0.0 109.802 178.202 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.736 ' HE3' ' HA2' ' A' ' 81' ' ' GLY . 0.0 OUTLIER -119.3 140.33 50.47 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.65 -179.661 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.667 HG22 ' O ' ' A' ' 82' ' ' PHE . 15.3 t -75.85 130.14 38.09 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 17.3 m -72.59 -6.24 7.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.309 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -67.45 -34.01 76.31 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.845 179.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.584 ' HA3' ' CE2' ' A' ' 82' ' ' PHE . . . -143.26 -20.58 0.21 Allowed Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.902 179.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.736 ' HA2' ' HE3' ' A' ' 76' ' ' LYS . . . 95.23 12.54 54.51 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.363 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.667 ' O ' HG22 ' A' ' 77' ' ' THR . 21.3 p90 -111.96 157.68 20.4 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 118.83 -0.605 . . . . 0.0 110.64 -178.49 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.701 ' HB2' ' HA ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 165.54 -152.49 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.633 0 O-C-N 124.107 0.879 . . . . 0.0 111.862 178.238 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -132.6 151.3 51.98 Favored 'General case' 0 C--O 1.225 -0.192 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.189 -178.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.592 ' HA ' ' HA ' ' A' ' 74' ' ' ARG . 45.3 ttt-85 -85.95 151.48 23.71 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.547 0.213 . . . . 0.0 110.62 -179.39 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.42 ' HG3' ' O ' ' A' ' 85' ' ' ARG . 35.6 mt-30 -154.05 -172.9 4.37 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.296 -178.76 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -141.54 144.47 14.46 Favored Glycine 0 N--CA 1.451 -0.34 0 N-CA-C 111.091 -0.804 . . . . 0.0 111.091 179.127 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 9.2 tt -131.77 137.53 54.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 120.935 0.398 . . . . 0.0 110.896 -179.144 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -82.03 136.88 35.18 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.269 179.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.762 HD13 HD11 ' A' ' 19' ' ' LEU . 50.8 mt -101.05 45.03 0.98 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.598 0.713 . . . . 0.0 110.587 -179.311 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.602 ' HA ' ' OG ' ' A' ' 2' ' ' SER . 0.9 OUTLIER -74.87 -0.94 20.16 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.931 -179.354 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 11.0 mtp180 -94.98 -11.98 27.53 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.809 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.601 HG13 HD22 ' A' ' 37' ' ' LEU . 23.5 mm -101.64 112.57 35.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 -179.268 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -129.1 162.21 28.24 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.589 0.709 . . . . 0.0 112.093 -178.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.489 ' HA ' ' O ' ' A' ' 99' ' ' ARG . 19.8 p-10 -106.94 124.55 49.78 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.728 -1.123 . . . . 0.0 110.308 179.144 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 46.1 t -106.69 104.02 16.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 33.9 m-80 59.78 19.39 8.21 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.71 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 119.44 -25.95 7.52 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.607 -0.806 . . . . 0.0 113.52 178.294 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.489 ' O ' ' HA ' ' A' ' 95' ' ' ASN . 1.9 ptm180 -86.76 144.7 26.95 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 117.092 0.446 . . . . 0.0 110.393 -179.267 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.523 HD23 ' HB2' ' A' ' 35' ' ' LEU . 6.9 tp -93.43 119.71 32.84 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 23.9 t -129.34 139.31 52.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.736 -178.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.453 ' HB2' HD11 ' A' ' 35' ' ' LEU . 13.7 t80 -82.98 130.68 35.17 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.873 -0.418 . . . . 0.0 109.873 178.508 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 . . . . . 0 C--N 1.316 -0.887 0 CA-C-O 118.37 -0.824 . . . . 0.0 110.117 179.63 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . 0.475 ' HB2' ' HD2' ' A' ' 69' ' ' ARG . 13.2 m . . . . . 0 N--CA 1.449 -0.486 0 CA-C-O 120.746 0.307 . . . . 0.0 111.13 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.455 ' CG ' HD11 ' A' ' 100' ' ' LEU . 18.9 p90 -57.6 -38.13 74.4 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.104 -0.498 . . . . 0.0 112.095 179.782 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.571 ' HB3' ' CG ' ' A' ' 69' ' ' ARG . . . -53.85 -18.72 3.55 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 -177.699 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -63.98 -30.41 71.49 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.381 0.61 . . . . 0.0 109.764 179.076 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 18.8 m -131.84 28.97 4.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.924 179.255 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.412 ' HA ' ' HZ3' ' A' ' 30' ' ' TRP . 13.6 m -143.33 155.98 44.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.921 -179.81 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.42 HH11 ' HD2' ' A' ' 8' ' ' ARG . 12.7 ptm180 -145.84 169.9 17.64 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 110.436 -0.209 . . . . 0.0 110.436 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 63.02 53.42 2.34 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 123.715 0.634 . . . . 0.0 110.803 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.478 ' HA ' ' HB2' ' A' ' 21' ' ' ALA . . . -92.06 119.86 32.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.201 -179.614 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 34.4 m -123.13 170.42 13.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.209 179.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.632 HD21 ' HG ' ' A' ' 64' ' ' LEU . 3.3 mm? -105.51 115.33 30.07 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.1 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.447 ' OG1' ' HB ' ' A' ' 18' ' ' THR . 21.8 p -112.26 171.23 7.64 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.35 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.45 ' HB3' ' HE ' ' A' ' 17' ' ' ARG . 87.1 m-20 58.9 45.88 14.57 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.486 179.509 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 88.56 -30.77 5.15 Favored Glycine 0 N--CA 1.451 -0.358 0 CA-C-N 115.892 -0.595 . . . . 0.0 112.366 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.554 ' HA2' ' HB3' ' A' ' 12' ' ' LEU . . . 131.31 53.72 0.09 OUTLIER Glycine 0 N--CA 1.445 -0.731 0 N-CA-C 111.059 -0.817 . . . . 0.0 111.059 -179.477 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.638 ' HB2' ' HB3' ' A' ' 38' ' ' ASP . 14.6 ptt180 -141.46 -29.28 0.64 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.864 0.364 . . . . 0.0 111.579 -179.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.485 ' CG2' ' HB3' ' A' ' 34' ' ' GLU . 3.7 m -95.92 132.62 41.02 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.417 -179.631 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.734 HD11 HD13 ' A' ' 90' ' ' LEU . 87.5 mt -93.76 114.33 26.59 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.08 179.533 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 56.0 ttp180 -112.1 119.78 39.58 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 178.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.478 ' HB2' ' HA ' ' A' ' 10' ' ' ALA . . . -154.15 167.47 29.76 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.209 -179.317 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.629 ' HB3' ' HB3' ' A' ' 30' ' ' TRP . 40.8 mt-10 -89.89 108.94 20.01 Favored 'General case' 0 CA--C 1.513 -0.466 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 177.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.557 ' SG ' HD13 ' A' ' 100' ' ' LEU . 18.7 m -96.23 128.36 43.08 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.252 -178.641 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.511 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 25.0 ttp180 -72.87 116.73 13.72 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 179.411 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.429 HD21 ' HB3' ' A' ' 29' ' ' ASN . 36.3 p30 -84.16 171.58 12.7 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.052 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.44 -28.88 47.19 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 112.654 0.612 . . . . 0.0 112.654 -178.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -75.56 -10.59 59.58 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.394 0.616 . . . . 0.0 110.368 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 86.03 28.15 29.27 Favored Glycine 0 N--CA 1.447 -0.629 0 N-CA-C 110.916 -0.874 . . . . 0.0 110.916 -179.264 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.511 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 3.3 t-20 -110.31 160.35 16.63 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.572 0.225 . . . . 0.0 110.92 -178.479 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.629 ' HB3' ' HB3' ' A' ' 22' ' ' GLU . 84.1 m95 -99.98 112.9 25.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.074 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.1 m -115.79 131.88 66.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.365 178.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 21.6 m -77.46 109.02 11.04 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.943 0.401 . . . . 0.0 110.747 -179.323 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 70.3 m -118.29 151.69 37.21 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.726 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.611 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 45.1 mt-10 -128.89 144.5 51.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.817 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.628 HD11 ' HB2' ' A' ' 102' ' ' PHE . 1.4 tm? -138.86 128.84 25.19 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 178.472 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.423 ' N ' HD13 ' A' ' 35' ' ' LEU . 10.9 m-20 -90.31 109.85 20.94 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.479 -179.161 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.483 HD23 HD12 ' A' ' 35' ' ' LEU . 0.8 OUTLIER -87.21 -14.34 41.38 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -179.652 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.638 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 0.9 OUTLIER -64.64 -17.18 63.8 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -177.698 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.426 HG23 ' SG ' ' A' ' 40' ' ' CYS . 9.3 t -85.02 -2.63 58.19 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.894 0.378 . . . . 0.0 110.486 179.622 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.426 ' SG ' HG23 ' A' ' 39' ' ' THR . 35.8 m -132.28 -14.12 3.01 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.698 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 57.2 mt -116.41 134.89 58.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 CA-C-O 120.745 0.307 . . . . 0.0 110.402 179.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.572 ' HA3' ' HB3' ' A' ' 52' ' ' MET . . . -153.16 164.64 30.99 Favored Glycine 0 N--CA 1.446 -0.635 0 N-CA-C 111.026 -0.83 . . . . 0.0 111.026 179.261 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.467 ' OD1' ' HB2' ' A' ' 55' ' ' PHE . 2.3 p-10 -157.14 52.44 0.6 Allowed Pre-proline 0 CA--C 1.537 0.468 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -179.586 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -69.4 -19.77 37.42 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 121.708 1.605 . . . . 0.0 111.899 -179.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -89.78 -2.84 58.33 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.463 179.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.552 ' HA3' ' HG2' ' A' ' 83' ' ' ARG . . . 95.32 4.86 60.82 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.477 -0.868 . . . . 0.0 112.699 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 52.6 m-85 -126.19 137.44 53.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.69 0.245 . . . . 0.0 110.648 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.465 HD23 HG22 ' A' ' 88' ' ' ILE . 5.5 mp -82.67 149.47 27.34 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.403 -179.313 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 171.4 171.98 37.07 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.396 178.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.48 ' CD1' HD11 ' A' ' 88' ' ' ILE . 91.8 m95 -95.62 133.8 39.26 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 138.65 -39.77 1.53 Allowed Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.879 -0.677 . . . . 0.0 111.636 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.572 ' HB3' ' HA3' ' A' ' 42' ' ' GLY . 4.4 tpt -94.03 -172.01 2.72 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.407 ' HG3' HD22 ' A' ' 54' ' ' ASN . 3.8 pt20 -146.13 169.96 17.67 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.178 -0.609 . . . . 0.0 111.955 -179.282 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.407 HD22 ' HG3' ' A' ' 53' ' ' GLN . 45.5 m-80 62.41 42.71 8.7 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.062 -0.972 . . . . 0.0 112.39 179.311 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.467 ' HB2' ' OD1' ' A' ' 43' ' ' ASN . 20.9 p90 -63.34 -32.65 74.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.06 0.457 . . . . 0.0 110.302 179.337 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.603 ' OG ' ' HB3' ' A' ' 17' ' ' ARG . 8.8 m -64.05 -35.52 81.01 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.464 -179.399 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 27.3 m80 -79.15 -5.03 53.22 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.84 0.353 . . . . 0.0 111.173 -179.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 6.2 p -128.0 20.49 6.42 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.544 -179.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 66.9 m -135.8 152.41 51.06 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 121.26 0.552 . . . . 0.0 112.239 -179.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 -114.05 149.4 35.51 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.052 179.126 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 15.7 t70 47.25 72.51 0.24 Allowed 'General case' 0 N--CA 1.469 0.513 0 O-C-N 124.15 0.906 . . . . 0.0 111.526 179.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.536 HG23 HD21 ' A' ' 71' ' ' LEU . 73.1 mt -90.56 117.68 34.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.19 -179.595 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -149.12 164.62 34.17 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.074 179.452 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.632 ' HG ' HD21 ' A' ' 12' ' ' LEU . 62.7 mt -91.07 136.42 33.09 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.085 0.469 . . . . 0.0 110.954 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -92.76 -66.1 0.95 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.841 -178.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -81.65 46.1 0.94 Allowed 'General case' 0 CA--C 1.514 -0.424 0 CA-C-O 120.985 0.421 . . . . 0.0 111.709 -178.58 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 57.77 22.46 47.3 Favored Glycine 0 C--N 1.317 -0.525 0 CA-C-N 115.174 -0.921 . . . . 0.0 113.189 179.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.606 ' HA2' HD13 ' A' ' 64' ' ' LEU . . . 121.53 -12.59 9.5 Favored Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 120.225 -0.988 . . . . 0.0 113.575 179.616 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.571 ' CG ' ' HB3' ' A' ' 4' ' ' ALA . 17.9 mtm105 -92.68 1.9 57.02 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 117.806 0.803 . . . . 0.0 110.899 -179.498 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 17.8 tttp -157.65 133.22 9.09 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 -179.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.591 ' HB2' HD11 ' A' ' 90' ' ' LEU . 10.5 tt -109.35 129.14 55.54 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -179.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.551 HG22 ' HA3' ' A' ' 87' ' ' GLY . 2.4 p -121.07 131.22 54.14 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.355 0.597 . . . . 0.0 111.575 -179.476 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.526 ' HB3' ' HA ' ' A' ' 62' ' ' ILE . 25.0 p -158.03 174.26 15.5 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.786 -179.494 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.567 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 57.1 ttt180 -106.72 100.11 29.2 Favored Pre-proline 0 C--N 1.319 -0.735 0 C-N-CA 121.084 -0.246 . . . . 0.0 110.449 178.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.693 ' O ' ' HB3' ' A' ' 83' ' ' ARG . 19.6 Cg_endo -65.39 126.12 15.68 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.493 2.129 . . . . 0.0 110.471 178.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.679 ' HA ' ' HB2' ' A' ' 83' ' ' ARG . 0.1 OUTLIER -120.26 145.01 47.47 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.987 0.423 . . . . 0.0 111.561 -179.806 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.644 HG22 ' O ' ' A' ' 82' ' ' PHE . 15.1 t -74.31 142.25 45.2 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.095 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.6 p -72.74 -12.05 15.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.525 -178.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -64.24 -28.52 69.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.558 179.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -161.24 -16.5 0.03 OUTLIER Glycine 0 CA--C 1.518 0.246 0 C-N-CA 120.065 -1.064 . . . . 0.0 113.496 -179.338 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.63 ' HA2' ' HD3' ' A' ' 76' ' ' LYS . . . 97.43 20.7 21.8 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.761 -0.733 . . . . 0.0 111.787 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.644 ' O ' HG22 ' A' ' 77' ' ' THR . 26.7 p90 -112.17 150.68 30.47 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 119.373 -0.346 . . . . 0.0 110.186 -179.202 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.693 ' HB3' ' O ' ' A' ' 75' ' ' PRO . 0.0 OUTLIER 167.13 -152.86 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.302 0 O-C-N 123.953 0.783 . . . . 0.0 109.482 179.247 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 48.8 mm-40 -117.05 175.78 5.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.453 0.168 . . . . 0.0 111.427 -177.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.567 ' HA ' ' HA ' ' A' ' 74' ' ' ARG . 23.6 ttt180 -111.89 149.73 31.43 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 178.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -168.35 -161.9 0.38 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.642 -178.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.551 ' HA3' HG22 ' A' ' 72' ' ' THR . . . -153.25 161.74 29.84 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.785 179.742 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.48 HD11 ' CD1' ' A' ' 50' ' ' TRP . 13.9 tt -130.82 139.92 49.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 179.645 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.48 ' HB3' HD22 ' A' ' 91' ' ' ASN . 18.1 m-20 -82.21 138.24 34.71 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.047 0.451 . . . . 0.0 110.812 -179.57 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.734 HD13 HD11 ' A' ' 19' ' ' LEU . 56.5 mt -104.94 50.32 0.79 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.618 0.723 . . . . 0.0 111.26 -178.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.48 HD22 ' HB3' ' A' ' 89' ' ' ASP . 34.5 m-80 -82.96 3.34 30.41 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.324 179.027 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 40.3 mtp180 -98.85 -2.71 37.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.58 179.034 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.401 HG13 HD22 ' A' ' 37' ' ' LEU . 21.7 mm -110.4 96.26 4.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 24.9 tp60 -112.04 148.33 34.09 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.489 -178.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.439 ' OD1' ' HA ' ' A' ' 3' ' ' TYR . 17.7 p-10 -94.36 119.72 33.52 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.862 179.015 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.9 p -114.59 119.37 61.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.689 179.392 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 59.18 27.22 16.16 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.802 -179.486 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 92.43 -8.48 77.16 Favored Glycine 0 N--CA 1.447 -0.628 0 CA-C-N 115.971 -0.559 . . . . 0.0 113.155 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.21 135.08 43.27 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 117.409 0.604 . . . . 0.0 110.932 -179.154 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.557 HD13 ' SG ' ' A' ' 23' ' ' CYS . 3.9 tp -80.74 118.77 22.57 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.689 179.495 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 47.0 t -132.57 138.07 52.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 120.926 0.393 . . . . 0.0 110.79 -179.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.628 ' HB2' HD11 ' A' ' 35' ' ' LEU . 12.1 t80 -80.93 129.3 34.46 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 178.348 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 . . . . . 0 C--N 1.313 -0.993 0 CA-C-O 118.309 -0.853 . . . . 0.0 110.185 -179.604 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . 0.564 ' OG ' ' HA ' ' A' ' 91' ' ' ASN . 3.8 m . . . . . 0 N--CA 1.449 -0.475 0 N-CA-C 110.17 -0.307 . . . . 0.0 110.17 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.43 ' HA ' ' OD1' ' A' ' 95' ' ' ASN . 21.4 p90 -59.54 -39.55 84.32 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.786 0.327 . . . . 0.0 110.915 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -56.24 -19.77 15.41 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 -178.328 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -69.69 -22.88 63.38 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.087 0.47 . . . . 0.0 110.35 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 24.0 m -138.36 35.6 2.28 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.456 0.646 . . . . 0.0 109.259 178.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.438 ' HA ' ' HZ3' ' A' ' 30' ' ' TRP . 9.0 t -138.18 161.03 37.87 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.477 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 25.0 ptt180 -149.49 165.58 31.73 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.496 -179.266 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 54.66 52.97 11.28 Favored 'General case' 0 C--N 1.331 -0.208 0 O-C-N 123.855 0.722 . . . . 0.0 111.704 178.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.436 ' HA ' ' HB2' ' A' ' 21' ' ' ALA . . . -86.51 117.83 25.54 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.095 179.61 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 34.5 m -118.22 169.08 9.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.328 -179.427 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.731 HD21 ' HG ' ' A' ' 64' ' ' LEU . 3.2 mm? -105.95 114.61 28.85 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.649 -179.115 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.436 ' OG1' ' HB ' ' A' ' 18' ' ' THR . 24.0 p -110.55 163.39 13.77 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.003 -179.733 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 62.7 27.76 16.26 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.043 179.342 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 98.8 -17.74 57.85 Favored Glycine 0 N--CA 1.454 -0.12 0 C-N-CA 120.457 -0.878 . . . . 0.0 112.583 179.459 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.634 ' HA2' ' HB3' ' A' ' 12' ' ' LEU . . . 121.86 35.13 0.8 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.802 -0.714 . . . . 0.0 112.09 179.514 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.461 ' HB2' ' HB3' ' A' ' 38' ' ' ASP . 3.5 ptm180 -118.76 -25.64 6.3 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.149 0.499 . . . . 0.0 110.551 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.436 ' HB ' ' OG1' ' A' ' 13' ' ' THR . 4.8 m -108.31 135.26 49.91 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.827 -179.686 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.667 HD11 HD13 ' A' ' 90' ' ' LEU . 63.0 mt -97.65 113.76 25.57 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.787 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.498 ' HA ' ' HG2' ' A' ' 34' ' ' GLU . 16.7 ttm180 -107.02 118.68 37.33 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 178.527 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.436 ' HB2' ' HA ' ' A' ' 10' ' ' ALA . . . -154.5 168.05 28.01 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.016 0.436 . . . . 0.0 111.853 -178.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -89.54 111.6 22.57 Favored 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 177.485 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.439 ' SG ' HD13 ' A' ' 100' ' ' LEU . 61.1 m -97.89 122.89 41.54 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 -179.36 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.411 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 19.0 ttt180 -77.23 111.07 12.46 Favored 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 179.073 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.449 HD21 ' HB3' ' A' ' 29' ' ' ASN . 34.9 p30 -74.96 168.0 20.81 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.168 179.713 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.68 -27.44 27.8 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -178.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -77.92 -4.56 47.44 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.342 0.591 . . . . 0.0 110.964 -179.099 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 81.28 29.5 40.55 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.962 -0.637 . . . . 0.0 111.568 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.449 ' HB3' HD21 ' A' ' 25' ' ' ASN . 8.0 t-20 -112.95 153.03 28.65 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.438 ' HZ3' ' HA ' ' A' ' 7' ' ' SER . 99.1 m95 -99.14 114.5 27.29 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.149 0.499 . . . . 0.0 111.205 -179.156 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 6.9 m -114.17 131.89 64.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.385 179.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 17.3 m -79.41 109.57 13.9 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.894 0.378 . . . . 0.0 110.45 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 74.3 m -123.1 154.44 38.59 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.753 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.645 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 46.1 mt-10 -132.84 132.98 42.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.786 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.575 HD11 ' HB2' ' A' ' 102' ' ' PHE . 2.5 tm? -124.37 131.61 53.51 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.259 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.45 ' N ' HD13 ' A' ' 35' ' ' LEU . 8.4 m-20 -89.86 108.52 19.75 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.082 -179.666 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.502 HD13 HD22 ' A' ' 90' ' ' LEU . 1.6 mt -81.69 -16.93 49.7 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.894 -179.571 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.461 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 4.7 p-10 -61.79 -11.88 14.49 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.442 -179.264 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 54.0 p -76.66 -24.68 53.24 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.431 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 34.8 t -128.64 -8.33 5.09 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.206 0.446 . . . . 0.0 112.206 -179.351 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 47.3 mt -103.44 132.67 49.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 O-C-N 121.851 -0.531 . . . . 0.0 110.046 178.324 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.564 ' HA3' ' HB3' ' A' ' 52' ' ' MET . . . -149.71 159.51 28.11 Favored Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.799 -0.715 . . . . 0.0 111.538 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.457 HD22 ' CD1' ' A' ' 48' ' ' LEU . 19.1 p30 -163.35 50.17 0.25 Allowed Pre-proline 0 CA--C 1.537 0.47 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -179.689 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -68.46 -23.52 37.48 Favored 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 121.924 1.749 . . . . 0.0 112.227 -179.03 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.425 ' O ' ' HD3' ' A' ' 83' ' ' ARG . 3.3 m-20 -87.31 -15.96 36.5 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.537 179.739 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.52 ' HA3' ' HG2' ' A' ' 83' ' ' ARG . . . 108.6 11.68 22.7 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.461 -0.876 . . . . 0.0 112.741 -179.161 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -125.82 132.07 52.31 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.62 0.248 . . . . 0.0 110.392 179.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.497 HD23 HG22 ' A' ' 88' ' ' ILE . 9.2 mp -83.7 144.8 29.13 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.878 -178.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 171.76 170.38 35.68 Favored Glycine 0 N--CA 1.439 -1.134 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.11 178.245 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 90.3 m95 -94.88 125.8 39.78 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 153.43 -52.87 0.46 Allowed Glycine 0 N--CA 1.448 -0.56 0 N-CA-C 111.191 -0.764 . . . . 0.0 111.191 -179.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.564 ' HB3' ' HA3' ' A' ' 42' ' ' GLY . 2.9 tpt -86.59 174.36 8.95 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.595 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.453 ' H ' ' HE2' ' A' ' 52' ' ' MET . 3.9 pt20 -133.67 169.8 16.49 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 118.69 0.677 . . . . 0.0 111.85 -179.174 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 65.81 38.57 5.09 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.389 -0.823 . . . . 0.0 112.855 178.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.515 ' HB3' ' HA2' ' A' ' 42' ' ' GLY . 14.0 p90 -61.78 -29.85 70.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.721 0.296 . . . . 0.0 110.929 179.644 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.45 ' HB2' ' HB3' ' A' ' 17' ' ' ARG . 23.3 t -56.61 -36.12 69.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.158 -0.474 . . . . 0.0 112.042 -178.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 28.2 m80 -80.92 -18.43 47.17 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.899 -0.32 . . . . 0.0 111.543 -179.207 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 19.8 m -106.75 19.37 20.58 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.527 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 49.3 m -136.82 152.77 50.66 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.331 0.586 . . . . 0.0 111.628 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -129.06 136.27 50.04 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.197 178.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.427 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 33.6 m-20 63.63 83.65 0.16 Allowed 'General case' 0 N--CA 1.469 0.511 0 O-C-N 123.608 0.567 . . . . 0.0 111.304 -179.317 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.504 HG23 HD21 ' A' ' 71' ' ' LEU . 70.2 mt -101.51 124.19 55.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.285 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.8 tptt -145.03 154.61 42.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.766 0.317 . . . . 0.0 111.247 -179.396 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.731 ' HG ' HD21 ' A' ' 12' ' ' LEU . 86.1 mt -99.5 124.83 45.03 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.018 178.412 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -86.62 -60.26 2.04 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-O 121.194 0.521 . . . . 0.0 111.42 -179.61 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.607 ' HB2' ' HB3' ' A' ' 69' ' ' ARG . 20.3 mt-10 -78.19 38.44 0.29 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.665 -178.42 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 67.73 -4.76 3.87 Favored Glycine 0 N--CA 1.454 -0.117 0 CA-C-N 115.77 -0.65 . . . . 0.0 113.633 179.075 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.57 ' HA2' HD13 ' A' ' 64' ' ' LEU . . . 145.98 -6.96 1.4 Allowed Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.129 -179.429 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.607 ' HB3' ' HB2' ' A' ' 66' ' ' GLU . 5.5 tpp180 -81.7 -18.23 45.13 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.087 0.47 . . . . 0.0 109.807 179.668 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.429 ' HE3' ' HB2' ' A' ' 70' ' ' LYS . 35.6 ttmt -143.42 136.21 27.54 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.916 -179.234 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.668 ' HB2' HD11 ' A' ' 90' ' ' LEU . 10.5 tt -115.07 118.45 33.41 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.47 -0.787 . . . . 0.0 109.923 -179.709 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.493 HG22 ' HA3' ' A' ' 87' ' ' GLY . 3.6 p -108.82 134.13 51.93 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.241 0.543 . . . . 0.0 110.874 179.388 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.451 ' SG ' HD21 ' A' ' 48' ' ' LEU . 18.0 p -156.55 164.25 38.43 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.001 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.583 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 33.4 ttt-85 -100.87 101.87 17.51 Favored Pre-proline 0 C--N 1.316 -0.872 0 C-N-CA 120.424 -0.511 . . . . 0.0 110.254 178.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.639 ' O ' ' HB3' ' A' ' 83' ' ' ARG . 57.9 Cg_endo -70.55 129.2 16.38 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.636 2.224 . . . . 0.0 110.167 178.631 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.69 ' HA ' ' HB2' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -121.2 140.99 51.28 Favored 'General case' 0 C--N 1.313 -1.009 0 O-C-N 123.28 0.362 . . . . 0.0 110.949 179.85 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.723 HG22 ' O ' ' A' ' 82' ' ' PHE . 14.0 t -76.86 130.73 38.01 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 178.478 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 35.3 m -72.66 -6.01 7.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 123.557 0.536 . . . . 0.0 111.492 -179.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -67.78 -35.97 79.62 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.229 178.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.431 ' HA3' ' CE2' ' A' ' 82' ' ' PHE . . . -145.3 -14.18 0.21 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.413 -0.898 . . . . 0.0 113.152 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.582 ' HA2' ' HE3' ' A' ' 76' ' ' LYS . . . 88.23 16.78 58.6 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.011 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.723 ' O ' HG22 ' A' ' 77' ' ' THR . 37.8 p90 -111.29 148.46 32.87 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 118.789 -0.624 . . . . 0.0 109.33 -179.195 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.69 ' HB2' ' HA ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 172.05 -160.14 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.987 0.423 . . . . 0.0 111.938 179.753 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 -125.74 173.22 9.19 Favored 'General case' 0 C--O 1.223 -0.317 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.006 -177.473 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.594 ' HA ' ' HD2' ' A' ' 75' ' ' PRO . 72.5 ttt180 -109.41 153.71 23.61 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 110.07 -0.344 . . . . 0.0 110.07 178.711 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -166.23 -170.24 1.64 Allowed 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.581 -179.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.493 ' HA3' HG22 ' A' ' 72' ' ' THR . . . -143.12 151.61 23.35 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.335 -0.936 . . . . 0.0 113.358 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.497 HG22 HD23 ' A' ' 48' ' ' LEU . 13.0 tt -123.31 137.49 56.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.025 0.441 . . . . 0.0 109.883 179.408 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -79.8 138.02 37.13 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.787 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.668 HD11 ' HB2' ' A' ' 71' ' ' LEU . 37.2 mt -106.08 40.88 1.5 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.499 0.666 . . . . 0.0 110.936 -179.014 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.564 ' HA ' ' OG ' ' A' ' 2' ' ' SER . 39.5 m-80 -76.03 3.55 10.15 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.079 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 20.9 mtp180 -96.95 -6.6 35.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.641 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 18.7 mm -98.78 116.75 42.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 -179.355 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 24.5 tp60 -126.81 143.36 51.28 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.275 0.559 . . . . 0.0 111.301 -178.229 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.43 ' OD1' ' HA ' ' A' ' 3' ' ' TYR . 12.9 p-10 -95.19 110.82 22.74 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.304 178.529 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 40.8 t -96.97 106.45 18.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.693 179.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 20.3 m-80 56.98 36.76 28.21 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.272 0.558 . . . . 0.0 111.304 -179.341 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 96.14 -22.05 41.82 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.828 -0.701 . . . . 0.0 113.388 179.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.426 HH11 ' HD3' ' A' ' 99' ' ' ARG . 3.6 mpt_? -86.21 122.61 30.45 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 117.295 0.547 . . . . 0.0 110.211 -179.474 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.439 HD13 ' SG ' ' A' ' 23' ' ' CYS . 11.6 tp -79.63 114.59 18.67 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 32.7 t -128.15 140.71 48.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 120.984 0.421 . . . . 0.0 110.878 -178.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.575 ' HB2' HD11 ' A' ' 35' ' ' LEU . 8.3 t80 -83.93 129.3 34.93 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.121 -0.491 . . . . 0.0 109.81 178.665 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 2.7 tp-100 . . . . . 0 C--O 1.249 1.073 0 CA-C-O 119.031 -0.509 . . . . 0.0 110.451 179.396 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.8 m . . . . . 0 N--CA 1.454 -0.274 0 CA-C-O 120.276 0.084 . . . . 0.0 110.98 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.589 ' HB3' ' HA ' ' A' ' 94' ' ' GLN . 9.8 p90 -59.62 -34.09 72.33 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.724 0.297 . . . . 0.0 111.543 179.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.475 ' HA ' ' HB3' ' A' ' 7' ' ' SER . . . -55.35 -18.32 6.39 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 112.84 0.681 . . . . 0.0 112.84 -178.649 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -56.24 -38.29 70.91 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.326 0.584 . . . . 0.0 110.064 178.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 44.3 m -129.02 40.58 3.61 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.218 179.214 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.475 ' HB3' ' HA ' ' A' ' 4' ' ' ALA . 29.3 t -148.1 148.44 30.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.264 -179.529 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -143.45 163.74 32.27 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.669 -179.671 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 64.22 49.04 2.71 Favored 'General case' 0 N--CA 1.465 0.318 0 O-C-N 123.718 0.636 . . . . 0.0 111.441 179.349 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.543 ' HA ' ' HB2' ' A' ' 21' ' ' ALA . . . -77.92 117.29 19.12 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.361 179.563 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 33.8 m -119.14 167.99 11.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.207 -179.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.599 ' HB3' ' HA2' ' A' ' 16' ' ' GLY . 3.3 mm? -104.38 114.53 28.82 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.661 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.476 HG21 ' NE ' ' A' ' 20' ' ' ARG . 28.4 p -112.4 166.69 11.07 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.548 -179.458 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 60.89 42.55 12.88 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.962 179.563 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 97.53 -48.03 1.54 Allowed Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 120.661 -0.781 . . . . 0.0 111.546 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.599 ' HA2' ' HB3' ' A' ' 12' ' ' LEU . . . 145.98 46.79 0.03 OUTLIER Glycine 0 N--CA 1.444 -0.824 0 N-CA-C 110.306 -1.117 . . . . 0.0 110.306 -179.388 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.573 ' HB2' ' HB2' ' A' ' 38' ' ' ASP . 7.1 ptp180 -132.95 -25.59 1.81 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.355 -0.423 . . . . 0.0 111.313 -178.595 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.47 ' HB ' ' OG1' ' A' ' 13' ' ' THR . 2.9 m -100.36 133.3 44.99 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.76 -179.688 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.792 HD11 HD13 ' A' ' 90' ' ' LEU . 68.8 mt -92.52 111.54 23.16 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.325 179.1 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.476 ' NE ' HG21 ' A' ' 13' ' ' THR . 37.4 ttm180 -110.42 120.22 41.73 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.721 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.543 ' HB2' ' HA ' ' A' ' 10' ' ' ALA . . . -152.96 167.24 29.83 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.76 0.314 . . . . 0.0 111.369 -179.125 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.423 ' O ' ' HA ' ' A' ' 7' ' ' SER . 37.1 mt-10 -91.01 107.76 19.41 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 178.262 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 65.9 m -100.32 133.11 45.23 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 120.914 0.387 . . . . 0.0 110.212 -179.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.44 HH11 ' HD2' ' A' ' 24' ' ' ARG . 6.7 ttp85 -80.78 117.63 21.61 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-O 120.918 0.39 . . . . 0.0 110.483 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 38.7 p30 -80.31 165.75 22.01 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.103 179.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.13 -18.69 38.04 Favored 'General case' 0 N--CA 1.464 0.266 0 O-C-N 123.807 0.692 . . . . 0.0 112.137 -179.012 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -75.85 -13.48 60.27 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.457 0.646 . . . . 0.0 109.716 179.192 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 91.0 23.83 28.9 Favored Glycine 0 N--CA 1.447 -0.58 0 CA-C-N 115.327 -0.851 . . . . 0.0 112.609 179.463 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -122.76 158.61 29.8 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.755 0.312 . . . . 0.0 111.67 -179.105 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 96.7 m95 -90.32 130.73 36.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.14 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.2 m -129.17 137.47 57.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.533 178.454 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 37.6 m -78.58 109.95 13.25 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.467 179.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 61.6 m -118.06 152.5 35.43 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.609 -179.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.599 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 44.9 mt-10 -132.5 154.41 49.96 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.156 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.555 ' HB2' HD23 ' A' ' 100' ' ' LEU . 1.1 tm? -150.5 126.31 10.38 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 178.78 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -88.77 109.21 19.98 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.54 HD13 HD22 ' A' ' 90' ' ' LEU . 2.2 mt -81.73 -12.73 58.48 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.329 -179.395 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.712 ' OD2' ' HA ' ' A' ' 54' ' ' ASN . 3.0 t70 -65.96 -5.85 10.71 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.115 0.484 . . . . 0.0 110.845 -179.271 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 49.6 p -85.45 -26.38 26.38 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.857 -0.61 . . . . 0.0 112.03 -179.383 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 16.1 t -127.19 -2.59 6.35 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.573 -0.451 . . . . 0.0 112.089 -178.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.433 ' HB ' ' CD1' ' A' ' 55' ' ' PHE . 54.8 mt -111.21 134.34 53.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 O-C-N 122.124 -0.36 . . . . 0.0 110.388 179.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -148.72 158.41 27.65 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 121.12 -0.562 . . . . 0.0 111.787 179.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.635 ' ND2' ' HB2' ' A' ' 55' ' ' PHE . 9.2 p30 -157.04 46.62 0.26 Allowed Pre-proline 0 CA--C 1.537 0.475 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 179.635 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.575 ' HG2' ' SD ' ' A' ' 52' ' ' MET . 14.0 Cg_exo -66.99 -19.67 51.64 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 121.75 1.634 . . . . 0.0 111.671 -179.678 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 73.9 m-20 -88.77 -8.89 53.63 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.559 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.601 ' CA ' ' HG2' ' A' ' 83' ' ' ARG . . . 98.52 7.71 55.47 Favored Glycine 0 N--CA 1.443 -0.885 0 C-N-CA 120.488 -0.863 . . . . 0.0 112.557 -179.309 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -125.57 135.61 52.41 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.753 0.311 . . . . 0.0 110.286 179.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.475 ' HB3' ' HB ' ' A' ' 88' ' ' ILE . 86.4 mt -83.66 141.84 31.21 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.532 -178.532 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 176.51 168.28 36.36 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.447 179.193 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.424 ' HH2' HD11 ' A' ' 93' ' ' ILE . 89.1 m95 -95.71 134.81 38.2 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 147.35 -52.25 0.56 Allowed Glycine 0 CA--C 1.508 -0.404 0 N-CA-C 111.676 -0.569 . . . . 0.0 111.676 179.45 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.575 ' SD ' ' HG2' ' A' ' 44' ' ' PRO . 36.7 ttm -95.74 172.12 8.23 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 178.783 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -123.7 173.23 8.25 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 118.824 0.738 . . . . 0.0 111.507 -178.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.712 ' HA ' ' OD2' ' A' ' 38' ' ' ASP . 13.9 m120 66.82 63.37 0.49 Allowed 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 114.926 -1.034 . . . . 0.0 111.68 178.59 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.635 ' HB2' ' ND2' ' A' ' 43' ' ' ASN . 20.7 p90 -87.11 -35.95 18.39 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.336 179.452 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 17.7 t -64.47 -27.56 69.06 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.353 -178.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 69.5 m80 -76.37 -12.81 60.12 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.881 -179.259 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.519 ' O ' ' HG3' ' A' ' 76' ' ' LYS . 24.3 p -128.19 26.29 5.76 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.878 0.37 . . . . 0.0 111.303 -179.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 68.2 m -132.99 151.08 52.11 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 120.576 -0.45 . . . . 0.0 111.173 179.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -119.39 134.31 55.28 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.303 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.437 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 38.2 t70 61.1 84.65 0.13 Allowed 'General case' 0 N--CA 1.465 0.286 0 O-C-N 124.037 0.836 . . . . 0.0 110.934 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.488 HG23 HD21 ' A' ' 71' ' ' LEU . 72.2 mt -101.51 118.07 47.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.03 -179.127 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.456 ' HD3' ' N ' ' A' ' 64' ' ' LEU . 1.2 tmtp? -145.44 150.21 36.11 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 -179.792 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.606 HD13 ' HA2' ' A' ' 68' ' ' GLY . 56.1 mt -83.01 123.19 29.22 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.315 0.579 . . . . 0.0 111.456 -179.517 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -78.37 -61.79 1.89 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.13 -0.941 . . . . 0.0 111.973 -178.372 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 33.6 mm-40 -79.54 34.8 0.27 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.15 0.5 . . . . 0.0 111.433 -179.504 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 66.01 10.44 51.44 Favored Glycine 0 C--N 1.316 -0.575 0 CA-C-N 115.295 -0.866 . . . . 0.0 112.569 179.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.606 ' HA2' HD13 ' A' ' 64' ' ' LEU . . . 137.7 -16.95 3.5 Favored Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 120.348 -0.929 . . . . 0.0 112.963 179.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 27.2 mtt180 -83.23 -9.85 58.9 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 117.349 0.574 . . . . 0.0 110.779 -179.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 66.3 tttt -150.13 138.07 20.17 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.983 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.567 ' HB2' HD11 ' A' ' 90' ' ' LEU . 10.4 tt -107.2 126.44 52.41 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.958 -179.262 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.0 p -116.53 132.0 56.8 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.991 179.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.437 ' HA ' ' O ' ' A' ' 61' ' ' ASP . 26.8 p -159.97 175.4 13.06 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.065 -179.602 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.606 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 29.4 ttt180 -107.34 99.12 26.09 Favored Pre-proline 0 C--N 1.315 -0.892 0 C-N-CA 120.228 -0.589 . . . . 0.0 110.405 178.627 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.614 ' O ' ' HB3' ' A' ' 83' ' ' ARG . 55.3 Cg_endo -69.38 125.44 12.35 Favored 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 122.713 2.275 . . . . 0.0 110.492 178.686 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.746 ' HA ' ' HB2' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -120.52 139.99 52.11 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.904 0.383 . . . . 0.0 111.422 -179.693 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.723 HG22 ' O ' ' A' ' 82' ' ' PHE . 15.2 t -73.39 135.63 44.26 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 179.649 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 26.9 m -76.22 -8.99 12.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.63 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.522 -179.35 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -68.57 -30.18 68.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.776 179.531 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.555 ' HA3' ' CE2' ' A' ' 82' ' ' PHE . . . -146.01 -19.26 0.14 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.502 -0.856 . . . . 0.0 113.281 179.431 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.498 ' HA2' ' HE3' ' A' ' 76' ' ' LYS . . . 92.97 14.05 55.47 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.931 -0.652 . . . . 0.0 111.86 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.723 ' O ' HG22 ' A' ' 77' ' ' THR . 37.6 p90 -111.8 157.37 20.63 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 118.901 -0.571 . . . . 0.0 110.173 -178.349 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.746 ' HB2' ' HA ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 166.6 -157.57 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.357 0 O-C-N 123.661 0.601 . . . . 0.0 112.258 178.456 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 41.5 mm-40 -123.42 176.57 6.08 Favored 'General case' 0 CA--C 1.521 -0.173 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.384 -177.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.606 ' HA ' ' HA ' ' A' ' 74' ' ' ARG . 30.9 ttt85 -98.85 154.75 17.79 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 178.009 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.42 ' HG2' ' N ' ' A' ' 87' ' ' GLY . 9.1 tt0 -161.92 171.48 17.61 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.533 -178.086 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.42 ' N ' ' HG2' ' A' ' 86' ' ' GLN . . . -134.12 138.25 9.93 Favored Glycine 0 N--CA 1.447 -0.622 0 N-CA-C 111.695 -0.562 . . . . 0.0 111.695 178.696 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.475 ' HB ' ' HB3' ' A' ' 48' ' ' LEU . 11.1 tt -118.4 134.82 60.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 121.052 0.453 . . . . 0.0 110.09 -179.667 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.505 ' HB3' HD22 ' A' ' 91' ' ' ASN . 7.7 m-20 -76.1 136.98 39.86 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.232 -178.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.792 HD13 HD11 ' A' ' 19' ' ' LEU . 52.4 mt -105.74 40.46 1.56 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.382 0.611 . . . . 0.0 111.451 -179.128 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.505 HD22 ' HB3' ' A' ' 89' ' ' ASP . 29.5 m-80 -74.29 -2.91 27.12 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.27 179.413 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 8.4 mtp180 -91.79 -7.45 49.52 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.741 179.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.424 HD11 ' HH2' ' A' ' 50' ' ' TRP . 23.4 mm -105.47 112.1 37.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 -179.332 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.589 ' HA ' ' HB3' ' A' ' 3' ' ' TYR . 7.9 mt-30 -132.56 159.38 39.62 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.143 0.497 . . . . 0.0 111.477 -179.433 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.421 ' HA ' ' O ' ' A' ' 99' ' ' ARG . 13.2 p-10 -104.48 134.0 48.4 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.876 179.523 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 49.3 t -114.93 105.08 17.94 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.395 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -179.496 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 17.7 m-80 61.81 26.91 16.38 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.858 -179.021 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 113.88 -35.84 4.3 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.688 -0.767 . . . . 0.0 114.602 178.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.421 ' O ' ' HA ' ' A' ' 95' ' ' ASN . 0.0 OUTLIER -86.8 139.33 30.8 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 118.029 0.914 . . . . 0.0 112.817 -177.891 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.555 HD23 ' HB2' ' A' ' 35' ' ' LEU . 7.1 tp -81.29 120.05 24.42 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.968 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 26.2 t -128.29 141.52 46.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.308 -179.102 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.444 ' HB2' HD11 ' A' ' 35' ' ' LEU . 16.9 t80 -80.53 132.24 35.64 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 178.705 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 2.7 tp-100 . . . . . 0 C--O 1.253 1.25 0 CA-C-O 118.595 -0.717 . . . . 0.0 110.045 179.703 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . 0.624 ' HB2' ' HG2' ' A' ' 69' ' ' ARG . 20.1 m . . . . . 0 N--CA 1.451 -0.379 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.483 ' HA ' ' OD1' ' A' ' 95' ' ' ASN . 12.6 p90 -54.89 -40.89 70.25 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -179.58 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.803 ' HB3' ' HG3' ' A' ' 69' ' ' ARG . . . -62.2 -18.45 61.08 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 -178.445 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.469 ' HB2' ' O ' ' A' ' 2' ' ' SER . 0.9 OUTLIER -64.43 -22.43 66.96 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 121.329 0.585 . . . . 0.0 110.572 179.626 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 49.6 m -140.92 39.21 1.8 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.274 179.075 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.478 ' HB3' ' HA ' ' A' ' 4' ' ' ALA . 13.2 t -145.63 154.66 42.37 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.926 -1.034 . . . . 0.0 108.698 179.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 21.0 ptt180 -140.47 164.09 31.08 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.734 0.302 . . . . 0.0 111.26 -179.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 57.96 51.42 8.98 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.686 178.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.514 ' HA ' ' HB2' ' A' ' 21' ' ' ALA . . . -81.98 117.39 22.16 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.206 179.444 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 26.7 m -119.24 169.88 9.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.349 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.643 ' HB3' ' HA2' ' A' ' 16' ' ' GLY . 3.2 mm? -105.15 115.27 29.98 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.803 -179.478 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 23.5 p -111.74 169.6 8.72 Favored 'General case' 0 C--O 1.243 0.72 0 CA-C-O 121.115 0.483 . . . . 0.0 111.692 -179.43 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 62.67 26.87 15.88 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 115.285 -0.87 . . . . 0.0 112.56 179.218 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 101.8 -14.3 57.53 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.437 179.274 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.643 ' HA2' ' HB3' ' A' ' 12' ' ' LEU . . . 116.8 43.17 0.63 Allowed Glycine 0 N--CA 1.443 -0.869 0 N-CA-C 111.209 -0.756 . . . . 0.0 111.209 -179.659 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.711 ' HB2' ' HB2' ' A' ' 38' ' ' ASP . 14.0 ptm180 -130.6 -29.69 1.93 Allowed 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.301 -0.45 . . . . 0.0 111.26 -179.384 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.431 ' HA ' ' HA ' ' A' ' 36' ' ' ASP . 10.3 m -104.37 136.32 44.17 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.435 -179.628 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.655 ' O ' ' HA ' ' A' ' 34' ' ' GLU . 84.5 mt -93.3 117.61 30.28 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.369 179.698 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 44.3 ttt85 -113.81 119.85 38.76 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 178.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.514 ' HB2' ' HA ' ' A' ' 10' ' ' ALA . . . -153.76 167.14 30.63 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.924 0.393 . . . . 0.0 111.443 -178.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -90.98 109.13 20.37 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 177.65 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.505 ' SG ' HD13 ' A' ' 100' ' ' LEU . 68.5 m -100.09 135.64 41.2 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 120.897 0.38 . . . . 0.0 111.313 -178.122 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 17.3 ttp180 -80.02 115.55 19.66 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.99 179.309 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 34.3 p30 -80.29 167.62 20.05 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.789 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -52.04 -32.24 33.49 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 -178.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -71.35 -13.45 61.87 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.288 0.566 . . . . 0.0 111.004 -179.335 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 90.43 28.91 15.42 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.971 -0.633 . . . . 0.0 111.644 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -120.01 157.82 28.06 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.618 0.247 . . . . 0.0 110.834 -179.507 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 91.9 m95 -90.34 131.43 36.14 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.755 0.312 . . . . 0.0 111.362 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.9 m -133.32 130.6 57.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.116 178.164 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.4 m -77.11 112.87 14.23 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.573 -179.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 66.4 m -124.11 160.19 28.32 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.978 -179.535 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.655 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 47.4 mt-10 -139.32 143.77 37.98 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.104 -179.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.456 HD11 ' HB2' ' A' ' 102' ' ' PHE . 1.8 tm? -138.47 127.77 24.44 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 178.61 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.431 ' HA ' ' HA ' ' A' ' 18' ' ' THR . 27.1 t70 -91.01 109.79 21.04 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.94 0.4 . . . . 0.0 110.599 -179.177 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.553 HD11 HD11 ' A' ' 19' ' ' LEU . 1.5 mt -81.23 -14.24 57.69 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.747 -179.645 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.763 ' OD2' ' HA ' ' A' ' 54' ' ' ASN . 6.6 t70 -63.23 -15.71 57.92 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.291 0.567 . . . . 0.0 110.55 -179.301 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 68.1 p -80.21 -22.41 41.87 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.554 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 21.0 m -122.94 -8.68 8.33 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -177.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 65.4 mt -111.73 134.16 55.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 110.335 -0.246 . . . . 0.0 110.335 179.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.465 ' HA3' ' HB3' ' A' ' 52' ' ' MET . . . -140.94 151.98 22.85 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.827 -0.702 . . . . 0.0 111.871 179.445 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.851 HD22 ' HB3' ' A' ' 75' ' ' PRO . 38.7 p-10 -160.57 48.53 0.25 Allowed Pre-proline 0 CA--C 1.54 0.561 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -179.308 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.562 ' HD3' ' N ' ' A' ' 43' ' ' ASN . 10.1 Cg_exo -68.28 -18.21 44.68 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 121.883 1.722 . . . . 0.0 111.798 -179.164 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -93.28 -6.63 47.07 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.294 -0.866 . . . . 0.0 111.146 -179.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.532 ' HA3' ' HD3' ' A' ' 83' ' ' ARG . . . 100.22 9.33 48.29 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.11 -1.043 . . . . 0.0 112.926 -179.506 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.718 ' HA ' HE22 ' A' ' 86' ' ' GLN . 49.5 m-85 -125.08 128.98 49.32 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.119 0.485 . . . . 0.0 110.891 179.776 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.47 HD11 ' SG ' ' A' ' 73' ' ' CYS . 84.7 mt -83.41 137.87 33.74 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.782 -178.116 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -178.94 170.69 42.61 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 120.874 -0.679 . . . . 0.0 111.659 178.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.417 ' HH2' HD11 ' A' ' 93' ' ' ILE . 90.4 m95 -95.78 135.44 37.48 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.991 0.424 . . . . 0.0 110.153 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 147.89 -67.12 0.39 Allowed Glycine 0 N--CA 1.445 -0.706 0 N-CA-C 111.498 -0.641 . . . . 0.0 111.498 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.465 ' HB3' ' HA3' ' A' ' 42' ' ' GLY . 14.7 ttt -80.35 -179.46 7.13 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.458 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -131.36 168.07 18.19 Favored 'General case' 0 C--N 1.321 -0.668 0 O-C-N 122.082 -0.386 . . . . 0.0 111.111 -179.327 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.763 ' HA ' ' OD2' ' A' ' 38' ' ' ASP . 0.9 OUTLIER 69.4 61.21 0.3 Allowed 'General case' 0 N--CA 1.461 0.087 0 O-C-N 124.079 0.862 . . . . 0.0 111.762 179.002 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.43 ' HD1' ' HA ' ' A' ' 38' ' ' ASP . 16.6 p90 -87.21 -37.35 17.35 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.319 179.484 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 72.2 p -64.74 -22.42 66.98 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.409 0.623 . . . . 0.0 110.501 -179.11 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 76.6 m80 -75.94 -11.53 59.98 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.096 -179.43 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.406 ' O ' ' HG3' ' A' ' 76' ' ' LYS . 3.0 p -133.65 33.65 3.49 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.556 179.201 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 38.6 m -136.45 154.19 50.85 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.311 0.577 . . . . 0.0 111.678 -179.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -131.22 146.52 52.35 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.142 -0.935 . . . . 0.0 109.652 179.399 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.49 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 33.4 t70 58.72 66.86 1.0 Allowed 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 121.335 0.588 . . . . 0.0 110.917 178.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.563 ' HA ' ' HB3' ' A' ' 73' ' ' CYS . 74.5 mt -93.9 114.15 29.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.633 -179.583 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 29.0 tptt -144.54 147.65 33.47 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.992 0.425 . . . . 0.0 110.305 -179.574 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.62 ' HG ' HD21 ' A' ' 12' ' ' LEU . 65.6 mt -83.35 140.89 32.16 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.401 179.69 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -102.41 -55.27 2.5 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.023 -0.535 . . . . 0.0 112.232 -178.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.429 ' H ' ' HB3' ' A' ' 70' ' ' LYS . 62.9 mm-40 -83.81 36.26 0.55 Allowed 'General case' 0 CA--C 1.515 -0.4 0 CA-C-O 121.061 0.457 . . . . 0.0 111.199 -179.667 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 70.49 -2.08 17.46 Favored Glycine 0 C--N 1.315 -0.589 0 CA-C-N 115.263 -0.881 . . . . 0.0 112.799 179.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.587 ' HA2' HD13 ' A' ' 64' ' ' LEU . . . 146.77 -12.84 1.51 Allowed Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.406 -0.902 . . . . 0.0 113.323 -179.712 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.803 ' HG3' ' HB3' ' A' ' 4' ' ' ALA . 53.3 mtm180 -94.2 4.21 54.2 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 117.557 0.678 . . . . 0.0 111.174 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.429 ' HB3' ' H ' ' A' ' 66' ' ' GLU . 39.9 tptt -151.45 119.74 6.37 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 -179.401 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.592 ' HB2' HD11 ' A' ' 90' ' ' LEU . 9.7 tt -104.29 120.07 40.36 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 -179.763 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.8 p -113.65 133.72 55.14 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.007 0.432 . . . . 0.0 110.798 179.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.563 ' HB3' ' HA ' ' A' ' 62' ' ' ILE . 26.2 p -159.98 175.61 12.82 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.887 -179.416 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.586 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 3.7 tmt_? -110.28 98.18 34.47 Favored Pre-proline 0 C--N 1.311 -1.084 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 178.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.851 ' HB3' HD22 ' A' ' 43' ' ' ASN . 59.1 Cg_endo -71.64 134.53 24.3 Favored 'Trans proline' 0 CA--C 1.515 -0.448 0 C-N-CA 123.221 2.614 . . . . 0.0 111.599 179.72 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.717 ' HA ' ' HB2' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -121.42 144.03 48.9 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 123.294 0.371 . . . . 0.0 111.347 179.44 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.763 HG22 ' O ' ' A' ' 82' ' ' PHE . 14.4 t -81.15 138.1 35.89 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.103 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 35.6 m -76.97 -4.68 6.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 O-C-N 124.057 0.848 . . . . 0.0 111.481 -179.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -69.95 -33.81 72.6 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.006 0.431 . . . . 0.0 110.352 178.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.45 ' HA3' ' CE2' ' A' ' 82' ' ' PHE . . . -148.25 -17.23 0.11 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.363 -0.922 . . . . 0.0 113.202 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.626 ' HA2' ' HE3' ' A' ' 76' ' ' LYS . . . 93.68 16.41 45.7 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.577 -0.82 . . . . 0.0 111.473 -179.431 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.763 ' O ' HG22 ' A' ' 77' ' ' THR . 33.2 p90 -112.2 154.16 25.98 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 118.754 -0.641 . . . . 0.0 109.478 -178.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.717 ' HB2' ' HA ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 170.8 -160.13 0.01 OUTLIER 'General case' 0 C--O 1.234 0.263 0 O-C-N 123.311 0.382 . . . . 0.0 111.772 179.477 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -124.77 -174.33 3.0 Favored 'General case' 0 C--O 1.226 -0.132 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.527 -177.489 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.586 ' HA ' ' HA ' ' A' ' 74' ' ' ARG . 35.1 ttt-85 -99.61 155.95 17.32 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 177.768 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.718 HE22 ' HA ' ' A' ' 47' ' ' PHE . 8.9 tt0 -163.73 165.78 22.8 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 121.088 0.47 . . . . 0.0 111.854 -178.766 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -134.95 144.3 16.22 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 121.066 -0.588 . . . . 0.0 111.636 179.413 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 12.1 tt -123.64 138.92 51.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 120.975 0.417 . . . . 0.0 110.312 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -78.63 129.69 35.04 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.561 -179.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.623 HD13 HD11 ' A' ' 19' ' ' LEU . 60.4 mt -99.44 45.69 0.99 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.711 0.767 . . . . 0.0 110.291 179.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.473 HD22 ' N ' ' A' ' 91' ' ' ASN . 0.8 OUTLIER -79.15 3.13 18.55 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 114.821 -1.081 . . . . 0.0 110.039 -179.609 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 11.7 mtp180 -101.89 0.18 35.05 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.267 -179.122 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.426 ' CD1' HD22 ' A' ' 37' ' ' LEU . 21.9 mm -107.19 114.96 47.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 -179.321 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 27.0 tp60 -125.78 144.59 50.57 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.908 -178.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.483 ' OD1' ' HA ' ' A' ' 3' ' ' TYR . 12.9 p-10 -95.36 102.02 13.8 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.276 178.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 54.1 t -86.37 109.3 18.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 179.564 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 26.3 m-80 57.64 31.6 20.62 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.02 0.438 . . . . 0.0 110.789 -178.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 95.1 -18.95 56.36 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.566 -0.826 . . . . 0.0 112.831 179.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 5.6 mpt_? -86.18 124.36 32.49 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 -179.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.505 HD13 ' SG ' ' A' ' 23' ' ' CYS . 6.7 tp -76.21 116.48 16.94 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 -179.648 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 44.9 t -130.99 143.19 41.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.622 -179.074 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.456 ' HB2' HD11 ' A' ' 35' ' ' LEU . 16.0 t80 -79.04 135.52 36.9 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.757 -0.461 . . . . 0.0 109.757 178.509 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.586 HE21 ' HA ' ' A' ' 103' ' ' GLN . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.653 -0.689 . . . . 0.0 110.163 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . 0.565 ' OG ' ' HA ' ' A' ' 91' ' ' ASN . 3.6 m . . . . . 0 N--CA 1.449 -0.522 0 CA-C-O 120.621 0.248 . . . . 0.0 110.46 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.446 ' CZ ' HD13 ' A' ' 19' ' ' LEU . 13.6 p90 -57.25 -34.43 68.6 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.037 0.446 . . . . 0.0 110.411 178.335 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -57.29 -23.06 46.02 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 115.481 -0.781 . . . . 0.0 112.531 -179.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -64.98 -16.78 63.78 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 121.063 0.459 . . . . 0.0 110.815 179.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 49.7 m -146.66 35.48 0.95 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.712 178.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 44.5 m -145.48 163.55 34.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.879 179.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 6.1 ptp180 -148.05 165.12 31.75 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.596 -179.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 61.1 m-80 59.51 51.83 6.22 Favored 'General case' 0 N--CA 1.464 0.248 0 O-C-N 123.689 0.618 . . . . 0.0 111.376 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.484 ' HA ' ' HB2' ' A' ' 21' ' ' ALA . . . -83.89 117.38 23.29 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.391 179.418 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 31.2 m -123.0 168.9 14.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.481 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.81 HD21 ' HG ' ' A' ' 64' ' ' LEU . 3.4 mm? -104.45 114.32 28.48 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.68 -179.457 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 18.4 p -107.56 168.57 9.16 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.516 -179.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 60.4 39.8 18.13 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.039 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 89.62 -31.21 5.32 Favored Glycine 0 CA--C 1.519 0.335 0 CA-C-N 115.941 -0.572 . . . . 0.0 112.657 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.577 ' HA2' ' HB3' ' A' ' 12' ' ' LEU . . . 136.29 56.49 0.06 OUTLIER Glycine 0 N--CA 1.449 -0.472 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 -179.314 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.5 ptm180 -142.52 -31.89 0.51 Allowed 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.856 0.36 . . . . 0.0 111.078 -179.379 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.444 HG22 ' HB3' ' A' ' 34' ' ' GLU . 5.5 m -101.3 136.77 40.6 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.764 -179.538 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.751 HD11 HD13 ' A' ' 90' ' ' LEU . 67.8 mt -94.63 118.07 31.12 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.65 179.052 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.402 ' HD2' HH11 ' A' ' 20' ' ' ARG . 21.8 ttt180 -114.6 119.97 38.57 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 178.708 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.484 ' HB2' ' HA ' ' A' ' 10' ' ' ALA . . . -154.05 168.94 24.75 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.693 0.282 . . . . 0.0 111.317 -178.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.453 ' HB3' ' HB3' ' A' ' 30' ' ' TRP . 43.4 mt-10 -87.65 106.2 17.87 Favored 'General case' 0 CA--C 1.513 -0.461 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 178.048 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.553 ' SG ' HD13 ' A' ' 100' ' ' LEU . 30.4 m -93.25 121.26 34.43 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.451 -177.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.529 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 9.5 ttp180 -70.03 112.94 6.77 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.147 179.264 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.457 ' ND2' ' HB3' ' A' ' 29' ' ' ASN . 36.2 p30 -78.69 170.65 16.32 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.359 -179.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.96 -27.4 52.36 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -178.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -80.31 -1.44 41.0 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.498 0.666 . . . . 0.0 110.409 -179.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.97 28.95 48.5 Favored Glycine 0 N--CA 1.448 -0.55 0 CA-C-N 115.534 -0.757 . . . . 0.0 112.107 179.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.529 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 57.7 t30 -110.98 163.02 14.25 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 121.212 -0.195 . . . . 0.0 110.818 -179.03 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.453 ' HB3' ' HB3' ' A' ' 22' ' ' GLU . 92.5 m95 -101.55 115.71 31.13 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.528 179.616 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.8 m -116.49 148.87 18.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 120.993 0.425 . . . . 0.0 110.835 179.224 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 28.3 m -86.11 110.52 19.6 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.269 179.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.482 ' HB2' ' SG ' ' A' ' 23' ' ' CYS . 70.1 m -128.99 147.22 50.84 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.682 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.648 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 51.9 mt-10 -129.84 148.72 51.74 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.548 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.553 HD11 ' HB2' ' A' ' 102' ' ' PHE . 1.8 tm? -140.51 129.34 23.15 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 178.753 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.456 ' N ' HD13 ' A' ' 35' ' ' LEU . 14.5 m-20 -87.13 109.21 19.29 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 -179.565 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.506 HD13 HD22 ' A' ' 90' ' ' LEU . 1.9 mt -85.12 -21.43 29.28 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -179.19 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.4 ' HA ' ' HD1' ' A' ' 55' ' ' PHE . 5.9 p-10 -65.18 -6.96 10.65 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.744 0.307 . . . . 0.0 111.568 -178.386 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 69.0 p -81.09 -16.14 53.99 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.641 179.034 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.409 ' HG ' ' HZ ' ' A' ' 102' ' ' PHE . 29.2 t -133.28 -10.02 2.91 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.718 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 51.1 mt -104.81 134.26 46.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 178.264 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.52 ' HA3' ' HB3' ' A' ' 52' ' ' MET . . . -148.33 155.73 26.55 Favored Glycine 0 N--CA 1.442 -0.919 0 C-N-CA 120.577 -0.821 . . . . 0.0 112.112 -179.643 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.628 ' N ' ' HD3' ' A' ' 44' ' ' PRO . 27.0 p30 -158.2 43.92 0.18 Allowed Pre-proline 0 CA--C 1.542 0.648 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.628 ' HD3' ' N ' ' A' ' 43' ' ' ASN . 16.2 Cg_exo -67.46 -23.06 44.24 Favored 'Trans proline' 0 C--N 1.356 0.952 0 C-N-CA 121.967 1.778 . . . . 0.0 111.683 -179.219 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 52.5 m-80 -89.3 -1.92 58.25 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.11 179.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.534 ' HA3' ' HG2' ' A' ' 83' ' ' ARG . . . 92.6 11.17 59.64 Favored Glycine 0 N--CA 1.443 -0.843 0 C-N-CA 120.385 -0.912 . . . . 0.0 112.657 -179.692 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 43.5 m-85 -125.19 132.44 53.02 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.767 0.318 . . . . 0.0 110.588 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.424 HD23 HG22 ' A' ' 88' ' ' ILE . 10.3 mp -86.0 146.03 26.84 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.892 -178.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 169.22 171.31 34.79 Favored Glycine 0 N--CA 1.442 -0.944 0 CA-C-N 115.476 -0.784 . . . . 0.0 112.066 178.156 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.438 ' CD1' HD11 ' A' ' 88' ' ' ILE . 90.3 m95 -95.48 125.18 39.91 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.496 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 153.29 -44.85 0.59 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.936 -0.649 . . . . 0.0 111.637 -179.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.52 ' HB3' ' HA3' ' A' ' 42' ' ' GLY . 12.7 tpt -94.2 174.61 7.06 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.784 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 -130.72 171.56 12.96 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.993 -179.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 64.23 37.41 8.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.991 177.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.498 ' HB3' ' HA2' ' A' ' 42' ' ' GLY . 11.7 p90 -62.33 -38.42 89.4 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.528 -0.469 . . . . 0.0 109.865 179.191 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 15.6 t -60.09 -29.98 68.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.12 -179.215 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 27.9 m80 -77.03 -12.62 59.96 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.815 0.341 . . . . 0.0 111.301 -179.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 19.7 m -126.54 27.77 6.06 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.078 0.466 . . . . 0.0 111.166 -179.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 38.6 m -132.41 147.56 52.38 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.195 0.522 . . . . 0.0 111.258 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.668 ' HG3' ' HB3' ' A' ' 74' ' ' ARG . 7.0 pt-20 -121.23 142.44 49.91 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.51 178.571 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.419 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 37.6 t70 58.43 80.39 0.18 Allowed 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.55 0.691 . . . . 0.0 110.477 -178.691 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.542 HG23 HD21 ' A' ' 71' ' ' LEU . 70.5 mt -102.77 119.66 51.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.997 -179.267 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.4 tpmt? -148.97 156.82 42.82 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 -179.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.81 ' HG ' HD21 ' A' ' 12' ' ' LEU . 71.9 mt -88.39 121.3 30.63 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.984 0.421 . . . . 0.0 110.099 178.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -71.88 -55.45 7.5 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.899 -178.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.534 ' CB ' ' HB2' ' A' ' 69' ' ' ARG . 8.8 mm-40 -87.08 13.57 9.09 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.884 -179.396 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 69.9 23.17 77.11 Favored Glycine 0 N--CA 1.448 -0.528 0 CA-C-N 115.7 -0.682 . . . . 0.0 112.578 179.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 145.27 -36.76 1.36 Allowed Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.029 -1.082 . . . . 0.0 112.956 179.332 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.534 ' HB2' ' CB ' ' A' ' 66' ' ' GLU . 8.3 mmt85 -72.39 -29.12 63.46 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.928 0.394 . . . . 0.0 111.396 -179.784 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 41.7 tttp -140.45 140.09 35.33 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.976 -177.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.616 ' HB2' HD11 ' A' ' 90' ' ' LEU . 9.9 tt -111.35 122.93 49.15 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 179.142 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.2 p -110.87 131.89 54.66 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.361 0.6 . . . . 0.0 110.873 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.419 ' HA ' ' O ' ' A' ' 61' ' ' ASP . 24.6 p -156.61 167.51 30.22 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.708 -179.659 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.668 ' HB3' ' HG3' ' A' ' 60' ' ' GLU . 67.5 ttt180 -103.81 101.3 23.99 Favored Pre-proline 0 C--N 1.314 -0.958 0 N-CA-C 109.865 -0.421 . . . . 0.0 109.865 178.807 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.64 ' O ' ' HB3' ' A' ' 83' ' ' ARG . 61.5 Cg_endo -71.04 119.01 6.0 Favored 'Trans proline' 0 CA--C 1.513 -0.54 0 C-N-CA 122.871 2.381 . . . . 0.0 111.029 179.483 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.699 ' HA ' ' HB2' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -119.63 135.76 54.67 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 120.76 0.314 . . . . 0.0 110.486 179.795 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.715 HG22 ' O ' ' A' ' 82' ' ' PHE . 14.7 t -70.18 128.67 37.08 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 12.4 p -71.41 -12.57 16.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.474 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -60.24 -30.42 69.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.08 179.277 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.597 ' HA3' ' CE2' ' A' ' 82' ' ' PHE . . . -146.5 -35.68 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.433 0 CA-C-N 115.578 -0.737 . . . . 0.0 112.458 179.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 111.91 12.41 14.35 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 121.237 -0.506 . . . . 0.0 112.058 -179.522 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.715 ' O ' HG22 ' A' ' 77' ' ' THR . 16.1 p90 -112.66 152.82 28.54 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 118.782 -0.628 . . . . 0.0 110.37 -178.55 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.699 ' HB2' ' HA ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 167.52 -158.25 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.603 0 O-C-N 123.682 0.614 . . . . 0.0 111.994 178.675 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 57.4 mm-40 -117.62 -173.26 2.39 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.978 -178.088 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.632 ' HA ' ' HD2' ' A' ' 75' ' ' PRO . 73.2 ttt180 -115.93 151.38 35.5 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 178.524 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.463 ' HG3' ' O ' ' A' ' 85' ' ' ARG . 27.0 mt-30 -157.95 -170.1 3.05 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.379 0.609 . . . . 0.0 112.335 -178.387 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -155.33 145.98 13.46 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.09 179.304 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.438 HD11 ' CD1' ' A' ' 50' ' ' TRP . 12.4 tt -128.46 142.17 44.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.953 0.377 . . . . 0.0 110.474 -179.628 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.408 ' HB3' HD22 ' A' ' 91' ' ' ASN . 3.8 m-20 -82.5 133.82 35.2 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.184 0.516 . . . . 0.0 110.693 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.751 HD13 HD11 ' A' ' 19' ' ' LEU . 26.5 mt -101.02 39.64 1.37 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.616 -179.247 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.565 ' HA ' ' OG ' ' A' ' 2' ' ' SER . 9.4 m-80 -73.88 2.95 7.4 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.068 -0.969 . . . . 0.0 111.048 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 9.8 mtp180 -97.23 -11.07 24.63 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.459 179.316 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.436 ' CD1' HD22 ' A' ' 37' ' ' LEU . 23.3 mm -96.56 102.73 13.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 121.392 0.615 . . . . 0.0 109.449 -179.354 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 8.4 mm-40 -107.83 153.82 22.45 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.563 -178.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.432 ' HB3' HD12 ' A' ' 100' ' ' LEU . 22.8 p-10 -112.57 112.09 23.37 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.723 178.363 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.421 HG22 HD22 ' A' ' 97' ' ' ASN . 9.0 p -111.51 120.51 62.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.105 0.479 . . . . 0.0 110.176 -179.695 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.421 HD22 HG22 ' A' ' 96' ' ' VAL . 38.1 m-80 59.15 28.93 18.37 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.98 -178.623 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 88.09 -9.73 73.63 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.517 -179.36 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 10.5 mpt_? -91.4 124.8 35.86 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 -179.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.553 HD13 ' SG ' ' A' ' 23' ' ' CYS . 5.9 tp -82.16 117.11 22.06 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 16.6 t -129.24 138.07 55.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 120.651 0.262 . . . . 0.0 110.77 -179.136 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.553 ' HB2' HD11 ' A' ' 35' ' ' LEU . 6.8 t80 -80.91 125.72 30.48 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 177.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 . . . . . 0 C--N 1.311 -1.076 0 CA-C-O 118.077 -0.964 . . . . 0.0 110.856 179.848 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . 0.5 ' OG ' ' HA ' ' A' ' 91' ' ' ASN . 11.8 m . . . . . 0 N--CA 1.452 -0.344 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 34.6 p90 -59.86 -35.14 74.16 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 121.094 -0.242 . . . . 0.0 110.99 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -55.84 -22.09 23.21 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 112.114 0.412 . . . . 0.0 112.114 -179.356 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -68.27 -22.68 64.73 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 120.878 0.371 . . . . 0.0 110.716 179.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 9.6 p -139.73 29.97 2.1 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.31 0.576 . . . . 0.0 110.181 179.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 9.3 t -150.71 156.82 42.09 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -179.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 9.4 ptp180 -149.07 166.93 27.24 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.655 0.264 . . . . 0.0 111.127 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 57.3 m-80 57.85 60.71 2.65 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.967 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -90.48 125.47 35.6 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.853 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 34.0 m -122.62 170.65 12.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.8 179.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.63 HD21 ' HG ' ' A' ' 64' ' ' LEU . 3.2 mm? -104.8 114.21 28.29 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.355 -179.235 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 21.6 p -110.3 167.47 10.17 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.812 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 57.52 50.34 11.3 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.889 179.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 85.29 -37.95 3.01 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 121.01 -0.614 . . . . 0.0 112.516 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.618 ' HA2' ' HB3' ' A' ' 12' ' ' LEU . . . 138.59 38.83 0.11 Allowed Glycine 0 N--CA 1.447 -0.595 0 N-CA-C 111.284 -0.727 . . . . 0.0 111.284 -179.709 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.64 ' HB3' ' HB3' ' A' ' 56' ' ' SER . 48.7 ptt85 -123.49 -23.23 4.84 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.939 0.4 . . . . 0.0 110.744 -179.267 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.3 m -105.28 137.5 42.96 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.027 -179.384 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.743 HD11 HD13 ' A' ' 90' ' ' LEU . 58.5 mt -97.05 116.17 28.78 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.576 179.294 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.82 119.68 40.12 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 178.242 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -152.33 168.07 26.6 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.979 0.419 . . . . 0.0 111.776 -178.348 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -89.99 106.09 18.25 Favored 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 178.513 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 58.1 m -97.95 130.68 44.8 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 120.761 0.315 . . . . 0.0 110.633 -178.218 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.527 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 10.5 ttp180 -78.37 122.2 25.47 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.497 179.831 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.448 HD21 ' HB3' ' A' ' 29' ' ' ASN . 35.6 p30 -86.83 168.36 13.53 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.827 179.415 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.84 -31.32 49.03 Favored 'General case' 0 N--CA 1.464 0.255 0 O-C-N 123.555 0.535 . . . . 0.0 112.356 -179.11 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -69.51 -17.84 63.63 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.446 0.641 . . . . 0.0 110.662 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 93.72 28.7 10.82 Favored Glycine 0 N--CA 1.446 -0.684 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.313 -179.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.527 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 43.9 t30 -112.91 160.97 17.52 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.644 0.259 . . . . 0.0 110.901 -179.106 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 94.6 m95 -100.37 114.33 27.77 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.93 0.395 . . . . 0.0 111.049 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.6 m -117.75 129.19 74.55 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.381 178.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 13.7 m -75.01 111.66 10.45 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.877 -0.602 . . . . 0.0 111.015 -179.415 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.417 ' HB3' ' H ' ' A' ' 100' ' ' LEU . 73.5 m -121.58 153.3 38.22 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.609 179.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.601 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 42.8 mt-10 -129.4 141.46 51.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.206 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.615 HD11 ' HB2' ' A' ' 102' ' ' PHE . 1.9 tm? -136.54 131.96 34.58 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.387 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.416 ' N ' HD13 ' A' ' 35' ' ' LEU . 31.8 m-20 -88.58 109.8 20.38 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 -179.646 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.527 HD13 HD22 ' A' ' 90' ' ' LEU . 4.4 mt -79.64 -20.56 46.45 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.286 -179.636 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.543 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 5.1 p-10 -65.99 -5.87 10.92 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.629 -0.259 . . . . 0.0 111.461 -178.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 72.9 p -81.08 -20.84 40.65 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.625 179.472 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.446 ' SG ' ' HE3' ' A' ' 50' ' ' TRP . 40.9 t -129.05 -11.51 4.72 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.616 -179.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 51.3 mt -100.14 128.8 51.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.083 178.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.517 ' HA3' ' HB3' ' A' ' 52' ' ' MET . . . -139.34 154.34 23.44 Favored Glycine 0 N--CA 1.443 -0.876 0 C-N-CA 120.852 -0.69 . . . . 0.0 111.518 179.497 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.939 HD22 ' HB3' ' A' ' 75' ' ' PRO . 33.0 p-10 -160.95 44.24 0.15 Allowed Pre-proline 0 CA--C 1.539 0.533 0 N-CA-C 113.142 0.794 . . . . 0.0 113.142 -179.263 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -70.95 -16.76 32.5 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 121.404 1.403 . . . . 0.0 111.895 -179.387 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -89.07 -9.55 50.75 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.493 179.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.562 ' CA ' ' HG2' ' A' ' 83' ' ' ARG . . . 102.21 6.47 48.16 Favored Glycine 0 N--CA 1.443 -0.899 0 C-N-CA 120.482 -0.866 . . . . 0.0 112.503 -179.38 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.501 ' HD1' HE22 ' A' ' 86' ' ' GLN . 64.5 m-85 -125.14 134.42 52.44 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 122.732 -0.275 . . . . 0.0 110.85 179.808 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.51 HD23 ' HB3' ' A' ' 43' ' ' ASN . 88.0 mt -83.99 146.42 27.99 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.218 -179.166 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 170.82 169.99 34.52 Favored Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 120.539 -0.839 . . . . 0.0 112.361 178.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.446 ' HE3' ' SG ' ' A' ' 40' ' ' CYS . 90.8 m95 -95.3 124.98 39.62 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 110.048 -0.352 . . . . 0.0 110.048 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 160.73 -60.05 0.3 Allowed Glycine 0 N--CA 1.448 -0.558 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.791 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.517 ' HB3' ' HA3' ' A' ' 42' ' ' GLY . 0.4 OUTLIER -86.69 -162.15 0.74 Allowed 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 -179.902 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -147.25 175.19 10.95 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.768 -0.373 . . . . 0.0 111.708 -179.468 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 43.7 m-80 62.72 54.15 2.39 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 123.936 0.773 . . . . 0.0 112.236 179.278 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -87.5 -17.25 32.54 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.179 178.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.64 ' HB3' ' HB3' ' A' ' 17' ' ' ARG . 6.1 p -55.21 -55.65 28.87 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 -177.741 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 47.4 m80 -80.96 -10.23 59.74 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.926 0.393 . . . . 0.0 111.264 -179.179 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.4 ' HB2' ' OD1' ' A' ' 43' ' ' ASN . 15.0 m -96.01 14.41 23.78 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.942 0.401 . . . . 0.0 110.79 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 19.5 m -136.56 152.93 51.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.0 0.428 . . . . 0.0 111.551 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -119.1 145.69 45.73 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.477 178.19 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 35.9 t70 49.93 74.59 0.2 Allowed 'General case' 0 N--CA 1.47 0.561 0 O-C-N 123.787 0.679 . . . . 0.0 111.662 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.518 HG23 HD21 ' A' ' 71' ' ' LEU . 75.0 mt -91.51 115.46 30.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.489 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 15.0 tptm -149.07 150.97 33.64 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 121.031 0.443 . . . . 0.0 111.532 -179.521 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.63 ' HG ' HD21 ' A' ' 12' ' ' LEU . 64.1 mt -88.95 129.93 35.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.383 179.35 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -86.43 -57.22 3.09 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-O 121.126 0.488 . . . . 0.0 111.186 -179.594 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.516 ' HG2' ' HB3' ' A' ' 70' ' ' LYS . 16.3 mm-40 -71.9 -5.74 36.79 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.189 -179.183 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 95.51 -0.07 63.14 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 121.014 -0.612 . . . . 0.0 111.759 -179.525 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 164.34 -39.55 0.31 Allowed Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.434 -0.889 . . . . 0.0 112.555 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 7.9 mmt180 -62.31 -33.48 74.76 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.516 ' HB3' ' HG2' ' A' ' 66' ' ' GLU . 32.2 ttpt -135.44 139.09 43.84 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.915 0.388 . . . . 0.0 111.962 -178.292 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.607 ' HB2' HD11 ' A' ' 90' ' ' LEU . 10.5 tt -117.55 132.81 56.47 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.485 -0.779 . . . . 0.0 109.355 179.42 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.454 HG22 ' HA3' ' A' ' 87' ' ' GLY . 18.7 p -125.64 144.78 50.44 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.937 0.398 . . . . 0.0 111.04 179.437 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.468 ' HB3' ' HA ' ' A' ' 62' ' ' ILE . 24.0 p -162.6 175.45 11.4 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.582 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 52.9 ttt180 -109.3 98.25 30.5 Favored Pre-proline 0 C--N 1.311 -1.101 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 178.616 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.939 ' HB3' HD22 ' A' ' 43' ' ' ASN . 32.1 Cg_endo -64.3 127.21 18.6 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 122.866 2.377 . . . . 0.0 110.279 179.338 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.721 ' HA ' ' HB2' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -120.28 147.56 44.83 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.068 0.461 . . . . 0.0 111.619 -179.663 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.713 HG22 ' O ' ' A' ' 82' ' ' PHE . 14.5 t -81.61 141.47 33.67 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 179.007 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.1 m -73.87 -8.3 11.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 O-C-N 123.923 0.764 . . . . 0.0 111.321 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 53.0 m-20 -63.89 -34.04 77.06 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-O 120.955 0.407 . . . . 0.0 110.312 179.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -157.0 -10.92 0.05 OUTLIER Glycine 0 CA--C 1.519 0.298 0 C-N-CA 120.468 -0.872 . . . . 0.0 113.183 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.35 18.49 42.07 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.768 -0.729 . . . . 0.0 111.881 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.713 ' O ' HG22 ' A' ' 77' ' ' THR . 39.2 p90 -111.4 157.85 19.77 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 118.677 -0.678 . . . . 0.0 109.418 -179.144 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.721 ' HB2' ' HA ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 167.36 -149.08 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.428 0 O-C-N 123.543 0.527 . . . . 0.0 111.516 179.659 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -130.31 157.04 43.62 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.088 -178.184 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.582 ' HA ' ' HA ' ' A' ' 74' ' ' ARG . 38.8 ttt85 -82.85 154.03 24.86 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 179.181 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.501 HE22 ' HD1' ' A' ' 47' ' ' PHE . 8.8 tt0 -162.57 164.57 26.74 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.795 -0.362 . . . . 0.0 111.309 -177.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.454 ' HA3' HG22 ' A' ' 72' ' ' THR . . . -128.22 146.0 16.45 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.094 179.6 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 12.3 tt -128.74 136.01 60.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 120.977 0.417 . . . . 0.0 110.305 179.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -80.34 138.85 36.76 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.057 0.456 . . . . 0.0 110.348 179.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.743 HD13 HD11 ' A' ' 19' ' ' LEU . 50.0 mt -101.98 43.38 1.07 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.804 0.811 . . . . 0.0 109.857 -179.755 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.5 ' HA ' ' OG ' ' A' ' 2' ' ' SER . 0.9 OUTLIER -76.67 0.28 20.89 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 114.689 -1.142 . . . . 0.0 111.097 -179.347 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 14.6 mtp180 -98.12 -6.11 32.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.517 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.415 HG13 HD22 ' A' ' 37' ' ' LEU . 22.8 mm -101.48 118.89 48.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 -179.131 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -132.1 143.89 50.33 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.004 -178.721 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -96.92 102.92 14.8 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.654 0.74 . . . . 0.0 110.487 178.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.2 p -87.81 117.84 32.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.232 0.539 . . . . 0.0 110.047 179.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 60.43 27.18 16.78 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.228 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 95.83 -9.42 68.37 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.813 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.483 ' N ' ' HD2' ' A' ' 99' ' ' ARG . 4.0 mpt_? -99.77 124.82 45.43 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 122.394 -0.474 . . . . 0.0 110.17 -179.642 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.417 ' H ' ' HB3' ' A' ' 33' ' ' SER . 12.2 tp -75.76 114.99 14.99 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.977 -179.247 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 45.7 t -130.4 145.73 35.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.25 -179.066 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.615 ' HB2' HD11 ' A' ' 35' ' ' LEU . 11.8 t80 -78.67 135.65 37.25 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 178.538 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.947 0 CA-C-O 118.774 -0.631 . . . . 0.0 109.996 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.448 -0.54 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.44 ' CB ' HD11 ' A' ' 100' ' ' LEU . 6.7 p90 -54.71 -39.89 68.66 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 -177.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.614 ' HA ' ' OG ' ' A' ' 7' ' ' SER . . . -60.62 -20.42 60.65 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -178.266 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -68.42 -35.48 77.69 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.418 0.628 . . . . 0.0 109.808 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 8.1 m -120.38 34.8 5.08 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.855 -179.12 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.614 ' OG ' ' HA ' ' A' ' 4' ' ' ALA . 92.6 p -142.73 167.14 22.79 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 121.053 0.454 . . . . 0.0 110.161 178.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 13.5 ptp180 -152.19 166.46 31.66 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.018 -179.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 51.0 m-80 59.31 47.57 11.25 Favored 'General case' 0 N--CA 1.466 0.367 0 O-C-N 123.646 0.591 . . . . 0.0 110.959 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.4 ' HA ' ' HB2' ' A' ' 21' ' ' ALA . . . -80.53 118.45 22.14 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.823 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 29.6 m -126.52 170.52 16.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.12 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.781 HD21 ' HG ' ' A' ' 64' ' ' LEU . 3.1 mm? -104.53 114.77 29.21 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.237 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.436 ' OG1' ' HB ' ' A' ' 18' ' ' THR . 14.8 p -109.89 166.37 10.98 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.736 179.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.528 ' O ' ' HG2' ' A' ' 17' ' ' ARG . 90.4 m-20 57.15 50.28 12.1 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.13 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 83.42 -34.2 2.91 Favored Glycine 0 N--CA 1.452 -0.27 0 CA-C-N 115.962 -0.563 . . . . 0.0 112.841 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.612 ' HA2' ' HB3' ' A' ' 12' ' ' LEU . . . 135.59 42.44 0.12 Allowed Glycine 0 N--CA 1.447 -0.567 0 N-CA-C 111.194 -0.762 . . . . 0.0 111.194 -179.348 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.528 ' HG2' ' O ' ' A' ' 14' ' ' ASN . 5.4 ptm180 -124.55 -27.53 3.7 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.95 0.405 . . . . 0.0 110.712 -179.419 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.467 HG22 ' HB3' ' A' ' 34' ' ' GLU . 2.3 m -102.63 134.52 45.87 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.192 -179.177 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.742 HD11 HD13 ' A' ' 90' ' ' LEU . 45.9 mt -94.43 111.08 22.82 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.05 178.75 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.457 ' HA ' ' HG2' ' A' ' 34' ' ' GLU . 25.7 ttt85 -106.98 120.03 40.96 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 179.421 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.4 ' HB2' ' HA ' ' A' ' 10' ' ' ALA . . . -155.06 167.03 31.73 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.873 0.368 . . . . 0.0 111.247 -179.706 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -89.09 108.03 19.37 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 177.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.592 ' SG ' HD13 ' A' ' 100' ' ' LEU . 46.8 m -95.93 129.73 43.11 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 120.778 0.323 . . . . 0.0 110.734 -178.376 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.571 ' HB2' ' CZ3' ' A' ' 30' ' ' TRP . 11.3 ttt85 -82.82 117.63 22.84 Favored 'General case' 0 N--CA 1.438 -1.06 0 N-CA-C 110.171 -0.307 . . . . 0.0 110.171 179.167 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 32.4 p30 -80.38 166.61 21.12 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.928 179.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.84 -26.03 44.82 Favored 'General case' 0 N--CA 1.465 0.285 0 O-C-N 123.702 0.626 . . . . 0.0 112.262 -178.59 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -71.12 -16.09 62.54 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.168 0.509 . . . . 0.0 110.091 179.663 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 93.21 24.67 21.48 Favored Glycine 0 N--CA 1.447 -0.567 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.22 179.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.44 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 32.7 m-20 -116.55 160.01 21.27 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.851 0.357 . . . . 0.0 111.449 -179.247 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.571 ' CZ3' ' HB2' ' A' ' 24' ' ' ARG . 93.5 m95 -95.73 122.62 38.7 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.067 0.46 . . . . 0.0 111.876 -179.305 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.4 m -122.8 134.08 67.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.59 178.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 23.1 m -75.23 113.09 12.19 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.05 179.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.407 ' HB2' ' SG ' ' A' ' 23' ' ' CYS . 74.4 m -128.43 153.57 46.96 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.08 -179.601 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.587 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 49.3 mt-10 -137.93 144.54 41.29 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.768 -179.582 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.455 HD12 HD23 ' A' ' 37' ' ' LEU . 1.8 tm? -137.86 129.28 27.91 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 178.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.435 ' N ' HD13 ' A' ' 35' ' ' LEU . 13.6 m-20 -86.88 109.74 19.51 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.417 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.534 HD13 HD22 ' A' ' 90' ' ' LEU . 3.0 mt -82.02 -18.27 43.89 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 112.57 0.581 . . . . 0.0 112.57 -178.655 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.459 ' HA ' ' HD1' ' A' ' 55' ' ' PHE . 6.7 p-10 -65.7 -6.18 10.76 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.708 0.29 . . . . 0.0 111.522 -178.56 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 46.9 p -78.76 -23.25 45.46 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.836 179.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.542 ' HG ' ' HZ ' ' A' ' 102' ' ' PHE . 17.2 t -130.31 -10.77 4.14 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -179.468 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.406 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 49.0 mt -99.77 128.76 51.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 178.504 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.533 ' HA3' ' HB3' ' A' ' 52' ' ' MET . . . -142.47 150.9 22.57 Favored Glycine 0 N--CA 1.442 -0.952 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.119 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.922 HD22 ' HB3' ' A' ' 75' ' ' PRO . 31.1 p-10 -157.11 47.94 0.31 Allowed Pre-proline 0 C--N 1.323 -0.579 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -179.713 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -73.01 -17.25 25.18 Favored 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 121.638 1.558 . . . . 0.0 111.87 -179.303 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -93.09 -5.84 49.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.467 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.593 ' HA3' ' HG2' ' A' ' 83' ' ' ARG . . . 101.56 7.15 49.13 Favored Glycine 0 N--CA 1.443 -0.871 0 C-N-CA 120.334 -0.936 . . . . 0.0 112.834 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -125.45 131.55 52.86 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.015 0.436 . . . . 0.0 111.309 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.451 HD23 ' HB3' ' A' ' 43' ' ' ASN . 81.7 mt -83.77 137.68 33.62 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.378 -178.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 177.62 171.66 41.32 Favored Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 120.861 -0.685 . . . . 0.0 111.854 179.08 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.48 ' CD2' ' HD3' ' A' ' 92' ' ' ARG . 90.6 m95 -96.29 125.04 40.52 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.997 0.427 . . . . 0.0 110.191 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 154.85 -58.3 0.39 Allowed Glycine 0 CA--C 1.507 -0.449 0 N-CA-C 110.916 -0.874 . . . . 0.0 110.916 -179.297 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.533 ' HB3' ' HA3' ' A' ' 42' ' ' GLY . 44.7 tpp -82.93 174.3 11.04 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 178.661 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -132.11 176.66 8.19 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 118.654 0.661 . . . . 0.0 111.798 -179.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 15.1 m-80 64.65 43.04 4.43 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.467 -0.788 . . . . 0.0 112.342 179.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.459 ' HD1' ' HA ' ' A' ' 38' ' ' ASP . 6.3 p90 -69.12 -25.5 64.43 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.997 -0.372 . . . . 0.0 109.997 179.217 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 9.4 p -58.24 -42.7 86.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.355 -179.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 41.4 m80 -80.26 -9.99 59.74 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.011 0.434 . . . . 0.0 111.215 -179.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.684 ' HA ' ' HD2' ' A' ' 76' ' ' LYS . 10.2 m -113.28 18.26 17.97 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.604 -178.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 23.5 m -131.85 143.64 50.32 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-O 121.158 0.504 . . . . 0.0 111.336 179.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 67.2 mm-40 -113.58 134.51 54.67 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.675 178.497 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 23.9 t70 57.34 79.6 0.19 Allowed 'General case' 0 C--N 1.322 -0.601 0 O-C-N 123.994 0.809 . . . . 0.0 111.33 -179.236 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.53 HG23 HD21 ' A' ' 71' ' ' LEU . 75.6 mt -91.6 123.57 43.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.882 179.691 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 27.8 tptt -149.05 149.88 31.85 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 110.156 -0.312 . . . . 0.0 110.156 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.781 ' HG ' HD21 ' A' ' 12' ' ' LEU . 70.3 mt -85.89 141.27 29.7 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.188 0.518 . . . . 0.0 110.608 179.233 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -100.68 -70.84 0.72 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.432 -0.804 . . . . 0.0 112.515 -178.283 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.452 ' HG3' ' HB3' ' A' ' 70' ' ' LYS . 31.3 mt-10 -74.67 49.0 0.38 Allowed 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -178.185 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 64.95 7.97 32.68 Favored Glycine 0 C--N 1.32 -0.326 0 CA-C-N 115.938 -0.574 . . . . 0.0 112.848 179.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.606 ' HA2' HD13 ' A' ' 64' ' ' LEU . . . 127.26 -3.3 7.24 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.645 -0.788 . . . . 0.0 113.122 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 29.9 ttp85 -95.43 0.38 53.31 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.793 0.806 . . . . 0.0 110.317 -179.448 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.452 ' HB3' ' HG3' ' A' ' 66' ' ' GLU . 0.5 OUTLIER -147.69 129.49 15.21 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.403 -179.984 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.575 ' HB2' HD11 ' A' ' 90' ' ' LEU . 10.0 tt -105.82 118.98 37.99 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 179.599 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.5 p -108.79 128.1 54.59 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.018 179.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.446 ' HB3' ' HA ' ' A' ' 62' ' ' ILE . 26.5 p -157.74 172.11 19.09 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.054 -179.727 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.531 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 78.9 ttt180 -108.16 100.44 36.82 Favored Pre-proline 0 C--N 1.31 -1.112 0 C-N-CA 120.225 -0.59 . . . . 0.0 109.971 178.614 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.922 ' HB3' HD22 ' A' ' 43' ' ' ASN . 19.2 Cg_endo -60.29 130.46 34.13 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 122.655 2.237 . . . . 0.0 110.246 178.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.684 ' HD2' ' HA ' ' A' ' 58' ' ' SER . 0.0 OUTLIER -119.97 154.14 34.93 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.256 0.551 . . . . 0.0 111.665 -179.133 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.716 ' HB ' ' HD2' ' A' ' 83' ' ' ARG . 6.3 t -94.08 147.64 22.94 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.69 -0.687 . . . . 0.0 109.551 179.131 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.4 p -72.34 -6.67 8.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 O-C-N 123.834 0.709 . . . . 0.0 111.941 -178.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -65.39 -23.15 66.89 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.108 0.48 . . . . 0.0 110.367 179.212 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -177.8 -8.99 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.987 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 94.42 22.1 25.27 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.707 -0.759 . . . . 0.0 111.72 179.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.627 ' O ' HG22 ' A' ' 77' ' ' THR . 26.7 p90 -111.33 153.1 26.45 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 -179.367 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.716 ' HD2' ' HB ' ' A' ' 77' ' ' THR . 0.0 OUTLIER 171.63 -148.39 0.0 OUTLIER 'General case' 0 C--O 1.233 0.224 0 O-C-N 123.683 0.614 . . . . 0.0 110.956 179.958 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -123.4 160.14 27.45 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.173 -177.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.531 ' HA ' ' HA ' ' A' ' 74' ' ' ARG . 41.8 ttt180 -86.66 155.09 20.54 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 179.562 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -163.99 169.32 18.16 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 121.091 0.472 . . . . 0.0 110.992 -178.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -136.85 133.06 6.29 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.841 -0.695 . . . . 0.0 111.686 179.169 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 10.1 tt -115.28 134.51 58.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-O 121.047 0.451 . . . . 0.0 110.18 -179.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -80.26 141.14 35.83 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.142 -179.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.742 HD13 HD11 ' A' ' 19' ' ' LEU . 16.6 mt -106.73 43.5 1.15 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.455 0.645 . . . . 0.0 110.887 -178.343 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 45.4 m-80 -79.63 3.28 19.52 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.463 -179.506 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.48 ' HD3' ' CD2' ' A' ' 50' ' ' TRP . 32.6 mtp180 -93.69 -9.89 36.28 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.576 178.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 17.2 mm -96.02 112.1 27.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 -179.57 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -119.1 147.01 44.63 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.149 -178.044 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 16.8 p-10 -95.6 102.89 14.73 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.51 0.671 . . . . 0.0 109.602 178.12 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 46.7 t -92.05 105.94 17.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.971 -179.351 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 60.7 33.88 20.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.842 -179.488 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 94.98 -23.03 35.03 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 121.037 -0.601 . . . . 0.0 113.007 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 3.7 mpt_? -87.13 129.39 34.95 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.945 0.373 . . . . 0.0 110.107 -179.181 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.592 HD13 ' SG ' ' A' ' 23' ' ' CYS . 6.7 tp -78.38 117.64 19.8 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -179.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 25.4 t -128.93 141.03 47.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.262 -179.155 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.542 ' HZ ' ' HG ' ' A' ' 40' ' ' CYS . 5.9 t80 -86.55 135.0 33.61 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 178.53 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.616 HE21 ' HA ' ' A' ' 103' ' ' GLN . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.178 0 CA-C-O 118.506 -0.759 . . . . 0.0 110.234 179.43 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.1 m . . . . . 0 N--CA 1.448 -0.527 0 CA-C-O 120.439 0.161 . . . . 0.0 110.645 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.511 ' HA ' ' OD1' ' A' ' 95' ' ' ASN . 11.0 p90 -57.49 -35.19 69.88 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.666 -0.243 . . . . 0.0 111.298 179.245 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -57.29 -22.24 40.37 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -178.978 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -66.27 -13.6 60.68 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.05 0.453 . . . . 0.0 110.977 179.565 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 11.0 p -149.25 33.98 0.73 Allowed 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 178.814 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 15.9 t -146.95 150.7 35.7 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.021 -179.268 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 34.6 ptt180 -129.55 164.5 23.67 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.666 -179.232 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 51.25 65.32 1.52 Allowed 'General case' 0 C--N 1.329 -0.299 0 O-C-N 123.826 0.704 . . . . 0.0 112.151 178.503 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.446 ' HA ' ' HB2' ' A' ' 21' ' ' ALA . . . -91.3 117.85 30.0 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.155 179.449 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 33.8 m -119.39 166.95 13.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.881 -179.372 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.636 HD21 ' HG ' ' A' ' 64' ' ' LEU . 3.1 mm? -105.22 117.14 33.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.014 -179.734 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.49 ' OG1' ' HB ' ' A' ' 18' ' ' THR . 23.5 p -111.29 164.21 13.14 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.639 -179.65 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.49 ' HB3' ' HD3' ' A' ' 17' ' ' ARG . 89.6 m-20 62.26 39.08 12.86 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.71 179.265 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 84.62 -8.47 68.77 Favored Glycine 0 CA--C 1.517 0.179 0 C-N-CA 120.742 -0.742 . . . . 0.0 113.325 179.144 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.495 ' HA2' ' HB3' ' A' ' 12' ' ' LEU . . . 114.09 53.88 0.43 Allowed Glycine 0 N--CA 1.443 -0.873 0 C-N-CA 120.527 -0.844 . . . . 0.0 111.383 179.421 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.49 ' HD3' ' HB3' ' A' ' 14' ' ' ASN . 3.4 ptm180 -137.78 -34.01 0.69 Allowed 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.088 0.471 . . . . 0.0 110.573 -179.91 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.49 ' HB ' ' OG1' ' A' ' 13' ' ' THR . 4.2 m -102.36 135.06 44.65 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.54 -179.798 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.713 HD11 HD13 ' A' ' 90' ' ' LEU . 62.6 mt -94.95 116.4 28.65 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.218 179.136 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.411 ' NE ' HG21 ' A' ' 13' ' ' THR . 33.5 ttm180 -111.4 120.39 42.0 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 178.732 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.446 ' HB2' ' HA ' ' A' ' 10' ' ' ALA . . . -153.7 165.34 36.29 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.862 0.363 . . . . 0.0 111.418 -179.526 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -91.44 106.0 18.17 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 177.801 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.404 ' HB3' HD22 ' A' ' 95' ' ' ASN . 64.0 m -96.01 134.89 38.49 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 120.911 0.386 . . . . 0.0 110.984 -178.495 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.511 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 15.1 ttp180 -77.54 111.41 13.24 Favored 'General case' 0 N--CA 1.439 -0.999 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.052 179.558 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.463 HD21 ' HB3' ' A' ' 29' ' ' ASN . 38.2 p30 -75.71 169.38 18.22 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.48 -179.786 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.86 -33.29 64.42 Favored 'General case' 0 C--O 1.235 0.296 0 O-C-N 123.416 0.447 . . . . 0.0 111.718 -179.151 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -68.22 -14.69 63.17 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.327 0.584 . . . . 0.0 110.677 179.969 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 88.66 37.56 7.38 Favored Glycine 0 N--CA 1.447 -0.589 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 -179.504 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.511 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 53.7 t30 -124.81 164.16 20.6 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.496 0.189 . . . . 0.0 110.891 -179.082 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 91.1 m95 -98.05 124.89 42.77 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.885 179.587 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.4 m -128.42 137.88 56.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.028 178.544 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 37.4 m -84.1 109.32 17.61 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.002 0.43 . . . . 0.0 111.055 -179.048 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 69.6 m -119.09 148.8 42.64 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.138 179.409 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.646 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 45.4 mt-10 -127.86 145.33 50.97 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.867 -179.955 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.798 HD11 ' HB2' ' A' ' 102' ' ' PHE . 1.8 tm? -139.71 130.58 26.12 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 179.507 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.49 ' N ' HD13 ' A' ' 35' ' ' LEU . 39.7 m-20 -87.26 110.53 20.26 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.002 179.825 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.524 HD13 HD22 ' A' ' 90' ' ' LEU . 1.8 mt -84.86 -20.79 30.27 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.845 0.355 . . . . 0.0 110.871 -179.923 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.423 ' HA ' ' HD1' ' A' ' 55' ' ' PHE . 5.6 p-10 -67.35 -5.88 16.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.983 -178.195 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.416 HG22 ' O ' ' A' ' 36' ' ' ASP . 10.6 t -84.65 -8.51 58.85 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.867 0.365 . . . . 0.0 110.358 179.415 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 21.8 t -140.49 -5.41 1.22 Allowed 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 179.511 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 59.5 mt -106.95 136.7 41.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 O-C-N 122.036 -0.415 . . . . 0.0 109.882 178.957 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.656 ' HA3' ' HB3' ' A' ' 52' ' ' MET . . . -146.72 154.38 25.94 Favored Glycine 0 N--CA 1.443 -0.846 0 C-N-CA 120.89 -0.671 . . . . 0.0 111.777 179.553 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.4 HD22 ' CD2' ' A' ' 48' ' ' LEU . 27.6 p30 -155.28 48.15 0.36 Allowed Pre-proline 0 CA--C 1.537 0.454 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 179.986 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -68.69 -23.75 35.83 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 121.722 1.614 . . . . 0.0 112.238 -179.084 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 72.0 m-20 -91.94 0.59 57.47 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.923 -179.582 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.546 ' CA ' ' HG2' ' A' ' 83' ' ' ARG . . . 93.05 7.28 62.59 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.287 -0.959 . . . . 0.0 112.049 -179.301 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.654 ' HA ' HE22 ' A' ' 86' ' ' GLN . 47.7 m-85 -122.55 133.95 54.55 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.851 0.357 . . . . 0.0 110.807 179.831 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.433 ' HB3' ' HB ' ' A' ' 88' ' ' ILE . 34.0 mt -84.5 147.89 26.81 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.536 -0.757 . . . . 0.0 111.664 -179.172 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 170.37 168.95 32.91 Favored Glycine 0 N--CA 1.441 -1.023 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.974 179.121 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.403 ' HH2' HD11 ' A' ' 93' ' ' ILE . 89.1 m95 -95.64 125.33 40.15 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 179.975 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 161.77 -53.72 0.32 Allowed Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 121.026 -0.607 . . . . 0.0 112.249 -179.696 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.656 ' HB3' ' HA3' ' A' ' 42' ' ' GLY . 4.1 tpt -90.92 -164.82 1.23 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 -179.952 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.414 ' HG3' HD22 ' A' ' 54' ' ' ASN . 12.0 pt20 -146.3 170.58 16.5 Favored 'General case' 0 C--O 1.234 0.275 0 O-C-N 122.025 -0.422 . . . . 0.0 111.939 -178.815 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.414 HD22 ' HG3' ' A' ' 53' ' ' GLN . 42.2 m-80 64.0 36.13 10.17 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.454 -0.794 . . . . 0.0 112.599 178.991 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.454 ' HB3' ' HA2' ' A' ' 42' ' ' GLY . 8.0 p90 -65.23 -29.75 70.58 Favored 'General case' 0 C--O 1.224 -0.288 0 CA-C-O 120.684 0.278 . . . . 0.0 111.193 -179.896 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.454 ' HB2' ' HB3' ' A' ' 17' ' ' ARG . 13.4 t -57.07 -36.69 70.85 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -178.315 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 13.3 m-70 -80.82 -6.56 58.72 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.151 0.5 . . . . 0.0 110.984 -179.528 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 12.9 m -119.03 25.78 9.96 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.118 -179.987 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.532 ' HB2' HD11 ' A' ' 62' ' ' ILE . 11.6 m -137.3 140.23 41.4 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-O 121.059 0.457 . . . . 0.0 111.321 179.788 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -108.71 141.2 41.04 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.179 179.063 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 39.1 t70 52.35 75.94 0.21 Allowed 'General case' 0 C--N 1.32 -0.7 0 O-C-N 123.998 0.811 . . . . 0.0 111.402 179.95 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.533 HG23 HD21 ' A' ' 71' ' ' LEU . 81.6 mt -90.22 122.25 41.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.235 179.591 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.7 tptm -146.97 160.32 42.5 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.124 -178.892 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.636 ' HG ' HD21 ' A' ' 12' ' ' LEU . 55.8 mt -93.66 130.01 39.75 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.267 0.556 . . . . 0.0 110.012 178.602 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.462 ' HB3' ' HB3' ' A' ' 70' ' ' LYS . 45.2 tp10 -77.71 -66.33 0.85 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.39 -178.108 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.534 ' HB2' ' HB3' ' A' ' 69' ' ' ARG . 23.7 mt-10 -88.68 31.43 0.84 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.189 -178.889 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 68.04 17.91 70.3 Favored Glycine 0 N--CA 1.446 -0.638 0 CA-C-N 115.8 -0.636 . . . . 0.0 113.091 179.83 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.517 ' HA2' HD22 ' A' ' 64' ' ' LEU . . . 137.14 -21.96 3.28 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 119.828 -1.177 . . . . 0.0 113.3 179.184 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.534 ' HB3' ' HB2' ' A' ' 66' ' ' GLU . 0.8 OUTLIER -76.74 -21.05 55.81 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.579 0.704 . . . . 0.0 109.987 -179.642 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.462 ' HB3' ' HB3' ' A' ' 65' ' ' GLU . 2.6 ttmp? -148.43 138.46 22.42 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.094 -178.708 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.641 ' HB2' HD11 ' A' ' 90' ' ' LEU . 10.2 tt -108.89 124.96 51.46 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.309 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.1 p -116.16 127.77 55.08 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.544 0.687 . . . . 0.0 111.014 179.561 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.496 ' HB3' ' HA ' ' A' ' 62' ' ' ILE . 26.6 p -153.51 175.86 12.7 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.314 -179.721 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.615 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 12.0 ttt180 -108.33 98.74 28.77 Favored Pre-proline 0 C--N 1.31 -1.114 0 C-N-CA 120.623 -0.431 . . . . 0.0 110.007 178.654 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.665 ' O ' ' HB3' ' A' ' 83' ' ' ARG . 49.4 Cg_endo -67.12 122.54 9.86 Favored 'Trans proline' 0 CA--C 1.516 -0.4 0 C-N-CA 122.835 2.357 . . . . 0.0 110.82 179.478 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.778 ' HA ' ' HB2' ' A' ' 83' ' ' ARG . 0.3 OUTLIER -120.29 147.04 45.5 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-O 120.914 0.388 . . . . 0.0 111.564 -179.333 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.771 HG22 ' O ' ' A' ' 82' ' ' PHE . 7.9 t -74.84 137.82 42.11 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 178.988 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 29.6 m -73.2 -12.33 15.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 123.82 0.7 . . . . 0.0 111.355 -179.635 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -63.55 -33.38 75.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.652 179.379 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.553 ' HA3' ' CE2' ' A' ' 82' ' ' PHE . . . -145.81 -23.07 0.12 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.42 -0.895 . . . . 0.0 113.088 179.73 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.616 ' HA2' ' HD3' ' A' ' 76' ' ' LYS . . . 98.68 14.7 36.6 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 121.049 -0.596 . . . . 0.0 111.877 -179.706 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.771 ' O ' HG22 ' A' ' 77' ' ' THR . 28.2 p90 -112.48 154.26 26.15 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 119.029 -0.51 . . . . 0.0 110.608 -178.492 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.778 ' HB2' ' HA ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 167.38 -153.13 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.461 0 O-C-N 123.745 0.653 . . . . 0.0 111.202 178.308 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.408 ' O ' ' HG3' ' A' ' 74' ' ' ARG . 18.7 mm-40 -116.48 -177.34 3.16 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.143 -177.24 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.615 ' HA ' ' HA ' ' A' ' 74' ' ' ARG . 68.0 ttt180 -107.21 155.31 20.05 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 178.783 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.654 HE22 ' HA ' ' A' ' 47' ' ' PHE . 8.9 tt0 -166.37 167.74 15.57 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 120.87 0.366 . . . . 0.0 111.491 -178.976 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.459 ' N ' ' HG2' ' A' ' 86' ' ' GLN . . . -130.39 144.08 15.4 Favored Glycine 0 N--CA 1.45 -0.428 0 N-CA-C 111.564 -0.614 . . . . 0.0 111.564 178.601 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.433 ' HB ' ' HB3' ' A' ' 48' ' ' LEU . 9.4 tt -126.57 138.92 53.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 120.93 0.395 . . . . 0.0 110.517 -179.846 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.443 ' HB3' HD22 ' A' ' 91' ' ' ASN . 5.0 m-20 -77.42 135.91 38.35 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.369 179.811 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.713 HD13 HD11 ' A' ' 19' ' ' LEU . 53.9 mt -105.38 39.43 1.74 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.688 -179.884 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.443 HD22 ' HB3' ' A' ' 89' ' ' ASP . 18.8 m-80 -75.35 2.53 11.03 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.104 -179.541 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 49.0 mtp180 -95.88 -10.48 28.72 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.657 -0.702 . . . . 0.0 109.967 178.33 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.476 HG13 HD22 ' A' ' 37' ' ' LEU . 20.9 mm -100.66 99.51 8.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -179.764 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 24.4 tp60 -115.98 143.14 45.85 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.089 -178.485 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.511 ' OD1' ' HA ' ' A' ' 3' ' ' TYR . 15.0 p-10 -95.18 122.81 38.25 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.008 178.728 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.455 HG22 HD22 ' A' ' 97' ' ' ASN . 7.3 p -115.04 115.75 50.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-O 121.16 0.505 . . . . 0.0 109.944 179.313 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.455 HD22 HG22 ' A' ' 96' ' ' VAL . 32.1 m-80 60.37 28.3 17.92 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.709 -179.166 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 94.77 -14.94 64.4 Favored Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 120.804 -0.712 . . . . 0.0 113.048 179.915 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.47 ' N ' ' HD2' ' A' ' 99' ' ' ARG . 3.3 mpt_? -91.7 131.93 36.74 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 117.158 0.479 . . . . 0.0 110.559 -179.12 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.41 ' HA ' HD12 ' A' ' 100' ' ' LEU . 8.5 tp -84.29 116.54 23.05 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.251 -179.28 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 24.4 t -125.54 140.3 48.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 120.798 0.332 . . . . 0.0 110.914 -179.287 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.798 ' HB2' HD11 ' A' ' 35' ' ' LEU . 3.9 t80 -91.67 124.37 35.76 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 178.396 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 . . . . . 0 C--N 1.314 -0.969 0 CA-C-O 118.002 -0.999 . . . . 0.0 110.955 179.82 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . 0.591 ' OG ' ' HA ' ' A' ' 91' ' ' ASN . 3.3 m . . . . . 0 N--CA 1.452 -0.355 0 N-CA-C 109.97 -0.382 . . . . 0.0 109.97 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.557 ' HA ' ' OD1' ' A' ' 95' ' ' ASN . 23.4 p90 -58.31 -37.65 75.5 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.53 0.205 . . . . 0.0 111.446 -179.892 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -55.09 -19.2 6.77 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.792 -0.64 . . . . 0.0 112.623 -178.794 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -59.15 -38.15 79.03 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.389 0.614 . . . . 0.0 109.956 179.168 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 49.2 m -133.08 46.5 2.6 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.15 179.086 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.431 ' HA ' ' HZ3' ' A' ' 30' ' ' TRP . 16.5 t -148.79 152.18 36.09 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.22 -179.329 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.449 ' HG3' HD22 ' A' ' 9' ' ' ASN . 3.9 ptp180 -149.39 171.69 16.14 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.314 -179.846 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.449 HD22 ' HG3' ' A' ' 8' ' ' ARG . 49.1 m-80 62.96 45.84 5.16 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 122.959 0.504 . . . . 0.0 110.437 -179.286 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -83.16 118.07 23.34 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.996 -179.718 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 27.1 m -126.24 170.69 15.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.193 179.519 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.565 ' HB3' ' HA2' ' A' ' 16' ' ' GLY . 3.0 mm? -105.37 117.64 34.53 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 -179.332 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.409 ' OG1' ' HB ' ' A' ' 18' ' ' THR . 28.0 p -113.87 162.17 16.69 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.974 0.416 . . . . 0.0 111.508 -179.745 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 64.32 30.33 13.39 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.526 179.652 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 95.92 -18.87 56.64 Favored Glycine 0 C--O 1.228 -0.255 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.755 179.46 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.565 ' HA2' ' HB3' ' A' ' 12' ' ' LEU . . . 123.47 42.6 0.38 Allowed Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.508 -0.853 . . . . 0.0 111.768 179.78 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -126.77 -29.02 2.9 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.096 0.474 . . . . 0.0 110.541 -179.91 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.409 ' HB ' ' OG1' ' A' ' 13' ' ' THR . 4.9 m -104.53 134.25 48.02 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.555 -179.877 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.803 HD11 HD13 ' A' ' 90' ' ' LEU . 33.6 mt -94.23 113.32 25.22 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.118 179.02 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 45.1 ttt180 -106.96 119.51 39.57 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 178.843 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -154.12 166.36 33.32 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.878 0.37 . . . . 0.0 111.151 -179.762 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.426 ' HG2' ' HB2' ' A' ' 9' ' ' ASN . 56.2 mm-40 -90.71 113.45 25.54 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 178.276 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.45 ' SG ' HD13 ' A' ' 100' ' ' LEU . 60.4 m -100.31 123.53 44.66 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 110.34 -0.245 . . . . 0.0 110.34 -178.957 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.514 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 11.7 ttp180 -72.6 114.47 10.77 Favored 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 179.015 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.407 HD21 ' HB3' ' A' ' 29' ' ' ASN . 35.4 p30 -77.66 171.04 15.54 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.85 -179.23 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.36 -33.87 63.77 Favored 'General case' 0 N--CA 1.464 0.252 0 O-C-N 123.675 0.609 . . . . 0.0 111.917 -178.776 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -67.92 -18.69 64.85 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.361 0.601 . . . . 0.0 110.613 -179.851 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 93.69 33.66 6.97 Favored Glycine 0 N--CA 1.443 -0.849 0 N-CA-C 111.085 -0.806 . . . . 0.0 111.085 -179.475 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.514 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 10.8 t-20 -118.49 159.89 22.71 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 110.013 -0.365 . . . . 0.0 110.013 -179.221 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.431 ' HZ3' ' HA ' ' A' ' 7' ' ' SER . 95.5 m95 -98.37 117.67 33.31 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.855 0.36 . . . . 0.0 110.6 179.918 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 12.5 m -119.23 132.27 69.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.38 178.773 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 27.9 m -74.86 110.36 9.09 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.021 0.439 . . . . 0.0 110.231 -179.624 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 60.7 m -121.29 145.62 47.68 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.599 -179.606 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.598 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 50.4 mt-10 -129.03 130.59 46.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.931 -179.505 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.449 HD11 ' HB2' ' A' ' 102' ' ' PHE . 2.4 tm? -124.86 131.62 53.42 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.437 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.423 ' N ' HD13 ' A' ' 35' ' ' LEU . 9.0 m-20 -89.78 109.16 20.17 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.841 0.353 . . . . 0.0 110.189 -179.114 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.529 HD13 HD22 ' A' ' 90' ' ' LEU . 2.4 mt -81.87 -17.84 45.9 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.164 -179.494 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -62.18 -10.18 9.78 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.817 0.342 . . . . 0.0 111.149 -179.317 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 59.5 p -78.99 -20.4 49.18 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.191 179.585 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.424 ' SG ' ' HE3' ' A' ' 50' ' ' TRP . 20.5 t -132.36 -8.66 3.32 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -179.191 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 53.9 mt -104.69 133.45 48.79 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 O-C-N 122.132 -0.355 . . . . 0.0 110.225 178.777 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.525 ' HA3' ' HB3' ' A' ' 52' ' ' MET . . . -147.84 160.28 28.27 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.921 -0.657 . . . . 0.0 111.823 179.91 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.464 HD22 ' CD1' ' A' ' 48' ' ' LEU . 21.6 p30 -162.3 54.15 0.46 Allowed Pre-proline 0 CA--C 1.537 0.45 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -179.799 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -72.16 -18.17 27.32 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 121.923 1.749 . . . . 0.0 112.311 -179.242 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.449 ' O ' ' HD3' ' A' ' 83' ' ' ARG . 93.0 m-20 -93.25 -16.51 24.69 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.437 179.822 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.538 ' HA3' ' HG2' ' A' ' 83' ' ' ARG . . . 109.82 9.64 24.3 Favored Glycine 0 N--CA 1.442 -0.964 0 C-N-CA 120.467 -0.873 . . . . 0.0 112.542 -179.333 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.527 ' HD1' HE22 ' A' ' 86' ' ' GLN . 54.6 m-85 -125.55 134.67 51.9 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.872 0.368 . . . . 0.0 110.623 179.716 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.595 HD23 HG22 ' A' ' 88' ' ' ILE . 10.5 mp -84.23 142.91 29.94 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.345 0.593 . . . . 0.0 111.848 -178.603 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 176.96 171.33 40.44 Favored Glycine 0 N--CA 1.439 -1.148 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.611 178.956 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.424 ' HE3' ' SG ' ' A' ' 40' ' ' CYS . 91.4 m95 -96.11 124.74 40.23 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 179.835 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 160.2 -58.81 0.31 Allowed Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 121.21 -0.519 . . . . 0.0 111.873 -179.708 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.525 ' HB3' ' HA3' ' A' ' 42' ' ' GLY . 12.8 tpt -85.89 175.2 8.77 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 -179.893 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -128.8 167.0 17.95 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.722 -0.391 . . . . 0.0 111.075 -179.712 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 11.3 m-80 64.56 49.79 2.3 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.449 179.026 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.453 ' HB3' ' HA2' ' A' ' 42' ' ' GLY . 21.1 p90 -68.48 -31.2 70.31 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.07 0.462 . . . . 0.0 110.187 179.021 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.443 ' HA ' HD11 ' A' ' 62' ' ' ILE . 3.5 p -56.53 -38.16 71.48 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.591 -178.699 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 22.4 m80 -72.49 -30.94 64.96 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.632 0.253 . . . . 0.0 111.331 -179.52 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 14.1 m -96.88 18.36 14.74 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.011 -179.488 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 45.4 m -130.79 165.31 23.25 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.199 0.523 . . . . 0.0 111.491 -179.756 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -137.64 136.14 37.19 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.245 -0.889 . . . . 0.0 108.95 178.589 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 37.0 t70 58.88 80.22 0.19 Allowed 'General case' 0 N--CA 1.467 0.425 0 O-C-N 123.649 0.593 . . . . 0.0 110.86 -179.705 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.525 ' HA ' ' HB3' ' A' ' 73' ' ' CYS . 59.9 mt -100.95 122.16 52.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.261 -179.13 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 72.9 tttt -149.22 165.1 32.89 Favored 'General case' 0 C--O 1.221 -0.407 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 179.466 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.525 ' HG ' HD21 ' A' ' 12' ' ' LEU . 71.2 mt -90.84 127.39 36.34 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.068 0.461 . . . . 0.0 111.072 -179.603 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -76.29 -57.97 3.55 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.443 -0.798 . . . . 0.0 110.676 -179.179 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.477 ' CB ' ' HB3' ' A' ' 69' ' ' ARG . 15.4 mm-40 -85.03 11.84 8.81 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.789 -179.521 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 71.61 28.07 69.98 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.383 179.973 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 136.86 -34.48 2.21 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.207 -0.996 . . . . 0.0 112.627 179.448 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.477 ' HB3' ' CB ' ' A' ' 66' ' ' GLU . 2.1 tpp180 -75.62 -18.47 59.69 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.116 0.484 . . . . 0.0 110.589 -179.551 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.45 ' HB3' ' HG2' ' A' ' 66' ' ' GLU . 38.9 ttmt -151.42 141.88 22.53 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.067 -178.804 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.562 ' HB2' HD11 ' A' ' 90' ' ' LEU . 10.5 tt -110.52 128.62 55.72 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.104 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.2 p -123.16 128.11 49.6 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.317 0.58 . . . . 0.0 111.293 -179.905 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.525 ' HB3' ' HA ' ' A' ' 62' ' ' ILE . 20.5 p -151.94 169.91 21.15 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.516 179.875 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.635 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 29.4 ttt180 -106.35 99.73 25.64 Favored Pre-proline 0 C--N 1.321 -0.645 0 C-N-CA 120.263 -0.575 . . . . 0.0 110.492 179.126 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.647 ' O ' ' HB3' ' A' ' 83' ' ' ARG . 60.5 Cg_endo -71.75 137.85 30.68 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 122.622 2.215 . . . . 0.0 110.273 178.718 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.712 ' HA ' ' HB2' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -121.39 140.68 51.82 Favored 'General case' 0 C--N 1.317 -0.807 0 O-C-N 123.483 0.49 . . . . 0.0 111.113 -179.883 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.732 HG22 ' O ' ' A' ' 82' ' ' PHE . 12.5 t -75.61 138.86 41.71 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 179.291 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 34.7 m -73.18 -9.78 13.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 O-C-N 124.122 0.889 . . . . 0.0 111.199 -179.826 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -66.92 -31.39 71.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.054 179.673 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.406 ' HA3' ' CE2' ' A' ' 82' ' ' PHE . . . -154.48 -12.49 0.06 OUTLIER Glycine 0 CA--C 1.521 0.428 0 C-N-CA 120.519 -0.848 . . . . 0.0 113.359 179.751 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.615 ' HA2' ' HE3' ' A' ' 76' ' ' LYS . . . 91.25 16.25 53.88 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.959 -0.639 . . . . 0.0 112.082 -179.792 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.732 ' O ' HG22 ' A' ' 77' ' ' THR . 35.4 p90 -111.76 158.35 19.45 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 118.694 -0.669 . . . . 0.0 109.612 -178.866 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.712 ' HB2' ' HA ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 171.37 -148.25 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 179.431 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -142.99 152.49 42.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.373 -0.831 . . . . 0.0 109.496 -178.195 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.635 ' HA ' ' HA ' ' A' ' 74' ' ' ARG . 27.8 ttt85 -77.84 150.43 34.22 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 123.229 0.331 . . . . 0.0 110.123 -179.794 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.527 HE22 ' HD1' ' A' ' 47' ' ' PHE . 8.9 tt0 -155.58 158.85 39.07 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.317 -178.806 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -123.32 144.34 15.58 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.088 179.412 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.595 HG22 HD23 ' A' ' 48' ' ' LEU . 12.8 tt -123.96 135.04 64.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 179.563 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.418 ' HB2' HD22 ' A' ' 91' ' ' ASN . 2.2 p-10 -77.1 140.92 40.4 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.068 0.461 . . . . 0.0 110.017 -179.882 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.803 HD13 HD11 ' A' ' 19' ' ' LEU . 26.4 mt -106.35 41.17 1.47 Allowed 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.334 0.588 . . . . 0.0 110.765 -179.424 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.591 ' HA ' ' OG ' ' A' ' 2' ' ' SER . 28.8 m-80 -75.06 2.85 9.62 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.763 -179.96 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 9.7 mtp180 -96.72 -16.54 20.84 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.165 179.797 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.434 HG13 HD22 ' A' ' 37' ' ' LEU . 22.4 mm -92.73 114.36 29.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 109.684 -0.488 . . . . 0.0 109.684 -178.904 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 23.1 tp60 -124.6 141.46 52.08 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.356 0.598 . . . . 0.0 111.545 -178.157 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.557 ' OD1' ' HA ' ' A' ' 3' ' ' TYR . 13.1 p-10 -94.62 102.22 14.13 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.673 178.176 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.7 p -90.56 110.41 22.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.504 -179.348 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 60.42 27.32 16.92 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.14 -179.919 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 100.29 -17.04 57.48 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.735 -0.745 . . . . 0.0 113.225 179.739 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.41 ' N ' ' HD2' ' A' ' 99' ' ' ARG . 1.7 mpt_? -91.53 126.09 36.49 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 117.23 0.515 . . . . 0.0 109.871 -179.541 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.45 HD13 ' SG ' ' A' ' 23' ' ' CYS . 11.2 tp -82.84 114.03 20.87 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.233 -179.203 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 38.4 t -131.47 146.48 33.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 120.694 0.283 . . . . 0.0 110.321 -179.338 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.449 ' HB2' HD11 ' A' ' 35' ' ' LEU . 11.7 t80 -78.67 133.94 37.17 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 178.771 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 . . . . . 0 C--O 1.247 0.951 0 CA-C-O 118.632 -0.699 . . . . 0.0 110.067 179.824 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . 0.848 ' HB2' ' HG2' ' A' ' 69' ' ' ARG . 4.7 m . . . . . 0 N--CA 1.452 -0.328 0 CA-C-O 120.639 0.257 . . . . 0.0 110.848 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.422 ' CD2' HD11 ' A' ' 100' ' ' LEU . 4.2 p90 -59.85 -33.27 71.56 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.228 -0.442 . . . . 0.0 112.032 -179.713 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.606 ' HA ' ' OG ' ' A' ' 7' ' ' SER . . . -55.16 -18.41 5.72 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -178.167 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -58.32 -42.85 87.65 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.976 0.417 . . . . 0.0 111.166 179.727 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.416 ' HB2' HD21 ' A' ' 95' ' ' ASN . 25.6 m -123.02 38.44 4.19 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 121.044 0.45 . . . . 0.0 110.903 -179.486 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.606 ' OG ' ' HA ' ' A' ' 4' ' ' ALA . 52.5 p -141.28 168.19 20.37 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.21 179.143 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 37.1 ptt180 -149.76 168.23 24.27 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.005 -178.564 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 55.25 43.24 29.52 Favored 'General case' 0 C--N 1.33 -0.244 0 O-C-N 124.089 0.868 . . . . 0.0 112.203 178.078 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.442 ' HA ' ' HB2' ' A' ' 21' ' ' ALA . . . -72.28 117.0 13.38 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 179.251 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.463 HG21 HH21 ' A' ' 20' ' ' ARG . 27.8 m -124.0 172.74 11.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.713 -179.423 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.637 ' HB3' ' HA2' ' A' ' 16' ' ' GLY . 3.7 mm? -104.74 115.81 30.95 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.775 -179.311 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 27.9 p -112.45 161.08 17.11 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.666 179.387 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 59.25 44.58 15.35 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.17 179.553 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 87.35 -23.61 11.62 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.218 -179.715 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.637 ' HA2' ' HB3' ' A' ' 12' ' ' LEU . . . 124.85 17.01 2.88 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 121.109 -0.567 . . . . 0.0 111.894 -179.867 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.749 ' HB2' ' HB2' ' A' ' 38' ' ' ASP . 3.6 ptm180 -95.78 -22.05 17.75 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.227 0.537 . . . . 0.0 110.375 -179.609 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.482 ' CG2' ' HB3' ' A' ' 34' ' ' GLU . 2.7 m -111.29 135.99 51.03 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.788 -178.978 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.727 HD11 HD13 ' A' ' 90' ' ' LEU . 41.8 mt -97.46 112.55 24.35 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.768 179.361 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.463 HH21 HG21 ' A' ' 11' ' ' VAL . 30.5 ttp180 -105.1 120.65 42.03 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 178.439 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.442 ' HB2' ' HA ' ' A' ' 10' ' ' ALA . . . -152.97 162.41 41.35 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.906 0.384 . . . . 0.0 111.062 -179.878 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -90.84 105.75 18.04 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 178.439 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.56 ' SG ' HD13 ' A' ' 100' ' ' LEU . 40.2 m -94.21 132.09 39.12 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 -179.449 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 8.0 ttp180 -84.28 116.46 23.0 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-O 120.776 0.322 . . . . 0.0 110.747 -179.886 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 31.4 p30 -82.07 162.23 22.63 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.086 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.49 -21.72 17.78 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -178.68 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -74.69 -13.77 60.66 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.317 0.58 . . . . 0.0 110.195 179.764 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 89.74 32.13 10.47 Favored Glycine 0 N--CA 1.449 -0.456 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.93 179.987 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 -124.47 151.62 44.34 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.826 0.346 . . . . 0.0 111.364 -179.519 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 93.9 m95 -90.96 120.59 32.09 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.568 179.384 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -118.56 127.3 75.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 116.247 -0.433 . . . . 0.0 109.918 178.079 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 25.5 m -76.48 111.52 12.04 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.194 179.935 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 66.7 m -123.06 145.66 48.35 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.906 -179.376 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.602 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 44.8 mt-10 -124.91 133.07 53.19 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.882 179.708 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.724 HD11 ' HB2' ' A' ' 102' ' ' PHE . 1.5 tm? -125.42 131.59 52.89 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.167 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.456 ' O ' HG22 ' A' ' 39' ' ' THR . 14.5 m-20 -90.05 110.27 21.27 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.012 0.434 . . . . 0.0 110.241 -179.779 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.495 HD13 HD22 ' A' ' 90' ' ' LEU . 1.5 mt -83.8 -23.89 31.25 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.031 -179.749 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.749 ' HB2' ' HB2' ' A' ' 17' ' ' ARG . 20.9 t70 -60.49 -15.14 24.06 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.19 -0.459 . . . . 0.0 112.151 -178.647 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.456 HG22 ' O ' ' A' ' 36' ' ' ASP . 11.6 t -77.44 -14.48 59.69 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.721 -0.218 . . . . 0.0 111.387 -179.656 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.411 ' SG ' ' HE3' ' A' ' 50' ' ' TRP . 42.5 t -134.33 -0.79 2.94 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -179.609 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.443 ' HB ' ' CD1' ' A' ' 55' ' ' PHE . 60.4 mt -108.84 135.24 48.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 178.589 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.486 ' HA3' ' HB3' ' A' ' 52' ' ' MET . . . -138.61 156.53 24.2 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.095 -179.826 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.764 HD21 ' HB3' ' A' ' 59' ' ' SER . 39.9 p-10 -164.81 43.79 0.09 OUTLIER Pre-proline 0 CA--C 1.542 0.664 0 N-CA-C 113.102 0.778 . . . . 0.0 113.102 -179.377 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.446 ' HG3' ' SD ' ' A' ' 52' ' ' MET . 74.4 Cg_endo -73.17 -22.65 18.92 Favored 'Trans proline' 0 C--N 1.354 0.858 0 C-N-CA 121.661 1.574 . . . . 0.0 112.346 -178.913 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -84.4 -14.11 50.31 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.819 179.923 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.5 ' CA ' ' HG2' ' A' ' 83' ' ' ARG . . . 107.29 8.17 31.49 Favored Glycine 0 N--CA 1.444 -0.81 0 C-N-CA 120.301 -0.952 . . . . 0.0 111.994 -178.866 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.58 ' HA ' HE22 ' A' ' 86' ' ' GLN . 71.3 m-85 -125.91 139.1 53.73 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 110.391 -0.226 . . . . 0.0 110.391 179.82 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 7.8 mp -89.89 151.04 21.94 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.225 0.536 . . . . 0.0 111.975 -178.931 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 167.24 170.99 32.79 Favored Glycine 0 N--CA 1.444 -0.782 0 CA-C-N 115.601 -0.727 . . . . 0.0 112.122 178.469 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.428 ' CD1' HD11 ' A' ' 88' ' ' ILE . 90.8 m95 -95.73 132.24 41.15 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 179.98 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 156.42 -63.08 0.33 Allowed Glycine 0 N--CA 1.451 -0.355 0 N-CA-C 111.573 -0.611 . . . . 0.0 111.573 179.915 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.486 ' HB3' ' HA3' ' A' ' 42' ' ' GLY . 39.7 ttm -88.63 176.63 7.04 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 179.34 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.422 ' HG3' HD22 ' A' ' 54' ' ' ASN . 3.9 pt20 -130.65 172.41 11.98 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 118.288 0.495 . . . . 0.0 111.654 -179.294 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.715 ' HA ' ' OD2' ' A' ' 38' ' ' ASP . 36.0 m-80 68.54 46.85 0.95 Allowed 'General case' 0 C--O 1.234 0.263 0 O-C-N 123.945 0.778 . . . . 0.0 111.697 179.129 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.443 ' CD1' ' HB ' ' A' ' 41' ' ' ILE . 13.7 p90 -76.6 -26.88 55.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.517 179.78 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 7.1 m -62.69 -30.45 71.41 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.199 0.523 . . . . 0.0 110.97 -178.694 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 17.7 m-70 -82.11 -3.54 55.0 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.754 -179.519 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 42.4 m -128.29 28.69 5.45 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.112 0.482 . . . . 0.0 110.358 179.333 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.764 ' HB3' HD21 ' A' ' 43' ' ' ASN . 15.4 p -143.61 157.85 44.11 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.105 179.829 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.438 ' HG3' ' HG2' ' A' ' 76' ' ' LYS . 50.6 mt-10 -127.0 136.86 52.82 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.991 179.663 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.43 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 36.5 t70 60.29 84.48 0.12 Allowed 'General case' 0 N--CA 1.467 0.381 0 O-C-N 123.608 0.568 . . . . 0.0 111.68 179.511 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 75.4 mt -97.92 120.38 47.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.103 179.547 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.6 tptm -147.33 148.19 31.13 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.123 -179.79 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.584 ' HG ' HD21 ' A' ' 12' ' ' LEU . 36.3 mt -88.56 145.23 25.84 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.868 -179.474 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -105.34 -62.14 1.39 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.044 -0.525 . . . . 0.0 112.107 -179.046 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.577 ' HB2' ' HB2' ' A' ' 69' ' ' ARG . 44.6 mm-40 -79.21 42.93 0.51 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.831 -178.527 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 62.49 20.41 61.27 Favored Glycine 0 C--N 1.317 -0.525 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.594 179.33 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.57 ' HA2' HD13 ' A' ' 64' ' ' LEU . . . 121.4 -14.88 9.31 Favored Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.388 -179.996 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.848 ' HG2' ' HB2' ' A' ' 2' ' ' SER . 48.3 mtm105 -84.02 2.27 39.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.13 0.491 . . . . 0.0 110.804 -179.718 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.492 ' HB3' ' HG2' ' A' ' 66' ' ' GLU . 37.3 ttmt -155.26 134.36 12.27 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.975 179.917 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.75 ' HB2' HD11 ' A' ' 90' ' ' LEU . 9.8 tt -116.77 125.71 52.03 Favored 'General case' 0 C--N 1.318 -0.794 0 O-C-N 123.576 0.548 . . . . 0.0 109.94 -179.723 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.7 p -113.97 136.29 53.06 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.769 179.208 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.43 ' HA ' ' O ' ' A' ' 61' ' ' ASP . 25.8 p -162.26 165.57 26.55 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.252 179.84 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.538 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 31.9 ttt180 -99.48 103.44 21.05 Favored Pre-proline 0 C--N 1.319 -0.745 0 C-N-CA 120.676 -0.409 . . . . 0.0 110.733 179.496 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.692 ' O ' ' HB3' ' A' ' 83' ' ' ARG . 43.8 Cg_endo -67.64 119.63 6.64 Favored 'Trans proline' 0 CA--C 1.512 -0.58 0 C-N-CA 122.569 2.18 . . . . 0.0 110.149 178.564 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.686 ' HA ' ' HB2' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -119.91 140.61 50.61 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 120.764 0.316 . . . . 0.0 111.682 -178.808 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.708 HG22 ' O ' ' A' ' 82' ' ' PHE . 12.9 t -72.52 135.22 45.59 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.695 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 26.7 m -73.33 -4.33 5.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 123.943 0.777 . . . . 0.0 112.056 -178.938 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -68.95 -32.9 72.83 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.13 0.49 . . . . 0.0 109.902 179.342 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -151.65 -20.23 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.678 179.819 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.22 20.73 22.25 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.751 -0.738 . . . . 0.0 111.949 -179.887 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.708 ' O ' HG22 ' A' ' 77' ' ' THR . 27.6 p90 -111.88 143.22 43.21 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 -178.876 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.692 ' HB3' ' O ' ' A' ' 75' ' ' PRO . 0.0 OUTLIER 175.06 -154.21 0.01 OUTLIER 'General case' 0 C--O 1.234 0.241 0 CA-C-O 120.796 0.332 . . . . 0.0 111.702 179.881 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -113.84 177.16 4.73 Favored 'General case' 0 C--O 1.225 -0.207 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.486 -178.708 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.558 ' HA ' ' HD2' ' A' ' 75' ' ' PRO . 59.1 ttt180 -110.39 150.86 28.2 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 178.77 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.58 HE22 ' HA ' ' A' ' 47' ' ' PHE . 22.1 mt-30 -156.84 -175.25 5.32 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -178.152 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -150.3 142.89 10.06 Favored Glycine 0 N--CA 1.45 -0.423 0 CA-C-N 114.803 -1.09 . . . . 0.0 111.108 179.09 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.428 HD11 ' CD1' ' A' ' 50' ' ' TRP . 13.2 tt -123.97 142.73 39.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 121.052 0.453 . . . . 0.0 110.649 -178.683 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.459 ' HB3' HD22 ' A' ' 91' ' ' ASN . 1.1 m-20 -79.14 133.61 36.73 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.623 179.807 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.75 HD11 ' HB2' ' A' ' 71' ' ' LEU . 74.9 mt -106.27 41.25 1.45 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.324 0.583 . . . . 0.0 111.286 -179.44 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.563 ' HA ' ' OG ' ' A' ' 2' ' ' SER . 22.8 m-80 -76.12 2.05 14.01 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.192 179.575 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 13.3 mtp180 -94.03 -6.98 44.02 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.783 179.392 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.432 HG13 HD22 ' A' ' 37' ' ' LEU . 17.7 mm -101.92 106.36 19.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -179.782 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 21.7 tp60 -118.93 149.35 41.74 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.994 -178.008 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.416 HD21 ' HB2' ' A' ' 6' ' ' SER . 14.7 p-10 -99.3 117.94 34.86 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.29 0.567 . . . . 0.0 110.435 178.858 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 48.1 t -103.71 100.4 10.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.5 179.191 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 7.3 m-80 58.69 43.5 18.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.858 -179.197 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 89.99 -23.42 20.76 Favored Glycine 0 N--CA 1.444 -0.792 0 CA-C-N 115.512 -0.767 . . . . 0.0 113.496 179.48 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.425 ' N ' ' HD2' ' A' ' 99' ' ' ARG . 4.4 mpt_? -86.78 123.39 31.87 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 117.116 0.458 . . . . 0.0 110.574 -179.271 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.56 HD13 ' SG ' ' A' ' 23' ' ' CYS . 5.6 tp -76.01 122.15 23.79 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.166 -179.403 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 24.1 t -129.35 138.95 53.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.933 -179.183 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.724 ' HB2' HD11 ' A' ' 35' ' ' LEU . 12.5 t80 -85.51 131.92 34.29 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.052 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 17.3 tt0 . . . . . 0 C--N 1.315 -0.892 0 CA-C-O 117.968 -1.015 . . . . 0.0 110.44 -179.954 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . 0.486 ' OG ' ' HA ' ' A' ' 91' ' ' ASN . 17.7 m . . . . . 0 N--CA 1.448 -0.539 0 CA-C-O 120.564 0.221 . . . . 0.0 110.663 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.444 ' CG ' HD11 ' A' ' 100' ' ' LEU . 25.2 p90 -57.17 -30.64 64.67 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.201 179.362 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.463 ' HB3' ' HD2' ' A' ' 69' ' ' ARG . . . -53.7 -18.86 3.42 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.33 -179.363 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -61.06 -36.27 79.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.296 0.57 . . . . 0.0 109.977 179.043 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 24.5 m -133.95 36.46 3.27 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.805 179.691 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.411 ' HA ' ' HZ3' ' A' ' 30' ' ' TRP . 23.2 t -148.75 145.77 27.76 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.399 -179.987 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 4.5 ptp180 -136.61 167.9 20.52 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.585 -0.279 . . . . 0.0 111.646 -178.874 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 67.1 m-80 55.78 65.21 1.51 Allowed 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.435 179.893 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.404 ' HB3' ' O ' ' A' ' 67' ' ' GLY . . . -92.55 120.03 32.61 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.661 179.622 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 26.6 m -120.41 169.11 12.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.317 -179.731 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.742 HD21 ' HG ' ' A' ' 64' ' ' LEU . 3.1 mm? -104.67 116.91 32.86 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.24 -179.634 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.49 ' OG1' ' HB ' ' A' ' 18' ' ' THR . 18.9 p -109.81 161.94 14.96 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.452 179.48 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 62.15 40.87 11.34 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.945 -179.803 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 91.02 -45.38 2.85 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 121.034 -0.603 . . . . 0.0 112.459 179.62 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.571 ' HA2' ' HB3' ' A' ' 12' ' ' LEU . . . 149.77 52.42 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.506 0 N-CA-C 111.481 -0.648 . . . . 0.0 111.481 -179.469 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.505 ' HB3' ' OG ' ' A' ' 56' ' ' SER . 3.7 ptm180 -135.57 -33.46 0.87 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.146 0.498 . . . . 0.0 110.808 -179.811 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.49 ' HB ' ' OG1' ' A' ' 13' ' ' THR . 3.0 m -97.53 133.5 42.01 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.524 -179.968 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.653 HD11 HD13 ' A' ' 90' ' ' LEU . 44.1 mt -95.89 113.65 25.29 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.231 179.349 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 17.9 ttm180 -107.86 120.68 42.94 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 178.76 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -152.77 167.85 27.64 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.929 0.395 . . . . 0.0 111.365 -178.896 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -89.63 106.09 18.23 Favored 'General case' 0 CA--C 1.512 -0.491 0 N-CA-C 107.969 -1.122 . . . . 0.0 107.969 178.405 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.579 ' SG ' HD13 ' A' ' 100' ' ' LEU . 58.5 m -96.39 125.91 41.22 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 120.713 0.292 . . . . 0.0 110.225 -178.959 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.622 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 22.4 ttt180 -77.94 111.83 14.2 Favored 'General case' 0 N--CA 1.44 -0.933 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.087 179.639 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.454 HD21 ' HB3' ' A' ' 29' ' ' ASN . 36.0 p30 -74.18 170.65 15.1 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.318 -179.62 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.26 -11.73 23.68 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -177.806 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -88.15 -10.23 50.62 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 178.676 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 88.45 27.94 23.59 Favored Glycine 0 N--CA 1.448 -0.511 0 CA-C-N 114.956 -1.02 . . . . 0.0 111.535 -179.522 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.622 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 51.9 t30 -112.75 161.45 16.88 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.526 0.203 . . . . 0.0 111.162 -178.661 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.449 ' CZ3' ' HB2' ' A' ' 24' ' ' ARG . 95.4 m95 -102.5 116.85 33.46 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.715 179.596 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 6.2 m -118.82 141.1 40.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.608 179.309 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 61.6 m -81.1 108.62 14.92 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 179.209 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 50.3 m -120.34 150.43 40.76 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.351 -179.536 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.601 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 48.3 mt-10 -131.2 145.6 52.0 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.915 -179.893 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.669 HD11 ' HB2' ' A' ' 102' ' ' PHE . 2.2 tm? -139.45 132.0 28.75 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 178.777 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.479 ' N ' HD13 ' A' ' 35' ' ' LEU . 5.7 m-20 -90.33 110.25 21.32 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.919 0.39 . . . . 0.0 110.992 179.967 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.531 HD11 HD11 ' A' ' 19' ' ' LEU . 2.4 mt -80.67 -19.73 44.57 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.705 179.268 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.523 ' OD1' ' HA ' ' A' ' 54' ' ' ASN . 22.4 t70 -58.74 -18.7 33.85 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.389 -0.823 . . . . 0.0 112.339 -178.812 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.449 HG22 ' O ' ' A' ' 36' ' ' ASP . 14.6 t -82.61 -6.74 59.52 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 121.103 -0.239 . . . . 0.0 111.449 -179.639 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.521 ' SG ' ' HE3' ' A' ' 50' ' ' TRP . 25.8 t -135.0 -18.63 1.81 Allowed 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.816 -0.354 . . . . 0.0 111.467 179.556 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 56.0 mt -98.28 129.13 48.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 178.359 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.615 ' HA3' ' HB3' ' A' ' 52' ' ' MET . . . -141.11 164.69 26.45 Favored Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 120.64 -0.791 . . . . 0.0 111.67 179.784 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.788 HD21 ' HB3' ' A' ' 59' ' ' SER . 32.1 p-10 -161.92 47.26 0.21 Allowed Pre-proline 0 CA--C 1.538 0.487 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 -179.144 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -71.9 -23.21 22.39 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 121.562 1.508 . . . . 0.0 111.625 -179.536 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -84.26 -14.95 48.51 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.588 -179.893 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.404 ' CA ' ' HG2' ' A' ' 83' ' ' ARG . . . 103.98 8.22 39.66 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.051 -178.831 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.408 ' HD1' HE22 ' A' ' 86' ' ' GLN . 64.1 m-85 -125.21 140.07 53.18 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 179.43 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.559 HD23 ' HB3' ' A' ' 43' ' ' ASN . 92.3 mt -86.68 145.64 26.61 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.012 -179.712 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 171.39 172.33 37.4 Favored Glycine 0 N--CA 1.444 -0.784 0 C-N-CA 120.785 -0.722 . . . . 0.0 111.745 179.207 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.521 ' HE3' ' SG ' ' A' ' 40' ' ' CYS . 87.2 m95 -95.53 125.2 39.96 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.826 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 159.99 -52.16 0.36 Allowed Glycine 0 CA--C 1.518 0.25 0 C-N-CA 121.129 -0.557 . . . . 0.0 112.453 -179.997 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.615 ' HB3' ' HA3' ' A' ' 42' ' ' GLY . 0.1 OUTLIER -97.15 178.03 5.39 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.29 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -129.99 171.78 12.42 Favored 'General case' 0 C--N 1.318 -0.798 0 O-C-N 122.04 -0.412 . . . . 0.0 111.295 -179.18 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.523 ' HA ' ' OD1' ' A' ' 38' ' ' ASP . 21.7 m-80 64.31 59.98 0.98 Allowed 'General case' 0 C--O 1.235 0.311 0 O-C-N 123.963 0.789 . . . . 0.0 111.285 179.458 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.452 ' HA ' ' OD1' ' A' ' 43' ' ' ASN . 18.6 p90 -86.56 -32.24 20.79 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.645 -179.991 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.505 ' OG ' ' HB3' ' A' ' 17' ' ' ARG . 13.3 m -62.05 -36.9 83.01 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.269 -179.024 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 38.2 m80 -81.28 -3.59 52.95 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.728 179.218 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.531 ' HB2' ' OD1' ' A' ' 43' ' ' ASN . 4.7 m -121.33 18.67 11.44 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.551 -179.676 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.788 ' HB3' HD21 ' A' ' 43' ' ' ASN . 58.1 p -145.55 171.69 14.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.097 0.475 . . . . 0.0 111.096 179.882 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.494 ' HG3' ' HD3' ' A' ' 74' ' ' ARG . 2.3 pt-20 -140.85 154.03 46.02 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.065 179.433 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.406 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 43.2 m-20 62.3 63.04 1.09 Allowed 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.022 0.439 . . . . 0.0 110.929 -179.703 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.482 HG23 HD21 ' A' ' 71' ' ' LEU . 63.6 mt -90.7 117.27 33.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.973 -179.681 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 42.5 tptt -148.85 149.45 31.32 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.772 -179.895 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.742 ' HG ' HD21 ' A' ' 12' ' ' LEU . 76.5 mt -82.46 132.57 35.2 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.931 0.396 . . . . 0.0 110.106 179.317 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -80.25 -62.61 1.63 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.488 -178.862 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.509 ' HB2' ' HB3' ' A' ' 69' ' ' ARG . 30.3 mt-10 -85.49 28.05 0.78 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.584 -179.86 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.404 ' O ' ' HB3' ' A' ' 10' ' ' ALA . . . 64.97 15.95 61.12 Favored Glycine 0 N--CA 1.448 -0.545 0 CA-C-N 115.624 -0.717 . . . . 0.0 113.066 179.812 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.539 ' HA2' HD13 ' A' ' 64' ' ' LEU . . . 142.66 -21.98 2.35 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 119.904 -1.141 . . . . 0.0 113.091 179.459 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.509 ' HB3' ' HB2' ' A' ' 66' ' ' GLU . 0.2 OUTLIER -79.34 -13.91 59.33 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.426 0.631 . . . . 0.0 109.713 -179.922 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.534 ' HG3' ' HA ' ' A' ' 89' ' ' ASP . 4.5 ttmp? -157.1 141.76 16.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.259 -179.233 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.604 ' HB2' HD11 ' A' ' 90' ' ' LEU . 10.0 tt -111.42 134.45 52.99 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 179.975 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.431 HG22 ' HA3' ' A' ' 87' ' ' GLY . 7.0 p -123.95 135.05 53.42 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 120.798 0.332 . . . . 0.0 111.156 179.852 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.437 ' HB3' ' HA ' ' A' ' 62' ' ' ILE . 26.9 p -159.52 168.8 25.28 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.134 -0.485 . . . . 0.0 109.998 179.988 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.566 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 56.6 ttt180 -99.66 101.97 15.34 Favored Pre-proline 0 C--N 1.314 -0.96 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.725 179.944 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.625 ' O ' ' HB3' ' A' ' 83' ' ' ARG . 58.7 Cg_endo -71.43 123.14 9.26 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 122.535 2.156 . . . . 0.0 110.856 178.868 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.697 ' HA ' ' HB2' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -119.57 139.84 51.5 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.845 0.355 . . . . 0.0 111.053 -179.69 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.705 HG22 ' O ' ' A' ' 82' ' ' PHE . 12.3 t -75.47 140.65 42.98 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 116.176 -0.466 . . . . 0.0 109.752 -179.765 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 31.3 m -76.32 -5.97 8.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.488 -179.482 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 -64.75 -35.25 80.45 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-O 121.155 0.502 . . . . 0.0 110.234 179.145 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -154.01 -9.74 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.512 -0.851 . . . . 0.0 112.768 -179.925 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.602 ' HA2' ' HE3' ' A' ' 76' ' ' LYS . . . 90.32 17.51 52.73 Favored Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.641 -0.79 . . . . 0.0 111.862 179.976 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.705 ' O ' HG22 ' A' ' 77' ' ' THR . 34.0 p90 -111.23 151.2 28.56 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 119.17 -0.443 . . . . 0.0 109.974 -178.773 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.697 ' HB2' ' HA ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 169.78 -153.36 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.293 0 O-C-N 123.641 0.588 . . . . 0.0 111.052 179.107 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 49.9 mm-40 -122.21 -177.58 3.64 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.736 -178.037 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.566 ' HA ' ' HA ' ' A' ' 74' ' ' ARG . 52.7 ttt180 -106.03 153.45 22.01 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 177.396 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.705 ' HG2' ' H ' ' A' ' 87' ' ' GLY . 8.3 tt0 -157.89 -174.98 5.11 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.662 -178.513 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.705 ' H ' ' HG2' ' A' ' 86' ' ' GLN . . . -148.92 140.54 8.28 Favored Glycine 0 N--CA 1.445 -0.704 0 N-CA-C 111.181 -0.767 . . . . 0.0 111.181 179.21 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 15.3 tt -119.28 131.41 72.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.544 0.688 . . . . 0.0 110.742 -179.548 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.534 ' HA ' ' HG3' ' A' ' 70' ' ' LYS . 16.0 t70 -75.94 140.7 42.22 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.401 -179.671 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.653 HD13 HD11 ' A' ' 19' ' ' LEU . 42.4 mt -109.84 44.19 1.24 Allowed 'General case' 0 C--O 1.234 0.253 0 N-CA-C 112.848 0.684 . . . . 0.0 112.848 -177.717 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.486 ' HA ' ' OG ' ' A' ' 2' ' ' SER . 3.9 m-80 -79.7 3.91 17.82 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-O 121.32 0.581 . . . . 0.0 110.834 178.759 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.48 ' HD3' ' CD2' ' A' ' 50' ' ' TRP . 36.6 mtp180 -95.86 -11.21 27.12 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.357 178.919 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.431 HG13 HD22 ' A' ' 37' ' ' LEU . 21.2 mm -100.8 109.08 24.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 -179.406 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -122.26 148.52 44.89 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.941 -178.108 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 27.2 p-10 -100.65 123.28 44.64 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.65 0.738 . . . . 0.0 110.268 178.448 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.472 HG12 HD22 ' A' ' 97' ' ' ASN . 59.5 t -114.73 114.3 46.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.672 -179.853 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.472 HD22 HG12 ' A' ' 96' ' ' VAL . 45.6 m-80 57.46 33.45 23.28 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.22 0.533 . . . . 0.0 110.562 -178.798 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 89.32 -15.24 58.92 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.867 -179.915 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 3.6 mpt_? -87.59 123.22 32.23 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 117.005 0.403 . . . . 0.0 110.048 -179.846 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.579 HD13 ' SG ' ' A' ' 23' ' ' CYS . 8.2 tp -77.16 115.05 16.61 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.474 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 11.3 t -122.73 140.37 46.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 120.964 0.411 . . . . 0.0 111.45 -178.271 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.669 ' HB2' HD11 ' A' ' 35' ' ' LEU . 3.9 t80 -84.65 132.85 34.43 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 177.401 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 3.9 tp-100 . . . . . 0 C--O 1.252 1.198 0 CA-C-O 118.545 -0.741 . . . . 0.0 110.794 -179.837 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . 0.652 ' OG ' ' HA ' ' A' ' 91' ' ' ASN . 39.2 m . . . . . 0 N--CA 1.45 -0.439 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.518 ' HA ' ' OD1' ' A' ' 95' ' ' ASN . 14.6 p90 -65.73 -33.36 75.69 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.091 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.529 ' HA ' ' OG ' ' A' ' 7' ' ' SER . . . -57.69 -22.4 46.0 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.055 -0.52 . . . . 0.0 112.051 -179.368 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -65.4 -19.68 66.05 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 121.022 0.439 . . . . 0.0 110.629 179.217 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 7.4 p -145.9 39.53 1.13 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.645 179.938 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.529 ' OG ' ' HA ' ' A' ' 4' ' ' ALA . 87.0 p -145.89 167.73 22.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.205 179.085 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 4.9 ptp180 -150.49 162.84 39.83 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.733 -179.6 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 56.59 60.05 3.28 Favored 'General case' 0 C--N 1.331 -0.233 0 O-C-N 123.982 0.801 . . . . 0.0 111.769 177.657 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.434 ' HA ' ' HB2' ' A' ' 21' ' ' ALA . . . -91.94 119.49 31.74 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.703 179.775 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 27.4 m -119.81 169.55 10.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.475 -179.897 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.58 ' HB3' ' HA2' ' A' ' 16' ' ' GLY . 3.2 mm? -105.76 114.55 28.78 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.518 -179.211 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.468 ' OG1' ' HB ' ' A' ' 18' ' ' THR . 26.3 p -109.86 164.7 12.33 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.018 179.988 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 61.61 43.7 9.73 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.838 179.731 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 88.76 -37.84 3.27 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.792 -0.718 . . . . 0.0 111.975 179.827 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.58 ' HA2' ' HB3' ' A' ' 12' ' ' LEU . . . 140.74 42.32 0.07 OUTLIER Glycine 0 N--CA 1.444 -0.808 0 N-CA-C 111.432 -0.667 . . . . 0.0 111.432 -179.529 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.566 ' HB2' ' HB3' ' A' ' 38' ' ' ASP . 18.2 ptt85 -127.19 -21.24 3.96 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.896 0.379 . . . . 0.0 111.126 -179.828 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.468 ' HB ' ' OG1' ' A' ' 13' ' ' THR . 3.8 m -106.63 131.29 53.95 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.374 179.889 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.712 HD11 HD13 ' A' ' 90' ' ' LEU . 57.3 mt -93.4 113.83 26.08 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.327 179.209 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 22.5 ttt180 -111.97 119.37 38.29 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 178.644 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.434 ' HB2' ' HA ' ' A' ' 10' ' ' ALA . . . -153.73 167.0 31.09 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.95 0.405 . . . . 0.0 111.362 -179.11 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -90.02 106.7 18.65 Favored 'General case' 0 CA--C 1.511 -0.523 0 N-CA-C 107.821 -1.178 . . . . 0.0 107.821 178.19 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.543 ' SG ' HD13 ' A' ' 100' ' ' LEU . 35.7 m -97.55 131.82 43.79 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.326 -178.627 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.52 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 13.1 ttp180 -76.25 119.45 20.16 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 116.174 -0.466 . . . . 0.0 109.945 179.38 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 36.9 p30 -81.75 168.83 17.64 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 179.535 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -52.93 -30.56 35.27 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 -179.013 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -72.57 -15.08 61.76 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.397 0.618 . . . . 0.0 110.483 179.982 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 92.18 24.5 24.41 Favored Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.549 179.985 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.52 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 8.2 t-20 -107.49 162.89 13.53 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.582 0.23 . . . . 0.0 110.476 -178.753 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.429 ' HZ3' ' HA ' ' A' ' 7' ' ' SER . 83.3 m95 -99.03 115.71 29.58 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.931 0.396 . . . . 0.0 111.694 -179.548 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.1 m -122.13 125.43 72.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.173 178.463 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 19.9 m -76.14 113.54 13.79 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.996 -179.559 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 57.8 m -120.43 155.91 32.52 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.74 179.887 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.634 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 46.7 mt-10 -131.46 136.95 48.36 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.191 -179.394 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.502 ' HB2' ' HB3' ' A' ' 100' ' ' LEU . 1.7 tm? -132.72 130.1 39.57 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 178.434 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.443 ' N ' HD13 ' A' ' 35' ' ' LEU . 9.0 m-20 -89.94 109.04 20.09 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 -179.997 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.568 HD11 HD11 ' A' ' 19' ' ' LEU . 3.3 mt -79.48 -20.63 46.87 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.57 -179.095 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.566 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 11.2 p-10 -65.78 -10.26 35.82 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.7 0.285 . . . . 0.0 111.713 -178.612 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 77.6 p -81.23 -11.91 59.27 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.996 0.427 . . . . 0.0 110.34 179.045 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 23.4 m -133.95 -15.92 2.28 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.982 -0.554 . . . . 0.0 112.4 -179.026 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 54.9 mt -99.84 135.29 36.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 O-C-N 122.093 -0.379 . . . . 0.0 109.991 179.081 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.629 ' HA3' ' HB3' ' A' ' 52' ' ' MET . . . -143.65 156.7 26.73 Favored Glycine 0 N--CA 1.443 -0.878 0 C-N-CA 120.386 -0.911 . . . . 0.0 112.263 179.804 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.662 ' N ' ' HD3' ' A' ' 44' ' ' PRO . 25.4 p30 -153.47 40.38 0.16 Allowed Pre-proline 0 CA--C 1.54 0.568 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -179.785 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.662 ' HD3' ' N ' ' A' ' 43' ' ' ASN . 7.1 Cg_exo -71.77 -17.46 29.28 Favored 'Trans proline' 0 C--N 1.355 0.902 0 C-N-CA 121.74 1.627 . . . . 0.0 111.377 -179.213 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -91.58 -2.84 56.98 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.06 179.853 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.597 ' CA ' ' HG2' ' A' ' 83' ' ' ARG . . . 91.79 8.03 64.01 Favored Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.214 -179.439 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -126.11 139.38 53.43 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.667 0.27 . . . . 0.0 110.568 179.646 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.518 HD23 ' HB3' ' A' ' 43' ' ' ASN . 81.7 mt -84.48 148.7 26.4 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.723 179.862 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 165.42 171.11 31.24 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 121.036 -0.602 . . . . 0.0 111.921 179.244 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 89.0 m95 -95.28 125.66 40.06 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 179.676 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 163.21 -57.79 0.28 Allowed Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.192 -179.628 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.629 ' HB3' ' HA3' ' A' ' 42' ' ' GLY . 0.0 OUTLIER -90.78 -166.01 1.49 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 179.719 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 28.2 pt20 -141.98 171.6 13.83 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.918 -0.313 . . . . 0.0 111.648 -179.047 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 29.0 m-80 63.12 36.3 12.27 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 115.493 -0.776 . . . . 0.0 112.628 178.749 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.43 ' HB3' ' HA2' ' A' ' 42' ' ' GLY . 12.4 p90 -61.21 -27.39 68.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.763 0.316 . . . . 0.0 111.371 -179.629 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.525 ' OG ' ' HB3' ' A' ' 17' ' ' ARG . 15.0 m -62.53 -30.58 71.4 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.038 0.384 . . . . 0.0 112.038 -178.958 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 35.7 m80 -82.04 -4.06 55.95 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.742 -0.383 . . . . 0.0 111.169 -179.14 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.575 ' HB2' ' OD1' ' A' ' 43' ' ' ASN . 30.3 m -130.77 29.85 4.71 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.347 0.594 . . . . 0.0 110.239 179.232 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.643 ' HB3' HD21 ' A' ' 43' ' ' ASN . 28.9 p -141.28 153.22 45.08 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.641 179.209 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 66.4 mt-10 -125.34 139.2 53.89 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.419 -179.687 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 36.0 t70 58.62 73.21 0.49 Allowed 'General case' 0 N--CA 1.466 0.363 0 O-C-N 123.83 0.706 . . . . 0.0 111.532 -179.766 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.548 HG23 HD21 ' A' ' 71' ' ' LEU . 77.4 mt -87.24 119.85 35.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 178.801 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.493 ' NZ ' ' HB2' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -148.87 159.79 43.84 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.843 -0.343 . . . . 0.0 111.033 -178.653 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.48 ' HG ' HD21 ' A' ' 12' ' ' LEU . 81.0 mt -99.94 123.54 44.3 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.845 0.355 . . . . 0.0 110.958 179.891 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 37.0 mm-40 -82.0 -61.48 1.9 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.502 -179.676 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.5 ' OE2' ' HE3' ' A' ' 70' ' ' LYS . 36.1 mt-10 -76.58 12.96 1.09 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.307 -179.658 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 76.5 18.79 78.81 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.348 -179.928 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.405 ' HA2' HD22 ' A' ' 64' ' ' LEU . . . 136.94 -17.16 3.66 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.0 -1.095 . . . . 0.0 112.924 179.384 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.45 ' HB3' ' HB2' ' A' ' 66' ' ' GLU . 0.1 OUTLIER -83.01 -17.96 41.5 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.194 0.521 . . . . 0.0 109.72 -179.854 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.5 ' HE3' ' OE2' ' A' ' 66' ' ' GLU . 37.9 ttmt -150.73 136.87 18.46 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.891 -179.278 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.609 ' HB2' HD11 ' A' ' 90' ' ' LEU . 10.0 tt -114.73 129.3 56.67 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.491 179.714 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 8.2 p -116.57 140.01 49.86 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.155 0.502 . . . . 0.0 111.28 179.828 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.489 ' HB3' ' HA ' ' A' ' 62' ' ' ILE . 13.0 p -163.28 164.03 25.09 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.089 179.02 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.537 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 28.1 ttt180 -99.4 100.39 10.42 Favored Pre-proline 0 C--N 1.317 -0.822 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 179.103 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.609 ' O ' ' HB3' ' A' ' 83' ' ' ARG . 53.2 Cg_endo -69.07 117.39 5.01 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.383 2.055 . . . . 0.0 109.864 178.545 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.868 ' HE3' ' HA2' ' A' ' 81' ' ' GLY . 0.0 OUTLIER -119.78 143.43 47.83 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.501 -178.978 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.684 HG22 ' O ' ' A' ' 82' ' ' PHE . 8.7 t -69.89 134.38 48.37 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.218 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 11.1 p -71.28 -12.43 16.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 O-C-N 124.088 0.867 . . . . 0.0 111.094 -179.284 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 32.8 m-20 -70.62 -16.72 62.86 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.506 -179.606 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.693 ' HA3' ' CE2' ' A' ' 82' ' ' PHE . . . -157.64 -30.2 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.441 -0.885 . . . . 0.0 112.628 179.215 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.868 ' HA2' ' HE3' ' A' ' 76' ' ' LYS . . . 101.83 16.13 24.71 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 121.024 -0.608 . . . . 0.0 111.916 -179.721 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.693 ' CE2' ' HA3' ' A' ' 80' ' ' GLY . 16.7 p90 -112.25 157.06 21.38 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 118.686 -0.673 . . . . 0.0 110.173 -178.622 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.813 ' HB2' ' HA ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 163.92 -151.03 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.556 0 O-C-N 124.253 0.971 . . . . 0.0 111.124 178.478 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -125.47 152.88 44.35 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.142 -177.927 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.537 ' HA ' ' HA ' ' A' ' 74' ' ' ARG . 39.7 ttt180 -83.91 145.8 28.39 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 179.621 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -150.63 -179.67 7.44 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.094 0.473 . . . . 0.0 111.756 -178.287 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -141.09 142.51 12.24 Favored Glycine 0 N--CA 1.451 -0.345 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.455 178.993 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 13.2 tt -125.09 136.58 60.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.028 0.442 . . . . 0.0 110.973 -179.199 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -80.59 141.28 35.19 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.467 -179.882 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.712 HD13 HD11 ' A' ' 19' ' ' LEU . 58.3 mt -107.59 46.36 0.95 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.674 0.749 . . . . 0.0 110.932 -179.816 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.652 ' HA ' ' OG ' ' A' ' 2' ' ' SER . 26.8 m-80 -79.9 3.67 19.11 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.634 179.762 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 12.9 mtp180 -98.47 -15.0 19.78 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.41 179.872 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 22.7 mm -94.37 98.07 7.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 121.356 0.598 . . . . 0.0 109.601 -179.029 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 22.3 tp60 -107.63 141.94 38.34 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.961 -178.443 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.518 ' OD1' ' HA ' ' A' ' 3' ' ' TYR . 16.1 p-10 -95.64 119.72 34.64 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.512 178.582 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 58.2 t -109.23 112.26 39.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.31 179.286 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 23.2 m-80 59.24 34.84 23.25 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-O 121.069 0.461 . . . . 0.0 110.56 -178.952 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 87.57 -8.96 75.51 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.757 -179.955 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.458 ' N ' ' HD2' ' A' ' 99' ' ' ARG . 7.9 mpt_? -94.65 134.43 37.24 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.661 0.267 . . . . 0.0 110.978 -179.052 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.543 HD13 ' SG ' ' A' ' 23' ' ' CYS . 2.9 tp -84.89 119.81 25.77 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.594 -0.276 . . . . 0.0 110.503 -179.681 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 20.8 t -129.28 141.53 46.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.609 -179.661 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.495 ' HB2' HD11 ' A' ' 35' ' ' LEU . 23.2 t80 -83.71 133.0 34.82 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 178.348 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 . . . . . 0 C--O 1.248 1.013 0 CA-C-O 118.336 -0.84 . . . . 0.0 110.108 179.271 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . 0.58 ' OG ' ' HA ' ' A' ' 91' ' ' ASN . 21.0 m . . . . . 0 N--CA 1.453 -0.306 0 N-CA-C 110.474 -0.195 . . . . 0.0 110.474 . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.405 ' CG ' HD11 ' A' ' 100' ' ' LEU . 11.7 p90 -55.32 -32.16 62.25 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.281 179.061 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -52.37 -20.89 3.07 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -178.801 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -55.93 -42.49 76.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.914 0.388 . . . . 0.0 110.959 178.743 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 47.7 m -132.01 36.02 3.69 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.001 179.828 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 16.7 m -144.57 153.24 41.6 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.483 179.531 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 7.9 ptp180 -149.53 172.7 14.58 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 110.317 -0.253 . . . . 0.0 110.317 179.951 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.469 HD22 ' N ' ' A' ' 9' ' ' ASN . 0.9 OUTLIER 67.02 44.63 1.92 Allowed 'General case' 0 N--CA 1.469 0.475 0 O-C-N 123.56 0.537 . . . . 0.0 110.5 -179.505 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.412 ' HA ' ' O ' ' A' ' 20' ' ' ARG . . . -87.83 118.26 27.24 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.425 -179.879 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 30.6 m -121.57 176.15 4.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.871 179.308 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.523 ' HB3' ' HA2' ' A' ' 16' ' ' GLY . 3.2 mm? -104.98 114.09 28.09 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 -179.752 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.529 ' OG1' ' HB ' ' A' ' 18' ' ' THR . 24.1 p -106.1 163.38 12.82 Favored 'General case' 0 C--O 1.245 0.823 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.923 -179.641 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 62.16 36.2 15.18 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.706 -179.482 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 92.56 -40.28 2.88 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.7 179.431 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.523 ' HA2' ' HB3' ' A' ' 12' ' ' LEU . . . 147.72 56.07 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.499 0 N-CA-C 110.979 -0.849 . . . . 0.0 110.979 -179.723 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.534 ' HB2' ' HB3' ' A' ' 38' ' ' ASP . 10.0 ptm180 -140.87 -32.19 0.58 Allowed 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.066 0.46 . . . . 0.0 111.211 -179.394 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.529 ' HB ' ' OG1' ' A' ' 13' ' ' THR . 3.7 m -102.99 138.27 40.08 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.348 -179.53 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.611 ' O ' ' HA ' ' A' ' 34' ' ' GLU . 34.4 mt -98.6 113.34 25.35 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.865 179.428 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.412 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 5.2 ttp180 -106.3 120.61 42.32 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 178.489 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -152.88 166.24 32.92 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.938 0.399 . . . . 0.0 111.734 -179.245 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.788 ' HB3' ' HB3' ' A' ' 30' ' ' TRP . 20.8 mm-40 -90.65 107.27 19.07 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 178.467 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.467 ' SG ' HD13 ' A' ' 100' ' ' LEU . 27.2 m -98.78 127.49 44.72 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.457 -178.754 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 19.6 ttp180 -74.39 109.52 7.94 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 179.27 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -87.27 173.48 9.17 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.718 -178.96 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -46.63 -34.1 4.75 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 -178.692 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -67.56 -10.74 54.68 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 121.498 0.666 . . . . 0.0 111.105 -179.464 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.45 23.63 56.01 Favored Glycine 0 N--CA 1.446 -0.634 0 N-CA-C 111.233 -0.747 . . . . 0.0 111.233 -179.94 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 -123.74 160.4 27.37 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.797 0.332 . . . . 0.0 111.197 -178.836 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.788 ' HB3' ' HB3' ' A' ' 22' ' ' GLU . 75.3 m95 -87.57 131.56 34.35 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.24 -178.858 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.414 HG22 ' O ' ' A' ' 23' ' ' CYS . 6.2 m -126.29 137.0 59.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.745 178.118 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 37.6 m -75.53 109.24 8.93 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.133 179.775 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 49.9 m -122.8 144.59 49.08 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.932 -179.966 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.611 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 43.9 mt-10 -128.88 135.45 49.09 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.433 -179.729 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.573 HD11 ' HB2' ' A' ' 102' ' ' PHE . 2.4 tm? -128.64 131.69 48.07 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 178.808 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.45 ' N ' HD13 ' A' ' 35' ' ' LEU . 11.4 m-20 -89.29 110.77 21.51 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.297 -179.794 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.476 HD23 HD12 ' A' ' 35' ' ' LEU . 0.9 OUTLIER -86.87 -16.12 37.03 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.938 179.947 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.534 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 0.5 OUTLIER -66.06 -13.81 60.62 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 -177.508 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.435 HG22 ' O ' ' A' ' 36' ' ' ASP . 8.8 t -83.08 -7.82 59.6 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.895 0.378 . . . . 0.0 110.653 179.193 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.427 ' SG ' HG23 ' A' ' 39' ' ' THR . 58.0 m -130.94 -17.2 3.15 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 112.181 0.437 . . . . 0.0 112.181 -179.341 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.46 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 57.2 mt -104.98 137.05 36.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.684 0.278 . . . . 0.0 110.766 179.731 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.576 ' HA3' ' HB3' ' A' ' 52' ' ' MET . . . -150.31 162.47 29.26 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 121.114 -0.565 . . . . 0.0 111.744 179.202 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.67 ' ND2' ' HB2' ' A' ' 55' ' ' PHE . 7.2 p30 -160.88 50.2 0.31 Allowed Pre-proline 0 CA--C 1.537 0.476 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -179.738 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -69.93 -13.07 33.77 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 121.658 1.572 . . . . 0.0 112.046 -179.653 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -101.94 5.02 40.62 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.735 179.83 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.559 ' CA ' ' HG2' ' A' ' 83' ' ' ARG . . . 85.43 11.66 74.59 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.362 -0.923 . . . . 0.0 112.37 -179.592 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.66 ' HA ' HE22 ' A' ' 86' ' ' GLN . 49.3 m-85 -125.31 131.81 52.98 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.013 0.435 . . . . 0.0 110.801 179.916 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.522 ' HB3' ' HB ' ' A' ' 88' ' ' ILE . 84.6 mt -86.31 135.57 33.48 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.461 -0.791 . . . . 0.0 111.722 -178.69 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -177.85 172.27 44.88 Favored Glycine 0 N--CA 1.447 -0.619 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.734 179.209 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.44 ' HH2' HD11 ' A' ' 93' ' ' ILE . 90.2 m95 -95.16 124.76 39.38 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 179.621 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 159.41 -54.71 0.35 Allowed Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.92 -0.657 . . . . 0.0 111.917 -179.26 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.576 ' HB3' ' HA3' ' A' ' 42' ' ' GLY . 0.0 OUTLIER -85.56 -166.06 1.41 Allowed 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 179.649 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -146.03 173.63 12.0 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.64 -0.424 . . . . 0.0 111.634 -179.55 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 60.21 39.86 18.75 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.717 179.376 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.67 ' HB2' ' ND2' ' A' ' 43' ' ' ASN . 6.2 p90 -61.84 -28.61 69.61 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.167 179.488 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.493 ' HB2' ' HB3' ' A' ' 17' ' ' ARG . 24.5 t -58.83 -44.94 91.04 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.727 -179.942 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 34.0 m80 -81.31 -13.76 58.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.082 0.467 . . . . 0.0 111.037 -179.734 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 15.7 m -96.33 -1.47 47.77 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.77 -178.928 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.421 ' HB3' ' HA ' ' A' ' 75' ' ' PRO . 56.5 p -137.95 172.97 12.15 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 121.71 -0.619 . . . . 0.0 111.235 -179.0 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.402 ' HG3' ' HG2' ' A' ' 76' ' ' LYS . 44.3 mt-10 -131.13 147.57 52.62 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.011 179.909 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 39.0 t70 56.66 77.69 0.25 Allowed 'General case' 0 N--CA 1.467 0.396 0 O-C-N 123.877 0.736 . . . . 0.0 110.722 179.903 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.542 ' HA ' ' HB3' ' A' ' 73' ' ' CYS . 67.3 mt -99.94 120.38 49.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.841 -179.292 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 76.9 tttt -148.9 156.96 43.05 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.211 -0.45 . . . . 0.0 109.858 179.554 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 44.1 mt -82.66 140.12 33.32 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.139 0.495 . . . . 0.0 111.271 -178.848 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -90.81 -61.56 1.64 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.985 -178.792 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.492 ' HB2' ' HB3' ' A' ' 69' ' ' ARG . 30.1 mm-40 -82.2 13.01 3.73 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.127 0.489 . . . . 0.0 111.106 -179.767 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 78.4 17.16 78.35 Favored Glycine 0 N--CA 1.45 -0.403 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.413 179.8 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 143.24 -30.95 1.98 Allowed Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.309 -0.948 . . . . 0.0 112.552 179.469 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.513 ' HD3' ' HB2' ' A' ' 2' ' ' SER . 4.6 tpp85 -75.45 -19.66 59.31 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.279 0.561 . . . . 0.0 110.565 -179.931 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.428 ' HB3' ' HG2' ' A' ' 66' ' ' GLU . 86.5 tttt -148.5 145.71 28.03 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.437 -178.33 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.733 ' HB2' HD11 ' A' ' 90' ' ' LEU . 10.2 tt -116.61 144.38 44.46 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.782 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.8 p -134.2 138.52 45.17 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 120.85 0.357 . . . . 0.0 110.697 179.747 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.542 ' HB3' ' HA ' ' A' ' 62' ' ' ILE . 26.5 p -162.55 174.58 12.45 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.85 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.495 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 4.1 tmt_? -109.29 97.46 26.31 Favored Pre-proline 0 C--N 1.315 -0.915 0 N-CA-C 109.111 -0.699 . . . . 0.0 109.111 179.087 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.65 ' O ' ' HB3' ' A' ' 83' ' ' ARG . 32.4 Cg_endo -64.58 129.55 24.03 Favored 'Trans proline' 0 CA--C 1.515 -0.473 0 C-N-CA 122.991 2.461 . . . . 0.0 110.807 -179.981 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.765 ' HA ' ' HB2' ' A' ' 83' ' ' ARG . 0.3 OUTLIER -121.22 149.78 42.32 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.217 0.532 . . . . 0.0 111.478 -179.569 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.655 HG22 ' O ' ' A' ' 82' ' ' PHE . 14.7 t -82.69 143.4 30.96 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 178.794 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 32.7 m -70.04 -9.33 12.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 O-C-N 123.862 0.727 . . . . 0.0 111.798 -179.494 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -62.57 -37.77 87.46 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-O 121.008 0.433 . . . . 0.0 110.374 179.246 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -160.38 -0.92 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.308 -0.949 . . . . 0.0 113.103 -179.519 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.591 ' HA2' ' HD3' ' A' ' 76' ' ' LYS . . . 84.88 21.52 55.46 Favored Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.488 -0.863 . . . . 0.0 112.041 179.304 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.655 ' O ' HG22 ' A' ' 77' ' ' THR . 40.2 p90 -111.07 154.91 23.57 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -179.588 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.805 ' HA ' ' HE ' ' A' ' 83' ' ' ARG . 0.0 OUTLIER 169.33 -145.34 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.241 0 O-C-N 123.805 0.691 . . . . 0.0 111.498 -179.999 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -129.53 157.46 41.97 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.688 -178.361 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.495 ' HA ' ' HA ' ' A' ' 74' ' ' ARG . 57.2 ttt180 -82.68 154.33 24.91 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 178.976 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.66 HE22 ' HA ' ' A' ' 47' ' ' PHE . 7.6 tt0 -164.81 -179.36 5.79 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 120.986 0.422 . . . . 0.0 111.741 -177.939 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.546 ' H ' ' HG2' ' A' ' 86' ' ' GLN . . . -142.55 153.26 24.42 Favored Glycine 0 CA--C 1.521 0.455 0 N-CA-C 111.841 -0.504 . . . . 0.0 111.841 179.257 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.522 ' HB ' ' HB3' ' A' ' 48' ' ' LEU . 12.0 tt -131.33 143.98 39.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.11 0.481 . . . . 0.0 110.618 -179.876 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.589 ' OD2' ' HB2' ' A' ' 91' ' ' ASN . 20.8 t70 -82.99 133.55 35.1 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.345 -179.184 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.733 HD11 ' HB2' ' A' ' 71' ' ' LEU . 86.7 mt -109.46 38.35 2.36 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -179.214 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.589 ' HB2' ' OD2' ' A' ' 89' ' ' ASP . 6.6 m-80 -75.68 3.07 10.4 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-O 121.485 0.66 . . . . 0.0 110.256 178.621 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 24.9 mtp180 -96.08 -5.57 40.59 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.879 179.567 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.471 ' CD1' HD22 ' A' ' 37' ' ' LEU . 25.0 mm -103.02 100.95 11.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.265 0.555 . . . . 0.0 109.994 -179.413 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.405 HE21 ' HA ' ' A' ' 94' ' ' GLN . 0.0 OUTLIER -110.24 156.34 20.8 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.725 -178.508 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 18.7 p-10 -110.07 113.18 25.67 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.378 178.172 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.7 p -109.9 114.99 48.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-O 121.339 0.59 . . . . 0.0 110.431 -179.777 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 65.12 23.54 12.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.559 179.697 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 95.45 -8.53 69.12 Favored Glycine 0 N--CA 1.447 -0.605 0 CA-C-N 115.481 -0.781 . . . . 0.0 112.404 -179.942 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 10.2 mtp180 -95.2 135.78 36.35 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -179.413 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.467 HD13 ' SG ' ' A' ' 23' ' ' CYS . 5.2 tp -88.22 116.11 26.19 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 -179.517 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 39.2 t -130.45 141.25 46.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.87 0.366 . . . . 0.0 110.65 -178.917 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.573 ' HB2' HD11 ' A' ' 35' ' ' LEU . 12.9 t80 -78.7 137.4 37.77 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.734 178.783 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 4.6 tp-100 . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.576 -0.726 . . . . 0.0 110.215 -179.994 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . 0.497 ' HA ' HE22 ' A' ' 94' ' ' GLN . 39.0 m . . . . . 0 N--CA 1.451 -0.423 0 CA-C-O 120.893 0.377 . . . . 0.0 111.352 . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.444 ' CB ' HD11 ' A' ' 100' ' ' LEU . 11.1 p90 -54.3 -32.63 56.9 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.518 178.062 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.558 ' HB3' ' HD2' ' A' ' 69' ' ' ARG . . . -57.43 -18.97 20.72 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 115.41 -0.814 . . . . 0.0 112.471 -179.056 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -69.41 -17.27 63.64 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 121.113 0.483 . . . . 0.0 110.891 179.641 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.413 ' HB2' HD21 ' A' ' 95' ' ' ASN . 74.6 m -144.27 37.05 1.24 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.076 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 23.2 t -150.83 157.17 42.6 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.686 -179.443 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 2.0 ptm180 -144.79 167.31 22.89 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 179.653 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 60.17 50.44 6.4 Favored 'General case' 0 N--CA 1.464 0.232 0 O-C-N 123.868 0.73 . . . . 0.0 111.186 179.492 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.505 ' HA ' ' HB2' ' A' ' 21' ' ' ALA . . . -84.81 117.36 23.81 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.467 179.721 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 33.5 m -122.42 168.77 14.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.916 -179.738 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.631 HD21 ' HG ' ' A' ' 64' ' ' LEU . 3.3 mm? -104.91 115.3 30.05 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.662 179.9 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 28.1 p -110.31 167.26 10.33 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.008 -179.891 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 59.83 46.78 10.94 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.089 179.398 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 85.5 -31.92 3.75 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 121.049 -0.596 . . . . 0.0 112.346 179.942 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.574 ' HA2' ' HB3' ' A' ' 12' ' ' LEU . . . 133.18 54.99 0.08 OUTLIER Glycine 0 N--CA 1.442 -0.905 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 -179.202 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.616 ' HB2' ' HB3' ' A' ' 38' ' ' ASP . 43.3 ptt85 -138.06 -32.73 0.72 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.889 0.376 . . . . 0.0 111.125 -179.664 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.451 HG22 ' HB3' ' A' ' 34' ' ' GLU . 5.2 m -98.56 132.32 44.07 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.479 179.93 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.744 HD11 HD13 ' A' ' 90' ' ' LEU . 69.5 mt -92.3 113.32 25.56 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.172 179.195 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 53.6 ttp180 -111.86 120.77 43.06 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 178.775 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.505 ' HB2' ' HA ' ' A' ' 10' ' ' ALA . . . -153.4 167.5 29.22 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.798 -179.271 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -90.36 106.15 18.3 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 178.437 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.556 ' SG ' HD13 ' A' ' 100' ' ' LEU . 58.5 m -93.15 130.59 38.75 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 -178.893 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 22.7 ttp85 -77.92 119.94 22.1 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 120.896 -0.322 . . . . 0.0 110.244 179.237 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.48 HD21 ' HB3' ' A' ' 29' ' ' ASN . 33.6 p30 -84.8 163.43 19.09 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.468 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.33 -15.43 25.47 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -178.232 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -82.21 -10.2 59.23 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.789 0.804 . . . . 0.0 109.289 179.168 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 87.23 35.36 9.7 Favored Glycine 0 N--CA 1.447 -0.605 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.702 -179.827 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.48 ' HB3' HD21 ' A' ' 25' ' ' ASN . 43.9 t30 -124.39 160.37 28.3 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.747 0.308 . . . . 0.0 111.316 -179.266 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 85.2 m95 -99.0 120.43 39.44 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.71 179.58 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.7 m -124.01 136.51 60.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.5 178.989 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 55.0 m -78.11 108.77 11.65 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 120.944 0.402 . . . . 0.0 110.135 179.696 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.478 ' HB2' ' SG ' ' A' ' 23' ' ' CYS . 70.6 m -119.26 142.46 48.03 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.383 -179.502 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.649 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 2.7 mp0 -128.38 152.6 47.99 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.344 -179.641 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.525 ' HB2' HD23 ' A' ' 100' ' ' LEU . 0.9 OUTLIER -143.53 126.96 16.81 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 178.292 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -87.26 109.65 19.64 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 -179.815 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.467 HD11 HD11 ' A' ' 19' ' ' LEU . 1.0 OUTLIER -86.94 -13.76 43.74 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.292 0.479 . . . . 0.0 112.292 -179.123 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.616 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 8.8 p-10 -64.98 -16.23 63.15 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 122.085 -0.384 . . . . 0.0 111.923 -178.314 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 15.1 t -91.15 0.79 57.46 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.119 0.485 . . . . 0.0 110.013 179.314 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 22.5 m -130.62 -19.5 3.0 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.993 -0.548 . . . . 0.0 111.783 -179.486 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 64.7 mt -112.79 139.95 35.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.823 0.344 . . . . 0.0 111.359 -179.287 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.577 ' HA3' ' HB3' ' A' ' 52' ' ' MET . . . -148.81 158.62 27.73 Favored Glycine 0 N--CA 1.449 -0.493 0 N-CA-C 110.841 -0.903 . . . . 0.0 110.841 179.171 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.6 ' N ' ' HD3' ' A' ' 44' ' ' PRO . 24.3 p30 -162.86 45.25 0.14 Allowed Pre-proline 0 CA--C 1.541 0.608 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 -179.317 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.6 ' HD3' ' N ' ' A' ' 43' ' ' ASN . 7.8 Cg_exo -71.84 -15.35 29.78 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 121.868 1.712 . . . . 0.0 111.277 179.959 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 70.9 m-20 -90.0 -0.75 57.75 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.703 -179.807 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.491 ' CA ' ' HG2' ' A' ' 83' ' ' ARG . . . 90.0 3.45 73.31 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.294 -0.955 . . . . 0.0 111.716 -179.167 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.71 ' HA ' HE22 ' A' ' 86' ' ' GLN . 64.7 m-85 -125.25 132.68 52.9 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.786 0.327 . . . . 0.0 110.449 179.988 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.545 HD23 HG22 ' A' ' 88' ' ' ILE . 11.1 mp -85.3 153.69 22.4 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.057 -179.273 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 170.99 171.97 36.77 Favored Glycine 0 N--CA 1.44 -1.094 0 C-N-CA 120.432 -0.89 . . . . 0.0 112.008 179.092 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.51 ' CD2' ' HD3' ' A' ' 92' ' ' ARG . 93.4 m95 -96.91 131.16 43.96 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.675 0.274 . . . . 0.0 110.506 -179.495 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 142.97 -62.47 0.51 Allowed Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 121.055 -0.593 . . . . 0.0 111.739 -179.866 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.577 ' HB3' ' HA3' ' A' ' 42' ' ' GLY . 2.4 ttt -72.07 -176.56 1.79 Allowed 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 179.345 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -142.84 169.16 18.09 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 121.517 -0.74 . . . . 0.0 112.605 -178.021 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 25.2 m-80 64.07 45.81 3.98 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.073 -0.967 . . . . 0.0 112.54 178.836 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 23.4 p90 -66.41 -32.71 74.26 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.837 179.512 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.448 ' HA ' HD11 ' A' ' 62' ' ' ILE . 4.3 m -63.09 -30.86 71.92 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.376 -179.169 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 28.1 m80 -81.76 -3.59 54.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.999 0.428 . . . . 0.0 111.025 -179.927 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 19.4 m -128.56 22.72 5.92 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.187 179.5 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 66.8 m -139.62 162.06 36.02 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.122 0.487 . . . . 0.0 111.671 -179.774 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -132.92 142.23 48.78 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.02 178.922 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 25.9 t70 60.0 73.52 0.48 Allowed 'General case' 0 N--CA 1.467 0.385 0 O-C-N 123.687 0.617 . . . . 0.0 110.707 -179.857 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.519 HG23 HD21 ' A' ' 71' ' ' LEU . 68.7 mt -93.19 114.42 29.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.415 -179.824 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.472 ' HD3' ' N ' ' A' ' 64' ' ' LEU . 13.7 tmtt? -147.38 149.88 33.6 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.079 -179.055 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.631 ' HG ' HD21 ' A' ' 12' ' ' LEU . 79.3 mt -83.29 122.54 28.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.145 0.498 . . . . 0.0 111.37 -179.521 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -74.02 -63.27 1.25 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.379 -179.143 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.515 ' HB2' ' HB2' ' A' ' 69' ' ' ARG . 29.3 mt-10 -86.13 35.35 0.64 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.843 0.354 . . . . 0.0 111.462 -179.008 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 56.93 22.09 40.3 Favored Glycine 0 CA--C 1.519 0.319 0 CA-C-N 115.679 -0.691 . . . . 0.0 113.591 179.327 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 139.22 -23.97 2.84 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 119.887 -1.149 . . . . 0.0 113.091 179.275 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.558 ' HD2' ' HB3' ' A' ' 4' ' ' ALA . 0.2 OUTLIER -78.73 -17.12 56.34 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 117.251 0.526 . . . . 0.0 110.838 -179.788 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.459 ' HE3' ' OE1' ' A' ' 66' ' ' GLU . 33.3 ttmt -153.56 138.34 17.06 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.521 -177.938 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.586 ' HB2' HD11 ' A' ' 90' ' ' LEU . 10.5 tt -108.55 129.75 55.3 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.102 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 6.4 p -117.61 136.36 53.34 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.819 0.342 . . . . 0.0 111.528 179.969 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 28.2 p -162.67 163.45 26.99 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.479 179.895 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.44 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 78.8 ttt180 -99.47 103.93 24.03 Favored Pre-proline 0 C--N 1.32 -0.71 0 C-N-CA 120.341 -0.543 . . . . 0.0 110.458 179.061 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.709 ' O ' ' HB3' ' A' ' 83' ' ' ARG . 69.2 Cg_endo -71.95 123.46 9.33 Favored 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 122.848 2.365 . . . . 0.0 111.036 179.174 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.758 ' HA ' ' HB2' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -120.21 143.33 48.32 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.335 -179.589 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.738 HG22 ' O ' ' A' ' 82' ' ' PHE . 15.2 t -75.71 136.78 40.35 Favored 'General case' 0 CA--C 1.513 -0.471 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 179.334 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 35.0 m -76.35 -6.88 9.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.991 -179.784 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -68.59 -31.54 70.8 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.637 179.645 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.486 ' HA3' ' CE2' ' A' ' 82' ' ' PHE . . . -147.04 -23.34 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.717 179.568 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 101.18 12.54 36.06 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.997 -0.62 . . . . 0.0 112.146 -179.495 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.738 ' O ' HG22 ' A' ' 77' ' ' THR . 31.5 p90 -111.91 158.46 19.45 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 118.892 -0.575 . . . . 0.0 110.221 -178.349 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.758 ' HB2' ' HA ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 164.32 -161.47 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.436 0 O-C-N 123.861 0.725 . . . . 0.0 111.307 178.327 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -110.16 176.08 5.19 Favored 'General case' 0 C--O 1.222 -0.354 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.36 -176.904 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.44 ' HA ' ' HA ' ' A' ' 74' ' ' ARG . 74.9 ttt180 -102.65 153.73 19.84 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 177.967 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.71 HE22 ' HA ' ' A' ' 47' ' ' PHE . 8.2 tt0 -166.09 179.2 5.89 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 120.361 -0.535 . . . . 0.0 111.848 -177.49 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.539 ' H ' ' HG2' ' A' ' 86' ' ' GLN . . . -145.54 155.16 26.37 Favored Glycine 0 N--CA 1.449 -0.493 0 N-CA-C 111.473 -0.651 . . . . 0.0 111.473 179.225 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.545 HG22 HD23 ' A' ' 48' ' ' LEU . 11.9 tt -132.06 134.84 59.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 110.105 -0.331 . . . . 0.0 110.105 179.883 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -77.78 139.09 39.31 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.221 0.534 . . . . 0.0 110.179 -179.949 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.744 HD13 HD11 ' A' ' 19' ' ' LEU . 68.3 mt -106.59 46.66 0.91 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.589 0.709 . . . . 0.0 111.201 -179.015 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 35.0 m-80 -79.16 3.19 18.41 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 115.344 -0.843 . . . . 0.0 110.176 179.555 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.51 ' HD3' ' CD2' ' A' ' 50' ' ' TRP . 17.8 mtp180 -97.09 -19.17 18.88 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.676 179.569 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.435 ' CD1' HD22 ' A' ' 37' ' ' LEU . 21.6 mm -91.56 100.76 11.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 -179.589 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.497 HE22 ' HA ' ' A' ' 2' ' ' SER . 21.1 mm-40 -109.48 165.92 11.28 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.285 -177.988 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.511 ' HA ' ' O ' ' A' ' 99' ' ' ARG . 18.4 p-10 -120.16 118.92 31.78 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.154 177.632 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.2 p -116.12 122.53 69.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 121.033 0.444 . . . . 0.0 110.339 -179.321 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 57.99 16.59 3.83 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.848 179.889 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 111.2 -12.15 28.82 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 121.076 -0.583 . . . . 0.0 113.707 178.859 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.511 ' O ' ' HA ' ' A' ' 95' ' ' ASN . 0.9 OUTLIER -101.0 147.06 26.62 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 117.422 0.611 . . . . 0.0 111.276 -178.906 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.556 HD13 ' SG ' ' A' ' 23' ' ' CYS . 5.2 tp -91.79 123.55 35.26 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.542 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 23.7 t -130.7 140.12 49.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.809 -178.951 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -85.65 125.07 32.87 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 177.397 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 . . . . . 0 C--N 1.309 -1.166 0 CA-C-O 118.46 -0.781 . . . . 0.0 110.862 179.675 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.9 m . . . . . 0 N--CA 1.45 -0.437 0 CA-C-O 120.536 0.208 . . . . 0.0 110.453 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.475 ' CZ ' HD13 ' A' ' 19' ' ' LEU . 18.0 p90 -55.43 -34.49 64.49 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.791 0.329 . . . . 0.0 111.114 178.555 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.546 ' HA ' ' OG ' ' A' ' 7' ' ' SER . . . -57.77 -18.69 23.08 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -178.546 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -69.48 -18.19 63.68 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 121.102 0.477 . . . . 0.0 111.168 179.875 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.419 ' HB2' HD21 ' A' ' 95' ' ' ASN . 50.7 m -141.64 36.51 1.64 Allowed 'General case' 0 N--CA 1.446 -0.646 0 CA-C-O 121.239 0.542 . . . . 0.0 109.899 179.361 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.546 ' OG ' ' HA ' ' A' ' 4' ' ' ALA . 77.8 p -148.7 165.47 31.26 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.36 179.205 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -148.22 165.57 30.53 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.068 179.918 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 62.09 42.44 9.81 Favored 'General case' 0 N--CA 1.464 0.237 0 O-C-N 123.594 0.559 . . . . 0.0 111.24 179.902 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.432 ' HA ' ' O ' ' A' ' 20' ' ' ARG . . . -80.13 117.21 20.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.153 179.627 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 28.2 m -126.41 172.38 13.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.708 -179.432 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.655 HD21 ' HG ' ' A' ' 64' ' ' LEU . 3.1 mm? -104.5 117.84 35.14 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.559 -179.216 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.45 ' OG1' ' HB ' ' A' ' 18' ' ' THR . 37.9 p -112.33 163.96 13.8 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.016 179.779 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 58.56 50.12 9.58 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.124 -179.909 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 84.63 -33.13 3.29 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.394 179.287 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.599 ' HA2' ' HB3' ' A' ' 12' ' ' LEU . . . 134.38 49.65 0.08 OUTLIER Glycine 0 N--CA 1.443 -0.855 0 N-CA-C 111.448 -0.661 . . . . 0.0 111.448 -179.652 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.681 ' HB2' ' HB2' ' A' ' 38' ' ' ASP . 20.4 ptt85 -133.79 -33.82 1.04 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.834 0.35 . . . . 0.0 111.021 179.96 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.509 ' CG2' ' HB3' ' A' ' 34' ' ' GLU . 19.2 m -94.76 135.68 35.96 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.15 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.656 ' O ' ' HA ' ' A' ' 34' ' ' GLU . 79.9 mt -97.54 114.98 26.97 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.559 -179.589 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.468 ' HA ' ' HG2' ' A' ' 34' ' ' GLU . 16.8 ttm180 -104.57 120.24 40.84 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 178.661 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -153.84 160.39 42.19 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.776 0.322 . . . . 0.0 111.571 -179.982 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.585 ' HB3' ' HB3' ' A' ' 30' ' ' TRP . 15.9 mm-40 -90.32 106.08 18.25 Favored 'General case' 0 CA--C 1.513 -0.479 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 177.927 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.505 ' SG ' HD13 ' A' ' 100' ' ' LEU . 48.9 m -93.74 127.56 39.52 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 120.989 0.423 . . . . 0.0 111.053 -178.016 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 23.3 ttp180 -75.35 110.19 9.5 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.772 179.17 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -82.74 169.28 16.35 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 119.223 -0.418 . . . . 0.0 109.979 -179.525 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -47.83 -34.38 8.64 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -178.085 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -68.04 -12.71 61.32 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.473 0.654 . . . . 0.0 111.317 -179.58 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 85.72 26.17 36.1 Favored Glycine 0 N--CA 1.444 -0.83 0 N-CA-C 110.806 -0.918 . . . . 0.0 110.806 -179.202 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -115.95 153.54 31.42 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.718 0.294 . . . . 0.0 110.899 -179.288 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.585 ' HB3' ' HB3' ' A' ' 22' ' ' GLU . 88.6 m95 -89.29 125.58 35.17 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.395 -179.505 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.409 HG22 ' O ' ' A' ' 23' ' ' CYS . 12.1 m -124.74 132.69 70.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 116.213 -0.449 . . . . 0.0 109.949 178.319 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 21.0 m -74.61 109.47 8.11 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.454 -179.904 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 68.7 m -123.18 142.94 50.37 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.358 179.826 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.656 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 49.1 mt-10 -128.38 134.93 48.93 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.31 -179.342 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.519 HD11 ' HB2' ' A' ' 102' ' ' PHE . 1.7 tm? -125.44 130.09 51.14 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 178.744 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.413 ' N ' HD13 ' A' ' 35' ' ' LEU . 15.2 t70 -88.98 111.3 21.98 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 110.14 -0.318 . . . . 0.0 110.14 -179.914 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.548 HD13 HD22 ' A' ' 90' ' ' LEU . 0.9 OUTLIER -86.38 -12.62 48.75 Favored 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 120.937 -0.305 . . . . 0.0 110.906 179.828 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.681 ' HB2' ' HB2' ' A' ' 17' ' ' ARG . 10.1 t70 -61.66 -36.32 80.5 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.653 0.264 . . . . 0.0 111.225 -178.928 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.3 t -72.75 1.27 8.78 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.199 -0.455 . . . . 0.0 112.0 -179.877 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 78.5 m -135.45 -21.43 1.55 Allowed 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 179.943 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.459 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 68.7 mt -107.58 137.21 39.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 179.771 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.491 ' HA2' ' HB3' ' A' ' 55' ' ' PHE . . . -149.55 160.13 28.34 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.393 -0.908 . . . . 0.0 112.492 179.951 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.705 ' ND2' ' HB2' ' A' ' 55' ' ' PHE . 8.3 p30 -158.23 51.21 0.44 Allowed Pre-proline 0 CA--C 1.535 0.4 0 N-CA-C 111.664 0.246 . . . . 0.0 111.664 178.967 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.402 ' HG3' ' HG2' ' A' ' 52' ' ' MET . 60.6 Cg_endo -71.83 -19.69 26.97 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 121.944 1.763 . . . . 0.0 111.823 -179.347 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -91.19 -9.2 46.25 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.883 179.515 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.594 ' HA3' ' HG2' ' A' ' 83' ' ' ARG . . . 102.7 7.47 44.89 Favored Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.772 -179.917 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -125.3 137.45 54.07 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.018 0.437 . . . . 0.0 111.076 -179.674 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.439 HD23 ' HB3' ' A' ' 43' ' ' ASN . 86.9 mt -82.92 146.52 28.79 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.922 -178.457 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 168.32 171.48 34.23 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.2 178.743 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.409 ' HH2' HD11 ' A' ' 93' ' ' ILE . 91.6 m95 -95.27 128.01 41.77 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 -179.998 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 154.35 -51.66 0.46 Allowed Glycine 0 N--CA 1.453 -0.196 0 C-N-CA 120.856 -0.688 . . . . 0.0 111.95 -179.905 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.449 ' HB3' ' HA3' ' A' ' 42' ' ' GLY . 14.0 tpt -93.05 174.03 7.43 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 179.848 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -128.97 173.19 10.64 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.846 -0.342 . . . . 0.0 111.005 179.698 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.678 ' HA ' ' OD2' ' A' ' 38' ' ' ASP . 0.7 OUTLIER 65.52 47.23 2.29 Favored 'General case' 0 N--CA 1.466 0.352 0 O-C-N 123.701 0.626 . . . . 0.0 111.128 -179.806 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.705 ' HB2' ' ND2' ' A' ' 43' ' ' ASN . 15.7 p90 -74.19 -32.11 62.92 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.673 -179.756 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.614 ' OG ' ' HB3' ' A' ' 17' ' ' ARG . 20.1 m -63.75 -33.74 76.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.035 0.445 . . . . 0.0 111.128 -179.046 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 15.7 m-70 -82.15 -7.95 59.64 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.101 0.476 . . . . 0.0 110.27 179.578 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 15.1 m -112.0 4.23 17.98 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.387 -179.292 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 36.4 p -138.38 157.54 46.03 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 122.203 -0.31 . . . . 0.0 110.752 -179.222 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 38.0 mm-40 -117.46 148.42 41.83 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.014 -179.401 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 24.1 t70 52.05 83.35 0.06 Allowed 'General case' 0 N--CA 1.468 0.462 0 O-C-N 124.333 1.02 . . . . 0.0 111.644 178.957 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.538 HD11 ' HA ' ' A' ' 56' ' ' SER . 77.9 mt -97.79 124.1 50.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.78 -179.942 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.455 ' HD3' ' N ' ' A' ' 64' ' ' LEU . 13.0 tmtt? -148.98 149.75 31.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.006 -179.857 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.655 ' HG ' HD21 ' A' ' 12' ' ' LEU . 76.2 mt -83.01 120.16 25.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.021 0.439 . . . . 0.0 111.532 -179.648 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -71.64 -60.2 2.36 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.267 -178.666 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.548 ' HB2' ' HB2' ' A' ' 69' ' ' ARG . 5.0 mm-40 -83.52 20.17 1.44 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.033 -178.767 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 68.66 19.23 72.88 Favored Glycine 0 N--CA 1.45 -0.425 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.923 179.701 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.519 ' HA2' HD13 ' A' ' 64' ' ' LEU . . . 144.18 -34.83 1.62 Allowed Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.315 -0.945 . . . . 0.0 113.251 179.697 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.548 ' HB2' ' HB2' ' A' ' 66' ' ' GLU . 5.4 mmt85 -71.57 -24.89 62.0 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.854 0.359 . . . . 0.0 111.829 -179.34 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 11.7 tttp -143.65 137.48 28.29 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.607 -177.81 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.606 ' HB2' HD11 ' A' ' 90' ' ' LEU . 10.5 tt -105.84 127.58 53.2 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 179.599 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.1 p -116.32 136.28 53.14 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 120.971 0.415 . . . . 0.0 111.233 179.967 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.403 ' HB3' ' HA ' ' A' ' 62' ' ' ILE . 21.0 p -162.58 175.87 10.98 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.747 -179.743 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.464 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 29.5 ttt180 -112.8 98.85 46.35 Favored Pre-proline 0 C--N 1.315 -0.902 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.303 178.97 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.647 ' O ' ' HB3' ' A' ' 83' ' ' ARG . 34.9 Cg_endo -66.19 130.44 24.13 Favored 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 122.674 2.249 . . . . 0.0 110.791 178.953 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.626 ' HA ' ' HB2' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -119.71 152.88 36.47 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.167 0.508 . . . . 0.0 111.049 -179.681 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.696 ' HB ' ' HD2' ' A' ' 83' ' ' ARG . 10.9 t -88.84 144.78 25.99 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 178.902 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 34.7 m -71.61 -4.81 5.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 O-C-N 123.992 0.808 . . . . 0.0 112.152 -179.141 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 39.1 m-20 -63.93 -37.21 86.55 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-O 121.118 0.485 . . . . 0.0 109.793 178.928 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.405 ' H ' ' H ' ' A' ' 81' ' ' GLY . . . -164.76 -4.94 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 115.461 -0.79 . . . . 0.0 112.854 -179.841 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.405 ' H ' ' H ' ' A' ' 80' ' ' GLY . . . 93.38 22.9 25.67 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.089 179.731 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.649 ' O ' HG22 ' A' ' 77' ' ' THR . 34.2 p90 -111.46 148.02 34.03 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 -179.42 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.696 ' HD2' ' HB ' ' A' ' 77' ' ' THR . 0.0 OUTLIER 174.55 -143.75 0.01 OUTLIER 'General case' 0 C--O 1.233 0.195 0 O-C-N 123.465 0.478 . . . . 0.0 111.304 -179.915 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -125.31 176.6 6.66 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.923 0.392 . . . . 0.0 110.579 -179.49 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.464 ' HA ' ' HA ' ' A' ' 74' ' ' ARG . 62.8 ttt180 -108.66 147.82 31.32 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 177.849 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.519 ' HG2' ' N ' ' A' ' 87' ' ' GLY . 9.0 tt0 -161.27 171.8 17.75 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.946 0.403 . . . . 0.0 111.79 -177.246 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.519 ' N ' ' HG2' ' A' ' 86' ' ' GLN . . . -132.12 141.65 13.01 Favored Glycine 0 N--CA 1.45 -0.387 0 N-CA-C 111.233 -0.747 . . . . 0.0 111.233 178.612 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 11.6 tt -120.45 138.74 49.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 120.976 0.417 . . . . 0.0 110.377 -179.221 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.418 ' HB3' HD22 ' A' ' 91' ' ' ASN . 39.6 m-20 -75.74 139.98 42.15 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.185 -179.472 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.612 HD13 HD11 ' A' ' 19' ' ' LEU . 29.8 mt -109.43 35.73 3.2 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.517 0.675 . . . . 0.0 110.376 179.317 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.418 HD22 ' HB3' ' A' ' 89' ' ' ASP . 13.5 m-80 -72.56 -5.41 36.92 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.594 -179.835 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 17.1 mtp180 -89.09 -7.74 55.21 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.001 178.731 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.438 HG13 HD22 ' A' ' 37' ' ' LEU . 27.5 mm -103.64 100.55 10.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -179.615 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 25.4 tp60 -117.55 146.76 43.37 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.342 -178.777 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.419 HD21 ' HB2' ' A' ' 6' ' ' SER . 12.5 p-10 -95.16 117.11 29.66 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.48 179.18 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 48.5 t -101.36 107.03 20.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.788 179.727 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 56.16 41.86 28.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.675 -179.284 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 89.5 -18.4 46.4 Favored Glycine 0 N--CA 1.447 -0.624 0 CA-C-N 115.783 -0.644 . . . . 0.0 113.342 179.681 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 8.7 mpt_? -88.31 123.13 32.59 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 117.163 0.481 . . . . 0.0 110.921 -179.216 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.505 HD13 ' SG ' ' A' ' 23' ' ' CYS . 7.6 tp -76.65 114.46 15.41 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.443 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 40.7 t -128.98 144.7 37.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.09 0.472 . . . . 0.0 111.367 -178.488 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.519 ' HB2' HD11 ' A' ' 35' ' ' LEU . 22.3 t80 -83.26 130.92 35.11 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.63 178.442 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 . . . . . 0 C--N 1.317 -0.846 0 CA-C-O 118.325 -0.845 . . . . 0.0 110.216 -179.725 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . 0.536 ' HB3' ' HA ' ' A' ' 91' ' ' ASN . 15.9 p . . . . . 0 N--CA 1.453 -0.3 0 N-CA-C 110.732 -0.099 . . . . 0.0 110.732 . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 4.4 p90 -55.91 -38.09 69.79 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -178.555 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -56.35 -21.57 25.41 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 -177.882 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -66.4 -28.7 68.84 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.255 0.55 . . . . 0.0 110.392 179.971 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 41.4 m -133.44 36.22 3.39 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.687 179.204 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 8.6 t -140.29 160.11 40.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.945 -179.66 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 1.1 ptp180 -149.97 169.86 20.19 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.632 -179.593 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 58.23 45.48 17.21 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.129 177.934 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.567 ' HA ' ' HB2' ' A' ' 21' ' ' ALA . . . -81.66 118.34 22.73 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.055 0.455 . . . . 0.0 110.69 179.957 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 29.5 m -119.24 170.55 8.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.393 179.794 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.712 HD21 ' HG ' ' A' ' 64' ' ' LEU . 3.2 mm? -105.12 114.94 29.44 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.434 -179.47 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 38.8 p -115.01 167.66 10.6 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.808 179.752 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 57.64 50.56 10.71 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.154 179.653 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 83.88 -22.94 7.25 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 121.069 -0.586 . . . . 0.0 112.374 -179.808 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.613 ' HA2' ' HB3' ' A' ' 12' ' ' LEU . . . 119.71 38.23 0.73 Allowed Glycine 0 N--CA 1.447 -0.583 0 N-CA-C 111.662 -0.575 . . . . 0.0 111.662 179.976 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.626 ' HB2' ' HB3' ' A' ' 38' ' ' ASP . 14.3 ptt180 -121.86 -22.6 5.7 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.944 0.402 . . . . 0.0 110.758 -179.486 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 4.2 m -102.55 133.06 48.14 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.592 -179.607 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.811 HD11 HD13 ' A' ' 90' ' ' LEU . 69.5 mt -92.65 112.62 24.64 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.297 179.142 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.411 HH11 ' HD2' ' A' ' 20' ' ' ARG . 30.7 ttt85 -111.06 118.57 36.4 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 178.94 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.567 ' HB2' ' HA ' ' A' ' 10' ' ' ALA . . . -154.9 166.92 32.02 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.862 0.363 . . . . 0.0 111.964 -178.783 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -90.69 113.37 25.43 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 177.371 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.477 ' SG ' HD13 ' A' ' 100' ' ' LEU . 59.7 m -102.66 134.95 45.18 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 -179.806 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.563 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 7.3 ttt180 -82.12 104.66 12.61 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-O 120.917 0.389 . . . . 0.0 109.965 -179.804 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.431 HD21 ' HB3' ' A' ' 29' ' ' ASN . 37.8 p30 -67.01 170.84 6.17 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 115.619 -0.718 . . . . 0.0 111.162 -179.214 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.52 -31.16 61.84 Favored 'General case' 0 N--CA 1.464 0.269 0 O-C-N 123.431 0.457 . . . . 0.0 111.781 -178.781 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -71.56 -11.71 61.0 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.331 0.586 . . . . 0.0 110.421 179.878 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 87.55 24.64 35.47 Favored Glycine 0 N--CA 1.45 -0.404 0 N-CA-C 111.373 -0.691 . . . . 0.0 111.373 -179.839 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.563 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 10.7 t-20 -108.56 160.09 16.19 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.672 0.272 . . . . 0.0 110.718 -178.349 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 90.4 m95 -98.36 119.18 36.6 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.984 0.421 . . . . 0.0 110.8 179.745 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.2 m -123.43 130.9 73.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.098 179.11 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 28.0 m -79.69 109.12 13.8 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.057 0.455 . . . . 0.0 110.32 -179.889 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 70.3 m -115.89 161.33 18.96 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.439 -179.817 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.636 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 51.5 mt-10 -140.02 138.92 35.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.241 -178.908 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.6 ' HB2' ' HB3' ' A' ' 100' ' ' LEU . 1.8 tm? -134.72 129.97 35.53 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 178.704 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.476 ' O ' HG22 ' A' ' 39' ' ' THR . 15.8 m-20 -88.64 109.64 20.28 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 179.971 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.534 HD13 HD22 ' A' ' 90' ' ' LEU . 1.4 mt -83.06 -12.42 57.16 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.831 -179.303 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.626 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 4.2 p-10 -66.23 -13.58 60.56 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 111.857 0.317 . . . . 0.0 111.857 -178.621 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.476 HG22 ' O ' ' A' ' 36' ' ' ASP . 12.1 t -87.97 -0.58 57.19 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.885 0.374 . . . . 0.0 110.296 179.387 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 67.2 m -136.58 -20.11 1.37 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.937 179.94 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 60.0 mt -107.96 132.49 55.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 178.877 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.557 ' HA3' ' HB3' ' A' ' 52' ' ' MET . . . -141.49 158.69 26.61 Favored Glycine 0 N--CA 1.446 -0.667 0 N-CA-C 111.256 -0.738 . . . . 0.0 111.256 179.527 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.613 ' OD1' ' HB2' ' A' ' 58' ' ' SER . 32.6 p30 -156.29 40.82 0.12 Allowed Pre-proline 0 CA--C 1.54 0.592 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 179.792 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.403 ' CD ' ' N ' ' A' ' 43' ' ' ASN . 52.5 Cg_endo -69.65 -15.86 37.73 Favored 'Trans proline' 0 C--N 1.357 0.975 0 C-N-CA 121.331 1.354 . . . . 0.0 111.41 -179.933 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -89.74 -8.12 52.98 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.623 179.077 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.589 ' HA3' ' HD3' ' A' ' 83' ' ' ARG . . . 99.38 5.25 55.91 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.659 -179.575 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -126.92 139.79 52.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 117.045 0.422 . . . . 0.0 111.568 -179.587 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.625 HD12 ' HG3' ' A' ' 86' ' ' GLN . 59.4 mt -84.5 138.86 32.54 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.735 -179.704 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 179.11 168.39 38.11 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.137 178.807 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 87.9 m95 -95.78 125.51 40.4 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.985 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 151.26 -42.61 0.72 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.895 -0.669 . . . . 0.0 111.519 -179.66 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.557 ' HB3' ' HA3' ' A' ' 42' ' ' GLY . 1.5 mtt -97.44 -172.07 2.33 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 179.399 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -142.96 169.81 16.88 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 119.757 -0.777 . . . . 0.0 112.343 -178.839 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 64.0 44.97 4.4 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.877 179.203 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.41 ' HD1' ' HA ' ' A' ' 38' ' ' ASP . 20.7 p90 -64.08 -33.6 76.13 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.464 -179.788 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 67.0 p -66.49 -23.84 66.32 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.208 0.527 . . . . 0.0 110.787 -179.36 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 16.1 m80 -76.97 -6.06 51.1 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.662 179.689 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.613 ' HB2' ' OD1' ' A' ' 43' ' ' ASN . 31.5 m -137.78 27.99 2.68 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.939 0.4 . . . . 0.0 110.782 179.492 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.554 ' HB3' HD21 ' A' ' 43' ' ' ASN . 35.6 p -141.73 149.81 40.98 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.169 0.509 . . . . 0.0 111.32 179.352 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -123.28 150.06 43.99 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.476 -179.626 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 27.6 t70 54.62 77.4 0.2 Allowed 'General case' 0 N--CA 1.47 0.546 0 O-C-N 123.778 0.674 . . . . 0.0 111.188 -179.922 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.51 ' HA ' ' HB3' ' A' ' 73' ' ' CYS . 69.4 mt -95.98 117.5 40.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.878 -179.404 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 41.6 tptt -142.25 150.45 40.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.699 -179.326 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.712 ' HG ' HD21 ' A' ' 12' ' ' LEU . 57.8 mt -92.93 144.7 25.01 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.362 179.432 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -101.42 -63.93 1.1 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.941 0.4 . . . . 0.0 111.963 -179.965 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.537 ' HB2' ' HB3' ' A' ' 69' ' ' ARG . 10.6 mm-40 -79.81 40.34 0.45 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.045 -178.098 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 64.11 22.09 66.61 Favored Glycine 0 C--N 1.314 -0.675 0 CA-C-N 115.229 -0.896 . . . . 0.0 113.123 178.858 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.598 ' HA2' HD13 ' A' ' 64' ' ' LEU . . . 120.56 -9.18 10.83 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 119.965 -1.112 . . . . 0.0 112.858 179.17 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.537 ' HB3' ' HB2' ' A' ' 66' ' ' GLU . 16.5 ttp85 -90.3 -3.06 58.01 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.665 0.745 . . . . 0.0 110.335 -179.794 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.517 ' HD3' ' HA ' ' A' ' 89' ' ' ASP . 5.6 tppp? -150.39 123.64 8.92 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.846 -179.77 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.677 ' HB2' HD11 ' A' ' 90' ' ' LEU . 9.5 tt -105.62 128.57 53.71 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 179.867 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 5.6 p -123.23 135.43 54.27 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.166 179.876 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.51 ' HB3' ' HA ' ' A' ' 62' ' ' ILE . 22.8 p -162.21 173.79 13.78 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 179.552 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.47 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 71.8 ttt180 -110.26 98.59 36.34 Favored Pre-proline 0 C--N 1.312 -1.035 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.276 179.606 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.646 ' O ' ' HB3' ' A' ' 83' ' ' ARG . 37.1 Cg_endo -69.92 132.65 23.5 Favored 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 122.342 2.028 . . . . 0.0 109.964 178.495 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.743 ' HA ' ' HB2' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -120.6 142.84 49.02 Favored 'General case' 0 C--N 1.32 -0.68 0 O-C-N 123.678 0.611 . . . . 0.0 111.452 -179.115 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.706 HG22 ' O ' ' A' ' 82' ' ' PHE . 14.6 t -76.81 143.31 39.87 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.614 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 22.5 m -77.4 1.07 2.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.573 -179.492 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -69.8 -34.26 73.48 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 121.371 0.605 . . . . 0.0 109.651 178.326 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -159.05 -12.77 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.517 0 CA-C-N 115.29 -0.868 . . . . 0.0 112.794 -179.814 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.704 ' HA2' ' HE3' ' A' ' 76' ' ' LYS . . . 97.23 20.21 23.72 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.108 179.983 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.706 ' O ' HG22 ' A' ' 77' ' ' THR . 33.8 p90 -111.83 155.42 23.62 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 118.996 -0.526 . . . . 0.0 109.904 -179.055 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.743 ' HB2' ' HA ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 171.49 -148.18 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 O-C-N 123.407 0.442 . . . . 0.0 111.48 179.651 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -134.99 153.51 52.06 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.157 -177.817 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.47 ' HA ' ' HA ' ' A' ' 74' ' ' ARG . 43.2 ttt85 -88.56 149.55 23.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.128 179.512 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.625 ' HG3' HD12 ' A' ' 48' ' ' LEU . 14.3 pt20 -165.28 177.51 7.54 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.146 -179.033 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -131.62 150.94 19.61 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.8 -0.715 . . . . 0.0 112.45 -179.994 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 9.5 tt -127.77 134.63 65.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 179.736 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.517 ' HA ' ' HD3' ' A' ' 70' ' ' LYS . 2.1 p-10 -76.94 140.27 40.42 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.997 0.427 . . . . 0.0 110.439 -179.178 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.811 HD13 HD11 ' A' ' 19' ' ' LEU . 62.2 mt -105.91 38.69 1.95 Allowed 'General case' 0 CA--C 1.512 -0.513 0 CA-C-O 121.412 0.625 . . . . 0.0 110.873 -178.892 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.536 ' HA ' ' HB3' ' A' ' 2' ' ' SER . 30.2 m-80 -75.19 0.05 17.71 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.794 -179.759 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 14.7 mtp180 -92.05 -7.67 48.09 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.595 179.339 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.424 ' CD1' HD22 ' A' ' 37' ' ' LEU . 28.1 mm -98.5 104.57 16.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.518 0.675 . . . . 0.0 109.747 -179.334 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -106.56 157.36 17.73 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.36 -178.346 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.477 ' HA ' ' O ' ' A' ' 99' ' ' ARG . 20.4 p-10 -113.7 124.64 52.78 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.425 178.073 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 46.8 t -107.71 109.28 27.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 -179.237 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 11.3 m-80 57.79 22.14 8.21 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.937 0.398 . . . . 0.0 111.577 -179.326 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 113.66 -25.36 11.08 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.728 -0.748 . . . . 0.0 113.935 178.47 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.477 ' O ' ' HA ' ' A' ' 95' ' ' ASN . 1.4 ptm180 -86.5 147.76 25.83 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 117.416 0.608 . . . . 0.0 110.666 -178.85 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.6 ' HB3' ' HB2' ' A' ' 35' ' ' LEU . 2.1 tp -92.68 122.92 35.57 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.718 0.294 . . . . 0.0 110.335 -179.366 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 41.7 t -134.12 141.84 42.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.654 -179.869 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.416 ' HB2' HD11 ' A' ' 35' ' ' LEU . 16.9 t80 -78.44 136.39 37.61 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.979 0.419 . . . . 0.0 110.106 179.268 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.087 0 CA-C-O 118.462 -0.78 . . . . 0.0 110.39 179.949 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . 0.582 ' HB3' ' HA ' ' A' ' 91' ' ' ASN . 0.3 OUTLIER . . . . . 0 N--CA 1.453 -0.312 0 N-CA-C 111.729 0.27 . . . . 0.0 111.729 . . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.442 ' CB ' HD11 ' A' ' 100' ' ' LEU . 13.3 p90 -47.03 -36.07 7.49 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 123.09 0.556 . . . . 0.0 112.422 -179.51 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.434 ' HB3' ' HD3' ' A' ' 69' ' ' ARG . . . -54.13 -20.45 6.67 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -178.664 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -64.11 -33.65 76.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.218 0.533 . . . . 0.0 109.867 178.896 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 26.1 m -132.31 41.8 3.18 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.619 179.121 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 22.7 t -154.77 149.24 26.26 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.307 -179.591 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.459 ' HG3' ' ND2' ' A' ' 9' ' ' ASN . 11.6 ptp180 -136.62 175.7 9.37 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.827 -179.474 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.459 ' ND2' ' HG3' ' A' ' 8' ' ' ARG . 4.6 p30 45.58 60.39 3.12 Favored 'General case' 0 N--CA 1.474 0.774 0 O-C-N 124.298 0.999 . . . . 0.0 112.286 -179.233 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.422 ' HA ' ' HB2' ' A' ' 21' ' ' ALA . . . -87.28 117.73 26.23 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.376 179.519 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 33.9 m -115.92 170.64 5.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.821 -179.852 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.582 ' HB3' ' HA2' ' A' ' 16' ' ' GLY . 3.7 mm? -105.18 120.75 42.29 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.592 -179.62 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.437 HG21 ' NE ' ' A' ' 20' ' ' ARG . 17.7 p -119.96 161.42 20.92 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.825 179.542 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 59.8 38.27 21.55 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.14 179.679 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 93.86 -23.34 31.39 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.066 179.896 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.582 ' HA2' ' HB3' ' A' ' 12' ' ' LEU . . . 124.93 11.78 4.23 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.628 -0.796 . . . . 0.0 111.847 -179.939 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.585 ' HB2' ' HB3' ' A' ' 38' ' ' ASP . 16.9 ptt180 -92.46 -23.05 19.27 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.264 0.554 . . . . 0.0 110.067 -179.954 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.463 HG22 ' HB3' ' A' ' 34' ' ' GLU . 4.3 m -105.96 133.48 50.61 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.782 -179.535 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.766 HD11 HD13 ' A' ' 90' ' ' LEU . 59.9 mt -97.47 114.41 26.27 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.419 179.163 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.481 ' HA ' ' HG2' ' A' ' 34' ' ' GLU . 32.9 ttm180 -109.84 120.19 41.7 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 178.813 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.422 ' HB2' ' HA ' ' A' ' 10' ' ' ALA . . . -153.36 166.12 33.63 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.969 0.414 . . . . 0.0 111.455 -179.675 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.714 ' HG3' ' HB3' ' A' ' 30' ' ' TRP . 1.0 OUTLIER -90.29 107.6 19.24 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 177.898 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.43 ' SG ' HD13 ' A' ' 100' ' ' LEU . 71.6 m -98.51 140.65 32.44 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.686 0.279 . . . . 0.0 110.69 -178.701 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.532 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 7.9 ttp180 -83.96 115.83 22.51 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-O 120.949 0.405 . . . . 0.0 110.2 179.412 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.423 HD21 ' HB3' ' A' ' 29' ' ' ASN . 37.0 p30 -76.55 174.2 10.62 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.262 179.919 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.74 -25.29 60.2 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -178.497 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -78.79 -9.81 59.57 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.65 0.738 . . . . 0.0 109.896 179.92 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 85.07 29.3 28.71 Favored Glycine 0 N--CA 1.445 -0.761 0 N-CA-C 110.718 -0.953 . . . . 0.0 110.718 -179.031 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.532 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 8.3 t-20 -111.53 158.45 19.17 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.74 -0.23 . . . . 0.0 110.687 -178.555 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.714 ' HB3' ' HG3' ' A' ' 22' ' ' GLU . 61.4 m95 -92.28 129.29 38.26 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.047 -179.899 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.4 HG22 ' O ' ' A' ' 23' ' ' CYS . 15.6 m -132.9 141.42 44.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.668 179.346 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.2 m -81.7 111.75 18.25 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.228 179.86 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 54.7 m -127.53 150.18 49.81 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.655 179.779 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.667 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 45.1 mt-10 -134.25 148.32 50.81 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.03 -179.611 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.544 HD12 HD23 ' A' ' 37' ' ' LEU . 2.1 tm? -139.25 134.42 32.64 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.55 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.478 ' N ' HD13 ' A' ' 35' ' ' LEU . 29.6 m-20 -91.76 109.69 21.02 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.359 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.544 HD23 HD12 ' A' ' 35' ' ' LEU . 1.4 mt -83.01 -20.62 34.72 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.816 -178.543 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.585 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 4.3 p-10 -61.5 -15.41 37.61 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 111.717 0.266 . . . . 0.0 111.717 -178.423 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 60.0 p -72.48 -22.58 61.04 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.055 0.455 . . . . 0.0 110.716 179.737 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 27.3 m -128.86 0.25 5.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.06 -0.518 . . . . 0.0 112.022 -178.669 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.438 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 53.7 mt -116.57 131.35 69.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 120.636 0.255 . . . . 0.0 110.342 178.861 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.562 ' HA3' ' HB3' ' A' ' 52' ' ' MET . . . -150.38 163.99 29.67 Favored Glycine 0 N--CA 1.445 -0.731 0 N-CA-C 111.328 -0.709 . . . . 0.0 111.328 179.445 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.6 ' ND2' ' HB2' ' A' ' 55' ' ' PHE . 7.3 p30 -161.91 51.08 0.32 Allowed Pre-proline 0 CA--C 1.535 0.386 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 179.813 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -63.5 -26.73 70.08 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 121.847 1.698 . . . . 0.0 111.75 -179.626 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -84.14 -12.59 54.73 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.797 179.898 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.599 ' HA3' ' HD3' ' A' ' 83' ' ' ARG . . . 103.36 7.96 41.92 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.283 -0.96 . . . . 0.0 112.954 -179.344 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.504 ' HA ' HE22 ' A' ' 86' ' ' GLN . 61.7 m-85 -124.88 133.62 53.01 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.003 0.43 . . . . 0.0 110.495 179.676 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.503 ' HB3' ' HB ' ' A' ' 88' ' ' ILE . 84.2 mt -83.09 138.0 33.87 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.498 -0.774 . . . . 0.0 112.251 -177.688 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -177.01 172.81 45.77 Favored Glycine 0 N--CA 1.447 -0.58 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.7 178.802 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.421 ' CD2' ' HD3' ' A' ' 92' ' ' ARG . 94.1 m95 -95.53 128.21 42.21 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.993 0.425 . . . . 0.0 110.321 -179.971 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 151.84 -62.69 0.39 Allowed Glycine 0 N--CA 1.449 -0.441 0 CA-C-N 116.019 -0.537 . . . . 0.0 112.076 -179.877 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.608 ' HA ' ' CE ' ' A' ' 52' ' ' MET . 1.0 OUTLIER -77.02 179.88 5.96 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 179.74 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -133.98 173.8 11.17 Favored 'General case' 0 C--N 1.326 -0.419 0 O-C-N 122.089 -0.382 . . . . 0.0 111.678 -178.982 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 61.74 45.99 7.4 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.642 -0.708 . . . . 0.0 112.33 179.174 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.6 ' HB2' ' ND2' ' A' ' 43' ' ' ASN . 8.5 p90 -65.83 -28.51 69.04 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 111.652 0.241 . . . . 0.0 111.652 -179.371 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 11.4 p -64.45 -28.4 69.65 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.917 0.389 . . . . 0.0 111.553 -179.104 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 50.5 m80 -82.27 -3.43 55.21 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.224 -179.433 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 14.9 m -126.52 13.53 7.57 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.792 179.793 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 63.9 m -135.49 151.94 50.85 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.382 0.61 . . . . 0.0 111.881 -178.891 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -121.55 141.46 51.05 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.404 179.279 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.43 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 31.4 t70 58.78 79.89 0.2 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.509 0.671 . . . . 0.0 111.39 179.704 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.535 HG23 HD21 ' A' ' 71' ' ' LEU . 74.3 mt -95.56 123.27 47.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.076 179.558 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.6 tptm -149.02 160.0 43.71 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 -179.769 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.547 ' HG ' HD21 ' A' ' 12' ' ' LEU . 44.7 mt -88.57 129.44 35.48 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.108 0.48 . . . . 0.0 109.973 178.965 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.415 ' HB3' ' HB3' ' A' ' 70' ' ' LYS . 34.1 tp10 -77.52 -69.47 0.53 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.264 -178.398 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.57 ' HB2' ' HB2' ' A' ' 69' ' ' ARG . 26.1 mt-10 -81.94 29.31 0.4 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.285 -179.284 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 68.11 14.64 66.36 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.903 -0.59 . . . . 0.0 113.282 179.757 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 145.98 -25.84 1.76 Allowed Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 119.591 -1.29 . . . . 0.0 113.373 179.361 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.57 ' HB2' ' HB2' ' A' ' 66' ' ' GLU . 9.6 mmt85 -76.19 -23.37 54.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.283 0.563 . . . . 0.0 110.431 -179.289 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.415 ' HB3' ' HB3' ' A' ' 65' ' ' GLU . 39.9 ttmt -146.02 148.73 33.0 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.801 -177.883 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.716 ' HB2' HD11 ' A' ' 90' ' ' LEU . 9.8 tt -115.94 125.66 52.86 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 179.332 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.1 p -113.72 128.35 56.39 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.346 0.594 . . . . 0.0 111.241 179.43 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . 0.43 ' HA ' ' O ' ' A' ' 61' ' ' ASP . 25.6 p -149.88 171.32 16.97 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.659 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.56 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 4.1 tmt_? -104.37 98.31 14.02 Favored Pre-proline 0 C--N 1.315 -0.896 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 179.267 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.591 ' O ' ' HB3' ' A' ' 83' ' ' ARG . 64.9 Cg_endo -72.62 125.02 10.23 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 123.002 2.468 . . . . 0.0 111.506 179.79 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.718 ' HA ' ' HB2' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -121.82 139.92 53.02 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.867 179.819 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.721 HG22 ' O ' ' A' ' 82' ' ' PHE . 11.6 t -74.77 131.54 40.89 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 178.499 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.1 m -74.18 -2.22 3.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.488 -179.256 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -68.83 -33.71 74.28 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.185 0.517 . . . . 0.0 109.738 179.309 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -148.56 -23.96 0.08 OUTLIER Glycine 0 N--CA 1.449 -0.436 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.591 179.796 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.527 ' HA2' ' HE2' ' A' ' 76' ' ' LYS . . . 101.58 19.03 16.83 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.021 -179.793 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.721 ' O ' HG22 ' A' ' 77' ' ' THR . 26.3 p90 -110.71 151.05 28.19 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 118.821 -0.609 . . . . 0.0 109.993 -178.885 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.718 ' HB2' ' HA ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 167.49 -153.95 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.572 0 O-C-N 123.729 0.643 . . . . 0.0 111.213 179.236 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -135.55 167.41 21.14 Favored 'General case' 0 C--O 1.226 -0.17 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.051 -178.842 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.56 ' HA ' ' HA ' ' A' ' 74' ' ' ARG . 44.5 ttt180 -81.75 156.25 25.07 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 178.407 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.61 ' HG2' ' H ' ' A' ' 87' ' ' GLY . 7.1 tt0 -161.04 -176.07 5.27 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.41 -0.516 . . . . 0.0 111.401 -178.161 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.61 ' H ' ' HG2' ' A' ' 86' ' ' GLN . . . -151.89 141.36 8.47 Favored Glycine 0 N--CA 1.449 -0.49 0 N-CA-C 111.778 -0.529 . . . . 0.0 111.778 179.379 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.503 ' HB ' ' HB3' ' A' ' 48' ' ' LEU . 10.4 tt -120.58 133.48 67.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.303 0.573 . . . . 0.0 110.77 -179.46 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.515 ' OD1' ' HB2' ' A' ' 91' ' ' ASN . 13.6 t70 -73.25 136.34 44.61 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.632 -179.868 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.766 HD13 HD11 ' A' ' 19' ' ' LEU . 63.8 mt -109.55 37.41 2.63 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -178.341 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.582 ' HA ' ' HB3' ' A' ' 2' ' ' SER . 7.1 m-80 -75.05 2.59 10.23 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 121.368 0.604 . . . . 0.0 111.221 179.231 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.421 ' HD3' ' CD2' ' A' ' 50' ' ' TRP . 24.7 mtp180 -92.29 -12.49 32.37 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.243 179.104 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.471 HG13 HD22 ' A' ' 37' ' ' LEU . 24.6 mm -94.94 103.47 14.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 121.453 0.644 . . . . 0.0 109.563 -179.622 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 3.9 mm-40 -112.25 152.08 28.88 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.714 -178.368 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 18.3 p-10 -105.27 126.02 51.63 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.742 178.564 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 40.5 t -115.72 116.47 52.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 -179.562 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 54.4 25.39 6.0 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.601 -179.841 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 109.13 -27.45 12.72 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.806 -0.712 . . . . 0.0 114.004 179.155 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -86.8 146.19 26.33 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 117.687 0.744 . . . . 0.0 111.53 -178.48 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.523 ' HB3' ' HB2' ' A' ' 35' ' ' LEU . 5.2 tp -92.14 121.52 33.76 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.906 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 24.1 t -129.73 140.88 47.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 120.804 0.335 . . . . 0.0 110.935 -178.821 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.432 ' HB2' HD11 ' A' ' 35' ' ' LEU . 20.7 t80 -79.21 130.73 35.77 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 178.475 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 . . . . . 0 C--N 1.312 -1.064 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.673 -179.57 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.9 mpp? . . . . . 0 N--CA 1.479 1.007 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.537 ' OG ' ' HA ' ' A' ' 91' ' ' ASN . 9.2 m -112.67 178.11 4.4 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.426 179.1 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 18.6 p90 -51.73 -34.18 37.98 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 123.448 0.468 . . . . 0.0 111.519 179.143 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -56.3 -18.8 11.77 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 -178.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -58.02 -32.91 68.4 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 121.261 0.553 . . . . 0.0 110.093 178.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 33.5 m -137.44 37.94 2.47 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.338 178.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.456 ' HA ' ' O ' ' A' ' 22' ' ' GLU . 20.3 t -147.23 147.97 30.99 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.271 -179.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 9.7 ptp180 -140.58 169.75 17.07 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.086 -179.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 65.7 m-80 57.39 52.32 8.8 Favored 'General case' 0 N--CA 1.465 0.296 0 O-C-N 123.93 0.769 . . . . 0.0 111.53 -179.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -82.47 118.12 23.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.465 179.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 27.0 m -121.55 170.8 11.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.67 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.641 HD21 ' HG ' ' A' ' 64' ' ' LEU . 3.3 mm? -105.14 114.57 28.85 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.118 -179.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.504 HG21 ' NE ' ' A' ' 20' ' ' ARG . 35.3 p -111.79 170.37 8.19 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.978 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 59.49 46.25 12.48 Favored 'General case' 0 CA--C 1.521 -0.137 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.289 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 86.01 -34.92 3.32 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 121.007 -0.616 . . . . 0.0 112.134 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.592 ' HA2' ' HB3' ' A' ' 12' ' ' LEU . . . 136.2 38.02 0.17 Allowed Glycine 0 N--CA 1.447 -0.583 0 N-CA-C 111.437 -0.665 . . . . 0.0 111.437 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.692 ' HB2' ' HB2' ' A' ' 38' ' ' ASP . 3.3 ptp180 -125.23 -12.91 6.81 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.256 0.55 . . . . 0.0 110.98 -179.389 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.519 ' CG2' ' HB3' ' A' ' 34' ' ' GLU . 9.5 m -115.21 137.74 51.69 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.429 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.831 HD11 HD13 ' A' ' 90' ' ' LEU . 59.6 mt -96.13 118.66 33.16 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.734 179.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.504 ' NE ' HG21 ' A' ' 13' ' ' THR . 34.5 ttm180 -113.84 120.98 42.61 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 178.262 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.413 ' O ' ' HA ' ' A' ' 32' ' ' THR . . . -152.72 167.32 29.37 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.827 0.346 . . . . 0.0 111.532 -179.122 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.697 ' HB3' ' HB3' ' A' ' 30' ' ' TRP . 39.4 mt-10 -89.68 105.95 18.14 Favored 'General case' 0 CA--C 1.512 -0.516 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 178.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.533 ' SG ' HD13 ' A' ' 100' ' ' LEU . 56.0 m -96.23 119.22 34.33 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 -179.276 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.486 ' HB2' ' CZ3' ' A' ' 30' ' ' TRP . 45.9 ttp180 -72.85 111.28 7.83 Favored 'General case' 0 N--CA 1.437 -1.113 0 N-CA-C 110.197 -0.297 . . . . 0.0 110.197 179.386 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 31.9 p30 -81.18 168.9 18.03 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.669 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -51.54 -32.01 26.39 Favored 'General case' 0 N--CA 1.465 0.284 0 O-C-N 123.643 0.59 . . . . 0.0 112.096 -179.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -67.65 -14.12 62.67 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.404 0.621 . . . . 0.0 110.94 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 89.15 22.07 39.49 Favored Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.772 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.431 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 2.3 m-80 -111.77 150.38 30.37 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.838 0.351 . . . . 0.0 111.449 -179.101 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.697 ' HB3' ' HB3' ' A' ' 22' ' ' GLU . 97.3 m95 -91.63 109.3 20.6 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.201 179.242 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.9 m -109.87 129.42 64.83 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 CA-C-O 120.965 0.412 . . . . 0.0 110.232 178.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.413 ' HA ' ' O ' ' A' ' 21' ' ' ALA . 27.7 m -78.98 113.16 16.87 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.854 -179.372 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 68.7 m -121.19 157.26 30.6 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.403 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.676 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 51.3 mt-10 -131.78 132.35 43.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.763 -179.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.472 ' HB2' HD23 ' A' ' 100' ' ' LEU . 1.9 tm? -124.91 132.63 53.27 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.571 -0.899 . . . . 0.0 108.571 178.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.449 ' N ' HD13 ' A' ' 35' ' ' LEU . 12.9 m-20 -91.45 109.95 21.25 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.76 0.314 . . . . 0.0 110.512 -179.113 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.451 HD13 HD22 ' A' ' 90' ' ' LEU . 0.9 OUTLIER -83.47 -15.99 47.43 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.296 -179.521 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.75 ' OD2' ' HA ' ' A' ' 54' ' ' ASN . 8.5 t70 -63.17 -8.48 8.11 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.071 0.462 . . . . 0.0 110.969 -179.297 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 73.0 p -87.14 -22.37 25.39 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.49 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.404 ' HB2' ' CZ3' ' A' ' 50' ' ' TRP . 29.0 m -125.56 -5.04 7.1 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -178.056 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 56.7 mt -113.72 136.16 51.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.66 0.267 . . . . 0.0 110.407 179.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.521 ' HA3' ' HB3' ' A' ' 52' ' ' MET . . . -146.65 157.35 27.37 Favored Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.86 -0.686 . . . . 0.0 111.855 179.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.618 ' N ' ' HD3' ' A' ' 44' ' ' PRO . 21.8 p30 -159.53 46.28 0.21 Allowed Pre-proline 0 CA--C 1.539 0.534 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.618 ' HD3' ' N ' ' A' ' 43' ' ' ASN . 7.0 Cg_exo -70.84 -19.16 31.31 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 122.182 1.922 . . . . 0.0 112.012 -178.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -96.53 1.93 51.88 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.912 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.433 ' HA2' ' HB2' ' A' ' 75' ' ' PRO . . . 92.89 8.44 61.88 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.185 -1.007 . . . . 0.0 112.693 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.545 ' HA ' HE22 ' A' ' 86' ' ' GLN . 56.6 m-85 -125.88 134.49 51.59 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.952 0.376 . . . . 0.0 110.716 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.491 HD23 HG22 ' A' ' 88' ' ' ILE . 10.8 mp -88.6 147.26 24.66 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.904 -178.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 172.18 175.32 40.22 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.968 -0.634 . . . . 0.0 111.825 178.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.45 ' HH2' HD11 ' A' ' 93' ' ' ILE . 95.8 m95 -97.72 130.35 44.7 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.952 0.406 . . . . 0.0 110.346 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 147.31 -60.81 0.46 Allowed Glycine 0 N--CA 1.447 -0.593 0 N-CA-C 111.542 -0.623 . . . . 0.0 111.542 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.588 ' HA ' ' CE ' ' A' ' 52' ' ' MET . 1.7 tpt -77.85 171.61 14.71 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 179.09 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -132.19 171.23 13.93 Favored 'General case' 0 C--N 1.32 -0.715 0 O-C-N 121.845 -0.534 . . . . 0.0 110.907 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.75 ' HA ' ' OD2' ' A' ' 38' ' ' ASP . 13.6 m120 65.3 45.7 2.83 Favored 'General case' 0 C--N 1.328 -0.336 0 O-C-N 124.041 0.838 . . . . 0.0 111.77 178.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.409 ' HB3' ' HA2' ' A' ' 42' ' ' GLY . 25.5 p90 -65.65 -30.02 70.67 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.411 179.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.419 ' OG ' ' HB3' ' A' ' 17' ' ' ARG . 12.0 m -59.48 -26.81 65.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.297 0.57 . . . . 0.0 110.767 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 75.5 m80 -75.96 -13.59 60.24 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.635 -178.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 27.1 m -131.66 32.23 4.16 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 120.853 0.359 . . . . 0.0 110.978 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 29.2 p -145.58 154.1 41.79 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.611 -0.436 . . . . 0.0 111.328 179.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.485 ' HG3' ' HG2' ' A' ' 76' ' ' LYS . 68.3 mt-10 -131.47 148.75 52.67 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.368 179.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 60.29 59.65 2.25 Favored 'General case' 0 C--N 1.331 -0.229 0 O-C-N 123.848 0.718 . . . . 0.0 110.956 178.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.576 HG23 HD21 ' A' ' 71' ' ' LEU . 75.2 mt -83.45 113.83 23.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.116 -179.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 35.7 ttmt -149.74 154.73 38.98 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.994 179.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.641 ' HG ' HD21 ' A' ' 12' ' ' LEU . 72.6 mt -82.63 130.65 35.16 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.834 0.35 . . . . 0.0 110.509 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -88.09 -58.52 2.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.634 -178.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.532 ' HB2' ' HB2' ' A' ' 69' ' ' ARG . 26.6 mt-10 -80.91 33.78 0.33 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.87 0.366 . . . . 0.0 111.318 -179.556 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 67.4 2.14 18.77 Favored Glycine 0 C--N 1.32 -0.342 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.879 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.546 ' HA2' HD13 ' A' ' 64' ' ' LEU . . . 145.37 -14.96 1.85 Allowed Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 120.095 -1.05 . . . . 0.0 112.669 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.532 ' HB2' ' HB2' ' A' ' 66' ' ' GLU . 19.1 mmt180 -79.67 -18.51 51.19 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.47 ' HB3' ' HG3' ' A' ' 66' ' ' GLU . 30.7 ttpt -149.22 140.24 22.94 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.123 -178.556 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.597 ' HB2' HD11 ' A' ' 90' ' ' LEU . 9.8 tt -109.49 124.26 50.76 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.306 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 6.6 p -111.41 137.01 49.74 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.232 0.539 . . . . 0.0 111.224 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.502 ' HB3' ' HA ' ' A' ' 62' ' ' ILE . 21.4 p -161.61 164.08 29.58 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.163 179.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.437 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 28.7 ttt180 -99.88 103.27 21.1 Favored Pre-proline 0 C--N 1.318 -0.78 0 CA-C-N 116.722 -0.217 . . . . 0.0 110.47 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.614 ' O ' ' HB3' ' A' ' 83' ' ' ARG . 56.6 Cg_endo -70.02 116.03 4.4 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 122.403 2.069 . . . . 0.0 110.002 178.314 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.906 ' HE2' ' HA2' ' A' ' 81' ' ' GLY . 0.0 OUTLIER -119.34 141.61 48.87 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.301 -179.182 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.695 HG22 ' O ' ' A' ' 82' ' ' PHE . 12.2 t -67.57 132.6 47.87 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 179.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 14.0 p -68.58 -14.19 18.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 O-C-N 124.149 0.905 . . . . 0.0 111.128 -179.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -64.54 -28.03 69.37 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.72 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.481 ' HA3' ' CE1' ' A' ' 82' ' ' PHE . . . -155.12 -26.67 0.03 OUTLIER Glycine 0 CA--C 1.518 0.266 0 C-N-CA 120.138 -1.03 . . . . 0.0 113.858 -179.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.906 ' HA2' ' HE2' ' A' ' 76' ' ' LYS . . . 102.94 18.64 14.73 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.998 -0.62 . . . . 0.0 111.599 -179.31 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.695 ' O ' HG22 ' A' ' 77' ' ' THR . 18.9 p90 -112.36 145.52 39.93 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 119.274 -0.393 . . . . 0.0 110.053 -178.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.739 ' HB2' ' HA ' ' A' ' 76' ' ' LYS . 0.1 OUTLIER 173.9 -145.34 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.84 0.352 . . . . 0.0 111.62 -179.86 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -128.64 160.3 32.88 Favored 'General case' 0 C--O 1.222 -0.353 0 CA-C-N 115.586 -0.733 . . . . 0.0 109.52 -179.033 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.47 ' HA ' ' HD2' ' A' ' 75' ' ' PRO . 25.0 ttt180 -89.47 154.97 19.61 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.302 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.545 HE22 ' HA ' ' A' ' 47' ' ' PHE . 1.6 mt-30 -155.31 -169.55 3.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.333 0.587 . . . . 0.0 111.981 -178.581 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -163.08 142.97 8.25 Favored Glycine 0 N--CA 1.445 -0.709 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.771 179.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.491 HG22 HD23 ' A' ' 48' ' ' LEU . 10.9 tt -127.21 132.61 69.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.042 0.449 . . . . 0.0 110.548 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -75.23 141.29 43.55 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 179.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.831 HD13 HD11 ' A' ' 19' ' ' LEU . 63.4 mt -107.3 61.71 0.62 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.691 0.757 . . . . 0.0 110.854 -178.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.537 ' HA ' ' OG ' ' A' ' 2' ' ' SER . 25.0 m-80 -90.89 -0.07 57.63 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.354 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 9.8 mtp180 -96.01 -15.51 22.23 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.995 179.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.45 HD11 ' HH2' ' A' ' 50' ' ' TRP . 28.1 mm -89.88 110.03 21.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 -179.277 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.463 HE22 ' HA ' ' A' ' 2' ' ' SER . 23.5 mm-40 -111.17 167.16 10.49 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.425 -178.018 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 21.4 p-10 -126.67 112.42 15.44 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.574 178.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.7 p -111.55 116.66 53.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 120.96 0.409 . . . . 0.0 110.407 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 13.6 m-80 56.32 35.09 25.25 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.762 -178.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 87.02 -10.26 69.13 Favored Glycine 0 N--CA 1.442 -0.906 0 CA-C-N 115.65 -0.705 . . . . 0.0 113.311 179.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -94.11 123.14 37.29 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 117.459 0.63 . . . . 0.0 110.119 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.533 HD13 ' SG ' ' A' ' 23' ' ' CYS . 5.7 tp -79.69 119.21 22.31 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 54.1 t -133.23 145.6 33.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.398 -178.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.411 ' HB2' HD11 ' A' ' 35' ' ' LEU . 26.2 t80 -78.24 129.7 35.39 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.005 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 . . . . . 0 C--O 1.25 1.111 0 CA-C-O 117.986 -1.007 . . . . 0.0 110.802 -179.191 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 47.0 mtt . . . . . 0 N--CA 1.478 0.927 0 CA-C-O 120.655 0.264 . . . . 0.0 110.338 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.443 ' O ' ' HB2' ' A' ' 5' ' ' ASP . 17.1 m -118.99 177.8 4.73 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.108 179.183 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.566 ' HB3' ' HA ' ' A' ' 94' ' ' GLN . 22.2 p90 -57.84 -36.77 72.75 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.083 0.468 . . . . 0.0 110.334 178.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.5 ' HB3' ' HD3' ' A' ' 69' ' ' ARG . . . -58.32 -18.71 29.29 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 115.446 -0.797 . . . . 0.0 112.523 -178.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.443 ' HB2' ' O ' ' A' ' 2' ' ' SER . 0.9 OUTLIER -62.41 -26.89 68.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.928 0.394 . . . . 0.0 110.298 179.161 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 27.1 m -134.63 30.08 3.49 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.819 179.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.413 ' HA ' ' HZ3' ' A' ' 30' ' ' TRP . 21.0 m -139.31 155.55 47.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.247 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.557 ' HG2' ' CZ3' ' A' ' 30' ' ' TRP . 2.3 ptp180 -142.1 169.84 16.84 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.869 -179.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 53.4 57.8 5.84 Favored 'General case' 0 C--O 1.232 0.179 0 O-C-N 123.769 0.668 . . . . 0.0 111.696 178.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -87.86 121.56 30.43 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.839 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 27.8 m -127.93 172.17 15.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.68 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.688 HD21 ' HG ' ' A' ' 64' ' ' LEU . 3.6 mm? -104.55 118.65 37.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.454 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 19.6 p -117.52 166.53 12.26 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.948 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 62.46 26.99 16.07 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.479 179.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 101.81 -22.68 37.49 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.485 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.578 ' HA2' ' HB3' ' A' ' 12' ' ' LEU . . . 124.51 21.49 2.21 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.703 -0.76 . . . . 0.0 111.981 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.564 ' HB2' ' HB3' ' A' ' 38' ' ' ASP . 11.5 ptm180 -106.41 -21.61 13.04 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.102 0.477 . . . . 0.0 110.031 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.482 ' CG2' ' HB3' ' A' ' 34' ' ' GLU . 3.6 m -111.89 136.11 51.64 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.953 -178.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.838 HD11 HD13 ' A' ' 90' ' ' LEU . 26.9 mt -96.95 117.06 30.31 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.18 179.08 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 24.5 ttm180 -109.9 121.01 44.25 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -152.58 166.62 31.5 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.645 -179.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -91.22 108.83 20.14 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 107.605 -1.258 . . . . 0.0 107.605 178.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.429 ' SG ' HD13 ' A' ' 100' ' ' LEU . 65.8 m -95.34 124.54 39.43 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 -179.065 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.51 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 38.4 ttt180 -76.11 112.34 12.46 Favored 'General case' 0 N--CA 1.439 -0.982 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 179.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 35.9 p30 -73.54 167.64 20.91 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.619 -179.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.06 -27.73 67.2 Favored 'General case' 0 C--N 1.33 -0.245 0 O-C-N 123.557 0.536 . . . . 0.0 111.507 -178.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -68.46 -18.21 64.36 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.22 0.533 . . . . 0.0 109.991 179.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 94.63 33.16 6.88 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.857 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.51 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 7.2 t-20 -123.92 164.38 19.41 Favored 'General case' 0 C--N 1.323 -0.571 0 O-C-N 122.773 -0.251 . . . . 0.0 110.734 -178.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.557 ' CZ3' ' HG2' ' A' ' 8' ' ' ARG . 98.4 m95 -100.51 120.41 39.97 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.385 -179.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 6.7 m -122.78 139.5 49.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.889 179.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 13.5 m -79.48 114.08 18.13 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.793 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 68.3 m -124.6 146.08 49.26 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.764 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.603 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 50.7 mt-10 -131.5 135.22 46.9 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.1 -179.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.534 ' HB2' HD23 ' A' ' 100' ' ' LEU . 1.6 tm? -130.08 131.67 45.85 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.166 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.452 ' N ' HD13 ' A' ' 35' ' ' LEU . 18.1 m-20 -87.11 110.23 19.97 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.842 0.353 . . . . 0.0 110.221 179.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.539 HD11 ' HG ' ' A' ' 19' ' ' LEU . 2.1 mt -86.54 -18.04 32.53 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.981 -179.479 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.564 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 0.5 OUTLIER -66.12 -13.91 60.91 Favored 'General case' 0 C--O 1.222 -0.357 0 C-N-CA 120.525 -0.47 . . . . 0.0 111.949 -177.72 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.403 HG22 ' O ' ' A' ' 36' ' ' ASP . 14.6 t -87.0 -4.38 59.17 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.135 0.493 . . . . 0.0 110.233 179.42 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 56.5 m -127.26 -22.73 3.67 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 120.872 0.367 . . . . 0.0 111.508 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.528 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 65.3 mt -102.57 138.81 25.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 110.235 -0.283 . . . . 0.0 110.235 179.405 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.572 ' HA3' ' HB3' ' A' ' 52' ' ' MET . . . -149.23 158.79 27.8 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.892 -0.67 . . . . 0.0 111.605 179.222 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.709 ' ND2' ' HB2' ' A' ' 55' ' ' PHE . 8.2 p30 -162.42 47.78 0.21 Allowed Pre-proline 0 CA--C 1.534 0.353 0 N-CA-C 112.788 0.662 . . . . 0.0 112.788 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -67.54 -21.73 45.72 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 121.501 1.467 . . . . 0.0 111.413 -179.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -84.53 -16.7 41.4 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.144 179.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.604 ' HA3' ' HG2' ' A' ' 83' ' ' ARG . . . 108.41 8.8 28.36 Favored Glycine 0 N--CA 1.442 -0.933 0 C-N-CA 120.341 -0.933 . . . . 0.0 113.374 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.465 ' HA ' HE22 ' A' ' 86' ' ' GLN . 71.6 m-85 -125.73 134.88 51.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 117.1 0.45 . . . . 0.0 111.043 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 91.2 mt -83.33 131.8 35.05 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.889 -178.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -175.34 170.2 43.19 Favored Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.842 178.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.415 ' CD2' ' HD3' ' A' ' 92' ' ' ARG . 84.8 m95 -95.63 135.02 37.85 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 179.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 137.09 16.22 0.76 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.375 -0.917 . . . . 0.0 113.527 179.233 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.572 ' HB3' ' HA3' ' A' ' 42' ' ' GLY . 1.1 ttt -155.8 -165.79 2.05 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.407 ' HG3' HD22 ' A' ' 54' ' ' ASN . 10.8 pt20 -147.3 167.88 23.15 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.307 -0.557 . . . . 0.0 111.718 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.407 HD22 ' HG3' ' A' ' 53' ' ' GLN . 39.0 m-80 67.14 41.67 2.53 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.061 -0.972 . . . . 0.0 112.254 178.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.709 ' HB2' ' ND2' ' A' ' 43' ' ' ASN . 3.2 p90 -70.15 -25.12 63.31 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.737 0.303 . . . . 0.0 111.07 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 44.9 t -60.76 -41.21 95.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.443 -178.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 8.5 m-70 -70.62 -14.85 62.64 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.459 -178.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.417 ' HA ' ' HD2' ' A' ' 76' ' ' LYS . 20.1 m -113.48 18.99 17.27 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 111.777 0.288 . . . . 0.0 111.777 -179.229 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 61.2 m -138.97 153.74 48.21 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 121.448 -0.783 . . . . 0.0 112.46 -179.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -118.83 142.76 47.43 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.343 179.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 56.25 77.12 0.26 Allowed 'General case' 0 N--CA 1.466 0.354 0 O-C-N 123.666 0.604 . . . . 0.0 112.127 178.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.505 HG23 HD21 ' A' ' 71' ' ' LEU . 88.2 mt -92.31 112.63 26.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 121.041 0.448 . . . . 0.0 110.278 179.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 34.3 ttmt -149.23 153.99 38.42 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.344 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.688 ' HG ' HD21 ' A' ' 12' ' ' LEU . 42.1 mt -81.91 126.44 31.92 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.462 0.649 . . . . 0.0 111.067 -179.046 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.491 ' HB2' ' CG2' ' A' ' 72' ' ' THR . 39.4 tt0 -74.52 -52.32 12.24 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 114.925 -1.034 . . . . 0.0 111.201 -179.151 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.503 ' HB2' ' HB2' ' A' ' 69' ' ' ARG . 21.0 mm-40 -89.37 0.91 56.48 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.003 179.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 77.09 32.36 49.15 Favored Glycine 0 N--CA 1.446 -0.692 0 CA-C-N 115.519 -0.764 . . . . 0.0 112.142 -179.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 142.79 -42.75 1.08 Allowed Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.391 -0.909 . . . . 0.0 112.422 179.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.503 ' HB2' ' HB2' ' A' ' 66' ' ' GLU . 13.3 mmt180 -70.02 -30.22 67.47 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.842 0.353 . . . . 0.0 111.117 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 46.2 tttt -144.36 145.97 32.27 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -177.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.549 ' HB2' HD11 ' A' ' 90' ' ' LEU . 10.5 tt -111.68 135.44 52.27 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.382 -0.826 . . . . 0.0 108.969 179.131 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.491 ' CG2' ' HB2' ' A' ' 65' ' ' GLU . 2.6 p -123.53 131.93 53.76 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.037 0.446 . . . . 0.0 111.501 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 26.0 p -158.99 164.46 35.54 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.338 -0.846 . . . . 0.0 108.717 179.262 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.443 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 31.6 ttt180 -99.76 103.55 22.54 Favored Pre-proline 0 C--N 1.317 -0.806 0 C-N-CA 120.424 -0.51 . . . . 0.0 110.394 179.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.621 ' O ' ' HB3' ' A' ' 83' ' ' ARG . 59.7 Cg_endo -71.31 127.91 13.97 Favored 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 122.543 2.162 . . . . 0.0 110.825 178.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.764 ' HA ' ' HB2' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -120.16 146.61 45.83 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.932 -179.81 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.719 HG22 ' O ' ' A' ' 82' ' ' PHE . 8.9 t -71.94 130.33 40.74 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 177.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 9.8 p -71.44 -8.16 10.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 O-C-N 123.619 0.574 . . . . 0.0 111.425 -178.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -70.71 -24.78 62.71 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.119 0.485 . . . . 0.0 110.612 179.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.544 ' HA3' ' CE2' ' A' ' 82' ' ' PHE . . . -151.58 -30.03 0.04 OUTLIER Glycine 0 CA--C 1.519 0.334 0 C-N-CA 120.623 -0.799 . . . . 0.0 113.015 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 104.54 17.16 15.78 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 121.051 -0.595 . . . . 0.0 112.112 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.719 ' O ' HG22 ' A' ' 77' ' ' THR . 17.2 p90 -112.72 153.71 27.29 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 118.904 -0.57 . . . . 0.0 109.766 -179.037 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.764 ' HB2' ' HA ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 169.3 -150.45 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.105 0.479 . . . . 0.0 112.138 179.481 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -129.29 154.9 46.39 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.355 -0.838 . . . . 0.0 110.428 -177.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.443 ' HA ' ' HA ' ' A' ' 74' ' ' ARG . 36.4 ttt180 -86.27 145.88 26.75 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.465 HE22 ' HA ' ' A' ' 47' ' ' PHE . 18.8 mt-30 -151.96 -171.3 3.89 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.565 -178.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -146.74 149.31 21.44 Favored Glycine 0 N--CA 1.448 -0.506 0 N-CA-C 111.261 -0.736 . . . . 0.0 111.261 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.403 HD11 ' CD1' ' A' ' 50' ' ' TRP . 12.0 tt -131.39 133.23 62.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 117.073 0.437 . . . . 0.0 110.877 -179.255 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -75.65 137.71 40.89 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.679 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.838 HD13 HD11 ' A' ' 19' ' ' LEU . 47.4 mt -101.52 40.23 1.33 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.48 0.657 . . . . 0.0 110.287 -179.513 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.482 HD22 ' N ' ' A' ' 91' ' ' ASN . 0.9 OUTLIER -74.12 0.04 15.11 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.657 -179.486 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.415 ' HD3' ' CD2' ' A' ' 50' ' ' TRP . 18.3 mtp180 -96.57 -12.63 23.74 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.926 179.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.45 HG13 HD22 ' A' ' 37' ' ' LEU . 23.0 mm -99.02 114.65 37.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 -179.214 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.566 ' HA ' ' HB3' ' A' ' 3' ' ' TYR . 20.6 mt-30 -132.33 156.53 46.42 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.136 0.493 . . . . 0.0 111.712 -178.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.411 ' HA ' ' O ' ' A' ' 99' ' ' ARG . 20.4 p-10 -104.58 131.92 51.42 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.499 179.367 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 40.9 t -115.18 111.61 36.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 179.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 28.4 m-80 58.06 19.49 6.05 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.866 -179.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 117.46 -28.35 7.19 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.681 -0.771 . . . . 0.0 113.92 178.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.411 ' O ' ' HA ' ' A' ' 95' ' ' ASN . 0.2 OUTLIER -87.11 142.23 28.08 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 117.277 0.538 . . . . 0.0 110.991 -178.916 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.534 HD23 ' HB2' ' A' ' 35' ' ' LEU . 8.6 tp -87.74 125.78 34.62 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 24.6 t -131.36 140.35 48.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.014 -178.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.491 ' HB2' HD11 ' A' ' 35' ' ' LEU . 13.6 t80 -82.04 131.38 35.24 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 177.58 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 . . . . . 0 C--N 1.312 -1.024 0 CA-C-O 118.906 -0.568 . . . . 0.0 111.241 -179.259 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.3 ptp . . . . . 0 N--CA 1.482 1.134 0 CA-C-O 120.706 0.289 . . . . 0.0 110.269 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.456 ' HB2' ' HG3' ' A' ' 69' ' ' ARG . 38.0 m -119.24 179.16 4.27 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.996 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.412 ' CZ ' HD13 ' A' ' 19' ' ' LEU . 9.3 p90 -54.23 -34.59 61.01 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.833 0.349 . . . . 0.0 110.867 178.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.589 ' HB3' ' HD2' ' A' ' 69' ' ' ARG . . . -57.27 -19.23 20.42 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.437 -179.029 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -70.75 -18.41 62.78 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.071 0.462 . . . . 0.0 110.867 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 41.6 m -140.67 33.8 1.81 Allowed 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 178.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 10.3 t -146.24 157.86 43.84 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.231 -179.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.422 ' HG2' ' CZ3' ' A' ' 30' ' ' TRP . 2.1 ptp180 -137.44 158.42 44.45 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.663 -0.244 . . . . 0.0 110.981 -179.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 57.54 61.62 2.41 Favored 'General case' 0 C--O 1.233 0.229 0 O-C-N 123.967 0.792 . . . . 0.0 111.127 178.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.603 ' HA ' ' HB2' ' A' ' 21' ' ' ALA . . . -89.83 118.52 29.48 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.917 -179.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 30.0 m -123.07 170.56 13.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.612 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.62 ' HB3' ' HA2' ' A' ' 16' ' ' GLY . 3.8 mm? -105.36 122.4 45.88 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.145 -179.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.426 ' OG1' ' HB ' ' A' ' 18' ' ' THR . 33.5 p -116.0 162.14 17.81 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.69 0.281 . . . . 0.0 110.892 179.543 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 63.51 29.29 15.38 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.904 -0.589 . . . . 0.0 112.078 179.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 97.09 -15.79 61.93 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.502 179.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.62 ' HA2' ' HB3' ' A' ' 12' ' ' LEU . . . 122.09 20.85 2.97 Favored Glycine 0 CA--C 1.507 -0.417 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.36 179.528 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 4.1 ptm180 -103.98 -22.64 13.44 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.029 0.442 . . . . 0.0 110.54 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.426 ' HB ' ' OG1' ' A' ' 13' ' ' THR . 5.5 m -113.48 137.89 50.89 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.893 -178.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.653 ' O ' ' HA ' ' A' ' 34' ' ' GLU . 83.8 mt -100.41 120.32 39.79 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.438 179.129 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 56.2 ttp180 -118.27 120.25 37.1 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.586 -0.446 . . . . 0.0 109.876 178.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.603 ' HB2' ' HA ' ' A' ' 10' ' ' ALA . . . -154.48 167.58 29.56 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.383 -179.416 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -89.43 105.96 18.14 Favored 'General case' 0 CA--C 1.51 -0.569 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 177.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 69.3 m -96.46 136.29 37.16 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 120.727 0.299 . . . . 0.0 110.625 -178.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.564 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 16.2 ttp180 -76.94 119.31 20.51 Favored 'General case' 0 N--CA 1.44 -0.934 0 CA-C-N 116.196 -0.457 . . . . 0.0 109.835 179.336 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 37.4 p30 -80.32 174.55 11.49 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.153 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.27 -30.87 63.03 Favored 'General case' 0 C--O 1.235 0.303 0 O-C-N 123.649 0.593 . . . . 0.0 112.516 -178.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -77.4 -10.51 59.5 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.319 0.58 . . . . 0.0 110.135 -179.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 89.82 29.36 15.96 Favored Glycine 0 N--CA 1.447 -0.597 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.472 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.564 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 4.8 t-20 -110.64 164.02 13.16 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 121.086 -0.246 . . . . 0.0 111.129 -178.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.422 ' CZ3' ' HG2' ' A' ' 8' ' ' ARG . 82.4 m95 -97.62 119.44 36.2 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.011 0.434 . . . . 0.0 111.954 -179.388 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 5.8 m -124.39 135.03 65.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.938 178.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 62.0 m -81.3 111.02 17.3 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.926 0.393 . . . . 0.0 110.506 -179.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 70.5 m -120.5 155.84 32.75 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.481 -179.269 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.653 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 41.6 mt-10 -135.12 142.65 46.25 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.564 179.319 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.547 HD11 ' HB2' ' A' ' 102' ' ' PHE . 1.4 tm? -138.92 131.39 28.68 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.304 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.441 ' O ' HG22 ' A' ' 39' ' ' THR . 22.1 m-20 -89.83 110.89 21.79 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.509 HD22 HG13 ' A' ' 93' ' ' ILE . 1.1 mt -86.62 -19.42 29.35 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.659 -178.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.434 ' HA ' ' HD1' ' A' ' 55' ' ' PHE . 3.2 p-10 -68.45 -8.68 42.97 Favored 'General case' 0 C--O 1.221 -0.398 0 N-CA-C 112.017 0.377 . . . . 0.0 112.017 -178.006 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.441 HG22 ' O ' ' A' ' 36' ' ' ASP . 13.7 t -87.27 -1.72 58.11 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 179.107 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 75.2 m -135.33 -23.32 1.47 Allowed 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 116.176 -0.465 . . . . 0.0 112.02 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.505 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 55.1 mt -96.91 145.03 9.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 O-C-N 122.222 -0.299 . . . . 0.0 110.476 -179.699 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.638 ' HA3' ' HB3' ' A' ' 52' ' ' MET . . . -153.1 158.39 27.9 Favored Glycine 0 N--CA 1.447 -0.569 0 N-CA-C 111.277 -0.729 . . . . 0.0 111.277 179.056 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.491 ' HB3' HD23 ' A' ' 48' ' ' LEU . 6.0 p30 -159.91 53.91 0.58 Allowed Pre-proline 0 CA--C 1.538 0.511 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -179.277 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -71.54 -16.93 30.45 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 121.942 1.762 . . . . 0.0 112.216 -179.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -102.61 13.65 33.95 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.092 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.504 ' CA ' ' HG2' ' A' ' 83' ' ' ARG . . . 79.47 12.56 83.64 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.463 -0.875 . . . . 0.0 112.961 179.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.81 ' HA ' HE22 ' A' ' 86' ' ' GLN . 37.9 m-85 -125.31 130.74 52.59 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.879 0.371 . . . . 0.0 110.303 179.718 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.558 ' HB3' ' HB ' ' A' ' 88' ' ' ILE . 87.6 mt -84.33 132.51 34.6 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.745 -178.413 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -171.95 170.49 43.45 Favored Glycine 0 N--CA 1.443 -0.837 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.139 179.165 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.414 ' HH2' HD11 ' A' ' 93' ' ' ILE . 87.4 m95 -96.22 131.51 42.62 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 141.56 17.72 0.34 Allowed Glycine 0 CA--C 1.519 0.333 0 C-N-CA 120.46 -0.876 . . . . 0.0 113.821 179.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.638 ' HB3' ' HA3' ' A' ' 42' ' ' GLY . 5.3 ttt -153.57 -156.05 0.65 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 117.366 0.583 . . . . 0.0 109.801 179.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.416 ' HA ' ' O ' ' A' ' 38' ' ' ASP . 27.6 pt20 -148.04 167.62 24.49 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.705 0.288 . . . . 0.0 111.137 -179.341 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 35.9 m-80 61.63 44.74 8.69 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.452 -0.794 . . . . 0.0 112.938 178.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.505 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 1.2 p90 -71.01 -26.81 63.29 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.523 -0.471 . . . . 0.0 110.73 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.533 ' HA ' HD11 ' A' ' 62' ' ' ILE . 79.6 p -72.94 -29.35 63.04 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.035 0.445 . . . . 0.0 110.504 -179.413 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 41.8 m80 -82.81 -9.25 59.42 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.398 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.3 p -114.89 6.94 15.56 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.961 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 72.0 m -130.21 153.29 48.73 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.128 0.49 . . . . 0.0 110.745 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 86.7 mt-10 -119.09 134.67 55.06 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.403 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.5 t70 58.53 82.89 0.13 Allowed 'General case' 0 N--CA 1.465 0.317 0 O-C-N 123.938 0.774 . . . . 0.0 111.507 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.534 HG23 HD21 ' A' ' 71' ' ' LEU . 72.0 mt -95.31 124.54 47.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.108 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.9 tptm -149.84 149.54 30.63 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.565 ' HG ' HD21 ' A' ' 12' ' ' LEU . 52.2 mt -83.39 135.94 34.52 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.823 0.344 . . . . 0.0 110.98 -179.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -91.82 -59.03 2.22 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.958 -179.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.433 ' CB ' ' HB2' ' A' ' 69' ' ' ARG . 20.2 mm-40 -82.03 27.03 0.49 Allowed 'General case' 0 CA--C 1.516 -0.348 0 CA-C-O 121.106 0.479 . . . . 0.0 111.507 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 62.84 16.65 56.98 Favored Glycine 0 N--CA 1.448 -0.507 0 CA-C-N 115.278 -0.874 . . . . 0.0 112.722 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.449 ' HA3' ' HB2' ' A' ' 4' ' ' ALA . . . 144.08 -30.4 1.9 Allowed Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 120.104 -1.046 . . . . 0.0 113.189 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.589 ' HD2' ' HB3' ' A' ' 4' ' ' ALA . 7.2 mpt_? -74.37 -24.12 59.11 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 117.553 0.677 . . . . 0.0 111.12 -179.397 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 33.4 tttp -141.37 139.91 33.61 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.842 -178.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.637 ' HB2' HD11 ' A' ' 90' ' ' LEU . 10.1 tt -112.89 133.82 54.69 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.618 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.9 p -119.46 135.09 54.91 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.902 0.382 . . . . 0.0 111.083 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 25.3 p -162.49 172.23 15.83 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.37 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.589 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 32.2 ttt180 -106.98 99.38 25.9 Favored Pre-proline 0 C--N 1.319 -0.758 0 C-N-CA 120.356 -0.538 . . . . 0.0 110.741 178.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.647 ' O ' ' HB3' ' A' ' 83' ' ' ARG . 46.0 Cg_endo -67.4 123.86 11.35 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 122.784 2.323 . . . . 0.0 110.103 178.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.863 ' HE3' ' HA2' ' A' ' 81' ' ' GLY . 0.0 OUTLIER -120.29 142.97 48.6 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.066 0.46 . . . . 0.0 111.956 -178.914 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.711 HG22 ' O ' ' A' ' 82' ' ' PHE . 14.8 t -75.38 138.69 41.89 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.027 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 11.1 p -76.18 -12.95 14.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.217 -179.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -66.05 -21.9 66.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.11 0.481 . . . . 0.0 111.002 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.703 ' HA3' ' CE2' ' A' ' 82' ' ' PHE . . . -155.63 -21.41 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.29 -0.957 . . . . 0.0 113.105 179.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.863 ' HA2' ' HE3' ' A' ' 76' ' ' LYS . . . 95.53 12.57 53.57 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.05 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.711 ' O ' HG22 ' A' ' 77' ' ' THR . 16.7 p90 -112.47 158.61 19.68 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 118.926 -0.559 . . . . 0.0 110.015 -178.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.782 ' HA ' ' HE ' ' A' ' 83' ' ' ARG . 0.0 OUTLIER 168.65 -152.42 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 O-C-N 123.805 0.691 . . . . 0.0 111.656 178.707 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -125.73 155.88 40.27 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.358 -177.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.589 ' HA ' ' HA ' ' A' ' 74' ' ' ARG . 32.2 ttt180 -80.3 155.52 27.23 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 179.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.81 HE22 ' HA ' ' A' ' 47' ' ' PHE . 8.8 tt0 -162.45 177.12 9.79 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 120.976 0.417 . . . . 0.0 111.407 -178.054 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.485 ' H ' ' HG2' ' A' ' 86' ' ' GLN . . . -140.2 143.82 14.13 Favored Glycine 0 N--CA 1.445 -0.711 0 N-CA-C 111.456 -0.657 . . . . 0.0 111.456 179.388 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.558 ' HB ' ' HB3' ' A' ' 48' ' ' LEU . 10.1 tt -124.38 140.69 46.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 109.751 -0.462 . . . . 0.0 109.751 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.459 ' HB3' HD22 ' A' ' 91' ' ' ASN . 61.9 m-20 -82.46 136.47 34.9 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.861 -179.528 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.637 HD11 ' HB2' ' A' ' 71' ' ' LEU . 83.2 mt -106.82 44.6 1.04 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.352 0.596 . . . . 0.0 110.861 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.459 HD22 ' HB3' ' A' ' 89' ' ' ASP . 18.5 m-80 -76.97 2.66 14.18 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.751 179.415 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 18.5 mtp180 -98.82 -15.05 19.4 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.087 -0.96 . . . . 0.0 110.316 179.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.584 HG21 HD12 ' A' ' 19' ' ' LEU . 29.3 mm -98.91 105.13 16.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 121.017 0.436 . . . . 0.0 109.993 -179.315 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.401 ' HA ' ' HB3' ' A' ' 3' ' ' TYR . 4.0 mt-30 -130.85 156.47 44.97 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.007 -179.262 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 13.1 p-10 -95.71 110.72 22.81 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.127 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 58.8 t -90.87 104.44 15.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.031 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 59.89 35.24 21.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.989 -179.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 98.45 -27.27 20.3 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.75 -0.738 . . . . 0.0 113.431 179.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.422 ' HD3' ' H ' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -86.92 128.82 35.06 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.944 0.372 . . . . 0.0 110.136 -178.936 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.424 HD12 ' HA ' ' A' ' 100' ' ' LEU . 9.2 tp -75.72 120.33 20.96 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 -179.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 32.2 t -129.61 142.09 44.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.168 -178.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.547 ' HB2' HD11 ' A' ' 35' ' ' LEU . 18.1 t80 -82.28 124.61 30.11 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 177.384 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.421 -0.799 . . . . 0.0 110.877 -179.504 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 mpt? . . . . . 0 N--CA 1.48 1.028 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.462 ' OG ' ' HA ' ' A' ' 91' ' ' ASN . 9.5 m -117.83 178.92 4.23 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.071 179.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.532 ' HA ' ' OD1' ' A' ' 95' ' ' ASN . 13.2 p90 -58.7 -38.14 77.62 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.524 0.202 . . . . 0.0 111.322 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -57.84 -23.93 55.07 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.357 -0.383 . . . . 0.0 112.023 -179.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -69.97 -16.24 63.16 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.654 0.242 . . . . 0.0 111.654 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 20.8 m -141.22 30.09 1.79 Allowed 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 22.4 t -144.92 158.46 43.8 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 115.509 -0.768 . . . . 0.0 110.103 -179.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 18.3 ptt180 -140.3 165.49 27.27 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.441 -179.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 55.18 54.76 8.37 Favored 'General case' 0 N--CA 1.467 0.378 0 O-C-N 123.829 0.705 . . . . 0.0 111.404 179.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.49 ' HA ' ' HB2' ' A' ' 21' ' ' ALA . . . -81.08 117.32 21.56 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.59 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 33.8 m -122.56 168.86 14.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.686 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.65 HD21 ' HG ' ' A' ' 64' ' ' LEU . 3.9 mm? -105.15 117.08 33.1 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.005 -179.546 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.478 HG21 ' NE ' ' A' ' 20' ' ' ARG . 20.9 p -115.48 165.89 12.49 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.062 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.436 ' O ' ' HG2' ' A' ' 17' ' ' ARG . 93.9 m-20 60.35 31.14 20.31 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.8 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 96.3 -17.96 58.33 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.827 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.576 ' HA2' ' HB3' ' A' ' 12' ' ' LEU . . . 122.86 10.15 5.93 Favored Glycine 0 C--O 1.229 -0.197 0 C-N-CA 121.025 -0.607 . . . . 0.0 111.608 -179.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.538 ' HB2' ' HB3' ' A' ' 38' ' ' ASP . 5.2 ptm180 -91.26 -24.17 19.94 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.257 0.551 . . . . 0.0 110.337 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.5 ' CG2' ' HB3' ' A' ' 34' ' ' GLU . 23.2 m -115.49 138.43 51.03 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.869 -178.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.739 HD11 HD13 ' A' ' 90' ' ' LEU . 92.1 mt -97.49 120.92 38.74 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.326 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.478 ' NE ' HG21 ' A' ' 13' ' ' THR . 34.5 ttm180 -114.12 120.46 40.62 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 178.252 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.49 ' HB2' ' HA ' ' A' ' 10' ' ' ALA . . . -153.11 167.71 28.35 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 120.938 0.399 . . . . 0.0 111.168 -178.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.649 ' HB3' ' HB3' ' A' ' 30' ' ' TRP . 10.4 mm-40 -88.9 105.95 18.09 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 178.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.423 ' SG ' ' HB2' ' A' ' 33' ' ' SER . 67.7 m -91.26 129.7 37.22 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.65 -178.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.528 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 24.7 ttp180 -75.69 116.38 16.35 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.521 179.124 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.411 HD21 ' HB3' ' A' ' 29' ' ' ASN . 36.2 p30 -82.16 173.3 12.25 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.177 179.545 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.18 -30.45 62.26 Favored 'General case' 0 N--CA 1.464 0.268 0 O-C-N 123.361 0.413 . . . . 0.0 112.084 -178.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -72.83 -13.5 61.31 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.662 0.744 . . . . 0.0 109.96 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 88.61 25.55 29.91 Favored Glycine 0 CA--C 1.503 -0.694 0 N-CA-C 110.8 -0.92 . . . . 0.0 110.8 -179.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.528 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 8.7 t-20 -106.6 161.97 14.16 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.575 -0.313 . . . . 0.0 110.323 -178.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.649 ' HB3' ' HB3' ' A' ' 22' ' ' GLU . 87.4 m95 -100.04 122.55 43.1 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.955 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 5.6 m -124.33 136.11 61.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.27 178.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 13.2 m -75.42 109.73 9.2 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.953 0.406 . . . . 0.0 110.958 -179.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.423 ' HB2' ' SG ' ' A' ' 23' ' ' CYS . 69.8 m -124.05 148.0 47.41 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.697 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.638 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 47.9 mt-10 -124.94 150.9 46.13 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.237 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.597 HD11 ' HB2' ' A' ' 102' ' ' PHE . 1.6 tm? -141.84 130.86 23.18 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 178.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.452 ' N ' HD13 ' A' ' 35' ' ' LEU . 2.1 p-10 -88.35 109.7 20.19 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.303 0.573 . . . . 0.0 110.605 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.477 HD11 ' HG ' ' A' ' 19' ' ' LEU . 1.0 OUTLIER -86.65 -21.05 26.95 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.965 179.532 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.538 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 5.1 p-10 -64.03 -13.73 49.02 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -178.445 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 64.1 p -83.63 -11.32 57.44 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 120.89 0.376 . . . . 0.0 110.801 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 35.5 m -130.41 -9.94 4.13 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.231 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.427 HD13 HD13 ' A' ' 88' ' ' ILE . 63.4 mt -113.26 137.05 47.67 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-O 120.682 0.277 . . . . 0.0 110.704 179.479 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.594 ' HA3' ' HB3' ' A' ' 52' ' ' MET . . . -149.45 159.03 27.9 Favored Glycine 0 N--CA 1.446 -0.7 0 C-N-CA 120.967 -0.635 . . . . 0.0 111.581 179.089 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.454 ' OD1' ' HB2' ' A' ' 58' ' ' SER . 24.8 p30 -157.57 48.31 0.31 Allowed Pre-proline 0 CA--C 1.535 0.367 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -68.74 -22.21 37.53 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 121.829 1.686 . . . . 0.0 112.166 -178.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 70.6 m-20 -91.79 0.44 57.49 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.43 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.539 ' CA ' ' HG2' ' A' ' 83' ' ' ARG . . . 92.48 6.74 64.02 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.669 -0.776 . . . . 0.0 112.236 -179.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -120.78 132.25 54.93 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.938 0.399 . . . . 0.0 110.798 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.452 HD12 ' HB3' ' A' ' 86' ' ' GLN . 14.8 mt -84.31 146.79 27.55 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.399 -178.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 169.35 171.0 34.57 Favored Glycine 0 N--CA 1.442 -0.904 0 C-N-CA 120.254 -0.974 . . . . 0.0 112.64 178.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.466 ' HH2' HD11 ' A' ' 93' ' ' ILE . 90.8 m95 -96.1 126.17 41.14 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 149.82 -43.94 0.73 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.995 -0.621 . . . . 0.0 111.853 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.63 ' HA ' ' CE ' ' A' ' 52' ' ' MET . 0.7 OUTLIER -94.24 -177.04 4.15 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 179.104 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.4 ' H ' ' HG3' ' A' ' 52' ' ' MET . 13.4 pt20 -143.14 170.19 16.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 119.076 0.853 . . . . 0.0 112.215 -178.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 30.0 m-80 66.11 36.68 5.54 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.091 -0.959 . . . . 0.0 112.307 179.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.531 ' HB3' ' HA2' ' A' ' 42' ' ' GLY . 9.1 p90 -62.86 -28.33 69.96 Favored 'General case' 0 C--O 1.221 -0.444 0 CA-C-O 120.651 0.262 . . . . 0.0 110.455 179.442 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.468 ' HB3' ' HB3' ' A' ' 17' ' ' ARG . 9.5 p -58.68 -34.34 71.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.351 -179.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 26.5 m80 -80.06 -10.05 59.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.553 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.454 ' HB2' ' OD1' ' A' ' 43' ' ' ASN . 16.4 m -123.5 28.98 6.79 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.45 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 45.0 m -137.49 150.31 47.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.062 0.458 . . . . 0.0 111.079 179.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.447 ' HG3' ' HG2' ' A' ' 76' ' ' LYS . 71.5 mt-10 -129.86 134.01 47.26 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.677 179.281 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 38.5 t70 61.62 79.73 0.24 Allowed 'General case' 0 N--CA 1.468 0.455 0 O-C-N 123.705 0.628 . . . . 0.0 110.689 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.524 HG23 HD21 ' A' ' 71' ' ' LEU . 64.3 mt -98.67 125.06 52.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.037 -179.25 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.1 tptm -149.21 156.07 41.59 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.016 0.436 . . . . 0.0 111.285 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.65 ' HG ' HD21 ' A' ' 12' ' ' LEU . 83.0 mt -98.99 128.84 45.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.144 179.086 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -93.52 -65.7 0.97 Allowed 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -178.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.527 ' HB2' ' HB2' ' A' ' 69' ' ' ARG . 4.8 mm-40 -76.29 50.28 0.63 Allowed 'General case' 0 CA--C 1.516 -0.33 0 CA-C-O 121.117 0.484 . . . . 0.0 112.192 -178.013 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 59.94 16.35 39.32 Favored Glycine 0 C--N 1.318 -0.44 0 CA-C-N 115.117 -0.947 . . . . 0.0 112.795 179.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.534 ' HA2' HD13 ' A' ' 64' ' ' LEU . . . 121.11 -12.29 9.8 Favored Glycine 0 N--CA 1.442 -0.909 0 C-N-CA 120.394 -0.907 . . . . 0.0 113.241 179.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.527 ' HB2' ' HB2' ' A' ' 66' ' ' GLU . 2.8 mtt85 -77.69 -22.16 50.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 117.525 0.663 . . . . 0.0 110.721 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 33.0 tptt -131.63 127.56 37.27 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.294 -178.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.668 ' HB2' HD11 ' A' ' 90' ' ' LEU . 10.6 tt -110.04 121.2 44.7 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.442 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.4 p -109.66 136.61 48.74 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.176 0.513 . . . . 0.0 110.837 179.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 17.7 p -162.87 169.43 19.8 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.102 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.562 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 30.2 ttt180 -103.8 102.45 31.09 Favored Pre-proline 0 C--N 1.313 -0.979 0 C-N-CA 120.095 -0.642 . . . . 0.0 110.609 179.116 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.645 ' O ' ' HB3' ' A' ' 83' ' ' ARG . 48.0 Cg_endo -67.77 116.15 4.13 Favored 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 122.539 2.159 . . . . 0.0 110.023 178.385 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.942 ' HE3' ' HA2' ' A' ' 81' ' ' GLY . 0.0 OUTLIER -117.86 144.97 44.94 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.088 0.47 . . . . 0.0 111.455 -178.927 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.71 HG22 ' O ' ' A' ' 82' ' ' PHE . 15.3 t -77.86 140.73 39.37 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 179.402 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 32.2 m -74.52 -1.64 3.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 O-C-N 123.989 0.806 . . . . 0.0 111.145 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 -68.4 -32.01 71.76 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.174 0.511 . . . . 0.0 110.144 179.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -160.67 -9.51 0.04 OUTLIER Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.476 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.942 ' HA2' ' HE3' ' A' ' 76' ' ' LYS . . . 90.63 19.71 43.42 Favored Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 120.577 -0.821 . . . . 0.0 111.776 179.627 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.71 ' O ' HG22 ' A' ' 77' ' ' THR . 26.3 p90 -110.93 146.64 36.21 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 119.226 -0.416 . . . . 0.0 110.047 -179.028 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.732 ' HB2' ' HA ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 170.53 -154.92 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.224 0 O-C-N 123.925 0.766 . . . . 0.0 110.433 179.27 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -118.37 173.02 7.06 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.41 -178.05 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.562 ' HA ' ' HA ' ' A' ' 74' ' ' ARG . 31.3 ttt85 -104.3 153.43 21.03 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 178.244 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.704 ' HG2' ' H ' ' A' ' 87' ' ' GLY . 9.0 tt0 -165.61 -174.65 3.19 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 120.655 0.264 . . . . 0.0 110.698 -178.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.704 ' H ' ' HG2' ' A' ' 86' ' ' GLN . . . -141.11 151.9 22.86 Favored Glycine 0 N--CA 1.45 -0.369 0 N-CA-C 111.736 -0.545 . . . . 0.0 111.736 179.181 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.427 HD13 HD13 ' A' ' 41' ' ' ILE . 12.1 tt -125.49 145.6 32.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 120.965 0.412 . . . . 0.0 110.208 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -82.47 121.98 27.45 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.845 -179.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.739 HD13 HD11 ' A' ' 19' ' ' LEU . 59.8 mt -98.59 37.08 1.53 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.558 0.695 . . . . 0.0 110.632 179.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.462 ' HA ' ' OG ' ' A' ' 2' ' ' SER . 0.9 OUTLIER -75.27 -0.65 20.32 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 114.949 -1.023 . . . . 0.0 110.381 -179.958 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 20.1 mtp180 -92.09 -14.81 28.66 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.226 -179.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.466 HD11 ' HH2' ' A' ' 50' ' ' TRP . 21.0 mm -92.22 111.7 24.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 -179.445 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 21.9 tp60 -124.71 134.85 52.69 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.283 0.563 . . . . 0.0 111.315 -178.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.532 ' OD1' ' HA ' ' A' ' 3' ' ' TYR . 19.6 p-10 -95.45 119.82 34.62 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.843 178.105 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.3 p -114.95 119.2 61.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.177 0.513 . . . . 0.0 110.602 -179.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 58.54 30.22 19.49 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.002 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 94.87 -15.79 62.65 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.774 -0.727 . . . . 0.0 113.289 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -93.03 123.18 36.1 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 117.555 0.677 . . . . 0.0 110.089 -179.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 16.1 tp -82.57 117.22 22.39 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.8 t -128.6 149.98 33.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.769 0.319 . . . . 0.0 111.088 -179.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.597 ' HB2' HD11 ' A' ' 35' ' ' LEU . 8.5 t80 -89.61 126.0 35.45 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 178.113 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.316 -0.89 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.321 179.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.0 ttt . . . . . 0 N--CA 1.48 1.041 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.565 ' HB3' ' HA ' ' A' ' 91' ' ' ASN . 10.8 p -117.97 178.25 4.49 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.73 -0.388 . . . . 0.0 111.319 178.67 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.443 ' HA ' ' OD1' ' A' ' 95' ' ' ASN . 12.8 p90 -58.59 -38.61 78.31 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -179.615 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.61 ' HA ' ' OG ' ' A' ' 7' ' ' SER . . . -55.29 -19.09 7.52 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 -177.371 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -61.71 -37.07 82.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.963 0.411 . . . . 0.0 111.037 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 8.1 t -130.63 45.02 2.88 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 121.295 0.569 . . . . 0.0 109.754 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.61 ' OG ' ' HA ' ' A' ' 4' ' ' ALA . 86.4 p -147.06 165.54 29.6 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.225 179.017 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 11.9 ptm180 -149.24 166.6 28.42 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.661 -179.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 59.44 54.43 4.66 Favored 'General case' 0 C--O 1.234 0.254 0 O-C-N 123.93 0.769 . . . . 0.0 111.136 179.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.404 ' HA ' ' HB2' ' A' ' 21' ' ' ALA . . . -86.69 117.36 25.4 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.014 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 34.2 m -124.57 168.49 17.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.786 -179.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.752 HD21 ' HG ' ' A' ' 64' ' ' LEU . 3.5 mm? -105.21 114.9 29.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.121 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 19.2 p -110.06 167.2 10.35 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.166 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 60.64 49.94 6.04 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.778 -0.647 . . . . 0.0 111.449 179.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 83.76 -30.15 3.57 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.348 179.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.557 ' HA2' ' HB3' ' A' ' 12' ' ' LEU . . . 130.64 48.09 0.13 Allowed Glycine 0 N--CA 1.446 -0.689 0 N-CA-C 111.133 -0.787 . . . . 0.0 111.133 -179.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.616 ' HB2' ' HB3' ' A' ' 38' ' ' ASP . 41.7 ptt85 -132.16 -27.07 1.85 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.017 0.436 . . . . 0.0 111.202 -179.403 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.449 ' CG2' ' HB3' ' A' ' 34' ' ' GLU . 4.2 m -100.94 133.88 44.76 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.828 -179.269 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.791 HD11 HD13 ' A' ' 90' ' ' LEU . 70.3 mt -94.17 115.95 28.3 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.275 179.084 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 53.3 ttp180 -114.36 121.28 43.12 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.504 -0.479 . . . . 0.0 109.983 178.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.404 ' HB2' ' HA ' ' A' ' 10' ' ' ALA . . . -153.43 166.05 33.89 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.845 0.355 . . . . 0.0 110.662 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -89.95 106.03 18.2 Favored 'General case' 0 CA--C 1.508 -0.643 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 178.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.457 ' SG ' HD13 ' A' ' 100' ' ' LEU . 45.3 m -98.81 132.17 44.37 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 120.876 -0.33 . . . . 0.0 110.191 -178.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.512 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 17.6 ttp85 -74.62 117.19 16.17 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.283 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.492 HD21 ' HB3' ' A' ' 29' ' ' ASN . 36.7 p30 -80.96 168.7 18.41 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.153 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.76 -33.21 55.06 Favored 'General case' 0 C--O 1.235 0.31 0 O-C-N 123.589 0.556 . . . . 0.0 112.118 -178.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -68.64 -17.88 64.18 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.289 0.566 . . . . 0.0 110.549 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 94.61 27.01 12.08 Favored Glycine 0 N--CA 1.446 -0.655 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.382 -179.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.512 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 62.0 t30 -111.09 164.06 13.23 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.547 0.213 . . . . 0.0 111.047 -178.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.413 ' HZ3' ' HA ' ' A' ' 7' ' ' SER . 89.8 m95 -100.36 113.84 26.88 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.534 179.318 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.9 m -116.55 131.03 70.36 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.877 179.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.3 m -74.93 109.22 8.22 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.445 179.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 66.9 m -119.26 146.62 45.09 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.408 -179.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.637 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 49.7 mt-10 -130.78 139.71 50.24 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.899 -179.301 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.521 HD12 HD23 ' A' ' 37' ' ' LEU . 1.4 tm? -132.81 129.12 38.12 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 178.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.449 ' N ' HD13 ' A' ' 35' ' ' LEU . 15.8 m-20 -88.88 108.93 19.81 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.521 HD23 HD12 ' A' ' 35' ' ' LEU . 0.5 OUTLIER -86.72 -9.11 56.66 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.363 -0.381 . . . . 0.0 112.017 -179.56 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.616 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 6.7 p-10 -66.16 -14.93 62.64 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -178.356 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 8.9 t -87.47 0.48 55.48 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.974 0.416 . . . . 0.0 110.609 179.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.538 ' SG ' ' HZ3' ' A' ' 50' ' ' TRP . 1.7 p -140.63 -14.8 0.95 Allowed 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 54.5 mt -111.65 135.98 49.21 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-O 120.733 0.302 . . . . 0.0 110.502 179.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.529 ' HA3' ' HB3' ' A' ' 52' ' ' MET . . . -152.93 158.33 27.84 Favored Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 111.468 -0.653 . . . . 0.0 111.468 179.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.694 ' ND2' ' HB2' ' A' ' 55' ' ' PHE . 3.7 p30 -161.72 52.03 0.37 Allowed Pre-proline 0 C--N 1.327 -0.412 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 179.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.559 ' HD3' ' N ' ' A' ' 43' ' ' ASN . 5.4 Cg_exo -78.03 -9.27 16.7 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.298 1.999 . . . . 0.0 111.647 -179.432 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 35.7 m-80 -99.35 2.04 44.96 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.618 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.478 ' CA ' ' HG2' ' A' ' 83' ' ' ARG . . . 93.33 0.74 67.27 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.402 -0.904 . . . . 0.0 112.093 -179.446 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.499 ' HA ' HE22 ' A' ' 86' ' ' GLN . 65.7 m-85 -125.47 131.37 52.86 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.986 0.422 . . . . 0.0 111.006 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.582 HD13 ' HB3' ' A' ' 86' ' ' GLN . 9.9 mp -84.58 153.99 22.89 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.479 -179.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 168.04 170.6 32.98 Favored Glycine 0 N--CA 1.443 -0.842 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.651 179.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.538 ' HZ3' ' SG ' ' A' ' 40' ' ' CYS . 90.5 m95 -95.86 125.24 40.29 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 149.24 -34.83 1.08 Allowed Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.804 -0.713 . . . . 0.0 112.405 -179.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.529 ' HB3' ' HA3' ' A' ' 42' ' ' GLY . 12.9 tpt -98.48 174.22 6.56 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 -179.319 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -128.71 168.97 15.05 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 117.93 0.332 . . . . 0.0 110.97 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 61.31 49.43 5.39 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.438 -0.801 . . . . 0.0 112.455 178.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.694 ' HB2' ' ND2' ' A' ' 43' ' ' ASN . 15.9 p90 -70.08 -25.72 63.66 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.104 179.157 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.5 ' HA ' HD11 ' A' ' 62' ' ' ILE . 10.6 p -60.93 -44.9 96.56 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.262 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 30.5 m80 -79.98 -11.36 59.79 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.999 0.428 . . . . 0.0 110.762 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 20.6 m -101.41 2.33 39.32 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.997 -178.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 62.3 p -144.57 160.82 40.52 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.548 -0.461 . . . . 0.0 111.421 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 59.1 mm-40 -117.23 152.23 35.27 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.966 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 50.22 76.36 0.15 Allowed 'General case' 0 N--CA 1.472 0.644 0 O-C-N 123.994 0.809 . . . . 0.0 111.777 179.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.562 HG23 HD21 ' A' ' 71' ' ' LEU . 83.8 mt -92.61 117.09 35.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.416 -179.334 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 32.1 ttmt -148.94 154.91 40.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.108 -0.497 . . . . 0.0 109.851 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.752 ' HG ' HD21 ' A' ' 12' ' ' LEU . 60.2 mt -83.73 135.95 34.36 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.193 0.52 . . . . 0.0 111.224 -179.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -92.17 -66.26 0.94 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.406 -0.815 . . . . 0.0 111.82 -178.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -78.6 40.98 0.39 Allowed 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 120.95 0.405 . . . . 0.0 111.671 -178.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 60.91 17.81 52.06 Favored Glycine 0 C--N 1.32 -0.324 0 CA-C-N 115.653 -0.703 . . . . 0.0 113.113 179.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.47 ' HA2' HD13 ' A' ' 64' ' ' LEU . . . 129.58 -16.06 5.67 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.222 -0.989 . . . . 0.0 112.668 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.52 ' HD2' ' HB3' ' A' ' 4' ' ' ALA . 0.1 OUTLIER -77.5 -19.17 56.26 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.134 0.492 . . . . 0.0 109.783 -179.796 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.47 ' HG3' ' HA ' ' A' ' 89' ' ' ASP . 65.3 tttt -150.35 144.33 25.43 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.936 -178.391 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.61 ' HB2' HD11 ' A' ' 90' ' ' LEU . 9.7 tt -112.29 126.66 55.48 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.56 179.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.5 p -114.04 137.71 51.36 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.099 0.476 . . . . 0.0 111.358 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.423 ' HB3' ' HA ' ' A' ' 62' ' ' ILE . 25.0 p -161.76 175.85 11.53 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.607 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.511 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 44.7 ttt180 -107.91 99.54 30.98 Favored Pre-proline 0 C--N 1.317 -0.833 0 N-CA-C 110.154 -0.313 . . . . 0.0 110.154 179.377 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.672 ' O ' ' HB3' ' A' ' 83' ' ' ARG . 56.1 Cg_endo -67.06 122.91 10.29 Favored 'Trans proline' 0 CA--C 1.513 -0.564 0 C-N-CA 123.129 2.553 . . . . 0.0 111.332 -179.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.74 ' HA ' ' HB2' ' A' ' 83' ' ' ARG . 0.2 OUTLIER -120.13 147.03 45.39 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 120.947 0.403 . . . . 0.0 111.191 -179.85 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.743 HG22 ' O ' ' A' ' 82' ' ' PHE . 10.3 t -74.21 130.22 39.33 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 178.55 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.1 m -72.18 -3.39 3.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 O-C-N 123.629 0.581 . . . . 0.0 111.204 -179.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -70.52 -34.54 72.42 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.789 178.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.41 ' HA3' ' CE1' ' A' ' 82' ' ' PHE . . . -144.51 -24.72 0.13 Allowed Glycine 0 CA--C 1.521 0.441 0 C-N-CA 120.73 -0.747 . . . . 0.0 113.285 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 102.65 14.79 26.48 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 121.022 -0.609 . . . . 0.0 112.277 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.743 ' O ' HG22 ' A' ' 77' ' ' THR . 29.4 p90 -112.85 157.9 20.82 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 118.372 -0.823 . . . . 0.0 110.105 -179.206 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.844 ' HA ' ' HE ' ' A' ' 83' ' ' ARG . 0.0 OUTLIER 163.44 -154.03 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.75 0 O-C-N 123.932 0.77 . . . . 0.0 112.381 178.528 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 47.8 mm-40 -109.14 -173.96 2.39 Favored 'General case' 0 C--O 1.226 -0.161 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.468 -178.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.535 ' HA ' ' HD2' ' A' ' 75' ' ' PRO . 61.5 ttt180 -113.75 156.03 24.56 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 177.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.787 ' HG2' ' H ' ' A' ' 87' ' ' GLY . 6.8 tt0 -169.07 -165.78 0.57 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 120.526 -0.47 . . . . 0.0 111.462 -178.284 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.787 ' H ' ' HG2' ' A' ' 86' ' ' GLN . . . -162.15 154.42 25.38 Favored Glycine 0 N--CA 1.449 -0.434 0 N-CA-C 111.217 -0.753 . . . . 0.0 111.217 179.424 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.485 HG22 HD23 ' A' ' 48' ' ' LEU . 12.8 tt -130.78 137.54 55.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.952 0.376 . . . . 0.0 110.323 -179.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.47 ' HA ' ' HG3' ' A' ' 70' ' ' LYS . 1.8 p-10 -76.65 140.58 41.0 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.961 0.41 . . . . 0.0 109.92 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.791 HD13 HD11 ' A' ' 19' ' ' LEU . 55.8 mt -109.44 40.02 1.95 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.347 0.594 . . . . 0.0 110.834 -179.473 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.565 ' HA ' ' HB3' ' A' ' 2' ' ' SER . 55.4 m-80 -75.45 2.36 11.69 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.806 -179.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 19.6 mtp180 -95.77 -11.25 27.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.015 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.407 ' CD1' HD22 ' A' ' 37' ' ' LEU . 23.1 mm -98.18 100.01 9.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 29.3 tp60 -107.21 145.6 32.42 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.953 -178.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.443 ' OD1' ' HA ' ' A' ' 3' ' ' TYR . 19.4 p-10 -94.78 118.82 32.38 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.54 178.144 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 47.5 t -106.28 107.78 23.52 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 27.8 m-80 59.46 32.51 21.78 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.022 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.407 ' O ' ' HB2' ' A' ' 23' ' ' CYS . . . 97.99 -25.69 26.51 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.571 -0.823 . . . . 0.0 113.239 179.397 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.408 ' HD2' ' H ' ' A' ' 99' ' ' ARG . 1.7 mpt_? -87.07 143.28 27.39 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 117.252 0.526 . . . . 0.0 110.603 -178.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.485 ' HB3' ' HB2' ' A' ' 35' ' ' LEU . 2.7 tp -87.42 124.23 33.2 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.78 0.324 . . . . 0.0 110.845 -179.25 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 21.7 t -131.19 138.15 53.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.419 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.425 ' HB2' HD11 ' A' ' 35' ' ' LEU . 10.3 t80 -83.14 130.95 35.15 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 177.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 22.0 tt0 . . . . . 0 C--O 1.25 1.119 0 CA-C-O 118.329 -0.844 . . . . 0.0 111.046 -179.076 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 85.5 mtp . . . . . 0 N--CA 1.479 0.999 0 CA-C-O 120.827 0.346 . . . . 0.0 110.439 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.406 ' OG ' ' HA ' ' A' ' 91' ' ' ASN . 13.4 m -118.21 178.44 4.43 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.46 179.135 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.482 ' CZ ' HD13 ' A' ' 19' ' ' LEU . 26.4 p90 -57.95 -38.5 76.12 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.672 0.273 . . . . 0.0 111.296 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.533 ' HA ' ' OG ' ' A' ' 7' ' ' SER . . . -58.97 -19.78 46.33 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -178.088 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -72.56 -17.78 61.68 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.297 0.57 . . . . 0.0 110.347 -179.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 48.8 m -136.74 36.42 2.64 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.333 179.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.533 ' OG ' ' HA ' ' A' ' 4' ' ' ALA . 68.6 p -149.61 171.43 16.67 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.485 179.373 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.553 ' HG3' ' HB2' ' A' ' 22' ' ' GLU . 1.9 ptp180 -149.98 167.11 27.64 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.948 -179.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 53.73 56.05 7.71 Favored 'General case' 0 C--O 1.233 0.192 0 O-C-N 123.867 0.729 . . . . 0.0 111.322 178.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.503 ' HA ' ' HB2' ' A' ' 21' ' ' ALA . . . -88.24 117.32 27.06 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.181 179.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 35.9 m -124.13 170.22 14.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.596 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.848 HD21 ' HG ' ' A' ' 64' ' ' LEU . 3.3 mm? -104.68 114.17 28.21 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.832 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 18.7 p -108.88 166.63 10.67 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.622 -0.263 . . . . 0.0 110.95 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 59.37 48.5 9.94 Favored 'General case' 0 CA--C 1.522 -0.112 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.912 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 86.76 -39.35 3.08 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.953 -0.641 . . . . 0.0 112.35 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.637 ' HA2' ' HB3' ' A' ' 12' ' ' LEU . . . 140.01 38.32 0.1 OUTLIER Glycine 0 N--CA 1.445 -0.709 0 N-CA-C 111.305 -0.718 . . . . 0.0 111.305 -179.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.552 ' HB2' ' HB3' ' A' ' 38' ' ' ASP . 39.2 ptt85 -122.14 -23.37 5.37 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.094 0.473 . . . . 0.0 110.779 -179.326 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.432 HG22 ' HB3' ' A' ' 34' ' ' GLU . 3.9 m -105.84 134.73 48.5 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.923 -179.166 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.665 HD11 HD13 ' A' ' 90' ' ' LEU . 81.9 mt -93.67 110.99 22.59 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.404 179.237 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 20.4 ttt180 -108.11 119.35 39.22 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 178.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.503 ' HB2' ' HA ' ' A' ' 10' ' ' ALA . . . -153.66 167.04 30.89 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.982 0.42 . . . . 0.0 111.483 -178.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.553 ' HB2' ' HG3' ' A' ' 8' ' ' ARG . 7.3 mm-40 -90.3 105.0 17.51 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 107.1 -1.445 . . . . 0.0 107.1 178.293 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.442 ' SG ' HD13 ' A' ' 100' ' ' LEU . 58.6 m -92.34 125.27 36.92 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.557 -178.218 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.437 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 33.8 ttp180 -73.3 117.82 15.51 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.582 179.055 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.406 HD21 ' HB3' ' A' ' 29' ' ' ASN . 35.1 p30 -82.35 167.62 18.35 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.62 -24.26 63.68 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 -178.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -75.08 -16.15 60.58 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.315 0.579 . . . . 0.0 109.727 179.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 93.32 36.32 5.97 Favored Glycine 0 N--CA 1.447 -0.624 0 CA-C-N 115.186 -0.915 . . . . 0.0 111.733 -179.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.437 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 9.2 t-20 -123.48 163.91 19.97 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.606 0.241 . . . . 0.0 110.417 -179.125 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.498 ' CZ3' ' HG2' ' A' ' 8' ' ' ARG . 89.2 m95 -101.16 118.47 37.05 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.381 -179.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.5 m -122.08 130.78 74.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.429 178.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 15.8 m -76.0 110.95 10.88 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.583 -179.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 67.8 m -123.25 154.65 38.52 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.745 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.647 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 50.4 mt-10 -135.02 143.08 46.58 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.055 -179.54 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.549 HD11 ' HB2' ' A' ' 102' ' ' PHE . 2.0 tm? -136.36 129.66 31.64 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 178.457 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.443 ' N ' HD13 ' A' ' 35' ' ' LEU . 15.1 m-20 -88.42 109.18 19.8 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 -179.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.554 HD13 HD22 ' A' ' 90' ' ' LEU . 3.8 mt -81.27 -20.01 41.82 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.764 -179.334 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.552 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 5.7 p-10 -66.26 -5.33 10.06 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.874 0.369 . . . . 0.0 111.341 -178.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 77.6 p -82.9 -11.57 58.08 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.686 179.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 29.0 t -141.48 -3.86 1.15 Allowed 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 57.7 mt -109.59 135.06 49.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 178.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.556 ' HA3' ' HB3' ' A' ' 52' ' ' MET . . . -146.0 155.63 26.6 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.93 -0.653 . . . . 0.0 111.519 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 23.6 p30 -159.69 45.19 0.19 Allowed Pre-proline 0 CA--C 1.538 0.486 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -179.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -66.66 -23.31 49.3 Favored 'Trans proline' 0 C--N 1.355 0.901 0 C-N-CA 121.793 1.662 . . . . 0.0 111.68 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 73.9 m-20 -83.95 -15.42 47.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.507 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 105.86 6.68 37.19 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.494 -0.86 . . . . 0.0 112.114 -179.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.793 ' HA ' HE22 ' A' ' 86' ' ' GLN . 55.7 m-85 -124.9 132.75 53.26 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.867 0.365 . . . . 0.0 110.171 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.591 ' HB3' ' HB ' ' A' ' 88' ' ' ILE . 11.0 mp -87.27 138.43 31.49 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.642 -0.708 . . . . 0.0 112.339 -178.173 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -177.37 171.14 43.87 Favored Glycine 0 N--CA 1.439 -1.14 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.611 178.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.427 ' HH2' HD11 ' A' ' 93' ' ' ILE . 91.6 m95 -94.99 125.39 39.63 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 156.11 -58.82 0.37 Allowed Glycine 0 N--CA 1.447 -0.58 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 -179.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.556 ' HB3' ' HA3' ' A' ' 42' ' ' GLY . 7.3 tpt -84.71 178.47 7.65 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 179.008 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.428 ' HG3' HD22 ' A' ' 54' ' ' ASN . 27.0 pt20 -137.2 177.7 7.66 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 118.596 0.635 . . . . 0.0 111.726 -179.408 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.428 HD22 ' HG3' ' A' ' 53' ' ' GLN . 44.9 m-80 62.73 39.68 10.78 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.408 -0.815 . . . . 0.0 112.083 179.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.443 ' HB3' ' HA2' ' A' ' 42' ' ' GLY . 10.1 p90 -66.26 -32.2 73.47 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 120.478 0.18 . . . . 0.0 111.296 -179.583 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.434 ' HB3' ' HB3' ' A' ' 17' ' ' ARG . 42.3 p -61.81 -31.84 72.09 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.057 0.456 . . . . 0.0 111.118 -179.005 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 38.4 m80 -78.39 -12.0 59.98 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.08 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 43.9 m -119.6 23.63 11.07 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.956 0.408 . . . . 0.0 110.704 179.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 66.2 m -138.4 152.27 48.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.085 0.469 . . . . 0.0 111.09 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 78.6 mt-10 -130.18 136.41 49.23 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.119 179.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 29.7 t70 65.58 82.62 0.18 Allowed 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.329 0.585 . . . . 0.0 110.268 -178.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.478 HG23 HD21 ' A' ' 71' ' ' LEU . 64.2 mt -104.68 121.98 57.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.197 -179.248 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 27.8 tptt -147.33 153.7 40.01 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.848 ' HG ' HD21 ' A' ' 12' ' ' LEU . 73.4 mt -85.89 125.95 33.71 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.962 0.411 . . . . 0.0 110.764 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -78.56 -58.32 3.31 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.593 -178.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.545 ' HB2' ' HB3' ' A' ' 69' ' ' ARG . 35.9 mt-10 -89.02 39.13 0.92 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.94 0.4 . . . . 0.0 111.175 -179.119 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 61.92 10.9 28.42 Favored Glycine 0 N--CA 1.453 -0.225 0 CA-C-N 115.516 -0.765 . . . . 0.0 113.28 179.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.516 ' HA2' HD13 ' A' ' 64' ' ' LEU . . . 136.66 -14.6 3.89 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.415 -0.898 . . . . 0.0 112.705 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.545 ' HB3' ' HB2' ' A' ' 66' ' ' GLU . 0.6 OUTLIER -79.07 -22.15 45.71 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.415 0.626 . . . . 0.0 109.349 -179.669 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.9 ttmp? -144.91 137.43 26.22 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.014 -179.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.598 ' HB2' HD11 ' A' ' 90' ' ' LEU . 10.6 tt -104.69 127.58 52.5 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.571 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.4 p -117.73 131.93 56.54 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.048 0.451 . . . . 0.0 111.405 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.481 ' SG ' HD21 ' A' ' 48' ' ' LEU . 28.4 p -158.2 165.57 34.56 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.604 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 12.0 ttt-85 -106.33 101.65 36.24 Favored Pre-proline 0 C--N 1.316 -0.885 0 C-N-CA 120.173 -0.611 . . . . 0.0 109.941 179.067 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.672 ' O ' ' HB3' ' A' ' 83' ' ' ARG . 55.8 Cg_endo -70.45 141.37 42.25 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 122.567 2.178 . . . . 0.0 110.417 178.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.785 ' HE3' ' HA2' ' A' ' 81' ' ' GLY . 0.0 OUTLIER -121.66 143.62 49.23 Favored 'General case' 0 C--N 1.318 -0.8 0 O-C-N 123.567 0.542 . . . . 0.0 111.098 179.913 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.678 ' HB ' ' HD2' ' A' ' 83' ' ' ARG . 11.4 t -79.83 143.14 34.64 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 178.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 8.8 p -70.4 -12.36 16.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 O-C-N 124.184 0.927 . . . . 0.0 111.577 -179.04 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 -63.43 -23.14 67.28 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.283 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -173.08 -14.62 0.02 OUTLIER Glycine 0 C--O 1.228 -0.255 0 C-N-CA 120.312 -0.947 . . . . 0.0 113.163 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.785 ' HA2' ' HE3' ' A' ' 76' ' ' LYS . . . 98.76 20.97 17.47 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.549 -0.834 . . . . 0.0 111.849 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.678 ' O ' HG22 ' A' ' 77' ' ' THR . 24.9 p90 -110.91 149.5 30.54 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -179.133 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.688 ' HB2' ' HA ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 177.35 -143.15 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.763 -0.375 . . . . 0.0 111.896 -179.768 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -143.91 152.46 41.15 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.051 -178.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.604 ' HA ' ' HA ' ' A' ' 74' ' ' ARG . 31.6 ttt-85 -77.55 154.1 32.7 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 110.206 -0.294 . . . . 0.0 110.206 -179.68 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.793 HE22 ' HA ' ' A' ' 47' ' ' PHE . 8.1 tt0 -161.72 179.68 7.94 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 120.586 0.231 . . . . 0.0 110.587 -179.028 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.608 ' H ' ' HG2' ' A' ' 86' ' ' GLN . . . -145.51 148.56 20.37 Favored Glycine 0 N--CA 1.448 -0.545 0 N-CA-C 111.683 -0.567 . . . . 0.0 111.683 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.591 ' HB ' ' HB3' ' A' ' 48' ' ' LEU . 14.8 tt -126.18 137.84 56.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.199 0.523 . . . . 0.0 110.538 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.445 ' HB3' HD22 ' A' ' 91' ' ' ASN . 4.0 m-20 -77.4 128.3 34.02 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.872 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.665 HD13 HD11 ' A' ' 19' ' ' LEU . 44.7 mt -96.7 42.06 1.1 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.613 0.721 . . . . 0.0 110.746 -179.163 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.445 HD22 ' HB3' ' A' ' 89' ' ' ASP . 11.2 m-80 -78.86 3.2 17.56 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 115.053 -0.976 . . . . 0.0 111.041 -179.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 24.7 mtp180 -100.18 -3.98 30.52 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.677 178.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.427 HD11 ' HH2' ' A' ' 50' ' ' TRP . 22.1 mm -104.16 108.99 25.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 -179.377 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 26.6 tp60 -122.18 141.96 50.91 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.985 -178.242 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 17.0 p-10 -94.73 119.72 33.8 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.066 178.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 44.2 t -104.82 104.81 17.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.641 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 34.9 m-80 61.0 37.19 18.26 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 121.273 0.559 . . . . 0.0 110.651 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 91.05 -16.64 58.14 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.924 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 7.1 mpt_? -87.1 123.09 31.78 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.442 HD13 ' SG ' ' A' ' 23' ' ' CYS . 9.0 tp -81.6 114.9 20.61 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.684 -0.488 . . . . 0.0 109.684 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 39.5 t -128.7 143.11 42.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 120.933 0.397 . . . . 0.0 111.001 -178.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.549 ' HB2' HD11 ' A' ' 35' ' ' LEU . 6.7 t80 -81.47 136.05 35.64 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 178.36 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 . . . . . 0 C--O 1.245 0.85 0 CA-C-O 118.805 -0.617 . . . . 0.0 110.686 -179.976 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.04 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.581 ' OG ' ' HA ' ' A' ' 91' ' ' ASN . 5.5 m -119.66 -179.88 4.02 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.946 0.403 . . . . 0.0 111.45 -179.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.503 ' HA ' ' OD1' ' A' ' 95' ' ' ASN . 21.0 p90 -59.06 -33.92 71.34 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.857 178.388 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.491 ' HB3' ' HG2' ' A' ' 69' ' ' ARG . . . -56.34 -19.22 13.52 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 -178.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -69.43 -14.53 62.94 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 121.107 0.48 . . . . 0.0 110.808 179.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 14.9 p -149.5 33.7 0.71 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.655 0.741 . . . . 0.0 109.354 178.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 17.4 t -148.47 155.78 41.62 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.256 -0.884 . . . . 0.0 109.394 -179.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 1.5 ptp180 -148.74 170.24 18.63 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.76 -0.2 . . . . 0.0 110.858 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 62.56 44.6 6.79 Favored 'General case' 0 C--O 1.232 0.151 0 O-C-N 124.003 0.814 . . . . 0.0 111.18 178.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.413 ' HA ' ' HB2' ' A' ' 21' ' ' ALA . . . -80.33 126.34 31.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.88 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 35.5 m -126.77 172.62 13.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.552 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -105.94 114.88 29.3 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.68 -179.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 22.6 p -111.15 166.87 10.71 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.951 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.432 ' O ' ' HG2' ' A' ' 17' ' ' ARG . 83.9 m-20 56.83 42.28 26.78 Favored 'General case' 0 N--CA 1.461 0.108 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.604 -179.206 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 87.69 -41.03 3.07 Favored Glycine 0 CA--C 1.517 0.212 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.542 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 146.33 44.29 0.04 OUTLIER Glycine 0 N--CA 1.447 -0.617 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.432 ' HG2' ' O ' ' A' ' 14' ' ' ASN . 6.4 ptm180 -126.24 -26.18 3.4 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.894 0.378 . . . . 0.0 110.93 -179.191 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 3.7 m -107.08 135.97 47.73 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.971 -179.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.815 HD11 HD13 ' A' ' 90' ' ' LEU . 39.7 mt -94.62 115.87 28.08 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.209 178.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 78.0 ttt180 -112.98 119.04 36.53 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 178.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.432 ' O ' ' HA ' ' A' ' 32' ' ' THR . . . -154.08 166.78 31.98 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.728 0.299 . . . . 0.0 111.461 -179.139 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -90.99 106.64 18.66 Favored 'General case' 0 CA--C 1.513 -0.458 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 178.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.468 ' SG ' HD13 ' A' ' 100' ' ' LEU . 70.2 m -99.01 135.76 39.94 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 120.76 0.314 . . . . 0.0 110.765 -178.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.4 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 15.9 ttp180 -77.66 120.02 22.01 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.791 179.334 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.43 HD21 ' HB3' ' A' ' 29' ' ' ASN . 36.4 p30 -86.13 168.63 13.85 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.971 -0.291 . . . . 0.0 110.385 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -52.59 -36.28 55.78 Favored 'General case' 0 C--N 1.328 -0.369 0 O-C-N 123.837 0.71 . . . . 0.0 112.02 -179.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -67.45 -17.21 64.61 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.329 0.585 . . . . 0.0 111.041 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 92.6 34.98 6.68 Favored Glycine 0 N--CA 1.448 -0.528 0 N-CA-C 111.304 -0.718 . . . . 0.0 111.304 -179.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.43 ' HB3' HD21 ' A' ' 25' ' ' ASN . 9.9 t-20 -119.77 158.08 27.27 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 110.237 -0.283 . . . . 0.0 110.237 -178.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 77.0 m95 -95.1 116.53 28.83 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.241 179.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.5 m -122.78 129.53 75.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.361 179.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.432 ' HA ' ' O ' ' A' ' 21' ' ' ALA . 21.0 m -74.77 114.5 13.29 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.202 0.525 . . . . 0.0 110.26 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.55 ' HB3' ' HB2' ' A' ' 100' ' ' LEU . 58.5 m -114.95 149.41 37.34 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.909 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.641 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 26.3 mt-10 -132.65 130.85 40.69 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.881 -178.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.591 HD11 ' HB2' ' A' ' 102' ' ' PHE . 2.1 tm? -132.64 132.83 42.87 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.461 ' N ' HD13 ' A' ' 35' ' ' LEU . 14.6 m-20 -88.96 110.19 20.9 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 -179.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.505 HD11 ' HG ' ' A' ' 19' ' ' LEU . 2.6 mt -81.11 -18.29 47.01 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.095 -179.123 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.465 ' HA ' ' HD1' ' A' ' 55' ' ' PHE . 5.7 p-10 -65.05 -7.22 11.08 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.28 -179.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 58.1 p -80.73 -13.04 59.34 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.271 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.457 ' HG ' ' HZ ' ' A' ' 102' ' ' PHE . 18.8 t -139.96 -12.9 1.09 Allowed 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 112.138 0.422 . . . . 0.0 112.138 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 54.3 mt -97.55 135.46 31.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 O-C-N 121.814 -0.554 . . . . 0.0 110.057 179.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -142.15 144.64 14.44 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.731 -0.747 . . . . 0.0 111.743 179.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.503 ' OD1' ' HB2' ' A' ' 58' ' ' SER . 27.8 p30 -152.95 48.37 0.43 Allowed Pre-proline 0 CA--C 1.539 0.542 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 -179.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -76.78 -16.46 16.4 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 121.697 1.598 . . . . 0.0 112.339 -178.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -96.19 2.71 53.26 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.921 -179.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.604 ' CA ' ' HG2' ' A' ' 83' ' ' ARG . . . 92.48 5.58 65.02 Favored Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.295 -0.955 . . . . 0.0 112.26 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.451 ' HD1' ' NE2' ' A' ' 86' ' ' GLN . 31.9 m-85 -125.85 134.49 51.62 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.899 0.38 . . . . 0.0 110.497 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.467 HD23 HG22 ' A' ' 88' ' ' ILE . 9.5 mp -85.04 158.51 20.44 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.58 -0.737 . . . . 0.0 111.653 -178.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 159.55 167.26 19.94 Favored Glycine 0 N--CA 1.443 -0.864 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.95 178.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.451 ' CD1' HD11 ' A' ' 88' ' ' ILE . 85.2 m95 -95.33 125.12 39.73 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 166.29 -43.01 0.27 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.87 -179.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 8.4 ttp -107.86 -156.94 0.6 Allowed 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.4 pt20 -146.83 173.92 11.95 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 121.091 -0.244 . . . . 0.0 110.899 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 63.03 45.43 5.28 Favored 'General case' 0 N--CA 1.465 0.285 0 O-C-N 123.663 0.602 . . . . 0.0 112.351 178.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.465 ' HD1' ' HA ' ' A' ' 38' ' ' ASP . 10.1 p90 -71.63 -28.79 64.02 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.978 -0.289 . . . . 0.0 110.76 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.45 ' HA ' HD11 ' A' ' 62' ' ' ILE . 35.0 p -61.39 -37.61 84.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.079 0.466 . . . . 0.0 110.917 -179.333 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 27.2 m80 -81.06 -3.46 51.97 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.106 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.503 ' HB2' ' OD1' ' A' ' 43' ' ' ASN . 12.2 m -119.13 12.68 12.74 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.396 -179.436 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 22.0 p -145.88 155.3 42.79 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 120.995 0.426 . . . . 0.0 111.459 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -116.35 148.05 40.99 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.872 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.405 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 28.1 t70 54.0 78.44 0.16 Allowed 'General case' 0 N--CA 1.467 0.401 0 O-C-N 123.921 0.763 . . . . 0.0 111.168 -179.614 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.586 ' HA ' ' HB3' ' A' ' 73' ' ' CYS . 67.0 mt -97.04 117.64 42.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.784 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -148.03 153.78 39.41 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.825 0.345 . . . . 0.0 110.626 -179.159 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.432 HD22 ' HA2' ' A' ' 68' ' ' GLY . 43.0 mt -83.07 133.14 35.08 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.24 0.543 . . . . 0.0 111.041 -179.173 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.439 ' OE2' ' HD3' ' A' ' 70' ' ' LYS . 35.4 tt0 -86.8 -61.44 1.73 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.68 -178.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.595 ' HB2' ' HB2' ' A' ' 69' ' ' ARG . 19.1 mt-10 -84.71 34.9 0.54 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.806 0.336 . . . . 0.0 111.42 -178.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 65.04 13.15 57.03 Favored Glycine 0 N--CA 1.452 -0.252 0 CA-C-N 115.972 -0.558 . . . . 0.0 113.504 179.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.432 ' HA2' HD22 ' A' ' 64' ' ' LEU . . . 140.26 -24.76 2.66 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.147 -1.025 . . . . 0.0 113.072 179.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.595 ' HB2' ' HB2' ' A' ' 66' ' ' GLU . 3.8 mmt85 -74.08 -21.34 59.95 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.967 0.413 . . . . 0.0 110.943 -179.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.591 ' HB3' ' HG3' ' A' ' 66' ' ' GLU . 81.9 tttt -146.17 143.05 29.03 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.743 -178.509 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.685 ' HB2' HD11 ' A' ' 90' ' ' LEU . 10.2 tt -113.19 135.32 53.94 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.013 -0.539 . . . . 0.0 109.617 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 8.9 p -127.16 139.13 53.17 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.018 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.586 ' HB3' ' HA ' ' A' ' 62' ' ' ILE . 26.4 p -162.54 172.0 16.14 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.269 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.664 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 75.1 ttt180 -108.86 98.87 31.88 Favored Pre-proline 0 C--N 1.321 -0.664 0 C-N-CA 120.562 -0.455 . . . . 0.0 110.349 178.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.689 ' O ' ' HB3' ' A' ' 83' ' ' ARG . 41.4 Cg_endo -66.74 128.4 18.88 Favored 'Trans proline' 0 N--CA 1.459 -0.5 0 C-N-CA 122.847 2.365 . . . . 0.0 110.828 179.302 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.763 ' HA ' ' HB2' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -120.78 141.57 50.38 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.349 -179.268 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.699 HG22 ' O ' ' A' ' 82' ' ' PHE . 9.5 t -70.86 131.47 43.82 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 178.402 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.7 m -70.55 -6.84 7.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 123.818 0.699 . . . . 0.0 112.069 -178.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -69.29 -33.91 73.9 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.956 0.408 . . . . 0.0 110.313 179.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.431 ' HA3' ' CE1' ' A' ' 82' ' ' PHE . . . -143.98 -25.45 0.14 Allowed Glycine 0 N--CA 1.453 -0.187 0 C-N-CA 120.557 -0.83 . . . . 0.0 112.7 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 100.66 17.62 23.15 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 121.02 -0.609 . . . . 0.0 112.133 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.699 ' O ' HG22 ' A' ' 77' ' ' THR . 24.7 p90 -111.8 153.11 27.05 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 118.763 -0.637 . . . . 0.0 109.878 -178.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.763 ' HB2' ' HA ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 167.04 -154.88 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.582 0 O-C-N 123.697 0.623 . . . . 0.0 111.364 179.4 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -123.44 170.84 9.96 Favored 'General case' 0 C--O 1.223 -0.304 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.265 -178.023 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.664 ' HA ' ' HA ' ' A' ' 74' ' ' ARG . 30.1 ttt85 -96.81 157.97 15.65 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.246 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.455 ' HG2' ' H ' ' A' ' 87' ' ' GLY . 6.4 tt0 -158.91 179.57 8.96 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.072 0.463 . . . . 0.0 111.58 -179.243 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.455 ' H ' ' HG2' ' A' ' 86' ' ' GLN . . . -144.54 143.82 12.53 Favored Glycine 0 N--CA 1.45 -0.426 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.612 179.22 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.467 HG22 HD23 ' A' ' 48' ' ' LEU . 13.9 tt -130.29 140.85 47.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.825 0.345 . . . . 0.0 110.556 -179.374 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.467 ' HB3' HD22 ' A' ' 91' ' ' ASN . 6.9 m-20 -80.15 137.4 36.7 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.815 HD13 HD11 ' A' ' 19' ' ' LEU . 64.2 mt -104.71 41.28 1.35 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.292 0.568 . . . . 0.0 111.382 -179.285 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.581 ' HA ' ' OG ' ' A' ' 2' ' ' SER . 21.3 m-80 -76.0 3.31 10.55 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.976 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.407 HH11 ' HD2' ' A' ' 92' ' ' ARG . 8.4 mtp180 -96.7 -11.19 25.44 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.562 178.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.492 HG13 HD22 ' A' ' 37' ' ' LEU . 21.7 mm -98.38 95.91 4.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 21.6 tp60 -106.15 139.54 40.5 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.201 -177.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.503 ' OD1' ' HA ' ' A' ' 3' ' ' TYR . 16.8 p-10 -94.67 116.35 28.65 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.596 178.314 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.7 p -114.13 123.57 69.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 116.185 -0.461 . . . . 0.0 109.938 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 62.57 20.11 11.75 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.956 -179.156 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 95.84 -9.59 68.36 Favored Glycine 0 N--CA 1.446 -0.657 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.759 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.446 ' O ' ' HA ' ' A' ' 95' ' ' ASN . 0.0 OUTLIER -96.1 144.41 26.38 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-N 117.257 0.529 . . . . 0.0 110.826 -178.944 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.55 ' HB2' ' HB3' ' A' ' 33' ' ' SER . 5.3 tp -89.55 116.38 27.66 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.145 -0.48 . . . . 0.0 109.796 -179.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 46.8 t -131.12 141.85 45.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.422 -179.353 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.591 ' HB2' HD11 ' A' ' 35' ' ' LEU . 22.8 t80 -80.27 128.68 33.82 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 179.153 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.163 -0.922 . . . . 0.0 110.864 -179.347 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.478 0.953 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.623 ' HB3' ' HA ' ' A' ' 91' ' ' ASN . 1.0 OUTLIER -117.22 178.87 4.21 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.464 179.058 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.619 ' HA ' ' OD1' ' A' ' 95' ' ' ASN . 8.3 p90 -58.22 -41.41 84.02 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.772 -0.195 . . . . 0.0 111.399 -179.429 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -60.18 -19.37 53.78 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.849 -178.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -68.29 -21.81 64.76 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.146 0.498 . . . . 0.0 110.429 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.405 ' HB2' HD21 ' A' ' 95' ' ' ASN . 51.1 m -138.85 34.88 2.17 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.671 179.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.433 ' HA ' ' HZ3' ' A' ' 30' ' ' TRP . 92.8 p -149.96 167.67 26.02 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.182 179.258 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 16.0 ptm180 -149.9 169.11 21.9 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.648 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 60.4 52.87 4.52 Favored 'General case' 0 N--CA 1.465 0.296 0 O-C-N 123.646 0.591 . . . . 0.0 110.692 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -90.12 119.96 30.89 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.209 -179.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 35.3 m -122.49 170.71 12.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.165 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.707 HD21 ' HG ' ' A' ' 64' ' ' LEU . 3.4 mm? -104.81 116.29 31.76 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 -179.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.456 ' OG1' ' HB ' ' A' ' 18' ' ' THR . 29.4 p -110.7 167.62 10.09 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.072 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 56.95 55.62 5.99 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.93 179.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 82.24 -37.97 2.58 Favored Glycine 0 N--CA 1.453 -0.206 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.337 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.602 ' HA2' ' HB3' ' A' ' 12' ' ' LEU . . . 137.29 36.57 0.17 Allowed Glycine 0 N--CA 1.445 -0.757 0 N-CA-C 111.381 -0.688 . . . . 0.0 111.381 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.534 ' HB2' ' HB3' ' A' ' 38' ' ' ASP . 34.5 ptt85 -120.46 -23.11 6.22 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.93 0.395 . . . . 0.0 110.71 -179.222 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.456 ' HB ' ' OG1' ' A' ' 13' ' ' THR . 4.6 m -103.33 134.7 46.27 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.841 -179.258 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.65 ' O ' ' HA ' ' A' ' 34' ' ' GLU . 68.8 mt -95.26 116.18 28.41 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.395 179.19 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 39.0 ttt-85 -111.01 120.18 41.52 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 178.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -153.58 166.63 32.16 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.845 0.355 . . . . 0.0 111.488 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.468 ' HB3' ' HB3' ' A' ' 30' ' ' TRP . 49.8 mt-10 -89.9 105.68 17.97 Favored 'General case' 0 CA--C 1.512 -0.49 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 178.117 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.561 ' SG ' HD13 ' A' ' 100' ' ' LEU . 58.7 m -92.72 128.74 38.69 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.134 -177.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.434 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 11.0 ttp180 -77.79 116.46 18.33 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.34 179.034 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.439 HD21 ' HB3' ' A' ' 29' ' ' ASN . 35.2 p30 -84.96 170.92 12.56 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.231 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -51.29 -31.41 21.28 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -179.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -73.88 -11.58 60.41 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.621 0.724 . . . . 0.0 110.601 -179.183 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 85.79 25.02 39.64 Favored Glycine 0 N--CA 1.447 -0.633 0 N-CA-C 110.629 -0.988 . . . . 0.0 110.629 -179.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.439 ' HB3' HD21 ' A' ' 25' ' ' ASN . 8.8 t-20 -104.73 156.12 18.27 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.459 -0.371 . . . . 0.0 110.243 -178.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.468 ' HB3' ' HB3' ' A' ' 22' ' ' GLU . 90.7 m95 -97.6 116.02 29.01 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.775 -179.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.3 m -118.64 128.32 75.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.349 178.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 19.7 m -74.48 109.35 7.89 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.362 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.44 ' HB3' ' HB2' ' A' ' 100' ' ' LEU . 69.3 m -122.12 147.66 45.86 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.445 -179.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.65 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 50.7 mt-10 -128.79 142.84 50.85 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.012 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.722 HD11 ' HB2' ' A' ' 102' ' ' PHE . 2.1 tm? -135.49 132.45 37.36 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.463 ' N ' HD13 ' A' ' 35' ' ' LEU . 16.2 m-20 -89.59 110.36 21.23 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.542 HD13 HD22 ' A' ' 90' ' ' LEU . 2.9 mt -82.25 -20.76 36.96 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.68 -178.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.534 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 5.1 p-10 -66.9 -5.2 11.58 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 121.008 -0.277 . . . . 0.0 111.272 -178.501 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 37.5 p -73.52 -28.12 61.72 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.055 0.455 . . . . 0.0 110.261 178.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 17.0 t -126.48 -4.39 6.62 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.909 -179.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.403 HD13 HD13 ' A' ' 88' ' ' ILE . 57.8 mt -104.7 134.65 45.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 O-C-N 121.718 -0.613 . . . . 0.0 110.655 179.145 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.503 ' HA3' ' HB3' ' A' ' 52' ' ' MET . . . -149.98 158.85 27.85 Favored Glycine 0 N--CA 1.449 -0.456 0 N-CA-C 111.463 -0.655 . . . . 0.0 111.463 179.51 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.672 ' OD1' ' HB2' ' A' ' 55' ' ' PHE . 1.7 p-10 -163.64 56.37 0.54 Allowed Pre-proline 0 CA--C 1.538 0.484 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -66.64 -25.52 46.95 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.134 1.889 . . . . 0.0 112.068 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -96.54 3.94 52.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.03 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.641 ' HA2' ' HB2' ' A' ' 75' ' ' PRO . . . 89.9 11.99 62.76 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.305 -0.95 . . . . 0.0 113.288 179.453 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.534 ' HA ' HE22 ' A' ' 86' ' ' GLN . 27.1 m-85 -118.38 123.48 45.37 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 120.929 0.395 . . . . 0.0 109.987 179.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.535 HD21 ' SG ' ' A' ' 73' ' ' CYS . 8.0 mp -83.56 137.51 33.81 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.734 -178.427 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -179.97 172.62 44.18 Favored Glycine 0 N--CA 1.437 -1.254 0 C-N-CA 120.748 -0.739 . . . . 0.0 111.422 178.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.43 ' CD2' ' HD3' ' A' ' 92' ' ' ARG . 91.2 m95 -95.05 125.03 39.43 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 -179.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 165.05 -55.25 0.27 Allowed Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.991 -179.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.503 ' HB3' ' HA3' ' A' ' 42' ' ' GLY . 5.6 ttt -91.69 -158.07 0.55 Allowed 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.825 0.312 . . . . 0.0 110.226 -179.176 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -148.57 167.64 24.89 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 120.788 0.328 . . . . 0.0 111.466 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 23.8 m-80 63.6 48.61 3.31 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.303 -0.862 . . . . 0.0 112.82 178.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.672 ' HB2' ' OD1' ' A' ' 43' ' ' ASN . 8.8 p90 -69.73 -27.94 65.38 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.856 0.36 . . . . 0.0 110.423 179.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.453 ' HB2' ' HB3' ' A' ' 17' ' ' ARG . 21.7 t -61.26 -33.1 72.98 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.156 -179.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 24.3 m80 -78.37 -3.51 43.51 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.918 -179.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 40.0 m -133.94 24.56 3.94 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.956 0.408 . . . . 0.0 110.942 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 22.1 m -139.55 147.75 41.63 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.136 0.493 . . . . 0.0 111.465 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -123.06 151.5 41.91 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.59 179.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.452 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 28.2 t70 54.01 73.81 0.36 Allowed 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.356 0.598 . . . . 0.0 111.245 179.313 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.472 HG23 HD21 ' A' ' 71' ' ' LEU . 56.3 mt -98.48 116.13 40.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.887 -179.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.2 tptt -144.45 149.84 36.66 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.258 -179.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.707 ' HG ' HD21 ' A' ' 12' ' ' LEU . 65.0 mt -83.67 130.83 34.97 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 179.417 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 16.2 tp10 -83.13 -58.01 3.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.259 -178.134 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.514 ' HB2' ' HB3' ' A' ' 69' ' ' ARG . 7.2 mm-40 -85.59 23.14 1.43 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.158 0.504 . . . . 0.0 111.21 -179.046 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 76.49 3.38 77.8 Favored Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 115.487 -0.778 . . . . 0.0 112.963 179.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.451 ' HA2' HD22 ' A' ' 64' ' ' LEU . . . 147.62 -22.5 1.5 Allowed Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.671 -0.776 . . . . 0.0 111.997 -179.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.514 ' HB3' ' HB2' ' A' ' 66' ' ' GLU . 2.8 tpp180 -74.01 -12.53 60.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.267 0.556 . . . . 0.0 110.048 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 48.5 tttp -160.14 142.41 13.13 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.269 -178.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.649 ' HB2' HD11 ' A' ' 90' ' ' LEU . 10.3 tt -112.39 139.02 48.3 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.5 p -127.77 134.83 49.51 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.748 179.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.535 ' SG ' HD21 ' A' ' 48' ' ' LEU . 25.7 p -158.39 175.83 13.22 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.021 0.439 . . . . 0.0 110.259 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.589 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 2.8 tmt_? -110.92 98.79 39.99 Favored Pre-proline 0 C--N 1.316 -0.881 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 178.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.65 ' O ' ' HB3' ' A' ' 83' ' ' ARG . 61.2 Cg_endo -71.18 124.98 10.96 Favored 'Trans proline' 0 CA--C 1.512 -0.604 0 C-N-CA 123.301 2.667 . . . . 0.0 111.468 179.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.691 ' HA ' ' HB2' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -120.63 138.47 53.9 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.942 179.56 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.715 HG22 ' O ' ' A' ' 82' ' ' PHE . 14.8 t -72.62 132.66 44.04 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.364 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.7 p -74.87 -10.0 13.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.84 -179.087 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -67.44 -29.51 69.0 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.233 179.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.596 ' HA3' ' CE2' ' A' ' 82' ' ' PHE . . . -146.49 -23.33 0.1 Allowed Glycine 0 C--O 1.228 -0.232 0 C-N-CA 120.342 -0.932 . . . . 0.0 113.676 -179.202 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.68 ' HA2' ' HE3' ' A' ' 76' ' ' LYS . . . 97.76 12.11 48.18 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.302 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.715 ' O ' HG22 ' A' ' 77' ' ' THR . 29.6 p90 -111.91 158.64 19.23 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 118.419 -0.8 . . . . 0.0 109.793 -178.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.691 ' HB2' ' HA ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 162.62 -158.94 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.588 0 O-C-N 123.956 0.785 . . . . 0.0 111.731 179.514 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -120.02 -171.09 2.08 Favored 'General case' 0 C--O 1.225 -0.189 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.625 -178.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.589 ' HA ' ' HA ' ' A' ' 74' ' ' ARG . 30.6 ttt180 -109.58 155.6 21.22 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 177.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.534 HE22 ' HA ' ' A' ' 47' ' ' PHE . 9.2 tt0 -169.1 162.06 10.69 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 120.407 -0.517 . . . . 0.0 112.265 -179.085 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -123.74 157.19 18.12 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 121.221 -0.514 . . . . 0.0 112.062 179.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.474 ' HB ' ' HB3' ' A' ' 48' ' ' LEU . 15.1 tt -131.43 143.82 39.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.027 0.441 . . . . 0.0 110.246 179.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.525 ' OD1' ' HB2' ' A' ' 91' ' ' ASN . 17.3 t70 -82.74 131.89 35.19 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.265 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.649 HD13 HD11 ' A' ' 19' ' ' LEU . 56.1 mt -105.34 34.15 3.37 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 112.943 0.719 . . . . 0.0 112.943 -177.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.623 ' HA ' ' HB3' ' A' ' 2' ' ' SER . 10.8 m-80 -74.72 3.69 7.53 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 121.096 0.474 . . . . 0.0 111.464 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.43 ' HD3' ' CD2' ' A' ' 50' ' ' TRP . 32.3 mtp180 -92.86 -11.14 34.3 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.493 178.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.509 HG13 HD22 ' A' ' 37' ' ' LEU . 19.9 mm -99.59 106.46 19.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -179.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 19.9 tp60 -117.4 140.24 49.83 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.085 0.469 . . . . 0.0 111.269 -178.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.619 ' OD1' ' HA ' ' A' ' 3' ' ' TYR . 16.5 p-10 -95.14 101.28 13.02 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.399 0.619 . . . . 0.0 109.808 177.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.2 p -91.42 114.39 28.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 121.439 0.638 . . . . 0.0 110.424 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 61.24 29.75 18.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.57 -179.61 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 91.08 -10.82 73.96 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.038 -179.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.417 ' N ' ' HD2' ' A' ' 99' ' ' ARG . 9.6 mpt_? -92.11 123.54 35.54 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.684 0.278 . . . . 0.0 110.327 -179.33 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.561 HD13 ' SG ' ' A' ' 23' ' ' CYS . 5.5 tp -78.71 114.56 17.74 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 -179.537 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 53.4 t -132.14 140.98 46.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.189 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.722 ' HB2' HD11 ' A' ' 35' ' ' LEU . 8.3 t80 -83.06 133.75 35.06 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.137 179.327 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 . . . . . 0 C--O 1.248 1.008 0 CA-C-O 118.764 -0.636 . . . . 0.0 109.956 179.994 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.2 mpp? . . . . . 0 N--CA 1.483 1.217 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.683 ' OG ' ' HA ' ' A' ' 91' ' ' ASN . 12.3 m -117.21 179.22 4.1 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.616 -0.265 . . . . 0.0 110.903 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.424 ' CZ ' HD13 ' A' ' 19' ' ' LEU . 22.8 p90 -58.21 -36.92 73.84 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.257 179.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -56.68 -21.04 24.76 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -178.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -73.55 -9.74 58.99 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 120.991 0.424 . . . . 0.0 111.006 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 51.0 m -148.07 29.23 0.9 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.317 0.58 . . . . 0.0 109.529 178.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 36.7 m -143.29 164.48 30.1 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.576 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 2.3 ptm180 -148.57 165.97 29.66 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.327 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 57.83 57.29 4.26 Favored 'General case' 0 N--CA 1.462 0.174 0 O-C-N 123.647 0.592 . . . . 0.0 111.46 178.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.421 ' HA ' ' HB2' ' A' ' 21' ' ' ALA . . . -88.93 125.91 35.17 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.934 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 23.0 m -129.05 174.19 12.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.4 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.671 HD21 ' HG ' ' A' ' 64' ' ' LEU . 3.5 mm? -106.0 114.42 28.55 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.945 -179.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 28.3 p -111.54 171.24 7.6 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.126 -179.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 56.67 40.27 29.33 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.608 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 90.02 -20.43 36.39 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.677 179.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.629 ' HA2' ' HB3' ' A' ' 12' ' ' LEU . . . 121.73 34.92 0.82 Allowed Glycine 0 N--CA 1.443 -0.84 0 C-N-CA 120.926 -0.654 . . . . 0.0 111.727 -179.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.563 ' HB2' ' HB3' ' A' ' 38' ' ' ASP . 11.9 ptt180 -124.34 -15.41 6.7 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.218 0.533 . . . . 0.0 110.477 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.428 ' CG2' ' HB3' ' A' ' 34' ' ' GLU . 11.4 m -114.18 138.67 50.15 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.231 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.698 HD11 HD13 ' A' ' 90' ' ' LEU . 56.8 mt -95.17 113.71 25.43 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.93 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.516 ' HD3' HG23 ' A' ' 32' ' ' THR . 4.5 tmm_? -107.94 119.46 39.53 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 178.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.421 ' HB2' ' HA ' ' A' ' 10' ' ' ALA . . . -153.71 167.23 30.31 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.95 0.405 . . . . 0.0 111.401 -179.158 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -89.52 105.96 18.14 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 178.064 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.529 ' SG ' HD13 ' A' ' 100' ' ' LEU . 22.5 m -96.82 133.27 41.63 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.565 -0.288 . . . . 0.0 110.584 -177.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 16.7 ttp180 -76.4 116.63 17.27 Favored 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 179.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.403 HD21 ' HB3' ' A' ' 29' ' ' ASN . 36.1 p30 -81.75 165.01 21.31 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 179.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.14 -15.68 15.76 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -177.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -87.49 -6.22 58.47 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.745 0.783 . . . . 0.0 109.974 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 83.41 37.76 11.82 Favored Glycine 0 N--CA 1.448 -0.561 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.677 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.403 ' HB3' HD21 ' A' ' 25' ' ' ASN . 9.8 t-20 -124.5 161.25 26.51 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 110.353 -0.24 . . . . 0.0 110.353 -179.329 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 72.8 m95 -98.56 120.87 39.72 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.72 179.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.6 m -124.67 134.87 65.68 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.979 179.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.516 HG23 ' HD3' ' A' ' 20' ' ' ARG . 46.1 m -75.76 109.38 9.31 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.756 179.066 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 55.4 m -122.83 153.51 39.48 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.755 -179.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.638 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 44.0 mt-10 -135.52 139.17 43.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.117 -179.483 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.701 HD11 ' HB2' ' A' ' 102' ' ' PHE . 2.5 tm? -131.71 131.95 43.5 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 179.049 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.478 ' O ' HG22 ' A' ' 39' ' ' THR . 38.8 m-20 -84.8 110.52 18.87 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.973 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.603 HD13 HD22 ' A' ' 90' ' ' LEU . 5.2 mt -81.2 -27.44 35.32 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.663 0.268 . . . . 0.0 111.385 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.563 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 4.6 p-10 -65.65 -5.79 9.42 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.292 0.479 . . . . 0.0 112.292 -177.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.478 HG22 ' O ' ' A' ' 36' ' ' ASP . 14.0 t -78.75 -10.15 59.67 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 110.274 -0.269 . . . . 0.0 110.274 178.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 40.2 t -141.53 3.84 1.72 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.463 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.407 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 56.9 mt -113.88 132.58 62.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 O-C-N 121.95 -0.468 . . . . 0.0 110.621 179.327 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.486 ' HA3' ' HB3' ' A' ' 52' ' ' MET . . . -146.47 155.48 26.55 Favored Glycine 0 N--CA 1.447 -0.568 0 N-CA-C 111.408 -0.677 . . . . 0.0 111.408 179.278 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.437 ' OD1' ' HB2' ' A' ' 55' ' ' PHE . 4.3 p-10 -153.3 45.16 0.27 Allowed Pre-proline 0 CA--C 1.541 0.626 0 N-CA-C 113.515 0.932 . . . . 0.0 113.515 -179.046 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.437 ' HG3' ' SD ' ' A' ' 52' ' ' MET . 57.5 Cg_endo -68.96 -20.38 38.77 Favored 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 121.522 1.481 . . . . 0.0 111.315 -179.535 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -81.07 -16.46 53.11 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.814 179.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 103.44 6.11 44.87 Favored Glycine 0 N--CA 1.443 -0.835 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.7 -178.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.428 ' HD1' HE22 ' A' ' 86' ' ' GLN . 67.4 m-85 -122.26 135.04 54.68 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.826 0.346 . . . . 0.0 110.389 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.623 HD12 ' HG3' ' A' ' 86' ' ' GLN . 94.2 mt -83.53 130.96 35.02 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.8 -178.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -174.64 172.47 45.44 Favored Glycine 0 N--CA 1.441 -0.98 0 C-N-CA 120.699 -0.762 . . . . 0.0 111.807 179.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.478 ' HH2' HD11 ' A' ' 93' ' ' ILE . 81.5 m95 -94.36 125.93 39.3 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 179.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 170.66 -58.33 0.18 Allowed Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.516 -179.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.486 ' HB3' ' HA3' ' A' ' 42' ' ' GLY . 11.0 ttp -95.0 -153.12 0.38 Allowed 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -146.54 170.5 16.77 Favored 'General case' 0 C--N 1.33 -0.25 0 O-C-N 122.184 -0.322 . . . . 0.0 111.336 -179.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 62.29 41.84 9.91 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 113.153 0.797 . . . . 0.0 113.153 178.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.437 ' HB2' ' OD1' ' A' ' 43' ' ' ASN . 8.8 p90 -63.23 -26.77 68.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.13 0.49 . . . . 0.0 110.464 179.113 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.556 ' HB2' ' HB3' ' A' ' 17' ' ' ARG . 32.3 t -62.69 -32.6 73.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.499 -179.253 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 30.0 m80 -82.61 -4.07 57.13 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.846 0.355 . . . . 0.0 111.084 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 24.1 m -125.36 16.13 8.31 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.484 179.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 65.1 m -137.58 149.17 46.48 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.133 0.492 . . . . 0.0 111.041 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -128.95 158.12 39.7 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.469 179.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.522 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 36.5 t70 57.22 67.69 0.95 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.477 0.656 . . . . 0.0 110.405 179.226 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.536 HG23 HD21 ' A' ' 71' ' ' LEU . 71.6 mt -95.21 114.06 30.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.147 -178.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.8 tptm -145.33 143.91 30.42 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.317 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.671 ' HG ' HD21 ' A' ' 12' ' ' LEU . 79.2 mt -82.3 120.82 25.89 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.803 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -72.71 -56.35 5.41 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.778 -179.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.46 ' HB2' ' HB2' ' A' ' 69' ' ' ARG . 29.4 mt-10 -82.72 4.22 25.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.954 0.407 . . . . 0.0 110.64 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 81.19 13.78 80.19 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.293 -179.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.43 ' HA2' HD13 ' A' ' 64' ' ' LEU . . . 155.34 -31.51 0.64 Allowed Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 119.916 -1.135 . . . . 0.0 113.299 179.377 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.547 ' HD3' ' HB2' ' A' ' 2' ' ' SER . 7.2 mmt85 -78.11 -33.15 50.72 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.022 0.439 . . . . 0.0 111.647 -179.47 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 28.6 tptt -131.65 135.23 46.75 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.437 -178.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.715 ' HB2' HD11 ' A' ' 90' ' ' LEU . 10.0 tt -110.68 124.5 52.05 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -112.2 128.14 56.15 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 120.972 0.415 . . . . 0.0 111.143 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.522 ' HA ' ' O ' ' A' ' 61' ' ' ASP . 24.5 p -155.0 166.21 34.29 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 179.53 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.545 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 29.3 ttt180 -101.29 100.61 14.0 Favored Pre-proline 0 C--N 1.314 -0.946 0 CA-C-O 120.797 0.332 . . . . 0.0 110.556 179.56 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.644 ' O ' ' HB3' ' A' ' 83' ' ' ARG . 46.0 Cg_endo -69.7 120.88 7.6 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 122.48 2.12 . . . . 0.0 109.897 178.159 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.999 ' HE3' ' HA2' ' A' ' 81' ' ' GLY . 0.0 OUTLIER -115.7 143.69 45.01 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.008 0.433 . . . . 0.0 110.884 -179.348 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.661 HG22 ' O ' ' A' ' 82' ' ' PHE . 13.1 t -78.49 142.0 37.79 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 179.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 28.9 m -70.59 -8.56 11.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 O-C-N 124.046 0.841 . . . . 0.0 112.002 -179.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -59.67 -35.11 73.8 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.046 0.45 . . . . 0.0 110.173 179.15 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.409 ' H ' ' H ' ' A' ' 81' ' ' GLY . . . -164.52 -13.08 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.56 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.611 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.999 ' HA2' ' HE3' ' A' ' 76' ' ' LYS . . . 99.73 23.0 11.29 Favored Glycine 0 N--CA 1.442 -0.961 0 C-N-CA 120.484 -0.865 . . . . 0.0 112.064 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.661 ' O ' HG22 ' A' ' 77' ' ' THR . 30.5 p90 -110.47 144.85 38.66 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 -178.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.659 ' HB2' ' HA ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 172.34 -151.82 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 O-C-N 123.645 0.591 . . . . 0.0 110.724 -179.676 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 23.9 mm-40 -122.41 176.56 5.82 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.09 -177.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.545 ' HA ' ' HA ' ' A' ' 74' ' ' ARG . 39.2 ttt-85 -112.74 151.01 30.77 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 177.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.623 ' HG3' HD12 ' A' ' 48' ' ' LEU . 10.4 pt20 -166.52 -172.37 2.16 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.86 0.362 . . . . 0.0 111.472 -179.263 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -135.22 152.48 20.84 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.462 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.4 HD13 HD13 ' A' ' 41' ' ' ILE . 13.4 tt -122.81 149.94 26.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -86.61 124.79 33.29 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.77 0.319 . . . . 0.0 111.104 -179.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.715 HD11 ' HB2' ' A' ' 71' ' ' LEU . 44.3 mt -97.88 34.43 1.9 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.644 0.735 . . . . 0.0 110.134 179.254 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.683 ' HA ' ' OG ' ' A' ' 2' ' ' SER . 0.9 OUTLIER -75.17 2.03 11.87 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 114.806 -1.088 . . . . 0.0 110.704 -179.726 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 18.8 mtp180 -98.52 1.21 46.37 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.256 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.507 HD12 HD12 ' A' ' 35' ' ' LEU . 22.1 mm -105.65 112.96 41.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.144 0.497 . . . . 0.0 109.885 -179.228 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 5.1 mm-40 -117.69 145.56 44.33 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.996 -178.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -97.41 102.32 14.06 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.548 178.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 46.7 t -92.13 106.56 17.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.835 -178.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 61.08 25.29 15.32 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.161 179.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 106.0 -23.4 29.28 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.533 -0.842 . . . . 0.0 112.751 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.12 132.49 34.3 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.902 0.351 . . . . 0.0 110.062 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.529 HD13 ' SG ' ' A' ' 23' ' ' CYS . 7.9 tp -82.54 114.69 21.12 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 -179.474 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 5.5 t -125.93 146.41 31.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 120.937 0.399 . . . . 0.0 111.155 -178.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.701 ' HB2' HD11 ' A' ' 35' ' ' LEU . 18.6 t80 -79.8 138.22 37.18 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 178.314 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 . . . . . 0 C--N 1.316 -0.852 0 CA-C-O 118.81 -0.614 . . . . 0.0 110.427 -179.198 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 mpt? . . . . . 0 N--CA 1.482 1.13 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.549 ' HB3' ' HA ' ' A' ' 91' ' ' ASN . 0.5 OUTLIER -103.81 178.41 4.57 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.563 -0.289 . . . . 0.0 111.548 179.676 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.51 ' HA ' ' OD1' ' A' ' 95' ' ' ASN . 11.8 p90 -48.73 -36.65 16.81 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -179.348 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.479 ' HB3' ' HD3' ' A' ' 69' ' ' ARG . . . -54.9 -19.32 6.37 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 -178.253 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -57.9 -39.19 77.3 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.237 0.541 . . . . 0.0 110.262 178.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.41 ' HB2' HD21 ' A' ' 95' ' ' ASN . 24.4 m -129.55 39.51 3.72 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.536 -0.757 . . . . 0.0 109.479 179.285 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.424 ' HB3' ' HA ' ' A' ' 4' ' ' ALA . 8.6 t -141.27 149.71 41.66 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.864 -179.603 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.407 HH11 ' HD2' ' A' ' 8' ' ' ARG . 10.6 ptm85 -138.16 158.55 44.08 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.633 -179.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 62.47 52.81 2.86 Favored 'General case' 0 N--CA 1.463 0.207 0 O-C-N 123.914 0.759 . . . . 0.0 111.374 179.035 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.507 ' HA ' ' HB2' ' A' ' 21' ' ' ALA . . . -82.25 117.58 22.46 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.239 179.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 36.0 m -124.18 169.17 15.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.05 -179.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.524 HD21 ' HG ' ' A' ' 64' ' ' LEU . 3.1 mm? -104.85 120.5 41.56 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.99 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 23.3 p -114.48 167.12 11.01 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 120.862 0.363 . . . . 0.0 111.277 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 64.03 31.4 13.59 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.402 179.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 92.36 -21.78 36.13 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.855 -0.688 . . . . 0.0 113.106 179.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.413 ' HA2' ' HB3' ' A' ' 12' ' ' LEU . . . 129.27 56.22 0.1 Allowed Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.775 -0.726 . . . . 0.0 111.407 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.411 ' HB3' ' OG ' ' A' ' 56' ' ' SER . 2.4 ptm180 -143.13 -32.25 0.47 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.983 0.42 . . . . 0.0 111.077 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.437 ' CG2' ' HB3' ' A' ' 34' ' ' GLU . 2.8 m -103.11 135.25 45.14 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.952 -179.553 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.654 HD11 HD13 ' A' ' 90' ' ' LEU . 62.5 mt -94.29 113.13 24.98 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.118 178.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.421 ' HE ' ' CD ' ' A' ' 34' ' ' GLU . 40.5 ttm180 -109.68 120.43 42.45 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 178.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.507 ' HB2' ' HA ' ' A' ' 10' ' ' ALA . . . -153.38 166.57 32.22 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.852 0.358 . . . . 0.0 111.048 -179.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -90.98 112.14 23.9 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 178.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.485 ' SG ' HD13 ' A' ' 100' ' ' LEU . 65.2 m -101.32 130.49 47.49 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.747 0.308 . . . . 0.0 110.816 -178.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.5 ttt180 -83.77 109.88 17.88 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 35.1 p30 -77.82 167.71 21.09 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.329 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -50.91 -33.07 22.68 Favored 'General case' 0 C--N 1.329 -0.292 0 O-C-N 123.674 0.609 . . . . 0.0 112.356 -179.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -67.24 -16.22 64.16 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.204 0.526 . . . . 0.0 110.825 -179.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 91.24 25.51 23.82 Favored Glycine 0 N--CA 1.446 -0.638 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.671 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -115.1 151.78 33.7 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.617 0.246 . . . . 0.0 111.074 -179.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -92.05 115.01 27.7 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.102 0.477 . . . . 0.0 110.911 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 5.0 m -113.38 132.79 61.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.561 179.106 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 53.2 m -79.58 110.19 14.68 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.037 0.446 . . . . 0.0 110.542 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 73.6 m -120.95 148.85 43.52 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.815 -179.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.566 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 46.3 mt-10 -130.92 138.55 49.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.832 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.565 HD11 ' HB2' ' A' ' 102' ' ' PHE . 1.9 tm? -132.38 130.2 40.37 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 179.026 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.412 ' N ' HD13 ' A' ' 35' ' ' LEU . 23.9 m-20 -88.86 109.58 20.33 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.969 0.414 . . . . 0.0 110.332 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.495 HD11 HD11 ' A' ' 19' ' ' LEU . 1.6 mt -84.67 -11.49 55.8 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.742 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -66.76 -6.0 14.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.156 -179.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 72.1 p -88.96 -13.09 39.75 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.018 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.537 ' SG ' ' HZ3' ' A' ' 50' ' ' TRP . 0.8 OUTLIER -136.05 -9.61 2.03 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -178.432 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.427 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 51.3 mt -107.16 132.17 55.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 O-C-N 122.241 -0.287 . . . . 0.0 110.455 178.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.528 ' HA3' ' HB3' ' A' ' 52' ' ' MET . . . -151.97 162.01 29.56 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.199 179.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.66 ' ND2' ' HB2' ' A' ' 55' ' ' PHE . 5.3 p30 -159.4 57.98 1.13 Allowed Pre-proline 0 CA--C 1.535 0.382 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -72.39 -15.36 28.03 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.059 1.839 . . . . 0.0 112.374 -179.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 53.5 m-80 -100.26 -5.12 28.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.953 0.406 . . . . 0.0 110.466 179.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.527 ' HA3' ' HG2' ' A' ' 83' ' ' ARG . . . 98.99 9.48 51.95 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.41 -179.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -123.46 133.1 54.09 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.928 0.394 . . . . 0.0 110.852 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.5 ' HB3' ' HB ' ' A' ' 88' ' ' ILE . 79.0 mt -83.49 139.82 32.68 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.406 -178.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 178.33 172.58 42.88 Favored Glycine 0 N--CA 1.44 -1.095 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.437 179.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.537 ' HZ3' ' SG ' ' A' ' 40' ' ' CYS . 93.0 m95 -94.82 125.03 39.21 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 158.76 -63.94 0.3 Allowed Glycine 0 N--CA 1.45 -0.416 0 N-CA-C 111.588 -0.605 . . . . 0.0 111.588 -179.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.528 ' HB3' ' HA3' ' A' ' 42' ' ' GLY . 13.1 tpt -78.31 173.82 11.89 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -129.55 172.39 11.62 Favored 'General case' 0 C--N 1.322 -0.599 0 O-C-N 122.159 -0.338 . . . . 0.0 111.399 -179.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 20.9 m-80 61.07 48.81 6.11 Favored 'General case' 0 C--O 1.233 0.187 0 O-C-N 123.982 0.801 . . . . 0.0 111.967 179.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.66 ' HB2' ' ND2' ' A' ' 43' ' ' ASN . 18.8 p90 -67.91 -28.51 67.56 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.628 -179.502 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.411 ' OG ' ' HB3' ' A' ' 17' ' ' ARG . 3.1 m -63.47 -28.38 69.93 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.873 0.368 . . . . 0.0 111.125 -179.312 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 26.4 m80 -79.99 -9.04 59.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.001 0.429 . . . . 0.0 111.013 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 47.5 p -125.58 15.31 8.18 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.064 0.459 . . . . 0.0 110.659 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 68.2 m -133.61 150.5 51.6 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.302 0.572 . . . . 0.0 111.052 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 57.2 mt-10 -125.68 142.3 51.58 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.412 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.433 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 21.4 t70 60.01 78.41 0.27 Allowed 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 121.402 0.62 . . . . 0.0 110.367 -179.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.541 HG23 HD21 ' A' ' 71' ' ' LEU . 73.2 mt -101.73 115.47 43.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.525 -0.761 . . . . 0.0 111.36 -178.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 36.6 ttmt -148.96 156.99 43.08 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 179.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.524 ' HG ' HD21 ' A' ' 12' ' ' LEU . 42.5 mt -83.2 135.93 34.6 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.161 0.505 . . . . 0.0 110.947 -179.448 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 18.7 tp10 -90.23 -57.29 2.9 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.934 -178.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.494 ' HB2' ' HB2' ' A' ' 69' ' ' ARG . 20.5 mm-40 -84.15 24.11 0.98 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.158 0.504 . . . . 0.0 111.1 -179.336 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 68.24 16.72 69.36 Favored Glycine 0 N--CA 1.45 -0.39 0 CA-C-N 115.429 -0.805 . . . . 0.0 112.435 179.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 141.24 -28.12 2.37 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.013 -1.089 . . . . 0.0 112.806 179.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.494 ' HB2' ' HB2' ' A' ' 66' ' ' GLU . 12.6 mmt180 -73.07 -25.34 60.87 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.057 0.456 . . . . 0.0 110.582 -179.407 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.436 ' HG3' ' HA ' ' A' ' 89' ' ' ASP . 36.6 ttpt -146.48 142.72 28.37 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.888 -178.185 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.677 ' HB2' HD11 ' A' ' 90' ' ' LEU . 8.9 tt -111.63 131.75 55.05 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.738 -0.468 . . . . 0.0 109.738 179.574 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.3 p -115.26 130.57 56.95 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.233 0.54 . . . . 0.0 111.066 179.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.433 ' HA ' ' O ' ' A' ' 61' ' ' ASP . 26.7 p -153.28 165.15 36.62 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.333 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.49 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 3.3 tmt_? -102.12 99.35 12.25 Favored Pre-proline 0 C--N 1.314 -0.958 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.418 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.67 ' O ' ' HB3' ' A' ' 83' ' ' ARG . 61.7 Cg_endo -70.09 123.14 9.71 Favored 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 122.801 2.334 . . . . 0.0 111.443 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.924 ' HE3' ' HA2' ' A' ' 81' ' ' GLY . 0.0 OUTLIER -119.67 144.21 47.31 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.76 -179.793 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.685 HG22 ' O ' ' A' ' 82' ' ' PHE . 14.6 t -76.92 140.78 40.63 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.547 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 8.9 p -73.8 -9.44 12.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.452 -0.794 . . . . 0.0 111.288 -179.042 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -64.2 -23.12 67.2 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.054 0.454 . . . . 0.0 110.872 179.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -166.26 -21.84 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.51 -0.852 . . . . 0.0 112.908 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.924 ' HA2' ' HE3' ' A' ' 76' ' ' LYS . . . 101.75 20.87 11.99 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.773 -0.727 . . . . 0.0 111.893 -179.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.685 ' O ' HG22 ' A' ' 77' ' ' THR . 22.2 p90 -111.15 147.7 34.35 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 119.031 -0.509 . . . . 0.0 109.766 -178.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.723 ' HB2' ' HA ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 169.26 -154.94 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.361 0 O-C-N 123.592 0.558 . . . . 0.0 111.315 179.716 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -117.62 -175.76 2.89 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.368 -178.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.544 ' HA ' ' HD2' ' A' ' 75' ' ' PRO . 31.6 ttt180 -110.59 155.68 22.01 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 177.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.534 ' HG2' ' H ' ' A' ' 87' ' ' GLY . 9.2 tt0 -165.17 176.69 8.25 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 120.512 -0.475 . . . . 0.0 111.712 -178.178 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.534 ' H ' ' HG2' ' A' ' 86' ' ' GLN . . . -137.91 140.83 11.54 Favored Glycine 0 N--CA 1.449 -0.466 0 N-CA-C 111.42 -0.672 . . . . 0.0 111.42 178.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.5 ' HB ' ' HB3' ' A' ' 48' ' ' LEU . 11.4 tt -118.44 133.84 63.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.371 0.605 . . . . 0.0 110.707 -179.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.457 ' OD1' ' HB2' ' A' ' 91' ' ' ASN . 14.5 t70 -74.79 136.48 41.66 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.809 -179.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.677 HD11 ' HB2' ' A' ' 71' ' ' LEU . 64.2 mt -110.77 37.34 2.81 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 -178.28 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.549 ' HA ' ' HB3' ' A' ' 2' ' ' SER . 6.4 m-80 -73.92 -1.87 21.49 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-O 121.194 0.521 . . . . 0.0 111.037 179.373 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 21.0 mtp180 -88.11 -10.88 48.65 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.174 179.07 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.442 ' CD1' HD22 ' A' ' 37' ' ' LEU . 22.7 mm -99.15 98.59 7.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -179.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 1.2 mm-40 -107.68 152.21 24.62 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.743 -178.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.51 ' OD1' ' HA ' ' A' ' 3' ' ' TYR . 19.4 p-10 -106.82 105.54 15.63 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.106 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.2 p -98.42 113.85 34.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-O 121.286 0.565 . . . . 0.0 110.177 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 59.44 30.22 19.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.814 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 92.97 -13.54 67.41 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 121.005 -0.617 . . . . 0.0 113.276 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.401 HH11 ' HD3' ' A' ' 99' ' ' ARG . 3.0 mpt_? -92.25 131.03 37.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 117.405 0.603 . . . . 0.0 110.257 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.485 HD13 ' SG ' ' A' ' 23' ' ' CYS . 3.2 tp -84.16 115.54 22.46 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.08 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 46.5 t -129.98 142.66 43.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.333 -179.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.565 ' HB2' HD11 ' A' ' 35' ' ' LEU . 5.5 t80 -84.2 122.81 29.37 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.236 0.541 . . . . 0.0 110.089 178.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 . . . . . 0 C--N 1.312 -1.034 0 CA-C-O 118.193 -0.908 . . . . 0.0 110.408 179.737 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 mpt? . . . . . 0 N--CA 1.48 1.042 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.495 ' OG ' ' HA ' ' A' ' 91' ' ' ASN . 19.5 m -117.23 169.75 9.22 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 121.065 -0.254 . . . . 0.0 111.128 179.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.536 ' HA ' ' OD1' ' A' ' 95' ' ' ASN . 28.6 p90 -55.51 -34.09 64.33 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.724 179.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -54.46 -18.74 4.59 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -178.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -57.34 -41.71 80.53 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.151 0.501 . . . . 0.0 110.426 179.018 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.426 ' HB2' HD21 ' A' ' 95' ' ' ASN . 50.0 m -130.48 35.66 4.02 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.093 179.52 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.4 ' HA ' ' HZ3' ' A' ' 30' ' ' TRP . 15.0 m -143.18 156.33 44.74 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.12 179.55 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.425 HH11 ' HD2' ' A' ' 8' ' ' ARG . 10.8 ptm85 -144.35 167.95 21.25 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.751 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 57.24 59.76 3.23 Favored 'General case' 0 C--O 1.235 0.337 0 O-C-N 123.736 0.648 . . . . 0.0 111.715 179.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.445 ' HA ' ' HB2' ' A' ' 21' ' ' ALA . . . -89.88 117.53 28.78 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.192 179.606 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 31.9 m -120.53 173.11 6.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.748 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.52 HD21 ' HG ' ' A' ' 64' ' ' LEU . 3.6 mm? -104.64 114.99 29.57 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.765 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.413 ' OG1' ' HB ' ' A' ' 18' ' ' THR . 21.0 p -108.53 164.65 12.16 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.479 179.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 62.16 43.67 8.45 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.412 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 87.73 -46.19 3.43 Favored Glycine 0 N--CA 1.449 -0.448 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.745 179.06 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 150.55 57.77 0.01 OUTLIER Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 110.404 -1.078 . . . . 0.0 110.404 -179.135 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.445 ' HB2' ' HB3' ' A' ' 38' ' ' ASP . 7.9 ptm180 -142.91 -30.37 0.53 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.947 0.403 . . . . 0.0 111.086 -179.024 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.453 ' CG2' ' HB3' ' A' ' 34' ' ' GLU . 3.0 m -103.92 137.95 41.18 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.189 -178.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.727 HD11 HD13 ' A' ' 90' ' ' LEU . 58.3 mt -98.17 115.86 29.19 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.171 178.585 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 45.3 ttp180 -112.67 123.0 49.31 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 178.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.445 ' HB2' ' HA ' ' A' ' 10' ' ' ALA . . . -151.77 167.2 28.98 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.928 0.394 . . . . 0.0 111.408 -179.307 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -90.08 105.98 18.18 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 178.058 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 80.2 m -99.3 127.18 45.28 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.636 -178.557 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 9.4 ttp180 -77.42 115.09 16.9 Favored 'General case' 0 N--CA 1.436 -1.144 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.887 179.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 36.7 p30 -76.54 165.72 24.4 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.22 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.07 -27.75 54.83 Favored 'General case' 0 N--CA 1.464 0.235 0 O-C-N 123.61 0.569 . . . . 0.0 111.993 -179.113 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -69.26 -19.39 63.93 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.296 0.57 . . . . 0.0 110.327 179.433 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 96.11 30.25 7.98 Favored Glycine 0 N--CA 1.449 -0.488 0 CA-C-N 115.536 -0.756 . . . . 0.0 112.244 179.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -124.91 150.43 46.54 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.514 0.157 . . . . 0.0 110.773 -179.095 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.4 ' HZ3' ' HA ' ' A' ' 7' ' ' SER . 94.1 m95 -84.88 123.1 30.09 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.755 0.312 . . . . 0.0 111.391 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.0 m -124.77 134.72 66.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 121.089 0.471 . . . . 0.0 110.593 178.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 16.2 m -79.5 116.33 19.65 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.816 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 72.4 m -126.73 159.53 33.45 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.372 179.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.623 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 46.3 mt-10 -139.1 145.9 40.06 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-O 120.867 0.365 . . . . 0.0 111.444 -178.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.622 HD11 ' HB2' ' A' ' 102' ' ' PHE . 1.5 tm? -138.81 132.29 30.36 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.054 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.477 ' N ' HD13 ' A' ' 35' ' ' LEU . 27.3 m-20 -90.98 110.59 21.85 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.025 0.441 . . . . 0.0 110.391 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.524 HD11 HD11 ' A' ' 19' ' ' LEU . 1.5 mt -86.1 -16.66 37.31 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.572 -179.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.453 ' HA ' ' HD1' ' A' ' 55' ' ' PHE . 4.4 p-10 -63.65 -20.39 65.65 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -178.021 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.417 HG23 ' SG ' ' A' ' 40' ' ' CYS . 12.3 t -83.23 0.62 44.65 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.121 0.486 . . . . 0.0 110.87 -179.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.417 ' SG ' HG23 ' A' ' 39' ' ' THR . 57.6 m -136.32 -26.44 1.13 Allowed 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -179.571 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.47 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 61.7 mt -94.49 137.21 23.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 110.204 -0.295 . . . . 0.0 110.204 179.405 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.593 ' HA3' ' HB3' ' A' ' 52' ' ' MET . . . -153.72 156.2 26.64 Favored Glycine 0 N--CA 1.443 -0.885 0 C-N-CA 120.685 -0.769 . . . . 0.0 111.617 179.401 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.599 ' ND2' ' HB2' ' A' ' 55' ' ' PHE . 6.3 p30 -154.24 50.68 0.57 Allowed Pre-proline 0 C--N 1.326 -0.446 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.26 -18.93 39.12 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 121.712 1.608 . . . . 0.0 111.868 -179.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.457 HD22 ' N ' ' A' ' 45' ' ' ASN . 0.9 OUTLIER -90.77 -5.74 55.28 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.316 179.614 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.57 ' HA3' ' HG2' ' A' ' 83' ' ' ARG . . . 95.95 8.57 57.92 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.407 -179.485 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.435 ' HD1' HE22 ' A' ' 86' ' ' GLN . 51.7 m-85 -125.28 135.89 52.97 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.764 0.316 . . . . 0.0 110.314 179.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.469 ' HB3' ' HB ' ' A' ' 88' ' ' ILE . 72.7 mt -83.29 137.24 34.07 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.325 -178.601 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 179.11 171.74 42.61 Favored Glycine 0 N--CA 1.445 -0.717 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.832 179.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.459 ' CD2' ' HD3' ' A' ' 92' ' ' ARG . 83.4 m95 -95.35 125.46 39.99 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.624 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 161.24 -47.81 0.37 Allowed Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.309 -179.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.593 ' HB3' ' HA3' ' A' ' 42' ' ' GLY . 0.0 OUTLIER -90.41 -161.28 0.78 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.643 0.259 . . . . 0.0 110.836 -179.188 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -146.82 168.98 20.07 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.685 -0.234 . . . . 0.0 110.444 -179.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 18.7 m-80 56.77 45.74 21.2 Favored 'General case' 0 N--CA 1.465 0.32 0 O-C-N 123.796 0.685 . . . . 0.0 112.253 178.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.599 ' HB2' ' ND2' ' A' ' 43' ' ' ASN . 7.5 p90 -65.65 -28.64 69.25 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.902 -0.319 . . . . 0.0 110.793 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.56 ' HA ' HD11 ' A' ' 62' ' ' ILE . 13.8 m -58.13 -37.12 74.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.534 -179.62 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 17.8 m80 -73.18 -17.83 61.32 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.042 0.448 . . . . 0.0 111.446 179.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 47.9 m -112.89 14.9 19.86 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.497 -178.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 54.5 m -136.1 148.44 48.26 Favored 'General case' 0 C--N 1.32 -0.684 0 O-C-N 121.749 -0.595 . . . . 0.0 111.641 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 60.9 mm-40 -117.58 145.62 44.16 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.825 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 55.87 58.83 4.14 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 123.925 0.765 . . . . 0.0 111.687 178.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.56 HD11 ' HA ' ' A' ' 56' ' ' SER . 81.5 mt -75.95 113.6 15.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.512 179.767 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.411 ' HD2' HD23 ' A' ' 12' ' ' LEU . 15.2 tptm -147.74 154.84 41.05 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 -179.692 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.536 HD13 ' HA2' ' A' ' 68' ' ' GLY . 67.2 mt -82.41 138.9 34.3 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.314 0.578 . . . . 0.0 111.233 -179.161 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -89.17 -75.27 0.44 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 114.697 -1.138 . . . . 0.0 111.129 -178.492 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.604 ' HB2' ' HB2' ' A' ' 69' ' ' ARG . 19.7 mt-10 -77.87 45.53 0.52 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.754 -178.317 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 65.39 2.46 10.17 Favored Glycine 0 CA--C 1.518 0.255 0 CA-C-N 115.837 -0.619 . . . . 0.0 113.671 179.254 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.536 ' HA2' HD13 ' A' ' 64' ' ' LEU . . . 141.63 -13.81 2.69 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.081 -1.056 . . . . 0.0 112.985 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.604 ' HB2' ' HB2' ' A' ' 66' ' ' GLU . 14.3 mmt180 -78.27 -19.48 53.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.261 0.553 . . . . 0.0 109.825 179.746 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.461 ' HB3' ' HG3' ' A' ' 66' ' ' GLU . 40.7 tttt -144.46 143.54 30.93 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.596 -178.623 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.625 ' HB2' HD11 ' A' ' 90' ' ' LEU . 10.1 tt -110.5 132.81 53.86 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.753 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.9 p -121.0 132.42 54.89 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.03 0.443 . . . . 0.0 111.586 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.537 ' HB3' ' HA ' ' A' ' 62' ' ' ILE . 24.7 p -161.19 167.36 26.25 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.208 179.526 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.407 ' HA ' ' HD2' ' A' ' 75' ' ' PRO . 25.0 ttt180 -100.4 102.83 20.05 Favored Pre-proline 0 C--N 1.316 -0.85 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.343 179.012 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.645 ' O ' ' HB3' ' A' ' 83' ' ' ARG . 39.0 Cg_endo -67.06 121.01 8.13 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 122.539 2.159 . . . . 0.0 110.58 178.649 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.649 ' HA ' ' HB2' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -119.25 146.58 45.1 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.764 -179.354 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.707 ' HB ' ' HD2' ' A' ' 83' ' ' ARG . 5.6 t -79.67 144.94 33.27 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 179.527 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.2 p -72.03 -9.47 12.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.436 -177.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -58.63 -29.37 66.45 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.224 0.535 . . . . 0.0 110.231 179.206 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -169.81 -24.62 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.304 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.869 -179.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.617 ' HA2' ' HD3' ' A' ' 76' ' ' LYS . . . 111.98 26.05 4.54 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.848 -0.692 . . . . 0.0 111.718 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.564 ' O ' HG22 ' A' ' 77' ' ' THR . 20.3 p90 -110.3 141.09 43.78 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 -178.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.707 ' HD2' ' HB ' ' A' ' 77' ' ' THR . 0.0 OUTLIER 174.13 -149.48 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 O-C-N 123.654 0.596 . . . . 0.0 110.027 -179.791 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -121.55 176.15 5.84 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 122.271 0.228 . . . . 0.0 110.982 -178.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.416 ' HA ' ' HD2' ' A' ' 75' ' ' PRO . 42.0 ttt-85 -98.35 156.81 16.55 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 178.075 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.435 HE22 ' HD1' ' A' ' 47' ' ' PHE . 9.2 tt0 -166.55 173.09 10.11 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 120.927 0.394 . . . . 0.0 111.524 -178.713 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.413 ' N ' ' HG2' ' A' ' 86' ' ' GLN . . . -135.8 144.42 16.23 Favored Glycine 0 N--CA 1.45 -0.388 0 N-CA-C 111.626 -0.589 . . . . 0.0 111.626 178.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.469 ' HB ' ' HB3' ' A' ' 48' ' ' LEU . 12.2 tt -121.57 134.67 64.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.093 0.473 . . . . 0.0 110.793 -179.439 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.479 ' HB3' HD22 ' A' ' 91' ' ' ASN . 4.2 m-20 -77.73 136.76 38.2 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.113 -179.416 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.727 HD13 HD11 ' A' ' 19' ' ' LEU . 68.6 mt -108.38 56.48 0.63 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.735 0.778 . . . . 0.0 111.219 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.495 ' HA ' ' OG ' ' A' ' 2' ' ' SER . 19.7 m-80 -91.09 3.19 55.42 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.686 179.478 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.459 ' HD3' ' CD2' ' A' ' 50' ' ' TRP . 36.9 mtp180 -96.77 -6.69 35.63 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.846 179.274 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.425 HD11 ' HH2' ' A' ' 50' ' ' TRP . 16.4 mm -105.47 101.64 12.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -179.525 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 27.8 tp60 -113.95 145.09 42.01 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.022 -178.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.536 ' OD1' ' HA ' ' A' ' 3' ' ' TYR . 19.2 p-10 -95.44 115.7 27.79 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.157 178.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 57.8 t -106.24 110.78 32.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.04 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 30.7 m-80 58.48 28.8 17.45 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.995 -179.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 100.2 -23.55 35.48 Favored Glycine 0 N--CA 1.445 -0.748 0 C-N-CA 120.522 -0.847 . . . . 0.0 113.157 179.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.413 ' N ' ' HD2' ' A' ' 99' ' ' ARG . 3.3 mpt_? -86.95 138.18 31.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 117.242 0.521 . . . . 0.0 110.195 -179.367 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.463 HD23 ' HB2' ' A' ' 35' ' ' LEU . 4.9 tp -86.21 123.57 31.63 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 14.6 t -128.21 143.78 39.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.93 -179.027 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.622 ' HB2' HD11 ' A' ' 35' ' ' LEU . 9.9 t80 -92.66 128.3 38.47 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.161 0.505 . . . . 0.0 109.788 178.161 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 . . . . . 0 C--O 1.25 1.091 0 CA-C-O 118.181 -0.914 . . . . 0.0 110.651 179.742 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.7 mtt . . . . . 0 N--CA 1.481 1.12 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.436 ' OG ' ' HA ' ' A' ' 91' ' ' ASN . 19.9 m -116.99 167.13 11.41 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.781 178.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.448 ' HB3' HD11 ' A' ' 100' ' ' LEU . 13.4 p90 -48.43 -37.53 17.38 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.476 ' HB3' ' HD2' ' A' ' 69' ' ' ARG . . . -53.18 -19.1 2.71 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -178.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -56.63 -42.62 79.16 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 121.335 0.588 . . . . 0.0 110.149 178.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.418 ' HB2' HD21 ' A' ' 95' ' ' ASN . 18.5 m -129.78 40.47 3.57 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.481 179.654 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.406 ' HA ' ' HZ3' ' A' ' 30' ' ' TRP . 18.5 t -146.67 150.44 35.43 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.186 -179.501 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.45 ' HG3' ' ND2' ' A' ' 9' ' ' ASN . 9.3 ptp180 -136.87 175.29 9.74 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.279 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.589 HD21 ' HB2' ' A' ' 22' ' ' GLU . 8.9 p30 47.06 46.86 16.17 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 124.254 0.971 . . . . 0.0 112.107 -179.38 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.604 ' HA ' ' HB2' ' A' ' 21' ' ' ALA . . . -74.01 118.44 16.96 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.619 179.59 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 27.4 m -122.14 168.28 14.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.842 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.754 HD21 ' HG ' ' A' ' 64' ' ' LEU . 3.3 mm? -104.75 123.02 46.92 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.634 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.479 HG21 ' CZ ' ' A' ' 20' ' ' ARG . 20.6 p -123.19 168.71 12.07 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.811 0.338 . . . . 0.0 111.81 -178.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 59.94 42.75 15.7 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.003 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 92.17 -23.02 29.05 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.812 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.627 ' HA2' ' HB3' ' A' ' 12' ' ' LEU . . . 122.32 41.23 0.48 Allowed Glycine 0 N--CA 1.445 -0.736 0 N-CA-C 111.39 -0.684 . . . . 0.0 111.39 179.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.657 ' HB2' ' HB2' ' A' ' 38' ' ' ASP . 15.9 ptt180 -126.14 -26.27 3.42 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.109 0.481 . . . . 0.0 110.582 -179.338 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.493 HG22 ' HB3' ' A' ' 34' ' ' GLU . 2.8 m -101.11 130.32 47.14 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.48 -179.245 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.638 HD11 HD13 ' A' ' 90' ' ' LEU . 92.9 mt -91.23 112.22 24.04 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.01 179.529 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.479 ' CZ ' HG21 ' A' ' 13' ' ' THR . 43.9 ttm180 -109.07 119.39 39.42 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 179.375 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.604 ' HB2' ' HA ' ' A' ' 10' ' ' ALA . . . -154.79 167.38 30.41 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.818 0.342 . . . . 0.0 111.293 -179.434 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.611 ' HG3' ' HB3' ' A' ' 30' ' ' TRP . 0.4 OUTLIER -88.54 111.74 22.2 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 177.427 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 69.4 m -99.65 126.97 45.75 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 -179.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.469 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 34.3 ttt180 -76.1 114.07 14.35 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 116.3 -0.409 . . . . 0.0 109.936 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.429 HD21 ' HB3' ' A' ' 29' ' ' ASN . 35.1 p30 -77.95 170.23 16.95 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.372 -179.616 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.75 -29.18 62.29 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 -178.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -73.98 -13.09 60.82 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.468 0.651 . . . . 0.0 110.253 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 91.21 27.89 16.84 Favored Glycine 0 N--CA 1.448 -0.54 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.629 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.469 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 10.7 t-20 -111.53 158.54 19.06 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 110.14 -0.319 . . . . 0.0 110.14 -178.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.611 ' HB3' ' HG3' ' A' ' 22' ' ' GLU . 98.9 m95 -99.57 119.43 38.04 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.953 0.406 . . . . 0.0 110.765 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 11.1 m -122.25 137.53 55.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.252 -179.461 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 16.8 m -75.92 109.57 9.65 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.105 179.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 69.3 m -122.43 137.13 54.97 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.41 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.609 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 3.0 mp0 -122.55 146.73 47.15 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.514 -179.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.462 HD11 ' HB2' ' A' ' 102' ' ' PHE . 1.2 tm? -138.53 126.83 22.97 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 178.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.409 ' N ' HD13 ' A' ' 35' ' ' LEU . 4.4 m-20 -85.95 110.07 19.2 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.868 0.366 . . . . 0.0 110.475 179.547 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.445 HD13 HD22 ' A' ' 90' ' ' LEU . 2.1 mt -83.91 -12.57 55.24 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.034 178.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.689 ' OD2' ' HA ' ' A' ' 54' ' ' ASN . 9.6 t70 -60.94 -29.23 69.51 Favored 'General case' 0 C--O 1.221 -0.426 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.89 -178.607 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.6 t -83.48 1.02 43.79 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.827 0.346 . . . . 0.0 111.459 -178.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 37.3 m -128.97 -24.68 2.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.829 0.347 . . . . 0.0 111.775 -179.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 71.9 mt -102.8 137.05 32.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.549 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -143.84 146.92 17.96 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.68 -0.771 . . . . 0.0 111.835 179.177 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.764 HD22 ' HB3' ' A' ' 75' ' ' PRO . 30.5 p-10 -152.44 48.86 0.48 Allowed Pre-proline 0 CA--C 1.539 0.557 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -178.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -71.79 -22.12 24.11 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 121.661 1.574 . . . . 0.0 111.747 -179.357 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -83.97 -14.54 50.53 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.885 179.173 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.544 ' CA ' ' HG2' ' A' ' 83' ' ' ARG . . . 106.26 8.62 33.14 Favored Glycine 0 N--CA 1.443 -0.874 0 C-N-CA 120.315 -0.945 . . . . 0.0 112.596 -179.149 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.576 ' HA ' HE22 ' A' ' 86' ' ' GLN . 66.5 m-85 -124.08 133.29 53.66 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.676 0.274 . . . . 0.0 110.282 179.476 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 95.3 mt -83.54 130.24 35.0 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.513 -178.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -173.5 172.65 45.36 Favored Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.097 179.029 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.408 ' HH2' HD11 ' A' ' 93' ' ' ILE . 88.3 m95 -95.03 125.1 39.47 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.758 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 168.64 -59.18 0.2 Allowed Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.493 -0.861 . . . . 0.0 112.602 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 6.1 ttp -96.75 -154.66 0.45 Allowed 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.46 ' HG3' HD22 ' A' ' 54' ' ' ASN . 3.4 pt20 -146.79 173.75 12.1 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.43 0.157 . . . . 0.0 111.013 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.689 ' HA ' ' OD2' ' A' ' 38' ' ' ASP . 42.7 m-80 64.92 55.37 1.18 Allowed 'General case' 0 C--O 1.237 0.416 0 O-C-N 123.858 0.724 . . . . 0.0 111.52 179.523 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.495 ' HD1' ' HA ' ' A' ' 38' ' ' ASP . 11.8 p90 -87.46 -26.17 23.38 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.16 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.411 ' HB3' ' HB3' ' A' ' 17' ' ' ARG . 32.4 p -61.0 -35.89 78.04 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.998 0.428 . . . . 0.0 111.105 -178.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 26.7 m80 -77.49 -11.94 59.91 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.192 179.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.483 ' HB2' ' OD1' ' A' ' 43' ' ' ASN . 2.7 m -113.41 20.25 16.25 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.053 0.454 . . . . 0.0 110.353 -179.624 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 24.8 m -136.1 156.0 49.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.09 0.471 . . . . 0.0 111.46 -179.371 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -129.2 138.31 51.64 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.282 178.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.44 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 32.2 t70 58.22 79.31 0.21 Allowed 'General case' 0 N--CA 1.469 0.49 0 O-C-N 123.735 0.647 . . . . 0.0 110.721 -179.291 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.55 HG23 HD21 ' A' ' 71' ' ' LEU . 68.0 mt -98.74 112.74 31.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.548 -179.566 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.28 164.94 26.59 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.307 -179.057 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.754 ' HG ' HD21 ' A' ' 12' ' ' LEU . 55.9 mt -96.05 114.84 26.58 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 178.481 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -65.95 -54.34 27.58 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.12 -177.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 43.1 mm-40 -88.36 7.84 30.5 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.112 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 73.23 21.09 80.01 Favored Glycine 0 N--CA 1.447 -0.623 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.678 -179.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 156.53 -49.84 0.45 Allowed Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 120.131 -1.033 . . . . 0.0 112.946 179.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.476 ' HD2' ' HB3' ' A' ' 4' ' ' ALA . 5.1 mpt_? -66.31 -26.66 67.41 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -179.365 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 32.0 ttpt -141.91 144.62 33.88 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.651 -0.419 . . . . 0.0 111.677 -178.471 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.628 ' HB2' HD11 ' A' ' 90' ' ' LEU . 8.7 tt -115.45 124.08 50.24 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.305 -0.861 . . . . 0.0 108.983 179.286 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.447 HG22 ' HA3' ' A' ' 87' ' ' GLY . 1.1 p -115.8 133.4 56.07 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.375 0.607 . . . . 0.0 111.114 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.546 ' HB3' ' HA ' ' A' ' 62' ' ' ILE . 26.3 p -156.2 172.32 18.66 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.336 -0.847 . . . . 0.0 108.868 -179.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.513 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 4.4 tmt_? -104.23 98.57 14.37 Favored Pre-proline 0 C--N 1.316 -0.861 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 179.283 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.764 ' HB3' HD22 ' A' ' 43' ' ' ASN . 54.9 Cg_endo -69.35 123.82 10.62 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 122.902 2.401 . . . . 0.0 110.653 179.026 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.963 ' HE3' ' HA2' ' A' ' 81' ' ' GLY . 0.0 OUTLIER -120.91 149.41 42.67 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.619 -179.077 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.709 HG22 ' O ' ' A' ' 82' ' ' PHE . 13.2 t -79.59 134.5 36.47 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 177.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 31.3 m -72.44 -7.85 10.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 O-C-N 123.706 0.629 . . . . 0.0 111.402 -179.22 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -66.98 -33.63 75.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.533 179.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -150.0 -20.34 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.364 -0.922 . . . . 0.0 113.162 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.963 ' HA2' ' HE3' ' A' ' 76' ' ' LYS . . . 98.01 18.04 28.21 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.579 -0.82 . . . . 0.0 111.685 -179.712 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.709 ' O ' HG22 ' A' ' 77' ' ' THR . 32.0 p90 -111.55 153.18 26.62 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 118.872 -0.585 . . . . 0.0 109.891 -178.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.716 ' HB2' ' HA ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 167.84 -150.4 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.405 0 O-C-N 123.679 0.612 . . . . 0.0 111.442 179.502 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -127.58 154.92 44.62 Favored 'General case' 0 C--O 1.226 -0.142 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.7 -178.471 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.513 ' HA ' ' HA ' ' A' ' 74' ' ' ARG . 35.8 ttt180 -84.32 146.83 27.52 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 178.335 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.576 HE22 ' HA ' ' A' ' 47' ' ' PHE . 36.8 mt-30 -151.49 -170.17 3.58 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.619 0.723 . . . . 0.0 112.091 -177.702 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.447 ' HA3' HG22 ' A' ' 72' ' ' THR . . . -155.05 142.99 9.43 Favored Glycine 0 N--CA 1.442 -0.904 0 N-CA-C 110.23 -1.148 . . . . 0.0 110.23 178.645 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 13.0 tt -122.75 134.83 64.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.257 0.551 . . . . 0.0 110.734 -178.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.446 ' HB3' HD22 ' A' ' 91' ' ' ASN . 7.5 m-20 -74.37 130.9 40.53 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.625 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.638 HD13 HD11 ' A' ' 19' ' ' LEU . 61.4 mt -102.04 46.55 0.93 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.676 0.751 . . . . 0.0 110.848 -179.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.446 HD22 ' HB3' ' A' ' 89' ' ' ASP . 13.6 m-80 -81.3 4.63 19.91 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.317 179.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 19.1 mtp180 -100.54 -6.64 25.1 Favored 'General case' 0 C--O 1.226 -0.179 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.7 178.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.408 HD11 ' HH2' ' A' ' 50' ' ' TRP . 23.5 mm -106.15 108.03 24.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 -178.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 20.9 tp60 -125.98 145.93 50.08 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.783 -178.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.418 HD21 ' HB2' ' A' ' 6' ' ' SER . 13.9 p-10 -95.08 115.31 27.27 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.331 0.586 . . . . 0.0 110.023 178.475 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 52.0 t -101.78 112.82 36.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.128 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 13.6 m-80 57.84 33.5 23.28 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.091 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 94.55 -23.87 30.33 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.837 179.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.24 124.89 33.81 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.945 0.372 . . . . 0.0 110.031 -179.486 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.46 HD23 ' HB2' ' A' ' 35' ' ' LEU . 11.8 tp -76.31 119.38 20.12 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 38.8 t -129.9 141.73 45.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.002 0.43 . . . . 0.0 111.154 -178.669 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.462 ' HB2' HD11 ' A' ' 35' ' ' LEU . 6.5 t80 -83.79 132.34 34.83 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 177.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 3.7 tp-100 . . . . . 0 C--N 1.314 -0.953 0 CA-C-O 118.745 -0.645 . . . . 0.0 110.231 179.946 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.1 mtt . . . . . 0 N--CA 1.483 1.19 0 CA-C-O 120.941 0.4 . . . . 0.0 110.295 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.602 ' OG ' ' HA ' ' A' ' 91' ' ' ASN . 8.7 m -120.67 -179.29 3.95 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.287 -179.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.434 ' CZ ' HD13 ' A' ' 19' ' ' LEU . 14.9 p90 -63.28 -34.46 77.73 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.667 0.27 . . . . 0.0 110.69 178.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -56.32 -24.26 42.42 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.806 -0.633 . . . . 0.0 112.597 -178.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -65.78 -16.51 63.86 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 121.205 0.526 . . . . 0.0 110.835 179.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 62.0 m -140.19 29.63 2.02 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.585 178.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 19.3 m -146.06 156.51 43.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.496 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 11.7 ptp180 -143.09 166.24 25.19 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.657 179.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 67.4 m-80 58.9 54.42 5.11 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.117 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.479 ' HA ' ' O ' ' A' ' 20' ' ' ARG . . . -88.65 118.47 28.34 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.311 179.555 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.407 HG22 ' HD2' ' A' ' 20' ' ' ARG . 27.3 m -118.93 171.58 6.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.193 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.581 HD21 ' HG ' ' A' ' 64' ' ' LEU . 3.3 mm? -104.99 115.0 29.54 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.147 -179.496 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.5 ' OG1' ' HB ' ' A' ' 18' ' ' THR . 21.9 p -110.06 167.73 9.96 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.931 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 57.97 53.27 6.97 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.948 -179.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 81.68 -35.36 2.48 Favored Glycine 0 CA--C 1.519 0.322 0 CA-C-N 116.035 -0.529 . . . . 0.0 112.686 179.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.564 ' HA2' ' HB3' ' A' ' 12' ' ' LEU . . . 136.75 49.22 0.07 OUTLIER Glycine 0 N--CA 1.447 -0.598 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 -179.504 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.555 ' HB3' ' HB2' ' A' ' 56' ' ' SER . 15.7 ptt180 -133.91 -27.65 1.44 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.885 0.374 . . . . 0.0 111.317 -179.415 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.5 ' HB ' ' OG1' ' A' ' 13' ' ' THR . 3.9 m -99.04 135.73 40.03 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.794 -178.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.762 HD11 HD13 ' A' ' 90' ' ' LEU . 61.6 mt -94.3 114.65 26.76 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.628 179.337 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.479 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 1.6 tmt_? -110.47 120.51 42.66 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 178.589 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -153.2 167.23 30.01 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.835 0.35 . . . . 0.0 111.63 -179.562 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.494 ' HB3' ' HB3' ' A' ' 30' ' ' TRP . 45.4 mt-10 -90.73 105.63 17.95 Favored 'General case' 0 CA--C 1.512 -0.49 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 177.603 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.456 ' SG ' HD13 ' A' ' 100' ' ' LEU . 83.7 m -92.61 122.8 35.39 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 120.88 0.372 . . . . 0.0 110.963 -178.474 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.514 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 37.3 ttp180 -71.12 110.95 6.1 Favored 'General case' 0 N--CA 1.435 -1.208 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.64 178.609 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.418 HD21 ' HB3' ' A' ' 29' ' ' ASN . 37.4 p30 -76.84 167.19 22.26 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.12 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.42 -31.45 45.21 Favored 'General case' 0 C--N 1.329 -0.324 0 O-C-N 123.672 0.607 . . . . 0.0 112.289 -178.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -70.9 -17.64 62.7 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.306 0.574 . . . . 0.0 110.773 -179.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 95.08 28.39 9.98 Favored Glycine 0 CA--C 1.51 -0.243 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.551 -179.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.514 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 13.9 t-20 -113.08 164.03 13.99 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 -178.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.494 ' HB3' ' HB3' ' A' ' 22' ' ' GLU . 96.6 m95 -105.21 116.82 32.59 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.77 0.319 . . . . 0.0 110.8 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.5 m -118.56 138.03 50.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.737 179.421 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 13.3 m -80.33 114.79 19.49 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.154 -179.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.493 ' HB3' ' HB2' ' A' ' 100' ' ' LEU . 75.5 m -126.13 147.6 49.58 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.244 179.268 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.663 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 50.9 mt-10 -131.7 141.39 49.55 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.887 -179.497 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.523 ' HB2' HD23 ' A' ' 100' ' ' LEU . 1.3 tm? -137.53 127.41 25.62 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.288 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.404 ' N ' HD13 ' A' ' 35' ' ' LEU . 18.6 m-20 -81.54 109.72 16.25 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.284 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.601 HD22 HG13 ' A' ' 93' ' ' ILE . 4.1 mt -82.01 -23.07 36.16 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 121.086 -0.246 . . . . 0.0 111.59 -178.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.523 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 6.5 p-10 -66.44 -6.16 13.61 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.796 0.332 . . . . 0.0 111.475 -178.421 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 55.7 p -76.55 -21.77 55.23 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.249 0.547 . . . . 0.0 109.727 178.361 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.456 ' SG ' ' HE3' ' A' ' 50' ' ' TRP . 29.0 t -128.79 -14.61 4.51 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.656 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.463 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 54.0 mt -99.42 133.98 40.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 O-C-N 122.149 -0.344 . . . . 0.0 110.136 178.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.526 ' HA3' ' HB3' ' A' ' 52' ' ' MET . . . -152.28 165.33 30.81 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 121.011 -0.614 . . . . 0.0 111.857 179.602 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.724 ' ND2' ' HB2' ' A' ' 55' ' ' PHE . 5.3 p30 -163.86 54.35 0.4 Allowed Pre-proline 0 CA--C 1.537 0.442 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -179.503 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.41 ' HG3' ' HG2' ' A' ' 52' ' ' MET . 58.4 Cg_endo -73.13 -22.74 18.92 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 121.753 1.635 . . . . 0.0 111.241 179.506 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -85.07 -17.11 38.41 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.311 179.02 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.612 ' CA ' ' HG2' ' A' ' 83' ' ' ARG . . . 105.66 13.65 23.52 Favored Glycine 0 N--CA 1.441 -0.977 0 CA-C-N 115.459 -0.791 . . . . 0.0 113.152 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.409 ' HA ' HE22 ' A' ' 86' ' ' GLN . 59.0 m-85 -125.3 134.2 52.35 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.831 0.348 . . . . 0.0 110.431 179.095 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 88.7 mt -82.79 129.85 35.05 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.107 -178.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -176.85 175.87 47.79 Favored Glycine 0 N--CA 1.442 -0.958 0 C-N-CA 120.663 -0.78 . . . . 0.0 111.873 179.241 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.456 ' HE3' ' SG ' ' A' ' 40' ' ' CYS . 88.1 m95 -96.22 125.45 40.75 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 159.88 -62.16 0.3 Allowed Glycine 0 N--CA 1.45 -0.373 0 N-CA-C 111.443 -0.663 . . . . 0.0 111.443 -179.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.526 ' HB3' ' HA3' ' A' ' 42' ' ' GLY . 42.4 tpp -80.67 173.82 12.22 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 179.755 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -129.44 166.85 18.78 Favored 'General case' 0 C--N 1.323 -0.558 0 O-C-N 122.147 -0.346 . . . . 0.0 111.629 -179.199 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 67.53 47.36 1.23 Allowed 'General case' 0 N--CA 1.463 0.212 0 O-C-N 124.175 0.922 . . . . 0.0 112.276 179.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.724 ' HB2' ' ND2' ' A' ' 43' ' ' ASN . 3.9 p90 -70.44 -26.19 63.54 Favored 'General case' 0 C--O 1.222 -0.343 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.589 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.555 ' HB2' ' HB3' ' A' ' 17' ' ' ARG . 32.9 t -60.34 -38.3 83.37 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.93 0.395 . . . . 0.0 110.834 -179.116 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 26.2 m80 -80.86 -2.81 48.92 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.57 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 49.8 m -124.91 16.28 8.59 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.648 0.261 . . . . 0.0 111.572 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 69.7 m -131.67 149.42 52.49 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.459 0.647 . . . . 0.0 111.981 -179.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.467 ' HG3' ' HG2' ' A' ' 76' ' ' LYS . 39.8 mt-10 -120.3 139.68 52.38 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.913 -1.04 . . . . 0.0 109.295 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.505 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 28.4 t70 61.34 72.07 0.53 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.482 0.658 . . . . 0.0 110.546 179.343 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.536 HG23 HD21 ' A' ' 71' ' ' LEU . 65.6 mt -96.3 113.48 30.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.242 -179.694 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.456 ' HE3' ' HB2' ' A' ' 63' ' ' LYS . 17.3 ttmt -150.33 149.99 30.86 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.859 0.361 . . . . 0.0 110.834 -179.776 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.604 HD13 ' HA2' ' A' ' 68' ' ' GLY . 33.7 mt -88.67 136.83 32.8 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.849 -179.411 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -91.23 -67.08 0.87 Allowed 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.09 0.471 . . . . 0.0 110.988 179.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.547 ' HB2' ' HB3' ' A' ' 69' ' ' ARG . 21.9 mm-40 -74.88 42.29 0.17 Allowed 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 115.395 -0.82 . . . . 0.0 112.07 -178.618 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 60.9 13.92 35.56 Favored Glycine 0 C--N 1.314 -0.662 0 CA-C-N 115.249 -0.887 . . . . 0.0 113.426 179.091 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.604 ' HA2' HD13 ' A' ' 64' ' ' LEU . . . 130.92 -13.82 5.51 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.103 -1.046 . . . . 0.0 113.197 179.587 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.547 ' HB3' ' HB2' ' A' ' 66' ' ' GLU . 2.3 ttp85 -78.17 -20.04 52.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.343 0.592 . . . . 0.0 109.869 179.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -140.26 140.88 35.85 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.432 -179.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.61 ' HB2' HD11 ' A' ' 90' ' ' LEU . 10.3 tt -118.54 132.1 56.22 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.989 -0.551 . . . . 0.0 109.927 -179.414 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -118.19 129.91 55.78 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.634 178.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.505 ' HA ' ' O ' ' A' ' 61' ' ' ASP . 28.8 p -157.84 163.55 37.87 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.475 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.592 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 33.4 ttt180 -99.76 104.16 26.36 Favored Pre-proline 0 C--N 1.316 -0.886 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.32 179.488 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.589 ' O ' ' HB3' ' A' ' 83' ' ' ARG . 43.5 Cg_endo -67.82 115.66 3.88 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 122.449 2.1 . . . . 0.0 109.802 178.202 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.736 ' HE3' ' HA2' ' A' ' 81' ' ' GLY . 0.0 OUTLIER -119.3 140.33 50.47 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.65 -179.661 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.667 HG22 ' O ' ' A' ' 82' ' ' PHE . 15.3 t -75.85 130.14 38.09 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 17.3 m -72.59 -6.24 7.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.309 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -67.45 -34.01 76.31 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.845 179.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.584 ' HA3' ' CE2' ' A' ' 82' ' ' PHE . . . -143.26 -20.58 0.21 Allowed Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.902 179.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.736 ' HA2' ' HE3' ' A' ' 76' ' ' LYS . . . 95.23 12.54 54.51 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.363 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.667 ' O ' HG22 ' A' ' 77' ' ' THR . 21.3 p90 -111.96 157.68 20.4 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 118.83 -0.605 . . . . 0.0 110.64 -178.49 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.701 ' HB2' ' HA ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 165.54 -152.49 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.633 0 O-C-N 124.107 0.879 . . . . 0.0 111.862 178.238 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -132.6 151.3 51.98 Favored 'General case' 0 C--O 1.225 -0.192 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.189 -178.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.592 ' HA ' ' HA ' ' A' ' 74' ' ' ARG . 45.3 ttt-85 -85.95 151.48 23.71 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.547 0.213 . . . . 0.0 110.62 -179.39 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.42 ' HG3' ' O ' ' A' ' 85' ' ' ARG . 35.6 mt-30 -154.05 -172.9 4.37 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.296 -178.76 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -141.54 144.47 14.46 Favored Glycine 0 N--CA 1.451 -0.34 0 N-CA-C 111.091 -0.804 . . . . 0.0 111.091 179.127 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 9.2 tt -131.77 137.53 54.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 120.935 0.398 . . . . 0.0 110.896 -179.144 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -82.03 136.88 35.18 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.269 179.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.762 HD13 HD11 ' A' ' 19' ' ' LEU . 50.8 mt -101.05 45.03 0.98 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.598 0.713 . . . . 0.0 110.587 -179.311 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.602 ' HA ' ' OG ' ' A' ' 2' ' ' SER . 0.9 OUTLIER -74.87 -0.94 20.16 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.931 -179.354 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 11.0 mtp180 -94.98 -11.98 27.53 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.809 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.601 HG13 HD22 ' A' ' 37' ' ' LEU . 23.5 mm -101.64 112.57 35.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 -179.268 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -129.1 162.21 28.24 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.589 0.709 . . . . 0.0 112.093 -178.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.489 ' HA ' ' O ' ' A' ' 99' ' ' ARG . 19.8 p-10 -106.94 124.55 49.78 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.728 -1.123 . . . . 0.0 110.308 179.144 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 46.1 t -106.69 104.02 16.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 33.9 m-80 59.78 19.39 8.21 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.71 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 119.44 -25.95 7.52 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.607 -0.806 . . . . 0.0 113.52 178.294 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.489 ' O ' ' HA ' ' A' ' 95' ' ' ASN . 1.9 ptm180 -86.76 144.7 26.95 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 117.092 0.446 . . . . 0.0 110.393 -179.267 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.523 HD23 ' HB2' ' A' ' 35' ' ' LEU . 6.9 tp -93.43 119.71 32.84 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 23.9 t -129.34 139.31 52.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.736 -178.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.453 ' HB2' HD11 ' A' ' 35' ' ' LEU . 13.7 t80 -82.98 130.68 35.17 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.873 -0.418 . . . . 0.0 109.873 178.508 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 . . . . . 0 C--N 1.316 -0.887 0 CA-C-O 118.37 -0.824 . . . . 0.0 110.117 179.63 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.3 mtt . . . . . 0 N--CA 1.479 0.975 0 CA-C-O 120.807 0.337 . . . . 0.0 110.494 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.475 ' HB2' ' HD2' ' A' ' 69' ' ' ARG . 13.2 m -118.24 168.89 10.18 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.13 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.455 ' CG ' HD11 ' A' ' 100' ' ' LEU . 18.9 p90 -57.6 -38.13 74.4 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.104 -0.498 . . . . 0.0 112.095 179.782 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.571 ' HB3' ' CG ' ' A' ' 69' ' ' ARG . . . -53.85 -18.72 3.55 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 -177.699 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -63.98 -30.41 71.49 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.381 0.61 . . . . 0.0 109.764 179.076 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 18.8 m -131.84 28.97 4.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.924 179.255 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.412 ' HA ' ' HZ3' ' A' ' 30' ' ' TRP . 13.6 m -143.33 155.98 44.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.921 -179.81 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.42 HH11 ' HD2' ' A' ' 8' ' ' ARG . 12.7 ptm180 -145.84 169.9 17.64 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 110.436 -0.209 . . . . 0.0 110.436 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 63.02 53.42 2.34 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 123.715 0.634 . . . . 0.0 110.803 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.478 ' HA ' ' HB2' ' A' ' 21' ' ' ALA . . . -92.06 119.86 32.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.201 -179.614 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 34.4 m -123.13 170.42 13.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.209 179.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.632 HD21 ' HG ' ' A' ' 64' ' ' LEU . 3.3 mm? -105.51 115.33 30.07 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.1 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.447 ' OG1' ' HB ' ' A' ' 18' ' ' THR . 21.8 p -112.26 171.23 7.64 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.35 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.45 ' HB3' ' HE ' ' A' ' 17' ' ' ARG . 87.1 m-20 58.9 45.88 14.57 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.486 179.509 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 88.56 -30.77 5.15 Favored Glycine 0 N--CA 1.451 -0.358 0 CA-C-N 115.892 -0.595 . . . . 0.0 112.366 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.554 ' HA2' ' HB3' ' A' ' 12' ' ' LEU . . . 131.31 53.72 0.09 OUTLIER Glycine 0 N--CA 1.445 -0.731 0 N-CA-C 111.059 -0.817 . . . . 0.0 111.059 -179.477 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.638 ' HB2' ' HB3' ' A' ' 38' ' ' ASP . 14.6 ptt180 -141.46 -29.28 0.64 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.864 0.364 . . . . 0.0 111.579 -179.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.485 ' CG2' ' HB3' ' A' ' 34' ' ' GLU . 3.7 m -95.92 132.62 41.02 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.417 -179.631 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.734 HD11 HD13 ' A' ' 90' ' ' LEU . 87.5 mt -93.76 114.33 26.59 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.08 179.533 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 56.0 ttp180 -112.1 119.78 39.58 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 178.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.478 ' HB2' ' HA ' ' A' ' 10' ' ' ALA . . . -154.15 167.47 29.76 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.209 -179.317 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.629 ' HB3' ' HB3' ' A' ' 30' ' ' TRP . 40.8 mt-10 -89.89 108.94 20.01 Favored 'General case' 0 CA--C 1.513 -0.466 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 177.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.557 ' SG ' HD13 ' A' ' 100' ' ' LEU . 18.7 m -96.23 128.36 43.08 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.252 -178.641 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.511 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 25.0 ttp180 -72.87 116.73 13.72 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 179.411 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.429 HD21 ' HB3' ' A' ' 29' ' ' ASN . 36.3 p30 -84.16 171.58 12.7 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.052 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.44 -28.88 47.19 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 112.654 0.612 . . . . 0.0 112.654 -178.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -75.56 -10.59 59.58 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.394 0.616 . . . . 0.0 110.368 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 86.03 28.15 29.27 Favored Glycine 0 N--CA 1.447 -0.629 0 N-CA-C 110.916 -0.874 . . . . 0.0 110.916 -179.264 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.511 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 3.3 t-20 -110.31 160.35 16.63 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.572 0.225 . . . . 0.0 110.92 -178.479 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.629 ' HB3' ' HB3' ' A' ' 22' ' ' GLU . 84.1 m95 -99.98 112.9 25.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.074 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.1 m -115.79 131.88 66.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.365 178.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 21.6 m -77.46 109.02 11.04 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.943 0.401 . . . . 0.0 110.747 -179.323 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 70.3 m -118.29 151.69 37.21 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.726 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.611 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 45.1 mt-10 -128.89 144.5 51.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.817 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.628 HD11 ' HB2' ' A' ' 102' ' ' PHE . 1.4 tm? -138.86 128.84 25.19 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 178.472 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.423 ' N ' HD13 ' A' ' 35' ' ' LEU . 10.9 m-20 -90.31 109.85 20.94 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.479 -179.161 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.483 HD23 HD12 ' A' ' 35' ' ' LEU . 0.8 OUTLIER -87.21 -14.34 41.38 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -179.652 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.638 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 0.9 OUTLIER -64.64 -17.18 63.8 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -177.698 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.426 HG23 ' SG ' ' A' ' 40' ' ' CYS . 9.3 t -85.02 -2.63 58.19 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.894 0.378 . . . . 0.0 110.486 179.622 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.426 ' SG ' HG23 ' A' ' 39' ' ' THR . 35.8 m -132.28 -14.12 3.01 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.698 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 57.2 mt -116.41 134.89 58.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 CA-C-O 120.745 0.307 . . . . 0.0 110.402 179.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.572 ' HA3' ' HB3' ' A' ' 52' ' ' MET . . . -153.16 164.64 30.99 Favored Glycine 0 N--CA 1.446 -0.635 0 N-CA-C 111.026 -0.83 . . . . 0.0 111.026 179.261 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.467 ' OD1' ' HB2' ' A' ' 55' ' ' PHE . 2.3 p-10 -157.14 52.44 0.6 Allowed Pre-proline 0 CA--C 1.537 0.468 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -179.586 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -69.4 -19.77 37.42 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 121.708 1.605 . . . . 0.0 111.899 -179.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -89.78 -2.84 58.33 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.463 179.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.552 ' HA3' ' HG2' ' A' ' 83' ' ' ARG . . . 95.32 4.86 60.82 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.477 -0.868 . . . . 0.0 112.699 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 52.6 m-85 -126.19 137.44 53.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.69 0.245 . . . . 0.0 110.648 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.465 HD23 HG22 ' A' ' 88' ' ' ILE . 5.5 mp -82.67 149.47 27.34 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.403 -179.313 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 171.4 171.98 37.07 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.396 178.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.48 ' CD1' HD11 ' A' ' 88' ' ' ILE . 91.8 m95 -95.62 133.8 39.26 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 138.65 -39.77 1.53 Allowed Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.879 -0.677 . . . . 0.0 111.636 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.572 ' HB3' ' HA3' ' A' ' 42' ' ' GLY . 4.4 tpt -94.03 -172.01 2.72 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.407 ' HG3' HD22 ' A' ' 54' ' ' ASN . 3.8 pt20 -146.13 169.96 17.67 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.178 -0.609 . . . . 0.0 111.955 -179.282 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.407 HD22 ' HG3' ' A' ' 53' ' ' GLN . 45.5 m-80 62.41 42.71 8.7 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.062 -0.972 . . . . 0.0 112.39 179.311 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.467 ' HB2' ' OD1' ' A' ' 43' ' ' ASN . 20.9 p90 -63.34 -32.65 74.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.06 0.457 . . . . 0.0 110.302 179.337 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.603 ' OG ' ' HB3' ' A' ' 17' ' ' ARG . 8.8 m -64.05 -35.52 81.01 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.464 -179.399 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 27.3 m80 -79.15 -5.03 53.22 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.84 0.353 . . . . 0.0 111.173 -179.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 6.2 p -128.0 20.49 6.42 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.544 -179.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 66.9 m -135.8 152.41 51.06 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 121.26 0.552 . . . . 0.0 112.239 -179.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 -114.05 149.4 35.51 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.052 179.126 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 15.7 t70 47.25 72.51 0.24 Allowed 'General case' 0 N--CA 1.469 0.513 0 O-C-N 124.15 0.906 . . . . 0.0 111.526 179.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.536 HG23 HD21 ' A' ' 71' ' ' LEU . 73.1 mt -90.56 117.68 34.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.19 -179.595 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -149.12 164.62 34.17 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.074 179.452 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.632 ' HG ' HD21 ' A' ' 12' ' ' LEU . 62.7 mt -91.07 136.42 33.09 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.085 0.469 . . . . 0.0 110.954 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -92.76 -66.1 0.95 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.841 -178.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -81.65 46.1 0.94 Allowed 'General case' 0 CA--C 1.514 -0.424 0 CA-C-O 120.985 0.421 . . . . 0.0 111.709 -178.58 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 57.77 22.46 47.3 Favored Glycine 0 C--N 1.317 -0.525 0 CA-C-N 115.174 -0.921 . . . . 0.0 113.189 179.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.606 ' HA2' HD13 ' A' ' 64' ' ' LEU . . . 121.53 -12.59 9.5 Favored Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 120.225 -0.988 . . . . 0.0 113.575 179.616 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.571 ' CG ' ' HB3' ' A' ' 4' ' ' ALA . 17.9 mtm105 -92.68 1.9 57.02 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 117.806 0.803 . . . . 0.0 110.899 -179.498 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 17.8 tttp -157.65 133.22 9.09 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 -179.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.591 ' HB2' HD11 ' A' ' 90' ' ' LEU . 10.5 tt -109.35 129.14 55.54 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -179.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.551 HG22 ' HA3' ' A' ' 87' ' ' GLY . 2.4 p -121.07 131.22 54.14 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.355 0.597 . . . . 0.0 111.575 -179.476 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.526 ' HB3' ' HA ' ' A' ' 62' ' ' ILE . 25.0 p -158.03 174.26 15.5 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.786 -179.494 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.567 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 57.1 ttt180 -106.72 100.11 29.2 Favored Pre-proline 0 C--N 1.319 -0.735 0 C-N-CA 121.084 -0.246 . . . . 0.0 110.449 178.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.693 ' O ' ' HB3' ' A' ' 83' ' ' ARG . 19.6 Cg_endo -65.39 126.12 15.68 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.493 2.129 . . . . 0.0 110.471 178.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.679 ' HA ' ' HB2' ' A' ' 83' ' ' ARG . 0.1 OUTLIER -120.26 145.01 47.47 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.987 0.423 . . . . 0.0 111.561 -179.806 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.644 HG22 ' O ' ' A' ' 82' ' ' PHE . 15.1 t -74.31 142.25 45.2 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.095 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.6 p -72.74 -12.05 15.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.525 -178.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -64.24 -28.52 69.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.558 179.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -161.24 -16.5 0.03 OUTLIER Glycine 0 CA--C 1.518 0.246 0 C-N-CA 120.065 -1.064 . . . . 0.0 113.496 -179.338 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.63 ' HA2' ' HD3' ' A' ' 76' ' ' LYS . . . 97.43 20.7 21.8 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.761 -0.733 . . . . 0.0 111.787 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.644 ' O ' HG22 ' A' ' 77' ' ' THR . 26.7 p90 -112.17 150.68 30.47 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 119.373 -0.346 . . . . 0.0 110.186 -179.202 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.693 ' HB3' ' O ' ' A' ' 75' ' ' PRO . 0.0 OUTLIER 167.13 -152.86 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.302 0 O-C-N 123.953 0.783 . . . . 0.0 109.482 179.247 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 48.8 mm-40 -117.05 175.78 5.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.453 0.168 . . . . 0.0 111.427 -177.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.567 ' HA ' ' HA ' ' A' ' 74' ' ' ARG . 23.6 ttt180 -111.89 149.73 31.43 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 178.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -168.35 -161.9 0.38 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.642 -178.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.551 ' HA3' HG22 ' A' ' 72' ' ' THR . . . -153.25 161.74 29.84 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.785 179.742 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.48 HD11 ' CD1' ' A' ' 50' ' ' TRP . 13.9 tt -130.82 139.92 49.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 179.645 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.48 ' HB3' HD22 ' A' ' 91' ' ' ASN . 18.1 m-20 -82.21 138.24 34.71 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.047 0.451 . . . . 0.0 110.812 -179.57 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.734 HD13 HD11 ' A' ' 19' ' ' LEU . 56.5 mt -104.94 50.32 0.79 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.618 0.723 . . . . 0.0 111.26 -178.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.48 HD22 ' HB3' ' A' ' 89' ' ' ASP . 34.5 m-80 -82.96 3.34 30.41 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.324 179.027 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 40.3 mtp180 -98.85 -2.71 37.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.58 179.034 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.401 HG13 HD22 ' A' ' 37' ' ' LEU . 21.7 mm -110.4 96.26 4.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 24.9 tp60 -112.04 148.33 34.09 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.489 -178.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.439 ' OD1' ' HA ' ' A' ' 3' ' ' TYR . 17.7 p-10 -94.36 119.72 33.52 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.862 179.015 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.9 p -114.59 119.37 61.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.689 179.392 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 59.18 27.22 16.16 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.802 -179.486 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 92.43 -8.48 77.16 Favored Glycine 0 N--CA 1.447 -0.628 0 CA-C-N 115.971 -0.559 . . . . 0.0 113.155 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.21 135.08 43.27 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 117.409 0.604 . . . . 0.0 110.932 -179.154 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.557 HD13 ' SG ' ' A' ' 23' ' ' CYS . 3.9 tp -80.74 118.77 22.57 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.689 179.495 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 47.0 t -132.57 138.07 52.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 120.926 0.393 . . . . 0.0 110.79 -179.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.628 ' HB2' HD11 ' A' ' 35' ' ' LEU . 12.1 t80 -80.93 129.3 34.46 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 178.348 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 . . . . . 0 C--N 1.313 -0.993 0 CA-C-O 118.309 -0.853 . . . . 0.0 110.185 -179.604 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.179 0 CA-C-O 121.082 0.468 . . . . 0.0 110.994 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.564 ' OG ' ' HA ' ' A' ' 91' ' ' ASN . 3.8 m -119.1 171.54 8.2 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.17 179.141 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.43 ' HA ' ' OD1' ' A' ' 95' ' ' ASN . 21.4 p90 -59.54 -39.55 84.32 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.786 0.327 . . . . 0.0 110.915 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -56.24 -19.77 15.41 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 -178.328 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -69.69 -22.88 63.38 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.087 0.47 . . . . 0.0 110.35 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 24.0 m -138.36 35.6 2.28 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.456 0.646 . . . . 0.0 109.259 178.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.438 ' HA ' ' HZ3' ' A' ' 30' ' ' TRP . 9.0 t -138.18 161.03 37.87 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.477 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 25.0 ptt180 -149.49 165.58 31.73 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.496 -179.266 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 54.66 52.97 11.28 Favored 'General case' 0 C--N 1.331 -0.208 0 O-C-N 123.855 0.722 . . . . 0.0 111.704 178.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.436 ' HA ' ' HB2' ' A' ' 21' ' ' ALA . . . -86.51 117.83 25.54 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.095 179.61 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 34.5 m -118.22 169.08 9.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.328 -179.427 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.731 HD21 ' HG ' ' A' ' 64' ' ' LEU . 3.2 mm? -105.95 114.61 28.85 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.649 -179.115 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.436 ' OG1' ' HB ' ' A' ' 18' ' ' THR . 24.0 p -110.55 163.39 13.77 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.003 -179.733 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 62.7 27.76 16.26 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.043 179.342 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 98.8 -17.74 57.85 Favored Glycine 0 N--CA 1.454 -0.12 0 C-N-CA 120.457 -0.878 . . . . 0.0 112.583 179.459 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.634 ' HA2' ' HB3' ' A' ' 12' ' ' LEU . . . 121.86 35.13 0.8 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.802 -0.714 . . . . 0.0 112.09 179.514 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.461 ' HB2' ' HB3' ' A' ' 38' ' ' ASP . 3.5 ptm180 -118.76 -25.64 6.3 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.149 0.499 . . . . 0.0 110.551 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.436 ' HB ' ' OG1' ' A' ' 13' ' ' THR . 4.8 m -108.31 135.26 49.91 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.827 -179.686 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.667 HD11 HD13 ' A' ' 90' ' ' LEU . 63.0 mt -97.65 113.76 25.57 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.787 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.498 ' HA ' ' HG2' ' A' ' 34' ' ' GLU . 16.7 ttm180 -107.02 118.68 37.33 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 178.527 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.436 ' HB2' ' HA ' ' A' ' 10' ' ' ALA . . . -154.5 168.05 28.01 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.016 0.436 . . . . 0.0 111.853 -178.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -89.54 111.6 22.57 Favored 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 177.485 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.439 ' SG ' HD13 ' A' ' 100' ' ' LEU . 61.1 m -97.89 122.89 41.54 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 -179.36 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.411 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 19.0 ttt180 -77.23 111.07 12.46 Favored 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 179.073 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.449 HD21 ' HB3' ' A' ' 29' ' ' ASN . 34.9 p30 -74.96 168.0 20.81 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.168 179.713 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.68 -27.44 27.8 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -178.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -77.92 -4.56 47.44 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.342 0.591 . . . . 0.0 110.964 -179.099 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 81.28 29.5 40.55 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.962 -0.637 . . . . 0.0 111.568 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.449 ' HB3' HD21 ' A' ' 25' ' ' ASN . 8.0 t-20 -112.95 153.03 28.65 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.438 ' HZ3' ' HA ' ' A' ' 7' ' ' SER . 99.1 m95 -99.14 114.5 27.29 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.149 0.499 . . . . 0.0 111.205 -179.156 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 6.9 m -114.17 131.89 64.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.385 179.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 17.3 m -79.41 109.57 13.9 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.894 0.378 . . . . 0.0 110.45 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 74.3 m -123.1 154.44 38.59 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.753 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.645 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 46.1 mt-10 -132.84 132.98 42.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.786 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.575 HD11 ' HB2' ' A' ' 102' ' ' PHE . 2.5 tm? -124.37 131.61 53.51 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 179.259 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.45 ' N ' HD13 ' A' ' 35' ' ' LEU . 8.4 m-20 -89.86 108.52 19.75 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.082 -179.666 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.502 HD13 HD22 ' A' ' 90' ' ' LEU . 1.6 mt -81.69 -16.93 49.7 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.894 -179.571 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.461 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 4.7 p-10 -61.79 -11.88 14.49 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.442 -179.264 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 54.0 p -76.66 -24.68 53.24 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.431 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 34.8 t -128.64 -8.33 5.09 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.206 0.446 . . . . 0.0 112.206 -179.351 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 47.3 mt -103.44 132.67 49.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 O-C-N 121.851 -0.531 . . . . 0.0 110.046 178.324 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.564 ' HA3' ' HB3' ' A' ' 52' ' ' MET . . . -149.71 159.51 28.11 Favored Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.799 -0.715 . . . . 0.0 111.538 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.457 HD22 ' CD1' ' A' ' 48' ' ' LEU . 19.1 p30 -163.35 50.17 0.25 Allowed Pre-proline 0 CA--C 1.537 0.47 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -179.689 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -68.46 -23.52 37.48 Favored 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 121.924 1.749 . . . . 0.0 112.227 -179.03 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.425 ' O ' ' HD3' ' A' ' 83' ' ' ARG . 3.3 m-20 -87.31 -15.96 36.5 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.537 179.739 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.52 ' HA3' ' HG2' ' A' ' 83' ' ' ARG . . . 108.6 11.68 22.7 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.461 -0.876 . . . . 0.0 112.741 -179.161 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -125.82 132.07 52.31 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.62 0.248 . . . . 0.0 110.392 179.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.497 HD23 HG22 ' A' ' 88' ' ' ILE . 9.2 mp -83.7 144.8 29.13 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.878 -178.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 171.76 170.38 35.68 Favored Glycine 0 N--CA 1.439 -1.134 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.11 178.245 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 90.3 m95 -94.88 125.8 39.78 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 153.43 -52.87 0.46 Allowed Glycine 0 N--CA 1.448 -0.56 0 N-CA-C 111.191 -0.764 . . . . 0.0 111.191 -179.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.564 ' HB3' ' HA3' ' A' ' 42' ' ' GLY . 2.9 tpt -86.59 174.36 8.95 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.595 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.453 ' H ' ' HE2' ' A' ' 52' ' ' MET . 3.9 pt20 -133.67 169.8 16.49 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 118.69 0.677 . . . . 0.0 111.85 -179.174 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 65.81 38.57 5.09 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.389 -0.823 . . . . 0.0 112.855 178.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.515 ' HB3' ' HA2' ' A' ' 42' ' ' GLY . 14.0 p90 -61.78 -29.85 70.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.721 0.296 . . . . 0.0 110.929 179.644 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.45 ' HB2' ' HB3' ' A' ' 17' ' ' ARG . 23.3 t -56.61 -36.12 69.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.158 -0.474 . . . . 0.0 112.042 -178.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 28.2 m80 -80.92 -18.43 47.17 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.899 -0.32 . . . . 0.0 111.543 -179.207 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 19.8 m -106.75 19.37 20.58 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.527 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 49.3 m -136.82 152.77 50.66 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.331 0.586 . . . . 0.0 111.628 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -129.06 136.27 50.04 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.197 178.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.427 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 33.6 m-20 63.63 83.65 0.16 Allowed 'General case' 0 N--CA 1.469 0.511 0 O-C-N 123.608 0.567 . . . . 0.0 111.304 -179.317 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.504 HG23 HD21 ' A' ' 71' ' ' LEU . 70.2 mt -101.51 124.19 55.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.285 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.8 tptt -145.03 154.61 42.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.766 0.317 . . . . 0.0 111.247 -179.396 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.731 ' HG ' HD21 ' A' ' 12' ' ' LEU . 86.1 mt -99.5 124.83 45.03 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.018 178.412 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -86.62 -60.26 2.04 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-O 121.194 0.521 . . . . 0.0 111.42 -179.61 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.607 ' HB2' ' HB3' ' A' ' 69' ' ' ARG . 20.3 mt-10 -78.19 38.44 0.29 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.665 -178.42 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 67.73 -4.76 3.87 Favored Glycine 0 N--CA 1.454 -0.117 0 CA-C-N 115.77 -0.65 . . . . 0.0 113.633 179.075 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.57 ' HA2' HD13 ' A' ' 64' ' ' LEU . . . 145.98 -6.96 1.4 Allowed Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.129 -179.429 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.607 ' HB3' ' HB2' ' A' ' 66' ' ' GLU . 5.5 tpp180 -81.7 -18.23 45.13 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.087 0.47 . . . . 0.0 109.807 179.668 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.429 ' HE3' ' HB2' ' A' ' 70' ' ' LYS . 35.6 ttmt -143.42 136.21 27.54 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.916 -179.234 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.668 ' HB2' HD11 ' A' ' 90' ' ' LEU . 10.5 tt -115.07 118.45 33.41 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.47 -0.787 . . . . 0.0 109.923 -179.709 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.493 HG22 ' HA3' ' A' ' 87' ' ' GLY . 3.6 p -108.82 134.13 51.93 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.241 0.543 . . . . 0.0 110.874 179.388 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.451 ' SG ' HD21 ' A' ' 48' ' ' LEU . 18.0 p -156.55 164.25 38.43 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.001 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.583 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 33.4 ttt-85 -100.87 101.87 17.51 Favored Pre-proline 0 C--N 1.316 -0.872 0 C-N-CA 120.424 -0.511 . . . . 0.0 110.254 178.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.639 ' O ' ' HB3' ' A' ' 83' ' ' ARG . 57.9 Cg_endo -70.55 129.2 16.38 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.636 2.224 . . . . 0.0 110.167 178.631 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.69 ' HA ' ' HB2' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -121.2 140.99 51.28 Favored 'General case' 0 C--N 1.313 -1.009 0 O-C-N 123.28 0.362 . . . . 0.0 110.949 179.85 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.723 HG22 ' O ' ' A' ' 82' ' ' PHE . 14.0 t -76.86 130.73 38.01 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 178.478 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 35.3 m -72.66 -6.01 7.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 123.557 0.536 . . . . 0.0 111.492 -179.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -67.78 -35.97 79.62 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.229 178.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.431 ' HA3' ' CE2' ' A' ' 82' ' ' PHE . . . -145.3 -14.18 0.21 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.413 -0.898 . . . . 0.0 113.152 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.582 ' HA2' ' HE3' ' A' ' 76' ' ' LYS . . . 88.23 16.78 58.6 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.011 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.723 ' O ' HG22 ' A' ' 77' ' ' THR . 37.8 p90 -111.29 148.46 32.87 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 118.789 -0.624 . . . . 0.0 109.33 -179.195 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.69 ' HB2' ' HA ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 172.05 -160.14 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.987 0.423 . . . . 0.0 111.938 179.753 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 -125.74 173.22 9.19 Favored 'General case' 0 C--O 1.223 -0.317 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.006 -177.473 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.594 ' HA ' ' HD2' ' A' ' 75' ' ' PRO . 72.5 ttt180 -109.41 153.71 23.61 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 110.07 -0.344 . . . . 0.0 110.07 178.711 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -166.23 -170.24 1.64 Allowed 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.581 -179.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.493 ' HA3' HG22 ' A' ' 72' ' ' THR . . . -143.12 151.61 23.35 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.335 -0.936 . . . . 0.0 113.358 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.497 HG22 HD23 ' A' ' 48' ' ' LEU . 13.0 tt -123.31 137.49 56.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.025 0.441 . . . . 0.0 109.883 179.408 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -79.8 138.02 37.13 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.787 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.668 HD11 ' HB2' ' A' ' 71' ' ' LEU . 37.2 mt -106.08 40.88 1.5 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.499 0.666 . . . . 0.0 110.936 -179.014 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.564 ' HA ' ' OG ' ' A' ' 2' ' ' SER . 39.5 m-80 -76.03 3.55 10.15 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.079 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 20.9 mtp180 -96.95 -6.6 35.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.641 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 18.7 mm -98.78 116.75 42.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 -179.355 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 24.5 tp60 -126.81 143.36 51.28 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.275 0.559 . . . . 0.0 111.301 -178.229 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.43 ' OD1' ' HA ' ' A' ' 3' ' ' TYR . 12.9 p-10 -95.19 110.82 22.74 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.304 178.529 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 40.8 t -96.97 106.45 18.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.693 179.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 20.3 m-80 56.98 36.76 28.21 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.272 0.558 . . . . 0.0 111.304 -179.341 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 96.14 -22.05 41.82 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.828 -0.701 . . . . 0.0 113.388 179.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.426 HH11 ' HD3' ' A' ' 99' ' ' ARG . 3.6 mpt_? -86.21 122.61 30.45 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 117.295 0.547 . . . . 0.0 110.211 -179.474 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.439 HD13 ' SG ' ' A' ' 23' ' ' CYS . 11.6 tp -79.63 114.59 18.67 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 32.7 t -128.15 140.71 48.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 120.984 0.421 . . . . 0.0 110.878 -178.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.575 ' HB2' HD11 ' A' ' 35' ' ' LEU . 8.3 t80 -83.93 129.3 34.93 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.121 -0.491 . . . . 0.0 109.81 178.665 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 2.7 tp-100 . . . . . 0 C--O 1.249 1.073 0 CA-C-O 119.031 -0.509 . . . . 0.0 110.451 179.396 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.672 ' HG3' HE22 ' A' ' 94' ' ' GLN . 22.0 ptp . . . . . 0 N--CA 1.483 1.204 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.8 m -118.33 178.04 4.59 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.779 -0.191 . . . . 0.0 110.98 179.294 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.589 ' HB3' ' HA ' ' A' ' 94' ' ' GLN . 9.8 p90 -59.62 -34.09 72.33 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.724 0.297 . . . . 0.0 111.543 179.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.475 ' HA ' ' HB3' ' A' ' 7' ' ' SER . . . -55.35 -18.32 6.39 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 112.84 0.681 . . . . 0.0 112.84 -178.649 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -56.24 -38.29 70.91 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.326 0.584 . . . . 0.0 110.064 178.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 44.3 m -129.02 40.58 3.61 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.218 179.214 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.475 ' HB3' ' HA ' ' A' ' 4' ' ' ALA . 29.3 t -148.1 148.44 30.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.264 -179.529 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -143.45 163.74 32.27 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.669 -179.671 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 64.22 49.04 2.71 Favored 'General case' 0 N--CA 1.465 0.318 0 O-C-N 123.718 0.636 . . . . 0.0 111.441 179.349 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.543 ' HA ' ' HB2' ' A' ' 21' ' ' ALA . . . -77.92 117.29 19.12 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.361 179.563 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 33.8 m -119.14 167.99 11.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.207 -179.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.599 ' HB3' ' HA2' ' A' ' 16' ' ' GLY . 3.3 mm? -104.38 114.53 28.82 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.661 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.476 HG21 ' NE ' ' A' ' 20' ' ' ARG . 28.4 p -112.4 166.69 11.07 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.548 -179.458 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 60.89 42.55 12.88 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.962 179.563 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 97.53 -48.03 1.54 Allowed Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 120.661 -0.781 . . . . 0.0 111.546 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.599 ' HA2' ' HB3' ' A' ' 12' ' ' LEU . . . 145.98 46.79 0.03 OUTLIER Glycine 0 N--CA 1.444 -0.824 0 N-CA-C 110.306 -1.117 . . . . 0.0 110.306 -179.388 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.573 ' HB2' ' HB2' ' A' ' 38' ' ' ASP . 7.1 ptp180 -132.95 -25.59 1.81 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.355 -0.423 . . . . 0.0 111.313 -178.595 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.47 ' HB ' ' OG1' ' A' ' 13' ' ' THR . 2.9 m -100.36 133.3 44.99 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.76 -179.688 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.792 HD11 HD13 ' A' ' 90' ' ' LEU . 68.8 mt -92.52 111.54 23.16 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.325 179.1 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.476 ' NE ' HG21 ' A' ' 13' ' ' THR . 37.4 ttm180 -110.42 120.22 41.73 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.721 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.543 ' HB2' ' HA ' ' A' ' 10' ' ' ALA . . . -152.96 167.24 29.83 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.76 0.314 . . . . 0.0 111.369 -179.125 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.423 ' O ' ' HA ' ' A' ' 7' ' ' SER . 37.1 mt-10 -91.01 107.76 19.41 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 178.262 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 65.9 m -100.32 133.11 45.23 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 120.914 0.387 . . . . 0.0 110.212 -179.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.44 HH11 ' HD2' ' A' ' 24' ' ' ARG . 6.7 ttp85 -80.78 117.63 21.61 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-O 120.918 0.39 . . . . 0.0 110.483 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 38.7 p30 -80.31 165.75 22.01 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.103 179.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.13 -18.69 38.04 Favored 'General case' 0 N--CA 1.464 0.266 0 O-C-N 123.807 0.692 . . . . 0.0 112.137 -179.012 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -75.85 -13.48 60.27 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.457 0.646 . . . . 0.0 109.716 179.192 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 91.0 23.83 28.9 Favored Glycine 0 N--CA 1.447 -0.58 0 CA-C-N 115.327 -0.851 . . . . 0.0 112.609 179.463 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -122.76 158.61 29.8 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.755 0.312 . . . . 0.0 111.67 -179.105 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 96.7 m95 -90.32 130.73 36.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.14 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.2 m -129.17 137.47 57.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.533 178.454 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 37.6 m -78.58 109.95 13.25 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.467 179.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 61.6 m -118.06 152.5 35.43 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.609 -179.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.599 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 44.9 mt-10 -132.5 154.41 49.96 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.156 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.555 ' HB2' HD23 ' A' ' 100' ' ' LEU . 1.1 tm? -150.5 126.31 10.38 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 178.78 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -88.77 109.21 19.98 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.54 HD13 HD22 ' A' ' 90' ' ' LEU . 2.2 mt -81.73 -12.73 58.48 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.329 -179.395 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.712 ' OD2' ' HA ' ' A' ' 54' ' ' ASN . 3.0 t70 -65.96 -5.85 10.71 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.115 0.484 . . . . 0.0 110.845 -179.271 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 49.6 p -85.45 -26.38 26.38 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.857 -0.61 . . . . 0.0 112.03 -179.383 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 16.1 t -127.19 -2.59 6.35 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.573 -0.451 . . . . 0.0 112.089 -178.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.433 ' HB ' ' CD1' ' A' ' 55' ' ' PHE . 54.8 mt -111.21 134.34 53.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 O-C-N 122.124 -0.36 . . . . 0.0 110.388 179.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -148.72 158.41 27.65 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 121.12 -0.562 . . . . 0.0 111.787 179.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.635 ' ND2' ' HB2' ' A' ' 55' ' ' PHE . 9.2 p30 -157.04 46.62 0.26 Allowed Pre-proline 0 CA--C 1.537 0.475 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 179.635 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.575 ' HG2' ' SD ' ' A' ' 52' ' ' MET . 14.0 Cg_exo -66.99 -19.67 51.64 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 121.75 1.634 . . . . 0.0 111.671 -179.678 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 73.9 m-20 -88.77 -8.89 53.63 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.559 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.601 ' CA ' ' HG2' ' A' ' 83' ' ' ARG . . . 98.52 7.71 55.47 Favored Glycine 0 N--CA 1.443 -0.885 0 C-N-CA 120.488 -0.863 . . . . 0.0 112.557 -179.309 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -125.57 135.61 52.41 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.753 0.311 . . . . 0.0 110.286 179.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.475 ' HB3' ' HB ' ' A' ' 88' ' ' ILE . 86.4 mt -83.66 141.84 31.21 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.532 -178.532 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 176.51 168.28 36.36 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.447 179.193 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.424 ' HH2' HD11 ' A' ' 93' ' ' ILE . 89.1 m95 -95.71 134.81 38.2 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 147.35 -52.25 0.56 Allowed Glycine 0 CA--C 1.508 -0.404 0 N-CA-C 111.676 -0.569 . . . . 0.0 111.676 179.45 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.575 ' SD ' ' HG2' ' A' ' 44' ' ' PRO . 36.7 ttm -95.74 172.12 8.23 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 178.783 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -123.7 173.23 8.25 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 118.824 0.738 . . . . 0.0 111.507 -178.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.712 ' HA ' ' OD2' ' A' ' 38' ' ' ASP . 13.9 m120 66.82 63.37 0.49 Allowed 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 114.926 -1.034 . . . . 0.0 111.68 178.59 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.635 ' HB2' ' ND2' ' A' ' 43' ' ' ASN . 20.7 p90 -87.11 -35.95 18.39 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.336 179.452 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 17.7 t -64.47 -27.56 69.06 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.353 -178.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 69.5 m80 -76.37 -12.81 60.12 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.881 -179.259 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.519 ' O ' ' HG3' ' A' ' 76' ' ' LYS . 24.3 p -128.19 26.29 5.76 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.878 0.37 . . . . 0.0 111.303 -179.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 68.2 m -132.99 151.08 52.11 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 120.576 -0.45 . . . . 0.0 111.173 179.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -119.39 134.31 55.28 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.303 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.437 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 38.2 t70 61.1 84.65 0.13 Allowed 'General case' 0 N--CA 1.465 0.286 0 O-C-N 124.037 0.836 . . . . 0.0 110.934 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.488 HG23 HD21 ' A' ' 71' ' ' LEU . 72.2 mt -101.51 118.07 47.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.03 -179.127 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.456 ' HD3' ' N ' ' A' ' 64' ' ' LEU . 1.2 tmtp? -145.44 150.21 36.11 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 -179.792 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.606 HD13 ' HA2' ' A' ' 68' ' ' GLY . 56.1 mt -83.01 123.19 29.22 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.315 0.579 . . . . 0.0 111.456 -179.517 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -78.37 -61.79 1.89 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.13 -0.941 . . . . 0.0 111.973 -178.372 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 33.6 mm-40 -79.54 34.8 0.27 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.15 0.5 . . . . 0.0 111.433 -179.504 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 66.01 10.44 51.44 Favored Glycine 0 C--N 1.316 -0.575 0 CA-C-N 115.295 -0.866 . . . . 0.0 112.569 179.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.606 ' HA2' HD13 ' A' ' 64' ' ' LEU . . . 137.7 -16.95 3.5 Favored Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 120.348 -0.929 . . . . 0.0 112.963 179.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 27.2 mtt180 -83.23 -9.85 58.9 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 117.349 0.574 . . . . 0.0 110.779 -179.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 66.3 tttt -150.13 138.07 20.17 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.983 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.567 ' HB2' HD11 ' A' ' 90' ' ' LEU . 10.4 tt -107.2 126.44 52.41 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.958 -179.262 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.0 p -116.53 132.0 56.8 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.991 179.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.437 ' HA ' ' O ' ' A' ' 61' ' ' ASP . 26.8 p -159.97 175.4 13.06 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.065 -179.602 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.606 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 29.4 ttt180 -107.34 99.12 26.09 Favored Pre-proline 0 C--N 1.315 -0.892 0 C-N-CA 120.228 -0.589 . . . . 0.0 110.405 178.627 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.614 ' O ' ' HB3' ' A' ' 83' ' ' ARG . 55.3 Cg_endo -69.38 125.44 12.35 Favored 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 122.713 2.275 . . . . 0.0 110.492 178.686 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.746 ' HA ' ' HB2' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -120.52 139.99 52.11 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.904 0.383 . . . . 0.0 111.422 -179.693 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.723 HG22 ' O ' ' A' ' 82' ' ' PHE . 15.2 t -73.39 135.63 44.26 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 179.649 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 26.9 m -76.22 -8.99 12.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.63 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.522 -179.35 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -68.57 -30.18 68.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.776 179.531 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.555 ' HA3' ' CE2' ' A' ' 82' ' ' PHE . . . -146.01 -19.26 0.14 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.502 -0.856 . . . . 0.0 113.281 179.431 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.498 ' HA2' ' HE3' ' A' ' 76' ' ' LYS . . . 92.97 14.05 55.47 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.931 -0.652 . . . . 0.0 111.86 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.723 ' O ' HG22 ' A' ' 77' ' ' THR . 37.6 p90 -111.8 157.37 20.63 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 118.901 -0.571 . . . . 0.0 110.173 -178.349 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.746 ' HB2' ' HA ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 166.6 -157.57 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.357 0 O-C-N 123.661 0.601 . . . . 0.0 112.258 178.456 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 41.5 mm-40 -123.42 176.57 6.08 Favored 'General case' 0 CA--C 1.521 -0.173 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.384 -177.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.606 ' HA ' ' HA ' ' A' ' 74' ' ' ARG . 30.9 ttt85 -98.85 154.75 17.79 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 178.009 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.42 ' HG2' ' N ' ' A' ' 87' ' ' GLY . 9.1 tt0 -161.92 171.48 17.61 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.533 -178.086 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.42 ' N ' ' HG2' ' A' ' 86' ' ' GLN . . . -134.12 138.25 9.93 Favored Glycine 0 N--CA 1.447 -0.622 0 N-CA-C 111.695 -0.562 . . . . 0.0 111.695 178.696 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.475 ' HB ' ' HB3' ' A' ' 48' ' ' LEU . 11.1 tt -118.4 134.82 60.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 121.052 0.453 . . . . 0.0 110.09 -179.667 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.505 ' HB3' HD22 ' A' ' 91' ' ' ASN . 7.7 m-20 -76.1 136.98 39.86 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.232 -178.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.792 HD13 HD11 ' A' ' 19' ' ' LEU . 52.4 mt -105.74 40.46 1.56 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.382 0.611 . . . . 0.0 111.451 -179.128 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.505 HD22 ' HB3' ' A' ' 89' ' ' ASP . 29.5 m-80 -74.29 -2.91 27.12 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.27 179.413 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 8.4 mtp180 -91.79 -7.45 49.52 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.741 179.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.424 HD11 ' HH2' ' A' ' 50' ' ' TRP . 23.4 mm -105.47 112.1 37.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 -179.332 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.672 HE22 ' HG3' ' A' ' 1' ' ' MET . 7.9 mt-30 -132.56 159.38 39.62 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.143 0.497 . . . . 0.0 111.477 -179.433 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.421 ' HA ' ' O ' ' A' ' 99' ' ' ARG . 13.2 p-10 -104.48 134.0 48.4 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.876 179.523 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 49.3 t -114.93 105.08 17.94 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.395 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -179.496 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 17.7 m-80 61.81 26.91 16.38 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.858 -179.021 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 113.88 -35.84 4.3 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.688 -0.767 . . . . 0.0 114.602 178.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.421 ' O ' ' HA ' ' A' ' 95' ' ' ASN . 0.0 OUTLIER -86.8 139.33 30.8 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 118.029 0.914 . . . . 0.0 112.817 -177.891 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.555 HD23 ' HB2' ' A' ' 35' ' ' LEU . 7.1 tp -81.29 120.05 24.42 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.968 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 26.2 t -128.29 141.52 46.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.308 -179.102 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.444 ' HB2' HD11 ' A' ' 35' ' ' LEU . 16.9 t80 -80.53 132.24 35.64 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 178.705 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 2.7 tp-100 . . . . . 0 C--O 1.253 1.25 0 CA-C-O 118.595 -0.717 . . . . 0.0 110.045 179.703 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.1 ptp . . . . . 0 N--CA 1.481 1.083 0 CA-C-O 121.007 0.432 . . . . 0.0 110.524 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.624 ' HB2' ' HG2' ' A' ' 69' ' ' ARG . 20.1 m -114.08 -179.31 3.6 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.042 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.483 ' HA ' ' OD1' ' A' ' 95' ' ' ASN . 12.6 p90 -54.89 -40.89 70.25 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -179.58 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.803 ' HB3' ' HG3' ' A' ' 69' ' ' ARG . . . -62.2 -18.45 61.08 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 -178.445 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.469 ' HB2' ' O ' ' A' ' 2' ' ' SER . 0.9 OUTLIER -64.43 -22.43 66.96 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 121.329 0.585 . . . . 0.0 110.572 179.626 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 49.6 m -140.92 39.21 1.8 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.274 179.075 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.478 ' HB3' ' HA ' ' A' ' 4' ' ' ALA . 13.2 t -145.63 154.66 42.37 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.926 -1.034 . . . . 0.0 108.698 179.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 21.0 ptt180 -140.47 164.09 31.08 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.734 0.302 . . . . 0.0 111.26 -179.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 57.96 51.42 8.98 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.686 178.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.514 ' HA ' ' HB2' ' A' ' 21' ' ' ALA . . . -81.98 117.39 22.16 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.206 179.444 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 26.7 m -119.24 169.88 9.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.349 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.643 ' HB3' ' HA2' ' A' ' 16' ' ' GLY . 3.2 mm? -105.15 115.27 29.98 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.803 -179.478 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 23.5 p -111.74 169.6 8.72 Favored 'General case' 0 C--O 1.243 0.72 0 CA-C-O 121.115 0.483 . . . . 0.0 111.692 -179.43 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 62.67 26.87 15.88 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 115.285 -0.87 . . . . 0.0 112.56 179.218 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 101.8 -14.3 57.53 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.437 179.274 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.643 ' HA2' ' HB3' ' A' ' 12' ' ' LEU . . . 116.8 43.17 0.63 Allowed Glycine 0 N--CA 1.443 -0.869 0 N-CA-C 111.209 -0.756 . . . . 0.0 111.209 -179.659 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.711 ' HB2' ' HB2' ' A' ' 38' ' ' ASP . 14.0 ptm180 -130.6 -29.69 1.93 Allowed 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.301 -0.45 . . . . 0.0 111.26 -179.384 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.431 ' HA ' ' HA ' ' A' ' 36' ' ' ASP . 10.3 m -104.37 136.32 44.17 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.435 -179.628 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.655 ' O ' ' HA ' ' A' ' 34' ' ' GLU . 84.5 mt -93.3 117.61 30.28 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.369 179.698 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 44.3 ttt85 -113.81 119.85 38.76 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 178.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.514 ' HB2' ' HA ' ' A' ' 10' ' ' ALA . . . -153.76 167.14 30.63 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.924 0.393 . . . . 0.0 111.443 -178.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -90.98 109.13 20.37 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 177.65 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.505 ' SG ' HD13 ' A' ' 100' ' ' LEU . 68.5 m -100.09 135.64 41.2 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 120.897 0.38 . . . . 0.0 111.313 -178.122 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 17.3 ttp180 -80.02 115.55 19.66 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.99 179.309 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 34.3 p30 -80.29 167.62 20.05 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.789 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -52.04 -32.24 33.49 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 -178.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -71.35 -13.45 61.87 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.288 0.566 . . . . 0.0 111.004 -179.335 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 90.43 28.91 15.42 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.971 -0.633 . . . . 0.0 111.644 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -120.01 157.82 28.06 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.618 0.247 . . . . 0.0 110.834 -179.507 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 91.9 m95 -90.34 131.43 36.14 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.755 0.312 . . . . 0.0 111.362 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.9 m -133.32 130.6 57.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.116 178.164 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.4 m -77.11 112.87 14.23 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.573 -179.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 66.4 m -124.11 160.19 28.32 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.978 -179.535 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.655 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 47.4 mt-10 -139.32 143.77 37.98 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.104 -179.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.456 HD11 ' HB2' ' A' ' 102' ' ' PHE . 1.8 tm? -138.47 127.77 24.44 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 178.61 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.431 ' HA ' ' HA ' ' A' ' 18' ' ' THR . 27.1 t70 -91.01 109.79 21.04 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.94 0.4 . . . . 0.0 110.599 -179.177 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.553 HD11 HD11 ' A' ' 19' ' ' LEU . 1.5 mt -81.23 -14.24 57.69 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.747 -179.645 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.763 ' OD2' ' HA ' ' A' ' 54' ' ' ASN . 6.6 t70 -63.23 -15.71 57.92 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.291 0.567 . . . . 0.0 110.55 -179.301 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 68.1 p -80.21 -22.41 41.87 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.554 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 21.0 m -122.94 -8.68 8.33 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -177.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 65.4 mt -111.73 134.16 55.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 110.335 -0.246 . . . . 0.0 110.335 179.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.465 ' HA3' ' HB3' ' A' ' 52' ' ' MET . . . -140.94 151.98 22.85 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.827 -0.702 . . . . 0.0 111.871 179.445 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.851 HD22 ' HB3' ' A' ' 75' ' ' PRO . 38.7 p-10 -160.57 48.53 0.25 Allowed Pre-proline 0 CA--C 1.54 0.561 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -179.308 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.562 ' HD3' ' N ' ' A' ' 43' ' ' ASN . 10.1 Cg_exo -68.28 -18.21 44.68 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 121.883 1.722 . . . . 0.0 111.798 -179.164 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -93.28 -6.63 47.07 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.294 -0.866 . . . . 0.0 111.146 -179.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.532 ' HA3' ' HD3' ' A' ' 83' ' ' ARG . . . 100.22 9.33 48.29 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.11 -1.043 . . . . 0.0 112.926 -179.506 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.718 ' HA ' HE22 ' A' ' 86' ' ' GLN . 49.5 m-85 -125.08 128.98 49.32 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.119 0.485 . . . . 0.0 110.891 179.776 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.47 HD11 ' SG ' ' A' ' 73' ' ' CYS . 84.7 mt -83.41 137.87 33.74 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.782 -178.116 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -178.94 170.69 42.61 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 120.874 -0.679 . . . . 0.0 111.659 178.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.417 ' HH2' HD11 ' A' ' 93' ' ' ILE . 90.4 m95 -95.78 135.44 37.48 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.991 0.424 . . . . 0.0 110.153 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 147.89 -67.12 0.39 Allowed Glycine 0 N--CA 1.445 -0.706 0 N-CA-C 111.498 -0.641 . . . . 0.0 111.498 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.465 ' HB3' ' HA3' ' A' ' 42' ' ' GLY . 14.7 ttt -80.35 -179.46 7.13 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.458 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -131.36 168.07 18.19 Favored 'General case' 0 C--N 1.321 -0.668 0 O-C-N 122.082 -0.386 . . . . 0.0 111.111 -179.327 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.763 ' HA ' ' OD2' ' A' ' 38' ' ' ASP . 0.9 OUTLIER 69.4 61.21 0.3 Allowed 'General case' 0 N--CA 1.461 0.087 0 O-C-N 124.079 0.862 . . . . 0.0 111.762 179.002 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.43 ' HD1' ' HA ' ' A' ' 38' ' ' ASP . 16.6 p90 -87.21 -37.35 17.35 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.319 179.484 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 72.2 p -64.74 -22.42 66.98 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.409 0.623 . . . . 0.0 110.501 -179.11 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 76.6 m80 -75.94 -11.53 59.98 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.096 -179.43 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.406 ' O ' ' HG3' ' A' ' 76' ' ' LYS . 3.0 p -133.65 33.65 3.49 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.556 179.201 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 38.6 m -136.45 154.19 50.85 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.311 0.577 . . . . 0.0 111.678 -179.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -131.22 146.52 52.35 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.142 -0.935 . . . . 0.0 109.652 179.399 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.49 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 33.4 t70 58.72 66.86 1.0 Allowed 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 121.335 0.588 . . . . 0.0 110.917 178.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.563 ' HA ' ' HB3' ' A' ' 73' ' ' CYS . 74.5 mt -93.9 114.15 29.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.633 -179.583 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 29.0 tptt -144.54 147.65 33.47 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.992 0.425 . . . . 0.0 110.305 -179.574 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.62 ' HG ' HD21 ' A' ' 12' ' ' LEU . 65.6 mt -83.35 140.89 32.16 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.401 179.69 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -102.41 -55.27 2.5 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.023 -0.535 . . . . 0.0 112.232 -178.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.429 ' H ' ' HB3' ' A' ' 70' ' ' LYS . 62.9 mm-40 -83.81 36.26 0.55 Allowed 'General case' 0 CA--C 1.515 -0.4 0 CA-C-O 121.061 0.457 . . . . 0.0 111.199 -179.667 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 70.49 -2.08 17.46 Favored Glycine 0 C--N 1.315 -0.589 0 CA-C-N 115.263 -0.881 . . . . 0.0 112.799 179.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.587 ' HA2' HD13 ' A' ' 64' ' ' LEU . . . 146.77 -12.84 1.51 Allowed Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.406 -0.902 . . . . 0.0 113.323 -179.712 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.803 ' HG3' ' HB3' ' A' ' 4' ' ' ALA . 53.3 mtm180 -94.2 4.21 54.2 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 117.557 0.678 . . . . 0.0 111.174 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.429 ' HB3' ' H ' ' A' ' 66' ' ' GLU . 39.9 tptt -151.45 119.74 6.37 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 -179.401 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.592 ' HB2' HD11 ' A' ' 90' ' ' LEU . 9.7 tt -104.29 120.07 40.36 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 -179.763 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.8 p -113.65 133.72 55.14 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.007 0.432 . . . . 0.0 110.798 179.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.563 ' HB3' ' HA ' ' A' ' 62' ' ' ILE . 26.2 p -159.98 175.61 12.82 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.887 -179.416 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.586 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 3.7 tmt_? -110.28 98.18 34.47 Favored Pre-proline 0 C--N 1.311 -1.084 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 178.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.851 ' HB3' HD22 ' A' ' 43' ' ' ASN . 59.1 Cg_endo -71.64 134.53 24.3 Favored 'Trans proline' 0 CA--C 1.515 -0.448 0 C-N-CA 123.221 2.614 . . . . 0.0 111.599 179.72 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.717 ' HA ' ' HB2' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -121.42 144.03 48.9 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 123.294 0.371 . . . . 0.0 111.347 179.44 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.763 HG22 ' O ' ' A' ' 82' ' ' PHE . 14.4 t -81.15 138.1 35.89 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.103 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 35.6 m -76.97 -4.68 6.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 O-C-N 124.057 0.848 . . . . 0.0 111.481 -179.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -69.95 -33.81 72.6 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.006 0.431 . . . . 0.0 110.352 178.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.45 ' HA3' ' CE2' ' A' ' 82' ' ' PHE . . . -148.25 -17.23 0.11 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.363 -0.922 . . . . 0.0 113.202 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.626 ' HA2' ' HE3' ' A' ' 76' ' ' LYS . . . 93.68 16.41 45.7 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.577 -0.82 . . . . 0.0 111.473 -179.431 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.763 ' O ' HG22 ' A' ' 77' ' ' THR . 33.2 p90 -112.2 154.16 25.98 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 118.754 -0.641 . . . . 0.0 109.478 -178.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.717 ' HB2' ' HA ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 170.8 -160.13 0.01 OUTLIER 'General case' 0 C--O 1.234 0.263 0 O-C-N 123.311 0.382 . . . . 0.0 111.772 179.477 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -124.77 -174.33 3.0 Favored 'General case' 0 C--O 1.226 -0.132 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.527 -177.489 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.586 ' HA ' ' HA ' ' A' ' 74' ' ' ARG . 35.1 ttt-85 -99.61 155.95 17.32 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 177.768 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.718 HE22 ' HA ' ' A' ' 47' ' ' PHE . 8.9 tt0 -163.73 165.78 22.8 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 121.088 0.47 . . . . 0.0 111.854 -178.766 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -134.95 144.3 16.22 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 121.066 -0.588 . . . . 0.0 111.636 179.413 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 12.1 tt -123.64 138.92 51.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 120.975 0.417 . . . . 0.0 110.312 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -78.63 129.69 35.04 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.561 -179.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.623 HD13 HD11 ' A' ' 19' ' ' LEU . 60.4 mt -99.44 45.69 0.99 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.711 0.767 . . . . 0.0 110.291 179.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.473 HD22 ' N ' ' A' ' 91' ' ' ASN . 0.8 OUTLIER -79.15 3.13 18.55 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 114.821 -1.081 . . . . 0.0 110.039 -179.609 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 11.7 mtp180 -101.89 0.18 35.05 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.267 -179.122 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.426 ' CD1' HD22 ' A' ' 37' ' ' LEU . 21.9 mm -107.19 114.96 47.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 -179.321 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 27.0 tp60 -125.78 144.59 50.57 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.908 -178.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.483 ' OD1' ' HA ' ' A' ' 3' ' ' TYR . 12.9 p-10 -95.36 102.02 13.8 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.276 178.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 54.1 t -86.37 109.3 18.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 179.564 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 26.3 m-80 57.64 31.6 20.62 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.02 0.438 . . . . 0.0 110.789 -178.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 95.1 -18.95 56.36 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.566 -0.826 . . . . 0.0 112.831 179.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 5.6 mpt_? -86.18 124.36 32.49 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 -179.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.505 HD13 ' SG ' ' A' ' 23' ' ' CYS . 6.7 tp -76.21 116.48 16.94 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 -179.648 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 44.9 t -130.99 143.19 41.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.622 -179.074 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.456 ' HB2' HD11 ' A' ' 35' ' ' LEU . 16.0 t80 -79.04 135.52 36.9 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.757 -0.461 . . . . 0.0 109.757 178.509 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.586 HE21 ' HA ' ' A' ' 103' ' ' GLN . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.653 -0.689 . . . . 0.0 110.163 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.5 mtt . . . . . 0 N--CA 1.484 1.241 0 CA-C-O 120.892 0.377 . . . . 0.0 110.415 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.565 ' OG ' ' HA ' ' A' ' 91' ' ' ASN . 3.6 m -118.52 179.18 4.2 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.46 179.464 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.446 ' CZ ' HD13 ' A' ' 19' ' ' LEU . 13.6 p90 -57.25 -34.43 68.6 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.037 0.446 . . . . 0.0 110.411 178.335 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -57.29 -23.06 46.02 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 115.481 -0.781 . . . . 0.0 112.531 -179.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -64.98 -16.78 63.78 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 121.063 0.459 . . . . 0.0 110.815 179.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 49.7 m -146.66 35.48 0.95 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.712 178.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 44.5 m -145.48 163.55 34.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.879 179.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 6.1 ptp180 -148.05 165.12 31.75 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.596 -179.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 61.1 m-80 59.51 51.83 6.22 Favored 'General case' 0 N--CA 1.464 0.248 0 O-C-N 123.689 0.618 . . . . 0.0 111.376 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.484 ' HA ' ' HB2' ' A' ' 21' ' ' ALA . . . -83.89 117.38 23.29 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.391 179.418 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 31.2 m -123.0 168.9 14.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.481 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.81 HD21 ' HG ' ' A' ' 64' ' ' LEU . 3.4 mm? -104.45 114.32 28.48 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.68 -179.457 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 18.4 p -107.56 168.57 9.16 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.516 -179.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 60.4 39.8 18.13 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.039 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 89.62 -31.21 5.32 Favored Glycine 0 CA--C 1.519 0.335 0 CA-C-N 115.941 -0.572 . . . . 0.0 112.657 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.577 ' HA2' ' HB3' ' A' ' 12' ' ' LEU . . . 136.29 56.49 0.06 OUTLIER Glycine 0 N--CA 1.449 -0.472 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 -179.314 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.5 ptm180 -142.52 -31.89 0.51 Allowed 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.856 0.36 . . . . 0.0 111.078 -179.379 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.444 HG22 ' HB3' ' A' ' 34' ' ' GLU . 5.5 m -101.3 136.77 40.6 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.764 -179.538 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.751 HD11 HD13 ' A' ' 90' ' ' LEU . 67.8 mt -94.63 118.07 31.12 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.65 179.052 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.402 ' HD2' HH11 ' A' ' 20' ' ' ARG . 21.8 ttt180 -114.6 119.97 38.57 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 178.708 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.484 ' HB2' ' HA ' ' A' ' 10' ' ' ALA . . . -154.05 168.94 24.75 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.693 0.282 . . . . 0.0 111.317 -178.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.453 ' HB3' ' HB3' ' A' ' 30' ' ' TRP . 43.4 mt-10 -87.65 106.2 17.87 Favored 'General case' 0 CA--C 1.513 -0.461 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 178.048 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.553 ' SG ' HD13 ' A' ' 100' ' ' LEU . 30.4 m -93.25 121.26 34.43 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.451 -177.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.529 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 9.5 ttp180 -70.03 112.94 6.77 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.147 179.264 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.457 ' ND2' ' HB3' ' A' ' 29' ' ' ASN . 36.2 p30 -78.69 170.65 16.32 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.359 -179.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.96 -27.4 52.36 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -178.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -80.31 -1.44 41.0 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.498 0.666 . . . . 0.0 110.409 -179.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.97 28.95 48.5 Favored Glycine 0 N--CA 1.448 -0.55 0 CA-C-N 115.534 -0.757 . . . . 0.0 112.107 179.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.529 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 57.7 t30 -110.98 163.02 14.25 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 121.212 -0.195 . . . . 0.0 110.818 -179.03 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.453 ' HB3' ' HB3' ' A' ' 22' ' ' GLU . 92.5 m95 -101.55 115.71 31.13 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.528 179.616 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.8 m -116.49 148.87 18.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 120.993 0.425 . . . . 0.0 110.835 179.224 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 28.3 m -86.11 110.52 19.6 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.269 179.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.482 ' HB2' ' SG ' ' A' ' 23' ' ' CYS . 70.1 m -128.99 147.22 50.84 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.682 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.648 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 51.9 mt-10 -129.84 148.72 51.74 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.548 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.553 HD11 ' HB2' ' A' ' 102' ' ' PHE . 1.8 tm? -140.51 129.34 23.15 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 178.753 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.456 ' N ' HD13 ' A' ' 35' ' ' LEU . 14.5 m-20 -87.13 109.21 19.29 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 -179.565 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.506 HD13 HD22 ' A' ' 90' ' ' LEU . 1.9 mt -85.12 -21.43 29.28 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -179.19 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.4 ' HA ' ' HD1' ' A' ' 55' ' ' PHE . 5.9 p-10 -65.18 -6.96 10.65 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.744 0.307 . . . . 0.0 111.568 -178.386 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 69.0 p -81.09 -16.14 53.99 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.641 179.034 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.409 ' HG ' ' HZ ' ' A' ' 102' ' ' PHE . 29.2 t -133.28 -10.02 2.91 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.718 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 51.1 mt -104.81 134.26 46.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 178.264 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.52 ' HA3' ' HB3' ' A' ' 52' ' ' MET . . . -148.33 155.73 26.55 Favored Glycine 0 N--CA 1.442 -0.919 0 C-N-CA 120.577 -0.821 . . . . 0.0 112.112 -179.643 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.628 ' N ' ' HD3' ' A' ' 44' ' ' PRO . 27.0 p30 -158.2 43.92 0.18 Allowed Pre-proline 0 CA--C 1.542 0.648 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.628 ' HD3' ' N ' ' A' ' 43' ' ' ASN . 16.2 Cg_exo -67.46 -23.06 44.24 Favored 'Trans proline' 0 C--N 1.356 0.952 0 C-N-CA 121.967 1.778 . . . . 0.0 111.683 -179.219 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 52.5 m-80 -89.3 -1.92 58.25 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.11 179.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.534 ' HA3' ' HG2' ' A' ' 83' ' ' ARG . . . 92.6 11.17 59.64 Favored Glycine 0 N--CA 1.443 -0.843 0 C-N-CA 120.385 -0.912 . . . . 0.0 112.657 -179.692 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 43.5 m-85 -125.19 132.44 53.02 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.767 0.318 . . . . 0.0 110.588 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.424 HD23 HG22 ' A' ' 88' ' ' ILE . 10.3 mp -86.0 146.03 26.84 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.892 -178.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 169.22 171.31 34.79 Favored Glycine 0 N--CA 1.442 -0.944 0 CA-C-N 115.476 -0.784 . . . . 0.0 112.066 178.156 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.438 ' CD1' HD11 ' A' ' 88' ' ' ILE . 90.3 m95 -95.48 125.18 39.91 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.496 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 153.29 -44.85 0.59 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.936 -0.649 . . . . 0.0 111.637 -179.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.52 ' HB3' ' HA3' ' A' ' 42' ' ' GLY . 12.7 tpt -94.2 174.61 7.06 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.784 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 -130.72 171.56 12.96 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.993 -179.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 64.23 37.41 8.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.991 177.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.498 ' HB3' ' HA2' ' A' ' 42' ' ' GLY . 11.7 p90 -62.33 -38.42 89.4 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.528 -0.469 . . . . 0.0 109.865 179.191 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 15.6 t -60.09 -29.98 68.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.12 -179.215 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 27.9 m80 -77.03 -12.62 59.96 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.815 0.341 . . . . 0.0 111.301 -179.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 19.7 m -126.54 27.77 6.06 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.078 0.466 . . . . 0.0 111.166 -179.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 38.6 m -132.41 147.56 52.38 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.195 0.522 . . . . 0.0 111.258 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.668 ' HG3' ' HB3' ' A' ' 74' ' ' ARG . 7.0 pt-20 -121.23 142.44 49.91 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.51 178.571 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.419 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 37.6 t70 58.43 80.39 0.18 Allowed 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.55 0.691 . . . . 0.0 110.477 -178.691 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.542 HG23 HD21 ' A' ' 71' ' ' LEU . 70.5 mt -102.77 119.66 51.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.997 -179.267 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.4 tpmt? -148.97 156.82 42.82 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 -179.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.81 ' HG ' HD21 ' A' ' 12' ' ' LEU . 71.9 mt -88.39 121.3 30.63 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.984 0.421 . . . . 0.0 110.099 178.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -71.88 -55.45 7.5 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.899 -178.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.534 ' CB ' ' HB2' ' A' ' 69' ' ' ARG . 8.8 mm-40 -87.08 13.57 9.09 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.884 -179.396 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 69.9 23.17 77.11 Favored Glycine 0 N--CA 1.448 -0.528 0 CA-C-N 115.7 -0.682 . . . . 0.0 112.578 179.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 145.27 -36.76 1.36 Allowed Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.029 -1.082 . . . . 0.0 112.956 179.332 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.534 ' HB2' ' CB ' ' A' ' 66' ' ' GLU . 8.3 mmt85 -72.39 -29.12 63.46 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.928 0.394 . . . . 0.0 111.396 -179.784 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 41.7 tttp -140.45 140.09 35.33 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.976 -177.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.616 ' HB2' HD11 ' A' ' 90' ' ' LEU . 9.9 tt -111.35 122.93 49.15 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 179.142 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.2 p -110.87 131.89 54.66 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.361 0.6 . . . . 0.0 110.873 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.419 ' HA ' ' O ' ' A' ' 61' ' ' ASP . 24.6 p -156.61 167.51 30.22 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.708 -179.659 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.668 ' HB3' ' HG3' ' A' ' 60' ' ' GLU . 67.5 ttt180 -103.81 101.3 23.99 Favored Pre-proline 0 C--N 1.314 -0.958 0 N-CA-C 109.865 -0.421 . . . . 0.0 109.865 178.807 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.64 ' O ' ' HB3' ' A' ' 83' ' ' ARG . 61.5 Cg_endo -71.04 119.01 6.0 Favored 'Trans proline' 0 CA--C 1.513 -0.54 0 C-N-CA 122.871 2.381 . . . . 0.0 111.029 179.483 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.699 ' HA ' ' HB2' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -119.63 135.76 54.67 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 120.76 0.314 . . . . 0.0 110.486 179.795 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.715 HG22 ' O ' ' A' ' 82' ' ' PHE . 14.7 t -70.18 128.67 37.08 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 12.4 p -71.41 -12.57 16.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.474 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -60.24 -30.42 69.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.08 179.277 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.597 ' HA3' ' CE2' ' A' ' 82' ' ' PHE . . . -146.5 -35.68 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.433 0 CA-C-N 115.578 -0.737 . . . . 0.0 112.458 179.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 111.91 12.41 14.35 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 121.237 -0.506 . . . . 0.0 112.058 -179.522 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.715 ' O ' HG22 ' A' ' 77' ' ' THR . 16.1 p90 -112.66 152.82 28.54 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 118.782 -0.628 . . . . 0.0 110.37 -178.55 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.699 ' HB2' ' HA ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 167.52 -158.25 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.603 0 O-C-N 123.682 0.614 . . . . 0.0 111.994 178.675 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 57.4 mm-40 -117.62 -173.26 2.39 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.978 -178.088 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.632 ' HA ' ' HD2' ' A' ' 75' ' ' PRO . 73.2 ttt180 -115.93 151.38 35.5 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 178.524 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.463 ' HG3' ' O ' ' A' ' 85' ' ' ARG . 27.0 mt-30 -157.95 -170.1 3.05 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.379 0.609 . . . . 0.0 112.335 -178.387 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -155.33 145.98 13.46 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.09 179.304 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.438 HD11 ' CD1' ' A' ' 50' ' ' TRP . 12.4 tt -128.46 142.17 44.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.953 0.377 . . . . 0.0 110.474 -179.628 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.408 ' HB3' HD22 ' A' ' 91' ' ' ASN . 3.8 m-20 -82.5 133.82 35.2 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.184 0.516 . . . . 0.0 110.693 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.751 HD13 HD11 ' A' ' 19' ' ' LEU . 26.5 mt -101.02 39.64 1.37 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.616 -179.247 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.565 ' HA ' ' OG ' ' A' ' 2' ' ' SER . 9.4 m-80 -73.88 2.95 7.4 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.068 -0.969 . . . . 0.0 111.048 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 9.8 mtp180 -97.23 -11.07 24.63 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.459 179.316 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.436 ' CD1' HD22 ' A' ' 37' ' ' LEU . 23.3 mm -96.56 102.73 13.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 121.392 0.615 . . . . 0.0 109.449 -179.354 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 8.4 mm-40 -107.83 153.82 22.45 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.563 -178.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.432 ' HB3' HD12 ' A' ' 100' ' ' LEU . 22.8 p-10 -112.57 112.09 23.37 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.723 178.363 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.421 HG22 HD22 ' A' ' 97' ' ' ASN . 9.0 p -111.51 120.51 62.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.105 0.479 . . . . 0.0 110.176 -179.695 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.421 HD22 HG22 ' A' ' 96' ' ' VAL . 38.1 m-80 59.15 28.93 18.37 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.98 -178.623 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 88.09 -9.73 73.63 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.517 -179.36 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 10.5 mpt_? -91.4 124.8 35.86 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 -179.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.553 HD13 ' SG ' ' A' ' 23' ' ' CYS . 5.9 tp -82.16 117.11 22.06 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 16.6 t -129.24 138.07 55.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 120.651 0.262 . . . . 0.0 110.77 -179.136 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.553 ' HB2' HD11 ' A' ' 35' ' ' LEU . 6.8 t80 -80.91 125.72 30.48 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 177.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 . . . . . 0 C--N 1.311 -1.076 0 CA-C-O 118.077 -0.964 . . . . 0.0 110.856 179.848 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.456 ' HG2' HE22 ' A' ' 94' ' ' GLN . 16.5 ttt . . . . . 0 N--CA 1.479 1.0 0 CA-C-O 120.603 0.24 . . . . 0.0 110.471 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.5 ' OG ' ' HA ' ' A' ' 91' ' ' ASN . 11.8 m -104.67 178.07 4.67 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 179.56 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 34.6 p90 -59.86 -35.14 74.16 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 121.094 -0.242 . . . . 0.0 110.99 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -55.84 -22.09 23.21 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 112.114 0.412 . . . . 0.0 112.114 -179.356 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -68.27 -22.68 64.73 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 120.878 0.371 . . . . 0.0 110.716 179.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 9.6 p -139.73 29.97 2.1 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.31 0.576 . . . . 0.0 110.181 179.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 9.3 t -150.71 156.82 42.09 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -179.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 9.4 ptp180 -149.07 166.93 27.24 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.655 0.264 . . . . 0.0 111.127 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 57.3 m-80 57.85 60.71 2.65 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.967 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -90.48 125.47 35.6 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.853 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 34.0 m -122.62 170.65 12.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.8 179.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.63 HD21 ' HG ' ' A' ' 64' ' ' LEU . 3.2 mm? -104.8 114.21 28.29 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.355 -179.235 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 21.6 p -110.3 167.47 10.17 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.812 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 57.52 50.34 11.3 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.889 179.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 85.29 -37.95 3.01 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 121.01 -0.614 . . . . 0.0 112.516 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.618 ' HA2' ' HB3' ' A' ' 12' ' ' LEU . . . 138.59 38.83 0.11 Allowed Glycine 0 N--CA 1.447 -0.595 0 N-CA-C 111.284 -0.727 . . . . 0.0 111.284 -179.709 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.64 ' HB3' ' HB3' ' A' ' 56' ' ' SER . 48.7 ptt85 -123.49 -23.23 4.84 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.939 0.4 . . . . 0.0 110.744 -179.267 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.3 m -105.28 137.5 42.96 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.027 -179.384 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.743 HD11 HD13 ' A' ' 90' ' ' LEU . 58.5 mt -97.05 116.17 28.78 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.576 179.294 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.82 119.68 40.12 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 178.242 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -152.33 168.07 26.6 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.979 0.419 . . . . 0.0 111.776 -178.348 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -89.99 106.09 18.25 Favored 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 178.513 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 58.1 m -97.95 130.68 44.8 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 120.761 0.315 . . . . 0.0 110.633 -178.218 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.527 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 10.5 ttp180 -78.37 122.2 25.47 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.497 179.831 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.448 HD21 ' HB3' ' A' ' 29' ' ' ASN . 35.6 p30 -86.83 168.36 13.53 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.827 179.415 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.84 -31.32 49.03 Favored 'General case' 0 N--CA 1.464 0.255 0 O-C-N 123.555 0.535 . . . . 0.0 112.356 -179.11 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -69.51 -17.84 63.63 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.446 0.641 . . . . 0.0 110.662 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 93.72 28.7 10.82 Favored Glycine 0 N--CA 1.446 -0.684 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.313 -179.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.527 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 43.9 t30 -112.91 160.97 17.52 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.644 0.259 . . . . 0.0 110.901 -179.106 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 94.6 m95 -100.37 114.33 27.77 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.93 0.395 . . . . 0.0 111.049 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.6 m -117.75 129.19 74.55 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.381 178.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 13.7 m -75.01 111.66 10.45 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.877 -0.602 . . . . 0.0 111.015 -179.415 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.417 ' HB3' ' H ' ' A' ' 100' ' ' LEU . 73.5 m -121.58 153.3 38.22 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.609 179.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.601 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 42.8 mt-10 -129.4 141.46 51.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.206 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.615 HD11 ' HB2' ' A' ' 102' ' ' PHE . 1.9 tm? -136.54 131.96 34.58 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.387 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.416 ' N ' HD13 ' A' ' 35' ' ' LEU . 31.8 m-20 -88.58 109.8 20.38 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 -179.646 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.527 HD13 HD22 ' A' ' 90' ' ' LEU . 4.4 mt -79.64 -20.56 46.45 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.286 -179.636 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.543 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 5.1 p-10 -65.99 -5.87 10.92 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.629 -0.259 . . . . 0.0 111.461 -178.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 72.9 p -81.08 -20.84 40.65 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.625 179.472 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.446 ' SG ' ' HE3' ' A' ' 50' ' ' TRP . 40.9 t -129.05 -11.51 4.72 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.616 -179.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 51.3 mt -100.14 128.8 51.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.083 178.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.517 ' HA3' ' HB3' ' A' ' 52' ' ' MET . . . -139.34 154.34 23.44 Favored Glycine 0 N--CA 1.443 -0.876 0 C-N-CA 120.852 -0.69 . . . . 0.0 111.518 179.497 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.939 HD22 ' HB3' ' A' ' 75' ' ' PRO . 33.0 p-10 -160.95 44.24 0.15 Allowed Pre-proline 0 CA--C 1.539 0.533 0 N-CA-C 113.142 0.794 . . . . 0.0 113.142 -179.263 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -70.95 -16.76 32.5 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 121.404 1.403 . . . . 0.0 111.895 -179.387 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -89.07 -9.55 50.75 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.493 179.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.562 ' CA ' ' HG2' ' A' ' 83' ' ' ARG . . . 102.21 6.47 48.16 Favored Glycine 0 N--CA 1.443 -0.899 0 C-N-CA 120.482 -0.866 . . . . 0.0 112.503 -179.38 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.501 ' HD1' HE22 ' A' ' 86' ' ' GLN . 64.5 m-85 -125.14 134.42 52.44 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 122.732 -0.275 . . . . 0.0 110.85 179.808 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.51 HD23 ' HB3' ' A' ' 43' ' ' ASN . 88.0 mt -83.99 146.42 27.99 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.218 -179.166 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 170.82 169.99 34.52 Favored Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 120.539 -0.839 . . . . 0.0 112.361 178.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.446 ' HE3' ' SG ' ' A' ' 40' ' ' CYS . 90.8 m95 -95.3 124.98 39.62 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 110.048 -0.352 . . . . 0.0 110.048 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 160.73 -60.05 0.3 Allowed Glycine 0 N--CA 1.448 -0.558 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.791 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.517 ' HB3' ' HA3' ' A' ' 42' ' ' GLY . 0.4 OUTLIER -86.69 -162.15 0.74 Allowed 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 -179.902 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -147.25 175.19 10.95 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.768 -0.373 . . . . 0.0 111.708 -179.468 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 43.7 m-80 62.72 54.15 2.39 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 123.936 0.773 . . . . 0.0 112.236 179.278 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -87.5 -17.25 32.54 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.179 178.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.64 ' HB3' ' HB3' ' A' ' 17' ' ' ARG . 6.1 p -55.21 -55.65 28.87 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 -177.741 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 47.4 m80 -80.96 -10.23 59.74 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.926 0.393 . . . . 0.0 111.264 -179.179 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.4 ' HB2' ' OD1' ' A' ' 43' ' ' ASN . 15.0 m -96.01 14.41 23.78 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.942 0.401 . . . . 0.0 110.79 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 19.5 m -136.56 152.93 51.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.0 0.428 . . . . 0.0 111.551 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -119.1 145.69 45.73 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.477 178.19 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 35.9 t70 49.93 74.59 0.2 Allowed 'General case' 0 N--CA 1.47 0.561 0 O-C-N 123.787 0.679 . . . . 0.0 111.662 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.518 HG23 HD21 ' A' ' 71' ' ' LEU . 75.0 mt -91.51 115.46 30.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.489 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 15.0 tptm -149.07 150.97 33.64 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 121.031 0.443 . . . . 0.0 111.532 -179.521 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.63 ' HG ' HD21 ' A' ' 12' ' ' LEU . 64.1 mt -88.95 129.93 35.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.383 179.35 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -86.43 -57.22 3.09 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-O 121.126 0.488 . . . . 0.0 111.186 -179.594 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.516 ' HG2' ' HB3' ' A' ' 70' ' ' LYS . 16.3 mm-40 -71.9 -5.74 36.79 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.189 -179.183 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 95.51 -0.07 63.14 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 121.014 -0.612 . . . . 0.0 111.759 -179.525 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 164.34 -39.55 0.31 Allowed Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.434 -0.889 . . . . 0.0 112.555 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 7.9 mmt180 -62.31 -33.48 74.76 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.516 ' HB3' ' HG2' ' A' ' 66' ' ' GLU . 32.2 ttpt -135.44 139.09 43.84 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.915 0.388 . . . . 0.0 111.962 -178.292 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.607 ' HB2' HD11 ' A' ' 90' ' ' LEU . 10.5 tt -117.55 132.81 56.47 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.485 -0.779 . . . . 0.0 109.355 179.42 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.454 HG22 ' HA3' ' A' ' 87' ' ' GLY . 18.7 p -125.64 144.78 50.44 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.937 0.398 . . . . 0.0 111.04 179.437 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.468 ' HB3' ' HA ' ' A' ' 62' ' ' ILE . 24.0 p -162.6 175.45 11.4 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.582 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 52.9 ttt180 -109.3 98.25 30.5 Favored Pre-proline 0 C--N 1.311 -1.101 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 178.616 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.939 ' HB3' HD22 ' A' ' 43' ' ' ASN . 32.1 Cg_endo -64.3 127.21 18.6 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 122.866 2.377 . . . . 0.0 110.279 179.338 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.721 ' HA ' ' HB2' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -120.28 147.56 44.83 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.068 0.461 . . . . 0.0 111.619 -179.663 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.713 HG22 ' O ' ' A' ' 82' ' ' PHE . 14.5 t -81.61 141.47 33.67 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 179.007 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.1 m -73.87 -8.3 11.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 O-C-N 123.923 0.764 . . . . 0.0 111.321 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 53.0 m-20 -63.89 -34.04 77.06 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-O 120.955 0.407 . . . . 0.0 110.312 179.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -157.0 -10.92 0.05 OUTLIER Glycine 0 CA--C 1.519 0.298 0 C-N-CA 120.468 -0.872 . . . . 0.0 113.183 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.35 18.49 42.07 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.768 -0.729 . . . . 0.0 111.881 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.713 ' O ' HG22 ' A' ' 77' ' ' THR . 39.2 p90 -111.4 157.85 19.77 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 118.677 -0.678 . . . . 0.0 109.418 -179.144 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.721 ' HB2' ' HA ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 167.36 -149.08 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.428 0 O-C-N 123.543 0.527 . . . . 0.0 111.516 179.659 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -130.31 157.04 43.62 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.088 -178.184 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.582 ' HA ' ' HA ' ' A' ' 74' ' ' ARG . 38.8 ttt85 -82.85 154.03 24.86 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 179.181 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.501 HE22 ' HD1' ' A' ' 47' ' ' PHE . 8.8 tt0 -162.57 164.57 26.74 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.795 -0.362 . . . . 0.0 111.309 -177.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.454 ' HA3' HG22 ' A' ' 72' ' ' THR . . . -128.22 146.0 16.45 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.094 179.6 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 12.3 tt -128.74 136.01 60.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 120.977 0.417 . . . . 0.0 110.305 179.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -80.34 138.85 36.76 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.057 0.456 . . . . 0.0 110.348 179.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.743 HD13 HD11 ' A' ' 19' ' ' LEU . 50.0 mt -101.98 43.38 1.07 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.804 0.811 . . . . 0.0 109.857 -179.755 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.5 ' HA ' ' OG ' ' A' ' 2' ' ' SER . 0.9 OUTLIER -76.67 0.28 20.89 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 114.689 -1.142 . . . . 0.0 111.097 -179.347 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 14.6 mtp180 -98.12 -6.11 32.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.517 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.415 HG13 HD22 ' A' ' 37' ' ' LEU . 22.8 mm -101.48 118.89 48.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 -179.131 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.456 HE22 ' HG2' ' A' ' 1' ' ' MET . 7.4 tp-100 -132.1 143.89 50.33 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.004 -178.721 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -96.92 102.92 14.8 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.654 0.74 . . . . 0.0 110.487 178.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.2 p -87.81 117.84 32.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.232 0.539 . . . . 0.0 110.047 179.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 60.43 27.18 16.78 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.228 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 95.83 -9.42 68.37 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.813 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.483 ' N ' ' HD2' ' A' ' 99' ' ' ARG . 4.0 mpt_? -99.77 124.82 45.43 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 122.394 -0.474 . . . . 0.0 110.17 -179.642 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.417 ' H ' ' HB3' ' A' ' 33' ' ' SER . 12.2 tp -75.76 114.99 14.99 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.977 -179.247 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 45.7 t -130.4 145.73 35.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.25 -179.066 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.615 ' HB2' HD11 ' A' ' 35' ' ' LEU . 11.8 t80 -78.67 135.65 37.25 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 178.538 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.947 0 CA-C-O 118.774 -0.631 . . . . 0.0 109.996 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.7 mtt . . . . . 0 N--CA 1.481 1.093 0 CA-C-O 120.647 0.26 . . . . 0.0 110.446 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -82.31 178.11 8.42 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 178.699 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.44 ' CB ' HD11 ' A' ' 100' ' ' LEU . 6.7 p90 -54.71 -39.89 68.66 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 -177.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.614 ' HA ' ' OG ' ' A' ' 7' ' ' SER . . . -60.62 -20.42 60.65 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -178.266 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -68.42 -35.48 77.69 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.418 0.628 . . . . 0.0 109.808 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 8.1 m -120.38 34.8 5.08 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.855 -179.12 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.614 ' OG ' ' HA ' ' A' ' 4' ' ' ALA . 92.6 p -142.73 167.14 22.79 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 121.053 0.454 . . . . 0.0 110.161 178.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 13.5 ptp180 -152.19 166.46 31.66 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.018 -179.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 51.0 m-80 59.31 47.57 11.25 Favored 'General case' 0 N--CA 1.466 0.367 0 O-C-N 123.646 0.591 . . . . 0.0 110.959 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.4 ' HA ' ' HB2' ' A' ' 21' ' ' ALA . . . -80.53 118.45 22.14 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.823 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 29.6 m -126.52 170.52 16.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.12 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.781 HD21 ' HG ' ' A' ' 64' ' ' LEU . 3.1 mm? -104.53 114.77 29.21 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.237 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.436 ' OG1' ' HB ' ' A' ' 18' ' ' THR . 14.8 p -109.89 166.37 10.98 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.736 179.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.528 ' O ' ' HG2' ' A' ' 17' ' ' ARG . 90.4 m-20 57.15 50.28 12.1 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.13 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 83.42 -34.2 2.91 Favored Glycine 0 N--CA 1.452 -0.27 0 CA-C-N 115.962 -0.563 . . . . 0.0 112.841 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.612 ' HA2' ' HB3' ' A' ' 12' ' ' LEU . . . 135.59 42.44 0.12 Allowed Glycine 0 N--CA 1.447 -0.567 0 N-CA-C 111.194 -0.762 . . . . 0.0 111.194 -179.348 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.528 ' HG2' ' O ' ' A' ' 14' ' ' ASN . 5.4 ptm180 -124.55 -27.53 3.7 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.95 0.405 . . . . 0.0 110.712 -179.419 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.467 HG22 ' HB3' ' A' ' 34' ' ' GLU . 2.3 m -102.63 134.52 45.87 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.192 -179.177 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.742 HD11 HD13 ' A' ' 90' ' ' LEU . 45.9 mt -94.43 111.08 22.82 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.05 178.75 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.457 ' HA ' ' HG2' ' A' ' 34' ' ' GLU . 25.7 ttt85 -106.98 120.03 40.96 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 179.421 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.4 ' HB2' ' HA ' ' A' ' 10' ' ' ALA . . . -155.06 167.03 31.73 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.873 0.368 . . . . 0.0 111.247 -179.706 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -89.09 108.03 19.37 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 177.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.592 ' SG ' HD13 ' A' ' 100' ' ' LEU . 46.8 m -95.93 129.73 43.11 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 120.778 0.323 . . . . 0.0 110.734 -178.376 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.571 ' HB2' ' CZ3' ' A' ' 30' ' ' TRP . 11.3 ttt85 -82.82 117.63 22.84 Favored 'General case' 0 N--CA 1.438 -1.06 0 N-CA-C 110.171 -0.307 . . . . 0.0 110.171 179.167 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 32.4 p30 -80.38 166.61 21.12 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.928 179.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.84 -26.03 44.82 Favored 'General case' 0 N--CA 1.465 0.285 0 O-C-N 123.702 0.626 . . . . 0.0 112.262 -178.59 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -71.12 -16.09 62.54 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.168 0.509 . . . . 0.0 110.091 179.663 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 93.21 24.67 21.48 Favored Glycine 0 N--CA 1.447 -0.567 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.22 179.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.44 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 32.7 m-20 -116.55 160.01 21.27 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.851 0.357 . . . . 0.0 111.449 -179.247 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.571 ' CZ3' ' HB2' ' A' ' 24' ' ' ARG . 93.5 m95 -95.73 122.62 38.7 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.067 0.46 . . . . 0.0 111.876 -179.305 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.4 m -122.8 134.08 67.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.59 178.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 23.1 m -75.23 113.09 12.19 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.05 179.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.407 ' HB2' ' SG ' ' A' ' 23' ' ' CYS . 74.4 m -128.43 153.57 46.96 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.08 -179.601 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.587 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 49.3 mt-10 -137.93 144.54 41.29 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.768 -179.582 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.455 HD12 HD23 ' A' ' 37' ' ' LEU . 1.8 tm? -137.86 129.28 27.91 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 178.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.435 ' N ' HD13 ' A' ' 35' ' ' LEU . 13.6 m-20 -86.88 109.74 19.51 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.417 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.534 HD13 HD22 ' A' ' 90' ' ' LEU . 3.0 mt -82.02 -18.27 43.89 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 112.57 0.581 . . . . 0.0 112.57 -178.655 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.459 ' HA ' ' HD1' ' A' ' 55' ' ' PHE . 6.7 p-10 -65.7 -6.18 10.76 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.708 0.29 . . . . 0.0 111.522 -178.56 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 46.9 p -78.76 -23.25 45.46 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.836 179.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.542 ' HG ' ' HZ ' ' A' ' 102' ' ' PHE . 17.2 t -130.31 -10.77 4.14 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -179.468 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.406 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 49.0 mt -99.77 128.76 51.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 178.504 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.533 ' HA3' ' HB3' ' A' ' 52' ' ' MET . . . -142.47 150.9 22.57 Favored Glycine 0 N--CA 1.442 -0.952 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.119 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.922 HD22 ' HB3' ' A' ' 75' ' ' PRO . 31.1 p-10 -157.11 47.94 0.31 Allowed Pre-proline 0 C--N 1.323 -0.579 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -179.713 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -73.01 -17.25 25.18 Favored 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 121.638 1.558 . . . . 0.0 111.87 -179.303 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -93.09 -5.84 49.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.467 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.593 ' HA3' ' HG2' ' A' ' 83' ' ' ARG . . . 101.56 7.15 49.13 Favored Glycine 0 N--CA 1.443 -0.871 0 C-N-CA 120.334 -0.936 . . . . 0.0 112.834 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -125.45 131.55 52.86 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.015 0.436 . . . . 0.0 111.309 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.451 HD23 ' HB3' ' A' ' 43' ' ' ASN . 81.7 mt -83.77 137.68 33.62 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.378 -178.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 177.62 171.66 41.32 Favored Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 120.861 -0.685 . . . . 0.0 111.854 179.08 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.48 ' CD2' ' HD3' ' A' ' 92' ' ' ARG . 90.6 m95 -96.29 125.04 40.52 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.997 0.427 . . . . 0.0 110.191 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 154.85 -58.3 0.39 Allowed Glycine 0 CA--C 1.507 -0.449 0 N-CA-C 110.916 -0.874 . . . . 0.0 110.916 -179.297 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.533 ' HB3' ' HA3' ' A' ' 42' ' ' GLY . 44.7 tpp -82.93 174.3 11.04 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 178.661 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -132.11 176.66 8.19 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 118.654 0.661 . . . . 0.0 111.798 -179.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 15.1 m-80 64.65 43.04 4.43 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.467 -0.788 . . . . 0.0 112.342 179.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.459 ' HD1' ' HA ' ' A' ' 38' ' ' ASP . 6.3 p90 -69.12 -25.5 64.43 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.997 -0.372 . . . . 0.0 109.997 179.217 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 9.4 p -58.24 -42.7 86.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.355 -179.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 41.4 m80 -80.26 -9.99 59.74 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.011 0.434 . . . . 0.0 111.215 -179.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.684 ' HA ' ' HD2' ' A' ' 76' ' ' LYS . 10.2 m -113.28 18.26 17.97 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.604 -178.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 23.5 m -131.85 143.64 50.32 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-O 121.158 0.504 . . . . 0.0 111.336 179.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 67.2 mm-40 -113.58 134.51 54.67 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.675 178.497 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 23.9 t70 57.34 79.6 0.19 Allowed 'General case' 0 C--N 1.322 -0.601 0 O-C-N 123.994 0.809 . . . . 0.0 111.33 -179.236 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.53 HG23 HD21 ' A' ' 71' ' ' LEU . 75.6 mt -91.6 123.57 43.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.882 179.691 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 27.8 tptt -149.05 149.88 31.85 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 110.156 -0.312 . . . . 0.0 110.156 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.781 ' HG ' HD21 ' A' ' 12' ' ' LEU . 70.3 mt -85.89 141.27 29.7 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.188 0.518 . . . . 0.0 110.608 179.233 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -100.68 -70.84 0.72 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.432 -0.804 . . . . 0.0 112.515 -178.283 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.452 ' HG3' ' HB3' ' A' ' 70' ' ' LYS . 31.3 mt-10 -74.67 49.0 0.38 Allowed 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -178.185 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 64.95 7.97 32.68 Favored Glycine 0 C--N 1.32 -0.326 0 CA-C-N 115.938 -0.574 . . . . 0.0 112.848 179.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.606 ' HA2' HD13 ' A' ' 64' ' ' LEU . . . 127.26 -3.3 7.24 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.645 -0.788 . . . . 0.0 113.122 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 29.9 ttp85 -95.43 0.38 53.31 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.793 0.806 . . . . 0.0 110.317 -179.448 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.452 ' HB3' ' HG3' ' A' ' 66' ' ' GLU . 0.5 OUTLIER -147.69 129.49 15.21 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.403 -179.984 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.575 ' HB2' HD11 ' A' ' 90' ' ' LEU . 10.0 tt -105.82 118.98 37.99 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 179.599 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.5 p -108.79 128.1 54.59 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.018 179.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.446 ' HB3' ' HA ' ' A' ' 62' ' ' ILE . 26.5 p -157.74 172.11 19.09 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.054 -179.727 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.531 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 78.9 ttt180 -108.16 100.44 36.82 Favored Pre-proline 0 C--N 1.31 -1.112 0 C-N-CA 120.225 -0.59 . . . . 0.0 109.971 178.614 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.922 ' HB3' HD22 ' A' ' 43' ' ' ASN . 19.2 Cg_endo -60.29 130.46 34.13 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 122.655 2.237 . . . . 0.0 110.246 178.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.684 ' HD2' ' HA ' ' A' ' 58' ' ' SER . 0.0 OUTLIER -119.97 154.14 34.93 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.256 0.551 . . . . 0.0 111.665 -179.133 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.716 ' HB ' ' HD2' ' A' ' 83' ' ' ARG . 6.3 t -94.08 147.64 22.94 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.69 -0.687 . . . . 0.0 109.551 179.131 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 7.4 p -72.34 -6.67 8.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 O-C-N 123.834 0.709 . . . . 0.0 111.941 -178.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -65.39 -23.15 66.89 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.108 0.48 . . . . 0.0 110.367 179.212 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -177.8 -8.99 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.987 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 94.42 22.1 25.27 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.707 -0.759 . . . . 0.0 111.72 179.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.627 ' O ' HG22 ' A' ' 77' ' ' THR . 26.7 p90 -111.33 153.1 26.45 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 -179.367 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.716 ' HD2' ' HB ' ' A' ' 77' ' ' THR . 0.0 OUTLIER 171.63 -148.39 0.0 OUTLIER 'General case' 0 C--O 1.233 0.224 0 O-C-N 123.683 0.614 . . . . 0.0 110.956 179.958 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -123.4 160.14 27.45 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.173 -177.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.531 ' HA ' ' HA ' ' A' ' 74' ' ' ARG . 41.8 ttt180 -86.66 155.09 20.54 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 179.562 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -163.99 169.32 18.16 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 121.091 0.472 . . . . 0.0 110.992 -178.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -136.85 133.06 6.29 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.841 -0.695 . . . . 0.0 111.686 179.169 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 10.1 tt -115.28 134.51 58.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-O 121.047 0.451 . . . . 0.0 110.18 -179.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -80.26 141.14 35.83 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.142 -179.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.742 HD13 HD11 ' A' ' 19' ' ' LEU . 16.6 mt -106.73 43.5 1.15 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.455 0.645 . . . . 0.0 110.887 -178.343 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 45.4 m-80 -79.63 3.28 19.52 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.463 -179.506 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.48 ' HD3' ' CD2' ' A' ' 50' ' ' TRP . 32.6 mtp180 -93.69 -9.89 36.28 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.576 178.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 17.2 mm -96.02 112.1 27.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 -179.57 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -119.1 147.01 44.63 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.149 -178.044 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 16.8 p-10 -95.6 102.89 14.73 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.51 0.671 . . . . 0.0 109.602 178.12 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 46.7 t -92.05 105.94 17.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.971 -179.351 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 60.7 33.88 20.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.842 -179.488 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 94.98 -23.03 35.03 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 121.037 -0.601 . . . . 0.0 113.007 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 3.7 mpt_? -87.13 129.39 34.95 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.945 0.373 . . . . 0.0 110.107 -179.181 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.592 HD13 ' SG ' ' A' ' 23' ' ' CYS . 6.7 tp -78.38 117.64 19.8 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -179.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 25.4 t -128.93 141.03 47.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.262 -179.155 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.542 ' HZ ' ' HG ' ' A' ' 40' ' ' CYS . 5.9 t80 -86.55 135.0 33.61 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 178.53 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.616 HE21 ' HA ' ' A' ' 103' ' ' GLN . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.178 0 CA-C-O 118.506 -0.759 . . . . 0.0 110.234 179.43 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.0 mpp? . . . . . 0 N--CA 1.479 0.999 0 CA-C-O 120.921 0.391 . . . . 0.0 110.158 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.1 m -118.55 179.53 4.1 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.645 -179.482 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.511 ' HA ' ' OD1' ' A' ' 95' ' ' ASN . 11.0 p90 -57.49 -35.19 69.88 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.666 -0.243 . . . . 0.0 111.298 179.245 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -57.29 -22.24 40.37 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -178.978 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -66.27 -13.6 60.68 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.05 0.453 . . . . 0.0 110.977 179.565 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 11.0 p -149.25 33.98 0.73 Allowed 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 178.814 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 15.9 t -146.95 150.7 35.7 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.021 -179.268 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 34.6 ptt180 -129.55 164.5 23.67 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.666 -179.232 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 51.25 65.32 1.52 Allowed 'General case' 0 C--N 1.329 -0.299 0 O-C-N 123.826 0.704 . . . . 0.0 112.151 178.503 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.446 ' HA ' ' HB2' ' A' ' 21' ' ' ALA . . . -91.3 117.85 30.0 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.155 179.449 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 33.8 m -119.39 166.95 13.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.881 -179.372 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.636 HD21 ' HG ' ' A' ' 64' ' ' LEU . 3.1 mm? -105.22 117.14 33.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.014 -179.734 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.49 ' OG1' ' HB ' ' A' ' 18' ' ' THR . 23.5 p -111.29 164.21 13.14 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.639 -179.65 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.49 ' HB3' ' HD3' ' A' ' 17' ' ' ARG . 89.6 m-20 62.26 39.08 12.86 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.71 179.265 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 84.62 -8.47 68.77 Favored Glycine 0 CA--C 1.517 0.179 0 C-N-CA 120.742 -0.742 . . . . 0.0 113.325 179.144 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.495 ' HA2' ' HB3' ' A' ' 12' ' ' LEU . . . 114.09 53.88 0.43 Allowed Glycine 0 N--CA 1.443 -0.873 0 C-N-CA 120.527 -0.844 . . . . 0.0 111.383 179.421 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.49 ' HD3' ' HB3' ' A' ' 14' ' ' ASN . 3.4 ptm180 -137.78 -34.01 0.69 Allowed 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.088 0.471 . . . . 0.0 110.573 -179.91 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.49 ' HB ' ' OG1' ' A' ' 13' ' ' THR . 4.2 m -102.36 135.06 44.65 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.54 -179.798 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.713 HD11 HD13 ' A' ' 90' ' ' LEU . 62.6 mt -94.95 116.4 28.65 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.218 179.136 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.411 ' NE ' HG21 ' A' ' 13' ' ' THR . 33.5 ttm180 -111.4 120.39 42.0 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 178.732 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.446 ' HB2' ' HA ' ' A' ' 10' ' ' ALA . . . -153.7 165.34 36.29 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.862 0.363 . . . . 0.0 111.418 -179.526 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -91.44 106.0 18.17 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 177.801 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.404 ' HB3' HD22 ' A' ' 95' ' ' ASN . 64.0 m -96.01 134.89 38.49 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 120.911 0.386 . . . . 0.0 110.984 -178.495 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.511 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 15.1 ttp180 -77.54 111.41 13.24 Favored 'General case' 0 N--CA 1.439 -0.999 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.052 179.558 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.463 HD21 ' HB3' ' A' ' 29' ' ' ASN . 38.2 p30 -75.71 169.38 18.22 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.48 -179.786 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.86 -33.29 64.42 Favored 'General case' 0 C--O 1.235 0.296 0 O-C-N 123.416 0.447 . . . . 0.0 111.718 -179.151 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -68.22 -14.69 63.17 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.327 0.584 . . . . 0.0 110.677 179.969 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 88.66 37.56 7.38 Favored Glycine 0 N--CA 1.447 -0.589 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 -179.504 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.511 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 53.7 t30 -124.81 164.16 20.6 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.496 0.189 . . . . 0.0 110.891 -179.082 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 91.1 m95 -98.05 124.89 42.77 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.885 179.587 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.4 m -128.42 137.88 56.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.028 178.544 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 37.4 m -84.1 109.32 17.61 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.002 0.43 . . . . 0.0 111.055 -179.048 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 69.6 m -119.09 148.8 42.64 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.138 179.409 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.646 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 45.4 mt-10 -127.86 145.33 50.97 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.867 -179.955 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.798 HD11 ' HB2' ' A' ' 102' ' ' PHE . 1.8 tm? -139.71 130.58 26.12 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 179.507 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.49 ' N ' HD13 ' A' ' 35' ' ' LEU . 39.7 m-20 -87.26 110.53 20.26 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.002 179.825 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.524 HD13 HD22 ' A' ' 90' ' ' LEU . 1.8 mt -84.86 -20.79 30.27 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.845 0.355 . . . . 0.0 110.871 -179.923 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.423 ' HA ' ' HD1' ' A' ' 55' ' ' PHE . 5.6 p-10 -67.35 -5.88 16.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.983 -178.195 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.416 HG22 ' O ' ' A' ' 36' ' ' ASP . 10.6 t -84.65 -8.51 58.85 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.867 0.365 . . . . 0.0 110.358 179.415 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 21.8 t -140.49 -5.41 1.22 Allowed 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 179.511 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 59.5 mt -106.95 136.7 41.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 O-C-N 122.036 -0.415 . . . . 0.0 109.882 178.957 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.656 ' HA3' ' HB3' ' A' ' 52' ' ' MET . . . -146.72 154.38 25.94 Favored Glycine 0 N--CA 1.443 -0.846 0 C-N-CA 120.89 -0.671 . . . . 0.0 111.777 179.553 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.4 HD22 ' CD2' ' A' ' 48' ' ' LEU . 27.6 p30 -155.28 48.15 0.36 Allowed Pre-proline 0 CA--C 1.537 0.454 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 179.986 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -68.69 -23.75 35.83 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 121.722 1.614 . . . . 0.0 112.238 -179.084 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 72.0 m-20 -91.94 0.59 57.47 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.923 -179.582 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.546 ' CA ' ' HG2' ' A' ' 83' ' ' ARG . . . 93.05 7.28 62.59 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.287 -0.959 . . . . 0.0 112.049 -179.301 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.654 ' HA ' HE22 ' A' ' 86' ' ' GLN . 47.7 m-85 -122.55 133.95 54.55 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.851 0.357 . . . . 0.0 110.807 179.831 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.433 ' HB3' ' HB ' ' A' ' 88' ' ' ILE . 34.0 mt -84.5 147.89 26.81 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.536 -0.757 . . . . 0.0 111.664 -179.172 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 170.37 168.95 32.91 Favored Glycine 0 N--CA 1.441 -1.023 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.974 179.121 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.403 ' HH2' HD11 ' A' ' 93' ' ' ILE . 89.1 m95 -95.64 125.33 40.15 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 179.975 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 161.77 -53.72 0.32 Allowed Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 121.026 -0.607 . . . . 0.0 112.249 -179.696 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.656 ' HB3' ' HA3' ' A' ' 42' ' ' GLY . 4.1 tpt -90.92 -164.82 1.23 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 -179.952 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.414 ' HG3' HD22 ' A' ' 54' ' ' ASN . 12.0 pt20 -146.3 170.58 16.5 Favored 'General case' 0 C--O 1.234 0.275 0 O-C-N 122.025 -0.422 . . . . 0.0 111.939 -178.815 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.414 HD22 ' HG3' ' A' ' 53' ' ' GLN . 42.2 m-80 64.0 36.13 10.17 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.454 -0.794 . . . . 0.0 112.599 178.991 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.454 ' HB3' ' HA2' ' A' ' 42' ' ' GLY . 8.0 p90 -65.23 -29.75 70.58 Favored 'General case' 0 C--O 1.224 -0.288 0 CA-C-O 120.684 0.278 . . . . 0.0 111.193 -179.896 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.454 ' HB2' ' HB3' ' A' ' 17' ' ' ARG . 13.4 t -57.07 -36.69 70.85 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -178.315 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 13.3 m-70 -80.82 -6.56 58.72 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.151 0.5 . . . . 0.0 110.984 -179.528 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 12.9 m -119.03 25.78 9.96 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.118 -179.987 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.532 ' HB2' HD11 ' A' ' 62' ' ' ILE . 11.6 m -137.3 140.23 41.4 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-O 121.059 0.457 . . . . 0.0 111.321 179.788 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -108.71 141.2 41.04 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.179 179.063 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 39.1 t70 52.35 75.94 0.21 Allowed 'General case' 0 C--N 1.32 -0.7 0 O-C-N 123.998 0.811 . . . . 0.0 111.402 179.95 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.533 HG23 HD21 ' A' ' 71' ' ' LEU . 81.6 mt -90.22 122.25 41.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.235 179.591 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.7 tptm -146.97 160.32 42.5 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.124 -178.892 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.636 ' HG ' HD21 ' A' ' 12' ' ' LEU . 55.8 mt -93.66 130.01 39.75 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.267 0.556 . . . . 0.0 110.012 178.602 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.462 ' HB3' ' HB3' ' A' ' 70' ' ' LYS . 45.2 tp10 -77.71 -66.33 0.85 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.39 -178.108 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.534 ' HB2' ' HB3' ' A' ' 69' ' ' ARG . 23.7 mt-10 -88.68 31.43 0.84 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.189 -178.889 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 68.04 17.91 70.3 Favored Glycine 0 N--CA 1.446 -0.638 0 CA-C-N 115.8 -0.636 . . . . 0.0 113.091 179.83 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.517 ' HA2' HD22 ' A' ' 64' ' ' LEU . . . 137.14 -21.96 3.28 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 119.828 -1.177 . . . . 0.0 113.3 179.184 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.534 ' HB3' ' HB2' ' A' ' 66' ' ' GLU . 0.8 OUTLIER -76.74 -21.05 55.81 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.579 0.704 . . . . 0.0 109.987 -179.642 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.462 ' HB3' ' HB3' ' A' ' 65' ' ' GLU . 2.6 ttmp? -148.43 138.46 22.42 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.094 -178.708 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.641 ' HB2' HD11 ' A' ' 90' ' ' LEU . 10.2 tt -108.89 124.96 51.46 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.309 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.1 p -116.16 127.77 55.08 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.544 0.687 . . . . 0.0 111.014 179.561 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.496 ' HB3' ' HA ' ' A' ' 62' ' ' ILE . 26.6 p -153.51 175.86 12.7 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.314 -179.721 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.615 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 12.0 ttt180 -108.33 98.74 28.77 Favored Pre-proline 0 C--N 1.31 -1.114 0 C-N-CA 120.623 -0.431 . . . . 0.0 110.007 178.654 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.665 ' O ' ' HB3' ' A' ' 83' ' ' ARG . 49.4 Cg_endo -67.12 122.54 9.86 Favored 'Trans proline' 0 CA--C 1.516 -0.4 0 C-N-CA 122.835 2.357 . . . . 0.0 110.82 179.478 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.778 ' HA ' ' HB2' ' A' ' 83' ' ' ARG . 0.3 OUTLIER -120.29 147.04 45.5 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-O 120.914 0.388 . . . . 0.0 111.564 -179.333 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.771 HG22 ' O ' ' A' ' 82' ' ' PHE . 7.9 t -74.84 137.82 42.11 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 178.988 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 29.6 m -73.2 -12.33 15.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 123.82 0.7 . . . . 0.0 111.355 -179.635 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -63.55 -33.38 75.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.652 179.379 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.553 ' HA3' ' CE2' ' A' ' 82' ' ' PHE . . . -145.81 -23.07 0.12 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.42 -0.895 . . . . 0.0 113.088 179.73 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.616 ' HA2' ' HD3' ' A' ' 76' ' ' LYS . . . 98.68 14.7 36.6 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 121.049 -0.596 . . . . 0.0 111.877 -179.706 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.771 ' O ' HG22 ' A' ' 77' ' ' THR . 28.2 p90 -112.48 154.26 26.15 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 119.029 -0.51 . . . . 0.0 110.608 -178.492 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.778 ' HB2' ' HA ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 167.38 -153.13 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.461 0 O-C-N 123.745 0.653 . . . . 0.0 111.202 178.308 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.408 ' O ' ' HG3' ' A' ' 74' ' ' ARG . 18.7 mm-40 -116.48 -177.34 3.16 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.143 -177.24 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.615 ' HA ' ' HA ' ' A' ' 74' ' ' ARG . 68.0 ttt180 -107.21 155.31 20.05 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 178.783 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.654 HE22 ' HA ' ' A' ' 47' ' ' PHE . 8.9 tt0 -166.37 167.74 15.57 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 120.87 0.366 . . . . 0.0 111.491 -178.976 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.459 ' N ' ' HG2' ' A' ' 86' ' ' GLN . . . -130.39 144.08 15.4 Favored Glycine 0 N--CA 1.45 -0.428 0 N-CA-C 111.564 -0.614 . . . . 0.0 111.564 178.601 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.433 ' HB ' ' HB3' ' A' ' 48' ' ' LEU . 9.4 tt -126.57 138.92 53.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 120.93 0.395 . . . . 0.0 110.517 -179.846 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.443 ' HB3' HD22 ' A' ' 91' ' ' ASN . 5.0 m-20 -77.42 135.91 38.35 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.369 179.811 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.713 HD13 HD11 ' A' ' 19' ' ' LEU . 53.9 mt -105.38 39.43 1.74 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.688 -179.884 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.443 HD22 ' HB3' ' A' ' 89' ' ' ASP . 18.8 m-80 -75.35 2.53 11.03 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.104 -179.541 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 49.0 mtp180 -95.88 -10.48 28.72 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.657 -0.702 . . . . 0.0 109.967 178.33 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.476 HG13 HD22 ' A' ' 37' ' ' LEU . 20.9 mm -100.66 99.51 8.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -179.764 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 24.4 tp60 -115.98 143.14 45.85 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.089 -178.485 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.511 ' OD1' ' HA ' ' A' ' 3' ' ' TYR . 15.0 p-10 -95.18 122.81 38.25 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.008 178.728 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.455 HG22 HD22 ' A' ' 97' ' ' ASN . 7.3 p -115.04 115.75 50.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-O 121.16 0.505 . . . . 0.0 109.944 179.313 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.455 HD22 HG22 ' A' ' 96' ' ' VAL . 32.1 m-80 60.37 28.3 17.92 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.709 -179.166 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 94.77 -14.94 64.4 Favored Glycine 0 N--CA 1.444 -0.773 0 C-N-CA 120.804 -0.712 . . . . 0.0 113.048 179.915 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.47 ' N ' ' HD2' ' A' ' 99' ' ' ARG . 3.3 mpt_? -91.7 131.93 36.74 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 117.158 0.479 . . . . 0.0 110.559 -179.12 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.41 ' HA ' HD12 ' A' ' 100' ' ' LEU . 8.5 tp -84.29 116.54 23.05 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.251 -179.28 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 24.4 t -125.54 140.3 48.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 120.798 0.332 . . . . 0.0 110.914 -179.287 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.798 ' HB2' HD11 ' A' ' 35' ' ' LEU . 3.9 t80 -91.67 124.37 35.76 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 178.396 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 . . . . . 0 C--N 1.314 -0.969 0 CA-C-O 118.002 -0.999 . . . . 0.0 110.955 179.82 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.8 mpp? . . . . . 0 N--CA 1.481 1.12 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.591 ' OG ' ' HA ' ' A' ' 91' ' ' ASN . 3.3 m -116.89 173.48 6.62 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.97 179.372 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.557 ' HA ' ' OD1' ' A' ' 95' ' ' ASN . 23.4 p90 -58.31 -37.65 75.5 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.53 0.205 . . . . 0.0 111.446 -179.892 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -55.09 -19.2 6.77 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.792 -0.64 . . . . 0.0 112.623 -178.794 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -59.15 -38.15 79.03 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.389 0.614 . . . . 0.0 109.956 179.168 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 49.2 m -133.08 46.5 2.6 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.15 179.086 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.431 ' HA ' ' HZ3' ' A' ' 30' ' ' TRP . 16.5 t -148.79 152.18 36.09 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.22 -179.329 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.449 ' HG3' HD22 ' A' ' 9' ' ' ASN . 3.9 ptp180 -149.39 171.69 16.14 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.314 -179.846 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.449 HD22 ' HG3' ' A' ' 8' ' ' ARG . 49.1 m-80 62.96 45.84 5.16 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 122.959 0.504 . . . . 0.0 110.437 -179.286 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -83.16 118.07 23.34 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.996 -179.718 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 27.1 m -126.24 170.69 15.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.193 179.519 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.565 ' HB3' ' HA2' ' A' ' 16' ' ' GLY . 3.0 mm? -105.37 117.64 34.53 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 -179.332 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.409 ' OG1' ' HB ' ' A' ' 18' ' ' THR . 28.0 p -113.87 162.17 16.69 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.974 0.416 . . . . 0.0 111.508 -179.745 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 64.32 30.33 13.39 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.526 179.652 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 95.92 -18.87 56.64 Favored Glycine 0 C--O 1.228 -0.255 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.755 179.46 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.565 ' HA2' ' HB3' ' A' ' 12' ' ' LEU . . . 123.47 42.6 0.38 Allowed Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.508 -0.853 . . . . 0.0 111.768 179.78 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -126.77 -29.02 2.9 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.096 0.474 . . . . 0.0 110.541 -179.91 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.409 ' HB ' ' OG1' ' A' ' 13' ' ' THR . 4.9 m -104.53 134.25 48.02 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.555 -179.877 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.803 HD11 HD13 ' A' ' 90' ' ' LEU . 33.6 mt -94.23 113.32 25.22 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.118 179.02 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 45.1 ttt180 -106.96 119.51 39.57 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 178.843 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -154.12 166.36 33.32 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.878 0.37 . . . . 0.0 111.151 -179.762 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.426 ' HG2' ' HB2' ' A' ' 9' ' ' ASN . 56.2 mm-40 -90.71 113.45 25.54 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 178.276 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.45 ' SG ' HD13 ' A' ' 100' ' ' LEU . 60.4 m -100.31 123.53 44.66 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 110.34 -0.245 . . . . 0.0 110.34 -178.957 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.514 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 11.7 ttp180 -72.6 114.47 10.77 Favored 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 179.015 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.407 HD21 ' HB3' ' A' ' 29' ' ' ASN . 35.4 p30 -77.66 171.04 15.54 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.85 -179.23 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.36 -33.87 63.77 Favored 'General case' 0 N--CA 1.464 0.252 0 O-C-N 123.675 0.609 . . . . 0.0 111.917 -178.776 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -67.92 -18.69 64.85 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.361 0.601 . . . . 0.0 110.613 -179.851 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 93.69 33.66 6.97 Favored Glycine 0 N--CA 1.443 -0.849 0 N-CA-C 111.085 -0.806 . . . . 0.0 111.085 -179.475 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.514 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 10.8 t-20 -118.49 159.89 22.71 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 110.013 -0.365 . . . . 0.0 110.013 -179.221 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.431 ' HZ3' ' HA ' ' A' ' 7' ' ' SER . 95.5 m95 -98.37 117.67 33.31 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.855 0.36 . . . . 0.0 110.6 179.918 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 12.5 m -119.23 132.27 69.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.38 178.773 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 27.9 m -74.86 110.36 9.09 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.021 0.439 . . . . 0.0 110.231 -179.624 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 60.7 m -121.29 145.62 47.68 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.599 -179.606 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.598 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 50.4 mt-10 -129.03 130.59 46.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.931 -179.505 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.449 HD11 ' HB2' ' A' ' 102' ' ' PHE . 2.4 tm? -124.86 131.62 53.42 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.437 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.423 ' N ' HD13 ' A' ' 35' ' ' LEU . 9.0 m-20 -89.78 109.16 20.17 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.841 0.353 . . . . 0.0 110.189 -179.114 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.529 HD13 HD22 ' A' ' 90' ' ' LEU . 2.4 mt -81.87 -17.84 45.9 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.164 -179.494 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -62.18 -10.18 9.78 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.817 0.342 . . . . 0.0 111.149 -179.317 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 59.5 p -78.99 -20.4 49.18 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.191 179.585 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.424 ' SG ' ' HE3' ' A' ' 50' ' ' TRP . 20.5 t -132.36 -8.66 3.32 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -179.191 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 53.9 mt -104.69 133.45 48.79 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 O-C-N 122.132 -0.355 . . . . 0.0 110.225 178.777 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.525 ' HA3' ' HB3' ' A' ' 52' ' ' MET . . . -147.84 160.28 28.27 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.921 -0.657 . . . . 0.0 111.823 179.91 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.464 HD22 ' CD1' ' A' ' 48' ' ' LEU . 21.6 p30 -162.3 54.15 0.46 Allowed Pre-proline 0 CA--C 1.537 0.45 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -179.799 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -72.16 -18.17 27.32 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 121.923 1.749 . . . . 0.0 112.311 -179.242 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.449 ' O ' ' HD3' ' A' ' 83' ' ' ARG . 93.0 m-20 -93.25 -16.51 24.69 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.437 179.822 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.538 ' HA3' ' HG2' ' A' ' 83' ' ' ARG . . . 109.82 9.64 24.3 Favored Glycine 0 N--CA 1.442 -0.964 0 C-N-CA 120.467 -0.873 . . . . 0.0 112.542 -179.333 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.527 ' HD1' HE22 ' A' ' 86' ' ' GLN . 54.6 m-85 -125.55 134.67 51.9 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.872 0.368 . . . . 0.0 110.623 179.716 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.595 HD23 HG22 ' A' ' 88' ' ' ILE . 10.5 mp -84.23 142.91 29.94 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.345 0.593 . . . . 0.0 111.848 -178.603 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 176.96 171.33 40.44 Favored Glycine 0 N--CA 1.439 -1.148 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.611 178.956 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.424 ' HE3' ' SG ' ' A' ' 40' ' ' CYS . 91.4 m95 -96.11 124.74 40.23 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 179.835 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 160.2 -58.81 0.31 Allowed Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 121.21 -0.519 . . . . 0.0 111.873 -179.708 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.525 ' HB3' ' HA3' ' A' ' 42' ' ' GLY . 12.8 tpt -85.89 175.2 8.77 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 -179.893 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -128.8 167.0 17.95 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.722 -0.391 . . . . 0.0 111.075 -179.712 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 11.3 m-80 64.56 49.79 2.3 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.449 179.026 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.453 ' HB3' ' HA2' ' A' ' 42' ' ' GLY . 21.1 p90 -68.48 -31.2 70.31 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.07 0.462 . . . . 0.0 110.187 179.021 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.443 ' HA ' HD11 ' A' ' 62' ' ' ILE . 3.5 p -56.53 -38.16 71.48 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.591 -178.699 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 22.4 m80 -72.49 -30.94 64.96 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.632 0.253 . . . . 0.0 111.331 -179.52 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 14.1 m -96.88 18.36 14.74 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.011 -179.488 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 45.4 m -130.79 165.31 23.25 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.199 0.523 . . . . 0.0 111.491 -179.756 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -137.64 136.14 37.19 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.245 -0.889 . . . . 0.0 108.95 178.589 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 37.0 t70 58.88 80.22 0.19 Allowed 'General case' 0 N--CA 1.467 0.425 0 O-C-N 123.649 0.593 . . . . 0.0 110.86 -179.705 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.525 ' HA ' ' HB3' ' A' ' 73' ' ' CYS . 59.9 mt -100.95 122.16 52.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.261 -179.13 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 72.9 tttt -149.22 165.1 32.89 Favored 'General case' 0 C--O 1.221 -0.407 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 179.466 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.525 ' HG ' HD21 ' A' ' 12' ' ' LEU . 71.2 mt -90.84 127.39 36.34 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.068 0.461 . . . . 0.0 111.072 -179.603 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -76.29 -57.97 3.55 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.443 -0.798 . . . . 0.0 110.676 -179.179 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.477 ' CB ' ' HB3' ' A' ' 69' ' ' ARG . 15.4 mm-40 -85.03 11.84 8.81 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.789 -179.521 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 71.61 28.07 69.98 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.383 179.973 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 136.86 -34.48 2.21 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.207 -0.996 . . . . 0.0 112.627 179.448 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.477 ' HB3' ' CB ' ' A' ' 66' ' ' GLU . 2.1 tpp180 -75.62 -18.47 59.69 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.116 0.484 . . . . 0.0 110.589 -179.551 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.45 ' HB3' ' HG2' ' A' ' 66' ' ' GLU . 38.9 ttmt -151.42 141.88 22.53 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.067 -178.804 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.562 ' HB2' HD11 ' A' ' 90' ' ' LEU . 10.5 tt -110.52 128.62 55.72 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.104 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.2 p -123.16 128.11 49.6 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.317 0.58 . . . . 0.0 111.293 -179.905 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.525 ' HB3' ' HA ' ' A' ' 62' ' ' ILE . 20.5 p -151.94 169.91 21.15 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.516 179.875 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.635 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 29.4 ttt180 -106.35 99.73 25.64 Favored Pre-proline 0 C--N 1.321 -0.645 0 C-N-CA 120.263 -0.575 . . . . 0.0 110.492 179.126 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.647 ' O ' ' HB3' ' A' ' 83' ' ' ARG . 60.5 Cg_endo -71.75 137.85 30.68 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 122.622 2.215 . . . . 0.0 110.273 178.718 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.712 ' HA ' ' HB2' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -121.39 140.68 51.82 Favored 'General case' 0 C--N 1.317 -0.807 0 O-C-N 123.483 0.49 . . . . 0.0 111.113 -179.883 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.732 HG22 ' O ' ' A' ' 82' ' ' PHE . 12.5 t -75.61 138.86 41.71 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 179.291 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 34.7 m -73.18 -9.78 13.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 O-C-N 124.122 0.889 . . . . 0.0 111.199 -179.826 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -66.92 -31.39 71.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.054 179.673 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.406 ' HA3' ' CE2' ' A' ' 82' ' ' PHE . . . -154.48 -12.49 0.06 OUTLIER Glycine 0 CA--C 1.521 0.428 0 C-N-CA 120.519 -0.848 . . . . 0.0 113.359 179.751 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.615 ' HA2' ' HE3' ' A' ' 76' ' ' LYS . . . 91.25 16.25 53.88 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.959 -0.639 . . . . 0.0 112.082 -179.792 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.732 ' O ' HG22 ' A' ' 77' ' ' THR . 35.4 p90 -111.76 158.35 19.45 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 118.694 -0.669 . . . . 0.0 109.612 -178.866 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.712 ' HB2' ' HA ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 171.37 -148.25 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 179.431 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -142.99 152.49 42.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.373 -0.831 . . . . 0.0 109.496 -178.195 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.635 ' HA ' ' HA ' ' A' ' 74' ' ' ARG . 27.8 ttt85 -77.84 150.43 34.22 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 123.229 0.331 . . . . 0.0 110.123 -179.794 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.527 HE22 ' HD1' ' A' ' 47' ' ' PHE . 8.9 tt0 -155.58 158.85 39.07 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.317 -178.806 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -123.32 144.34 15.58 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.088 179.412 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.595 HG22 HD23 ' A' ' 48' ' ' LEU . 12.8 tt -123.96 135.04 64.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 179.563 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.418 ' HB2' HD22 ' A' ' 91' ' ' ASN . 2.2 p-10 -77.1 140.92 40.4 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.068 0.461 . . . . 0.0 110.017 -179.882 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.803 HD13 HD11 ' A' ' 19' ' ' LEU . 26.4 mt -106.35 41.17 1.47 Allowed 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.334 0.588 . . . . 0.0 110.765 -179.424 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.591 ' HA ' ' OG ' ' A' ' 2' ' ' SER . 28.8 m-80 -75.06 2.85 9.62 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.763 -179.96 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 9.7 mtp180 -96.72 -16.54 20.84 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.165 179.797 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.434 HG13 HD22 ' A' ' 37' ' ' LEU . 22.4 mm -92.73 114.36 29.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 109.684 -0.488 . . . . 0.0 109.684 -178.904 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 23.1 tp60 -124.6 141.46 52.08 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.356 0.598 . . . . 0.0 111.545 -178.157 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.557 ' OD1' ' HA ' ' A' ' 3' ' ' TYR . 13.1 p-10 -94.62 102.22 14.13 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.673 178.176 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 3.7 p -90.56 110.41 22.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.504 -179.348 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 60.42 27.32 16.92 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.14 -179.919 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 100.29 -17.04 57.48 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.735 -0.745 . . . . 0.0 113.225 179.739 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.41 ' N ' ' HD2' ' A' ' 99' ' ' ARG . 1.7 mpt_? -91.53 126.09 36.49 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 117.23 0.515 . . . . 0.0 109.871 -179.541 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.45 HD13 ' SG ' ' A' ' 23' ' ' CYS . 11.2 tp -82.84 114.03 20.87 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.233 -179.203 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 38.4 t -131.47 146.48 33.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 120.694 0.283 . . . . 0.0 110.321 -179.338 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.449 ' HB2' HD11 ' A' ' 35' ' ' LEU . 11.7 t80 -78.67 133.94 37.17 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 178.771 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 . . . . . 0 C--O 1.247 0.951 0 CA-C-O 118.632 -0.699 . . . . 0.0 110.067 179.824 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.8 ptp . . . . . 0 N--CA 1.482 1.168 0 CA-C-O 120.724 0.297 . . . . 0.0 110.548 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.848 ' HB2' ' HG2' ' A' ' 69' ' ' ARG . 4.7 m -116.75 174.67 5.95 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.848 179.441 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.422 ' CD2' HD11 ' A' ' 100' ' ' LEU . 4.2 p90 -59.85 -33.27 71.56 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.228 -0.442 . . . . 0.0 112.032 -179.713 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.606 ' HA ' ' OG ' ' A' ' 7' ' ' SER . . . -55.16 -18.41 5.72 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -178.167 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -58.32 -42.85 87.65 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.976 0.417 . . . . 0.0 111.166 179.727 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.416 ' HB2' HD21 ' A' ' 95' ' ' ASN . 25.6 m -123.02 38.44 4.19 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 121.044 0.45 . . . . 0.0 110.903 -179.486 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.606 ' OG ' ' HA ' ' A' ' 4' ' ' ALA . 52.5 p -141.28 168.19 20.37 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.21 179.143 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 37.1 ptt180 -149.76 168.23 24.27 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.005 -178.564 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 55.25 43.24 29.52 Favored 'General case' 0 C--N 1.33 -0.244 0 O-C-N 124.089 0.868 . . . . 0.0 112.203 178.078 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.442 ' HA ' ' HB2' ' A' ' 21' ' ' ALA . . . -72.28 117.0 13.38 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 179.251 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.463 HG21 HH21 ' A' ' 20' ' ' ARG . 27.8 m -124.0 172.74 11.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.713 -179.423 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.637 ' HB3' ' HA2' ' A' ' 16' ' ' GLY . 3.7 mm? -104.74 115.81 30.95 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.775 -179.311 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 27.9 p -112.45 161.08 17.11 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.666 179.387 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 59.25 44.58 15.35 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.17 179.553 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 87.35 -23.61 11.62 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.218 -179.715 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.637 ' HA2' ' HB3' ' A' ' 12' ' ' LEU . . . 124.85 17.01 2.88 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 121.109 -0.567 . . . . 0.0 111.894 -179.867 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.749 ' HB2' ' HB2' ' A' ' 38' ' ' ASP . 3.6 ptm180 -95.78 -22.05 17.75 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.227 0.537 . . . . 0.0 110.375 -179.609 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.482 ' CG2' ' HB3' ' A' ' 34' ' ' GLU . 2.7 m -111.29 135.99 51.03 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.788 -178.978 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.727 HD11 HD13 ' A' ' 90' ' ' LEU . 41.8 mt -97.46 112.55 24.35 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.768 179.361 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.463 HH21 HG21 ' A' ' 11' ' ' VAL . 30.5 ttp180 -105.1 120.65 42.03 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 178.439 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.442 ' HB2' ' HA ' ' A' ' 10' ' ' ALA . . . -152.97 162.41 41.35 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.906 0.384 . . . . 0.0 111.062 -179.878 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -90.84 105.75 18.04 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 178.439 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.56 ' SG ' HD13 ' A' ' 100' ' ' LEU . 40.2 m -94.21 132.09 39.12 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 -179.449 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 8.0 ttp180 -84.28 116.46 23.0 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-O 120.776 0.322 . . . . 0.0 110.747 -179.886 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 31.4 p30 -82.07 162.23 22.63 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.086 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.49 -21.72 17.78 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -178.68 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -74.69 -13.77 60.66 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.317 0.58 . . . . 0.0 110.195 179.764 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 89.74 32.13 10.47 Favored Glycine 0 N--CA 1.449 -0.456 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.93 179.987 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 -124.47 151.62 44.34 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.826 0.346 . . . . 0.0 111.364 -179.519 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 93.9 m95 -90.96 120.59 32.09 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.568 179.384 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -118.56 127.3 75.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 116.247 -0.433 . . . . 0.0 109.918 178.079 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 25.5 m -76.48 111.52 12.04 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.194 179.935 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 66.7 m -123.06 145.66 48.35 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.906 -179.376 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.602 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 44.8 mt-10 -124.91 133.07 53.19 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.882 179.708 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.724 HD11 ' HB2' ' A' ' 102' ' ' PHE . 1.5 tm? -125.42 131.59 52.89 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.167 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.456 ' O ' HG22 ' A' ' 39' ' ' THR . 14.5 m-20 -90.05 110.27 21.27 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.012 0.434 . . . . 0.0 110.241 -179.779 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.495 HD13 HD22 ' A' ' 90' ' ' LEU . 1.5 mt -83.8 -23.89 31.25 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.031 -179.749 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.749 ' HB2' ' HB2' ' A' ' 17' ' ' ARG . 20.9 t70 -60.49 -15.14 24.06 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.19 -0.459 . . . . 0.0 112.151 -178.647 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.456 HG22 ' O ' ' A' ' 36' ' ' ASP . 11.6 t -77.44 -14.48 59.69 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.721 -0.218 . . . . 0.0 111.387 -179.656 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.411 ' SG ' ' HE3' ' A' ' 50' ' ' TRP . 42.5 t -134.33 -0.79 2.94 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -179.609 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.443 ' HB ' ' CD1' ' A' ' 55' ' ' PHE . 60.4 mt -108.84 135.24 48.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 178.589 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.486 ' HA3' ' HB3' ' A' ' 52' ' ' MET . . . -138.61 156.53 24.2 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.095 -179.826 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.764 HD21 ' HB3' ' A' ' 59' ' ' SER . 39.9 p-10 -164.81 43.79 0.09 OUTLIER Pre-proline 0 CA--C 1.542 0.664 0 N-CA-C 113.102 0.778 . . . . 0.0 113.102 -179.377 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.446 ' HG3' ' SD ' ' A' ' 52' ' ' MET . 74.4 Cg_endo -73.17 -22.65 18.92 Favored 'Trans proline' 0 C--N 1.354 0.858 0 C-N-CA 121.661 1.574 . . . . 0.0 112.346 -178.913 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -84.4 -14.11 50.31 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.819 179.923 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.5 ' CA ' ' HG2' ' A' ' 83' ' ' ARG . . . 107.29 8.17 31.49 Favored Glycine 0 N--CA 1.444 -0.81 0 C-N-CA 120.301 -0.952 . . . . 0.0 111.994 -178.866 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.58 ' HA ' HE22 ' A' ' 86' ' ' GLN . 71.3 m-85 -125.91 139.1 53.73 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 110.391 -0.226 . . . . 0.0 110.391 179.82 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 7.8 mp -89.89 151.04 21.94 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.225 0.536 . . . . 0.0 111.975 -178.931 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 167.24 170.99 32.79 Favored Glycine 0 N--CA 1.444 -0.782 0 CA-C-N 115.601 -0.727 . . . . 0.0 112.122 178.469 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.428 ' CD1' HD11 ' A' ' 88' ' ' ILE . 90.8 m95 -95.73 132.24 41.15 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 179.98 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 156.42 -63.08 0.33 Allowed Glycine 0 N--CA 1.451 -0.355 0 N-CA-C 111.573 -0.611 . . . . 0.0 111.573 179.915 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.486 ' HB3' ' HA3' ' A' ' 42' ' ' GLY . 39.7 ttm -88.63 176.63 7.04 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 179.34 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.422 ' HG3' HD22 ' A' ' 54' ' ' ASN . 3.9 pt20 -130.65 172.41 11.98 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 118.288 0.495 . . . . 0.0 111.654 -179.294 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.715 ' HA ' ' OD2' ' A' ' 38' ' ' ASP . 36.0 m-80 68.54 46.85 0.95 Allowed 'General case' 0 C--O 1.234 0.263 0 O-C-N 123.945 0.778 . . . . 0.0 111.697 179.129 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.443 ' CD1' ' HB ' ' A' ' 41' ' ' ILE . 13.7 p90 -76.6 -26.88 55.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.517 179.78 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 7.1 m -62.69 -30.45 71.41 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.199 0.523 . . . . 0.0 110.97 -178.694 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 17.7 m-70 -82.11 -3.54 55.0 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.754 -179.519 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 42.4 m -128.29 28.69 5.45 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.112 0.482 . . . . 0.0 110.358 179.333 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.764 ' HB3' HD21 ' A' ' 43' ' ' ASN . 15.4 p -143.61 157.85 44.11 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.105 179.829 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.438 ' HG3' ' HG2' ' A' ' 76' ' ' LYS . 50.6 mt-10 -127.0 136.86 52.82 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.991 179.663 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.43 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 36.5 t70 60.29 84.48 0.12 Allowed 'General case' 0 N--CA 1.467 0.381 0 O-C-N 123.608 0.568 . . . . 0.0 111.68 179.511 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 75.4 mt -97.92 120.38 47.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.103 179.547 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.6 tptm -147.33 148.19 31.13 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.123 -179.79 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.584 ' HG ' HD21 ' A' ' 12' ' ' LEU . 36.3 mt -88.56 145.23 25.84 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.868 -179.474 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -105.34 -62.14 1.39 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.044 -0.525 . . . . 0.0 112.107 -179.046 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.577 ' HB2' ' HB2' ' A' ' 69' ' ' ARG . 44.6 mm-40 -79.21 42.93 0.51 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.831 -178.527 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 62.49 20.41 61.27 Favored Glycine 0 C--N 1.317 -0.525 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.594 179.33 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.57 ' HA2' HD13 ' A' ' 64' ' ' LEU . . . 121.4 -14.88 9.31 Favored Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.388 -179.996 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.848 ' HG2' ' HB2' ' A' ' 2' ' ' SER . 48.3 mtm105 -84.02 2.27 39.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.13 0.491 . . . . 0.0 110.804 -179.718 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.492 ' HB3' ' HG2' ' A' ' 66' ' ' GLU . 37.3 ttmt -155.26 134.36 12.27 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.975 179.917 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.75 ' HB2' HD11 ' A' ' 90' ' ' LEU . 9.8 tt -116.77 125.71 52.03 Favored 'General case' 0 C--N 1.318 -0.794 0 O-C-N 123.576 0.548 . . . . 0.0 109.94 -179.723 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.7 p -113.97 136.29 53.06 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.769 179.208 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.43 ' HA ' ' O ' ' A' ' 61' ' ' ASP . 25.8 p -162.26 165.57 26.55 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.252 179.84 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.538 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 31.9 ttt180 -99.48 103.44 21.05 Favored Pre-proline 0 C--N 1.319 -0.745 0 C-N-CA 120.676 -0.409 . . . . 0.0 110.733 179.496 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.692 ' O ' ' HB3' ' A' ' 83' ' ' ARG . 43.8 Cg_endo -67.64 119.63 6.64 Favored 'Trans proline' 0 CA--C 1.512 -0.58 0 C-N-CA 122.569 2.18 . . . . 0.0 110.149 178.564 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.686 ' HA ' ' HB2' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -119.91 140.61 50.61 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 120.764 0.316 . . . . 0.0 111.682 -178.808 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.708 HG22 ' O ' ' A' ' 82' ' ' PHE . 12.9 t -72.52 135.22 45.59 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.695 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 26.7 m -73.33 -4.33 5.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 123.943 0.777 . . . . 0.0 112.056 -178.938 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -68.95 -32.9 72.83 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.13 0.49 . . . . 0.0 109.902 179.342 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -151.65 -20.23 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.678 179.819 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.22 20.73 22.25 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.751 -0.738 . . . . 0.0 111.949 -179.887 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.708 ' O ' HG22 ' A' ' 77' ' ' THR . 27.6 p90 -111.88 143.22 43.21 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 -178.876 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.692 ' HB3' ' O ' ' A' ' 75' ' ' PRO . 0.0 OUTLIER 175.06 -154.21 0.01 OUTLIER 'General case' 0 C--O 1.234 0.241 0 CA-C-O 120.796 0.332 . . . . 0.0 111.702 179.881 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -113.84 177.16 4.73 Favored 'General case' 0 C--O 1.225 -0.207 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.486 -178.708 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.558 ' HA ' ' HD2' ' A' ' 75' ' ' PRO . 59.1 ttt180 -110.39 150.86 28.2 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 178.77 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.58 HE22 ' HA ' ' A' ' 47' ' ' PHE . 22.1 mt-30 -156.84 -175.25 5.32 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -178.152 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -150.3 142.89 10.06 Favored Glycine 0 N--CA 1.45 -0.423 0 CA-C-N 114.803 -1.09 . . . . 0.0 111.108 179.09 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.428 HD11 ' CD1' ' A' ' 50' ' ' TRP . 13.2 tt -123.97 142.73 39.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 121.052 0.453 . . . . 0.0 110.649 -178.683 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.459 ' HB3' HD22 ' A' ' 91' ' ' ASN . 1.1 m-20 -79.14 133.61 36.73 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.623 179.807 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.75 HD11 ' HB2' ' A' ' 71' ' ' LEU . 74.9 mt -106.27 41.25 1.45 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.324 0.583 . . . . 0.0 111.286 -179.44 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.563 ' HA ' ' OG ' ' A' ' 2' ' ' SER . 22.8 m-80 -76.12 2.05 14.01 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.192 179.575 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 13.3 mtp180 -94.03 -6.98 44.02 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.783 179.392 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.432 HG13 HD22 ' A' ' 37' ' ' LEU . 17.7 mm -101.92 106.36 19.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -179.782 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 21.7 tp60 -118.93 149.35 41.74 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.994 -178.008 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.416 HD21 ' HB2' ' A' ' 6' ' ' SER . 14.7 p-10 -99.3 117.94 34.86 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.29 0.567 . . . . 0.0 110.435 178.858 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 48.1 t -103.71 100.4 10.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.5 179.191 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 7.3 m-80 58.69 43.5 18.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.858 -179.197 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 89.99 -23.42 20.76 Favored Glycine 0 N--CA 1.444 -0.792 0 CA-C-N 115.512 -0.767 . . . . 0.0 113.496 179.48 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.425 ' N ' ' HD2' ' A' ' 99' ' ' ARG . 4.4 mpt_? -86.78 123.39 31.87 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 117.116 0.458 . . . . 0.0 110.574 -179.271 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.56 HD13 ' SG ' ' A' ' 23' ' ' CYS . 5.6 tp -76.01 122.15 23.79 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.166 -179.403 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 24.1 t -129.35 138.95 53.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.933 -179.183 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.724 ' HB2' HD11 ' A' ' 35' ' ' LEU . 12.5 t80 -85.51 131.92 34.29 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.052 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 17.3 tt0 . . . . . 0 C--N 1.315 -0.892 0 CA-C-O 117.968 -1.015 . . . . 0.0 110.44 -179.954 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mpt? . . . . . 0 N--CA 1.481 1.075 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.486 ' OG ' ' HA ' ' A' ' 91' ' ' ASN . 17.7 m -116.55 169.07 9.62 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.708 -0.224 . . . . 0.0 110.663 179.304 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.444 ' CG ' HD11 ' A' ' 100' ' ' LEU . 25.2 p90 -57.17 -30.64 64.67 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.201 179.362 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.463 ' HB3' ' HD2' ' A' ' 69' ' ' ARG . . . -53.7 -18.86 3.42 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.33 -179.363 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -61.06 -36.27 79.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.296 0.57 . . . . 0.0 109.977 179.043 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 24.5 m -133.95 36.46 3.27 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.805 179.691 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.411 ' HA ' ' HZ3' ' A' ' 30' ' ' TRP . 23.2 t -148.75 145.77 27.76 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.399 -179.987 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 4.5 ptp180 -136.61 167.9 20.52 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.585 -0.279 . . . . 0.0 111.646 -178.874 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 67.1 m-80 55.78 65.21 1.51 Allowed 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.435 179.893 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.404 ' HB3' ' O ' ' A' ' 67' ' ' GLY . . . -92.55 120.03 32.61 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.661 179.622 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 26.6 m -120.41 169.11 12.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.317 -179.731 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.742 HD21 ' HG ' ' A' ' 64' ' ' LEU . 3.1 mm? -104.67 116.91 32.86 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.24 -179.634 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.49 ' OG1' ' HB ' ' A' ' 18' ' ' THR . 18.9 p -109.81 161.94 14.96 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.452 179.48 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 62.15 40.87 11.34 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.945 -179.803 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 91.02 -45.38 2.85 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 121.034 -0.603 . . . . 0.0 112.459 179.62 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.571 ' HA2' ' HB3' ' A' ' 12' ' ' LEU . . . 149.77 52.42 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.506 0 N-CA-C 111.481 -0.648 . . . . 0.0 111.481 -179.469 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.505 ' HB3' ' OG ' ' A' ' 56' ' ' SER . 3.7 ptm180 -135.57 -33.46 0.87 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.146 0.498 . . . . 0.0 110.808 -179.811 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.49 ' HB ' ' OG1' ' A' ' 13' ' ' THR . 3.0 m -97.53 133.5 42.01 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.524 -179.968 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.653 HD11 HD13 ' A' ' 90' ' ' LEU . 44.1 mt -95.89 113.65 25.29 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.231 179.349 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 17.9 ttm180 -107.86 120.68 42.94 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 178.76 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -152.77 167.85 27.64 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.929 0.395 . . . . 0.0 111.365 -178.896 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -89.63 106.09 18.23 Favored 'General case' 0 CA--C 1.512 -0.491 0 N-CA-C 107.969 -1.122 . . . . 0.0 107.969 178.405 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.579 ' SG ' HD13 ' A' ' 100' ' ' LEU . 58.5 m -96.39 125.91 41.22 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 120.713 0.292 . . . . 0.0 110.225 -178.959 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.622 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 22.4 ttt180 -77.94 111.83 14.2 Favored 'General case' 0 N--CA 1.44 -0.933 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.087 179.639 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.454 HD21 ' HB3' ' A' ' 29' ' ' ASN . 36.0 p30 -74.18 170.65 15.1 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.318 -179.62 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.26 -11.73 23.68 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -177.806 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -88.15 -10.23 50.62 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 178.676 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 88.45 27.94 23.59 Favored Glycine 0 N--CA 1.448 -0.511 0 CA-C-N 114.956 -1.02 . . . . 0.0 111.535 -179.522 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.622 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 51.9 t30 -112.75 161.45 16.88 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.526 0.203 . . . . 0.0 111.162 -178.661 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.449 ' CZ3' ' HB2' ' A' ' 24' ' ' ARG . 95.4 m95 -102.5 116.85 33.46 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.715 179.596 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 6.2 m -118.82 141.1 40.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.608 179.309 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 61.6 m -81.1 108.62 14.92 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 179.209 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 50.3 m -120.34 150.43 40.76 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.351 -179.536 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.601 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 48.3 mt-10 -131.2 145.6 52.0 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.915 -179.893 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.669 HD11 ' HB2' ' A' ' 102' ' ' PHE . 2.2 tm? -139.45 132.0 28.75 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 178.777 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.479 ' N ' HD13 ' A' ' 35' ' ' LEU . 5.7 m-20 -90.33 110.25 21.32 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.919 0.39 . . . . 0.0 110.992 179.967 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.531 HD11 HD11 ' A' ' 19' ' ' LEU . 2.4 mt -80.67 -19.73 44.57 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.705 179.268 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.523 ' OD1' ' HA ' ' A' ' 54' ' ' ASN . 22.4 t70 -58.74 -18.7 33.85 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.389 -0.823 . . . . 0.0 112.339 -178.812 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.449 HG22 ' O ' ' A' ' 36' ' ' ASP . 14.6 t -82.61 -6.74 59.52 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 121.103 -0.239 . . . . 0.0 111.449 -179.639 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.521 ' SG ' ' HE3' ' A' ' 50' ' ' TRP . 25.8 t -135.0 -18.63 1.81 Allowed 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.816 -0.354 . . . . 0.0 111.467 179.556 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 56.0 mt -98.28 129.13 48.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 178.359 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.615 ' HA3' ' HB3' ' A' ' 52' ' ' MET . . . -141.11 164.69 26.45 Favored Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 120.64 -0.791 . . . . 0.0 111.67 179.784 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.788 HD21 ' HB3' ' A' ' 59' ' ' SER . 32.1 p-10 -161.92 47.26 0.21 Allowed Pre-proline 0 CA--C 1.538 0.487 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 -179.144 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -71.9 -23.21 22.39 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 121.562 1.508 . . . . 0.0 111.625 -179.536 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -84.26 -14.95 48.51 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.588 -179.893 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.404 ' CA ' ' HG2' ' A' ' 83' ' ' ARG . . . 103.98 8.22 39.66 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.051 -178.831 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.408 ' HD1' HE22 ' A' ' 86' ' ' GLN . 64.1 m-85 -125.21 140.07 53.18 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 179.43 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.559 HD23 ' HB3' ' A' ' 43' ' ' ASN . 92.3 mt -86.68 145.64 26.61 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.012 -179.712 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 171.39 172.33 37.4 Favored Glycine 0 N--CA 1.444 -0.784 0 C-N-CA 120.785 -0.722 . . . . 0.0 111.745 179.207 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.521 ' HE3' ' SG ' ' A' ' 40' ' ' CYS . 87.2 m95 -95.53 125.2 39.96 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.826 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 159.99 -52.16 0.36 Allowed Glycine 0 CA--C 1.518 0.25 0 C-N-CA 121.129 -0.557 . . . . 0.0 112.453 -179.997 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.615 ' HB3' ' HA3' ' A' ' 42' ' ' GLY . 0.1 OUTLIER -97.15 178.03 5.39 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.29 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -129.99 171.78 12.42 Favored 'General case' 0 C--N 1.318 -0.798 0 O-C-N 122.04 -0.412 . . . . 0.0 111.295 -179.18 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.523 ' HA ' ' OD1' ' A' ' 38' ' ' ASP . 21.7 m-80 64.31 59.98 0.98 Allowed 'General case' 0 C--O 1.235 0.311 0 O-C-N 123.963 0.789 . . . . 0.0 111.285 179.458 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.452 ' HA ' ' OD1' ' A' ' 43' ' ' ASN . 18.6 p90 -86.56 -32.24 20.79 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.645 -179.991 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.505 ' OG ' ' HB3' ' A' ' 17' ' ' ARG . 13.3 m -62.05 -36.9 83.01 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.269 -179.024 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 38.2 m80 -81.28 -3.59 52.95 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.728 179.218 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.531 ' HB2' ' OD1' ' A' ' 43' ' ' ASN . 4.7 m -121.33 18.67 11.44 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.551 -179.676 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.788 ' HB3' HD21 ' A' ' 43' ' ' ASN . 58.1 p -145.55 171.69 14.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.097 0.475 . . . . 0.0 111.096 179.882 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.494 ' HG3' ' HD3' ' A' ' 74' ' ' ARG . 2.3 pt-20 -140.85 154.03 46.02 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.065 179.433 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.406 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 43.2 m-20 62.3 63.04 1.09 Allowed 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.022 0.439 . . . . 0.0 110.929 -179.703 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.482 HG23 HD21 ' A' ' 71' ' ' LEU . 63.6 mt -90.7 117.27 33.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.973 -179.681 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 42.5 tptt -148.85 149.45 31.32 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.772 -179.895 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.742 ' HG ' HD21 ' A' ' 12' ' ' LEU . 76.5 mt -82.46 132.57 35.2 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.931 0.396 . . . . 0.0 110.106 179.317 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -80.25 -62.61 1.63 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.488 -178.862 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.509 ' HB2' ' HB3' ' A' ' 69' ' ' ARG . 30.3 mt-10 -85.49 28.05 0.78 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.584 -179.86 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.404 ' O ' ' HB3' ' A' ' 10' ' ' ALA . . . 64.97 15.95 61.12 Favored Glycine 0 N--CA 1.448 -0.545 0 CA-C-N 115.624 -0.717 . . . . 0.0 113.066 179.812 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.539 ' HA2' HD13 ' A' ' 64' ' ' LEU . . . 142.66 -21.98 2.35 Favored Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 119.904 -1.141 . . . . 0.0 113.091 179.459 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.509 ' HB3' ' HB2' ' A' ' 66' ' ' GLU . 0.2 OUTLIER -79.34 -13.91 59.33 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.426 0.631 . . . . 0.0 109.713 -179.922 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.534 ' HG3' ' HA ' ' A' ' 89' ' ' ASP . 4.5 ttmp? -157.1 141.76 16.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.259 -179.233 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.604 ' HB2' HD11 ' A' ' 90' ' ' LEU . 10.0 tt -111.42 134.45 52.99 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 179.975 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.431 HG22 ' HA3' ' A' ' 87' ' ' GLY . 7.0 p -123.95 135.05 53.42 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 120.798 0.332 . . . . 0.0 111.156 179.852 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.437 ' HB3' ' HA ' ' A' ' 62' ' ' ILE . 26.9 p -159.52 168.8 25.28 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.134 -0.485 . . . . 0.0 109.998 179.988 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.566 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 56.6 ttt180 -99.66 101.97 15.34 Favored Pre-proline 0 C--N 1.314 -0.96 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.725 179.944 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.625 ' O ' ' HB3' ' A' ' 83' ' ' ARG . 58.7 Cg_endo -71.43 123.14 9.26 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 122.535 2.156 . . . . 0.0 110.856 178.868 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.697 ' HA ' ' HB2' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -119.57 139.84 51.5 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.845 0.355 . . . . 0.0 111.053 -179.69 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.705 HG22 ' O ' ' A' ' 82' ' ' PHE . 12.3 t -75.47 140.65 42.98 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 116.176 -0.466 . . . . 0.0 109.752 -179.765 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 31.3 m -76.32 -5.97 8.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.488 -179.482 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 -64.75 -35.25 80.45 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-O 121.155 0.502 . . . . 0.0 110.234 179.145 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -154.01 -9.74 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.512 -0.851 . . . . 0.0 112.768 -179.925 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.602 ' HA2' ' HE3' ' A' ' 76' ' ' LYS . . . 90.32 17.51 52.73 Favored Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.641 -0.79 . . . . 0.0 111.862 179.976 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.705 ' O ' HG22 ' A' ' 77' ' ' THR . 34.0 p90 -111.23 151.2 28.56 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 119.17 -0.443 . . . . 0.0 109.974 -178.773 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.697 ' HB2' ' HA ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 169.78 -153.36 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.293 0 O-C-N 123.641 0.588 . . . . 0.0 111.052 179.107 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 49.9 mm-40 -122.21 -177.58 3.64 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.736 -178.037 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.566 ' HA ' ' HA ' ' A' ' 74' ' ' ARG . 52.7 ttt180 -106.03 153.45 22.01 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 177.396 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.705 ' HG2' ' H ' ' A' ' 87' ' ' GLY . 8.3 tt0 -157.89 -174.98 5.11 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.662 -178.513 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.705 ' H ' ' HG2' ' A' ' 86' ' ' GLN . . . -148.92 140.54 8.28 Favored Glycine 0 N--CA 1.445 -0.704 0 N-CA-C 111.181 -0.767 . . . . 0.0 111.181 179.21 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 15.3 tt -119.28 131.41 72.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.544 0.688 . . . . 0.0 110.742 -179.548 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.534 ' HA ' ' HG3' ' A' ' 70' ' ' LYS . 16.0 t70 -75.94 140.7 42.22 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.401 -179.671 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.653 HD13 HD11 ' A' ' 19' ' ' LEU . 42.4 mt -109.84 44.19 1.24 Allowed 'General case' 0 C--O 1.234 0.253 0 N-CA-C 112.848 0.684 . . . . 0.0 112.848 -177.717 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.486 ' HA ' ' OG ' ' A' ' 2' ' ' SER . 3.9 m-80 -79.7 3.91 17.82 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-O 121.32 0.581 . . . . 0.0 110.834 178.759 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.48 ' HD3' ' CD2' ' A' ' 50' ' ' TRP . 36.6 mtp180 -95.86 -11.21 27.12 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.357 178.919 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.431 HG13 HD22 ' A' ' 37' ' ' LEU . 21.2 mm -100.8 109.08 24.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 -179.406 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -122.26 148.52 44.89 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.941 -178.108 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 27.2 p-10 -100.65 123.28 44.64 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.65 0.738 . . . . 0.0 110.268 178.448 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.472 HG12 HD22 ' A' ' 97' ' ' ASN . 59.5 t -114.73 114.3 46.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.672 -179.853 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.472 HD22 HG12 ' A' ' 96' ' ' VAL . 45.6 m-80 57.46 33.45 23.28 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.22 0.533 . . . . 0.0 110.562 -178.798 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 89.32 -15.24 58.92 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.867 -179.915 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 3.6 mpt_? -87.59 123.22 32.23 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 117.005 0.403 . . . . 0.0 110.048 -179.846 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.579 HD13 ' SG ' ' A' ' 23' ' ' CYS . 8.2 tp -77.16 115.05 16.61 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.474 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 11.3 t -122.73 140.37 46.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 120.964 0.411 . . . . 0.0 111.45 -178.271 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.669 ' HB2' HD11 ' A' ' 35' ' ' LEU . 3.9 t80 -84.65 132.85 34.43 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 177.401 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 3.9 tp-100 . . . . . 0 C--O 1.252 1.198 0 CA-C-O 118.545 -0.741 . . . . 0.0 110.794 -179.837 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.1 ttt . . . . . 0 N--CA 1.48 1.054 0 N-CA-C 110.089 -0.338 . . . . 0.0 110.089 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.652 ' OG ' ' HA ' ' A' ' 91' ' ' ASN . 39.2 m -114.03 177.09 4.76 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.468 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.518 ' HA ' ' OD1' ' A' ' 95' ' ' ASN . 14.6 p90 -65.73 -33.36 75.69 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.091 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.529 ' HA ' ' OG ' ' A' ' 7' ' ' SER . . . -57.69 -22.4 46.0 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.055 -0.52 . . . . 0.0 112.051 -179.368 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -65.4 -19.68 66.05 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 121.022 0.439 . . . . 0.0 110.629 179.217 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 7.4 p -145.9 39.53 1.13 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.645 179.938 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.529 ' OG ' ' HA ' ' A' ' 4' ' ' ALA . 87.0 p -145.89 167.73 22.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.205 179.085 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 4.9 ptp180 -150.49 162.84 39.83 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.733 -179.6 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 56.59 60.05 3.28 Favored 'General case' 0 C--N 1.331 -0.233 0 O-C-N 123.982 0.801 . . . . 0.0 111.769 177.657 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.434 ' HA ' ' HB2' ' A' ' 21' ' ' ALA . . . -91.94 119.49 31.74 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.703 179.775 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 27.4 m -119.81 169.55 10.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.475 -179.897 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.58 ' HB3' ' HA2' ' A' ' 16' ' ' GLY . 3.2 mm? -105.76 114.55 28.78 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.518 -179.211 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.468 ' OG1' ' HB ' ' A' ' 18' ' ' THR . 26.3 p -109.86 164.7 12.33 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.018 179.988 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 61.61 43.7 9.73 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.838 179.731 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 88.76 -37.84 3.27 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.792 -0.718 . . . . 0.0 111.975 179.827 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.58 ' HA2' ' HB3' ' A' ' 12' ' ' LEU . . . 140.74 42.32 0.07 OUTLIER Glycine 0 N--CA 1.444 -0.808 0 N-CA-C 111.432 -0.667 . . . . 0.0 111.432 -179.529 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.566 ' HB2' ' HB3' ' A' ' 38' ' ' ASP . 18.2 ptt85 -127.19 -21.24 3.96 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.896 0.379 . . . . 0.0 111.126 -179.828 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.468 ' HB ' ' OG1' ' A' ' 13' ' ' THR . 3.8 m -106.63 131.29 53.95 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.374 179.889 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.712 HD11 HD13 ' A' ' 90' ' ' LEU . 57.3 mt -93.4 113.83 26.08 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.327 179.209 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 22.5 ttt180 -111.97 119.37 38.29 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 178.644 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.434 ' HB2' ' HA ' ' A' ' 10' ' ' ALA . . . -153.73 167.0 31.09 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.95 0.405 . . . . 0.0 111.362 -179.11 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -90.02 106.7 18.65 Favored 'General case' 0 CA--C 1.511 -0.523 0 N-CA-C 107.821 -1.178 . . . . 0.0 107.821 178.19 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.543 ' SG ' HD13 ' A' ' 100' ' ' LEU . 35.7 m -97.55 131.82 43.79 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.326 -178.627 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.52 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 13.1 ttp180 -76.25 119.45 20.16 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 116.174 -0.466 . . . . 0.0 109.945 179.38 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 36.9 p30 -81.75 168.83 17.64 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 179.535 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -52.93 -30.56 35.27 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 -179.013 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -72.57 -15.08 61.76 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.397 0.618 . . . . 0.0 110.483 179.982 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 92.18 24.5 24.41 Favored Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.549 179.985 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.52 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 8.2 t-20 -107.49 162.89 13.53 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.582 0.23 . . . . 0.0 110.476 -178.753 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.429 ' HZ3' ' HA ' ' A' ' 7' ' ' SER . 83.3 m95 -99.03 115.71 29.58 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.931 0.396 . . . . 0.0 111.694 -179.548 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.1 m -122.13 125.43 72.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.173 178.463 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 19.9 m -76.14 113.54 13.79 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.996 -179.559 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 57.8 m -120.43 155.91 32.52 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.74 179.887 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.634 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 46.7 mt-10 -131.46 136.95 48.36 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.191 -179.394 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.502 ' HB2' ' HB3' ' A' ' 100' ' ' LEU . 1.7 tm? -132.72 130.1 39.57 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 178.434 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.443 ' N ' HD13 ' A' ' 35' ' ' LEU . 9.0 m-20 -89.94 109.04 20.09 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 -179.997 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.568 HD11 HD11 ' A' ' 19' ' ' LEU . 3.3 mt -79.48 -20.63 46.87 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.57 -179.095 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.566 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 11.2 p-10 -65.78 -10.26 35.82 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.7 0.285 . . . . 0.0 111.713 -178.612 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 77.6 p -81.23 -11.91 59.27 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.996 0.427 . . . . 0.0 110.34 179.045 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 23.4 m -133.95 -15.92 2.28 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.982 -0.554 . . . . 0.0 112.4 -179.026 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 54.9 mt -99.84 135.29 36.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 O-C-N 122.093 -0.379 . . . . 0.0 109.991 179.081 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.629 ' HA3' ' HB3' ' A' ' 52' ' ' MET . . . -143.65 156.7 26.73 Favored Glycine 0 N--CA 1.443 -0.878 0 C-N-CA 120.386 -0.911 . . . . 0.0 112.263 179.804 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.662 ' N ' ' HD3' ' A' ' 44' ' ' PRO . 25.4 p30 -153.47 40.38 0.16 Allowed Pre-proline 0 CA--C 1.54 0.568 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -179.785 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.662 ' HD3' ' N ' ' A' ' 43' ' ' ASN . 7.1 Cg_exo -71.77 -17.46 29.28 Favored 'Trans proline' 0 C--N 1.355 0.902 0 C-N-CA 121.74 1.627 . . . . 0.0 111.377 -179.213 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -91.58 -2.84 56.98 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.06 179.853 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.597 ' CA ' ' HG2' ' A' ' 83' ' ' ARG . . . 91.79 8.03 64.01 Favored Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.214 -179.439 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -126.11 139.38 53.43 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.667 0.27 . . . . 0.0 110.568 179.646 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.518 HD23 ' HB3' ' A' ' 43' ' ' ASN . 81.7 mt -84.48 148.7 26.4 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.723 179.862 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 165.42 171.11 31.24 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 121.036 -0.602 . . . . 0.0 111.921 179.244 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 89.0 m95 -95.28 125.66 40.06 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 179.676 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 163.21 -57.79 0.28 Allowed Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.192 -179.628 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.629 ' HB3' ' HA3' ' A' ' 42' ' ' GLY . 0.0 OUTLIER -90.78 -166.01 1.49 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 179.719 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 28.2 pt20 -141.98 171.6 13.83 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.918 -0.313 . . . . 0.0 111.648 -179.047 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 29.0 m-80 63.12 36.3 12.27 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 115.493 -0.776 . . . . 0.0 112.628 178.749 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.43 ' HB3' ' HA2' ' A' ' 42' ' ' GLY . 12.4 p90 -61.21 -27.39 68.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.763 0.316 . . . . 0.0 111.371 -179.629 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.525 ' OG ' ' HB3' ' A' ' 17' ' ' ARG . 15.0 m -62.53 -30.58 71.4 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.038 0.384 . . . . 0.0 112.038 -178.958 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 35.7 m80 -82.04 -4.06 55.95 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.742 -0.383 . . . . 0.0 111.169 -179.14 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.575 ' HB2' ' OD1' ' A' ' 43' ' ' ASN . 30.3 m -130.77 29.85 4.71 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.347 0.594 . . . . 0.0 110.239 179.232 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.643 ' HB3' HD21 ' A' ' 43' ' ' ASN . 28.9 p -141.28 153.22 45.08 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.641 179.209 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 66.4 mt-10 -125.34 139.2 53.89 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.419 -179.687 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 36.0 t70 58.62 73.21 0.49 Allowed 'General case' 0 N--CA 1.466 0.363 0 O-C-N 123.83 0.706 . . . . 0.0 111.532 -179.766 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.548 HG23 HD21 ' A' ' 71' ' ' LEU . 77.4 mt -87.24 119.85 35.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 178.801 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.493 ' NZ ' ' HB2' ' A' ' 63' ' ' LYS . 0.0 OUTLIER -148.87 159.79 43.84 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.843 -0.343 . . . . 0.0 111.033 -178.653 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.48 ' HG ' HD21 ' A' ' 12' ' ' LEU . 81.0 mt -99.94 123.54 44.3 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.845 0.355 . . . . 0.0 110.958 179.891 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 37.0 mm-40 -82.0 -61.48 1.9 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.502 -179.676 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.5 ' OE2' ' HE3' ' A' ' 70' ' ' LYS . 36.1 mt-10 -76.58 12.96 1.09 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.307 -179.658 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 76.5 18.79 78.81 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.348 -179.928 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.405 ' HA2' HD22 ' A' ' 64' ' ' LEU . . . 136.94 -17.16 3.66 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.0 -1.095 . . . . 0.0 112.924 179.384 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.45 ' HB3' ' HB2' ' A' ' 66' ' ' GLU . 0.1 OUTLIER -83.01 -17.96 41.5 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.194 0.521 . . . . 0.0 109.72 -179.854 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.5 ' HE3' ' OE2' ' A' ' 66' ' ' GLU . 37.9 ttmt -150.73 136.87 18.46 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.891 -179.278 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.609 ' HB2' HD11 ' A' ' 90' ' ' LEU . 10.0 tt -114.73 129.3 56.67 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.491 179.714 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 8.2 p -116.57 140.01 49.86 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.155 0.502 . . . . 0.0 111.28 179.828 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.489 ' HB3' ' HA ' ' A' ' 62' ' ' ILE . 13.0 p -163.28 164.03 25.09 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.089 179.02 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.537 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 28.1 ttt180 -99.4 100.39 10.42 Favored Pre-proline 0 C--N 1.317 -0.822 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 179.103 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.609 ' O ' ' HB3' ' A' ' 83' ' ' ARG . 53.2 Cg_endo -69.07 117.39 5.01 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.383 2.055 . . . . 0.0 109.864 178.545 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.868 ' HE3' ' HA2' ' A' ' 81' ' ' GLY . 0.0 OUTLIER -119.78 143.43 47.83 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.501 -178.978 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.684 HG22 ' O ' ' A' ' 82' ' ' PHE . 8.7 t -69.89 134.38 48.37 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.218 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 11.1 p -71.28 -12.43 16.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 O-C-N 124.088 0.867 . . . . 0.0 111.094 -179.284 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 32.8 m-20 -70.62 -16.72 62.86 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.506 -179.606 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.693 ' HA3' ' CE2' ' A' ' 82' ' ' PHE . . . -157.64 -30.2 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.441 -0.885 . . . . 0.0 112.628 179.215 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.868 ' HA2' ' HE3' ' A' ' 76' ' ' LYS . . . 101.83 16.13 24.71 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 121.024 -0.608 . . . . 0.0 111.916 -179.721 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.693 ' CE2' ' HA3' ' A' ' 80' ' ' GLY . 16.7 p90 -112.25 157.06 21.38 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 118.686 -0.673 . . . . 0.0 110.173 -178.622 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.813 ' HB2' ' HA ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 163.92 -151.03 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.556 0 O-C-N 124.253 0.971 . . . . 0.0 111.124 178.478 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -125.47 152.88 44.35 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.142 -177.927 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.537 ' HA ' ' HA ' ' A' ' 74' ' ' ARG . 39.7 ttt180 -83.91 145.8 28.39 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 179.621 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -150.63 -179.67 7.44 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.094 0.473 . . . . 0.0 111.756 -178.287 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -141.09 142.51 12.24 Favored Glycine 0 N--CA 1.451 -0.345 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.455 178.993 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 13.2 tt -125.09 136.58 60.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.028 0.442 . . . . 0.0 110.973 -179.199 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -80.59 141.28 35.19 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.467 -179.882 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.712 HD13 HD11 ' A' ' 19' ' ' LEU . 58.3 mt -107.59 46.36 0.95 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.674 0.749 . . . . 0.0 110.932 -179.816 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.652 ' HA ' ' OG ' ' A' ' 2' ' ' SER . 26.8 m-80 -79.9 3.67 19.11 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.634 179.762 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 12.9 mtp180 -98.47 -15.0 19.78 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.41 179.872 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 22.7 mm -94.37 98.07 7.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 121.356 0.598 . . . . 0.0 109.601 -179.029 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 22.3 tp60 -107.63 141.94 38.34 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.961 -178.443 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.518 ' OD1' ' HA ' ' A' ' 3' ' ' TYR . 16.1 p-10 -95.64 119.72 34.64 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.512 178.582 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 58.2 t -109.23 112.26 39.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.31 179.286 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 23.2 m-80 59.24 34.84 23.25 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-O 121.069 0.461 . . . . 0.0 110.56 -178.952 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 87.57 -8.96 75.51 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.757 -179.955 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.458 ' N ' ' HD2' ' A' ' 99' ' ' ARG . 7.9 mpt_? -94.65 134.43 37.24 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.661 0.267 . . . . 0.0 110.978 -179.052 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.543 HD13 ' SG ' ' A' ' 23' ' ' CYS . 2.9 tp -84.89 119.81 25.77 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.594 -0.276 . . . . 0.0 110.503 -179.681 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 20.8 t -129.28 141.53 46.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.609 -179.661 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.495 ' HB2' HD11 ' A' ' 35' ' ' LEU . 23.2 t80 -83.71 133.0 34.82 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 178.348 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 . . . . . 0 C--O 1.248 1.013 0 CA-C-O 118.336 -0.84 . . . . 0.0 110.108 179.271 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.2 mmt . . . . . 0 N--CA 1.481 1.077 0 CA-C-O 120.621 0.248 . . . . 0.0 110.562 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.58 ' OG ' ' HA ' ' A' ' 91' ' ' ASN . 21.0 m -117.72 175.04 5.84 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.723 -0.217 . . . . 0.0 110.474 179.082 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.405 ' CG ' HD11 ' A' ' 100' ' ' LEU . 11.7 p90 -55.32 -32.16 62.25 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.281 179.061 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -52.37 -20.89 3.07 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -178.801 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -55.93 -42.49 76.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.914 0.388 . . . . 0.0 110.959 178.743 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 47.7 m -132.01 36.02 3.69 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.001 179.828 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 16.7 m -144.57 153.24 41.6 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.483 179.531 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 7.9 ptp180 -149.53 172.7 14.58 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 110.317 -0.253 . . . . 0.0 110.317 179.951 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.469 HD22 ' N ' ' A' ' 9' ' ' ASN . 0.9 OUTLIER 67.02 44.63 1.92 Allowed 'General case' 0 N--CA 1.469 0.475 0 O-C-N 123.56 0.537 . . . . 0.0 110.5 -179.505 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.412 ' HA ' ' O ' ' A' ' 20' ' ' ARG . . . -87.83 118.26 27.24 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.425 -179.879 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 30.6 m -121.57 176.15 4.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.871 179.308 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.523 ' HB3' ' HA2' ' A' ' 16' ' ' GLY . 3.2 mm? -104.98 114.09 28.09 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 -179.752 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.529 ' OG1' ' HB ' ' A' ' 18' ' ' THR . 24.1 p -106.1 163.38 12.82 Favored 'General case' 0 C--O 1.245 0.823 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.923 -179.641 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 62.16 36.2 15.18 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.706 -179.482 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 92.56 -40.28 2.88 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.7 179.431 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.523 ' HA2' ' HB3' ' A' ' 12' ' ' LEU . . . 147.72 56.07 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.499 0 N-CA-C 110.979 -0.849 . . . . 0.0 110.979 -179.723 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.534 ' HB2' ' HB3' ' A' ' 38' ' ' ASP . 10.0 ptm180 -140.87 -32.19 0.58 Allowed 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.066 0.46 . . . . 0.0 111.211 -179.394 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.529 ' HB ' ' OG1' ' A' ' 13' ' ' THR . 3.7 m -102.99 138.27 40.08 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.348 -179.53 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.611 ' O ' ' HA ' ' A' ' 34' ' ' GLU . 34.4 mt -98.6 113.34 25.35 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.865 179.428 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.412 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 5.2 ttp180 -106.3 120.61 42.32 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 178.489 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -152.88 166.24 32.92 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.938 0.399 . . . . 0.0 111.734 -179.245 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.788 ' HB3' ' HB3' ' A' ' 30' ' ' TRP . 20.8 mm-40 -90.65 107.27 19.07 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 178.467 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.467 ' SG ' HD13 ' A' ' 100' ' ' LEU . 27.2 m -98.78 127.49 44.72 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.457 -178.754 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 19.6 ttp180 -74.39 109.52 7.94 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 179.27 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -87.27 173.48 9.17 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.718 -178.96 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -46.63 -34.1 4.75 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 -178.692 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -67.56 -10.74 54.68 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 121.498 0.666 . . . . 0.0 111.105 -179.464 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.45 23.63 56.01 Favored Glycine 0 N--CA 1.446 -0.634 0 N-CA-C 111.233 -0.747 . . . . 0.0 111.233 -179.94 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 -123.74 160.4 27.37 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.797 0.332 . . . . 0.0 111.197 -178.836 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.788 ' HB3' ' HB3' ' A' ' 22' ' ' GLU . 75.3 m95 -87.57 131.56 34.35 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.24 -178.858 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.414 HG22 ' O ' ' A' ' 23' ' ' CYS . 6.2 m -126.29 137.0 59.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.745 178.118 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 37.6 m -75.53 109.24 8.93 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.133 179.775 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 49.9 m -122.8 144.59 49.08 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.932 -179.966 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.611 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 43.9 mt-10 -128.88 135.45 49.09 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.433 -179.729 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.573 HD11 ' HB2' ' A' ' 102' ' ' PHE . 2.4 tm? -128.64 131.69 48.07 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 178.808 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.45 ' N ' HD13 ' A' ' 35' ' ' LEU . 11.4 m-20 -89.29 110.77 21.51 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.297 -179.794 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.476 HD23 HD12 ' A' ' 35' ' ' LEU . 0.9 OUTLIER -86.87 -16.12 37.03 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.938 179.947 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.534 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 0.5 OUTLIER -66.06 -13.81 60.62 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 -177.508 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.435 HG22 ' O ' ' A' ' 36' ' ' ASP . 8.8 t -83.08 -7.82 59.6 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.895 0.378 . . . . 0.0 110.653 179.193 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.427 ' SG ' HG23 ' A' ' 39' ' ' THR . 58.0 m -130.94 -17.2 3.15 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 112.181 0.437 . . . . 0.0 112.181 -179.341 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.46 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 57.2 mt -104.98 137.05 36.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.684 0.278 . . . . 0.0 110.766 179.731 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.576 ' HA3' ' HB3' ' A' ' 52' ' ' MET . . . -150.31 162.47 29.26 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 121.114 -0.565 . . . . 0.0 111.744 179.202 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.67 ' ND2' ' HB2' ' A' ' 55' ' ' PHE . 7.2 p30 -160.88 50.2 0.31 Allowed Pre-proline 0 CA--C 1.537 0.476 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -179.738 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -69.93 -13.07 33.77 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 121.658 1.572 . . . . 0.0 112.046 -179.653 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -101.94 5.02 40.62 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.735 179.83 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.559 ' CA ' ' HG2' ' A' ' 83' ' ' ARG . . . 85.43 11.66 74.59 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.362 -0.923 . . . . 0.0 112.37 -179.592 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.66 ' HA ' HE22 ' A' ' 86' ' ' GLN . 49.3 m-85 -125.31 131.81 52.98 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.013 0.435 . . . . 0.0 110.801 179.916 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.522 ' HB3' ' HB ' ' A' ' 88' ' ' ILE . 84.6 mt -86.31 135.57 33.48 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.461 -0.791 . . . . 0.0 111.722 -178.69 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -177.85 172.27 44.88 Favored Glycine 0 N--CA 1.447 -0.619 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.734 179.209 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.44 ' HH2' HD11 ' A' ' 93' ' ' ILE . 90.2 m95 -95.16 124.76 39.38 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 179.621 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 159.41 -54.71 0.35 Allowed Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.92 -0.657 . . . . 0.0 111.917 -179.26 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.576 ' HB3' ' HA3' ' A' ' 42' ' ' GLY . 0.0 OUTLIER -85.56 -166.06 1.41 Allowed 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 179.649 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -146.03 173.63 12.0 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.64 -0.424 . . . . 0.0 111.634 -179.55 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 60.21 39.86 18.75 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.717 179.376 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.67 ' HB2' ' ND2' ' A' ' 43' ' ' ASN . 6.2 p90 -61.84 -28.61 69.61 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.167 179.488 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.493 ' HB2' ' HB3' ' A' ' 17' ' ' ARG . 24.5 t -58.83 -44.94 91.04 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.727 -179.942 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 34.0 m80 -81.31 -13.76 58.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.082 0.467 . . . . 0.0 111.037 -179.734 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 15.7 m -96.33 -1.47 47.77 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.77 -178.928 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.421 ' HB3' ' HA ' ' A' ' 75' ' ' PRO . 56.5 p -137.95 172.97 12.15 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 121.71 -0.619 . . . . 0.0 111.235 -179.0 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.402 ' HG3' ' HG2' ' A' ' 76' ' ' LYS . 44.3 mt-10 -131.13 147.57 52.62 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.011 179.909 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 39.0 t70 56.66 77.69 0.25 Allowed 'General case' 0 N--CA 1.467 0.396 0 O-C-N 123.877 0.736 . . . . 0.0 110.722 179.903 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.542 ' HA ' ' HB3' ' A' ' 73' ' ' CYS . 67.3 mt -99.94 120.38 49.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.841 -179.292 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 76.9 tttt -148.9 156.96 43.05 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.211 -0.45 . . . . 0.0 109.858 179.554 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 44.1 mt -82.66 140.12 33.32 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.139 0.495 . . . . 0.0 111.271 -178.848 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -90.81 -61.56 1.64 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.985 -178.792 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.492 ' HB2' ' HB3' ' A' ' 69' ' ' ARG . 30.1 mm-40 -82.2 13.01 3.73 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.127 0.489 . . . . 0.0 111.106 -179.767 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 78.4 17.16 78.35 Favored Glycine 0 N--CA 1.45 -0.403 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.413 179.8 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 143.24 -30.95 1.98 Allowed Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.309 -0.948 . . . . 0.0 112.552 179.469 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.513 ' HD3' ' HB2' ' A' ' 2' ' ' SER . 4.6 tpp85 -75.45 -19.66 59.31 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.279 0.561 . . . . 0.0 110.565 -179.931 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.428 ' HB3' ' HG2' ' A' ' 66' ' ' GLU . 86.5 tttt -148.5 145.71 28.03 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.437 -178.33 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.733 ' HB2' HD11 ' A' ' 90' ' ' LEU . 10.2 tt -116.61 144.38 44.46 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.782 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.8 p -134.2 138.52 45.17 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 120.85 0.357 . . . . 0.0 110.697 179.747 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.542 ' HB3' ' HA ' ' A' ' 62' ' ' ILE . 26.5 p -162.55 174.58 12.45 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.85 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.495 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 4.1 tmt_? -109.29 97.46 26.31 Favored Pre-proline 0 C--N 1.315 -0.915 0 N-CA-C 109.111 -0.699 . . . . 0.0 109.111 179.087 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.65 ' O ' ' HB3' ' A' ' 83' ' ' ARG . 32.4 Cg_endo -64.58 129.55 24.03 Favored 'Trans proline' 0 CA--C 1.515 -0.473 0 C-N-CA 122.991 2.461 . . . . 0.0 110.807 -179.981 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.765 ' HA ' ' HB2' ' A' ' 83' ' ' ARG . 0.3 OUTLIER -121.22 149.78 42.32 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.217 0.532 . . . . 0.0 111.478 -179.569 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.655 HG22 ' O ' ' A' ' 82' ' ' PHE . 14.7 t -82.69 143.4 30.96 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 178.794 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 32.7 m -70.04 -9.33 12.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 O-C-N 123.862 0.727 . . . . 0.0 111.798 -179.494 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -62.57 -37.77 87.46 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-O 121.008 0.433 . . . . 0.0 110.374 179.246 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -160.38 -0.92 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.308 -0.949 . . . . 0.0 113.103 -179.519 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.591 ' HA2' ' HD3' ' A' ' 76' ' ' LYS . . . 84.88 21.52 55.46 Favored Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.488 -0.863 . . . . 0.0 112.041 179.304 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.655 ' O ' HG22 ' A' ' 77' ' ' THR . 40.2 p90 -111.07 154.91 23.57 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -179.588 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.805 ' HA ' ' HE ' ' A' ' 83' ' ' ARG . 0.0 OUTLIER 169.33 -145.34 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.241 0 O-C-N 123.805 0.691 . . . . 0.0 111.498 -179.999 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -129.53 157.46 41.97 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.688 -178.361 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.495 ' HA ' ' HA ' ' A' ' 74' ' ' ARG . 57.2 ttt180 -82.68 154.33 24.91 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 178.976 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.66 HE22 ' HA ' ' A' ' 47' ' ' PHE . 7.6 tt0 -164.81 -179.36 5.79 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 120.986 0.422 . . . . 0.0 111.741 -177.939 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.546 ' H ' ' HG2' ' A' ' 86' ' ' GLN . . . -142.55 153.26 24.42 Favored Glycine 0 CA--C 1.521 0.455 0 N-CA-C 111.841 -0.504 . . . . 0.0 111.841 179.257 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.522 ' HB ' ' HB3' ' A' ' 48' ' ' LEU . 12.0 tt -131.33 143.98 39.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.11 0.481 . . . . 0.0 110.618 -179.876 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.589 ' OD2' ' HB2' ' A' ' 91' ' ' ASN . 20.8 t70 -82.99 133.55 35.1 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.345 -179.184 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.733 HD11 ' HB2' ' A' ' 71' ' ' LEU . 86.7 mt -109.46 38.35 2.36 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -179.214 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.589 ' HB2' ' OD2' ' A' ' 89' ' ' ASP . 6.6 m-80 -75.68 3.07 10.4 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-O 121.485 0.66 . . . . 0.0 110.256 178.621 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 24.9 mtp180 -96.08 -5.57 40.59 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.879 179.567 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.471 ' CD1' HD22 ' A' ' 37' ' ' LEU . 25.0 mm -103.02 100.95 11.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.265 0.555 . . . . 0.0 109.994 -179.413 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.405 HE21 ' HA ' ' A' ' 94' ' ' GLN . 0.0 OUTLIER -110.24 156.34 20.8 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.725 -178.508 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 18.7 p-10 -110.07 113.18 25.67 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.378 178.172 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.7 p -109.9 114.99 48.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-O 121.339 0.59 . . . . 0.0 110.431 -179.777 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 65.12 23.54 12.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.559 179.697 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 95.45 -8.53 69.12 Favored Glycine 0 N--CA 1.447 -0.605 0 CA-C-N 115.481 -0.781 . . . . 0.0 112.404 -179.942 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 10.2 mtp180 -95.2 135.78 36.35 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -179.413 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.467 HD13 ' SG ' ' A' ' 23' ' ' CYS . 5.2 tp -88.22 116.11 26.19 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 -179.517 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 39.2 t -130.45 141.25 46.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.87 0.366 . . . . 0.0 110.65 -178.917 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.573 ' HB2' HD11 ' A' ' 35' ' ' LEU . 12.9 t80 -78.7 137.4 37.77 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.734 178.783 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 4.6 tp-100 . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.576 -0.726 . . . . 0.0 110.215 -179.994 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.0 mpp? . . . . . 0 N--CA 1.481 1.082 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.497 ' HA ' HE22 ' A' ' 94' ' ' GLN . 39.0 m -119.52 179.2 4.29 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.893 0.377 . . . . 0.0 111.352 -179.506 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.444 ' CB ' HD11 ' A' ' 100' ' ' LEU . 11.1 p90 -54.3 -32.63 56.9 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.518 178.062 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.558 ' HB3' ' HD2' ' A' ' 69' ' ' ARG . . . -57.43 -18.97 20.72 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 115.41 -0.814 . . . . 0.0 112.471 -179.056 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -69.41 -17.27 63.64 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 121.113 0.483 . . . . 0.0 110.891 179.641 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.413 ' HB2' HD21 ' A' ' 95' ' ' ASN . 74.6 m -144.27 37.05 1.24 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.076 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 23.2 t -150.83 157.17 42.6 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.686 -179.443 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 2.0 ptm180 -144.79 167.31 22.89 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 179.653 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 60.17 50.44 6.4 Favored 'General case' 0 N--CA 1.464 0.232 0 O-C-N 123.868 0.73 . . . . 0.0 111.186 179.492 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.505 ' HA ' ' HB2' ' A' ' 21' ' ' ALA . . . -84.81 117.36 23.81 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.467 179.721 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 33.5 m -122.42 168.77 14.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.916 -179.738 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.631 HD21 ' HG ' ' A' ' 64' ' ' LEU . 3.3 mm? -104.91 115.3 30.05 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.662 179.9 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 28.1 p -110.31 167.26 10.33 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.008 -179.891 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 59.83 46.78 10.94 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.089 179.398 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 85.5 -31.92 3.75 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 121.049 -0.596 . . . . 0.0 112.346 179.942 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.574 ' HA2' ' HB3' ' A' ' 12' ' ' LEU . . . 133.18 54.99 0.08 OUTLIER Glycine 0 N--CA 1.442 -0.905 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 -179.202 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.616 ' HB2' ' HB3' ' A' ' 38' ' ' ASP . 43.3 ptt85 -138.06 -32.73 0.72 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.889 0.376 . . . . 0.0 111.125 -179.664 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.451 HG22 ' HB3' ' A' ' 34' ' ' GLU . 5.2 m -98.56 132.32 44.07 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.479 179.93 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.744 HD11 HD13 ' A' ' 90' ' ' LEU . 69.5 mt -92.3 113.32 25.56 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.172 179.195 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 53.6 ttp180 -111.86 120.77 43.06 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 178.775 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.505 ' HB2' ' HA ' ' A' ' 10' ' ' ALA . . . -153.4 167.5 29.22 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.798 -179.271 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -90.36 106.15 18.3 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 178.437 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.556 ' SG ' HD13 ' A' ' 100' ' ' LEU . 58.5 m -93.15 130.59 38.75 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 -178.893 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 22.7 ttp85 -77.92 119.94 22.1 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 120.896 -0.322 . . . . 0.0 110.244 179.237 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.48 HD21 ' HB3' ' A' ' 29' ' ' ASN . 33.6 p30 -84.8 163.43 19.09 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.468 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.33 -15.43 25.47 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -178.232 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -82.21 -10.2 59.23 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.789 0.804 . . . . 0.0 109.289 179.168 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 87.23 35.36 9.7 Favored Glycine 0 N--CA 1.447 -0.605 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.702 -179.827 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.48 ' HB3' HD21 ' A' ' 25' ' ' ASN . 43.9 t30 -124.39 160.37 28.3 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.747 0.308 . . . . 0.0 111.316 -179.266 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 85.2 m95 -99.0 120.43 39.44 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.71 179.58 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.7 m -124.01 136.51 60.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.5 178.989 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 55.0 m -78.11 108.77 11.65 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 120.944 0.402 . . . . 0.0 110.135 179.696 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.478 ' HB2' ' SG ' ' A' ' 23' ' ' CYS . 70.6 m -119.26 142.46 48.03 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.383 -179.502 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.649 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 2.7 mp0 -128.38 152.6 47.99 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.344 -179.641 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.525 ' HB2' HD23 ' A' ' 100' ' ' LEU . 0.9 OUTLIER -143.53 126.96 16.81 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 178.292 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -87.26 109.65 19.64 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 -179.815 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.467 HD11 HD11 ' A' ' 19' ' ' LEU . 1.0 OUTLIER -86.94 -13.76 43.74 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.292 0.479 . . . . 0.0 112.292 -179.123 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.616 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 8.8 p-10 -64.98 -16.23 63.15 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 122.085 -0.384 . . . . 0.0 111.923 -178.314 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 15.1 t -91.15 0.79 57.46 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.119 0.485 . . . . 0.0 110.013 179.314 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 22.5 m -130.62 -19.5 3.0 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.993 -0.548 . . . . 0.0 111.783 -179.486 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 64.7 mt -112.79 139.95 35.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.823 0.344 . . . . 0.0 111.359 -179.287 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.577 ' HA3' ' HB3' ' A' ' 52' ' ' MET . . . -148.81 158.62 27.73 Favored Glycine 0 N--CA 1.449 -0.493 0 N-CA-C 110.841 -0.903 . . . . 0.0 110.841 179.171 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.6 ' N ' ' HD3' ' A' ' 44' ' ' PRO . 24.3 p30 -162.86 45.25 0.14 Allowed Pre-proline 0 CA--C 1.541 0.608 0 N-CA-C 113.903 1.075 . . . . 0.0 113.903 -179.317 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.6 ' HD3' ' N ' ' A' ' 43' ' ' ASN . 7.8 Cg_exo -71.84 -15.35 29.78 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 121.868 1.712 . . . . 0.0 111.277 179.959 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 70.9 m-20 -90.0 -0.75 57.75 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.703 -179.807 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.491 ' CA ' ' HG2' ' A' ' 83' ' ' ARG . . . 90.0 3.45 73.31 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.294 -0.955 . . . . 0.0 111.716 -179.167 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.71 ' HA ' HE22 ' A' ' 86' ' ' GLN . 64.7 m-85 -125.25 132.68 52.9 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.786 0.327 . . . . 0.0 110.449 179.988 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.545 HD23 HG22 ' A' ' 88' ' ' ILE . 11.1 mp -85.3 153.69 22.4 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.057 -179.273 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 170.99 171.97 36.77 Favored Glycine 0 N--CA 1.44 -1.094 0 C-N-CA 120.432 -0.89 . . . . 0.0 112.008 179.092 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.51 ' CD2' ' HD3' ' A' ' 92' ' ' ARG . 93.4 m95 -96.91 131.16 43.96 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.675 0.274 . . . . 0.0 110.506 -179.495 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 142.97 -62.47 0.51 Allowed Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 121.055 -0.593 . . . . 0.0 111.739 -179.866 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.577 ' HB3' ' HA3' ' A' ' 42' ' ' GLY . 2.4 ttt -72.07 -176.56 1.79 Allowed 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 179.345 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -142.84 169.16 18.09 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 121.517 -0.74 . . . . 0.0 112.605 -178.021 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 25.2 m-80 64.07 45.81 3.98 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.073 -0.967 . . . . 0.0 112.54 178.836 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 23.4 p90 -66.41 -32.71 74.26 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.837 179.512 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.448 ' HA ' HD11 ' A' ' 62' ' ' ILE . 4.3 m -63.09 -30.86 71.92 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.376 -179.169 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 28.1 m80 -81.76 -3.59 54.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.999 0.428 . . . . 0.0 111.025 -179.927 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 19.4 m -128.56 22.72 5.92 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.187 179.5 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 66.8 m -139.62 162.06 36.02 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.122 0.487 . . . . 0.0 111.671 -179.774 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -132.92 142.23 48.78 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.02 178.922 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 25.9 t70 60.0 73.52 0.48 Allowed 'General case' 0 N--CA 1.467 0.385 0 O-C-N 123.687 0.617 . . . . 0.0 110.707 -179.857 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.519 HG23 HD21 ' A' ' 71' ' ' LEU . 68.7 mt -93.19 114.42 29.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.415 -179.824 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.472 ' HD3' ' N ' ' A' ' 64' ' ' LEU . 13.7 tmtt? -147.38 149.88 33.6 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.079 -179.055 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.631 ' HG ' HD21 ' A' ' 12' ' ' LEU . 79.3 mt -83.29 122.54 28.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.145 0.498 . . . . 0.0 111.37 -179.521 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -74.02 -63.27 1.25 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.379 -179.143 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.515 ' HB2' ' HB2' ' A' ' 69' ' ' ARG . 29.3 mt-10 -86.13 35.35 0.64 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.843 0.354 . . . . 0.0 111.462 -179.008 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 56.93 22.09 40.3 Favored Glycine 0 CA--C 1.519 0.319 0 CA-C-N 115.679 -0.691 . . . . 0.0 113.591 179.327 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 139.22 -23.97 2.84 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 119.887 -1.149 . . . . 0.0 113.091 179.275 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.558 ' HD2' ' HB3' ' A' ' 4' ' ' ALA . 0.2 OUTLIER -78.73 -17.12 56.34 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 117.251 0.526 . . . . 0.0 110.838 -179.788 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.459 ' HE3' ' OE1' ' A' ' 66' ' ' GLU . 33.3 ttmt -153.56 138.34 17.06 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.521 -177.938 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.586 ' HB2' HD11 ' A' ' 90' ' ' LEU . 10.5 tt -108.55 129.75 55.3 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.102 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 6.4 p -117.61 136.36 53.34 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.819 0.342 . . . . 0.0 111.528 179.969 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 28.2 p -162.67 163.45 26.99 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.479 179.895 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.44 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 78.8 ttt180 -99.47 103.93 24.03 Favored Pre-proline 0 C--N 1.32 -0.71 0 C-N-CA 120.341 -0.543 . . . . 0.0 110.458 179.061 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.709 ' O ' ' HB3' ' A' ' 83' ' ' ARG . 69.2 Cg_endo -71.95 123.46 9.33 Favored 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 122.848 2.365 . . . . 0.0 111.036 179.174 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.758 ' HA ' ' HB2' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -120.21 143.33 48.32 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.335 -179.589 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.738 HG22 ' O ' ' A' ' 82' ' ' PHE . 15.2 t -75.71 136.78 40.35 Favored 'General case' 0 CA--C 1.513 -0.471 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 179.334 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 35.0 m -76.35 -6.88 9.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.991 -179.784 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -68.59 -31.54 70.8 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.637 179.645 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.486 ' HA3' ' CE2' ' A' ' 82' ' ' PHE . . . -147.04 -23.34 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.717 179.568 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 101.18 12.54 36.06 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.997 -0.62 . . . . 0.0 112.146 -179.495 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.738 ' O ' HG22 ' A' ' 77' ' ' THR . 31.5 p90 -111.91 158.46 19.45 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 118.892 -0.575 . . . . 0.0 110.221 -178.349 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.758 ' HB2' ' HA ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 164.32 -161.47 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.436 0 O-C-N 123.861 0.725 . . . . 0.0 111.307 178.327 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -110.16 176.08 5.19 Favored 'General case' 0 C--O 1.222 -0.354 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.36 -176.904 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.44 ' HA ' ' HA ' ' A' ' 74' ' ' ARG . 74.9 ttt180 -102.65 153.73 19.84 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 177.967 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.71 HE22 ' HA ' ' A' ' 47' ' ' PHE . 8.2 tt0 -166.09 179.2 5.89 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 120.361 -0.535 . . . . 0.0 111.848 -177.49 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.539 ' H ' ' HG2' ' A' ' 86' ' ' GLN . . . -145.54 155.16 26.37 Favored Glycine 0 N--CA 1.449 -0.493 0 N-CA-C 111.473 -0.651 . . . . 0.0 111.473 179.225 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.545 HG22 HD23 ' A' ' 48' ' ' LEU . 11.9 tt -132.06 134.84 59.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 110.105 -0.331 . . . . 0.0 110.105 179.883 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -77.78 139.09 39.31 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.221 0.534 . . . . 0.0 110.179 -179.949 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.744 HD13 HD11 ' A' ' 19' ' ' LEU . 68.3 mt -106.59 46.66 0.91 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.589 0.709 . . . . 0.0 111.201 -179.015 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 35.0 m-80 -79.16 3.19 18.41 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 115.344 -0.843 . . . . 0.0 110.176 179.555 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.51 ' HD3' ' CD2' ' A' ' 50' ' ' TRP . 17.8 mtp180 -97.09 -19.17 18.88 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.676 179.569 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.435 ' CD1' HD22 ' A' ' 37' ' ' LEU . 21.6 mm -91.56 100.76 11.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 -179.589 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.497 HE22 ' HA ' ' A' ' 2' ' ' SER . 21.1 mm-40 -109.48 165.92 11.28 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.285 -177.988 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.511 ' HA ' ' O ' ' A' ' 99' ' ' ARG . 18.4 p-10 -120.16 118.92 31.78 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.154 177.632 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.2 p -116.12 122.53 69.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 121.033 0.444 . . . . 0.0 110.339 -179.321 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 57.99 16.59 3.83 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.848 179.889 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 111.2 -12.15 28.82 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 121.076 -0.583 . . . . 0.0 113.707 178.859 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.511 ' O ' ' HA ' ' A' ' 95' ' ' ASN . 0.9 OUTLIER -101.0 147.06 26.62 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 117.422 0.611 . . . . 0.0 111.276 -178.906 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.556 HD13 ' SG ' ' A' ' 23' ' ' CYS . 5.2 tp -91.79 123.55 35.26 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.542 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 23.7 t -130.7 140.12 49.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.809 -178.951 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -85.65 125.07 32.87 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 177.397 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 . . . . . 0 C--N 1.309 -1.166 0 CA-C-O 118.46 -0.781 . . . . 0.0 110.862 179.675 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.9 mpp? . . . . . 0 N--CA 1.481 1.099 0 CA-C-O 120.989 0.424 . . . . 0.0 110.375 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.9 m -119.29 -179.73 3.94 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.453 -179.78 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.475 ' CZ ' HD13 ' A' ' 19' ' ' LEU . 18.0 p90 -55.43 -34.49 64.49 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.791 0.329 . . . . 0.0 111.114 178.555 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.546 ' HA ' ' OG ' ' A' ' 7' ' ' SER . . . -57.77 -18.69 23.08 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -178.546 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -69.48 -18.19 63.68 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 121.102 0.477 . . . . 0.0 111.168 179.875 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.419 ' HB2' HD21 ' A' ' 95' ' ' ASN . 50.7 m -141.64 36.51 1.64 Allowed 'General case' 0 N--CA 1.446 -0.646 0 CA-C-O 121.239 0.542 . . . . 0.0 109.899 179.361 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.546 ' OG ' ' HA ' ' A' ' 4' ' ' ALA . 77.8 p -148.7 165.47 31.26 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.36 179.205 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -148.22 165.57 30.53 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.068 179.918 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 62.09 42.44 9.81 Favored 'General case' 0 N--CA 1.464 0.237 0 O-C-N 123.594 0.559 . . . . 0.0 111.24 179.902 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.432 ' HA ' ' O ' ' A' ' 20' ' ' ARG . . . -80.13 117.21 20.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.153 179.627 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 28.2 m -126.41 172.38 13.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.708 -179.432 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.655 HD21 ' HG ' ' A' ' 64' ' ' LEU . 3.1 mm? -104.5 117.84 35.14 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.559 -179.216 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.45 ' OG1' ' HB ' ' A' ' 18' ' ' THR . 37.9 p -112.33 163.96 13.8 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.016 179.779 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 58.56 50.12 9.58 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.124 -179.909 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 84.63 -33.13 3.29 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.394 179.287 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.599 ' HA2' ' HB3' ' A' ' 12' ' ' LEU . . . 134.38 49.65 0.08 OUTLIER Glycine 0 N--CA 1.443 -0.855 0 N-CA-C 111.448 -0.661 . . . . 0.0 111.448 -179.652 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.681 ' HB2' ' HB2' ' A' ' 38' ' ' ASP . 20.4 ptt85 -133.79 -33.82 1.04 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.834 0.35 . . . . 0.0 111.021 179.96 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.509 ' CG2' ' HB3' ' A' ' 34' ' ' GLU . 19.2 m -94.76 135.68 35.96 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.15 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.656 ' O ' ' HA ' ' A' ' 34' ' ' GLU . 79.9 mt -97.54 114.98 26.97 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.559 -179.589 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.468 ' HA ' ' HG2' ' A' ' 34' ' ' GLU . 16.8 ttm180 -104.57 120.24 40.84 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 178.661 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -153.84 160.39 42.19 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.776 0.322 . . . . 0.0 111.571 -179.982 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.585 ' HB3' ' HB3' ' A' ' 30' ' ' TRP . 15.9 mm-40 -90.32 106.08 18.25 Favored 'General case' 0 CA--C 1.513 -0.479 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 177.927 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.505 ' SG ' HD13 ' A' ' 100' ' ' LEU . 48.9 m -93.74 127.56 39.52 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 120.989 0.423 . . . . 0.0 111.053 -178.016 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 23.3 ttp180 -75.35 110.19 9.5 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.772 179.17 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -82.74 169.28 16.35 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 119.223 -0.418 . . . . 0.0 109.979 -179.525 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -47.83 -34.38 8.64 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -178.085 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -68.04 -12.71 61.32 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.473 0.654 . . . . 0.0 111.317 -179.58 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 85.72 26.17 36.1 Favored Glycine 0 N--CA 1.444 -0.83 0 N-CA-C 110.806 -0.918 . . . . 0.0 110.806 -179.202 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -115.95 153.54 31.42 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.718 0.294 . . . . 0.0 110.899 -179.288 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.585 ' HB3' ' HB3' ' A' ' 22' ' ' GLU . 88.6 m95 -89.29 125.58 35.17 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.395 -179.505 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.409 HG22 ' O ' ' A' ' 23' ' ' CYS . 12.1 m -124.74 132.69 70.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 116.213 -0.449 . . . . 0.0 109.949 178.319 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 21.0 m -74.61 109.47 8.11 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.454 -179.904 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 68.7 m -123.18 142.94 50.37 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.358 179.826 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.656 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 49.1 mt-10 -128.38 134.93 48.93 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.31 -179.342 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.519 HD11 ' HB2' ' A' ' 102' ' ' PHE . 1.7 tm? -125.44 130.09 51.14 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 178.744 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.413 ' N ' HD13 ' A' ' 35' ' ' LEU . 15.2 t70 -88.98 111.3 21.98 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 110.14 -0.318 . . . . 0.0 110.14 -179.914 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.548 HD13 HD22 ' A' ' 90' ' ' LEU . 0.9 OUTLIER -86.38 -12.62 48.75 Favored 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 120.937 -0.305 . . . . 0.0 110.906 179.828 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.681 ' HB2' ' HB2' ' A' ' 17' ' ' ARG . 10.1 t70 -61.66 -36.32 80.5 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.653 0.264 . . . . 0.0 111.225 -178.928 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.3 t -72.75 1.27 8.78 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.199 -0.455 . . . . 0.0 112.0 -179.877 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 78.5 m -135.45 -21.43 1.55 Allowed 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 179.943 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.459 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 68.7 mt -107.58 137.21 39.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 179.771 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.491 ' HA2' ' HB3' ' A' ' 55' ' ' PHE . . . -149.55 160.13 28.34 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.393 -0.908 . . . . 0.0 112.492 179.951 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.705 ' ND2' ' HB2' ' A' ' 55' ' ' PHE . 8.3 p30 -158.23 51.21 0.44 Allowed Pre-proline 0 CA--C 1.535 0.4 0 N-CA-C 111.664 0.246 . . . . 0.0 111.664 178.967 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.402 ' HG3' ' HG2' ' A' ' 52' ' ' MET . 60.6 Cg_endo -71.83 -19.69 26.97 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 121.944 1.763 . . . . 0.0 111.823 -179.347 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -91.19 -9.2 46.25 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.883 179.515 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.594 ' HA3' ' HG2' ' A' ' 83' ' ' ARG . . . 102.7 7.47 44.89 Favored Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.772 -179.917 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -125.3 137.45 54.07 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.018 0.437 . . . . 0.0 111.076 -179.674 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.439 HD23 ' HB3' ' A' ' 43' ' ' ASN . 86.9 mt -82.92 146.52 28.79 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.922 -178.457 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 168.32 171.48 34.23 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.2 178.743 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.409 ' HH2' HD11 ' A' ' 93' ' ' ILE . 91.6 m95 -95.27 128.01 41.77 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 -179.998 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 154.35 -51.66 0.46 Allowed Glycine 0 N--CA 1.453 -0.196 0 C-N-CA 120.856 -0.688 . . . . 0.0 111.95 -179.905 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.449 ' HB3' ' HA3' ' A' ' 42' ' ' GLY . 14.0 tpt -93.05 174.03 7.43 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 179.848 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -128.97 173.19 10.64 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.846 -0.342 . . . . 0.0 111.005 179.698 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.678 ' HA ' ' OD2' ' A' ' 38' ' ' ASP . 0.7 OUTLIER 65.52 47.23 2.29 Favored 'General case' 0 N--CA 1.466 0.352 0 O-C-N 123.701 0.626 . . . . 0.0 111.128 -179.806 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.705 ' HB2' ' ND2' ' A' ' 43' ' ' ASN . 15.7 p90 -74.19 -32.11 62.92 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.673 -179.756 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.614 ' OG ' ' HB3' ' A' ' 17' ' ' ARG . 20.1 m -63.75 -33.74 76.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.035 0.445 . . . . 0.0 111.128 -179.046 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 15.7 m-70 -82.15 -7.95 59.64 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.101 0.476 . . . . 0.0 110.27 179.578 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 15.1 m -112.0 4.23 17.98 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.387 -179.292 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 36.4 p -138.38 157.54 46.03 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 122.203 -0.31 . . . . 0.0 110.752 -179.222 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 38.0 mm-40 -117.46 148.42 41.83 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.014 -179.401 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 24.1 t70 52.05 83.35 0.06 Allowed 'General case' 0 N--CA 1.468 0.462 0 O-C-N 124.333 1.02 . . . . 0.0 111.644 178.957 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.538 HD11 ' HA ' ' A' ' 56' ' ' SER . 77.9 mt -97.79 124.1 50.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.78 -179.942 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.455 ' HD3' ' N ' ' A' ' 64' ' ' LEU . 13.0 tmtt? -148.98 149.75 31.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.006 -179.857 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.655 ' HG ' HD21 ' A' ' 12' ' ' LEU . 76.2 mt -83.01 120.16 25.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.021 0.439 . . . . 0.0 111.532 -179.648 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -71.64 -60.2 2.36 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.267 -178.666 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.548 ' HB2' ' HB2' ' A' ' 69' ' ' ARG . 5.0 mm-40 -83.52 20.17 1.44 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.033 -178.767 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 68.66 19.23 72.88 Favored Glycine 0 N--CA 1.45 -0.425 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.923 179.701 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.519 ' HA2' HD13 ' A' ' 64' ' ' LEU . . . 144.18 -34.83 1.62 Allowed Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.315 -0.945 . . . . 0.0 113.251 179.697 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.548 ' HB2' ' HB2' ' A' ' 66' ' ' GLU . 5.4 mmt85 -71.57 -24.89 62.0 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.854 0.359 . . . . 0.0 111.829 -179.34 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 11.7 tttp -143.65 137.48 28.29 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.607 -177.81 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.606 ' HB2' HD11 ' A' ' 90' ' ' LEU . 10.5 tt -105.84 127.58 53.2 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 179.599 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.1 p -116.32 136.28 53.14 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 120.971 0.415 . . . . 0.0 111.233 179.967 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.403 ' HB3' ' HA ' ' A' ' 62' ' ' ILE . 21.0 p -162.58 175.87 10.98 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.747 -179.743 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.464 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 29.5 ttt180 -112.8 98.85 46.35 Favored Pre-proline 0 C--N 1.315 -0.902 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.303 178.97 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.647 ' O ' ' HB3' ' A' ' 83' ' ' ARG . 34.9 Cg_endo -66.19 130.44 24.13 Favored 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 122.674 2.249 . . . . 0.0 110.791 178.953 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.626 ' HA ' ' HB2' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -119.71 152.88 36.47 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.167 0.508 . . . . 0.0 111.049 -179.681 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.696 ' HB ' ' HD2' ' A' ' 83' ' ' ARG . 10.9 t -88.84 144.78 25.99 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 178.902 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 34.7 m -71.61 -4.81 5.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 O-C-N 123.992 0.808 . . . . 0.0 112.152 -179.141 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 39.1 m-20 -63.93 -37.21 86.55 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-O 121.118 0.485 . . . . 0.0 109.793 178.928 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.405 ' H ' ' H ' ' A' ' 81' ' ' GLY . . . -164.76 -4.94 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 115.461 -0.79 . . . . 0.0 112.854 -179.841 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.405 ' H ' ' H ' ' A' ' 80' ' ' GLY . . . 93.38 22.9 25.67 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.089 179.731 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.649 ' O ' HG22 ' A' ' 77' ' ' THR . 34.2 p90 -111.46 148.02 34.03 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 -179.42 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.696 ' HD2' ' HB ' ' A' ' 77' ' ' THR . 0.0 OUTLIER 174.55 -143.75 0.01 OUTLIER 'General case' 0 C--O 1.233 0.195 0 O-C-N 123.465 0.478 . . . . 0.0 111.304 -179.915 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -125.31 176.6 6.66 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.923 0.392 . . . . 0.0 110.579 -179.49 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.464 ' HA ' ' HA ' ' A' ' 74' ' ' ARG . 62.8 ttt180 -108.66 147.82 31.32 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 177.849 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.519 ' HG2' ' N ' ' A' ' 87' ' ' GLY . 9.0 tt0 -161.27 171.8 17.75 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.946 0.403 . . . . 0.0 111.79 -177.246 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.519 ' N ' ' HG2' ' A' ' 86' ' ' GLN . . . -132.12 141.65 13.01 Favored Glycine 0 N--CA 1.45 -0.387 0 N-CA-C 111.233 -0.747 . . . . 0.0 111.233 178.612 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 11.6 tt -120.45 138.74 49.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 120.976 0.417 . . . . 0.0 110.377 -179.221 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.418 ' HB3' HD22 ' A' ' 91' ' ' ASN . 39.6 m-20 -75.74 139.98 42.15 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.185 -179.472 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.612 HD13 HD11 ' A' ' 19' ' ' LEU . 29.8 mt -109.43 35.73 3.2 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.517 0.675 . . . . 0.0 110.376 179.317 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.418 HD22 ' HB3' ' A' ' 89' ' ' ASP . 13.5 m-80 -72.56 -5.41 36.92 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.594 -179.835 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 17.1 mtp180 -89.09 -7.74 55.21 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.001 178.731 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.438 HG13 HD22 ' A' ' 37' ' ' LEU . 27.5 mm -103.64 100.55 10.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -179.615 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 25.4 tp60 -117.55 146.76 43.37 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.342 -178.777 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.419 HD21 ' HB2' ' A' ' 6' ' ' SER . 12.5 p-10 -95.16 117.11 29.66 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.48 179.18 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 48.5 t -101.36 107.03 20.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.788 179.727 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 56.16 41.86 28.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.675 -179.284 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 89.5 -18.4 46.4 Favored Glycine 0 N--CA 1.447 -0.624 0 CA-C-N 115.783 -0.644 . . . . 0.0 113.342 179.681 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 8.7 mpt_? -88.31 123.13 32.59 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 117.163 0.481 . . . . 0.0 110.921 -179.216 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.505 HD13 ' SG ' ' A' ' 23' ' ' CYS . 7.6 tp -76.65 114.46 15.41 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.443 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 40.7 t -128.98 144.7 37.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.09 0.472 . . . . 0.0 111.367 -178.488 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.519 ' HB2' HD11 ' A' ' 35' ' ' LEU . 22.3 t80 -83.26 130.92 35.11 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.63 178.442 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 . . . . . 0 C--N 1.317 -0.846 0 CA-C-O 118.325 -0.845 . . . . 0.0 110.216 -179.725 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 tmt? . . . . . 0 N--CA 1.481 1.102 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.536 ' HB3' ' HA ' ' A' ' 91' ' ' ASN . 15.9 p -112.98 177.58 4.58 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.732 179.525 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 4.4 p90 -55.91 -38.09 69.79 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -178.555 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -56.35 -21.57 25.41 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 -177.882 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -66.4 -28.7 68.84 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.255 0.55 . . . . 0.0 110.392 179.971 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 41.4 m -133.44 36.22 3.39 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.687 179.204 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 8.6 t -140.29 160.11 40.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.945 -179.66 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 1.1 ptp180 -149.97 169.86 20.19 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.632 -179.593 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 58.23 45.48 17.21 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.129 177.934 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.567 ' HA ' ' HB2' ' A' ' 21' ' ' ALA . . . -81.66 118.34 22.73 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.055 0.455 . . . . 0.0 110.69 179.957 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 29.5 m -119.24 170.55 8.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.393 179.794 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.712 HD21 ' HG ' ' A' ' 64' ' ' LEU . 3.2 mm? -105.12 114.94 29.44 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.434 -179.47 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 38.8 p -115.01 167.66 10.6 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.808 179.752 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 57.64 50.56 10.71 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.154 179.653 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 83.88 -22.94 7.25 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 121.069 -0.586 . . . . 0.0 112.374 -179.808 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.613 ' HA2' ' HB3' ' A' ' 12' ' ' LEU . . . 119.71 38.23 0.73 Allowed Glycine 0 N--CA 1.447 -0.583 0 N-CA-C 111.662 -0.575 . . . . 0.0 111.662 179.976 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.626 ' HB2' ' HB3' ' A' ' 38' ' ' ASP . 14.3 ptt180 -121.86 -22.6 5.7 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.944 0.402 . . . . 0.0 110.758 -179.486 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 4.2 m -102.55 133.06 48.14 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.592 -179.607 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.811 HD11 HD13 ' A' ' 90' ' ' LEU . 69.5 mt -92.65 112.62 24.64 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.297 179.142 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.411 HH11 ' HD2' ' A' ' 20' ' ' ARG . 30.7 ttt85 -111.06 118.57 36.4 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 178.94 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.567 ' HB2' ' HA ' ' A' ' 10' ' ' ALA . . . -154.9 166.92 32.02 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.862 0.363 . . . . 0.0 111.964 -178.783 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -90.69 113.37 25.43 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 177.371 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.477 ' SG ' HD13 ' A' ' 100' ' ' LEU . 59.7 m -102.66 134.95 45.18 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 -179.806 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.563 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 7.3 ttt180 -82.12 104.66 12.61 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-O 120.917 0.389 . . . . 0.0 109.965 -179.804 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.431 HD21 ' HB3' ' A' ' 29' ' ' ASN . 37.8 p30 -67.01 170.84 6.17 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 115.619 -0.718 . . . . 0.0 111.162 -179.214 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.52 -31.16 61.84 Favored 'General case' 0 N--CA 1.464 0.269 0 O-C-N 123.431 0.457 . . . . 0.0 111.781 -178.781 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -71.56 -11.71 61.0 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.331 0.586 . . . . 0.0 110.421 179.878 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 87.55 24.64 35.47 Favored Glycine 0 N--CA 1.45 -0.404 0 N-CA-C 111.373 -0.691 . . . . 0.0 111.373 -179.839 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.563 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 10.7 t-20 -108.56 160.09 16.19 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.672 0.272 . . . . 0.0 110.718 -178.349 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 90.4 m95 -98.36 119.18 36.6 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.984 0.421 . . . . 0.0 110.8 179.745 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.2 m -123.43 130.9 73.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.098 179.11 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 28.0 m -79.69 109.12 13.8 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.057 0.455 . . . . 0.0 110.32 -179.889 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 70.3 m -115.89 161.33 18.96 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.439 -179.817 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.636 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 51.5 mt-10 -140.02 138.92 35.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.241 -178.908 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.6 ' HB2' ' HB3' ' A' ' 100' ' ' LEU . 1.8 tm? -134.72 129.97 35.53 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 178.704 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.476 ' O ' HG22 ' A' ' 39' ' ' THR . 15.8 m-20 -88.64 109.64 20.28 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 179.971 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.534 HD13 HD22 ' A' ' 90' ' ' LEU . 1.4 mt -83.06 -12.42 57.16 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.831 -179.303 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.626 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 4.2 p-10 -66.23 -13.58 60.56 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 111.857 0.317 . . . . 0.0 111.857 -178.621 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.476 HG22 ' O ' ' A' ' 36' ' ' ASP . 12.1 t -87.97 -0.58 57.19 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.885 0.374 . . . . 0.0 110.296 179.387 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 67.2 m -136.58 -20.11 1.37 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.937 179.94 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 60.0 mt -107.96 132.49 55.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 178.877 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.557 ' HA3' ' HB3' ' A' ' 52' ' ' MET . . . -141.49 158.69 26.61 Favored Glycine 0 N--CA 1.446 -0.667 0 N-CA-C 111.256 -0.738 . . . . 0.0 111.256 179.527 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.613 ' OD1' ' HB2' ' A' ' 58' ' ' SER . 32.6 p30 -156.29 40.82 0.12 Allowed Pre-proline 0 CA--C 1.54 0.592 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 179.792 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.403 ' CD ' ' N ' ' A' ' 43' ' ' ASN . 52.5 Cg_endo -69.65 -15.86 37.73 Favored 'Trans proline' 0 C--N 1.357 0.975 0 C-N-CA 121.331 1.354 . . . . 0.0 111.41 -179.933 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -89.74 -8.12 52.98 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.623 179.077 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.589 ' HA3' ' HD3' ' A' ' 83' ' ' ARG . . . 99.38 5.25 55.91 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.659 -179.575 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -126.92 139.79 52.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 117.045 0.422 . . . . 0.0 111.568 -179.587 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.625 HD12 ' HG3' ' A' ' 86' ' ' GLN . 59.4 mt -84.5 138.86 32.54 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.735 -179.704 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 179.11 168.39 38.11 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.137 178.807 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 87.9 m95 -95.78 125.51 40.4 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.985 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 151.26 -42.61 0.72 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.895 -0.669 . . . . 0.0 111.519 -179.66 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.557 ' HB3' ' HA3' ' A' ' 42' ' ' GLY . 1.5 mtt -97.44 -172.07 2.33 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 179.399 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -142.96 169.81 16.88 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 119.757 -0.777 . . . . 0.0 112.343 -178.839 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 64.0 44.97 4.4 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.877 179.203 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.41 ' HD1' ' HA ' ' A' ' 38' ' ' ASP . 20.7 p90 -64.08 -33.6 76.13 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.464 -179.788 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 67.0 p -66.49 -23.84 66.32 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.208 0.527 . . . . 0.0 110.787 -179.36 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 16.1 m80 -76.97 -6.06 51.1 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.662 179.689 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.613 ' HB2' ' OD1' ' A' ' 43' ' ' ASN . 31.5 m -137.78 27.99 2.68 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.939 0.4 . . . . 0.0 110.782 179.492 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.554 ' HB3' HD21 ' A' ' 43' ' ' ASN . 35.6 p -141.73 149.81 40.98 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.169 0.509 . . . . 0.0 111.32 179.352 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -123.28 150.06 43.99 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.476 -179.626 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 27.6 t70 54.62 77.4 0.2 Allowed 'General case' 0 N--CA 1.47 0.546 0 O-C-N 123.778 0.674 . . . . 0.0 111.188 -179.922 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.51 ' HA ' ' HB3' ' A' ' 73' ' ' CYS . 69.4 mt -95.98 117.5 40.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.878 -179.404 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 41.6 tptt -142.25 150.45 40.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.699 -179.326 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.712 ' HG ' HD21 ' A' ' 12' ' ' LEU . 57.8 mt -92.93 144.7 25.01 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.362 179.432 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -101.42 -63.93 1.1 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.941 0.4 . . . . 0.0 111.963 -179.965 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.537 ' HB2' ' HB3' ' A' ' 69' ' ' ARG . 10.6 mm-40 -79.81 40.34 0.45 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.045 -178.098 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 64.11 22.09 66.61 Favored Glycine 0 C--N 1.314 -0.675 0 CA-C-N 115.229 -0.896 . . . . 0.0 113.123 178.858 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.598 ' HA2' HD13 ' A' ' 64' ' ' LEU . . . 120.56 -9.18 10.83 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 119.965 -1.112 . . . . 0.0 112.858 179.17 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.537 ' HB3' ' HB2' ' A' ' 66' ' ' GLU . 16.5 ttp85 -90.3 -3.06 58.01 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.665 0.745 . . . . 0.0 110.335 -179.794 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.517 ' HD3' ' HA ' ' A' ' 89' ' ' ASP . 5.6 tppp? -150.39 123.64 8.92 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.846 -179.77 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.677 ' HB2' HD11 ' A' ' 90' ' ' LEU . 9.5 tt -105.62 128.57 53.71 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 179.867 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 5.6 p -123.23 135.43 54.27 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.166 179.876 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.51 ' HB3' ' HA ' ' A' ' 62' ' ' ILE . 22.8 p -162.21 173.79 13.78 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 179.552 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.47 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 71.8 ttt180 -110.26 98.59 36.34 Favored Pre-proline 0 C--N 1.312 -1.035 0 C-N-CA 120.7 -0.4 . . . . 0.0 110.276 179.606 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.646 ' O ' ' HB3' ' A' ' 83' ' ' ARG . 37.1 Cg_endo -69.92 132.65 23.5 Favored 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 122.342 2.028 . . . . 0.0 109.964 178.495 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.743 ' HA ' ' HB2' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -120.6 142.84 49.02 Favored 'General case' 0 C--N 1.32 -0.68 0 O-C-N 123.678 0.611 . . . . 0.0 111.452 -179.115 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.706 HG22 ' O ' ' A' ' 82' ' ' PHE . 14.6 t -76.81 143.31 39.87 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.614 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 22.5 m -77.4 1.07 2.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.573 -179.492 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -69.8 -34.26 73.48 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 121.371 0.605 . . . . 0.0 109.651 178.326 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -159.05 -12.77 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.517 0 CA-C-N 115.29 -0.868 . . . . 0.0 112.794 -179.814 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.704 ' HA2' ' HE3' ' A' ' 76' ' ' LYS . . . 97.23 20.21 23.72 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.108 179.983 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.706 ' O ' HG22 ' A' ' 77' ' ' THR . 33.8 p90 -111.83 155.42 23.62 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 118.996 -0.526 . . . . 0.0 109.904 -179.055 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.743 ' HB2' ' HA ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 171.49 -148.18 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 O-C-N 123.407 0.442 . . . . 0.0 111.48 179.651 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -134.99 153.51 52.06 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.157 -177.817 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.47 ' HA ' ' HA ' ' A' ' 74' ' ' ARG . 43.2 ttt85 -88.56 149.55 23.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.128 179.512 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.625 ' HG3' HD12 ' A' ' 48' ' ' LEU . 14.3 pt20 -165.28 177.51 7.54 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.146 -179.033 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -131.62 150.94 19.61 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.8 -0.715 . . . . 0.0 112.45 -179.994 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 9.5 tt -127.77 134.63 65.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 179.736 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.517 ' HA ' ' HD3' ' A' ' 70' ' ' LYS . 2.1 p-10 -76.94 140.27 40.42 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.997 0.427 . . . . 0.0 110.439 -179.178 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.811 HD13 HD11 ' A' ' 19' ' ' LEU . 62.2 mt -105.91 38.69 1.95 Allowed 'General case' 0 CA--C 1.512 -0.513 0 CA-C-O 121.412 0.625 . . . . 0.0 110.873 -178.892 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.536 ' HA ' ' HB3' ' A' ' 2' ' ' SER . 30.2 m-80 -75.19 0.05 17.71 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.794 -179.759 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 14.7 mtp180 -92.05 -7.67 48.09 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.595 179.339 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.424 ' CD1' HD22 ' A' ' 37' ' ' LEU . 28.1 mm -98.5 104.57 16.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.518 0.675 . . . . 0.0 109.747 -179.334 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -106.56 157.36 17.73 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.36 -178.346 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.477 ' HA ' ' O ' ' A' ' 99' ' ' ARG . 20.4 p-10 -113.7 124.64 52.78 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.425 178.073 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 46.8 t -107.71 109.28 27.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 -179.237 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 11.3 m-80 57.79 22.14 8.21 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.937 0.398 . . . . 0.0 111.577 -179.326 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 113.66 -25.36 11.08 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.728 -0.748 . . . . 0.0 113.935 178.47 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.477 ' O ' ' HA ' ' A' ' 95' ' ' ASN . 1.4 ptm180 -86.5 147.76 25.83 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 117.416 0.608 . . . . 0.0 110.666 -178.85 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.6 ' HB3' ' HB2' ' A' ' 35' ' ' LEU . 2.1 tp -92.68 122.92 35.57 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.718 0.294 . . . . 0.0 110.335 -179.366 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 41.7 t -134.12 141.84 42.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.654 -179.869 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.416 ' HB2' HD11 ' A' ' 35' ' ' LEU . 16.9 t80 -78.44 136.39 37.61 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.979 0.419 . . . . 0.0 110.106 179.268 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.087 0 CA-C-O 118.462 -0.78 . . . . 0.0 110.39 179.949 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 70.5 mtm . . . . . 0 N--CA 1.482 1.173 0 CA-C-O 120.842 0.353 . . . . 0.0 110.297 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.582 ' HB3' ' HA ' ' A' ' 91' ' ' ASN . 0.3 OUTLIER -97.93 179.91 4.63 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.729 179.92 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.442 ' CB ' HD11 ' A' ' 100' ' ' LEU . 13.3 p90 -47.03 -36.07 7.49 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 123.09 0.556 . . . . 0.0 112.422 -179.51 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.434 ' HB3' ' HD3' ' A' ' 69' ' ' ARG . . . -54.13 -20.45 6.67 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -178.664 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -64.11 -33.65 76.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.218 0.533 . . . . 0.0 109.867 178.896 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 26.1 m -132.31 41.8 3.18 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.619 179.121 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 22.7 t -154.77 149.24 26.26 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.307 -179.591 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.459 ' HG3' ' ND2' ' A' ' 9' ' ' ASN . 11.6 ptp180 -136.62 175.7 9.37 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.827 -179.474 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.459 ' ND2' ' HG3' ' A' ' 8' ' ' ARG . 4.6 p30 45.58 60.39 3.12 Favored 'General case' 0 N--CA 1.474 0.774 0 O-C-N 124.298 0.999 . . . . 0.0 112.286 -179.233 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.422 ' HA ' ' HB2' ' A' ' 21' ' ' ALA . . . -87.28 117.73 26.23 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.376 179.519 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 33.9 m -115.92 170.64 5.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.821 -179.852 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.582 ' HB3' ' HA2' ' A' ' 16' ' ' GLY . 3.7 mm? -105.18 120.75 42.29 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.592 -179.62 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.437 HG21 ' NE ' ' A' ' 20' ' ' ARG . 17.7 p -119.96 161.42 20.92 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.825 179.542 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 59.8 38.27 21.55 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.14 179.679 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 93.86 -23.34 31.39 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.066 179.896 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.582 ' HA2' ' HB3' ' A' ' 12' ' ' LEU . . . 124.93 11.78 4.23 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.628 -0.796 . . . . 0.0 111.847 -179.939 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.585 ' HB2' ' HB3' ' A' ' 38' ' ' ASP . 16.9 ptt180 -92.46 -23.05 19.27 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.264 0.554 . . . . 0.0 110.067 -179.954 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.463 HG22 ' HB3' ' A' ' 34' ' ' GLU . 4.3 m -105.96 133.48 50.61 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.782 -179.535 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.766 HD11 HD13 ' A' ' 90' ' ' LEU . 59.9 mt -97.47 114.41 26.27 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.419 179.163 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.481 ' HA ' ' HG2' ' A' ' 34' ' ' GLU . 32.9 ttm180 -109.84 120.19 41.7 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 178.813 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.422 ' HB2' ' HA ' ' A' ' 10' ' ' ALA . . . -153.36 166.12 33.63 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.969 0.414 . . . . 0.0 111.455 -179.675 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.714 ' HG3' ' HB3' ' A' ' 30' ' ' TRP . 1.0 OUTLIER -90.29 107.6 19.24 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 177.898 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.43 ' SG ' HD13 ' A' ' 100' ' ' LEU . 71.6 m -98.51 140.65 32.44 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.686 0.279 . . . . 0.0 110.69 -178.701 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.532 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 7.9 ttp180 -83.96 115.83 22.51 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-O 120.949 0.405 . . . . 0.0 110.2 179.412 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.423 HD21 ' HB3' ' A' ' 29' ' ' ASN . 37.0 p30 -76.55 174.2 10.62 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.262 179.919 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.74 -25.29 60.2 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -178.497 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -78.79 -9.81 59.57 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.65 0.738 . . . . 0.0 109.896 179.92 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 85.07 29.3 28.71 Favored Glycine 0 N--CA 1.445 -0.761 0 N-CA-C 110.718 -0.953 . . . . 0.0 110.718 -179.031 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.532 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 8.3 t-20 -111.53 158.45 19.17 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.74 -0.23 . . . . 0.0 110.687 -178.555 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.714 ' HB3' ' HG3' ' A' ' 22' ' ' GLU . 61.4 m95 -92.28 129.29 38.26 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.047 -179.899 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.4 HG22 ' O ' ' A' ' 23' ' ' CYS . 15.6 m -132.9 141.42 44.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.668 179.346 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.2 m -81.7 111.75 18.25 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.228 179.86 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 54.7 m -127.53 150.18 49.81 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.655 179.779 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.667 ' HA ' ' O ' ' A' ' 19' ' ' LEU . 45.1 mt-10 -134.25 148.32 50.81 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.03 -179.611 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.544 HD12 HD23 ' A' ' 37' ' ' LEU . 2.1 tm? -139.25 134.42 32.64 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.55 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.478 ' N ' HD13 ' A' ' 35' ' ' LEU . 29.6 m-20 -91.76 109.69 21.02 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.359 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.544 HD23 HD12 ' A' ' 35' ' ' LEU . 1.4 mt -83.01 -20.62 34.72 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.816 -178.543 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.585 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 4.3 p-10 -61.5 -15.41 37.61 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 111.717 0.266 . . . . 0.0 111.717 -178.423 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 60.0 p -72.48 -22.58 61.04 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.055 0.455 . . . . 0.0 110.716 179.737 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 27.3 m -128.86 0.25 5.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.06 -0.518 . . . . 0.0 112.022 -178.669 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.438 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 53.7 mt -116.57 131.35 69.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 120.636 0.255 . . . . 0.0 110.342 178.861 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.562 ' HA3' ' HB3' ' A' ' 52' ' ' MET . . . -150.38 163.99 29.67 Favored Glycine 0 N--CA 1.445 -0.731 0 N-CA-C 111.328 -0.709 . . . . 0.0 111.328 179.445 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.6 ' ND2' ' HB2' ' A' ' 55' ' ' PHE . 7.3 p30 -161.91 51.08 0.32 Allowed Pre-proline 0 CA--C 1.535 0.386 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 179.813 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -63.5 -26.73 70.08 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 121.847 1.698 . . . . 0.0 111.75 -179.626 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -84.14 -12.59 54.73 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.797 179.898 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.599 ' HA3' ' HD3' ' A' ' 83' ' ' ARG . . . 103.36 7.96 41.92 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.283 -0.96 . . . . 0.0 112.954 -179.344 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.504 ' HA ' HE22 ' A' ' 86' ' ' GLN . 61.7 m-85 -124.88 133.62 53.01 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.003 0.43 . . . . 0.0 110.495 179.676 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.503 ' HB3' ' HB ' ' A' ' 88' ' ' ILE . 84.2 mt -83.09 138.0 33.87 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.498 -0.774 . . . . 0.0 112.251 -177.688 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -177.01 172.81 45.77 Favored Glycine 0 N--CA 1.447 -0.58 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.7 178.802 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.421 ' CD2' ' HD3' ' A' ' 92' ' ' ARG . 94.1 m95 -95.53 128.21 42.21 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.993 0.425 . . . . 0.0 110.321 -179.971 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 151.84 -62.69 0.39 Allowed Glycine 0 N--CA 1.449 -0.441 0 CA-C-N 116.019 -0.537 . . . . 0.0 112.076 -179.877 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.608 ' HA ' ' CE ' ' A' ' 52' ' ' MET . 1.0 OUTLIER -77.02 179.88 5.96 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 179.74 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -133.98 173.8 11.17 Favored 'General case' 0 C--N 1.326 -0.419 0 O-C-N 122.089 -0.382 . . . . 0.0 111.678 -178.982 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 61.74 45.99 7.4 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.642 -0.708 . . . . 0.0 112.33 179.174 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.6 ' HB2' ' ND2' ' A' ' 43' ' ' ASN . 8.5 p90 -65.83 -28.51 69.04 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 111.652 0.241 . . . . 0.0 111.652 -179.371 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 11.4 p -64.45 -28.4 69.65 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.917 0.389 . . . . 0.0 111.553 -179.104 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 50.5 m80 -82.27 -3.43 55.21 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.224 -179.433 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 14.9 m -126.52 13.53 7.57 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.792 179.793 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 63.9 m -135.49 151.94 50.85 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.382 0.61 . . . . 0.0 111.881 -178.891 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -121.55 141.46 51.05 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.404 179.279 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.43 ' O ' ' HA ' ' A' ' 73' ' ' CYS . 31.4 t70 58.78 79.89 0.2 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.509 0.671 . . . . 0.0 111.39 179.704 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.535 HG23 HD21 ' A' ' 71' ' ' LEU . 74.3 mt -95.56 123.27 47.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.076 179.558 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.6 tptm -149.02 160.0 43.71 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 -179.769 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.547 ' HG ' HD21 ' A' ' 12' ' ' LEU . 44.7 mt -88.57 129.44 35.48 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.108 0.48 . . . . 0.0 109.973 178.965 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.415 ' HB3' ' HB3' ' A' ' 70' ' ' LYS . 34.1 tp10 -77.52 -69.47 0.53 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.264 -178.398 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.57 ' HB2' ' HB2' ' A' ' 69' ' ' ARG . 26.1 mt-10 -81.94 29.31 0.4 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.285 -179.284 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 68.11 14.64 66.36 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.903 -0.59 . . . . 0.0 113.282 179.757 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 145.98 -25.84 1.76 Allowed Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 119.591 -1.29 . . . . 0.0 113.373 179.361 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.57 ' HB2' ' HB2' ' A' ' 66' ' ' GLU . 9.6 mmt85 -76.19 -23.37 54.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.283 0.563 . . . . 0.0 110.431 -179.289 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.415 ' HB3' ' HB3' ' A' ' 65' ' ' GLU . 39.9 ttmt -146.02 148.73 33.0 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.801 -177.883 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.716 ' HB2' HD11 ' A' ' 90' ' ' LEU . 9.8 tt -115.94 125.66 52.86 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 179.332 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.1 p -113.72 128.35 56.39 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.346 0.594 . . . . 0.0 111.241 179.43 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . 0.43 ' HA ' ' O ' ' A' ' 61' ' ' ASP . 25.6 p -149.88 171.32 16.97 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.659 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.56 ' HA ' ' HA ' ' A' ' 85' ' ' ARG . 4.1 tmt_? -104.37 98.31 14.02 Favored Pre-proline 0 C--N 1.315 -0.896 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 179.267 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.591 ' O ' ' HB3' ' A' ' 83' ' ' ARG . 64.9 Cg_endo -72.62 125.02 10.23 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 123.002 2.468 . . . . 0.0 111.506 179.79 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.718 ' HA ' ' HB2' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -121.82 139.92 53.02 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.867 179.819 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.721 HG22 ' O ' ' A' ' 82' ' ' PHE . 11.6 t -74.77 131.54 40.89 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 178.499 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.1 m -74.18 -2.22 3.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.488 -179.256 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -68.83 -33.71 74.28 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.185 0.517 . . . . 0.0 109.738 179.309 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -148.56 -23.96 0.08 OUTLIER Glycine 0 N--CA 1.449 -0.436 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.591 179.796 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.527 ' HA2' ' HE2' ' A' ' 76' ' ' LYS . . . 101.58 19.03 16.83 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.021 -179.793 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.721 ' O ' HG22 ' A' ' 77' ' ' THR . 26.3 p90 -110.71 151.05 28.19 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 118.821 -0.609 . . . . 0.0 109.993 -178.885 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.718 ' HB2' ' HA ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER 167.49 -153.95 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.572 0 O-C-N 123.729 0.643 . . . . 0.0 111.213 179.236 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -135.55 167.41 21.14 Favored 'General case' 0 C--O 1.226 -0.17 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.051 -178.842 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.56 ' HA ' ' HA ' ' A' ' 74' ' ' ARG . 44.5 ttt180 -81.75 156.25 25.07 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 178.407 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.61 ' HG2' ' H ' ' A' ' 87' ' ' GLY . 7.1 tt0 -161.04 -176.07 5.27 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.41 -0.516 . . . . 0.0 111.401 -178.161 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.61 ' H ' ' HG2' ' A' ' 86' ' ' GLN . . . -151.89 141.36 8.47 Favored Glycine 0 N--CA 1.449 -0.49 0 N-CA-C 111.778 -0.529 . . . . 0.0 111.778 179.379 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.503 ' HB ' ' HB3' ' A' ' 48' ' ' LEU . 10.4 tt -120.58 133.48 67.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.303 0.573 . . . . 0.0 110.77 -179.46 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.515 ' OD1' ' HB2' ' A' ' 91' ' ' ASN . 13.6 t70 -73.25 136.34 44.61 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.632 -179.868 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.766 HD13 HD11 ' A' ' 19' ' ' LEU . 63.8 mt -109.55 37.41 2.63 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -178.341 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.582 ' HA ' ' HB3' ' A' ' 2' ' ' SER . 7.1 m-80 -75.05 2.59 10.23 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 121.368 0.604 . . . . 0.0 111.221 179.231 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.421 ' HD3' ' CD2' ' A' ' 50' ' ' TRP . 24.7 mtp180 -92.29 -12.49 32.37 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.243 179.104 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.471 HG13 HD22 ' A' ' 37' ' ' LEU . 24.6 mm -94.94 103.47 14.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 121.453 0.644 . . . . 0.0 109.563 -179.622 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 3.9 mm-40 -112.25 152.08 28.88 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.714 -178.368 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 18.3 p-10 -105.27 126.02 51.63 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.742 178.564 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 40.5 t -115.72 116.47 52.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 -179.562 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 54.4 25.39 6.0 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.601 -179.841 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 109.13 -27.45 12.72 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.806 -0.712 . . . . 0.0 114.004 179.155 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -86.8 146.19 26.33 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 117.687 0.744 . . . . 0.0 111.53 -178.48 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.523 ' HB3' ' HB2' ' A' ' 35' ' ' LEU . 5.2 tp -92.14 121.52 33.76 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.906 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 24.1 t -129.73 140.88 47.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 120.804 0.335 . . . . 0.0 110.935 -178.821 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.432 ' HB2' HD11 ' A' ' 35' ' ' LEU . 20.7 t80 -79.21 130.73 35.77 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 178.475 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 . . . . . 0 C--N 1.312 -1.064 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.673 -179.57 . . . . . . . . 0 0 . 1 stop_ save_